PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Beyer, K; Poetschke, C; Partecke, LI; von Bernstorff, W; Maier, S; Broeker, BM; Heidecke, CD				Beyer, Katharina; Poetschke, Christian; Partecke, Lars Ivo; von Bernstorff, Wolfram; Maier, Stefan; Broeker, Barbara M.; Heidecke, Claus-Dieter			TRAIL Induces Neutrophil Apoptosis and Dampens Sepsis-Induced Organ Injury in Murine Colon Ascendens Stent Peritonitis	PLOS ONE			English	Article							ANIMAL-MODELS; MODULATION; PREVENTION; RESPONSES; SURVIVAL; CELLS	TNF-related apoptosis inducing ligand (TRAIL) influences several inflammatory reactions by partially still unknown mechanisms. TRAIL is produced and expressed by several cells of the immune system. Murine Colon Ascendens Stent Peritonitis (CASP) represents a hyperinflammatory model of diffuse peritonitis. As we have shown previously, TRAIL strongly improves survival in murine CASP. This is accompanied by a significantly reduced infiltration of neutrophils in the associated lymphoid tissue. Additionally, it is known that TRAIL induces apoptosis in neutrophils and acceleration of neutrophil apoptosis enhances resolution of inflammatory reactions. In this study, we investigated the correlation of the protective effect of TRAIL in sepsis and its influence on neutrophils. We found that neutrophils infiltrating the lymphoid organs express the TRAIL-receptor DR5 at high density. Furthermore, we demonstrated that TRAIL-treatment enhances apoptosis of neutrophils in the spleen, lung and liver and decreases organ injury during sepsis. To further examine a role for neutrophils in TRAIL-mediated protection in CASP, we have depleted neutrophils 24 hours prior to CASP. In these depleted mice, administration of TRAIL was ineffective. We conclude that TRAIL induces apoptosis in tissue-infiltrating neutrophils thereby protecting organs from sepsis-induced injury.	[Beyer, Katharina; Poetschke, Christian; Partecke, Lars Ivo; von Bernstorff, Wolfram; Maier, Stefan; Broeker, Barbara M.; Heidecke, Claus-Dieter] Univ Med Greifswald, Klin Allgemein Viszeral Thorax & Gefasschirurg, Greifswald, Germany; [Poetschke, Christian; Broeker, Barbara M.] Univ Med Greifswald, Immunol Abt, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School	Beyer, K (corresponding author), Univ Med Greifswald, Klin Allgemein Viszeral Thorax & Gefasschirurg, Greifswald, Germany.	cziupka@uni-greifswald.de	Maier, Stefan/V-2883-2019	Maier, Stefan/0000-0001-9704-7902				Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045; Barrera G, 2011, INFECT IMMUN, V79, P1280, DOI 10.1128/IAI.01127-10; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Collison A, 2009, CLIN EXP PHARMACOL P, V36, P1049, DOI 10.1111/j.1440-1681.2009.05258.x; Cziupka K, 2010, CRIT CARE MED; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; McGrath EE, 2011, J LEUKOCYTE BIOL, V90, P855, DOI 10.1189/jlb.0211062; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Sarangi PP, 2012, SHOCK, V38, P281, DOI 10.1097/SHK.0b013e31826136f8; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Wu Z, 2011, INFECT IMMUN, V79, P2865, DOI 10.1128/IAI.01317-10; Xiao H, 2011, J CLIN IMMUNOL, V31, P1112, DOI 10.1007/s10875-011-9559-x; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97451	10.1371/journal.pone.0097451	http://dx.doi.org/10.1371/journal.pone.0097451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887152	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300018
J	Shi, JH; Li, J; Guan, H; Cai, WX; Bai, XZ; Fang, XB; Hu, XL; Wang, YJ; Wang, HT; Zheng, Z; Su, LL; Hu, DH; Zhu, XX				Shi, Jihong; Li, Jun; Guan, Hao; Cai, Weixia; Bai, Xiaozhi; Fang, Xiaobing; Hu, Xiaolong; Wang, Yaojun; Wang, Hongtao; Zheng, Zhao; Su, Linlin; Hu, Dahai; Zhu, Xiongxiang			Anti-Fibrotic Actions of Interleukin-10 against Hypertrophic Scarring by Activation of PI3K/AKT and STAT3 Signaling Pathways in Scar-Forming Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; I COLLAGEN; TGF-BETA; KELOIDS; IL-10; MODEL; MICE	Background: The hypertrophic scar (HS) is a serious fibrotic skin condition and a major clinical problem. Interleukin-10 (IL-10) has been identified as a prospective scar-improving compound based on preclinical trials. Our previous work showed that IL-10 has anti-fibrotic effects in transforming growth factor (TGF)-beta 1-stimulated fibroblasts, as well as potential therapeutic benefits for the prevention and reduction of scar formation. However, relatively little is known about the mechanisms underlying IL-10-mediated anti-fibrotic and scar-improvement actions. Objective: To explore the expression of the IL-10 receptor in human HS tissue and primary HS fibroblasts (HSFs), and the molecular mechanisms contributing to the anti-fibrotic and scar-improvement capabilities of IL-10. Methods: Expression of the IL-10 receptor was assessed in HS tissue and HSFs by immunohistochemistry, immunofluorescence microscopy, and polymerase chain reaction analysis. Primary HSFs were treated with IL-10, a specific phosphatidylinositol 3 kinase (PI3K) inhibitor (LY294002) or a function-blocking antibody against the IL-10 receptor (IL-10RB). Next, Western blot analysis was used to evaluate changes in the phosphorylation status of AKT and signal transducers and activators of transcription (STAT) 3, as well as the expression levels of fibrosis-related proteins. Results: HS tissue and primary HSFs were characterized by expression of the IL-10 receptor and by high expression of fibrotic markers relative to normal controls. Primary HSFs expressed the IL-10 receptor, while IL-10 induced AKT and STAT3 phosphorylation in these cells. In addition, LY294002 blocked AKT and STAT phosphorylation, and also up-regulated expression levels of type I and type III collagen (Col 1 and Col 3) and alpha-smooth muscle actin (alpha-SMA) in IL-10-treated cells. Similarly, IL-10RB reduced STAT3/AKT phosphorylation and blocked the IL-10-mediated mitigation of fibrosis in HSFs. Conclusion: IL-10 apparently inhibits fibrosis by activating AKT and STAT3 phosphorylation downstream of the IL-10 receptor, and by facilitating crosstalk between the PI3K/AKT and STAT3 signal transduction pathways.	[Shi, Jihong; Li, Jun; Guan, Hao; Cai, Weixia; Bai, Xiaozhi; Fang, Xiaobing; Hu, Xiaolong; Wang, Yaojun; Wang, Hongtao; Zheng, Zhao; Su, Linlin; Hu, Dahai; Zhu, Xiongxiang] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Peoples R China	Air Force Military Medical University	Hu, DH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Peoples R China.	biojhshi@126.com; zhuxiang@fmmu.edu.cn		/0000-0002-3640-6729; Li, Jun/0000-0001-8702-8054	National Natural Science Foundation of China [81272098, 81171811]; Xijing Hospital [XJZT12D01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xijing Hospital	The work was supported by the National Natural Science Foundation of China (Grant Number: 81272098, 81171811) and the Grant-in-Aid for scientific research from Xijing Hospital assist in 2012 (XJZT12D01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Arai T, 2000, AM J PHYSIOL-LUNG C, V278, pL914, DOI 10.1152/ajplung.2000.278.5.L914; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Campaner AB, 2006, J INVEST DERMATOL, V126, P1168, DOI 10.1038/sj.jid.5700200; Diao JS, 2011, ARCH DERMATOL RES, V303, P573, DOI 10.1007/s00403-011-1140-1; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hsu YC, 2010, ARCH DERMATOL RES, V302, P717, DOI 10.1007/s00403-010-1075-y; Hu XL, 2013, ARCH DERMATOL RES, V305, P433, DOI 10.1007/s00403-013-1334-9; Kircik LH, 2013, J DRUGS DERMATOL, V12, P86; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Mrowietz U, 2009, ACTAS DERMO-SIFILOGR, V100, P75, DOI 10.1016/S0001-7310(09)73382-4; Nakagome K, 2006, THORAX, V61, P886, DOI 10.1136/thx.2005.056317; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Occleston NL, 2008, DRUG DISCOV TODAY, V13, P973, DOI 10.1016/j.drudis.2008.08.009; Ong CT, 2007, EXP DERMATOL, V16, P394, DOI 10.1111/j.1600-0625.2007.00550.x; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saito M, 2012, ARCH DERMATOL RES, V304, P217, DOI 10.1007/s00403-011-1184-2; Seifert O, 2009, ARCH DERMATOL RES, V301, P259, DOI 10.1007/s00403-009-0952-8; Shi JH, 2013, ARCH DERMATOL RES, V305, P341, DOI 10.1007/s00403-013-1314-0; Shi JH, 2012, ARCH DERMATOL RES, V304, P209, DOI 10.1007/s00403-012-1204-x; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tang B, 2011, ARCH DERMATOL RES, V303, P563, DOI 10.1007/s00403-010-1114-8; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Weiss E, 2004, J AM ACAD DERMATOL, V50, P657, DOI 10.1016/j.jaad.2003.11.075; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Yamamoto T, 2001, BIOCHEM BIOPH RES CO, V281, P200, DOI 10.1006/bbrc.2001.4321; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031157; Zhang ZF, 2011, BURNS, V37, P665, DOI 10.1016/j.burns.2010.12.001	43	72	75	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98228	10.1371/journal.pone.0098228	http://dx.doi.org/10.1371/journal.pone.0098228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878845	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500040
J	Haberle, SG; Bowman, DMJS; Newnham, RM; Johnston, FH; Beggs, PJ; Buters, J; Campbell, B; Erbas, B; Godwin, I; Green, BJ; Huete, A; Jaggard, AK; Medek, D; Murray, F; Newbigin, E; Thibaudon, M; Vicendese, D; Williamson, GJ; Davies, JM				Haberle, Simon G.; Bowman, David M. J. S.; Newnham, Rewi M.; Johnston, Fay H.; Beggs, Paul J.; Buters, Jeroen; Campbell, Bradley; Erbas, Bircan; Godwin, Ian; Green, Brett J.; Huete, Alfredo; Jaggard, Alison K.; Medek, Danielle; Murray, Frank; Newbigin, Ed; Thibaudon, Michel; Vicendese, Don; Williamson, Grant J.; Davies, Janet M.			The Macroecology of Airborne Pollen in Australian and New Zealand Urban Areas	PLOS ONE			English	Article							BIRCH POLLEN; GRASS-POLLEN; SEASONAL DISTRIBUTION; EASTERN AUSTRALIA; CLIMATE-CHANGE; BETULA POLLEN; ATMOSPHERE; SOUTH; ALLERGENS; AEROALLERGENS	The composition and relative abundance of airborne pollen in urban areas of Australia and New Zealand are strongly influenced by geographical location, climate and land use. There is mounting evidence that the diversity and quality of airborne pollen is substantially modified by climate change and land-use yet there are insufficient data to project the future nature of these changes. Our study highlights the need for long-term aerobiological monitoring in Australian and New Zealand urban areas in a systematic, standardised, and sustained way, and provides a framework for targeting the most clinically significant taxa in terms of abundance, allergenic effects and public health burden.	[Haberle, Simon G.] Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia; [Bowman, David M. J. S.; Williamson, Grant J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Newnham, Rewi M.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Johnston, Fay H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Beggs, Paul J.; Jaggard, Alison K.] Macquarie Univ, Fac Sci, Dept Geog & Environm, Sydney, NSW 2109, Australia; [Buters, Jeroen] Tech Univ Munich, Ctr Allergy & Environm, D-80290 Munich, Germany; [Campbell, Bradley; Godwin, Ian] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Erbas, Bircan; Vicendese, Don] La Trobe Univ, Sch Publ Hlth & Human Biosci, Bundoora, Vic, Australia; [Green, Brett J.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Huete, Alfredo] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Medek, Danielle] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Murray, Frank] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia; [Newbigin, Ed] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Thibaudon, Michel] European Aerobiol Soc, Reseau Natl Surveillance Aerobiol, Lyon, Rhone Alpes, France; [Davies, Janet M.] Univ Queensland, Sch Med, Lung & Allergy Res Ctr, Woolloongabba, Qld, Australia; [Davies, Janet M.] Univ Queensland, Translat Res Inst, Woolloongabba, Qld, Australia	Australian National University; University of Tasmania; Victoria University Wellington; University of Tasmania; Macquarie University; Technical University of Munich; University of Queensland; La Trobe University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Technology Sydney; Australian National University; Murdoch University; University of Melbourne; University of Queensland; University of Queensland	Haberle, SG (corresponding author), Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia.	simon.haberle@anu.edu.au	Campbell, Bradley C./AAV-7020-2020; Bowman, David M.J.S./A-2930-2011; Huete, Alfredo R/C-1294-2008; Haberle, Simon/U-4118-2019; BUTERS, JEROEN/AAF-6949-2020; Buters, Jeroen T/G-5070-2011; Williamson, Grant/J-7514-2014; Davies, Janet/C-7989-2009	Campbell, Bradley C./0000-0003-0815-930X; Bowman, David M.J.S./0000-0001-8075-124X; Huete, Alfredo R/0000-0003-2809-2376; Williamson, Grant/0000-0002-3469-7550; Davies, Janet/0000-0002-6378-4119; Beggs, Paul/0000-0001-9949-1783; Vicendese, Don/0000-0002-0176-0314; Godwin, Ian/0000-0002-4006-4426; Buters, Jeroen/0000-0003-3581-5472; Johnston, Fay Helena/0000-0002-5150-8678; Haberle, Simon/0000-0001-5802-6535; Newbigin, Ed/0000-0002-9644-302X	Australian Centre for Ecological Analysis and Synthesis (ACEAS)	Australian Centre for Ecological Analysis and Synthesis (ACEAS)	Funding support for the Working Group came from the Australian Centre for Ecological Analysis and Synthesis (ACEAS). Terrestrial Ecosystem Research Network ( TERN). Merck Sharp and Dohme provided additional independent untied co-sponsorship for the Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Economics PL, 2007, EC IMP ALL DIS AUSTR; Altintas Derya Ufuk, 2004, Clin Dev Immunol, V11, P87, DOI 10.1080/10446670410001670544; Baldo BA, 1984, MED J AUSTRALIA, V141, pS12; Bass D, 1997, GRANA, V36, P293, DOI 10.1080/00173139709362620; Bass DJ, 2000, ANN ALLERG ASTHMA IM, V85, P374, DOI 10.1016/S1081-1206(10)62549-5; Bass DJ, 2000, AEROBIOLOGIA, V16, P107, DOI DOI 10.1023/A:1007696112953; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Burbach GJ, 2009, ALLERGY, V64, P1507, DOI 10.1111/j.1398-9995.2009.02089.x; Buters JTM, 2012, ATMOS ENVIRON, V55, P496, DOI 10.1016/j.atmosenv.2012.01.054; Chapman JA, 1982, IMMUNOL ALLERGY PRAC, V4, P13; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comtois P., 1999, Aerobiologia, V15, P19, DOI 10.1023/A:1007501017470; Comtois P, 1997, AEROBIOLOGIA, V13, P149, DOI DOI 10.1007/BF02694501; Cuneo Peter, 2006, Cunninghamia, V9, P545; D'Amato G, 2002, ALLERGY, V57, P35, DOI 10.1034/j.1398-9995.2002.057s71035.x; Davies Janet Mary, 2012, Clin Transl Allergy, V2, P4, DOI 10.1186/2045-7022-2-4; DCosta D, 1997, AUST J BOT, V45, P583, DOI 10.1071/BT96046; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Emberlin J, 1999, CLIN EXP ALLERGY, V29, P347, DOI 10.1046/j.1365-2222.1999.00369.x; Fletcher MS, 2007, REV PALAEOBOT PALYNO, V146, P146, DOI 10.1016/j.revpalbo.2007.03.002; Giri C, 2005, REMOTE SENS ENVIRON, V94, P123, DOI 10.1016/j.rse.2004.09.005; Green BJ, 2002, GRANA, V41, P242, DOI 10.1080/001731302321012031; Green Brett James, 2004, Aerobiologia, V20, P43, DOI 10.1023/B:AERO.0000022983.13951.e8; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Group European Aerobiology Society Quality Control Working, 2011, INT AEROBIOLOGY NEWS, V72, P1; Hanigan IC, 2007, CLIN EXP ALLERGY, V37, P1556, DOI 10.1111/j.1365-2222.2007.02800.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; Hjelmroos M, 1999, AIRBORNE ALLERGENS I; HOWLETT BJ, 1982, CLIN ALLERGY, V12, P259, DOI 10.1111/j.1365-2222.1982.tb02526.x; Hutchinson MF, 2005, GLOBAL ECOL BIOGEOGR, V14, P197, DOI [10.1111/j.1466-822X.2005.00154.x, 10.1111/j.1466-822x.2005.00154.x]; Jato V, 2006, AEROBIOLOGIA, V22, P13, DOI 10.1007/s10453-005-9011-x; Johnston FH, 2009, ECOHEALTH, V6, P99, DOI 10.1007/s10393-009-0225-1; Knox RB, 1979, POLLEN ALLERGY; Lacey ME., 2006, AIR SPORA MANUAL CAT; LAZARIDES M, 1991, Australian Systematic Botany, V4, P591, DOI 10.1071/SB9910591; Liam CK, 2002, RESPIROLOGY, V7, P345, DOI 10.1046/j.1440-1843.2002.00409.x; Medek DE, 2012, ECOHEALTH, V9, P440, DOI 10.1007/s10393-012-0787-1; Newnham RM, 2013, INT J BIOMETEOROL, V57, P391, DOI 10.1007/s00484-012-0563-5; Newnham R.M, 1995, AEROBIOLOGIA, V11, P239; NEWNHAM RM, 1999, AEROBIOLOGIA, V15, P87, DOI DOI 10.1023/A:1007595615115; NILSSON S, 1981, Grana, V20, P179, DOI 10.1080/00173138109427661; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ong E. K., 1995, Aerobiologia, V11, P51, DOI 10.1007/BF02136145; ONG EK, 1995, GRANA, V34, P58, DOI 10.1080/00173139509429034; Patel NJ, 2000, IMMUNOL ALLERGY CLIN, V20, P323, DOI 10.1016/S0889-8561(05)70151-X; Rodriguez-Rajo FJ, 2003, INT J BIOMETEOROL, V47, P117, DOI 10.1007/s00484-002-0153-z; Rutherford S, 2001, AIR POLLUTION ASTHMA; Schappi GF, 1998, AEROBIOLOGIA, V14, P29, DOI DOI 10.1007/BF02694592; Smith M, 2009, AEROBIOLOGIA, V25, P321, DOI 10.1007/s10453-009-9136-4; Sofiev M, 2013, INT J BIOMETEOROL, V57, P45, DOI 10.1007/s00484-012-0532-z; Spangler RE, 2003, AUST SYST BOT, V16, P279, DOI 10.1071/SB01006; SPIEKSMA FTM, 1995, GRANA, V34, P51, DOI 10.1080/00173139509429033; Sritipsukho P, 2004, ASIAN PAC J ALLERGY, V22, P91; Stevenson J, 2007, GRANA, V46, P34, DOI 10.1080/00173130601178250; SWEENEY M, 1994, INT ARCH ALLERGY IMM, V105, P289, DOI 10.1159/000236771; Tng DYP, 2010, AUST J BOT, V58, P440, DOI 10.1071/BT10095; White JF, 2003, ANN ALLERG ASTHMA IM, V91, P425, DOI 10.1016/S1081-1206(10)61509-8; Wilmshurst JM, 2005, REV PALAEOBOT PALYNO, V136, P1, DOI 10.1016/j.revpalbo.2005.03.007; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	63	47	49	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97925	10.1371/journal.pone.0097925	http://dx.doi.org/10.1371/journal.pone.0097925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874807	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800015
J	Palmer, GD; Attur, MG; Yang, Q; Liu, J; Moon, P; Beier, F; Abramson, SB				Palmer, Glyn D.; Attur, Mukundan G.; Yang, Qing; Liu, James; Moon, Paxton; Beier, Frank; Abramson, Steven B.			F-Spondin Deficient Mice Have a High Bone Mass Phenotype	PLOS ONE			English	Article							TGF-BETA; ACID-PHOSPHATASE; GENE-EXPRESSION; DIFFERENTIATION; PROTEIN; MATURATION; DIFFER; CELLS	F-spondin is a pericellular matrix protein upregulated in developing growth plate cartilage and articular cartilage during osteoarthritis. To address its function in bone and cartilage in vivo, we generated mice that were deficient for the F-spondin gene, Spon1. Spon1(-/-) mice were viable and developed normally to adulthood with no major skeletal abnormalities. At 6 months, femurs and tibiae of Spon1(-/-) mice exhibited increased bone mass, evidenced by histological staining and micro CT analyses, which persisted up to 12 months. In contrast, no major abnormalities were observed in articular cartilage at any age group. Immunohistochemical staining of femurs and tibiae revealed increased levels of periostin, alkaline phosphate and tartrate resistant acid phosphatase (TRAP) activity in the growth plate region of Spon1(-/-) mice, suggesting elevated bone synthesis and turnover. However, there were no differences in serum levels of TRAP, the bone resorption marker, CTX-1, or osteoclast differentiation potential between genotypes. Knockout mice also exhibited reduced levels of TGF-beta 1 in serum and cultured costal chondrocytes relative to wild type. This was accompanied by increased levels of the BMP-regulatory SMADs, P-SMAD1/5 in tibiae and chondrocytes. Our findings indicate a previously unrecognized role for Spon1 as a negative regulator of bone mass. We speculate that Spon1 deletion leads to a local and systemic reduction of TGF-beta levels resulting in increased BMP signaling and increased bone deposition in adult mice.	[Palmer, Glyn D.; Attur, Mukundan G.; Yang, Qing; Liu, James; Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY USA; [Palmer, Glyn D.; Attur, Mukundan G.; Yang, Qing; Liu, James; Abramson, Steven B.] NYU, Hosp Joint Dis, New York, NY USA; [Moon, Paxton; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Western University (University of Western Ontario)	Palmer, GD (corresponding author), Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL 32611 USA.	palmegd@ortho.ufl.edu	Beier, Frank/G-4595-2013; Beier, Frank/T-4734-2019; Attur, Mukundan/O-1578-2019	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537; Attur, Mukundan/0000-0001-7080-8118; Abramson, Steven/0000-0002-0668-6344	National Institute of Health [AR054817]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054817] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for the project was provided by National Institute of Health grant AR054817 (SBA), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; Ehnert S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-101; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Ferguson CM, 2000, ENDOCRINOLOGY, V141, P4728, DOI 10.1210/en.141.12.4728; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; Kitagawa M, 2012, BIOCHEM BIOPH RES CO, V418, P229, DOI 10.1016/j.bbrc.2011.12.155; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LIU CC, 1987, J HISTOCHEM CYTOCHEM, V35, P1355, DOI 10.1177/35.12.3680930; Matsumoto Y, 2012, MOL CELL ENDOCRINOL, V350, P78, DOI 10.1016/j.mce.2011.11.023; Miyamoto K, 2001, ARCH BIOCHEM BIOPHYS, V390, P93, DOI 10.1006/abbi.2001.2367; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Oka H, 2011, J PERIODONTOL, V82, P1776, DOI 10.1902/jop.2011.110111; Palmer GD, 2010, J ORTHOP RES, V28, P1323, DOI 10.1002/jor.21130; Peterziel H, 2011, MOL CELL NEUROSCI, V46, P483, DOI 10.1016/j.mcn.2010.12.001; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tzarfati-Majar V, 2001, P NATL ACAD SCI USA, V98, P4722, DOI 10.1073/pnas.081062398; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Xiao Y, 2007, BONE, V40, P700, DOI 10.1016/j.bone.2006.10.021; Zuscik MJ, 2004, J CELL BIOCHEM, V92, P316, DOI 10.1002/jcb.20050	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98388	10.1371/journal.pone.0098388	http://dx.doi.org/10.1371/journal.pone.0098388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875054	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800038
J	Nekohashi, M; Ogawa, M; Ogihara, T; Nakazawa, K; Kato, H; Misaka, T; Abe, K; Kobayashi, S				Nekohashi, Mari; Ogawa, Mana; Ogihara, Takuo; Nakazawa, Kyoko; Kato, Hisanori; Misaka, Takumi; Abe, Keiko; Kobayashi, Shoko			Luteolin and Quercetin Affect the Cholesterol Absorption Mediated by Epithelial Cholesterol Transporter Niemann-Pick C1-Like 1 in Caco-2 Cells and Rats	PLOS ONE			English	Article							DECREASE MICELLAR SOLUBILITY; INTESTINAL-ABSORPTION; NPC1L1 PROTEIN; EZETIMIBE; BIOAVAILABILITY; POLYPHENOLS; INHIBITOR; FIBER	Niemann-Pick C1-Like 1 (NPC1L1) mediates cholesterol absorption, and ezetimibe is a potent NPC1L1 inhibitor applicable for medication of hypercholesterolemia. Epidemiological studies demonstrated that consumption of polyphenols correlates with a decreased risk for atherosclerosis due to their antioxidant effect. This activity can hardly be attributable to the antioxidant activity only, and we hypothesized that polyphenols inhibit intestinal transport of cholesterol. We elucidated the kinetic parameters of intestinal cholesterol absorption, screened several polyphenols for their ability to specifically inhibit intestinal cholesterol absorption, and determined the inhibitory effects of selected flavonoids in vitro and in vivo. The concentration-dependent uptake of cholesterol by Caco-2 cells obeyed a monophasic saturation process. This indicates the involvement of an active-passive transport, i.e., NPC1L1. Parameters of cholesterol uptake by Caco-2 cells were as follows: J(max), K-t, and K-d were 6.89 +/- 2.96 19.03 +/- 11.58 mu M, and 0.11 +/- 0.02 pmol/min/mg protein, respectively. Luteolin and quercetin inhibited cholesterol absorption by Caco-2 cells and human embryonic kidney 293T cells expressing NPC1L1. When preincubated Caco-2 cells with luteolin and quercetin before the assay, cholesterol uptake significantly decreased. The inhibitory effects of these flavonoids were maintained for up to 120 min. The level of inhibition and irreversible effects were similar to that of ezetimibe. Serum cholesterol levels significantly decreased more in rats fed both cholesterol and luteolin (or quercetin), than in those observed in the cholesterol feeding group. As quercetin induced a significant decrease in the levels of NPC1L1 mRNA in Caco-2 cells, the in vivo inhibitory effect may be due to the expression of NPC1L1. These results suggest that luteolin and quercetin reduce high blood cholesterol levels by specifically inhibiting intestinal cholesterol absorption mediated by NPC1L1.	[Nekohashi, Mari; Ogawa, Mana; Kobayashi, Shoko] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan; [Ogihara, Takuo] Takasaki Univ Hlth & Welf, Fac Pharm, Takasaki, Gunma, Japan; [Nakazawa, Kyoko; Kato, Hisanori] Univ Tokyo, Org Interdisciplinary Res Projects, Corp Sponsored Res Program Food Life, Tokyo, Japan; [Kato, Hisanori; Misaka, Takumi; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Abe, Keiko] Kanagawa Acad Sci & Technol, Life Sci & Environm Res Ctr 4F C4, Kawasaki, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kanagawa Academy Science & Technology	Kobayashi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan.	ashoko@mail.ecc.u-tokyo.ac.jp		Misaka, Takumi/0000-0002-9547-5767	Japan Society for the Promotion of Science [22700761]; Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, a Grant-Aid for C (22700761). This work was supported in part by Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Annaba F, 2010, AM J PHYSIOL-GASTR L, V298, pG467, DOI 10.1152/ajpgi.00360.2009; Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Devroey D, 2014, INT J CLIN PRACT, V68, P180, DOI 10.1111/ijcp.12315; Feng D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-40; Gadgil MD, 2014, J ACAD NUTR DIET, V114, P238, DOI 10.1016/j.jand.2013.09.021; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Guerra-Araiza C, 2013, FREE RADICAL RES, V47, P451, DOI 10.3109/10715762.2013.795649; IKEDA I, 1992, BIOCHIM BIOPHYS ACTA, V1127, P141, DOI 10.1016/0005-2760(92)90269-2; Ikeda I, 2010, J AGR FOOD CHEM, V58, P8591, DOI 10.1021/jf1015285; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Iwayanagi Y, 2011, PHARM RES-DORDR, V28, P405, DOI 10.1007/s11095-010-0294-4; Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233; Li PS, 2014, NAT MED, V20, P80, DOI 10.1038/nm.3417; Miura S, 2008, INTERNAL MED, V47, P1165, DOI 10.2169/internalmedicine.47.1099; Opie LH, 2007, EUR HEART J, V28, P1683, DOI 10.1093/eurheartj/ehm149; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Schneeman BO, 1999, J NUTR, V129, p1424S, DOI 10.1093/jn/129.7.1424S; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Wyman M, 2010, CLEV CLIN J MED, V77, P435, DOI 10.3949/ccjm.77a.09078; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Zern TL, 2005, J NUTR, V135, P2291, DOI 10.1093/jn/135.10.2291; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	27	60	64	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97901	10.1371/journal.pone.0097901	http://dx.doi.org/10.1371/journal.pone.0097901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859282	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400031
J	Catone, MV; Ruiz, JA; Castellanos, M; Segura, D; Espin, G; Lopez, NI				Catone, Mariela V.; Ruiz, Jimena A.; Castellanos, Mildred; Segura, Daniel; Espin, Guadalupe; Lopez, Nancy I.			High Polyhydroxybutyrate Production in Pseudomonas extremaustralis Is Associated with Differential Expression of Horizontally Acquired and Core Genome Polyhydroxyalkanoate Synthase Genes	PLOS ONE			English	Article							CHAIN-LENGTH POLYHYDROXYALKANOATES; GRANULE-ASSOCIATED PROTEIN; POLY-BETA-HYDROXYBUTYRATE; PUTIDA KT2442; ANTARCTIC BACTERIUM; RALSTONIA-EUTROPHA; ESCHERICHIA-COLI; PHA GENES; POLY(3-HYDROXYBUTYRATE); IDENTIFICATION	Pseudomonas extremaustralis produces mainly polyhydroxybutyrate (PHB), a short chain length polyhydroxyalkanoate (sclPHA) infrequently found in Pseudomonas species. Previous studies with this strain demonstrated that PHB genes are located in a genomic island. In this work, the analysis of the genome of P. extremaustralis revealed the presence of another PHB cluster phbFPX, with high similarity to genes belonging to Burkholderiales, and also a cluster, phaC1ZC2D, coding for medium chain length PHA production (mclPHA). All mclPHA genes showed high similarity to genes from Pseudomonas species and interestingly, this cluster also showed a natural insertion of seven ORFs not related to mclPHA metabolism. Besides PHB, P. extremaustralis is able to produce mclPHA although in minor amounts. Complementation analysis demonstrated that both mclPHA synthases, PhaC1 and PhaC2, were functional. RT-qPCR analysis showed different levels of expression for the PHB synthase, phbC, and the mclPHA synthases. The expression level of phbC, was significantly higher than the obtained for phaC1 and phaC2, in late exponential phase cultures. The analysis of the proteins bound to the PHA granules showed the presence of PhbC and PhaC1, whilst PhaC2 could not be detected. In addition, two phasin like proteins (PhbP and PhaI) associated with the production of scl and mcl PHAs, respectively, were detected. The results of this work show the high efficiency of a foreign gene (phbC) in comparison with the mclPHA core genome genes (phaC1 and phaC2) indicating that the ability of P. extremaustralis to produce high amounts of PHB could be explained by the different expression levels of the genes encoding the scl and mcl PHA synthases.	[Catone, Mariela V.; Ruiz, Jimena A.; Lopez, Nancy I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Ruiz, Jimena A.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biociencias Agr & Ambientales, RA-1033 Buenos Aires, DF, Argentina; [Castellanos, Mildred; Segura, Daniel; Espin, Guadalupe] Univ Nacl Autonoma Mexico, Dept Mol Microbiol, Inst Biol, Cuernavaca 62191, Morelos, Mexico; [Lopez, Nancy I.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional Autonoma de Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lopez, NI (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar		Lopez, Nancy/0000-0002-2966-3014	Universidad de Buenos Aires (UBACyT) [20020100100854]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP) [0338]; Agencia Nacional de Promocion Cientifica (ANPCyT: PICT), Argentina [0639]; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [127979]; ANPCyT; program Ciencia y Tecnologia para el Desarrollo (CYTED)	Universidad de Buenos Aires (UBACyT)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica (ANPCyT: PICT), Argentina; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ANPCyT(ANPCyT); program Ciencia y Tecnologia para el Desarrollo (CYTED)	This work was supported by grants from Universidad de Buenos Aires (UBACyT 2011-2014, No 20020100100854), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2011, No 0338) and Agencia Nacional de Promocion Cientifica (ANPCyT: PICT 2007, No 0639), Argentina and from Consejo Nacional de Ciencia y Tecnologia (CONACyT, grant 127979), Mexico. J.A.R. and N.I.L. are career investigators from CONICET, and M.V.C. has received a graduate student fellowship from ANPCyT and financial support from the program Ciencia y Tecnologia para el Desarrollo (CYTED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub ND, 2007, PLASMID, V58, P240, DOI 10.1016/j.plasmid.2007.05.003; Ayub ND, 2006, FEMS MICROBIOL LETT, V264, P125, DOI 10.1111/j.1574-6968.2006.00446.x; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Conte E, 2006, APPL MICROBIOL BIOT, V72, P1054, DOI 10.1007/s00253-006-0373-y; de Almeida A, 2011, APPL ENVIRON MICROB, V77, P6622, DOI 10.1128/AEM.05469-11; de Roo G, 2000, J MICROBIOL METH, V41, P1, DOI 10.1016/S0167-7012(00)00129-9; Diard S, 2002, SYST APPL MICROBIOL, V25, P183, DOI 10.1078/0723-2020-00114; FRIEDRICH B, 1981, J BACTERIOL, V147, P198, DOI 10.1128/JB.147.1.198-205.1981; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Han MJ, 2006, J MICROBIOL BIOTECHN, V16, P901; Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8; Hoffmann N, 2004, FEMS MICROBIOL LETT, V237, P1, DOI 10.1111/j.1574-6968.2004.tb09671.x; Hu FQ, 2007, J IND MICROBIOL BIOT, V34, P255, DOI 10.1007/s10295-006-0180-6; HUIJBERTS GNM, 1994, J BACTERIOL, V176, P1661, DOI 10.1128/jb.176.6.1661-1666.1994; HUISMAN GW, 1991, J BIOL CHEM, V266, P2191; de Eugenio LI, 2010, ENVIRON MICROBIOL, V12, P207, DOI [10.1111/j.1462-2920.2009.02061.x, 10.1111/j.1462-2920.2010.02199.x]; Jaenecke S, 1999, Int Microbiol, V2, P29; Jendrossek D, 2007, APPL MICROBIOL BIOT, V74, P1186, DOI 10.1007/s00253-007-0860-9; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Kessler B, 2000, INT J SYST EVOL MICR, V50, P711, DOI 10.1099/00207713-50-2-711; Knoll M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-89; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsusaki H, 1998, J BACTERIOL, V180, P6459, DOI 10.1128/JB.180.24.6459-6467.1998; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Pettinari MJ, 2003, PLASMID, V50, P36, DOI 10.1016/S0147-619X(03)00009-X; Pfeiffer D, 2011, MOL MICROBIOL, V82, P936, DOI 10.1111/j.1365-2958.2011.07869.x; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; SHAGGER H, 1987, ANAL BIOCHEM, V166, P386; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solaiman DKY, 2008, J IND MICROBIOL BIOT, V35, P111, DOI 10.1007/s10295-007-0272-y; TIMM A, 1992, EUR J BIOCHEM, V209, P15, DOI 10.1111/j.1432-1033.1992.tb17256.x; Tirapelle EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075066; Tortajada M, 2013, INT MICROBIOL, V16, P1, DOI 10.2436/20.1501.01.175; Tribelli PM, 2012, J BACTERIOL, V194, P2381, DOI 10.1128/JB.00172-12; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105	47	21	21	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98873	10.1371/journal.pone.0098873	http://dx.doi.org/10.1371/journal.pone.0098873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887088	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300115
J	Wang, B; Yang, Q; Bai, WW; Xing, YF; Lu, XT; Sun, YY; Zhao, YX				Wang, Bo; Yang, Qing; Bai, Wen-wu; Xing, Yi-fan; Lu, Xiao-ting; Sun, Yuan-yuan; Zhao, Yu-xia			Tongxinluo Protects against Pressure Overload-Induced Heart Failure in Mice Involving VEGF/Akt/eNOS Pathway Activation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; CARDIOMYOCYTE-SPECIFIC OVEREXPRESSION; INDUCED CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; CELL MOBILIZATION; OXIDATIVE STRESS; KNOCKOUT MICE; FAILING HEART	Background: It has been demonstrated that Tongxinluo (TXL), a traditional Chinese medicine compound, improves ischemic heart disease in animal models via vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS). The present study aimed to investigate whether TXL protects against pressure overload-induced heart failure in mice and explore the possible mechanism of action. Methods and Results: Transverse aortic constriction (TAC) surgery was performed in mice to induce heart failure. Cardiac function was evaluated by echocardiography. Myocardial pathology was detected using hematoxylin and eosin or Masson trichrome staining. We investigated cardiomyocyte ultrastructure using transmission electron microscopy. Angiogenesis and oxidative stress levels were determined using CD31 and 8-hydroxydeoxyguanosine immunostaining and malondialdehyde assay, respectively. Fetal gene expression was measured using real-time PCR. Protein expression of VEGF, phosphorylated (p)-VEGF receptor 2 (VEGFR2), p-phosphatidylinositol 3-kinase (PI3K), p-Akt, p-eNOS, heme oxygenase-1 (HO-1), and NADPH oxidase 4 (Nox4) were measured with western blotting. Twelve-week low-and high-dose TXL treatment following TAC improved cardiac systolic and diastolic function and ameliorated left ventricular hypertrophy, fibrosis, and myocardial ultrastructure derangement. Importantly, TXL increased myocardial capillary density significantly and attenuated oxidative stress injury in failing hearts. Moreover, TXL upregulated cardiac nitrite content and the protein expression of VEGF, p-VEGFR2, p-PI3K, p-Akt, p-eNOS, and HO-1, but decreased Nox4 expression in mouse heart following TAC. Conclusion: Our findings indicate that TXL protects against pressure overload-induced heart failure in mice. Activation of the VEGF/Akt/eNOS signaling pathway might be involved in TXL improvement of the failing heart.	[Wang, Bo; Xing, Yi-fan; Zhao, Yu-xia] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Peoples R China; [Yang, Qing] Shandong Univ, Inst Pathogen Biol, Jinan 250100, Peoples R China; [Bai, Wen-wu; Lu, Xiao-ting; Sun, Yuan-yuan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Peoples R China.	yu_xia_zhao@163.com			National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [81100103, 30873325, 81173251]; Natural Science Foundation of Shandong Province [ZR2011HQ020]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National 973 Basic Research Program of China (2012CB518603), the National Natural Science Foundation of China (81100103, 30873325, and 81173251), and the Natural Science Foundation of Shandong Province (ZR2011HQ020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov A, 2013, CIRCULATION, V127, P424, DOI 10.1161/CIRCULATIONAHA.112.127472; Bai Wen-Wu, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/813247; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; *CHIN PHARM COMM, 2005, PHARM PEOPL REP CHIN, V1; Di Napoli P, 2005, CARDIOVASC RES, V66, P462, DOI 10.1016/j.cardiores.2005.02.008; Elrod JW, 2006, ARTERIOSCL THROM VAS, V26, P1517, DOI 10.1161/01.ATV.0000224324.52466.e6; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Higashikuni Y, 2012, ARTERIOSCL THROM VAS, V32, P654, DOI 10.1161/ATVBAHA.111.240341; Janssens S, 2004, CIRC RES, V94, P1256, DOI 10.1161/01.RES.0000126497.38281.23; Khoo NKH, 2010, FREE RADICAL BIO MED, V48, P230, DOI 10.1016/j.freeradbiomed.2009.10.046; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Li XD, 2010, AM J PHYSIOL-HEART C, V299, pH1255, DOI 10.1152/ajpheart.00459.2010; Liang JQ, 2011, J ETHNOPHARMACOL, V133, P517, DOI 10.1016/j.jep.2010.10.031; Liao YL, 2004, CIRCULATION, V110, P692, DOI 10.1161/01.CIR.0000137831.08683.E1; Liu YH, 2002, HYPERTENSION, V39, P375, DOI 10.1161/hy02t2.102796; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nako H, 2012, HYPERTENS RES, V35, P194, DOI 10.1038/hr.2011.175; Patel VB, 2013, CIRC RES, V112, P1542, DOI 10.1161/CIRCRESAHA.111.300299; PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085; Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Serpi R, 2011, CARDIOVASC RES, V89, P204, DOI 10.1093/cvr/cvq267; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2012, AM J PATHOL, V181, P1969, DOI 10.1016/j.ajpath.2012.08.020; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Xu XH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-54; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009	39	34	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98047	10.1371/journal.pone.0098047	http://dx.doi.org/10.1371/journal.pone.0098047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887083	gold, Green Published			2022-12-27	WOS:000336956300035
J	Yagi, M; Bang, G; Tougan, T; Palacpac, NMQ; Arisue, N; Aoshi, T; Matsumoto, Y; Ishii, KJ; Egwang, TG; Druilhe, P; Horii, T				Yagi, Masanori; Bang, Gilles; Tougan, Takahiro; Palacpac, Nirianne M. Q.; Arisue, Nobuko; Aoshi, Taiki; Matsumoto, Yoshitsugu; Ishii, Ken J.; Egwang, Thomas G.; Druilhe, Pierre; Horii, Toshihiro			Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences	PLOS ONE			English	Article							SERINE REPEAT ANTIGEN; ANTIBODY-MEDIATED INHIBITION; DISORDERED PROTEINS; PARASITE GROWTH; TARGET; DYNAMICS; HUMANS; DOMAIN	The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we have previously shown the inhibitory effects of SE36 specific antibodies on in vitro parasite growth and the negative correlation between antibody level and malaria symptoms. A phase 1 b trial of the BK-SE36 vaccine in Uganda elicited 72% protective efficacy against symptomatic malaria in children aged 620 years during the follow-up period 130-365 days post-second vaccination. Here, we performed epitope mapping with synthetic peptides covering the whole sequence of SE36 to identify and map dominant epitopes in Ugandan adult serum presumed to have clinical immunity to P. falciparum malaria. High titer sera from the Ugandan adults predominantly reacted with peptides corresponding to two successive N-terminal regions of SERA5 containing octamer repeats and serine rich sequences, regions of SERA5 that were previously reported to have limited polymorphism. Affinity purified antibodies specifically recognizing the octamer repeats and serine rich sequences exhibited a high antibody-dependent cellular inhibition (ADCI) activity that inhibited parasite growth. Furthermore, protein structure predictions and structural analysis of SE36 using spectroscopic methods indicated that N-terminal regions possessing inhibitory epitopes are intrinsically unstructured. Collectively, these results suggest that strict tertiary structure of SE36 epitopes is not required to elicit protective antibodies in naturally immune Ugandan adults.	[Yagi, Masanori; Tougan, Takahiro; Palacpac, Nirianne M. Q.; Arisue, Nobuko; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Bang, Gilles; Druilhe, Pierre] Inst Pasteur, Biochem Parasitol Lab, Paris, France; [Aoshi, Taiki; Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Osaka, Japan; [Aoshi, Taiki; Ishii, Ken J.] Osaka Univ, Immunol Frontier Res Ctr, Lab Vaccine Sci, Suita, Osaka, Japan; [Matsumoto, Yoshitsugu] Univ Tokyo, Lab Mol Immunol, Sch Agr & Life Sci, Tokyo, Japan; [Egwang, Thomas G.] Med Biotech Labs, Kampala, Uganda	Osaka University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute of Health Sciences - Japan; Osaka University; University of Tokyo	Horii, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan.	horii@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Tougan, Takahiro/AAP-5129-2020	Ishii, Ken J/0000-0002-6728-3872; Palacpac, Nirianne Marie/0000-0003-4098-3972; Horii, Toshihiro/0000-0002-3000-2045	Japanese Ministry of Education, Science, Sports, Culture and Technology [22770151, 24249024]; Global Health Innovative Technology Fund [GHIT RFP 2013-001]	Japanese Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Health Innovative Technology Fund	This work was supported by Grant-in-Aid for Young Scientists (B) (22770151) and Grant-in-Aid for Global COE (Centers of Excellence) Program to MY; Grant-in-Aid for Scientific Research (A) (24249024), Program for the Promotion of International Policy Dialogues Contributing to the Development of Science and Technology Diplomacy to TH from the Japanese Ministry of Education, Science, Sports, Culture and Technology. The authors would like to acknowledge the funding support of Global Health Innovative Technology Fund (GHIT RFP 2013-001) to TH under the project Clinical development of BK-SE36/CpG malaria vaccine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2012, INFECT IMMUN, V80, P4177, DOI 10.1128/IAI.00665-12; [Anonymous], 2012, WHO WORLD MALARIA RE; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289; Chauhan VS, 2010, HUM VACCINES, V6, P757, DOI 10.4161.hv.6.9.12468; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fox BA, 2002, EXP PARASITOL, V101, P69, DOI 10.1016/S0014-4894(02)00034-6; Fox BA, 1997, EXP PARASITOL, V85, P121, DOI 10.1006/expr.1996.4118; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Horii T, 2010, PARASITOL INT, V59, P380, DOI 10.1016/j.parint.2010.05.002; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kulangara C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046112; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Okech BA, 2001, AM J TROP MED HYG, V65, P912, DOI 10.4269/ajtmh.2001.65.912; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Palacpac NMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064073; Palacpac NMQ, 2011, VACCINE, V29, P5837, DOI 10.1016/j.vaccine.2011.06.052; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Pang XL, 1999, INFECT IMMUN, V67, P1821; Pang XL, 1998, VACCINE, V16, P1299, DOI 10.1016/S0264-410X(98)00057-7; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Soe S, 2002, INFECT IMMUN, V70, P7182, DOI 10.1128/IAI.70.12.7182-7184.2002; Tanabe K, 2012, VACCINE, V30, P1583, DOI 10.1016/j.vaccine.2011.12.124; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	43	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98460	10.1371/journal.pone.0098460	http://dx.doi.org/10.1371/journal.pone.0098460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886718	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300068
J	Llopis, S; Hernandez-Haro, C; Monteoliva, L; Querol, A; Molina, M; Fernandez-Espinar, MT				Llopis, Silvia; Hernandez-Haro, Carolina; Monteoliva, Lucia; Querol, Amparo; Molina, Maria; Fernandez-Espinar, Maria T.			Pathogenic Potential of Saccharomyces Strains Isolated from Dietary Supplements	PLOS ONE			English	Article							CANDIDA-ALBICANS; CEREVISIAE FUNGEMIA; BREWERS-YEAST; NATURAL HYBRIDS; GASTROINTESTINAL COLONIZATION; MOLECULAR CHARACTERIZATION; SPECIES IDENTIFICATION; GLUCOSE-TOLERANCE; SERUM-LIPIDS; VIRULENCE	Saccharomyces cerevisiae plays a beneficial role in health because of its intrinsic nutritional value and bio-functional properties, which is why it is also used as a dietary supplement. However, the perception that S. cerevisiae is harmless has changed due to an increasing number of infections caused by this yeast. Given this scenario, we have tested whether viable strains contained in dietary supplements displayed virulence-associated phenotypic traits that could contribute to virulence in humans. We have also performed an in vivo study of the pathogenic potential of these strains using a murine model of systemic infection by intravenous inoculation. A total of 5 strains were isolated from 22 commercial products and tested. Results highlight one strain (D14) in terms of burden levels in brains and kidneys and ability to cause death, whereas the other two strains (D2 and D4) were considered of low virulence. Our results suggest a strong relationship between some of the virulence-associated phenotypic traits (ability to grow at 39 degrees C and pseudohyphal growth) and the in vivo virulence in a mouse model of intravenous inoculation for isolates under study. The isolate displaying greatest virulence (D14) was evaluated in an experimental murine model of gastrointestinal infection with immunosuppression and disruption of mucosal integrity, which are common risk factors for developing infection in humans, and results were compared with an avirulent strain (D23). We showed that D14 was able to spread to mesenteric nodes and distant organs under these conditions. Given the widespread consumption of dietary supplements, we recommend only safe strains be used.	[Llopis, Silvia; Querol, Amparo; Fernandez-Espinar, Maria T.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, E-46010 Valencia, Spain; [Hernandez-Haro, Carolina; Monteoliva, Lucia; Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Hernandez-Haro, Carolina; Monteoliva, Lucia; Molina, Maria] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Complutense University of Madrid	Fernandez-Espinar, MT (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	tfer@iata.csic.es	Monteoliva, Lucia/G-8720-2015; Fernández-Espinar, M Teresa/H-4547-2012; Querol, Amparo/H-3782-2012; Querol, Amparo/AAW-7469-2020; Molina, Maria/ABE-7186-2021	Monteoliva, Lucia/0000-0003-4949-0664; Fernández-Espinar, M Teresa/0000-0001-6285-8174; Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845; Molina, Maria/0000-0003-0074-3309	CICYT grant from the Ministerio de Ciencia y Tecnologia, Spain [AGL2006-12710-C02-01, AGL2006-12710-C02-02]; Comunidad Autonoma de Madrid (Spain) [PROMPT S2010/BMD-2414]; Ministerio de Ciencia y Tecnologia (Spain)	CICYT grant from the Ministerio de Ciencia y Tecnologia, Spain; Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was financially supported by a CICYT grant (Grant Nos AGL2006-12710-C02-01 and AGL2006-12710-C02-02) from the Ministerio de Ciencia y Tecnologia, Spain, to M. T. F.-E. and M. M., and by PROMPT S2010/BMD-2414 from Comunidad Autonoma de Madrid (Spain), to M. M. S. L. and C.H.-H. wish to thank the Ministerio de Ciencia y Tecnologia (Spain) for their FPU and an FPI predoctoral fellowships respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrutis KA, 2000, J CLIN MICROBIOL, V38, P2317; AOKI S, 1994, MYCOPATHOLOGIA, V128, P143, DOI 10.1007/BF01138475; Bahijiri SM, 2000, SAUDI MED J, V21, P831; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; BYRON JK, 1995, INFECT IMMUN, V63, P478, DOI 10.1128/IAI.63.2.478-485.1995; CartwrightShamoon J, 1996, GUT, V39, P204, DOI 10.1136/gut.39.2.204; CARTWRIGHTSHAMOON J, 1995, J DRUG TARGET, V3, P61, DOI 10.3109/10611869509015935; Cesaro S, 2000, SUPPORT CARE CANCER, V8, P504, DOI 10.1007/s005200000123; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; Clemons KV, 1996, J MED VET MYCOL, V34, P259; de Llanos R, 2004, SYST APPL MICROBIOL, V27, P427, DOI 10.1078/0723202041438473; de Llanos R, 2011, INT J FOOD MICROBIOL, V144, P393, DOI 10.1016/j.ijfoodmicro.2010.10.025; de Llanos R, 2006, ANTON LEEUW INT J G, V90, P221, DOI 10.1007/s10482-006-9077-7; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; de Llanos R, 2010, YEAST, V27, P549, DOI 10.1002/yea.1799; Debelian GJ, 1997, INT ENDOD J, V30, P313, DOI 10.1046/j.1365-2591.1997.00101.x; El-Azizi Mohamed, 1999, Indian Journal of Experimental Biology, V37, P941; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Fernandez-Espinar MT, 2000, ANTON LEEUW INT J G, V78, P87; Fernandez-Espinar MT, 2001, INT J FOOD MICROBIOL, V70, P1, DOI 10.1016/S0168-1605(01)00502-5; Fung KSC, 1996, SCAND J INFECT DIS, V28, P83, DOI 10.3109/00365549609027155; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Hennequin C, 2000, EUR J CLIN MICROBIOL, V19, P16, DOI 10.1007/s100960050003; Herbrecht R, 2005, CLIN INFECT DIS, V40, P1635, DOI 10.1086/429926; Jain N, 2006, INFECT IMMUN, V74, P896, DOI 10.1128/IAI.74.2.896-903.2006; JENSEN DP, 1976, ARCH INTERN MED, V136, P332, DOI 10.1001/archinte.136.3.332; Klingberg TD, 2008, FEMS YEAST RES, V8, P631, DOI 10.1111/j.1567-1364.2008.00365.x; Lherm T, 2002, INTENS CARE MED, V28, P797, DOI 10.1007/s00134-002-1267-9; LI YC, 1994, BIOL TRACE ELEM RES, V41, P341, DOI 10.1007/BF02917434; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Martin H, 1993, MOL GEN GENET, V241, P177; Martins FS, 2007, J MED MICROBIOL, V56, P352, DOI 10.1099/jmm.0.46525-0; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P2613, DOI 10.1128/JCM.36.9.2613-2617.1998; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; Mellado E, 2000, DIAGN MICR INFEC DIS, V38, P21, DOI 10.1016/S0732-8893(00)00165-6; Moyad Mark A, 2007, Urol Nurs, V27, P560; Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916; Murphy AR, 2001, MED MYCOL, V39, P123, DOI 10.1080/mmy.39.1.123.127; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nakamura T, 2001, BIOSCI BIOTECH BIOCH, V65, P774, DOI 10.1271/bbb.65.774; NESS F, 1993, J SCI FOOD AGR, V62, P89, DOI 10.1002/jsfa.2740620113; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Peret LA, 1998, J MED MICROBIOL, V47, P111, DOI 10.1099/00222615-47-2-111; Perez-Torrado R, 2012, INT J FOOD MICROBIOL, V157, P59, DOI 10.1016/j.ijfoodmicro.2012.04.012; POPE LM, 1982, SCAN ELECTRON MICROS, P1667; PRICE MF, 1982, SABOURAUDIA, V20, P7; QUEROL A, 1992, SYST APPL MICROBIOL, V15, P439, DOI 10.1016/S0723-2020(11)80219-5; Querol A, 2009, FEMS MICROBIOL LETT, V293, P1, DOI 10.1111/j.1574-6968.2008.01480.x; Reddy BS, 2000, INT J MOL MED, V5, P327; Riquelme AJ, 2003, J CLIN GASTROENTEROL, V36, P41, DOI 10.1097/00004836-200301000-00013; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; ROTROSEN D, 1986, REV INFECT DIS, V8, P73; Samonis G, 2011, MED MYCOL, V49, P395, DOI 10.3109/13693786.2010.533203; Smith D, 2002, J CLIN MICROBIOL, V40, P2691, DOI 10.1128/JCM.40.7.2691-2692.2002; SOLL DR, 1988, J CLIN MICROBIOL, V26, P1448, DOI 10.1128/JCM.26.8.1448-1459.1988; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; Takahashi K, 2003, MICROB PATHOGENESIS, V35, P179, DOI 10.1016/j.micpath.2003.06.001; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; van Burik JAH, 2001, ANNU REV MICROBIOL, V55, P743, DOI 10.1146/annurev.micro.55.1.743; Wells CL, 2007, J MED MICROBIOL, V56, P688, DOI 10.1099/jmm.0.47049-0; Wheeler RT, 2003, P NATL ACAD SCI USA, V100, P2766, DOI 10.1073/pnas.0437995100; Whelan K, 2010, AM J CLIN NUTR, V91, P687, DOI 10.3945/ajcn.2009.28759; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yanez A., 2009, Open Mycology Journal, V3, P37, DOI 10.2174/1874437000903010037; Zupan J, 2008, J MICROBIOL METH, V73, P100, DOI 10.1016/j.mimet.2008.02.009	75	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98094	10.1371/journal.pone.0098094	http://dx.doi.org/10.1371/journal.pone.0098094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879417	Green Accepted, gold, Green Published			2022-12-27	WOS:000338101500030
J	Nedosyko, AM; Young, JE; Edwards, JW; da Silva, KB				Nedosyko, Anita M.; Young, Jeanne E.; Edwards, John W.; da Silva, Karen Burke			Searching for a Toxic Key to Unlock the Mystery of Anemonefish and Anemone Symbiosis	PLOS ONE			English	Article							SEA-ANEMONE; FINDING NEMO; HOST; FISH; STOICHACTIS; SELECTION; ANTHOZOA; PATTERNS; STUNG	Twenty-six species of anemonefish of the genera Amphiprion and monospecific Premnas, use only 10 species of anemones as hosts in the wild (Families: Actiniidae, Stichodactylidae and Thalassianthidae). Of these 10 anemone species some are used by multiple species of anemonefish while others have only a single anemonefish symbiont. Past studies have explored the different patterns of usage between anemonefish species and anemone species; however the evolution of this relationship remains unknown and has been little studied over the past decade. Here we reopen the case, comparing the toxicity of crude venoms obtained from anemones that host anemonefish as a way to investigate why some anemone species are used as a host more than others. Specifically, for each anemone species we investigated acute toxicity using Artemia francisca (LC50), haemolytic toxicity using ovine erythrocytes (EC50) and neurotoxicity using shore crabs (Ozius truncatus). We found that haemolytic and neurotoxic activity varied among host anemone species. Generally anemone species that displayed greater haemolytic activity also displayed high neurotoxic activity and tend to be more toxic on average as indicated by acute lethality analysis. An overall venom toxicity ranking for each anemone species was compared with the number of anemonefish species that are known to associate with each anemone species in the wild. Interestingly, anemones with intermediate toxicity had the highest number of anemonefish associates, whereas anemones with either very low or very high toxicity had the fewest anemonefish associates. These data demonstrate that variation in toxicity among host anemone species may be important in the establishment and maintenance of anemonefish anemone symbiosis.	[Nedosyko, Anita M.; Young, Jeanne E.; Edwards, John W.; da Silva, Karen Burke] Flinders Univ South Australia, Fac Sci & Engn, Adelaide, SA, Australia	Flinders University South Australia	da Silva, KB (corresponding author), Flinders Univ South Australia, Fac Sci & Engn, Adelaide, SA, Australia.	karen.burkedasilva@flinders.edu.au		, Karen/0000-0002-0294-6583	School of Biological Sciences, Flinders University of SA	School of Biological Sciences, Flinders University of SA	Funding for this project was from The School of Biological Sciences, Flinders University of SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1975, ANEMONEFISHES CLASSI; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Arvedlund M., 2000, Naga, V23, P18; Astakhov DA, 2002, P 1 C ICHTH RUSS VNI, P9; Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Buston PM, 2007, J FISH BIOL, V70, P1710, DOI 10.1111/j.1095-8649.2007.01445.x; Chadwick NE, 2005, J MAR BIOL ASSOC UK, V85, P1287, DOI 10.1017/S0025315405012440; Daly M, 2008, MOL PHYLOGENET EVOL, V48, P292, DOI 10.1016/j.ympev.2008.02.022; DAVENPORT D, 1958, BIOL BULL, V115, P397, DOI 10.2307/1539105; DUNN DF, 1981, T AM PHILOS SOC, V71, P3, DOI 10.2307/1006382; Elliot J.K., 1996, J EXP MAR BIOL ECOL, V208, P57; Elliott JK, 2001, MAR BIOL, V138, P23, DOI 10.1007/s002270000441; ELLIOTT JK, 1994, J EXP MAR BIOL ECOL, V179, P99, DOI 10.1016/0022-0981(94)90019-1; FAUTIN DG, 1991, SYMBIOSIS, V10, P23; FAUTIN DG, 1986, ENVIRON BIOL FISH, V15, P171, DOI 10.1007/BF00002992; Fautin DG, 1997, ANEMONEFISHES THEIR; Fautin DG, 1985, P 5 INT COR REEF C, V5, P373; Huerta V, 2001, TOXICON, V39, P1253, DOI 10.1016/S0041-0101(00)00247-6; Ishida M, 1997, TOXICON, V35, P537, DOI 10.1016/S0041-0101(96)00143-2; JANSSEN A, 1989, FUNCT ECOL, V3, P469, DOI 10.2307/2389621; Jones AM, 2008, J FISH BIOL, V73, P753, DOI 10.1111/j.1095-8649.2008.01969.x; LUBBOCK R, 1979, J EXP BIOL, V83, P283; LUBBOCK R, 1980, PROC R SOC SER B-BIO, V207, P35, DOI 10.1098/rspb.1980.0013; LUBBOCK R, 1981, PARASITOLOGY, V82, P159, DOI 10.1017/S0031182000041962; MARISCAL R N, 1970, Journal of Experimental Marine Biology and Ecology, V4, P134, DOI 10.1016/0022-0981(70)90020-1; MARISCAL RN, 1969, EXPERIENTIA, V25, P1114, DOI 10.1007/BF01901467; MEBS D, 1994, TOXICON, V32, P1059, DOI 10.1016/0041-0101(94)90390-5; Mebs D, 2009, TOXICON, V54, P1071, DOI 10.1016/j.toxicon.2009.02.027; MIYAGAWA K, 1989, ETHOLOGY, V80, P19; MOYER J T, 1976, Japanese Journal of Ichthyology, V23, P23; MURATA M, 1986, SCIENCE, V234, P585, DOI 10.1126/science.234.4776.585; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Pohnert G, 2004, TOP CURR CHEM, V239, P179, DOI 10.1007/b95453; Ricciardi F, 2010, ENVIRON BIOL FISH, V87, P333, DOI 10.1007/s10641-010-9606-0; Rivero A, 2000, ECOL ENTOMOL, V25, P467, DOI 10.1046/j.1365-2311.2000.00276.x; Santini S, 2006, GENE, V385, P19, DOI 10.1016/j.gene.2006.03.028; Schlichter D., 1976, P433; Schulz S., TOPICS CURRENT CHEM, V239; SENCIC L, 1990, COMP BIOCHEM PHYS B, V97, P687, DOI 10.1016/0305-0491(90)90108-6; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Srinivasan M, 1999, MAR ECOL PROG SER, V186, P283, DOI 10.3354/meps186283; Standker L, 2006, TOXICON, V48, P211, DOI 10.1016/j.toxicon.2006.05.001; Vanhaecke P, 1984, ECOTOXICOLOGICAL TES, V2, P143	45	20	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98449	10.1371/journal.pone.0098449	http://dx.doi.org/10.1371/journal.pone.0098449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878777	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500060
J	Zhou, P; Kannan, R; Spee, C; Sreekumar, PG; Dou, GR; Hinton, DR				Zhou, Peng; Kannan, Ram; Spee, Christine; Sreekumar, Parameswaran G.; Dou, Guorui; Hinton, David R.			Protection of Retina by alpha B Crystallin in Sodium Iodate Induced Retinal Degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; PHOTORECEPTOR DEGENERATION; GEOGRAPHIC ATROPHY; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; AGE; MODEL; EXPRESSION; DISEASE	Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world. The retinal pigment epithelium (RPE) is a critical site of pathology in AMD and alpha B crystallin expression is increased in RPE and associated drusen in AMD. The purpose of this study was to investigate the role of alpha B crystallin in sodium iodate (NaIO3)-induced retinal degeneration, a model of AMD in which the primary site of pathology is the RPE. Dose dependent effects of intravenous NaIO3 (20-70 mg/kg) on development of retinal degeneration (fundus photography) and RPE and retinal neuronal loss (histology) were determined in wild type and alpha B crystallin knockout mice. Absence of alpha B crystallin augmented retinal degeneration in low dose (20 mg/kg) NaIO3-treated mice and increased retinal cell apoptosis which was mainly localized to the RPE layer. Generation of reactive oxygen species (ROS) was observed with NaIO3 in mouse and human RPE which increased further after alpha B crystallin knockout or siRNA knockdown, respectively. NaIO3 upregulated AKT phosphorylation and peroxisome proliferator-activator receptor-gamma (PPAR(gamma)) which was suppressed after alpha B crystallin siRNA knockdown. Further, PPAR(gamma) ligand inhibited NaIO3-induced ROS generation. Our data suggest that alpha B crystallin plays a critical role in protection of NaIO3-induced oxidative stress and retinal degeneration in part through upregulation of AKT phosphorylation and PPAR(gamma) expression.	[Zhou, Peng; Kannan, Ram; Sreekumar, Parameswaran G.; Dou, Guorui] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Spee, Christine; Hinton, David R.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	Doheny Eye Institute; University of Southern California; University of Southern California	Hinton, DR (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	dhinton@usc.edu	kannan, ram/ABB-7154-2020	kannan, ram/0000-0002-1583-3414; /0000-0002-9425-3986	Arnold and Mabel Beckman Foundation; Research to Prevent Blindness Inc., New York, NY;  [EY01545];  [EY03040]; NATIONAL EYE INSTITUTE [P30EY003040, R01EY001545] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; Research to Prevent Blindness Inc., New York, NY(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by grants EY01545 (DRH) and by core grant EY03040, the Arnold and Mabel Beckman Foundation, and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness Inc., New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Brownell SE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00074; Cheng HC, 2008, MOL VIS, V14, P95; Chung SS, 2011, AM J PHYSIOL-ENDOC M, V301, pE912, DOI 10.1152/ajpendo.00120.2011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Enzmann V, 2006, EXP EYE RES, V82, P441, DOI 10.1016/j.exer.2005.08.002; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kiuchi K, 2002, CURR EYE RES, V25, P373, DOI 10.1076/ceyr.25.6.373.14227; Klein ML, 2008, OPHTHALMOLOGY, V115, P1026, DOI 10.1016/j.ophtha.2007.08.030; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Kolosova NG, 2012, AM J PATHOL, V181, P472, DOI 10.1016/j.ajpath.2012.04.018; Liu B, 2011, BIOCHEM BIOPH RES CO, V321, P254; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Markovets AM, 2011, AGING-US, V3, P44; Martin HL, 2012, EXP NEUROL, V235, P528, DOI 10.1016/j.expneurol.2012.02.017; Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Organisciak D, 2006, PHOTOCHEM PHOTOBIOL, V82, P1088, DOI 10.1562/2005-06-30-RA-599; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Redfern WS, 2011, J PHARMACOL TOXICOL, V63, P102, DOI 10.1016/j.vascn.2010.06.008; RINGVOLD A, 1981, EXP EYE RES, V33, P361, DOI 10.1016/S0014-4835(81)80088-7; Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033420; Sreekumar PG, 2012, OXID STRESS APPL BAS, P181, DOI 10.1007/978-1-61779-606-7_9; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Whiteside C, 2009, EXP DIABETES RES, DOI 10.1155/2009/910783; Xi JH, 2003, MOL VIS, V9, P410; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043173; Zhu C, 2011, AGING, V3, P346; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200; Zhu XM, 2005, J NEUROCHEM, V95, P1351, DOI 10.1111/j.1471-4159.2005.03460.x	56	48	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98275	10.1371/journal.pone.0098275	http://dx.doi.org/10.1371/journal.pone.0098275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874187	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800030
J	Coman, A; Maftei, DN; Krueger, WS; Heil, GL; Chereches, RM; Sirlincan, E; Bria, P; Dragnea, C; Kasler, I; Valentine, MA; Gray, GC				Coman, Alexandru; Maftei, Daniel N.; Krueger, Whitney S.; Heil, Gary L.; Chereches, Razvan M.; Sirlincan, Emanuela; Bria, Paul; Dragnea, Claudiu; Kasler, Iosif; Valentine, Marissa A.; Gray, Gregory C.			A Prospective Study of Romanian Agriculture Workers for Zoonotic Influenza Infections	PLOS ONE			English	Article							AVIAN INFLUENZA; SWINE INFLUENZA; VIRUSES	Background: In this prospective study we sought to examine seroepidemiological evidence for acute zoonotic influenza virus infection among Romanian agricultural workers. Methods: Sera were drawn upon enrollment (2009) and again at 12 and 24 months from 312 adult agriculture workers and 51 age-group matched controls. Participants were contacted monthly for 24 months and queried regarding episodes of acute influenza-like illnesses (ILI). Cohort members meeting ILI criteria permitted respiratory swab collections as well as acute and convalescent serum collection. Serologic assays were performed against 9 avian, 3 swine, and 3 human influenza viruses. Results: During the two-year follow-up, a total of 23 ILI events were reported. Two subjects' specimens were identified as influenza A by rRT-PCR. During the follow-up period, three individuals experienced elevated microneutralization antibody titers >= 1:80 against three (one each) avian influenza viruses: A/Teal/Hong Kong/w312/97(H6N1), A/Hong Kong/1073/ 1999(H9N2), or A/Duck/Alberta/60/1976(H12N5). However, none of these participants met the criteria for poultry exposure. A number of subjects demonstrated four-fold increases over time in hemagglutination inhibition (HI) assay titers for at least one of the three swine influenza viruses (SIVs); however, it seems likely that two of these three responses were due to crossreacting antibody against human influenza. Only elevated antibody titers against A/Swine/Flanders/1/1998(H3N2) lacked evidence for such confounding. In examining risk factors for elevated antibody against this SIV with multiple logistic regression, swine exposure (adjusted OR = 1.8, 95% CI 1.1-2.8) and tobacco use (adjusted OR = 1.8; 95% CI 1.1-2.9) were important predictors. Conclusions: While Romania has recently experienced multiple incursions of highly pathogenic avian influenza among domestic poultry, this cohort of Romanian agriculture workers had sparse evidence of avian influenza virus infections. In contrast, there was evidence, especially among the swine exposed participants, of infections with human and one swine H3N2 influenza virus.	[Coman, Alexandru; Maftei, Daniel N.; Chereches, Razvan M.; Sirlincan, Emanuela; Bria, Paul; Dragnea, Claudiu; Kasler, Iosif] Univ Babes Bolyai, Ctr Hlth Policy & Publ Hlth, Inst Social Res, Fac Polit Adm & Commun Sci, R-3400 Cluj Napoca, Romania; [Krueger, Whitney S.; Heil, Gary L.; Valentine, Marissa A.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Krueger, Whitney S.; Heil, Gary L.; Valentine, Marissa A.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Babes Bolyai University from Cluj; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020; Maftei, Daniel/GLT-6228-2022	Gray, Gregory/0000-0002-4628-5908; Coman, Alexandru/0000-0002-9417-5033	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; ARRA supplement grant from the National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; ARRA supplement grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by multiple grants from the US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program (Dr. Gray, principal investigator) and an ARRA supplement grant from the National Institute of Allergy and Infectious Diseases (R01 AI068803-Dr. Gray). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INF ROM CLASS SWIN F, P1; Coman A, 2013, J INFECT PUBLIC HLTH; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kendal AP, 1982, CONCEPTS PROCEDURES; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nicoll A, 2005, EUROSURVEILLANCE, V10; Oprisan G, 2006, Roum Arch Microbiol Immunol, V65, P79; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid SM, 2011, TRANSBOUND EMERG DIS, V58, P76, DOI 10.1111/j.1865-1682.2010.01175.x; ROWE WP, 1958, P SOC EXP BIOL MED, V97, P465, DOI 10.3181/00379727-97-23776	16	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98248	10.1371/journal.pone.0098248	http://dx.doi.org/10.1371/journal.pone.0098248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869796	Green Published, gold			2022-12-27	WOS:000336858300029
J	Graudenzi, A; Caravagna, G; De Matteis, G; Antoniotti, M				Graudenzi, Alex; Caravagna, Giulio; De Matteis, Giovanni; Antoniotti, Marco			Investigating the Relation between Stochastic Differentiation, Homeostasis and Clonal Expansion in Intestinal Crypts via Multiscale Modeling	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; MIGRATION; NETWORK; CANCER; NOISE; MECHANISMS; EQUILIBRIUM; POPULATIONS; ACTIVATION	Colorectal tumors originate and develop within intestinal crypts. Even though some of the essential phenomena that characterize crypt structure and dynamics have been effectively described in the past, the relation between the differentiation process and the overall crypt homeostasis is still only partially understood. We here investigate this relation and other important biological phenomena by introducing a novel multiscale model that combines a morphological description of the crypt with a gene regulation model: the emergent dynamical behavior of the underlying gene regulatory network drives cell growth and differentiation processes, linking the two distinct spatio-temporal levels. The model relies on a few a priori assumptions, yet accounting for several key processes related to crypt functioning, such as: dynamic gene activation patterns, stochastic differentiation, signaling pathways ruling cell adhesion properties, cell displacement, cell growth, mitosis, apoptosis and the presence of biological noise. We show that this modeling approach captures the major dynamical phenomena that characterize the regular physiology of crypts, such as cell sorting, coordinate migration, dynamic turnover, stem cell niche correct positioning and clonal expansion. All in all, the model suggests that the process of stochastic differentiation might be sufficient to drive the crypt to homeostasis, under certain crypt configurations. Besides, our approach allows to make precise quantitative inferences that, when possible, were matched to the current biological knowledge and it permits to investigate the role of gene-level perturbations, with reference to cancer development. We also remark the theoretical framework is general and may be applied to different tissues, organs or organisms.	[Graudenzi, Alex; Caravagna, Giulio; Antoniotti, Marco] Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy; [De Matteis, Giovanni] Northumbria Univ, Dept Math & Informat, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	University of Milano-Bicocca; Northumbria University	Graudenzi, A (corresponding author), Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy.	alex.graudenzi@unimib.it	Graudenzi, Alex/AAY-5241-2020; Caravagna, Giulio/F-5011-2015	Graudenzi, Alex/0000-0001-5452-1918; Caravagna, Giulio/0000-0003-4240-3265	ASTIL program project RetroNet" [12-4-5148000-40]; U.A [053]; NEDD Project Fondo Accordi Istituzionali 2009 [ID14546A Rif SAL-7]	ASTIL program project RetroNet"; U.A; NEDD Project Fondo Accordi Istituzionali 2009	This work was partially supported by the ASTIL program, project RetroNet '', grant n. 12-4-5148000-40; U.A 053 and NEDD Project [ID14546A Rif SAL-7] Fondo Accordi Istituzionali 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts B., 2010, MOL BIOL CELL; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Antoniotti M, 2013, BIOINFORMATICS, V29, P513, DOI 10.1093/bioinformatics/bts726; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BarabuYSi A., 2003, LINKED EVERYTHING IS; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bjerknes M, 1996, J THEOR BIOL, V178, P381, DOI 10.1006/jtbi.1996.0034; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boman BM, 2001, CANCER RES, V61, P8408; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Caravagna G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051174; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Damiani C, 2011, IET SYST BIOL, V5, P137, DOI 10.1049/iet-syb.2010.0039; De Matteis G, 2013, J MATH BIOL, V66, P1409, DOI 10.1007/s00285-012-0539-4; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Frank S, 2007, DYNAMICS CANCER; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Graudenzi A, 2012, P WIV 2012 IT WORKSH; Graudenzi A, 2011, J COMPUT BIOL, V18, P1291, DOI 10.1089/cmb.2010.0069; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grefenstette J, 2006, BIOSYSTEMS, V84, P81, DOI 10.1016/j.biosystems.2005.09.009; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hocker M, 1998, ANN NY ACAD SCI, V859, P160, DOI 10.1111/j.1749-6632.1998.tb11120.x; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; Kauffman S., 1995, HOME UNIVERSE SEARCH; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUR P, 1986, CELL TISSUE KINET, V19, P591, DOI 10.1111/j.1365-2184.1986.tb00760.x; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lestas I, 2008, IEEE T AUTOMAT CONTR, V53, P189, DOI 10.1109/TAC.2007.911347; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Murray PJ, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026011; Nachman MW, 2000, GENETICS, V156, P297; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Peixoto TP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036108; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 1987, J THEOR BIOL, V127, P381, DOI 10.1016/S0022-5193(87)80136-4; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramo P, 2006, J THEOR BIOL, V242, P164, DOI 10.1016/j.jtbi.2006.02.011; Ristma L, 2014, NATURE, V507, P362; Robertson C, 2008, ATLAS CANC MORTALITY, P91; Ryu Seongho, 2008, Syst Synth Biol, V2, P49, DOI 10.1007/s11693-009-9022-y; Sanchez L, 1997, J THEOR BIOL, V189, P377, DOI 10.1006/jtbi.1997.0523; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schroeder T, 2007, CELL STEM CELL, V1, P479, DOI 10.1016/j.stem.2007.10.016; Scianna M, 2013, CH CRC MATH COMP BIO, P1, DOI 10.1201/b14075; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Southern J, 2008, PROGR BIOPHYSICS MOL, V96; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1577, DOI 10.1073/pnas.48.9.1577; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tamborero D, 2013, NATURE SCI REPORTS, V3; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Villani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017703; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	106	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97272	10.1371/journal.pone.0097272	http://dx.doi.org/10.1371/journal.pone.0097272			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869488	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336858300007
J	Kitano, YF; Benzoni, F; Arrigoni, R; Shirayama, Y; Wallace, CC; Fukami, H				Kitano, Yuko F.; Benzoni, Francesca; Arrigoni, Roberto; Shirayama, Yoshihisa; Wallace, Carden C.; Fukami, Hironobu			A Phylogeny of the Family Poritidae (Cnidaria, Scleractinia) Based on Molecular and Morphological Analyses	PLOS ONE			English	Article							SPECIES BOUNDARIES; CORAL; GENUS; ANTHOZOA; REEF; MITOCHONDRIAL; ACROPORIDAE; ATLANTIC; PACIFIC; GROWTH	The family Poritidae formerly included 6 genera: Alveopora, Goniopora, Machadoporites, Porites, Poritipora, and Stylaraea. Morphologically, the genera can be differentiated based on the number of tentacles, the number of septa and their arrangement, the length of the polyp column, and the diameter of the corallites. However, the phylogenetic relationships within and between the genera are unknown or contentious. On the one hand, Alveopora has been transferred to the Acroporidae recently because it was shown to be more closely related to this family than to the Poritidae by previous molecular studies. On the other hand, Goniopora is morphologically similar to 2 recently described genera, Machadoporites and Poritipora, particularly with regard to the number of septa (approximately 24), but they have not yet been investigated at the molecular level. In this study, we analyzed 93 samples from all 5 poritid genera and Alveopora using 2 genetic markers (the barcoding region of the mitochondrial COI and the ITS region of the nuclear rDNA) to investigate their phylogenetic relationships and to revise their taxonomy. The reconstructed molecular trees confirmed that Alveopora is genetically distant from all poritid genera but closely related to the family Acroporidae, whereas the other genera are genetically closely related. The molecular trees also revealed that Machadoporites and Poritipora were indistinguishable from Goniopora. However, Goniopora stutchburyi was genetically isolated from the other congeneric species and formed a sister group to Goniopora together with Porites and Stylaraea, thus suggesting that 24 septa could be an ancestral feature in the Poritidae. Based on these data, we move G. stutchburyi into a new genus, Bernardpora gen. nov., whereas Machadoporites and Poritipora are merged with Goniopora.	[Kitano, Yuko F.; Shirayama, Yoshihisa] Kyoto Univ, Field Sci & Educ Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Kitano, Yuko F.; Fukami, Hironobu] Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan; [Benzoni, Francesca; Arrigoni, Roberto] Univ Milano Bicocca, Deptartment Biotechnol & Biosci, Milan, Italy; [Shirayama, Yoshihisa] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Wallace, Carden C.] Museum Trop Queensland, Townsville, Qld, Australia	Kyoto University; University of Miyazaki; University of Milano-Bicocca; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Fukami, H (corresponding author), Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan.	hirofukami@cc.miyazaki-u.ac.jp	Benzoni, Francesca/G-1304-2010	Benzoni, Francesca/0000-0001-8906-1309; Arrigoni, Roberto/0000-0002-6825-6331; Kitano, Yuko/0000-0001-6118-4884	Japan science society [23-515];  [223070033]	Japan science society; 	Financial support was provided by a grant to H. F. from Grant-in-Aid for Scientific Research (B) (No. 223070033) and by Sasagawa Science Research grant from the Japan science society (23-515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2011, Bulletin of Zoological Nomenclature, V68, P162; Arrigoni R, 2012, MOL PHYLOGENET EVOL, V65, P183, DOI 10.1016/j.ympev.2012.06.001; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Basett-Smith PW, 1890, ANN MAG NAT HIST SER, V6, P353; Bedot M., 1907, Revue Suisse de Zoologie, V15; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Benzoni F, 2012, SYST BIODIVERS, V10, P417, DOI 10.1080/14772000.2012.744369; Benzoni Francesca, 2012, Zootaxa, V3447, P56; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Bernard H. M., 1903, CATALOGUE MADREPORAR, V4, P1; Bernard HM, 1905, CATALOGUE MADREPORAR, V5, P1; Bernard HM, 1906, CATALOG MADREPORARIA, V6, P1; Bernard HN, 1906, CAT MADREPORARIAN CO, V6, P145; Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Budd AF, 2011, J MORPHOL, V272, P66, DOI 10.1002/jmor.10899; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; Claereboudt MR, 2004, ZOOTAXA, P1; Crossland C., 1952, Scientific Reports Great Barrier Reef Expedition, V6, P85; Dai C. F., 2009, SCLERACTINIA FAUNA T; Dana J. D., 1846, ZOOPHYTES US EXPLORI, V7; Eguchi M, 1965, NEW ILLUSTRATED ENCY, V1, P270; Eguchi M., 1968, HYDROCORALS SCLERACT; FAUSTINO LEOPOLDO A., 1927, BUR SCI MANILA P I MONOGR NO, V22, P1; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; HEYWARD AJ, 1985, HEREDITY, V55, P269, DOI 10.1038/hdy.1985.101; Hoffmeister J. E., 1925, PAPERS DEP MARINE BI, VXXII, P1; Hunter Cynthia L., 1997, P1599; Jameson SC, 2012, P BIOL SOC WASH, V125, P189, DOI 10.2988/11-07.1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keshavmurthy S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01520; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kitano YF, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-25; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Milne-Edwards H., 1851, ARCH MUSEUM HIST NAT, V5, P1; Nemenzo F, 1955, NATURAL APPL SCI B, V15, P3; Nishihira M., 1995, HERMATYPIC CORALS JA; Nylander J.A.A., 2004, MR MODELTEST V2; Ortmann A., 1888, Zoologische Jahrbuecher, Viii, P143; Peach MB, 1999, INVERTEBR BIOL, V118, P1, DOI 10.2307/3226906; Quelch JJ, 1886, REP SCI RESULTS VOYA, V16, P1, DOI DOI 10.5962/BHL.TITLE.11615; Reijnen BT, 2014, MOL PHYLOGENET EVOL, V70, P383, DOI 10.1016/j.ympev.2013.09.028; Romano SL, 2000, B MAR SCI, V67, P1043; ROSEN BR, 1969, SCIENCE, V166, P119, DOI 10.1126/science.166.3901.119; Saville-Kent W, 1891, REC AUST MUS, V1, P123; Saville-Kent William, 1893, GREAT BARRIER REEF A; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Stimson J, 2011, CORAL REEFS, V30, P133, DOI 10.1007/s00338-010-0672-8; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tseng CC, 2005, CORAL REEFS, V24, P502, DOI 10.1007/s00338-005-0499-x; van Oppen MJH, 2002, J MOL EVOL, V55, P1, DOI 10.1007/s00239-001-0075-0; Vaughan T.W., 1943, GEOLOGICAL SOC AM SP, V44, P1, DOI DOI 10.1130/SPE44-P1; Vaughan T. Wayland, 1907, Proceedings of the United States National Museum Smithsonian Institution Washington, V32; VAUGHAN TW, 1918, PAPERS DEP MARINE BI, V9, P51; Veron J.E.N., 1982, Australian Institute of Marine Science Monograph Series, V5, P1; VERON J E N, 1990, Galaxea, V9, P95; VERON J E N, 1985, Records of the Western Australian Museum, V12, P147; Veron JEN, 2002, AUSTR I MARINE SCI M, V11, P1; Veron JEN, 2000, CORALS WORLD, V3; Verrill AE., 1864, B MUS COMP ZO L HARV, V1, P29; Wallace CC, 2012, GEOL BELG, V15, P388; Wallace CC, 2011, J NAT HIST, V45, P1905, DOI 10.1080/00222933.2011.573098; Wallace Carden C., 2009, Memoirs of the Queensland Museum, V54, P1; Wei NWV, 2006, ZOOL STUD, V45, P404; Wells J. W., 1956, pf328; WELLS JW, 1968, PAC SCI, V22, P274; Wells JW, 1955, U QUEENSL PAP DEP GE, V4, P1; WoRMS Editorial Board, 2013, WORLD REGISTER MARIN; Zwickl D. J, 2006, GENETIC ALGORITHM AP	78	40	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98406	10.1371/journal.pone.0098406	http://dx.doi.org/10.1371/journal.pone.0098406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871224	Green Published, gold			2022-12-27	WOS:000336858300041
J	Lancha, A; Rodriguez, A; Catalan, V; Becerril, S; Sainz, N; Ramirez, B; Burrell, MA; Salvador, J; Fruhbeck, G; Gomez-Ambrosi, J				Lancha, Andoni; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Sainz, Neira; Ramirez, Beatriz; Burrell, Maria A.; Salvador, Javier; Fruehbeck, Gema; Gomez-Ambrosi, Javier			Osteopontin Deletion Prevents the Development of Obesity and Hepatic Steatosis via Impaired Adipose Tissue Matrix Remodeling and Reduced Inflammation and Fibrosis in Adipose Tissue and Liver in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; DEFICIENCY PROTECTS; PLASMA OSTEOPONTIN; ANGIOTENSIN-II; UP-REGULATION; EXPRESSION; LEPTIN; ACCUMULATION	Osteopontin (OPN) is a multifunctional extracellular matrix (ECM) protein involved in multiple physiological processes. OPN expression is dramatically increased in visceral adipose tissue in obesity and the lack of OPN protects against the development of insulin resistance and inflammation in mice. We sought to unravel the potential mechanisms involved in the beneficial effects of the absence of OPN. We analyzed the effect of the lack of OPN in the development of obesity and hepatic steatosis induced by a high-fat diet (HFD) using OPN-KO mice. OPN expression was upregulated in epididymal white adipose tissue (EWAT) and liver in wild type (WT) mice with HFD. OPN-KO mice had higher insulin sensitivity, lower body weight and fat mass with reduced adipose tissue ECM remodeling and reduced adipocyte size than WT mice under a HFD. Reduced MMP2 and MMP9 activity was involved in the decreased ECM remodeling. Crown-like structure number in EWAT as well as F4/80-positive cells and Emr1 expression in EWAT and liver increased with HFD, while OPN-deficiency blunted the increase. Moreover, our data show for the first time that OPN-KO under a HFD mice display reduced fibrosis in adipose tissue and liver, as well as reduced oxidative stress in adipose tissue. Gene expression of collagens Col1a1, Col6a1 and Col6a3 in EWAT and liver, as well as the profibrotic cytokine Tgfb1 in EWAT were increased with HFD, while OPN-deficiency prevented this increase. OPN deficiency prevented hepatic steatosis via reduction in the expression of molecules involved in the onset of fat accumulation such as Pparg, Srebf1, Fasn, Mogat1, Dgat2 and Cidec. Furthermore, OPN-KO mice exhibited higher body temperature and improved BAT function. The present data reveal novel mechanisms of OPN in the development of obesity, pointing out the inhibition of OPN as a promising target for the treatment of obesity and fatty liver.	[Lancha, Andoni; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Sainz, Neira; Ramirez, Beatriz; Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra Clin, Metab Res Lab, Pamplona, Spain; [Lancha, Andoni; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Ramirez, Beatriz; Burrell, Maria A.; Salvador, Javier; Fruehbeck, Gema; Gomez-Ambrosi, Javier] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Burrell, Maria A.] Univ Navarra, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Salvador, Javier; Fruehbeck, Gema] Univ Navarra Clin, Dept Endocrinol & Nutr, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra; University of Navarra	Gomez-Ambrosi, J (corresponding author), Univ Navarra Clin, Metab Res Lab, Pamplona, Spain.	jagomez@unav.es	Burrell, María A/J-2570-2012; Gómez-Ambrosi, Javier/D-2984-2017; Sáinz, Neira/AAA-4624-2019; Burrell, María Ángela/AAB-5465-2022; Ramírez, Beatriz/I-1922-2017; Catalan, Victoria/H-3566-2017; Rodriguez, Amaia/D-3044-2019	Burrell, María A/0000-0002-8018-764X; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Burrell, María Ángela/0000-0002-8018-764X; Ramírez, Beatriz/0000-0003-3381-7220; Catalan, Victoria/0000-0002-7513-7509; Becerril, Sara/0000-0002-3441-1970; Rodriguez, Amaia/0000-0002-2180-461X	Fondo de Investigacion Sanitaria-FEDER; Instituto de Salud Carlos III (ISCIII) [PI081146, PI11/02681, PI12/00515]; Departments of Health and Education of the Gobierno de Navarra of Spain [58/2011, res228/2008]	Fondo de Investigacion Sanitaria-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Departments of Health and Education of the Gobierno de Navarra of Spain	This work was supported by grants from the Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII), (PI081146, PI11/02681, and PI12/00515); and from the Departments of Health (58/2011) and Education (res228/2008) of the Gobierno de Navarra of Spain. CIBERobn is an initiative of the ISCIII, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Becerril S, 2012, PHYSIOL GENOMICS, V44, P678, DOI 10.1152/physiolgenomics.00039.2012; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Borkham-Kamphorst E, 2011, LIVER INT, V31, P656, DOI 10.1111/j.1478-3231.2011.02495.x; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; CONTI M, 1991, CLIN CHEM, V37, P1273; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Fruhbeck G, 2005, NATURE, V438, P436, DOI 10.1038/438436b; FRUHBECK G, 1995, ANAL BIOCHEM, V225, P206, DOI 10.1006/abio.1995.1145; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Georgiadou P, 2008, EXPERT OPIN THER TAR, V12, P917, DOI 10.1517/14728222.12.8.917 ; Gerstenfeld LC, 1999, J BONE MINER RES, V14, P850, DOI 10.1359/jbmr.1999.14.6.850; Gomez-Ambrosi J, 2008, OBES SURG, V18, P1134, DOI 10.1007/s11695-008-9548-1; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hopps E, 2012, EUR J INTERN MED, V23, P99, DOI 10.1016/j.ejim.2011.09.012; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; Lai CF, 2006, CIRC RES, V98, P1479, DOI 10.1161/01.RES.0000227550.00426.60; Lancha A, 2012, NUTR RES REV, V25, P223, DOI 10.1017/S0954422412000145; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Liu H, 2010, CANCER LETT, V295, P27, DOI 10.1016/j.canlet.2010.02.012; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; Matsui Y, 2004, HYPERTENSION, V43, P1195, DOI 10.1161/01.HYP.0000128621.68160.dd; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Morales-Ibanez O, 2013, HEPATOLOGY, V58, P1742, DOI 10.1002/hep.26521; Muruzabal FJ, 2002, GEN COMP ENDOCR, V128, P149, DOI 10.1016/S0016-6480(02)00072-2; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sainz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029389; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhang LJ, 2010, J CELL BIOCHEM, V110, P219, DOI 10.1002/jcb.22529	59	54	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98398	10.1371/journal.pone.0098398	http://dx.doi.org/10.1371/journal.pone.0098398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871103	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300040
J	Rodger, AJ; Phillips, A; Speakman, A; Gilson, R; Fisher, M; Wilkins, E; Anderson, J; Johnson, M; O'Connell, R; Collins, S; Elford, J; Sherr, L; Lampe, FC				Rodger, Alison J.; Phillips, Andrew; Speakman, Andrew; Gilson, Richard; Fisher, Martin; Wilkins, Ed; Anderson, Jane; Johnson, Margaret; O'Connell, Rebecca; Collins, Simon; Elford, Jonathan; Sherr, Lorraine; Lampe, Fiona C.		ASTRA Antiretrovirals Sexual	Attitudes of People in the UK with HIV Who Are Antiretroviral (ART) Naive to Starting ART at High CD4 Counts for Potential Health Benefit or to Prevent HIV Transmission	PLOS ONE			English	Article							VIRAL LOAD; THERAPY; QUESTIONNAIRE; INFECTION; VALIDITY; SUPPORT	Objective: To assess if a strategy of early ART to prevent HIV transmission is acceptable to ART naive people with HIV with high CD4 counts. Design: ASTRA is a UK multicentre, cross sectional study of 3258 HIV outpatients in 2011/12. A self-completed questionnaire collected sociodemographic, behavioral and health data, and attitudes to ART; CD4 count was recorded from clinical records. Methods: ART naive participants with CD4 >= 350 cells/mu L (n = 281) were asked to agree/disagree/undecided with the statements (i) I would want to start treatment now if this would slightly reduce my risk of getting a serious illness, and (ii) I would want to start treatment now if this would make me less infectious to a sexual partner, even if there was no benefit to my own health. Results: Participants were 85% MSM, 76% white, 11% women. Of 281 participants, 49.5% and 45.2% agreed they would start ART for reasons (i) and (ii) respectively; 62.6% agreed with either (i) or (ii); 12.5% agreed with neither; 24.9% were uncertain. Factors independently associated (p<0.1) with agreement to (i) were: lower CD4, more recent HIV diagnosis, physical symptoms, not being depressed, greater financial hardship, and with agreement to (ii) were: being heterosexual, more recent HIV diagnosis, being sexually active. Conclusions: A strategy of starting ART at high CD4 counts is likely to be acceptable to the majority of HIV-diagnosed individuals. Almost half with CD4 >350 would start ART to reduce infectiousness, even if treatment did not benefit their own health. However a significant minority would not like to start ART either for modest health benefit or to reduce infectivity. Any change in approach to ART initiation must take account of individual preferences. Transmission models of potential benefit of early ART should consider that ART uptake may be lower than that seen with low CD4 counts.	[Rodger, Alison J.; Phillips, Andrew; Speakman, Andrew; Gilson, Richard; Sherr, Lorraine; Lampe, Fiona C.] UCL, London, England; [Fisher, Martin] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Wilkins, Ed] Pennine Acute Hosp NHS Trust, Manchester, Lancs, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, London, England; [Johnson, Margaret] Royal Free NHS London Fdn Trust, London, England; [O'Connell, Rebecca] Newham Univ NHS Hosp Trust, London, England; [Collins, Simon] HIV I Base, London, England; [Elford, Jonathan] City Univ London, London EC1V 0HB, England	University of London; University College London; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; City University London	Rodger, AJ (corresponding author), UCL, London, England.	alison.rodger@ucl.ac.uk	Collins, Simon/AAB-5123-2022; Anderson, Jane/A-1632-2012; Phillips, Andrew N/B-4427-2008; Lampe, Fiona/I-5826-2019	Anderson, Jane/0000-0001-5294-8707; Phillips, Andrew N/0000-0003-2384-4807; Lampe, Fiona/0000-0001-6851-5471; Sherr, Lorraine/0000-0002-5902-8011; Hart, Graham/0000-0001-9676-6577; Collins, Simon/0000-0002-3537-2432; Speakman, Andrew/0000-0003-1386-0627; Geretti, Anna Maria/0000-0002-3670-6588; Daskalopoulou, Marina/0000-0001-9927-0358; Wayal, Sonali/0000-0002-5878-7665; Haddow, Lewis/0000-0003-3016-2986; Johnson, Anne/0000-0003-1330-7100	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme [RP-PG-0608-10142]; National Institute for Health Research [NF-SI-0611-10255, RP-PG-0608-10142] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The ASTRA study presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme(RP-PG-0608-10142). The views expressed in this presentation are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EARLY ANTIRETROVIRAL; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Babiker AG, 2013, CLIN TRIALS, V10, pS5, DOI 10.1177/1740774512440342; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Department of Health, BHIVA EAGA POS STAT; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gamble T. M, 2013, 20 CROI ATL MARCH 3; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hirnschall G, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18757; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rodger AJ, 2013, ANTIVIR THER, V18, P285, DOI 10.3851/IMP2609; Sabin CA, 2013, AIDS, V27, P1839, DOI 10.1097/QAD.0b013e328360d546; Speakman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077230; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; US Department of Health and Human Services, GUIDELINES USE ANTIR; Williams I, 2012, HIV MED, V13, P1, DOI [10.1111/j.1468-1293.2012.01029_1.x, 10.1111/j.1468-1293.2012.01029.x]; World Health Organization, 2012, GUID OR PREEXP PROPH	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97340	10.1371/journal.pone.0097340	http://dx.doi.org/10.1371/journal.pone.0097340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869805	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000336858300009
J	Chavez, O; Godinez, FA; Beltran, A; Garcia, A; Zenit, R				Chavez, Oscar; Godinez, Francisco A.; Beltran, Alberto; Garcia, Armando; Zenit, Roberto			A Conjugate Thermo-Electric Model for a Composite Medium	PLOS ONE			English	Article								Electrical transmission signals have been used for decades to characterize the internal structure of composite materials. We theoretically analyze the transmission of an electrical signal through a composite material which consists of two phases with different chemical compositions. We assume that the temperature of the biphasic system increases as a result of Joule heating and its electrical resistivity varies linearly with temperature; this last consideration leads to simultaneously study the electrical and thermal effects. We propose a nonlinear conjugate thermo-electric model, which is solved numerically to obtain the current density and temperature profiles for each phase. We study the effect of frequency, resistivities and thermal conductivities on the current density and temperature. We validate the prediction of the model with comparisons with experimental data obtained from rock characterization tests.	[Chavez, Oscar; Beltran, Alberto; Zenit, Roberto] Univ Nacl Autonoma Mexico, Inst Invest Mat, Ciudad Univ, Mexico City 04510, DF, Mexico; [Godinez, Francisco A.] Univ Nacl Autonoma Mexico, Inst Ingn, Mexico City 04510, DF, Mexico; [Garcia, Armando] Tecnol Aplicada Explorac & Prod Petrolera Inc, Polanco, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Zenit, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Mat, Ciudad Univ, Mexico City 04510, DF, Mexico.	zenit@unam.mx	Godínez, Francisco/GPS-5022-2022	Beltran, Alberto/0000-0003-3920-5217; Zenit, Roberto/0000-0002-2717-4954	CONACyT-Mexico through its SENER-HIDROCARBUROS program [143927]	CONACyT-Mexico through its SENER-HIDROCARBUROS program	This research was funded by CONACyT-Mexico through its SENER-HIDROCARBUROS program (grant number: 143927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal K. C., 2001, NEWNES POWER ENG SER, pxvi; Ahrens TJ., 1995, ROCK PHYS PHASE RELA, DOI 10.1029/RF003; Archie G. E., 1942, T AIME, V146; Borai AM, 1985, 60 ANN TECHN C EXH S; Brovelli A, 2010, GEOPHYS J INT, V180, P225, DOI [10.1111/j.1365-246X.2009.04415.x, 10.1111/J.1365-246X.2009.04415.X]; Chavez O, 2011, APPL THERMAL ENG, V31; Chui ST, 2013, ELECTROMAGNETIC BEHA, P105; Dongqing L., 2004, ELECTROKINETICS MICR; Endres AL, 2000, EXPLORATION GEOPHYS, V31; GHANDAKLY AA, 1990, IEEE T IND APPL, V26, P1043, DOI 10.1109/28.62385; Hunt, 2005, PERCOLATION THEORY F; Hussain S, 2003, JORNAL EUROPEAN CERA, V23; Jackson J., 1975, CLASSICAL ELECTRODYN; Kagawa Y, 2007, J MAT SCI, V42; Kakati BK, 2011, INT J HYDROGEN ENERG, V36, P14851, DOI 10.1016/j.ijhydene.2011.02.136; Katsube TJ, 2000, TECHNICAL REPORT; Laukaitis A, 2008, ACTA PHYS POLONICA A, V113; M'Peko JC, 2003, SOLID STATE IONICS, V156, P59, DOI 10.1016/S0167-2738(02)00611-2; Maciej M, 2012, AIP C P, P1453; Makoviny I, 2011, EUROPEAN J WOOD WOOD, V59; Ozisik M.N., 1993, HEAT CONDUCTION; Ozisik M. N, 1994, FINITE DIFFERENCE ME; Palacky G.J., 1987, ELECTROMAGNETIC METH, V1; Sahimi M., 2011, FLOW TRANSPORT POROU, V2nd rev. enlarged ed., DOI DOI 10.1002/9783527636693; Salem HS, 2001, ENERGY SOURCES, V23; Schwartz LM, 1994, PHYSICA A; Singh BP, 2011, J NANOPARTICLE RES, V13; Sung YK, 2002, MACROMOLECULAR RES, V10; Timofte C, 2013, COMPUT MATH APPL, V66, P1573, DOI 10.1016/j.camwa.2012.12.003; Wang M, 2009, APPL THERMAL ENG, V29; Wang Z, 1991, TECHNICAL REPORT; Yue WZ, 2013, GEOPHYS J INT, V195, P282, DOI 10.1093/gji/ggt231	32	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97895	10.1371/journal.pone.0097895	http://dx.doi.org/10.1371/journal.pone.0097895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867618	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100026
J	Kalpakci, KN; Brown, WE; Hu, JC; Athanasiou, KA				Kalpakci, Kerem N.; Brown, Wendy E.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Cartilage Tissue Engineering Using Dermis Isolated Adult Stem Cells: The Use of Hypoxia during Expansion versus Chondrogenic Differentiation	PLOS ONE			English	Article							LOW-OXYGEN TENSION; INFRAPATELLAR FAT PAD; HUMAN MENISCUS CELLS; IN-VITRO; ARTICULAR-CARTILAGE; HYDROSTATIC-PRESSURE; STROMAL CELLS; COLLAGEN; CHONDROINDUCTION; PROLIFERATION	Dermis isolated adult stem (DIAS) cells, a subpopulation of dermis cells capable of chondrogenic differentiation in the presence of cartilage extracellular matrix, are a promising source of autologous cells for tissue engineering. Hypoxia, through known mechanisms, has profound effects on in vitro chondrogenesis of mesenchymal stem cells and could be used to improve the expansion and differentiation processes for DIAS cells. The objective of this study was to build upon the mechanistic knowledge of hypoxia and translate it to tissue engineering applications to enhance chondrogenic differentiation of DIAS cells through exposure to hypoxic conditions (5% O-2) during expansion and/or differentiation. DIAS cells were isolated and expanded in hypoxic (5% O2) or normoxic (20% O-2) conditions, then differentiated for 2 weeks in micromass culture on chondroitin sulfate-coated surfaces in both environments. Monolayer cells were examined for proliferation rate and colony forming efficiency. Micromasses were assessed for cellular, biochemical, and histological properties. Differentiation in hypoxic conditions following normoxic expansion increased per cell production of collagen type II 2.3 fold and glycosaminoglycans 1.2 fold relative to continuous normoxic culture (p<0.0001). Groups expanded in hypoxia produced 51% more collagen and 23% more GAGs than those expanded in normoxia (p<0.0001). Hypoxia also limited cell proliferation in monolayer and in 3D culture. Collectively, these data show hypoxic differentiation following normoxic expansion significantly enhances chondrogenic differentiation of DIAS cells, improving the potential utility of these cells for cartilage engineering.	[Kalpakci, Kerem N.] Medtron Spine & Biol, Memphis, TN USA; [Brown, Wendy E.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Athanasiou, KA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	athanasiou@ucdavis.edu			California Institute for Regenerative Medicine (CIRM) [TR3-05709]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by California Institute for Regenerative Medicine (CIRM) grant #TR3-05709 (http://www.cirm.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Adesida AB, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt100; Adesida AB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2267; AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021, DOI 10.1152/ajplung.2001.281.4.L1021; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Boraldi F, 2007, BBA-PROTEINS PROTEOM, V1774, P1402, DOI 10.1016/j.bbapap.2007.08.011; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Chung HM, 2009, EXPERT OPIN BIOL TH, V9, P1499, DOI 10.1517/14712590903307362; Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Deng Y, 2007, ARTHRITIS RHEUM-US, V56, P168, DOI 10.1002/art.22300; Diekman BO, 2009, TISSUE ENG A; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; FALANGA V, 1993, J CELL PHYSIOL, V157, P408, DOI 10.1002/jcp.1041570225; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Fu WL, 2011, CHINESE MED J-PEKING, V124, P3959, DOI 10.3760/cma.j.issn.0366-6999.2011.23.022; Glowacki J, 2005, Orthod Craniofac Res, V8, P200, DOI 10.1111/j.1601-6343.2005.00333.x; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1; HASELGROVE JC, 1993, AM J PHYSIOL, V265, pC497, DOI 10.1152/ajpcell.1993.265.2.C497; Hoben GA, 2008, BIOTECHNOL BIOENG, V100, P587, DOI 10.1002/bit.21768; Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641; Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Lavoie JF, 2009, STEM CELLS DEV, V18, P893, DOI 10.1089/scd.2008.0260; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; Malladi P, 2007, TISSUE ENG, V13, P1159, DOI 10.1089/ten.2006.0265; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Mizuno S, 2005, CELLS TISSUES ORGANS, V180, P151, DOI 10.1159/000088243; Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5; Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249; Oberringer M, 2005, HISTOCHEM CELL BIOL, V123, P595, DOI 10.1007/s00418-005-0782-5; Pacifici M, 2000, CONNECT TISSUE RES, V41, P175, DOI 10.3109/03008200009005288; Provot S, 2007, ANN NY ACAD SCI, V1117, P26, DOI 10.1196/annals.1402.076; Qu CJ, 2012, CELL TISSUE RES, V348, P109, DOI 10.1007/s00441-012-1366-z; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Sanchez-Adams J, 2012, BIOMATERIALS, V33, P109, DOI 10.1016/j.biomaterials.2011.09.038; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Siddiqui Aamir, 1996, Wound Repair and Regeneration, V4, P211, DOI 10.1046/j.1524-475X.1996.40207.x; Steinbrech DS, 1999, J SURG RES, V84, P127, DOI 10.1006/jsre.1999.5627; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050	60	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98570	10.1371/journal.pone.0098570	http://dx.doi.org/10.1371/journal.pone.0098570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867063	Green Published, gold			2022-12-27	WOS:000336914100063
J	Muller, I; Larsson, K; Frenzel, A; Oliynyk, G; Zirath, H; Prochownik, EV; Westwood, NJ; Henriksson, MA				Muller, Inga; Larsson, Karin; Frenzel, Anna; Oliynyk, Ganna; Zirath, Hanna; Prochownik, Edward V.; Westwood, Nicholas J.; Henriksson, Marie Arsenian			Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE ANALYSES; N-MYC; NEURONAL DIFFERENTIATION; NEOPLASTIC PHENOTYPE; MYC/MAX DIMERIZATION; MURINE DEVELOPMENT; INDUCED APOPTOSIS; TUMOR DORMANCY; NEURAL-NETWORK	Members of the MYC family are the most frequently deregulated oncogenes in human cancer and are often correlated with aggressive disease and/or poorly differentiated tumors. Since patients with MYCN-amplified neuroblastoma have a poor prognosis, targeting MYCN using small molecule inhibitors could represent a promising therapeutic approach. We have previously demonstrated that the small molecule 10058-F4, known to bind to the c-MYC bHLHZip dimerization domain and inhibiting the c-MYC/MAX interaction, also interferes with the MYCN/MAX dimerization in vitro and imparts anti-tumorigenic effects in neuroblastoma tumor models with MYCN overexpression. Our previous work also revealed that MYCN-inhibition leads to mitochondrial dysfunction resulting in accumulation of lipid droplets in neuroblastoma cells. To expand our understanding of how small molecules interfere with MYCN, we have now analyzed the direct binding of 10058-F4, as well as three of its analogs; #474, #764 and 10058-F4(7RH), one metabolite C-m/z 232, and a structurally unrelated c-MYC inhibitor 10074-G5, to the bHLHZip domain of MYCN. We also assessed their ability to induce apoptosis, neurite outgrowth and lipid accumulation in neuroblastoma cells. Interestingly, all c-MYC binding molecules tested also bind MYCN as assayed by surface plasmon resonance. Using a proximity ligation assay, we found reduced interaction between MYCN and MAX after treatment with all molecules except for the 10058-F4 metabolite C-m/z 232 and the non-binder 10058-F4(7RH). Importantly, 10074-G5 and 10058-F4 were the most efficient in inducing neuronal differentiation and lipid accumulation in MYCN-amplified neuroblastoma cells. Together our data demonstrate MYCN-binding properties for a selection of small molecules, and provide functional information that could be of importance for future development of targeted therapies against MYCN-amplified neuroblastoma.	[Muller, Inga; Larsson, Karin; Frenzel, Anna; Oliynyk, Ganna; Zirath, Hanna; Henriksson, Marie Arsenian] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Prochownik, Edward V.] UMPC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA USA; [Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of St Andrews; University of St Andrews	Henriksson, MA (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Marie.Henriksson@ki.se	Henriksson, Marie Arsenian/F-5010-2015; Larsson, Karin/AAO-7701-2021	Larsson, Karin/0000-0002-6403-2736; Oliynyk, Ganna/0000-0002-6274-4465; Arsenian Henriksson, Marie/0000-0001-6376-7792; Westwood, Nicholas/0000-0003-0630-0138	Swedish Research Council; Swedish Cancer Society; KI (KID)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); KI (KID)	This study was funded by grants from the Swedish Research Council and the Swedish Cancer Society. IM and HZ were recipients of graduate student grants from KI (KID), MAH was recipient of a Senior Investigator Award from the Swedish Cancer Society, and NJW was a Royal Society University Research Fellow when this work began. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Clausen DM, 2010, J PHARMACOL EXP THER, V335, P715, DOI 10.1124/jpet.110.170555; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fieber W, 2001, J MOL BIOL, V307, P1395, DOI 10.1006/jmbi.2001.4537; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Guo JX, 2009, CANCER CHEMOTH PHARM, V63, P615, DOI 10.1007/s00280-008-0774-y; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Harvey SR, 2012, J AM CHEM SOC, V134, P19384, DOI 10.1021/ja306519h; HIRVONEN H, 1990, ONCOGENE, V5, P1787; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lin CP, 2007, ANTI-CANCER DRUG, V18, P161, DOI 10.1097/CAD.0b013e3280109424; LOKE SL, 1988, CURR TOP MICROBIOL, V141, P282; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Michel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041070; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Prochownik Edward V, 2010, Genes Cancer, V1, P650; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shachaf CM, 2005, CANCER RES, V65, P4471, DOI 10.1158/0008-5472.CAN-05-1172; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597; STANTON BR, 1992, BRAIN PATHOL, V2, P71; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang HB, 2013, ONCOTARGET, V4, P936, DOI 10.18632/oncotarget.1108; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yap JL, 2013, BIOORG MED CHEM LETT, V23, P370, DOI 10.1016/j.bmcl.2012.10.013; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	54	54	55	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97285	10.1371/journal.pone.0097285	http://dx.doi.org/10.1371/journal.pone.0097285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859015	Green Accepted, Green Published, gold			2022-12-27	WOS:000336839400010
J	Gao, Y; Liu, JJ; Zhu, SY; Yi, X				Gao, Y.; Liu, J-J; Zhu, S-Y; Yi, X.			The Diagnostic Accuracy of Ultrasonography versus Endoscopy for Primary Nasopharyngeal Carcinoma (vol 9, e90412, 2014)	PLOS ONE			English	Correction																		Gao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090412	1	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e99679	10.1371/journal.pone.0099679	http://dx.doi.org/10.1371/journal.pone.0099679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887439	gold, Green Published			2022-12-27	WOS:000336956300126
J	Hamilton, ST; Milbradt, J; Marschall, M; Rawlinson, WD				Hamilton, Stuart T.; Milbradt, Jens; Marschall, Manfred; Rawlinson, William D.			Human Cytomegalovirus Replication Is Strictly Inhibited by siRNAs Targeting UL54, UL97 or UL122/123 Gene Transcripts	PLOS ONE			English	Article							COMPOUND AIC246 LETERMOVIR; IMMEDIATE-EARLY PROMOTER; EFFICIENT INHIBITION; DNA-REPLICATION; IN-VITRO; EXPRESSION; CELL; INTERFERENCE; INFECTION; PROTEINS	Human cytomegalovirus (HCMV) causes severe sequelae in immunocompromised hosts. Current antiviral therapies have serious adverse effects, with treatment in many clinical settings problematic, making new therapeutic approaches necessary. We examined the in vitro efficacy of small interfering RNAs (siRNAs) targeting the HCMV gene transcripts UL54 (DNA polymerase), UL97 (protein kinase) and UL122/123 (immediate-early proteins) as inhibitors of viral protein expression and virus replication in cell cultures. Two siRNAs for each HCMV target (designated A and B) were assessed for inhibition efficacy using western blot and standard plaque assays. Continuous human embryonic kidney 293T cells were treated with HCMV or non-specific scrambled (siSc) siRNA followed by transfection with plasmids expressing the target transcripts. Human MRC-5 fibroblasts were HCMV-siRNA or siSc treated, infected with HCMV strain AD169 (1 pfu/cell) and HCMV immediate-early (IE1p72 and IE2p86), early (pp65), early-late (pUL97) and true late (MCP) protein and virus progeny production measured during a single round of replication. Concordant results showed siUL54B, siUL97A and siUL122B displayed the most potent inhibitory effects with a reduction of 92.7%, 99.6% and 93.7% in plasmid protein expression, 65.9%, 58.1% and 64.8% in total HCMV protein expression and 97.2%, 96.2% and 94.3% (p < 0.0001) in viral progeny production respectively. Analysing the siRNA inhibitory effects during multiple rounds of HCMV replication at a multiplicity of infection of 0.001 pfu/cell, siUL54B, siUL97A and siUL122B treatment resulted in a reduction of 80.0%, 59.6% and 84.5% in total HCMV protein expression, 52.9%, 49.2% and 58.3% in number of cells infected and 98.5%, 91.4% and 99.1%(p < 0.0001) in viral progeny production at 7 dpi respectively. These results suggest potential in vivo siRNA therapies targeting the HCMV gene transcripts UL54, UL97 and UL122/123 would be highly effective, however, the antiviral efficacy of siRNAs targeting UL97 may be more highly dependent on viral load and methods of administration.	[Hamilton, Stuart T.; Rawlinson, William D.] Prince Wales Hosp, SEALS Microbiol, Div Virol, Sydney, NSW, Australia; [Hamilton, Stuart T.; Rawlinson, William D.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Milbradt, Jens; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of New South Wales Sydney; University of New South Wales Sydney; University of Erlangen Nuremberg	Rawlinson, WD (corresponding author), Prince Wales Hosp, SEALS Microbiol, Div Virol, Sydney, NSW, Australia.	w.rawlinson@unsw.edu.au		Rawlinson, William/0000-0003-0988-7827; Hamilton, Stuart/0000-0002-2170-4889; Milbradt, Jens/0000-0003-2172-7471	Stillbirth Foundation Australia; NHMRC [APP1045989]; Deutsche Forschungsgemeinschaft [SFB796, C3]; DAAD/Go8 [54390135]	Stillbirth Foundation Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD/Go8(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Stillbirth Foundation Australia (http://www.stillbirthfoundation.org.au), the NHMRC (APP1045989), the Deutsche Forschungsgemeinschaft SFB796 (grant C3) and DAAD/Go8 (grant 54390135), support which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 1999, J VIROL, V73, P10458, DOI 10.1128/JVI.73.12.10458-10471.1999; Bai ZQ, 2010, BIOSCI BIOTECH BIOCH, V74, P1368, DOI 10.1271/bbb.90966; Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Duan QJ, 2009, J BASIC MICROB, V49, P531, DOI 10.1002/jobm.200800364; E XF, 2012, J VIROL, V86, P5660, DOI 10.1128/JVI.06338-11; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Goldner T, 2011, J VIROL, V85, P10884, DOI 10.1128/JVI.05265-11; Graf L, 2013, VIRUSES-BASEL, V5, P3213, DOI 10.3390/v5123213; Hamilton ST, 2013, J GEN VIROL, V94, P2495, DOI 10.1099/vir.0.052878-0; Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899; Hertel L, 2007, PLOS PATHOG, V3, P14, DOI 10.1371/journal.ppat.0030006; Isomura H, 2004, J VIROL, V78, P12788, DOI 10.1128/JVI.78.23.12788-12799.2004; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Kerry JA, 1996, J VIROL, V70, P373, DOI 10.1128/JVI.70.1.373-382.1996; Lischka P, 2010, ANTIMICROB AGENTS CH, V54, P1290, DOI 10.1128/AAC.01596-09; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Marschall M, 2012, ANTIMICROB AGENTS CH, V56, P1135, DOI 10.1128/AAC.05908-11; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Nekhai S, 2006, CURR OPIN MOL THER, V8, P52; Renzette N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003735; Renzette N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001344; Sadanari H, 2005, ARCH VIROL, V150, P1763, DOI 10.1007/s00705-005-0559-0; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shin MC, 2006, ACTA VIROL, V50, P263; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Tao R, 2008, CURR MICROBIOL, V57, P395, DOI 10.1007/s00284-008-9210-0; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wang KZ, 2013, ACTA BIOCH BIOPH SIN, V45, P401, DOI 10.1093/abbs/gmt025; Wiebusch L, 2004, J GEN VIROL, V85, P179, DOI 10.1099/vir.0.19453-0; Wu J, 2004, EXPERT OPIN BIOL TH, V4, P1649, DOI 10.1517/14712598.4.10.1649; Zheng ZM, 2005, ANN NY ACAD SCI, V1058, P105, DOI 10.1196/annals.1359.019	38	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97231	10.1371/journal.pone.0097231	http://dx.doi.org/10.1371/journal.pone.0097231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887060	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300014
J	Rosa-Ribeiro, R; Nishan, U; Vidal, RO; Barbosa, GO; Reis, LO; Cesar, CL; Carvalho, HF				Rosa-Ribeiro, Rafaela; Nishan, Umar; Vidal, Ramon Oliveira; Barbosa, Guilherme Oliveira; Reis, Leonardo Oliveira; Cesar, Carlos Lenz; Carvalho, Hernandes F.			Transcription Factors Involved in Prostate Gland Adaptation to Androgen Deprivation	PLOS ONE			English	Article							VENTRAL PROSTATE; B-MYB; PROGRAMMED DEATH; CELL-CYCLE; KAPPA-B; RECEPTOR; CANCER; EXPRESSION; APOPTOSIS; PROLIFERATION	Androgens regulate prostate physiology, and exert their effects through the androgen receptor. We hypothesized that androgen deprivation needs additional transcription factors to orchestrate the changes taking place in the gland after castration and for the adaptation of the epithelial cells to the androgen-deprived environment, ultimately contributing to the origin of castration-resistant prostate cancer. This study was undertaken to identify transcription factors that regulate gene expression after androgen deprivation by castration (Cas). For the sake of comparison, we extended the analysis to the effects of administration of a high dose of 17 beta-estradiol (E2) and a combination of both (Cas+ E2). We approached this by (i) identifying gene expression profiles and enrichment terms, and by searching for transcription factors in the derived regulatory pathways; and (ii) by determining the density of putative transcription factor binding sites in the proximal promoter of the 10 most up- or down-regulated genes in each experimental group in comparison to the controls Gapdh and Tbp7. Filtering and validation confirmed the expression and localized EVI1 (Mecom), NFY, ELK1, GATA2, MYBL1, MYBL2, and NFkB family members (NFkB1, NFkB2, REL, RELA and RELB) in the epithelial and/or stromal cells. These transcription factors represent major regulators of epithelial cell survival and immaturity as well as an adaptation of the gland as an immune barrier in the absence of functional stimulation by androgens. Elk1 was expressed in smooth muscle cells and was up-regulated after day 4. Evi1 and Nfy genes are expressed in both epithelium and stroma, but were apparently not affected by androgen deprivation.	[Rosa-Ribeiro, Rafaela; Nishan, Umar; Barbosa, Guilherme Oliveira; Carvalho, Hernandes F.] Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Vidal, Ramon Oliveira] Natl Ctr Res Energy & Mat, Lab Bioinformat, Sao Paulo, Brazil; [Reis, Leonardo Oliveira] Univ Estadual Campinas, Div Urol, Sao Paulo, Brazil; [Cesar, Carlos Lenz] Univ Estadual Campinas, Dept Quantum Phys, Sao Paulo, Brazil; [Cesar, Carlos Lenz; Carvalho, Hernandes F.] Univ Estadual Campinas, Natl Inst Photon Appl Cell Biol INFABiC, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Carvalho, HF (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil.	hern@unicamp.br	Lenz Cesar, Carlos/F-2442-2018; Barbosa, Guilherme Oliveira/AAB-6855-2019; MSc, Leonardo O. Reis MD/B-3652-2011	Lenz Cesar, Carlos/0000-0001-5573-9636; Barbosa, Guilherme Oliveira/0000-0002-5881-0896; MSc, Leonardo O. Reis MD/0000-0003-2092-414X; da Rosa Ribeiro, Rafaela/0000-0003-1297-2205	FAPESP [2009/16150-6]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by grants from FAPESP (Grant nr 2009/16150-6) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli E, 2004, J ANDROL, V25, P50; Asirvatham AJ, 2006, ENDOCRINOLOGY, V147, P257, DOI 10.1210/en.2005-0942; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BERGES RR, 1993, P NATL ACAD SCI USA, V90, P8910, DOI 10.1073/pnas.90.19.8910; Bohm M, 2009, ONCOGENE, V28, P3847, DOI 10.1038/onc.2009.243; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Culig Z, 2012, WORLD J UROL, V30, P297, DOI 10.1007/s00345-011-0797-6; Desai KV, 2004, MOL ENDOCRINOL, V18, P2895, DOI 10.1210/me.2004-0033; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; FURUYA Y, 1993, ENDOCRINOLOGY, V133, P2660, DOI 10.1210/en.133.6.2660; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; Garcia-Florez M, 2005, BRAZ J MED BIOL RES, V38, P487, DOI 10.1590/S0100-879X2005000400002; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; Grassilli E, 1999, CANCER RES, V59, P2451; Griekspoor A, 2007, NUCL RECEPT SIGNAL, V5, P1; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; LEAV I, 1989, PROSTATE, V15, P23, DOI 10.1002/pros.2990150104; Leimgruber C, 2013, J CELL PHYSIOL, V228, P1551, DOI 10.1002/jcp.24314; Leimgruber C, 2011, PROSTATE, V71, P1097, DOI 10.1002/pros.21322; Lim KC, 2012, J CLIN INVEST, V122, P3705, DOI 10.1172/JCI61619; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; Mirosevich J, 1999, J ENDOCRINOL, V162, P341, DOI 10.1677/joe.0.1620341; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; NEUMANN F, 1986, J STEROID BIOCHEM, V25, P885, DOI 10.1016/0022-4731(86)90320-1; Otto-Duessel M, 2012, ENDOCR RES, V37, P203, DOI 10.3109/07435800.2012.668254; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187; Quintar AA, 2012, INT J ANDROL, V35, P845, DOI 10.1111/j.1365-2605.2012.01288.x; Robinson C, 1996, ONCOGENE, V12, P1855; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Srivastava SK, 2012, CARCINOGENESIS, V33, P1149, DOI 10.1093/carcin/bgs134; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Uramoto H, 2004, J CELL SCI, V117, P5323, DOI 10.1242/jcs.01384; Vilamaior PSL, 2000, PROSTATE, V45, P253; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; Zhang GJ, 1998, ONCOL REP, V5, P1211	61	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97080	10.1371/journal.pone.0097080	http://dx.doi.org/10.1371/journal.pone.0097080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886974	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300012
J	Takebayashi, H; Yamamoto, N; Umino, A; Nishikawa, T				Takebayashi, Hironao; Yamamoto, Naoki; Umino, Asami; Nishikawa, Toru			Identification of Developmentally Regulated PCP-Responsive Non-Coding RNA, prt6, in the Rat Thalamus	PLOS ONE			English	Article							INDUCED C-FOS; MICRORNA EXPRESSION; PREFRONTAL CORTEX; NMDA RECEPTOR; SAP97 GENE; SCHIZOPHRENIA; PHENCYCLIDINE; PROTEIN; PATTERNS; ABNORMALITIES	Schizophrenia and similar psychoses induced by NMDA-type glutamate receptor antagonists, such as phencyclidine (PCP) and ketamine, usually develop after adolescence. Moreover, adult-type behavioral disturbance following NMDA receptor antagonist application in rodents is observed after a critical period at around 3 postnatal weeks. These observations suggest that the schizophrenic symptoms caused by and psychotomimetic effects of NMDA antagonists require the maturation of certain brain neuron circuits and molecular networks, which differentially respond to NMDA receptor antagonists across adolescence and the critical period. From this viewpoint, we have identified a novel developmentally regulated phencyclidine-responsive transcript from the rat thalamus, designated as prt6, as a candidate molecule involved in the above schizophrenia-related systems using a DNA microarray technique. The transcript is a non-coding RNA that includes sequences of at least two microRNAs, miR132 and miR212, and is expressed strongly in the brain and testis, with trace or non-detectable levels in the spleen, heart, liver, kidney, lung and skeletal muscle, as revealed by Northern blot analysis. The systemic administration of PCP (7.5 mg/kg, subcutaneously (s.c.)) significantly elevated the expression of prt6 mRNA in the thalamus at postnatal days (PD) 32 and 50, but not at PD 8, 13, 20, or 24 as compared to saline-treated controls. At PD 50, another NMDA receptor antagonist, dizocilpine (0.5 mg/kg, s.c.), and a schizophrenomimetic dopamine agonist, methamphetamine (4.8 mg/kg, s.c.), mimicked a significant increase in the levels of thalamic prt6 mRNAs, while a D2 dopmamine receptor antagonist, haloperidol, partly inhibited the increasing influence of PCP on thalamic prt6 expression without its own effects. These data indicate that prt6 may be involved in the pathophysiology of the onset of drug-induced schizophrenia-like symptoms and schizophrenia through the possible dysregulation of target genes of the long non-coding RNA or microRNAs in the transcript.	[Takebayashi, Hironao; Yamamoto, Naoki; Umino, Asami; Nishikawa, Toru] Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Nishikawa, T (corresponding author), Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	tnis.psyc@tmd.ac.jp			Tokyo Medical and Dental University Funds; Ministry of Education, Culture, Sports, Science and Technology of Japan	Tokyo Medical and Dental University Funds; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Tokyo Medical and Dental University Funds. In addition, a part of this study is the result of "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. These institutions had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Brugger S, 2011, BIOL PSYCHIAT, V69, P495, DOI 10.1016/j.biopsych.2010.10.004; Celada P, 2013, INT J NEUROPSYCHOPH, V16, P2145, DOI 10.1017/S1461145713000643; Clinton SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1353, DOI 10.1038/sj.npp.1300451; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; DRAGUNOW M, 1990, NEUROSCI LETT, V111, P39, DOI 10.1016/0304-3940(90)90341-6; Duncan GE, 1999, BRAIN RES, V843, P171, DOI 10.1016/S0006-8993(99)01776-X; Fujiwara Y, 1987, BEHAVIORAL; GREIFENSTEIN F E, 1958, Anesth Analg, V37, P283; Hiraoka S, 2010, EUR NEUROPSYCHOPHARM, V20, P176, DOI 10.1016/j.euroneuro.2009.08.007; Ito T, 2007, INT J NEUROPSYCHOPH, V10, P717, DOI 10.1017/S1461145707007882; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krishnan J, 2014, FEBS J, V281, P34, DOI 10.1111/febs.12578; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; MIYASAKA M, 1968, INT J NEUROPHARMACOL, V7, P557; Murata M, 2001, NEUROSCI LETT, V303, P99, DOI 10.1016/S0304-3940(01)01710-4; NISHIKAWA T, 1991, TANIG SYMP BRAIN SCI, V14, P65; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; PETERSEN R C, 1978, National Institute on Drug Abuse Research Monograph, P1; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Sakurai S, 2004, J NEUROCHEM, V90, P1378, DOI 10.1111/j.1471-4159.2004.02592.x; Santana N, 2011, BIOL PSYCHIAT, V69, P918, DOI 10.1016/j.biopsych.2010.10.030; Sato D, 1997, NEUROSCI LETT, V239, P21, DOI 10.1016/S0304-3940(97)00879-3; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; SHINTOMI K, 1975, EUR J PHARMACOL, V31, P195, DOI 10.1016/0014-2999(75)90040-0; Shirayama Y, 2000, SYNAPSE, V35, P292, DOI 10.1002/(SICI)1098-2396(20000315)35:4<292::AID-SYN7>3.3.CO;2-V; Sim K, 2006, J NEURAL TRANSM, V113, P907, DOI 10.1007/s00702-005-0363-8; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Takebayashi H, 2009, INT J NEUROPSYCHOPH, V12, P1111, DOI 10.1017/S1461145709009997; TANII Y, 1994, J PHARMACOL EXP THER, V269, P1040; Tsuchida K, 1994, ONTOGENY ENHANCED ST; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2; Umino A, 1998, BRIT J PHARMACOL, V124, P377, DOI 10.1038/sj.bjp.0701830; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vollenweider FX, 1997, EUR NEUROPSYCHOPHARM, V7, P25, DOI 10.1016/S0924-977X(96)00042-9; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Watis L, 2008, J NEURAL TRANSM, V115, P493, DOI 10.1007/s00702-007-0859-5	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97955	10.1371/journal.pone.0097955	http://dx.doi.org/10.1371/journal.pone.0097955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886782	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300029
J	Wang, JF; Wu, XZ; Xiao, R; Dong, PT; Wang, CG				Wang, Jun Feng; Wu, Xue Zhong; Xiao, Rui; Dong, Pei Tao; Wang, Chao Guang			Performance-Enhancing Methods for Au Film over Nanosphere Surface-Enhanced Raman Scattering Substrate and Melamine Detection Application	PLOS ONE			English	Article							COLLOIDAL SILVER; DNA DETECTION; SPECTROSCOPY; SERS; NANOPARTICLES; LITHOGRAPHY; LABEL	A new high-performance surface-enhanced Raman scattering (SERS) substrate with extremely high SERS activity was produced. This SERS substrate combines the advantages of Au film over nanosphere (AuFON) substrate and Ag nanoparticles (AgNPs). A three order enhancement of SERS was observed when Rhodamine 6G (R6G) was used as a probe molecule to compare the SERS effects of the new substrate and commonly used AuFON substrate. These new SERS substrates can detect R6G down to 1 nM. The new substrate was also utilized to detect melamine, and the limit of detection (LOD) is 1 ppb. A linear relationship was also observed between the SERS intensity at Raman peak 682 cm(-1) and the logarithm of melamine concentrations ranging from 10 ppm to 1 ppb. This ultrasensitive SERS substrate is a promising tool for detecting trace chemical molecules because of its simple and effective fabrication procedure, high sensitivity and high reproducibility of the SERS effect.	[Wang, Jun Feng; Wu, Xue Zhong; Dong, Pei Tao; Wang, Chao Guang] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Xiao, Rui] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Jun Feng; Dong, Pei Tao] Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai, Peoples R China	National University of Defense Technology - China; Academy of Military Medical Sciences - China; Chinese Academy of Sciences	Xiao, R (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	ruixiao203@sina.com; ptdong@nudt.edu.cn			National University of Defense Technology [kxk130302]; Foundation of State Key Laboratories of Transducer Technology [SKT1201]	National University of Defense Technology; Foundation of State Key Laboratories of Transducer Technology	This work was funded by the Research Project of National University of Defense Technology under Grant No. kxk130302 and the Foundation of State Key Laboratories of Transducer Technology under Grant No. SKT1201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2013, APPL SURF SCI, V270, P6, DOI 10.1016/j.apsusc.2012.11.165; Chen J, 2008, MATER CHEM PHYS, V108, P421, DOI 10.1016/j.matchemphys.2007.10.019; Dasary SSR, 2009, J AM CHEM SOC, V131, P13806, DOI 10.1021/ja905134d; Dick LA, 2002, J PHYS CHEM B, V106, P853, DOI 10.1021/jp013638l; Du XB, 2010, APPL SPECTROSC, V64, P781, DOI 10.1366/000370210791666426; Fan MK, 2011, ANAL CHIM ACTA, V693, P7, DOI 10.1016/j.aca.2011.03.002; Fang C, 2008, BIOSENS BIOELECTRON, V24, P216, DOI 10.1016/j.bios.2008.03.032; Harpster MH, 2009, BIOSENS BIOELECTRON, V25, P674, DOI 10.1016/j.bios.2009.05.020; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; HILDEBRANDT P, 1984, J PHYS CHEM-US, V88, P5935, DOI 10.1021/j150668a038; Kang T, 2010, NANO LETT, V10, P1189, DOI 10.1021/nl1000086; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Lin M, 2008, J FOOD SCI, V73, pT129, DOI 10.1111/j.1750-3841.2008.00901.x; Liu BH, 2012, ANAL CHEM, V84, P255, DOI 10.1021/ac202452t; MOODY RL, 1987, APPL SPECTROSC, V41, P966, DOI 10.1366/0003702874447761; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Raveendran P, 2006, GREEN CHEM, V8, P34, DOI 10.1039/b512540e; RUNDQUIST PA, 1989, J CHEM PHYS, V91, P4932, DOI 10.1063/1.456734; Shende Chetan, 2010, Sensing and Instrumentation for Food Quality and Safety, V4, P101, DOI 10.1007/s11694-010-9100-6; Tsoutsi D, 2013, NANOSCALE, V5, P5841, DOI 10.1039/c3nr01518a; Velikov KP, 2003, LANGMUIR, V19, P1384, DOI 10.1021/la026610p; Vo-Dinh T, 1998, TRAC-TREND ANAL CHEM, V17, P557, DOI 10.1016/S0165-9936(98)00069-7; Wang YQ, 2013, CHEM REV, V113, P1391, DOI 10.1021/cr300120g; Yang SM, 2006, SMALL, V2, P458, DOI 10.1002/smll.200500390; Zhao YH, 2013, TALANTA, V113, P7, DOI 10.1016/j.talanta.2013.03.075	25	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97976	10.1371/journal.pone.0097976	http://dx.doi.org/10.1371/journal.pone.0097976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886913	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300031
J	Yaung, SJ; Esvelt, KM; Church, GM				Yaung, Stephanie J.; Esvelt, Kevin M.; Church, George M.			CRISPR/Cas9-Mediated Phage Resistance Is Not Impeded by the DNA Modifications of Phage T4	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRISPR RNA; BACTERIOPHAGE; GENE; TRANSCRIPTION; INTERFERENCE; RESTRICTION; GENOME	Bacteria rely on two known DNA-level defenses against their bacteriophage predators: restriction-modification and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-associated (Cas) systems. Certain phages have evolved countermeasures that are known to block endonucleases. For example, phage T4 not only adds hydroxymethyl groups to all of its cytosines, but also glucosylates them, a strategy that defeats almost all restriction enzymes. We sought to determine whether these DNA modifications can similarly impede CRISPR-based defenses. In a bioinformatics search, we found naturally occurring CRISPR spacers that potentially target phages known to modify their DNA. Experimentally, we show that the Cas9 nuclease from the Type II CRISPR system of Streptococcus pyogenes can overcome a variety of DNA modifications in Escherichia coli. The levels of Cas9-mediated phage resistance to bacteriophage T4 and the mutant phage T4 gt, which contains hydroxymethylated but not glucosylated cytosines, were comparable to phages with unmodified cytosines, T7 and the T4-like phage RB49. Our results demonstrate that Cas9 is not impeded by N-6-methyladenine, 5-methylcytosine, 5-hydroxymethylated cytosine, or glucosylated 5-hydroxymethylated cytosine.	[Yaung, Stephanie J.; Esvelt, Kevin M.; Church, George M.] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Yaung, Stephanie J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Yaung, Stephanie J.] MIT, Harvard Mit Div Hlth Sci & Technol, Program Med Engn & Med Phys, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Church, GM (corresponding author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969; Esvelt, Kevin/0000-0001-8797-3945; Yaung, Stephanie/0000-0003-4203-2505	US Department of Energy [DE-FG02-02ER63445]; Wyss Institute for Biologically Inspired Engineering; National Science Foundation; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK102669, R00DK102669] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); Wyss Institute for Biologically Inspired Engineering; National Science Foundation(National Science Foundation (NSF)); Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US Department of Energy grant DE-FG02-02ER63445 (to GMC) and the Wyss Institute for Biologically Inspired Engineering. SJY was supported by a National Science Foundation Graduate Research Fellowship and KME by the Wyss Technology Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Choo Y, 1998, NAT STRUCT BIOL, V5, P264, DOI 10.1038/nsb0498-264; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fineran PC, 2014, P NATL ACAD SCI US; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; GEORGOPOULOS CP, 1967, BIOCHEM BIOPH RES CO, V28, P179, DOI 10.1016/0006-291X(67)90426-3; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KELLEHER JE, 1991, J BACTERIOL, V173, P5220, DOI 10.1128/jb.173.16.5220-5223.1991; KORNBERG S, 1961, J BIOL CHEM, V236, P1487; LEHMAN IR, 1960, J BIOL CHEM, V235, P3254; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheludchenko MS, 2010, APPL ENVIRON MICROB, V76, P4337, DOI 10.1128/AEM.00128-10; SNYDER L, 1976, P NATL ACAD SCI USA, V73, P3098, DOI 10.1073/pnas.73.9.3098; Toro M, 2014, APPL ENVIRON MICROB, V80, P1411, DOI 10.1128/AEM.03018-13; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033	33	24	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98811	10.1371/journal.pone.0098811	http://dx.doi.org/10.1371/journal.pone.0098811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886988	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300112
J	Zhu, B; Ellis, MS; Fancher, KL; Rudstam, LG				Zhu, Bin; Ellis, Michael S.; Fancher, Kelly L.; Rudstam, Lars G.			Shading as a Control Method for Invasive European Frogbit (Hydrocharis morsus-ranae L.)	PLOS ONE			English	Article							LAKE; MACROPHYTES; GROWTH; DEPTH	Invasive European frogbit (Hydrocharis morsus-ranae L.) has negative environmental and economic impacts in North American water bodies. It is therefore important to develop effective management tools to control this invasive species. This study investigated shading as a control method for European frogbit in both greenhouse and lake mesocosm experiments. A series of shade treatments (0%, 50%, 60%, 70%, 80%, and 100%) were tested in the greenhouse for three weeks. Results showed that the 100% shade was most effective at controlling European frogbit, and other shade treatments greater than 50% were less effective, reducing frogbit biomass up to 38.2%. There were no differences found in temperature between treatments, but dissolved oxygen decreased as shading increased. A lake mesocosm experiment utilizing 0% shade, 70% shade, and 100% shade treatments was performed in a sheltered inlet of Oneida Lake in New York State for over one month. Resulting European frogbit biomass was significantly (25 times) less in areas treated with the 70% shade and nearly zero with the 100% shade. Shading did not affect temperature but improved DO conditions. Results on the shading effects on submerged macrophytes were not conclusive: no significant differences in changes in species richness and abundance between the three groups at the end of studied period suggested no shading effects; significant differences between the beginning and end communities in the 70% shade and the 100% shade but not in the control group indicated significant impacts of shading. This study is the first one to investigate shading as a control method for European frogbit and it is concluded that a moderately high density shade can effective remove European frogbit likely with minor impacts on the environment. More experiments with larger scales and longer time periods are recommended for further investigation.	[Zhu, Bin; Fancher, Kelly L.] Univ Hartford, Dept Biol, Hartford, CT 06117 USA; [Ellis, Michael S.] Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA; [Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	University of Hartford; Cornell University	Zhu, B (corresponding author), Univ Hartford, Dept Biol, Hartford, CT 06117 USA.	zhu@hartford.edu		Rudstam, Lars/0000-0002-3732-6368	New York Great Lakes Protection Fund; Vincent B. Coffin Grant; A&S Dean's Research Fund at the University of Hartford	New York Great Lakes Protection Fund; Vincent B. Coffin Grant; A&S Dean's Research Fund at the University of Hartford	This project was supported by the New York Great Lakes Protection Fund and the Vincent B. Coffin Grant and the A&S Dean's Research Fund at the University of Hartford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATLING P M, 1988, Naturaliste Canadien (Quebec), V115, P131; Catling PM, 2003, CAN J PLANT SCI, V83, P1001, DOI 10.4141/P02-033; Chiariello NR, 1991, RESPONSE PLANTS MULT, P161, DOI DOI 10.1016/B978-0-08-092483-0.50013-X; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COOK CDK, 1982, AQUAT BOT, V14, P177, DOI 10.1016/0304-3770(82)90097-3; DORE W G, 1968, Canadian Field-Naturalist, V82, P76; FROEMMING E., 1954, PHARMAZIE, V9, P766; Holz W, 1963, 5 DTSCH ARB FRAG UNK; Hudon C, 2000, CAN J FISH AQUAT SCI, V57, P31, DOI 10.1139/f99-232; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Kuehl R, 2000, DESIGN EXPT STAT PRI; LANGDON S., 2007, ERADICATION EUROPEAN; Madsen JD, 1997, ASSESSMENT MANAGEMEN, P145, DOI [10.1007/978-1-4612-1926-2_13, DOI 10.1007/978-1-4612-1926-2_13]; Magomaev F. M., 1973, Sbornik Nauchnykh Trudov, Vsesoyuznyi Nauchno-Issledovatel'skii Institut Prudovogo Rybnogo Khozyaistva, P192; MILLER JD, 1993, J AQUAT PLANT MANAGE, V31, P101; MINSHALL W. HAROLD, 1959, CANADIAN JOUR BOT, V37, P1134, DOI 10.1139/b59-090; New York State Department of Environmental Conservation, 2005, PRIM AQ PLANT MAN NE; Panetta FD, 2009, INVAS PLANT SCI MANA, V2, P360, DOI 10.1614/IPSM-09-003.1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Renard C, 1963, COMPT REND C COM FRA; RICHARDS A J, 1975, Watsonia, V10, P273; ROBERTS ML, 1981, RHODORA, V83, P147; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schooler SS, 2008, J AQUAT PLANT MANAGE, V46, P168; Skubinna JP, 1995, J GREAT LAKES RES, V21, P476, DOI 10.1016/S0380-1330(95)71060-7; SPENCE DHN, 1982, ADV ECOL RES, V12, P37, DOI 10.1016/S0065-2504(08)60077-X; Vaananen Veli-Matti, 2003, Suomen Riista, V49, P7; Wade P. M., 1990, AQUATIC WEEDS ECOLOG, P93; Zhu B, 2006, ECOSYSTEMS, V9, P1017, DOI 10.1007/s10021-005-0049-y; Zhu B, 2008, J AQUAT PLANT MANAGE, V46, P186; Zhu B, 2007, J GREAT LAKES RES, V33, P122, DOI 10.3394/0380-1330(2007)33[122:QOHCOS]2.0.CO;2	33	8	8	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98488	10.1371/journal.pone.0098488	http://dx.doi.org/10.1371/journal.pone.0098488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886916	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300071
J	Freeman, CM; Quillin, RC; Wilson, GC; Nojima, H; Johnson, BL; Sutton, JM; Schuster, RM; Blanchard, J; Edwards, MJ; Caldwell, CC; Lentsch, AB				Freeman, Christopher M.; Quillin, Ralph C., III; Wilson, Gregory C.; Nojima, Hiroyuki; Johnson, Bobby L., III; Sutton, Jeffrey M.; Schuster, Rebecca M.; Blanchard, John; Edwards, Michael J.; Caldwell, Charles C.; Lentsch, Alex B.			Characterization of Microparticles after Hepatic Ischemia-Reperfusion Injury	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; PLATELET MICROPARTICLES; RAT-LIVER; ISCHEMIA/REPERFUSION INJURY; NEUTROPHIL; MECHANISMS; SEPSIS; MICROVESICLES; MODULATION	Background: Hepatic ischemia-reperfusion (I/R) is a well-studied model of liver injury and has demonstrated a biphasic followed by recovery and regeneration. Microparticles (MPs) are a developing field of study and these small membrane bound vesicles have been shown to have effector function in other physiologic and pathologic states. This study was designed to quantify the levels of MPs from various cell origins-platelets, neutrophils, and endolethial cells-following hepatic ischemia-reperfusion injury. Methods: A murine model was used with mice undergoing 90 minutes of partial hepatic ischemia followed by various times of reperfusion. Following reperfusion, plasma samples were taken and MPs of various cell origins were labeled and levels were measured using flow cytometry. Additionally, cell specific MPs were further assessed by Annexin V, which stains for the presence of phosphatidylserine, a cell surface marker linked to apoptosis. Statistical analysis was performed using one-way analysis of variance with subsequent Student-Newman-Keuls test with data presented as the mean and standard error of the mean. Results: MPs from varying sources show an increase in circulating levels following hepatic I/R injury. However, the timing of the appearance of different MP subtypes differs for each cell type. Platelet and neutrophil-derived MP levels demonstrated an acute elevation following injury whereas endothelial-derived MP levels demonstrated a delayed elevation. Conclusion: This is the first study to characterize circulating levels of cell-specific MPs after hepatic I/R injury and suggests that MPs derived from platelets and neutrophils serve as markers of inflammatory injury and may be active participants in this process. In contrast, MPs derived from endothelial cells increase after the injury response during the reparative phase and may be important in angiogenesis that occurs in the regenerating liver.	[Freeman, Christopher M.; Quillin, Ralph C., III; Wilson, Gregory C.; Nojima, Hiroyuki; Johnson, Bobby L., III; Sutton, Jeffrey M.; Schuster, Rebecca M.; Blanchard, John; Edwards, Michael J.; Caldwell, Charles C.; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Lentsch, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA.	alex.lentsch@uc.edu	NOJIMA, HIROYUKI/E-3782-2017	Caldwell, Charles/0000-0003-1692-4550; Wilson, Gregory/0000-0001-6237-0136; NOJIMA, HIROYUKI/0000-0003-3983-2501	National Institutes Health [DK56029, GM08478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK056029] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes Health grants DK56029 and GM08478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Luciano C P, 2007, Recent Pat Cardiovasc Drug Discov, V2, P41, DOI 10.2174/157489007779606121; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089; Densmore JC, 2006, SHOCK, V26, P464, DOI 10.1097/01.shk.0000228791.10550.36; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Forlow SB, 2000, BLOOD, V95, P1317, DOI 10.1182/blood.V95.4.1317.004k30_1317_1323; Gasser O, 2005, EXP CELL RES, V307, P381, DOI 10.1016/j.yexcr.2005.03.011; GEORGE JN, 1982, BLOOD, V60, P834; HUGUET C, 1994, J AM COLL SURGEONS, V178, P454; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Husted TL, 2006, CURR PHARM DESIGN, V12, P2867, DOI 10.2174/138161206777947597; JAESCHKE H, 1992, J LEUKOCYTE BIOL, V52, P377, DOI 10.1002/jlb.52.4.377; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; JAESCHKE H, 1990, FASEB J, V4, P3355, DOI 10.1096/fasebj.4.15.2253850; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Janiszewski M, 2004, CRIT CARE MED, V32, P818, DOI 10.1097/01.CCM.0000114829.17746.19; Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Lemasters JJ, 1997, ANNU REV PHARMACOL, V37, P327, DOI 10.1146/annurev.pharmtox.37.1.327; Lentsch AB, 1998, HEPATOLOGY, V27, P1172; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Liu DL, 1996, ARCH SURG-CHICAGO, V131, P442; Mesri C, 1998, J IMMUNOL, V161, P4382; Mesri M, 1999, J BIOL CHEM, V274, P23111, DOI 10.1074/jbc.274.33.23111; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Nagendra S, 2004, CYTOM PART A, V58A, P195, DOI 10.1002/cyto.a.20007; Ogura H, 2004, J TRAUMA, V56, P823, DOI 10.1097/01.TA.0000084517.39244.46; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Yadav SS, 1999, HEPATOLOGY, V29, P1494, DOI 10.1002/hep.510290505	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97945	10.1371/journal.pone.0097945	http://dx.doi.org/10.1371/journal.pone.0097945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879335	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500027
J	Muller, HK; Kragballe, M; Fjorback, AW; Wiborg, O				Muller, Heidi Kaastrup; Kragballe, Marie; Fjorback, Anja Winther; Wiborg, Ove			Differential Regulation of the Serotonin Transporter by Vesicle-Associated Membrane Protein 2 in Cells of Neuronal versus Non-Neuronal Origin	PLOS ONE			English	Article							CALMODULIN-DEPENDENT REGULATION; NEUROTRANSMITTER TRANSPORTERS; PLASMA-MEMBRANE; TETANUS-TOXIN; RN46A CELLS; SYNAPTOBREVIN; TRAFFICKING; NEUROTOXINS; ENDOCYTOSIS; EXPRESSION	The serotonin transporter (SERT) is a key regulator of serotonergic signalling as it mediates the re-uptake of synaptic serotonin into nerve terminals, thereby terminating or modulating its signal. It is well-known that SERT regulation is a dynamic process orchestrated by a wide array of proteins and mechanisms. However, molecular details on possible coordinated regulation of SERT activity and 5-HT release are incomplete. Here, we report that vesicle-associated membrane protein 2 (VAMP2), a SNARE protein that mediates vesicle fusion with the plasma membrane, interacts with SERT. This was documented in vitro, through GST pull-down assays, by co-immunoprecipitation experiments on heterologous cells and rat hippocampal synaptosomes, and with FRET analysis in live transfected HEK-293 MSR cells. The related isoforms VAMP1 and VAMP3 also physically interact with SERT. However, comparison of the three VAMP isoforms shows that only VAMP2 possesses a functionally distinct role in relation to SERT. VAMP2 influences 5-HT uptake, cell surface expression and the delivery rate of SERT to the plasma membrane differentially in HEK-293 MSR and PC12 cells. Moreover, siRNA-mediated knock-down of endogenous VAMP2 reduces 5-HT uptake in CAD cells stably expressing low levels of heterologous SERT. Deletion and mutant analysis suggest a role for the isoform specific C-terminal domain of VAMP2 in regulating SERT function. Our data identify a novel interaction between SERT and a synaptic vesicle protein and support a link between 5-HT release and re-uptake.	[Muller, Heidi Kaastrup; Kragballe, Marie; Wiborg, Ove] Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark; [Fjorback, Anja Winther] Univ Aarhus, Dept Clin Med, Ctr Stochast Geometry & Adv Bioimaging, Stereol & Electron Microscopy Lab, Aarhus, Denmark	Aarhus University; Aarhus University	Muller, HK (corresponding author), Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark.	heidmull@rm.dk		Kaastrup Muller, Heidi/0000-0002-9842-8114	Lundbeck Foundation; Augustinus Foundation; Aase and Ejnar Danielsens Foundation; Else and Mogens Wedell-Wedellsborgs Foundation; Direktor Jacob Madsen and Hustru Olga Madsens Foundation; Kong Christian den Tiendes Foundation	Lundbeck Foundation(Lundbeckfonden); Augustinus Foundation; Aase and Ejnar Danielsens Foundation; Else and Mogens Wedell-Wedellsborgs Foundation; Direktor Jacob Madsen and Hustru Olga Madsens Foundation; Kong Christian den Tiendes Foundation	This study was supported by Grants from the Lundbeck Foundation, Augustinus Foundation, Aase and Ejnar Danielsens Foundation, Else and Mogens Wedell-Wedellsborgs Foundation, Direktor Jacob Madsen and Hustru Olga Madsens Foundation, and Kong Christian den Tiendes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; De Haro L, 2003, BIOL CELL, V95, P459, DOI 10.1016/S0248-4900(03)00076-5; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Grote E, 1996, J CELL BIOL, V132, P537, DOI 10.1083/jcb.132.4.537; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Inserte J, 1999, BIOCHEM PHARMACOL, V57, P111, DOI 10.1016/S0006-2952(98)00281-0; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Koo Seong Joo, 2011, Cell Logist, V1, P168; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Li YL, 2007, J NEUROSCI RES, V85, P2601, DOI 10.1002/jnr.21216; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Muller HK, 2011, BRAIN RES, V1385, P26, DOI 10.1016/j.brainres.2011.02.048; Qi YP, 1997, J NEUROSCI, V17, P1217; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Quick MW, 2002, INT J DEV NEUROSCI, V20, P219, DOI 10.1016/S0736-5748(02)00021-7; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SURI C, 1993, J NEUROSCI, V13, P1280; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yammamoto H, 2013, J PHARMACOL SCI, V121, P25, DOI 10.1254/jphs.12229FP; YOFFE JR, 1982, MOL PHARMACOL, V21, P368; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X	42	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97540	10.1371/journal.pone.0097540	http://dx.doi.org/10.1371/journal.pone.0097540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878716	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500017
J	Nakanishi, T; Kato, Y; Matsuura, T; Watanabe, H				Nakanishi, Takashi; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime			CRISPR/Cas-Mediated Targeted Mutagenesis in Daphnia magna	PLOS ONE			English	Article							HOMEOBOX-CONTAINING GENE; XENOPUS-TROPICALIS; WATER FLEA; C. ELEGANS; GENOME; DROSOPHILA; SYSTEM; PAX6; CAS9; EYE	The water flea Daphnia magna has been used as an animal model in ecology, evolution, and environmental sciences. Thanks to the recent progress in Daphnia genomics, genetic information such as the draft genome sequence and expressed sequence tags (ESTs) is now available. To investigate the relationship between phenotypes and the available genetic information about Daphnia, some gene manipulation methods have been developed. However, a technique to induce targeted mutagenesis into Daphnia genome remains elusive. To overcome this problem, we focused on an emerging genome editing technique mediated by the clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR/Cas) system to introduce genomic mutations. In this study, we targeted a functionally conserved regulator of eye development, the eyeless gene in D. magna. When we injected Cas9 mRNAs and eyeless-targeting guide RNAs into eggs, 1847% of the survived juveniles exhibited abnormal eye morphology. After maturation, up to 8.2% of the adults produced progenies with deformed eyes, which carried mutations in the eyeless loci. These results showed that CRISPR/Cas system could introduce heritable mutations into the endogenous eyeless gene in D. magna. This is the first report of a targeted gene knockout technique in Daphnia and will be useful in uncovering Daphnia gene functions.	[Nakanishi, Takashi; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Osaka University	Watanabe, H (corresponding author), Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp	WATANABE, Hajime/AAJ-8904-2021; Kato, Yasuhiko/AES-3929-2022; Matsuura, Tomoaki/W-6086-2019; matsuura, tomoaki/O-7368-2018; Watanabe, Hajime/S-8957-2019	Kato, Yasuhiko/0000-0002-1041-1044; Matsuura, Tomoaki/0000-0003-1015-6781; matsuura, tomoaki/0000-0003-1015-6781; Watanabe, Hajime/0000-0001-9657-6554	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Asahi Glass Foundation; Osaka University, MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Osaka University, MEXT	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and partially supported by the Asahi Glass Foundation. One of the authors (Y.K.) would like to acknowledge the Frontier Research Base for Global Young Researchers, Osaka University, based on the Program of MEXT, for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Callaerts P, 2006, ARTHROPOD STRUCT DEV, V35, P379, DOI 10.1016/j.asd.2006.09.002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sagawa K, 2005, GENE EXPR PATTERNS, V5, P669, DOI 10.1016/j.modgep.2005.02.007; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao P, 2014, CELL RES, V24, P247, DOI 10.1038/cr.2014.9; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	42	64	69	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98363	10.1371/journal.pone.0098363	http://dx.doi.org/10.1371/journal.pone.0098363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878568	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500053
J	Parkkari, T; Haavikko, R; Laitinen, T; Navia-Paldanius, D; Rytilahti, R; Vaara, M; Lehtonen, M; Alakurtti, S; Yli-Kauhaluoma, J; Nevalainen, T; Savinainen, JR; Laitinen, JT				Parkkari, Teija; Haavikko, Raisa; Laitinen, Tuomo; Navia-Paldanius, Dina; Rytilahti, Roosa; Vaara, Miia; Lehtonen, Marko; Alakurtti, Sami; Yli-Kauhaluoma, Jari; Nevalainen, Tapio; Savinainen, Juha R.; Laitinen, Jarmo T.			Discovery of Triterpenoids as Reversible Inhibitors of alpha/beta-hydrolase Domain Containing 12 (ABHD12)	PLOS ONE			English	Article							OLEANOLIC ACID; BETULINIC ACID; HYDROLYSIS; PATHWAYS; POTENT	Background: alpha/beta-hydrolase domain containing (ABHD) 12 is a recently discovered serine hydrolase that acts in vivo as a lysophospholipase for lysophosphatidylserine. Dysfunctional ABHD12 has been linked to the rare neurodegenerative disorder called PHARC (polyneuropathy, hearing loss, ataxia, retinosis pigmentosa, cataract). In vitro, ABHD12 has been implicated in the metabolism of the endocannabinoid 2-arachidonoylglycerol (2-AG). Further studies on ABHD12 function are hampered as no selective inhibitor have been identified to date. In contrast to the situation with the other endocannabinoid hydrolases, ABHD12 has remained a challenging target for inhibitor development as no crystal structures are available to facilitate drug design. Methodology/Principal Findings: Here we report the unexpected discovery that certain triterpene-based structures inhibit human ABHD12 hydrolase activity in a reversible manner, the best compounds showing submicromolar potency. Based on structure activity relationship (SAR) data collected for 68 natural and synthetic triterpenoid structures, a pharmacophore model has been constructed. A pentacyclic triterpene backbone with carboxyl group at position 17, small hydrophobic substituent at the position 4, hydrogen bond donor or acceptor at position 3 accompanied with four axial methyl substituents was found crucial for ABHD12 inhibitor activity. Although the triterpenoids typically may have multiple protein targets, we witnessed unprecedented selectivity for ABHD12 among the metabolic serine hydrolases, as activity-based protein profiling of mouse brain membrane proteome indicated that the representative ABHD12 inhibitors did not inhibit other serine hydrolases, nor did they target cannabinoid receptors. Conclusions/Significance: We have identified reversibly-acting triterpene-based inhibitors that show remarkable selectivity for ABHD12 over other metabolic serine hydrolases. Based on SAR data, we have constructed the first pharmacophore model of ABHD12 inhibitors. This model should pave the way for further discovery of novel lead structures for ABHD12 selective inhibitors.	[Parkkari, Teija; Navia-Paldanius, Dina; Rytilahti, Roosa; Vaara, Miia; Savinainen, Juha R.; Laitinen, Jarmo T.] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland; [Parkkari, Teija; Laitinen, Tuomo; Lehtonen, Marko; Nevalainen, Tapio] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland; [Haavikko, Raisa; Alakurtti, Sami; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Alakurtti, Sami] VTT Tech Res Ctr Finland, Helsinki, Finland	University of Eastern Finland; University of Eastern Finland; University of Helsinki; VTT Technical Research Center Finland	Laitinen, JT (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland.	jarmo.laitinen@uef.fi		Laitinen, Tuomo/0000-0003-1539-2142; Savinainen, Juha/0000-0002-1301-9064; Haavikko, Raisa/0000-0002-2445-503X; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Laitinen, Jarmo T/0000-0002-9490-3686; Lehtonen, Marko/0000-0002-5611-0466	Academy of Finland [139620, 139140, 256515, 264020]; European Commission [EU-KBBE-227239-ForestSpeCs]; Finnish Cultural Foundation; Biocenter Finland/DDCB	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biocenter Finland/DDCB	This research was supported by the Academy of Finland (grant 139620 to JTL, grant 139140 to TN, grants 256515 and 264020 to JYK), the European Commission (Contract no EU-KBBE-227239-ForestSpeCs to JYK), and the Finnish Cultural Foundation (RH). TL was supported by Biocenter Finland/DDCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen N, 2013, CHEM BIOL, V20, P379, DOI 10.1016/j.chembiol.2013.01.012; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Alakurtti S, 2010, BIOORGAN MED CHEM, V18, P1573, DOI 10.1016/j.bmc.2010.01.003; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Chicca A, 2012, BRIT J PHARMACOL, V167, P1596, DOI 10.1111/j.1476-5381.2012.02059.x; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Fulda S, 2008, INT J MOL SCI, V9, P1096, DOI 10.3390/ijms9061096; Gao HY, 2003, CHEM PHARM BULL, V51, P1318, DOI 10.1248/cpb.51.1318; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Haavikko R, 2014, MEDCHEMCOMM, V5, P445, DOI 10.1039/c3md00282a; Hao J, 2009, TETRAHEDRON, V65, P7975, DOI 10.1016/j.tet.2009.07.047; He XJ, 2007, J AGR FOOD CHEM, V55, P4366, DOI 10.1021/jf063563o; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; King AR, 2009, CHEM BIOL, V16, P1045, DOI 10.1016/j.chembiol.2009.09.012; KUMAR NS, 1985, PHYTOCHEMISTRY, V24, P1337, DOI 10.1016/S0031-9422(00)81128-0; Laitinen T, 2014, MOL PHARMACOL, V85, P510, DOI 10.1124/mol.113.090795; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Liu QC, 2013, EUR J MED CHEM, V64, P1, DOI 10.1016/j.ejmech.2013.04.016; Moura-Letts G, 2006, J NAT PROD, V69, P978, DOI 10.1021/np0601152; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Patel JZ, 2013, J MED CHEM, V56, P8484, DOI 10.1021/jm400923s; Pohjala L, 2009, J NAT PROD, V72, P1917, DOI 10.1021/np9003245; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Saario SM, 2006, J MED CHEM, V49, P4650, DOI 10.1021/jm060394q; Safe SH, 2012, ANTI-CANCER AGENT ME, V12, P1211; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Santos RC, 2010, BIOORGAN MED CHEM, V18, P4385, DOI 10.1016/j.bmc.2010.04.085; Savinainen JR, 2005, BRIT J PHARMACOL, V145, P636, DOI 10.1038/sj.bjp.0706230; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Siewert B, 2014, EUR J MED CHEM, V72, P84, DOI 10.1016/j.ejmech.2013.11.025; da Silva KABS, 2011, PAIN, V152, P1872, DOI 10.1016/j.pain.2011.04.005; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428	35	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98286	10.1371/journal.pone.0098286	http://dx.doi.org/10.1371/journal.pone.0098286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879289	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500044
J	Roeder, E; Henrionnet, C; Goebel, JC; Gambier, N; Beuf, O; Grenier, D; Chen, BL; Vuissoz, PA; Gillet, P; Pinzano, A				Roeder, Emilie; Henrionnet, Christel; Goebel, Jean Christophe; Gambier, Nicolas; Beuf, Olivier; Grenier, Denis; Chen, Bailiang; Vuissoz, Pierre-Andre; Gillet, Pierre; Pinzano, Astrid			Dose-Response of Superparamagnetic Iron Oxide Labeling on Mesenchymal Stem Cells Chondrogenic Differentiation: A Multi-Scale In Vitro Study	PLOS ONE			English	Article							COLLAGEN SCAFFOLDS; VIVO TRACKING; NANOPARTICLES; CHONDROCYTES; EXPRESSION; PARTICLES; RELEVANCE; CAPACITY; DELIVERY; REPAIR	Aim: The aim of this work was the development of successful cell therapy techniques for cartilage engineering. This will depend on the ability to monitor non-invasively transplanted cells, especially mesenchymal stem cells (MSCs) that are promising candidates to regenerate damaged tissues. Methods: MSCs were labeled with superparamagnetic iron oxide particles (SPIO). We examined the effects of long-term labeling, possible toxicological consequences and the possible influence of progressive concentrations of SPIO on chondrogenic differentiation capacity. Results: No influence of various SPIO concentrations was noted on human bone marow MSC viability or proliferation. We demonstrated long-term (4 weeks) in vitro retention of SPIO by human bone marrow MSCs seeded in collagenic sponges under TGF-beta 1 chondrogenic conditions, detectable by Magnetic Resonance Imaging (MRI) and histology. Chondrogenic differentiation was demonstrated by molecular and histological analysis of labeled and unlabeled cells. Chondrogenic gene expression (COL2A2, ACAN, SOX9, COL10, COMP) was significantly altered in a dose-dependent manner in labeled cells, as were GAG and type II collagen staining. As expected, SPIO induced a dramatic decrease of MRI T2 values of sponges at 7T and 3T, even at low concentrations. Conclusions: This study clearly demonstrates (1) long-term in vitro MSC traceability using SPIO and MRI and (2) a deleterious dose-dependence of SPIO on TGF-beta 1 driven chondrogenesis in collagen sponges. Low concentrations (12.5-25 mu g Fe/mL) seem the best compromise to optimize both chondrogenesis and MRI labeling.	[Roeder, Emilie; Henrionnet, Christel; Gambier, Nicolas; Gillet, Pierre; Pinzano, Astrid] Univ Lorraine, CNRS, Unite Mixte Recherches 7365, Vandoeuvre Les Nancy, France; [Goebel, Jean Christophe; Beuf, Olivier; Grenier, Denis] Univ Lyon, CNRS, Ctr Rech Acquisit & Traitement Image Sante, Inst Natl Sci Appl Lyon,Inst Natl Sante & Rech Me, Villeurbanne, France; [Chen, Bailiang; Vuissoz, Pierre-Andre] Inst Natl Sante & Rech Med, U947, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gillet, P (corresponding author), Univ Lorraine, CNRS, Unite Mixte Recherches 7365, Vandoeuvre Les Nancy, France.	Pierre.Gillet@univ-lorraine.fr	PINZANO, Astrid/ABD-5162-2020; BEUF, Olivier/H-6966-2014; Grenier, Denis/H-7904-2014; Vuissoz, Pierre-André/Y-8259-2019; CHEN, Bailiang/U-9572-2019	PINZANO, Astrid/0000-0002-3867-2676; BEUF, Olivier/0000-0002-4516-4565; Vuissoz, Pierre-André/0000-0003-3519-1743; CHEN, Bailiang/0000-0003-1038-7846; GILLET, Pierre/0000-0002-0598-7508; Roeder, Emilie/0000-0001-5992-6623; Christel, HENRIONNET/0000-0001-7484-0377	Agence Nationale de la Recherche-programme ANR Blanc 2009: Cartilage Engineering and MRI: Assessment of Biointegration and Biofunctionality in the Rat (CEMABIR) [ANR-09-BLANC-0150-01]; Region Lorraine Communaute Urbaine du Grand Nancy; Conseil General de Meurthe et Moselle	Agence Nationale de la Recherche-programme ANR Blanc 2009: Cartilage Engineering and MRI: Assessment of Biointegration and Biofunctionality in the Rat (CEMABIR)(French National Research Agency (ANR)); Region Lorraine Communaute Urbaine du Grand Nancy(Region Grand-Est); Conseil General de Meurthe et Moselle	This work was supported by grants from Agence Nationale de la Recherche -programme ANR Blanc 2009: Cartilage Engineering and MRI: Assessment of Biointegration and Biofunctionality in the Rat (CEMABIR, ANR-09-BLANC-0150-01) and grants from the Region Lorraine Communaute Urbaine du Grand Nancy, and Conseil General de Meurthe et Moselle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Babic M, 2008, BIOCONJUGATE CHEM, V19, P740, DOI 10.1021/bc700410z; Boddington SE, 2011, MOL IMAGING BIOL, V13, P3, DOI 10.1007/s11307-010-0322-0; Boutry S, 2008, CONTRAST MEDIA MOL I, V3, P223, DOI 10.1002/cmmi.256; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Chajra H, 2008, BIO-MED MATER ENG, V18, pS33; Chen JR, 2012, ANN BIOMED ENG, V40, P2568, DOI 10.1007/s10439-012-0621-5; Daldrup-Link HE, 2003, RADIOLOGY, V228, P760, DOI 10.1148/radiol.2283020322; Farrell E, 2009, OSTEOARTHR CARTILAGE, V17, P961, DOI 10.1016/j.joca.2008.11.016; Farrell E, 2008, BIOCHEM BIOPH RES CO, V369, P1076, DOI 10.1016/j.bbrc.2008.02.159; Feng Y, 2011, J HUAZHONG U SCI-MED, V31, P204, DOI 10.1007/s11596-011-0253-2; Foldager CB, 2011, J MAGN RESON IMAGING, V33, P724, DOI 10.1002/jmri.22470; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Henrionnet C, 2010, BIO-MED MATER ENG, V20, P175, DOI 10.3233/BME-2010-0629; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hong H, 2010, CURR PHARM BIOTECHNO, V11, P685, DOI 10.2174/138920110792246500; Jing XH, 2008, JOINT BONE SPINE, V75, P432, DOI 10.1016/j.jbspin.2007.09.013; Khan WS, 2010, KNEE, V17, P369, DOI 10.1016/j.knee.2009.12.003; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Markides H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt337; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Nieminen MT, 2012, J MAGN RESON IMAGING, V36, P1287, DOI 10.1002/jmri.23644; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Perrier E, 2011, BIOTECHNOL LETT, V33, P2091, DOI 10.1007/s10529-011-0653-1; Qi Y, 2013, MOL BIOL REP; Ramaswamy S, 2009, TISSUE ENG PT A, V15, P3899, DOI 10.1089/ten.tea.2008.0677; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Saha S, 2013, J TISSUE ENG REGEN M, V7, P461, DOI 10.1002/term.544; Schafer R, 2009, CYTOTHERAPY, V11, P68, DOI 10.1080/14653240802666043; Shintani N, 2011, Eur Cell Mater, V22, P302; Shintani N, 2011, EUR CELLS MATER, V22, P319; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Sykova E, 2011, METHODS MOL BIOL, V750, P79, DOI 10.1007/978-1-61779-145-1_5; Terrovitis JV, 2006, TISSUE ENG, V12, P2765, DOI 10.1089/ten.2006.12.2765; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Yang CY, 2011, MOL IMAGING BIOL, V13, P443, DOI 10.1007/s11307-010-0360-7; Zhu WZ, 2007, J HUAZHONG U SCI-MED, V27, P107, DOI 10.1007/s11596-007-0130-1	41	40	41	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98451	10.1371/journal.pone.0098451	http://dx.doi.org/10.1371/journal.pone.0098451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878844	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500061
J	Takeda, Y; Yamanaka, K; Yamagishi, N; Sato, M				Takeda, Yusuke; Yamanaka, Kentaro; Yamagishi, Noriko; Sato, Masa-aki			Revealing Time-Unlocked Brain Activity from MEG Measurements by Common Waveform Estimation	PLOS ONE			English	Article							DENOISING SOURCE SEPARATION; EVENT-RELATED POTENTIALS; HUMAN AUDITORY-CORTEX; ALPHA OSCILLATIONS; ATTENTIONAL MODULATION; SELECTIVE ATTENTION; CORTICAL CURRENTS; VISUAL-CORTEX; 10-HZ RHYTHM; MINDS EYE	Brain activities related to cognitive functions, such as attention, occur with unknown and variable delays after stimulus onsets. Recently, we proposed a method (Common Waveform Estimation, CWE) that could extract such brain activities from magnetoencephalography (MEG) or electroencephalography (EEG) measurements. CWE estimates spatiotemporal MEG/EEG patterns occurring with unknown and variable delays, referred to here as unlocked waveforms, without hypotheses about their shapes. The purpose of this study is to demonstrate the usefulness of CWE for cognitive neuroscience. For this purpose, we show procedures to estimate unlocked waveforms using CWE and to examine their role. We applied CWE to the MEG epochs during Go trials of a visual Go/NoGo task. This revealed unlocked waveforms with interesting properties, specifically large alpha oscillations around the temporal areas. To examine the role of the unlocked waveform, we attempted to estimate the strength of the brain activity of the unlocked waveform in various conditions. We made a spatial filter to extract the component reflecting the brain activity of the unlocked waveform, applied this spatial filter to MEG data under different conditions (a passive viewing, a simple reaction time, and Go/NoGo tasks), and calculated the powers of the extracted components. Comparing the powers across these conditions suggests that the unlocked waveforms may reflect the inhibition of the task-irrelevant activities in the temporal regions while the subject attends to the visual stimulus. Our results demonstrate that CWE is a potential tool for revealing new findings of cognitive brain functions without any hypothesis in advance.	[Takeda, Yusuke; Sato, Masa-aki] ATR Neural Informat Anal Labs, Dept Computat Brain Imaging, Kyoto, Japan; [Yamanaka, Kentaro] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo, Japan; [Yamagishi, Noriko] ATR Cognit Mech Labs, Dept Cognit Neurosci, Kyoto, Japan; [Yamagishi, Noriko] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Brain Networks & Commun Lab, Osaka, Japan; [Yamagishi, Noriko] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Japan Science & Technology Agency (JST)	Takeda, Y (corresponding author), ATR Neural Informat Anal Labs, Dept Computat Brain Imaging, Kyoto, Japan.	takeda@atr.jp	Yamanaka, Kentaro/HII-3291-2022	Yamanaka, Kentaro/0000-0002-5578-440X	National Institute of Information and Communications Technology; JSPS KAKENHI Grant [23700499]; Grants-in-Aid for Scientific Research [26540075] Funding Source: KAKEN	National Institute of Information and Communications Technology; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by contracts with the National Institute of Information and Communications Technology entitled, "Multimodal integration for brain imaging measurements'' and "Development of network dynamics modeling methods for human brain data simulation systems'', and JSPS KAKENHI Grant Number 23700499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara T, 2012, NEUROIMAGE, V59, P4006, DOI 10.1016/j.neuroimage.2011.09.087; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; [Anonymous], 2000, EEGLAB ICA TOOLBOX P; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Callan D, 2010, NEUROIMAGE, V51, P844, DOI 10.1016/j.neuroimage.2010.02.027; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; de Cheveigne A, 2010, J NEUROSCI METH, V189, P113, DOI 10.1016/j.jneumeth.2010.03.002; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; KOK A, 1988, BIOL PSYCHOL, V27, P51, DOI 10.1016/0301-0511(88)90005-1; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lehtela L, 1997, NEUROSCI LETT, V222, P111, DOI 10.1016/S0304-3940(97)13361-4; Mo J, 2011, J NEUROSCI, V31, P878, DOI 10.1523/JNEUROSCI.5295-10.2011; Morioka H, 2014, NEUROIMAGE, V90, P128, DOI 10.1016/j.neuroimage.2013.12.035; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PHAM D T, 1987, Biometrika, V74, P525; RIERADIAZ JJ, 1995, INT J BIOMED COMPUT, V38, P109, DOI 10.1016/0020-7101(94)01030-5; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rinne Teemu, 2010, Open Neuroimag J, V4, P187, DOI 10.2174/1874440001004010187; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Shibata K, 2008, CEREB CORTEX, V18, P1664, DOI 10.1093/cercor/bhm194; Takeda Y, 2008, NEUROIMAGE, V41, P777, DOI 10.1016/j.neuroimage.2008.03.012; Takeda Y, 2008, NEUROIMAGE, V39, P742, DOI 10.1016/j.neuroimage.2007.09.003; Takeda Y, 2010, NEUROIMAGE, V51, P629, DOI 10.1016/j.neuroimage.2010.02.002; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TIIHONEN J, 1991, NEUROSCI LETT, V129, P303, DOI 10.1016/0304-3940(91)90486-D; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; VERLEGER R, 1988, BIOL PSYCHOL, V27, P45, DOI 10.1016/0301-0511(88)90004-X; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0; Yamagishi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074962; Yin G, 2011, IEEE T BIO-MED ENG, V58, P1534, DOI 10.1109/TBME.2010.2090152; Yin G, 2009, J NEUROSCI METH, V178, P219, DOI 10.1016/j.jneumeth.2008.11.022; Yoshimura N, 2012, NEUROIMAGE, V59, P1324, DOI 10.1016/j.neuroimage.2011.08.029; Yoshioka T, 2008, NEUROIMAGE, V42, P1397, DOI 10.1016/j.neuroimage.2008.06.013; Zhang J, 1998, J NEUROSCI METH, V80, P49, DOI 10.1016/S0165-0270(97)00194-5	50	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98014	10.1371/journal.pone.0098014	http://dx.doi.org/10.1371/journal.pone.0098014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879410	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500029
J	Yi, GS; Wang, J; Wei, XL; Tsang, KM; Chan, WL; Deng, B				Yi, Guo-Sheng; Wang, Jiang; Wei, Xi-Le; Tsang, Kai-Ming; Chan, Wai-Lok; Deng, Bin			Neuronal Spike Initiation Modulated by Extracellular Electric Fields	PLOS ONE			English	Article							RAT HIPPOCAMPAL SLICES; MAGNETIC STIMULATION; IN-VITRO; EPILEPTIFORM ACTIVITY; SYNCHRONIZATION; EXCITABILITY; MODEL; POLARIZATION; OSCILLATIONS; BIFURCATION	Based on a reduced two-compartment model, the dynamical and biophysical mechanism underlying the spike initiation of the neuron to extracellular electric fields is investigated in this paper. With stability and phase plane analysis, we first investigate in detail the dynamical properties of neuronal spike initiation induced by geometric parameter and internal coupling conductance. The geometric parameter is the ratio between soma area and total membrane area, which describes the proportion of area occupied by somatic chamber. It is found that varying it could qualitatively alter the bifurcation structures of equilibrium as well as neuronal phase portraits, which remain unchanged when varying internal coupling conductance. By analyzing the activating properties of somatic membrane currents at subthreshold potentials, we explore the relevant biophysical basis of spike initiation dynamics induced by these two parameters. It is observed that increasing geometric parameter could greatly decrease the intensity of the internal current flowing from soma to dendrite, which switches spike initiation dynamics from Hopf bifurcation to SNIC bifurcation; increasing internal coupling conductance could lead to the increase of this outward internal current, whereas the increasing range is so small that it could not qualitatively alter the spike initiation dynamics. These results highlight that neuronal geometric parameter is a crucial factor in determining the spike initiation dynamics to electric fields. The finding is useful to interpret the functional significance of neuronal biophysical properties in their encoding dynamics, which could contribute to uncovering how neuron encodes electric field signals.	[Yi, Guo-Sheng; Wang, Jiang; Wei, Xi-Le; Deng, Bin] Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China; [Tsang, Kai-Ming; Chan, Wai-Lok] Hong Kong Polytech Univ, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China	Tianjin University; Hong Kong Polytechnic University	Wei, XL (corresponding author), Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China.	xilewei@tju.edu.cn		TSANG, Kai Ming/0000-0002-1516-3174; CHAN, Wai Lok/0000-0002-4637-0344	National Natural Science Foundation of China [61072012, 61172009, 61372010]; Tianjin Municipal Natural Science Foundation [12JCZDJC21100, 13JCZDJC27900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work is supported by the National Natural Science Foundation of China under Grants 61072012 (URL:http://www.nsfc.gov.cn/publish/portal0/default.htm), 61172009 (URL: http://www.nsfc.gov.cn/publish/portal0/default.htm) and 61372010 (URL: http://www.nsfc.gov.cn/publish/portal0/default.htm), and Tianjin Municipal Natural Science Foundation under Grants 12JCZDJC21100 (URL: http://www.tstc.gov.cn/) and 13JCZDJC27900 (URL: http://www.tstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAWIN SM, 1984, BRAIN RES, V323, P227, DOI 10.1016/0006-8993(84)90293-2; Berzhanskaya J, 2013, J COMPUT NEUROSCI, V34, P369, DOI 10.1007/s10827-012-0426-4; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Colwell LJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000265; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Durand DM, 2003, RADIAT PROT DOSIM, V106, P325, DOI 10.1093/oxfordjournals.rpd.a006368; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gluckman BJ, 1996, J NEUROPHYSIOL, V76, P4202, DOI 10.1152/jn.1996.76.6.4202; Gluckman BJ, 2001, J NEUROSCI, V21, P590, DOI 10.1523/JNEUROSCI.21-02-00590.2001; Izhikevich E M, 2005, DYNAMICAL SYSTEMS NE; JEFFERYS JGR, 1981, J PHYSIOL-LONDON, V319, P143, DOI 10.1113/jphysiol.1981.sp013897; Lazutkin D, 2010, IEEE ENG MED BIO, P581, DOI 10.1109/IEMBS.2010.5626402; Nguyen LH, 2012, BIOL CYBERN, V106, P587, DOI 10.1007/s00422-012-0508-4; Lundstrom BN, 2009, J COMPUT NEUROSCI, V27, P277, DOI 10.1007/s10827-009-0142-x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Park EH, 2005, J COMPUT NEUROSCI, V19, P53, DOI 10.1007/s10827-005-0214-5; Park EH, 2003, NEUROCOMPUTING, V52-4, P169, DOI 10.1016/S0925-2312(02)00820-2; Pashut T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002022; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Peterchev AV, 2010, J ECT, V26, P159, DOI 10.1097/YCT.0b013e3181e48165; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Prescott SA, 2008, J NEUROSCI, V28, P13649, DOI 10.1523/JNEUROSCI.1792-08.2008; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Richardson KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028103; Rotem A, 2006, IEEE T BIO-MED ENG, V53, P414, DOI 10.1109/TBME.2005.869770; Rotem A, 2008, BIOPHYS J, V94, P5065, DOI 10.1529/biophysj.107.125708; Sunderam S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046009; Svirskis G, 1997, BIOPHYS J, V73, P3004, DOI 10.1016/S0006-3495(97)78329-2; Thomas AW, 2007, PAIN RES MANAG, V12, P249, DOI 10.1155/2007/626072; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wang HX, 2013, COGN NEURODYNAMICS, V7, P121, DOI 10.1007/s11571-012-9222-0; Wang HX, 2011, CHAOS SOLITON FRACT, V44, P667, DOI 10.1016/j.chaos.2011.06.003; Wei XL, 2014, COGN NEURODYNAMICS, V8, P177, DOI 10.1007/s11571-013-9269-6; Wester JC, 2013, J COMPUT NEUROSCI, V35, P1, DOI 10.1007/s10827-012-0436-2; Yi GS, 2014, J COMPUT NEUROSCI, V36, P383, DOI 10.1007/s10827-013-0479-z	43	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97481	10.1371/journal.pone.0097481	http://dx.doi.org/10.1371/journal.pone.0097481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873827	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800007
J	Carlson, BE; McGinley, S; Rowe, MP				Carlson, Bradley E.; McGinley, Shannen; Rowe, Matthew P.			Meek Males and Fighting Females: Sexually-Dimorphic Antipredator Behavior and Locomotor Performance Is Explained by Morphology in Bark Scorpions (Centruroides vittatus)	PLOS ONE			English	Article							SIZE DIMORPHISM; SPRINT SPEED; TROPHIC MORPHOLOGY; TRAIT COMPENSATION; ECOLOGICAL CAUSES; GRAVID LIZARDS; LIFE-HISTORY; BUTHIDAE; EVOLUTION; ALLOMETRY	Sexual dimorphism can result from sexual or ecological selective pressures, but the importance of alternative reproductive roles and trait compensation in generating phenotypic differences between the sexes is poorly understood. We evaluated morphological and behavioral sexual dimorphism in striped bark scorpions (Centruroides vittatus). We propose that reproductive roles have driven sexually dimorphic body mass in this species which produces sex differences in locomotor performance. Poor locomotor performance in the females (due to the burden of being gravid) favors compensatory aggression as part of an alternative defensive strategy, while male morphology is coadapted to support a sprinting-based defensive strategy. We tested the effects of sex and morphology on stinging and sprinting performance and characterized overall differences between the sexes in aggressiveness towards simulated threats. Greater body mass was associated with higher sting rates and slower sprinting within sexes, which explained the greater aggression of females (the heavier sex) and, along with longer legs in males, the improved sprint performance in males. These findings suggest females are aggressive to compensate for locomotor costs of reproduction while males possess longer legs to enhance sprinting for predator evasion and mate finding. Sexual dimorphism in the metasoma ("tail'') was unrelated to stinging and sprinting performance and may best be explained by sexual selection.	[Carlson, Bradley E.; McGinley, Shannen] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Carlson, Bradley E.] Penn State Univ, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Rowe, Matthew P.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas State University System; Sam Houston State University	Carlson, BE (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	bec169@psu.edu	Carlson, Bradley E/A-8766-2012	Carlson, Bradley E/0000-0001-8667-0416	National Science Foundation grant (IOS) [1122115]; Department of Biological Sciences at Sam Houston State University	National Science Foundation grant (IOS); Department of Biological Sciences at Sam Houston State University	This research was partially supported by a National Science Foundation grant (IOS # 1122115) to A. Rowe, H. Zakon, and M. Rowe, as well as by the Department of Biological Sciences at Sam Houston State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A. J., 1959, Proceedings of the Zoological Society of London, V133, P145; BALLINGER RE, 1979, HERPETOLOGICA, V35, P114; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Booncham U, 2007, NU SCI J, V4, P42; Brandt Y, 2007, FUNCT ECOL, V21, P379, DOI 10.1111/j.1365-2435.2007.01243.x; Brown CA, 2000, AM MIDL NAT, V144, P406, DOI 10.1674/0003-0031(2000)144[0406:PCBITS]2.0.CO;2; Bulte G, 2008, FUNCT ECOL, V22, P824, DOI 10.1111/j.1365-2435.2008.01422.x; CAMILLERI C, 1990, COPEIA, P649, DOI 10.2307/1446430; Carlson BE, 2009, J ARACHNOL, V37, P321, DOI 10.1636/Hi09-06.1; Carrier DR, 2001, J EXP BIOL, V204, P3917; COOPER WE, 1990, BEHAV ECOL SOCIOBIOL, V27, P153; Cotton PA, 2004, ECOLOGY, V85, P1581, DOI 10.1890/03-3104; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; Foellmer MW, 2005, OECOLOGIA, V142, P653, DOI 10.1007/s00442-004-1756-3; Framenau VW, 2005, J ARACHNOL, V33, P334, DOI 10.1636/04-57.1; FRANCKE OF, 1979, J ARACHNOL, V7, P223; FRANCKE OF, 1982, J ARACHNOL, V10, P223; HARINGTON A, 1977, J ARACHNOL, V5, P243; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Husak JF, 2008, EVOL ECOL RES, V10, P213; Husak JF, 2011, FUNCT ECOL, V25, P608, DOI 10.1111/j.1365-2435.2010.01827.x; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Kaltsas D, 2010, J NAT HIST, V44, P1445, DOI 10.1080/00222931003632732; Koch L.E., 1977, Records W Aust Mus, V5, P83; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Martin J, 1998, FUNCT ECOL, V12, P794, DOI 10.1046/j.1365-2435.1998.00247.x; MCDANIEL M M, 1968, Entomological News, V79, P278; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; Newlands G., 1972, Koedoe, V15, P37; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Nisani Z, 2012, TOXICON, V60, P315, DOI 10.1016/j.toxicon.2012.04.343; O'Connell DJ, 1998, J HERPETOL, V32, P75, DOI 10.2307/1565482; Olsson M, 2000, J EVOLUTION BIOL, V13, P263; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; POLIS GA, 1979, J ARACHNOL, V7, P33; Polis GA, 1990, BIOL SCORPIONS, P224; Prendini L, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)502[0001:NSAFRS]2.0.CO;2; Prenter J, 2010, FUNCT ECOL, V24, P400, DOI 10.1111/j.1365-2435.2009.01633.x; Pruitt JN, 2010, J ZOOL, V281, P39, DOI 10.1111/j.1469-7998.2009.00677.x; Pruitt JN, 2010, FUNCT ECOL, V24, P392, DOI 10.1111/j.1365-2435.2009.01655.x; Pullin AO, 2012, IEEE INT CONF ROBOT, P5086, DOI 10.1109/ICRA.2012.6225261; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Sanchez-Quiros C, 2012, J ARACHNOL, V40, P338, DOI 10.1636/B12-14.1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaffer LR, 1996, ANIM BEHAV, V51, P1017, DOI 10.1006/anbe.1996.0104; SHELLEY RM, 1995, J ARACHNOL, V23, P100; Shine R, 2000, BEHAV ECOL, V11, P239, DOI 10.1093/beheco/11.3.239; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Shine R, 2003, OECOLOGIA, V136, P450, DOI 10.1007/s00442-003-1281-9; Shine R, 1998, J ZOOL, V246, P203; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Smith DG, 1997, BEHAV ECOL, V8, P622, DOI 10.1093/beheco/8.6.622; Stahnke HL, 1957, AM BIOL TEACH, V19, P75; van der Meijden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078955; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; WILLIAMS SC, 1987, ANNU REV ENTOMOL, V32, P275, DOI 10.1146/annurev.en.32.010187.001423; YAMASHITA T, 2004, EUSCORPIUS, V17, P25	62	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97648	10.1371/journal.pone.0097648	http://dx.doi.org/10.1371/journal.pone.0097648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870611	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300017
J	Chaiyachati, KH; Gordon, K; Long, T; Levin, W; Khan, A; Meyer, E; Justice, A; Brienza, R				Chaiyachati, Krisda H.; Gordon, Kirsha; Long, Theodore; Levin, Woody; Khan, Ali; Meyer, Emily; Justice, Amy; Brienza, Rebecca			Continuity in a VA Patient-Centered Medical Home Reduces Emergency Department Visits	PLOS ONE			English	Article							CONTROLLED-TRIAL; HEALTH SYSTEM; PRIMARY-CARE; VETERANS; LESSONS; DISEASE	Background: One major goal of the Patient-Centered Medical Home (PCMH) is to improve continuity of care between patients and providers and reduce the utilization of non-primary care services like the emergency department (ED). Objective: To characterize continuity under the Veterans Health Administration's PCMH model - the Patient Aligned Care Team (PACT), at one large Veterans Affair's (VA's) primary care clinic, determine the characteristics associated with high levels of continuity, and assess the association between continuity and ED visits. Design: Retrospective, observational cohort study of patients at the West Haven VA (WHVA) Primary Care Clinic from March 2011 to February 2012. Patients: The 13,495 patients with established care at the Clinic, having at least one visit, one year before March 2011. Main Measures: Our exposure variable was continuity of care -a patient seeing their assigned primary care provider (PCP) at each clinic visit. The outcome of interest was having an ED visit. Results: The patients encompassed 42,969 total clinic visits, and 3185 (24%) of them had 15,458 ED visits. In a multivariable logistic regression analysis, patients with continuity of care - at least one visit with their assigned PCP - had lower ED utilization compared to individuals without continuity (adjusted odds ratio [AOR] 0.54; 95% CI: 0.41, 0.71), controlling for frequency of primary care visits, comorbidities, insurance, distance from the ED, and having a trainee PCP assigned. Likewise, the adjusted rate of ED visits was 544/1000 person-year (PY) for patients with continuity vs. 784/1000 PY for patients without continuity (p = 0.001). Compared to patients with low continuity (<33% of visits), individuals with medium (33-50%) and high (>50%) continuity were less likely to utilize the ED. Conclusions: Strong continuity of care is associated with decreased ED utilization in a PCMH model and improving continuity may help reduce the utilization of non-primary care services.	[Chaiyachati, Krisda H.; Long, Theodore; Khan, Ali; Meyer, Emily; Justice, Amy; Brienza, Rebecca] VA Connecticut Healthcare Syst, Ctr Excellence Primary Care Educ, West Haven, CT 06516 USA; [Chaiyachati, Krisda H.; Long, Theodore; Khan, Ali; Justice, Amy; Brienza, Rebecca] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Gordon, Kirsha; Levin, Woody; Justice, Amy; Brienza, Rebecca] VA Connecticut Healthcare Syst, West Haven, CT USA; [Long, Theodore] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Levin, Woody] Evergreen Design, Guilford, CT USA; [Khan, Ali] Iora Hlth, Collect Primary Care, Brooklyn, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Chaiyachati, KH (corresponding author), VA Connecticut Healthcare Syst, Ctr Excellence Primary Care Educ, West Haven, CT 06516 USA.	Krisda.Chaiyachati@yale.edu		Chaiyachati, Krisda/0000-0003-3326-6641	Office of Academic Affiliations; VA Connecticut Health System Center of Excellence in Primary Care Education; Evergreen Design; Iora Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020790] Funding Source: NIH RePORTER	Office of Academic Affiliations(US Department of Veterans Affairs); VA Connecticut Health System Center of Excellence in Primary Care Education; Evergreen Design; Iora Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This publication was supported by the Office of Academic Affiliations and the VA Connecticut Health System Center of Excellence in Primary Care Education. Neither funding source had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation or review of the manuscript. The Office of Academic Affiliation did approve the manuscript for publication, but no modifications were made to the manuscript. Evergreen Design provided support in the form of a salary for author WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Iora Health provided support in the form of a salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2007, JOINT PRINC PAT CTR; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Chang A, 2012, J GEN INTERN MED; Dewan NA, 2011, COPD, V8, P153, DOI 10.3109/15412555.2011.560129; Dewing S, 2012, AIDS BEHAV, V16, P1286, DOI 10.1007/s10461-011-0059-z; Duncan LG, 2012, J PAIN SYMPTOM MANAG, V43, P161, DOI 10.1016/j.jpainsymman.2011.04.007; Fields D, 2010, HEALTH AFFAIR, V29, P819, DOI 10.1377/hlthaff.2010.0009; Flores-Mateo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035903; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Grafstein E, 2013, ACAD EMERG MED, V20, P63, DOI 10.1111/acem.12063; Grumbach K., 2010, OUTCOMES IMPLEMENTIN; Harbrecht MG, 2012, HEALTH AFFAIR, V31, P2010, DOI 10.1377/hlthaff.2012.0359; Henschen BL, 2013, J GEN INTERN MED; Hochman ME, 2013, JAMA INTERN MED; Ionescu-Ittu R, 2007, CAN MED ASSOC J, V177, P1362, DOI 10.1503/cmaj.061615; Ishani A, 2011, DIABETES CARE, V34, P1689, DOI 10.2337/dc10-2121; Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c; Kuehn BM, 2012, JAMA-J AM MED ASSOC, V307, P442, DOI 10.1001/jama.2012.47; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; MAGILL MK, 1987, J FAM PRACTICE, V24, P165; Markova T, 2012, J AM BOARD FAM MED, V25, P224, DOI 10.3122/jabfm.2012.02.110181; McCusker J, 2012, CAN MED ASSOC J, V184, pE307, DOI 10.1503/cmaj.111069; Nutting PA, 2011, HEALTH AFFAIR, V30, P439, DOI 10.1377/hlthaff.2010.0159; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Roby DH, 2010, MED CARE RES REV, V67, P412, DOI 10.1177/1077558710368682; Rosland AM, 2013, AM J MANAG CARE, V19, pE263; Sia C, 2004, PEDIATRICS, V113, P1473; Sidorov JE, 2008, HEALTH AFFAIR, V27, P1231, DOI 10.1377/hlthaff.27.5.1231; Westover AN, 2007, ARCH GEN PSYCHIAT, V64, P495, DOI 10.1001/archpsyc.64.4.495; Wharam JF, 2013, HEALTH AFFAIR, V32, P1398, DOI 10.1377/hlthaff.2012.1426	34	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96356	10.1371/journal.pone.0096356	http://dx.doi.org/10.1371/journal.pone.0096356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24867300	Green Submitted, gold, Green Published			2022-12-27	WOS:000336914100004
J	Greco, M; Saez, CA; Brown, MT; Bitonti, MB				Greco, Maria; Saez, Claudio A.; Brown, Murray T.; Bitonti, Maria Beatrice			A Simple and Effective Method for High Quality Co-Extraction of Genomic DNA and Total RNA from Low Biomass Ectocarpus siliculosus, the Model Brown Alga	PLOS ONE			English	Article							MARINE FOULING ALGA; PHENOLIC-COMPOUNDS; COPPER TOLERANCE; LARGE-SCALE; EXTRACTION; POLYSACCHARIDES; PHAEOPHYCEAE; PROTOCOL; NORMALIZATION; LAMINARIALES	The brown seaweed Ectocarpus siliculosus is an emerging model species distributed worldwide in temperate coastal ecosystems. Over 1500 strains of E. siliculosus are available in culture from a broad range of geographic locations and ecological niches. To elucidate the molecular mechanisms underlying its capacity to cope with different environmental and biotic stressors, genomic and transcriptomic studies are necessary; this requires the co-isolation of genomic DNA and total RNA. In brown algae, extraction of nucleic acids is hindered by high concentrations of secondary metabolites that co-precipitate with nucleic acids. Here, we propose a reliable, rapid and cost-effective procedure for the co-isolation of high-quality nucleic acids using small quantities of biomass (25-, 50- and 100 mg) from strains of E. siliculosus (RHO12; LIA4A; EC524 and REP10-11) isolated from sites with different environmental conditions. The procedure employs a high pH extraction buffer (pH 9.5) which contains 100 mM Tris-HCl and 150 mM NaCl, with the addition of 5 mM DTT and 1% sarkosyl to ensure maximum solubility of nucleic acids, effective inhibition of nuclease activity and removal of interfering contaminants (e. g. polysaccharides, polyphenols). The use of sodium acetate together with isopropanol shortened precipitation time and enhanced the yields of DNA/RNA. A phenol: chlorophorm:isoamyl alcohol step was subsequently used to purify the nucleic acids. The present protocol produces high yields of nucleic acids from only 25 mg of fresh algal biomass (0.195 and 0.284 mu g mg(-1) fresh weigh of RNA and DNA, respectively) and the high quality of the extracted nucleic acids was confirmed through spectrophotometric and electrophoretic analyses. The isolated RNA can be used directly in downstream applications such as RT-PCR and the genomic DNA was suitable for PCR, producing reliable restriction enzyme digestion patterns. Co-isolation of DNA/RNA from different strains indicates that this method is likely to have wider applications for intra-and inter-specific studies on other brown algae.	[Greco, Maria; Bitonti, Maria Beatrice] Univ Calabria, Dept Biol Ecol & Earth Sci, Lab Plant Cytophysiol, I-87036 Cosenza, Italy; [Saez, Claudio A.; Brown, Murray T.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Saez, Claudio A.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile	University of Calabria; University of Plymouth; Universidad de Santiago de Chile	Greco, M (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, Lab Plant Cytophysiol, I-87036 Cosenza, Italy.	maria.greco@unical.it	Sáez, Claudio/AAP-6923-2021; Saez, Claudio/F-5978-2015; Bitonti, Maria/AAO-7345-2020; Brown, Murray/K-5291-2014	Sáez, Claudio/0000-0002-5037-3484; Saez, Claudio/0000-0002-5037-3484; Greco, Maria/0000-0002-1404-6937; Brown, Murray/0000-0003-2655-8611	CONICYT Becas Chile Scholarship [72110557]	CONICYT Becas Chile Scholarship	This study was funded by CONICYT Becas Chile Scholarship (72110557) awarded to Claudio A. Saez for doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C., 1994, Plant Molecular Biology Reporter, V12, P198, DOI 10.1007/BF02668741; ARAKI S, 1992, NIPPON SUISAN GAKK, V58, P477; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Azevedo H, 2003, PLANT MOL BIOL REP, V21, P333, DOI 10.1007/BF02772582; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Birtic S, 2006, PHYTOCHEM ANALYSIS, V17, P144, DOI 10.1002/pca.903; Boehringer Mannheim, 1990, REAG MOL BIOL CAT, P255; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Brooks G., 1998, BIOTECHNOLOGY HEALTH; Buckingham L, 2007, MOL DIAGNOSTICS FUND; Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Coelho Susana M, 2012, Cold Spring Harb Protoc, V2012, P365, DOI 10.1101/pdb.prot067967; COYER JA, 1995, J PHYCOL, V31, P177, DOI 10.1111/j.0022-3646.1995.00177.x; CRONSHAW J, 1958, BIOCHIM BIOPHYS ACTA, V27, P89, DOI 10.1016/0006-3002(58)90295-6; Cseke L.J., 2004, HDB MOL CELLULAR MET; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davis RH, 2004, NAT REV GENET, V5, p69A, DOI 10.1038/nrg1250; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Deville C, 2004, J SCI FOOD AGR, V84, P1030, DOI 10.1002/jsfa.1754; Dittami SM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-2; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dolferus R, 1991, LAB GUIDE CELLULAR M, P133; Doyle K., 1996, SOURCE DISCOVERY PRO; Eggermont K, 1996, PLANT MOL BIOL REP, V14, P273, DOI 10.1007/BF02671663; FANG G, 1992, BIOTECHNIQUES, V13, P52; Gao JianWei, 2001, Plant Molecular Biology Reporter, V19, P185, DOI 10.1007/BF02772163; HALL A, 1981, BOT MAR, V24, P223, DOI 10.1515/botm.1981.24.4.223; HALL A, 1979, MAR BIOL, V54, P195, DOI 10.1007/BF00395780; HALL A, 1980, NEW PHYTOL, V85, P73, DOI 10.1111/j.1469-8137.1980.tb04449.x; Hoarau G, 2007, MOL ECOL NOTES, V7, P191, DOI 10.1111/j.1471-8286.2006.01587.x; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; HONG YK, 1995, J APPL PHYCOL, V7, P101, DOI 10.1007/BF00693055; Hughes DW, 1988, PLANT MOL BIOL REP, V6, P253, DOI DOI 10.1007/BF02670385; Jaakola L, 2001, PLANT MOL BIOL REP, V19, P125, DOI 10.1007/BF02772901; Jin HJ, 1997, J APPL PHYCOL, V9, P383, DOI 10.1023/A:1007925202219; KENDALL TL, 1991, ANAL BIOCHEM, V195, P74, DOI 10.1016/0003-2697(91)90297-7; KIRBY KS, 1956, BIOCHEM J, V64, P405, DOI 10.1042/bj0640405; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Kojima K, 2002, US Patent No, Patent No. [20,020,192,667, 20020192667]; LaClaire JW, 1997, PLANT MOL BIOL REP, V15, P263, DOI 10.1023/A:1007486419576; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Li ZW, 2005, BIOTECHNIQUES, V38, P872, DOI 10.2144/05386BM05; Liu JJ, 1998, PLANT MOL BIOL REP, V16, P87, DOI 10.1023/A:1007492421119; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; MABEAU S, 1990, PHYTOCHEMISTRY, V29, P2441, DOI 10.1016/0031-9422(90)85163-A; Manickavelu A, 2007, COLLOID SURFACE B, V54, P254, DOI 10.1016/j.colsurfb.2006.10.024; MANNING K, 1991, ANAL BIOCHEM, V195, P45, DOI 10.1016/0003-2697(91)90292-2; Matthews CK, 2000, BIOCHEMISTRY-US, p[48, 209]; MAYES C, 1992, J PHYCOL, V28, P712, DOI 10.1111/j.0022-3646.1992.00712.x; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Muller DG, 1998, ADV VIRUS RES, V50, P49, DOI 10.1016/S0065-3527(08)60805-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pearson G, 2006, EUR J PHYCOL, V41, P97, DOI 10.1080/09670260500505011; Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806; Peters AF, 2004, J PHYCOL, V40, P1079, DOI 10.1111/j.1529-8817.2004.04058.x; Peters AF, 2008, DEVELOPMENT, V135, P1503, DOI 10.1242/dev.016303; Phillips Naomi, 2001, Phycological Research, V49, P97, DOI 10.1111/j.1440-1835.2001.tb00239.x; Provasoli L, 1974, ALGAL PHYSL BIOCH, P741; QUATRANO RS, 1976, PLANT PHYSIOL, V58, P224, DOI 10.1104/pp.58.2.224; Rioux LE, 2007, CARBOHYD POLYM, V69, P530, DOI 10.1016/j.carbpol.2007.01.009; RUSSELL G, 1970, NATURE, V228, P288, DOI 10.1038/228288a0; Saez CA, 2012, CHEM ECOL, V28, P1, DOI 10.1080/02757540.2011.619529; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Sambrook J., 2001, MOL CLONING LAB MANU; Schoenwaelder MEA, 2000, PLANT BIOLOGY, V2, P24, DOI 10.1055/s-2000-9178; Schultz D. J., 1994, Plant Molecular Biology Reporter, V12, P310, DOI 10.1007/BF02669273; Singh G., 2003, PLANT MOL BIOL REP, V21, P93, DOI DOI 10.1007/BF02773401; Smith SDA, 1996, MAR POLLUT BULL, V33, P309, DOI 10.1016/S0025-326X(96)00124-5; Smith SDA, 1996, AUST J ECOL, V21, P144, DOI 10.1111/j.1442-9993.1996.tb00595.x; Stone BA, 1992, CHEM BIOL 1 3 BETA G; SU X, 1988, ANAL BIOCHEM, V174, P650, DOI 10.1016/0003-2697(88)90068-1; THOMAS DN, 1991, BOT ACTA, V104, P26, DOI 10.1111/j.1438-8677.1991.tb00190.x; THOMAS DN, 1991, PHYSIOL PLANTARUM, V83, P281, DOI 10.1111/j.1399-3054.1991.tb02154.x; Vicient CM, 1999, ANAL BIOCHEM, V268, P412, DOI 10.1006/abio.1998.3045; Villegas MJ, 2008, HELGOLAND MAR RES, V62, pS33, DOI 10.1007/s10152-007-0096-1; Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x; WALLACE DM, 1987, METHOD ENZYMOL, V152, P33; Wang GG, 2005, J APPL PHYCOL, V17, P75, DOI 10.1007/s10811-005-5557-9; Wang TY, 2011, GENET MOL RES, V10, P519, DOI 10.4238/vol10-1gmr1055; Wilkins Thea A., 1996, P21; Wink M, 2006, METHODS APPL MODERN; Yao JT, 2009, J APPL PHYCOL, V21, P233, DOI 10.1007/s10811-008-9354-0	86	33	35	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96470	10.1371/journal.pone.0096470	http://dx.doi.org/10.1371/journal.pone.0096470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867404	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100005
J	Mesman, S; von Oerthel, L; Smidt, MP				Mesman, Simone; von Oerthel, Lars; Smidt, Marten P.			Mesodiencephalic Dopaminergic Neuronal Differentiation Does Not Involve GLI2A-Mediated SHH-Signaling and Is under the Direct Influence of Canonical WNT Signaling	PLOS ONE			English	Article							PROGENITORS IN-VIVO; SONIC-HEDGEHOG; FLOOR PLATE; NEURAL PLATE; MIDBRAIN; EXPRESSION; MOUSE; MICE; MESENCEPHALON; NEUROGENESIS	Sonic Hedgehog (SHH) and WNT proteins are key regulators in many developmental processes, like embryonic patterning and brain development. In the brain, SHH is expressed in a gradient starting in the floor plate (FP) progressing ventrally in the midbrain, where it is thought to be involved in the development and specification of mesodiencephalic dopaminergic (mdDA) neurons. GLI2A-mediated SHH-signaling induces the expression of Gli1, which is inhibited when cells start expressing SHH themselves. To determine whether mdDA neurons receive GLI2A-mediated SHH-signaling during differentiation, we used a BAC-transgenic mouse model expressing eGFP under the control of the Gli1 promoter. This mouse-model allowed for mapping of GLI2A-mediated SHH-signaling temporal and spatial in the mouse midbrain. Since mdDA neurons are born from E10.5, peaking at E11.0-E12.0, we examined Gli1-eGFP embryos at E11.5, E12.5, and E13.5, indicating whether Gli1 was induced before or during mdDA development and differentiation. Our data indicate that GLI2A-mediated SHH-signaling is not involved in mdDA neuronal differentiation. However, it appears to be involved in the differentiation of neurons which make up a subset of the red nucleus (RN). In order to detect whether mdDA neuronal differentiation may be under the control of canonical WNT-signaling, we used a transgenic mouse-line expressing LacZ under the influence of stable beta-catenin. Here, we show that TH+ neurons of the midbrain receive canonical WNT-signaling during differentiation. Therefore, we suggest that early SHH-signaling is indirectly involved in mdDA development through early patterning of the midbrain area, whereas canonical WNT-signaling is directly involved in the differentiation of the mdDA neuronal population.	[Mesman, Simone; von Oerthel, Lars; Smidt, Marten P.] FNWI Univ Amsterdam, CNS, Swammerdam Inst Life Sci, Amsterdam, Netherlands	University of Amsterdam	Smidt, MP (corresponding author), FNWI Univ Amsterdam, CNS, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X; Mesman, Simone/0000-0002-9728-5828	NWO-ALW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Aard en Levenswetenschappen) VICI grant [865.09.002]	NWO-ALW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Aard en Levenswetenschappen) VICI grant	This work was sponsored by the NWO-ALW (Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Aard en Levenswetenschappen) VICI grant (865.09.002) awarded to Prof. Dr. Marten P. Smidt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2001, BRAIN RES REV, V38, P129, DOI 10.1016/S0006-8993(01)02902-X; Bai CB, 2002, DEVELOPMENT, V129, P4753; BAYER SA, 1995, EXP BRAIN RES, V105, P191; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Brown A, 2011, J COMP NEUROL, V519, P2978, DOI 10.1002/cne.22710; BURRUS LW, 1995, EXP CELL RES, V220, P363, DOI 10.1006/excr.1995.1327; Bye CR, 2012, EXP NEUROL, V236, P58, DOI 10.1016/j.expneurol.2012.04.002; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Demyanenko GP, 2001, DEV BRAIN RES, V126, P21, DOI 10.1016/S0165-3806(00)00129-2; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Frizzo ME, 2007, HIPPOCAMPUS, V17, P305, DOI 10.1002/hipo.20269; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hayes L, 2013, DEV BIOL, V374, P115, DOI 10.1016/j.ydbio.2012.11.016; Hayes L, 2011, J COMP NEUROL, V519, P3001, DOI 10.1002/cne.22711; Hebsgaard JB, 2009, GLIA, V57, P1648, DOI 10.1002/glia.20877; Hoekstra EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074049; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Joksimovic M, 2014, J MOL CELL BIOL, V6, P27, DOI 10.1093/jmcb/mjt043; Joksimovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030266; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Kolk SM, 2009, J NEUROSCI, V29, P12542, DOI 10.1523/JNEUROSCI.2521-09.2009; Liang HZ, 2012, BRAIN STRUCT FUNCT, V217, P221, DOI 10.1007/s00429-011-0348-3; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mavromatakis YE, 2011, MECH DEVELOP, V128, P90, DOI 10.1016/j.mod.2010.11.002; Mittag J, 2013, J CLIN INVEST, V123, P509, DOI 10.1172/JCI65252; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Ohyama K, 1998, DEV BRAIN RES, V107, P219, DOI 10.1016/S0165-3806(97)00220-4; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Park HL, 2000, DEVELOPMENT, V127, P1593; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Santos MTA, 2011, NEURAL DEV, V6, P23, DOI [10.1186/1749-8104-6-23, DOI 10.1186/1749-8104-6-23]; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smits SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076037; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Super H, 2001, CEREB CORTEX, V11, P1101, DOI 10.1093/cercor/11.12.1101; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Wurst W, 2014, J MOL CELL BIOL, V6, P34, DOI 10.1093/jmcb/mjt046; Yang J, 2013, DEVELOPMENT, V140, P1342, DOI 10.1242/dev.080630; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	57	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97926	10.1371/journal.pone.0097926	http://dx.doi.org/10.1371/journal.pone.0097926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865218	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100027
J	Pallante, P; Sepe, R; Federico, A; Forzati, F; Bianco, M; Fusco, A				Pallante, Pierlorenzo; Sepe, Romina; Federico, Antonella; Forzati, Floriana; Bianco, Mimma; Fusco, Alfredo			CBX7 Modulates the Expression of Genes Critical for Cancer Progression	PLOS ONE			English	Article							TRYPSIN-INHIBITOR; C-FOS; TRANSCRIPTION FACTORS; PROTEIN EXPRESSION; CHROMOBOX PROTEIN; OSTEOPONTIN; CARCINOMA; GROWTH; TRANSFORMATION; METASTASIS	Background: We have previously shown that the expression of CBX7 is drastically decreased in several human carcinomas and that its expression progressively decreases with the appearance of a highly malignant phenotype. The aim of our study has been to investigate the mechanism by which the loss of CBX7 expression may contribute to the emergence of a more malignant phenotype. Methods: We analyzed the gene expression profile of a thyroid carcinoma cell line after the restoration of CBX7 and, then, analyzed the transcriptional regulation of identified genes. Finally, we evaluated the expression of CBX7 and regulated genes in a panel of thyroid and lung carcinomas. Results: We found that CBX7 negatively or positively regulates the expression of several genes (such as SPP1, SPINK1, STEAP1, and FOS, FOSB, EGR1, respectively) associated to cancer progression, by interacting with their promoter regions and modulating their transcriptional activity. Quantitative RT-PCR analyses in human thyroid and lung carcinoma tissues revealed a negative correlation between CBX7 and its down-regulated genes, while a positive correlation was observed with up-regulated genes. Conclusion: In conclusion, the loss of CBX7 expression might play a critical role in advanced stages of carcinogenesis by deregulating the expression of specific effector genes.	[Pallante, Pierlorenzo; Sepe, Romina; Federico, Antonella; Forzati, Floriana; Bianco, Mimma; Fusco, Alfredo] Univ Naples Federico II, IEOS, CNR, DMMBM, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Fusco, A (corresponding author), Univ Naples Federico II, IEOS, CNR, DMMBM, Naples, Italy.	alfusco@unina.it	Pallante, Pierlorenzo/AAX-8758-2020	Fusco, Alfredo/0000-0003-3332-5197	Associazione Italiana per la Ricerca sul Cancro-AIRC [IG 5346]; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica-MIUR (PRIN); Progetto di Interesse strategico Invecchiamento (PNR-CNR Aging Program) PNR-CNR; Progetto "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti" [PON01-02782]	Associazione Italiana per la Ricerca sul Cancro-AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica e Tecnologica-MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)); Progetto di Interesse strategico Invecchiamento (PNR-CNR Aging Program) PNR-CNR; Progetto "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti"	This work was supported by grants from: Associazione Italiana per la Ricerca sul Cancro-AIRC (IG 5346), Ministero dell'Universita e della Ricerca Scientifica e Tecnologica-MIUR (PRIN 2008), "Progetto di Interesse strategico Invecchiamento (PNR-CNR Aging Program) PNR-CNR 2012-2014" and Progetto PON01-02782: "Nuove strategie nanotecnologiche per la messa a punto di farmaci e presidi diagnostici diretti verso cellule cancerose circolanti". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PMS, 2006, CANCER IMMUNOL IMMUN, V55, P1515, DOI 10.1007/s00262-006-0165-3; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Furger Kara A., 2001, Current Molecular Medicine (Hilversum), V1, P621, DOI 10.2174/1566524013363339; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Gaber A, 2009, BRIT J CANCER, V100, P1540, DOI 10.1038/sj.bjc.6605047; Gaber A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-498; Geissinger E, 2002, CANCER RES, V62, P4820; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; HUHTALA ML, 1982, J BIOL CHEM, V257, P13713; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Karamitopoulou E, 2010, EUR J CANCER, V46, P1438, DOI 10.1016/j.ejca.2010.01.033; Liu CT, 1998, CANCER GENE THER, V5, P3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Mansueto Gelsomina, 2010, Genes Cancer, V1, P210, DOI 10.1177/1947601910366860; Mikula M, 2003, ONCOGENE, V22, P6725, DOI 10.1038/sj.onc.1206781; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Milde-Langosch K, 2004, BREAST CANCER RES TR, V86, P139, DOI 10.1023/B:BREA.0000032982.49024.71; Milde-Langosch K, 2003, BREAST CANCER RES TR, V77, P265, DOI 10.1023/A:1021887100216; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Paju A, 2004, CLIN CANCER RES, V10, P4761, DOI 10.1158/1078-0432.CCR-0204-03; Paju A, 2001, J UROLOGY, V165, P959, DOI 10.1016/S0022-5347(05)66584-6; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pallante P, 2010, EUR J CANCER, V46, P2304, DOI 10.1016/j.ejca.2010.05.011; Prevarskaya N, 2007, CELL DEATH DIFFER, V14, P1295, DOI 10.1038/sj.cdd.4402162; Rudland PS, 2002, CANCER RES, V62, P3417; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shariat SF, 2005, EUR UROL, V48, P424, DOI 10.1016/j.eururo.2005.04.034; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Stenman UH, 2002, CLIN CHEM, V48, P1206; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tuck AB, 1999, ONCOGENE, V18, P4237, DOI 10.1038/sj.onc.1202799; Venesmaa P, 1998, BRIT J OBSTET GYNAEC, V105, P508, DOI 10.1111/j.1471-0528.1998.tb10150.x; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Wu MY, 2001, WORLD J GASTROENTERO, V7, P490; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	46	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98295	10.1371/journal.pone.0098295	http://dx.doi.org/10.1371/journal.pone.0098295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865347	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100048
J	Harrold, TC; Randall, DA; Falster, MO; Lujic, S; Jorm, LR				Harrold, Timothy C.; Randall, Deborah A.; Falster, Michael O.; Lujic, Sanja; Jorm, Louisa R.			The Contribution of Geography to Disparities in Preventable Hospitalisations between Indigenous and Non-Indigenous Australians	PLOS ONE			English	Article							CARE-SENSITIVE CONDITIONS; MULTILEVEL ANALYSIS; RACIAL DISPARITIES; NEW-ZEALAND; HEALTH	Objectives: To quantify the independent roles of geography and Indigenous status in explaining disparities in Potentially Preventable Hospital (PPH) admissions between Indigenous and non-Indigenous Australians. Design, setting and participants: Analysis of linked hospital admission data for New South Wales (NSW), Australia, for the period July 1 2003 to June 30 2008. Main outcome measures: Age-standardised admission rates, and rate ratios adjusted for age, sex and Statistical Local Area (SLA) of residence using multilevel models. Results: PPH diagnoses accounted for 987,604 admissions in NSW over the study period, of which 3.7% were for Indigenous people. The age-standardised PPH admission rate was 76.5 and 27.3 per 1,000 for Indigenous and non-Indigenous people respectively. PPH admission rates in Indigenous people were 2.16 times higher than in non-Indigenous people of the same age group and sex who lived in the same SLA. The largest disparities in PPH admission rates were seen for diabetes complications, chronic obstructive pulmonary disease and rheumatic heart disease. Both rates of PPH admission in Indigenous people, and the disparity in rates between Indigenous than non-Indigenous people, varied significantly by SLA, with greater disparities seen in regional and remote areas than in major cities. Conclusions: Higher rates of PPH admission among Indigenous people are not simply a function of their greater likelihood of living in rural and remote areas. The very considerable geographic variation in the disparity in rates of PPH admission between Indigenous and non-Indigenous people indicates that there is potential to reduce unwarranted variation by characterising outlying areas which contribute the most to this disparity.	[Harrold, Timothy C.; Randall, Deborah A.; Falster, Michael O.; Lujic, Sanja; Jorm, Louisa R.] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia	Western Sydney University	Harrold, TC (corresponding author), Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia.	tharr@doh.health.nsw.gov.au	Dalla Zuanna, Teresa/G-3133-2015; Falster, Michael/X-7118-2019; Jorm, Louisa/AAN-6874-2020	Falster, Michael/0000-0001-6444-7272; Jorm, Louisa/0000-0003-0390-661X; Lujic, Sanja/0000-0002-9555-0261; Randall, Deborah/0000-0002-5075-0227	National Health and Medical Research Council [573313]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council grant number 573313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2008, REG POP GROWTH; Australian bureau of Statistics, 2012, 2006 CDATA ONL; Australian Bureau of Statistics, 2012, YB AUSTR 2012; Australian Bureau of Statistics, 2008, EXP EST AB TORR STRA; Australian Bureau of Statistics, 2010, HLTH WELF AUSTR AB T; Australian Institute of Health and Welfare, 2010, IND ID HOSP SEP DAT; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare, 2011, AUSTR HOSP STAT 2009; Australian Institute of Health Welfare, 2012, NATL HEALTHCARE AGRE; Bentley Jason P, 2012, N S W Public Health Bull, V23, P17, DOI 10.1071/NB11034; Biddle N., 2013, CAEPR INDIGENOUS POP; Brown A, 2009, HEART LUNG CIRC, V18, P96, DOI 10.1016/j.hlc.2009.01.005; Canadian Institute for Health Information, 2013, CAN I HLTH INF FACT; Council of Australian Governments, 2008, INT AGR IGA FED FIN; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Department of Health Victoria, 2012, VICT AMB CAR SENS CO; Gaskin DJ, 2000, MED CARE RES REV, V57, P85, DOI 10.1177/107755800773743619; Health Department of, 2010, HLTH LIF PROGR FRAM; Jackson G, 2001, AUST NZ J PUBL HEAL, V25, P212, DOI 10.1111/j.1467-842X.2001.tb00565.x; Katterl R, 2012, PHC RIS POLICY ISSUE; Laditka JN, 2006, ETHNIC HEALTH, V11, P247, DOI 10.1080/13557850600565640; Li SQ, 2009, MED J AUSTRALIA, V190, P532, DOI 10.5694/j.1326-5377.2009.tb02551.x; McDermott R, 2004, QUAL SAF HEALTH CARE, V13, P295, DOI 10.1136/qhc.13.4.295; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; National Centre for Classification in Health, 2006, INT STAT CLASS DIS H; National Statistics Service, 2013, STAT INT INV COMM DA; NSW Health, 2012, NSW HLTH STAT HOSP P; O'Neil SS, 2010, AM J PREV MED, V38, P381, DOI 10.1016/j.amepre.2009.12.026; Office of Economic and Statistical Research (OESR), 2010, SYNTH EST RES POP IN; Pellekaan SMV, 2005, POSTGRAD MED J, V81, P618, DOI 10.1136/pgmj.2004.031377; Probst JC, 2004, AM J PUBLIC HEALTH, V94, P1695, DOI 10.2105/AJPH.94.10.1695; Queensland Health, 2012, HLTH QUEENSL REP CHI; Randall DA, 2013, AUST NZ J PUBL HEAL, V37, P442, DOI 10.1111/1753-6405.12114; Rasbash J., 2012, MLWIN VERSION 2 25; Richardson K, 2009, SOC SCI MED, V69, P1252, DOI 10.1016/j.socscimed.2009.07.036; SAS Institute, 2010, SAS VERS 9 3; Scribner RA, 2009, SOC SCI MED, V69, P1584, DOI 10.1016/j.socscimed.2009.08.010; Sentell TL, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120340; Steering Committee for the Review of Government Service Provision (SCRGSP), 2010, NAT AGR PERF INF 200; Subramanian SV, 2005, AM J PUBLIC HEALTH, V95, P260, DOI 10.2105/AJPH.2003.034132; Tobias M, 2006, AUST NZ J PUBL HEAL, V30, P457, DOI 10.1111/j.1467-842X.2006.tb00464.x	41	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97892	10.1371/journal.pone.0097892	http://dx.doi.org/10.1371/journal.pone.0097892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4ML	24859265	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400030
J	Jia, YY; Lu, J; Huang, Y; Liu, G; Gao, P; Wan, YZ; Zhang, R; Zhang, ZQ; Yang, RF; Tang, XQ; Xu, J; Wang, X; Chen, HZ; Liu, DP				Jia, Yu-Yan; Lu, Jie; Huang, Yue; Liu, Guang; Gao, Peng; Wan, Yan-Zhen; Zhang, Ran; Zhang, Zhu-Qin; Yang, Rui-Feng; Tang, Xiaoqiang; Xu, Jing; Wang, Xu; Chen, Hou-Zao; Liu, De-Pei			The Involvement of NFAT Transcriptional Activity Suppression in SIRT1-Mediated Inhibition of COX-2 Expression Induced by PMA/Ionomycin	PLOS ONE			English	Article							ACTIVATED T-CELLS; ENDOTHELIAL GROWTH-FACTOR; NUCLEAR-FACTOR; CYCLOSPORINE-A; KAPPA-B; HISTONE MODIFICATIONS; SIRT1 DEACETYLASE; GENE-EXPRESSION; PROTEIN-KINASE; CYCLOOXYGENASE-2	SIRT1, a class III histone deacetylase, acts as a negative regulator for many transcription factors, and plays protective roles in inflammation and atherosclerosis. Transcription factor nuclear factor of activated T cells (NFAT) has been previously shown to play pro-inflammatory roles in endothelial cells. Inhibition of NFAT signaling may be an attractive target to regulate inflammation in atherosclerosis. However, whether NFAT transcriptional activity is suppressed by SIRT1 remains unknown. In this study, we found that SIRT1 suppressed NFAT-mediated transcriptional activity. SIRT1 interacted with NFAT, and the NHR and RHR domains of NFAT mediated the interaction with SIRT1. Moreover, we found that SIRT1 primarily deacetylated NFATc3. Adenoviral over-expression of SIRT1 suppressed PMA and calcium ionophore Ionomycin (PMA/Io)-induced COX-2 expression in human umbilical vein endothelial cells (HUVECs), while SIRT1 RNAi reversed the effects in HUVECs. Moreover, inhibition of COX-2 expression by SIRT1 in PMA/Io-treated HUVECs was largely abrogated by inhibiting NFAT activation. Furthermore, SIRT1 inhibited NFAT-induced COX-2 promoter activity, and reduced NFAT binding to the COX-2 promoter in PMA/Io-treated HUVECs. These results suggest that suppression of NFAT transcriptional activity is involved in SIRT1-mediated inhibition of COX-2 expression induced by PMA/Io, and that the negative regulatory mechanisms of NFAT by SIRT1 may contribute to its anti-inflammatory effects in atherosclerosis.	[Jia, Yu-Yan; Lu, Jie; Gao, Peng; Wan, Yan-Zhen; Zhang, Ran; Zhang, Zhu-Qin; Yang, Rui-Feng; Tang, Xiaoqiang; Xu, Jing; Wang, Xu; Chen, Hou-Zao; Liu, De-Pei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Jia, Yu-Yan; Lu, Jie; Huang, Yue; Liu, Guang; Gao, Peng; Wan, Yan-Zhen; Zhang, Ran; Zhang, Zhu-Qin; Yang, Rui-Feng; Tang, Xiaoqiang; Xu, Jing; Wang, Xu; Chen, Hou-Zao; Liu, De-Pei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jia, Yu-Yan; Huang, Yue; Liu, Guang] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Chen, HZ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China.	houzao@gmail.com; liudp@pumc.edu.cn	Zhang, Ran/GZG-8709-2022; Tang, Xiaoqiang/G-4319-2013; Gao, Peng/AAC-1510-2020	Tang, Xiaoqiang/0000-0003-1314-3417; Liu, De-Pei/0000-0002-2636-4297; Chen, Hou-Zao/0000-0001-6805-3182	National Basic Research Program of China [2011CB503902]; National Natural Science Foundation of China [31271227, 30121091, 81161120551]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (grant number 2011CB503902) and the National Natural Science Foundation of China (grant numbers 31271227, 30121091, and 81161120551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Arroyo MV, 2002, CIRC RES, V91, P202, DOI 10.1161/01.RES.0000027562.91075.56; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Bosc LVG, 2004, J BIOL CHEM, V279, P10702, DOI 10.1074/jbc.M312920200; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; COCKERILL GW, 1995, BLOOD, V86, P2689; Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jia YY, 2013, SCI CHINA LIFE SCI, V56, P19, DOI 10.1007/s11427-012-4407-7; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Stein S, 2010, AGING-US, V2, P353, DOI 10.18632/aging.100162; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592	40	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97999	10.1371/journal.pone.0097999	http://dx.doi.org/10.1371/journal.pone.0097999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859347	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400033
J	Puenpa, J; Mauleekoonphairoj, J; Linsuwanon, P; Suwannakarn, K; Chieochansin, T; Korkong, S; Theamboonlers, A; Poovorawan, Y				Puenpa, Jiratchaya; Mauleekoonphairoj, John; Linsuwanon, Piyada; Suwannakarn, Kamol; Chieochansin, Thaweesak; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong			Prevalence and Characterization of Enterovirus Infections among Pediatric Patients with Hand Foot Mouth Disease, Herpangina and Influenza Like Illness in Thailand, 2012	PLOS ONE			English	Article							COXSACKIEVIRUS A6; BC LOOP; OUTBREAK; TAIWAN; EPIDEMIOLOGY; CIRCULATION; VP1; A10; SEROTYPES; EVOLUTION	Hand, foot, and mouth disease (HFMD) and herpangina are common infectious diseases caused by several genotypes of human enterovirus species A and frequently occurring in young children. This study was aimed at analyzing enteroviruses from patients with these diseases in Thailand in 2012. Detection and genotype determination of enteroviruses were accomplished by reverse transcription-polymerase chain reaction and sequencing of the VP1 region. Enterovirus-positive samples were differentiated into 17 genotypes (coxsackievirus A4 (CAV4), A5, A6, A8, A9, A10, A12, A16, A21, B1, B2, B4, B5, echovirus 7, 16, 25 and Enterovirus 71). The result showed CAV6 (33.5%), followed by CAV16 (9.4%) and EV71 (8.8%) as the most frequent genotypes in HFMD, CAV8 (19.3%) in herpangina and CAV6 (1.5%) in influenza like illness. Enterovirus infections were most prevalent during July with 34.4% in HFMD, 39.8% in herpangina and 1.6% in ILI. The higher enterovirus infection associated with HFMD and herpangina occurred in infants over one year-old. This represents the first report describing the circulation of multiple enteroviruses in Thailand.	[Puenpa, Jiratchaya; Mauleekoonphairoj, John; Linsuwanon, Piyada; Suwannakarn, Kamol; Chieochansin, Thaweesak; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	Linsuwanon, Piyada/AAS-7642-2020; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Mauleekoonphairoj, John/0000-0001-7644-0940; Poovorawan, Yong/0000-0002-2337-6807	National Research Council of Thailand; Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission [HR1155A]; Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; King Chulalongkorn Memorial Hospital Thai Red Cross Society; RGJ PhD program [PHD/0087/2554, PHD/0083/2552]	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission; Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; King Chulalongkorn Memorial Hospital Thai Red Cross Society; RGJ PhD program	This study was supported by the National Research Council of Thailand; The Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission (HR1155A); the Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project (CU56-HR01); the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093); the Outstanding Professor of the Thailand Research Fund (DPG5480002); King Chulalongkorn Memorial Hospital Thai Red Cross Society; and the RGJ PhD program (PHD/0087/2554) and (PHD/0083/2552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Flett K, 2012, EMERG INFECT DIS, V18, P1702, DOI 10.3201/eid1810.120813; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; He Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/481580; Herrero LJ, 2003, ARCH VIROL, V148, P1369, DOI 10.1007/s00705-003-0100-2; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Kapusinszky B, 2010, VIRUS GENES, V40, P163, DOI 10.1007/s11262-009-0440-4; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Thoa LPK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069895; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Montes M, 2013, EMERG INFECT DIS, V19, P676, DOI 10.3201/eid1904.121589; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438; Park K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-205; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Shah VA, 2003, ANN ACAD MED SINGAP, V32, P381; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; STIRK HJ, 1994, PROTEIN ENG, V7, P47, DOI 10.1093/protein/7.1.47; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; World Health Organization, 2006, COLL PRES SHIPP SPEC, P42; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719	51	47	63	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98888	10.1371/journal.pone.0098888	http://dx.doi.org/10.1371/journal.pone.0098888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887237	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300119
J	Shaffer, SA; Clatterbuck, CA; Kelsey, EC; Naiman, AD; Young, LC; VanderWerf, EA; Warzybok, P; Bradley, R; Jahncke, J; Bower, GC				Shaffer, Scott A.; Clatterbuck, Corey A.; Kelsey, Emma C.; Naiman, Alex D.; Young, Lindsay C.; VanderWerf, Eric A.; Warzybok, Pete; Bradley, Russell; Jahncke, Jaime; Bower, Geoff C.			As the Egg Turns: Monitoring Egg Attendance Behavior in Wild Birds Using Novel Data Logging Technology	PLOS ONE			English	Article							HUMAN DISTURBANCE; HEART-RATE; INCUBATION; PENGUINS; EMBRYOS; CONSEQUENCES; TEMPERATURES; FREQUENCY; FAILURE; SUCCESS	Egg turning is unique to birds and critical for embryonic development in most avian species. Technology that can measure changes in egg orientation and temperature at fine temporal scales (1 Hz) was neither readily available nor small enough to fit into artificial eggs until recently. Here we show the utility of novel miniature data loggers equipped with 3-axis (i.e., triaxial) accelerometers, magnetometers, and a temperature thermistor to study egg turning behavior in free-ranging birds. Artificial eggs containing egg loggers were deployed in the nests of three seabird species for 1-7 days of continuous monitoring. These species (1) turned their eggs more frequently (up to 6.5 turns h(-1)) than previously reported for other species, but angular changes were often small (1-10 degrees most common), (2) displayed similar mean turning rates (ca. 2 turns h(-1)) despite major differences in reproductive ecology, and (3) demonstrated distinct diurnal cycling in egg temperatures that varied between 1.4 and 2.4 degrees C. These novel egg loggers revealed high-resolution, three-dimensional egg turning behavior heretofore never measured in wild birds. This new form of biotechnology has broad applicability for addressing fundamental questions in avian breeding ecology, life history, and development, and can be used as a tool to monitor birds that are sensitive to disturbance while breeding.	[Shaffer, Scott A.; Clatterbuck, Corey A.; Kelsey, Emma C.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Naiman, Alex D.; Bower, Geoff C.] Stanford Univ, Dept Aeronaut & Astronaut, Stanford, CA 94305 USA; [Young, Lindsay C.; VanderWerf, Eric A.] Pacif Rim Conservat, Honolulu, HI USA; [Warzybok, Pete; Bradley, Russell; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA USA	California State University System; San Jose State University; Stanford University	Shaffer, SA (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	scott.shaffer@sjsu.edu	Shaffer, Scott A/D-5015-2009	Shaffer, Scott A/0000-0002-7751-5059; , Corey/0000-0003-1351-8565; Kelsey, Emma/0000-0002-0107-3530	California State University Program for Education and Research in Biotechnology (CSUPERB); California State University Council on Ocean Affairs, Science and Technology (CSU COAST); Dr. Earl H. Myers and Ethel M. Myers Oceanographic and Marine Biology Trust; Frank M. Chapman Memorial Fund; San Jose State University Research, Scholarship and Activity (RSCA) grants; Pacific Rim Conservation	California State University Program for Education and Research in Biotechnology (CSUPERB); California State University Council on Ocean Affairs, Science and Technology (CSU COAST); Dr. Earl H. Myers and Ethel M. Myers Oceanographic and Marine Biology Trust; Frank M. Chapman Memorial Fund; San Jose State University Research, Scholarship and Activity (RSCA) grants; Pacific Rim Conservation	This research was supported by grants from the California State University Program for Education and Research in Biotechnology (CSUPERB); California State University Council on Ocean Affairs, Science and Technology (CSU COAST); Dr. Earl H. Myers and Ethel M. Myers Oceanographic and Marine Biology Trust; Frank M. Chapman Memorial Fund; and San Jose State University Research, Scholarship and Activity (RSCA) grants. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pacific Rim Conservation provided support in the form of salaries for authors LCY and EAVW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu M, 2010, POLAR BIOL, V33, P485, DOI 10.1007/s00300-009-0725-z; BEER CG, 1965, AUK, V82, P1; BOONE RB, 1989, J FIELD ORNITHOL, V60, P315; CALDWELL PJ, 1975, AUK, V92, P706, DOI 10.2307/4084783; De Villiers M, 2006, POLAR BIOL, V29, P717, DOI 10.1007/s00300-006-0137-2; Deeming D.C., 2002, AVIAN INCUBATION BEH; DEEMING DC, 1989, BRIT POULTRY SCI, V30, P591, DOI 10.1080/00071668908417182; DEEMING DC, 1989, J MORPHOL, V201, P179, DOI 10.1002/jmor.1052010207; Drent R. H., 1970, P1; Drent R. H, 1970, pUnpaginated; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; Elibol O, 2006, POULTRY SCI, V85, P1433, DOI 10.1093/ps/85.8.1433; Ellenberg U, 2006, BIOL CONSERV, V133, P95, DOI 10.1016/j.biocon.2006.05.019; Eycleshymer AC, 1907, BIOL BULL-US, V12, P360, DOI 10.2307/1535688; Fernandez MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061030; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; GEE GF, 1995, ZOO BIOL, V14, P159, DOI 10.1002/zoo.1430140209; Giese M, 1999, J FIELD ORNITHOL, V70, P49; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Holmes N, 2005, BIOL CONSERV, V126, P339, DOI 10.1016/j.biocon.2005.06.009; HOWEY P, 1984, IBIS, V126, P16, DOI 10.1111/j.1474-919X.1984.tb03660.x; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; NEW DAT, 1957, J EMBRYOL EXP MORPH, V5, P293; Nimon AJ, 1996, PHYSIOL BEHAV, V60, P1019; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; Reid JM, 2000, FUNCT ECOL, V14, P560, DOI 10.1046/j.1365-2435.2000.00446.x; Reneerkens J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016834; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Thierry AM, 2013, HORM BEHAV, V64, P737, DOI 10.1016/j.yhbeh.2013.06.003; Thierry AM, 2013, HORM BEHAV, V63, P475, DOI 10.1016/j.yhbeh.2012.12.011; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Tona K, 2005, POULTRY SCI, V84, P315, DOI 10.1093/ps/84.2.315; TULLETT SG, 1987, BRIT POULTRY SCI, V28, P239, DOI 10.1080/00071668708416958; Walsh PT, 2007, BIRD STUDY, V54, P133, DOI 10.1080/00063650709461466; Weathers Wesley W., 2010, Western Birds, V41, P2; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Yoda K, 2001, J EXP BIOL, V204, P685	40	20	25	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97898	10.1371/journal.pone.0097898	http://dx.doi.org/10.1371/journal.pone.0097898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887441	gold, Green Published			2022-12-27	WOS:000336956300025
J	Govindan, S; Shapiro, L; Langa, KM; Iwashyna, TJ				Govindan, Sushant; Shapiro, Letitia; Langa, Kenneth M.; Iwashyna, Theodore J.			Death Certificates Underestimate Infections as Proximal Causes of Death in the US	PLOS ONE			English	Article							SEVERE SEPSIS; CANCER-MORTALITY; ACCURACY; AUTOPSY; TRENDS; STATISTICS	Background: Death certificates are a primary data source for assessing the population burden of diseases; however, there are concerns regarding their accuracy. Diagnosis-Related Group (DRG) coding of a terminal hospitalization may provide an alternative view. We analyzed the rate and patterns of disagreement between death certificate data and hospital claims for patients who died during an inpatient hospitalization. Methods: We studied respondents from the Health and Retirement Study (a nationally representative sample of older Americans who had an inpatient death documented in the linked Medicare claims from 1993-2007). Causes of death abstracted from death certificates were aggregated to the standard National Center for Health Statistics List of 50 Rankable Causes of Death. Centers for Medicare and Medicaid Services (CMS)-DRGs were manually aggregated into a parallel classification. We then compared the two systems via 2x2, focusing on concordance. Our primary analysis was agreement between the two data sources, assessed with percentages and Cohen's kappa statistic. Results: 2074 inpatient deaths were included in our analysis. 36.6% of death certificate cause-of-death codes agreed with the reason for the terminal hospitalization in the Medicare claims at the broad category level; when re-classifying DRGs without clear alignment as agreements, the concordance only increased to 61%. Overall Kappa was 0.21, or "fair.'' Death certificates in this cohort redemonstrated the conventional top 3 causes of death as diseases of the heart, malignancy, and cerebrovascular disease. However, hospitalization claims data showed infections, diseases of the heart, and cerebrovascular disease as the most common diagnoses for the same terminal hospitalizations. Conclusion: There are significant differences between Medicare claims and death certificate data in assigning cause of death for inpatients. The importance of infections as proximal causes of death is underestimated by current death certificate-based strategies.	[Govindan, Sushant; Shapiro, Letitia; Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] HSR&D Ctr Excellence, VA Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Iwashyna, TJ (corresponding author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.	tiwashyn@umich.edu		Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [K08 HL091249, R01 AG030155, U01 AG09740]; Department of Veterans Affairs Health Services Research & Development Service [IIR 11-109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG030155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Health Services Research & Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants K08 HL091249, R01 AG030155, and U01 AG09740 from the National Institutes of Health, and IIR 11-109 from the Department of Veterans Affairs Health Services Research & Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2011, STAT ABSTR US 2012; [Anonymous], 2013, CAUSES DEATH ST 0302; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doria-Rose VP, 2009, LUNG CANCER, V63, P295, DOI 10.1016/j.lungcan.2008.05.019; Farmer SA, 2013, JAMA-J AM MED ASSOC, V309, P349, DOI 10.1001/jama.2012.191276; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005; HASUO Y, 1989, J CLIN EPIDEMIOL, V42, P577, DOI 10.1016/0895-4356(89)90154-6; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Heron Melonie, 2011, Natl Vital Stat Rep, V59, P1; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V185, P835, DOI 10.1164/rccm.201109-1660OC; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Johansson LA, 2002, J EPIDEMIOL COMMUN H, V56, P301, DOI 10.1136/jech.56.4.301; Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lund JL, 2010, CANCER INVEST, V28, P758, DOI 10.3109/07357901003630959; Mlangeni DA, 2011, J HOSP INFECT, V77, P370, DOI 10.1016/j.jhin.2010.12.016; MODELMOG D, 1992, CANCER CAUSE CONTROL, V3, P541, DOI 10.1007/BF00052751; Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0; MOUSSA MAA, 1990, J CLIN EPIDEMIOL, V43, P1285, DOI 10.1016/0895-4356(90)90094-6; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	34	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97714	10.1371/journal.pone.0097714	http://dx.doi.org/10.1371/journal.pone.0097714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878897	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500022
J	Wang, JH; He, LL; Zheng, HR; Lu, ZL				Wang, Jinghua; He, Lili; Zheng, Hairong; Lu, Zhong-Lin			Optimizing the Magnetization-Prepared Rapid Gradient-Echo (MP-RAGE) Sequence	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; OPTIMIZATION; MRI	The three-dimension (3D) magnetization-prepared rapid gradient-echo (MP-RAGE) sequence is one of the most popular sequences for structural brain imaging in clinical and research settings. The sequence captures high tissue contrast and provides high spatial resolution with whole brain coverage in a short scan time. In this paper, we first computed the optimal k-space sampling by optimizing the contrast of simulated images acquired with the MP-RAGE sequence at 3.0 Tesla using computer simulations. Because the software of our scanner has only limited settings for k-space sampling, we then determined the optimal k-space sampling for settings that can be realized on our scanner. Subsequently we optimized several major imaging parameters to maximize normal brain tissue contrasts under the optimal k-space sampling. The optimal parameters are flip angle of 12 degrees, effective inversion time within 900 to 1100 ms, and delay time of 0 ms. In vivo experiments showed that the quality of images acquired with our optimal protocol was significantly higher than that of images obtained using recommended protocols in prior publications. The optimization of k-spacing sampling and imaging parameters significantly improved the quality and detection sensitivity of brain images acquired with MP-RAGE.	[Wang, Jinghua; Lu, Zhong-Lin] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA; [He, Lili] Nationwide Childrens Hosp, Ctr Perinatal Res, Columbus, OH USA; [Zheng, Hairong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Wang, JH (corresponding author), Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA.	wang.3131@osu.edu		Lu, Zhong-Lin/0000-0002-7295-727X	NSFC [61072114]	NSFC(National Natural Science Foundation of China (NSFC))	Support from NSFC 61072114 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Briellmann RS, 2003, EPILEPTIC DISORD, V5, P3; CONSTABLE RT, 1992, MAGNET RESON MED, V28, P9, DOI 10.1002/mrm.1910280103; Deichmann R, 2000, NEUROIMAGE, V12, P112, DOI 10.1006/nimg.2000.0601; EPSTEIN FH, 1994, MAGN RESON MED, V31, P164, DOI 10.1002/mrm.1910310210; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; GOWLAND PA, 1992, MAGNET RESON MED, V26, P79, DOI 10.1002/mrm.1910260109; Helms G, 2008, MAGN RESON MED, V59, P667, DOI 10.1002/mrm.21542; Hennig J, 1999, EUR RADIOL, V9, P1020, DOI 10.1007/s003300050788; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kim KA, 2011, J MAGN RESON IMAGING, V33, P160, DOI 10.1002/jmri.22436; Lin C, 2008, MAGN RESON MED, V59, P434, DOI 10.1002/mrm.21448; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Moratal D, 2008, Biomed Imaging Interv J, V4, pe15, DOI 10.2349/biij.4.1.e15; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Nkongchu K, 2005, MAGN RESON IMAGING, V23, P801, DOI 10.1016/j.mri.2005.06.009; Pell GS, 2008, NEUROIMAGE, V39, P1151, DOI 10.1016/j.neuroimage.2007.09.061; Sastre-Garriga J, 2009, J NEUROL SCI, V282, P120, DOI 10.1016/j.jns.2008.12.019; Stocker T, 2006, MAGN RESON MED, V56, P824, DOI 10.1002/mrm.21011; Tardif CL, 2010, HUM BRAIN MAPP, V31, P943, DOI 10.1002/hbm.20908; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Tintore M, 2008, J NEUROL SCI, V274, P80, DOI 10.1016/j.jns.2008.08.036; Wang JH, 2006, J MAGN RESON, V182, P283, DOI 10.1016/j.jmr.2006.07.005; Williams LA, 2007, MAGN RESON IMAGING, V25, P1162, DOI 10.1016/j.mri.2007.01.119; Wu HH, 2010, MAGN RESON MED, V63, P1210, DOI 10.1002/mrm.22288; Yang QX, 1997, MAGNET RESON MED, V37, P331, DOI 10.1002/mrm.1910370304; ZUR Y, 1991, MAGNET RESON MED, V21, P251, DOI 10.1002/mrm.1910210210	28	70	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96899	10.1371/journal.pone.0096899	http://dx.doi.org/10.1371/journal.pone.0096899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879508	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500009
J	Cava, C; Bertoli, G; Ripamonti, M; Mauri, G; Zoppis, I; Della Rosa, PA; Gilardi, MC; Castiglioni, I				Cava, Claudia; Bertoli, Gloria; Ripamonti, Marilena; Mauri, Giancarlo; Zoppis, Italo; Della Rosa, Pasquale Anthony; Gilardi, Maria Carla; Castiglioni, Isabella			Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXM1; HISTONE VARIANT H2A.Z; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; CLINICOPATHOLOGICAL FEATURES; HEPATOCELLULAR-CARCINOMA; CHROMOSOMAL IMBALANCES; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; MOLECULAR PORTRAITS	Defining the aggressiveness and growth rate of a malignant cell population is a key step in the clinical approach to treating tumor disease. The correct grading of breast cancer (BC) is a fundamental part in determining the appropriate treatment. Biological variables can make it difficult to elucidate the mechanisms underlying BC development. To identify potential markers that can be used for BC classification, we analyzed mRNAs expression profiles, gene copy numbers, microRNAs expression and their association with tumor grade in BC microarray-derived datasets. From mRNA expression results, we found that grade 2 BC is most likely a mixture of grade 1 and grade 3 that have been misclassified, being described by the gene signature of either grade 1 or grade 3. We assessed the potential of the new approach of integrating mRNA expression profile, copy number alterations, and microRNA expression levels to select a limited number of genomic BC biomarkers. The combination of mRNA profile analysis and copy number data with microRNA expression levels led to the identification of two gene signatures of 42 and 4 altered genes (FOXM1, KPNA4, H2AFV and DDX19A) respectively, the latter obtained through a meta-analytical procedure. The 42-based gene signature identifies 4 classes of up-or down-regulated microRNAs (17 microRNAs) and of their 17 target mRNA, and the 4-based genes signature identified 4 microRNAs (Hsa-miR-320d, Hsa-miR-139-5p, Hsa-miR-567 and Hsa-let-7c). These results are discussed from a biological point of view with respect to pathological features of BC. Our identified mRNAs and microRNAs were validated as prognostic factors of BC disease progression, and could potentially facilitate the implementation of assays for laboratory validation, due to their reduced number.	[Cava, Claudia; Bertoli, Gloria; Ripamonti, Marilena; Della Rosa, Pasquale Anthony; Gilardi, Maria Carla; Castiglioni, Isabella] CNR, Inst Mol Bioimaging & Physiol IBFM, I-20133 Milan, Italy; [Mauri, Giancarlo; Zoppis, Italo] Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Milano-Bicocca	Castiglioni, I (corresponding author), CNR, Inst Mol Bioimaging & Physiol IBFM, I-20133 Milan, Italy.	isabella.castiglioni@ibfm.cnr.it	Ripamonti, Marilena/AAY-4013-2020; Castiglioni, Isabella/AAC-4949-2022; Mauri, Giancarlo/M-3258-2013; Cava, Claudia/P-2257-2018; Rosa, Pasquale Anthony Della/AAC-3459-2019; Bertoli, Gloria/J-6559-2016	Mauri, Giancarlo/0000-0003-3520-4022; Cava, Claudia/0000-0002-5540-4104; Rosa, Pasquale Anthony Della/0000-0002-3137-1731; Bertoli, Gloria/0000-0002-5901-4269; ZOPPIS, ITALO FRANCESCO/0000-0001-7312-7123; Castiglioni, Isabella/0000-0001-7191-5417; GILARDI, MARIA CARLA/0000-0002-5472-3509; RIPAMONTI, MARILENA/0000-0001-9403-9915	INTEROMICS flagship project; National Research Council CUP [B91J12000190001]	INTEROMICS flagship project; National Research Council CUP	This study was partially supported by INTEROMICS flagship project (url: http://www.interomics.eu/it/home), National Research Council CUP grant B91J12000190001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelhaleem M, 2004, ANTICANCER RES, V24, P3951; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Alexandrov Peter N, 2012, Int J Biochem Mol Biol, V3, P365; Altintas DM, 2012, MOL ENDOCRINOL, V26, P1531, DOI 10.1210/me.2012-1016; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Andrews J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008665; Angeloni Debora, 2007, Briefings in Functional Genomics & Proteomics, V6, P19, DOI 10.1093/bfgp/elm007; Arigami T, 2012, ONCOLOGY-BASEL, V83, P158, DOI 10.1159/000341390; Ayaz L, 2013, J CANCER RES CLIN, V139, P1499, DOI 10.1007/s00432-013-1469-2; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bambang IF, 2013, ONCOGENE, V32, P1240, DOI 10.1038/onc.2012.149; Banigan MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048814; Barrio-Real L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003543; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bevilacqua V, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S9; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callagy G, 2005, J PATHOL, V205, P388, DOI 10.1002/path.1694; Carlson Robert W, 2007, J Natl Compr Canc Netw, V5, P246; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Cava C, 2013, IEEE ENG MED BIO, P608, DOI 10.1109/EMBC.2013.6609573; Cava Claudia, 2013, Artificial Intelligence in Medicine. 14th Conference on Artificial Intelligence in Medicine, AIME 2013. Proceedings, P104, DOI 10.1007/978-3-642-38326-7_16; Cava Claudia, 2014, J Clin Bioinforma, V4, P2, DOI 10.1186/2043-9113-4-2; Cazzoli R, 2013, J THORAC ONCOL, V8, P1156, DOI 10.1097/JTO.0b013e318299ac32; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZH, 2012, PROSTATE, V72, P1443, DOI 10.1002/pros.22495; Cheng I, 2012, GENE CHROMOSOME CANC, V51, P66, DOI 10.1002/gcc.20932; Chi B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-243; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chiu L Y, 2013, J GASTROENTEROL, P1; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; Debnath R, 2010, BIOSYSTEMS, V100, P39, DOI 10.1016/j.biosystems.2009.12.006; Duan ZJ, 2013, PROSTATE, V73, P455, DOI 10.1002/pros.22587; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; El-Murr N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031862; Eo HS, 2012, MOL CELLS, V34, P393, DOI 10.1007/s10059-012-0177-0; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gao F, 2014, ONCOL REP, V31, P351, DOI 10.3892/or.2013.2830; Garcia-Tunon I, 2005, HISTOPATHOLOGY, V47, P82, DOI 10.1111/j.1365-2559.2005.02178.x; Gilam A, 2013, BREAST CANCER RES TR, V138, P753, DOI 10.1007/s10549-013-2502-5; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; Hedges LV, 2014, STAT METHODS META AN; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang NJ, 2012, J CELL BIOL, V197, P361, DOI [10.1083/jcb.201111141, 10.1083/jcb.201108062]; Hyman E, 2002, CANCER RES, V62, P6240; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Kim K, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-34; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Krishnan K, 2013, RNA, V19, P1767, DOI 10.1261/rna.042143.113; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Kumar D, 2013, 2013 IEEE CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGIES (ICT 2013), P594; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kurubanjerdjit N, 2013, COMPUT BIOL MED, V43, P1645, DOI 10.1016/j.compbiomed.2013.08.010; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Lahti L, 2013, BRIEF BIOINFORM, V14, P27, DOI 10.1093/bib/bbs005; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P265, DOI 10.1016/j.urolonc.2009.02.002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Li X, 2012, PLOS ONE, V7; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Li Y, 2013, ANAL CHEM, V85, P11174, DOI 10.1021/ac403462f; Liu C. Y., 2012, TYROSINE PHOSPHORYLA; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077068; Liu X, 2013, MED ONCOL, V30, P1, DOI DOI 10.1007/S12032-013-0735-0; Liu XL, 2004, WORLD J GASTROENTERO, V10, P2340; Liu YF, 2007, ONCOL REP, V18, P943; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manuylov NL, 2007, ONCOGENE, V26, P5204, DOI 10.1038/sj.onc.1210333; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Metzger O, 2011, CRIT REV ONCOL HEMAT, V77, P21, DOI 10.1016/j.critrevonc.2010.01.011; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Morello LG, 2011, NUCLEIC ACIDS RES, V39, P648, DOI 10.1093/nar/gkq758; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Orsetti B, 2004, CANCER RES, V64, P6453, DOI 10.1158/0008-5472.CAN-04-0756; Padi SKR, 2013, GASTROENTEROLOGY, V145, P437, DOI 10.1053/j.gastro.2013.04.012; Page DL, 1998, J NATL CANCER I, V90, P88, DOI 10.1093/jnci/90.2.88; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Parikesit A A, 2013, MALAYSIAN J FUNDAMEN, V10; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pennanen PI, 2009, STEROIDS, V74, P404, DOI 10.1016/j.steroids.2008.12.005; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pinho FG, 2013, CANCER RES, V73, P5936, DOI 10.1158/0008-5472.CAN-13-0158; Polanowska J, 2000, GENE CHROMOSOME CANC, V28, P126, DOI 10.1002/(SICI)1098-2264(200005)28:1<126::AID-GCC15>3.0.CO;2-G; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Rakha EA, 2008, BREAST CANCER RES TR, V111, P121, DOI 10.1007/s10549-007-9768-4; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Rennstam K, 2003, CANCER RES, V63, P8861; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Roa W, 2010, CLIN INVEST MED, V33, pE124; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sadakata T, 2013, FEBS LETT, V587, P54, DOI 10.1016/j.febslet.2012.10.047; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071480; Sakurai M, 2012, J STEROID BIOCHEM, V131, P101, DOI 10.1016/j.jsbmb.2011.10.007; Salhab M, 2012, BREAST CANCER-TOKYO, V19, P153, DOI 10.1007/s12282-010-0228-3; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Su CH, 2014, NUCLEIC ACIDS RES, V42, P3073, DOI 10.1093/nar/gkt1341; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Therneau T.M., 2000, MODELING SURVIVAL DA; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang PY, 2013, FEBS LETT, V587, P2675, DOI 10.1016/j.febslet.2013.07.004; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wells WA, 1998, J NATL CANCER I, V90, P142, DOI 10.1093/jnci/90.2.142; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Xu XE, 2010, PROTEOMICS, V10, P1374, DOI 10.1002/pmic.200900380; Xu Y, 2012, J BIOMED RES, V26, P125, DOI 10.1016/S1674-8301(12)60022-0; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang C, 2013, CANCER GENE THER, V20, P117, DOI 10.1038/cgt.2012.94; Yang LQ, 2012, FUTURE ONCOL, V8, P431, DOI [10.2217/FON.12.27, 10.2217/fon.12.27]; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhao J, 2013, MED ONCOL, V30, P1; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056718	209	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97681	10.1371/journal.pone.0097681	http://dx.doi.org/10.1371/journal.pone.0097681			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866763	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100020
J	Erickson, ME; Found-Jackson, C; Boyce, MS				Erickson, Mara E.; Found-Jackson, Christine; Boyce, Mark S.			Using Latent Selection Difference to Model Persistence in a Declining Population	PLOS ONE			English	Article							CLIMATE-CHANGE; WOODLAND CARIBOU; NESTING ECOLOGY; WESTERN GREBES; CONSERVATION; LAKE; ABUNDANCE; BEARS	Population persistence is a direct measure of the viability of a population. Monitoring the distribution of declining populations or subpopulations over time can yield estimates of persistence, which we show can be modeled as a latent selection difference (LSD) contrasting attributes of sites where populations have persisted versus those that have not. Predicted persistence can be modeled with predictor covariates to identify factors correlated with species persistence. We demonstrate how to model persistence based on changes in occupancy that can include adjustments for detection probability. Using a known historical distribution of the western grebe (Aechmophorus occidentalis), we adapted methods originally developed for occupancy modeling to evaluate how environmental covariates including emergent vegetation and human developments have affected western grebe persistence in Alberta. The relative probability of persistence was correlated with the extent of shoreline bulrush (Scirpus lacustris), which is important vegetation for nesting cover. We also documented that western grebe populations were less likely to persist on lakes in the boreal forest, primarily located on the northern boundary of the species' range. Factors influencing occupancy were different than those determining persistence by western grebes; persistence and occupancy were not correlated. Persistence was more likely on lakes with recreational development, reflecting reliance by grebes on the larger, fish-bearing waterbodies that also are attractive for lakeshore development. Unfortunately, the correlation with recreational development on Alberta's lakes puts grebes at risk for loss of brood-rearing habitats-primary threats to altricial birds-if steps are not taken to prevent disturbance to bulrush stands. Identifying factors related to the persistence of a species-especially one in decline-is a fundamental step in conservation management.	[Erickson, Mara E.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Found-Jackson, Christine] Alberta Environm & Sustainable Resource Dev, Edmonton, AB, Canada	University of Alberta	Erickson, ME (corresponding author), Alberta Fish & Game Assoc, Operat Grassland Commun, Edmonton, AB, Canada.	m.erickson@ualberta.ca	Boyce, Mark S/A-2620-2014	Boyce, Mark S/0000-0001-5811-325X	Alberta Conservation Association [030-00-90-146]; Natural Sciences and Engineering Research Council of Canada [227081-09]; North American Waterfowl Management Plan [520811]; Alberta Sport, Recreation, Parks & Wildlife Foundation (SPR) [SPR09/0332]	Alberta Conservation Association; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); North American Waterfowl Management Plan; Alberta Sport, Recreation, Parks & Wildlife Foundation (SPR)	Funding was received from the following sources: Alberta Conservation Association (Grant Eligible Conservation Fund #030-00-90-146; http://www.ab-conservation.com/; MEE,MSB), the Natural Sciences and Engineering Research Council of Canada (#227081-09; http://www.nserc-crsng.gc.ca/index_eng.asp, MSB), the North American Waterfowl Management Plan (#520811; http://nawmp.wetlandnetwork.ca/; MEE,CF,MSB), and Alberta Sport, Recreation, Parks & Wildlife Foundation (SPR#: SPR09/0332; http://www.albertasport.ca/; MEE, MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agri-Environment Services Branch (AESB) Agriculture and Agri-Food Canada, 2008, LAND COV AGR REG CAN; Alberta Environment and Sustainable Resource Development and Alberta Conservation Association, 2013, 60 ALB ENV SUST RES; Allen JH, 2008, WATERBIRDS, V31, P402, DOI 10.1675/1524-4695-31.3.402; Allen JH, 2008, WATERBIRDS, V31, P411, DOI 10.1675/1524-4695-31.3.411; B.C. Resources Inventory Committee, 1998, INV METH COL NEST FR; Berg G, 2004, 94 ALB SUST RES DEV; Bower John L., 2009, Marine Ornithology, V37, P9; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burger AE, 1997, WR87 BC ENV WILDL BR; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Cross PC, 2001, CONSERV BIOL, V15, P1335, DOI 10.1046/j.1523-1739.2001.00031.x; Drever MC, 2012, GLOBAL CHANGE BIOL, V18, P480, DOI 10.1111/j.1365-2486.2011.02541.x; *ENV SYST RES I, 2008, ARCGIS REL 9 3; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Feerer J.L., 1977, Cal-Neva Wildlife, V1977, P80; Fischer LA, 2005, CAN J ZOOL, V83, P1162, DOI 10.1139/Z05-117; Fjeldsa J., 1993, Bird Conservation International, V3, P221; Forbes L. C., 1984, NESTING ECOLOGY W GR; Found C, 2008, CAN J ZOOL, V86, P277, DOI 10.1139/Z07-137; Found C, 2004, 88 ALB SUST RES DEV; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hines JE, 2006, PRESENCE 2 4 SOFTWAR; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Humple D. L., 2009, THESIS SONOMA STATE; Johnson CJ, 2004, J WILDLIFE MANAGE, V68, P966, DOI 10.2193/0022-541X(2004)068[0966:MSAOTA]2.0.CO;2; Kemper C, 2008, 121 ALB SUST RES DEV; LaBastille A, 1984, ENVIRON CONSERV, V11, P346; LaPorte N, 1992, BIRDS N AM ONLINE; Latham ADM, 2011, CAN J ZOOL, V89, P267, DOI [10.1139/z10-115, 10.1139/Z10-115]; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; LINDVALL ML, 1982, CONDOR, V84, P66, DOI 10.2307/1367823; Lutolf M, 2009, ENVIRON MANAGE, V43, P436, DOI 10.1007/s00267-008-9256-6; MacArthur R.H., 1972, pvii; Mace GM, 2010, PHILOS T R SOC B, V365, P3743, DOI 10.1098/rstb.2010.0264; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Morita K, 2002, CONSERV BIOL, V16, P1318, DOI 10.1046/j.1523-1739.2002.01476.x; Mueller C, 2004, URSUS, V15, P35, DOI 10.2192/1537-6176(2004)015<0035:DOSGBI>2.0.CO;2; Newbrey JL, 2012, HYDROBIOLOGIA, V697, P73, DOI 10.1007/s10750-012-1171-4; Newbrey JL, 2005, WATERBIRDS, V28, P478, DOI 10.1675/1524-4695(2005)28[478:EOLCAH]2.0.CO;2; Nuechterlein G, 1975, THESIS COLORADO STAT; Nuechterlein G.L., 1982, National Geographic Magazine, V161, P624; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; PIERSMA T, 1988, ARDEA, V76, P96; Radomski P, 2001, N AM J FISH MANAGE, V21, P46, DOI 10.1577/1548-8675(2001)021<0046:COHLDO>2.0.CO;2; RAHEL FJ, 1990, AM NAT, V136, P328, DOI 10.1086/285101; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Riske M.E., 1976, THESIS U CALGARY CAL; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Semenchuk G. P, 2007, ATLAS BREEDING BIRDS; Short H. L., 1984, HABITAT SUITABILITY; StataCorp L, 2007, STAT DAT AN STAT SOF; Stattersfield AJ, 2000, THREAT BIRDS WORLD; Stout BE, 2003, WATERBIRDS, V26, P88, DOI 10.1675/1524-4695(2003)026[0088:TALOWM]2.0.CO;2; Traylor JJ, 2004, AUK, V121, P950, DOI 10.1642/0004-8038(2004)121[0950:NEOWSM]2.0.CO;2; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wilson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065408	59	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98126	10.1371/journal.pone.0098126	http://dx.doi.org/10.1371/journal.pone.0098126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866172	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100035
J	Jain, S; Rana, V; Shrinet, J; Sharma, A; Tridibes, A; Sunil, S; Bhatnagar, RK				Jain, Shanu; Rana, Vandita; Shrinet, Jatin; Sharma, Anil; Tridibes, Adak; Sunil, Sujatha; Bhatnagar, Raj K.			Blood Feeding and Plasmodium Infection Alters the miRNome of Anopheles stephensi	PLOS ONE			English	Article							RNA-INTERFERENCE; GENE-EXPRESSION; NUCLEAR EXPORT; WEB SERVER; MICRORNA; MOSQUITO; MALARIA; TARGET; GAMBIAE; VECTOR	Blood feeding is an integral process required for physiological functions and propagation of the malaria vector Anopheles. During blood feeding, presence of the malaria parasite, Plasmodium in the blood induces several host effector molecules including microRNAs which play important roles in the development and maturation of the parasite within the mosquito. The present study was undertaken to elucidate the dynamic expression of miRNAs during gonotrophic cycle and parasite development in Anopheles stephensi. Using next generation sequencing technology, we identified 126 miRNAs of which 17 were novel miRNAs. The miRNAs were further validated by northern hybridization and cloning. Blood feeding and parasitized blood feeding in the mosquitoes revealed regulation of 13 and 16 miRNAs respectively. Expression profiling of these miRNAs revealed that significant miRNAs were down-regulated upon parasitized blood feeding with a repertoire of miRNAs showing stage specific up-regulation. Expression profiles of significantly modulated miRNAs were further validated by real time PCR. Target prediction of regulated miRNAs revealed overlapping targeting by different miRNAs. These targets included several metabolic pathways including metabolic, redox homeostasis and protein processing machinery components. Our analysis revealed tight regulation of specific miRNAs post blood feeding and parasite infection in An. stephensi. Such regulated expression suggests possible role of these miRNAs during gonotrophic cycle in mosquito. Another set of miRNAs were also significantly regulated at 42 h and 5 days post infection indicating parasite stage-specific role of host miRNAs. This study will result in better understanding of the role of miRNAs during gonotrophic cycle and parasite development in mosquito and can probably facilitate in devising novel malaria control strategies at vector level.	[Jain, Shanu; Rana, Vandita; Shrinet, Jatin; Sharma, Anil; Sunil, Sujatha; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Tridibes, Adak] Natl Inst Malaria Res, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sunil, S (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi, India.	sujatha@icgeb.res.in; raj@icgeb.res.in	SHRINET, JATIN/P-9088-2014; Bhatnagar, Raj/AAP-2311-2021	Sunil, Sujatha/0000-0002-6531-7768; SHRINET, JATIN/0000-0002-4274-613X; Jain, Shanu/0000-0003-3110-1990	Science and Engineering Research Board (SERB) [SR/FT/LS-109/2011]; ICGEB; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, India	Science and Engineering Research Board (SERB); ICGEB; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded through Science and Engineering Research Board (SERB) Young Scientist grant (SR/FT/LS-109/2011) awarded to SS and through ICGEB internal funds. SS is a recipient of Ramanujan Fellowship, Department of Science and Technology, Government of India and their support is duly acknowledged. SJ and VR are recipients of senior research fellowships from the Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ AMM, 1991, REV I MED TROP, V33, P421, DOI [10.1590/S0036-46651991000600001, 10.1590/S0036-46651991000600013]; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bahia Ana C, 2014, Environ Microbiol, V16, P2980, DOI 10.1111/1462-2920.12381; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Biron DG, 2013, J EXP BIOL, V216, P148, DOI 10.1242/jeb.073825; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P267, DOI 10.1016/j.dci.2011.03.034; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Goncalves RLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041083; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021; Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mathias DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003757; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Nagpal, 1995, INDIAN ANOPHELINES, P1; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Puthiyakunnon S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-230; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Surachetpong W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000366; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	55	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98402	10.1371/journal.pone.0098402	http://dx.doi.org/10.1371/journal.pone.0098402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866389	gold, Green Submitted, Green Published			2022-12-27	WOS:000336914100059
J	Roberts, B; Murphy, A; Chikovani, I; Makhashvili, N; Patel, V; McKee, M				Roberts, Bayard; Murphy, Adrianna; Chikovani, Ivdity; Makhashvili, Nino; Patel, Vikram; McKee, Martin			Individual and Community Level Risk-Factors for Alcohol Use Disorder among Conflict-Affected Persons in Georgia	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATIONAL EPIDEMIOLOGIC SURVEY; FORMER SOVIET-UNION; MAJOR DEPRESSION; DISPLACED PERSONS; MENTAL-HEALTH; NICOTINE DEPENDENCE; OUTLET DENSITY; DRUG-USE; CONSUMPTION	Background: The evidence on alcohol use disorder among conflict-affected civilian populations remains extremely weak, despite a number of potential risk-factors. The aim of this study is to examine patterns of alcohol use disorder among conflict-affected persons in the Republic of Georgia. Methods: A cross-sectional survey of 3600 randomly selected internally displaced persons (IDPs) and former IDPs. Two alcohol use disorder outcomes were measured: (i) having at least hazardous alcohol use (AUDIT score >= 8); (ii) episodic heavy drinking (consuming >60 grams of pure alcohol per drinking session at least once a week). Individual level demographic and socio-economic characteristics were also recorded, including mental disorders. Community level alcohol environment characteristics relating to alcohol availability, marketing and pricing were recorded in the respondents' communities and a factor analysis conducted to produce a summary alcohol environment factor score. Logistic regression analyses examined associations between individual and community level factors with the alcohol use disorder outcomes (among men only). Results: Of the total sample, 71% of men and 16% of women were current drinkers. Of the current drinkers (N = 1386), 28% of men and 1% of women were classified as having at least hazardous alcohol use; and 12% of men and 2% of women as episodic heavy drinkers. Individual characteristics significantly associated with both outcomes were age and experiencing a serious injury, while cumulative trauma events and depression were also associated with having at least hazardous alcohol use. For the community level analysis, a one unit increase in the alcohol environment factor was associated with a 1.27 fold increase in episodic heavy drinking among men (no significant association with hazardous alcohol use). Conclusion: The findings suggest potential synergies for treatment responses for alcohol use disorder and depression among conflict-affected populations in Georgia, as well as the need for stronger alcohol control policies in Georgia.	[Roberts, Bayard; Murphy, Adrianna; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit ECOHOST, London WC1, England; [Chikovani, Ivdity] Curatio Int Fdn, Tbilisi, Georgia; [Makhashvili, Nino] Ilia State Univ, Global Initiat Psychiat Tbilisi, Tbilisi, Georgia; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; Ilia State University; University of London; London School of Hygiene & Tropical Medicine	Roberts, B (corresponding author), London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit ECOHOST, London WC1, England.	bayard.roberts@lshtm.ac.uk	Chikovani, Ivdity/AAL-9870-2020; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; makhashvili, nino/ABF-4921-2021	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; makhashvili, nino/0000-0002-2365-2939; Patel, Vikram/0000-0003-1066-8584; Roberts, Bayard/0000-0003-4482-5859; Chikovani, Ivdity/0000-0001-6925-4904	Wellcome Trust [093562/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (093562/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelekan M., 2006, RAPID ASSESSMENT SUB; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; [Anonymous], 2009, FORCED MIGRATION REV, DOI DOI 10.1016/B978-0-7020-3008-6.50008-9; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Babor TF., 2001, AUDIT ALCOHOL USE DI; Boas M, 2005, ALCHOL DRUG CONSUMPT; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Bryden A, 2012, HEALTH PLACE, V18, P349, DOI 10.1016/j.healthplace.2011.11.003; Centers for Disease Control and Prevention, 2012, ALC PUBL HLTH FACT S; Chen MJ, 2010, ADDICTION, V105, P270, DOI 10.1111/j.1360-0443.2009.02772.x; Chow CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014294; Conway KP, 2006, J CLIN PSYCHIAT, V67, P247, DOI 10.4088/JCP.v67n0211; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; de Jong JTVM, 2003, LANCET, V361, P2128, DOI 10.1016/S0140-6736(03)13692-6; De Jong JTVM, 2002, PL S STRESS, P1; Demaio A, 2013, PLOS CURR, V5; Ezard N, 2012, DISASTERS, V36, P533, DOI 10.1111/j.1467-7717.2011.01261.x; Ezard N, 2010, INTERVENTION, V8, P223, DOI 10.1097/WTF.0b013e3283413134; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4; Grant VV, 2009, PSYCHOL ADDICT BEHAV, V23, P226, DOI 10.1037/a0015006; GRUENEWALD PJ, 1993, ALCOHOL CLIN EXP RES, V17, P38, DOI 10.1111/j.1530-0277.1993.tb00723.x; Hasin DS, 2002, ARCH GEN PSYCHIAT, V59, P794, DOI 10.1001/archpsyc.59.9.794; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; IDMC, 2012, GEORG PART PROGR DUR; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; IoM, 2012, MIGR HLTH SURV; Javakhishvili D, 2011, DRUG SITUATION GEORG; Johnson TP, 1996, SUBST USE MISUSE, V31, P1853, DOI 10.3109/10826089609064003; Jones E, 2011, INT REV PSYCHIATR, V23, P166, DOI 10.3109/09540261.2010.550868; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Kirk SFL, 2010, OBES REV, V11, P109, DOI 10.1111/j.1467-789X.2009.00611.x; Kizza D, 2012, CRISIS, V33, P95, DOI 10.1027/0227-5910/a000119; Kozaric-Kovacic D, 2000, CROAT MED J, V41, P173; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuo PH, 2006, PSYCHOL MED, V36, P1153, DOI 10.1017/S0033291706007860; Kwate NOA, 2009, AM J PUBLIC HEALTH, V99, P228, DOI 10.2105/AJPH.2007.132217; Lee Juliet P, 2008, J Ethn Subst Abuse, V7, P357, DOI 10.1080/15332640802508200; Leifman H., 2002, CONTEMP DRUG PROBL, V29, P477; Luitel NP, 2013, ALCOHOL ALCOHOLISM, V48, P349, DOI 10.1093/alcalc/agt009; Makhashvili N, 2014, MENTAL DISO IN PRESS; Makhashvili N, 2010, TRAUMATOLOGY, V16, P63, DOI [DOI 10.1177/1534765610388302, 10.1177/1534765610388302]; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; Miller KE, 2004, MENTAL HEALTH OF REFUGEES, P1; Murphy A, 2013, USING MULTI IN PRESS; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Piralishvili G, 2013, Georgian Med News, P28; Pollack CE, 2005, INT J EPIDEMIOL, V34, P772, DOI 10.1093/ije/dyi026; Pomerleau J, 2005, ADDICTION, V100, P1647, DOI 10.1111/j.1360-0443.2005.01233.x; Pomerleau J, 2008, ALCOHOL ALCOHOLISM, V43, P351, DOI 10.1093/alcalc/agm167; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; RHODES JE, 1990, J CONSULT CLIN PSYCH, V58, P395, DOI 10.1037/0022-006X.58.4.395; Roberts B, 2013, INT J ENV RES PUB HE, V10, P2185, DOI 10.3390/ijerph10062185; Roberts B, 2011, ADDICT BEHAV, V36, P870, DOI 10.1016/j.addbeh.2011.03.006; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Sacco P, 2009, J STUD ALCOHOL DRUGS, V70, P829, DOI 10.15288/jsad.2009.70.829; SAUNDERS JB, 1993, ADDICTION, V88, P349, DOI 10.1111/j.1360-0443.1993.tb00822.x; Scherrer JF, 2008, COMPR PSYCHIAT, V49, P297, DOI 10.1016/j.comppsych.2007.11.001; Silove, 2004, MEASURING TRAUMA MEA; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Streel E, 2010, INTERVENTION, V8, P268, DOI 10.1097/WTF.0b013e328341315f; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; UNHCR/WHO, 2008, RAP ASS ALC OTH SUBS; United Nations Health Council for Refugees (UNHCR), 2013, OP GUID MENT HLTH PS; United Nations Security Council, 2009, PROM PROT ALL HUM RI; USAID, 2013, INT DEPR ALC AB SCRE; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; VANOERS JAM, 1993, J STUD ALCOHOL, V54, P739, DOI 10.15288/jsa.1993.54.739; Wang JL, 2002, DEPRESS ANXIETY, V15, P42, DOI 10.1002/da.1084; Watson K, 2013, EUR J PUBLIC HEALTH, V23, P291, DOI 10.1093/eurpub/cks054; Weaver H, 2010, SUBST USE MISUSE; Weitzman ER, 2003, HEALTH PLACE, V9, P1, DOI 10.1016/S1353-8292(02)00014-X; WHO, 2011, GLOB STRAT RED HARMF; WHO, 2008, WHOEPIMLM9110; WHO/Children of Georgia, 2009, ASS MENT HLTH PSYCH; WHO Europe, 2007, NONC DIS RISK FACT S; WHO Europe, 2014, ALC CONTR DAT; WHO GHO, 2013, HEAV EP DRINK DRINK; World Health Organization, 2009, EV EFF COST EFF INT; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2021, VIOL WOM PREV EST 20	90	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98299	10.1371/journal.pone.0098299	http://dx.doi.org/10.1371/journal.pone.0098299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24865450	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336914100049
J	Sandoval-Castellanos, E; Palkopoulou, E; Dalen, L				Sandoval-Castellanos, Edson; Palkopoulou, Eleftheria; Dalen, Love			Back to BaySICS: A User-Friendly Program for Bayesian Statistical Inference from Coalescent Simulations	PLOS ONE			English	Article							CHAIN MONTE-CARLO; POPULATION-GENETICS; ENVIRONMENTAL-CHANGE; COMPUTATION; EVOLUTION; MODEL; LIKELIHOODS; DEMOGRAPHY; ABC; PHYLOCHRONOLOGY	Inference of population demographic history has vastly improved in recent years due to a number of technological and theoretical advances including the use of ancient DNA. Approximate Bayesian computation (ABC) stands among the most promising methods due to its simple theoretical fundament and exceptional flexibility. However, limited availability of user-friendly programs that perform ABC analysis renders it difficult to implement, and hence programming skills are frequently required. In addition, there is limited availability of programs able to deal with heterochronous data. Here we present the software BaySICS: Bayesian Statistical Inference of Coalescent Simulations. BaySICS provides an integrated and user-friendly platform that performs ABC analyses by means of coalescent simulations from DNA sequence data. It estimates historical demographic population parameters and performs hypothesis testing by means of Bayes factors obtained from model comparisons. Although providing specific features that improve inference from datasets with heterochronous data, BaySICS also has several capabilities making it a suitable tool for analysing contemporary genetic datasets. Those capabilities include joint analysis of independent tables, a graphical interface and the implementation of Markov-chain Monte Carlo without likelihoods.	[Sandoval-Castellanos, Edson; Palkopoulou, Eleftheria; Dalen, Love] Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden; [Sandoval-Castellanos, Edson; Palkopoulou, Eleftheria] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Swedish Museum of Natural History; Stockholm University	Sandoval-Castellanos, E (corresponding author), Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden.	EdsonSandovalC@outlook.com	Dalén, Love/A-6686-2008; Sandoval-Castellanos, Edson/A-2720-2013	Dalén, Love/0000-0001-8270-7613; Sandoval-Castellanos, Edson/0000-0002-0840-8225	Formas via the ERA-NET Biodiversa project Climigrate; Strategic Research Programme Ekoklim at Stockholm University; Swedish Research Council; Stiftelsen Lars Hiertas Minne; operational program "Education and Lifelong Learning" of the European Social Fund (ESF); NSRF	Formas via the ERA-NET Biodiversa project Climigrate; Strategic Research Programme Ekoklim at Stockholm University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stiftelsen Lars Hiertas Minne; operational program "Education and Lifelong Learning" of the European Social Fund (ESF); NSRF	This work was supported by Formas via the ERA-NET Biodiversa project Climigrate and the Strategic Research Programme Ekoklim at Stockholm University. It received also funding from the Swedish Research Council and EP acknowledges funding from Stiftelsen Lars Hiertas Minne, as well as the project "IKY scholarships" financed by the operational program "Education and Lifelong Learning" of the European Social Fund (ESF) and the NSRF 2007-2013. The funders had NO role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Chan YL, 2011, MOL ECOL, V20, P4592, DOI 10.1111/j.1365-294X.2011.05295.x; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hamilton G, 2005, GENETICS, V170, P409, DOI 10.1534/genetics.104.034199; Hein J, 2010, GENE GENEALOGIES VAR; HUDSON RR, 1987, ENVIRON HEALTH PERSP, V75, P126; Jensen JD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000198; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; Lopes JS, 2010, INFECT GENET EVOL, V10, P826, DOI 10.1016/j.meegid.2009.10.010; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Mellows A, 2012, P ROY SOC B-BIOL SCI, V279, P4568, DOI 10.1098/rspb.2012.1796; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Nystrom V, 2012, MOL ECOL, V21, P3391, DOI 10.1111/j.1365-294X.2012.05525.x; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; R Core Team, 2018, R LANG ENV STAT COMP; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; Ratmann O, 2009, P NATL ACAD SCI USA, V106, P10576, DOI 10.1073/pnas.0807882106; Robert CP, 2011, P NATL ACAD SCI USA, V108, P15112, DOI 10.1073/pnas.1102900108; Shoemaker JS, 1999, TRENDS GENET, V15, P354, DOI 10.1016/S0168-9525(99)01751-5; Shriner D, 2006, EVOLUTION, V60, P1165, DOI 10.1554/05-473.1; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sjodin P, 2012, MOL BIOL EVOL, V29, P1851, DOI 10.1093/molbev/mss061; Sousa VC, 2009, GENETICS, V181, P1507, DOI 10.1534/genetics.108.098129; Turner BM, 2012, J MATH PSYCHOL, V56, P69, DOI 10.1016/j.jmp.2012.02.005; van Tuinen M, 2004, PHILOS T R SOC A, V362, P2795, DOI 10.1098/rsta.2004.1465; Wegmann D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-116; Wegmann D, 2009, GENETICS, V182, P1207, DOI 10.1534/genetics.109.102509	42	2	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98011	10.1371/journal.pone.0098011	http://dx.doi.org/10.1371/journal.pone.0098011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865457	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100029
J	Wang, HW; Lo, HH; Chiu, YL; Chang, SJ; Huang, PH; Liao, KH; Tasi, CF; Wu, CH; Tsai, TN; Cheng, CC; Cheng, SM				Wang, Hsei-Wei; Lo, Hung-Hao; Chiu, Ya-Lin; Chang, Shing-Jyh; Huang, Po-Hsun; Liao, Ko-Hsun; Tasi, Cheng-Fong; Wu, Chun-Hsien; Tsai, Tsung-Neng; Cheng, Cheng-Chung; Cheng, Shu-Meng			Dysregulated miR-361-5p/VEGF Axis in the Plasma and Endothelial Progenitor Cells of Patients with Coronary Artery Disease	PLOS ONE			English	Article							BONE-MARROW; CIRCULATING MICRORNAS; CARDIOVASCULAR-DISEASE; ANGIOGENESIS; EXPRESSION; VEGF; INFLAMMATION; RECRUITMENT; GROWTH; BLOOD	Dysfunction and reduction of circulating endothelial progenitor cell (EPC) is correlated with the onset of cardiovascular disorders including coronary artery disease (CAD). VEGF is a known mitogen for EPC to migrate out of bone marrow to possess angiogenic activities, and the plasma levels of VEGF are inversely correlated to the progression of CAD. Circulating microRNAs (miRNAs) in patient body fluids have recently been considered to hold the potential of being novel disease biomarkers and drug targets. However, how miRNAs and VEGF cooperate to regulate CAD progression is still unclear. Through the small RNA sequencing (smRNA-seq), we deciphered the miRNome patterns of EPCs with different angiogenic activities, hypothesizing that miRNAs targeting VEGF must be more abundant in EPCs with lower angiogenic activities. Candidates of anti-VEGF miRNAs, including miR-361-5p and miR-484, were enriched in not only diseased EPCs but also the plasma of CAD patients. However, we found out only miR-361-5p, but not miR-484, was able to suppress VEGF expression and EPC activities. Reporter assays confirmed the direct binding and repression of miR-361-5p to the 3'-UTR of VEGF mRNA. Knock down of miR-361-5p not only restored VEGF levels and angiogenic activities of diseased EPCs in vitro, but further promoted blood flow recovery in ischemic limbs of mice. Collectively, we discovered a miR-361-5p/VEGF-dependent regulation that could help to develop new therapeutic modalities not only for ischemia-related diseases but also for tumor angiogenesis.	[Wang, Hsei-Wei; Lo, Hung-Hao; Chiu, Ya-Lin; Liao, Ko-Hsun] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Canc Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei; Tasi, Cheng-Fong] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chang, Shing-Jyh] Hsin Chu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Huang, Po-Hsun] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Po-Hsun] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Wu, Chun-Hsien; Tsai, Tsung-Neng; Cheng, Cheng-Chung; Cheng, Shu-Meng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Cardiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital	Cheng, SM (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	chengsm@cm1.hinet.net	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council [NSC] [NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003, NSC101-2321-B-010-011]; Tri-Service General Hospital [TSGH-C102-027]; Veterans General Hospitals University System of Taiwan (VGHUST); Tsou's Foundation [VGHUST103-G7-2-3]; National Health Research Institutes [NHRI-EX102-10254SI]; Taipei City Hospital [10201-62-070]; National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]; UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan NSC I-RiCE Program [NSC102-2911-I-009-101]	National Science Council [NSC](Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Veterans General Hospitals University System of Taiwan (VGHUST); Tsou's Foundation; National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; National Yang-Ming University [Ministry of Education, Aim for the Top University Plan](Ministry of Education, Taiwan); UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan NSC I-RiCE Program	This work was supported by National Science Council [NSC; NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003 and NSC101-2321-B-010-011], Tri-Service General Hospital [TSGH-C102-027], Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program, Tsou's Foundation [VGHUST103-G7-2-3], National Health Research Institutes [NHRI-EX102-10254SI], Taipei City Hospital [10201-62-070], and National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]. This work was also support in part by the UST-UCSD International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan NSC I-RiCE Program [NSC102-2911-I-009-101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Badran A, 2004, BIOCHEM BIOPH RES CO, V314, P902, DOI 10.1016/j.bbrc.2003.12.178; Briasoulis A, 2010, CARDIOVASC THER; Briguori C, 2010, FASEB J, V24, P1981, DOI 10.1096/fj.09-138198; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Cheng CC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-447; Cheng WC, 2013, NUCLEIC ACIDS RES, V41, pD285, DOI 10.1093/nar/gks1238; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Dang LTH, 2013, ARTERIOSCL THROM VAS, V33, P193, DOI 10.1161/ATVBAHA.112.300142; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Grisar JC, 2011, BIOMARK MED, V5, P731, DOI [10.2217/BMM.11.92, 10.2217/bmm.11.92]; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Huang PH, 2013, ARTERIOSCL THROM VAS, V33, P709, DOI 10.1161/ATVBAHA.112.300318; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Kumar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037601; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-476; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Mobius-Winkler S, 2009, CYTOM PART A, V75A, P25, DOI 10.1002/cyto.a.20669; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Real Carla, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P185, DOI 10.2174/187152908785849071; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Smythe J, 2008, TISSUE ENG PT C-METH, V14, P59, DOI 10.1089/tec.2007.0251; Szczyrba J, 2013, INT J CANCER, V132, P775, DOI 10.1002/ijc.27731; Tabuchi T, 2012, CLIN SCI, V123, P161, DOI 10.1042/CS20110563; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vecchione A, 2013, P NATL ACAD SCI USA, V110, P9845, DOI 10.1073/pnas.1305472110; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Yu J, 2012, BIOMATERIALS, V33, P8062, DOI 10.1016/j.biomaterials.2012.07.042; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	50	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98070	10.1371/journal.pone.0098070	http://dx.doi.org/10.1371/journal.pone.0098070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865854	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100032
J	Ohba, K; Ichiyama, K; Yajima, M; Gemma, N; Nikaido, M; Wu, QQ; Chong, PP; Mori, S; Yamamoto, R; Wong, JEL; Yamamoto, N				Ohba, Kenji; Ichiyama, Koji; Yajima, Misako; Gemma, Nobuhiro; Nikaido, Masaru; Wu, Qingqing; Chong, PeiPei; Mori, Seiichiro; Yamamoto, Rain; Wong, John Eu Li; Yamamoto, Naoki			In Vivo and In Vitro Studies Suggest a Possible Involvement of HPV Infection in the Early Stage of Breast Carcinogenesis via APOBEC3B Induction	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ESTROGEN-RECEPTOR-ALPHA; HUMAN PAPILLOMA-VIRUS; MUTATIONAL PROCESSES; CANCER; PREVALENCE; EXPRESSION; DNA; MUTAGENESIS; ROLES	High prevalence of infection with high-risk human papilloma virus (HPV) ranging from 25 to 100% (average 31%) was observed in breast cancer (BC) patients in Singapore using novel DNA chip technology. Early stage of BC demonstrated higher HPV positivity, and BC positive for estrogen receptor (ER) showed significantly higher HPV infection rate. This unique association of HPV with BC in vivo prompted us to investigate a possible involvement of HPV in early stages of breast carcinogenesis. Using normal breast epithelial cells stably transfected with HPV-18, we showed apparent upregulation of mRNA for the cytidine deaminase, APOBEC3B (A3B) which is reported to be a source of mutations in BC. HPV-induced A3B overexpression caused significant gamma H2AX focus formation, and DNA breaks which were cancelled by shRNA to HPV18 E6, E7 and A3B. These results strongly suggest an active involvement of HPV in the early stage of BC carcinogenesis via A3B induction.	[Ohba, Kenji; Ichiyama, Koji; Yajima, Misako; Wu, Qingqing; Chong, PeiPei; Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Infect Dis, Singapore 117595, Singapore; [Gemma, Nobuhiro] Toshiba Co Ltd, Toshiba Res & Dev Ctr, Kawasaki, Kanagawa 210, Japan; [Nikaido, Masaru] Toshiba Co Ltd, Mat & Devices Div, Minato Ku, Tokyo, Japan; [Chong, PeiPei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Selangor Darul Ehsan, Malaysia; [Mori, Seiichiro] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Yamamoto, Rain] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Wong, John Eu Li] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Canc Inst, Dept Hematol Med Oncol, Singapore 117595, Singapore	National University of Singapore; Toshiba Corporation; Toshiba Corporation; Universiti Putra Malaysia; National Institute of Infectious Diseases (NIID); Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore	Yamamoto, N (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Infect Dis, Singapore 117595, Singapore.	naoki_yamamoto@nuhs.edu.sg	Chong, Pei Pei/AAP-4227-2021; Ohba, Kenji/D-8072-2015; Chong, Pei pei/G-1367-2018; Yajima, Misako/ABH-7217-2020	Chong, Pei Pei/0000-0002-8229-3593; Ohba, Kenji/0000-0002-4936-8186; Chong, Pei pei/0000-0002-8229-3593; Yamamoto, Rain/0000-0002-8928-8797; Yajima, Misako/0000-0002-6437-1404	NUS SoM Start-up Grant [R-182-000-160-733]	NUS SoM Start-up Grant	This work was supported by NUS SoM Start-up Grant (R-182-000-160-733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo F, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-7; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allred DC, 2004, BREAST CANCER RES, V6, P240, DOI 10.1186/bcr938; Antonsson A, 2011, J MED VIROL, V83, P2157, DOI 10.1002/jmv.22223; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; de Leon DC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-26; Chansaenroj J, 2012, ASIAN PAC J CANCER P, V13, P1151, DOI 10.7314/APJCP.2012.13.4.1151; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Chiba T, 2009, J MOL MED-JMM, V87, P1023, DOI 10.1007/s00109-009-0527-3; Chung SH, 2008, CANCER RES, V68, P9928, DOI 10.1158/0008-5472.CAN-08-2051; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; De Marco F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034366; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Duensing S, 2002, CANCER RES, V62, P7075; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Engels K, 2008, APPL IMMUNOHISTO M M, V16, P521, DOI 10.1097/PAI.0b013e3181758ce5; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Kroupis C, 2006, CLIN BIOCHEM, V39, P727, DOI 10.1016/j.clinbiochem.2006.03.005; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lawson JS, 2006, FUTURE MICROBIOL, V1, P33, DOI 10.2217/17460913.1.1.33; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Mammas IN, 2011, PATHOL ONCOL RES, V17, P103, DOI 10.1007/s12253-010-9288-0; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Mori S, 2011, CANCER SCI, V102, P1223, DOI 10.1111/j.1349-7006.2011.01922.x; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schmitz KM, 2012, SEMIN IMMUNOL, V24, P241, DOI 10.1016/j.smim.2012.07.001; Sedelnikova OA, 2010, MUTAT RES-REV MUTAT, V704, P152, DOI 10.1016/j.mrrev.2009.12.005; Shai A, 2008, CANCER RES, V68, P2622, DOI 10.1158/0008-5472.CAN-07-5266; Simoes PW, 2012, INT J GYNECOL CANCER, V22, P343, DOI 10.1097/IGC.0b013e31823c712e; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V341, P314, DOI 10.1016/j.bbrc.2005.12.192; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Williams VM, 2011, FUTURE VIROL, V6, P45, DOI 10.2217/FVL.10.73; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046; zur Hausen H, 2009, ANGEW CHEM INT EDIT, V48, P5798, DOI 10.1002/anie.200901917	53	66	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97787	10.1371/journal.pone.0097787	http://dx.doi.org/10.1371/journal.pone.0097787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858917	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400026
J	Piek, E; Kollen, BJ; van der Meer, K; Penninx, BWJH; Nolen, WA				Piek, Ellen; Kollen, Boudewijn J.; van der Meer, Klaas; Penninx, Brenda W. J. H.; Nolen, Willem A.			Maintenance Use of Antidepressants in Dutch General Practice: Non-Guideline Concordant	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; MENTAL-HEALTH-CARE; 5-YEAR FOLLOW-UP; RELIABILITY; INVENTORY; ANXIETY; NETHERLANDS; RECALL	Background: There is hardly evidence on maintenance treatment with antidepressants in primary care. Nevertheless, depression guidelines recommend maintenance treatment i.e. treatment to prevent recurrences, in patients with high risk of recurrence, and many patients use maintenance treatment with antidepressants. This study explores the characteristics of patients on maintenance treatment with antidepressants in general practice, and compares these characteristics with guideline recommendations for maintenance treatment. Methods: We used data (baseline, two-year and four-year follow-up) of primary care respondents with remitted depressive disorder (>= 6 months) from the Netherlands Study of Depression and Anxiety (n = 776). Maintenance treatment was defined as the use of an antidepressant for >= 12 months. Multilevel logistic regression was used to describe the association between sociodemographic, clinical and care characteristics and use of maintenance treatment with antidepressants. Results: Older patients, patients with a lower education, those using benzodiazepines or receiving psychological/psychiatric care and patients with a concurrent history of a dysthymic or anxiety disorder more often received maintenance treatment with antidepressants. Limitations: Measurements were not made at the start of an episode, but at predetermined points in time. Diagnoses were based on interview (CIDI) data and could therefore in some cases have been different from the GP diagnosis. Conclusions: Since patients with chronic or recurrent depression do not use maintenance treatment with antidepressants more often, characteristics of patients on maintenance treatment do not fully correspond with guideline recommendations. However, patients on maintenance treatment appear to be those with more severe disorder and/or more comorbidity.	[Piek, Ellen; Kollen, Boudewijn J.; van der Meer, Klaas] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Penninx, Brenda W. J. H.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands	University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Piek, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands.	e.piek@umcg.nl	Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). There was no additional funding for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews G, 1999, PSYCHOL MED, V29, P787, DOI 10.1017/S0033291799008648; Bauer M, 2007, WORLD J BIOL PSYCHIA, V8, P67, DOI 10.1080/15622970701227829; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Burton C, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625166; Denicoff KD, 1997, J PSYCHIAT RES, V31, P593, DOI 10.1016/S0022-3956(96)00027-1; Holma IAK, 2008, BRIT J PSYCHIAT, V193, P163, DOI 10.1192/bjp.bp.107.045708; Honig A, 2001, PATIENT EDUC COUNS, V43, P43, DOI 10.1016/S0738-3991(00)00144-0; Institute for Clinical Systems Improvement, 2009, ICSI HLTH CAR GUID M; Kaymaz N, 2008, J CLIN PSYCHIAT, V69, P1423, DOI 10.4088/JCP.v69n0910; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Korner A, 2008, PSYCHOTHER PSYCH MED, V58, P238, DOI 10.1055/s-2007-986199; Meadows G, 2000, SOC PSYCH PSYCH EPID, V35, P427, DOI 10.1007/s001270050260; Meeuwissen JAC, 2009, MULTIDISCIPLINAIRE R; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Collaborating Centre for Mental Health, 2009, DEPR TREATM MAN DEPR; National Institute for Clinical Excellence, 2009, DEPR AD TREATM MAN D; Patten S B, 2000, Chronic Dis Can, V21, P68; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Piek E, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-41; Piek E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014784; Piek E, 2010, EUR J GEN PRACT, V16, P106, DOI 10.3109/13814781003692463; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; Saucier G, 1998, J PERS ASSESS, V70, P263, DOI 10.1207/s15327752jpa7002_6; Sunderland M, 2010, SOC PSYCH PSYCH EPID, V46, P775; Susser E, 2000, SCHIZOPHR RES, V42, P67, DOI 10.1016/S0920-9964(99)00088-2; Tacchini G, 1994, Minerva Psichiatr, V35, P63; ten Doesschate MC, 2009, J CLIN PSYCHIAT, V70, P63, DOI 10.4088/JCP.08m04119; TERLUIN B, 2004, HUISARTS WET, V47, P26; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van der Veen WJ, 2009, INT J METH PSYCH RES, V18, P229, DOI 10.1002/mpr.297; Van Weel-Baumgarten EM., 2012, HUISARTS WET, V55, P252; VANMARWIJK HWJ, 2003, HUISARTS WET, V46, P614; Wells JE, 2004, PSYCHOL MED, V34, P1001, DOI 10.1017/S0033291703001843; Wilson I, 2003, FAM PRACT, V20, P685, DOI 10.1093/fampra/cmg611; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97463	10.1371/journal.pone.0097463	http://dx.doi.org/10.1371/journal.pone.0097463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858011	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400018
J	Wandall-Frostholm, C; Skaarup, LM; Sadda, V; Nielsen, G; Hedegaard, ER; Mogensen, S; Kohler, R; Simonsen, U				Wandall-Frostholm, Christine; Skaarup, Lykke Moran; Sadda, Veeranjaneyulu; Nielsen, Gorm; Hedegaard, Elise Roge; Mogensen, Susie; Kohler, Ralf; Simonsen, Ulf			Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in K(Ca)2.3 and K(Ca)3.1 Channels	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; NITRIC-OXIDE SYNTHASE; CA2+-ACTIVATED K+ CHANNEL; HYPERPOLARIZING FACTOR; SMALL-CONDUCTANCE; CHRONIC HYPOXIA; DEPENDENT RELAXATION; MEDIATED RELAXATION; SMOOTH-MUSCLE; ARTERIAL TONE	Objective: In vascular biology, endothelial K(Ca)2.3 and K(Ca)3.1 channels contribute to arterial blood pressure regulation by producing membrane hyperpolarization and smooth muscle relaxation. The role of K(Ca)2.3 and K(Ca)3.1 channels in the pulmonary circulation is not fully established. Using mice with genetically encoded deficit of K(Ca)2.3 and K(Ca)3.1 channels, this study investigated the effect of loss of the channels in hypoxia-induced pulmonary hypertension. Approach and Result: Male wild type and K(Ca)3.1(-/-)/K(Ca)2.3(T/T(+DOX)) mice were exposed to chronic hypoxia for four weeks to induce pulmonary hypertension. The degree of pulmonary hypertension was evaluated by right ventricular pressure and assessment of right ventricular hypertrophy. Segments of pulmonary arteries were mounted in a wire myograph for functional studies and morphometric studies were performed on lung sections. Chronic hypoxia induced pulmonary hypertension, right ventricular hypertrophy, increased lung weight, and increased hematocrit levels in either genotype. The K(Ca)3.1(-/-)/K(Ca)2.3(T/T(+DOX)) mice developed structural alterations in the heart with increased right ventricular wall thickness as well as in pulmonary vessels with increased lumen size in partially-and fully-muscularized vessels and decreased wall area, not seen in wild type mice. Exposure to chronic hypoxia up-regulated the gene expression of the K(Ca)2.3 channel by twofold in wild type mice and increased by 2.5-fold the relaxation evoked by the K(Ca)2.3 and K(Ca)3.1 channel activator NS309, whereas the acetylcholine-induced relaxation - sensitive to the combination of K(Ca)2.3 and K(Ca)3.1 channel blockers, apamin and charybdotoxin - was reduced by 2.5-fold in chronic hypoxic mice of either genotype. Conclusion: Despite the deficits of the K(Ca)2.3 and K(Ca)3.1 channels failed to change hypoxia-induced pulmonary hypertension, the up-regulation of K(Ca)2.3-gene expression and increased NS309-induced relaxation in wild-type mice point to a novel mechanism to counteract pulmonary hypertension and to a potential therapeutic utility of K(Ca)2.3/K(Ca)3.1 activators for the treatment of pulmonary hypertension.	[Wandall-Frostholm, Christine; Skaarup, Lykke Moran; Sadda, Veeranjaneyulu; Hedegaard, Elise Roge; Mogensen, Susie; Simonsen, Ulf] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Sadda, Veeranjaneyulu; Nielsen, Gorm; Kohler, Ralf] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Odense, Denmark; [Kohler, Ralf] Aragon Inst Hlth Sci I CS, Zaragoza, Spain; [Kohler, Ralf] ARAID, Zaragoza, Spain	Aarhus University; University of Southern Denmark	Wandall-Frostholm, C (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	cwf@farm.au.dk		Hedegaard, Elise/0000-0002-6687-3838; Kohler, Ralf/0000-0001-9563-2913; Skaarup, Lykke/0000-0002-1408-0027	NovoNordisk Foundation; Danish Heart Foundation; EC; Deutsche Forschungsgemeinschaft [KO1899/11-1]; Fondo de Investigacion Sanitaria [Red HERACLES RD12/0042/0014]	NovoNordisk Foundation(Novo Nordisk Foundation); Danish Heart Foundation; EC(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	NovoNordisk Foundation supported Ulf Simonsen and Ralf Kohler. Ulf Simonsen is supported by the Danish Heart Foundation and he is member of LiPhos (Living Photonics: Monitoring light propagation through cells), which is funded by the EC Seventh Framework programme. Ralf Kohler is supported by a grant of the Deutsche Forschungsgemeinschaft (KO1899/11-1) and the Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNOT S, 1991, J CLIN INVEST, V87, P155, DOI 10.1172/JCI114965; Baandrup JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015859; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Burnham MP, 2002, BRIT J PHARMACOL, V135, P1133, DOI 10.1038/sj.bjp.0704551; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Bychkov R, 2002, BRIT J PHARMACOL, V137, P1346, DOI 10.1038/sj.bjp.0705057; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Corriu C, 1996, BRIT J PHARMACOL, V119, P959, DOI 10.1111/j.1476-5381.1996.tb15765.x; Dalsgaard T, 2010, EXPERT OPIN THER TAR, V14, P825, DOI 10.1517/14728222.2010.500616; Dalsgaard T, 2009, INVEST OPHTH VIS SCI, V50, P3819, DOI 10.1167/iovs.08-3168; Damkjaer M, 2012, BRIT J PHARMACOL, V165, P223, DOI 10.1111/j.1476-5381.2011.01546.x; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Feletou M, 2006, ARTERIOSCL THROM VAS, V26, P1215, DOI 10.1161/01.ATV.0000217611.81085.c5; Feletou M, 2012, ANN MED, V44, P694, DOI 10.3109/07853890.2011.585658; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Fike CD, 1998, AM J PHYSIOL-LUNG C, V274, pL517, DOI 10.1152/ajplung.1998.274.4.L517; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fuloria M, 2002, AM J PHYSIOL-LUNG C, V283, pL383, DOI 10.1152/ajplung.00444.2001; Grgic I, 2009, BRIT J PHARMACOL, V157, P509, DOI 10.1111/j.1476-5381.2009.00132.x; Guerard P, 2004, EUR J PHARMACOL, V501, P127, DOI 10.1016/j.ejphar.2004.08.007; Hercule HC, 2009, ARTERIOSCL THROM VAS, V29, P54, DOI 10.1161/ATVBAHA.108.171298; Herrera GM, 2003, J PHYSIOL-LONDON, V551, P893, DOI 10.1113/jphysiol.2003.045914; Huang CL, 2013, DIABETES, V62, P2923, DOI 10.2337/db13-0135; IGNARRO LJ, 1984, J PHARMACOL EXP THER, V228, P682; Karamsetty MR, 2001, AM J PHYSIOL-LUNG C, V280, pL458, DOI 10.1152/ajplung.2001.280.3.L458; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kroigaard C, 2013, EXP PHYSIOL, V98, P957, DOI 10.1113/expphysiol.2012.066340; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Kroigaard C, 2010, AM J PHYSIOL-LUNG C, V298, pL531, DOI 10.1152/ajplung.00220.2009; Le Cras TD, 1998, J CLIN INVEST, V101, P795, DOI 10.1172/JCI786; LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164, DOI 10.1152/ajplung.1996.270.1.L164; Littler CM, 2005, AM J PHYSIOL-LUNG C, V289, pL1083, DOI 10.1152/ajplung.00472.2004; Mam V, 2010, J PHARMACOL EXP THER, V332, P455, DOI 10.1124/jpet.109.160119; MONCADA S, 1978, PHARMACOL REV, V30, P293; Morimura K, 2006, J PHARMACOL SCI, V100, P237, DOI 10.1254/jphs.SC0060011; Morio Y, 2007, J VASC RES, V44, P325, DOI 10.1159/000101778; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Petersson J, 1997, BRIT J PHARMACOL, V120, P1344, DOI 10.1038/sj.bjp.0701032; Resta TC, 1997, AM J PHYSIOL-HEART C, V272, pH806, DOI 10.1152/ajpheart.1997.272.2.H806; SHAUL PW, 1995, AM J RESP CELL MOL, V13, P167, DOI 10.1165/ajrcmb.13.2.7542896; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; Yamanaka A, 1998, J PHARMACOL EXP THER, V285, P480	53	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97687	10.1371/journal.pone.0097687	http://dx.doi.org/10.1371/journal.pone.0097687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858807	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400024
J	Xu, Y; Dugat-Bony, E; Zaheer, R; Selinger, L; Barbieri, R; Munns, K; McAllister, TA; Selinger, LB				Xu, Yong; Dugat-Bony, Eric; Zaheer, Rahat; Selinger, Lorna; Barbieri, Ruth; Munns, Krysty; McAllister, Tim A.; Selinger, L. Brent			Escherichia coli O157:H7 Super-Shedder and Non-Shedder Feedlot Steers Harbour Distinct Fecal Bacterial Communities	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BOVINE GASTROINTESTINAL-TRACT; MICROBIAL COMMUNITY; ANIMAL VARIATION; GUT MICROBIOTA; CATTLE; O157-H7; FECES; COLONIZATION; DIVERSITY	Escherichia coli O157:H7 is a major foodborne human pathogen causing disease worldwide. Cattle are a major reservoir for this pathogen and those that shed E. coli O157: H7 at >10(4) CFU/g feces have been termed "super-shedders". A rich microbial community inhabits the mammalian intestinal tract, but it is not known if the structure of this community differs between super-shedder cattle and their non-shedding pen mates. We hypothesized that the super-shedder state is a result of an intestinal dysbiosis of the microbial community and that a "normal" microbiota prevents E. coli O157: H7 from reaching super-shedding levels. To address this question, we applied 454 pyrosequencing of bacterial 16S rRNA genes to characterize fecal bacterial communities from 11 super-shedders and 11 contemporary pen mates negative for E. coli O157: H7. The dataset was analyzed by using five independent clustering methods to minimize potential biases and to increase confidence in the results. Our analyses collectively indicated significant variations in microbiome composition between super-shedding and non-shedding cattle. Super-shedders exhibited higher bacterial richness and diversity than non-shedders. Furthermore, seventy-two operational taxonomic units, mostly belonging to Firmicutes and Bacteroidetes phyla, were identified showing differential abundance between these two groups of cattle. The operational taxonomic unit affiliation provides new insight into bacterial populations that are present in feces arising from super-shedders of E. coli O157:H7.	[Xu, Yong; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Dugat-Bony, Eric] INRA, AgroParisTech, Grignon, France; [Zaheer, Rahat; Selinger, Lorna; Barbieri, Ruth; Munns, Krysty; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	University of Lethbridge; AgroParisTech; INRAE; Agriculture & Agri Food Canada	Selinger, LB (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	selibl@uleth.ca	Dugat-Bony, Eric/K-2455-2014; McAllister, Tim A./R-9201-2017	Dugat-Bony, Eric/0000-0002-5182-0063; McAllister, Tim A./0000-0002-8266-6513; Zaheer, Rahat/0000-0003-3307-4666	Genome Alberta	Genome Alberta	The project was funded by Genome Alberta (genomealberta.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, GUIDE CARE USE EXPT, V2nd ed; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Cernicchiaro N, 2010, FOODBORNE PATHOG DIS, V7, P1071, DOI 10.1089/fpd.2009.0531; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004; Durso LM, 2012, LETT APPL MICROBIOL, V55, P109, DOI 10.1111/j.1472-765X.2012.03265.x; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edrington TS, 2009, CURR MICROBIOL, V58, P227, DOI 10.1007/s00284-008-9312-8; Erickson DL, 2002, CAN J MICROBIOL, V48, P374, DOI 10.1139/w02-022; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Grauke LJ, 2002, APPL ENVIRON MICROB, V68, P2269, DOI 10.1128/AEM.68.5.2269-2277.2002; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Hughes DT, 2010, P NATL ACAD SCI USA, V107, P9831, DOI 10.1073/pnas.1002551107; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Price SB, 2004, APPL ENVIRON MICROB, V70, P4792, DOI 10.1128/AEM.70.8.4792-4799.2004; Rice WC, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-25; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Robinson SE, 2009, J R SOC INTERFACE, V6, P169, DOI 10.1098/rsif.2008.0183; Romero M, 2010, FEMS MICROBIOL LETT, V304, P131, DOI 10.1111/j.1574-6968.2009.01889.x; Sawant AA, 2011, APPL ENVIRON MICROB, V77, P2345, DOI 10.1128/AEM.03150-09; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Sheng HQ, 2006, INFECT IMMUN, V74, P4685, DOI 10.1128/IAI.00406-06; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Stephens TP, 2009, J ANIM SCI, V87, P4151, DOI 10.2527/jas.2009-1967; Sun YJ, 2012, BRIEF BIOINFORM, V13, P107, DOI 10.1093/bib/bbr009; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	54	42	43	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98115	10.1371/journal.pone.0098115	http://dx.doi.org/10.1371/journal.pone.0098115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858731	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400043
J	Yan, LR; Wang, DX; Liu, H; Zhang, XX; Zhao, H; Hua, L; Xu, P; Li, YS				Yan, Li-rong; Wang, Dong-xue; Liu, Hong; Zhang, Xiao-xing; Zhao, Hui; Hua, Lu; Xu, Ping; Li, Yi-shi			A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SERUM-AMYLOID-A; APOLIPOPROTEIN C-II; ESTER TRANSFER PROTEIN; CARDIOVASCULAR-DISEASE; REACTIVE PROTEIN; ARTERY-DISEASE; CHOLESTEROL; PLASMA; INFLAMMATION	Objectives: This study aims to compare the protein composition of high-density lipoprotein (HDL) particles in coronary heart disease (CHD) patients and controls by proteomic methods. Background: HDL has been reported to exert pro-atherogenic properties in CHD patients. Accumulating evidence indicates that HDL composition, rather than the HDL-C level, determines its functions. The changes in HDL composition involved in the conversion of anti-atherogenic to pro-atherogenic properties in CHD patients are currently unknown. Methods and Results: iTRAQ combined with nanoLC-MS/MS was performed to obtain a differential expression profile of the HDL pooled samples of the male age-matched CHD patients and controls (n = 10/group). Of the 196 proteins identified in the examined HDL, 12 were differentially expressed between the CHD patients and the controls, including five up-regulated proteins and seven down-regulated proteins. Using GO analysis, we determined that the up-regulated proteins were mostly involved in inflammatory reactions, displaying a potential pro-atherogenic profile. In contrast, the down-regulated proteins were mostly involved in lipid metabolism processes, displaying anti-atherogenic properties. To confirm the proteomic results, serum amyloid A (SAA) and apoC-I were selected and quantified by ELISA, in the same population as the proteomic analysis, as well as another independent population (n = 120/group). Consistent with the proteomic results, the amount of SAA was significantly increased, and apoC-I was significantly decreased in the HDL particles of CHD patients compared with those of controls (P < 0.05). Conclusions: Our study shows that the HDL proteome changes to a pro-atherogenic profile in CHD patients, which might compromise the protective effects of HDL. Proteomic analysis of HDL composition may provide more relevant information regarding their functional properties than steady-state HDL-C levels.	[Yan, Li-rong; Wang, Dong-xue; Liu, Hong; Zhang, Xiao-xing; Zhao, Hui; Hua, Lu; Xu, Ping; Li, Yi-shi] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, FuWai Hosp, Key Lab Clin Trial Res Cardiovasc Drugs,Minist Hl, Beijing 100730, Peoples R China; [Yan, Li-rong; Wang, Dong-xue; Liu, Hong; Zhang, Xiao-xing; Zhao, Hui; Hua, Lu; Xu, Ping; Li, Yi-shi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Dong-xue] Nanjing Med Univ, Wuxi People Hosp, Dept Cardiol, Wuxi, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nanjing Medical University	Li, YS (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, FuWai Hosp, Key Lab Clin Trial Res Cardiovasc Drugs,Minist Hl, Beijing 100730, Peoples R China.	liyishi@public3.bta.net.cn	Xu, Ping/F-6543-2016		National Key Clinical Specialty Project; National Science and Technology Major Project from the Ministry of Science and Technology of China [2012ZX09303008-001]	National Key Clinical Specialty Project; National Science and Technology Major Project from the Ministry of Science and Technology of China	This work was supported by the National Key Clinical Specialty Project and the National Science and Technology Major Project from the Ministry of Science and Technology of China.(NO. 2012ZX09303008-001; http://www.nmp.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; Asztalos BF, 2007, AM J CARDIOL, V99, P681, DOI 10.1016/j.amjcard.2006.09.117; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; BAGGIO G, 1986, J CLIN INVEST, V77, P520, DOI 10.1172/JCI112332; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Brewis IA, 2010, ADV PROTEIN CHEM STR, V80, P1, DOI [10.1016/S1876-1623(10)80001-X, 10.1016/B978-0-12-381264-3.00001-1]; Chen GL, 2010, CHINESE MED J-PEKING, V123, P658, DOI 10.3760/cma.j.issn.0366-6999.2010.06.004; della Rovere GR, 2003, NUTR METAB CARDIOVAS, V13, P46, DOI 10.1016/S0939-4753(03)80167-9; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dumont L, 2005, J BIOL CHEM, V280, P38108, DOI 10.1074/jbc.M504678200; Eren E, 2013, CHOLESTEROL, DOI 10.1155/2013/792090; FELLIN R, 1983, ATHEROSCLEROSIS, V49, P55, DOI 10.1016/0021-9150(83)90007-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Huang C, 2013, J PROTEOME RES, V12, P1838, DOI 10.1021/pr3011815; Hughes J, 2011, REPRODUCTION, V141, P105, DOI 10.1530/REP-10-0337; Jeyaseelan R, 1997, J BIOL CHEM, V272, P5828, DOI 10.1074/jbc.272.9.5828; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Katayama T, 2005, CIRC J, V69, P1186, DOI 10.1253/circj.69.1186; Kei AA, 2012, METABOLISM, V61, P906, DOI 10.1016/j.metabol.2011.12.002; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Kosuge M, 2007, CIRC J, V71, P186, DOI 10.1253/circj.71.186; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; Liu RJ, 2009, INT J BIOCHEM CELL B, V41, P1371, DOI 10.1016/j.biocel.2008.12.002; Mange A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034107; Marsche G, 2013, PHARMACOL THERAPEUT, V137, P341, DOI 10.1016/j.pharmthera.2012.12.001; McEneny J, 2013, PEDIATR RES, V74, P279, DOI 10.1038/pr.2013.93; Natarajan P, 2010, J AM COLL CARDIOL, V55, P1283, DOI 10.1016/j.jacc.2010.01.008; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Pemberton AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009884; Pillois X, 2012, J LIPID RES, V53, P1200, DOI 10.1194/jlr.M022988; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Saremi A, 2009, AM J THER, V16, P421, DOI 10.1097/MJT.0b013e3180a5f0bb; SIPE JD, 1985, BIOCHEMISTRY-US, V24, P2931, DOI 10.1021/bi00333a018; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Speidl WS, 2011, J THROMB HAEMOST, V9, P428, DOI 10.1111/j.1538-7836.2010.04172.x; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vaisar T, 2012, CURR VASC PHARMACOL, V10, P410, DOI 10.2174/157016112800812755; Vekrellis K, 2004, MOL NEUROBIOL, V30, P1, DOI 10.1385/MN:30:1:001; Wang DX, 2013, CHINESE MED J-PEKING, V126, P3656, DOI 10.3760/cma.j.issn.0366-6999.20130400; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; Watanabe J, 2009, J BIOL CHEM, V284, P18292, DOI 10.1074/jbc.M109.017202	61	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98368	10.1371/journal.pone.0098368	http://dx.doi.org/10.1371/journal.pone.0098368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859250	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400070
J	Green, A; de Azevedo, V; Patten, G; Davies, MA; Ibeto, M; Cox, V				Green, Ann; de Azevedo, Virginia; Patten, Gabriela; Davies, Mary-Ann; Ibeto, Mary; Cox, Vivian			Clinical Mentorship of Nurse Initiated Antiretroviral Therapy in Khayelitsha, South Africa: A Quality of Care Assessment	PLOS ONE			English	Article							SUSTAINABILITY	Introduction: To combat the AIDS epidemic and increase HIV treatment access, the South African government implemented a nurse-based, doctor-supported model of care that decentralizes administration of antiretroviral treatment (ART) for HIV positive patients through nurse initiated and managed ART. Medecins Sans Frontieres (MSF) implemented a mentorship programme to ensure successful task-shifting, subsequently assessing the quality of clinical care provided by nurses. Methods: A before-after cross-sectional study was conducted on nurses completing the mentorship programme in Khayelitsha, South Africa, from February 2011-September 2012. Routine clinical data from 229 patient folders and 21 self-assessment questionnaires was collected to determine the number of patients initiated on ART by nurses; quality of ART management before-after mentorship; patient characteristics for doctor and nurse ART initiations; and nurse self-assessments after mentorship. Results: Twenty one nurses were authorized by one nurse mentor with one part-time medical officer's support, resulting in nurses initiating 77% of ART eligible patients. Improvements in ART management were found for drawing required bloods (91% vs 99%, p = 0.03), assessing adherence (50% vs 78%, p < 0.001) and WHO staging (63% vs 91%, p < 0.001). Nurse ART initiation indicators were successfully completed at 95-100% for 11 of 16 indicators: clinical presentation; patient weight; baseline blood work (CD4, creatinine, haemoglobin); STI screening; WHO stage, correlating medical history; medications prescribed appropriately; ART start date; and documented return date. Doctors initiated more patients with TB/HIV co-infection and WHO Stage 3 and 4 disease than nurses. Nurse confidence improved for managing HIV-infected children and pregnant women, blood result interpretation and long-term side effects. Conclusions: Implementation of a clinical mentorship programme in Khayelitsha led to nurse initiation of a majority of eligible patients, enabling medical officers to manage complex cases. As mentorship can increase clinical confidence and enhance professional development, it should be considered essential for universal ART access in resource limited settings.	[Green, Ann; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [de Azevedo, Virginia] City Cape Town, Dept Hlth, Cape Town, South Africa; [Patten, Gabriela; Ibeto, Mary; Cox, Vivian] Med Sans Frontieres Khayelitsha, Khayelitsha, South Korea	University of Cape Town	Green, A (corresponding author), Vanderbilt Inst Global Hlth, Nashville, TN 37203 USA.	annfordgreen@gmail.com	Patten, Gabriela/J-3461-2019	Patten, Gabriela/0000-0003-2511-1367; Green, Ann/0000-0002-9248-2216				Bachmann MO, 2012, LANCET, V380, P1908, DOI 10.1016/S0140-6736(12)62111-4; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Bingham A, 2003, SALUD PUBLICA MEXICO, V45, pS408; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Cameron D, 2012, SAMJ S AFR MED J, V102, P98, DOI 10.7196/SAMJ.5195; Chung J, 2008, HIV AIDS IMPL M 3 7; Department of Social Services and Poverty Alleviation, 2006, POP REG UPD KHAYEL 2; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; International Agency for Research on Cancer, 2010, GLOBOCAN 2008 FAST S; Kiweewa FM, 2013, J ACQUIRED IMMUNE DE, V63; Kredo T, 2012, TASK SHIFTING DOCTOR; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Medecins Sans Frontieres, 2012, CLIN MENT TOOLK; Medecins Sans Frontieres, 2011, KHAYEL 2001 2011 ACT; Naranbhai V, 2012, LANCET, V380, P1907, DOI 10.1016/S0140-6736(12)62110-2; Penazzato M, 2014, JAIDS-J ACQ IMM DEF, V65, P414, DOI 10.1097/QAI.0000000000000024; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; South African National Department of Health, 2011, CLIN MENT MAN INT SE; South African National Department of Health, 2011, NAT STRAT PLAN HIV A; StataCorp, 2011, STAT STAT SOFTW REL; Stinson K, 2014, S AFR J HIV MED, V15, P30, DOI [10.7196/sajhivmed.1025, 10.7196/SAJHIVMED.1025]; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Western Cape's HIV&AIDS STI TB Directorate, 2012, FRAM NURS IN MAN ANT; Workneh G, 2013, AIDS CARE, V25, P11, DOI 10.1080/09540121.2012.674096; World Health Organization, 2008, TASK SHIFT RAT RED T	26	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98389	10.1371/journal.pone.0098389	http://dx.doi.org/10.1371/journal.pone.0098389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887260	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300060
J	Ye, Q; Shao, WX; Xu, XJ; Yang, YZ				Ye, Qing; Shao, Wen-Xia; Xu, Xiao-Jun; Yang, Ying-zhi			The Clinical Application Value of Cytokines in Treating Infectious Diseases	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-6; SEVERE SEPSIS; CELL; INFLAMMATION; CHILDREN; IL-10	We performed a prospective study to evaluate the abilities of inflammatory cytokines to rule out the potential risk of sepsis and intracranial infection and to estimate the function of inflammatory cytokines in discriminating Gram-negative bacteria from Gram-positive ones through ROC analysis. During the course of the study, Levels of serum inflammatory cytokines were measured by flow cytometry at the onset of diseases of patients who suffered from sepsis or intracranial infection. A total of 299 cases of sepsis and 43 cases of intracranial infection were observed during the study. It is noticed that there is no difference of inflammatory cytokine levels between sepsis group and intracranial infection group. The area under ROC curve (AUC) of cytokines, such as IL-2, IL-6 and IL-10 were 0.901, 0.86, 0.888, respectively, which was employed to rule out the diseases of sepsis and intracranial infection. Through comparisons with the patients who were infected by Gram-positive bacteria or Gram-negative ones, it is estimated that IL-6 and IL-10 sharply elevated in patients with Gram-negative bacteria infection (median levels, pg/mL: IL-6: 116.6 vs. 25.4, P = 0.000; IL-10: 13.7 vs. 6.3, P = 0.000). Additionally, IL-2 significantly decreased when patients suffered from Gram-negative bacteria infection (median levels, pg/mL: IL-2: 2.2 vs. 2.7, P = 0.031). The AUCs for detecting cytokines, including IL-2, IL-10 and LOGREGR. Pred_IL-2+IL-10 were 0.581 (95% CI, 0.526 to 0.634), 0.661 (95% CI, 0.608 to 0.712) and 0.735 (95% CI, 0.685 to 0.782), respectively, which was used to evaluate the function of inflammatory cytokines in discriminating Gram-negative bacteria from Gram-positive ones infection. This paper indicates that IL-2, IL-6 and IL-10 are effective biomarkers to rule out sepsis and intracranial infection. Additionally, the combination of IL-2 and IL-10 is an effective biomarkers to diagnose whether patients afflicted by Gram-negative bacteria.	[Ye, Qing] Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Wen-Xia] Hangzhou First Peoples Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiao-Jun] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Hematol Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ying-zhi] Zhejiang Univ City Coll, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University City College	Ye, Q (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	yeqingkaoyan@163.com		Xu, Xiaojun/0000-0003-1388-2535				Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Finney SJ, 2012, INTENS CARE MED, V38, P324, DOI 10.1007/s00134-011-2444-5; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Foerster BR, 2007, ACTA RADIOL, V48, P875, DOI 10.1080/02841850701477728; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hartman ME, 2013, PEDIATR CRIT CARE ME, P1; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; Jenabian MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003319; Jinquan T, 2000, IMMUNOLOGY, V99, P402, DOI 10.1046/j.1365-2567.2000.00954.x; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MARKHAM JL, 1975, INFECT IMMUN, V12, P378, DOI 10.1128/IAI.12.2.378-386.1975; Richens JL, 2010, J BIOMOL SCREEN, V15, P562, DOI 10.1177/1087057110362099; Salinas N, 2013, J IMMUNOL, V190; Sciuca S, 2013, ALLERGY, V68, P347; Sharma R, 2011, J AUTOIMMUN, V36, P91, DOI 10.1016/j.jaut.2011.01.001; Sharma R, 2011, J IMMUNOL, V186, P1268, DOI 10.4049/jimmunol.1002677; VELDHUIS GJ, 1995, J CLIN ONCOL, V13, P2585, DOI 10.1200/JCO.1995.13.10.2585; Watson R Scott, 2005, Pediatr Crit Care Med, V6, pS3; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Wolfler A, 2008, INTENS CARE MED, V34, P1690, DOI 10.1007/s00134-008-1148-y; Xu XJ, 2013, INTENS CARE MED, V39, P319, DOI 10.1007/s00134-012-2752-4; Ye Q, 2011, J PEDIAT HEMATOL ONC, V33, pE186, DOI 10.1097/MPH.0b013e31821ba92c	30	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98745	10.1371/journal.pone.0098745	http://dx.doi.org/10.1371/journal.pone.0098745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887408	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300103
J	Kuo, MW; Lou, SW; Chung, BC				Kuo, Ming-Wei; Lou, Show-Wan; Chung, Bon-chu			Hedgehog-PKA Signaling and gnrh3 Regulate the Development of Zebrafish gnrh3 Neurons	PLOS ONE			English	Article							ONTOGENIC DEVELOPMENT; HORMONE NEURONS; EMBRYONIC-DEVELOPMENT; KALLMANN-SYNDROME; NEURAL CREST; DANIO-RERIO; EXPRESSION; BRAIN; GENE; INDUCTION	GnRH neurons secrete GnRH that controls the development of the reproduction system. Despite many studies, the signals controlling the development of GnRH neurons from its progenitors have not been fully established. To understand the development of GnRH neurons, we examined the development of gnrh3-expressing cells using a transgenic zebrafish line that expresses green fluorescent protein (GFP) and LacZ driven by the gnrh3 promoter. GFP and LacZ expression recapitulated that of gnrh3 in the olfactory region, olfactory bulb and telencephalon. Depletion of gnrh3 by morpholinos led to a reduction of GFP- and gnrh3-expressing cells, while over-expression of gnrh3 mRNA increased the number of these cells. This result indicates a positive feed-forward regulation of gnrh3 cells by gnrh3. The gnrh3 cells were absent in embryos that lack Hedgehog signaling, but their numbers were increased in embryos overexpressing shhb. We manipulated the amounts of kinase that antagonizes the Hedgehog signaling pathway, protein kinase A (PKA), by treating embryos with PKA activator forskolin or by injecting mRNAs encoding its constitutively active catalytic subunit (PKA*) and dominant negative regulatory subunit (PKI) into zebrafish embryos. PKA* misexpression or forskolin treatment decreased GFP cell numbers, while PKI misexpression led to ectopic production of GFP cells. Our data indicate that the Hedgehog-PKA pathway participates in the development of gnrh3-expressing neurons during embryogenesis.	[Kuo, Ming-Wei; Chung, Bon-chu] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Kuo, Ming-Wei; Lou, Show-Wan] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chung, BC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	mbchung@sinica.edu.tw		Chung, Bon-chu/0000-0002-8612-0219	National Science Council [NSC 102-2923-B-001-003-MY3]; NHRI [NHRI- EX102-10210SI]; Academia Sinica, Republic of China [AS-101-TP-B05]	National Science Council(Ministry of Science and Technology, Taiwan); NHRI(National Health Research Institutes - Taiwan); Academia Sinica, Republic of China(Academia Sinica - Taiwan)	This work was supported by grants NSC 102-2923-B-001-003-MY3 from the National Science Council, NHRI- EX102-10210SI from NHRI, and AS-101-TP-B05 from Academia Sinica, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; AGUZZI A, 1994, HISTOCHEMISTRY, V102, P477, DOI 10.1007/BF00269579; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Amano M, 2004, ZOOL SCI, V21, P311, DOI 10.2108/zsj.21.311; Amano M, 1998, CELL TISSUE RES, V293, P427, DOI 10.1007/s004410051134; Balmer CW, 2004, J COMP NEUROL, V472, P292, DOI 10.1002/cne.20053; Barnett DK, 2006, ENDOCRINOLOGY, V147, P615, DOI 10.1210/en.2005-0662; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Berghard A, 2012, FASEB J, V26, P3464, DOI 10.1096/fj.12-206193; CHIBA A, 1994, NEUROSCI LETT, V178, P51, DOI 10.1016/0304-3940(94)90287-9; Cornesse Y, 2005, DEV BIOL, V277, P296, DOI 10.1016/j.ydbio.2004.09.016; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gill JC, 2004, ENDOCRINOLOGY, V145, P3830, DOI 10.1210/en.2004-0214; Gonzalez-Martinez D, 2002, J CHEM NEUROANAT, V23, P255, DOI 10.1016/S0891-0618(02)00004-2; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Kramer PR, 2000, DEV BIOL, V227, P343, DOI 10.1006/dbio.2000.9896; Kuo MW, 2005, J BIOMED SCI, V12, P629, DOI 10.1007/s11373-005-7457-z; LaMantia AS, 2000, NEURON, V28, P411, DOI 10.1016/S0896-6273(00)00121-5; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Meng AM, 1999, DEVELOPMENT, V126, P1259; Ogawa S, 2006, NEUROSCI LETT, V403, P201, DOI 10.1016/j.neulet.2006.02.041; Okubo K, 2006, ENDOCRINOLOGY, V147, P1076, DOI 10.1210/en.2005-0468; Palevitch O, 2010, GEN COMP ENDOCR, V165, P262, DOI 10.1016/j.ygcen.2009.07.001; PARHAR IS, 1995, J COMP NEUROL, V362, P256, DOI 10.1002/cne.903620208; Ramakrishnan S, 2010, GEN COMP ENDOCR, V168, P401, DOI 10.1016/j.ygcen.2010.05.009; Romanelli RG, 2004, J BIOL CHEM, V279, P117, DOI 10.1074/jbc.M307955200; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 1997, DEVELOPMENT, V124, P327; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Tong SK, 2001, J STEROID BIOCHEM, V79, P299, DOI 10.1016/S0960-0760(01)00146-7; Toro S, 2007, SEMIN CELL DEV BIOL, V18, P534, DOI 10.1016/j.semcdb.2007.04.003; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Uchida H, 2005, J NEUROBIOL, V65, P1, DOI 10.1002/neu.20156; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whitlock KE, 2003, DEV BIOL, V257, P140, DOI 10.1016/S0012-1606(03)00039-3; Whitlock KE, 2005, TRENDS ENDOCRIN MET, V16, P145, DOI 10.1016/j.tem.2005.03.005; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e95545	10.1371/journal.pone.0095545	http://dx.doi.org/10.1371/journal.pone.0095545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879419	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500003
J	Maiwald, S; Sivapalaratnam, S; Motazacker, MM; van Capelleveen, JC; Bot, I; de Jager, SC; van Eck, M; Jolley, J; Kuiper, J; Stephens, J; Albers, CA; Vosmeer, CR; Kruize, H; Geerke, DP; van der Wal, AC; van der Loos, CM; Kastelein, JJP; Trip, MD; Ouwehand, WH; Dallinga-Thie, GM; Hovingh, GK				Maiwald, Stephanie; Sivapalaratnam, Suthesh; Motazacker, Mahdi M.; van Capelleveen, Julian C.; Bot, Ilze; de Jager, Saskia C.; van Eck, Miranda; Jolley, Jennifer; Kuiper, Johan; Stephens, Jonathon; Albers, Cornelius A.; Vosmeer, C. Ruben; Kruize, Heleen; Geerke, Daan P.; van der Wal, Allard C.; van der Loos, Chris M.; Kastelein, John J. P.; Trip, Mieke D.; Ouwehand, Willem H.; Dallinga-Thie, Geesje M.; Hovingh, G. Kees			Mutation in KERA Identified by Linkage Analysis and Targeted Resequencing in a Pedigree with Premature Atherosclerosis	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; RECESSIVE CORNEA PLANA; MYOCARDIAL-INFARCTION; RISK-FACTORS; SUSCEPTIBILITY; LOCUS; MEF2A; ACCUMULATION; ASSOCIATION	Aims: Genetic factors explain a proportion of the inter-individual variation in the risk for atherosclerotic events, but the genetic basis of atherosclerosis and atherothrombosis in families with Mendelian forms of premature atherosclerosis is incompletely understood. We set out to unravel the molecular pathology in a large kindred with an autosomal dominant inherited form of premature atherosclerosis. Methods and Results: Parametric linkage analysis was performed in a pedigree comprising 4 generations, of which a total of 11 members suffered from premature vascular events. A parametric LOD-score of 3.31 was observed for a 4.4 Mb interval on chromosome 12. Upon sequencing, a non-synonymous variant in KERA (c. 920C. G; p. Ser307Cys) was identified. The variant was absent from nearly 28,000 individuals, including 2,571 patients with premature atherosclerosis. KERA, a proteoglycan protein, was expressed in lipid-rich areas of human atherosclerotic lesions, but not in healthy arterial specimens. Moreover, KERA expression in plaques was significantly associated with plaque size in a carotid-collar Apoe 2/2 mice (r(2) = 0.69; p, 0.0001). Conclusion: A rare variant in KERA was identified in a large kindred with premature atherosclerosis. The identification of KERA in atherosclerotic plaque specimen in humans and mice lends support to its potential role in atherosclerosis.	[Maiwald, Stephanie; Sivapalaratnam, Suthesh; van Capelleveen, Julian C.; Kastelein, John J. P.; Trip, Mieke D.; Dallinga-Thie, Geesje M.; Hovingh, G. Kees] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Maiwald, Stephanie; Motazacker, Mahdi M.; Dallinga-Thie, Geesje M.] Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [Bot, Ilze; de Jager, Saskia C.; van Eck, Miranda; Kuiper, Johan] Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Jolley, Jennifer; Stephens, Jonathon; Albers, Cornelius A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Jolley, Jennifer; Stephens, Jonathon; Albers, Cornelius A.; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Vosmeer, C. Ruben; Kruize, Heleen; Geerke, Daan P.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Div Mol & Computat Toxicol, Amsterdam Inst Mol Med & Syst, Amsterdam, Netherlands; [van der Wal, Allard C.; van der Loos, Chris M.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Bot, Ilze; de Jager, Saskia C.; van Eck, Miranda; Kuiper, Johan] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, Cambs, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Cambridge; NHS Blood & Transplant (NHSBT); Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Wellcome Trust Sanger Institute	Dallinga-Thie, GM (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	g.m.dallinga@amc.nl; g.k.hovingh@amc.nl	Kastelein, John/AAF-7950-2020; Vosmeer, Ruben/H-2025-2014; de+Jager, Saskia/AAE-1132-2022; de+Jager, Saskia/ABC-4264-2020; Geerke, Daan/A-1839-2015	Geerke, Daan/0000-0002-5262-6166; van Eck, Miranda/0000-0003-3936-3194; de Jager, Saskia/0000-0002-5233-0066; Ouwehand, Willem/0000-0002-7744-1790; Bot, Ilze/0000-0002-1242-1959; van der Wal, Allard/0000-0001-5590-3758; dallinga-thie, geesje/0000-0001-5412-5923; Stephens, Jonathan/0000-0003-2020-9330	Marie-Curie NetSim ITN grant from the European Commission 7th Framework Programme [EC-215820]; Ipse Movet; ATHEROS; Fondation LeDucq; Dutch Heart Foundation [2010T082]; National Institute for Health Research (NIHR) [RP-PG-0310-1002]; British Heart Foundation [RG/09/12/28096]; European Commission and the Medical Research Council; Netherlands Organisation for Scientific Research (NWO) [91612122]; CardioVascular Research Initiative [CVON2011-19]; European Union; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1002, NF-SI-0513-10151, NF-SI-0510-10214] Funding Source: researchfish	Marie-Curie NetSim ITN grant from the European Commission 7th Framework Programme; Ipse Movet; ATHEROS; Fondation LeDucq(Leducq Foundation); Dutch Heart Foundation(Netherlands Heart Foundation); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); European Commission and the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CardioVascular Research Initiative; European Union(European Commission); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	SM has been supported by the Marie-Curie NetSim ITN grant [grant number EC-215820] from the European Commission 7th Framework Programme and Ipse Movet. SS is supported by a grant from ATHEROS. MMM is supported by Fondation LeDucq (Transatlantic Network, 2009-2014). MvE is an Established Investigator [2007T056] of the Dutch Heart Foundation. JJPK is a recipient of the Lifetime Achievement Award of the Dutch Heart Foundation [2010T082]. Research in WHO group is supported by programme grants from the National Institute for Health Research (NIHR) (RP-PG-0310-1002), from the British Heart Foundation [RG/09/12/28096], from the European Commission and the Medical Research Council. The project made use of NHS Blood and Transplant donors from the Cambridge BioResource (http://www.cambridgebioresource.org.uk/). This local resource for genotype-phenotype association studies is supported by a grant from the NIHR to the Cambridge Biomedical Research Centre. GKH is holder of a Veni grant [91612122] from the Netherlands Organisation for Scientific Research (NWO). This work is supported by CardioVascular Research Initiative [CVON2011-19; Genius] and the European Union [Resolve: FP7-305707' TransCard: FP7603091- 2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, OPHTHALMIC GENET, V28, P57, DOI 10.1080/13816810701351321; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dudakova L, 2014, OPHTHALMIC GENET, V35, P252, DOI 10.3109/13816810.2013.811272; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Forsius H, 1998, ACTA OPHTHALMOL SCAN, V76, P196, DOI 10.1034/j.1600-0420.1998.760215.x; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; Hauser ER, 2003, AM HEART J, V145, P602, DOI 10.1067/mhj.2003.13; Huijgen Roeland, 2008, Expert Rev Cardiovasc Ther, V6, P567, DOI 10.1586/14779072.6.4.567; Keramati AR, 2011, P NATL ACAD SCI USA, V108, P1914, DOI 10.1073/pnas.1019443108; Khan Arif, 2004, Ophthalmic Genet, V25, P147, DOI 10.1080/13816810490514397; Khan AO, 2006, OPHTHALMOLOGY, V113, P1773, DOI 10.1016/j.ophtha.2006.04.026; Lee K, 2012, EUR J PREV CARDIOL, V19, P1161, DOI 10.1177/1741826711422763; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Liskova P, 2007, MOL VIS, V13, P1339; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Vergeer M, 2010, CIRCULATION, V122, P470, DOI 10.1161/CIRCULATIONAHA.109.912519; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Wentz-Hunter K, 2001, MOL MED, V7, P470, DOI 10.1007/BF03401852; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98289	10.1371/journal.pone.0098289	http://dx.doi.org/10.1371/journal.pone.0098289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879339	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500046
J	Pan, HT; Zhu, CL; Zhang, F; Yuan, Y; Zhang, SM; Zhang, WH; Li, CJ; Wang, L; Xia, JL				Pan, Haitao; Zhu, Cailin; Zhang, Feng; Yuan, Ying; Zhang, Shemin; Zhang, Wenhong; Li, Chanjuan; Wang, Ling; Xia, Jielai			The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Model Selection Approach	PLOS ONE			English	Article								Grade information has been considered in Yuan et al. (2007) wherein they proposed a Quasi-CRM method to incorporate the grade toxicity information in phase I trials. A potential problem with the Quasi-CRM model is that the choice of skeleton may dramatically vary the performance of the CRM model, which results in similar consequences for the Quasi-CRM model. In this paper, we propose a new model by utilizing bayesian model selection approach - Robust Quasi-CRM model - to tackle the above-mentioned pitfall with the Quasi-CRM model. The Robust Quasi-CRM model literally inherits the BMA-CRM model proposed by Yin and Yuan (2009) to consider a parallel of skeletons for Quasi-CRM. The superior performance of Robust Quasi-CRM model was demonstrated by extensive simulation studies. We conclude that the proposed method can be freely used in real practice.	[Pan, Haitao; Zhang, Shemin; Zhang, Wenhong] Xian Univ Finance & Econ, Sch Stat, Xian, Peoples R China; [Zhu, Cailin] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Gastrointestinal Surg, Xian 710032, Peoples R China; [Zhang, Feng] Shandong Univ, Shandong Prov Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Ying] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Li, Chanjuan; Wang, Ling; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China	Xi'an University of Finance & Economics; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University	Li, CJ (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China.	chanjuanli@sohu.com; medstat@gmail.com; jielaixia@yahoo.com	Pan, Haitao/N-2529-2018	Pan, Haitao/0000-0003-4457-7349	National Science Foundation of China [81302513, 81273176, 81001290, 81302509, 11XTJ003]; Teaching Research Project of Xi'an University of Finance and Economics [13xcj41]; Research Project of Xi'an University of Finance and Economics [13JD01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Teaching Research Project of Xi'an University of Finance and Economics; Research Project of Xi'an University of Finance and Economics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Haitao Pan's work was partially supported by Research Grant 81302513 from National Science Foundation of China, Teaching Research Project of Xi'an University of Finance and Economics (13xcj41), and Research Project of Xi'an University of Finance and Economics (13JD01). Dr. Jielai Xia's work was partially supported by Research Grant 81273176 and 81001290 from National Science Foundation of China. Dr. Ling Wang's work was partially supported by Research Grant 81302509 from National Science Foundation of China. Dr. Wenhong Zhang's work was partially supported by National Social Science Foundation of China 11XTJ003. No other additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekele BN, 2004, J AM STAT ASSOC, V99, P26, DOI 10.1198/016214504000000043; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Ji YA, 2010, CLIN TRIALS, V7, P653, DOI 10.1177/1740774510382799; McCullagh P, 1989, GEN LINEAR MODELS; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Pan HT, 2014, CLIN TRIALS, V11, P49, DOI 10.1177/1740774513500081; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Van Meter EM, 2012, CLIN TRIALS, V9, P303, DOI 10.1177/1740774512443593; Yin GS, 2009, J AM STAT ASSOC, V104, P954, DOI 10.1198/jasa.2009.ap08425; Yuan Z, 2007, BIOMETRICS, V63, P173, DOI 10.1111/j.1541-0420.2006.00666.x	12	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98147	10.1371/journal.pone.0098147	http://dx.doi.org/10.1371/journal.pone.0098147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875783	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800025
J	Pearcey, GEP; Power, KE; Button, DC				Pearcey, Gregory E. P.; Power, Kevin E.; Button, Duane C.			Differences in Supraspinal and Spinal Excitability during Various Force Outputs of the Biceps Brachii in Chronic- and Non-Resistance Trained Individuals	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CROSS-SECTIONAL AREA; MOTONEURONS IN-VIVO; MOTOR UNIT BEHAVIOR; LOWER-LIMB MUSCLES; VOLUNTARY CONTRACTIONS; NEURAL ADAPTATIONS; CORTICOSPINAL STIMULATION; FATIGUING CONTRACTION; SYSTEMATIC VARIATIONS	Motor evoked potentials (MEP) and cervicomedullary evoked potentials (CMEP) may help determine the corticospinal adaptations underlying chronic resistance training-induced increases in voluntary force production. The purpose of the study was to determine the effect of chronic resistance training on corticospinal excitability (CE) of the biceps brachii during elbow flexion contractions at various intensities and the CNS site (i.e. supraspinal or spinal) predominantly responsible for any training-induced differences in CE. Fifteen male subjects were divided into two groups: 1) chronic resistance-trained (RT), (n = 8) and 2) non-RT, (n = 7). Each group performed four sets of,5 s elbow flexion contractions of the dominant arm at 10 target forces (from 10%-100% MVC). During each contraction, subjects received 1) transcranial magnetic stimulation, 2) transmastoid electrical stimulation and 3) brachial plexus electrical stimulation, to determine MEP, CMEP and compound muscle action potential (M-max) amplitudes, respectively, of the biceps brachii. All MEP and CMEP amplitudes were normalized to M-max. MEP amplitudes were similar in both groups up to 50% MVC, however, beyond 50% MVC, MEP amplitudes were lower in the chronic RT group (p<0.05). CMEP amplitudes recorded from 10-100% MVC were similar for both groups. The ratio of MEP amplitude/absolute force and CMEP amplitude/absolute force were reduced (p<0.012) at all contraction intensities from 10-100% MVC in the chronic-RT compared to the non-RT group. In conclusion, chronic resistance training alters supraspinal and spinal excitability. However, adaptations in the spinal cord (i.e. motoneurone) seem to have a greater influence on the altered CE.	[Pearcey, Gregory E. P.; Power, Kevin E.; Button, Duane C.] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada; [Button, Duane C.] Mem Univ Newfoundland, Fac Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Button, DC (corresponding author), Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada.	dbutton@mun.ca	Behm, David George/I-6509-2019	Behm, David George/0000-0002-9406-6056; Pearcey, Gregory/0000-0002-6751-4351; Power, Kevin/0000-0001-5958-0271	Memorial University start-up grant [208604]	Memorial University start-up grant	This research was supported by a Memorial University start-up grant 208604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Beaumont E, 2003, MUSCLE NERVE, V27, P228, DOI 10.1002/mus.10308; Beaumont E, 2002, J PHYSIOL-LONDON, V540, P129, DOI 10.1113/jphysiol.2001.013084; Beck S, 2007, BRAIN RES, V1179, P51, DOI 10.1016/j.brainres.2007.08.048; Button DC, 2006, J PHYSIOL-LONDON, V573, P663, DOI 10.1113/jphysiol.2006.107292; CAROLAN B, 1992, J APPL PHYSIOL, V73, P911, DOI 10.1152/jappl.1992.73.3.911; CARP JS, 1994, J NEUROPHYSIOL, V72, P431, DOI 10.1152/jn.1994.72.1.431; Carroll TJ, 2011, ACTA PHYSIOL, V202, P119, DOI 10.1111/j.1748-1716.2011.02271.x; Carroll TJ, 2009, ACTA PHYSIOL, V197, P161, DOI 10.1111/j.1748-1716.2009.01992.x; Carroll TJ, 2002, J PHYSIOL-LONDON, V544, P641, DOI 10.1113/jphysiol.2002.024463; Carroll TJ, 2001, SPORTS MED, V31, P829, DOI 10.2165/00007256-200131120-00001; Davidson AW, 2010, MUSCLE NERVE, V42, P514, DOI 10.1002/mus.21717; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113, DOI 10.1113/jphysiol.1982.sp014293; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; del Olmo MF, 2006, EUR J APPL PHYSIOL, V96, P722, DOI 10.1007/s00421-006-0153-5; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Dragert K, 2013, EXP BRAIN RES, V225, P93, DOI 10.1007/s00221-012-3351-x; Enoka RM, 1997, J BIOMECH, V30, P447, DOI 10.1016/S0021-9290(96)00170-4; Falvo MJ, 2010, EUR J APPL PHYSIOL, V109, P923, DOI 10.1007/s00421-010-1432-8; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Gandevia SC, 1999, J PHYSIOL-LONDON, V521, P749, DOI 10.1111/j.1469-7793.1999.00749.x; Gardiner P, 2006, J APPL PHYSIOL, V101, P1228, DOI 10.1152/japplphysiol.00482.2006; GARFINKEL S, 1992, MED SCI SPORT EXER, V24, P1220; Gelli F, 2007, EUR J NEUROSCI, V25, P3469, DOI 10.1111/j.1460-9568.2007.05590.x; Goodwill AM, 2012, MUSCLE NERVE, V46, P384, DOI 10.1002/mus.23316; Griffin L, 2007, J ELECTROMYOGR KINES, V17, P446, DOI 10.1016/j.jelekin.2006.05.001; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Heckman CJ, 2003, EXERC SPORT SCI REV, V31, P96, DOI 10.1097/00003677-200304000-00008; Heckman CJ, 2008, NEUROSCIENTIST; Jensen JL, 2005, J APPL PHYSIOL, V99, P1558, DOI 10.1152/japplphysiol.01408.2004; Jones KE, 1997, J NEUROPHYSIOL, V77, P405, DOI 10.1152/jn.1997.77.1.405; Khan SI, 2012, J PHYSIOL-LONDON, V590, P4957, DOI 10.1113/jphysiol.2012.235697; Kidgell DJ, 2010, J STRENGTH COND RES, V24, P3123, DOI 10.1519/JSC.0b013e3181f56794; Kidgell DJ, 2010, HUM MOVEMENT SCI, V29, P631, DOI 10.1016/j.humov.2010.01.004; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Levenez M, 2008, J NEUROPHYSIOL, V99, P554, DOI 10.1152/jn.00963.2007; MacDonell CW, 2012, J NEUROPHYSIOL, V107, P265, DOI 10.1152/jn.00122.2011; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Martin PG, 2006, J NEUROPHYSIOL, V95, P3512, DOI 10.1152/jn.01230.2005; Martin PG, 2009, J NEUROPHYSIOL, V102, P606, DOI 10.1152/jn.91348.2008; Matthews PBC, 1999, J PHYSIOL-LONDON, V518, P867, DOI 10.1111/j.1469-7793.1999.0867p.x; MAZZOCCHIO R, 1994, J PHYSIOL-LONDON, V474, P261, DOI 10.1113/jphysiol.1994.sp020018; McNeil CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00152; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; Narici MV, 1996, ACTA PHYSIOL SCAND, V157, P175, DOI 10.1046/j.1365-201X.1996.483230000.x; OLIVIER E, 1995, J PHYSIOL-LONDON, V485, P257, DOI 10.1113/jphysiol.1995.sp020728; Oya T, 2008, J APPL PHYSIOL, V105, P1527, DOI 10.1152/japplphysiol.90586.2008; Pearcey GEP, 2013, APPL PHYSIOL NUTR ME, V38, P1069; Rossi A, 2012, J NEUROPHYSIOL, V108, P2473, DOI 10.1152/jn.00477.2012; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Tallent J, 2013, J ELECTROMYOGR KINES, V23, P1075, DOI 10.1016/j.jelekin.2013.04.014; Taylor JL, 2006, J ELECTROMYOGR KINES, V16, P215, DOI 10.1016/j.jelekin.2005.07.001; Taylor JL, 2002, J PHYSIOL-LONDON, V541, P949, DOI 10.1113/jphysiol.2002.016782; Tillin NA, 2011, MUSCLE NERVE, V43, P375, DOI 10.1002/mus.21885; Ugawa Y, 1995, ELECTROMYOGR MOTOR C, V97, P451, DOI 10.1016/0924-980X(95)00214-6; UGAWA Y, 1991, ANN NEUROL, V29, P418, DOI 10.1002/ana.410290413; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Vila-Cha C, 2010, J APPL PHYSIOL, V109, P1455, DOI 10.1152/japplphysiol.01213.2009; Weier AT, 2012, ACTA PHYSIOL, V206, P109, DOI 10.1111/j.1748-1716.2012.02454.x	61	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98468	10.1371/journal.pone.0098468	http://dx.doi.org/10.1371/journal.pone.0098468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875495	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800042
J	Pearson, T; Kabayo, T; Ng, R; Chamberlain, J; McArdle, A; Jackson, MJ				Pearson, Timothy; Kabayo, Tabitha; Ng, Rainer; Chamberlain, Jeffrey; McArdle, Anne; Jackson, Malcolm J.			Skeletal Muscle Contractions Induce Acute Changes in Cytosolic Superoxide, but Slower Responses in Mitochondrial Superoxide and Cellular Hydrogen Peroxide	PLOS ONE			English	Article							NITRIC-OXIDE; INTRACELLULAR SUPEROXIDE; OXIDATIVE STRESS; RELEASE; PRODUCT; DIHYDROETHIDIUM; HYDROETHIDINE; FLUORESCENCE; GENERATION; ETHIDIUM	Skeletal muscle generation of reactive oxygen species (ROS) is increased following contractile activity and these species interact with multiple signaling pathways to mediate adaptations to contractions. The sources and time course of the increase in ROS during contractions remain undefined. Confocal microscopy with specific fluorescent probes was used to compare the activities of superoxide in mitochondria and cytosol and the hydrogen peroxide content of the cytosol in isolated single mature skeletal muscle (flexor digitorum brevis) fibers prior to, during, and after electrically stimulated contractions. Superoxide in mitochondria and cytoplasm were assessed using MitoSox red and dihydroethidium (DHE) respectively. The product of superoxide with DHE, 2-hydroxyethidium (2-HE) was acutely increased in the fiber cytosol by contractions, whereas hydroxy-MitoSox showed a slow cumulative increase. Inhibition of nitric oxide synthases increased the contraction-induced formation of hydroxy-MitoSox only with no effect on 2-HE formation. These data indicate that the acute increases in cytosolic superoxide induced by contractions are not derived from mitochondria. Data also indicate that, in muscle mitochondria, nitric oxide (NO) reduces the availability of superoxide, but no effect of NO on cytosolic superoxide availability was detected. To determine the relationship of changes in superoxide to hydrogen peroxide, an alternative specific approach was used where fibers were transduced using an adeno-associated viral vector to express the hydrogen peroxide probe, HyPer within the cytoplasmic compartment. HyPer fluorescence was significantly increased in fibers following contractions, but surprisingly followed a relatively slow time course that did not appear directly related to cytosolic superoxide. These data demonstrate for the first time temporal and site specific differences in specific ROS that occur in skeletal muscle fibers during and after contractile activity.	[Pearson, Timothy; Kabayo, Tabitha; McArdle, Anne; Jackson, Malcolm J.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Ng, Rainer; Chamberlain, Jeffrey] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	University of Liverpool; University of Washington; University of Washington Seattle	Jackson, MJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.	m.j.jackson@liverpool.ac.uk		Jackson, Malcolm/0000-0003-3683-8297; Pearson, Tim/0000-0002-3653-4421; Chamberlain, Jeffrey/0000-0001-5299-0059	Medical Research Council [G1002120]; National Institutes of Health (NIA) [AG033610]; National Research Services Award from the National Institutes of Health (NINDS) [1F32AR057651]; MRC [MR/K006312/1, G0700919, G1002120] Funding Source: UKRI; Medical Research Council [G0700919, MR/K006312/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057651, R01AR044533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033610] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Research Services Award from the National Institutes of Health (NINDS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was suuported by the Medical Research Council (grant #G1002120). JSC was supported by grant #AG033610 from the National Institutes of Health (NIA). RN was supported by a National Research Services Award from the National Institutes of Health (NINDS, #1F32AR057651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast S, 2004, AM J PHYSIOL-REG I, V287, pR698, DOI 10.1152/ajpregu.00072.2004; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Close GL, 2005, COMP BIOCHEM PHYS A, V142, P257, DOI 10.1016/j.cbpa.2005.08.005; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Halliwell B, 1989, FREE RADICAL BIOL ME; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; Michaelson LP, 2010, MUSCLE NERVE, V42, P522, DOI 10.1002/mus.21724; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murrant CL, 1999, ACTA PHYSIOL SCAND, V166, P111; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Palomero J, 2008, ANTIOXID REDOX SIGN, V10, P1463, DOI 10.1089/ars.2007.2009; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Pye D, 2007, J PHYSIOL-LONDON, V581, P309, DOI 10.1113/jphysiol.2006.125930; Rabinowitz JE, 1998, CURR OPIN BIOTECH, V9, P470, DOI 10.1016/S0958-1669(98)80031-1; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sakellanou G-K, 2013, PLOS ONE, V8; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Vasilaki A, 2006, MECH AGEING DEV, V127, P830, DOI 10.1016/j.mad.2006.08.004; Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x; Vasilaki A, 2007, PROTEOM CLIN APPL, V1, P362, DOI 10.1002/prca.200600702; Whiteman M, 2009, METHOD MOL BIOL, V476, P28; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	38	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e96378	10.1371/journal.pone.0096378	http://dx.doi.org/10.1371/journal.pone.0096378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875639	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800002
J	Prabhu, V; Rao, SBS; Fernandes, EM; Rao, ACK; Prasad, K; Mahato, KK				Prabhu, Vijendra; Rao, Satish B. S.; Fernandes, Edward Mark; Rao, Anuradha C. K.; Prasad, Keerthana; Mahato, Krishna K.			Objective Assessment of Endogenous Collagen In Vivo during Tissue Repair by Laser Induced Fluorescence	PLOS ONE			English	Article							SKIN; THERAPY; PROTEOGLYCAN; SPECTROSCOPY; MORPHOLOGY	Collagen, a triple helical protein with the primary role of mechanical function, provides tensile strength to the skin, and plays a pivotal task in tissue repair. During tissue regeneration, collagen level increases gradually and therefore, monitoring of such changes in vivo by laser induced fluorescence was the main objective behind the present study. In order to accomplish this, 15 mm diameter excisional wounds were created on six to eight week old Swiss albino mice. The collagen deposition accelerated upon irradiation of single exposure of 2 J/cm(2) He-Ne laser dose immediately after wounding was recorded by laser induced autofluorescence in vivo along with un-illuminated and un-wounded controls. Autofluorescence spectra were recorded for each animal of the experimental groups on 0, 5, 10, 30, 45 and 60 days post-wounding, by exciting the granulation tissue/skin with 325 nm He-Cd laser. The variations in the average collagen intensities from the granulation tissue/skin of mice were inspected as a function of age and gender. Further, the spectral findings of the collagen synthesis in wound granulation tissue/un-wounded skin tissues were validated by Picro-Sirius red-polarized light microscopy in a blinded manner through image analysis of the respective collagen birefringence. The in vivo autofluorescence studies have shown a significant increase in collagen synthesis in laser treated animals as compared to the un-illuminated controls. Image analysis of the collagen birefringence further authenticated the ability of autofluorescence in the objective monitoring of collagen in vivo. Our results clearly demonstrate the potential of laser induced autofluorescence in the monitoring of collegen synthesis during tissue regeneration, which may have clinical implications.	[Prabhu, Vijendra; Fernandes, Edward Mark; Mahato, Krishna K.] Manipal Univ, Sch Life Sci, Biophys Unit, Manipal, India; [Rao, Satish B. S.] Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, India; [Fernandes, Edward Mark] Manipal Univ, Sch Life Sci, Div Biotechnol, Manipal, India; [Rao, Anuradha C. K.] Manipal Univ, Dept Pathol, Kasturba Med Coll, Manipal, India; [Prasad, Keerthana] Manipal Univ, Sch Informat Sci, Manipal, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE)	Mahato, KK (corresponding author), Manipal Univ, Sch Life Sci, Biophys Unit, Manipal, India.	kkmahato@gmail.com	Prabhu, Vijendra/F-7469-2014; Fernandes, Edward/GXW-1837-2022; MAHATO, KRISHNA K./H-8205-2015	Prabhu, Vijendra/0000-0001-5927-2180; MAHATO, KRISHNA K./0000-0001-9873-3445; Prasad, Keerthana/0000-0002-4138-6814; Rao Bola Sadashiva, Satish/0000-0002-9631-9731	patronage of DRDO - GOI [DLS/81/48222/LSRB-164/BDB/2008]	patronage of DRDO - GOI	The patronage of DRDO - GOI (Grant No. DLS/81/48222/LSRB-164/BDB/2008, 2008-2011) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova A, 2009, J PHOTOCH PHOTOBIO B, V96, P178, DOI 10.1016/j.jphotobiol.2009.06.004; American National Standard for Safe Use of Lasers, 1993, Z13611993 ANSI LAS I; Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Cavanagh HD, 2000, CORNEA, V19, P712, DOI 10.1097/00003226-200009000-00016; Curtis A, 2011, MOL IMAGING BIOL, V13, P1114, DOI 10.1007/s11307-010-0440-8; Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x; da Silva Dde F, 2006, J BIOMED OPT, V11; Deka G, 2014, PROC SPIE, V8948, DOI 10.1117/12.2038472; Deka G, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061222; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hegde VN, 2011, PHOTOCHEM PHOTOBIOL, V87, P1433, DOI 10.1111/j.1751-1097.2011.00991.x; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Kamath SD, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437738; Kiernan JA., 2015, HISTOLOGICAL HISTOCH, P184; Kollias N, 1998, J INVEST DERMATOL, V111, P776, DOI 10.1046/j.1523-1747.1998.00377.x; Korol RM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714055; KRIEG T, 1985, ARCH DERMATOL RES, V277, P373, DOI 10.1007/BF00509236; Luo T, 2009, LASER PHYS, V19, P478, DOI 10.1134/S1054660X09030219; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Monstrey S, 2008, BURNS, V34, P761, DOI 10.1016/j.burns.2008.01.009; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Mostaco-Guidolin LB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02190; Nissi MJ, 2004, J ORTHOP RES, V22, P557, DOI 10.1016/j.orthres.2003.09.008; OLERUD JE, 1995, J SURG RES, V59, P349, DOI 10.1006/jsre.1995.1175; Ooi GJ, 2008, MED PHYS, V35, P2151, DOI 10.1118/1.2890391; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; Prabhu V, 2010, PHOTOCHEM PHOTOBIOL, V86, P1364, DOI 10.1111/j.1751-1097.2010.00791.x; Prasad K, 2012, COMPUT METH PROG BIO, V106, P27, DOI 10.1016/j.cmpb.2011.08.004; Razzaque MS, 2003, PATHOL INT, V53, P133, DOI 10.1046/j.1440-1827.2003.01446.x; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; Robles DT, 2007, CLIN DERMATOL, V25, P26, DOI 10.1016/j.clindermatol.2006.09.009; Schaffer CJ, 1996, INT REV CYTOL, V169, P151, DOI 10.1016/S0074-7696(08)61986-5; Schulz R, 2005, BASIC RES CARDIOL, V100, P48, DOI 10.1007/s00395-004-0497-5; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Singer AJ, 2007, ACAD EMERG MED, V14, P387, DOI 10.1197/j.aem.2006.11.022; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; UITTO J, 1980, J AM ACAD DERMATOL, V3, P441, DOI 10.1016/S0190-9622(80)80106-X; van Zuijlen PPM, 2003, BURNS, V29, P423, DOI 10.1016/S0305-4179(03)00052-4; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Walsh AJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116015; Woodruff LD, 2004, PHOTOMED LASER SURG, V22, P241, DOI 10.1089/1549541041438623; Wysocki AB, 1996, INT J DERMATOL, V35, P82, DOI 10.1111/j.1365-4362.1996.tb03266.x	44	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98609	10.1371/journal.pone.0098609	http://dx.doi.org/10.1371/journal.pone.0098609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874229	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800050
J	Schramm, AE; Marinazzo, D; Gener, T; Graham, LJ				Schramm, Adrien E.; Marinazzo, Daniele; Gener, Thomas; Graham, Lyle J.			The Touch and Zap Method for In Vivo Whole-Cell Patch Recording of Intrinsic and Visual Responses of Cortical Neurons and Glial Cells	PLOS ONE			English	Article							AUDITORY-CORTEX; CLAMP RECORDINGS; SYNAPTIC INPUTS; MAMMALIAN BRAIN; DIRECTION SELECTIVITY; INTRACRANIAL-PRESSURE; SPREADING DEPRESSION; INFERIOR COLLICULUS; SLEEP OSCILLATIONS; CEREBRAL-CORTEX	Whole-cell patch recording is an essential tool for quantitatively establishing the biophysics of brain function, particularly in vivo. This method is of particular interest for studying the functional roles of cortical glial cells in the intact brain, which cannot be assessed with extracellular recordings. Nevertheless, a reasonable success rate remains a challenge because of stability, recording duration and electrical quality constraints, particularly for voltage clamp, dynamic clamp or conductance measurements. To address this, we describe "Touch and Zap", an alternative method for whole-cell patch clamp recordings, with the goal of being simpler, quicker and more gentle to brain tissue than previous approaches. Under current clamp mode with a continuous train of hyperpolarizing current pulses, seal formation is initiated immediately upon cell contact, thus the "Touch". By maintaining the current injection, whole-cell access is spontaneously achieved within seconds from the cell-attached configuration by a self-limited membrane electroporation, or "Zap", as seal resistance increases. We present examples of intrinsic and visual responses of neurons and putative glial cells obtained with the revised method from cat and rat cortices in vivo. Recording parameters and biophysical properties obtained with the Touch and Zap method compare favourably with those obtained with the traditional blind patch approach, demonstrating that the revised approach does not compromise the recorded cell. We find that the method is particularly well-suited for whole-cell patch recordings of cortical glial cells in vivo, targeting a wider population of this cell type than the standard method, with better access resistance. Overall, the gentler Touch and Zap method is promising for studying quantitative functional properties in the intact brain with minimal perturbation of the cell's intrinsic properties and local network. Because the Touch and Zap method is performed semi-automatically, this approach is more reproducible and less dependent on experimenter technique.	[Schramm, Adrien E.; Marinazzo, Daniele; Gener, Thomas; Graham, Lyle J.] Univ Paris 05, CNRS UMR 8154, INSERM U603, Neurophysiol & New Microscopies Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Graham, LJ (corresponding author), Univ Paris 05, CNRS UMR 8154, INSERM U603, Neurophysiol & New Microscopies Lab, Paris, France.	lyle@biomedicale.univ-paris5.fr	Marinazzo, Daniele/H-4793-2019	Marinazzo, Daniele/0000-0002-9803-0122; gener, thomas/0000-0001-9209-9228	Agence Nationale de Recherche grant (FUNVISYNIN); HFSP grant [RGP0049/2002]; Marie Curie grant	Agence Nationale de Recherche grant (FUNVISYNIN)(French National Research Agency (ANR)); HFSP grant; Marie Curie grant(European Commission)	This work was supported by an Agence Nationale de Recherche grant (FUNVISYNIN) and an HFSP grant (RGP0049/2002) to LJG. AES was also supported in part by a Marie Curie grant to Sophie Deneve and Boris Gutkin (Ecole Normale Superieure Paris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Amzica F, 1999, J NEUROPHYSIOL, V82, P2731, DOI 10.1152/jn.1999.82.5.2731; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; de Sa VR, 2001, NEUROCOMPUTING, V38, P1651, DOI 10.1016/S0925-2312(01)00525-2; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; DeWeese MR, 2007, CURRENT PROTOCOLS NE; EDWARDS FA, 1992, METHOD ENZYMOL, V207, P208; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FERSTER D, 1992, J NEUROSCI, V12, P1262; Furue Hidemasa, 2007, V38, P229; Graham L. J., 2009, DYNAMIC CLAMP PRINCI; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Helmchen F, 2002, EUR J PHARMACOL, V447, P119, DOI 10.1016/S0014-2999(02)01836-8; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; KARAHASHI Y, 1966, ELECTROEN CLIN NEURO, V20, P600, DOI 10.1016/0013-4694(66)90024-1; KELLY JP, 1974, J PHYSIOL-LONDON, V238, P515, DOI 10.1113/jphysiol.1974.sp010541; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Kramar P, 2007, BIOELECTROCHEMISTRY, V70, P23, DOI 10.1016/j.bioelechem.2006.03.022; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Levy M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00101; MAEDA M, 1988, J AUTONOM NERV SYST, V25, P155, DOI 10.1016/0165-1838(88)90020-3; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mishima T, 2007, J NEUROSCI METH, V166, P32, DOI 10.1016/j.jneumeth.2007.06.021; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Nagtegaal AP, 2010, J NEUROPHYSIOL, V104, P940, DOI 10.1152/jn.00264.2010; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Penner R, 2009, SINGLE CHANNEL RECOR, P3; Rae JL, 2002, PFLUG ARCH EUR J PHY, V443, P664, DOI 10.1007/s00424-001-0753-1; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; REN JQ, 1992, EXP BRAIN RES, V92, P1; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tan ML, 2007, J NEUROPHYSIOL, V98, P443, DOI 10.1152/jn.01273.2006; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Walz W, 2007, PATCH CLAMP ANAL; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; XING P, 1991, NEUROREPORT, V2, P485	62	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97310	10.1371/journal.pone.0097310	http://dx.doi.org/10.1371/journal.pone.0097310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875855	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800005
J	Chen, X; Long, H; Gao, P; Deng, GB; Pan, ZF; Liang, JJ; Tang, YW; Tashi, N; Yu, MQ				Chen, Xin; Long, Hai; Gao, Ping; Deng, Guangbing; Pan, Zhifen; Liang, Junjun; Tang, Yawei; Tashi, Nyima; Yu, Maoqun			Transcriptome Assembly and Analysis of Tibetan Hulless Barley (Hordeum vulgare L. var. nudum) Developing Grains, with Emphasis on Quality Properties	PLOS ONE			English	Article							BOUND STARCH SYNTHASE; FULL-LENGTH CDNAS; GENE-EXPRESSION; CEREAL GENOMICS; BETA-GLUCAN; IN-VITRO; RNA-SEQ; IDENTIFICATION; (1,3/1,4)-BETA-D-GLUCAN; ANNOTATION	Background: Hulless barley is attracting increasing attention due to its unique nutritional value and potential health benefits. However, the molecular biology of the barley grain development and nutrient storage are not well understood. Furthermore, the genetic potential of hulless barley has not been fully tapped for breeding. Methodology/Principal Findings: In the present study, we investigated the transcriptome features during hulless barley grain development. Using Illumina paired-end RNA-Sequencing, we generated two data sets of the developing grain transcriptomes from two hulless barley landraces. A total of 13.1 and 12.9 million paired-end reads with lengths of 90 bp were generated from the two varieties and were assembled to 48,863 and 45,788 unigenes, respectively. A combined dataset of 46,485 All-Unigenes were generated from two transcriptomes with an average length of 542 bp, and 36,278 among were annotated with gene descriptions, conserved protein domains or gene ontology terms. Furthermore, sequences and expression levels of genes related to the biosynthesis of storage reserve compounds (starch, protein, and beta-glucan) were analyzed, and their temporal and spatial patterns were deduced from the transcriptome data of cultivated barley Morex. Conclusions/Significance: We established a sequences and functional annotation integrated database and examined the expression profiles of the developing grains of Tibetan hulless barley. The characterization of genes encoding storage proteins and enzymes of starch synthesis and (1-3; 1-4)-beta-D-glucan synthesis provided an overview of changes in gene expression associated with grain nutrition and health properties. Furthermore, the characterization of these genes provides a gene reservoir, which helps in quality improvement of hulless barley.	[Chen, Xin; Long, Hai; Deng, Guangbing; Pan, Zhifen; Liang, Junjun; Yu, Maoqun] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Chen, Xin; Gao, Ping] Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Chen, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Yawei; Tashi, Nyima] Tibet Acad Agr & Anim Husb Sci, Lhasa, Tibet, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, MQ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	yumaoqun@cib.ac.cn			National Natural Foundation of China [31101150]; West Light Foundation of the Chinese Academy of Sciences; National Science and Technology Supporting Programs [2012BAD03B01]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Supporting Programs	This study is supported by National Natural Foundation of China (31101150), the West Light Foundation of the Chinese Academy of Sciences and the National Science and Technology Supporting Programs (2012BAD03B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Natural Foundation of China: www.nsfc.gov.cn; Chinese Academy of Sciences: english.cas.cn/; Ministry of National Science and Technology of China: www.most.gov.cn/eng/.	Abdel-Aal E. S. M., 2005, SPECIALTY GRAINS FOO; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asare EK, 2011, J AGR FOOD CHEM, V59, P4743, DOI 10.1021/jf200054e; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHATTY RS, 1993, CEREAL CHEM, V70, P397; BUNCE NAC, 1986, SEED SCI TECHNOL, V14, P419; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dickin E, 2012, EUPHYTICA, V184, P85, DOI 10.1007/s10681-011-0567-y; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; EDNEY MJ, 1992, J SCI FOOD AGR, V60, P451, DOI 10.1002/jsfa.2740600408; Eggert K, 2011, PROTEOMICS, V11, P972, DOI 10.1002/pmic.201000322; FINCHER GB, 1976, J I BREWING, V82, P347, DOI 10.1002/j.2050-0416.1975.tb06961.x; FINCHER GB, 1975, J I BREWING, V81, P116, DOI 10.1002/j.2050-0416.1975.tb03672.x; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fulton DC, 2002, J BIOL CHEM, V277, P10834, DOI 10.1074/jbc.M111579200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu YQ, 2003, GENOME, V46, P1084, DOI [10.1139/g03-071, 10.1139/G03-071]; Gutierrez-Gonzalez JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-471; HECK GR, 1993, MOL GEN GENET, V239, P209, DOI 10.1007/BF00281620; Hecker KD, 1998, J SCI FOOD AGR, V77, P179, DOI 10.1002/(SICI)1097-0010(199806)77:2&lt;179::AID-JSFA23&gt;3.0.CO;2-0; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Ibrahim Adel F. M., 2005, Functional & Integrative Genomics, V5, P163, DOI 10.1007/s10142-005-0135-4; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jadhav SJ, 1998, CRIT REV FOOD SCI, V38, P123, DOI 10.1080/10408699891274183; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konzak C F, 1977, Adv Genet, V19, P407, DOI 10.1016/S0065-2660(08)60249-7; Kriz AL, 1999, 7S GLOBULINS CEREALS, P477; Leymarie J, 2007, J EXP BOT, V58, P425, DOI 10.1093/jxb/erl211; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li ZY, 2000, PLANT PHYSIOL, V123, P613, DOI 10.1104/pp.123.2.613; Liu C. T., 1996, HULLESS BARLEY NEW L; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Marshall J, 1996, PLANT CELL, V8, P1121, DOI 10.1105/tpc.8.7.1121; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morell MK, 2003, PLANT J, V34, P172, DOI 10.1046/j.1365-313X.2003.01712.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemeth C, 2010, PLANT PHYSIOL, V152, P1209, DOI 10.1104/pp.109.151712; Newman RK, 2008, BARLEY TAXONOMY MORP, P18; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piston F, 2004, THEOR APPL GENET, V108, P1359, DOI 10.1007/s00122-003-1548-x; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; SAASTAMOINEN M, 1989, J CEREAL SCI, V10, P199, DOI 10.1016/S0733-5210(89)80049-9; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; Sharma P, 2010, J FOOD ENG, V97, P329, DOI 10.1016/j.jfoodeng.2009.10.025; Shewry P, 1983, HEREDITY, V50; SHEWRY PR, 1985, FEBS LETT, V190, P61, DOI 10.1016/0014-5793(85)80427-0; SHEWRY PR, 1985, BIOCHEM GENET, V23, P391, DOI 10.1007/BF00499082; Sreenivasulu N, 2004, PLANT J, V37, P539, DOI 10.1046/j.1365-313X.2003.01981.x; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Sun LJ, 1999, GENET RESOUR CROP EV, V46, P361, DOI 10.1023/A:1008606613602; Taketa S, 2012, J EXP BOT, V63, P381, DOI 10.1093/jxb/err285; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Tomlinson K, 1998, PLANTA, V204, P86, DOI 10.1007/s004250050233; van de Wal M, 1998, J BIOL CHEM, V273, P22232, DOI 10.1074/jbc.273.35.22232; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; Wei KeSu, 2009, Acta Agronomica Sinica, V35, P18, DOI 10.3724/SP.J.1006.2009.00018; White J, 2006, PLANT BIOTECHNOL J, V4, P289, DOI 10.1111/j.1467-7652.2006.00181.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin YQ, 2003, THEOR APPL GENET, V107, P837, DOI 10.1007/s00122-003-1328-7; Zhang XQ, 2008, MOL BREEDING, V22, P227, DOI 10.1007/s11032-008-9169-3; Zhao N-C, 2009, ACTA AGRONOMICA SINI, V34, P1977; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	78	14	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98144	10.1371/journal.pone.0098144	http://dx.doi.org/10.1371/journal.pone.0098144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871534	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300026
J	Keeping, D; Pelletier, R				Keeping, Derek; Pelletier, Rick			Animal Density and Track Counts: Understanding the Nature of Observations Based on Animal Movements	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; PRESENCE-ABSENCE DATA; PHOTOGRAPHIC RATES; POPULATION-DENSITY; MAMMALIAN CARNIVORES; BEHAVIORAL-RESPONSES; RELATIVE ABUNDANCE; TIGER POPULATIONS; INDIVIDUAL TIGERS; CRYPTIC MAMMALS	Counting animals to estimate their population sizes is often essential for their management and conservation. Since practitioners frequently rely on indirect observations of animals, it is important to better understand the relationship between such indirect indices and animal abundance. The Formozov-Malyshev-Pereleshin (FMP) formula provides a theoretical foundation for understanding the relationship between animal track counts and the true density of species. Although this analytical method potentially has universal applicability wherever animals are readily detectable by their tracks, it has long been unique to Russia and remains widely underappreciated. In this paper, we provide a test of the FMP formula by isolating the influence of animal travel path tortuosity (i.e., convolutedness) on track counts. We employed simulations using virtual and empirical data, in addition to a field test comparing FMP estimates with independent estimates from line transect distance sampling. We verify that track counts (total intersections between animals and transects) are determined entirely by density and daily movement distances. Hence, the FMP estimator is theoretically robust against potential biases from specific shapes or patterns of animal movement paths if transects are randomly situated with respect to those movements (i.e., the transects do not influence animals' movements). However, detectability (the detection probability of individual animals) is not determined simply by daily travel distance but also by tortuosity, so ensuring that all intersections with transects are counted regardless of the number of individual animals that made them becomes critical for an accurate density estimate. Additionally, although tortuosity has no bearing on mean track encounter rates, it does affect encounter rate variance and therefore estimate precision. We discuss how these fundamental principles made explicit by the FMP formula have widespread implications for methods of assessing animal abundance that rely on indirect observations.	[Keeping, Derek; Pelletier, Rick] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Keeping, D (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	dkeeping@ualberta.ca		Pelletier, Rick/0000-0002-1900-4963	Comanis Foundation; Kanabo Conservation Link; Natural Sciences and Engineering Research Council of Canada; Safari Club International Foundation and Conservation Force	Comanis Foundation; Kanabo Conservation Link; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Safari Club International Foundation and Conservation Force	This work was supported by Comanis Foundation, Kanabo Conservation Link, Natural Sciences and Engineering Research Council of Canada, Safari Club International Foundation and Conservation Force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Biodiversity Monitoring Institute, 2012, TERR FIELD DAT COLL; Alibhai SK, 1992, SYSTEMATIC GROUND SU; Allen L, 1996, WILDLIFE RES, V23, P197, DOI 10.1071/WR9960197; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Ballard Warren B., 1995, Canadian Circumpolar Institute Occasional Publication, V35, P469; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; BECKER EF, 1991, J WILDLIFE MANAGE, V55, P730, DOI 10.2307/3809525; Beier P, 1996, WILDLIFE SOC B, V24, P540; Blaum N, 2008, WILDLIFE RES, V35, P72, DOI 10.1071/WR07023; Boast LK, 2012, S AFR J WILDL RES, V42, P138, DOI 10.3957/056.042.0202; Buckland S.T., 2001, pi; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Carbone C, 2002, ANIM CONSERV, V5, P121, DOI 10.1017/S1367943002002172; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Carrillo E, 2000, CONSERV BIOL, V14, P1580, DOI 10.1046/j.1523-1739.2000.99103.x; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Chiarello AG, 2000, CONSERV BIOL, V14, P1649, DOI 10.1046/j.1523-1739.2000.99071.x; Clevenger AP, 1996, WILDLIFE BIOL, V2, P275, DOI 10.2981/wlb.1996.031; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Danilov Pjotr, 1996, Finnish Game Research, V49, P18; Duckworth JW, 1998, J ZOOL, V246, P466, DOI 10.1111/j.1469-7998.1998.tb00183.x; DZIECIOLOWSKI R, 1976, Acta Theriologica, V21, P217; Edelmann F, 1999, NORTHWEST SCI, V73, P295; Edwards GP, 2000, WILDLIFE RES, V27, P143, DOI 10.1071/WR98067; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engeman RM, 2007, AFR J ECOL, V45, P184, DOI 10.1111/j.1365-2028.2006.00695.x; Engeman RM, 2002, WILDLIFE RES, V29, P85, DOI 10.1071/WR01046; Engeman RM, 2003, WILDLIFE SOC B, V31, P286; Engeman RM, 2001, ENVIRON CONSERV, V28, P235, DOI 10.1017/S0376892901000248; Evans JW, 2009, J WILDLIFE MANAGE, V73, P426, DOI 10.2193/2007-514; Forsey ES, 2001, FOREST ECOL MANAG, V145, P163, DOI 10.1016/S0378-1127(00)00404-7; Fritz H, 2003, LANDSCAPE ECOL, V18, P293, DOI 10.1023/A:1024411711670; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; FUNSTON PJ, 2001, KALAHARI TRANSFRONTI; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Gurarie E, 2013, THEOR ECOL-NETH, V6, P189, DOI 10.1007/s12080-012-0170-4; Gusset M, 2005, AFR J ECOL, V43, P320, DOI 10.1111/j.1365-2028.2005.00581.x; Halfpenny James C., 1995, U S Forest Service General Technical Report PSW, V157, P91; Hayward GD, 2002, WILDLIFE SOC B, V30, P1150; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Houser AM, 2009, J ZOOL, V278, P108, DOI 10.1111/j.1469-7998.2009.00554.x; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Jachmann H., 1984, Nyala, V10, P77; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Jennelle CS, 2002, ANIM CONSERV, V5, P119, DOI 10.1017/S1367943002002160; Jewell ZC, 2001, J ZOOL, V254, P1, DOI 10.1017/S0952836901000516; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Keeping D, 2014, ANIM CONSERV, V17, P486, DOI 10.1111/acv.12113; KENDALL KC, 1992, ECOL APPL, V2, P422, DOI 10.2307/1941877; Keswick T, 2012, THESIS U W CAPE; Kurki S, 1998, J ANIM ECOL, V67, P874, DOI 10.1046/j.1365-2656.1998.6760874.x; Liebenberg L., 1990, ART TRACKING ORIGIN; Linden Harto, 1996, Finnish Game Research, V49, P4; Linnell JDC, 2007, WILDLIFE BIOL, V13, P456, DOI 10.2981/0909-6396(2007)13[456:AEOSSS]2.0.CO;2; Lizcano DJ, 2000, BIOTROPICA, V32, P165; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI 10.1111/j.1523-1739.2000.98402.x; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; Mills MGL, 1990, KALAHARI HYAENAS COM; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Norbury GL, 1998, J WILDLIFE MANAGE, V62, P45, DOI 10.2307/3802263; Norris D, 2008, MAMMALIA, V72, P15, DOI 10.1515/MAMM.2008.002; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; ODonoghue M, 1997, OIKOS, V80, P150, DOI 10.2307/3546526; RAINE RM, 1983, CAN J ZOOL, V61, P25, DOI 10.1139/z83-002; REID DG, 1987, CAN FIELD NAT, V101, P576; Riordan P, 1998, ANIM CONSERV, V1, P253, DOI 10.1111/j.1469-1795.1998.tb00036.x; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; SARRAZIN JP, 1973, J MAMMAL, V54, P369, DOI 10.2307/1379124; SERVIN JI, 1987, ACTA THERIOL, V32, P489; Sharma S, 2005, J ZOOL, V267, P9, DOI 10.1017/S0952836905007119; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; SKARPE C, 1986, VEGETATIO, V68, P3; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SMALLWOOD KS, 1993, BIOL CONSERV, V65, P51, DOI 10.1016/0006-3207(93)90196-8; SMALLWOOD KS, 1995, BIOL CONSERV, V71, P251, DOI 10.1016/0006-3207(94)00034-N; Southgate R, 2007, J ARID ENVIRON, V68, P438, DOI 10.1016/j.jaridenv.2006.06.006; Southgate R, 2008, TRACK BASED MONITORI; SOUTIERE EC, 1979, J WILDLIFE MANAGE, V43, P850, DOI 10.2307/3808268; Squires JR, 2004, CAN FIELD NAT, V118, P583, DOI 10.22621/cfn.v118i4.60; Stander PE, 1997, J ZOOL, V242, P329; Stander PE, 1998, J APPL ECOL, V35, P378, DOI 10.1046/j.1365-2664.1998.00313.x; Stanley TR, 2005, J WILDLIFE MANAGE, V69, P874, DOI 10.2193/0022-541X(2005)069[0874:ESOAAU]2.0.CO;2; Stephens PA, 2006, ANIM CONSERV, V9, P339, DOI 10.1111/j.1469-1795.2006.00044.x; Stephens P. A., 2006, ANAL LONG TERM DYNAM; Strayer DL, 1999, CONSERV BIOL, V13, P1034, DOI 10.1046/j.1523-1739.1999.98143.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; THOMPSON ID, 1989, CAN J ZOOL, V67, P1816, DOI 10.1139/z89-258; Thorn M, 2011, BIOL CONSERV, V144, P1799, DOI 10.1016/j.biocon.2011.03.009; Vojta CD, 2005, J WILDLIFE MANAGE, V69, P845, DOI 10.2193/0022-541X(2005)069[0845:ODNTIW]2.0.CO;2; WARD RMP, 1985, CAN J ZOOL, V63, P2817, DOI 10.1139/z85-421; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Wharton CA, 2006, THESIS TEXAS A M U; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Wong PBY, 2011, CAN FIELD NAT, V125, P140, DOI 10.22621/cfn.v125i2.1197; WRANGHAM RW, 1993, BEHAV ECOL SOCIOBIOL, V32, P199; Zielinski WJ, 1996, ECOL APPL, V6, P1254, DOI 10.2307/2269605	107	29	30	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e96598	10.1371/journal.pone.0096598	http://dx.doi.org/10.1371/journal.pone.0096598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871490	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300004
J	Li, C; Sun, DX; Zhang, SL; Wang, S; Wu, XP; Zhang, Q; Liu, L; Li, YH; Qiao, L				Li, Cong; Sun, Dongxiao; Zhang, Shengli; Wang, Sheng; Wu, Xiaoping; Zhang, Qin; Liu, Lin; Li, Yanhua; Qiao, Lv			Genome Wide Association Study Identifies 20 Novel Promising Genes Associated with Milk Fatty Acid Traits in Chinese Holstein	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; PPAR-ALPHA; CARBOXYPEPTIDASE-M; SIGNALING PATHWAY; FERTILITY TRAITS; MAMMARY-GLAND; IKK-ALPHA; COA; POLYMORPHISM; LACTATION	Detecting genes associated with milk fat composition could provide valuable insights into the complex genetic networks of genes underling variation in fatty acids synthesis and point towards opportunities for changing milk fat composition via selective breeding. In this study, we conducted a genome-wide association study (GWAS) for 22 milk fatty acids in 784 Chinese Holstein cows with the PLINK software. Genotypes were obtained with the Illumina BovineSNP50 Bead chip and a total of 40,604 informative, high-quality single nucleotide polymorphisms (SNPs) were used. Totally, 83 genome-wide significant SNPs and 314 suggestive significant SNPs associated with 18 milk fatty acid traits were detected. Chromosome regions that affect milk fatty acid traits were mainly observed on BTA1, 2, 5, 6, 7, 9, 13, 14, 18, 19, 20, 21, 23, 26 and 27. Of these, 146 SNPs were associated with more than one milk fatty acid trait; most of studied fatty acid traits were significant associated with multiple SNPs, especially C18:0 (105 SNPs), C18 index (93 SNPs), and C14 index (84 SNPs); Several SNPs are close to or within the DGAT1, SCD1 and FASN genes which are well-known to affect milk composition traits of dairy cattle. Combined with the previously reported QTL regions and the biological functions of the genes, 20 novel promising candidates for C10:0, C12:0, C14:0, C14:1, C14 index, C18:0, C18:1n9c, C18 index, SFA, UFA and SFA/UFA were found, which composed of HTR1B, CPM, PRKG1, MINPP1, LIPJ, LIPK, EHHADH, MOGAT1, ECHS1, STAT1, SORBS1, NFKB2, AGPAT3, CHUK, OSBPL8, PRLR, IGF1R, ACSL3, GHR and OXCT1. Our findings provide a groundwork for unraveling the key genes and causal mutations affecting milk fatty acid traits in dairy cattle.	[Li, Cong; Sun, Dongxiao; Zhang, Shengli; Wang, Sheng; Wu, Xiaoping; Zhang, Qin] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China; [Liu, Lin; Li, Yanhua; Qiao, Lv] Beijing Dairy Cattle Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Sun, DX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Beijing 100094, Peoples R China.	sundx@cau.edu.cn	Wang, Sheng/G-5321-2019; Wang, Sheng/M-2681-2019	Wang, Sheng/0000-0003-2611-3559; Wang, Sheng/0000-0003-2611-3559; Li, Cong/0000-0003-2588-4781	High Technology Research and Development Program of China [2013AA102504]; National Key Technologies R D Program [2011BAD28B02, 2012BAD12B01]; Beijing Dairy Industry Innovation Team; 948 Program [2011-G2A]; Beijing Research and Technology program [D121100003312001]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Technologies R D Program(National Key Technology R&D Program); Beijing Dairy Industry Innovation Team; 948 Program(Ministry of Agriculture & Rural Affairs); Beijing Research and Technology program; Program for Changjiang Scholar and Innovation Research Team in University	This work was supported by the High Technology Research and Development Program of China (2013AA102504), National Key Technologies R & D Program (2011BAD28B02, 2012BAD12B01), Beijing Dairy Industry Innovation Team, 948 Program (2011-G2A), Beijing Research and Technology program (D121100003312001), and Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Blott S, 2003, GENETICS, V163, P253; Bobe G, 2008, J DAIRY SCI, V91, P1209, DOI 10.3168/jds.2007-0252; Bonakdar E, 2010, GENET MOL RES, V9, P1726, DOI 10.4238/vol9-3gmr874; Bouwknecht JA, 2001, BIOL PSYCHIAT, V49, P557, DOI 10.1016/S0006-3223(00)01018-0; Bouwman AC, 2012, BMC GENET, V13, P1, DOI 10.1186/1471-2156-13-93; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Brym Pawel, 2005, Journal of Applied Genetics, V46, P179; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Cobanoglu O, 2006, J DAIRY SCI, V89, P4433, DOI 10.3168/jds.S0022-0302(06)72491-2; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Conte G, 2010, J DAIRY SCI, V93, P753, DOI 10.3168/jds.2009-2581; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Denis CJ, 2013, CLIN CHIM ACTA, V415, P306, DOI 10.1016/j.cca.2012.11.012; Garnsworthy PC, 2006, J DAIRY SCI, V89, P1604, DOI 10.3168/jds.S0022-0302(06)72227-5; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Haas B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000511; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Harvatine KJ, 2006, J NUTR, V136, P2468, DOI 10.1093/jn/136.10.2468; Hayes KC, 2002, ASIA PAC J CLIN NUTR, V11, pS394, DOI 10.1046/j.1440-6047.11.s.7.13.x; Houten SM, 2012, J LIPID RES, V53, P1296, DOI 10.1194/jlr.M024463; Imanishi T, 2002, CIRC J, V66, P1060, DOI 10.1253/circj.66.1060; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Jiang SZ, 2012, BIOTECHNOL LETT, V34, P1991, DOI 10.1007/s10529-012-1009-1; Kay JK, 2005, J DAIRY SCI, V88, P3886, DOI 10.3168/jds.S0022-0302(05)73074-5; Kelsey JA, 2003, J DAIRY SCI, V86, P2588, DOI 10.3168/jds.S0022-0302(03)73854-5; Kirkpatrick BW, 2010, ANIM GENET; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; Mele M, 2007, J DAIRY SCI, V90, P4458, DOI 10.3168/jds.2006-617; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Moioli B, 2007, J DAIRY SCI, V90, P3553, DOI 10.3168/jds.2006-855; Morris CA, 2007, MAMM GENOME, V18, P64, DOI 10.1007/s00335-006-0102-y; Munoz G, 2003, ANIM GENET, V34, P234, DOI 10.1046/j.1365-2052.2003.00987.x; Murdoch BM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-20; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Poppelreuther M, 2012, J LIPID RES, V53, P888, DOI 10.1194/jlr.M024562; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi C, 1999, J BIOL CHEM, V274, P15775, DOI 10.1074/jbc.274.22.15775; Rasmussen BM, 2006, AM J CLIN NUTR, V83, P221; Rincon G, 2012, J DAIRY RES, V79, P66, DOI 10.1017/S002202991100080X; Rodriguez-Cruz M, 2006, J LIPID RES, V47, P553, DOI 10.1194/jlr.M500407-JLR200; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schennink A, 2008, J DAIRY SCI, V91, P2135, DOI 10.3168/jds.2007-0825; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schennink A, 2009, J DAIRY SCI, V92, P4676, DOI 10.3168/jds.2008-1965; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Schulman NF, 2011, ANIM GENET, V42, P263, DOI 10.1111/j.1365-2052.2010.02149.x; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Soyeurt H, 2007, J DAIRY SCI, V90, P4435, DOI 10.3168/jds.2007-0054; Stoop WM, 2008, J DAIRY SCI, V91, P385, DOI 10.3168/jds.2007-0181; Stoop WM, 2009, J DAIRY SCI, V92, P4664, DOI 10.3168/jds.2008-1966; Takahashi M, 2007, ANTIVIR RES, V75, P152, DOI 10.1016/j.antiviral.2007.02.002; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Tsakiris I, 2012, LAB INVEST, V92, P345, DOI 10.1038/labinvest.2011.168; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yang WS, 2003, OBES RES, V11, P586, DOI 10.1038/oby.2003.82; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang CL, 2008, RES VET SCI, V85, P265, DOI 10.1016/j.rvsc.2007.10.014; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078	72	50	55	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96186	10.1371/journal.pone.0096186	http://dx.doi.org/10.1371/journal.pone.0096186			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858810	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400002
J	Miller, KA; Motaleb, MA; Liu, J; Hu, B; Caimano, MJ; Miller, MR; Charon, NW				Miller, Kelly A.; Motaleb, Md. A.; Liu, Jun; Hu, Bo; Caimano, Melissa J.; Miller, Michael R.; Charon, Nyles W.			Initial Characterization of the FlgE Hook High Molecular Weight Complex of Borrelia burgdorferi	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; BASAL BODY COMPLEX; FLAGELLAR-HOOK; SALMONELLA-TYPHIMURIUM; TREPONEMA-PHAGEDENIS; PERIPLASMIC FLAGELLA; O-ACETYLATION; ISOPEPTIDE BONDS; LENGTH CONTROL; MOTILITY	The spirochete periplasmic flagellum has many unique attributes. One unusual characteristic is the flagellar hook. This structure serves as a universal joint coupling rotation of the membrane-bound motor to the flagellar filament. The hook is comprised of about 120 FlgE monomers, and in most bacteria these structures readily dissociate to monomers (similar to 50 kDa) when treated with heat and detergent. However, in spirochetes the FlgE monomers form a large mass of over 250 kDa [referred to as a high molecular weight complex (HMWC)] that is stable to these and other denaturing conditions. In this communication, we examined specific aspects with respect to the formation and structure of this complex. We found that the Lyme disease spirochete Borrelia burgdorferi synthesized the HMWC throughout the in vitro growth cycle, and also in vivo when implanted in dialysis membrane chambers in rats. The HMWC was stable to formic acid, which supports the concept that the stability of the HMWC is dependent on covalent cross-linking of individual FlgE subunits. Mass spectrometry analysis of the HMWC from both wild type periplasmic flagella and polyhooks from a newly constructed Delta fliK mutant indicated that other proteins besides FlgE were not covalently joined to the complex, and that FlgE was the sole component of the complex. In addition, mass spectrometry analysis also indicated that the HMWC was composed of a polymer of the FlgE protein with both the N-and C-terminal regions remaining intact. These initial studies set the stage for a detailed characterization of the HMWC. Covalent cross-linking of FlgE with the accompanying formation of the HMWC we propose strengthens the hook structure for optimal spirochete motility.	[Miller, Kelly A.; Charon, Nyles W.] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA; [Motaleb, Md. A.] E Carolina Univ, Dept Microbiol & Immunol, Greenville, NC USA; [Liu, Jun; Hu, Bo] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Caimano, Melissa J.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; [Miller, Michael R.] W Virginia Univ, Dept Biochem, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA	West Virginia University; University of North Carolina; East Carolina University; University of Texas System; University of Texas Health Science Center Houston; University of Connecticut; West Virginia University	Miller, MR (corresponding author), W Virginia Univ, Dept Biochem, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA.	mmiller@hsc.wvu.edu	Caimano, Melissa J./AAR-6578-2020; Caimano, Melissa J./AAQ-7573-2021	MOTALEB, MD/0000-0003-2761-5104	National Institutes of Health (NIH) [NIAID R21AI093917, NIH R01DE02343]; NIH [RO1AI29735]; NIH NIAMS [R01AR060834]; American Heart Association; WVU Nano graduate fellowships; NIH NIAID [R01AI087946]; Welch Foundation [AU-1714]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087946, R01AI029735, R21AI093917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023431] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association(American Heart Association); WVU Nano graduate fellowships; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding provided by National Institutes of Health (NIH) NIAID R21AI093917 and NIH R01DE02343 to NWC and MRM; NIH RO1AI29735 to MJC; NIH NIAMS R01AR060834 to MAM; and American Heart Association and WVU Nano graduate fellowships to KAM. JJL and BH were supported by NIH NIAID R01AI087946 and Welch Foundation AU-1714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Bakker RG, 2007, APPL ENVIRON MICROB, V73, P1180, DOI 10.1128/AEM.01913-06; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bonifield HR, 2000, J BACTERIOL, V182, P4044, DOI 10.1128/JB.182.14.4044-4050.2000; Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; Caimano Melissa J, 2005, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c03s00; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; CHARON NW, 1991, J BACTERIOL, V173, P4820, DOI 10.1128/jb.173.15.4820-4826.1991; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chi B, 2002, INFECT IMMUN, V70, P2233, DOI 10.1128/IAI.70.4.2233-2237.2002; COCKAYNE A, 1987, J GEN MICROBIOL, V133, P1397; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; DIMMITT K, 1971, J BACTERIOL, V108, P282, DOI 10.1128/JB.108.1.282-286.1971; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Erhardt M, 2010, MOL MICROBIOL, V75, P1272, DOI 10.1111/j.1365-2958.2010.07050.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998; Ge YG, 1997, J BACTERIOL, V179, P2289, DOI 10.1128/jb.179.7.2289-2299.1997; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Harman MW, 2012, P NATL ACAD SCI USA, V109, P3059, DOI 10.1073/pnas.1114362109; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Kamal N, 2007, MICROBIOL-SGM, V153, P3099, DOI 10.1099/mic.0.2007/007401-0; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08; Li CH, 2010, J BACTERIOL, V192, P2596, DOI 10.1128/JB.01502-09; Limberger RJ, 1999, J BACTERIOL, V181, P3743, DOI 10.1128/JB.181.12.3743-3750.1999; LIMBERGER RJ, 1994, J BACTERIOL, V176, P3631, DOI 10.1128/JB.176.12.3631-3637.1994; LIMBERGER RJ, 1986, J BACTERIOL, V166, P105, DOI 10.1128/jb.166.1.105-112.1986; Limberger RJ, 1996, J BACTERIOL, V178, P4628, DOI 10.1128/jb.178.15.4628-4634.1996; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Minamino T, 2009, MOL MICROBIOL, V74, P239, DOI 10.1111/j.1365-2958.2009.06871.x; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Motaleb MA, 2011, J BACTERIOL, V193, P3324, DOI 10.1128/JB.00202-11; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004; Muramoto K, 1998, J MOL BIOL, V277, P871, DOI 10.1006/jmbi.1998.1659; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Paster B.J., 2010, BERGEYS MANUAL OF SY, P471, DOI [10.1007/978-0-387-68572-4_4, DOI 10.1007/978-0-387-68572-4_4]; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Ryan KA, 2005, J BACTERIOL, V187, P5742, DOI 10.1128/JB.187.16.5742-5750.2005; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; SWIM SC, 1983, INFECT IMMUN, V42, P446, DOI 10.1128/IAI.42.2.446-452.1983; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vig DK, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.218104; West MA, 1997, BIOCHEM BIOPH RES CO, V238, P733, DOI 10.1006/bbrc.1997.7359; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Yang J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.268101; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x	67	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98338	10.1371/journal.pone.0098338	http://dx.doi.org/10.1371/journal.pone.0098338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859001	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400067
J	Chen, YQ; Lu, ZX; Li, Q; Hoffmann, BD; Zhang, W				Chen, Youqing; Lu, Zhixing; Li, Qiao; Hoffmann, Benjamin D.; Zhang, Wei			Multiple Ant Species Tending Lac Insect Kerria yunnanensis (Hemiptera: Kerriidae) Provide Asymmetric Protection against Parasitoids	PLOS ONE			English	Article							COMPETITION; FORMICIDAE; MUTUALISM; ASSOCIATION; HYMENOPTERA; ATTENDANCE; HOMOPTERA; OUTCOMES; DEFENSE	This study investigated the effects of ant attendance on the parasitoid community and parasitism of lac insect Kerria yunnanensis aggregations in Yunnan province, China. We manipulated ant attendance to establish three treatments: (1) ant exclusion; (2) low ant attendance by several ant species; and (3) high ant attendance by Crematogaster macaoensis. Five parasitoid species were collected, with two species contributing 82.7 and 13.2% of total abundance respectively. Total parasitoid abundance was lowest in the February sample when K. yunnanensis was in its younger life stage, being significantly lower in the ant exclusion treatment. In April, all three treatments had significantly different parasitoid abundances, being highest in the ant exclusion treatment and the lowest in the high ant attendance treatment. When ants were present, there were strong negative relationships between total parasitoid abundance and ant abundance, with the relationships being dependent upon the ant species composition and abundance. The patterns of total parasitoid abundance were driven by the two most abundant parasitoid species. Parasitoid species richness did not differ among treatments or between sample times, however, multivariate analysis confirmed that overall parasitoid community structure differed significantly among treatments and between sample times, with the high ant attendance treatment differing most from the other two treatments. Interestingly the absence of ants did not result in increased parasitism from four of the five parasitoids. Ants in lac insect farming systems have a clear role for agricultural pest management. A full understanding of the asymmetric abilities of ants to influence parasitoid communities, and affect parasitism of hosts will require further experimental manipulation to assess the relative roles of 1) the abundance of each individual ant species on parasitoid access to hosts, 2) competition among parasitoids, and 3) the interaction between the first two factors.	[Chen, Youqing; Lu, Zhixing] Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China; [Li, Qiao; Zhang, Wei] Southwest Forestry Univ, Sch Forestry, Kunming, Yunnan, Peoples R China; [Hoffmann, Benjamin D.] CSIRO Ecosyst Sci, Trop Ecosyst Res Ctr, Darwin, NT, Australia	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Southwest Forestry University - China; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Chen, YQ (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China.	cyqcaf@126.com	Hoffmann, Ben D/A-2746-2011; LU, ZHIXING/AAL-7700-2021	Hoffmann, Ben D/0000-0002-4010-4723; LU, ZHIXING/0000-0002-1329-7929	Special Fund for Forestry Research in the Public Interest [201204602]; National Natural Science Foundation (NSF) [31270561]	Special Fund for Forestry Research in the Public Interest; National Natural Science Foundation (NSF)(National Natural Science Foundation of China (NSFC))	This research was partly supported from grant 201204602 provided by Special Fund for Forestry Research in the Public Interest and National Natural Science Foundation (NSF) grant 31270561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1978, CAN J ZOOL, V56, P2093, DOI 10.1139/z78-283; ADDICOTT JF, 1979, CAN J ZOOL, V57, P558, DOI 10.1139/z79-066; Agarwal V. M., 2005, Entomon, V30, P263; Bannerman JA, 2014, OIKOS, V123, P89, DOI 10.1111/j.1600-0706.2013.00686.x; BHAGAT M L, 1985, Journal of Entomological Research (New Delhi), V9, P240; BRETON LM, 1992, ECOLOGY, V73, P2175, DOI 10.2307/1941465; BRISTOW CM, 1984, J ANIM ECOL, V53, P715, DOI 10.2307/4654; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; BUCKLEY R, 1991, BIOTROPICA, V23, P282, DOI 10.2307/2388205; Cerda X, 1998, OECOLOGIA, V117, P404, DOI 10.1007/s004420050674; Chen XM, 2008, LAC INSECT CULTIVATI; Chen YQ, 2013, TROP ECOL, V54, P301; Chen YouQing, 2007, World Forestry Research, V20, P61; CUSHMAN JH, 1991, OIKOS, V61, P138, DOI 10.2307/3545416; CUSHMAN JH, 1991, ANT - PLANT INTERACTIONS, P92; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; Del-Claro K, 2000, OECOLOGIA, V124, P156, DOI 10.1007/s004420050002; Eastwood R, 2004, AUST J ENTOMOL, V43, P1, DOI 10.1111/j.1440-6055.2003.00371.x; Gibernau M, 2001, OECOLOGIA, V126, P53, DOI 10.1007/s004420000479; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Inouye BD, 2004, ECOL ENTOMOL, V29, P692, DOI 10.1111/j.0307-6946.2004.00652.x; Itioka T, 1996, OECOLOGIA, V106, P448, DOI 10.1007/BF00329700; Jaiswal A. K., 1995, Journal of Entomological Research (New Delhi), V19, P27; Janzen D.H., 1985, P40; Liao DX, 1987, EC INSECT FAUNA CHIN, V34, P1; MAHDIHASSAN S, 1981, Pakistan Journal of Scientific and Industrial Research, V24, P148; MESSINA FJ, 1981, ECOLOGY, V62, P1433, DOI 10.2307/1941499; MILLER DR, 1979, ANNU REV ENTOMOL, V24, P1, DOI 10.1146/annurev.en.24.010179.000245; Morales MA, 2000, OIKOS, V90, P469, DOI 10.1034/j.1600-0706.2000.900305.x; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Peng R, 2013, J APPL ENTOMOL, V137, P711, DOI 10.1111/jen.12058; Peng RK, 2004, INT J PEST MANAGE, V50, P107, DOI 10.1080/09670870410001658125; Santini G, 2007, ECOL ENTOMOL, V32, P319, DOI 10.1111/j.1365-2311.2007.00882.x; Sharma K. K., 2001, Indian Journal of Entomology, V63, P456; Sharma KK, 1999, BEE WORLD, V80, P115, DOI 10.1080/0005772X.1999.11099439; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SRIVASTAVA D C, 1984, Indian Journal of Ecology, V11, P37; Srivastava DC, 1984, INDIAN J ECOL, V11, P96; Srivastava DC, 1984, INDIAN SHELLAC, P24; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Wang Si-ming, 2011, Yingyong Shengtai Xuebao, V22, P229; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515	44	1	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98975	10.1371/journal.pone.0098975	http://dx.doi.org/10.1371/journal.pone.0098975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887398	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300122
J	Lim, SI; Mizuta, Y; Takasu, A; Kim, YH; Kwon, I				Lim, Sung In; Mizuta, Yukina; Takasu, Akinori; Kim, Yong Hwan; Kwon, Inchan			Site-Specific Bioconjugation of a Murine Dihydrofolate Reductase Enzyme by Copper(I)-Catalyzed Azide-Alkyne Cycloaddition with Retained Activity	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; DIMETHYL-SULFOXIDE; GENETIC-CODE; PROTEIN; ACID; IMMOBILIZATION; CONJUGATION; MUTAGENESIS; TRAFFICKING; EFFICACY	Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) is an efficient reaction linking an azido and an alkynyl group in the presence of copper catalyst. Incorporation of a non-natural amino acid (NAA) containing either an azido or an alkynyl group into a protein allows site-specific bioconjugation in mild conditions via CuAAC. Despite its great potential, bioconjugation of an enzyme has been hampered by several issues including low yield, poor solubility of a ligand, and protein structural/functional perturbation by CuAAC components. In the present study, we incorporated an alkyne-bearing NAA into an enzyme, murine dihydrofolate reductase (mDHFR), in high cell density cultivation of Escherichia coli, and performed CuAAC conjugation with fluorescent azide dyes to evaluate enzyme compatibility of various CuAAC conditions comprising combination of commercially available Cu(I)-chelating ligands and reductants. The condensed culture improves the protein yield 19-fold based on the same amount of non-natural amino acid, and the enzyme incubation under the optimized reaction condition did not lead to any activity loss but allowed a fast and high-yield bioconjugation. Using the established conditions, a biotin-azide spacer was efficiently conjugated to mDHFR with retained activity leading to the site-specific immobilization of the biotin-conjugated mDHFR on a streptavidin-coated plate. These results demonstrate that the combination of reactive non-natural amino acid incorporation and the optimized CuAAC can be used to bioconjugate enzymes with retained enzymatic activity.	[Lim, Sung In; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA; [Mizuta, Yukina; Takasu, Akinori] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi, Japan; [Kim, Yong Hwan] Kwangwoon Univ, Dept Chem Engn, Seoul, South Korea; [Kwon, Inchan] GIST, Sch Mat Sci & Engn, Kwangju, South Korea	University of Virginia; Nagoya Institute of Technology; Kwangwoon University; Gwangju Institute of Science & Technology (GIST)	Kwon, I (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA.	ik4t@virginia.edu		Kwon, Inchan/0000-0003-0806-4116	Korea CCS RD Center (KCRC) [2013M1A8A1038187]; University of Virginia	Korea CCS RD Center (KCRC); University of Virginia	This work was supported by the Korea CCS R&D Center (KCRC) grant (2013M1A8A1038187). This article was published in part thanks to funds provided by the University of Virginia Library Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Aissaoui N, 2013, ENZYME MICROB TECH, V52, P336, DOI 10.1016/j.enzmictec.2013.02.018; Albayrak C, 2013, NUCLEIC ACIDS RES, V41, P5949, DOI 10.1093/nar/gkt226; Anderson JC, 2003, BIOCHEMISTRY-US, V42, P9598, DOI 10.1021/bi034550w; Averick SE, 2012, LANGMUIR, V28, P1954, DOI 10.1021/la204077v; Banerjee D, 2010, CHEMBIOCHEM, V11, P1273, DOI 10.1002/cbic.201000125; Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008; Beatty KE, 2005, J AM CHEM SOC, V127, P14150, DOI 10.1021/ja054643W; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Brennan JL, 2006, BIOCONJUGATE CHEM, V17, P1373, DOI 10.1021/bc0601018; Budisa N, 2013, CURR OPIN BIOTECH, V24, P591, DOI 10.1016/j.copbio.2013.02.026; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Busby WF, 1999, DRUG METAB DISPOS, V27, P246; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Christen EH, 2012, ORG BIOMOL CHEM, V10, P6629, DOI 10.1039/c2ob25556a; Cody V, 2008, ACTA CRYSTALLOGR D, V64, P977, DOI 10.1107/S0907444908022348; Cody V, 2006, PROTEINS, V65, P959, DOI 10.1002/prot.21131; Easterbrook J, 2001, DRUG METAB DISPOS, V29, P141; Gillmeister MP, 2011, BIOCONJUGATE CHEM, V22, P556, DOI 10.1021/bc900445g; Goerke AR, 2009, BIOTECHNOL BIOENG, V102, P400, DOI 10.1002/bit.22070; Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Kislukhin AA, 2013, BIOCONJUGATE CHEM, V24, P684, DOI 10.1021/bc300672b; Kwon I, 2003, J AM CHEM SOC, V125, P7512, DOI 10.1021/ja0350076; Kwon I, 2006, J AM CHEM SOC, V128, P11778, DOI 10.1021/ja0626281; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Levengood MR, 2009, CHEMBIOCHEM, V10, P911, DOI 10.1002/cbic.200800752; Lim SI, 2013, J CONTROL RELEASE, V170, P219, DOI 10.1016/j.jconrel.2013.05.023; Liu J, 2010, BIOORG MED CHEM LETT, V20, P5613, DOI 10.1016/j.bmcl.2010.08.049; McLoughlin SY, 2013, P NATL ACAD SCI USA, V110, P19396, DOI 10.1073/pnas.1311761110; Nairn NW, 2012, BIOCONJUGATE CHEM, V23, P2087, DOI 10.1021/bc300295x; Patel KG, 2011, BIOCONJUGATE CHEM, V22, P376, DOI 10.1021/bc100367u; Presolski Stanislav I, 2011, Curr Protoc Chem Biol, V3, P153; Redeker ES, 2013, BIOCONJUGATE CHEM, V24, P1761, DOI 10.1021/bc4002823; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Santoro SW, 2003, NUCLEIC ACIDS RES, V31, P6700, DOI 10.1093/nar/gkg903; Schneider D, 2013, BIOORGAN MED CHEM, V21, P3430, DOI 10.1016/j.bmc.2013.03.063; Schoffelen S, 2008, BIOCONJUGATE CHEM, V19, P1127, DOI 10.1021/bc800019v; Schoffelen S, 2013, BIOCONJUGATE CHEM, V24, P987, DOI 10.1021/bc400021j; Seo MH, 2011, ANAL CHEM, V83, P2841, DOI 10.1021/ac103334b; Shah V, 2006, BIOTECHNOL LETT, V28, P651, DOI 10.1007/s10529-006-0031-6; Sisido M, 2005, METHODS, V36, P270, DOI 10.1016/j.ymeth.2005.04.009; Sivakumar K, 2004, ORG LETT, V6, P4603, DOI 10.1021/ol047955x; Soundrarajan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046741; Steinmetz NF, 2009, J AM CHEM SOC, V131, P17093, DOI 10.1021/ja902293w; Takasu A, 2011, BIOMACROMOLECULES, V12, P3444, DOI 10.1021/bm200522d; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Zheng S, 2012, BIOTECHNOL J, V7, P47, DOI 10.1002/biot.201100267; Zheng XT, 2013, ACS NANO, V7, P6278, DOI 10.1021/nn4023137	59	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98403	10.1371/journal.pone.0098403	http://dx.doi.org/10.1371/journal.pone.0098403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887377	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300062
J	Prompetchara, E; Ketloy, C; Keelapang, P; Sittisombut, N; Ruxrungtham, K				Prompetchara, Eakachai; Ketloy, Chutitorn; Keelapang, Poonsook; Sittisombut, Nopporn; Ruxrungtham, Kiat			Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines	PLOS ONE			English	Article							IMMUNE-RESPONSES; PROTECTIVE EFFICACY; IMMUNOGENICITY; SEROTYPES; SAFETY; FORMULATIONS; INTERFERENCE; MUCOSAL; TRIAL; PRNT	DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluated neutralizing antibody (NAb) induction of a dengue tetravalent DNA (TDNA) vaccine candidate administered by intramuscular-electroporation (IM-EP) and the benefit of homologous TDNA boosting in mice. Consensus humanized pre-membrane (prM) and envelope (E) of each serotypes, based on isolates from year 1962-2003, were separately cloned into a pCMVkan expression vector. ICR mice, five-six per group were immunized for three times (2-week interval) with TDNA at 100 mu g (group I; 25 mu g/monovalent) or 10 mu g (group II; 2.5 mu g/monovalent). In group I, mice received an addtional TDNA boosting 13 weeks later. Plaque reduction neutralization tests (PRNT) were performed at 4 weeks post-last immunization. Both 100 mu g and 10 mu g doses of TDNA induced high NAb levels against all DENV serotypes. The median PRNT50 titers were comparable among four serotypes of DENV after TDNA immunization. Median PRNT50 titers ranged 240-320 in 100 mu g and 160-240 in 10 mu g groups (p = ns). A time course study of the 100 mu g dose of TDNA showed detectable NAb at 2 weeks after the second injection. The NAb peaked at 4 weeks after the third injection then declined over time but remained detectable up to 13 weeks. An additional homologous TDNA boosting significantly enhanced the level of NAb from the nadir for at least ten-fold (p < 0.05). Of interest, we have found that the use of more recent dengue viral strain for both vaccine immunogen design and neutralization assays is critical to avoid a mismatching outcome. In summary, this TDNA vaccine candidate induced good neutralizing antibody responses in mice; and the DNA/DNA prime/boost strategy is promising and warranted further evaluation in non-human primates.	[Prompetchara, Eakachai; Ketloy, Chutitorn; Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Chula Vaccine Res Ctr ChulaVRC, Dengue Vaccine Res Unit, Bangkok 10330, Thailand; [Ketloy, Chutitorn] Chulalongkorn Univ, Fac Med, Dept Lab Med, Bangkok 10330, Thailand; [Keelapang, Poonsook; Sittisombut, Nopporn] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Sittisombut, Nopporn] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Med Biotechnol Unit, Bangkok, Thailand; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Vaccine & Cellular Immunol Lab, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Sittisombut, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	nsittiso@mail.med.cmu.ac.th; rkiatchula@gmail.com	Ketloy, Chutitorn/ACW-3484-2022	Keelapang, Poonsook/0000-0003-2036-4437; Ruxrungtham, Kiat/0000-0001-7348-2352	National Science and Technology Development Agency (NSTDA), Thailand [P-00-10146]; Senior Researcher Scholar, Thailand Research Fund (TRF); Royal Golden Jubilee Ph.D. Program [Ph.D. 0035/2551]; Thailand Research Fund MRG [5480150]	National Science and Technology Development Agency (NSTDA), Thailand; Senior Researcher Scholar, Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Thailand Research Fund MRG	This research project was fully sponsored by National Science and Technology Development Agency (NSTDA), Thailand (P-00-10146); and KR was partially supported by the Senior Researcher Scholar, Thailand Research Fund (TRF); EP and KR were also supported by The Royal Golden Jubilee Ph.D. Program (Ph.D. 0035/2551). CK was supported by Thailand Research Fund MRG (5480150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KB, 2011, J INFECT DIS, V204, P442, DOI 10.1093/infdis/jir279; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050; Brave A, 2009, VACCINE, V27, P3692, DOI 10.1016/j.vaccine.2009.04.013; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936; Eick-Cost AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041435; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302; Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Holman DH, 2007, CLIN VACCINE IMMUNOL, V14, P182, DOI 10.1128/CVI.00330-06; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kitchener S, 2006, VACCINE, V24, P1238, DOI 10.1016/j.vaccine.2005.09.029; Konishi E, 2006, VACCINE, V24, P2200, DOI 10.1016/j.vaccine.2005.11.002; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Lima DM, 2011, VACCINE, V29, P831, DOI 10.1016/j.vaccine.2010.10.078; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916; Pasetti MF, 2009, J VIROL, V83, P2789, DOI 10.1128/JVI.02191-08; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085; Pulsawat P, 2013, IMMUNOL LETT, V151, P23, DOI 10.1016/j.imlet.2013.01.013; Ramanathan MP, 2009, VACCINE, V27, P6444, DOI 10.1016/j.vaccine.2009.06.061; Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Sun W, 2009, HUM VACCINES, V5, P33, DOI 10.4161/hv.5.1.6348; Swaminathan S, 2013, LANCET INFECT DIS, V13, P191, DOI 10.1016/S1473-3099(13)70028-8; Thaisomboonsuk B, 2012, INT J INFECT DIS, V16, pE113, DOI 10.1016/j.ijid.2012.05.261; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; World Health Organization, 2009, DENGUE GUIDELINES DI	36	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e92643	10.1371/journal.pone.0092643	http://dx.doi.org/10.1371/journal.pone.0092643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887426	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300003
J	Tytgat, B; Verleyen, E; Obbels, D; Peeters, K; De Wever, A; D'hondt, S; De Meyer, T; Van Criekinge, W; Vyverman, W; Willems, A				Tytgat, Bjorn; Verleyen, Elie; Obbels, Dagmar; Peeters, Karolien; De Wever, Aaike; D'hondt, Sofie; De Meyer, Tim; Van Criekinge, Wim; Vyverman, Wim; Willems, Anne			Bacterial Diversity Assessment in Antarctic Terrestrial and Aquatic Microbial Mats: A Comparison between Bidirectional Pyrosequencing and Cultivation	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SP-NOV.; LOW-TEMPERATURE; SOIL; GENE; COMMUNITY; SEQUENCES; IMPACT; GROWTH; BIAS	The application of high-throughput sequencing of the 16S rRNA gene has increased the size of microbial diversity datasets by several orders of magnitude, providing improved access to the rare biosphere compared with cultivation-based approaches and more established cultivation-independent techniques. By contrast, cultivation-based approaches allow the retrieval of both common and uncommon bacteria that can grow in the conditions used and provide access to strains for biotechnological applications. We performed bidirectional pyrosequencing of the bacterial 16S rRNA gene diversity in two terrestrial and seven aquatic Antarctic microbial mat samples previously studied by heterotrophic cultivation. While, not unexpectedly, 77.5% of genera recovered by pyrosequencing were not among the isolates, 25.6% of the genera picked up by cultivation were not detected by pyrosequencing. To allow comparison between both techniques, we focused on the five phyla (Proteobacteria, Actinobacteria, Bacteroidetes, Firmicutes and Deinococcus-Thermus) recovered by heterotrophic cultivation. Four of these phyla were among the most abundantly recovered by pyrosequencing. Strikingly, there was relatively little overlap between cultivation and the forward and reverse pyrosequencing-based datasets at the genus (17.1-22.2%) and OTU (3.5-3.6%) level (defined on a 97% similarity cut-off level). Comparison of the V1-V2 and V3-V2 datasets of the 16S rRNA gene revealed remarkable differences in number of OTUs and genera recovered. The forward dataset missed 33% of the genera from the reverse dataset despite comprising 50% more OTUs, while the reverse dataset did not contain 40% of the genera of the forward dataset. Similar observations were evident when comparing the forward and reverse cultivation datasets. Our results indicate that the region under consideration can have a large impact on perceived diversity, and should be considered when comparing different datasets. Finally, a high number of OTUs could not be classified using the RDP reference database, suggesting the presence of a large amount of novel diversity.	[Tytgat, Bjorn; Peeters, Karolien; Willems, Anne] Univ Ghent, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium; [Verleyen, Elie; Obbels, Dagmar; De Wever, Aaike; D'hondt, Sofie; Vyverman, Wim] Univ Ghent, Dept Biol, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [De Meyer, Tim; Van Criekinge, Wim] Univ Ghent, Lab Bioinformat & Computat Genom, Dept Math Modelling Stat & Bioinformat, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Tytgat, B (corresponding author), Univ Ghent, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium.	bjorn.tytgat@ugent.be	Willems, Anne/B-2872-2010; De Wever, Aaike/A-4691-2009; De Meyer, Tim/D-3892-2011	Willems, Anne/0000-0002-8421-2881; De Meyer, Tim/0000-0003-2994-9693; De Wever, Aaike/0000-0001-8804-8321	Special Research Fund BOF-UGent [0J28410]; Belgian Science Policy Office (BelSPO) project AMBIO; Belgian Science Policy Office (BelSPO) project BELDIVA; Belgian Science Policy Office (BelSPO) project CCAMBIO	Special Research Fund BOF-UGent; Belgian Science Policy Office (BelSPO) project AMBIO; Belgian Science Policy Office (BelSPO) project BELDIVA; Belgian Science Policy Office (BelSPO) project CCAMBIO	This work was funded by the Special Research Fund BOF-UGent (grant 0J28410) and by the Belgian Science Policy Office (BelSPO) projects AMBIO, BELDIVA and CCAMBIO. http://www.belspo.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Aislabie JM, 2006, SOIL BIOL BIOCHEM, V38, P3041, DOI 10.1016/j.soilbio.2006.02.018; [Anonymous], 2013, NAT REV MICROBIOL, V11, P1, DOI 10.1038/nrmicro2948; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; Brambilla E, 2001, EXTREMOPHILES, V5, P23, DOI 10.1007/s007920000169; Cavicchioli R, 2002, CURR OPIN BIOTECH, V13, P253, DOI 10.1016/S0958-1669(02)00317-8; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Corinaldesi C, 2005, APPL ENV MICROBIOLOG, V71; Cowan DA, 2004, ANNU REV MICROBIOL, V58, P649, DOI 10.1146/annurev.micro.57.030502.090811; Datta Susmita, 2010, J Proteomics Bioinform, V3, P183; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Delavat F, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-28; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Devos DP, 2013, CURR BIOL, V23, pR705, DOI 10.1016/j.cub.2013.07.013; Donachie SP, 2007, ISME J, V1, P97, DOI 10.1038/ismej.2007.22; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Ghiglione JF, 2012, ENV MICROBIOLOGY, V14; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gregoire P, 2011, INT J SYST EVOL MICR, V61, P1436, DOI 10.1099/ijs.0.025676-0; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hirsch P, 2004, SYST APPL MICROBIOL, V27, P636, DOI 10.1078/0723202042370008; Hodgson DA, 2011, P NATL ACAD SCI USA, V108, P18859, DOI 10.1073/pnas.1116515108; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lee CK, 2012, ISME J, V6, P1046, DOI 10.1038/ismej.2011.170; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Leff JW, 2012, ECOSYSTEMS, V15, P284, DOI 10.1007/s10021-011-9510-2; Loperena L, 2012, WORLD J MICROBIOLOGY, V28; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Newsham KK, 2010, MICROBIOL RES, V165, P523, DOI 10.1016/j.micres.2009.11.005; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pearce DA, 2012, FRONTIERS MICROBIOLO, V3, P13; Pearce DA, 2010, EXTREMOPHILES, V14, P145, DOI 10.1007/s00792-009-0293-8; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; PedrosAlio C., 2012, ANN REV MARINE SCI, V4; Peeters K, 2011, MICROBIAL ECOLOGY, V62; Peeters K, 2012, POLAR BIOL, V35, P543, DOI 10.1007/s00300-011-1100-4; Peeters K, 2011, FEMS MICROBIOL LETT, V321, P130, DOI 10.1111/j.1574-6968.2011.02326.x; Peeters K, 2011, SYST APPL MICROBIOL, V34, P360, DOI 10.1016/j.syapm.2011.02.002; Pointing SB, 2009, P NATL ACAD SCI USA, V106, P19964, DOI 10.1073/pnas.0908274106; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NATURE METHODS, V6; Schloss Patrick D, 2011, Appl Environ Microbiol, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Shade A, 2012, ENV MICROBIOLOGY, V14; Shivaji S, 2011, RES MICROBIOL, V162, P191, DOI 10.1016/j.resmic.2010.09.020; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sogin ML, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-I19; Soo RM, 2009, ENVIRON MICROBIOL, V11, P715, DOI 10.1111/j.1462-2920.2009.01859.x; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; Van Trappen S, 2002, SYST APPL MICROBIOL, V25, P603, DOI 10.1078/07232020260517742; Varin T, 2012, APPL ENV MICROBIOLOG, V78; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Youssef N, 2009, APPL ENV MICROBIOLOG, V75; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2	83	46	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97564	10.1371/journal.pone.0097564	http://dx.doi.org/10.1371/journal.pone.0097564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887330	Green Published, gold			2022-12-27	WOS:000336956300021
J	van der Zwan, YG; Rijlaarsdam, MA; Rossello, FJ; Notini, AJ; de Boer, S; Watkins, DN; Gillis, AJM; Dorssers, LCJ; White, SJ; Looijenga, LHJ				van der Zwan, Yvonne G.; Rijlaarsdam, Martin A.; Rossello, Fernando J.; Notini, Amanda J.; de Boer, Suzan; Watkins, D. Neil; Gillis, Ad J. M.; Dorssers, Lambert C. J.; White, Stefan J.; Looijenga, Leendert H. J.			Seminoma and Embryonal Carcinoma Footprints Identified by Analysis of Integrated Genome-Wide Epigenetic and Expression Profiles of Germ Cell Cancer Cell Lines	PLOS ONE			English	Article							DNA METHYLATION; STEM-CELLS; MICRORNAS MIR-371-3; ESTROGEN-RECEPTOR; SERUM BIOMARKERS; IN-SITU; TUMORS; DMRT1; INITIATION; BINDING	Background: Originating from Primordial Germ Cells/gonocytes and developing via a precursor lesion called Carcinoma In Situ (CIS), Germ Cell Cancers (GCC) are the most common cancer in young men, subdivided in seminoma (SE) and non-seminoma (NS). During physiological germ cell formation/maturation, epigenetic processes guard homeostasis by regulating the accessibility of the DNA to facilitate transcription. Epigenetic deregulation through genetic and environmental parameters (i.e. genvironment) could disrupt embryonic germ cell development, resulting in delayed or blocked maturation. This potentially facilitates the formation of CIS and progression to invasive GCC. Therefore, determining the epigenetic and functional genomic landscape in GCC cell lines could provide insight into the pathophysiology and etiology of GCC and provide guidance for targeted functional experiments. Results: This study aims at identifying epigenetic footprints in SE and EC cell lines in genome-wide profiles by studying the interaction between gene expression, DNA CpG methylation and histone modifications, and their function in the pathophysiology and etiology of GCC. Two well characterized GCC-derived cell lines were compared, one representative for SE (TCam-2) and the other for EC (NCCIT). Data were acquired using the Illumina HumanHT-12-v4 (gene expression) and HumanMethylation450 BeadChip (methylation) microarrays as well as ChIP-sequencing (activating histone modifications (H3K4me3, H3K27ac)). Results indicate known germ cell markers not only to be differentiating between SE and NS at the expression level, but also in the epigenetic landscape. Conclusion: The overall similarity between TCam-2/NCCIT support an erased embryonic germ cell arrested in early gonadal development as common cell of origin although the exact developmental stage from which the tumor cells are derived might differ. Indeed, subtle difference in the (integrated) epigenetic and expression profiles indicate TCam-2 to exhibit a more germ cell-like profile, whereas NCCIT shows a more pluripotent phenotype. The results provide insight into the functional genome in GCC cell lines.	[van der Zwan, Yvonne G.; Rijlaarsdam, Martin A.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands; [Rossello, Fernando J.; Watkins, D. Neil] Monash Univ, MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Notini, Amanda J.; de Boer, Suzan; White, Stefan J.] Monash Univ, MIMR PHI Inst Med Res, Ctr Genet Dis, Clayton, Vic, Australia	Erasmus University Rotterdam; Erasmus MC; Monash University; Prince Henry's Institute of Medical Research; Monash University; Prince Henry's Institute of Medical Research	Looijenga, LHJ (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Rossello, Fernando/B-1208-2015; Looijenga, Leendert/B-8145-2019	Rossello, Fernando/0000-0003-3885-8777; Looijenga, Leendert/0000-0002-8146-1911; Rijlaarsdam, Martin/0000-0002-2528-8077	European Society for Pediatric Endocrinology Research Fellowship; Translational Grant, Erasmus MC; Monash University; Victorian Government's Operational Infrastructure Support Program	European Society for Pediatric Endocrinology Research Fellowship; Translational Grant, Erasmus MC; Monash University(Monash University); Victorian Government's Operational Infrastructure Support Program	This work is supported by funding from the European Society for Pediatric Endocrinology Research Fellowship (YZ). MR is supported by a Translational Grant, Erasmus MC. SB is supported by APA and IPRS scholarships from Monash University. This work was supported by funding from Monash University (SW). MIMR receives support from the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-313; Ammerpohl O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073288; Andreassen KE, 2013, HUM REPROD, V28, P1995, DOI 10.1093/humrep/det127; Banks Kimberly, 2012, Front Endocrinol (Lausanne), V3, P182, DOI 10.3389/fendo.2012.00182; Belge G, 2012, EUR UROL, V61, P1068, DOI 10.1016/j.eururo.2012.02.037; Bhat GK, 2006, J ANDROL, V27, P302, DOI 10.2164/jandrol.05133; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Del Mazo J, 2013, INT J DEV BIOL, V57, P225, DOI 10.1387/ijdb.130042jd; Demichelis F, 2013, NAT MED, V19, P966, DOI 10.1038/nm.3285; Dieckmann KP, 2012, BRIT J CANCER, V107, P1754, DOI 10.1038/bjc.2012.469; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Elzinga-Tinke JE, 2010, INT J ANDROL, V33, P597, DOI 10.1111/j.1365-2605.2009.00997.x; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Godmann M, 2009, MICROSC RES TECHNIQ, V72, P603, DOI 10.1002/jemt.20715; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kratz CP, 2010, BEST PRACT RES CL EN, V24, P503, DOI 10.1016/j.beem.2010.01.005; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Looijenga LHJ, 2011, INT J ANDROL, V34, pE234, DOI 10.1111/j.1365-2605.2011.01157.x; Looijenga LHJ, 2013, INT J DEV BIOL, V57, P241, DOI 10.1387/ijdb.130026ll; Looijenga LHJ, 2009, J PATHOL, V218, P146, DOI 10.1002/path.2522; MacDonald WA, 2014, MOL REPROD DEV, V81, P126, DOI 10.1002/mrd.22220; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Mirbahai L, 2014, MUTAT RES-GEN TOX EN, V764, P10, DOI 10.1016/j.mrgentox.2013.10.003; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Murray MJ, 2012, NAT REV UROL, V9, P298, DOI 10.1038/nrurol.2012.86; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Nettersheim D, 2012, GENE CHROMOSOME CANC, V51, P717, DOI 10.1002/gcc.21958; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Ohnesorg T, 2012, METHODS MOL BIOL, V786, P201, DOI 10.1007/978-1-61779-292-2_12; Ohnesorg T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-412; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Orso F, 2004, BIOCHEM J, V377, P429, DOI 10.1042/BJ20031133; Rada-Iglesias A, 2011, GENOME MED, V3, DOI 10.1186/gm252; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Rijlaarsdam MA, 2014, BMC BIOINFO IN PRESS; Schemmer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071113; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Schuur ER, 2001, J BIOL CHEM, V276, P15519, DOI 10.1074/jbc.M009001200; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Shu WJ, 2011, NUCLEIC ACIDS RES, V39, P7428, DOI 10.1093/nar/gkr443; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; TESHIMA S, 1988, LAB INVEST, V59, P328; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Van der Zwan YG, 2013, INT J DEV BIOL, V57, P299, DOI 10.1387/ijdb.130017ll; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; White SJ, 2004, METHOD CELL BIOL, V75, P751; WOODWARD PJ, 2004, WHO CLASSIFICATION T, P217	81	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98330	10.1371/journal.pone.0098330	http://dx.doi.org/10.1371/journal.pone.0098330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887064	gold, Green Published			2022-12-27	WOS:000336956300054
J	Yeh, WL; Lin, HY; Wu, HM; Chen, DR				Yeh, Wei-Lan; Lin, Hui-Yi; Wu, Hung-Ming; Chen, Dar-Ren			Combination Treatment of Tamoxifen with Risperidone in Breast Cancer	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CASPASE-MEDIATED APOPTOSIS; CELL-CYCLE PROGRESSION; QUALITY-OF-LIFE; HOT FLASHES; GLIOMA CANCER; WOMEN; ESTROGEN; THERAPY; METABOLISM	Tamoxifen has long been used and still is the most commonly used endocrine therapy for treatment of both early and advanced estrogen receptor-positive breast cancer in pre- and post-menopause women. Tamoxifen exerts its cytotoxic effect primarily through cytostasis which is associated with the accumulation of cells in the G(0)/G(1) phase of the cell cycle. Apoptotic activity can also be exerted by tamoxifen which involves cleavage of caspase 9, caspase 7, caspase 3, and poly-ADP-ribose polymerase (PARP). Down-regulation of anti-apoptotic proteins Bcl-2 and Bcl-xL and up-regulation of proapoptotic proteins Bax and Bak have also been observed. In addition, stress response protein of GRP 94 and GRP 78 have also been induced by tamoxifen in our study. However, side effects occur during tamoxifen treatment in breast cancer patients. Researching into combination regimen of tamoxifen and drug(s) that relieves tamoxifen-induced hot flushes is important, because drug interactions may decrease tamoxifen efficacy. Risperidone has been shown to be effective in reducing or eliminating hot flushes on women with hormonal variations. In this present study, we demonstrated that combination of tamoxifen with risperidone did not interfered tamoxifen-induced cytotoxic effects in both in vitro and in vivo models, while fluoxetine abrogated the effects of tamoxifen. This is the first paper suggesting the possibility of combination treatment of tamoxifen with risperidone in breast cancer patients, providing a conceivable resolution of tamoxifen-induced side effects without interfering the efficacy of tamoxifen against breast cancer.	[Yeh, Wei-Lan] Changhua Christian Hosp, Dept Cell & Tissue Engn, Changhua, Taiwan; [Lin, Hui-Yi] China Med Univ, Sch Pharm, Taichung, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan	Changhua Christian Hospital; China Medical University Taiwan; Changhua Christian Hospital; Changhua Christian Hospital	Yeh, WL (corresponding author), Changhua Christian Hosp, Dept Cell & Tissue Engn, Changhua, Taiwan.	blue_lan0816@yahoo.com.tw; darren_chen@cch.org.tw			Ministry of Science and Technology [NSC 100-2314-B-371-001-MY3, NSC 102-2320-B-371-002]; Changhua Christian Hospital [101-CCH-PRJ-07, 102-CCH-IRP-096]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Changhua Christian Hospital	This work was supported by grants from the Ministry of Science and Technology (NSC 100-2314-B-371-001-MY3 and NSC 102-2320-B-371-002) and Changhua Christian Hospital (101-CCH-PRJ-07 and 102-CCH-IRP-096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; [Anonymous], 1998, LANCET, V351, P1451; Appiani F, 2011, ANN CLIN PSYCHIATRY, V23, P152; Aubert EJS, 2009, AM SOC CLIN ONC ANN; Avis NE, 2008, J CLIN ONCOL, V26, P5008, DOI 10.1200/JCO.2008.18.2170; Avis NE, 2003, MED CARE, V41, P1262, DOI 10.1097/01.MLR.0000093479.39115.AF; Berecz R, 2004, CURR DRUG TARGETS, V5, P573, DOI 10.2174/1389450043345263; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Carpenter Janet S, 2002, Oncol Nurs Forum, V29, pE16, DOI 10.1188/02.ONF.E16-E25; Carpenter JS, 1998, CANCER-AM CANCER SOC, V82, P1682, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.3.CO;2-8; Charalambous C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-238; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; COUZI RJ, 1995, J CLIN ONCOL, V13, P2737, DOI 10.1200/JCO.1995.13.11.2737; Dekkers OM, 2010, PITUITARY, V13, P195, DOI 10.1007/s11102-009-0214-y; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; GINSBURG J, 1981, BRIT J OBSTET GYNAEC, V88, P925, DOI 10.1111/j.1471-0528.1981.tb02230.x; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Graf Maria C, 2003, Clin J Oncol Nurs, V7, P637, DOI 10.1188/03.CJON.637-640; Haddad PM, 2004, DRUGS, V64, P2291, DOI 10.2165/00003495-200464200-00003; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Henry NL, 2008, AM J PSYCHIAT, V165, P1251, DOI 10.1176/appi.ajp.2008.08040482; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Joffe H, 2007, J CLIN PSYCHIAT, V68, P10; Jordan VC, 2006, EUR J CANCER, V42, P2909, DOI 10.1016/j.ejca.2006.09.012; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; KIANG DT, 1977, ANN INTERN MED, V87, P687, DOI 10.7326/0003-4819-87-6-687; Kim R, 2005, CANCER-AM CANCER SOC, V103, P2199, DOI 10.1002/cncr.21029; Kotoh T, 1999, SURGERY, V125, P536, DOI 10.1016/S0039-6060(99)70206-0; KRONENBERG F, 1994, EXP GERONTOL, V29, P319, DOI 10.1016/0531-5565(94)90012-4; Kumari M, 2005, J CLIN EPIDEMIOL, V58, P719, DOI 10.1016/j.jclinepi.2004.09.016; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li CB, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007474.pub2; Li ZS, 2008, MOL CANCER THER, V7, P3056, DOI 10.1158/1535-7163.MCT-07-2142; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; LOPRINZI CL, 2002, J CLIN ONCOL, V20, P1578; Lu DY, 2013, J CELL PHYSIOL, V228, P563, DOI 10.1002/jcp.24163; Lu DY, 2012, PHYTOMEDICINE, V19, P1093, DOI 10.1016/j.phymed.2012.06.010; MacDowell KS, 2013, INT J NEUROPSYCHOPH, V16, P121, DOI 10.1017/S1461145711001775; Mas S, 2012, PHARMACOGENOMICS J, V12, P255, DOI 10.1038/tpj.2010.91; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mom CH, 2006, CRIT REV ONCOL HEMAT, V57, P63, DOI 10.1016/j.critrevonc.2005.04.009; Mooney LM, 2002, BRIT J CANCER, V87, P909, DOI 10.1038/sj.bjc.6600541; Muly EC, 2012, J PHARMACOL EXP THER, V341, P81, DOI 10.1124/jpet.111.189076; Myong NH, 2009, KOREAN J PATHOL, V43, P56, DOI 10.4132/KoreanJPathol.2009.43.1.56; OSBORNE CK, 1985, CANCER RES, V45, P584; Pritchard KI, 2001, ONCOLOGIST, V6, P353, DOI 10.1634/theoncologist.6-4-353; Ray A, 1996, BRIT MED J, V313, P1484, DOI 10.1136/bmj.313.7070.1484b; Rixe O, 2007, CLIN CANCER RES, V13, P7280, DOI 10.1158/1078-0432.CCR-07-2141; Ruddy Jean Marie B., 2002, Journal of Biomedicine and Biotechnology, V2, P7, DOI 10.1155/S1110724302000359; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Singh MS, 2011, BREAST, V20, P111, DOI 10.1016/j.breast.2010.11.003; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stathopoulos GP, 2013, J BUON, V18, P532; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Stearns V, 2002, J CLIN ONCOL, V20, P1436, DOI 10.1200/JCO.2002.20.6.1436; TAYLOR IW, 1983, CANCER RES, V43, P4007; Travis MJ, 1998, BRIT J PSYCHIAT, V173, P236, DOI 10.1192/bjp.173.3.236; Tsai CF, 2014, INT J MOL SCI, V15, P3889, DOI 10.3390/ijms15033889; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Weston RT, 2010, ADV EXP MED BIOL, V687, P65; Williams C, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.370; Wu H-M, 2010, TREATMENT HOT FLASHE; Wu H-M, 2010, METHOD TREATING SYMP; Yamaguchi I, 2009, J PHARMACOL EXP THER, V328, P256, DOI 10.1124/jpet.108.141895; Yeh WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060889; Yeh WL, 2012, J CELL PHYSIOL, V227, P558, DOI 10.1002/jcp.22746	73	20	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98805	10.1371/journal.pone.0098805	http://dx.doi.org/10.1371/journal.pone.0098805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886861	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300110
J	Lund, AM; Kildegaard, HF; Petersen, MBK; Rank, J; Hansen, BG; Andersen, MR; Mortensen, UH				Lund, Anne Mathilde; Kildegaard, Helene Faustrup; Petersen, Maja Borup Kjaer; Rank, Julie; Hansen, Bjarne Gram; Andersen, Mikael Rordam; Mortensen, Uffe Hasbro			A Versatile System for USER Cloning-Based Assembly of Expression Vectors for Mammalian Cell Engineering	PLOS ONE			English	Article							GENE; TRANSMEMBRANE; SUFFICIENT; SEQUENCES; FUSION; MUSCLE; SIGNAL	A new versatile mammalian vector system for protein production, cell biology analyses, and cell factory engineering was developed. The vector system applies the ligation-free uracil-excision based technique - USER cloning - to rapidly construct mammalian expression vectors of multiple DNA fragments and with maximum flexibility, both for choice of vector backbone and cargo. The vector system includes a set of basic vectors and a toolbox containing a multitude of DNA building blocks including promoters, terminators, selectable marker- and reporter genes, and sequences encoding an internal ribosome entry site, cellular localization signals and epitope-and purification tags. Building blocks in the toolbox can be easily combined as they contain defined and tested Flexible Assembly Sequence Tags, FASTs. USER cloning with FASTs allows rapid swaps of gene, promoter or selection marker in existing plasmids and simple construction of vectors encoding proteins, which are fused to fluorescence-, purification-, localization-, or epitope tags. The mammalian expression vector assembly platform currently allows for the assembly of up to seven fragments in a single cloning step with correct directionality and with a cloning efficiency above 90%. The functionality of basic vectors for FAST assembly was tested and validated by transient expression of fluorescent model proteins in CHO, U-2-OS and HEK293 cell lines. In this test, we included many of the most common vector elements for heterologous gene expression in mammalian cells, in addition the system is fully extendable by other users. The vector system is designed to facilitate high-throughput genome-scale studies of mammalian cells, such as the newly sequenced CHO cell lines, through the ability to rapidly generate high-fidelity assembly of customizable gene expression vectors.	[Lund, Anne Mathilde; Petersen, Maja Borup Kjaer; Rank, Julie; Hansen, Bjarne Gram; Andersen, Mikael Rordam; Mortensen, Uffe Hasbro] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Kildegaard, Helene Faustrup] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Technical University of Denmark; Technical University of Denmark	Andersen, MR (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	mr@bio.dtu.dk	Andersen, Mikael R/F-9377-2013; Mortensen, Uffe/AAQ-1150-2021; Andersen, Mikael Rørdam/P-6743-2019	Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; Nyman Kjaer, Maja/0000-0003-0944-6175; Kildegaard, Helene Faustrup/0000-0003-3727-5721	Lundbeck foundation; Novo Nordisk Foundation; Lundbeck Foundation [R34-2009-3625] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [CHO Cell Line Engineering & Design] Funding Source: researchfish	Lundbeck foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	H. F. K. thanks the Lundbeck foundation and the Novo Nordisk Foundation for financial support. J.R. and A. M. L. thank Novozymes, Bavarian Nordic, ALK-Abello, DNA Technology, Integrated DNA Technologies, Pharma Denmark and the Lundbeck Foundation for financial support during the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; BURKE J, 1992, J BIOL CHEM, V267, P24433; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY PW, 1982, NATURE, V295, P503, DOI 10.1038/295503a0; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659; TATE SS, 1990, FASEB J, V4, P227, DOI 10.1096/fasebj.4.2.2298343; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; ZHOU MY, 1995, BIOTECHNIQUES, V19, P34	30	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96693	10.1371/journal.pone.0096693	http://dx.doi.org/10.1371/journal.pone.0096693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879460	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500008
J	Tan, LJ; Zhu, H; He, H; Wu, KH; Li, J; Chen, XD; Zhang, JG; Shen, H; Tian, Q; Krousel-Wood, M; Papasian, CJ; Bouchard, C; Perusse, L; Deng, HW				Tan, Li-Jun; Zhu, Hu; He, Hao; Wu, Ke-Hao; Li, Jian; Chen, Xiang-Ding; Zhang, Ji-Gang; Shen, Hui; Tian, Qing; Krousel-Wood, Marie; Papasian, Christopher J.; Bouchard, Claude; Perusse, Louis; Deng, Hong-Wen			Replication of 6 Obesity Genes in a Meta-Analysis of Genome-Wide Association Studies from Diverse Ancestries	PLOS ONE			English	Article							BODY-MASS INDEX; FTO GENE; QUANTITATIVE TRAITS; SUSCEPTIBILITY LOCI; PHYSICAL-ACTIVITY; EARLY-ONSET; FAT MASS; VARIANTS; RISK; POLYMORPHISMS	Obesity is a major public health problem with a significant genetic component. Multiple DNA polymorphisms/genes have been shown to be strongly associated with obesity, typically in populations of European descent. The aim of this study was to verify the extent to which 6 confirmed obesity genes (FTO, CTNNBL1, ADRB2, LEPR, PPARG and UCP2 genes) could be replicated in 8 different samples (n = 11,161) and to explore whether the same genes contribute to obesity-susceptibility in populations of different ancestries (five Caucasian, one Chinese, one African-American and one Hispanic population). GWAS-based data sets with 1000 G imputed variants were tested for association with obesity phenotypes individually in each population, and subsequently combined in a meta-analysis. Multiple variants at the FTO locus showed significant associations with BMI, fat mass (FM) and percentage of body fat (PBF) in meta-analysis. The strongest association was detected at rs7185735 (P-value = 1.01 x 10(-7) for BMI, 1.80 x 10(-6) for FM, and 5.29 x 10(-4) for PBF). Variants at the CTNNBL1, LEPR and PPARG loci demonstrated nominal association with obesity phenotypes (meta-analysis P-values ranging from 1.15 x 10(-3) to 4.94 x 10(-2)). There was no evidence of association with variants at ADRB2 and UCP2 genes. When stratified by sex and ethnicity, FTO variants showed sex-specific and ethnic-specific effects on obesity traits. Thus, it is likely that FTO has an important role in the sex-and ethnic-specific risk of obesity. Our data confirmed the role of FTO, CTNNBL1, LEPR and PPARG in obesity predisposition. These findings enhanced our knowledge of genetic associations between these genes and obesity-related phenotypes, and provided further justification for pursuing functional studies of these genes in the pathophysiology of obesity. Sex and ethnic differences in genetic susceptibility across populations of diverse ancestries may contribute to a more targeted prevention and customized treatment of obesity.	[Tan, Li-Jun; Zhu, Hu; Wu, Ke-Hao; Chen, Xiang-Ding; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Tan, Li-Jun; Zhu, Hu; Wu, Ke-Hao; Chen, Xiang-Ding; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [He, Hao; Li, Jian; Zhang, Ji-Gang; Shen, Hui; Tian, Qing; Krousel-Wood, Marie; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [He, Hao; Li, Jian; Zhang, Ji-Gang; Shen, Hui; Tian, Qing; Krousel-Wood, Marie; Deng, Hong-Wen] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Papasian, Christopher J.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Bouchard, Claude] Pennington Biomed Res Ctr, Human Genom Lab, Baton Rouge, LA 70808 USA; [Perusse, Louis] Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada	Hunan Normal University; Hunan Normal University; Tulane University; Tulane University; University of Missouri System; University of Missouri Kansas City; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Laval University	Perusse, L (corresponding author), Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada.	Louis.Perusse@kin.ulaval.ca; hwdeng@hunnu.edu.cn	Li, Jian/G-4445-2015; Perusse, Louis/A-3444-2012; Tan, Li-Jun/AAO-1130-2020; Bouchard, Claude/A-7637-2009; Bouchard, Claude/AAE-2035-2019	Perusse, Louis/0000-0001-6440-9698; Bouchard, Claude/0000-0002-0048-491X; Deng, Hong-Wen/0000-0002-0387-8818	NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal [30811120436]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [2013-448]; Natural Science Foundation of China (NSFC) [31071097, 31271344, 30900810]; NIH [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Franklin D. Dickson/Missouri Endowment; John W. Barton Sr. Chair in Genetics and Nutrition; National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility [P01-AG018397]; Johns Hopkins University Center; NIH NIA; National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, R01AR059781, R01AR041398, R01AR057049, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG018397, R01AG026564] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032108, N01WH042122, N01WH042126, N01WH022110, N01WH042113, N01WH042112, N01WH042131, N01WH032122, N01WH032112, N01WH032105, N01WH032106, N01WH042130, N01WH042121, N01WH042111, N01WH042124, N01WH042129, N01WH042117, N01WH032111, N01WH032109, N01WH042116, N01WH032119, N01WH032100, N01WH042118, N01WH042115, N01WH042110, N01WH042125, N01WH032118, N01WH032102, N01WH032115, N01WH042123, N01WH032113, N01WH042114, N01WH042109, N01WH042119, N01WH042108, N01WH042120, N01WH042107, N01WH032101] Funding Source: NIH RePORTER	NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal(Canadian Institutes of Health Research (CIHR)); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; John W. Barton Sr. Chair in Genetics and Nutrition; National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA Division of Geriatrics and Clinical Gerontology; Genetic Determinants of Bone Fragility; Johns Hopkins University Center; NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal (30811120436), Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (2013-448), and Natural Science Foundation of China (NSFC; 31071097, 31271344, and 30900810). HWD was supported in part by grants from NIH (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221) and the Franklin D. Dickson/Missouri Endowment. CB is partially funded by the John W. Barton Sr. Chair in Genetics and Nutrition. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. Funding support for the Framingham Whole Body DXA dataset was provided by NIH grants R01 AR/AG 41398. The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap through dbGaP accession phs000007. v14. p6. Funding support for the Genetic Determinants of Bone Fragility was provided through the NIA Division of Geriatrics and Clinical Gerontology. Genetic Determinants of Bone Fragility is a genomewide association studies funded as part of the NIA Division of Geriatrics and Clinical Gerontology. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the NIA Division of Geriatrics and Clinical Gerontology and the NIA Division of Aging Biology. Support for the collection of datasets and samples were provided by the parent grant, Genetic Determinants of Bone Fragility (P01-AG018397). Funding support for the genotyping which was performed at the Johns Hopkins University Center for Inherited Diseases Research was provided by the NIH NIA. The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www. ncbi. nlm. nih. gov/sites/entrez? db = gap through dbGaP accession phs000138. v2. p1. The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U. S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. This manuscript was not prepared in collaboration with investigators of the WHI, has not been reviewed and/or approved by the Women's Health Initiative (WHI), and does not necessarily reflect the opinions of the WHI investigators or the NHLBI. The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www. ncbi. nlm. nih. gov/sites/entrez? db = gap through dbGaP accession phs000200. v6. p2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, DIABETES, V59, P1549, DOI 10.2337/db09-1252; Allison DB, 2000, MED CLIN N AM, V84, P305, DOI 10.1016/S0025-7125(05)70223-6; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Andreasen CH, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-17; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Benjamin AM, 2011, J OBES, V2011, DOI 10.1155/2011/329038; Bollepalli S, 2010, OBESITY, V18, P1959, DOI 10.1038/oby.2010.82; Cauley JA, 2011, J BONE MINER RES, V26, P2378, DOI 10.1002/jbmr.449; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Dorajoo R, 2012, INT J OBESITY, V36, P159, DOI 10.1038/ijo.2011.86; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Galbete C, 2012, CHRONOBIOL INT, V29, P1397, DOI 10.3109/07420528.2012.728657; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Hassanein MT, 2010, HUM MOL GENET, V19, P2907, DOI 10.1093/hmg/ddq178; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jalba MS, 2008, OBESITY, V16, P2096, DOI 10.1038/oby.2008.327; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LAFONTAN M, 1993, J LIPID RES, V34, P1057; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Lu YC, 2013, GENOME MED, V5, DOI 10.1186/gm459; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Murugesan Devi, 2010, Indian J Hum Genet, V16, P72, DOI 10.4103/0971-6866.69350; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Pei YF, 2014, HUM MOL GENET, V23, P820, DOI 10.1093/hmg/ddt464; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Plourde M, 2013, OBESITY, V21, P185, DOI 10.1002/oby.20242; Prakash J, 2012, AM J HUM BIOL, V24, P454, DOI 10.1002/ajhb.22245; Prentice A M, 2001, Obes Rev, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Qian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058939; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Song YQ, 2008, OBESITY, V16, P2472, DOI 10.1038/oby.2008.408; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Vogel CIG, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-14; Wan ES, 2011, AM J RESP CELL MOL, V45, P304, DOI 10.1165/rcmb.2010-0294OC; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wing MR, 2011, INT J OBESITY, V35, P1173, DOI 10.1038/ijo.2010.244; Xi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056472; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375; Zhang L, 2009, ANN HUM GENET, V73, P601, DOI 10.1111/j.1469-1809.2009.00539.x; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	65	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96149	10.1371/journal.pone.0096149	http://dx.doi.org/10.1371/journal.pone.0096149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879436	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500005
J	Cole, MH; van den Hoorn, W; Kavanagh, JK; Morrison, S; Hodges, PW; Smeathers, JE; Kerr, GK				Cole, Michael H.; van den Hoorn, Wolbert; Kavanagh, Justin K.; Morrison, Steven; Hodges, Paul W.; Smeathers, James E.; Kerr, Graham K.			Concurrent Validity of Accelerations Measured Using a Tri-Axial Inertial Measurement Unit while Walking on Firm, Compliant and Uneven Surfaces	PLOS ONE			English	Article							MOBILITY-RELATED ACTIVITIES; TEST-RETEST RELIABILITY; AGE-RELATED DIFFERENCES; TRUNK ACCELEROMETRY; WEARABLE SYSTEMS; HEAD STABILITY; GAIT; PATTERNS; PELVIS; COORDINATION	Although accelerometers are extensively used for assessing gait, limited research has evaluated the concurrent validity of these devices on less predictable walking surfaces or the comparability of different methods used for gravitational acceleration compensation. This study evaluated the concurrent validity of trunk accelerations derived from a tri-axial inertial measurement unit while walking on firm, compliant and uneven surfaces and contrasted two methods used to remove gravitational accelerations; i) subtraction of the best linear fit from the data (detrending); and ii) use of orientation information (quaternions) from the inertial measurement unit. Twelve older and twelve younger adults walked at their preferred speed along firm, compliant and uneven walkways. Accelerations were evaluated for the thoracic spine (T12) using a tri-axial inertial measurement unit and an eleven-camera Vicon system. The findings demonstrated excellent agreement between accelerations derived from the inertial measurement unit and motion analysis system, including while walking on uneven surfaces that better approximate a real-world setting (all differences <0.16 m.s(-2)). Detrending produced slightly better agreement between the inertial measurement unit and Vicon system on firm surfaces (delta range: -0.05 to 0.06 vs. 0.00 to 0.14 m.s(-2)), whereas the quaternion method performed better when walking on compliant and uneven walkways (delta range: -0.16 to -0.02 vs. -0.07 to 0.07 m.s(-2)). The technique used to compensate for gravitational accelerations requires consideration in future research, particularly when walking on compliant and uneven surfaces. These findings demonstrate trunk accelerations can be accurately measured using a wireless inertial measurement unit and are appropriate for research that evaluates healthy populations in complex environments.	[Cole, Michael H.] Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia; [Cole, Michael H.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [van den Hoorn, Wolbert; Hodges, Paul W.] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia; [Kavanagh, Justin K.] Griffith Univ, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia; [Morrison, Steven] Old Dominion Univ, Sch Phys Therapy & Athlet Training, Norfolk, VA USA; [Smeathers, James E.; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia	Australian Catholic University; Queensland University of Technology (QUT); University of Queensland; Griffith University; Old Dominion University; Queensland University of Technology (QUT)	Cole, MH (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia.	michael.cole@acu.edu.au; g.kerr@qut.edu.au	van den Hoorn, Wolbert/F-6894-2010; Cole, Michael H/O-6816-2018; Hodges, Paul W/B-6578-2008	van den Hoorn, Wolbert/0000-0002-9658-2388; Hodges, Paul W/0000-0002-1206-9107; Kavanagh, Justin/0000-0002-1046-260X; Cole, Michael/0000-0003-1817-7528; Kerr, Graham/0000-0002-1008-256X	National Health and Medical Research Council of Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Institute of Health and Biomedical Innovation, Queensland University of Technology	This research was supported by a project grant and Research Fellowship (PWH) from the National Health and Medical Research Council of Australia and grants from the Institute of Health and Biomedical Innovation, Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allet L, 2010, SENSORS-BASEL, V10, P9026, DOI 10.3390/s101009026; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnet V, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-29; Cole MH, 2011, PARKINSONISM RELAT D, V17, P610, DOI 10.1016/j.parkreldis.2011.05.019; de Bruin Eling D, 2012, J Aging Res, V2012, P954378, DOI 10.1155/2012/954378; de Bruin ED, 2008, CLIN REHABIL, V22, P878, DOI 10.1177/0269215508090675; Grimpampi E, 2013, GAIT POSTURE, V38, P523, DOI 10.1016/j.gaitpost.2013.01.031; Hartmann A, 2009, GAIT POSTURE, V30, P351, DOI 10.1016/j.gaitpost.2009.06.008; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Hendrick P, 2010, J REHABIL RES DEV, V47, P157, DOI 10.1682/JRRD.2009.04.0047; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Jurman D, 2007, SENSOR ACTUAT A-PHYS, V138, P411, DOI 10.1016/j.sna.2007.05.008; Kavanagh J, 2005, EUR J APPL PHYSIOL, V94, P468, DOI 10.1007/s00421-005-1328-1; Kavanagh JJ, 2005, HUM MOVEMENT SCI, V24, P574, DOI 10.1016/j.humov.2005.07.003; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kavanagh J, 2006, EXP BRAIN RES, V172, P454, DOI 10.1007/s00221-006-0353-6; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Kavanagh JJ, 2006, J APPL PHYSIOL, V101, P1118, DOI 10.1152/japplphysiol.00165.2006; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Luinge H J, 1999, Technol Health Care, V7, P455; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Mazza C, 2012, GAIT POSTURE, V35, P138, DOI 10.1016/j.gaitpost.2011.08.024; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Patel S, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P234, DOI 10.1109/P3644.52; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Sabatini AM, 2005, MED BIOL ENG COMPUT, V43, P94, DOI 10.1007/BF02345128; Schepers HM, 2010, MED BIOL ENG COMPUT, V48, P27, DOI 10.1007/s11517-009-0562-9; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; Wilson J.S., 2004, SENSOR TECHNOLOGY HD	37	21	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98395	10.1371/journal.pone.0098395	http://dx.doi.org/10.1371/journal.pone.0098395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866262	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100058
J	Lim, JKH; Nguyen, CTO; He, Z; Vingrys, AJ; Bui, BV				Lim, Jeremiah K. H.; Nguyen, Christine T. O.; He, Zheng; Vingrys, Algis J.; Bui, Bang V.			The Effect of Ageing on Ocular Blood Flow, Oxygen Tension and Retinal Function during and after Intraocular Pressure Elevation	PLOS ONE			English	Article							OPTIC-NERVE HEAD; POSTISCHEMIC REPERFUSION; HYPERBARIC OXYGENATION; GANGLION-CELLS; RABBIT RETINA; TRANSIT-TIME; B-WAVE; AGE; METABOLISM; RAT	Purpose: To investigate the effect of ageing on the recovery of ocular blood flow, intravitreal oxygen tension and retinal function during and after intraocular pressure (IOP) elevation. Methods: Long Evans rats (3- and 14-month-old) underwent acute stepwise IOP elevation from 10 to 120 mmHg (5 mmHg steps each 3 minutes). IOP was then returned to baseline and recovery was monitored for 2 hours. Photopic electroretinograms (ERG) were recorded at each IOP step during stress and at each minute during recovery. Ocular blood flow and vitreal oxygen tension (pO(2)) were assayed continuously and simultaneously using a combined laser Doppler flow meter (LDF) and an oxygen sensitive fibre-optic probe, respectively. The combined sensor was placed in the vitreous chamber, proximal to the retina. Data were binned into 3 minute intervals during stress and 1 min intervals during recovery. Recovery data was described using a bi-logistic function. Results: Rats of both ages showed similar susceptibility to IOP elevation, with pO(2) showing a closer relationship to ERG than LDF. During recovery, both ages showed a distinctive two-phased recovery for all three measures with the exception of the LDF in 3-month-old rats, which showed only 1 phase. In all animals, LDF recovered fastest (<1 minute), followed by pO2 (<10 minute) and ERG (>1 hour). 14-month-old rats showed surprisingly faster and greater LDF recovery compared to the younger group, with similar levels of pO(2) recovery. However, the ERG in these middle-aged animals did not fully recover after two hours, despite showing no difference in susceptibility to IOP during stress compared to the young group. Conclusions: Young and middle-aged eyes showed similar susceptibility to IOP elevation in terms of pO(2), LDF and ERG. Despite this lack of difference during stress, older eyes did not completely recover function, suggesting a more subtle age-related susceptibility to IOP.	[Lim, Jeremiah K. H.; Nguyen, Christine T. O.; He, Zheng; Vingrys, Algis J.; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia	University of Melbourne	Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia.	bvb@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Lim, Jeremiah Kah Heng/AAC-4260-2019	Bui, Bang/0000-0001-7298-1352; Lim, Jeremiah Kah Heng/0000-0002-4694-9479; Nguyen, Christine/0000-0002-3298-3086; He, Zheng/0000-0001-6496-3971; Vingrys, Algis/0000-0001-5920-4604	National Health and Medical Research Council [566570]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council Project Grant 566570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah W, 2011, INVEST OPHTH VIS SCI, V52, P1035, DOI 10.1167/iovs.09-4516; ALDER VA, 1989, AM J PHYSIOL, V256, pH1627, DOI 10.1152/ajpheart.1989.256.6.H1627; ALDER VA, 1985, CURR EYE RES, V4, P121, DOI 10.3109/02713688508999977; ALDER VA, 1991, EXP EYE RES, V52, P293, DOI 10.1016/0014-4835(91)90093-T; ALDER VA, 1986, CURR EYE RES, V5, P249, DOI 10.3109/02713688609020050; ALM A, 1970, ACTA PHYSIOL SCAND, V80, P19, DOI 10.1111/j.1748-1716.1970.tb04765.x; ALM A, 1972, ACTA PHYSIOL SCAND, V84, P306, DOI 10.1111/j.1748-1716.1972.tb05182.x; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; AMES A, 1963, J NEUROPHYSIOL, V26, P617, DOI 10.1152/jn.1963.26.4.617; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; ANDERSON B, 1965, ARCH OPHTHALMOL-CHIC, V73, P315; ANDERSON B, 1965, SOUTHERN MED J, V58, P1047, DOI 10.1097/00007611-196508000-00023; BENNUN J, 1988, INVEST OPHTH VIS SCI, V29, P298; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P523; Bui BV, 2003, INVEST OPHTH VIS SCI, V44, P2708, DOI 10.1167/iovs.02-1054; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; BUNAG RD, 1973, J APPL PHYSIOL, V34, P279, DOI 10.1152/jappl.1973.34.2.279; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cantini C, 2001, HYPERTENSION, V38, P943, DOI 10.1161/hy1001.096211; Casson RJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P361, DOI 10.1001/archopht.122.3.361; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chrysostomou V, 2010, OPHTHALMIC RES, V44, P173, DOI 10.1159/000316478; Chu CS, 2011, PHOTONIC SENS, V1, P234, DOI 10.1007/s13320-011-0025-4; CRINGLE SJ, 1988, INVEST OPHTH VIS SCI, V29, P1044; DOBREE J H, 1956, Br J Ophthalmol, V40, P1, DOI 10.1136/bjo.40.1.1; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Ehrlich R, 2009, GRAEF ARCH CLIN EXP, V247, P583, DOI 10.1007/s00417-008-1018-x; Embleton SJ, 2002, EYE, V16, P156; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V304, P59, DOI 10.1113/jphysiol.1980.sp013310; ERNEST JT, 1973, INVEST OPHTH VISUAL, V12, P927; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fredriksson I., 2007, LASER DOPPLER FLOWME; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; GRAYMORE CN, 1970, BRIT MED BULL, V26, P130, DOI 10.1093/oxfordjournals.bmb.a070763; Groh MJM, 1996, OPHTHALMOLOGY, V103, P529; GUTIERREZ G, 1986, RESP PHYSIOL, V63, P79, DOI 10.1016/0034-5687(86)90032-0; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Hatta Shiro, 1993, Nippon Ganka Gakkai Zasshi, V97, P181; HAYREH SS, 1994, GRAEF ARCH CLIN EXP, V232, P745, DOI 10.1007/BF00184278; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; He Z, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.55; He Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031104; Hughes S, 2006, NEUROBIOL AGING, V27, P1838, DOI 10.1016/j.neurobiolaging.2005.10.021; Ishihara M, 2000, JPN J PHYSIOL, V50, P125, DOI 10.2170/jjphysiol.50.125; Kalliokoski KK, 2004, MICROVASC RES, V67, P125, DOI 10.1016/j.mvr.2003.11.004; Katano H, 2001, JPN J PHYSIOL, V51, P89, DOI 10.2170/jjphysiol.51.89; KIEL JW, 1992, INVEST OPHTH VIS SCI, V33, P2399; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x; Kong YXG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.026; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, pE22, DOI 10.1161/01.ATV.0000158419.98675.d7; la Cour M, 2000, BRIT J OPHTHALMOL, V84, P1045; Landers M B 3rd, 1978, Trans Am Ophthalmol Soc, V76, P528; Liao DP, 2004, STROKE, V35, P837, DOI 10.1161/01.STR.0000120310.43457.AD; Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647; LINSENMEIER RA, 1990, GRAEF ARCH CLIN EXP, V228, P143, DOI 10.1007/BF02764309; LINSENMEIER RA, 1981, EXP EYE RES, V32, P369, DOI 10.1016/S0014-4835(81)80016-4; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Matsuura K, 1998, JPN J PHYSIOL, V48, P9, DOI 10.2170/jjphysiol.48.9; McFarland RA, 1940, J GEN PHYSIOL, V24, P69, DOI 10.1085/jgp.24.1.69; MEYER P, 1994, TECHNOL FORECAST SOC, V47, P89, DOI 10.1016/0040-1625(94)90042-6; MILDENBERGER RR, 1977, CAN J PHYSIOL PHARM, V55, P478, DOI 10.1139/y77-068; Mojumder DK, 2008, J PHYSIOL-LONDON, V586, P2551, DOI 10.1113/jphysiol.2008.150755; Mozaffarieh M, 2008, MOL VIS, V14, P224; Park YH, 2011, BRIT J OPHTHALMOL, V95, P118, DOI 10.1136/bjo.2010.186064; PETERSON JI, 1984, SCIENCE, V224, P123, DOI 10.1126/science.6422554; PETERSON JI, 1984, ANAL CHEM, V56, P62, DOI 10.1021/ac00265a017; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Pittman RN, 2005, MICROCIRCULATION, V12, P59, DOI 10.1080/10739680590895064; POURNARAS CJ, 1989, EXP EYE RES, V49, P347, DOI 10.1016/0014-4835(89)90045-6; Quinones-Hinojosa A, 1999, J NEUROSCI METH, V90, P107, DOI 10.1016/S0165-0270(99)00068-0; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; RIVA CE, 1981, INVEST OPHTH VIS SCI, V21, P34; RIVA CE, 1986, J APPL PHYSIOL, V61, P592, DOI 10.1152/jappl.1986.61.2.592; RIZZO JF, 1991, INVEST OPHTH VIS SCI, V32, P3263; Rochtchina E, 2002, CLIN EXP OPHTHALMOL, V30, P173, DOI 10.1046/j.1442-9071.2002.00519.x; RUSSELL RWR, 1973, LANCET, V2, P1048; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schulte K, 1996, GER J OPHTHALMOL, V5, P1; Smith LM, 2004, AM J PHYSIOL-HEART C, V287, pH401, DOI 10.1152/ajpheart.00980.2002; TORNQUIST P, 1979, ACTA PHYSIOL SCAND, V106, P351, DOI 10.1111/j.1748-1716.1979.tb06409.x; WILSON CA, 1995, INVEST OPHTH VIS SCI, V36, P131; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Xuan B, 1999, J OCUL PHARMACOL TH, V15, P135, DOI 10.1089/jop.1999.15.135; YANCEY CM, 1988, INVEST OPHTH VIS SCI, V29, P700; Yu DY, 1999, INVEST OPHTH VIS SCI, V40, P2082; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220	90	41	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98393	10.1371/journal.pone.0098393	http://dx.doi.org/10.1371/journal.pone.0098393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866182	Green Submitted, Green Published, gold			2022-12-27	WOS:000336914100057
J	Tho, NV; Trang, LTH; Murakami, Y; Ogawa, E; Ryujin, Y; Kanda, R; Nakagawa, H; Goto, K; Fukunaga, K; Higami, Y; Seto, R; Nagao, T; Oguma, T; Yamaguchi, M; Lan, LTT; Nakano, Y				Nguyen Van Tho; Le Thi Huyen Trang; Murakami, Yoshitaka; Ogawa, Emiko; Ryujin, Yasushi; Kanda, Rie; Nakagawa, Hiroaki; Goto, Kenichi; Fukunaga, Kentaro; Higami, Yuichi; Seto, Ruriko; Nagao, Taishi; Oguma, Tetsuya; Yamaguchi, Masafumi; Le Thi Tuyet Lan; Nakano, Yasutaka			Airway Wall Area Derived from 3-Dimensional Computed Tomography Analysis Differs among Lung Lobes in Male Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; THIN-SECTION CT; REFERENCE VALUES; CHEST CT; EMPHYSEMA; COPD; DIMENSIONS; SEGMENTATION; THICKNESS; ATTENUATION	Background: It is time-consuming to obtain the square root of airway wall area of the hypothetical airway with an internal perimeter of 10 mm (root Aaw at Pi10), a comparable index of airway dimensions in chronic obstructive pulmonary disease (COPD), from all airways of the whole lungs using 3-dimensional computed tomography (CT) analysis. We hypothesized that root Aaw at Pi10 differs among the five lung lobes and root Aaw at Pi10 derived from one certain lung lobe has a high level of agreement with that derived from the whole lungs in smokers. Methods: Pulmonary function tests and chest volumetric CTs were performed in 157 male smokers (102 COPD, 55 non-COPD). All visible bronchial segments from the 3rd to 5th generations were segmented and measured using commercially available 3-dimensional CT analysis software. root Aaw at Pi10 of each lung lobe was estimated from all measurable bronchial segments of that lobe. Results: Using a mixed-effects model, root Aaw at Pi10 differed significantly among the five lung lobes (R-2 = 0.78, P<0.0001). The Bland-Altman plots show that root Aaw at Pi10 derived from the right or left upper lobe had a high level of agreement with that derived from the whole lungs, while root Aaw at Pi10 derived from the right or left lower lobe did not. Conclusion: In male smokers, CT-derived airway wall area differs among the five lung lobes, and airway wall area derived from the right or left upper lobe is representative of the whole lungs.	[Nguyen Van Tho; Ogawa, Emiko; Ryujin, Yasushi; Kanda, Rie; Nakagawa, Hiroaki; Goto, Kenichi; Fukunaga, Kentaro; Higami, Yuichi; Seto, Ruriko; Nagao, Taishi; Oguma, Tetsuya; Yamaguchi, Masafumi; Nakano, Yasutaka] Shiga Univ Med Sci, Div Resp Med, Dept Med, Shiga, Japan; [Murakami, Yoshitaka] Shiga Univ Med Sci, Dept Med Stat, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Shiga, Japan; [Nguyen Van Tho; Le Thi Huyen Trang; Le Thi Tuyet Lan] Univ Med Ctr, Resp Care Ctr, Ho Chi Minh City, Vietnam	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Nakano, Y (corresponding author), Shiga Univ Med Sci, Div Resp Med, Dept Med, Shiga, Japan.	nakano@belle.shiga-med.ac.jp		Fukunaga, Kentaro/0000-0002-6261-0344; Tho, Nguyen Van/0000-0003-4004-9872; Nguyen, Tho/0000-0002-0198-6284	Japan Society for the Promotion of Science KAKENHI [24390174]; Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partly supported by the Japan Society for the Promotion of Science KAKENHI Grant No. 24390174 and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Grydeland TB, 2010, AM J RESP CRIT CARE, V181, P353, DOI 10.1164/rccm.200907-1008OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montaudon M, 2007, RADIOLOGY, V242, P563, DOI 10.1148/radiol.2422060029; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 1999, THORAX, V54, P384, DOI 10.1136/thx.54.5.384; Ohara T, 2006, RESPIROLOGY, V11, P579, DOI 10.1111/j.1440-1843.2006.00899.x; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Shimizu K, 2011, RESP MED, V105, P1275, DOI 10.1016/j.rmed.2011.04.007; Tho NV, 2013, AM J RESP CRIT CARE, V187; THO NV, 2012, AM J RESP CRIT CARE, V185, pA4338; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1529, DOI 10.1109/TMI.2005.857654; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1540, DOI 10.1109/TMI.2005.857653; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Xu Z., 2013, P MICCAI, V8150, P559; Zhang L, 2006, IEEE T MED IMAGING, V25, P1, DOI 10.1109/TMI.2005.859209	30	10	10	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98335	10.1371/journal.pone.0098335	http://dx.doi.org/10.1371/journal.pone.0098335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865661	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100051
J	Buscone, S; Garavello, W; Pagni, F; Gaini, RM; Cattoretti, G				Buscone, Serena; Garavello, Werner; Pagni, Fabio; Gaini, Renato Maria; Cattoretti, Giorgio			Nasopharyngeal Tonsils (Adenoids) Contain Extrathymic Corticothymocytes	PLOS ONE			English	Article							T-LYMPHOBLASTIC PROLIFERATION; INTRAEPITHELIAL LYMPHOCYTES; CELLS; EXPRESSION; LYMPHOPOIESIS; ASSOCIATION; GENERATION; ONTOGENY; LINEAGE; THYMUS	Adenoidal tissue (also known as nasopharyngeal tonsils) of 58% of humans in the pediatric age group contains immature T-lymphoid cells with the phenotype of thymocytes (TdT+, CD1abc+, cytoplasmic CD3+, coexpressing CD4 and CD8, lacking an Intraepithelial Lymphocyte-associated phenotype). The notable difference in comparison to palatine tonsils is the clustering in groups and sheets, comprising hundreds or thousands of cells (1.7%+/- 0.2 of total T cells). The thymic epithelium is morphologically and phenotypically absent. Adenoids share with tonsils and lymph nodes the presence of immature B cell precursors (TdT+, CD1a-, Pax5+, Surrogate light chain +/-), however in these latter the presence of TdT+, CD1a+, Pax5-precursors is absent or limited to individual cells. Human adenoids are distinct among the Waldeyer's ring lymphoid tissue because of the known embryogenic derivation from the third pharyngeal pouch, from which the thymus develops; in addition, they may display phenotypic incomplete features of a vestigial thymus.	[Buscone, Serena; Pagni, Fabio; Cattoretti, Giorgio] Univ Milano Bicocca, Dept Surg & Translat Med, Milan, Italy; [Garavello, Werner; Gaini, Renato Maria] Univ Milano Bicocca, Dept Surg & Translat Med, Milan, Italy; [Pagni, Fabio; Cattoretti, Giorgio] Azienda Osped San Gerardo, Monza, Italy	University of Milano-Bicocca; University of Milano-Bicocca	Cattoretti, G (corresponding author), Univ Milano Bicocca, Dept Surg & Translat Med, Milan, Italy.	giorgio.cattoretti@unimib.it		Cattoretti, Giorgio/0000-0003-3799-3221; Pagni, Fabio/0000-0001-9625-1637	Fondazione per la Ricerca Scientifica Termale (FoRST)	Fondazione per la Ricerca Scientifica Termale (FoRST)	This project has been supported by Fondazione per la Ricerca Scientifica Termale (FoRST), IV call grants (Project "Lymphopoiesis In Secondary Lymphoid Tissue"). Serena Buscone is supported by a grant from the Fondazione per la Ricerca Scientifica Termale (FoRST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; BOYD AW, 1987, PATHOLOGY, V19, P329, DOI 10.3109/00313028709103879; CATTORETTI G, 1989, EUR J IMMUNOL, V19, P493, DOI 10.1002/eji.1830190313; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; CERFBENSUSSAN N, 1992, EUR J IMMUNOL, V22, P273, DOI 10.1002/eji.1830220140; DEUSCH K, 1991, EUR J IMMUNOL, V21, P1053, DOI 10.1002/eji.1830210429; Dooley J, 2006, J IMMUNOL, V176, P6484, DOI 10.4049/jimmunol.176.11.6484; Eun S, 2010, J KOREAN MED SCI, V25, P309, DOI 10.3346/jkms.2010.25.2.309; Fink PJ, 2000, IMMUNOL TODAY, V21, P561, DOI 10.1016/S0167-5699(00)01734-5; Fokkens WJ, 1998, CLIN EXP ALLERGY, V28, P187; Fusco A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081786; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Kim WY, 2010, HUM PATHOL, V41, P129, DOI 10.1016/j.humpath.2009.05.014; Klein F, 2003, P NATL ACAD SCI USA, V100, P6747, DOI 10.1073/pnas.1031503100; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Lewin SR, 2002, BLOOD, V100, P2235, DOI 10.1182/blood.V100.6.2235.h81802002235_2235_2242; Li J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3959; LUNDQVIST C, 1995, INT IMMUNOL, V7, P1473, DOI 10.1093/intimm/7.9.1473; McClory S, 2012, J CLIN INVEST, V122, P1403, DOI 10.1172/JCI46125; Meru N, 2002, BLOOD, V99, P531, DOI 10.1182/blood.V99.2.531; O'Malley DP, 2006, HAEMATOLOGICA, V91, P1139; Ohgami RS, 2013, ADV ANAT PATHOL, V20, P137, DOI 10.1097/PAP.0b013e31828d17ec; Ohgami RS, 2012, AM J SURG PATHOL, V36, P1619, DOI 10.1097/PAS.0b013e318264e223; Papatziamos G, 1999, ALLERGY, V54, P916, DOI 10.1034/j.1398-9995.1999.00033.x; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Ramond C, 2013, NAT IMMUNOL; Strauchen JA, 2001, AM J CLIN PATHOL, V116, P12; Strauchen JA, 2001, AM J SURG PATHOL, V25, P411, DOI 10.1097/00000478-200103000-00018; Suzuki K, 2000, IMMUNITY, V13, P691, DOI 10.1016/S1074-7613(00)00068-6; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tsuganezawa K, 1998, BLOOD, V92, P4317, DOI 10.1182/blood.V92.11.4317.423k43_4317_4324; Velankar MM, 1999, AM J SURG PATHOL, V23, P977, DOI 10.1097/00000478-199908000-00017; WEINBERG K, 1993, J CLIN INVEST, V92, P596, DOI 10.1172/JCI116626; Welner RS, 2008, NAT REV IMMUNOL, V8, P95, DOI 10.1038/nri2234; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; WILLIAMS MA, 1987, J CRAN GENET DEV BIO, V7, P23; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725; Zou D, 2006, DEV BIOL, V293, P499, DOI 10.1016/j.ydbio.2005.12.015	41	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98222	10.1371/journal.pone.0098222	http://dx.doi.org/10.1371/journal.pone.0098222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858437	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400058
J	Huang, L; Kondo, F; Gosho, M; Feng, GG; Harato, M; Xia, ZY; Ishikawa, N; Fujiwara, Y; Okada, S				Huang, Lei; Kondo, Fumio; Gosho, Masahiko; Feng, Guo-Gang; Harato, Misako; Xia, Zhong-yuan; Ishikawa, Naohisa; Fujiwara, Yoshihiro; Okada, Shoshiro			Enhanced Expression of WD Repeat-Containing Protein 35 via CaMKK/AMPK Activation in Bupivacaine-Treated Neuro2a Cells (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							KINASE-KINASE-BETA; P38 MAPK; APOPTOSIS	We previously reported that bupivacaine induces reactive oxygen species (ROS) generation, p38 mitogen-activated protein kinase (MAPK) activation and nuclear factor-kappa B activation, resulting in an increase in expression of WD repeatcontaining protein 35 (WDR35) in mouse neuroblastoma Neuro2a cells. However, the identity of signaling upstream of p38 MAPK pathways to WDR35 expression remains unclear. It has been shown that AMP-activated protein kinase (AMPK) can activate p38 MAPK through diverse mechanisms. In addition, several kinases acting upstream of AMPK have been identified including Ca2+/calmodulin-dependent protein kinase kinase (CaMKK). Recent studies reported that AMPK may be involved in bupivacaine-induced cytotoxicity in Schwann cells and in human neuroblastoma SH-SY5Y cells. The present study was undertaken to test whether CaMKK and AMPK are involved in bupivacaine-induced WDR35 expression in Neuro2a cells. Our results showed that bupivacaine induced activation of AMPK and p38 MAPK in Neuro2a cells. The AMPK inhibitors, compound C and iodotubercidin, attenuated the bupivacaine-induced activation of AMPK and p38 MAPK, resulting in an inhibition of the bupivacaine-induced increase in WDR35 expression. Treatment with the CaMKK inhibitor STO-609 also attenuated the bupivacaine-induced activation of AMPK and p38 MAPK, resulting in an inhibition of the bupivacaine-induced increase in WDR35 expression. These results suggest that bupivacaine activates AMPK and p38 MAPK via CaMKK in Neuro2a cells, and that the CaMKK/AMPK/p38 MAPK pathway is involved in regulating WDR35 expression.	[Huang, Lei; Kondo, Fumio; Feng, Guo-Gang; Ishikawa, Naohisa; Okada, Shoshiro] Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 48011, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Nagakute, Aichi 48011, Japan; [Harato, Misako; Fujiwara, Yoshihiro] Aichi Med Univ, Sch Med, Dept Anesthesiol, Nagakute, Aichi 48011, Japan; [Huang, Lei; Xia, Zhong-yuan] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan, Hubei, Peoples R China	Aichi Medical University; Aichi Medical University; Aichi Medical University; Wuhan University	Huang, L (corresponding author), Aichi Med Univ, Sch Med, Dept Pharmacol, Nagakute, Aichi 48011, Japan.	honey326@qq.com		xia, zhongyuan/0000-0002-5807-9554	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1101027];  [23790885]; Grants-in-Aid for Scientific Research [23592689] Funding Source: KAKEN	Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (No. 23790885) and by a Strategic Research Foundation Grant-aided Project for Private Universities grant (S1101027) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, CELL CYCLE, V10, P3452, DOI 10.4161/cc.10.20.17953; Bacino CA, 2012, AM J MED GENET A, V158A, P2917, DOI 10.1002/ajmg.a.35608; Bae CH, 2011, BIOCHEM BIOPH RES CO, V409, P669, DOI 10.1016/j.bbrc.2011.05.062; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Berisha SZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016729; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Fan JH, 2012, HEPATOL RES, V42, P696, DOI 10.1111/j.1872-034X.2012.00972.x; Feng GG, 2010, BIOCHEM BIOPH RES CO, V394, P153, DOI 10.1016/j.bbrc.2010.02.133; Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13; Harato M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-149; Huang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086336; Karniel M, 2000, MOL GENET METAB, V69, P40, DOI 10.1006/mgme.1999.2954; Kim SH, 2013, BIOCHEM BIOPH RES CO, V439, P66, DOI 10.1016/j.bbrc.2013.08.027; Kondo A, 2012, INT J MOL MED, V30, P1487, DOI 10.3892/ijmm.2012.1159; Lee SJ, 2010, J DENT RES, V89, P797, DOI 10.1177/0022034510366823; Lirk P, 2008, ANESTH ANALG, V106, P1456, DOI 10.1213/ane.0b013e318168514b; Lu J, 2011, EUR J PHARMACOL, V657, P51, DOI 10.1016/j.ejphar.2011.01.055; Lu J, 2011, PHARMACOLOGY, V87, P121, DOI 10.1159/000323402; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Nakamura Y, 2001, NEUROSCI RES, V39, P175, DOI 10.1016/S0168-0102(00)00209-1; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Park CJ, 2005, J DENT RES, V84, P852, DOI 10.1177/154405910508400914; Pfisterer SG, 2011, MOL PHARMACOL, V80, P1066, DOI 10.1124/mol.111.071761; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Sato Y, 2010, CLIN EXP NEPHROL, V14, P205, DOI 10.1007/s10157-010-0276-1; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Tsunekawa K, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-4; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Weisova P, 2011, ANTIOXID REDOX SIGN, V14, P1863, DOI 10.1089/ars.2010.3544; Wen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062942	34	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98185	10.1371/journal.pone.0098185	http://dx.doi.org/10.1371/journal.pone.0098185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859235	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400051
J	Kobori, M; Ni, YH; Takahashi, Y; Watanabe, N; Sugiura, M; Ogawa, K; Nagashimada, M; Kaneko, S; Naito, S; Ota, T				Kobori, Masuko; Ni, Yinhua; Takahashi, Yumiko; Watanabe, Natsumi; Sugiura, Minoru; Ogawa, Kazunori; Nagashimada, Mayumi; Kaneko, Shuichi; Naito, Shigehiro; Ota, Tsuguhito			beta-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; SERUM CAROTENOIDS; OXIDATIVE STRESS; CELLS; MODEL; ACTIVATION; DAMAGE; CONSUMPTION; FIBROSIS	Recent nutritional epidemiological surveys showed that serum beta-cryptoxanthin inversely associates with the risks for insulin resistance and liver dysfunction. Consumption of beta-cryptoxanthin possibly prevents nonalcoholic steatohepatitis (NASH), which is suggested to be caused by insulin resistance and oxidative stress from nonalcoholic fatty liver disease. To evaluate the effect of beta-cryptoxanthin on diet-induced NASH, we fed a high-cholesterol and high-fat diet (CL diet) with or without 0.003% beta-cryptoxanthin to C56BL/6J mice for 12 weeks. After feeding, beta-cryptoxanthin attenuated fat accumulation, increases in Kupffer and activated stellate cells, and fibrosis in CL diet-induced NASH in the mice. Comprehensive gene expression analysis showed that although beta-cryptoxanthin histochemically reduced steatosis, it was more effective in inhibiting inflammatory gene expression change in NASH. beta-Cryptoxanthin reduced the alteration of expression of genes associated with cell death, inflammatory responses, infiltration and activation of macrophages and other leukocytes, quantity of T cells, and free radical scavenging. However, it showed little effect on the expression of genes related to cholesterol and other lipid metabolism. The expression of markers of M1 and M2 macrophages, T helper cells, and cytotoxic T cells was significantly induced in NASH and reduced by beta-cryptoxanthin. beta-Cryptoxanthin suppressed the expression of lipopolysaccharide (LPS)-inducible and/or TNF alpha-inducible genes in NASH. Increased levels of the oxidative stress marker thiobarbituric acid reactive substances (TBARS) were reduced by beta-cryptoxanthin in NASH. Thus, beta-cryptoxanthin suppresses inflammation and the resulting fibrosis probably by primarily suppressing the increase and activation of macrophages and other immune cells. Reducing oxidative stress is likely to be a major mechanism of inflammation and injury suppression in the livers of mice with NASH.	[Kobori, Masuko; Takahashi, Yumiko; Watanabe, Natsumi; Naito, Shigehiro] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Ni, Yinhua; Nagashimada, Mayumi; Ota, Tsuguhito] Kanazawa Univ, Brain Liver Interface Med Res Ctr, Dept Cell Metab & Nutr, Kanazawa, Ishikawa, Japan; [Ni, Yinhua; Kaneko, Shuichi; Ota, Tsuguhito] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Sugiura, Minoru] Natl Agr & Food Res Org, Citrus Res Div, NARO Inst Fruit Tree Sci, Shimizu, Shizuoka, Japan; [Ogawa, Kazunori] Natl Agr & Food Res Org, Grape & Persimmon Res Div, NARO Inst Fruit Tree Sci, Higashihiroshima, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Kanazawa University; Kanazawa University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Kobori, M (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	kobori@affrc.go.jp	Yinhua, Ni/H-3079-2015	Yinhua, Ni/0000-0001-7738-5971	Ministry of Agriculture, Forestry and Fisheries; Kao Research Council for the Study of Healthcare Science; Japan Research Foundation for Clinical Pharmacology	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Kao Research Council for the Study of Healthcare Science; Japan Research Foundation for Clinical Pharmacology	Funding was provided by "New developmental project for practical technologies to promote policies for agriculture, forestry, and fisheries" (the Ministry of Agriculture, Forestry and Fisheries), Kao Research Council for the Study of Healthcare Science (T.O.), and Japan Research Foundation for Clinical Pharmacology (T.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haegele AD, 2000, CANCER EPIDEM BIOMAR, V9, P421; Ignatova ID, 2013, MOL ENDOCRINOL, V27, P1036, DOI 10.1210/me.2013-1051; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Kobori M, 2008, J AGR FOOD CHEM, V56, P4004, DOI 10.1021/jf800052y; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Labenski H, 2011, EUR J HUM GENET, V19, P1281, DOI 10.1038/ejhg.2011.129; Lorenzo Y, 2009, CARCINOGENESIS, V30, P308, DOI 10.1093/carcin/bgn270; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Nagai K, 2009, BRIT J PHARMACOL, V158, P907, DOI 10.1111/j.1476-5381.2009.00365.x; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Niwa M, 2009, BIOL PHARM BULL, V32, P203, DOI 10.1248/bpb.32.203; Ogawa K, 2013, J JPN SOC FOOD SCI, V60, P498; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71; Sugiura M, 2005, J EPIDEMIOL, V15, P180, DOI 10.2188/jea.15.180; Sugiura M, 2004, J NUTR SCI VITAMINOL, V50, P196, DOI 10.3177/jnsv.50.196; Sugiura M, 2002, J HEALTH SCI, V48, P350, DOI 10.1248/jhs.48.350; Sugiura M, 2013, BIOL PHARM BULL, V36, P147, DOI 10.1248/bpb.b12-00836; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Tucker KL, 1999, J NUTR, V129, P438, DOI 10.1093/jn/129.2.438; Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311; van Kappel AL, 2001, PUBLIC HEALTH NUTR, V4, P829, DOI 10.1079/PHN2000115; Wan J., 2013, HEPATOLOGY; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Westfall PH, 2011, P MULTTEST MULT COMP, P406; Zar JH, 1999, UNDERLYING ASSUMPTIO, P185; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783	42	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98294	10.1371/journal.pone.0098294	http://dx.doi.org/10.1371/journal.pone.0098294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858832	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400063
J	Meng, L; Wang, L; Tang, HY; Tang, XF; Jiang, XY; Zhao, JH; Gao, J; Li, B; Fu, XH; Chen, Y; Yao, WY; Zhan, WY; Wu, B; Duan, DW; Shen, CB; Cheng, H; Zuo, XB; Yang, S; Sun, LD; Zhang, XJ				Meng, Li; Wang, Li; Tang, Huayang; Tang, Xianfa; Jiang, Xiaoyun; Zhao, Jinhua; Gao, Jing; Li, Bing; Fu, Xuhui; Chen, Yan; Yao, Weiyi; Zhan, Wenying; Wu, Bo; Duan, Dawei; Shen, Changbing; Cheng, Hui; Zuo, Xianbo; Yang, Sen; Sun, Liangdan; Zhang, Xuejun			Filaggrin Gene Mutation c.3321delA Is Associated with Various Clinical Features of Atopic Dermatitis in the Chinese Han Population	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; CAUSE ICHTHYOSIS VULGARIS; NULL MUTATIONS; SKIN PHENOTYPE; EARLY-ONSET; ECZEMA; PREDISPOSE; PREVALENT; CHILDREN; ACID	Background: We confirmed that the filaggrin gene mutation c.3321delA is associated with atopic dermatitis in our previous genome wide association study of the Chinese Han population. c.3321delA is the most common filaggrin gene mutation in Chinese atopic dermatitis patients but is not present in European populations. Objective: To investigate the genetic model for the c.3321delA mutation and to determine the correlation between c.3321delA and atopic dermatitis clinical phenotypes in the Chinese Han population. Method: The filaggrin gene mutation c.3321delA was sequenced in 1,080 atopic dermatitis patients and 908 controls from the Chinese population. The x 2 test, ANOVA, nonparametric tests and logistic regression were used to investigate the relationship between the c.3321delA genotype and atopic dermatitis clinical phenotypes in the Chinese Han population. Results: Analyses of the genetic model revealed that the additive model best described the c.3321delA mutation (P = 3.09E-11, OR = 3.43, 95% CI = 2.38-4.96). Stratified analyses showed that the c.3321delA allele frequency distribution is significantly associated with concomitant skin xerosis (P = 1.68E-03, OR = 2.13,95% CI = 1.32-3.46), palmar hyperlinearity (P = 3.64E-17, OR = 4.0,95% CI = 2.86-5.70), white dermatographism (P = 4.25E-03, OR = 1.82,95% CI = 1.22-2.71), food intolerance (P = 1.51E-03, OR = 1.76,95% CI = 1.23-2.50) and disease severity (P = 9.67E-05). Conclusion: Our study indicates that the filaggrin gene mutation c.3321delA is associated with clinical phenotypes of atopic dermatitis in the Chinese Han population, which might help us gain a better understanding on the pathogenesis of atopic dermatitis.	[Meng, Li; Wang, Li; Tang, Huayang; Tang, Xianfa; Jiang, Xiaoyun; Zhao, Jinhua; Gao, Jing; Li, Bing; Fu, Xuhui; Chen, Yan; Yao, Weiyi; Zhan, Wenying; Wu, Bo; Duan, Dawei; Shen, Changbing; Cheng, Hui; Zuo, Xianbo; Yang, Sen; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, Inst Dermatol, Hefei, Anhui, Peoples R China; [Meng, Li; Wang, Li; Tang, Huayang; Tang, Xianfa; Jiang, Xiaoyun; Zhao, Jinhua; Gao, Jing; Li, Bing; Fu, Xuhui; Chen, Yan; Yao, Weiyi; Zhan, Wenying; Wu, Bo; Duan, Dawei; Shen, Changbing; Cheng, Hui; Zuo, Xianbo; Yang, Sen; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Anhui, Peoples R China; [Meng, Li; Wang, Li; Tang, Huayang; Tang, Xianfa; Jiang, Xiaoyun; Zhao, Jinhua; Gao, Jing; Li, Bing; Fu, Xuhui; Chen, Yan; Yao, Weiyi; Zhan, Wenying; Wu, Bo; Duan, Dawei; Shen, Changbing; Cheng, Hui; Zuo, Xianbo; Yang, Sen; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Meng, Li; Wang, Li; Tang, Huayang; Tang, Xianfa; Jiang, Xiaoyun; Zhao, Jinhua; Gao, Jing; Li, Bing; Fu, Xuhui; Chen, Yan; Yao, Weiyi; Zhan, Wenying; Wu, Bo; Duan, Dawei; Shen, Changbing; Cheng, Hui; Zuo, Xianbo; Yang, Sen; Sun, Liangdan; Zhang, Xuejun] Anhui Med Univ, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Zhang, Xuejun] Anhui Med Univ, Dept Dermatol, Hosp 2, Hefei, Anhui, Peoples R China; [Zhang, Xuejun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Fudan University	Zhang, XJ (corresponding author), Anhui Med Univ, Inst Dermatol, Hefei, Anhui, Peoples R China.	ahmusld@163.com; ayzxj@vip.sina.com	Zhao, Jinhua/GYV-4433-2022		General Program of National Natural Science Foundation of China [31171224, 31000528]; Program for New Century Excellent Talents in University [NCET-11-0889]; Science and Technological Foundation of Anhui Province for Outstanding Youth [1108085J10]; Pre-project of State Key Basic Research Program 973 of China [2012CB722404]; Hospital incubation program [3101005002354]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Science and Technological Foundation of Anhui Province for Outstanding Youth; Pre-project of State Key Basic Research Program 973 of China; Hospital incubation program	This study was funded by General Program of National Natural Science Foundation of China (31171224, 31000528), Program for New Century Excellent Talents in University (NCET-11-0889), Science and Technological Foundation of Anhui Province for Outstanding Youth (1108085J10), Pre-project of State Key Basic Research Program 973 of China (No. 2012CB722404), and Hospital incubation program (3101005002354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Brown SJ, 2009, BRIT J DERMATOL, V161, P884, DOI 10.1111/j.1365-2133.2009.09339.x; Brown SJ, 2008, J INVEST DERMATOL, V128, P1591, DOI 10.1038/sj.jid.5701206; Carson CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048678; Chen H, 2011, BRIT J DERMATOL, V165, P106, DOI 10.1111/j.1365-2133.2011.10331.x; Cheng RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049158; Enomoto H, 2008, J HUM GENET, V53, P615, DOI 10.1007/s10038-008-0293-z; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Ginger RS, 2005, ARCH DERMATOL RES, V297, P235, DOI 10.1007/s00403-005-0590-8; Greisenegger EK, 2010, J EUR ACAD DERMATOL, V24, P607, DOI 10.1111/j.1468-3083.2009.03469.x; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; HORII I, 1989, BRIT J DERMATOL, V121, P587, DOI 10.1111/j.1365-2133.1989.tb08190.x; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; JACOBSON TM, 1990, J INVEST DERMATOL, V95, P296, DOI 10.1111/1523-1747.ep12484970; Li M, 2013, J EUR ACAD DERMATOL, V27, P169, DOI 10.1111/j.1468-3083.2011.04435.x; Linneberg A, 2013, INT ARCH ALLERGY IMM, V161, P234, DOI 10.1159/000345949; Ma L, 2010, BRIT J DERMATOL, V162, P225, DOI 10.1111/j.1365-2133.2009.09539.x; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; McLoone P, 2005, J INVEST DERMATOL, V124, P1071, DOI 10.1111/j.0022-202X.2005.23731.x; MEVORAH B, 1985, BRIT J DERMATOL, V112, P679, DOI 10.1111/j.1365-2133.1985.tb02336.x; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Novak N, 2008, J INVEST DERMATOL, V128, P1430, DOI 10.1038/sj.jid.5701190; Poninska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016933; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; Schuttelaar MLA, 2009, ALLERGY, V64, P1758, DOI 10.1111/j.1398-9995.2009.02080.x; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035334; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weidinger S, 2007, J INVEST DERMATOL, V127, P724, DOI 10.1038/sj.jid.5700630; Williams H, 2008, J ALLERGY CLIN IMMUN, V121, P947, DOI 10.1016/j.jaci.2007.11.004; Zhang H, 2011, ALLERGY, V66, P420, DOI 10.1111/j.1398-9995.2010.02493.x	38	23	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98235	10.1371/journal.pone.0098235	http://dx.doi.org/10.1371/journal.pone.0098235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858702	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400060
J	Sebastiana, M; Vieira, B; Lino-Neto, T; Monteiro, F; Figueiredo, A; Sousa, L; Pais, MS; Tavares, R; Paulo, OS				Sebastiana, Monica; Vieira, Bruno; Lino-Neto, Teresa; Monteiro, Filipa; Figueiredo, Andreia; Sousa, Lisete; Pais, Maria Salome; Tavares, Rui; Paulo, Octaavio S.			Oak Root Response to Ectomycorrhizal Symbiosis Establishment: RNA-Seq Derived Transcript Identification and Expression Profiling	PLOS ONE			English	Article							FUNGUS LACCARIA-BICOLOR; RECEPTOR-LIKE KINASES; PISOLITHUS-TINCTORIUS; ARABIDOPSIS-THALIANA; SECRETORY PATHWAY; PINUS-SYLVESTRIS; CELL-FATE; PLANT; PROTEIN; FLAVONOIDS	Ectomycorrhizal symbiosis is essential for the life and health of trees in temperate and boreal forests where it plays a major role in nutrient cycling and in functioning of the forest ecosystem. Trees with ectomycorrhizal root tips are more tolerant to environmental stresses, such as drought, and biotic stresses such as root pathogens. Detailed information on these molecular processes is essential for the understanding of symbiotic tissue development in order to optimize the benefits of this natural phenomenon. Next generation sequencing tools allow the analysis of non model ectomycorrhizal plant-fungal interactions that can contribute to find the "symbiosis toolkits'' and better define the role of each partner in the mutualistic interaction. By using 454 pyrosequencing we compared ectomycorrhizal cork oak roots with non-symbiotic roots. From the two cDNA libraries sequenced, over 2 million reads were obtained that generated 19552 cork oak root unique transcripts. A total of 2238 transcripts were found to be differentially expressed when ECM roots were compared with non-symbiotic roots. Identification of up-and down-regulated gens in ectomycorrhizal roots lead to a number of insights into the molecular mechanisms governing this important symbiosis. In cork oak roots, ectomycorrhizal colonization resulted in extensive cell wall remodelling, activation of the secretory pathway, alterations in flavonoid biosynthesis, and expression of genes involved in the recognition of fungal effectors. In addition, we identified genes with putative roles in symbiotic processes such as nutrient exchange with the fungal partner, lateral root formation or root hair decay. These findings provide a global overview of the transcriptome of an ectomycorrhizal host root, and constitute a foundation for future studies on the molecular events controlling this important symbiosis.	[Sebastiana, Monica; Monteiro, Filipa; Figueiredo, Andreia; Pais, Maria Salome] Univ Lisbon, Fac Sci, Plant Syst Biol Lab, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal; [Vieira, Bruno; Paulo, Octaavio S.] Univ Lisbon, Fac Sci, Ctr Environm Biol, P-1699 Lisbon, Portugal; [Lino-Neto, Teresa; Tavares, Rui] Univ Minho, Plant Funct Biol Ctr, Ctr Biodivers Funct & Integrat Genom, Braga, Portugal; [Sousa, Lisete] Univ Lisbon, Fac Sci, Dept Stat & Operat Res, Ctr Stat & Applicat Lisbon Univ, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade do Minho; Universidade de Lisboa	Sebastiana, M (corresponding author), Univ Lisbon, Fac Sci, Plant Syst Biol Lab, Ctr Biodivers Funct & Integrat Genom, P-1699 Lisbon, Portugal.	mgsebastiana@fc.ul.pt	Tavares, Rui M/D-9692-2012; Lino-Neto, Teresa/D-9691-2012; Sousa, Lisete M R/M-1842-2015; Sebastiana, Monica/M-7415-2015; Monteiro, Filipa/I-6116-2012; Paulo, Octávio/D-9921-2011; Figueiredo, Andreia/G-2887-2014	Tavares, Rui M/0000-0002-1702-256X; Lino-Neto, Teresa/0000-0002-1385-4799; Sousa, Lisete M R/0000-0002-2114-720X; Sebastiana, Monica/0000-0001-8735-7632; Monteiro, Filipa/0000-0002-1505-2140; Paulo, Octávio/0000-0001-5408-5212; Figueiredo, Andreia/0000-0001-8156-7700; Vieira, Bruno/0000-0002-4878-6431	Portuguese Foundation for Science and Technology in the frame of the project Cork Oak EST Consortium [SOBREIRO/0034/2009]; Portuguese Foundation for Science and Technology [SFRH/BPD/25661/2005]	Portuguese Foundation for Science and Technology in the frame of the project Cork Oak EST Consortium; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was funded by the Portuguese Foundation for Science and Technology (www.fct.pt) in the frame of the project Cork Oak EST Consortium SOBREIRO/0034/2009. Post-doc grant to MS was supported by the Portuguese Foundation for Science and Technology (SFRH/BPD/25661/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barkefors I, 2011, J BIOL CHEM, V286, P24189, DOI 10.1074/jbc.M110.212209; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Cairney JWG, 1997, MYCORRHIZA, V7, P117, DOI 10.1007/s005720050172; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DENFERT C, 1992, EMBO J, V11, P4205, DOI 10.1002/j.1460-2075.1992.tb05514.x; Ditengou FA, 2000, PLANTA, V211, P722, DOI 10.1007/s004250000342; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Duplessis S, 2005, NEW PHYTOL, V165, P599, DOI 10.1111/j.1469-8137.2004.01248.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; El-Kasmi F, 2011, PLANT J, V66, P268, DOI 10.1111/j.1365-313X.2011.04487.x; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Felten J, 2010, PLANT SIGNAL BEHAV, V5, P864, DOI [10.4161/psb.5.7.11896, 10.1104/pp.109.147231]; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Flores-Monterroso A, 2013, PLANTA, V237, P1637, DOI 10.1007/s00425-013-1874-4; Fotelli MN, 2011, J EXP BOT, V62, P2959, DOI 10.1093/jxb/err009; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Gebbie LK, 2005, J EXP BOT, V56, P1079, DOI 10.1093/jxb/eri099; Gutjahr C, 2009, NEW PHYTOL, V183, P53, DOI 10.1111/j.1469-8137.2009.02871.x; Hancock KR, 2012, PLANT PHYSIOL, V159, P1204, DOI 10.1104/pp.112.195420; Heller G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-19; Heller G, 2012, MYCORRHIZA, V22, P271, DOI 10.1007/s00572-011-0402-2; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Hobson G., 1993, BIOCH FRUIT RIPENING, P405, DOI [DOI 10.1007/978-94-011-1584-1_14, 10.1007/978-94-011-1584-1_14]; HORAN DP, 1988, NEW PHYTOL, V109, P451, DOI 10.1111/j.1469-8137.1988.tb03720.x; Johansson T, 2004, MOL PLANT MICROBE IN, V17, P202, DOI 10.1094/MPMI.2004.17.2.202; Kikuchi K, 2007, MYCORRHIZA, V17, P563, DOI 10.1007/s00572-007-0131-8; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Kusano H, 2008, PLANT CELL, V20, P367, DOI 10.1105/tpc.107.056119; Larsen PE, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-70; Le Quere A, 2005, MOL PLANT MICROBE IN, V18, P659, DOI 10.1094/MPMI-18-0659; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2007, CURR OPIN PLANT BIOL, V10, P204, DOI 10.1016/j.pbi.2007.01.006; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MORANDI D, 1992, AGRONOMIE, V12, P811, DOI 10.1051/agro:19921012; Morandi D, 2009, MYCORRHIZA, V19, P435, DOI 10.1007/s00572-009-0242-5; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muller T, 2007, PHYTOCHEMISTRY, V68, P41, DOI 10.1016/j.phytochem.2006.09.021; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Nehls U, 2007, PHYTOCHEMISTRY, V68, P82, DOI 10.1016/j.phytochem.2006.09.024; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; Nomura M, 2006, PLANT CELL PHYSIOL, V47, P613, DOI 10.1093/pcp/pcj028; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Peleg-Grossman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008399; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose JKC, 2010, PLANT PHYSIOL, V153, P433, DOI 10.1104/pp.110.154872; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Sebastiana M, 2013, NEW FOREST, V44, P937, DOI 10.1007/s11056-013-9386-4; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Song SK, 2011, PLANT PHYSIOL, V157, P1196, DOI 10.1104/pp.111.185785; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Sulieman S, 2011, PLANT SIGNAL BEHAV, V6, P32, DOI 10.4161/psb.6.1.14318; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Trillas MI, 2000, PHYSIOL MOL PLANT P, V56, P107, DOI 10.1006/pmpp.1999.0254; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang D, 2011, MOL PLANT, V4, P581, DOI 10.1093/mp/ssr053; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wu XQ, 2008, J PROTEOME RES, V7, P4299, DOI 10.1021/pr800241u; Zhao J, 2010, PLANT PHYSIOL, V153, P437, DOI 10.1104/pp.110.155432	87	33	34	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98376	10.1371/journal.pone.0098376	http://dx.doi.org/10.1371/journal.pone.0098376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859293	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400072
J	Song, K; Yoon, IS; Kim, NA; Kim, DH; Lee, J; Lee, HJ; Lee, S; Choi, S; Choi, MK; Kim, HH; Jeong, SH; Son, WS; Kim, DD; Shin, YK				Song, Kyoung; Yoon, In-Soo; Kim, Nam Ah; Kim, Dong-Hwan; Lee, Jongmin; Lee, Hee Jung; Lee, Saehyung; Choi, Sunghyun; Choi, Min-Koo; Kim, Ha Hyung; Jeong, Seong Hoon; Son, Woo Sung; Kim, Dae-Duk; Shin, Young Kee			Glycoengineering of Interferon-beta 1a Improves Its Biophysical and Pharmacokinetic Properties	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; POLYETHYLENE-GLYCOL; PROTEIN AGGREGATION; RECEPTOR-BINDING; GLYCOSYLATION; SITE; PATHOGENESIS; PEGYLATION; THERAPIES; STABILITY	The purpose of this study was to develop a biobetter version of recombinant human interferon-beta 1a (rhIFN-beta 1a) to improve its biophysical properties, such as aggregation, production and stability, and pharmacokinetic properties without jeopardizing its activity. To achieve this, we introduced additional glycosylation into rhIFN-beta 1a via site-directed mutagenesis. Glycoengineering of rhIFN-beta 1a resulted in a new molecular entity, termed R27T, which was defined as a rhIFN-beta mutein with two N-glycosylation sites at 80th (original site) and at an additional 25th amino acid due to a mutation of Thr for Arg at position 27th of rhIFN-beta 1a. Glycoengineering had no effect on rhIFN-beta ligand-receptor binding, as no loss of specific activity was observed. R27T showed improved stability and had a reduced propensity for aggregation and an increased half-life. Therefore, hyperglycosylated rhIFN-beta could be a biobetter version of rhIFN-beta 1a with a potential for use as a drug against multiple sclerosis.	[Song, Kyoung; Kim, Dong-Hwan; Lee, Saehyung; Kim, Dae-Duk; Shin, Young Kee] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Song, Kyoung; Kim, Dong-Hwan; Lee, Saehyung; Kim, Dae-Duk; Shin, Young Kee] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Shin, Young Kee] Seoul Natl Univ, Inst Entrepreneurial BioConvergence, Seoul, South Korea; [Song, Kyoung; Lee, Hee Jung; Choi, Sunghyun] Res Inst Reference Biolabs Inc, Seoul, South Korea; [Yoon, In-Soo] Mokpo Natl Univ, Coll Pharm, Jeonnam, South Korea; [Yoon, In-Soo] Mokpo Natl Univ, Nat Med Res Inst, Jeonnam, South Korea; [Kim, Nam Ah; Jeong, Seong Hoon] Dongguk Univ Seoul, Coll Pharm, Gyeonggi Do, South Korea; [Lee, Jongmin] PanGen Biotech Inc, Gyeonggi Do, South Korea; [Choi, Min-Koo] DanKook Univ, Coll Pharm, Chungnam, South Korea; [Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Biotherapeut & Glyc Lab, Seoul 156756, South Korea; [Son, Woo Sung] CHA Univ, Coll Pharm, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Mokpo National University; Mokpo National University; Dongguk University; Dankook University; Chung Ang University; Pochon Cha University	Shin, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ykeeshin@snu.ac.kr	Shin, Young Kee/C-8929-2011; Yoon, In-Soo/ABG-2948-2021; Kim, Dae Duk/D-8864-2013	Shin, Young Kee/0000-0003-0896-718X; Yoon, In-Soo/0000-0002-0997-5723; 	Basic Science Research Program through the National Research Foundation (NRF) [NRF-2012R1A1A1043288]; Korea Drug Development Fund of Korea - Ministry of Education, Science and Technology [20100030032]	Basic Science Research Program through the National Research Foundation (NRF); Korea Drug Development Fund of Korea - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation (NRF)(NRF-2012R1A1A1043288, URL https://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none) and Project through Korea Drug Development Fund (20100030032, URL http://www.kddf.org/Main/) of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2012, INT J MOL SCI, V13, P13438, DOI 10.3390/ijms131013438; Basma M, 2001, J COMPUT CHEM, V22, P1125, DOI 10.1002/jcc.1072; Castro-Borrero W, 2012, THER ADV NEUROL DISO, V5, P205, DOI 10.1177/1756285612450936; de Seze J, 2012, PATIENT PREFER ADHER, V6, P263, DOI 10.2147/PPA.S27038; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; DERYNCK R, 1980, NATURE, V287, P193, DOI 10.1038/287193a0; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; Fan HH, 2005, J PHARM SCI-US, V94, P1893, DOI 10.1002/jps.20410; Fang YW, 2009, PERITON DIALYSIS INT, V29, P199; Fitzner D, 2010, CURR NEUROPHARMACOL, V8, P305, DOI 10.2174/157015910792246218; Gasperini C, 2011, EXPERT OPIN EMERG DR, V16, P697, DOI 10.1517/14728214.2011.642861; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hubbard S. J., 1993, NACCESS; KAGAWA Y, 1988, J BIOL CHEM, V263, P17508; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; Karpusas M, 1998, CELL MOL LIFE SCI, V54, P1203, DOI 10.1007/s000180050248; KATRE NV, 1993, ADV DRUG DELIVER REV, V10, P91, DOI 10.1016/0169-409X(93)90005-O; Kieseier BC, 2012, CNS DRUGS, V26, P205, DOI 10.2165/11596970-000000000-00000; Kim JE, 2013, XENOBIOTICA, V43, P579, DOI 10.3109/00498254.2012.751140; Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798; Kirschner KN, 2001, J PHYS CHEM A, V105, P4150, DOI 10.1021/jp004413y; KNIGHT P, 1989, BIO-TECHNOL, V7, P35, DOI 10.1038/nbt0189-35; MARK DF, 1984, P NATL ACAD SCI-BIOL, V81, P5662, DOI 10.1073/pnas.81.18.5662; Nicholas R, 2011, DRUG DES DEV THER, V5, P255, DOI 10.2147/DDDT.S10498; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pepinsky RB, 2001, J PHARMACOL EXP THER, V297, P1059; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quadt-Akabayov SR, 2006, PROTEIN SCI, V15, P2656, DOI 10.1110/ps.062283006; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Rodriguez J, 2010, J BIOTECHNOL, V150, P509, DOI 10.1016/j.jbiotec.2010.09.959; Runkel L, 1998, J BIOL CHEM, V273, P8003, DOI 10.1074/jbc.273.14.8003; Runkel L, 2000, BIOCHEMISTRY-US, V39, P2538, DOI 10.1021/bi991631c; Runkel L, 1998, PHARM RES-DORDR, V15, P641, DOI 10.1023/A:1011974512425; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wanic-Kossowska Maria, 2006, Pol Arch Med Wewn, V116, P663; Watt GM, 2003, CHEM BIOL, V10, P807, DOI 10.1016/j.chembiol.2003.08.006; Yang CH, 2004, J BIOMOL STRUCT DYN, V22, P101, DOI 10.1080/07391102.2004.10506985; Yoon I, 2012, XENOBIOTICA, V42, P1110, DOI 10.3109/00498254.2012.700139	43	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96967	10.1371/journal.pone.0096967	http://dx.doi.org/10.1371/journal.pone.0096967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858932	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400007
J	Hao, XP; Xing, YZ; Moore, MW; Zhang, JN; Han, DM; Schulte, BA; Dubno, JR; Lang, HN				Hao, Xinping; Xing, Yazhi; Moore, Michael W.; Zhang, Jianning; Han, Demin; Schulte, Bradley A.; Dubno, Judy R.; Lang, Hainan			Sox10 Expressing Cells in the Lateral Wall of the Aged Mouse and Human Cochlea	PLOS ONE			English	Article							SPIRAL LIGAMENT PATHOLOGY; STRIA VASCULARIS; INNER-EAR; CARBONIC-ANHYDRASE; MARGINAL CELLS; FINE-STRUCTURE; K+ CHANNEL; FIBROCYTES; LOCALIZATION; MECHANISMS	Age-related hearing loss (presbycusis) is a common human disorder, affecting one in three Americans aged 60 and over. Previous studies have shown that presbyacusis is associated with a loss of non-sensory cells in the cochlear lateral wall. Sox10 is a transcription factor crucial to the development and maintenance of neural crest-derived cells including some non-sensory cell types in the cochlea. Mutations of the Sox10 gene are known to cause various combinations of hearing loss and pigmentation defects in humans. This study investigated the potential relationship between Sox10 gene expression and pathological changes in the cochlear lateral wall of aged CBA/CaJ mice and human temporal bones from older donors. Cochlear tissues prepared from young adult (1-3 month-old) and aged (2-2.5 year-old) mice, and human temporal bone donors were examined using quantitative immunohistochemical analysis and transmission electron microscopy. Cells expressing Sox10 were present in the stria vascularis, outer sulcus and spiral prominence in mouse and human cochleas. The Sox10(+) cell types included marginal and intermediate cells and outer sulcus cells, including those that border the scala media and those extending into root processes (root cells) in the spiral ligament. Quantitative analysis of immunostaining revealed a significant decrease in the number of Sox10(+) marginal cells and outer sulcus cells in aged mice. Electron microscopic evaluation revealed degenerative alterations in the surviving Sox10(+) cells in aged mice. Strial marginal cells in human cochleas from donors aged 87 and older showed only weak immunostaining for Sox10. Decreases in Sox10 expression levels and a loss of Sox10(+) cells in both mouse and human aged ears suggests an important role of Sox10 in the maintenance of structural and functional integrity of the lateral wall. A loss of Sox10(+) cells may also be associated with a decline in the repair capabilities of non-sensory cells in the aged ear.	[Hao, Xinping; Han, Demin] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Hao, Xinping; Xing, Yazhi; Zhang, Jianning; Schulte, Bradley A.; Dubno, Judy R.; Lang, Hainan] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Moore, Michael W.; Schulte, Bradley A.; Dubno, Judy R.] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA; [Zhang, Jianning] Shanghai Yueyang Integrated Med Hosp, Dept Otolaryngol, Shanghai, Peoples R China	Capital Medical University; Medical University of South Carolina; Medical University of South Carolina	Han, DM (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	handm@trhos.com; langh@musc.edu	Xing, Yazhi/HDO-1842-2022; Xing, Yazhi/GVU-8191-2022	Xing, Yazhi/0000-0001-8975-7242; Lang, Hainan/0000-0003-2210-7856	National Institutes of Health (NIH) [NIH DC12058, NIH DC00422]; South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award [NIH/NCRR UL1RR029882]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC000422, P01DC000422, R01DC012058] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH), Grant number: NIH DC12058 (HL), Grant number: NIH DC00422 (HL, JRD). This work also benefited from the South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award (NIH/NCRR UL1RR029882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 1999, CELL TISSUE RES, V298, P179, DOI 10.1007/s004419900066; ANNIKO M, 1980, ARCH OTO-RHINO-LARYN, V229, P281, DOI 10.1007/BF02565531; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Cunningham CD, 2001, LARYNGOSCOPE, V111, P278, DOI 10.1097/00005537-200102000-00017; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hibino H, 1997, J NEUROSCI, V17, P4711; Hibino H, 2004, EUR J NEUROSCI, V19, P76, DOI 10.1111/j.1460-9568.2004.03092.x; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; HIEBER V, 1989, J NEUROSCI RES, V23, P9, DOI 10.1002/jnr.490230103; HILDING DA, 1977, ACTA OTO-LARYNGOL, V84, P24, DOI 10.3109/00016487709123939; HINOJOSA R, 1966, AM J ANAT, V118, P631, DOI 10.1002/aja.1001180218; Jagger DJ, 2010, J ASS RES OTOLARYNGO; Jagger DJ, 2012, HEARING RES, V303, P1; JAHNKE K, 1975, ANAT EMBRYOL, V147, P189, DOI 10.1007/BF00306733; Kelsh RN, 2002, RES PRO CEL, V40, P216; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kusunoki T, 2004, OTOLARYNG HEAD NECK, V131, P897, DOI 10.1016/j.otohns.2004.05.022; Lang H, 2003, JARO-J ASSOC RES OTO, V4, P164, DOI 10.1007/s10162-002-2056-4; Lang H, 2013, ASS RES OT ABSTR, V35, P905; Lang HN, 2011, JARO-J ASSOC RES OTO, V12, P151, DOI 10.1007/s10162-010-0244-1; Lang HN, 2010, JARO-J ASSOC RES OTO, V11, P419, DOI 10.1007/s10162-010-0214-7; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; LIM DJ, 1983, AM J OTOLARYNG, V4, P33, DOI 10.1016/S0196-0709(83)80005-2; LOWE N, 1991, GENOMICS, V10, P882, DOI 10.1016/0888-7543(91)90176-F; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mistrik P, 2009, J R SOC INTERFACE, V6, P279, DOI 10.1098/rsif.2008.0201; Neng LL, 2013, JARO-J ASSOC RES OTO, V14, P175, DOI 10.1007/s10162-012-0365-9; Ohlemiller KK, 2006, HEARING RES, V220, P10, DOI 10.1016/j.heares.2006.06.012; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Ohlemiller KK, 2009, BRAIN RES, V1277, P70, DOI 10.1016/j.brainres.2009.02.079; Patuzzi R, 2011, HEARING RES, V277, P4, DOI 10.1016/j.heares.2011.01.010; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; SALT AN, 1987, LARYNGOSCOPE, V97, P984; Santi PA, 2005, OTOLARYNGOLOGY HEAD; SANTOS-SACCHI J, 1982, HEARING RES, V6, P7, DOI 10.1016/0378-5955(82)90003-X; Schlierf B, 2006, J MOL BIOL, V361, P11, DOI 10.1016/j.jmb.2006.05.072; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Schmiedt RA, 2010, SPRINGER HANDB AUDIT, V34, P9, DOI 10.1007/978-1-4419-0993-0_2; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SCHULNECHT H, 1968, Archives of Otolaryngology, V87, P129; SCHULTE BA, 1992, HEARING RES, V61, P35, DOI 10.1016/0378-5955(92)90034-K; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P127, DOI 10.1177/37.2.2536055; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; SPICER SS, 1990, AM J ANAT, V187, P55, DOI 10.1002/aja.1001870107; Spicer SS, 2005, HEARING RES, V205, P225, DOI 10.1016/j.heares.2005.03.022; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; SPICER SS, 1991, HEARING RES, V56, P53, DOI 10.1016/0378-5955(91)90153-Z; Spicer SS, 1997, HEARING RES, V111, P93, DOI 10.1016/S0378-5955(97)00097-X; Steel KP, 1999, SCIENCE, V285, P1363, DOI 10.1126/science.285.5432.1363; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Thomopoulos GN, 1997, HEARING RES, V111, P31, DOI 10.1016/S0378-5955(97)00080-4; Wakaoka T, 2013, HEARING RES, V302, P17, DOI 10.1016/j.heares.2013.05.003; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Watanabe K, 2000, MOL BRAIN RES, V84, P141, DOI 10.1016/S0169-328X(00)00236-9; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500	72	15	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97389	10.1371/journal.pone.0097389	http://dx.doi.org/10.1371/journal.pone.0097389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887110	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300017
J	Bassaganas, S; Carvalho, S; Dias, AM; Perez-Garay, M; Ortiz, MR; Figueras, J; Reis, CA; Pinho, SS; Peracaula, R				Bassaganas, Sonia; Carvalho, Sandra; Dias, Ana M.; Perez-Garay, Marta; Ortiz, M. Rosa; Figueras, Joan; Reis, Celso A.; Pinho, Salome S.; Peracaula, Rosa			Pancreatic Cancer Cell Glycosylation Regulates Cell Adhesion and Invasion through the Modulation of alpha 2 beta 1 Integrin and E-Cadherin Function	PLOS ONE			English	Article							N-GLYCOSYLATION; MALIGNANT PHENOTYPE; ACID RESIDUES; I COLLAGEN; EXPRESSION; MIGRATION; ADENOCARCINOMA; SURFACE; METASTASIS; PROMOTES	In our previous studies we have described that ST3Gal III transfected pancreatic adenocarcinoma Capan-1 and MDAPanc-28 cells show increased membrane expression levels of sialyl-Lewis x (SLe(x)) along with a concomitant decrease in alpha 2,6-sialic acid compared to control cells. Here we have addressed the role of this glycosylation pattern in the functional properties of two glycoproteins involved in the processes of cancer cell invasion and migration, alpha 2 beta 1 integrin, the main receptor for type 1 collagen, and E-cadherin, responsible for cell-cell contacts and whose deregulation determines cell invasive capabilities. Our results demonstrate that ST3Gal III transfectants showed reduced cell-cell aggregation and increased invasive capacities. ST3Gal III transfected Capan-1 cells exhibited higher SLe(x) and lower alpha 2,6-sialic acid content on the glycans of their alpha 2 beta 1 integrin molecules. As a consequence, higher phosphorylation of focal adhesion kinase tyrosine 397, which is recognized as one of the first steps of integrin-derived signaling pathways, was observed in these cells upon adhesion to type 1 collagen. This molecular mechanism underlies the increased migration through collagen of these cells. In addition, the pancreatic adenocarcinoma cell lines as well as human pancreatic tumor tissues showed colocalization of SLe(x) and Ecadherin, which was higher in the ST3Gal III transfectants. In conclusion, changes in the sialylation pattern of alpha 2 beta 1 integrin and E-cadherin appear to influence the functional role of these two glycoproteins supporting the role of these glycans as an underlying mechanism regulating pancreatic cancer cell adhesion and invasion.	[Bassaganas, Sonia; Perez-Garay, Marta; Peracaula, Rosa] Univ Girona, Dept Biol, Biochem & Mol Biol Unit, Girona, Spain; [Carvalho, Sandra; Dias, Ana M.; Reis, Celso A.; Pinho, Salome S.] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Ortiz, M. Rosa] Dr Josep Trueta Univ Hosp, Dept Pathol, Girona, Spain; [Figueras, Joan] Dr Josep Trueta Univ Hosp, Dept Surg, IdIBGi, Girona, Spain; [Carvalho, Sandra; Dias, Ana M.; Reis, Celso A.; Pinho, Salome S.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Oporto, Portugal; [Reis, Celso A.] Univ Porto, Fac Med, Oporto, Portugal	Universitat de Girona; Universidade do Porto; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universidade do Porto; Universidade do Porto	Pinho, SS (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	salomep@ipatimup.pt; rosa.peracaula@udg.edu	Dias, Ana/AAE-8828-2020; Carvalho, Sandra/ABA-8715-2020; Carvalho, Sandra S/K-1724-2016; REIS, Celso A/B-9969-2008; Pinho, Salome/F-1764-2011	Carvalho, Sandra/0000-0003-3647-3582; Carvalho, Sandra S/0000-0003-3647-3582; REIS, Celso A/0000-0002-0286-6639; Peracaula, Rosa/0000-0003-3513-524X; Dias, Ana/0000-0003-0060-2872; Pinho, Salome/0000-0002-3484-5162; Ortiz, Rosa/0000-0002-8973-0493	Spanish Ministery of Science and Innovation [BIO 2010-16922]; La Marato de TV3 Foundation [050932]; Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/111358/2009, PTDC/BBB-EBI/0786/2012, EXPL/BIM-MEC/0149/ 2012]; "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER'; e do Quadro de Referencia Estrategia Nacional QREN; FCT; Government of Catalonia for a pre-doctoral fellowship; University of Girona for a mobility grant; SSP [SFRH/BPD/63094/2009]; SC [SFRH/BD/77386/2011]	Spanish Ministery of Science and Innovation(European Commission); La Marato de TV3 Foundation; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER'; e do Quadro de Referencia Estrategia Nacional QREN; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Government of Catalonia for a pre-doctoral fellowship; University of Girona for a mobility grant; SSP; SC	This work was supported by grants from the Spanish Ministery of Science and Innovation [grant BIO 2010-16922], La Marato de TV3 Foundation [grant 050932], the Portuguese Foundation for Science and Technology (FCT), project grants [PTDC/CVT/111358/2009; PTDC/BBB-EBI/0786/2012; EXPL/BIM-MEC/0149/ 2012], "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER'', e do Quadro de Referencia Estrategia Nacional QREN. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT. SB acknowledges the Government of Catalonia for a pre-doctoral fellowship and the University of Girona for a mobility grant. SSP [SFRH/BPD/63094/2009] and SC [SFRH/BD/77386/2011] also acknowledge FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bassaganas S, 2014, PANCREAS, V43, P109, DOI 10.1097/MPA.0b013e31829d9090; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Boterberg T, 2004, METHODS MOL MED, V58, P33; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Grzesiak JJ, 2007, PANCREAS, V35, P293, DOI 10.1097/mpa.0b013e31811f4526; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guo HB, 2002, CANCER RES, V62, P6837; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hall D, 2004, METHODS MOL MED, V58, P61; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kariya Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027084; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Lee CY, 2011, J ONCOL, V2011, DOI 10.1155/2011/365651; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mousa SA, 2008, MOL BIOTECHNOL, V38, P33, DOI 10.1007/s12033-007-0072-7; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Ohlund D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-154; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Peracaula R, 2005, GLYCOCONJUGATE J, V22, P135, DOI 10.1007/s10719-005-0734-2; Perez-Garay M, 2013, INT J BIOCHEM CELL B, V45, P1748, DOI 10.1016/j.biocel.2013.05.015; Perez-Garay M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012524; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pinho SS, 2013, TRENDS MOL MED, V19, P664, DOI [10.1016/j.molmed.2013, 10.1016/j.molmed.2013.07.003]; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sobin LH., 2010, TNM CLASSIFICATION M; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Wang FL, 2009, CANCER DETECT PREV, V32, P437, DOI 10.1016/j.cdp.2009.01.001; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	71	46	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98595	10.1371/journal.pone.0098595	http://dx.doi.org/10.1371/journal.pone.0098595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878505	Green Submitted, gold, Green Published			2022-12-27	WOS:000338101500071
J	Bifano, TD; Ueti, MW; Esteves, E; Reif, KE; Braz, GRC; Scoles, GA; Bastos, RG; White, SN; Daffre, S				Bifano, Thais D.; Ueti, Massaro W.; Esteves, Eliane; Reif, Kathryn E.; Braz, Gloria R. C.; Scoles, Glen A.; Bastos, Reginaldo G.; White, Stephen N.; Daffre, Sirlei			Knockdown of the Rhipicephalus microplus Cytochrome c Oxidase Subunit III Gene Is Associated with a Failure of Anaplasma marginale Transmission	PLOS ONE			English	Article							PROTECTIVE ANTIGEN SUBOLESIN; GLUTATHIONE-S-TRANSFERASE; IXODES-SCAPULARIS ACARI; CELL-LINE BME26; BOOPHILUS-MICROPLUS; DIFFERENTIAL EXPRESSION; SALIVARY-GLANDS; A-PHAGOCYTOPHILUM; OXIDATIVE STRESS; BABESIA-BOVIS	Rhipicephalus microplus is an obligate hematophagous ectoparasite of cattle and an important biological vector of Anaplasma marginale in tropical and subtropical regions. The primary determinants for A. marginale transmission are infection of the tick gut, followed by infection of salivary glands. Transmission of A. marginale to cattle occurs via infected saliva delivered during tick feeding. Interference in colonization of either the tick gut or salivary glands can affect transmission of A. marginale to naive animals. In this study, we used the tick embryonic cell line BME26 to identify genes that are modulated in response to A. marginale infection. Suppression-subtractive hybridization libraries (SSH) were constructed, and five up-regulated genes {glutathione S-transferase (GST), cytochrome c oxidase sub III (COXIII), dynein (DYN), synaptobrevin (SYN) and phosphatidylinositol-3,4,5-triphosphate 3-phosphatase (PHOS)} were selected as targets for functional in vivo genomic analysis. RNA interference (RNAi) was used to determine the effect of tick gene knockdown on A. marginale acquisition and transmission. Although RNAi consistently knocked down all individually examined tick genes in infected tick guts and salivary glands, only the group of ticks injected with dsCOXIII failed to transmit A. marginale to naive calves. To our knowledge, this is the first report demonstrating that RNAi of a tick gene is associated with a failure of A. marginale transmission.	[Bifano, Thais D.; Esteves, Eliane; Daffre, Sirlei] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Bifano, Thais D.; Reif, Kathryn E.; Bastos, Reginaldo G.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Ueti, Massaro W.; Scoles, Glen A.; White, Stephen N.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Inst Quim, Dept Biochem, Rio De Janeiro, RJ, Brazil; [Braz, Gloria R. C.; Daffre, Sirlei] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Washington State University; United States Department of Agriculture (USDA); Washington State University; Universidade Federal do Rio de Janeiro	Bifano, TD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	thaisbifano@usp.br	Esteves, Eliane/H-9508-2013; Esteves, Eliane/H-1037-2015; Bifano, Thaís D/F-8411-2013; Daffre, Sirlei/M-4233-2013	Daffre, Sirlei/0000-0002-9966-0433; Esteves, Eliane/0000-0002-4347-798X; White, Stephen N./0000-0001-9255-6054	Sao Paulo Research Foundation (FAPESP) [2008/56408-0, 2010/50940-1, 2011/22124-8]; CNPq; CAPES; U.S. Department of Agriculture [ARS 5348-32000-033-00D]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Sao Paulo Research Foundation (FAPESP) grants 2008/56408-0, 2010/50940-1, 2011/22124-8, CNPq, CAPES and U.S. Department of Agriculture grant ARS 5348-32000-033-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos RG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-111; Bastos RG, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-57; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Blouin EF, 1998, J MED ENTOMOL, V35, P788, DOI 10.1093/jmedent/35.5.788; Bode M, 2013, ANTIOXID REDOX SIGN, V18, P1597, DOI 10.1089/ars.2012.4685; Brown CGD, 1997, TROP ANIM HEALTH PRO, V29, p1S, DOI 10.1007/BF02632905; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CONNELL M, 1972, AUST VET J, V48, P477, DOI 10.1111/j.1751-0813.1972.tb02298.x; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; de la Fuente J, 2006, PARASITOL RES, V100, P85, DOI 10.1007/s00436-006-0244-6; de la Fuente J, 2008, ANN NY ACAD SCI, V1149, P27, DOI 10.1196/annals.1428.056; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Esteves E, 2009, VET PARASITOL, V161, P150, DOI 10.1016/j.vetpar.2008.12.006; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Lasmar PVF, 2012, REV BRAS PARASITOL V, V21, P112, DOI 10.1590/S1984-29612012000200008; Freitas DRJ, 2007, COMP BIOCHEM PHYS A, V146, P688, DOI 10.1016/j.cbpa.2006.04.032; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Galletti MFBM, 2009, INFECT IMMUN, V77, P1459, DOI 10.1128/IAI.01518-08; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Harada T, 2012, BIOL PHARM BULL, V35, P1460, DOI 10.1248/bpb.b11-00011; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Karim S, 2005, BIOCHEM BIOPH RES CO, V334, P1336, DOI 10.1016/j.bbrc.2005.07.036; Karim S, 2004, INSECT BIOCHEM MOLEC, V34, P407, DOI 10.1016/j.ibmb.2004.01.005; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Knowles D, 1996, J CLIN MICROBIOL, V34, P2225, DOI 10.1128/JCM.34.9.2225-2230.1996; Kocan KM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-42; Kocan KM, 2008, EXP APPL ACAROL, V46, P17, DOI 10.1007/s10493-008-9159-5; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; KOCAN KM, 1992, AM J VET RES, V53, P499; Kocan KM, 2000, ANN NY ACAD SCI, V916, P501, DOI 10.1111/j.1749-6632.2000.tb05329.x; Lewis S, 2000, CURR OPIN STRUC BIOL, V10, P349, DOI 10.1016/S0959-440X(00)00095-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MASON CA, 1981, VET PARASITOL, V8, P185, DOI 10.1016/0304-4017(81)90046-7; Mercado-Curiel RF, 2011, INT J PARASITOL, V41, P851, DOI 10.1016/j.ijpara.2011.03.003; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Reddy BPN, 2011, COMPUT BIOL CHEM, V35, P114, DOI 10.1016/j.compbiolchem.2011.03.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; SAMISH M, 1993, AM J VET RES, V54, P411; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Scoles GA, 2005, J MED ENTOMOL, V42, P668, DOI 10.1603/0022-2585(2005)042[0668:REOBTO]2.0.CO;2; Scoles GA, 2007, J MED ENTOMOL, V44, P484, DOI 10.1603/0022-2585(2007)44[484:COTPOA]2.0.CO;2; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Ueti MW, 2007, INFECT IMMUN, V75, P2959, DOI 10.1128/IAI.00284-07; Ulienberg G, 1968, REV ELEV MED VET PAY, V21, P467; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Zivkovic Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-186; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7; Zivkovic Z, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/705034	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98614	10.1371/journal.pone.0098614	http://dx.doi.org/10.1371/journal.pone.0098614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878588	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500074
J	Impullitti, AE; Malvick, DK				Impullitti, Ann E.; Malvick, Dean K.			Anatomical Response and Infection of Soybean during Latent and Pathogenic Infection by Type A and B of Phialophora gregata	PLOS ONE			English	Article							STEM ROT RESISTANCE; CEPHALOSPORIUM-GREGATUM; GENOTYPE-A; MAIZE; TRANSFORMATION; COLONIZATION; CULTIVARS; HISTOPATHOLOGY; REGISTRATION; CADOPHORA	Growth and anatomical responses of plants during latent and pathogenic infection by fungal pathogens are not well understood. The interactions between soybean (Glycine max) and two types of the pathogen Phialophora gregata were investigated to determine how plants respond during latent and pathogenic infection. Stems of soybean cultivars with different or no genes for resistance to infection by P. gregata were inoculated with wildtype or GFP and RFP-labeled strains of types A or B of P. gregata. Plants were sectioned during latent and pathogenic infection, examined with transmitted light or fluorescent microscopy, and quantitative differences in vessels and qualitative differences in infection were assessed using captured images. During latent infection, the number of vessels was similar in resistant and susceptible plants infected with type A or B compared to the control, and fungal infection was rarely observed in vessels. During pathogenic infection, the resistant cultivars had 20 to 25% more vessels than the uninfected plants, and fungal hyphae were readily observed in the vessels. Furthermore, during the pathogenic phase in a resistant cultivar, P. gregata type A-GFP was limited to outside of the primary xylem, while P. gregata type B-RFP was observed in the primary xylem. The opposite occurred with the susceptible cultivar, where PgA-GFP was observed in the primary xylem and PgB-RFP was limited to the interfascicular region. In summary, soybean cultivars with resistance to BSR produced more vessels and can restrict or exclude P. gregata from the vascular system compared to susceptible cultivars. Structural resistance mechanisms potentially compensate for loss of vessel function and disrupted water movement.	[Impullitti, Ann E.; Malvick, Dean K.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Impullitti, AE (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA.	impullit@augsburg.edu		Malvick, Dean/0000-0002-0131-8411	University of Minnesota Graduate School; Minnesota Soybean Research and Promotion Council	University of Minnesota Graduate School(University of Minnesota System); Minnesota Soybean Research and Promotion Council	This research was supported by the Doctoral Dissertation Fellowship and Thesis Research Grant program at the University of Minnesota Graduate School and the Minnesota Soybean Research and Promotion Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINGTON WB, 1948, PHYTOPATHOLOGY, V38, P793; Andrie RM, 2005, MYCOLOGIA, V97, P1152, DOI 10.3852/mycologia.97.5.1152; BAAYEN RP, 1985, NETH J PLANT PATHOL, V91, P119, DOI 10.1007/BF01976386; Bacon CW, 1996, CAN J BOT, V74, P1195, DOI 10.1139/b96-144; Chen WD, 2000, PHYTOPATHOLOGY, V90, P875, DOI 10.1094/PHYTO.2000.90.8.875; De Cal A, 2000, PHYTOPATHOLOGY, V90, P260, DOI 10.1094/PHYTO.2000.90.3.260; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI [10.1111/j.1574-6968.2004.tb09695.x, 10.1016/j.femsle.2004.07.013]; Dodd J. L., 1980, Plant Disease, V64, P533, DOI 10.1094/PD-64-533; Eckert M, 2005, FEMS MICROBIOL LETT, V253, P67, DOI 10.1016/j.femsle.2005.09.041; GRAY LE, 1971, PHYTOPATHOLOGY, V61, P1410, DOI 10.1094/Phyto-61-1410; HANSON PM, 1988, CROP SCI, V28, P41, DOI 10.2135/cropsci1988.0011183X002800010010x; Harrington TC, 2003, MYCOTAXON, V87, P141; Horowitz S, 2002, PHYTOPATHOLOGY, V92, P743, DOI 10.1094/PHYTO.2002.92.7.743; Hughes TJ, 2002, PLANT DIS, V86, P729, DOI 10.1094/PDIS.2002.86.7.729; Impullitti AE, 2009, PLANT DIS, V93, P734, DOI 10.1094/PDIS-93-7-0734; KEDERA CJ, 1994, PHYTOPATHOLOGY, V84, P603, DOI 10.1094/Phyto-84-603; Lersten N.R., 2004, SOYBEANS IMPROVEMENT, V3 ed, P15; Lewers KS, 1999, MOL BREEDING, V5, P33, DOI 10.1023/A:1009634710039; Malvick DK, 2007, PLANT DIS, V91, P736, DOI 10.1094/PDIS-91-6-0736; Malvick DK, 2008, CAN J PLANT PATHOL, V30, P581, DOI 10.1080/07060660809507558; Malvick DK, 2003, PLANT DIS, V87, P1250, DOI 10.1094/PDIS.2003.87.10.1250; McCully ME, 2001, AUST J PLANT PHYSIOL, V28, P983, DOI 10.1071/PP01101; MENGISTU A, 1986, PLANT DIS, V70, P1005, DOI 10.1094/PD-70-1005; Nickell CD, 1997, CROP SCI, V37, P1987, DOI 10.2135/cropsci1997.0011183X003700060067x; Oren L, 2003, APPL ENVIRON MICROB, V69, P1695, DOI 10.1128/AEM.69.3.1695-1701.2003; Patzoldt ME, 2005, CROP SCI, V45, P1241, DOI 10.2135/cropsci2003.0615; PENNYPACKER BW, 1993, PHYTOPATHOLOGY, V83, P80, DOI 10.1094/Phyto-83-80; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Rasband W.S., 1997, IMAGE J; SCHNEIDER RW, 1972, PHYTOPATHOLOGY, V62, P345, DOI 10.1094/Phyto-62-345; SINCLAIR JB, 1991, PLANT DIS, V75, P220, DOI 10.1094/PD-75-0220; Sinclair JB, 1996, LATENT INFECT VS END; Stanosz GR, 2001, NEW PHYTOL, V149, P531, DOI 10.1046/j.1469-8137.2001.00052.x; Tabor GM, 2007, PLANT DIS, V91, P574, DOI 10.1094/PDIS-91-5-0574; Tabor GM, 2006, PLANT DIS, V90, P1186, DOI 10.1094/PD-90-1186; TACHIBANA H, 1987, CROP SCI, V27, P612, DOI 10.2135/cropsci1987.0011183X002700030045x; TESSIER BJ, 1990, PHYTOPATHOLOGY, V80, P756, DOI 10.1094/Phyto-80-756; TURGEON BG, 1993, MOL GEN GENET, V238, P270; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; TURGEON BG, 1985, MOL GEN GENET, V201, P450, DOI 10.1007/BF00331338; USDA, 2009, NAT PLANT GERMPL SYS; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; Yates IE, 1997, PLANT DIS, V81, P723, DOI 10.1094/PDIS.1997.81.7.723	43	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98311	10.1371/journal.pone.0098311	http://dx.doi.org/10.1371/journal.pone.0098311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879418	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500049
J	Lofvendahl, S; Theander, E; Svensson, A; Carlsson, KS; Englund, M; Petersson, IF				Lofvendahl, Sofia; Theander, Elke; Svensson, Ake; Carlsson, Katarina Steen; Englund, Martin; Petersson, Ingemar F.			Validity of Diagnostic Codes and Prevalence of Physician-Diagnosed Psoriasis and Psoriatic Arthritis in Southern Sweden - A Population-Based Register Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PLAQUE PSORIASIS; ECONOMIC BURDEN; EPIDEMIOLOGY; DATABASES; CARE	Objective: To validate diagnostic codes for psoriasis and psoriatic arthritis (PsA) and estimate physician-diagnosed prevalence of psoriasis and PsA in the Skane region, Sweden. Methods: In the Skane Healthcare Register (SHR), all healthcare consultations are continuously collected for all inhabitants in the Skane region (population 1.2 million). During 2005-2010 we identified individuals with >= 1 physician-consultations consistent with psoriasis (ICD-10). Within this group we also identified those diagnosed with PsA. We performed a validation by reviewing medical records in 100 randomly selected cases for psoriasis and psoriasis with PsA, respectively. Further, we estimated the pre- and post-validation point prevalence by December 31, 2010. Results: We identified 16 171 individuals (psoriasis alone: n = 13 185, psoriasis with PsA n = 2 986). The proportion of ICD-10 codes that could be confirmed by review of medical records was 81% for psoriasis and 63% for psoriasis with PsA with highest percentage of confirmed codes for cases diagnosed >= 2 occasions in specialized care. For 19% and 29% of the cases respectively it was not possible to determine diagnosis due to insufficient information. Thus, the positive predicted value (PPV) of one ICD-10 code for psoriasis and psoriasis with PsA ranged between 81-100% and 63-92%, respectively. Assuming the most conservative PPV, the post-validation prevalence was 1.23% (95% CI: 1.21-1.25) for psoriasis (with or without PsA), 1.02% (95% CI: 1.00-1.03) for psoriasis alone and 0.21% (95% CI: 0.20-0.22) for psoriasis with PsA. The post-validation prevalence of PsA in the psoriasis cohort was 17.3% (95% CI: 16.65-17.96). Conclusions: The proportion of diagnostic codes in SHR that could be verified varied with frequency of diagnostic codes and level of care highlighting the importance of sensitivity analyses using different case ascertainment criteria. The prevalence of physician-diagnosed psoriasis and PsA confirm other population-based studies, also after adjustment due to misclassification of disease.	[Lofvendahl, Sofia; Englund, Martin; Petersson, Ingemar F.] Lund Univ, Dept Orthoped, Lund, Sweden; [Lofvendahl, Sofia; Englund, Martin; Petersson, Ingemar F.] Skane Univ Hosp, Epidemiol & Register Ctr South, Lund, Sweden; [Theander, Elke] Lund Univ, Skane Univ Hosp Malmo, Dept Rheumatol, Malmo, Sweden; [Svensson, Ake] Lund Univ, Skane Univ Hosp Malmo, Dept Dermatol, Malmo, Sweden; [Carlsson, Katarina Steen] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden; [Englund, Martin] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Petersson, Ingemar F.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Boston University; Keele University	Lofvendahl, S (corresponding author), Lund Univ, Dept Orthoped, Lund, Sweden.	Hsofia.lofvendahl@med.lu.se	Englund, Martin/J-7245-2012	Englund, Martin/0000-0003-3320-2437; Steen Carlsson, Katarina/0000-0002-2325-5634; Petersson, Ingemar/0000-0001-9139-1892	Region Skane; Swedish Social Insurance Agency; Swedish Research Council, Faculty of Medicine, Lund University; Osterlund and Kock Foundations; King Gustav V 80 Year Fund; Swedish Rheumatism Associa-tion	Region Skane; Swedish Social Insurance Agency; Swedish Research Council, Faculty of Medicine, Lund University(Swedish Research Council); Osterlund and Kock Foundations; King Gustav V 80 Year Fund; Swedish Rheumatism Associa-tion	This study was supported by grants from the Region Skane, the Swedish Social Insurance Agency, the Swedish Research Council, Faculty of Medicine, Lund University, the Osterlund and Kock Foundations, King Gustav V 80 Year Fund and the Swedish Rheumatism Associa-tion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari MM, 2013, PHARMACOEPIDEM DR S, V22, P842, DOI 10.1002/pds.3447; Bhutani T, 2013, JAMA DERMATOL, V149, P717, DOI 10.1001/jamadermatol.2013.133; Biondi Oriente C, 1989, Acta Derm Venereol Suppl (Stockh), V146, P69; Boehncke WH, 2013, AM J CLIN DERMATOL, V14, P377, DOI 10.1007/s40257-013-0032-x; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Cortesi PA, 2012, CLIN EXP RHEUMATOL, V30, pS126; Englund M, 2010, RHEUMATOLOGY, V49, P1563, DOI 10.1093/rheumatology/keq127; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Ghatnekar O, 2012, EUR J DERMATOL, V22, P238, DOI 10.1684/ejd.2011.1635; Haglund E, 2011, ANN RHEUM DIS; Hellgren L, 1967, PSORIASIS PREVALENCE; Helmick CG, 2013, AM J PREV MED, V44, P424, DOI 10.1016/j.amepre.2013.01.004; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Icen M, 2008, J AM ACAD DERMATOL, V59, P981, DOI 10.1016/j.jaad.2008.08.034; Joud A, 2012, ARTHRIT CARE RES, V64, P1084, DOI 10.1002/acr.21642; Kimball AB, 2011, J EUR ACAD DERMATOL, V25, P157, DOI 10.1111/j.1468-3083.2010.03730.x; Levy AR, 2012, INT J DERMATOL, V51, P1432, DOI 10.1111/j.1365-4632.2011.05359.x; Love TJ, 2011, SEMIN ARTHRITIS RHEU, V40, P413, DOI 10.1016/j.semarthrit.2010.05.002; Mease PJ, 2013, J AM ACAD DERMATOL; Nossent JC, 2009, SCAND J RHEUMATOL, V38, P251, DOI 10.1080/03009740802609558; Ogdie A, 2013, RHEUMATOLOGY, V52, P568, DOI 10.1093/rheumatology/kes324; Olivieri I, 2008, J RHEUMATOL, V35, P3; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Pedersen OBV, 2008, ANN RHEUM DIS, V67, P1422, DOI 10.1136/ard.2007.082172; Prey S, 2010, J EUR ACAD DERMATOL, V24, P31, DOI 10.1111/j.1468-3083.2009.03565.x; Radtke MA, 2009, J EUR ACAD DERMATOL, V23, P683, DOI 10.1111/j.1468-3083.2009.03159.x; Richardson Stephen K, 2008, Adv Dermatol, V24, P171, DOI 10.1016/j.yadr.2008.09.006; SALVARANI C, 1995, J RHEUMATOL, V22, P1499; SCARPA R, 1984, BRIT J RHEUMATOL, V23, P246; Seminara NM, 2011, BRIT J DERMATOL, V164, P602, DOI 10.1111/j.1365-2133.2010.10134.x; Shbeeb M, 2000, J RHEUMATOL, V27, P1247; Singh JA, 2007, ARTHRIT RHEUM-ARTHR, V57, P648, DOI 10.1002/art.22682; Strombeck B, 2010, J RHEUMATOL; SWANBECK G, 1994, BRIT J DERMATOL, V131, P32, DOI 10.1111/j.1365-2133.1994.tb08454.x; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Wilson FC, 2009, J RHEUMATOL, V36, P361, DOI 10.3899/jrheum.080691; Zachariae H, 2002, ACTA DERM-VENEREOL, V82, P108, DOI 10.1080/00015550252948130	38	83	84	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98024	10.1371/journal.pone.0098024	http://dx.doi.org/10.1371/journal.pone.0098024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875275	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800020
J	Wang, P; Shi, LF; Zhao, QH; Hong, Z; Guo, QH				Wang, Ping; Shi, Langfeng; Zhao, Qianhua; Hong, Zhen; Guo, Qihao			Longitudinal Changes in Clock Drawing Test (CDT) Performance before and after Cognitive Decline	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; SCORING METHODS; SCREENING TOOL; DEMENTIA; IMPAIRMENT; SHANGHAI; VERSION; IMPACT	Background: Many scoring systems exist for clock drawing task variants. However, none of them are reliable in evaluating longitudinal changes of cognitive function. The purpose of this study is to create a simple yet optimal scoring procedure to evaluate cognitive decline using a clinic-based sample. Methods: Clock-drawings from 121 participants (76 individuals with no dementia and later did not develop dementia after a mean 41.2-month follow-up, 45 individuals with no dementia became demented after a mean 42.3-month follow-up) were analyzed using t-test to determine a new and simplified CDT scoring system. The new scoring method was then compared with other commonly used systems. Results: In the converters, there were only 7 items that are significantly different between the initial visits and the second visits. We propose a new scoring system that includes the seven critical items: numbers are equally spaced (12-3-6-9) (p = 0.031), the other eight numbers are marked (p = 0.022), numbers are clockwise (p = 0.002), all numbers are correct (p = 0.030), distance between numbers is constant (p = 0.016), clock has two hands (p = 0.000), arrows are drawn (p = 0.003). Compared with other traditionally used scoring methods, this based change clock drawing test (BCCDT) has one of the most balanced sensitivities/specificities with a clinic-based sample. Conclusions: The new CDT scoring system provides further evidence in support of a simple and reliable clock-drawing scoring system in follow-up studies to evaluate cognitive decline, which can be used in assessing the efficacy of medicine.	[Wang, Ping; Shi, Langfeng; Zhao, Qianhua; Hong, Zhen; Guo, Qihao] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Fudan University	Guo, QH (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com	Wang, Ping/GZB-2001-2022					Babins L, 2008, J CLIN EXP NEUROPSYC, V30, P173, DOI 10.1080/13803390701336411; Brodaty H, 1997, INT J GERIATR PSYCH, V12, P619, DOI 10.1002/(SICI)1099-1166(199706)12:6<619::AID-GPS554>3.0.CO;2-H; Ehreke L, 2010, INT PSYCHOGERIATR, V22, P56, DOI 10.1017/S1041610209990676; Ferrucci L, 1996, J AM GERIATR SOC, V44, P1326, DOI 10.1111/j.1532-5415.1996.tb01403.x; Freedman M., 1994, CLOCK DRAWING NEUROP; Guo Q, 2000, CHINESE J CLIN PSYCH, V8, P205, DOI DOI 10.16128/J.CNKI.1005-3611.2000.04.003; Guo Q.H., 2005, CHINESE J NEUROMEDIC, V4, P701, DOI DOI 10.3760/CMA.J.ISSN.1671-8925.2005.07-17; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; [郭起浩 GUO QiHao], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P81; Heinik J, 2004, ARCH GERONTOL GERIAT, V38, P77, DOI 10.1016/j.archger.2003.08.004; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Lee JH, 2011, ARCH GERONTOL GERIAT, V53, pE179, DOI 10.1016/j.archger.2010.08.010; Lee KS, 2008, DEMENT GERIATR COGN, V26, P483, DOI 10.1159/000167879; Lessig MC, 2008, INT PSYCHOGERIATR, V20, P459, DOI 10.1017/S1041610207006035; Mainland BJ, 2014, INT J GERIATR PSYCH, V29, P127, DOI 10.1002/gps.3992; MANOS PJ, 1994, INT J PSYCHIAT MED, V24, P229, DOI 10.2190/5A0F-936P-VG8N-0F5R; MENDEZ MF, 1992, J AM GERIATR SOC, V40, P1095, DOI 10.1111/j.1532-5415.1992.tb01796.x; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Palmqvist S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038639; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pinto E, 2009, DEMENT GERIATR COGN, V27, P201, DOI 10.1159/000203344; ROULEAU I, 1992, BRAIN COGNITION, V18, P70, DOI 10.1016/0278-2626(92)90112-Y; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Samton JB, 2005, J NEUROPSYCH CLIN N, V17, P533, DOI 10.1176/appi.neuropsych.17.4.533; Shulman K. I., 1986, INT J GERIATR PSYCH, V1, P135, DOI [10.1002/gps.930010209, DOI 10.1002/GPS.930010209]; SHULMAN KI, 1993, INT J GERIATR PSYCH, V8, P487, DOI 10.1002/gps.930080606; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; Tierney MC, 2003, J AM GERIATR SOC, V51, P813, DOI 10.1046/j.1365-2389.2003.51262.x; TUOKKO H, 1992, J AM GERIATR SOC, V40, P579, DOI 10.1111/j.1532-5415.1992.tb02106.x; WATSON YI, 1993, J AM GERIATR SOC, V41, P1235, DOI 10.1111/j.1532-5415.1993.tb07308.x; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zhou Ru-Qian, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P793	38	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97873	10.1371/journal.pone.0097873	http://dx.doi.org/10.1371/journal.pone.0097873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874454	gold, Green Submitted, Green Published			2022-12-27	WOS:000336790800012
J	Di Pace, E; Saracini, C				Di Pace, Enrico; Saracini, Chiara			Action Imitation Changes Perceptual Alternations in Binocular Rivalry	PLOS ONE			English	Article							BIOLOGICAL MOTION PERCEPTION; FACIAL EXPRESSIONS; VISUAL AWARENESS; ATTENTION; DOMINANCE; RESPONSES; MECHANISMS; SIMULATION; PLASTICITY; LANGUAGE	Binocular rivalry is a visual phenomenon in which perception alternates between two different monocular images presented to each of the two eyes. Here, we propose using this phenomenon as a method to study the relation between action execution and action perception. In our experiment, a simple background (a checkerboard) was contrasted with a video representing a hand continuously grasping and releasing a ball. In Experiment 1, our subjects were asked to reproduce the perceived movement with their right hand whenever they became aware of it and to stop doing this when the checkerboard dominated. Our results revealed that motor imitation of the perceived action significantly increased the time spent perceiving the hand. Three control experiments showed that these effects were not due to a generic involvement of focused attention (Experiment 2 and 3), to a verbal description of the performed action (Experiment 3) or to the execution of an unrelated movement of the hand (Experiment 4). Although an intrinsic connection between action execution and attention cannot be excluded with certainty, and the boundary between action imitation and unrelated action execution may vary along various degrees of similarity, on the whole, the present results seem to suggest, at least on a preliminary basis, that action imitation do play a relevant role in the perception of action. We discuss these findings in the frame of current theories concerning the relation between perception and action.	[Di Pace, Enrico] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Di Pace, Enrico; Saracini, Chiara] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Di Pace, E (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	enrico.dipace@uniroma1.it	Saracini, Chiara/AAP-9256-2020	Saracini, Chiara/0000-0002-1594-7382	Italian Ministry of Health [RC13.D]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by Italian Ministry of Health (grant RC13.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alpers GW, 2007, EMOTION, V7, P495, DOI 10.1037/1528-3542.7.3.495; Alpers GW, 2005, INT J PSYCHOPHYSIOL, V57, P25, DOI 10.1016/j.ijpsycho.2005.01.008; Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; Anderson E, 2011, J EXP SOC PSYCHOL, V47, P856, DOI 10.1016/j.jesp.2011.02.009; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; Bahrami B, 2008, PERCEPTION, V37, P1520, DOI 10.1068/p5999; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; Beets IAM, 2010, VISION RES, V50, P2633, DOI 10.1016/j.visres.2010.10.004; Bekkering H, 2004, Q J EXP PSYCHOL-A, V57, P1345, DOI 10.1080/02724980343000765; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Carlson TA, 2000, CURR BIOL, V10, P1055, DOI 10.1016/S0960-9822(00)00672-2; CARNEY T, 1987, NATURE, V328, P647, DOI 10.1038/328647a0; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Craighero L, 1998, VIS COGN, V5, P109, DOI 10.1080/713756780; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fagioli S, 2007, PSYCHOL RES-PSYCH FO, V71, P22, DOI 10.1007/s00426-005-0033-3; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibson J.J., 1979, ECOLOGICAL APPROACH; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; GREENWAL.AG, 1970, J EXP PSYCHOL, V86, P20, DOI 10.1037/h0029960; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hugrass L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035963; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Kanai R, 2006, CURR BIOL, V16, P2332, DOI 10.1016/j.cub.2006.10.001; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Laubrock J, 2008, J VISION, V8, DOI 10.1167/8.14.13; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Lindemann O, 2009, J EXP PSYCHOL HUMAN, V35, P1062, DOI 10.1037/a0015023; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; LOGOTHETIS NK, 1990, VISION RES, V30, P1409, DOI 10.1016/0042-6989(90)90022-D; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Mitsumatsu H, 2009, PERCEPTION, V38, P1522, DOI 10.1068/p6298; Musseler J, 1997, J EXP PSYCHOL HUMAN, V23, P861, DOI 10.1037/0096-1523.23.3.861; Nagamine M, 2007, PHYSIOL BEHAV, V91, P161, DOI 10.1016/j.physbeh.2007.02.016; Necker L.A, 1832, LONDON EDINBURGH PHI, V1, P329, DOI 10.1080/14786443208647909; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Salomon R, 2013, J VISION, V13, DOI 10.1167/13.7.2; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; Sun FC, 2002, BRAIN RES, V944, P56, DOI 10.1016/S0006-8993(02)02706-3; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wohlschlager A, 2000, VISION RES, V40, P925, DOI 10.1016/S0042-6989(99)00239-4; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714; Zhang P, 2011, NEURON, V71, P362, DOI 10.1016/j.neuron.2011.05.035; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	89	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98305	10.1371/journal.pone.0098305	http://dx.doi.org/10.1371/journal.pone.0098305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24870450	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300035
J	Albi, E; Curcio, F; Lazzarini, A; Floridi, A; Cataldi, S; Lazzarini, R; Loreti, E; Ferri, I; Ambesi-Impiombato, FS				Albi, Elisabetta; Curcio, Francesco; Lazzarini, Andrea; Floridi, Alessandro; Cataldi, Samuela; Lazzarini, Remo; Loreti, Elisabetta; Ferri, Ivana; Ambesi-Impiombato, Francesco Saverio			A Firmer Understanding of the Effect of Hypergravity on Thyroid Tissue: Cholesterol and Thyrotropin Receptor	PLOS ONE			English	Article							LIPID RAFTS; ALTERED GRAVITY; CYTOSKELETON; CELLS; LOCALIZATION; MICRODOMAINS; CAVEOLAE; MISSION; ACTIN	Maintaining a good health requires the maintenance of a body homeostasis which largely depends on correct functioning of thyroid gland. The cells of the thyroid tissue are strongly sensitive to hypogravity, as already proven in mice after returning to the earth from long-term space missions. Here we studied whether hypergravity may be used to counteract the physiological deconditioning of long-duration spaceflight. We investigated the influence of hypergravity on key lipids and proteins involved in thyroid tissue function. We quantified cholesterol (CHO) and different species of sphingomyelin (SM) and ceramide, analysed thyrotropin (TSH) related molecules such as thyrotropin-receptor (TSHR), cAMP, Caveolin-1 and molecule signalling such as Signal transducer and activator of transcription-3 (STAT3). The hypergravity treatment resulted in the upregulation of the TSHR and Caveolin-1 and downregulation of STAT3 without changes of cAMP. TSHR lost its specific localization and spread throughout the cell membrane; TSH treatment facilitated the shedding of a subunit of TSHR and its releasing into the extracellular space. No specific variations were observed for each species of SM and ceramide. Importantly, the level of CHO was strongly reduced. In conclusion, hypergravity conditions induce change in CHO and TSHR of thyroid gland. The possibility that lipid rafts are strongly perturbed by hypergravity-induced CHO depletion by influencing TSH-TSHR interaction was discussed.	[Albi, Elisabetta; Lazzarini, Andrea; Floridi, Alessandro; Cataldi, Samuela; Lazzarini, Remo] CRABioN, Lab Nucl Lipid BioPathol, Perugia, Italy; [Curcio, Francesco; Lazzarini, Andrea; Ambesi-Impiombato, Francesco Saverio] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Loreti, Elisabetta; Ferri, Ivana] Univ Perugia, Inst Pathol Anat & Histol, Osped Santa Maria Misericordia, I-06100 Perugia, Italy	University of Udine; Hospital Santa Maria della Misericordia; University of Perugia	Albi, E (corresponding author), CRABioN, Lab Nucl Lipid BioPathol, Perugia, Italy.	elisabetta.albi@yahoo.com	Curcio, Francesco/K-4669-2014; Albi, Elisabetta/K-3369-2016	Albi, Elisabetta/0000-0002-5745-5343; Migliaccio, Antimo/0000-0002-4197-2055; CURCIO, Francesco/0000-0002-9070-4807	Agenzia Spaziale Italiana (ASI)	Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	This work has been supported by Agenzia Spaziale Italiana (ASI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albi E, 2012, ASTROBIOLOGY, V12, P1035, DOI 10.1089/ast.2012.0881; Albi E, 2011, ASTROBIOLOGY, V11, P57, DOI 10.1089/ast.2010.0519; Albi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048518; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; Cascianelli G, 2008, MOL BIOL CELL, V19, P5289, DOI 10.1091/mbc.E08-05-0517; Chubinskiy-Nadezhdin VI, 2013, CELL BIOL INT, V37, P617, DOI 10.1002/cbin.10079; Ciofani G, 2012, J BIOSCI BIOENG, V113, P258, DOI 10.1016/j.jbiosc.2011.09.025; Costa MJ, 2004, ENDOCRINOLOGY, V145, P1464, DOI 10.1210/en.2003-1432; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Dai KS, 2009, THROMB HAEMOSTASIS, V101, P902, DOI 10.1160/TH08-11-0750; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Klappe K, 2010, BIOCHEM J, V430, P519, DOI 10.1042/BJ20091882; Latif R, 2003, ENDOCRINOLOGY, V144, P4725, DOI 10.1210/en.2003-0932; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068140; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Misrahi M, 1997, EUR J ENDOCRINOL, V137, P599, DOI 10.1530/eje.0.1370599; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Rabagny Y, 2011, ANAL BIOANAL CHEM, V401, P891, DOI 10.1007/s00216-011-5154-5; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Schmidt W, 2004, MICROGRAVITY SCI TEC, V15, P42, DOI 10.1007/BF02870951; Soga K, 2013, J PLANT RES, V126, P589, DOI 10.1007/s10265-013-0572-4; Tauber S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-32; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98250	10.1371/journal.pone.0098250	http://dx.doi.org/10.1371/journal.pone.0098250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866829	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100040
J	Blum, CA; Mirza, U; Christ-Crain, M; Mueller, B; Schindler, C; Puder, JJ				Blum, Claudine A.; Mirza, Uzma; Christ-Crain, Mirjam; Mueller, Beat; Schindler, Christian; Puder, Jardena J.			Copeptin Levels Remain Unchanged during the Menstrual Cycle	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; LOW-GRADE INFLAMMATION; BODY-FLUID; VASOPRESSIN; WOMEN; SECRETION; RELIABILITY; PLASMA; IMPEDANCE; PRECURSOR	Background: Copeptin, a surrogate marker for arginin vasopressin production, is evaluated as an osmo-dependent stress and inflammatory biomarker in different diseases. We investigated copeptin during the menstrual cycle and its relationship to sex hormones, markers of subclinical inflammation and estimates of body fluid. Methods: In 15 healthy women with regular menstrual cycles, blood was drawn on fifteen defined days of their menstrual cycle and was assayed for copeptin, progesterone, estradiol, luteinizing hormone, high-sensitive C-reactive protein, tumor necrosis factor-alpha and procalcitonin. Symptoms of fluid retention were assessed on each visit, and bio impedance analysis was measured thrice to estimate body fluid changes. Mixed linear model analysis was performed to assess the changes of copeptin across the menstrual cycle and the relationship of sex hormones, markers of subclinical inflammation and estimates of body fluid with copeptin. Results: Copeptin levels did not significantly change during the menstrual cycle (p = 0.16). Throughout the menstrual cycle, changes in estradiol (p = 0.002) and in the physical premenstrual symptom score (p = 0.01) were positively related to copeptin, but changes in other sex hormones, in markers of subclinical inflammation or in bio impedance analysis-estimated body fluid were not (all p = ns). Conclusion: Although changes in estradiol and the physical premenstrual symptom score appear to be related to copeptin changes, copeptin does not significantly change during the menstrual cycle.	[Blum, Claudine A.; Mirza, Uzma; Mueller, Beat] Kantonsspital Aarau, Med Univ Clin, Aarau, Switzerland; [Blum, Claudine A.; Christ-Crain, Mirjam] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Puder, Jardena J.] Univ Lausanne Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland; [Schindler, Christian] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Kantonsspital Aarau AG (KSA); University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; Swiss Tropical & Public Health Institute	Blum, CA (corresponding author), Kantonsspital Aarau, Med Univ Clin, Aarau, Switzerland.	claudineblum@yahoo.com	Schindler, Christian/D-3472-2015; Mueller, Beat/G-2662-2012; Blum, Claudine Angela A/G-8467-2016	Blum, Claudine Angela A/0000-0003-0487-5587; Puder, Jardena/0000-0002-0460-7614; Christ-Crain, Mirjam/0000-0002-6336-0965	Gottfried and Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland; University of Basel, Switzerland (Nachwuchsfoerderung); W&W-Fonds of the Kantonsspital Aarau AG, Switzerland; Swiss National Science Foundation [PP00P3-12346]	Gottfried and Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland; University of Basel, Switzerland (Nachwuchsfoerderung); W&W-Fonds of the Kantonsspital Aarau AG, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Gottfried and Julia Bangerter-Rhyner-Stiftung, 3011 Bern, Switzerland (to CAB), by the University of Basel, Switzerland (Nachwuchsfoerderung) (to CAB), by the W&W-Fonds of the Kantonsspital Aarau AG, Switzerland (to CAB), and Grant PP00P3-12346 from the Swiss National Science Foundation (to MCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2001, J CLIN ENDOCR METAB, V86, P2525, DOI 10.1210/jc.86.6.2525; Blum CA, 2005, J CLIN ENDOCR METAB, V90, P3230, DOI 10.1210/jc.2005-0231; Darzy KH, 2010, CLIN CHEM, V56, P1190, DOI 10.1373/clinchem.2009.141689; FORSLING ML, 1982, J ENDOCRINOL, V95, P147, DOI 10.1677/joe.0.0950147; Freeman EW, 1996, PSYCHIAT RES, V65, P97, DOI 10.1016/S0165-1781(96)02929-0; GLEICHAUF CN, 1989, AM J CLIN NUTR, V50, P903, DOI 10.1093/ajcn/50.5.903; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Katan M, 2010, EUR J MED SERVICES, V140, P13101; Kostoglou-Athanassiou I, 1998, CLIN ENDOCRINOL, V49, P209, DOI 10.1046/j.1365-2265.1998.00504.x; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; PREIBISZ JJ, 1983, HYPERTENSION, V5, pI129, DOI 10.1161/01.HYP.5.2_Pt_2.I129; Puder JJ, 2006, EUR J CLIN INVEST, V36, P58, DOI 10.1111/j.1365-2362.2006.01591.x; PUNNONEN R, 1983, HORM RES, V17, P90, DOI 10.1159/000179681; ROBERTSON GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423; Russell JA, 2009, CRIT CARE MED, V37, P749, DOI 10.1097/CCM.0b013e318194d117; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Sergi G, 2006, SCAND J CLIN LAB INV, V66, P19, DOI 10.1080/00365510500402158; Stachenfeld NS, 2009, J APPL PHYSIOL, V107, P864, DOI 10.1152/japplphysiol.91211.2008; Steinwall M, 1998, ACTA OBSTET GYN SCAN, V77, P983, DOI 10.1034/j.1600-0412.1998.771007.x; WILLIAMS TDM, 1985, CLIN ENDOCRINOL, V22, P589, DOI 10.1111/j.1365-2265.1985.tb02994.x	20	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98240	10.1371/journal.pone.0098240	http://dx.doi.org/10.1371/journal.pone.0098240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866705	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336914100039
J	Fraser, SDS; Roderick, PJ; McIntyre, NJ; Harris, S; McIntyre, C; Fluck, R; Taal, MW				Fraser, Simon D. S.; Roderick, Paul J.; McIntyre, Natasha J.; Harris, Scott; McIntyre, Christopher; Fluck, Richard; Taal, Maarten W.			Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; CARDIOVASCULAR MORTALITY; ALL-CAUSE; NONDIABETIC INDIVIDUALS; URINARY ALBUMIN; METAANALYSIS; ASSOCIATION; RISK; PROGRESSION	Background and Objective: Proteinuria assessment is key in investigating chronic kidney disease (CKD) but uncertainty exists regarding optimal methods. Albuminuria, reflecting glomerular damage, is usually measured, but non-albumin proteinuria (NAP), reflecting tubular damage, may be important. This study investigated the prevalence and associations of albuminuria and NAP, and the optimum number of urine specimens required. Methods: 1,741 patients with CKD stage 3, recruited from primary care, underwent medical history, clinical assessment, blood sampling, and submitted three early morning urine samples for albumin to creatinine ratio (uACR) and protein to creatinine ratios (uPCR). Albuminuria was defined as uACR >= 3 mg/mmol in at least two of three samples. Isolated NAP was defined as uPCR >= 17 mg/mmol in two of three samples and uACR<3 mg/mmol in all three. Prevalence and associations of albuminuria and NAP, degree of agreement between single uACR and average of three uACRs, and urine albumin to protein ratio (uAPR = uACR/uPCR) were identified. Results: Albuminuria prevalence was 16% and NAP 6%. Using a <1 mg/mmol threshold for uACR reduced NAP prevalence to 3.6%. Independent associations of albuminuria were: males (OR 3.06 (95% CI, 2.23-4.19)), diabetes (OR 2.14 (1.53-3.00)), lower estimated glomerular filtration rate ((OR 2.06 (1.48-2.85) 30-44 vs 45-59), and high sensitivity CRP ((OR 1.70 (1.25-2.32)). NAP was independently associated with females (OR 6.79 (3.48-13.26)), age (OR 1.62 (1.02-2.56) 80 s vs 70-79) and high sensitivity CRP ((OR 1.74 (1.14-2.66)). Of those with uPCR >= 17 mg/mmol, 62% had uAPR<0.4. Sensitivity of single uACR was 95%, specificity 98%, PPV 90%. Bland Altman plot one vs average of three uACRs showed: mean difference 0.0064 mg/mmol (SD 4.69, limits of agreement -9.19 to +9.20, absolute mean difference 0.837). Conclusions: In CKD stage 3, albuminuria has associations distinct from those of isolated NAP (except for inflammatory markers). Single uACR categorised albuminuria but average of three performed better for quantification.	[Fraser, Simon D. S.; Roderick, Paul J.; Harris, Scott] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McIntyre, Natasha J.; Fluck, Richard; Taal, Maarten W.] Royal Derby Hosp NHS Fdn Trust, Dept Renal Med, Derby, England; [McIntyre, Christopher] Univ Nottingham, Div Med Sci & Grad Entry Med, Nottingham NG7 2RD, England	University of Southampton; University of Nottingham	Fraser, SDS (corresponding author), Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England.	s.fraser@soton.ac.uk	Fraser, Simon DS/HCH-3208-2022; McIntyre, Christopher W/O-8927-2014	Taal, Maarten/0000-0002-9065-212X; Fraser, Simon D/0000-0002-4172-4406	Kidney Research UK; British Renal Society; Roche Products plc	Kidney Research UK(Kidney Research UK (KRUK)); British Renal Society; Roche Products plc	This study was supported by a fellowship grant from Kidney Research UK (http://www.kidneyresearchuk.org/) and the British Renal Society (http://www.britishrenal.org/), as well as an unrestricted educational grant from Roche Products plc (http://www.roche.co.uk/portal/uk). The authors declare that they have no financial or non-financial conflicts of interest to declare. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Lusignana S, 2013, KIDNEY INT, V84, P609, DOI 10.1038/ki.2013.96; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P1; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311; McTaggart MP, 2013, CLIN CHEM LAB MED, V51, P1961, DOI 10.1515/cclm-2013-0225; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Methven S, 2011, QJM-INT J MED, V104, P663, DOI 10.1093/qjmed/hcr026; Methven S, 2011, AM J KIDNEY DIS, V57, P21, DOI 10.1053/j.ajkd.2010.08.009; Methven S, 2010, NEPHROL DIAL TRANSPL, V25, P2991, DOI 10.1093/ndt/gfq140; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; SHAW AB, 1983, BRIT MED J, V287, P929, DOI 10.1136/bmj.287.6397.929; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1534, DOI 10.1093/ndt/gfr708; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Warnock DG, 2010, AM J KIDNEY DIS, V56, P861, DOI 10.1053/j.ajkd.2010.05.017; World Health Organization, 2006, DEF DIAGN DIAB MELL	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98261	10.1371/journal.pone.0098261	http://dx.doi.org/10.1371/journal.pone.0098261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867154	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336914100042
J	Chen, GY; Wang, W; Meng, SK; Zhang, LC; Wang, WX; Jiang, ZM; Yu, M; Cui, QH; Li, MZ				Chen, Guiyuan; Wang, Wei; Meng, Shengke; Zhang, Lichao; Wang, Wenxue; Jiang, Zongmin; Yu, Min; Cui, Qinghua; Li, Meizhang			CXC Chemokine CXCL12 and Its Receptor CXCR4 in Tree Shrews (Tupaia belangeri): Structure, Expression and Function	PLOS ONE			English	Article							PHYLOGENETIC POSITION; HIV-1 CORECEPTOR; NERVOUS-SYSTEM; CELL-SURVIVAL; STEM-CELLS; CHINENSIS; HEPATITIS; INFECTION; AMD3100; IMMUNE	Chemokines are small secreted proteins functionally involved in the immune system's regulation of lymphocyte migration across numerous mammalian species. Given its growing popularity in immunological models, we investigated the structure and function of chemokine CXCL12 protein in tree shrews. We found that CXCL12 and its receptor CXCR4 in tree shrew had structural similarities to their homologous human proteins. Phylogenetic analysis supports the view that tree shrew is evolutionarily-close to the primates. Our results also showed that the human recombinant CXCL12 protein directly enhanced the migration of tree shrew's lymphocytes in vitro, while AMD3100 enhanced the mobilization of hematopoietic progenitor cells (HPCs) from bone marrow into peripheral blood in tree shrew in vivo. Collectively, these findings suggested that chemokines in tree shrews may play the same or similar roles as those in humans, and that the tree shrew is a viable animal model for studying human immunological diseases.	[Chen, Guiyuan; Wang, Wei; Meng, Shengke; Wang, Wenxue; Jiang, Zongmin; Yu, Min; Cui, Qinghua; Li, Meizhang] Yunnan Univ, Sch Life Sci, Dept Biochem & Mol Biol, Kunming, Peoples R China; [Chen, Guiyuan] Dali Univ, Sch Basic Med, Dept Biochem & Mol Biol, Dali, Peoples R China; [Wang, Wei] Kunming Med Univ, Affiliated Hosp 1, Dept Rheumatol & Immunol, Kunming, Peoples R China; [Zhang, Lichao] Kunming Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Kunming, Peoples R China	Yunnan University; Dali University; Kunming Medical University; Kunming Medical University	Li, MZ (corresponding author), Yunnan Univ, Sch Life Sci, Dept Biochem & Mol Biol, Kunming, Peoples R China.	mzhli@ynu.edu.cn			National Natural Science Foundation of China [81271330, 31160237, 31260276]; Yunnan Province Science and Technology Innovation Team [2011CI123]; Talent Program of Yunnan Province [W8110305]; Foundation of School of Life Sciences of Yunnan University [2012S301]; Natural Science Foundation of Yunnan Province [2011BC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Science and Technology Innovation Team; Talent Program of Yunnan Province; Foundation of School of Life Sciences of Yunnan University; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported by grants from the National Natural Science Foundation of China (No. 81271330, No. 31160237, and No. 31260276), Yunnan Province Science and Technology Innovation Team (No. 2011CI123), Talent Program of Yunnan Province (No. W8110305), Foundation of School of Life Sciences of Yunnan University (No. 2012S301), and the Natural Science Foundation of Yunnan Province (No. 2011BC003). The funders had no roles in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Brunn A, 2013, NEUROPATH APPL NEURO, V39, P772, DOI 10.1111/nan.12039; Burman A, 2005, J IMMUNOL, V174, P1693, DOI 10.4049/jimmunol.174.3.1693; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Flugge P, 2002, IMMUNOGENETICS, V53, P984, DOI 10.1007/s00251-001-0401-0; Forster R, 1998, J IMMUNOL, V160, P1522; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Guergnon J, 2012, IMMUNOL LETT, V145, P15, DOI 10.1016/j.imlet.2012.04.010; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; Hau J., 2008, SOURCEBOOK MODELS BI, P3, DOI DOI 10.1007/978-1-59745-285-4_1; Helgen K.M., 2005, MAMMAL SPECIES WORLD, P104; Kawasawa Y, 2003, GENOME RES, V13, P1466, DOI 10.1101/gr.1087603; Klein RS, 2004, TRENDS IMMUNOL, V25, P306, DOI 10.1016/j.it.2004.04.002; Kucia M, 2004, J MOL HISTOL, V35, P233; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larochelle A, 2006, BLOOD, V107, P3772, DOI 10.1182/blood-2005-09-3592; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li Yao, 2011, Zoological Research, V32, P97, DOI 10.3724/SP.J.1141.2011.01097; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Olson LE, 2005, MOL PHYLOGENET EVOL, V35, P656, DOI 10.1016/j.ympev.2005.01.005; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thomas AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032290; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Wang Q, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-170; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu Ling, 2013, Zoological Research, V34, P70, DOI 10.3724/SP.J.1141.2013.02070; Xu L, 2012, J GENET GENOMICS, V39, P131, DOI 10.1016/j.jgg.2012.02.003; Yang ZX, 2013, J APPL MATH, DOI 10.1155/2013/367107; Zhan MY, 1981, ACTA ACAD MED SIN, V3, P148; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Zhu B, 2012, STEM CELLS, V30, P2571, DOI 10.1002/stem.1239; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	54	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98231	10.1371/journal.pone.0098231	http://dx.doi.org/10.1371/journal.pone.0098231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858548	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400059
J	Hossain, MI; Roulston, CL; Stapleton, DI				Hossain, Mohammed Iqbal; Roulston, Carli Lorraine; Stapleton, David Ian			Molecular Basis of Impaired Glycogen Metabolism during Ischemic Stroke and Hypoxia	PLOS ONE			English	Article							BRAIN GLYCOGEN; MEMORY CONSOLIDATION; GLUCOSE DEPRIVATION; LACTATE SHUTTLE; NEURONAL DEATH; PROTEIN-KINASE; ASTROCYTES; RECEPTOR; MECHANISMS; PHOSPHORYLASE	Background: Ischemic stroke is the combinatorial effect of many pathological processes including the loss of energy supplies, excessive intracellular calcium accumulation, oxidative stress, and inflammatory responses. The brain's ability to maintain energy demand through this process involves metabolism of glycogen, which is critical for release of stored glucose. However, regulation of glycogen metabolism in ischemic stroke remains unknown. In the present study, we investigate the role and regulation of glycogen metabolizing enzymes and their effects on the fate of glycogen during ischemic stroke. Results: Ischemic stroke was induced in rats by peri-vascular application of the vasoconstrictor endothelin-1 and forebrains were collected at 1, 3, 6 and 24 hours post-stroke. Glycogen levels and the expression and activity of enzymes involved in glycogen metabolism were analyzed. We found elevated glycogen levels in the ipsilateral hemispheres compared with contralateral hemispheres at 6 and 24 hours (25% and 39% increase respectively; P<0.05). Glycogen synthase activity and glycogen branching enzyme expression were found to be similar between the ipsilateral, contralateral, and sham control hemispheres. In contrast, the rate-limiting enzyme for glycogen breakdown, glycogen phosphorylase, had 58% lower activity (P<0.01) in the ipsilateral hemisphere (24 hours post-stroke), which corresponded with a 48% reduction in cAMP-dependent protein kinase A (PKA) activity (P<0.01). In addition, glycogen debranching enzyme expression 24 hours poststroke was 77% (P<0.01) and 72% lower (P<0.01) at the protein and mRNA level, respectively. In cultured rat primary cerebellar astrocytes, hypoxia and inhibition of PKA activity significantly reduced glycogen phosphorylase activity and increased glycogen accumulation but did not alter glycogen synthase activity. Furthermore, elevated glycogen levels provided metabolic support to astrocytes during hypoxia. Conclusion: Our study has identified that glycogen breakdown is impaired during ischemic stroke, the molecular basis of which includes reduced glycogen debranching enzyme expression level together with reduced glycogen phosphorylase and PKA activity.	[Hossain, Mohammed Iqbal; Stapleton, David Ian] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Roulston, Carli Lorraine] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Hossain, MI (corresponding author), Univ Melbourne, Dept Physiol, St Vincents Campus, Melbourne, Vic, Australia.	mihos@unimelb.edu.au			National Health and Medical Research Council [NHMRC-628698]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the National Health and Medical Research Council (NHMRC-628698) to DIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Brucklacher RM, 2002, DEV NEUROSCI-BASEL, V24, P411, DOI 10.1159/000069051; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; DiNuzzo M, 2013, NEUROCHEM INT, V63, P458, DOI 10.1016/j.neuint.2013.08.004; DiNuzzo M, 2012, NEUROCHEM RES, V37, P2432, DOI 10.1007/s11064-012-0802-5; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P586, DOI 10.1038/jcbfm.2009.232; Dong JH, 2012, J MOL NEUROSCI, V48, P456, DOI 10.1007/s12031-012-9742-4; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gold MG, 2013, J CELL SCI, V126, P4537, DOI 10.1242/jcs.133751; Govender Dhirendra, 2004, Ann Diagn Pathol, V8, P69, DOI 10.1053/j.anndiagpath.2004.01.002; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Hertz L, 2003, BRAIN RES, V994, P226, DOI 10.1016/j.brainres.2003.09.044; Hertz L, 2009, J NEUROCHEM, V109, P10, DOI 10.1111/j.1471-4159.2009.05939.x; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Kong JM, 2002, J NEUROSCI, V22, P5581; Lau X, 2013, DIABETOLOGIA, V56, P675, DOI 10.1007/s00125-012-2805-9; Laureys G, 2010, PROG NEUROBIOL, V91, P189, DOI 10.1016/j.pneurobio.2010.01.011; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Lombardi MS, 2004, STROKE, V35, P981, DOI 10.1161/01.STR.0000121644.82596.7e; Mamedova LK, 2003, MOL CELL BIOCHEM, V250, P11, DOI 10.1023/A:1024980710799; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; Oz G, 2009, DIABETES, V58, P1978, DOI 10.2337/db09-0226; Paquet M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-9; Parker GJ, 2007, BIOCHEM BIOPH RES CO, V362, P811, DOI 10.1016/j.bbrc.2007.08.080; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; Rahman B, 2000, NEUROSCI LETT, V290, P169, DOI 10.1016/S0304-3940(00)01369-0; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Roulston CL, 2008, EUR J PHARMACOL, V584, P100, DOI 10.1016/j.ejphar.2008.01.046; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; SORG O, 1992, J NEUROSCI, V12, P4923; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; VILLARPA.C, 1970, ANNU REV BIOCHEM, V39, P639, DOI 10.1146/annurev.bi.39.070170.003231; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Wang DJ, 2013, DIABETES, V62, P1697, DOI 10.2337/db12-1025; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Weston RM, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/648061; Xu JN, 2013, NEUROCHEM RES, V38, P472, DOI 10.1007/s11064-012-0938-3; Xu L, 2010, MINI-REV MED CHEM, V10, P1188, DOI 10.2174/1389557511009011188; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	60	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97570	10.1371/journal.pone.0097570	http://dx.doi.org/10.1371/journal.pone.0097570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858129	Green Published, gold			2022-12-27	WOS:000336839400019
J	Kim, HS; Koh, JS; Choi, YB; Ro, J; Kim, HK; Kim, MK; Nam, BH; Kim, KT; Chandra, V; Seol, HS; Noh, WC; Kim, EK; Park, J; Bae, CD; Hong, KM				Kim, Han-Seong; Koh, Jae-Soo; Choi, Yong-Bock; Ro, Jungsil; Kim, Hyun-Kyoung; Kim, Mi-Kyung; Nam, Byung-Ho; Kim, Kyung-Tae; Chandra, Vishal; Seol, Hye-Sil; Noh, Woo-Chul; Kim, Eun-Kyu; Park, Joobae; Bae, Chang-Dae; Hong, Kyeong-Man			Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer	PLOS ONE			English	Article							SUBTYPES; KI-67; EXPRESSION; SURVIVAL; PROTEIN; RECOMMENDATIONS; CLASSIFICATION; IDENTIFICATION; DOCETAXEL; THERAPY	Background: The level of proliferation activity is a strong prognostic or predictive indicator in breast cancer, but its optimal measurement is still in debate, necessitating new proliferation markers. In the present study, the prognostic significance of the CKAP2-positive cell count (CPCC), a new proliferation marker, was evaluated, and the results were compared with those for the mitotic activity index (MAI). Methods: This study included 375 early-stage breast cancer samples collected from two institutions between 2000 and 2006. Immunohistochemical staining was performed using a CKAP2 monoclonal antibody. Cox proportional hazard regression models were fitted to determine the association between the CPCC and relapse-free survival (RFS) amongst three groups formed on the basis of the CPCC or MAI value: groups 2 and 3 showing the middle and highest values, respectively, and group 1 the lowest. Results: After adjustment for age, T stage, N stage, HER2 status, estrogen receptor status, progesterone receptor status, institution, and year of surgical resection, the CPCC was associated with a significantly worse RFS {hazard ratio [HR] = 4.10 (95% CI: 1.64-10.29) for group 2; HR = 4.35 (95% CI: 2.04-10.35) for group 3}. Moreover, its prognostic significance was similar to or higher than that based on the MAI {HR = 2.05 (95% CI: 0.94-4.65) for group 2; HR = 2.35 (95% CI: 1.09-5.10) for group 3}. In subgroup analyses, the CPCC showed a prognostic significance in the luminal A and triple-negative subgroups, but not in the HER2-positive subgroup. Conclusions: Chromatin CKAP2 is an independent prognostic marker for RFS in early-stage breast cancer, and could potentially replace the MAI in clinical evaluation of proliferation activity. Additionally, our study results suggest that the prognostic significance of proliferation activity differs among the various subgroups of breast cancer.	[Kim, Han-Seong] Inje Univ, Ilsan Paik Hosp, Dept Pathol, Goyang, South Korea; [Koh, Jae-Soo; Seol, Hye-Sil] Korea Canc Ctr Hosp, Dept Pathol, Seoul, South Korea; [Choi, Yong-Bock; Ro, Jungsil; Kim, Hyun-Kyoung; Kim, Mi-Kyung; Nam, Byung-Ho; Kim, Kyung-Tae; Chandra, Vishal; Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang, South Korea; [Noh, Woo-Chul; Kim, Eun-Kyu] Korea Canc Ctr Hosp, Breast Canc Ctr, Dept Surg, Seoul, South Korea; [Park, Joobae; Bae, Chang-Dae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; [Park, Joobae; Bae, Chang-Dae] Samsung Biomed Res Inst, Suwon, South Korea	Inje University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU)	Bae, CD (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Pathol, Goyang, South Korea.	cdbae@skku.edu; kmhong@ncc.re.kr	Chandra, Vishal/AAN-8756-2020		National Cancer Center, Korea [1410050]; Samsung Biomedical Research Institute, Korea [BB01022]; National Research Foundation, Korea [1230950]	National Cancer Center, Korea; Samsung Biomedical Research Institute, Korea; National Research Foundation, Korea(National Research Foundation of Korea)	This work was supported by a research grant to K.-M.H. from the National Cancer Center, Korea (1410050); by a grant to C.-D.B. from the Samsung Biomedical Research Institute, Korea (BB01022), and by a grant to J.R. from the National Research Foundation, Korea (1230950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleskandarany MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3084; Amadori D, 2000, J CLIN ONCOL, V18, P3125, DOI 10.1200/JCO.2000.18.17.3125; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Bossard C, 2006, J CLIN PATHOL, V59, P706, DOI 10.1136/jcp.2005.030452; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ferguson NL, 2013, BREAST J, V19, P22, DOI 10.1111/tbj.12059; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hong KU, 2008, EXP MOL MED, V40, P377, DOI 10.3858/emm.2008.40.4.377; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kim HS, 2012, J CANCER RES CLIN, V138, P95, DOI 10.1007/s00432-011-1053-6; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Maouche-Chretien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048; Munzone E, 2012, BREAST CANCER RES TR, V134, P277, DOI 10.1007/s10549-012-2040-6; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spyratos F, 2002, CANCER-AM CANCER SOC, V94, P2151, DOI 10.1002/cncr.10458; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98160	10.1371/journal.pone.0098160	http://dx.doi.org/10.1371/journal.pone.0098160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887265	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300040
J	Richter, MKS; Voorham, JMD; Pedraza, ST; Hoornweg, TE; van de Pol, DPI; Rodenhuis-Zybert, IA; Wilschut, J; Smit, JM				Richter, Mareike K. S.; Voorham, Julia M. da Silva; Torres Pedraza, Silvia; Hoornweg, Tabitha E.; van de Pol, Denise P. I.; Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M.			Immature Dengue Virus Is Infectious in Human Immature Dendritic Cells via Interaction with the Receptor Molecule DC-SIGN	PLOS ONE			English	Article							WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; CELLULAR ATTACHMENT; HEMORRHAGIC-FEVER; CLEAVAGE; PRM; NEUTRALIZATION; FLAVIVIRUSES; PATHOGENESIS; NONINTEGRIN	Background: Dengue Virus (DENV) is the most common mosquito-borne viral infection worldwide. Important target cells during DENV infection are macrophages, monocytes, and immature dendritic cells (imDCs). DENV-infected cells are known to secrete a large number of partially immature and fully immature particles alongside mature virions. Fully immature DENV particles are considered non-infectious, but antibodies have been shown to rescue their infectious properties. This suggests that immature DENV particles only contribute to the viral load observed in patients with a heterologous DENV re-infection. Methodology/Principal findings: In this study, we re-evaluated the infectious properties of fully immature particles in absence and presence of anti-DENV human serum. We show that immature DENV is infectious in cells expressing DC-SIGN. Furthermore, we demonstrate that immature dendritic cells, in contrast to macrophage-like cells, do not support antibody-dependent enhancement of immature DENV. Conclusions/Significance: Our data shows that immature DENV can infect imDCs through interaction with DC-SIGN, suggesting that immature and partially immature DENV particles may contribute to dengue pathogenesis during primary infection. Furthermore, since antibodies do not further stimulate DENV infectivity on imDCs we propose that macrophages/monocytes rather than imDCs contribute to the increased viral load observed during severe heterotypic DENV re-infections.	[Richter, Mareike K. S.; Voorham, Julia M. da Silva; Torres Pedraza, Silvia; Hoornweg, Tabitha E.; van de Pol, Denise P. I.; Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Richter, Mareike K. S.; Voorham, Julia M. da Silva; Torres Pedraza, Silvia; Hoornweg, Tabitha E.; van de Pol, Denise P. I.; Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Torres Pedraza, Silvia] Univ Antioquia, Grp Immunovirol, Medellin, Colombia	University of Groningen; University of Groningen; Universidad de Antioquia	Smit, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	jolanda.smit@umcg.nl	Rodenhuis-Zybert, Izabela A/N-7967-2017; Rodenhuis-Zybert, Izabela/AAD-3379-2021	Rodenhuis-Zybert, Izabela A/0000-0002-7820-8624; Rodenhuis-Zybert, Izabela/0000-0002-7820-8624	Dutch Organization for Scientific research (NWO- Earth and Life Sciences); Dutch Organization for Scientific research (NWO-ZonMW AGIKO); University Medical Center Groningen	Dutch Organization for Scientific research (NWO- Earth and Life Sciences)(Netherlands Organization for Scientific Research (NWO)); Dutch Organization for Scientific research (NWO-ZonMW AGIKO); University Medical Center Groningen	This work was supported by the Dutch Organization for Scientific research (NWO- Earth and Life Sciences (grant to JMS) and NWO-ZonMW AGIKO (grant to JW) and by the University Medical Center Groningen (grant to MKSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0; da Silva Voorham J. M., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0029957; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Flipse J, 2012, MOL MECH INVOLVED AN; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kwan WH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000311; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0; Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Takhampunya R, 2009, VIRUS RES, V145, P31, DOI 10.1016/j.virusres.2009.05.016; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	43	27	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98785	10.1371/journal.pone.0098785	http://dx.doi.org/10.1371/journal.pone.0098785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886790	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300109
J	Yoon, S; Assimes, TL; Quertermous, T; Hsiao, CF; Chuang, LM; Hwu, CM; Rajaratnam, B; Olshen, RA				Yoon, Sangho; Assimes, Themistocles L.; Quertermous, Thomas; Hsiao, Chin-Fu; Chuang, Lee-Ming; Hwu, Chii-Min; Rajaratnam, Bala; Olshen, Richard A.			Insulin Resistance: Regression and Clustering	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; SUPPRESSION TEST; LOCI; TRIGLYCERIDES; ASSOCIATION; DISPOSAL; SEQUENCE; GENE	In this paper we try to define insulin resistance (IR) precisely for a group of Chinese women. Our definition deliberately does not depend upon body mass index (BMI) or age, although in other studies, with particular random effects models quite different from models used here, BMI accounts for a large part of the variability in IR. We accomplish our goal through application of Gauss mixture vector quantization (GMVQ), a technique for clustering that was developed for application to lossy data compression. Defining data come from measurements that play major roles in medical practice. A precise statement of what the data are is in Section 1. Their family structures are described in detail. They concern levels of lipids and the results of an oral glucose tolerance test (OGTT). We apply GMVQ to residuals obtained from regressions of outcomes of an OGTT and lipids on functions of age and BMI that are inferred from the data. A bootstrap procedure developed for our family data supplemented by insights from other approaches leads us to believe that two clusters are appropriate for defining IR precisely. One cluster consists of women who are IR, and the other of women who seem not to be. Genes and other features are used to predict cluster membership. We argue that prediction with "main effects'' is not satisfactory, but prediction that includes interactions may be.	[Yoon, Sangho] Google Inc, Mountain View, CA USA; [Assimes, Themistocles L.; Quertermous, Thomas] Falk Cardiovasc Res Ctr, Dept Med, Div Cardiovasc Med, Stanford, CA USA; [Hsiao, Chin-Fu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Taipei, Miaoli County, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yoon, Sangho; Olshen, Richard A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Olshen, Richard A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Rajaratnam, Bala; Olshen, Richard A.] Dept Environm Earth Syst Sci, Stanford, CA USA	Google Incorporated; National Health Research Institutes - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Stanford University; Stanford University		olshen@stanford.edu	Chuang, Lee-Ming/AAF-3324-2019; Assimes, Themistocles Leonard/D-9696-2015; Hwu, Chii-Min/AAZ-7384-2021; Hsiao, Chin-Fu/E-3993-2010	Assimes, Themistocles Leonard/0000-0003-2349-0009; CHUANG, LEE-MING/0000-0003-0978-2662; Quertermous, Thomas/0000-0002-7645-9067; Hsiao, Chin-Fu/0000-0003-1284-7260	U.S. National Science Foundation (NSF) [DMS-1106642]; U.S. National Institutes of Health (NIH) MERIT Award [R37EB02784];  [NSA H98230-11-0194];  [SUWIEVP10-SMSCVISG0906]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH) MERIT Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	BR was supported in part by the U.S. National Science Foundation (NSF) under Grant DMS-1106642 and grants NSA H98230-11-0194 and SUWIEVP10-SMSCVISG0906. SY and RAO were supported in part by U.S. National Institutes of Health (NIH) MERIT Award R37EB02784. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyer A, 2005, SIGNAL PROCESS-IMAGE, V20, P459, DOI 10.1016/j.image.2005.03.003; Aiyer A, 2001, THESIS STANFORD U; Assimes TL, 2008, ASS MULTIPLE MARKERS; August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Bloch DA, 2002, J COMPUT GRAPH STAT, V11, P263, DOI 10.1198/106186002760180509; Boerwinkle E, 2002, HYPERTENSION, V39, P3; BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286; Brieman L, 1984, CLASSIFICATION REGRE; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CHOU PA, 1989, IEEE T ACOUST SPEECH, V37, P31, DOI 10.1109/29.17498; COCHRAN WG, 1968, TECHNOMETRICS, V10, P637, DOI 10.2307/1267450; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cover T. M., 1991, ELEMENTS INFORM THEO; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Fuller W.A., 2009, MEASUREMENT ERROR MO; George L, 2011, J CLIN ENDOCR METAB, V96, P2136, DOI 10.1210/jc.2010-2813; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray R.M., 1992, VECTOR QUANTIZATION; Gray RM, 2003, IEEE T INFORM THEORY, V49, P1204, DOI 10.1109/TIT.2003.810637; GREENFIELD MS, 1981, DIABETES, V30, P387, DOI 10.2337/diabetes.30.5.387; Hedelin P, 2000, IEEE T SPEECH AUDI P, V8, P385, DOI 10.1109/89.848220; HOLLENBECK CB, 1985, J AM GERIATR SOC, V33, P273, DOI 10.1111/j.1532-5415.1985.tb07116.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; JARRETT RJ, 1978, INT J EPIDEMIOL, V7, P15, DOI 10.1093/ije/7.1.15; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Knowles JW, 2013, METABOLISM, V62, P548, DOI 10.1016/j.metabol.2012.10.002; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Ozonat KM, 2004, IEEE IMAGE PROC, P1887; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Reaven G, 2003, J CLIN ENDOCRINOLOGY, V88, P2239; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; ROSENTHAL M, 1983, DIABETES, V32, P408, DOI 10.2337/diabetes.32.5.408; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sonquist J, 1964, I SOCIAL RES MONOGRA; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; Therneau TM, RPART PACKAGE R PORT; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vapnik VN., 1996, COMPUTATIONAL LEARNI; Wang JG, 2012, DIABETES-METAB RES, V28, P67, DOI 10.1002/dmrr.2356; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yan WL, 2004, OBES RES, V12, P1733, DOI 10.1038/oby.2004.214; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yoon S, 2005, P INT C IM PROC, V2, P1198; Yoon S, 2007, INT CONF ACOUST SPEE, P1081	66	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e94129	10.1371/journal.pone.0094129	http://dx.doi.org/10.1371/journal.pone.0094129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887437	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300004
J	Chen, Y; Mcgee, J; Chen, XM; Doman, TN; Gong, XQ; Zhang, YY; Hamm, N; Ma, XW; Higgs, RE; Bhagwat, SV; Buchanan, S; Peng, SB; Staschke, KA; Yadav, V; Yue, Y; Kouros-Mehr, H				Chen, Ying; McGee, Jeremy; Chen, Xianming; Doman, Thompson N.; Gong, Xueqian; Zhang, Youyan; Hamm, Nicole; Ma, Xiwen; Higgs, Richard E.; Bhagwat, Shripad V.; Buchanan, Sean; Peng, Sheng-Bin; Staschke, Kirk A.; Yadav, Vipin; Yue, Yong; Kouros-Mehr, Hosein			Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets	PLOS ONE			English	Article							BREAST-CANCER; GROWTH-FACTOR; AMPLIFICATION; EPIGENETICS; INHIBITORS; EXPRESSION; RECEPTOR; PROTEIN; GRB7; AMPK	The Cancer Genome Atlas (TCGA) projects have advanced our understanding of the driver mutations, genetic backgrounds, and key pathways activated across cancer types. Analysis of TCGA datasets have mostly focused on somatic mutations and translocations, with less emphasis placed on gene amplifications. Here we describe a bioinformatics screening strategy to identify putative cancer driver genes amplified across TCGA datasets. We carried out GISTIC2 analysis of TCGA datasets spanning 16 cancer subtypes and identified 486 genes that were amplified in two or more datasets. The list was narrowed to 75 cancer-associated genes with potential "druggable'' properties. The majority of the genes were localized to 14 amplicons spread across the genome. To identify potential cancer driver genes, we analyzed gene copy number and mRNA expression data from individual patient samples and identified 42 putative cancer driver genes linked to diverse oncogenic processes. Oncogenic activity was further validated by siRNA/shRNA knockdown and by referencing the Project Achilles datasets. The amplified genes represented a number of gene families, including epigenetic regulators, cell cycle-associated genes, DNA damage response/repair genes, metabolic regulators, and genes linked to the Wnt, Notch, Hedgehog, JAK/STAT, NF-KB and MAPK signaling pathways. Among the 42 putative driver genes were known driver genes, such as EGFR, ERBB2 and PIK3CA. Wild-type KRAS was amplified in several cancer types, and KRAS-amplified cancer cell lines were most sensitive to KRAS shRNA, suggesting that KRAS amplification was an independent oncogenic event. A number of MAP kinase adapters were co-amplified with their receptor tyrosine kinases, such as the FGFR adapter FRS2 and the EGFR family adapters GRB2 and GRB7. The ubiquitin-like ligase DCUN1D1 and the histone methyltransferase NSD3 were also identified as novel putative cancer driver genes. We discuss the patient tailoring implications for existing cancer drug targets and we further discuss potential novel opportunities for drug discovery efforts.	[Chen, Ying; McGee, Jeremy; Chen, Xianming; Doman, Thompson N.; Gong, Xueqian; Zhang, Youyan; Hamm, Nicole; Ma, Xiwen; Higgs, Richard E.; Bhagwat, Shripad V.; Buchanan, Sean; Peng, Sheng-Bin; Staschke, Kirk A.; Yadav, Vipin; Yue, Yong; Kouros-Mehr, Hosein] Eli Lilly & Co, Dept Oncol, Indianapolis, IN 46285 USA	Eli Lilly	Kouros-Mehr, H (corresponding author), Eli Lilly & Co, Dept Oncol, Indianapolis, IN 46285 USA.	kouros.mehr@gmail.com	gong, xue/GYQ-8649-2022; Staschke, Kirk/HGC-5664-2022	Staschke, Kirk/0000-0001-8722-9585	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This study was funded by Eli Lilly and Company. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Birkeland E, 2012, BRIT J CANCER, V107, P1997, DOI 10.1038/bjc.2012.477; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dabir S, 2014, INT J CANCER, V134, P1045, DOI 10.1002/ijc.28448; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Franci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058183; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kang D, 2013, GENE CHROMOSOME CANC, V52, P126, DOI 10.1002/gcc.22012; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Li CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-357; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lucio-Eterovic AK, 2011, TRANSCR-AUSTIN, V2, P158, DOI 10.4161/trns.2.4.16217; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morishita M, 2011, BBA-REV CANCER, V1816, P158, DOI 10.1016/j.bbcan.2011.05.004; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nencioni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009024; Nobusawa S, 2011, NEUROPATHOLOGY, V31, P583, DOI 10.1111/j.1440-1789.2011.01204.x; Qin CH, 2001, CLIN CANCER RES, V7, P818; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rodriguez-Paredes M., 2013, ONCOGENE, DOI 10.1038/onc.2013.239; Rytinki M, 2012, MOL CELL BIOL, V32, P4195, DOI 10.1128/MCB.00753-12; Saito M, 2012, FEBS LETT, V586, P1708, DOI 10.1016/j.febslet.2012.05.003; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Vidler LR, 2013, J MED CHEM, V56, P8073, DOI 10.1021/jm4011302; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Walch A, 2004, INT J CANCER, V112, P747, DOI 10.1002/ijc.20411; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708	58	79	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98293	10.1371/journal.pone.0098293	http://dx.doi.org/10.1371/journal.pone.0098293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874471	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800032
J	Zhang, GL; Ma, JY; Sun, Q; Hu, MW; Yang, XY; Gao, SH; Jiang, GJ				Zhang, Guang-Li; Ma, Jun-Yu; Sun, Quan; Hu, Meng-Wen; Yang, Xiu-yan; Gao, Si-Hua; Jiang, Guang-Jian			Effects of Postmortem Interval on Mouse Ovary Oocyte Survival and Maturation	PLOS ONE			English	Article							GERMINAL VESICLE STAGE; PORCINE OOCYTES; IN-VITRO; CRYOPRESERVATION; VITRIFICATION; EMBRYOS	To study the time-and temperature-dependent survival of ovarian oocytes collected from postmortem carcass, ICR mice were killed and placed for different periods (0, 1, 2, 4, 6, 8 and 10 h) at different temperatures (25 degrees C, 4 degrees C and 37 degrees C). After preservation, oocyte morphology, germinal vesicle (GV) oocyte number, oocyte meiotic maturation percentage, mitochondrial distribution and intracellular glutathione (GSH) level were evaluated. The results showed no surviving oocytes could be collected by 2h, 6h, and 12 h after carcass preservation at 37 degrees C, 25 degrees C and 4 degrees C, respectively. The number of collected GV oocytes in the ovary deceased as the preservation time lasted at the same temperature. Meanwhile at the same point in time, the ratio of germinal vesicle breakdown (GVBD) and the first polar body emission (PBE) gradually reduced as preservation temperature increased. In addition, the percentage of abnormal mitochondrial distribution in the preserved oocytes was obviously higher than that in the control oocytes, while GSH level was not altered in collected oocytes. Unexpectedly, neither chromosome arrangement nor spindle organization was affected as long as the oocytes from preserved carcasses could complete maturation. These data are helpful for proper use of ovary oocytes from postmortem carcass of valuable individuals.	[Zhang, Guang-Li; Sun, Quan; Yang, Xiu-yan; Gao, Si-Hua; Jiang, Guang-Jian] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China; [Zhang, Guang-Li; Sun, Quan; Jiang, Guang-Jian] Hebei United Univ, Dept Biochem & Mol Biol, Tangshan, Peoples R China; [Ma, Jun-Yu] Qingdao Agr Univ, Dept Anim Sci & Technol, Qingdao, Peoples R China; [Ma, Jun-Yu; Hu, Meng-Wen] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Beijing University of Chinese Medicine; North China University of Science & Technology; Qingdao Agricultural University; Chinese Academy of Sciences; Institute of Zoology, CAS	Jiang, GJ (corresponding author), Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China.	jguangjian@yahoo.com		Hu, Mengwen/0000-0002-7480-6432	National Natural Science Foundation of China [NSFC81274041, NSFC81273995]; International Cooperation Projects of MOE [2011DFA30920]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Projects of MOE	This work was supported by Grants from the National Natural Science Foundation of China (NSFC81274041, NSFC81273995, http://isisn.nsfc.gov.cn) the International Cooperation Projects of MOE (2011DFA30920, http://www.istcp.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleary M, 2001, CRYOBIOLOGY, V42, P121, DOI 10.1006/cryo.2001.2315; DIDION BA, 1990, J ANIM SCI, V68, P2803; FUNAHASHI H, 1994, BIOL REPROD, V51, P633, DOI 10.1095/biolreprod51.4.633; Ge L, 2008, FERTIL STERIL, V90, P2376, DOI 10.1016/j.fertnstert.2007.10.054; Gualtieri R, 2009, FERTIL STERIL, V91, P1023, DOI 10.1016/j.fertnstert.2008.01.076; Hinrichs K, 2005, BIOL REPROD, V72, P1142, DOI 10.1095/biolreprod.104.036012; Liu RH, 2003, ZYGOTE, V11, P299, DOI 10.1017/S0967199403002351; Miao DQ, 2007, MOL REPROD DEV, V74, P468, DOI 10.1002/mrd.20572; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; SCHROEDER AC, 1991, J EXP ZOOL, V258, P240, DOI 10.1002/jez.1402580214; Shi LY, 2007, ANIM REPROD SCI, V100, P128, DOI 10.1016/j.anireprosci.2006.06.020; Snow M, 2001, REPROD FERT DEVELOP, V13, P389, DOI 10.1071/RD00130; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242	15	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98384	10.1371/journal.pone.0098384	http://dx.doi.org/10.1371/journal.pone.0098384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874949	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800037
J	Fouda, MA; El-Gowelli, HM; El-Gowilly, SM; Rashed, L; El-Mas, MM				Fouda, Mohamed A.; El-Gowelli, Hanan M.; El-Gowilly, Sahar M.; Rashed, Laila; El-Mas, Mahmoud M.			Impairment of Nitric Oxide Synthase but Not Heme Oxygenase Accounts for Baroreflex Dysfunction Caused by Chronic Nicotine in Female Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; NUCLEUS-TRACTUS-SOLITARIUS; CARBON-MONOXIDE; SODIUM-NITROPRUSSIDE; BLOOD-PRESSURE; NERVE ACTIVITY; HEART-RATE; IN-VIVO; INDUCTION; SYSTEM	We recently reported that chronic nicotine impairs reflex chronotropic activity in female rats. Here, we sought evidence to implicate nitric oxide synthase (NOS) and/or heme oxygenase (HO) in the nicotine-baroreflex interaction. Baroreflex curves relating changes in heart rate to increases (phenylephrine) or decreases (sodium nitroprusside) in blood pressure were generated in conscious female rats treated with nicotine or saline in absence and presence of pharmacological modulators of NOS or HO activity. Compared with saline-treated rats, nicotine (2 mg/kg/day i.p., for 14 days) significantly reduced the slopes of baroreflex curves, a measure of baroreflex sensitivity (BRS). Findings that favor the involvement of NOS inhibition in the nicotine effect were (i) NOS inhibition (N-omega-Nitro-L-arginine methyl ester, L-NAME) reduced BRS in control rats but failed to do so in nicotine-treated rats, (ii) L-arginine, NO donor, reversed the BRS inhibitory effect of nicotine. Alternatively, HO inhibition (zinc protoporphyrin IX, ZnPP) had no effect on BRS in nicotine-or control rats and failed to reverse the beneficial effect of L-arginine on nicotine-BRS interaction. Similar to female rats, BRS was reduced by L-NAME, but not ZnPP, in male rats and the L-NAME effect was not accentuated after concomitant administration of nicotine. Baroreflex dysfunction caused by nicotine in female rats was blunted after supplementation with hemin (HO inducer) but not tricarbonyldichlororuthenium(II) dimer (CORM-2), a carbon monoxide (CO) releasing molecule, or bilirubin, the breakdown product of heme catabolism. The facilitatory effect of hemin was abolished upon simultaneous treatment with L-NAME or 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one (inhibitor of soluble guanylate cyclase, sGC). The activities of HO and NOS in brainstem tissues were also significantly increased by hemin. Thus, the inhibition of NOS, but not HO, accounts for the baroreflex depressant of chronic nicotine. Further, hemin alleviates the nicotine effect through a mechanism that is NOS/sGC but not CO or bilirubin-dependent.	[Fouda, Mohamed A.; El-Gowelli, Hanan M.; El-Gowilly, Sahar M.; Rashed, Laila; El-Mas, Mahmoud M.] Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	El-Mas, MM (corresponding author), Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt.	mahelm@hotmail.com	El-Mas, Mahmoud M./B-9047-2009; Gowelli, Hanan M. El/F-9500-2010	El-Mas, Mahmoud M./0000-0001-8855-7070; Gowelli, Hanan M. El/0000-0001-8145-7608	Science and Technology Development Fund (STDF), Egypt [502]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	This project was supported by the Science and Technology Development Fund (STDF), Egypt, Grant No. 502.(http://www.stdf.org.eg/ndex.php?option = com_contact&view = contact&id = 1&Itemid = 57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAHMAN AA, 1992, CAN J PHYSIOL PHARM, V70, P1217, DOI 10.1139/y92-169; Achouh Paul E, 2008, Interact Cardiovasc Thorac Surg, V7, P959, DOI 10.1510/icvts.2008.180489; Ashworth-Preece M, 1998, NEUROSCIENCE, V83, P1113, DOI 10.1016/S0306-4522(97)00476-4; Aziz MTA, 2009, J SEX MED, V6, P3254, DOI 10.1111/j.1743-6109.2009.01517.x; Balakumar P, 2009, PHARMACOL RES, V60, P361, DOI 10.1016/j.phrs.2009.06.005; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Bullen Christopher, 2008, Expert Rev Cardiovasc Ther, V6, P883, DOI 10.1586/14779072.6.6.883; Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409; El-Gowelli HM, 2011, J CARDIOVASC PHARM, V58, P173, DOI 10.1097/FJC.0b013e31821ed803; El-Mas MA, 2001, BRAIN RES, V912, P79, DOI 10.1016/S0006-8993(01)02727-5; El-Mas MM, 2012, EUR J PHARMACOL, V694, P82, DOI 10.1016/j.ejphar.2012.08.021; El-Mas MM, 2012, J PHARMACOL EXP THER, V342, P568, DOI 10.1124/jpet.112.191940; El-Mas MM, 2012, NEUROPHARMACOLOGY, V62, P1890, DOI 10.1016/j.neuropharm.2011.12.017; ElMas MM, 1997, EUR J PHARMACOL, V322, P201, DOI 10.1016/S0014-2999(97)00010-1; ElMas MM, 1997, NEUROSCIENCE, V79, P581, DOI 10.1016/S0306-4522(96)00648-3; ELMAS MM, 1993, J PHARMACOL EXP THER, V264, P1198; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; GIANNATTASIO C, 1994, J HYPERTENS, V12, P691; Heaton DA, 2005, J MOL CELL CARDIOL, V39, P159, DOI 10.1016/j.yjmcc.2005.03.018; Hirooka Y, 2011, AM J PHYSIOL-REG I, V300, pR818, DOI 10.1152/ajpregu.00426.2010; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Kinderlerer AR, 2009, BLOOD, V113, P1598, DOI 10.1182/blood-2008-04-152934; Kirkby K, 2007, AM J PHYSIOL-RENAL, V292, pF888, DOI 10.1152/ajprenal.00064.2006; KUMAGAI H, 1993, HYPERTENSION, V21, P476, DOI 10.1161/01.HYP.21.4.476; Lande RG, 2010, J AM OSTEOPATH ASSOC, V110, P127; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; Lin CH, 2004, J PHARMACOL EXP THER, V308, P1213, DOI 10.1124/jpet.103.060186; Liu JL, 1996, AM J PHYSIOL-REG I, V270, pR1361, DOI 10.1152/ajpregu.1996.270.6.R1361; Lo W J, 1996, Chin J Physiol, V39, P57; Lo WC, 2006, J PHARMACOL EXP THER, V318, P8, DOI 10.1124/jpet.105.099051; Lo WC, 2000, HYPERTENSION, V35, P1253, DOI 10.1161/01.HYP.35.6.1253; Mancia G, 1997, AM J PHYSIOL-HEART C, V273, pH1555, DOI 10.1152/ajpheart.1997.273.3.H1555; Moreira TS, 2011, AUTON NEUROSCI-BASIC, V159, P62, DOI 10.1016/j.autneu.2010.08.003; Morin A, 2011, REGUL TOXICOL PHARM, V61, pS3, DOI 10.1016/j.yrtph.2010.09.020; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nakao A, 2003, SURGERY, V134, P285, DOI 10.1067/msy.2003.238; Ndisang JF, 2002, HYPERTENSION, V40, P315, DOI 10.1161/01.HYP.0000028488.71068.16; Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Pae HO, 2010, NITRIC OXIDE-BIOL CH, V23, P251, DOI 10.1016/j.niox.2010.08.002; Roethig HJ, 2009, NICOTINE TOB RES, V11, P1216, DOI 10.1093/ntr/ntp126; Schubert R, 2004, HYPERTENSION, V43, P891, DOI 10.1161/01.HYP.0000121882.42731.6b; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; SPYER KM, 1982, J EXP BIOL, V100, P109; Stern JE, 2005, J PHYSIOL-LONDON, V562, P725, DOI 10.1113/jphysiol.2004.077735; Tzeng E, 2009, VASCULAR, V17, pS55, DOI 10.2310/6670.2008.00090; Wang R, 2006, HYPERTENSION, V48, P685, DOI 10.1161/01.HYP.0000239673.80332.2f; WANG YX, 1993, BRIT J PHARMACOL, V108, P398, DOI 10.1111/j.1476-5381.1993.tb12816.x; Zhang F, 2001, AM J HYPERTENS, V14, p62S, DOI 10.1016/S0895-7061(01)02071-4	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98681	10.1371/journal.pone.0098681	http://dx.doi.org/10.1371/journal.pone.0098681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870610	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300056
J	Lam, CSC; Cheung, AHK; Wong, SKM; Wan, TMH; Ng, L; Chow, AKM; Cheng, NSM; Pak, RCH; Li, HS; Man, JHW; Yau, TCC; Lo, OSH; Poon, JTC; Pang, RWC; Law, WL				Lam, Colin Siu-Chi; Cheung, Alvin Ho-Kwan; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Ng, Lui; Chow, Ariel Ka-Man; Cheng, Nathan Shiu-Man; Pak, Ryan Chung-Hei; Li, Hung-Sing; Man, Johnny Hon-Wai; Yau, Thomas Chung-Cheung; Lo, Oswens Siu-Hung; Poon, Jensen Tung-Chung; Pang, Roberta Wen-Chi; Law, Wai Lun			Prognostic Significance of CD26 in Patients with Colorectal Cancer	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; CARCINOEMBRYONIC ANTIGEN CEA; FECAL-OCCULT-BLOOD; EXTRACELLULAR-MATRIX; SERUM CD26; CARCINOMA; DIAGNOSIS; BINDING; MORTALITY; SURFACE	Background: CD26, dipeptidyl peptidase IV, was discovered firstly as a membrane-associated peptidase on the surface of leukocyte. We previously demonstrated that a subpopulation of CD26(+) cells were associated with the development of distant metastasis, enhanced invasiveness and chemoresistance in colorectal cancer (CRC). In order to understand the clinical impact of CD26, the expression was investigated in CRC patient's specimens. This study investigated the prognostic significance of tumour CD26 expression in patients with CRC. Examination of CD26+ cells has significant clinical impact for the prediction of distant metastasis development in colorectal cancer, and could be used as a selection criterion for further therapy. Methods: Tumour CD26 expression levels were studied by immunohistochemistry using Formalin-fixed paraffin embedded (FFPE) tissues in 143 patients with CRC. Tumour CD26 expression levels were correlated with clinicopathological features of the CRC patients. The prognostic significance of tumour tissue CD26 expression levels was assessed by univariate and multivariate analyses. Result: CD26 expression levels in CRC patients with distant metastasis were significantly higher than those in non-metastatic. High expression levels of CD26 were significantly associated with advanced tumour staging. Patients with a high CD26 expression level had significantly worse overall survival than those with a lower level (p < 0.001). Conclusions: The expression of CD26 was positively associated with clinicopathological correlation such as TNM staging, degree of differentiation and development of metastasis. A high CD26 expression level is a predictor of poor outcome after resection of CRC. CD26 may be a useful prognostic marker in patients with CRC.	[Lam, Colin Siu-Chi; Cheung, Alvin Ho-Kwan; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Ng, Lui; Chow, Ariel Ka-Man; Cheng, Nathan Shiu-Man; Pak, Ryan Chung-Hei; Li, Hung-Sing; Man, Johnny Hon-Wai; Lo, Oswens Siu-Hung; Poon, Jensen Tung-Chung; Pang, Roberta Wen-Chi; Law, Wai Lun] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Yau, Thomas Chung-Cheung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lam, Colin Siu-Chi; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Ng, Lui; Chow, Ariel Ka-Man; Cheng, Nathan Shiu-Man; Li, Hung-Sing; Man, Johnny Hon-Wai; Pang, Roberta Wen-Chi] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Pang, RWC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Wan, Timothy/AAA-2432-2021; Ng, Lui/AAG-4397-2019; Chow, Ariel/HGF-2363-2022; Yau, Thomas Chung Cheung/B-3429-2011	Wan, Timothy/0000-0002-9235-2913; Ng, Lui/0000-0002-9010-2654; Chow, Ariel/0000-0002-5729-5415; Yau, Thomas Chung Cheung/0000-0002-7114-0305; /0000-0003-2801-5717; Li, Hung Sing/0000-0002-2156-8362; Cheung, Alvin Ho-Kwan/0000-0002-3913-8117				[Anonymous], 1972, Can Med Assoc J, V107, P25; Ayude D, 2003, DIS MARKERS, V19, P267; BAUVOIS B, 1988, BIOCHEM J, V252, P723, DOI 10.1042/bj2520723; Benoist S, 2006, J CLIN ONCOL, V24, P3939, DOI 10.1200/JCO.2006.05.8727; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; De La Haba-Rodriguez J, 2002, NEOPLASMA, V49, P307; DHAR P, 1972, J AMER MED ASSOC, V221, P31, DOI 10.1001/jama.221.1.31; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; HERRERA MA, 1976, ANN SURG, V183, P5, DOI 10.1097/00000658-197601000-00002; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Hunter Kent W, 2008, Breast Cancer Res, V10 Suppl 1, pS2, DOI 10.1186/bcr1988; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LOGERFO P, 1972, AM J SURG, V123, P127; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Sedo Aleksi, 2008, Expert Opin Med Diagn, V2, P677, DOI 10.1517/17530059.2.6.677; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; TANAKA T, 1992, J IMMUNOL, V149, P481; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Winawer Sidney J, 2005, Surg Oncol Clin N Am, V14, P699, DOI 10.1016/j.soc.2005.05.009; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Yamada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062304; ZAMCHECK N, 1972, NEW ENGL J MED, V286, P83, DOI 10.1056/NEJM197201132860207	34	58	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98582	10.1371/journal.pone.0098582	http://dx.doi.org/10.1371/journal.pone.0098582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870408	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300054
J	Lee, BS; Kim, SH; Oh, J; Jin, T; Choi, EY; Park, S; Lee, SH; Chung, JH; Kang, SM				Lee, Beom Seob; Kim, Soo Hyuk; Oh, Jaewon; Jin, Taewon; Choi, Eun Young; Park, Sungha; Lee, Sang-Hak; Chung, Ji Hyung; Kang, Seok-Min			C-Reactive Protein Inhibits Survivin Expression via Akt/mTOR Pathway Downregulation by PTEN Expression in Cardiac Myocytes	PLOS ONE			English	Article							APOPTOSIS	C-reactive protein (CRP) is one of the most important biomarkers for arteriosclerosis and cardiovascular disease. Recent studies have shown that CRP affects cell cycle and inflammatory process in cardiac myocytes. Survivin is also involved in cardiac myocytes replication and apoptosis. Reduction of survivin expression is associated with less favorable cardiac remodeling in animal models. However, the effect of CRP on survivin expression and its cellular mechanism has not yet been studied. We demonstrated that treatment of CRP resulted in a significant decrease of survivin protein expression in a concentration-dependent manner in cardiac myocytes. The upstream signaling proteins of survivin, such as Akt, mTOR and p70S6K, were also downregulated by CRP treatment. In addition, CRP increased the protein and mRNA levels of PTEN. The siRNA transfection or specific inhibitor treatment for PTEN restored the CRP-induced downregulation of Akt/mTOR/p70S6K pathway and survivin protein expression. Moreover, pretreatment with a specific p53 inhibitor decreased the CRP-induced PTEN expression. ERK-specific inhibitor also blocked the p53 phosphorylation and PTEN expression induced by CRP. Our study provides a novel insight into CRP-induced downregulation of survivin protein expression in cardiac myocytes through mechanisms that involved in downregulation of Akt/mTOR/p70S6K pathway by expression of PTEN.	[Lee, Beom Seob; Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young] Yonsei Univ, Grad Program Sci Aging, Seoul 120749, South Korea; [Lee, Beom Seob; Oh, Jaewon; Park, Sungha; Lee, Sang-Hak; Kang, Seok-Min] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, Seoul, South Korea; [Lee, Beom Seob; Oh, Jaewon; Park, Sungha; Lee, Sang-Hak; Kang, Seok-Min] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Beom Seob; Kang, Seok-Min] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young; Chung, Ji Hyung] CHA Univ, Coll Life Sci, Dept Appl Biosci, Gyeonggi Do, South Korea; [Kang, Seok-Min] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System	Chung, JH (corresponding author), CHA Univ, Coll Life Sci, Dept Appl Biosci, Gyeonggi Do, South Korea.	jhchung@cha.ac.kr; smkang@yuhs.ac		Oh, Jaewon/0000-0002-4585-1488; Kang, Seok-Min/0000-0001-9856-9227; Park, Sungha/0000-0001-5362-478X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012R1A1A2006347, NRF- 2012R1A1A2006779]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2006347, NRF- 2012R1A1A2006779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2006, INT J CARDIOL, V111, P371, DOI 10.1016/j.ijcard.2005.07.061; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Baldassarre D, 2008, ANN MED, V40, P21, DOI 10.1080/07853890701645399; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Choi JW, 2011, BIOCHEM BIOPH RES CO, V410, P525, DOI 10.1016/j.bbrc.2011.06.016; Cui CJ, 2012, CELL SIGNAL, V24, P810, DOI 10.1016/j.cellsig.2011.11.019; Danenberg HD, 2003, CIRCULATION, V108, P512, DOI 10.1161/01.CIR.0000085568.13915.1E; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599; Kawahara KI, 2008, CARDIOVASC PATHOL, V17, P129, DOI 10.1016/j.carpath.2007.08.006; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Lee BS, 2013, KOREAN CIRC J, V43, P400, DOI 10.4070/kcj.2013.43.6.400; Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160; Levkau B, 2011, J MOL CELL CARDIOL, V50, P6, DOI 10.1016/j.yjmcc.2010.10.013; Li D, 2013, CANCER GENE THER, V20, P251, DOI 10.1038/cgt.2013.14; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Modgil A, 2012, AM J PHYSIOL-HEART C, V302, pH1116, DOI 10.1152/ajpheart.00832.2011; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schneeweis C, 2010, J ATHEROSCLER THROMB, V17, P203, DOI 10.5551/jat.3004; Si R, 2011, J MOL CELL CARDIOL, V50, P16, DOI 10.1016/j.yjmcc.2010.08.017; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Suh W, 2004, BIOCHEM BIOPH RES CO, V321, P65, DOI 10.1016/j.bbrc.2004.06.107; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98113	10.1371/journal.pone.0098113	http://dx.doi.org/10.1371/journal.pone.0098113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866016	Green Submitted, Green Published, gold			2022-12-27	WOS:000336914100033
J	Leitch, CC; Zaghloul, NA				Leitch, Carmen C.; Zaghloul, Norann A.			BBS4 Is Necessary for Ciliary Localization of TrkB Receptor and Activation by BDNF	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; NEUROTROPHIC FACTOR; PRIMARY-CILIUM; LEPTIN RESISTANCE; SYNDROME PROTEINS; EPITHELIAL-CELLS; SITUS-INVERSUS; OBESITY; DIFFERENTIATION; CILIOPATHY	Primary cilia regulate an expanding list of signaling pathways in many different cell types. It is likely that identification of the full catalog of pathways associated with cilia will be necessary to fully understand their role in regulation of signaling and the implications for diseases associated with their dysfunction, ciliopathies. Bardet-Biedl Syndrome (BBS) is one such ciliopathy which is characterized by a spectrum of phenotypes. These include neural defects such as impaired cognitive development, centrally mediated hyperphagia and peripheral sensory defects. Here we investigate potential defects in a signaling pathway associated with neuronal function, brain derived neurotrophic factor (BDNF) signaling. Upon loss of BBS4 expression in cultured cells, we observed decreased phosphorylation and activation by BDNF of its target receptor, TrkB. Assessment of ciliary localization revealed that, TrkB localized to the axonemes or basal bodies of cilia only in the presence of BDNF. Axonemal localization, specifically, was abrogated with loss of BBS4. Finally, we present evidence that loss of the ciliary axoneme through depletion of KIF3A impedes activation of TrkB. Taken together, these data suggest the possibility of a previously uninvestigated pathway associated with perturbation of ciliary proteins.	[Leitch, Carmen C.; Zaghloul, Norann A.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zaghloul, NA (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	zaghloul@umaryland.edu			University of Maryland School of Medicine;  [K01DK092402]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, K01DK092402, P30DK072488, R01DK102001] Funding Source: NIH RePORTER	University of Maryland School of Medicine; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by University of Maryland School of Medicine seed funding as well as a K01DK092402 to Dr. Zaghloul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima R, 2011, NAT CELL BIOL, V13, P636, DOI 10.1038/ncb0611-636; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Beales PL, 1999, J MED GENET, V36, P437; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2013, P NATL ACAD SCI USA, V110, P7796, DOI 10.1073/pnas.1210192110; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Hackett SF, 1998, BRAIN RES, V789, P201, DOI 10.1016/S0006-8993(97)01440-6; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kodani A, 2013, EMBO J, V32, P597, DOI 10.1038/emboj.2013.3; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Scheidecker S, 2013, J MED GENETICS; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Spalluto C, 2013, FEBS OPEN BIO, V3, P334, DOI 10.1016/j.fob.2013.08.002; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Vanesvki F, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00037; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	34	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98687	10.1371/journal.pone.0098687	http://dx.doi.org/10.1371/journal.pone.0098687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867303	Green Submitted, Green Published			2022-12-27	WOS:000336914100065
J	Simmonds, B; Fox, K; Davis, M; Ku, PW; Gray, S; Hillsdon, M; Sharp, D; Stathi, A; Thompson, J; Coulson, J; Trayers, T				Simmonds, Bethany; Fox, Kenneth; Davis, Mark; Ku, Po-Wen; Gray, Selena; Hillsdon, Melvyn; Sharp, Debbie; Stathi, Afroditi; Thompson, Janice; Coulson, Joanna; Trayers, Tanya			Objectively Assessed Physical Activity and Subsequent Health Service Use of UK Adults Aged 70 and Over: A Four to Five Year Follow Up Study	PLOS ONE			English	Article							LIFE-STYLE INTERVENTIONS; OLDER-ADULTS; CARE UTILIZATION; INDEPENDENCE; ELDERS; ASSOCIATION; DISABILITY; MORTALITY; MOBILITY; PEOPLE	Objectives: To examine the associations between volume and intensity of older peoples' physical activity, with their subsequent health service usage over the following four to five years. Study Design: A prospective cohort design using baseline participant characteristics, objectively assessed physical activity and lower limb function provided by Project OPAL (Older People and Active Living). OPAL-PLUS provided data on numbers of primary care consultations, prescriptions, unplanned hospital admissions, and secondary care referrals, extracted from medical records for up to five years following the baseline OPAL data collection. Participants and Data Collection: OPAL participants were a diverse sample of 240 older adults with a mean age of 78 years. They were recruited from 12 General Practitioner surgeries from low, middle, and high areas of deprivation in a city in the West of England. Primary care consultations, secondary care referrals, unplanned hospital admissions, number of prescriptions and new disease diagnoses were assessed for 213 (104 females) of the original 240 OPAL participants who had either consented to participate in OPAL-PLUS or already died during the follow-up period. Results: In regression modelling, adjusted for socio-economic variables, existing disease, weight status, minutes of moderate-to-vigorous physical activity (MVPA) per day predicted subsequent numbers of prescriptions. Steps taken per day and MVPA also predicted unplanned hospital admissions, although the strength of the effect was reduced when further adjustment was made for lower limb function. Conclusions: Community-based programs are needed which are successful in engaging older adults in their late 70s and 80s in more walking, MVPA and activity that helps them avoid loss of physical function. There is a potential for cost savings to health services through reduced reliance on prescriptions and fewer unplanned hospital admissions.	[Simmonds, Bethany; Fox, Kenneth; Davis, Mark; Coulson, Joanna] Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol, Avon, England; [Ku, Po-Wen] Natl Changhua Univ Educ, Grad Inst Sports & Hlth, Changua, Taiwan; [Gray, Selena] Univ W England, Dept Hlth & Appl Social Sci, Bristol BS16 1QY, Avon, England; [Hillsdon, Melvyn] Univ Exeter, Exeter, Devon, England; [Sharp, Debbie; Trayers, Tanya] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Stathi, Afroditi] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Fox, Kenneth; Thompson, Janice] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England	University of Bristol; National Changhua University of Education; University of West England; University of Exeter; University of Bristol; University of Bath; University of Birmingham	Simmonds, B (corresponding author), Bristol Royal Infirm & Gen Hosp, Univ Hosp Bristol, Dept Rheumatol, Bristol, Avon, England.	bethany.simmonds@bristol.ac.uk	Ku, Po-Wen/S-7723-2019; STATHI, AFRODITI/AAM-4377-2020	STATHI, AFRODITI/0000-0003-2162-777X; Simmonds, Bethany Adela Joanna/0000-0003-2463-7623; Ku, Po-Wen/0000-0001-9724-018X; sharp, deborah/0000-0003-3071-9860; Thompson, Janice/0000-0002-7312-3226; Fox, Kenneth/0000-0003-2216-4287	Dunhill Medical Trust [R200/0511]; Avon Primary Care Research Collaborative; South West General Practitioners Trust; National Prevention Research Initiative - British Heart Foundation [G0501312]; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; World Cancer Research Fund; MRC [MR/K00414X/1, G0501312] Funding Source: UKRI; Medical Research Council [MR/K00414X/1, G0501312] Funding Source: researchfish; The Dunhill Medical Trust [R200/0511] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); Avon Primary Care Research Collaborative; South West General Practitioners Trust; National Prevention Research Initiative - British Heart Foundation; Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Dunhill Medical Trust(Dunhill Medical Trust)	This follow-up work (OPAL-PLUS) was supported by The Dunhill Medical Trust grant number R200/0511 with additional support from the Avon Primary Care Research Collaborative and the South West General Practitioners Trust. Project OPAL provided the baseline data and was funded by Phase 1 of the National Prevention Research Initiative (http://www.npri.org.uk; grant No. G0501312) that was supported by the British Heart Foundation, Cancer Research UK, Department of Health, Diabetes UK, Economic and Social Research Council, Medical Research Council, Research and Development Office for the Northern Ireland Health and Social Services, Chief Scientist Office, Scottish Executive Health Department, Welsh Assembly Government, and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; [Anonymous], 2010, WHO GLOB STAT REP NO; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Breeze E, 2005, INT J EPIDEMIOL, V34, P276, DOI 10.1093/ije/dyh328; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Craig R, 2009, HLTH SURVEY ENGLAND; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Department of Health, 2011, START ACT STAY ACT R; Fox KR, 2011, HEALTH PLACE, V17, P633, DOI 10.1016/j.healthplace.2011.01.002; Gine-Garriga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066392; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; House of Lords Select Committee on Public Service and Demographic Change, 2013, READ AG REP; Ip EH, 2013, J GERONTOL A-BIOL, V68, P426, DOI 10.1093/gerona/gls186; Lai JKC, 2013, J BONE MINER RES, V28, P2222, DOI 10.1002/jbmr.1963; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Marsh AP, 2011, J GERONTOL A-BIOL, V66, P1376, DOI 10.1093/gerona/glr158; Martin MY, 2006, J AGING PHYS ACTIV, V14, P392, DOI 10.1123/japa.14.4.392; Meltzer D, 2012, HLTH CARE QUALITY AC; Morina N, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-39; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; NICE, 2013, PHYS ACT BRIEF ADV A, V44, P44; Office for National Statistics, 2007, IND DEPR 2007 SUP OU; Perkins AJ, 2001, PREV MED, V32, P492, DOI 10.1006/pmed.2001.0832; Petrella RJ, 1999, PREV MED, V29, P571, DOI 10.1006/pmed.1999.0573; Prior MK, 2012, SOC WORK HEALTH CARE, V51, P345, DOI 10.1080/00981389.2011.644103; Rejeski WJ, 2013, CLIN INTERV AGING, V8, P1119, DOI 10.2147/CIA.S49737; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Sari N, 2011, MATURITAS, V70, P285, DOI 10.1016/j.maturitas.2011.08.004; Sari N, 2010, CAN J PUBLIC HEALTH, V101, P385, DOI 10.1007/BF03404858; Cabrera MAS, 2012, CAN J AGING, V31, P357, DOI 10.1017/S0714980812000244; Smee D. J., 2012, CURRENT GERONTOLOGY; Tooth LR, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-179; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Wang FF, 2005, OBES RES, V13, P1450, DOI 10.1038/oby.2005.175; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	38	26	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97676	10.1371/journal.pone.0097676	http://dx.doi.org/10.1371/journal.pone.0097676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866573	Green Published, gold			2022-12-27	WOS:000336914100019
J	Knoblauch, A; Korner, E; Korner, U; Sommer, FT				Knoblauch, Andreas; Koerner, Edgar; Koerner, Ursula; Sommer, Friedrich T.			Structural Synaptic Plasticity Has High Memory Capacity and Can Explain Graded Amnesia, Catastrophic Forgetting, and the Spacing Effect	PLOS ONE			English	Article							NEURAL ASSOCIATIVE MEMORY; STORAGE CAPACITY; VISUAL-CORTEX; PYRAMIDAL NEURONS; HIPPOCAMPAL; MODEL; CONSOLIDATION; DYNAMICS; SYNCHRONIZATION; CONNECTIVITY	Although already William James and, more explicitly, Donald Hebb's theory of cell assemblies have suggested that activity-dependent rewiring of neuronal networks is the substrate of learning and memory, over the last six decades most theoretical work on memory has focused on plasticity of existing synapses in prewired networks. Research in the last decade has emphasized that structural modification of synaptic connectivity is common in the adult brain and tightly correlated with learning and memory. Here we present a parsimonious computational model for learning by structural plasticity. The basic modeling units are "potential synapses'' defined as locations in the network where synapses can potentially grow to connect two neurons. This model generalizes well-known previous models for associative learning based on weight plasticity. Therefore, existing theory can be applied to analyze how many memories and how much information structural plasticity can store in a synapse. Surprisingly, we find that structural plasticity largely outperforms weight plasticity and can achieve a much higher storage capacity per synapse. The effect of structural plasticity on the structure of sparsely connected networks is quite intuitive: Structural plasticity increases the "effectual network connectivity'', that is, the network wiring that specifically supports storage and recall of the memories. Further, this model of structural plasticity produces gradients of effectual connectivity in the course of learning, thereby explaining various cognitive phenomena including graded amnesia, catastrophic forgetting, and the spacing effect.	[Knoblauch, Andreas] Albstadt Sigmaringen Univ, Fac Engn, Albstadt, Germany; [Knoblauch, Andreas; Koerner, Edgar; Koerner, Ursula] Honda Res Inst Europe, Offenbach, Germany; [Sommer, Friedrich T.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA	Honda Motor Company; University of California System; University of California Berkeley	Knoblauch, A (corresponding author), Albstadt Sigmaringen Univ, Fac Engn, Albstadt, Germany.	knoblauch@hs-albsig.de			National Science Foundation [NSF-0855272, NSF-1219212]	National Science Foundation(National Science Foundation (NSF))	FTS received support from the National Science Foundation through the grants NSF-0855272 and NSF-1219212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; [Anonymous], 1881, MALADIES MEMOIRE; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Aviel Y, 2005, NEURAL COMPUT, V17, P691, DOI 10.1162/0899766053019962; Baddeley AD., 1990, HUMAN MEMORY THEORY; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bosch H, 1998, NEURAL NETWORKS, V11, P869, DOI 10.1016/S0893-6080(98)00035-5; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Braitenberg V, 1991, ANATOMY CORTEX STAT; BREGMAN AS, 1967, CAN J PSYCHOLOGY, V21, P1, DOI 10.1037/h0082962; BUCKINGHAM J, 1993, NETWORK-COMP NEURAL, V4, P441, DOI 10.1088/0954-898X/4/4/003; BUCKINGHAM J, 1992, NETWORK-COMP NEURAL, V3, P407, DOI 10.1088/0954-898X/3/4/005; Butz M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003259; Butz M, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.010.2009; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carpenter G.A., 2003, HDB BRAIN THEORY NEU, P87, DOI DOI 10.1016/J.NEUNET.2012.09.017]; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cepeda NJ, 2008, PSYCHOL SCI, V19, P1095, DOI 10.1111/j.1467-9280.2008.02209.x; Chechik G, 1998, NEURAL COMPUT, V10, P1759, DOI 10.1162/089976698300017124; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Crowder R.G., 1976, PRINCIPLES LEARNING; Dammasch I, 1989, MODELS BRAIN FUNCTIO, P539; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Deger M, 2011, FRONT COMP NEUR C CO; Deger M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002689; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; Ebbinghaus H., 1885, BER GED CHTNIS UNTER; Elston GN, 2009, J NEUROSCI, V29, P3271, DOI 10.1523/JNEUROSCI.5216-08.2009; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fares T, 2009, P NATL ACAD SCI USA, V106, P16463, DOI 10.1073/pnas.0813265106; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; French R. M., 1992, Connection Science, V4, P365, DOI 10.1080/09540099208946624; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P271, DOI 10.1088/0305-4470/21/1/031; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GLENBERG AM, 1979, MEM COGNITION, V7, P95, DOI 10.3758/BF03197590; GRAHAM B, 1995, BIOL CYBERN, V72, P337, DOI 10.1007/BF00202789; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GREENE RL, 1989, J EXP PSYCHOL LEARN, V15, P371, DOI 10.1037/0278-7393.15.3.371; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Helias M, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.007.2008; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hertz JA, 2018, INTRO THEORY NEURAL; Hofer S, 2009, J MOL MED, V88, P235; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Knoblauch A, 2003, NEUROCOMPUTING, V52-4, P301, DOI 10.1016/S0925-2312(02)00792-0; Knoblauch A, 2002, BIOL CYBERN, V87, P168, DOI 10.1007/s00422-002-0332-3; Knoblauch A, 2009, PROG NEURAL PROCESS, V18, P79, DOI 10.1142/9789812834232_0007; Knoblauch A, 2001, NEURAL NETWORKS, V14, P763, DOI 10.1016/S0893-6080(01)00084-3; KNOBLAUCH A, 2006, 0602 HRIEU; Knoblauch A., 2007, 0705 HRIEU; Knoblauch A, 2013, EFFICIENT ASS UNPUB; Knoblauch A, 2010, P 14 INT C COGN NEUR, P66; Knoblauch A., 2010, P INT JOINT C NEUR N, P4271; Knoblauch A, 2008, 0804 HRIEU; Knoblauch A, 2009, 0903 HRIEU; Knoblauch A, 2009, BMC NEUROSCIENCE S1, pO16; Knoblauch A., 2008, 0805 HRIEU; Knoblauch A, 2010, FRONT SYST NEUR C CO; Knoblauch A, 2014, STRUCTURAL PLA UNPUB; Knoblauch A, 2003, THESIS U ULM GERMANY; Knoblauch A, 2014, EFFICIENT SIMU UNPUB; Knoblauch A, 2012, FRONTIERS COMPUTATIO, V6, P1; Knoblauch A., 2010, P INT JOINT C NEUR N, P3205; Knoblauch A, 2008, SIAM J APPL MATH, V69, P169, DOI 10.1137/070700012; Knoblauch A, 2011, NEURAL COMPUT, V23, P1393, DOI 10.1162/NECO_a_00127; Knoblauch A, 2010, NEURAL COMPUT, V22, P289, DOI 10.1162/neco.2009.08-07-588; KOSKO B, 1988, IEEE T SYST MAN CYB, V18, P49, DOI 10.1109/21.87054; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Latham PE, 2004, NEURAL COMPUT, V16, P1385, DOI 10.1162/089976604323057434; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Lubenov EV, 2008, NEURON, V58, P118, DOI 10.1016/j.neuron.2008.01.036; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCloskey M., 1989, PSYCHOL LEARN MOTIV, V24, P109, DOI [10.1016/S0079-7421(08)60536-8, DOI 10.1016/S0079-7421(08)60536-8]; McNamara A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003845; Meeter M, 2005, COGN NEUROPSYCHOL, V22, P559, DOI 10.1080/02643290442000194; Miyoshi S, 2004, IEEE T NEURAL NETWOR, V15, P1215, DOI 10.1109/TNN.2004.832711; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Murre J. M., 1992, LEARNING CATEGORIZAT; NADAL JP, 1986, EUROPHYS LETT, V1, P535, DOI 10.1209/0295-5075/1/10/008; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; PALM G, 1980, BIOL CYBERN, V36, P19, DOI 10.1007/BF00337019; Palm G., 1991, CONCEPTS NEUROSCI, V2, P97; Palm G., 1996, MODELS NEURAL NETWOR, P79, DOI 10.1007/978-1-4612-0723-8_3; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; RAISMAN G, 1969, BRAIN RES, V14, P25, DOI 10.1016/0006-8993(69)90029-8; Robins A, 1998, CONNECT SCI, V10, P121, DOI 10.1080/095400998116530; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Sandberg A, 2000, NEUROCOMPUTING, V32, P987, DOI 10.1016/S0925-2312(00)00270-8; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schuemann A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00113; Schwenker F, 1996, NEURAL NETWORKS, V9, P445, DOI 10.1016/0893-6080(95)00112-3; Shannon C. E., 1949, MATH THEORY COMMUNIC; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Sommer FT, 1999, NEURAL NETWORKS, V12, P281, DOI 10.1016/S0893-6080(98)00125-7; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O., 2007, SCHOLARPEDIA, V2, P4695, DOI [10.4249/scholarpedia.4695, DOI 10.4249/SCHOLARPEDIA.4695, DOI 10.4249/SCH0LARPEDIA.4695]; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; STEINBUCH K, 1961, KYBERNETIK, V1, P36, DOI 10.1007/BF00293853; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; VANHEMMEN JL, 1988, EUROPHYS LETT, V5, P663, DOI 10.1209/0295-5075/5/7/016; Waydo S, 2006, J NEUROSCI, V26, P10232, DOI 10.1523/JNEUROSCI.2101-06.2006; Weinberger NM, 2009, NEUROBIOL LEARN MEM, V91, P273, DOI 10.1016/j.nlm.2008.10.012; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; WOOLLEY CS, 1999, DENDRITES, P339; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zola S, 2000, PATIENT BASED APPROA, P275	145	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96485	10.1371/journal.pone.0096485	http://dx.doi.org/10.1371/journal.pone.0096485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858841	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400004
J	Li, XY; Bai, L; Fang, J; Hou, SP; Zhou, QY; Yu, HS; Kijlstra, A; Yang, PZ				Li, Xinyu; Bai, Lin; Fang, Jing; Hou, Shengping; Zhou, Qingyun; Yu, Hongsong; Kijlstra, Aize; Yang, Peizeng			Genetic Variations of IL-12B, IL-12R beta 1, IL-12R beta 2 in Behcet's Disease and VKH Syndrome	PLOS ONE			English	Article							CHINESE HAN POPULATION; KOYANAGI-HARADA-SYNDROME; T-CELLS; SUSCEPTIBILITY; ASSOCIATION; POLYMORPHISM; IL12B; TH1; INTERLEUKIN-12; PSORIASIS	Purpose: To investigate the associations of single nucleotide polymorphisms (SNPs) of three genes (IL-12B, IL-12R beta 1 and IL-12R beta 2) in Behcet's disease (BD) and Vogt-Koyanagi-Harada (VKH) syndrome in a Chinese Han population. Methods: A total of 806 BD cases, 820 VKH patients, and 1600 healthy controls were involved in this study. The first investigation included 400 BD patients, 400 VKH cases, and 600 healthy individuals. A second confirmatory study included a separate set of 406 BD patients, 420 VKH cases and another 1000 normal controls. Genotyping was carried out by PCR-restriction fragment length polymorphism assay and results were validated by using direct sequencing. The chi(2) test was performed to compare the allele and genotype frequencies between cases and healthy controls. Results: This study comprised two phases. In the first phase study, a significantly increased frequency of the rs3212227/IL-12B genotype CC and C allele was found in BD patients as compared to controls (Bonferroni corrected p value (p(c)) = 0.009, OR 1.8; p(c) = 0.024, OR 1.3, respectively). Moreover, the frequency of the C allele of rs3212227/IL-12B was also significantly increased in VKH patients (p(c) = 0.012, OR 1.3, 95% CI 1.1 to 1.6). No associations were found for the other seven tested SNPs either in BD or VKH disease. The second study as well as the combined data confirmed the significant association of rs3212227/IL-12B with BD (CC genotype: combined p(c) = 6.3x10(-7), OR = 1.8; C allele: combined p(c) = 2.0x10(-5), OR = 1.3, respectively) and the C allele frequency of rs3212227/IL-12B as the risk factor to VKH patients (combined p(c) = 2.5x10(-5), OR 1.3, 95% CI 1.2 to 1.5). Conclusions: Our study revealed that the IL-12B gene is involved both in the susceptibility to BD as well as VKH syndrome.	[Li, Xinyu; Bai, Lin; Fang, Jing; Hou, Shengping; Zhou, Qingyun; Yu, Hongsong; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Li, Xinyu; Bai, Lin; Fang, Jing; Hou, Shengping; Zhou, Qingyun; Yu, Hongsong; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Eye Clin Maastricht, Maastricht, Netherlands	Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yu, Hongsong/J-9106-2014	Yu, Hongsong/0000-0002-1209-2104	Natural Science Foundation Major International (Regional) Joint Research Project [81320108009]; Natural Science Foundation [81130019]; National Natural Science Foundation [31370893]; Research Fund for the Doctoral Program of Higher Education of China [20115503110002]; Ministry of Health, Basic Research program of Chongqing [cstc2013jcyjC10001]; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of Health Bureau of Chongqing [2012-1-003]; Fund for PAR-EU Scholars Program	Natural Science Foundation Major International (Regional) Joint Research Project; Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Health, Basic Research program of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Key Project of Health Bureau of Chongqing; Fund for PAR-EU Scholars Program	This work was supported by Natural Science Foundation Major International (Regional) Joint Research Project (81320108009), Key Project of Natural Science Foundation (81130019), National Natural Science Foundation Project (31370893), Research Fund for the Doctoral Program of Higher Education of China (20115503110002), Clinic Key Project of Ministry of Health, Basic Research program of Chongqing (cstc2013jcyjC10001), Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Key Project of Health Bureau of Chongqing (2012-1-003) and Fund for PAR-EU Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alayli G, 2007, CLIN RHEUMATOL, V26, P1299, DOI 10.1007/s10067-006-0503-z; Alpsoy E, 2003, DERMATOLOGY, V207, P354, DOI 10.1159/000074113; Alpsoy E, 2007, YONSEI MED J, V48, P573, DOI 10.3349/ymj.2007.48.4.573; Bang Dongsik, 1995, Journal of Dermatology (Tokyo), V22, P926; Bank I, 2003, J LAB CLIN MED, V141, P33, DOI 10.1067/mlc.2003.1; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chi W, 2008, INVEST OPHTH VIS SCI, V49, P3058, DOI 10.1167/iovs.07-1390; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Cleary AM, 2003, J IMMUNOL, V170, P597, DOI 10.4049/jimmunol.170.1.597; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Fang J, 2013, INVEST OPHTH VIS SCI, V54, P8384, DOI 10.1167/iovs.13-12878; Fang J, 2014, AM J OPHTHALMOL, V157, P488, DOI 10.1016/j.ajo.2013.10.010; Fauconnier M, 2012, J IMMUNOL, V188, P1905, DOI 10.4049/jimmunol.1101978; Guenane H, 2006, J FR OPHTALMOL, V29, P146, DOI 10.1016/S0181-5512(06)73762-7; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hu K, 2010, HUM IMMUNOL, V71, P723, DOI 10.1016/j.humimm.2010.04.007; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Johnston A, 2013, HUM MOL GENET, V22, P1807, DOI 10.1093/hmg/ddt034; Kaarvatn MH, 2012, SCAND J IMMUNOL, V76, P329, DOI 10.1111/j.1365-3083.2012.02736.x; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kulaber A, 2007, RHEUMATOL INT, V27, P1113, DOI 10.1007/s00296-007-0367-9; Lim HX, 2013, CYTOKINE, V63, P179, DOI 10.1016/j.cyto.2013.04.029; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Murthy Somasheila I., 2007, International Ophthalmology, V27, P131, DOI 10.1007/s10792-007-9046-9; Na SY, 2013, CLIN EXP RHEUMATOL, V31, pS32; Namkung JH, 2010, J DERMATOL SCI, V57, P199, DOI 10.1016/j.jdermsci.2009.12.003; Oka A, 2013, IMMUNOGENETICS, V65, P823, DOI 10.1007/s00251-013-0721-x; Ong'echa JM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-69; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; SILMAN AJ, 1990, LANCET, V335, P1078; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tao YP, 2012, J CANCER RES CLIN, V138, P1891, DOI 10.1007/s00432-012-1269-0; Toh ML, 2010, ANN RHEUM DIS, V69, P1562, DOI 10.1136/ard.2009.111757; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van de Vosse E, 2013, HUM MUTAT, V34, P1329, DOI 10.1002/humu.22380; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Wang JL, 2013, DNA CELL BIOL, V32, P605, DOI 10.1089/dna.2013.2098; Wong RH, 2012, J RHEUMATOL, V39, P135, DOI 10.3899/jrheum.110613; Yanagihori H, 2004, J DERMATOL SCI, V34, P112, DOI 10.1016/j.jdermsci.2003.12.004; Yang PZ, 2007, OPHTHALMOLOGY, V114, P606, DOI 10.1016/j.ophtha.2006.07.040; Zhang GX, 2003, J IMMUNOL, V171, P4485, DOI 10.4049/jimmunol.171.9.4485; ZHAO M, 1991, ARCH OPHTHALMOL-CHIC, V109, P368, DOI 10.1001/archopht.1991.01080030070041	46	12	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98373	10.1371/journal.pone.0098373	http://dx.doi.org/10.1371/journal.pone.0098373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859272	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400071
J	Pathak, S; Meng, WJ; Zhang, H; Gnosa, S; Nandy, SK; Adell, G; Holmlund, B; Sun, XF				Pathak, Surajit; Meng, Wen-Jian; Zhang, Hong; Gnosa, Sebastian; Nandy, Suman Kumar; Adell, Gunnar; Holmlund, Birgitta; Sun, Xiao-Feng			Tafazzin Protein Expression Is Associated with Tumorigenesis and Radiation Response in Rectal Cancer: A Study of Swedish Clinical Trial on Preoperative Radiotherapy	PLOS ONE			English	Article							LIVIN EXPRESSION	Background: Tafazzin (TAZ), a transmembrane protein contributes in mitochondrial structural and functional modifications through cardiolipin remodeling. TAZ mutations are associated with several diseases, but studies on the role of TAZ protein in carcinogenesis and radiotherapy (RT) response is lacking. Therefore we investigated the TAZ expression in rectal cancer, and its correlation with RT, clinicopathological and biological variables in the patients participating in a clinical trial of preoperative RT. Methods: 140 rectal cancer patients were included in this study, of which 65 received RT before surgery and the rest underwent surgery alone. TAZ expression was determined by immunohistochemistry in primary cancer, distant, adjacent normal mucosa and lymph node metastasis. In-silico protein-protein interaction analysis was performed to study the predictive functional interaction of TAZ with other oncoproteins. Results: TAZ showed stronger expression in primary cancer and lymph node metastasis compared to distant or adjacent normal mucosa in both non-RT and RT patients. Strong TAZ expression was significantly higher in stages I-III and non-mucinious cancer of non-RT patients. In RT patients, strong TAZ expression in biopsy was related to distant recurrence, independent of gender, age, stages and grade (p = 0.043, HR, 6.160, 95% CI, 1.063-35.704). In silico protein-protein interaction study demonstrated that TAZ was positively related to oncoproteins, Livin, MAC30 and FXYD-3. Conclusions: Strong expression of TAZ protein seems to be related to rectal cancer development and RT response, it can be a predictive biomarker of distant recurrence in patients with preoperative RT.	[Pathak, Surajit; Meng, Wen-Jian; Gnosa, Sebastian; Adell, Gunnar; Holmlund, Birgitta; Sun, Xiao-Feng] Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci, Cty Council Ostergorland,Ivis Oncol, Linkoping, Sweden; [Meng, Wen-Jian] Sichuan Univ, West China Hosp, Epartment Gastrointestinal Surg, Chengdu 610064, Peoples R China; [Zhang, Hong] Univ Orebro, Chool Med, SE-70182 Orebro, Sweden; [Nandy, Suman Kumar] Kalyani Univ, Dept Biochem & Biophys, Kalyani, W Bengal, India	City Council Ostergotland; Linkoping University; Sichuan University; Orebro University; Kalyani University	Sun, XF (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci, Cty Council Ostergorland,Ivis Oncol, Linkoping, Sweden.	xiao-feng.sun@liu.se	Nandy, Suman Kumar/O-8302-2017; Pathak, Surajit/AAH-4022-2020	Nandy, Suman Kumar/0000-0003-3644-516X; Pathak, Surajit/0000-0002-7306-1272	Swedish Cancer Foundation; Swedish Research Council; Health Research Council in the South-East of Sweden	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Health Research Council in the South-East of Sweden	This study was financially supported by grants from the Swedish Cancer Foundation, Swedish Research Council and the Health Research Council in the South-East of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; Chevillard S, 2004, CLIN CANCER RES, V10, P6586, DOI 10.1158/1078-0432.CCR-04-0053; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ding ZY, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-281; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Hwang H, 2009, PROTEIN PROTEIN DOCK, P147; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kayed H, 2006, INT J CANCER, V118, P43, DOI 10.1002/ijc.21257; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Loftas P, 2009, INT J RADIAT ONCOL, V75, P137, DOI 10.1016/j.ijrobp.2008.10.076; Makaryan V, 2009, BLOOD, P114; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Neuwald AF, 1997, CURR BIOL, V7, pR465; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; van den Brink M, 2004, J CLIN ONCOL, V22, P244, DOI 10.1200/JCO.2004.04.198; Warburg OH, 2013, PRIME CAUSE PREVENTI; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilson LD, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-25; Xi RC, 2011, ONKOLOGIE, V34, P428, DOI 10.1159/000331132; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zhang ZY, 2006, ONCOLOGY-BASEL, V71, P259, DOI 10.1159/000106449	29	17	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98317	10.1371/journal.pone.0098317	http://dx.doi.org/10.1371/journal.pone.0098317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858921	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400065
J	Hao, R; Hu, XX; Wu, CX; Li, N				Hao, Rui; Hu, Xiaoxiang; Wu, Changxin; Li, Ning			Hypoxia-Induced miR-15a Promotes Mesenchymal Ablation and Adaptation to Hypoxia during Lung Development in Chicken	PLOS ONE			English	Article							GAS-EXCHANGE; TIBET CHICKEN; BRANCHING MORPHOGENESIS; PULMONARY-HYPERTENSION; INDUCIBLE FACTOR-1; DOMESTIC-FOWL; TURKEY EGGS; AVIAN LUNG; MICRORNA; TARGET	The lungs undergo changes that are adaptive for high elevation in certain animal species. In chickens, animals bred at high elevations (e. g., Tibet chickens) are better able to hatch and survive under high-altitude conditions. In addition, lowland chicken breeds undergo physiological effects and suffer greater mortality when they are exposed to hypoxic conditions during embryonic development. Although these physiological effects have been noted, the mechanisms that are responsible for hypoxia-induced changes in lung development and function are not known. Here we have examined the role of a particular microRNA (miRNA) in the regulation of lung development under hypoxic conditions. When chicks were incubated in low oxygen (hypoxia), miR-15a was significantly increased in embryonic lung tissue. The expression level of miR-15a in hypoxic Tibet chicken embryos increased and remained relatively high at embryonic day (E) 16-20, whereas in normal chickens, expression increased and peaked at E19-20, at which time the cross-current gas exchange system (CCGS) is developing. Bcl-2 was a translationally repressed target of miR-15a in these chickens. miR-16, a cluster and family member of miR-15a, was detected but did not participate in the posttranscriptional regulation of bcl-2. Around E19, the hypoxia-induced decrease in Bcl-2 protein resulted in apoptosis in the mesenchyme around the migrating tubes, which led to an expansion and migration of the tubes that would become the air capillary network and the CCGS. Thus, interfering with miR-15a expression in lung tissue may be a novel therapeutic strategy for hypoxia insults and altitude adaptation.	[Hao, Rui; Hu, Xiaoxiang; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wu, Changxin] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Li, Ning] Yunnan Agr Univ, Coll Anim Sci, Kunming, Peoples R China	China Agricultural University; China Agricultural University; Yunnan Agricultural University	Li, N (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglcau@cau.edu.cn			High-Tech Research and Development Program of China [2011AA100301]; Yunnan Flexible Talents Development Program [2010C1118]	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Yunnan Flexible Talents Development Program	This work was funded by The High-Tech Research and Development Program of China (2011AA100301) and Yunnan Flexible Talents Development Program (2010C1118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azzam MA, 2007, RESP PHYSIOL NEUROBI, V159, P155, DOI 10.1016/j.resp.2007.06.003; Bao HG, 2007, POULTRY SCI, V86, P2210, DOI 10.1093/ps/86.10.2210; Bao HG, 2011, POULTRY SCI, V90, P648, DOI 10.3382/ps.2010-00994; BARROSODELJESUS A, 2011, FASEB J; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; CHRISTENSEN VL, 1984, POULTRY SCI, V63, P1350, DOI 10.3382/ps.0631350; CHRISTENSEN VL, 1988, POULTRY SCI, V67, P956, DOI 10.3382/ps.0670956; CHRISTENSEN VL, 1989, POULTRY SCI, V68, P724, DOI 10.3382/ps.0680724; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Duncker H R, 1971, Ergeb Anat Entwicklungsgesch, V45, P7; DURMOWICZ AG, 1993, J APPL PHYSIOL, V74, P2276, DOI 10.1152/jappl.1993.74.5.2276; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; GALLAGHER BC, 1986, J EMBRYOL EXP MORPH, V94, P173; GALLAGHER BC, 1986, J EMBRYOL EXP MORPH, V94, P189; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; KALENGA M, 1995, PEDIATR RES, V37, P789, DOI 10.1203/00006450-199506000-00019; King AS, 1989, FORM FUNCTION BIRDS; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; LALTHANTLUANGA R, 1985, H-S Z PHYSIOL CHEM, V366, P63; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; MAINA JN, 1989, PHILOS T R SOC B, V326, P1, DOI 10.1098/rstb.1989.0104; Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2; Maina JN, 2003, ANAT EMBRYOL, V207, P119, DOI 10.1007/s00429-003-0333-6; Makanya AN, 2011, MICROSC RES TECHNIQ, V74, P159, DOI 10.1002/jemt.20887; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Molina JN, 2004, TISSUE CELL, V36, P129, DOI 10.1016/j.tice.2003.11.002; Mortola J. P., 2001, RESP PHYSL NEWBORN M; Mujahid S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-13; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; POWELL FL, 1982, FED PROC, V41, P2131; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Shan F, 2014, J CELL PHYSL; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Tang JR, 2010, AM J PHYSIOL-LUNG C, V299, pL735, DOI 10.1152/ajplung.00153.2010; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tuder RM, 2007, J MOL MED, V85, P1317, DOI 10.1007/s00109-007-0280-4; VISSCHEDIJK AHJ, 1985, J APPL PHYSIOL, V58, P416, DOI 10.1152/jappl.1985.58.2.416; VISSCHEDIJK AHJ, 1980, RESP PHYSIOL, V39, P33, DOI 10.1016/0034-5687(80)90012-2; VISSCHEDIJK AHJ, 1985, RESP PHYSIOL, V59, P339, DOI 10.1016/0034-5687(85)90137-9; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Wang XY, 2013, ANIM GENET, V44, P472, DOI 10.1111/age.12020; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yang Y, 2012, INT J MOL MED, V29, P393, DOI 10.3892/ijmm.2011.855; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Yue JQ, 2013, LAB INVEST, V93, P748, DOI 10.1038/labinvest.2013.63; Zhang H, 2012, POULTRY SCI, V91, P3191, DOI 10.3382/ps.2012-02449; [张浩 ZHANG Hao], 2006, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V37, P112; Zhang X, 2011, ONCOGENE	85	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98868	10.1371/journal.pone.0098868	http://dx.doi.org/10.1371/journal.pone.0098868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887070	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300114
J	Hohne, J; Tangermann, M				Hoehne, Johannes; Tangermann, Michael			Towards User-Friendly Spelling with an Auditory Brain-Computer Interface: The CharStreamer Paradigm	PLOS ONE			English	Article							CLASSIFICATION; PERFORMANCE; COMPONENTS; ATTENTION; DESIGN; SYSTEM; BCI	Realizing the decoding of brain signals into control commands, brain-computer interfaces (BCI) aim to establish an alternative communication pathway for locked-in patients. In contrast to most visual BCI approaches which use event-related potentials (ERP) of the electroencephalogram, auditory BCI systems are challenged with ERP responses, which are less class-discriminant between attended and unattended stimuli. Furthermore, these auditory approaches have more complex interfaces which imposes a substantial workload on their users. Aiming for a maximally user-friendly spelling interface, this study introduces a novel auditory paradigm: "CharStreamer". The speller can be used with an instruction as simple as "please attend to what you want to spell". The stimuli of CharStreamer comprise 30 spoken sounds of letters and actions. As each of them is represented by the sound of itself and not by an artificial substitute, it can be selected in a one-step procedure. The mental mapping effort (sound stimuli to actions) is thus minimized. Usability is further accounted for by an alphabetical stimulus presentation: contrary to random presentation orders, the user can foresee the presentation time of the target letter sound. Healthy, normal hearing users (n = 10) of the CharStreamer paradigm displayed ERP responses that systematically differed between target and non-target sounds. Class-discriminant features, however, varied individually from the typical N1-P2 complex and P3 ERP components found in control conditions with random sequences. To fully exploit the sequential presentation structure of CharStreamer, novel data analysis approaches and classification methods were introduced. The results of online spelling tests showed that a competitive spelling speed can be achieved with CharStreamer. With respect to user rating, it clearly outperforms a control setup with random presentation sequences.	[Hoehne, Johannes] Berlin Inst Technol, Machine Learning Lab, Berlin, Germany; [Hoehne, Johannes] Berlin Inst Technol, Neurotechnol Grp, Berlin, Germany; [Tangermann, Michael] Univ Freiburg, BrainLinks BrainTools Excellence Cluster, D-79106 Freiburg, Germany	Technical University of Berlin; Technical University of Berlin; University of Freiburg	Hohne, J (corresponding author), Berlin Inst Technol, Machine Learning Lab, Berlin, Germany.	j.hoehne@tu-berlin.de; michael.tangermann@blbt.uni-freiburg.de	Tangermann, Michael/ABE-4178-2020	Tangermann, Michael/0000-0001-6729-0290	European Information and Communication Technologies (ICT) Programme [FP7-224631]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-2, EXC 1086]; Bundesministerium fur Bildung und Forschung [BMBF 01GQ0850]; Albert Ludwigs University Freiburg	European Information and Communication Technologies (ICT) Programme; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Albert Ludwigs University Freiburg	This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631, by the Deutsche Forschungsgemeinschaft (DFG) (grants MU 987/3-2, EXC 1086) and Bundesministerium fur Bildung und Forschung (BMBF 01GQ0850). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; Acqualagna L, 2010, IEEE ENG MED BIO, P2686, DOI 10.1109/IEMBS.2010.5626548; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Clemmensen L, 2011, TECHNOMETRICS, V53, P406, DOI 10.1198/TECH.2011.08118; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; De Vos M, 2013, INT J PSYCHOPHYSIOLO; Dornhege G, 2003, ADV NEURAL INF P SYS, V15, P1115; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gao S, 2013, IEEE T BIOMEDICAL EN; Geuze J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016009; Hill NJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026011; Hill N. J., 2004, NEURAL INF PROCESS S, V17, P569; Hohne J, 2012, IEEE ENG MED BIO, P1802, DOI 10.1109/EMBC.2012.6346300; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Hohne J, 2010, IEEE ENG MED BIO, P4185, DOI 10.1109/IEMBS.2010.5627379; Holz EM, 2013, ARTIF INTELL MED, V59, P111, DOI 10.1016/j.artmed.2013.08.001; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kubler A, 2013, ARTIF INTELL MED, V59, P55, DOI 10.1016/j.artmed.2013.08.002; Leeb R, 2010, IEEE ENG MED BIO, P4343, DOI 10.1109/IEMBS.2010.5626233; Lopez-Gordo MA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036013; Matsumoto Y., 2013, SIGN INF PROC ASS AN, P1, DOI 10.1109/APSIPA.2013.66943412-s2.0-84893246153; Quek M, 2012, PRACTICAL BRAIN COMP, P173, DOI [10.1007/978-3-642-29746-5, DOI 10.1007/978-3-642-29746-5]; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Schreuder M., 2011, FRONTIERS NEUROSCIEN, V5; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Schreuder M, 2012, IEEE ENG MED BIO, P6707, DOI 10.1109/EMBC.2012.6347533; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; TANGERMANN M, 2012, ENG MED BIOL SOC EMB, P2501; Townsend G, 2012, NEUROSCIENCE LETT; Treder MS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026009; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van der Waal M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045002; Wills SA, 2006, IEEE T NEUR SYS REH, V14, P244, DOI 10.1109/TNSRE.2006.875573; Winkler I, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-30; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu HL, 2013, CLIN NEUROPHYSIOL, V124, P83, DOI 10.1016/j.clinph.2012.06.004	46	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98322	10.1371/journal.pone.0098322	http://dx.doi.org/10.1371/journal.pone.0098322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24886978	Green Published, gold			2022-12-27	WOS:000336956300052
J	Mommer, BC; Bell, AM				Mommer, Brett C.; Bell, Alison M.			Maternal Experience with Predation Risk Influences Genome-Wide Embryonic Gene Expression in Threespined Sticklebacks (Gasterosteus aculeatus)	PLOS ONE			English	Article							PRENATAL STRESS; OFFSPRING SURVIVAL; AXIS ACTIVITY; FETAL-GROWTH; RECEPTOR; SIZE; DNA; REPRODUCTION; MECHANISMS; RESPONSES	There is growing evidence for nongenetic effects of maternal experience on offspring. For example, previous studies have shown that female threespined stickleback fish (Gasterosteus aculeatus) exposed to predation risk produce offspring with altered behavior, metabolism and stress physiology. Here, we investigate the effect of maternal exposure to predation risk on the embryonic transcriptome in sticklebacks. Using RNA-sequencing we compared genome-wide transcription in three day post-fertilization embryos of predator-exposed and control mothers. There were hundreds of differentially expressed transcripts between embryos of predator-exposed mothers and embryos of control mothers including several non-coding RNAs. Gene Ontology analysis revealed biological pathways involved in metabolism, epigenetic inheritance, and neural proliferation and differentiation that differed between treatments. Interestingly, predation risk is associated with an accelerated life history in many vertebrates, and several of the genes and biological pathways that were identified in this study suggest that maternal exposure to predation risk accelerates the timing of embryonic development. Consistent with this hypothesis, embryos of predator-exposed mothers were larger than embryos of control mothers. These findings point to some of the molecular mechanisms that might underlie maternal effects.	[Mommer, Brett C.; Bell, Alison M.] Univ Illinois, Sch Integrat Biol, Dept Anim Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Mommer, BC (corresponding author), Univ Illinois, Sch Integrat Biol, Dept Anim Biol, Urbana, IL 61801 USA.	bmommer2@illinois.edu		Mommer, Brett/0000-0001-8721-7154	National Science Foundation [IOS 1121980]; National Institutes of Health R01 [GM082937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082937] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1121980] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (grant IOS 1121980), www.nsf.gov, and the National Institutes of Health R01 (GM082937), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2002, ECOLOGY, V83, P3408, DOI 10.1890/0012-9658(2002)083[3408:HAMEMA]2.0.CO;2; Badyaev AV, 2003, EVOLUTION, V57, P384; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bell AM, 2007, PHYSIOL BEHAV, V91, P15, DOI 10.1016/j.physbeh.2007.01.012; Blanchard RJ, 1998, PHYSIOL BEHAV, V63, P561, DOI 10.1016/S0031-9384(97)00508-8; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Canoine V, 2002, BEHAVIOUR, V139, P1303, DOI 10.1163/156853902321104172; Caserta MT, 2008, BRAIN BEHAV IMMUN, V22, P933, DOI 10.1016/j.bbi.2008.01.007; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chivers DP, 2001, OIKOS, V92, P135, DOI 10.1034/j.1600-0706.2001.920116.x; CLARKE AS, 1994, DEV PSYCHOBIOL, V27, P257, DOI 10.1002/dev.420270502; CLARKE AS, 1993, DEV PSYCHOBIOL, V26, P293, DOI 10.1002/dev.420260506; Coe CL, 2007, PEDIATR RES, V61, P520, DOI 10.1203/pdr.0b013e318045be53; de Longh RU, 2001, DEVELOPMENT, V128, P3995; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Gagliano M, 2009, OECOLOGIA, V160, P657, DOI 10.1007/s00442-009-1335-8; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; Gliwicz ZM, 1996, J PLANKTON RES, V18, P863, DOI 10.1093/plankt/18.6.863; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Graw J, 1997, BIOL CHEM, V378, P1331; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Hu F, 2008, ENDOCRINOLOGY, V149, P5470, DOI 10.1210/en.2008-0767; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Joo JY, 2011, BIOCHEM BIOPH RES CO, V406, P627, DOI 10.1016/j.bbrc.2011.02.108; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; Lewis ZR, 2008, J MORPHOL, V269, P909, DOI 10.1002/jmor.10608; Li M, 2010, MOL REPROD DEV, V77, P922, DOI 10.1002/mrd.21239; MAGNHAGEN C, 1990, BEHAV ECOL SOCIOBIOL, V26, P331; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marasco V, 2012, J EXP BIOL, V215, P3955, DOI 10.1242/jeb.071423; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matthews SG, 2010, ENDOCRINOLOGY, V151, P7, DOI 10.1210/en.2009-0916; McCormick MI, 2009, OIKOS, V118, P744, DOI 10.1111/j.1600-0706.2008.17410.x; McCormick MI, 2006, ECOLOGY, V87, P1104, DOI 10.1890/0012-9658(2006)87[1104:MMCLTS]2.0.CO;2; McGhee KE, 2012, FUNCT ECOL, V26, P932, DOI 10.1111/j.1365-2435.2012.02008.x; Millet S, 1996, DEVELOPMENT, V122, P3785; Mommer BC, 2013, PHYSIOL BEHAV, V122, P222, DOI 10.1016/j.physbeh.2013.04.004; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Mueller T., 2005, ATLAS EARLY ZEBRAFIS; Nishio H, 2001, INT J DEV NEUROSCI, V19, P37, DOI 10.1016/S0736-5748(00)00070-8; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PRICE WA, 1992, ENDOCRINOLOGY, V130, P1424, DOI 10.1210/en.130.3.1424; Purves D., 2001, NEUROSCIENCE; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche DP, 2012, BIOL LETTERS, V8, P932, DOI 10.1098/rsbl.2012.0685; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sanogo YO, 2011, BRAIN BEHAV EVOLUT, V77, P270, DOI 10.1159/000328221; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Shine R, 1999, OECOLOGIA, V119, P1, DOI 10.1007/s004420050754; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; STIBOR H, 1992, OECOLOGIA, V92, P162, DOI 10.1007/BF00317358; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; SWARUP H, 1958, J EMBRYOL EXP MORPH, V6, P373; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Triant DA, 2009, J HERED, V100, P246, DOI 10.1093/jhered/esn083; Van Buskirk J, 1998, OIKOS, V82, P20; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC	76	29	29	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98564	10.1371/journal.pone.0098564	http://dx.doi.org/10.1371/journal.pone.0098564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887438	Green Published, gold			2022-12-27	WOS:000336956300084
J	Novotna, A; Srovnalova, A; Svecarova, M; Korhonova, M; Bartonkova, I; Dvorak, Z				Novotna, Aneta; Srovnalova, Alzbeta; Svecarova, Michaela; Korhonova, Martina; Bartonkova, Iveta; Dvorak, Zdenek			Differential Effects of Omeprazole and Lansoprazole Enantiomers on Aryl Hydrocarbon Receptor in Human Hepatocytes and Cell Lines	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; STEREOSELECTIVE METABOLISM; CYTOCHROME-P450 ENZYMES; AH RECEPTOR; CYP1A1; PHARMACOKINETICS; INDUCTION; ESOMEPRAZOLE; PANTOPRAZOLE; DISPOSITION	Proton pump inhibitors omeprazole and lansoprazole contain chiral sulfur atom and they are administered as a racemate, i.e. equimolar mixture of S- and R-enantiomers. The enantiopure drugs esomeprazole and dexlansoprazole have been developed and introduced to clinical practice due to their improved clinical and therapeutic properties. Since omeprazole and lansoprazole are activators of aryl hydrocarbon receptor (AhR) and inducers of CYP1A genes, we examined their enantiospecific effects on AhR-CYP1A pathway in human cancer cells and primary human hepatocytes. We performed gene reporter assays for transcriptional activity of AhR, RT-PCR analyses for CYP1A1/2 mRNAs, western blots for CYP1A1/2 proteins and EROD assay for CYP1A1/2 catalytic activity. Lansoprazole and omeprazole enantiomers displayed differential effects on AhR-CYP1A1/2 pathway. In general, S-enantiomers were stronger activators of AhR and inducers of CYP1A genes as compared to R-enantiomers in lower concentrations, i.e. 1-10 mu M for lansoprazole and 10-100 mu M for omeprazole. In contrast, R-enantiomers were stronger AhR activators and CYP1A inducers than S-enantiomers in higher concentrations, i.e. 100 mu M for lansoprazole and 250 mu M for omeprazole. In conclusion, we provide the first evidence of enantiospecific effects of omeprazole and lansoprazole on AhR signaling pathway.	[Novotna, Aneta; Srovnalova, Alzbeta; Svecarova, Michaela; Korhonova, Martina; Bartonkova, Iveta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Agency [GACR 13-01809S]; Palacky University [PrF-2014-004]	Czech Science Agency; Palacky University	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] and by the student project from Palacky University [PrF-2014-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelo A, 2000, DRUG METAB DISPOS, V28, P966; Andersson T, 1996, CLIN PHARMACOKINET, V31, P9, DOI 10.2165/00003088-199631010-00002; Andersson T, 2001, ALIMENT PHARM THERAP, V15, P1563, DOI 10.1046/j.1365-2036.2001.01087.x; Andersson T, 2008, CLIN DRUG INVEST, V28, P263, DOI 10.2165/00044011-200828050-00001; CURIPEDROSA R, 1994, J PHARMACOL EXP THER, V269, P384; Katsuki H, 1996, PHARMACEUT RES, V13, P611, DOI 10.1023/A:1016062508580; Kendall MJ, 2003, ALIMENT PHARM THERAP, V17, P1, DOI 10.1046/j.1365-2036.17.s1.1.x; Kim KA, 2003, DRUG METAB DISPOS, V31, P1227, DOI 10.1124/dmd.31.10.1227; KOHL B, 1992, J MED CHEM, V35, P1049, DOI 10.1021/jm00084a010; Krusekopf S, 2003, XENOBIOTICA, V33, P107, DOI 10.1080/0049825021000023978; LESCA P, 1995, BIOCHEM BIOPH RES CO, V209, P474, DOI 10.1006/bbrc.1995.1526; LINDBERG P, 1986, J MED CHEM, V29, P1327, DOI 10.1021/jm00158a001; LUSSKA A, 1992, J BIOL CHEM, V267, P15146; Metz DC, 2009, ALIMENT PHARM THER, V29, P928, DOI 10.1111/j.1365-2036.2009.03984.x; Miura M, 2006, YAKUGAKU ZASSHI, V126, P395, DOI 10.1248/yakushi.126.395; NEUHOLD LA, 1989, MOL CELL BIOL, V9, P2378, DOI 10.1128/MCB.9.6.2378; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; PICHARD L, 1995, MOL PHARMACOL, V47, P410; Sachs G, 1993, ALIMENT PHARM THER S, V7, P4; Sachs G, 1993, ALIMENT PHARM THE S1, V7, P29; Shih H, 1999, HUM EXP TOXICOL, V18, P95, DOI 10.1191/096032799678839699; Shin JM, 2004, BIOCHEM PHARMACOL, V68, P2117, DOI 10.1016/j.bcp.2004.07.035; Vrzal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074917; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035	24	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98711	10.1371/journal.pone.0098711	http://dx.doi.org/10.1371/journal.pone.0098711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887303	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300100
J	Perez-Cidoncha, M; Killip, MJ; Asensio, VJ; Fernandez, Y; Bengoechea, JA; Randall, RE; Ortin, J				Perez-Cidoncha, Maite; Killip, Marian J.; Asensio, Victor J.; Fernandez, Yolanda; Bengoechea, Jose A.; Randall, Richard E.; Ortin, Juan			Generation of Replication-Proficient Influenza Virus NS1 Point Mutants with Interferon-Hyperinducer Phenotype	PLOS ONE			English	Article							A VIRUS; TRANSLATION INITIATION; MESSENGER-RNAS; ANTIVIRAL RESPONSES; POLYMERASE COMPLEX; CELLULAR-PROTEIN; INFECTED-CELLS; BINDING-SITE; IN-VITRO; RIG-I	The NS1 protein of influenza A viruses is the dedicated viral interferon (IFN)-antagonist. Viruses lacking NS1 protein expression cannot multiply in normal cells but are viable in cells deficient in their ability to produce or respond to IFN. Here we report an unbiased mutagenesis approach to identify positions in the influenza A NS1 protein that modulate the IFN response upon infection. A random library of virus ribonucleoproteins containing circa 40 000 point mutants in NS1 were transferred to infectious virus and amplified in MDCK cells unable to respond to interferon. Viruses that activated the interferon (IFN) response were subsequently selected by their ability to induce expression of green-fluorescent protein (GFP) following infection of A549 cells bearing an IFN promoter-dependent GFP gene. Using this approach we isolated individual mutant viruses that replicate to high titers in IFN-compromised cells but, compared to wild type viruses, induced higher levels of IFN in IFN-competent cells and had a reduced capacity to counteract exogenous IFN. Most of these viruses contained not previously reported NS1 mutations within either the RNA-binding domain, the effector domain or the linker region between them. These results indicate that subtle alterations in NS1 can reduce its effectiveness as an IFN antagonist without affecting the intrinsic capacity of the virus to multiply. The general approach reported here may facilitate the generation of replication-proficient, IFN-inducing virus mutants, that potentially could be developed as attenuated vaccines against a variety of viruses.	[Perez-Cidoncha, Maite; Fernandez, Yolanda; Ortin, Juan] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Killip, Marian J.; Randall, Richard E.] Univ St Andrews, Ctr Biomol Sci, Sch Biol, St Andrews, Fife, Scotland; [Asensio, Victor J.] FISIB, Bunyola, Mallorca, Spain; [Bengoechea, Jose A.] FISIB, Lab Microbial Pathogenesis, Bunyola, Mallorca, Spain; [Perez-Cidoncha, Maite; Fernandez, Yolanda; Bengoechea, Jose A.; Ortin, Juan] Ciber Enfermedades Resp ISCIII, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of St Andrews; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	jortin@cnb.csic.es	Ortin, Juan/L-3622-2013	Bengoechea, Jose/0000-0002-9677-8751; Moron, Yolanda Fernandez/0000-0002-2256-163X; Ortin, Juan/0000-0002-6200-4678; Randall, Richard/0000-0002-9304-6678	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC]; Fundacion Marcelino Botin; Wellcome Trust [087751/A/08/Z]; Spanish Research Council (CSIC); Wellcome Trust [101788/Z/13/Z] Funding Source: researchfish	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marcelino Botin; Wellcome Trust(Wellcome Trust); Spanish Research Council (CSIC); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) (www.mineco.gob.es/portal/site/mineco/idi) (grant BFU2010-17540/BMC) (JO), by Fundacion Marcelino Botin (www.fundacionbotin.org/) (JO) and The Wellcome Trust (www.wellcome.ac.uk/) (grant 087751/A/08/Z) (RER). MP-C was a predoctoral fellow and awardee of a short-term travel fellowship from the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Bourmakina SV, 2005, J VIROL, V79, P7926, DOI 10.1128/JVI.79.12.7926-7932.2005; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen S, 2010, VIROLOGY, V407, P247, DOI 10.1016/j.virol.2010.08.008; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; DELALUNA S, 1995, J VIROL, V69, P2427, DOI 10.1128/JVI.69.4.2427-2433.1995; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garaigorta U, 2005, J VIROL, V79, P15246, DOI 10.1128/JVI.79.24.15246-15257.2005; Garcia-Robles I, 2005, VIROLOGY, V332, P329, DOI 10.1016/j.virol.2004.09.036; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Graef KM, 2010, J VIROL; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Hatada E, 1999, J VIROL, V73, P2425, DOI 10.1128/JVI.73.3.2425-2433.1999; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Iwai A, 2010, J BIOL CHEM; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Killip MJ, 2011, VIROLOGY, V415, P39, DOI 10.1016/j.virol.2011.03.027; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; KRUG RM, 1979, CELL, V18, P329, DOI 10.1016/0092-8674(79)90052-7; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Li S.F., 2006, AQUAC RES, V2006, P1; Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Marion RM, 1997, NUCLEIC ACIDS RES, V25, P4271, DOI 10.1093/nar/25.21.4271; MARK GE, 1979, J VIROL, V29, P744, DOI 10.1128/JVI.29.2.744-752.1979; Martin-Benito J, 2013, ADV VIRUS RES, V87, P113, DOI 10.1016/B978-0-12-407698-3.00004-1; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Moore TC, 2011, VIROLOGY, V418, P40, DOI 10.1016/j.virol.2011.06.028; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; ORTIN J, 1983, GENE, V23, P233, DOI 10.1016/0378-1119(83)90055-0; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Perez-Cidoncha M, 2014, J VIROL IN PRESS; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; ROSE JK, 1991, BIOTECHNIQUES, V10, P520; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; SCHOLTISSEK C, 1970, VIROLOGY, V40, P989, DOI 10.1016/0042-6822(70)90145-5; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Yanguez E, 2011, VIRUS RES, V156, P1, DOI 10.1016/j.virusres.2010.12.016; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y	78	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98668	10.1371/journal.pone.0098668	http://dx.doi.org/10.1371/journal.pone.0098668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887174	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000336956300098
J	Reeves, D; Blickem, C; Vassilev, I; Brooks, H; Kennedy, A; Richardson, G; Rogers, A				Reeves, David; Blickem, Christian; Vassilev, Ivaylo; Brooks, Helen; Kennedy, Anne; Richardson, Gerry; Rogers, Anne			The Contribution of Social Networks to the Health and Self-Management of Patients with Long-Term Conditions: A Longitudinal Study	PLOS ONE			English	Article							CARE ACTIVITIES MEASURE; INFORMAL CARE; FORMAL CARE; RELIABILITY; VALIDITY; SPREAD; WORK; EXPERIENCES; RESOURCES; DYNAMICS	Evidence for the effectiveness of patient education programmes in changing individual self-management behaviour is equivocal. More distal elements of personal social relationships and the availability of social capital at the community level may be key to the mobilisation of resources needed for long-term condition self-management to be effective. Aim: To determine how the social networks of people with long-term conditions (diabetes and heart disease) are associated with health-related outcomes and changes in outcomes over time. Methods: Patients with chronic heart disease (CHD) or diabetes (n = 300) randomly selected from the disease registers of 19 GP practices in the North West of England. Data on personal social networks collected using a postal questionnaire, alongside face-to-face interviewing. Follow-up at 12 months via postal questionnaire using a self-report grid for network members identified at baseline. Analysis: Multiple regression analysis of relationships between health status, self-management and health-economics outcomes, and characteristics of patients' social networks. Results: Findings indicated that: (1) social involvement with a wider variety of people and groups supports personal self-management and physical and mental well-being; (2) support work undertaken by personal networks expands in accordance with health needs helping people to cope with their condition; (3) network support substitutes for formal care and can produce substantial saving in traditional health service utilisation costs. Health service costs were significantly (p < 0.01) reduced for patients receiving greater levels of illness work through their networks. Conclusions: Support for self-management which achieves desirable policy outcomes should be construed less as an individualised set of actions and behaviour and more as a social network phenomenon. This study shows the need for a greater focus on harnessing and sustaining the capacity of networks and the importance of social involvement with community groups and resources for producing a more desirable and cost-effective way of supporting long term illness management.	[Reeves, David; Blickem, Christian] Univ Manchester, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Inst Populat Hlth, Ctr Primary Care, Manchester, Lancs, England; [Vassilev, Ivaylo; Kennedy, Anne; Rogers, Anne] Univ Southampton, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Fac Hlth Sci, Southampton, Hants, England; [Brooks, Helen] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Richardson, Gerry] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Richardson, Gerry] Univ York, NIHR Res Design Serv Yorkshire & Humber, York YO10 5DD, N Yorkshire, England	University of Manchester; University of Southampton; University of Manchester; University of York - UK; University of York - UK	Reeves, D (corresponding author), Univ Manchester, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Inst Populat Hlth, Ctr Primary Care, Manchester, Lancs, England.	David.Reeves@manchester.ac.uk	Reeves, David/H-6203-2014; Brooks, Helen/O-4307-2014; Brooks, Helen/N-3849-2018	Reeves, David/0000-0001-6377-6859; Brooks, Helen/0000-0002-2157-0200; Brooks, Helen/0000-0002-2157-0200; Vassilev, Ivaylo/0000-0002-2206-8247	Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Greater Manchester	Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Greater Manchester	This research was funded by the Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for Greater Manchester. CLAHRC Greater Manchester is a partnership between the Greater Manchester NHS Trusts and the University of Manchester and is part of the National Institute for Health Research. http://clahrc-gm.nihr.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021179; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bolin K, 2008, HEALTH ECON, V17, P393, DOI 10.1002/hec.1275; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Brooks HL, 2013, CHRONIC ILLN, V9, P87, DOI 10.1177/1742395312452620; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Cornwell B, 2009, J AGING HEALTH, V21, P129, DOI 10.1177/0898264308328649; Department of Health, 2005, SELF CAR REAL CHOIC; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Fiori KL, 2007, J GERONTOL B-PSYCHOL, V62, pP322, DOI 10.1093/geronb/62.6.P322; Flori KL, 2006, J GERONTOL B-PSYCHOL, V61, pP25, DOI 10.1093/geronb/61.1.P25; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hann M, 2008, QUAL LIFE RES, V17, P413, DOI 10.1007/s11136-008-9310-0; Hlebec V., 2009, METODOLOSKI ZVEZKI, V6, P85; Kahana E, 2013, J AGING HEALTH, V25, P159, DOI 10.1177/0898264312469665; Kav S, 2010, J CLIN NURS, V19, P2933, DOI 10.1111/j.1365-2702.2010.03329.x; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kehusmaa S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-317; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Kline P., 2000, HDB PSYCHOL TESTING; Kogovsek T, 2005, SOC NETWORKS, V27, P205, DOI 10.1016/j.socnet.2005.01.001; Litwin H, 1997, J Cross Cult Gerontol, V12, P45, DOI 10.1023/A:1006593025061; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mednick SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009775; Mihaylova B, 2011, HEALTH ECON, V20, P897, DOI 10.1002/hec.1653; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Morrow-Howell Nancy, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS137; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Perry BL, 2012, AM J SOCIOL, V118, P134, DOI 10.1086/666377; Petrou S, 2008, HEALTH ECON, V17, P127, DOI 10.1002/hec.1242; Rogers A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-19; Rogers A, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-56; Shaw M, 2004, BRIT J GEN PRACT, V54, P899; St John of God Health Care, 2019, OUR VIS; StataCorp, 2011, STAT REL 12; Theurer K, 2010, AGEING SOC, V30, P157, DOI 10.1017/S0144686X09008848; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338; Vincent D, 2008, NURS RES, V57, P101, DOI 10.1097/01.NNR.0000313484.18670.ab; Wanless, 2002, SECURING OUR FUTURE; Webber MP, 2007, SOC SCI MED, V65, P481, DOI 10.1016/j.socscimed.2007.03.030; Wellman B, 1997, SOC NETWORKS, V19, P27, DOI 10.1016/S0378-8733(96)00289-4; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; Wenger GC, 1997, AGING MENT HEALTH, V1, P311, DOI 10.1080/13607869757001; Ziebland S, 2012, MILBANK Q, V90, P219, DOI 10.1111/j.1468-0009.2012.00662.x	53	116	117	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98340	10.1371/journal.pone.0098340	http://dx.doi.org/10.1371/journal.pone.0098340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24887107	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300057
J	Sauerland, M; Sagana, A; Otgaar, H; Broers, NJ				Sauerland, Melanie; Sagana, Anna; Otgaar, Henry; Broers, Nick J.			Self-Relevance Does Not Moderate Choice Blindness in Adolescents and Children	PLOS ONE			English	Article							MEMORY	In two experiments we tested the choice blindness phenomenon in adolescents aged 11-16 years (Experiment 1, N = 87) and children aged 7-10 years (Experiment 2, N = 117) for the first time. Analogous to previously reported findings with adult participants, we expected to replicate the robust effect in these age groups. Furthermore, we investigated the hypothesis that self-relevance of choices, defined as the extent to which the self is implicated in a choice, moderates the choice blindness effect in adolescents and children. To this end, we directly compared high and low self-relevance conditions. As expected, the choice blindness effect was robust across age groups. Little support was found for the idea that self-relevance moderates the choice blindness effect. Specifically, no effect of self-relevance on choice blindness was found in adolescents, while the findings in the child sample were inconsistent. Different possible interpretations of the results as well as the possible role of ambiguity for the choice blindness effect are discussed.	[Sauerland, Melanie; Sagana, Anna; Otgaar, Henry] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Broers, Nick J.] Maastricht Univ, Dept Stat, Maastricht, Netherlands	Maastricht University; Maastricht University	Sauerland, M (corresponding author), Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands.	melanie.sauerland@maastrichtuniversity.nl	Sauerland, Melanie/AAB-3877-2019; Sagana, Anna/V-4521-2019; Sauerland, Melanie/ABD-9558-2020; Otgaar, Henry/M-3410-2017	Sagana, Anna/0000-0003-4776-8431; Sauerland, Melanie/0000-0002-7401-1365; 				BARGH JA, 1982, J PERS SOC PSYCHOL, V43, P425, DOI 10.1037/0022-3514.43.3.425; Bassili JN, 1996, J PERS SOC PSYCHOL, V71, P637, DOI 10.1037/0022-3514.71.4.637; Block SD, 2009, J APPL SOC PSYCHOL, V39, P2859, DOI 10.1111/j.1559-1816.2009.00553.x; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Bruck M, 1999, ANNU REV PSYCHOL, V50, P419, DOI 10.1146/annurev.psych.50.1.419; CECI SJ, 1993, PSYCHOL BULL, V113, P403, DOI 10.1037/0033-2909.113.3.403; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Cunningham SJ, 2013, BRIT J DEV PSYCHOL, V31, P289, DOI 10.1111/bjdp.12005; Fletcher-Watson S, 2009, DEVELOPMENTAL SCI, V12, P438, DOI 10.1111/j.1467-7687.2008.00784.x; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; FORSYTH DR, 1993, TEACH PSYCHOL, V20, P237, DOI 10.1207/s15328023top2004_11; Hall L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060554; Hall L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045457; Hall L, 2010, COGNITION, V117, P54, DOI 10.1016/j.cognition.2010.06.010; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Johansson P, 2008, PSYCHOLOGIA, V51, P142, DOI 10.2117/psysoc.2008.142; LINDSAY DS, 1991, J EXP CHILD PSYCHOL, V52, P297, DOI 10.1016/0022-0965(91)90065-Z; Merckelbach H, 2011, MISINFORMATION INCRE; Moore J, 2006, CONSCIOUS COGN, V15, P693, DOI 10.1016/j.concog.2006.09.003; Panayiotou G, 2004, MOTIV EMOTION, V28, P171, DOI 10.1023/B:MOEM.0000032313.69675.0d; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Sagana A, 2012, MIND; Sagana A, 2013, BEHAV SCI LAW, V31, P624, DOI 10.1002/bsl.2082; Sauerland M, 2013, LEGAL CRIMINOL PSYCH, V18, P371, DOI 10.1111/j.2044-8333.2012.02049.x; Sauerland M, 2013, BEHAV SCI LAW, V31, P239, DOI 10.1002/bsl.2063; Shore DI, 2006, DEVELOPMENTAL SCI, V9, P490, DOI 10.1111/j.1467-7687.2006.00516.x; Stober J, 1999, DIAGNOSTICA, V45, P173, DOI 10.1026//0012-1924.45.4.173; Sui J, 2005, INT J BEHAV DEV, V29, P382, DOI 10.1080/01650250500172673; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Zhu L, 2012, HIPPOCAMPUS, V22, P1540, DOI 10.1002/hipo.20994	31	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98563	10.1371/journal.pone.0098563	http://dx.doi.org/10.1371/journal.pone.0098563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24887431	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300083
J	Tengroth, L; Millrud, CR; Kvarnhammar, AM; Georen, SK; Latif, L; Cardell, LO				Tengroth, Lotta; Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Georen, Susanna Kumlien; Latif, Leith; Cardell, Lars-Olaf			Functional Effects of Toll-Like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 Stimulation in Nasal Epithelial Cells	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; INNATE IMMUNITY; EXPRESSION; RNA; RECOGNITION; TLR3; NEUTROPHIL; INDUCTION; INFECTION; VIRUSES	Background: The human nasal epithelium is an important physical barrier, and a part of the innate immune defense that protect against pathogens. The epithelial cells recognize microbial components by pattern-recognition receptors (PRRs), and thereby trigger an immune response. Even though TLR3, TLR7, TLR9, RIG-I and MDA-5 are all known to respond to viral stimulation, their potential role in chronic airway inflammation triggered by local cytokine release remains to be established. Methods: mRNA and corresponding protein expression of TLR3, TLR7, TLR9, RIG-I and MDA-5 were analyzed in nasal biopsies and various upper airway epithelial cell lines using real-time reverse transcription PCR, immunohistochemistry and flow cytometry. Ligand induced, cytokine release, was evaluated with ELISA. Results: Nasal biopsies were found to express TLR3, TLR7, TLR9, RIG-I and MDA-5, with the most abundant expression in the surface epithelium. These receptors were verified in primary human nasal epithelial cell (HNEC) as well as in the airway epithelial cell lines Detroit-562 and FaDu. Poly(I: C) (TLR3) and R-837 (TLR7) stimulation increased secretion of IL-6 and GMCSF from the nasal mucosa and the epithelial cell lines. CpG (TLR9) stimulation caused release of IL-8 in the nasal mucosa and in FaDu. Poly(I: C)/LyoVec (RIG-I/MDA-5) stimulation activated the secretion of IFN-beta in the nasal mucosa. A corresponding release was also detected from HNEC and Detroit-562. Conclusion: The nasal epithelium has the ability to recognize viral intrusion through TLR and RLR receptors, and the subsequent response might have a role in exacerbation of inflammatory diseases like allergic rhinitis and chronic rhinosinusitis.	[Tengroth, Lotta; Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden; [Latif, Leith] Lund Univ, Dept Otorhinolaryngol, Skane Univ Hosp, Malmo, Sweden	Karolinska Institutet; Lund University; Skane University Hospital	Cardell, LO (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255; Rydberg Millrud, Camilla/0000-0002-5873-2197	Swedish Medical Research Council [2011-3357]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The authors would like to acknowledge the support from the Swedish Medical Research Council, Grant number: 2011-3357, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Bogefors J, 2011, AM J RHINOL ALLERGY, V25, pE262, DOI 10.2500/ajra.2011.25.3712; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Canonica GW, 2009, CLIN EXP IMMUNOL, V158, P260, DOI 10.1111/j.1365-2249.2009.04017.x; Chehadeh W, 2013, VIRUS RES, V174, P88, DOI 10.1016/j.virusres.2013.03.006; Dassonville C, 2007, Acta Otorhinolaryngol Ital, V27, P78; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Fransson M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-17; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Gaajetaan GR, 2013, J INFECTION, V66, P163, DOI 10.1016/j.jinf.2012.11.008; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Golebski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087768; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1224; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hartmann G, 2007, INFLAMM RES, V56, pS328; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Janssens S, 2003, CLIN MICROBIOLOGY RE, V16, P637; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; LEONARD EJ, 1990, AM J RESP CELL MOL, V2, P479, DOI 10.1165/ajrcmb/2.6.479; Lesmeister MJ, 2006, INT J PEDIATR OTORHI, V70, P987, DOI 10.1016/j.ijporl.2005.10.009; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; Matijevic T, 2009, SCAND J IMMUNOL, V70, P18, DOI 10.1111/j.1365-3083.2009.02262.x; Matijevic T, 2011, CLIN EXP METASTAS, V28, P701, DOI 10.1007/s10585-011-9402-z; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P355; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Zhao CY, 2011, INT ARCH ALLERGY IMM, V156, P297, DOI 10.1159/000323767	51	43	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98239	10.1371/journal.pone.0098239	http://dx.doi.org/10.1371/journal.pone.0098239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886842	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300050
J	Hossain, MS; Ramachandiran, S; Gewirtz, AT; Waller, EK				Hossain, Mohammad S.; Ramachandiran, Sampath; Gewirtz, Andrew T.; Waller, Edmund K.			Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; MURINE CYTOMEGALOVIRUS-INFECTION; BONE-MARROW TRANSPLANTATION; NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; VIRUS-INFECTION; ANTIVIRAL IMMUNITY; VIRAL-INFECTIONS; ACTIVATION; RESPONSES	Prior work using allogeneic bone marrow transplantation (allo-BMT) models showed that peritransplant administration of flagellin, a toll-like receptor 5 (TLR5) agonist protected murine allo-BMT recipients from CMV infection while limiting graft-vs- host disease (GvHD). However, the mechanism by which flagellin-TLR5 interaction promotes anti-CMV immunity was not defined. Here, we investigated the anti-CMV immunity of NK cells in C57BL/6 (B6) mice treated with a highly purified cGMP grade recombinant flagellin variant CBLB502 (rflagellin) followed by murine CMV (mCMV) infection. A single dose of rflagellin administered to mice between 48 to 72 hours prior to MCMV infection resulted in optimal protection from mCMV lethality. Anti-mCMV immunity in rflagellin-treated mice correlated with a significantly reduced liver viral load and increased numbers of Ly49H+ and Ly49D+ activated cytotoxic NK cells. Additionally, the increased anti-mCMV immunity of NK cells was directly correlated with increased numbers of IFN-gamma, granzyme B-and CD107a producing NK cells following mCMV infection. rFlagellin-induced anti-mCMV immunity was TLR5-dependent as rflagellin-treated TLR5 KO mice had,similar to 10-fold increased liver viral load compared with rflagellin-treated WT B6 mice. However, the increased anti-mCMV immunity of NK cells in rflagellin-treated mice is regulated indirectly as mouse NK cells do not express TLR5. Collectively, these data suggest that rflagellin treatment indirectly leads to activation of NK cells, which may be an important adjunct benefit of administering rflagellin in allo-BMT recipients.	[Hossain, Mohammad S.; Ramachandiran, Sampath; Waller, Edmund K.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst,Div Stem Cell & Bone Marrow Tra, Atlanta, GA 30322 USA; [Gewirtz, Andrew T.] Georgia State Univ, Dept Biol, Atlanta, GA USA	Emory University; University System of Georgia; Georgia State University	Waller, EK (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst,Div Stem Cell & Bone Marrow Tra, Atlanta, GA 30322 USA.	ewaller@emory.edu	Waller, Edmund K/AAP-3055-2020		National Institutes of Health [R01 CA-74364-03]; NATIONAL CANCER INSTITUTE [R01CA074364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA-74364-03 (to E. K. W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; ANTIN JH, 1992, BLOOD, V80, P2964; Babic M, 2011, TRENDS MOL MED, V17, P677, DOI 10.1016/j.molmed.2011.07.003; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Biron Christine A., 1996, Methods (Orlando), V9, P379, DOI 10.1006/meth.1996.0043; BRAUTIGAM AR, 1979, J GEN VIROL, V44, P349, DOI 10.1099/0022-1317-44-2-349; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Ding XL, 2012, J IMMUNOL, V189, P4719, DOI 10.4049/jimmunol.1201206; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; Graubardt N, 2013, HEPATOLOGY, V57, P1969, DOI 10.1002/hep.26008; HOKLAND M, 1988, TRANSPLANTATION, V45, P1080, DOI 10.1097/00007890-198806000-00016; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Hossain MS, 2011, J IMMUNOL, V187, P5130, DOI 10.4049/jimmunol.1101334; Hossain MS, 1999, IMMUNOPHARMACOLOGY, V41, P169, DOI 10.1016/S0162-3109(98)00066-6; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kofoed EM, 2012, BIOESSAYS, V34, P589, DOI 10.1002/bies.201200013; Langston AA, 2002, BLOOD, V99, P1085, DOI 10.1182/blood.V99.3.1085; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lenac T, 2008, MED MICROBIOL IMMUN, V197, P159, DOI 10.1007/s00430-008-0080-7; Li JM, 2013, BLOOD, V121, P2347, DOI 10.1182/blood-2012-06-437640; Li JM, 2011, J IMMUNOL, V187, P1057, DOI 10.4049/jimmunol.1100686; NOMURA F, 1990, JPN J MED, V29, P595; Ohta M, 2005, EUR J IMMUNOL, V35, P2210, DOI 10.1002/eji.200425897; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Paar DP, 1996, ADV EXP MED BIOL, V394, P145; Pyzik M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/641702; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Salem ML, 2000, INT J IMMUNOPHARMACO, V22, P729, DOI 10.1016/S0192-0561(00)00036-9; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; TANAKA J, 1995, LEUKEMIA LYMPHOMA, V19, P27, DOI 10.3109/10428199509059660; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; Wu X, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/759765; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051	46	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96165	10.1371/journal.pone.0096165	http://dx.doi.org/10.1371/journal.pone.0096165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879439	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500006
J	Ryan, MJ; Fuller, MM; Scott, NJ; Cook, JA; Poe, S; Willink, B; Chaves, G; Bolanos, F				Ryan, Mason J.; Fuller, Michael M.; Scott, Norman J.; Cook, Joseph A.; Poe, Steven; Willink, Beatriz; Chaves, Gerardo; Bolanos, Federico			Individualistic Population Responses of Five Frog Species in Two Changing Tropical Environments over Time	PLOS ONE			English	Article							AMPHIBIAN DECLINES; CLIMATE-CHANGE; DISEASE; BIODIVERSITY; TEMPERATURE; EXTINCTION; ECOLOGY; PRECIPITATION; CONSERVATION; DIVERSITY	Roughly 40% of amphibian species are in decline with habitat loss, disease, and climate change being the most cited threats. Heterogeneity of extrinsic (e. g. climate) and intrinsic (e. g. local adaptations) factors across a species' range should influence population response to climate change and other threats. Here we examine relative detectability changes for five direct-developing leaf litter frogs between 42-year sampling periods at one Lowland Tropical Forest site (51 m.a.s.l.) and one Premontane Wet Forest site (1100 m.a.s.l.) in southwest Costa Rica. We identify individualistic changes in relative detectability among populations between sampling periods at different elevations. Both common and rare species showed site-specific declines, and no species exhibited significant declines at both sites. Detection changes are correlated with changes in temperature, dry season rainfall, and leaf litter depth since1969. Our study species share Least Concern conservation status, life history traits, and close phylogenetic relationship, yet their populations changed individualistically both within and among species. These results counter current views of the uniformity or predictability of amphibian decline response and suggest additional complexity for conservation decisions.	[Ryan, Mason J.; Fuller, Michael M.; Scott, Norman J.; Cook, Joseph A.; Poe, Steven] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Ryan, Mason J.; Scott, Norman J.; Cook, Joseph A.; Poe, Steven] Univ New Mexico, Museum Southwestern Biol, Albuquerque, NM 87131 USA; [Willink, Beatriz; Chaves, Gerardo; Bolanos, Federico] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	University of New Mexico; University of New Mexico; Universidad Costa Rica	Ryan, MJ (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	mjryan42@gmail.com	Willink, Beatriz/J-9931-2015; Willink, Beatriz/X-5198-2019	Willink, Beatriz/0000-0002-4579-6909; Willink, Beatriz/0000-0002-4579-6909; Chaves, Gerardo/0000-0002-4301-6569; Ryan, Mason/0000-0003-3713-649X	A UNM Grove Scholarship; LAII PhD Fellowship; IdeaWild grant; NSF [DEB 0844624]	A UNM Grove Scholarship; LAII PhD Fellowship; IdeaWild grant; NSF(National Science Foundation (NSF))	A UNM Grove Scholarship, LAII PhD Fellowship, and IdeaWild grant to MJ Ryan and NSF grant DEB 0844624 to S. Poe funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Angilleta MJ, 2010, THERMAL ADAPTATION; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053055; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chalcraft DR, 1999, OECOLOGIA, V119, P285, DOI 10.1007/s004420050788; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Donnelly MA, 1998, CLIMATIC CHANGE, V39, P541, DOI 10.1023/A:1005315821841; Dorazio RM, 2013, ECOLOGY, V94, P1472, DOI 10.1890/0012-9658-94.7.1472; Dosch JJ, 2007, J TROP ECOL, V23, P151, DOI 10.1017/S0266467406003853; Gordo I, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0239; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hulme M., 1998, POTENTIAL IMPACTS CL, P5; Joyce A.T, 2006, LAND USE CHANGE COST; Kilburn VL, 2011, DIS AQUAT ORGAN, V97, P127, DOI 10.3354/dao02409; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mac Nally R, 2014, GLOBAL ECOL BIOGEOGR, V23, P223, DOI 10.1111/geb.12104; MacArthur R.H., 1972, pvii; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McDiarmid RW, 2005, Ecology & Evolution in the Tropics: A Herpetological Perspective, P366; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Moritz C, 2012, PHILOS T R SOC B, V367, P1680, DOI 10.1098/rstb.2012.0018; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Picco AM, 2007, J HERPETOL, V41, P746, DOI 10.1670/07-033.1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; R Core Team, 2018, R LANG ENV STAT COMP; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rouifed S, 2010, OECOLOGIA, V163, P247, DOI 10.1007/s00442-009-1528-1; Ryan MJ, 2008, BIOL CONSERV, V141, P1636, DOI 10.1016/j.biocon.2008.04.014; Santos-Barrera G, 2008, REV BIOL TROP, V56, P755; Savage J.M., 2002, AMPHIBIANS REPTILES; SCOTT N J JR, 1976, Biotropica, V8, P41, DOI 10.2307/2387818; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Socci AM, 2005, HERPETOLOGICA, V61, P233, DOI 10.1655/04-67.1; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stewart Margaret M., 1996, P273; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; TAPER ML, 1995, OECOLOGIA, V101, P478, DOI 10.1007/BF00329427; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; TOFT CA, 1981, J HERPETOL, V15, P139, DOI 10.2307/1563372; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x	64	7	9	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98351	10.1371/journal.pone.0098351	http://dx.doi.org/10.1371/journal.pone.0098351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878504	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500051
J	Tuteja, N; Banu, MSA; Huda, KMK; Gill, SS; Jain, P; Pham, XH; Tuteja, R				Tuteja, Narendra; Banu, Mst. Sufara Akhter; Huda, Kazi Md. Kamrul; Gill, Sarvajeet Singh; Jain, Parul; Xuan Hoi Pham; Tuteja, Renu			Pea p68, a DEAD-Box Helicase, Provides Salinity Stress Tolerance in Transgenic Tobacco by Reducing Oxidative Stress and Improving Photosynthesis Machinery	PLOS ONE			English	Article							RNA HELICASE; MESSENGER-RNA; SALT TOLERANCE; DNA HELICASE; PLASMODIUM-FALCIPARUM; ANTIOXIDANT MACHINERY; GENE; PROTEIN; RESPONSES; COLD	Background: The DEAD-box helicases are required mostly in all aspects of RNA and DNA metabolism and they play a significant role in various abiotic stresses, including salinity. The p68 is an important member of the DEAD-box proteins family and, in animal system, it is involved in RNA metabolism including pre-RNA processing and splicing. In plant system, it has not been well characterized. Here we report the cloning and characterization of p68 from pea (Pisum sativum) and its novel function in salinity stress tolerance in plant. Results: The pea p68 protein self-interacts and is localized in the cytosol as well as the surrounding of cell nucleus. The transcript of pea p68 is upregulated in response to high salinity stress in pea. Overexpression of p68 driven by constitutive cauliflower mosaic virus-35S promoter in tobacco transgenic plants confers enhanced tolerances to salinity stress by improving the growth, photosynthesis and antioxidant machinery. Under stress treatment, pea p68 overexpressing tobacco accumulated higher K+ and lower Na+ level than the wild-type plants. Reactive oxygen species (ROS) accumulation was remarkably regulated by the overexpression of pea p68 under salinity stress conditions, as shown from TBARS content, electrolyte leakage, hydrogen peroxide accumulation and 8-OHdG content and antioxidant enzyme activities. Conclusions: To the best of our knowledge this is the first direct report, which provides the novel function of pea p68 helicase in salinity stress tolerance. The results suggest that p68 can also be exploited for engineering abiotic stress tolerance in crop plants of economic importance.	[Tuteja, Narendra; Banu, Mst. Sufara Akhter; Huda, Kazi Md. Kamrul; Jain, Parul; Xuan Hoi Pham; Tuteja, Renu] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Gill, Sarvajeet Singh] Maharshi Dayanand Univ, Ctr Biotechnol, Stress Physiol & Mol Biol Lab, Rohtak, Haryana, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Maharshi Dayanand University	Tuteja, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	narendra@icgeb.res.in	Gill, Sarvajeet Singh/ABD-6031-2021; Gill, Sarvajeet Singh/Q-4021-2017	Gill, Sarvajeet Singh/0000-0002-8953-7714; Gill, Sarvajeet Singh/0000-0002-8953-7714; Pham, Xuan Hoi/0000-0002-9629-2970	Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India; CSIR, New Delhi	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Work on RNA/DNA metabolism and plant abiotic stress tolerance in N.T.'s laboratory is partially supported by Department of Biotechnology (DBT), Government of India and Department of Science and Technology (DST), Government of India. S.S.G. acknowledges the receipt of research grants from CSIR, New Delhi for helicase work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Dang HQ, 2011, PLANT MOL BIOL, V76, P19, DOI 10.1007/s11103-011-9758-0; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gendra E, 2004, PLANT J, V38, P875, DOI 10.1111/j.1365-313X.2004.02095.x; Gill S. S., 2012, Improving crop resistance to abiotic stress, volume 1 & volume 2, P49; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; Hill CB, 2013, MOL PLANT, V6, P350, DOI 10.1093/mp/sss125; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huda KMK, 2013, PLANT J, V76, P997, DOI 10.1111/tpj.12352; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Janknecht R, 2010, AM J TRANSL RES, V2, P223; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Kammel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060644; Kanai M, 2013, PLANT CELL PHYSIOL, V54, P1431, DOI 10.1093/pcp/pct091; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Liu HH, 2008, J EXP BOT, V59, P633, DOI 10.1093/jxb/erm355; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Luna CM, 2005, J EXP BOT, V56, P417, DOI 10.1093/jxb/eri039; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2010, METHODS MOL BIOL, V639, P371, DOI 10.1007/978-1-60761-702-0_23; Nakamura T, 2004, PLANT SCI, V167, P63, DOI 10.1016/j.plantsci.2004.03.001; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Pham XH, 2000, PLANT J, V24, P219, DOI 10.1046/j.1365-313x.2000.00869.x; Pradhan A, 2005, MOL BIOCHEM PARASIT, V144, P133, DOI 10.1016/j.molbiopara.2005.08.006; Pradhan A, 2005, MOL BIOCHEM PARASIT, V140, P55, DOI 10.1016/j.molbiopara.2004.12.004; Rajagopal D, 2007, MOL BREEDING, V19, P137, DOI 10.1007/s11032-006-9052-z; Sahoo RK, 2012, PLANT SIGNAL BEHAV, V7, P1042, DOI 10.4161/psb.20915; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Shabala S, 2009, J EXP BOT, V60, P709, DOI 10.1093/jxb/erp013; Shimizu KK, 2008, PLANT CELL PHYSIOL, V49, P1478, DOI 10.1093/pcp/pcn130; Soumen Bhattacharjee, 2012, Journal of Botany, V2012, P985298; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tuteja N, 2000, CRIT REV PLANT SCI, V19, P449; Tuteja N, 2012, IMPROVING CROP RESIS, P433; Tuteja N, 2013, PLANT J, V76, P115, DOI 10.1111/tpj.12277; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; WILLEKENS H, 1994, P NATL ACAD SCI USA, V91, P10450, DOI 10.1073/pnas.91.22.10450; Zhang ZhenHua, 2012, African Journal of Agricultural Research, V7, P19	55	45	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98287	10.1371/journal.pone.0098287	http://dx.doi.org/10.1371/journal.pone.0098287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879307	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500045
J	van Oostveen, CJ; Ubbink, DT; Veld, JGHIH; Bakker, PJ; Vermeulen, H				van Oostveen, Catharina J.; Ubbink, Dirk T.; Veld, Judith G. Huis In Het; Bakker, Piet J.; Vermeulen, Hester			Factors and Models Associated with the amount of Hospital Care Services as Demanded by Hospitalized Patients: A Systematic Review	PLOS ONE			English	Review							DIAGNOSIS-RELATED GROUPS; LENGTH-OF-STAY; NURSING WORKLOAD; HEART-FAILURE; COST; HIP; CLASSIFICATION; ORGANIZATION; REPLACEMENT; OUTCOMES	Background: Hospitals are constantly being challenged to provide high-quality care despite ageing populations, diminishing resources, and budgetary restraints. While the costs of care depend on the patients' needs, it is not clear which patient characteristics are associated with the demand for care and inherent costs. The aim of this study was to ascertain which patient-related characteristics or models can predict the need for medical and nursing care in general hospital settings. Methods: We systematically searched MEDLINE, Embase, Business Source Premier and CINAHL. Pre-defined eligibility criteria were used to detect studies that explored patient characteristics and health status parameters associated to the use of hospital care services for hospitalized patients. Two reviewers independently assessed study relevance, quality with the STROBE instrument, and performed data analysis. Results: From 2,168 potentially relevant articles, 17 met our eligibility criteria. These showed a large variety of factors associated with the use of hospital care services; models were found in only three studies. Age, gender, medical and nursing diagnoses, severity of illness, patient acuity, comorbidity, and complications were the characteristics found the most. Patient acuity and medical and nursing diagnoses were the most influencing characteristics. Models including medical or nursing diagnoses and patient acuity explain the variance in the use of hospital care services for at least 56.2%, and up to 78.7% when organizational factors were added. Conclusions: A larger variety of factors were found to be associated with the use of hospital care services. Models that explain the extent to which hospital care services are used should contain patient characteristics, including patient acuity, medical or nursing diagnoses, and organizational and staffing characteristics, e. g., hospital size, organization of care, and the size and skill mix of staff. This would enable healthcare managers at different levels to evaluate hospital care services and organize or reorganize patient care.	[van Oostveen, Catharina J.; Ubbink, Dirk T.; Vermeulen, Hester] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Ubbink, Dirk T.; Veld, Judith G. Huis In Het; Bakker, Piet J.; Vermeulen, Hester] Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands; [Vermeulen, Hester] Univ Amsterdam, Amsterdam Sch Hlth Profess, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Ubbink, DT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands.	d.ubbink@amc.nl	Ubbink, Dirk/AAF-1266-2021; Vermeulen, Hester/P-5739-2016	Vermeulen, Hester/0000-0002-0743-2979; Ubbink, Dirk/0000-0001-9398-8879; van Oostveen, Catharina/0000-0002-3483-2206				Aiken LH, 2002, INT J QUAL HEALTH C, V14, P5, DOI 10.1093/intqhc/14.1.5; Altman DG, 2007, PLOS MED, V4, P296; Bostrom J, 1991, Nurs Econ, V9, P105; Bostrom J M, 1994, Nurs Econ, V12, P250; Campbell T, 1997, J Nurs Manag, V5, P237, DOI 10.1046/j.1365-2834.1997.00007.x; CATERINICCHIO RP, 1983, SOC SCI MED, V17, P259, DOI 10.1016/0277-9536(83)90328-3; Dubois CA, 2013, INT J QUAL HEALTH C, V25, P110, DOI 10.1093/intqhc/mzt019; Fagerstrom L, 2000, J ADV NURS, V31, P481, DOI 10.1046/j.1365-2648.2000.01277.x; Fasoli DiJon R, 2010, Annu Rev Nurs Res, V28, P295; Fries JF, 1998, HEALTH AFFAIR, V17, P70, DOI 10.1377/hlthaff.17.2.70; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Geissler A, 2012, HEALTH ECON, V21, P103, DOI 10.1002/hec.2848; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; GIOVANNETTI P, 1990, J NURS ADMIN, V20, P33; HALLORAN EJ, 1985, RES NURS HEALTH, V8, P421, DOI 10.1002/nur.4770080415; Ishak KJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-439; Mahmoud NN, 2009, SURG INFECT, V10, P539, DOI 10.1089/sur.2009.006; Mainz J, 2013, INT J QUAL HEALTH C, V15, P523; MCMAHON LF, 1992, MED CARE, V30, P445, DOI 10.1097/00005650-199205000-00006; Mion L C, 1988, Nurs Manage, V19, P26; Mion LC, 1988, NURSING MANAGEMENT, V19, P30; Mion LC, 1988, NURSING MANAGEMENT, V19, P32; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Morris R, 2007, J ADV NURS, V57, P463, DOI 10.1111/j.1365-2648.2006.04134.x; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; O'Brien-Pallas L, 1989, Healthc Manage Forum, V2, P26; Parikh A, 2012, CRIT CARE MED, V40, P2754, DOI 10.1097/CCM.0b013e31825b26ef; Polverejan E, 2003, HEALTH ECON, V12, P935, DOI 10.1002/hec.774; Robinson JC, 2012, J BONE JOINT SURG AM, V94A, P1693, DOI 10.2106/JBJS.K.00355; Sermeus W, 2008, INT J NURS STUD, V45, P1011, DOI 10.1016/j.ijnurstu.2007.05.006; Shukla R K, 1992, Health Serv Manage Res, V5, P174; Titler M, 2007, NURS OUTLOOK, V55, P5, DOI 10.1016/j.outlook.2006.06.006; Titler MG, 2008, HEALTH SERV RES, V43, P635, DOI 10.1111/j.1475-6773.2007.00789.x; Tump E, 2013, EUR J PEDIATR, V172, P1379, DOI 10.1007/s00431-013-2054-z; Twigg D, 2009, INT J NURS STUD, V46, P132, DOI 10.1016/j.ijnurstu.2008.08.005; Van den Heede K, 2009, INT J NURS STUD, V46, P928, DOI 10.1016/j.ijnurstu.2008.05.007; van Oostveen CJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-42; Wang GJ, 2010, AM J MANAG CARE, V16, P769	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98102	10.1371/journal.pone.0098102	http://dx.doi.org/10.1371/journal.pone.0098102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878506	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500031
J	Milani, D; Cabral-de-Mello, DC				Milani, Diogo; Cabral-de-Mello, Diogo Cavalcanti			Microsatellite Organization in the Grasshopper Abracris flavolineata (Orthoptera: Acrididae) Revealed by FISH Mapping: Remarkable Spreading in the A and B Chromosomes	PLOS ONE			English	Article							SEQUENCE REPEATS SSRS; REPETITIVE DNA; A-CHROMOSOME; EYPREPOCNEMIS-PLORANS; SEX-CHROMOSOMES; EVOLUTIONARY DYNAMICS; RIBOSOMAL DNA; ORIGIN; GENOME; HYMENOPTERA	With the aim of acquiring deeper knowledge about repetitive DNAs chromosomal organization in grasshoppers, we used fluorescent in situ hybridization (FISH) to map the distribution of 16 microsatellite repeats, including mono-, di-, tri- and tetra-nucleotides, in the chromosomes of the species Abracris flavolineata (Acrididae), which harbors B chromosome. FISH revealed two main patterns: (i) exclusively scattered signals, and (ii) scattered and specific signals, forming evident blocks. The enrichment was observed in both euchromatic and heterochromatic areas and only the motif (C)(30) was absent in heterochromatin. The A and B chromosomes were enriched with all the elements that were mapped, being observed in the B chromosome more distinctive blocks for (GA)(15) and (GAG)(10). For A complement distinctive blocks were noticed for (A)(30), (CA)(15), (CG)(15), (GA)(15), (CAC)(10), (CAA)(10), (CGG)(10), (GAA)(10), (GAC)(10) and (GATA)(8). These results revealed an intense spreading of microsatellites in the A. flavolineata genome that was independent of the A+T or G+C enrichment in the repeats. The data indicate that the microsatellites compose the B chromosome and could be involved in the evolution of this element in this species, although no specific relationship with any A chromosome was observed to discuss about its origin. The systematic analysis presented here contributes to the knowledge of repetitive DNA chromosomal organization among grasshoppers including the B chromosomes.	[Milani, Diogo; Cabral-de-Mello, Diogo Cavalcanti] UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Sao Paulo, Brazil	Universidade Estadual Paulista	Cabral-de-Mello, DC (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Sao Paulo, Brazil.	mellodc@rc.unesp.br	Milani, Diogo/AAS-9977-2020; Cabral-de-Mello, Diogo Cavalcanti/E-7656-2012; Cabral-de-Mello, Diogo C/F-5328-2010	Cabral-de-Mello, Diogo Cavalcanti/0000-0002-4721-2655; Milani, Diogo/0000-0002-8886-5767	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [2011/19481-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [475308/2011-5]; PROPE-UNESP; PIBIC/CNPq program [27785]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPE-UNESP; PIBIC/CNPq program	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (2011/19481-3), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (475308/2011-5) and PROPE-UNESP. The scholarships of Milani D were granted by PIBIC/CNPq program (process number 27785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz M, 2007, CYTOGENET GENOME RES, V119, P143, DOI 10.1159/000109631; BEUKEBOOM LW, 1994, HEREDITY, V73, P328, DOI 10.1038/hdy.1994.140; Bidau CJ, 2004, CYTOGENET GENOME RES, V106, P295, DOI 10.1159/000079302; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Bugrov AG, 2004, CYTOGENET GENOME RES, V106, P284, DOI 10.1159/000079300; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Butcher RDJ, 2000, INSECT MOL BIOL, V9, P375, DOI 10.1046/j.1365-2583.2000.00199.x; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 2003, CHROMOSOME RES, V11, P375, DOI 10.1023/A:1024127525756; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Carmona A, 2013, ANN BOT-LONDON, V112, P1845, DOI 10.1093/aob/mct245; Chang SB, 2008, CHROMOSOME RES, V16, P919, DOI 10.1007/s10577-008-1249-z; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Comeron JM, 2001, CURR OPIN GENET DEV, V11, P652, DOI 10.1016/S0959-437X(00)00249-5; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; Cuadrado A, 2007, CYTOGENET GENOME RES, V119, P91, DOI 10.1159/000109624; Cuadrado A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-205; Cuadrado A, 2010, CHROMOSOMA, V119, P495, DOI 10.1007/s00412-010-0273-x; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Grandi Fiorella C, 2013, Mob Genet Elements, V3, pe25674; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; Johnson PCD, 2006, MOL BIOCHEM PARASIT, V148, P210, DOI 10.1016/j.molbiopara.2006.04.011; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; Jones RN, 2008, CYTOGENET GENOME RES, V120, P265, DOI 10.1159/000121076; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Kejnovsky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045519; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Loreto V, 2008, CHROMOSOME RES, V16, P233, DOI 10.1007/s10577-007-1188-0; Marques A, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-34; Matsubara K, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-60; Messier W, 1996, NATURE, V381, P483, DOI 10.1038/381483a0; Montiel EE, 2012, GENETICA, V140, P365, DOI 10.1007/s10709-012-9686-1; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; NANDA I, 1990, J MOL EVOL, V30, P456, DOI 10.1007/BF02101117; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Oliveira NL, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-24; Palacios-Gimenez O, 2014, EUR J ENTOMOL, DOI 10.14411/eje.2014.000; Palestis BG, 2010, GENETICA, V138, P1181, DOI 10.1007/s10709-010-9509-1; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; Santos J, 2010, CHROMOSOME RES, V18, P213, DOI 10.1007/s10577-010-9112-4; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shapiro JA, 2004, BIOL REV, V80, P1; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Terencio ML, 2013, SEX DEV, V7, P325, DOI 10.1159/000356691; Teruel M, 2009, CYTOGENET GENOME RES, V125, P286, DOI 10.1159/000235935; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; THOREN PA, 1995, INSECT MOL BIOL, V4, P141, DOI 10.1111/j.1365-2583.1995.tb00019.x; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Ustinova J, 2006, J MOL EVOL, V62, P158, DOI 10.1007/s00239-005-0022-6; Vanzela Andre L. L., 2002, Cytologia (Tokyo), V67, P9, DOI 10.1508/cytologia.67.9; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; WEBB GC, 1978, CHROMOSOMA, V67, P309, DOI 10.1007/BF00285964; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814	68	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97956	10.1371/journal.pone.0097956	http://dx.doi.org/10.1371/journal.pone.0097956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871300	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300022
J	Morton, CO; Fliesser, M; Dittrich, M; Mueller, T; Bauer, R; Kneitz, S; Hope, W; Rogers, TR; Einsele, H; Loeffler, J				Morton, Charles Oliver; Fliesser, Mirjam; Dittrich, Marcus; Mueller, Tobias; Bauer, Ruth; Kneitz, Susanne; Hope, William; Rogers, Thomas Richard; Einsele, Hermann; Loeffler, Juergen			Gene Expression Profiles of Human Dendritic Cells Interacting with Aspergillus fumigatus in a Bilayer Model of the Alveolar Epithelium/Endothelium Interface	PLOS ONE			English	Article							IN-VITRO MODEL; INNATE IMMUNE-RESPONSE; CANDIDA-ALBICANS; ANTIFUNGAL THERAPY; PULMONARY-DISEASE; HUMAN MONOCYTES; CONIDIA; LYMPHOCYTES; MOLECULES; INFECTION	The initial stages of the interaction between the host and Aspergillus fumigatus at the alveolar surface of the human lung are critical in the establishment of aspergillosis. Using an in vitro bilayer model of the alveolus, including both the epithelium (human lung adenocarcinoma epithelial cell line, A549) and endothelium (human pulmonary artery epithelial cells, HPAEC) on transwell membranes, it was possible to closely replicate the in vivo conditions. Two distinct sub-groups of dendritic cells (DC), monocyte-derived DC (moDC) and myeloid DC (mDC), were included in the model to examine immune responses to fungal infection at the alveolar surface. RNA in high quantity and quality was extracted from the cell layers on the transwell membrane to allow gene expression analysis using tailored custom-made microarrays, containing probes for 117 immunerelevant genes. This microarray data indicated minimal induction of immune gene expression in A549 alveolar epithelial cells in response to germ tubes of A. fumigatus. In contrast, the addition of DC to the system greatly increased the number of differentially expressed immune genes. moDC exhibited increased expression of genes including CLEC7A, CD209 and CCL18 in the absence of A. fumigatus compared to mDC. In the presence of A. fumigatus, both DC subgroups exhibited up-regulation of genes identified in previous studies as being associated with the exposure of DC to A. fumigatus and exhibiting chemotactic properties for neutrophils, including CXCL2, CXCL5, CCL20, and IL1B. This model closely approximated the human alveolus allowing for an analysis of the host pathogen interface that complements existing animal models of IA.	[Morton, Charles Oliver] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Fliesser, Mirjam; Bauer, Ruth; Einsele, Hermann; Loeffler, Juergen] Univ Wurzburg, Med Klin & Poliklin 2, WU4i, D-97070 Wurzburg, Germany; [Dittrich, Marcus; Mueller, Tobias; Kneitz, Susanne] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Hope, William] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Rogers, Thomas Richard] Univ Dublin Trinity Coll, Sir Patrick Res Lab, Dept Clin Microbiol, Dublin 2, Ireland	Western Sydney University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Wurzburg; University of Liverpool; Trinity College Dublin	Loeffler, J (corresponding author), Univ Wurzburg, Med Klin & Poliklin 2, WU4i, D-97070 Wurzburg, Germany.	loeffler_j@ukw.de	Morton, Charles O/H-4000-2012	Morton, Charles Oliver/0000-0003-1702-0545; Rogers, Thomas/0000-0003-4336-7729; Hope, William/0000-0001-6187-878X	European Union; Development of Novel Management Strategies for Invasive Aspergillosis "MANASP'' from Sanderstiftung; Pathogenic fungi and their hosts - Networks of interaction - FungiNet [CRC/TR124]; National Institute for Health Research [CS/08/08/10] Funding Source: researchfish	European Union(European Commission); Development of Novel Management Strategies for Invasive Aspergillosis "MANASP'' from Sanderstiftung; Pathogenic fungi and their hosts - Networks of interaction - FungiNet; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a European Union Framework 6 grant as part of a project entitled Development of Novel Management Strategies for Invasive Aspergillosis "MANASP,'' by a grant from the Sanderstiftung, and by the CRC/TR124, Pathogenic fungi and their hosts - Networks of interaction - FungiNet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Ballarin A, 2012, AM J RESP CRIT CARE, V186, P233, DOI 10.1164/rccm.201112-2142OC; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; CHANG MS, 1994, J BIOL CHEM, V269, P25277; Chiang LY, 2008, INFECT IMMUN, V76, P3429, DOI 10.1128/IAI.01510-07; Cortez KJ, 2006, INFECT IMMUN, V74, P2353, DOI 10.1128/IAI.74.4.2353-2365.2006; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Gafa V, 2006, INFECT IMMUN, V74, P1480, DOI 10.1128/IAI.74.3.1480-1489.2006; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hope WW, 2007, J INFECT DIS, V195, P455, DOI 10.1086/510535; Hope WW, 2009, MED MYCOL, V47, pS291, DOI 10.1080/13693780802510232; Hope WW, 2005, MED MYCOL, V43, pS207, DOI 10.1080/13693780400025179; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Loeffler J, 2009, J MED MICROBIOL, V58, P49, DOI 10.1099/jmm.0.003293-0; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Moalli F, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/830421; Morton CO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016016; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Ok M, 2011, INT J MED MICROBIOL, V301, P445, DOI 10.1016/j.ijmm.2011.04.013; Oksanen J., 2016, R PACKAG; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Park SJ, 2010, J IMMUNOL, V185, P6190, DOI 10.4049/jimmunol.1002064; Park SJ, 2009, CLIN MICROBIOL REV, V22, P535, DOI 10.1128/CMR.00014-09; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Schaller M, 2005, INFECT IMMUN, V73, P2758, DOI 10.1128/IAI.73.5.2758-2765.2005; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Schaller M, 2002, J MED MICROBIOL, V51, P672, DOI 10.1099/0022-1317-51-8-672; Shetron-Rama LM, 2010, MICROB PATHOGENESIS, V49, P38, DOI 10.1016/j.micpath.2010.02.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spinnler K, 2010, MED MYCOL, V48, P589, DOI 10.3109/13693780903420625; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410-1384SO; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98279	10.1371/journal.pone.0098279	http://dx.doi.org/10.1371/journal.pone.0098279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870357	gold, Green Published, Green Submitted			2022-12-27	WOS:000336858300032
J	Zaal, FTJM; Bongers, RM				Zaal, Frank T. J. M.; Bongers, Raoul M.			Movements of Individual Digits in Bimanual Prehension Are Coupled into a Grasping Component	PLOS ONE			English	Article							CHANGING OBJECT SIZE; SELECTIVE PERTURBATION; VISUAL INPUT; VIEW; TRANSPORT; RESPONSES; POSITION; TASKS; THUMB; REACH	The classic understanding of prehension is that of coordinated reaching and grasping. An alternative view is that the grasping in prehension emerges from independently controlled individual digit movements (the double-pointing model). The current study tested this latter model in bimanual prehension: participants had to grasp an object between their two index fingers. Right after the start of the movement, the future end position of one of the digits was perturbed. The perturbations resulted in expected changes in the kinematics of the perturbed digit but also in adjusted kinematics in the unperturbed digit. The latter effects showed up when the end position of the right index finger was perturbed, but not when the end position of the left index finger was perturbed. Because the absence of a coupling between the digits is the core assumption of the double-pointing model, finding any perturbation effects challenges this account of prehension; the double-pointing model predicts that the unperturbed digit would be unaffected by the perturbation. The authors conclude that the movement of the digits in prehension is coupled into a grasping component.	[Zaal, Frank T. J. M.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Zaal, FTJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	f.t.j.m.zaal@umcg.nl	Zaal, Frank TJM/A-5578-2008; Bongers, Raoul/C-1094-2012	Zaal, Frank TJM/0000-0003-2697-3612; Bongers, Raoul/0000-0002-3518-7464				ABBS JH, 1984, J NEUROPHYSIOL, V51, P705, DOI 10.1152/jn.1984.51.4.705; Arbib M.A., 1985, EXP BRAIN RES S, V10, P111, DOI DOI 10.1007/978-3-642-70105-4_; Bongers RM, 2012, HUM MOVEMENT SCI, V31, P487, DOI 10.1016/j.humov.2011.07.014; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; Diedrichsen J, 2004, EUR J NEUROSCI, V19, P1643, DOI 10.1111/j.1460-9568.2004.03242.x; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Galea MP, 2001, NEUROREPORT, V12, P2185, DOI 10.1097/00001756-200107200-00028; GENTILUCCI M, 1992, BEHAV BRAIN RES, V47, P71, DOI 10.1016/S0166-4328(05)80253-0; Haggard P, 1997, J MOTOR BEHAV, V29, P282, DOI 10.1080/00222899709600842; IBERALL T, 1986, EXPT BRAIN RES SERIE, V15, P158; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson-Frey SH, 2004, VIS COGN, V11, P371, DOI 10.1080/13506280344000329; Kelso J.A., 1984, J EXPER PSYCH HUM PE, V6, P812; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Marteniuk RG, 1999, MOTOR CONTROL, V3, P272, DOI 10.1123/mcj.3.3.272; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; Neilson PD, 1999, MOTOR CONTROL, V3, P280, DOI 10.1123/mcj.3.3.280; Newell KM, 1999, MOTOR CONTROL, V3, P285, DOI 10.1123/mcj.3.3.285; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; Rosenbaum DA, 1999, MOTOR CONTROL, V3, P289, DOI 10.1123/mcj.3.3.289; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Savelsbergh GJP, 1999, MOTOR CONTROL, V3, P298, DOI 10.1123/mcj.3.3.298; Schot WD, 2011, EXP BRAIN RES, V212, P487, DOI 10.1007/s00221-011-2756-2; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Smeets JBJ, 1999, MOTOR CONTROL, V3, P316, DOI 10.1123/mcj.3.3.316; Smeets JBJ, 2001, EXP BRAIN RES, V139, P92, DOI 10.1007/s002210100748; Smeets JBJ, 2010, EXP BRAIN RES, V203, P339, DOI 10.1007/s00221-010-2236-0; Smeets JBJ, 2009, ADV EXP MED BIOL, V629, P499, DOI 10.1007/978-0-387-77064-2_27; Steenbergen B, 1999, MOTOR CONTROL, V3, P302, DOI 10.1123/mcj.3.3.302; Tresilian JR, 1997, EXP BRAIN RES, V115, P283, DOI 10.1007/PL00005697; van de Kamp C, 2007, EXP BRAIN RES, V182, P27, DOI 10.1007/s00221-007-0968-2; van de Kamp C, 2009, J MOTOR BEHAV, V41, P427, DOI 10.3200/35-08-033; Verheij R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033150; Wang JS, 1999, MOTOR CONTROL, V3, P307, DOI 10.1123/mcj.3.3.307; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297, DOI 10.1080/14640748308402135; ZAAL FTJM, 1995, J MOTOR BEHAV, V27, P193, DOI 10.1080/00222895.1995.9941710	45	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97790	10.1371/journal.pone.0097790	http://dx.doi.org/10.1371/journal.pone.0097790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870948	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300019
J	Tong, JH; Li, Z; Shi, J; Li, HM; Wang, Y; Fu, LY; Liu, YP				Tong, Jian-hua; Li, Zhi; Shi, Jing; Li, He-ming; Wang, Yan; Fu, Ling-yu; Liu, Yun-peng			Passive Smoking Exposure from Partners as a Risk Factor for ER plus /PR plus Double Positive Breast Cancer in Never-Smoking Chinese Urban Women: A Hospital-Based Matched Case Control Study	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ACTIVE SMOKING; CIGARETTE-SMOKING; SECONDHAND SMOKE; RECEPTOR STATUS; ASSOCIATION; POPULATION; ESTROGEN; EPIDEMIOLOGY; VARIANTS	Background: The relationship between passive smoking exposure (PSE) and breast cancer risk is of major interest. Objective: To evaluate the relationship between PSE from partners and breast cancer risk stratified by hormone-receptor (HR) status in Chinese urban women population. Design: Hospital-based matched case control study. Setting: Chinese urban breast cancer patients without current or previous active smoking history in China Medical University 1st Hospital, Liaoning Province, China between Jan 2009 and Nov 2009. Patients: Each breast cancer patient was matched 1:1 with healthy controls by gender and age (+/- 2 years) from the same hospital. Measurements: The authors used unconditional logistic regression analyses to estimate odds ratio for women with PSE from partners and breast cancer risk. Results: 312 pairs were included in the study. Women who endured PSE had significantly increased risk of breast cancer (adjusted OR: 1.46; 95% CI: 1.05-2.03; P = 0.027), comparing with unexposed women. Women who exposed to >5 cigarettes/day also had significant increased risk (adjusted OR: 1.99; 95% CI: 1.28-3.10; P = 0.002), as were women exposed to passive smoke for 16-25 years (adjusted OR: 1.87 95% CI: 1.22-2.86; P = 0.004), and those exposed to > 4 pack-years (adjusted OR: 1.71 95% CI: 1.17-2.50; P = 0.004). Similar trends were significant for estrogen receptor (ER)/progesterone receptor (PR) double positive subgroup(adjusted OR: 1.71; 2.20; 1.99; 1.92, respectively), but not for ER+/PR-, ER-/PR+, or ER-/PR- subgroups. Limitations: limitations of the hospital-based retrospective study, lack of information on entire lifetime PSE and low statistical power. Conclusions: Our findings provide further evidence that PSE from partners contributes to increased risk of breast cancer, especially for ER/PR double positive breast cancer, in Chinese urban women.	[Tong, Jian-hua; Li, Zhi; Shi, Jing; Li, He-ming; Wang, Yan; Fu, Ling-yu; Liu, Yun-peng] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China	China Medical University	Liu, YP (corresponding author), China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Peoples R China.	cmuliuyunpeng@hotmail.com	cmu, wy/HDO-5017-2022; Li, Zhi/ABE-5902-2022	Li, Zhi/0000-0002-6437-0348	National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2010ZX09401-304]	National Science and Technology Major Projects for "Major New Drugs Innovation and Development"	This study was supported financially, in part, by the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (Grant No. 2010ZX09401-304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Anderson LN, 2012, AM J EPIDEMIOL, V175, P289, DOI 10.1093/aje/kwr324; Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; Chen Z, 2013, ASIA PAC J PUBLIC HL; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Folkerd EJ, 2010, J CLIN ONCOL, V28, P4038, DOI 10.1200/JCO.2009.27.4290; Gammon MD, 2004, ENVIRON RES, V96, P176, DOI 10.1016/j.envres.2003.08.009; Gao CM, 2013, ASIAN PAC J CANCER P, V14, P993, DOI 10.7314/APJCP.2013.14.2.993; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P775, DOI 10.1007/s10552-011-9750-7; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Lash TL, 2002, BREAST CANCER RES TR, V75, P181, DOI 10.1023/A:1019625102365; Lee CH, 2011, BREAST CANCER RES TR, V129, P331, DOI 10.1007/s10549-010-1209-0; Li CI, 2009, J CLIN ONCOL, V27, P5312, DOI 10.1200/JCO.2009.23.1597; Li L, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-167; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Linnoila RI, 2010, JNCI-J NATL CANCER I, V102, P1298, DOI 10.1093/jnci/djq314; Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Morabia A, 2000, AM J EPIDEMIOL, V152, P226, DOI 10.1093/aje/152.3.226; Morabia A, 1998, INT J CANCER, V75, P339, DOI 10.1002/(SICI)1097-0215(19980130)75:3<339::AID-IJC2>3.0.CO;2-3; Nelson NJ, 2006, J NATL CANCER I, V98, P436, DOI 10.1093/jnci/djj147; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Schick S, 2006, TOB CONTROL, V15, P424, DOI 10.1136/tc.2006.016162; Shrubsole MJ, 2004, INT J CANCER, V110, P605, DOI 10.1002/ijc.20168; Slattery ML, 2008, BREAST CANCER RES TR, V109, P101, DOI 10.1007/s10549-007-9629-1; SMITH SJ, 1994, BRIT J CANCER, V70, P112, DOI 10.1038/bjc.1994.258; Suzuki R, 2009, INT J CANCER, V124, P698, DOI 10.1002/ijc.23943; Tamimi RM, 2012, BREAST CANCER RES TR, V131, P159, DOI 10.1007/s10549-011-1702-0; Terry PD, 2011, WOMENS HEALTH, V7, P405, DOI [10.2217/WHE.11.39, 10.2217/whe.11.39]; Tworoger SS, 2013, CANCER RES, V73, P4810, DOI 10.1158/0008-5472.CAN-13-0665; Wartenberg D, 2000, J NATL CANCER I, V92, P1666, DOI 10.1093/jnci/92.20.1666; Wen WQ, 2006, BMJ-BRIT MED J, V333, P376, DOI 10.1136/bmj.38834.522894.2F; Wu CH, 2011, CLIN CANCER RES, V17, P3533, DOI 10.1158/1078-0432.CCR-10-2434; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang L, 2010, ACTA OBSTET GYN SCAN, V89, P549, DOI 10.3109/00016341003713851; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077029; Zhang M, 2003, INT J CANCER, V105, P838, DOI 10.1002/ijc.11165; Zhang M, 2007, CARCINOGENESIS, V28, P1074, DOI 10.1093/carcin/bgl252; Zheng S, 2012, INT J CANCER, V131, P2622, DOI 10.1002/ijc.27513; Zhong LJ, 1999, CANCER CAUSE CONTROL, V10, P607, DOI 10.1023/A:1008962025001; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	55	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97498	10.1371/journal.pone.0097498	http://dx.doi.org/10.1371/journal.pone.0097498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866166	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100015
J	Afonso, P; McGinty, N; Graca, G; Fontes, J; Inacio, M; Totland, A; Menezes, G				Afonso, Pedro; McGinty, Niall; Graca, Goncalo; Fontes, Jorge; Inacio, Monica; Totland, Atle; Menezes, Gui			Vertical Migrations of a Deep-Sea Fish and Its Prey	PLOS ONE			English	Article							SHARK ALOPIAS-SUPERCILIOSUS; TUNA THUNNUS-OBESUS; AZORES NE ATLANTIC; CONDOR SEAMOUNT; VARIABILITY; ZOOPLANKTON; PATTERNS; OCEAN	It has been speculated that some deep-sea fishes can display large vertical migrations and likely doing so to explore the full suite of benthopelagic food resources, especially the pelagic organisms of the deep scattering layer (DSL). This would help explain the success of fishes residing at seamounts and the increased biodiversity found in these features of the open ocean. We combined active plus passive acoustic telemetry of blackspot seabream with in situ environmental and biological (backscattering) data collection at a seamount to verify if its behaviour is dominated by vertical movements as a response to temporal changes in environmental conditions and pelagic prey availability. We found that seabream extensively migrate up and down the water column, that these patterns are cyclic both in short-term (tidal, diel) as well as long-term (seasonal) scales, and that they partially match the availability of potential DSL prey components. Furthermore, the emerging pattern points to a more complex spatial behaviour than previously anticipated, suggesting a seasonal switch in the diel behaviour mode (benthic vs. pelagic) of seabream, which may reflect an adaptation to differences in prey availability. This study is the first to document the fine scale three-dimensional behaviour of a deep-sea fish residing at seamounts.	[Afonso, Pedro; McGinty, Niall; Graca, Goncalo; Fontes, Jorge; Inacio, Monica; Menezes, Gui] Univ Azores, Dept Oceanog & Fisheries, IMAR Inst Marine Res, Horta, Portugal; [Afonso, Pedro; Graca, Goncalo; Fontes, Jorge; Inacio, Monica; Menezes, Gui] LARSyS Lab Robot & Syst Engn & Sci, Lisbon, Portugal; [McGinty, Niall] Univ Iceland, Fac Life & Environm Sci, MARICE, Reykjavik, Iceland; [Totland, Atle] Inst Marine Res, N-5024 Bergen, Norway	Universidade dos Acores; University of Iceland; Institute of Marine Research - Norway	Afonso, P (corresponding author), Univ Azores, Dept Oceanog & Fisheries, IMAR Inst Marine Res, Horta, Portugal.	afonso@uac.pt	Menezes, Gui M./A-3956-2009; Afonso, Pedro/B-7815-2013	Menezes, Gui M./0000-0003-0781-4579; Afonso, Pedro/0000-0002-4618-2589; Fontes, Jorge/0000-0002-8451-5532	Portuguese Science and Technology Foundation (FCT/MCTES); European FEDER/COMPETE program through the Seamov Project [PTDC/MAR/108232/2008]; Laboratory of Robotics and Systems in Engineering and Science (LARSyS) Strategic Project [PEst/OE/EEI/LA00009/2011]; EEA Grants through the Condor project [PT-0040]; Ocean Tracking Network	Portuguese Science and Technology Foundation (FCT/MCTES)(Portuguese Foundation for Science and Technology); European FEDER/COMPETE program through the Seamov Project; Laboratory of Robotics and Systems in Engineering and Science (LARSyS) Strategic Project; EEA Grants through the Condor project; Ocean Tracking Network	This work was funded by the Portuguese Science and Technology Foundation (FCT/MCTES) and the European FEDER/COMPETE program through the Seamov Project (PTDC/MAR/108232/2008), the Laboratory of Robotics and Systems in Engineering and Science (LARSyS) Strategic Project (PEst/OE/EEI/LA00009/2011), and through individual support to PA (Ciencia 2008/POPH/QREN) and JF (COMPETE/FRH/BD/12788/2003); by EEA Grants through the Condor project (PT-0040); and by the Ocean Tracking Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2012, J EXP MAR BIOL ECOL, V436, P1, DOI 10.1016/j.jembe.2012.08.003; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Carmo V, 2013, DEEP-SEA RES PT II, V98, P63, DOI 10.1016/j.dsr2.2013.08.007; Colaco A, 2013, DEEP-SEA RES PT II, V98, P178, DOI 10.1016/j.dsr2.2013.01.010; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Harris PT, 2012, ELSEV INSIGHT, P1; HOLLAND KN, 1992, NATURE, V358, P410, DOI 10.1038/358410a0; Jarvis ET, 2008, CAN J FISH AQUAT SCI, V65, P1286, DOI 10.1139/F08-071; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Menezes GM, 2006, MAR ECOL PROG SER, V324, P241, DOI 10.3354/meps324241; Menezes GM, 2013, DEEP-SEA RES PT II, V98, P101, DOI 10.1016/j.dsr2.2013.08.010; Morato T, 2001, B MAR SCI, V69, P1073; Morato T, 1999, LIFE MAR SCI A, V17A, P51, DOI 10.1111/j.1439-0426.2010.01467.x; Morato T, 2007, SEAMOUNTS ECOLOGY FI; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; Morato T, 2009, DEEP-SEA RES PT II, V56, P2713, DOI 10.1016/j.dsr2.2008.12.029; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; Porteiro FM, 2013, DEEP-SEA RES PT II, V98, P114, DOI 10.1016/j.dsr2.2013.09.015; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Sanchez F, 1983, ICES COUNC M 1983; Santos M, 2013, DEEP-SEA RES PT II, V98, P52, DOI 10.1016/j.dsr2.2013.05.037; Simpfendorfer CA, 2012, CAN J FISH AQUAT SCI, V69, P565, DOI 10.1139/F2011-179; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Weng KC, 2004, FISH B-NOAA, V102, P221	26	25	25	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97884	10.1371/journal.pone.0097884	http://dx.doi.org/10.1371/journal.pone.0097884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859231	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400029
J	Dier, U; Shin, DH; Hemachandra, LPMP; Uusitalo, LM; Hempel, N				Dier, Usawadee; Shin, Dong-Hui; Hemachandra, L. P. Madhubhani P.; Uusitalo, Larissa M.; Hempel, Nadine			Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DYNAMIN-RELATED PROTEIN-1; DNA CONTENT; MUTATIONS; CARCINOMA; DRP1; CARCINOGENESIS; ENDOMETRIOSIS; PROGRESSION; ASSOCIATION	Epithelial ovarian cancer (EOC) is the most lethal of all gynecological cancers, and encompasses distinct histological subtypes that have specific genetic and tissues-of-origin differences. Ovarian clear cell carcinoma (OCCC) represents approximately 10% of cases and has been termed a stress responsive cancer. OCCC is characterized by increased expression of oxidative stress and glycolysis-related genes. In the present study, we hypothesized that bioenergetic profiling might uniquely distinguish OCCC from other EOC histological subtypes. Using an extracellular flux analyzer, OCCC lines (ES-2, TOV-21-G) were shown to be highly metabolically active, with high oxygen consumption rate (OCR) and high extracellular acidification rate (ECAR), indicative of enhanced mitochondrial oxidative phosphorylation and glycolytic rate, respectively. A high bioenergetics profile was associated with the cell lines' ability to form anchorage independent spheroids. Given their high glycolytic and mitochondrial activity, OCCC cells displayed strong sensitivity to 2-deoxy-D-glucose and Rotenone growth inhibition, although this chemosensitivity profile was not specific to only OCCC cells. Bioenergetic profiling also identified a non-OCCC cell line, OVCA420, to have severely compromised mitochondrial function, based on low OCR and a lack of stimulation of maximal respiration following application of the uncoupler FCCP. This was accompanied by mitochondrial morphology changes indicative of enhanced fission, increased expression of the mitochondrial fission protein Drp1, a loss of mitochondrial membrane potential and dependence on glycolysis. Importantly, this loss of mitochondrial function was accompanied by the inability of OVCA420 cells to cope with hypoxic stress, and a compromised ability to stabilize HIF-1 alpha in response to 1% O-2 hypoxia. This knowledge may be imperative for researchers planning to utilize this cell line for further studies of metabolism and hypoxia, and suggests that altered mitochondrial fission dynamics represents a phenotype of a subpopulation of EOCs.	[Dier, Usawadee; Shin, Dong-Hui; Hemachandra, L. P. Madhubhani P.; Uusitalo, Larissa M.; Hempel, Nadine] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Hempel, N (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12222 USA.	nhempel@albany.edu	Hempel, Nadine/F-1700-2014	Hempel, Nadine/0000-0002-5574-8783; Hemachandra, L P Madhubhani/0000-0001-7756-6190	National Institutes of Health (NIH) grant from the National Cancer Institute [R00CA143229]; NATIONAL CANCER INSTITUTE [R00CA143229] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant R00CA143229 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Andre N, 2000, CANCER RES, V60, P5349; Andre N, 2002, FEBS LETT, V532, P256, DOI 10.1016/S0014-5793(02)03691-8; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandel NS, 2010, ADV EXP MED BIOL, V661, P339, DOI 10.1007/978-1-60761-500-2_22; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Cuff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074562; Dehne N, 2012, ANTIOXID REDOX SIGNA; Dilokthornsakul P, 2013, INT J GYNECOL CANCER, V23, P1544, DOI 10.1097/IGC.0b013e3182a80a21; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Fabian C, 2012, FEBS J, V279, P882, DOI 10.1111/j.1742-4658.2012.08479.x; Ferlini C, 2003, MOL PHARMACOL, V64, P51, DOI 10.1124/mol.64.1.51; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Hashiguchi Y, 2006, GYNECOL ONCOL, V101, P71, DOI 10.1016/j.ygyno.2005.09.047; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Loar P, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.883; Mandai M, 2011, CANCER LETT, V310, P129, DOI 10.1016/j.canlet.2011.06.039; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Okamoto T, 2013, MOL CARCINOG; Pejznochova M, 2008, PHYSIOL RES, V57, P947, DOI 10.33549/physiolres.931246; Qian W, 2013, EXPERT OPIN THER TAR, V17, P997, DOI 10.1517/14728222.2013.823160; RAMAKRISHNAN S, 1989, J CLIN INVEST, V83, P921, DOI 10.1172/JCI113977; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rescigno P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852839; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Sullivan EJ, 2013, CANC CHEMOTHER PHARM; Tan DSP, 2013, BRIT J CANCER, V108, P1553, DOI 10.1038/bjc.2013.126; Tan DSP, 2011, CLIN CANCER RES, V17, P1521, DOI 10.1158/1078-0432.CCR-10-1688; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Thrall MM, 2007, GYNECOL ONCOL, V105, P17, DOI 10.1016/j.ygyno.2006.10.060; Tian CQ, 2009, CANCER-AM CANCER SOC, V115, P1395, DOI 10.1002/cncr.24152; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Yamaguchi K, 2008, CLIN CANCER RES, V14, P32, DOI 10.1158/1078-0432.CCR-07-1614; Yamamoto Y, 2008, INT J GYNECOL OBSTET, V102, P124, DOI 10.1016/j.ijgo.2008.02.019; Zhang XD, 2006, ANTICANCER RES, V26, P3561	59	55	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98479	10.1371/journal.pone.0098479	http://dx.doi.org/10.1371/journal.pone.0098479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858344	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400078
J	Huang, HS; Yoon, BJ; Brooks, S; Bakal, R; Berrios, J; Larsen, RS; Wallace, ML; Han, JE; Chung, EH; Zylka, MJ; Philpot, BD				Huang, Hsien-Sung; Yoon, Bong-June; Brooks, Sherian; Bakal, Robert; Berrios, Janet; Larsen, Rylan S.; Wallace, Michael L.; Han, Ji Eun; Chung, Eui Hwan; Zylka, Mark J.; Philpot, Benjamin D.			Snx14 Regulates Neuronal Excitability, Promotes Synaptic Transmission, and Is Imprinted in the Brain of Mice	PLOS ONE			English	Article							ORIGIN ALLELIC EXPRESSION; SORTING NEXIN 27; POTASSIUM CHANNELS; DNA METHYLATION; MOUSE-BRAIN; GENOMES; DOMAIN; GENES	Genomic imprinting describes an epigenetic process through which genes can be expressed in a parent-of-origin-specific manner. The monoallelic expression of imprinted genes renders them particularly susceptible to disease causing mutations. A large proportion of imprinted genes are expressed in the brain, but little is known about their functions. Indeed, it has proven difficult to identify cell type-specific imprinted genes due to the heterogeneity of cell types within the brain. Here we used laser capture microdissection of visual cortical neurons and found evidence that sorting nexin 14 (Snx14) is a neuronally imprinted gene in mice. SNX14 protein levels are high in the brain and progressively increase during neuronal development and maturation. Snx14 knockdown reduces intrinsic excitability and severely impairs both excitatory and inhibitory synaptic transmission. These data reveal a role for monoallelic Snx14 expression in maintaining normal neuronal excitability and synaptic transmission.	[Huang, Hsien-Sung; Brooks, Sherian; Bakal, Robert; Larsen, Rylan S.; Han, Ji Eun; Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Yoon, Bong-June] Korea Univ, Div Life Sci, Seoul, South Korea; [Berrios, Janet; Wallace, Michael L.; Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Chung, Eui Hwan] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC USA; [Zylka, Mark J.; Philpot, Benjamin D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Korea University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	bphilpot@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , UNC Flow Cytometry Core/AGU-9839-2022; Yoon, Bong June/L-7126-2017; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Larsen, Rylan/0000-0002-7136-1175; Wallace, Michael/0000-0002-7270-8521; Huang, Hsien-Sung/0000-0003-2657-3635	NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award; NC TraCS [2KR30907]; Simons Foundation; NIMH [R01MH093372]; National Research Foundation of Korea (NRF) [NRF-2009-0075797]; NINDS [5P30NS045892]; NICHD [P30HD03110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110, U54HD079124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award; NC TraCS; Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	HSH was supported by a NARSAD grant from the Brain and Behavior Research Foundation Young Investigator Award and NC TraCS (2KR30907). MJZ and BDP were supported by grants from The Simons Foundation and NIMH (R01MH093372). BJY was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (NRF-2009-0075797). Laser capture microdissection was performed in the Microscopy Services Laboratory, UNC Department of Pathology and Laboratory Medicine. Confocal imaging was performed at the UNC Confocal and Multiphoton Imaging Facility, which is funded by grants from NINDS (5P30NS045892) and NICHD (P30HD03110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Becker K, 2012, EUR J MED GENET, V55, P490, DOI 10.1016/j.ejmg.2012.03.003; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Crespi B, 2008, BIOL REV, V83, P441, DOI 10.1111/j.1469-185X.2008.00050.x; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Kamikihara T, 2005, INT J CANCER, V115, P690, DOI 10.1002/ijc.20971; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Maenaka S, 2006, ONCOL REP, V15, P791; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Seelan RS, 2008, NEUROSCIENCE, V151, P1184, DOI 10.1016/j.neuroscience.2007.10.045; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Vervoort VS, 2002, J MED GENET, V39, P893, DOI 10.1136/jmg.39.12.893; Wang X, 2013, NAT MED, V19, P473, DOI 10.1038/nm.3117; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	25	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98383	10.1371/journal.pone.0098383	http://dx.doi.org/10.1371/journal.pone.0098383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859318	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400073
J	Donat, U; Rother, J; Schafer, S; Hess, M; Hartl, B; Kober, C; Langbein-Laugwitz, J; Stritzker, J; Chen, NG; Aguilar, RJ; Weibel, S; Szalay, AA				Donat, Ulrike; Rother, Juliane; Schaefer, Simon; Hess, Michael; Haertl, Barbara; Kober, Christina; Langbein-Laugwitz, Johanna; Stritzker, Jochen; Chen, Nanhai G.; Aguilar, Richard J.; Weibel, Stephanie; Szalay, Aladar A.			Characterization of Metastasis Formation and Virotherapy in the Human C33A Cervical Cancer Model	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HUMAN PROSTATE-CANCER; HUMAN BREAST-CANCER; NUDE-MOUSE MODEL; VACCINIA VIRUS; IN-VIVO; ORTHOTOPIC MODEL; CARCINOMA; TUMORS; MICE	More than 90% of cancer mortalities are due to cancer that has metastasized. Therefore, it is crucial to intensify research on metastasis formation and therapy. Here, we describe for the first time the metastasizing ability of the human cervical cancer cell line C33A in athymic nude mice after subcutaneous implantation of tumor cells. In this model, we demonstrated a steady progression of lumbar and renal lymph node metastases during tumor development. Besides predominantly occurring lymphatic metastases, we visualized the formation of hematogenous metastases utilizing red fluorescent protein (RFP) expressing C33A-RFP cells. RFP positive cancer cells were found migrating in blood vessels and forming micrometastases in lungs of tumor-bearing mice. Next, we set out to analyze the influence of oncolytic virotherapy in the C33A-RFP model and demonstrated an efficient virus-mediated reduction of tumor size and metastatic burden. These results suggest the C33A-RFP cervical cancer model as a new platform to analyze cancer metastases as well as to test novel treatment options to combat metastases.	[Donat, Ulrike; Rother, Juliane; Schaefer, Simon; Hess, Michael; Haertl, Barbara; Kober, Christina; Langbein-Laugwitz, Johanna; Stritzker, Jochen; Weibel, Stephanie; Szalay, Aladar A.] Univ Wurzburg, Inst Biochem, Wurzburg, Germany; [Stritzker, Jochen; Chen, Nanhai G.; Aguilar, Richard J.; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, Dept Radiat Med & Appl Sci, San Diego, CA 92103 USA; [Haertl, Barbara; Szalay, Aladar A.] Genelux GmbH, Bernried, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolph Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany	University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Univ Wurzburg, Inst Biochem, Rontgenring 11, Wurzburg, Germany.	aaszalay@genelux.com			Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp.; Genelux Corporation	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp.; Genelux Corporation	This work was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wuerzburg, Germany funded by Genelux Corp. UD and SW received postdoctoral fellowship. JR, CK, SS, and MH received a graduate fellowship from Genelux Corporation awarded to the University of Wuerzburg. AAS, JS, NGC, and RJA are salaried employees of Genelux Corporation and have financial interests in Genelux Corporation. BH is a salaried employee of Genelux GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Bastide C, 2002, PROSTATE CANCER P D, V5, P311, DOI 10.1038/sj.pcan.4500606; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Chen JM, 2002, NUTR CANCER, V43, P187, DOI 10.1207/S15327914NC432_9; CREDE R H, 1949, Cinci J Med, V30, P139; Donat U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045942; Duan P, 2012, EUR J GYNAECOL ONCOL, V33, P472; Fujihara T, 1998, CLIN EXP METASTAS, V16, P389; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gu J, 2003, DIS COLON RECTUM, V46, P1659, DOI 10.1007/BF02660772; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P745, DOI 10.1023/B:CLIN.0000006817.25962.87; Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Leong SPL, 2007, CANCER TREAT RES, P209; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Pearson HB, 2012, MODELING METASTASIS; Reinhardt MJ, 2001, RADIOLOGY, V218, P776, DOI 10.1148/radiology.218.3.r01mr19776; Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55; SMITH JA, 1981, J UROLOGY, V126, P591, DOI 10.1016/S0022-5347(17)54638-8; Stubenrauch F, 2007, INT J CANCER, V121, P2284, DOI 10.1002/ijc.22907; Sugarbaker P H, 1981, Curr Probl Surg, V18, P753, DOI 10.1016/S0011-3840(81)80010-X; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Triest JA, 1998, CLIN CANCER RES, V4, P2009; Tsutsumi S, 2001, CANCER LETT, V169, P77, DOI 10.1016/S0304-3835(00)00622-4; Unno Y, 2005, CLIN CANCER RES, V11, P4553, DOI 10.1158/1078-0432.CCR-04-2610; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Yamaguchi K, 2000, J EXP CLIN CANC RES, V19, P113; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zhang Q, 2009, MOL GENET GENOMICS, V282, P417, DOI 10.1007/s00438-009-0475-1	39	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98533	10.1371/journal.pone.0098533	http://dx.doi.org/10.1371/journal.pone.0098533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887184	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300077
J	Dong, ZX; Xu, J; Zhang, HB; Dou, Z; Mi, GD; Ruan, YH; Shen, LM; Min, XD; Lan, GH; Li, F; Li, T; Ning, Z; Wu, GH; She, M; Wu, ZY				Dong, Zhenxin; Xu, Jie; Zhang, Hongbo; Dou, Zhi; Mi, Guodong; Ruan, Yuhua; Shen, Limei; Min, Xiangdong; Lan, Guanghua; Li, Fan; Li, Tian; Ning, Zhen; Wu, Guohui; She, Min; Wu, Zunyou		China Natl HIV Prevention Study Gr	HIV Incidence and Risk Factors in Chinese Young Men Who Have Sex with Men-A Prospective Cohort Study	PLOS ONE			English	Article							HEPATITIS-B; SYPHILIS; PREVALENCE; INFECTIONS; BEHAVIOR; VIRUS; EPIDEMIC; PROVINCE; SPREAD	Objectives: To assess HIV incidence and its associated risk factors among young men who have sex with men (YMSM) in urban areas, China. Design: The study used a prospective cohort study design and standard diagnostic tests. Methods: A twelve-month prospective cohort study was conducted among YMSM (18-25 years old) in 8 large cities in China. The participants were recruited via snowball sampling. A total of 1102 HIV-negative YMSM completed baseline assessment, 878 YMSM participants completed 6-month follow-up, and 902 completed 12-month follow-up. HIV was screened by an enzyme-linked immunosorbent assay and confirmed with Western Blot. Syphilis was screened via rapid plasma reagent and confirmed by treponema pallidum particle agglutination assay. Results: 78 HIV seroconversions were identified within 1168.4 person-year observations yielding an incidence rate of 6.7 per 100 person-years. HIV seroconversion was associated with non-student status (RR = 2.61, 90% CI = 1.3-5.26), low HIV transmission knowledge (RR = 8.87, 90% CI = 2.16-36.43), and syphilis infection (RR = 5.04, 90% CI = 2.57-9.90). Conclusions: Incidence of HIV among YMSM is high in urban areas of China. Interventions measures are required to contain the HIV epidemic within this population.	[Dong, Zhenxin; Zhang, Hongbo; She, Min] Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China; [Xu, Jie; Dou, Zhi; Mi, Guodong; Ruan, Yuhua; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Shen, Limei] Guizhou Prov Ctr Dis Control & Prevent, Xingyi, Guizhou, Peoples R China; [Min, Xiangdong] Yunnan Prov Ctr Dis Control & Prevent, Beijing, Yunnan, Peoples R China; [Lan, Guanghua] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Li, Fan] Xinjiang Ctr Dis Control & Prevent, Xinjiang, Peoples R China; [Li, Tian] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Ning, Zhen] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wu, Guohui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Anhui Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zhang, HB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China.	zhhongbo62@163.com; wuzy@263.net		Liu, Enwu/0000-0003-2580-3523	National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health [2008ZX10001-016]	National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health	This study was supported by the National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health (Grant No. 2008ZX10001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Buchacz K, 2005, SEX TRANSM DIS, V32, pS73, DOI 10.1097/01.olq.0000180466.62579.4b; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; DEAN L, 1995, J ACQ IMMUN DEF SYND, V8, P208; Elkington KS, 2010, J YOUTH ADOLESCENCE, V39, P514, DOI 10.1007/s10964-010-9524-7; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; He Q, 2009, SEX TRANSM INFECT, V85, P383, DOI 10.1136/sti.2009.035808; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Liu J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-356; Liu J, 2011, AIDS PATIENT CARE ST, V25, P423, DOI 10.1089/apc.2010.0333; Lyons T, 2013, J HIV-AIDS SOC SERV, V12, P368, DOI 10.1080/15381501.2013.816211; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; National Center for AIDS/STD Prevention and Control China CDC, 2010, 2009 UPD HIV AIDS EP; National Center for AIDS/STD Prevention and Control China CDC, 2011, 2011 UPD HIV AIDS EP; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; Vian Taryn, 2012, Open AIDS J, V6, P259, DOI 10.2174/1874613601206010259; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Wei S, 2013, AIDS BEHAV, V17, P1151, DOI 10.1007/s10461-011-0110-0; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; [许娟 XU Juan], 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P205; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919	33	25	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97527	10.1371/journal.pone.0097527	http://dx.doi.org/10.1371/journal.pone.0097527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878586	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500015
J	Lalwani, A; Stokes, RA; Lau, SM; Gunton, JE				Lalwani, Amit; Stokes, Rebecca A.; Lau, Sue Mei; Gunton, Jenny E.			Deletion of ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) in beta-Cells Causes Islet Transplant Failure with Impaired beta-Cell Function	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; TYPE-1 DIABETES-MELLITUS; GENE-EXPRESSION; DEFICIENT MICE; ALPHA; PANCREAS; ARNT/HIF1-BETA; PANCREATECTOMY; TRANSCRIPTION; ACTIVATION	background: Replacing beta-cells by islet-transplantation can cure type 1 diabetes, but up to 70% of beta-cells die within 10 days of transplantation. ARNT (Aryl hydrocarbon Receptor Nuclear Translocator) regulates beta-cell function, and potentially survival. Lack of ARNT impairs the ability of beta-cells to respond to physiological stress and potentiates the onset of diabetes, but the exact role of ARNT in graft outcome is unknown. Aim: To investigate the effect of beta-cell deletion of ARNT on graft outcomes. Methods: Islets were isolated from donor mice which had beta-cell specific ARNT-deletion (beta-ARNT) or littermate floxed controls. The islets were transplanted into diabetic SCID recipients in ratios of (a) 3 donors:1 recipient, (b) 1 donor:1 recipient or (c) 1/2 of the islets from 1 donor:1 recipient. After 28 days, the kidney containing the graft was removed (nephrectomy) to exclude regeneration of the endogenous pancreas. Results: In the supra-physiological-mass model (3:1), both groups achieved reasonable glycaemia, with slightly higher levels in beta-ARNT-recipients. In adequate-mass model (1:1), beta-ARNT recipients had poor glucose control versus floxed-control recipients and versus the beta-ARNT donors. In the low-beta-cell-mass model (1/2:1) beta-ARNT transplants completely failed, whereas controls had good outcomes. Unexpectedly, there was no difference in the graft insulin content or beta-cell mass between groups indicating that the defect was not due to early altered beta-cell survival. Conclusion: Outcomes for islet transplants lacking beta-cell ARNT were poor, unless markedly supra-physiological masses of islets were transplanted. In the 1:1 transplant model, there was no difference in beta-cell volume. This is surprising because transplants of islets lacking one of the ARNT-partners HIF-1 alpha have increased apoptosis and decreased islet volume. ARNT also partners HIF-2 alpha and AhR (aryl hydrocarbon receptor) to form active transcriptional complexes, and further work to understand the roles of HIF-2 alpha and AhR in transplant outcomes is needed.	[Lalwani, Amit; Stokes, Rebecca A.; Lau, Sue Mei; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Lalwani, Amit; Gunton, Jenny E.] Univ Sydney, Westmead Hosp, Fac Med, Sydney, NSW 2006, Australia; [Lau, Sue Mei; Gunton, Jenny E.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of Sydney; University of New South Wales Sydney; University of Sydney	Gunton, JE (corresponding author), Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.	j.gunton@garvan.org.au	Gunton, Jenny E/AAH-7719-2021		Juvenile Diabetes Research Foundation (JDRF); National Health and Medical Research Council of Australia (NHMRC); Diabetes Australia Research Trust (DART)	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust (DART)	Funding provided by Juvenile Diabetes Research Foundation (JDRF), National Health and Medical Research Council of Australia (NHMRC) and Diabetes Australia Research Trust (DART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Czech MP, 2006, NAT MED, V12, P39, DOI 10.1038/nm0106-39; da Silva Xavier G, 2004, P NATL ACAD SCI USA, V101, P8319, DOI 10.1073/pnas.0307737101; Das SK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-16; De Sa JR, 2008, ARQ BRAS ENDOCRINOL, V52, P355, DOI 10.1590/S0004-27302008000200024; Deters NA, 2011, ARCH IMMUNOL THER EX, V59, P421, DOI 10.1007/s00005-011-0143-0; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Huang JJ, 2000, ANN SURG, V231, P890, DOI 10.1097/00000658-200006000-00014; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Klinge CM, 1999, MOL CELL ENDOCRINOL, V157, P105, DOI 10.1016/S0303-7207(99)00165-3; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; LACY PE, 1987, CLIN INVEST MED, V10, P496; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; Lau SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077419; Levisetti MG, 2005, CELL METAB, V2, P78, DOI 10.1016/j.cmet.2005.07.005; Litwin J, 2008, PANCREAS, V36, P26, DOI 10.1097/mpa.0b013e318137aa61; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Molina MG, 2005, TRANSPL P, V37, P1443, DOI 10.1016/j.transproceed.2005.02.049; PARR EL, 1980, TRANSPLANTATION, V30, P135, DOI 10.1097/00007890-198008000-00012; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Robertson RP, 2000, DIABETES CARE, V23, P112, DOI 10.2337/diacare.23.1.112; Ruby CE, 2002, MOL PHARMACOL, V62, P722, DOI 10.1124/mol.62.3.722; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; Sutherland DER, 2004, TRANSPLANT P, V36, P1697, DOI 10.1016/j.transproceed.2004.06.069; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wong Mary S, 2010, Self Nonself, V1, P165, DOI 10.4161/self.1.3.12643; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Yim SH, 2006, HEPATOLOGY, V44, P550, DOI 10.1002/hep.21284	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98435	10.1371/journal.pone.0098435	http://dx.doi.org/10.1371/journal.pone.0098435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878748	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500059
J	Fitzmaurice, G; Lipsitz, S; Natarajan, S; Gawande, A; Sinha, D; Greenberg, C; Giovannucci, E				Fitzmaurice, Garrett; Lipsitz, Stuart; Natarajan, Sundar; Gawande, Atul; Sinha, Debajyoti; Greenberg, Caprice; Giovannucci, Edward			Simple Methods of Determining Confidence Intervals for Functions of Estimates in Published Results	PLOS ONE			English	Article								Often, the reader of a published paper is interested in a comparison of parameters that has not been presented. It is not possible to make inferences beyond point estimation since the standard error for the contrast of the estimated parameters depends upon the (unreported) correlation. This study explores approaches to obtain valid confidence intervals when the correlation (rho) is unknown. We illustrate three proposed approaches using data from the National Health Interview Survey. The three approaches include the Bonferroni method and the standard confidence interval assuming rho = - 1 (most conservative) or rho = 0 (when the correlation is known to be non-negative). The Bonferroni approach is found to be the most conservative. For the difference in two estimated parameter, the standard confidence interval assuming rho = 1 yields a 95% confidence interval that is approximately 12.5% narrower than the Bonferroni confidence interval; when the correlation is known to be positive, the standard 95% confidence interval assuming rho = 0 is approximately 38% narrower than the Bonferroni. In summary, this article demonstrates simple methods to determine confidence intervals for unreported comparisons. We suggest use of the standard confidence interval assuming rho = - 1 if no information is available or rho = - 1 if the correlation is known to be non-negative.	[Fitzmaurice, Garrett] McLean Hosp, Lab Psychiat Biostat, Belmont, MA 02178 USA; [Lipsitz, Stuart] Brigham & Womens Hosp, Div Internal Med, Boston, MA 02115 USA; [Lipsitz, Stuart; Gawande, Atul] Ariadne Labs, Boston, MA USA; [Natarajan, Sundar] NYU, Sch Med, Dept Med, New York, NY USA; [Sinha, Debajyoti] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Greenberg, Caprice] Univ Wisconsin, Dept Surg, Madison, WI USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Brigham & Women's Hospital; New York University; State University System of Florida; Florida State University; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Fitzmaurice, G (corresponding author), McLean Hosp, Lab Psychiat Biostat, 115 Mill St, Belmont, MA 02178 USA.	gfitzmaurice@partners.org		Natarajan, Sundar/0000-0002-6737-1995	U.S. National Institutes of Health [MH 054693, CA 160679, CA 06922]; NATIONAL CANCER INSTITUTE [R01CA069222, R01CA160679] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support provided by grants MH 054693, CA 160679, and CA 06922 from the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drazer MW, 2011, J CLIN ONCOL, V29, P1736, DOI 10.1200/JCO.2010.31.9004; Goodman SN, 1998, AM J EPIDEMIOL, V147, P807, DOI 10.1093/oxfordjournals.aje.a009531; Natarajan S, 2007, STAT MED, V26, P3229, DOI 10.1002/sim.2779; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960	6	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98498	10.1371/journal.pone.0098498	http://dx.doi.org/10.1371/journal.pone.0098498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869806	Green Published, gold			2022-12-27	WOS:000336858300049
J	Bezerra, GA; Viertlmayr, R; Moura, TR; Delatorre, P; Rocha, BAM; do Nascimento, KS; Figueiredo, JG; Bezerra, IG; Teixeira, CS; Simoes, RC; Nagano, CS; de Alencar, NMN; Gruber, K; Cavada, BS				Bezerra, Gustavo Arruda; Viertlmayr, Roland; Moura, Tales Rocha; Delatorre, Plinio; Matias Rocha, Bruno Anderson; do Nascimento, Kyria Santiago; Figueiredo, Jozi Godoy; Bezerra, Ingrid Goncalves; Teixeira, Cicero Silvano; Simoes, Rafael Conceicao; Nagano, Celso Shiniti; Nunes de Alencar, Nylane Maria; Gruber, Karl; Cavada, Benildo Sousa			Structural Studies of an Anti-Inflammatory Lectin from Canavalia boliviana Seeds in Complex with Dimannosides	PLOS ONE			English	Article							DIMER-TETRAMER EQUILIBRIUM; X-RAY DIFFRACTION; CRYSTAL-STRUCTURE; PLANT-LECTINS; PAW EDEMA; CARBOHYDRATE-RECOGNITION; BIOLOGICAL-ACTIVITY; SOLUTION SCATTERING; GRANDIFLORA SEEDS; CONCANAVALIN-A	Plant lectins, especially those purified from species of the Leguminosae family, represent the best-studied group of carbohydrate-binding proteins. Lectins purified from seeds of the Diocleinae subtribe exhibit a high degree of sequence identity notwithstanding that they show very distinct biological activities. Two main factors have been related to this feature: variance in key residues influencing the carbohydrate-binding site geometry and differences in the pH-dependent oligomeric state profile. In this work, we have isolated a lectin from Canavalia boliviana (Cbol) and solved its x-ray crystal structure in the unbound form and in complex with the carbohydrates Man(alpha 1-3)Man(alpha 1-O)Me, Man(alpha 1-4) Man(alpha 1-O) Me and 5-bromo-4-chloro-3-indolyl-alpha-D-mannose. We evaluated its oligomerization profile at different pH values using Small Angle X-ray Scattering and compared it to that of Concanavalin A. Based on predicted pKa-shifts of amino acids in the subunit interfaces we devised a model for the dimer-tetramer equilibrium phenomena of these proteins. Additionally, we demonstrated Cbol anti-inflammatory properties and further characterized them using in vivo and in vitro models.	[Bezerra, Gustavo Arruda; Viertlmayr, Roland; Gruber, Karl] Graz Univ, Inst Mol Biosci, Graz, Austria; [Moura, Tales Rocha; Matias Rocha, Bruno Anderson; do Nascimento, Kyria Santiago; Teixeira, Cicero Silvano; Simoes, Rafael Conceicao; Cavada, Benildo Sousa] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Delatorre, Plinio] Univ Fed Paraiba, Dept Mol Biol, BR-58059900 Joao Pessoa, Paraiba, Brazil; [Figueiredo, Jozi Godoy; Bezerra, Ingrid Goncalves; Nunes de Alencar, Nylane Maria] Univ Fed Ceara, Dept Physiol & Pharmacol, Fortaleza, Ceara, Brazil; [Nagano, Celso Shiniti] Univ Fed Ceara, Dept Fishing Engn, Fortaleza, Ceara, Brazil	University of Graz; Universidade Federal do Ceara; Universidade Federal da Paraiba; Universidade Federal do Ceara; Universidade Federal do Ceara	Bezerra, GA (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	gustavo.bezerra@univie.ac.at; bscavada@ufc.br	Cavada, Benildo/CEA-4997-2022; Nagano, Celso Shiniti/J-9649-2012; Rocha, B.A.M./E-2919-2015; Gruber, Karl/GPP-6706-2022	Cavada, Benildo/0000-0002-5791-6170; Nagano, Celso Shiniti/0000-0001-5988-5868; Rocha, B.A.M./0000-0002-7157-0321; Gruber, Karl/0000-0002-3485-9740; Rocha de Moura, Tales/0000-0001-5492-8419; Arruda Bezerra, Gustavo/0000-0003-4471-821X	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES; National Synchrotron Light Laboratory - LNLS, Brazil; Doktoratskolleg "Molecular Enzymology" Grant from the Austrian Science Fund [W901-B05]; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Synchrotron Light Laboratory - LNLS, Brazil; Doktoratskolleg "Molecular Enzymology" Grant from the Austrian Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is funded by Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico - FUNCAP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES, National Synchrotron Light Laboratory - LNLS, Brazil. BSC is senior investigator of CNPq. Additional funding was provided by the Doktoratskolleg "Molecular Enzymology" Grant W901-B05 from the Austrian Science Fund (to KG and GAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AGRAWAL BBL, 1968, ARCH BIOCHEM BIOPHYS, V124, P218, DOI 10.1016/0003-9861(68)90322-6; Alencar NMN, 1999, MEDIAT INFLAMM, V8, P107, DOI 10.1080/09629359990603; Alencar NMN, 2004, PROTEIN PEPTIDE LETT, V11, P195, DOI 10.2174/0929866043478284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade JL, 1999, CELL IMMUNOL, V194, P98, DOI 10.1006/cimm.1999.1494; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Assreuy AMS, 1997, MEDIAT INFLAMM, V6, P201, DOI 10.1080/09629359791695; BENTO CAM, 1993, AGENTS ACTIONS, V38, P48, DOI 10.1007/BF02027213; Bezerra GA, 2007, J STRUCT BIOL, V160, P168, DOI 10.1016/j.jsb.2007.07.012; Blanchet CE, 2012, J APPL CRYSTALLOGR, V45, P489, DOI 10.1107/S0021889812013490; Bouckaert J, 1999, J BIOL CHEM, V274, P29188, DOI 10.1074/jbc.274.41.29188; Cavada BS, 2001, CURR PROTEIN PEPT SC, V2, P123, DOI 10.2174/1389203013381152; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de Oliveira TM, 2008, J STRUCT BIOL, V164, P177, DOI 10.1016/j.jsb.2008.05.012; Deacon A, 1997, J CHEM SOC FARADAY T, V93, P4305, DOI 10.1039/a704140c; Delatorre P, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-52; Delatorre P, 2006, J STRUCT BIOL, V154, P280, DOI 10.1016/j.jsb.2006.03.011; DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97; DIROSA M, 1972, J PATHOL, V105, P239; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; Figueiredo JG, 2009, TOXICON, V54, P736, DOI 10.1016/j.toxicon.2009.05.037; Gabius H.-J., 1997, GLYCOSCIENCE STATUS; Gadelha CAD, 2005, J STRUCT BIOL, V152, P185, DOI 10.1016/j.jsb.2005.07.012; Golias C, 2011, CELL COMMUN ADHES, V18, P19, DOI 10.3109/15419061.2011.606381; Havt A, 2003, PROTEIN PEPTIDE LETT, V10, P191, DOI 10.2174/0929866033479130; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LANDUCCI ECT, 1995, BRIT J PHARMACOL, V114, P578, DOI 10.1111/j.1476-5381.1995.tb17178.x; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lipson H., 1956, ACTA CRYSTALLOGR, V9, P839; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lopes FC, 2005, BRAZ J MED BIOL RES, V38, P935, DOI 10.1590/S0100-879X2005000600016; Loris R, 2004, J MOL BIOL, V335, P1227, DOI 10.1016/j.jmb.2003.11.043; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; MANDAL DK, 1994, BIOCHEMISTRY-US, V33, P1149, DOI 10.1021/bi00171a014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moura TR, 2009, ACTA CRYSTALLOGR F, V65, P213, DOI 10.1107/S1744309109000797; Nagano CS, 2008, BIOCHEM J, V409, P417, DOI 10.1042/BJ20070942; Nunes BS, 2009, N-S ARCH PHARMACOL, V379, P609, DOI 10.1007/s00210-009-0397-9; Pusztai A, 2008, FRONT BIOSCI-LANDMRK, V13, P1130, DOI 10.2741/2750; Ribeiro RA, 1997, INT ARCH ALLERGY IMM, V112, P27, DOI 10.1159/000237427; Rocha BAM, 2011, BIOCHIMIE, V93, P806, DOI 10.1016/j.biochi.2011.01.006; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; ROZDZINSKI E, 1993, J EXP MED, V178, P917, DOI 10.1084/jem.178.3.917; Bezerra EHS, 2011, BIOCHEM BIOPH RES CO, V408, P566, DOI 10.1016/j.bbrc.2011.04.061; SanzAparicio J, 1997, FEBS LETT, V405, P114, DOI 10.1016/S0014-5793(97)00137-3; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simoes RC, 2012, RAPID COMMUN MASS SP, V26, P811, DOI 10.1002/rcm.6171; Srimal S, 1996, BIOCHEM J, V315, P679, DOI 10.1042/bj3150679; Srinivas VR, 2001, BBA-GEN SUBJECTS, V1527, P102, DOI 10.1016/S0304-4165(01)00153-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; Wah DA, 2001, J MOL BIOL, V310, P885, DOI 10.1006/jmbi.2001.4814; YANG AS, 1993, J MOL BIOL, V231, P459, DOI 10.1006/jmbi.1993.1294	62	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97015	10.1371/journal.pone.0097015	http://dx.doi.org/10.1371/journal.pone.0097015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865454	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100009
J	de la Haye, K; D'Amico, EJ; Miles, JNV; Ewing, B; Tucker, JS				de la Haye, Kayla; D'Amico, Elizabeth J.; Miles, Jeremy N. V.; Ewing, Brett; Tucker, Joan S.			Covariance among Multiple Health Risk Behaviors in Adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SUBSTANCE-USE; RACIAL/ETHNIC DIFFERENCES; SCALE RELIABILITY; CIGARETTE-SMOKING; PATTERNS; YOUTH; INITIATION; EDUCATION; CHILDREN	Purpose: In a diverse group of early adolescents, this study explores the co-occurrence of a broad range of health risk behaviors: alcohol, cigarette, and marijuana use; physical inactivity; sedentary computing/gaming; and the consumption of low-nutrient energy-dense food. We tested differences in the associations of unhealthy behaviors over time, and by gender, race/ethnicity, and socioeconomic status. Methods: Participants were 8360 students from 16 middle schools in California (50% female; 52% Hispanic, 17% Asian, 16% White, and 15% Black/multiethnic/other). Behaviors were measured with surveys in Spring 2010 and Spring 2011. Confirmatory factor analysis was used to assess if an underlying factor accounted for the covariance of multiple behaviors, and composite reliability methods were used to determine the degree to which behaviors were related. Results: The measured behaviors were explained by two moderately correlated factors: a 'substance use risk factor' and an 'unhealthy eating and sedentary factor'. Physical inactivity did not reflect the latent factors as expected. There were few differences in the associations among these behaviors over time or by demographic characteristics. Conclusions: Two distinct, yet related groups of health compromising behaviors were identified that could be jointly targeted in multiple health behavior change interventions among early adolescents of diverse backgrounds.	[de la Haye, Kayla; D'Amico, Elizabeth J.; Miles, Jeremy N. V.; Ewing, Brett; Tucker, Joan S.] RAND Corp, Santa Monica, CA 90407 USA	RAND Corporation	de la Haye, K (corresponding author), RAND Corp, Santa Monica, CA 90407 USA.	delahaye@rand.org			National Institute of Alcohol Abuse and Alcoholism [R01AA016577]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016577] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	All phases of this study were supported by a grant from the National Institute of Alcohol Abuse and Alcoholism (R01AA016577) awarded to E. J. D'Amico. Website: http://www.niaaa.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman JG, 2011, J STUD ALCOHOL DRUGS, V72, P279, DOI 10.15288/jsad.2011.72.279; BasenEngquist K, 1996, J CONSULT CLIN PSYCH, V64, P764, DOI 10.1037/0022-006X.64.4.764; Carson V, 2011, PREV MED, V52, P99, DOI 10.1016/j.ypmed.2010.07.005; Centers for Disease Control and Prevention, 2010, SMOK TOB US HIGHL ST; Chan D, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P309; D'Amico EJ, 2005, J STUD ALCOHOL, V66, P766, DOI 10.15288/jsa.2005.66.766; D'Amico EJ, 2006, J ADOLESCENT HEALTH, V39, P481, DOI 10.1016/j.jadohealth.2006.02.010; D'Amico EJ, 2012, PREV SCI, V13, P415, DOI 10.1007/s11121-011-0269-7; Dennis M, 2002, ADDICTION, V97, P16, DOI 10.1046/j.1360-0443.97.s01.2.x; DONOVAN JE, 1991, HEALTH PSYCHOL, V10, P52, DOI 10.1037/0278-6133.10.1.52; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Efron B., 1994, INTRO BOOTSTRAP; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Jessor R., 1977, PROBLEM BEHAV PSYCHO; Johnson RA, 2000, J HEALTH SOC BEHAV, V41, P392, DOI 10.2307/2676293; Johnston LD, 2009, MONITORING FUTURE NA, V09-7402, P1; Kandel DB, 2004, AM J PUBLIC HEALTH, V94, P128, DOI 10.2105/AJPH.94.1.128; Little T. D., 2009, LONGITUDINAL STRUCTU; LYTLE LA, 1995, HEALTH EDUC RES, V10, P133, DOI 10.1093/her/10.2.133; MacArthur GJ, 2012, J PUBLIC HEALTH-UK, V34, pI20, DOI 10.1093/pubmed/fds006; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Muthen BO, 2011, MPLUS 6 11; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; Oliver I, 2012, IEEE IC COMP COM NET; Pearson R., 2007, American Journal of Health Studies, V22, P170; Prochaska JJ, 2008, PREV MED, V46, P181, DOI 10.1016/j.ypmed.2008.02.001; Raykov T, 2010, STRUCT EQU MODELING, V17, P265, DOI 10.1080/10705511003659417; Raykov T, 2009, MEAS EVAL COUNS DEV, V42, P223, DOI 10.1177/0748175609344096; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; SAMHSA, 2008, RES 2007 NAT SURV DR; Sanchez A, 2007, AM J PREV MED, V32, P124, DOI 10.1016/j.amepre.2006.10.012; Shih RA, 2010, J STUD ALCOHOL DRUGS, V71, P640, DOI 10.15288/jsad.2010.71.640; Shillington AM, 2000, DRUG ALCOHOL DEPEN, V60, P19, DOI 10.1016/S0376-8716(99)00137-4; WestEd, 2011, CAL HLTH KIDS SURV	34	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98141	10.1371/journal.pone.0098141	http://dx.doi.org/10.1371/journal.pone.0098141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4ML	24858838	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400046
J	Yanagawa, H; Suzuki, H; Suzuki, Y; Kiryluk, K; Gharavi, AG; Matsuoka, K; Makita, Y; Julian, BA; Novak, J; Tomino, Y				Yanagawa, Hiroyuki; Suzuki, Hitoshi; Suzuki, Yusuke; Kiryluk, Krzysztof; Gharavi, Ali G.; Matsuoka, Kiyoshi; Makita, Yuko; Julian, Bruce A.; Novak, Jan; Tomino, Yasuhiko			A Panel of Serum Biomarkers Differentiates IgA Nephropathy from Other Renal Diseases	PLOS ONE			English	Article							CIRCULATING IMMUNE-COMPLEXES; GALACTOSE-DEFICIENT IGA1; O-GLYCOSYLATION; HINGE REGION; ANTIBODIES	Background and Objectives: There is increasing evidence that galactose-deficient IgA1 (Gd-IgA1) and Gd-IgA1-containing immune complexes are important for the pathogenesis of IgA nephropathy (IgAN). In the present study, we assessed a novel noninvasive multi-biomarker approach in the diagnostic test for IgAN. Materials and Methods: We compared serum levels of IgA, IgG, Gd-IgA1, Gd-IgA1-specific IgG and Gd-IgA1-specific IgA in 135 IgAN patients, 79 patients with non-IgAN chronic kidney disease (CKD) controls and 106 healthy controls. Serum was collected at the time of kidney biopsy from all IgAN and CKD patients. Results: Each serum marker was significantly elevated in IgAN patients compared to CKD (P<0.001) and healthy controls (P<0.001). While 41% of IgAN patients had elevated serum Gd-IgA1 levels, 91% of these patients exhibited Gd-IgA1-specific IgG levels above the 90th percentile for healthy controls (sensitivity 89%, specificity 92%). Although up to 25% of CKD controls, particularly those with immune-mediated glomerular diseases including lupus nephritis, also had elevated serum levels of Gd-IgA1-specific IgG, most IgAN patients had elevated levels of Gd-IgA1-specific antibody of both isotypes. Serum levels of Gd-IgA1-specific IgG were associated with renal histological grading. Furthermore, there was a trend toward higher serum levels of Gd-IgA1-specific IgG in IgAN patients with at least moderate proteinuria (>= 1.0 g/g), compared to patients with less proteinuria. Conclusions: Serum levels of Gd-IgA1-specific antibodies are elevated in most IgAN patients, and their assessment, together with serum levels of Gd-IgA1, improves the specificity of the assays. Our observations suggest that a panel of serum biomarkers may be helpful in differentiating IgAN from other glomerular diseases.	[Yanagawa, Hiroyuki; Suzuki, Hitoshi; Suzuki, Yusuke; Makita, Yuko; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Kiryluk, Krzysztof; Gharavi, Ali G.] Columbia Univ Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA; [Matsuoka, Kiyoshi] Juntendo Univ, Fac Med, Clin Res Ctr, Tokyo, Japan; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Juntendo University; Columbia University; Juntendo University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp			Study Group on IgA Nephropathy; Ministry of Health, Labour and Welfare of Japan; KAKENHI [22790802]; National Institutes of Health [DK078244, DK082753, DK083663, DK075868, GM098539]; Glomerular Center at Columbia University; National Institute of Health [K23DK090207, R03-DK099654]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK083663, R01DK082753, K23DK090207, R01DK078244, R21DK075868, R56DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	Study Group on IgA Nephropathy; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glomerular Center at Columbia University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by a research grant from the Study Group on IgA Nephropathy, a Grant-in-Aid for Progressive Renal Disease Research, Research on Intractable Disease from the Ministry of Health, Labour and Welfare of Japan, and by KAKENHI (22790802). BAJ and JN were supported, in part, by National Institutes of Health grants DK078244, DK082753, DK083663, DK075868, and GM098539. KK was supported by the Glomerular Center at Columbia University and the National Institute of Health grant K23DK090207 and R03-DK099654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583; Coppo R, 2004, KIDNEY INT, V65, P1544, DOI 10.1111/j.1523-1755.2004.05407.x; CZERKINSKY C, 1986, J CLIN INVEST, V77, P1931, DOI 10.1172/JCI112522; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DAMICO G, 1987, Q J MED, V64, P709; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HIKI Y, 1995, CONTRIB NEPHROL, V111, P73; Julian BA, 2004, CURR OPIN NEPHROL HY, V13, P171, DOI 10.1097/00041552-200403000-00005; JULIAN BA, 1988, AM J MED, V84, P129, DOI 10.1016/0002-9343(88)90019-8; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Moore JS, 2007, MOL IMMUNOL, V44, P2598, DOI 10.1016/j.molimm.2006.12.011; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Novak J, 2002, KIDNEY INT, V62, P465, DOI 10.1046/j.1523-1755.2002.00477.x; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2008, SEMIN NEPHROL, V28, P78, DOI 10.1016/j.semnephrol.2007.10.009; RUSSELL MW, 1986, J CLIN IMMUNOL, V6, P74, DOI 10.1007/BF00915367; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Takahashi K, 2010, MOL CELL PROTEOMICS, V9, P2545, DOI 10.1074/mcp.M110.001834; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; Tomino Yasuhiko, 2003, Clin Exp Nephrol, V7, P93, DOI 10.1007/s10157-003-0232-4; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2487, DOI 10.1093/ndt/gfh394; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011	33	66	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98081	10.1371/journal.pone.0098081	http://dx.doi.org/10.1371/journal.pone.0098081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858067	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400038
J	Chu, YG; Huang, QJ; Zhang, BY; Ding, CJ; Su, XH				Chu, Yanguang; Huang, Qinjun; Zhang, Bingyu; Ding, Changjun; Su, Xiaohua			Expression and Molecular Evolution of Two DREB1 Genes in Black Poplar (Populus nigra)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE DIVERSITY; LOW-TEMPERATURE; TRANSCRIPTIONAL ACTIVATOR; NATURAL-POPULATIONS; STRESS TOLERANCE; CBF GENES; DNA; FAMILY	Environmental stresses such as low temperature, drought, and high salinity significantly affect plant growth and yield. As selective forces, these adverse factors play essential roles in shaping phenotypic variation in plant populations. Black poplar (Populus nigra) is an economically and ecologically important forest tree species with widely distributed populations and is thus suitable for experiments detecting evolutionary footprints left by stress. Here, we performed expression and evolutionary analysis of two duplicated DREB A1-subgroup (DREB1) genes, PnDREB68 and PnDREB69, encoding transcription factors that are involved in stress responses. The two genes showed partially overlapping but distinct expression patterns in response to stresses. These genes were strongly and rapidly induced by cold stress in leaves, stems, and roots. In leaf tissue, dehydration stress induced the expression of PnDREB68 but not PnDREB69. PnDREB69 displayed more rapid responses and longer expression durations than PnDREB68 under salt and ABA stress, respectively. Based on single nucleotide polymorphism (SNP) analysis, we found significant population genetic differentiation, with a greater FST value (0.09189) for PnDREB69 than for PnDREB68 (0.07743). Nucleotide diversity analysis revealed a two-fold higher pT for PnDREB68 than for PnDREB69 (0.00563 vs. 0.00243), reflecting strong purifying selection acting on the former. The results suggest that positive selection acted on PnDREB69, as evidenced by neutral testing using Tajima's D statistic. The distinct selective forces to which each of the genes was subjected may be associated with expression divergence. Linkage disequilibrium (LD) was low for the sequenced region, with a higher level for PnDREB68 than for PnDREB69. Additionally, analysis of the relationship among carbon isotope ratios, SNP classes and gene expression, together with motif and domain analysis, suggested that 14 polymorphisms within the two genes may be candidates for an association study of important traits such as water use efficiency/drought tolerance in black poplar.	[Chu, Yanguang; Huang, Qinjun; Zhang, Bingyu; Ding, Changjun; Su, Xiaohua] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Su, XH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.	suxh@caf.ac.cn			National Natural Science Foundation of China [31000310]; National High-tech R&D Program of China [2011AA100201]; National Key Technology R&D Program for the Eleventh Five-Year-Plan of China [2006BAD01A15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Key Technology R&D Program for the Eleventh Five-Year-Plan of China(National Key Technology R&D Program)	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31000310), the National High-tech R&D Program of China (Grant No. 2011AA100201), and the National Key Technology R&D Program for the Eleventh Five-Year-Plan of China (Grant No. 2006BAD01A15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artlip TS, 2013, TREE PHYSIOL, V33, P866, DOI 10.1093/treephys/tpt056; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Benedict C, 2006, PLANT CELL ENVIRON, V29, P1259, DOI 10.1111/j.1365-3040.2006.01505.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breen AL, 2009, NEW PHYTOL, V182, P763, DOI 10.1111/j.1469-8137.2009.02779.x; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Chazen O, 2006, PLANT CELL ENVIRON, V18, P727; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chu YG, 2009, GENETICA, V137, P141, DOI 10.1007/s10709-009-9371-1; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Cong L, 2008, BIOCHEM BIOPH RES CO, V371, P702, DOI 10.1016/j.bbrc.2008.04.126; Eckenwalder James E., 1996, P7; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FU YX, 1993, GENETICS, V133, P693; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-146; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-111; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Maestrini P, 2009, J PLANT PHYSIOL, V166, P1544, DOI 10.1016/j.jplph.2009.03.014; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; MARTIN B, 1988, PLANT PHYSIOL, V88, P213, DOI 10.1104/pp.88.1.213; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mboup M, 2012, MOL BIOL EVOL, V29, P3641, DOI 10.1093/molbev/mss176; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Navarro M, 2011, PLANT BIOTECHNOL J, V9, P50, DOI 10.1111/j.1467-7652.2010.00530.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohno S., 1970, P1; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Smulders MJM, 2008, FOREST ECOL MANAG, V255, P1388, DOI 10.1016/j.foreco.2007.10.063; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang QY., 2002, DPS DATA PROCESSING; Tian JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053116; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vanden BA, 2003, EUFORGEN TECHNICAL G, P1; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wisniewski M, 2011, PLANTA, V233, P971, DOI 10.1007/s00425-011-1358-3; Zhang DQ, 2011, TREE GENET GENOMES, V7, P443, DOI 10.1007/s11295-010-0346-2; Zhang DQ, 2010, TREE GENET GENOMES, V6, P331, DOI 10.1007/s11295-009-0252-7; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	68	21	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98334	10.1371/journal.pone.0098334	http://dx.doi.org/10.1371/journal.pone.0098334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887081	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300055
J	Li, X; Yang, YQ; Ma, L; Sun, XD; Yang, SH; Kong, XX; Hu, XY; Yang, YP				Li, Xiong; Yang, Yunqiang; Ma, Lan; Sun, Xudong; Yang, Shihai; Kong, Xiangxiang; Hu, Xiangyang; Yang, Yongping			Comparative Proteomics Analyses of Kobresia pygmaea Adaptation to Environment along an Elevational Gradient on the Central Tibetan Plateau	PLOS ONE			English	Article							STOMATAL DENSITY; OXIDATIVE STRESS; HIGH-TEMPERATURE; NITRIC-OXIDE; ANTIOXIDANT ENZYMES; ABSCISIC-ACID; PLANT LIFE; LEAF-AREA; RESPONSES; LEAVES	Variations in elevation limit the growth and distribution of alpine plants because multiple environmental stresses impact plant growth, including sharp temperature shifts, strong ultraviolet radiation exposure, low oxygen content, etc. Alpine plants have developed special strategies to help survive the harsh environments of high mountains, but the internal mechanisms remain undefined. Kobresia pygmaea, the dominant species of alpine meadows, is widely distributed in the Southeastern Tibet Plateau, Tibet Autonomous Region, China. In this study, we mainly used comparative proteomics analyses to investigate the dynamic protein patterns for K. pygmaea located at four different elevations (4600, 4800, 4950 and 5100 m). A total of 58 differentially expressed proteins were successfully detected and functionally characterized. The proteins were divided into various functional categories, including material and energy metabolism, protein synthesis and degradation, redox process, defense response, photosynthesis, and protein kinase. Our study confirmed that increasing levels of antioxidant and heat shock proteins and the accumulation of primary metabolites, such as proline and abscisic acid, conferred K. pygmaea with tolerance to the alpine environment. In addition, the various methods K. pygmaea used to regulate material and energy metabolism played important roles in the development of tolerance to environmental stress. Our results also showed that the way in which K. pygmaea mediated stomatal characteristics and photosynthetic pigments constitutes an enhanced adaptation to alpine environmental stress. According to these findings, we concluded that K. pygmaea adapted to the high-elevation environment on the Tibetan Plateau by aggressively accumulating abiotic stress-related metabolites and proteins and by the various life events mediated by proteins. Based on the species'lexible physiological and biochemical processes, we surmised that environment change has only a slight impact on K. pygmaea except for possible impacts to populations on vulnerable edges of the species' range.	[Li, Xiong; Yang, Yunqiang; Ma, Lan; Sun, Xudong; Kong, Xiangxiang; Hu, Xiangyang; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Biodivers & Biogeog East Asia, Kunming, Peoples R China; [Li, Xiong; Yang, Yunqiang; Ma, Lan; Sun, Xudong; Kong, Xiangxiang; Hu, Xiangyang; Yang, Yongping] Chinese Acad Sci, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming Inst Bot, Kunming, Peoples R China; [Li, Xiong; Yang, Yunqiang; Ma, Lan; Yang, Shihai; Kong, Xiangxiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yang, Shihai] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Hu, XY (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Biodivers & Biogeog East Asia, Kunming, Peoples R China.	huxiangyang@mail.kib.ac.cn; yangyp@mail.kib.ac.cn	Yang, Shihai/J-1593-2012; Sun, Xudong/HHN-3905-2022; Li, Xiong/K-1074-2014; Hu, Xiangyang/AAQ-3313-2021	Yang, Shihai/0000-0002-6497-968X; Li, Xiong/0000-0002-1754-8721; 	Major State Basic Research Development Program [2010CB951700]; National Natural Sciences Foundation of China [31170256]; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2012HB041]	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Young Academic and Technical Leader Raising Foundation of Yunnan Province	This work was supported by the Major State Basic Research Development Program (2010CB951700), the National Natural Sciences Foundation of China (31170256) and the Young Academic and Technical Leader Raising Foundation of Yunnan Province (2012HB041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2008, PLANT BIOTECHNOL, V25, P257, DOI 10.5511/plantbiotechnology.25.257; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bai XG, 2011, J PROTEOME RES, V10, P4349, DOI 10.1021/pr200333f; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEERLING DJ, 1993, ANN BOT-LONDON, V71, P431, DOI 10.1006/anbo.1993.1056; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Bettarini I, 1998, GLOBAL CHANGE BIOL, V4, P17, DOI 10.1046/j.1365-2486.1998.00098.x; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Duan BL, 2005, PHYSIOL PLANTARUM, V124, P476, DOI 10.1111/j.1399-3054.2005.00535.x; Franks PJ, 2001, PLANT PHYSIOL, V125, P935, DOI 10.1104/pp.125.2.935; Fraser LH, 2009, ANN BOT-LONDON, V103, P769, DOI 10.1093/aob/mcn252; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; GALE J, 1972, ECOLOGY, V53, P494, DOI 10.2307/1934239; Gepstein S, 2013, PLANT MOL BIOL, V82, P623, DOI 10.1007/s11103-013-0038-z; Gottfried M, 1998, ARCTIC ALPINE RES, V30, P207, DOI 10.2307/1551968; Higashi K, 1998, PLANT CELL PHYSIOL, V39, P418, DOI 10.1093/oxfordjournals.pcp.a029385; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Israelsson M, 2006, CURR OPIN PLANT BIOL, V9, P654, DOI 10.1016/j.pbi.2006.09.006; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Joshi PN, 2008, RES J BIOTECHNOL, P319; KATO S, 1993, PLANT CELL PHYSIOL, V34, P367; KORNER C, 1986, OECOLOGIA, V69, P577, DOI 10.1007/BF00410366; Kosova K, 2011, PLANT SCI, V180, P46, DOI 10.1016/j.plantsci.2010.07.003; Kuznetsov VV, 1997, PHYSIOL PLANTARUM, V100, P320, DOI 10.1034/j.1399-3054.1997.1000214.x; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; Lee DH, 2000, PLANT SCI, V159, P75, DOI 10.1016/S0168-9452(00)00326-5; Li X, 2013, PROTEIN LEVELS UNPUB; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu YF, 2012, PLANT SCI, V196, P8, DOI 10.1016/j.plantsci.2012.07.005; Lou B, 2011, AFR J AGR RES, V6, P2875; Ma L, 2013, COMP PROTEOME UNPUB; Marini L, 2009, GLOBAL ECOL BIOGEOGR, V18, P652, DOI 10.1111/j.1466-8238.2009.00484.x; Miehe G, 2011, J ARID ENVIRON, V75, P711, DOI 10.1016/j.jaridenv.2011.03.001; Miehe G, 2008, AMBIO, V37, P272, DOI 10.1579/0044-7447(2008)37[272:SADOTK]2.0.CO;2; Mihailova G, 2011, PHOTOSYNTH RES, V108, P5, DOI 10.1007/s11120-011-9644-2; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; PENUELAS J, 1990, J EXP BOT, V41, P1119, DOI 10.1093/jxb/41.9.1119; Qiang WY, 2003, TREES-STRUCT FUNCT, V17, P258, DOI 10.1007/s00468-002-0235-x; Reddy KR, 1998, ENVIRON EXP BOT, V39, P117, DOI 10.1016/S0098-8472(97)00028-2; Salguero A, 2005, APPL MICROBIOL BIOT, V66, P506, DOI 10.1007/s00253-004-1711-6; Siaussat D, 2013, POLAR BIOL, V36, P201, DOI 10.1007/s00300-012-1252-x; Taylor SH, 2012, NEW PHYTOL, V193, P387, DOI 10.1111/j.1469-8137.2011.03935.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang F, 2010, PHYSIOL PLANTARUM, V139, P388, DOI 10.1111/j.1399-3054.2010.01375.x; Yang LM, 2013, J PROTEOME RES, V12, P1316, DOI 10.1021/pr300971n; Yang YQ, 2012, J PROTEOME RES, V11, P3605, DOI 10.1021/pr300027a; Yu C, 2013, BIOLOGIA, V68, P404, DOI 10.2478/s11756-013-0167-5; Zhang AY, 2011, PLANT CELL PHYSIOL, V52, P181, DOI 10.1093/pcp/pcq187	54	23	25	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98410	10.1371/journal.pone.0098410	http://dx.doi.org/10.1371/journal.pone.0098410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887403	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300063
J	Sargeant, DP; Deverasetty, S; Strong, CL; Alaniz, IJ; Bartlett, A; Brandon, NR; Brooks, SB; Brown, FA; Bufi, F; Chakarova, M; David, RP; Dobritch, KM; Guerra, HP; Hedden, MW; Kumra, R; Levitt, KS; Mathew, KR; Matti, R; Maza, DQ; Mistry, S; Novakovic, N; Pomerantz, A; Portillo, J; Rafalski, TF; Rathnayake, VR; Rezapour, N; Songao, S; Tuggle, SL; Yousif, S; Dorsky, DI; Schiller, MR				Sargeant, David P.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Hedden, Michael W.; Kumra, Rma; Levitt, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Portillo, Josue; Rafalski, Timothy F.; Rathnayake, Viraj R.; Rezapour, Noura; Songao, Sarah; Tuggle, Sean L.; Yousif, Sandy; Dorsky, David I.; Schiller, Martin R.			The HIVToolbox 2 Web System Integrates Sequence, Structure, Function and Mutation Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; VIROLOGICAL RESPONSE; HELICAL INTERACTIONS; INHIBITORY-ACTIVITY; PROTEIN DATA; TAT PROTEIN; TYPE-1 VPR; GP41 CORE; RNA	There is enormous interest in studying HIV pathogenesis for improving the treatment of patients with HIV infection. HIV infection has become one of the best-studied systems for understanding how a virus can hijack a cell. To help facilitate discovery, we previously built HIVToolbox, a web system for visual data mining. The original HIVToolbox integrated information for HIV protein sequence, structure, functional sites, and sequence conservation. This web system has been used for almost 40,000 searches. We report improvements to HIVToolbox including new functions and workflows, data updates, and updates for ease of use. HIVToolbox2, is an improvement over HIVToolbox with new functions. HIVToolbox2 has new functionalities focused on HIV pathogenesis including drug-binding sites, drug-resistance mutations, and immune epitopes. The integrated, interactive view enables visual mining to generate hypotheses that are not readily revealed by other approaches. Most HIV proteins form multimers, and there are posttranslational modification and protein-protein interaction sites at many of these multimerization interfaces. Analysis of protease drug binding sites reveals an anatomy of drug resistance with different types of drug-resistance mutations regionally localized on the surface of protease. Some of these drug-resistance mutations have a high prevalence in specific HIV-1 M subtypes. Finally, consolidation of Tat functional sites reveals a hotspot region where there appear to be 30 interactions or posttranslational modifications. A cursory analysis with HIVToolbox2 has helped to identify several global patterns for HIV proteins. An initial analysis with this tool identifies homomultimerization of almost all HIV proteins, functional sites that overlap with multimerization sites, a global drug resistance anatomy for HIV protease, and specific distributions of some DRMs in specific HIV M subtypes. HIVToolbox2 is an open-access web application available at [http://hivtoolbox2.bio-toolkit.com].	[Sargeant, David P.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Hedden, Michael W.; Kumra, Rma; Levitt, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Portillo, Josue; Rafalski, Timothy F.; Rathnayake, Viraj R.; Rezapour, Noura; Songao, Sarah; Tuggle, Sean L.; Yousif, Sandy; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Dorsky, David I.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06032 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut	Schiller, MR (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Novakovic, Nemanja/0000-0002-1681-7715; Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [AI07870, AI078708-03S1, GM07689, RR016464]; National Science Foundation [1005223]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078708, F32AI007870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by grants from the National Institutes of Health (AI07870, AI078708-03S1, GM07689, and RR016464) and the National Science Foundation (1005223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Andreola ML, 2009, CURR PHARM DESIGN, V15, P2508, DOI 10.2174/138161209788682244; Auclair JR, 2007, PROTEINS, V69, P270, DOI 10.1002/prot.21471; Bannwarth L, 2009, BIOCHEMISTRY-US, V48, P379, DOI 10.1021/bi801422u; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Buxton P, 2005, J VIROL, V79, P6338, DOI 10.1128/JVI.79.10.6338-6348.2005; Camarasa MJ, 2006, ANTIVIR RES, V71, P260, DOI 10.1016/j.antiviral.2006.05.021; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Colonno R, 2004, J INFECT DIS, V189, P1802, DOI 10.1086/386291; Colonno RJ, 2003, ANTIMICROB AGENTS CH, V47, P1324, DOI 10.1128/AAC.47.4.1324-1333.2003; Descamps D, 2009, J ANTIMICROB CHEMOTH, V63, P585, DOI 10.1093/jac/dkn544; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Doherty RS, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-18; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1988, P NATL ACAD SCI USA, V85, P6297, DOI 10.1073/pnas.85.17.6297; Gautier VW, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-47; Hagan NA, 2007, J MOL BIOL, V365, P396, DOI 10.1016/j.jmb.2006.09.081; He JJ, 2009, RNA BIOL, V6, P384, DOI 10.4161/rna.6.4.8920; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jenkins Y, 2001, J VIROL, V75, P10537, DOI 10.1128/JVI.75.21.10537-10542.2001; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kagan R, 2004, AIDS RES HUM RETROV, V20, P1, DOI 10.1089/088922204322749440; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kuiken Carla, 2003, AIDS Reviews, V5, P52; LEITNER T, 2005, HIV SEQUENCE COMPEND; Maes M, 2012, FEBS J, V279, P2795, DOI 10.1111/j.1742-4658.2012.08680.x; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Mulky A, 2005, ANTIMICROB AGENTS CH, V49, P3762, DOI 10.1128/AAC.49.9.3762-3769.2005; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Pagans S, 2011, METHODS, V53, P91, DOI 10.1016/j.ymeth.2010.07.001; Prasanna MD, 2006, PROTEINS, V63, P907, DOI 10.1002/prot.20914; Rato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009276; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Richter SN, 2006, CURR MED CHEM, V13, P1305, DOI 10.2174/092986706776872989; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sargeant D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020122; Sarmady M., 2011, PLOS ONE, V6; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Sharpe S, 2006, BIOCHEMISTRY-US, V45, P918, DOI 10.1021/bi051766k; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Sluis-Cremer N, 2002, EUR J BIOCHEM, V269, P5103, DOI 10.1046/j.1432-1033.2002.03216.x; Solbak SMO, 2013, BBA-BIOMEMBRANES, V1828, P816, DOI 10.1016/j.bbamem.2012.11.010; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Techtmann SM, 2012, BIOCHEMISTRY-US, V51, P2078, DOI 10.1021/bi201738a; Venkatachari NJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-119; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Yang B, 2003, J BIOL CHEM, V278, P6596, DOI 10.1074/jbc.M210164200; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	66	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98810	10.1371/journal.pone.0098810	http://dx.doi.org/10.1371/journal.pone.0098810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886930	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300111
J	Caton, SJ; Blundell, P; Ahern, SM; Nekitsing, C; Olsen, A; Moller, P; Hausner, H; Remy, E; Nicklaus, S; Chabanet, C; Issanchou, S; Hetherington, MM				Caton, Samantha J.; Blundell, Pam; Ahern, Sara M.; Nekitsing, Chandani; Olsen, Annemarie; Moller, Per; Hausner, Helene; Remy, Eloise; Nicklaus, Sophie; Chabanet, Claire; Issanchou, Sylvie; Hetherington, Marion M.			Learning to Eat Vegetables in Early Life: The Role of Timing, Age and Individual Eating Traits	PLOS ONE			English	Article							FLAVOR-FLAVOR; REPEATED EXPOSURE; FOOD NEOPHOBIA; MERE EXPOSURE; CHILDRENS WILLINGNESS; INFANTS ACCEPTANCE; EXPERIENCE; PREFERENCES; CONSUMPTION; LIKING	Vegetable intake is generally low among children, who appear to be especially fussy during the pre-school years. Repeated exposure is known to enhance intake of a novel vegetable in early life but individual differences in response to familiarisation have emerged from recent studies. In order to understand the factors which predict different responses to repeated exposure, data from the same experiment conducted in three groups of children from three countries (n = 332) aged 4-38 m (18.9 +/- 9.9 m) were combined and modelled. During the intervention period each child was given between 5 and 10 exposures to a novel vegetable (artichoke puree) in one of three versions (basic, sweet or added energy). Intake of basic artichoke puree was measured both before and after the exposure period. Overall, younger children consumed more artichoke than older children. Four distinct patterns of eating behaviour during the exposure period were defined. Most children were "learners'' (40%) who increased intake over time. 21% consumed more than 75% of what was offered each time and were labelled "plate-clearers''. 16% were considered "non-eaters'' eating less than 10 g by the 5th exposure and the remainder were classified as "others'' (23%) since their pattern was highly variable. Age was a significant predictor of eating pattern, with older pre-school children more likely to be non-eaters. Plate-clearers had higher enjoyment of food and lower satiety responsiveness than non-eaters who scored highest on food fussiness. Children in the added energy condition showed the smallest change in intake over time, compared to those in the basic or sweetened artichoke condition. Clearly whilst repeated exposure familiarises children with a novel food, alternative strategies that focus on encouraging initial tastes of the target food might be needed for the fussier and older pre-school children.	[Caton, Samantha J.; Blundell, Pam; Ahern, Sara M.; Nekitsing, Chandani; Hetherington, Marion M.] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Caton, Samantha J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England; [Olsen, Annemarie; Moller, Per; Hausner, Helene] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark; [Remy, Eloise; Nicklaus, Sophie; Chabanet, Claire; Issanchou, Sylvie] CNRS, UMR6265, Ctr Sci Gout & Alimentat, Dijon, France; [Remy, Eloise; Nicklaus, Sophie; Chabanet, Claire; Issanchou, Sylvie] INRA, UMR1324, Ctr Sci Gout & Alimentat, F-21034 Dijon, France; [Remy, Eloise; Nicklaus, Sophie; Chabanet, Claire; Issanchou, Sylvie] Univ Bourgogne, Ctr Sci Gout & Alimentat, Dijon, France	University of Leeds; University of Sheffield; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Hetherington, MM (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	m.hetherington@leeds.ac.uk	Caton, Samantha/CAJ-0198-2022; Birtill, Pam/V-2372-2019; Olsen, Annemarie/N-1412-2014	Olsen, Annemarie/0000-0002-8335-0588; Caton, Samantha/0000-0002-9096-0800; Blundell-Birtill, Pam/0000-0002-4690-2558; Ahern, Sara/0000-0002-9248-4887; Nicklaus, Sophie/0000-0002-0659-2823; Hetherington, Marion/0000-0001-8677-5234	European Community's Seventh Framework Program (FP7) [FP7-245012-HabEat]; Regional Council of Burgundy	European Community's Seventh Framework Program (FP7); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the grant agreement noFP7-245012-HabEat. The French part was also supported by the Regional Council of Burgundy. The authors have no conflict of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EC, 2012, PUBLIC HEALTH NUTR, V15, P1705, DOI 10.1017/S1368980012002686; Addessi E, 2005, APPETITE, V45, P264, DOI 10.1016/j.appet.2005.07.007; Ahern SM, 2013, APPETITE, V71, P48, DOI [10.1016/j.appet.2013.06.008, 10.1016/j.appet.2013.07.005]; Anderson AS, 2005, PUBLIC HEALTH NUTR, V8, P650, DOI 10.1079/PHN2004721; Anzman-Frasca S, 2012, APPETITE, V58, P543, DOI 10.1016/j.appet.2011.11.012; Ashcroft J, 2008, EUR J CLIN NUTR, V62, P985, DOI 10.1038/sj.ejcn.1602855; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Birch LL, 1998, APPETITE, V30, P283, DOI 10.1006/appe.1997.0146; BIRCH LL, 1990, PHYSIOL BEHAV, V47, P501, DOI 10.1016/0031-9384(90)90116-L; BIRCH LL, 1987, APPETITE, V9, P171, DOI 10.1016/S0195-6663(87)80011-9; Bordi Jr PL, 2013, J ACAD NUTR DIETETIC; Brunstrom JM, 2008, PHYSIOL BEHAV, V93, P13, DOI 10.1016/j.physbeh.2007.07.009; Capaldi ED, 2008, APPETITE, V50, P139, DOI 10.1016/j.appet.2007.06.008; Carruth BR, 2004, J AM DIET ASSOC, V104, pS57, DOI 10.1016/j.jada.2003.10.024; CASHDAN E, 1994, HUM NATURE-INT BIOS, V5, P279, DOI 10.1007/BF02692155; Caton SJ, 2013, BRIT J NUTR, V109, P2089, DOI 10.1017/S0007114512004126; Caton SJ, 2011, APPETITE, V57, P816, DOI 10.1016/j.appet.2011.05.319; Cooke L, 2003, APPETITE, V41, P205, DOI 10.1016/S0195-6663(03)00048-5; Cooke LJ, 2005, BRIT J NUTR, V93, P741, DOI 10.1079/BJN20051389; Cooke LJ, 2011, APPETITE, V57, P493, DOI 10.1016/j.appet.2011.06.016; de Wild VWT, 2013, APPETITE, V64, P89, DOI 10.1016/j.appet.2013.01.006; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Field A., 2012, DISCOVERING STAT USI; Gerrish CJ, 2001, AM J CLIN NUTR, V73, P1080; Gregory JE, 2011, APPETITE, V57, P167, DOI 10.1016/j.appet.2011.04.012; Hausner H, 2012, APPETITE, V58, P1152, DOI 10.1016/j.appet.2012.03.009; Hausner H, 2010, CLIN NUTR, V29, P141, DOI 10.1016/j.clnu.2009.11.007; Havermans RC, 2007, APPETITE, V48, P259, DOI 10.1016/j.appet.2006.08.063; JOHNSON SL, 1991, PHYSIOL BEHAV, V50, P1245, DOI 10.1016/0031-9384(91)90590-K; Johnston CA, 2011, J AM DIET ASSOC, V111, P716, DOI 10.1016/j.jada.2011.02.006; KALAT JW, 1973, J COMP PHYSIOL PSYCH, V83, P198, DOI 10.1037/h0034424; KERN DL, 1993, PHYSIOL BEHAV, V54, P71, DOI 10.1016/0031-9384(93)90045-H; Lakkakula A, 2010, APPETITE, V55, P226, DOI 10.1016/j.appet.2010.06.003; Loewen R, 1999, APPETITE, V32, P351, DOI 10.1006/appe.1998.0216; Maier AS, 2008, CLIN NUTR, V27, P849, DOI 10.1016/j.clnu.2008.08.002; Mennella JA, 2012, INT J OBESITY, V36, P1285, DOI 10.1038/ijo.2012.51; Mennella J A, 1995, J Hum Lact, V11, P39, DOI 10.1177/089033449501100122; MENNELLA JA, 1991, PEDIATRICS, V88, P737; Mennella JA, 1999, DEV PSYCHOBIOL, V35, P197, DOI 10.1002/(SICI)1098-2302(199911)35:3&lt;197::AID-DEV4&gt;3.0.CO;2-J; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Nicklaus S, 2005, APPETITE, V44, P289, DOI 10.1016/j.appet.2005.01.006; PLINER P, 1982, APPETITE, V3, P283, DOI 10.1016/S0195-6663(82)80026-3; Pliner P, 2000, APPETITE, V34, P95, DOI 10.1006/appe.1999.0290; Ransley JK, 2007, J EPIDEMIOL COMMUN H, V61, P699, DOI 10.1136/jech.2006.052696; Remy E, 2013, J NUTR, V143, P1194, DOI 10.3945/jn.113.175646; Schwartz C, 2011, APPETITE, V57, P796, DOI 10.1016/j.appet.2011.05.316; Scott JA, 2012, BMC PUBLIC HEALTH, V12, P1471; Spill MK, 2011, AM J CLIN NUTR, V94, P735, DOI 10.3945/ajcn.111.015206; Steiner J E, 1979, Adv Child Dev Behav, V13, P257, DOI 10.1016/S0065-2407(08)60349-3; Steiner J.E., 1977, FOGARTY INT CTR P, P173; SULLIVAN SA, 1994, PEDIATRICS, V93, P271; SULLIVAN SA, 1990, DEV PSYCHOL, V26, P546, DOI 10.1037/0012-1649.26.4.546; Svensson V, 2011, INT J BEHAV NUTR PHS, V8, P1479; Thijs C, 2008, INT J BEHAV NUTR PHY, P1479; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zeinstra GG, 2009, APPETITE, V52, P528, DOI 10.1016/j.appet.2008.11.006	58	91	92	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97609	10.1371/journal.pone.0097609	http://dx.doi.org/10.1371/journal.pone.0097609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878745	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338101500019
J	Sun, YW; Skidmore, AK; Wang, TJ; van Gils, HAMJ; Wang, Q; Qing, BP; Ding, CQ				Sun, Yiwen; Skidmore, Andrew K.; Wang, Tiejun; van Gils, Hein A. M. J.; Wang, Qi; Qing, Baoping; Ding, Changqing			Reduced Dependence of Crested Ibis on Winter-Flooded Rice Fields: Implications for Their Conservation	PLOS ONE			English	Article							NEST-SITE SELECTION; HABITAT; POPULATION; CLASSIFICATION; PATTERNS; MODEL	The Crested Ibis Nipponia nippon was once thought to be extinct in the wild until seven birds were discovered in a remote mountain village in China in 1981. Studies suggested that winter-flooded rice fields play an essential role in nest site selection by the Crested Ibis and hence in their survival. Considerable efforts were therefore made to conserve the winter-flooded rice fields, but these have caused conflicts between the agricultural and conservation communities. The population and geographical range of the wild Crested Ibis has expanded greatly since 1981, but there is no spatial information on the winter-flooded rice fields, nor on the current association of nest sites and winter-flooded rice fields. We mapped winter-flooded rice fields across the entire current range of Crested Ibis using innovative remote sensing and geographical information systems (GIS) techniques. The spatial relationships between the nest site clusters and winter-flooded rice fields were quantified using Ward's hierarchical clustering method and Ripley's K-function. We show that both have significantly clumped distribution patterns and that they are positively associated. However, the dependence of Crested Ibis on the winter-flooded rice fields varied significantly among the nest site clusters and has decreased over the years, indicating the absence of winter-flooded rice fields is not constraining their recovery and population expansion. We therefore recommend that efforts should be made to protect the existing winter-flooded rice fields and to restore the functionality of natural and semi-natural wetlands, to encourage both in-situ conservation and the re-introduction of the Crested Ibis. In addition, we recommend that caution should be exercised when interpreting the habitat requirements of species with a narrow distribution, particularly when that interpretation is based only on their current habitat.	[Sun, Yiwen; Skidmore, Andrew K.; Wang, Tiejun; van Gils, Hein A. M. J.] Univ Twente, Fac Geoinformat Sci & Earth Observat, Dept Nat Resources, NL-7500 AE Enschede, Netherlands; [Wang, Tiejun] Bioresources Key Lab Shaanxi Prov, Hanzhong, Shaanxi Provinc, Peoples R China; [Wang, Qi] Shaanxi Univ Technol, Coll Biol Sci & Engn, Hanzhong, Shaanxi Provinc, Peoples R China; [Wang, Qi] Shaanxi Hanzhong Crested Ibis Natl Nat Reserve, Hanzhong, Shaanxi Provinc, Peoples R China; [Ding, Changqing] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China	University of Twente; Shaanxi University of Technology; Beijing Forestry University	Wang, TJ (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat, Dept Nat Resources, POB 217, NL-7500 AE Enschede, Netherlands.	t.wang@utwente.nl	Skidmore, Andrew K/C-7441-2011; Wang, Tiejun/A-4671-2010	Skidmore, Andrew K/0000-0002-7446-8429; Wang, Tiejun/0000-0002-1138-8464	China Scholarship Council [2011627018]; ITC Research Fund [93002773]; Shaanxi Provincial Education Department [13JS023]	China Scholarship Council(China Scholarship Council); ITC Research Fund; Shaanxi Provincial Education Department	This work was supported by the China Scholarship Council (No. 2011627018, www.csc.edu.cn) and co-funded by the ITC Research Fund (No. 93002773, www.itc.nl). This work was also part of the scientific research program funded by Shaanxi Provincial Education Department (Program No. 13JS023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barea LP, 2012, EMU, V112, P39, DOI 10.1071/MU10082; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; BirdLife International, 2012, IUCN 2013 IUCN RED L; BirdLife International, 2001, THREAT BIRDS AS BIRD; Boyle Terence P., 2004, Wetlands Ecology and Management, V12, P563, DOI 10.1007/s11273-005-1761-2; Brown M, 1999, ECOL MODEL, V120, P167, DOI 10.1016/S0304-3800(99)00100-3; Cody M.L., 1985, HABITATS SELECTION B; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cornulier T, 2006, ECOGRAPHY, V29, P240, DOI 10.1111/j.2006.0906-7590.04287.x; De Leeuw J, 2006, INT J REMOTE SENS, V27, P223, DOI 10.1080/01431160500275762; Dillner AM, 2005, ATMOS ENVIRON, V39, P1525, DOI 10.1016/j.atmosenv.2004.11.035; Ding C., 2004, RES CRESTED IBIS; Ding Changqing, 2010, Chinese Birds, V1, P156; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Dong J. P., 1992, Acta Universitatis Agriculturalis Borealis-Occidentalis, V20, P79; Elphick CS, 2003, AGR ECOSYST ENVIRON, V94, P17, DOI 10.1016/S0167-8809(02)00022-1; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; Fritz LL, 2011, BIODIVERS CONSERV, V20, P2211, DOI 10.1007/s10531-011-0083-3; Gonzalez LM, 2008, BIRD CONSERV INT, V18, P242, DOI 10.1017/S0959270908000245; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Guillen G, 2004, J MARINE SYST, V45, P221, DOI 10.1016/j.jmarsys.2003.11.006; Jia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065843; Johnson Matthew, 2011, Zoological Research, V32, P128, DOI 10.3724/SP.J.1141.2011.02128; KIESTER AR, 1974, THEOR POPUL BIOL, V6, P1, DOI 10.1016/0040-5809(74)90028-8; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li X., 2001, BIODIVERSITY SCI, V9, P352; Li XH, 2006, LANDSCAPE ECOL, V21, P1207, DOI 10.1007/s10980-006-0021-z; Li XH, 2009, BIODIVERS CONSERV, V18, P2165, DOI 10.1007/s10531-009-9580-z; LIN YZ, 1981, ACTA ZOOL SINICA, V27, P273; Liu Dong-Ping, 2003, Acta Zoologica Sinica, V49, P755; Lopez-Jamar J, 2011, BIRD CONSERV INT, V21, P328, DOI 10.1017/S0959270910000535; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maltchik L, 2011, REV BIOL TROP, V59, P1895; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Meissner Wlodzimierz, 2012, Wader Study Group Bulletin, V119, P89; Melles SJ, 2009, LANDSCAPE ECOL, V24, P519, DOI 10.1007/s10980-009-9329-9; Moreno-Opo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033469; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; Okolelov AY, 2003, ZOOL ZH, V82, P388; Pelissier R, 2010, ADS SPATIAL POINT PA; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Senapathi D, 2007, IBIS, V149, P328, DOI 10.1111/j.1474-919X.2006.00634.x; Skidmore A. K., 1990, International Journal of Geographical Information Systems, V4, P33, DOI 10.1080/02693799008941527; SKIDMORE AK, 1989, PHOTOGRAMM ENG REM S, V55, P1449; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Toral GM, 2011, IBIS, V153, P684, DOI 10.1111/j.1474-919X.2011.01147.x; Treinys R, 2008, J ORNITHOL, V149, P75, DOI 10.1007/s10336-007-0220-7; Wang GM, 2008, WATERBIRDS, V31, P489, DOI 10.1675/1524-4695-31.3.489; Wang Zhong-yu, 2008, Sichuan Journal of Zoology, V27, P82; Wang Zhong-Yu, 2000, Chinese Journal of Zoology, V35, P28; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wood C, 2010, WATERBIRDS, V33, P30, DOI 10.1675/063.033.s103; Yu XP, 2010, WILSON J ORNITHOL, V122, P228; Yu XP, 2006, BIRD CONSERV INT, V16, P325, DOI 10.1017/S0959270906000499; Zhai Tian-Qing, 2001, Acta Zoologica Sinica, V47, P508	59	11	13	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98690	10.1371/journal.pone.0098690	http://dx.doi.org/10.1371/journal.pone.0098690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874870	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800055
J	Centanni, TM; Chen, FY; Booker, AM; Engineer, CT; Sloan, AM; Rennaker, RL; LoTurco, JJ; Kilgard, MP				Centanni, Tracy M.; Chen, Fuyi; Booker, Anne M.; Engineer, Crystal T.; Sloan, Andrew M.; Rennaker, Robert L.; LoTurco, Joseph J.; Kilgard, Michael P.			Speech Sound Processing Deficits and Training-Induced Neural Plasticity in Rats with Dyslexia Gene Knockdown	PLOS ONE			English	Article							IN-UTERO RNAI; DEVELOPMENTAL DYSLEXIA; SUSCEPTIBILITY GENE; BEHAVIORAL IMPAIRMENTS; GABAERGIC INHIBITION; READING DISABILITIES; RESPONSE PATTERNS; CORPUS-CALLOSUM; AUDITORY-CORTEX; CHILDREN	In utero RNAi of the dyslexia-associated gene Kiaa0319 in rats (KIA-) degrades cortical responses to speech sounds and increases trial-by-trial variability in onset latency. We tested the hypothesis that KIA- rats would be impaired at speech sound discrimination. KIA- rats needed twice as much training in quiet conditions to perform at control levels and remained impaired at several speech tasks. Focused training using truncated speech sounds was able to normalize speech discrimination in quiet and background noise conditions. Training also normalized trial-by-trial neural variability and temporal phase locking. Cortical activity from speech trained KIA-rats was sufficient to accurately discriminate between similar consonant sounds. These results provide the first direct evidence that assumed reduced expression of the dyslexia-associated gene KIAA0319 can cause phoneme processing impairments similar to those seen in dyslexia and that intensive behavioral therapy can eliminate these impairments.	[Centanni, Tracy M.; Engineer, Crystal T.; Sloan, Andrew M.; Rennaker, Robert L.; Kilgard, Michael P.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Chen, Fuyi; Booker, Anne M.; LoTurco, Joseph J.] Univ Connecticut, Storrs, CT USA	University of Texas System; University of Texas Dallas; University of Connecticut	Centanni, TM (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	tmcentanni@gmail.com	; Rennaker II, Robert/K-9049-2013	Kilgard, Michael/0000-0002-6699-1818; Engineer, Crystal/0000-0002-2188-2335; Rennaker II, Robert/0000-0003-1260-1973	National Institute for Deafness and Communication Disorders at the National Institutes of Health [R01DC010433]; National Institute of Child Health and Human Development at the National Institutes of Health [HD055655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010433] Funding Source: NIH RePORTER	National Institute for Deafness and Communication Disorders at the National Institutes of Health; National Institute of Child Health and Human Development at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute for Deafness and Communication Disorders at the National Institutes of Health (R01DC010433 to MPK) and the National Institute of Child Health and Human Development at the National Institutes of Health (HD055655 to JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Adler WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065179; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Bai J, 2008, DEV NEUROSCI-BASEL, V30, P144, DOI 10.1159/000109859; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bates TC, 2011, BEHAV GENET, V41, P50, DOI 10.1007/s10519-010-9402-9; Blondeau C, 2007, BIOL PSYCHIAT, V61, P1340, DOI 10.1016/j.biopsych.2006.06.030; Boscariol Mirela, 2010, Pró-Fono R. Atual. Cient., V22, P537, DOI 10.1590/S0104-56872010000400030; Brasselet R, 2012, J NEUROSCI, V32, P2998, DOI 10.1523/JNEUROSCI.5435-11.2012; BRYANT PE, 1989, J CHILD LANG, V16, P407, DOI 10.1017/S0305000900010485; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; Centanni TM, 2014, CEREB CORTEX, V24, P1753, DOI 10.1093/cercor/bht028; Centanni TM, 2013, J NEUROPHYSIOL, V110, P177, DOI 10.1152/jn.00092.2013; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; Coffin JM, 2005, CORTEX, V41, P389, DOI 10.1016/S0010-9452(08)70275-2; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Couto JM, 2010, AM J MED GENET B, V153B, P447, DOI 10.1002/ajmg.b.30999; Currier TA, 2011, NEUROSCIENCE, V172, P535, DOI 10.1016/j.neuroscience.2010.11.002; Czamara D, 2011, BEHAV GENET, V41, P110, DOI 10.1007/s10519-010-9413-6; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eden GF, 2002, NAT NEUROSCI, V5, P1080, DOI 10.1038/nn946; Elbro C, 2004, J EDUC PSYCHOL, V96, P660, DOI 10.1037/0022-0663.96.4.660; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Engineer CT, 2008, SPEECH SOUND CODING; Engineer N, 2012, NEUROSCIENCE; Farmer ME, 1995, PSYCHON B REV, V2, P460, DOI 10.3758/BF03210983; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; FLOWERS DL, 1991, ARCH NEUROL-CHICAGO, V48, P637, DOI 10.1001/archneur.1991.00530180095023; Foffani G, 2005, I IEEE EMBS C NEUR E, P206; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Fine JG, 2007, NEUROPSYCHOLOGY, V21, P235, DOI 10.1037/0894-4105.21.2.235; Goswami U., 1990, PHONOLOGICAL SKILLS; Green DM, 1966, SIGNAL DETECTION THE; Habib M, 2002, INT J LANG COMM DIS, V37, P289, DOI 10.1080/13682820210136278; Hari R, 1996, NEUROSCI LETT, V205, P138, DOI 10.1016/0304-3940(96)12393-4; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Heim S, 2013, NEUROPSYCHOLOGIA, V51, P990, DOI 10.1016/j.neuropsychologia.2013.01.011; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Hornickel J, 2012, P NATL ACAD SCI USA, V109, P16731, DOI 10.1073/pnas.1206628109; Jakkamsetti V, 2012, J NEUROPHYSIOL, V107, P1457, DOI 10.1152/jn.01057.2010; Kawahara H, 1997, INT CONF ACOUST SPEE, P1303, DOI 10.1109/ICASSP.1997.596185; Kovelman I, 2012, CEREB CORTEX, V22, P754, DOI 10.1093/cercor/bhr094; Kraus N, 2012, TRENDS COGN SCI, V16, P12, DOI 10.1016/j.tics.2011.12.001; Lind PA, 2010, EUR J HUM GENET, V18, P668, DOI 10.1038/ejhg.2009.237; Loos M, 2010, BEHAV BRAIN RES, V214, P216, DOI 10.1016/j.bbr.2010.05.027; LOVETT MW, 1989, BRAIN LANG, V37, P90, DOI 10.1016/0093-934X(89)90103-X; Lovio R, 2012, BRAIN RES, V1448, P42, DOI 10.1016/j.brainres.2012.01.071; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Ma HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052942; Marino C, 2007, GENES BRAIN BEHAV, V6, P640, DOI 10.1111/j.1601-183X.2006.00291.x; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; Nagarajan S, 1999, P NATL ACAD SCI USA, V96, P6483, DOI 10.1073/pnas.96.11.6483; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Paul LK, 2011, J NEURODEV DISORD, V3, P3, DOI 10.1007/s11689-010-9059-y; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Penolazzi B, 2010, BEHAV BRAIN RES, V209, P179, DOI 10.1016/j.bbr.2010.01.029; Perez CA, 2013, CEREB CORTEX, V23, P670, DOI 10.1093/cercor/bhs045; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Peterson R. L, 2012, LANCET; Pinel P, 2012, J NEUROSCI, V32, P817, DOI 10.1523/JNEUROSCI.5996-10.2012; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Poon M, 2011, J BIOCH MOL BIOL POS, V65; Porter BA, 2011, BEHAV BRAIN RES, V219, P68, DOI 10.1016/j.bbr.2010.12.015; Puckett AC, 2007, J NEUROPHYSIOL, V98, P253, DOI 10.1152/jn.01309.2006; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Ranasinghe KG, 2012, HEARING RES, V289, P1, DOI 10.1016/j.heares.2012.04.020; Ranasinghe KG, 2012, JARO-J ASSOC RES OTO, P1; Raschle NM, 2012, P NATL ACAD SCI USA, V109, P2156, DOI 10.1073/pnas.1107721109; Rey V, 2002, BRAIN LANG, V80, P576, DOI 10.1006/brln.2001.2618; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Schulte-Korne G, 2010, DTSCH ARZTEBL INT, V107, P718, DOI 10.3238/arztebl.2010.0718; Schulte-Korne G, 1998, NEUROREPORT, V9, P337, DOI 10.1097/00001756-199801260-00029; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Sloan AM, 2009, HEARING RES, V251, P60, DOI 10.1016/j.heares.2009.02.009; SNOWLING MJ, 1980, J EXP CHILD PSYCHOL, V29, P294, DOI 10.1016/0022-0965(80)90021-1; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Szalkowski CE, 2012, INT J DEV NEUROSCI, V30, P293, DOI 10.1016/j.ijdevneu.2012.01.009; Szalkowski CE, 2012, INT J DEV NEUROSCI, V1, P116; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TALLAL P, 1974, NEUROPSYCHOLOGIA, V12, P83, DOI 10.1016/0028-3932(74)90030-X; Tallal P, 1991, ANONYMOUS READING DI, P175; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Van Ingelghem M, 2001, NEUROREPORT, V12, P3603, DOI 10.1097/00001756-200111160-00046; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x; Zou L, 2012, AM J MED GENET B, V159B, P970, DOI 10.1002/ajmg.b.32102	113	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98439	10.1371/journal.pone.0098439	http://dx.doi.org/10.1371/journal.pone.0098439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871331	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300044
J	Pethybridge, HR; Parrish, CC; Bruce, BD; Young, JW; Nichols, PD				Pethybridge, Heidi R.; Parrish, Christopher C.; Bruce, Barry D.; Young, Jock W.; Nichols, Peter D.			Lipid, Fatty Acid and Energy Density Profiles of White Sharks: Insights into the Feeding Ecology and Ecophysiology of a Complex Top Predator	PLOS ONE			English	Article							CARCHARODON-CARCHARIAS; STOMACH CONTENT; NORTHERN GULF; TIGER SHARK; DIET; LIVER; FISHES; PREY; REQUIREMENTS; METABOLISM	Lipids are major sources of metabolic energy in sharks and are closely linked to environmental conditions and biological cycles, such as those related to diet, reproduction and migration. In this study, we report for the first time, the total lipid content, lipid class composition and fatty acid profiles of muscle and liver tissue of white sharks, Carcharodon carcharias, of various lengths (1.5-3.9 m), sampled at two geographically separate areas off southern and eastern Australia. Muscle tissue was low in total lipid content (<0.9% wet mass, wm) and was dominated by phospholipids (>90% of total lipid) and polyunsaturated fatty acids (34 +/- 12% of total fatty acids). In contrast, liver was high in total lipid which varied between 51-81% wm and was dominated by triacylglycerols (>93%) and monounsaturated fatty acids (36 +/- 12%). With knowledge of total lipid and dry tissue mass, we estimated the energy density of muscle (18.4 +/- 0.1 kJ g(-1) dm) and liver (34.1 +/- 3.2 kJ g(-1) dm), demonstrating that white sharks have very high energetic requirements. High among- individual variation in these biochemical parameters and related trophic markers were observed, but were not related to any one biological or environmental factor. Signature fatty acid profiles suggest that white sharks over the size range examined are generalist predators with fish, elasmobranchs and mammalian blubber all contributing to the diet. The ecological applications and physiological influences of lipids in white sharks are discussed along with recommendations for future research, including the use of non-lethal sampling to examine the nutritional condition, energetics and dietary relationships among and between individuals. Such knowledge is fundamental to better understand the implications of environmental perturbations on this iconic and threatened species.	[Pethybridge, Heidi R.; Bruce, Barry D.; Young, Jock W.; Nichols, Peter D.] CSIRO Wealth Ocean Flagship, Div Marine & Atmospher Res, Hobart, Tas, Australia; [Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Memorial University Newfoundland	Pethybridge, HR (corresponding author), CSIRO Wealth Ocean Flagship, Div Marine & Atmospher Res, Hobart, Tas, Australia.	Heidi.Pethybridge@csiro.au	Pethybridge, Heidi/AEO-8594-2022; Nichols, Peter D/C-5128-2011; Pethybridge, Heidi/AAI-9824-2021	Pethybridge, Heidi/0000-0002-7291-5766; 	Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship; CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program; Marine Biodiversity Hub	Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship; CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program; Marine Biodiversity Hub	Funding was provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship. HP was supported by a CSIRO Office of the Executive Chief Postdoctoral Award. BDB's time on this paper was supported by the Australia Governments' National Environmental Research Program, Marine Biodiversity Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Ballantyne JS, 1997, COMP BIOCHEM PHYS B, V118, P703, DOI 10.1016/S0305-0491(97)00272-1; Barnett A, 2010, MAR ECOL PROG SER, V416, P189, DOI 10.3354/meps08778; Beckmann CL, 2013, J EXP MAR BIOL ECOL, V448, P10, DOI 10.1016/j.jembe.2013.06.009; Belicka LL, 2012, MAR ECOL PROG SER, V455, P245, DOI 10.3354/meps09674; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce Barry D., 2012, P225; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Chipps SR, 2008, T AM FISH SOC, V137, P298, DOI 10.1577/T05-236.1; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cooper MH, 2005, J COMP PHYSIOL B, V175, P133, DOI 10.1007/s00360-004-0469-6; CORTES E, 1990, COPEIA, P204; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Davidson B, 2002, FISH PHYSIOL BIOCHEM, V26, P171, DOI 10.1023/A:1025447718625; Davidson BC, 2007, IN VIVO, V21, P333; Davidson B, 2011, FISH PHYSIOL BIOCHEM, V37, P105, DOI 10.1007/s10695-010-9421-8; Davidson B, 2011, FISH PHYSIOL BIOCHEM, V37, P613, DOI 10.1007/s10695-010-9463-y; Del Raye G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0836; Drazen JC, 2007, DEEP-SEA RES PT I, V54, P203, DOI 10.1016/j.dsr.2006.10.007; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; El-Sabaawi R, 2009, MAR BIOL, V156, P225, DOI 10.1007/s00227-008-1073-1; Fallows C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060797; GRAEVE M, 1994, J EXP MAR BIOL ECOL, V182, P97, DOI 10.1016/0022-0981(94)90213-5; Hammerschlag N, 2013, FUNCT ECOL, V27, P1273, DOI 10.1111/1365-2435.12157; Hoffmayer ER, 2006, J FISH BIOL, V68, P645, DOI 10.1111/j.0022-1112.2006.00942.x; Hussey Nigel E., 2012, P27; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jayasinghe C, 2003, FISHERIES SCI, V69, P644, DOI 10.1046/j.1444-2906.2003.00668.x; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; McMeans BC, 2012, J EXP MAR BIOL ECOL, V429, P55, DOI 10.1016/j.jembe.2012.06.017; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Navarro-Garcia G., 2000, Journal of Food Composition and Analysis, V13, P791, DOI 10.1006/jfca.2000.0928; Nichols PD, 1998, MAR FRESHWATER RES, V49, P763, DOI 10.1071/MF97241; Nichols PD, 2001, 99369 FRDC CSIRO; Nordoy ES, 1995, DEV MAR BIO, V4, P307; Parrish CC, 2014, DEEP SEA 2 IN PRESS; Pethybridge H, 2011, MAR BIOL, V158, P2741, DOI 10.1007/s00227-011-1773-9; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pethybridge H, 2010, MAR BIOL, V157, P1367, DOI 10.1007/s00227-010-1416-6; Phleger CF, 1998, AM ZOOL, V38, P321; Powter DM, 2010, MAR FRESHWATER RES, V61, P74, DOI 10.1071/MF09021; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; SARGENT JR, 1973, J MAR BIOL ASSOC UK, V53, P649, DOI 10.1017/S0025315400058847; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Semmens JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01471; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Taylor JKD, 2013, MAR MAMMAL SCI, V29, P204, DOI 10.1111/j.1748-7692.2011.00542.x; Tierney M, 2008, J EXP MAR BIOL ECOL, V367, P65, DOI 10.1016/j.jembe.2008.07.046; Vanella FA, 2005, SCI MAR, V69, P305, DOI 10.3989/scimar.2005.69s2305; VANVLEET ES, 1984, COMP BIOCHEM PHYS B, V79, P549, DOI 10.1016/0305-0491(84)90364-X; Walker T, 1989, SO SHARK ASSESSMENT; Waugh CA, 2012, MAR ECOL PROG SER, V471, P271, DOI 10.3354/meps10059	59	47	49	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97877	10.1371/journal.pone.0097877	http://dx.doi.org/10.1371/journal.pone.0097877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871223	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300021
J	Suzuki, Y; Kitahara, T; Soma, K; Konno, S; Sato, K; Suzuki, S; Oka, H; Yamada, M; Fujii, K; Kitahara, Y; Yamamoto, Y; Otsuka, T; Sugiura, Y; Kanoh, Y; Tamai, Y; Ohto, H				Suzuki, Yuhko; Kitahara, Takao; Soma, Kazui; Konno, Shingo; Sato, Kimitoshi; Suzuki, Sachio; Oka, Hidehiro; Yamada, Masaru; Fujii, Kiyotaka; Kitahara, Yukio; Yamamoto, Yuji; Otsuka, Takashi; Sugiura, Yoshihiro; Kanoh, Yuhsaku; Tamai, Yoshiko; Ohto, Hitoshi			Impact of Platelet Transfusion on Survival of Patients with Intracerebral Hemorrhage after Administration of Anti-Platelet Agents at a Tertiary Emergency Center	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR-DISEASE; HEMATOMA EXPANSION; CONTROLLED-TRIAL; HIGH-RISK; THERAPY; ASPIRIN; CLOPIDOGREL; STROKE; EVENTS	This study examined the impact of platelet transfusion (PLT) on the survival of intracerebral hemorrhage (ICH) patients who had been administered anti-platelet agents (APA). This retrospective cohort analysis investigated 432 patients (259 men, 60%) who were newly diagnosed with ICH between January 2006 and June 2011 at the tertiary emergency center of Kitasato University Hospital. Median age on arrival was 67.0 years (range, 40-95 years). ICH was subcortical in 72 patients (16.7%), supratentorial in 233 (53.9%), and infratentorial in 133 (30.8%). PLT was performed in 16 patients (3.7%). Within 90 days after admission to the center, 178 patients (41.2%) had died due to ICH. Before the onset of ICH, 66 patients had been prescribed APA because of atherosclerotic diseases. Multivariate regression analysis indicated APA administration was an independent risk factor for death within 7 days (odds ratio, 5.12; P = 0.006) and within 90 days (hazard ratio, 1.87; P = 0.006) after arrival. Regarding the effect of a PLT in ICH patients with APA, no patient with PLT died. PLT had a survival benefit on patients with ICH, according to our analysis. Further prospective analysis is necessary to confirm the effects of PLT on survival in ICH with APA.	[Suzuki, Yuhko; Ohto, Hitoshi] Fukushima Med Univ, Dept Blood Transfus, Fukushima, Japan; [Suzuki, Yuhko; Ohto, Hitoshi] Fukushima Med Univ, Dept Transplantat Immunol, Fukushima, Japan; [Kitahara, Takao; Soma, Kazui; Konno, Shingo] Kitasato Univ, Sch Med, Dept Emergency Med, Sagamihara, Kanagawa 228, Japan; [Kitahara, Takao; Soma, Kazui; Konno, Shingo] Kitasato Univ, Sch Med, Dept Crit Care Med, Sagamihara, Kanagawa 228, Japan; [Sato, Kimitoshi; Suzuki, Sachio; Oka, Hidehiro; Yamada, Masaru; Fujii, Kiyotaka] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 228, Japan; [Kitahara, Yukio] Fuchinobe Gen Hosp, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Yamamoto, Yuji] Ashigarakami Hosp, Dept Neurosurg, Ashigarakami, Kanagawa, Japan; [Otsuka, Takashi] Sagamihara Chuo Hosp, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Sugiura, Yoshihiro] Fukushima Med Univ, Dept Neurol, Fukushima, Japan; [Kanoh, Yuhsaku] Kitasato Univ, Sch Med, Dept Clin Lab Med, Sagamihara, Kanagawa 228, Japan; [Tamai, Yoshiko] Hirosaki Univ, Sch Med, Dept Transfus, Hirosaki, Aomori 036, Japan	Fukushima Medical University; Fukushima Medical University; Kitasato University; Kitasato University; Kitasato University; Fukushima Medical University; Kitasato University; Hirosaki University	Suzuki, Y (corresponding author), Fukushima Med Univ, Dept Blood Transfus, Fukushima, Japan.	ysuzuki-hki@umin.ac.jp						Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Butler AC, 1998, BLOOD REV, V12, P35, DOI 10.1016/S0268-960X(98)90028-5; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; De Schryver EL, 2010, COCHRANE DB SYST REV; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FitzGerald R, 2011, PHARMACOL THERAPEUT, V130, P213, DOI 10.1016/j.pharmthera.2011.01.011; Flaherty ML, 2010, SEMIN NEUROL, V30, P565, DOI 10.1055/s-0030-1268866; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; FLORESRUNK P, 1993, ANN PHARMACOTHER, V27, P1090, DOI 10.1177/106002809302700915; Garg RK, 2012, STROKE, V43, P67, DOI 10.1161/STROKEAHA.111.629493; Hankey GJ, 2000, STROKE, V31, P1779, DOI 10.1161/01.STR.31.7.1779; Hennekens C, 2013, NONRESPONSE RESISTAN; Hennekens CH, 2013, SECONDARY PREVENTION; Hermosillo AJ, 2008, ANN PHARMACOTHER, V42, P790, DOI 10.1345/aph.1K591; Hoshino K, 2009, CIRC J, V73, P336, DOI 10.1253/circj.CJ-08-0559; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jinnai T, 2009, CIRC J, V73, P1498, DOI 10.1253/circj.CJ-09-0019; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Menon RS, 2012, ANN NEUROL, V71, P199, DOI 10.1002/ana.22668; Miyata Shigeki, 2008, Brain and Nerve (Tokyo), V60, P1357; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Roquer J, 2005, J NEUROL, V252, P412, DOI 10.1007/s00415-005-0659-5; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Samama CM, 2005, CAN J ANAESTH, V52, P30, DOI 10.1007/BF03018577; Sarafoff N, 2012, CURR PHARM DESIGN, V18, P5224, DOI 10.2174/138161212803251853; Seizer P, 2013, THROMB HAEMOST, V110; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Steinhubl SR, 2009, ANN INTERN MED, V150, P379, DOI 10.7326/0003-4819-150-6-200903170-00006; TANAKA H, 1981, STROKE, V12, P460, DOI 10.1161/01.STR.12.4.460; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Toyoda K, 2008, STROKE, V39, P1740, DOI 10.1161/STROKEAHA.107.504993; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wijeyeratne YD, 2011, BRIT J CLIN PHARMACO, V72, P647, DOI 10.1111/j.1365-2125.2011.03999.x	45	19	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97328	10.1371/journal.pone.0097328	http://dx.doi.org/10.1371/journal.pone.0097328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869669	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300008
J	Afanasyeva, MA; Britanova, LV; Korneev, KV; Mitkin, NA; Kuchmiy, AA; Kuprash, DV				Afanasyeva, Marina A.; Britanova, Liudmila V.; Korneev, Kirill V.; Mitkin, Nikita A.; Kuchmiy, Anna A.; Kuprash, Dmitry V.			Clusterin Is a Potential Lymphotoxin Beta Receptor Target That Is Upregulated and Accumulates in Germinal Centers of Mouse Spleen during Immune Response	PLOS ONE			English	Article							GENE-EXPRESSION; LYMPH-NODE; NUCLEAR CLUSTERIN; M-CELLS; MARKER; ORGANOGENESIS; MICE; LOCALIZATION; DEFICIENT; SURFACE	Clusterin is a multifunctional protein that participates in tissue remodeling, apoptosis, lipid transport, complement-mediated cell lysis and serves as an extracellular chaperone. The role of clusterin in cancer and neurodegeneration has been extensively studied, however little is known about its functions in the immune system. Using expression profiling we found that clusterin mRNA is considerably down-regulated in mouse spleen stroma upon knock-out of lymphotoxin beta receptor which plays pivotal role in secondary lymphoid organ development, maintenance and function. Using immunohistochemistry and western blot we studied clusterin protein level and distribution in mouse spleen and mesenteric lymph nodes in steady state and upon immunization with sheep red blood cells. We showed that clusterin protein, represented mainly by the secreted heterodimeric form, is present in all stromal compartments of secondary lymphoid organs except for marginal reticular cells. Clusterin protein level rose after immunization and accumulated in light zones of germinal centers in spleen the effect that was not observed in lymph nodes. Regulation of clusterin expression by the lymphotoxin beta signaling pathway and its protein dynamics during immune response suggest a specific role of this enigmatic protein in the immune system that needs further study.	[Afanasyeva, Marina A.; Britanova, Liudmila V.; Korneev, Kirill V.; Mitkin, Nikita A.; Kuchmiy, Anna A.; Kuprash, Dmitry V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Korneev, Kirill V.; Kuprash, Dmitry V.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Immunol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University	Kuprash, DV (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	kuprash@eimb.ru	Britanova, Liudmila/AAC-3823-2022; Kuchmiy, Anna/N-7960-2019; Kuprash, Dmitry/O-4899-2015; Kuchmiy, Anna/S-2275-2016; Korneev, Kirill V/H-3644-2016; Mitkin, Nikita A/T-5892-2017	Kuchmiy, Anna/0000-0001-7277-736X; Kuprash, Dmitry/0000-0002-1488-4148; Kuchmiy, Anna/0000-0001-7277-736X; Korneev, Kirill V/0000-0003-3570-8327; Mitkin, Nikita A/0000-0002-1014-9250; Afanasyeva, Marina/0000-0001-5294-970X	Russian Foundation for Basic Research [11-04-01334a]; MCB grant from the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); MCB grant from the Russian Academy of Sciences	This project has been funded by the grant 11-04-01334a from the Russian Foundation for Basic Research (www.rfbr.ru) and by MCB grant from the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Browning JL, 1997, J IMMUNOL, V159, P3288; BROWNING JL, 1995, J IMMUNOL, V154, P33; BUTTYAN R, 1989, MOL CELL BIOL, V9, P3473, DOI 10.1128/MCB.9.8.3473; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; FRENCH LE, 1993, J CELL BIOL, V122, P1119, DOI 10.1083/jcb.122.5.1119; FRENCH LE, 1992, J CLIN INVEST, V90, P1919, DOI 10.1172/JCI116069; French LE, 1996, BIOL REPROD, V55, P1213, DOI 10.1095/biolreprod55.6.1213; FRENCH LE, 1994, IMMUNOLOGY, V82, P328; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Grogg KL, 2004, AM J SURG PATHOL, V28, P988, DOI 10.1097/01.pas.0000112536.76973.7f; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Kim N, 2011, ANAT CELL BIOL, V44, P169, DOI 10.5115/acb.2011.44.3.169; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; Matsumoto M, 1999, J IMMUNOL, V163, P1584; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Schedin P, 2004, MOL CARCINOGEN, V41, P207, DOI 10.1002/mc.20058; Shakhov AN, 2000, J LEUKOCYTE BIOL, V68, P151; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Stopfer P, 2004, CLIN EXP IMMUNOL, V136, P21, DOI 10.1111/j.1365-2249.2004.02402.x; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2013, GERONTOLOGY; Verbrugghe P, 2006, J PATHOL, V209, P240, DOI 10.1002/path.1970; Verbrugghe P, 2008, HISTOCHEM CELL BIOL, V129, P311, DOI 10.1007/s00418-007-0369-4; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MFR, 2007, EUR J IMMUNOL, V37, pS46, DOI 10.1002/eji.200737528; Wellmann A, 2000, BLOOD, V96, P398; WORKMAN C, 2002, GENOME BIOL, V0003; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Zindl CL, 2009, IMMUNITY, V30, P408, DOI 10.1016/j.immuni.2009.01.010	43	11	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98349	10.1371/journal.pone.0098349	http://dx.doi.org/10.1371/journal.pone.0098349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865838	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100052
J	Lin, SH; Yeh, YY				Lin, Szu-Hung; Yeh, Yei-Yu			Domain-Specific Control of Selective Attention	PLOS ONE			English	Article							WORKING-MEMORY LOAD; SHORT-TERM-MEMORY; VISUAL-SEARCH; COGNITIVE LOAD; SPATIAL FOCUS; CAPACITY; STORAGE; INTERFERENCE; EFFICIENCY; FEATURES	Previous research has shown that loading information on working memory affects selective attention. However, whether the load effect on selective attention is domain-general or domain-specific remains unresolved. The domain-general effect refers to the findings that load in one content (e.g. phonological) domain in working memory influences processing in another content (e.g., visuospatial) domain. Attentional control supervises selection regardless of information domain. The domain-specific effect refers to the constraint of influence only when maintenance and processing operate in the same domain. Selective attention operates in a specific content domain. This study is designed to resolve this controversy. Across three experiments, we manipulated the type of representation maintained in working memory and the type of representation upon which the participants must exert control to resolve conflict and select a target into the focus of attention. In Experiments 1a and 1b, participants maintained digits and nonverbalized objects, respectively, in working memory while selecting a target in a letter array. In Experiment 2, we presented auditory digits with a letter flanker task to exclude the involvement of resource competition within the same input modality. In Experiments 3a and 3b, we replaced the letter flanker task with an object flanker task while manipulating the memory load on object and digit representation, respectively. The results consistently showed that memory load modulated distractibility only when the stimuli of the two tasks were represented in the same domain. The magnitude of distractor interference was larger under high load than under low load, reflecting a lower efficacy of information prioritization. When the stimuli of the two tasks were represented in different domains, memory load did not modulate distractibility. Control of processing priority in selective attention demands domain-specific resources.	[Lin, Szu-Hung; Yeh, Yei-Yu] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan	National Taiwan University	Yeh, YY (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	yyy@ntu.edu.tw		YEH, YEI-YU/0000-0001-6278-9404; Lin, Szu-Hung/0000-0002-2296-4383	National Science Council [NSC 102-2420-H-002-009-MY2]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the National Science Council (NSC 102-2420-H-002-009-MY2) to Y.-Y. Yeh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RJ, 2012, Q J EXP PSYCHOL, V65, P2369, DOI 10.1080/17470218.2012.687384; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley AD, 1999, MODELS WORKING MEMOR, P28, DOI DOI 10.1017/CBO9781139174909.005; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Barrouillet P, 2007, J EXP PSYCHOL LEARN, V33, P570, DOI 10.1037/0278-7393.33.3.570; Burnham BR, 2013, J EXP PSYCHOL HUMAN; Caparos S, 2010, J EXP PSYCHOL HUMAN, V36, P1080, DOI 10.1037/a0020367; Caparos S, 2009, VIS COGN, V17, P1218, DOI 10.1080/13506280902924083; Cocchini G, 2002, MEM COGNITION, V30, P1086, DOI 10.3758/BF03194326; de Fockert JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00287; de Fockert JW, 2011, COGNITION, V121, P400, DOI 10.1016/j.cognition.2011.08.016; de Fockert JW, 2009, EUR J COGN PSYCHOL, V21, P961, DOI 10.1080/09541440802689302; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fan J, 2008, CEREB CORTEX, V18, P796, DOI 10.1093/cercor/bhm125; Fougnie D, 2011, J EXP PSYCHOL LEARN, V37, P1329, DOI 10.1037/a0024834; Guerard K, 2008, J EXP PSYCHOL LEARN, V34, P556, DOI 10.1037/0278-7393.34.3.556; Jarrold C, 2011, J EXP PSYCHOL LEARN, V37, P688, DOI 10.1037/a0022527; Kelley TA, 2011, CEREB CORTEX, V21, P659, DOI 10.1093/cercor/bhq139; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Konstantinou N, 2013, J EXP PSYCHOL HUMAN, V39, P919, DOI 10.1037/a0033037; Lavie N, 2005, PSYCHON B REV, V12, P669, DOI 10.3758/BF03196756; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Linnell KJ, 2011, J EXP PSYCHOL HUMAN, V37, P1643, DOI 10.1037/a0024669; LOGIE RH, 1990, ACTA PSYCHOL, V75, P55, DOI 10.1016/0001-6918(90)90066-O; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Marciano H, 2011, VIS COGN, V19, P367, DOI 10.1080/13506285.2010.537711; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Oberauer K, 2009, MEM COGNITION, V37, P346, DOI 10.3758/MC.37.3.346; Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; Olsson H, 2005, P NATL ACAD SCI USA, V102, P8776, DOI 10.1073/pnas.0500810102; Park S, 2007, J EXP PSYCHOL HUMAN, V33, P1062, DOI 10.1037/0096-1523.33.5.1062; Pratt N, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00057; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vergauwe E, 2010, PSYCHOL SCI, V21, P384, DOI 10.1177/0956797610361340; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339; Yeh YY, 2013, J EXP PSYCHOL HUMAN, V39, P872, DOI 10.1037/a0030486	46	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98260	10.1371/journal.pone.0098260	http://dx.doi.org/10.1371/journal.pone.0098260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866977	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100041
J	Wang, WL; Han, RM; Wan, YJ; Liu, B; Tang, XY; Liang, B; Wang, GX				Wang Wenlin; Han Ruiming; Wan Yinjing; Liu Bo; Tang Xiaoyan; Liang Bin; Wang Guoxiang			Spatio-Temporal Patterns in Rhizosphere Oxygen Profiles in the Emergent Plant Species Acorus calamus	PLOS ONE			English	Article							ROOTS; DYNAMICS; TRANSPORT; GROWTH; RICE; PHOTOSYNTHESIS; EXCRETION; DISTANCE; FLOW; L.	Rhizosphere oxygen profiles are the key to understanding the role of wetland plants in ecological remediation. Though in situ determination of the rhizosphere oxygen profiles has been performed occasionally at certain growing stages within days, comprehensive study on individual roots during weeks is still missing. Seedlings of Acorus calamus, a wetland monocot, were cultivated in silty sediment and the rhizosphere oxygen profiles were characterized at regular intervals, using micro-optodes to examine the same root at four positions along the root axis. The rhizosphere oxygen saturation culminated at 42.9% around the middle part of the root and was at its lowest level, 3.3%, at the basal part of the root near the aboveground portion. As the plant grew, the oxygen saturation at the four positions remained nearly constant until shoot height reached 15 cm. When shoot height reached 60 cm, oxygen saturation was greatest at the point halfway along the root, followed by the point three-quarters of the way down the root, the tip of the root, and the point one-quarter of the way down. Both the internal and rhizosphere oxygen saturation steadily increased, as did the thickness of stably oxidized microzones, which ranged from 20 mu m in younger seedlings to a maximum of 320 mu m in older seedlings. The spatial patterns of rhizosphere oxygen profiles in sediment contrast with those from previous studies on radial oxygen loss in A. calamus that used conventional approaches. Rhizosphere oxygen saturation peaked around the middle part of roots and the thickness of stably oxidized zones increased as the roots grew.	[Wang Wenlin; Han Ruiming; Liu Bo; Wang Guoxiang] Nanjing Normal Univ, Coll Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China; [Wang Wenlin; Tang Xiaoyan; Liang Bin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wan Yinjing] Jiangsu Environm Engn Consulting Ctr, Nanjing, Jiangsu, Peoples R China; [Liu Bo] Nantong Univ, Sch Geog Sci, Nantong, Peoples R China	Nanjing Normal University; Nantong University	Wang, GX (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China.	wangguoxiang@njnu.edu.cn			National Natural Science Foundation of China [41173078]; International Science and Technology Cooperation of China [2010DFB33960]; National Water Pollution Control and Management Technology Major Projects [2012ZX07506-007]; National Forestry Commonweal Project [200904001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation of China; National Water Pollution Control and Management Technology Major Projects; National Forestry Commonweal Project	This study was supported by the National Natural Science Foundation of China (41173078), International Science and Technology Cooperation of China (2010DFB33960), National Water Pollution Control and Management Technology Major Projects (2012ZX07506-007) and National Forestry Commonweal Project (200904001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong J, 2001, AM J BOT, V88, P1359, DOI 10.2307/3558443; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Blossfeld S, 2007, PLANT CELL ENVIRON, V30, P176, DOI 10.1111/j.1365-3040.2006.01616.x; Blossfeld S, 2011, SOIL BIOL BIOCHEM, V43, P1186, DOI 10.1016/j.soilbio.2011.02.007; Blossfeld S, 2010, PLANT SOIL, V330, P173, DOI 10.1007/s11104-009-0190-z; BRIX H, 1992, LIMNOL OCEANOGR, V37, P1420, DOI 10.4319/lo.1992.37.7.1420; Chabbi A, 2001, ENVIRON EXP BOT, V46, P237, DOI 10.1016/S0098-8472(01)00101-0; Colmer TD, 2008, NEW PHYTOL, V178, P326, DOI 10.1111/j.1469-8137.2007.02364.x; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Connell EL, 1999, AQUAT BOT, V63, P219, DOI 10.1016/S0304-3770(98)00126-0; Deng H, 2004, ENVIRON POLLUT, V132, P29, DOI 10.1016/j.envpol.2004.03.030; [邓泓 DENG Hong], 2007, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P69; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P1072, DOI 10.4319/lo.2006.51.2.1072; Gansert D, 2001, PLANT CELL ENVIRON, V24, P1055, DOI 10.1046/j.1365-3040.2001.00751.x; GROSSE W, 1991, AQUAT BOT, V39, P89, DOI 10.1016/0304-3770(91)90024-Y; Han RM, 2012, PLANT GROWTH REGUL, V68, P97, DOI 10.1007/s10725-012-9697-z; Huang Danping, 2012, Hupo Kexue, V24, P83; Inoue TM, 2008, LIMNOLOGY, V9, P207, DOI 10.1007/s10201-008-0253-5; Jacob DL, 2004, ENVIRON POLLUT, V130, P337, DOI 10.1016/j.envpol.2004.01.006; Jensen SI, 2005, MAR ECOL PROG SER, V293, P49, DOI 10.3354/meps293049; Lai WL, 2012, ECOL ENG, V39, P24, DOI 10.1016/j.ecoleng.2011.11.010; Laskov C, 2006, AQUAT BOT, V84, P333, DOI 10.1016/j.aquabot.2005.12.005; Li YL, 2013, PLANT SOIL, V365, P115, DOI 10.1007/s11104-012-1378-1; Lu MD, 2002, HYDROPHYTIC BIOL FRE, P46; Macek, 2006, PHYTOREMEDIATION RHI, P57; Mainiero R, 2005, PLANT SOIL, V270, P311, DOI 10.1007/s11104-004-1724-z; Pedersen O, 1998, MAR ECOL PROG SER, V169, P283, DOI 10.3354/meps169283; Peverill K., 1999, SOIL ANAL INTERPRETA; Pi N, 2010, ENVIRON POLLUT, V158, P381, DOI 10.1016/j.envpol.2009.09.004; Pi N, 2009, AQUAT BOT, V90, P222, DOI 10.1016/j.aquabot.2008.10.002; [曲久辉 QU Jiuhui], 2009, [环境科学学报, Acta Scientiae Circumstantiae], V29, P2; REDDY KR, 1990, J ENVIRON QUAL, V19, P261, DOI 10.2134/jeq1990.00472425001900020011x; Revsbech NP, 1998, LIMNOL OCEANOGR, V43, P986, DOI 10.4319/lo.1998.43.5.0986; Schreiber CM, 2012, J PLANT NUTR SOIL SC, V175, P761, DOI 10.1002/jpln.201000427; Visser EJW, 2000, PLANT CELL ENVIRON, V23, P1237, DOI 10.1046/j.1365-3040.2000.00628.x; Vojtiskova L, 2004, HYDROBIOLOGIA, V518, P9, DOI 10.1023/B:HYDR.0000025052.81373.f3; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wu ZB, 2000, ACTA PHYSL SIN, V26, P177; Xia Jin, 2012, Journal of Ecology and Rural Environment, V28, P422; Zhao YJ, 2011, ECOL ENG, V37, P1546, DOI 10.1016/j.ecoleng.2011.06.005	41	7	11	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98457	10.1371/journal.pone.0098457	http://dx.doi.org/10.1371/journal.pone.0098457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866504	Green Published, gold			2022-12-27	WOS:000336914100060
J	Kohli, A; Islam, A; Moyes, DL; Murciano, C; Shen, CG; Challacombe, SJ; Naglik, JR				Kohli, Arinder; Islam, Ayesha; Moyes, David L.; Murciano, Celia; Shen, Chengguo; Challacombe, Stephen J.; Naglik, Julian R.			Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE REPRODUCTIVE-TRACT; HUMAN CERVICAL TISSUE; CD4(+) T-CELLS; SEXUAL TRANSMISSION; DENDRITIC CELLS; TYPE-1 RNA; IN-VITRO; INTRAVAGINAL INOCULATION; MUCOSAL TRANSMISSION	The majority of HIV-1 infections worldwide are acquired via mucosal surfaces. However, unlike the vaginal mucosa, the issue of whether the oral mucosa can act as a portal of entry for HIV-1 infection remains controversial. To address potential differences with regard to the fate of HIV-1 after exposure to oral and vaginal epithelium, we utilized two epithelial cell lines representative of buccal (TR146) and pharyngeal (FaDu) sites of the oral cavity and compared them with a cell line derived from vaginal epithelium (A431) in order to determine (i) HIV-1 receptor gene and protein expression, (ii) whether HIV-1 genome integration into epithelial cells occurs, (iii) whether productive viral infection ensues, and (iv) whether infectious virus can be transferred to permissive cells. Using flow cytometry to measure captured virus by HIV-1 gp120 protein detection and western blot to detect HIV-1 p24 gag protein, we demonstrate that buccal, pharyngeal and vaginal epithelial cells capture CXCR4- and CCR5-utilising virus, probably via non-canonical receptors. Both oral and vaginal epithelial cells are able to transfer infectious virus to permissive cells either directly through cell-cell attachment or via transcytosis of HIV-1 across epithelial cells. However, HIV-1 integration, as measured by real-time PCR and presence of early gene mRNA transcripts and de novo protein production were not detected in either epithelial cell type. Importantly, both oral and vaginal epithelial cells were able to support integration and productive infection if HIV-1 entered via the endocytic pathway driven by VSV-G. Our data demonstrate that under normal conditions productive HIV-1 infection of epithelial cells leading to progeny virion production is unlikely, but that epithelial cells can act as mediators of systemic viral dissemination through attachment and transfer of HIV-1 to permissive cells.	[Kohli, Arinder; Islam, Ayesha; Moyes, David L.; Murciano, Celia; Shen, Chengguo; Challacombe, Stephen J.; Naglik, Julian R.] Kings Coll London, Inst Dent, Dept Oral Immunol Clin & Diagnost Sci, London WC2R 2LS, England; [Islam, Ayesha] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA; [Murciano, Celia] Univ Valencia, Dept Microbiol & Ecol, Valencia, Spain	University of London; King's College London; Boston University; University of Valencia	Naglik, JR (corresponding author), Kings Coll London, Inst Dent, Dept Oral Immunol Clin & Diagnost Sci, London WC2R 2LS, England.	julian.naglik@kcl.ac.uk	Challacombe, Stephen J/ABE-2105-2021; Murciano, Celia/K-8816-2014	Murciano, Celia/0000-0003-0035-5306; Kohli, Arinder/0000-0003-3199-3554; Shen, Chengguo/0000-0003-2813-8143; Moyes, David/0000-0002-1657-918X; challacombe, stephen/0000-0002-7327-6927; Naglik, Julian/0000-0002-8072-7917	NIDCR [DE017514]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; King's College London Overseas Research Studentship; Wellcome VIP award; Federation of European Microbiological Societies Advanced Fellowship; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017514] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; King's College London Overseas Research Studentship; Wellcome VIP award; Federation of European Microbiological Societies Advanced Fellowship; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors acknowledge financial support from by the NIDCR (DE017514) and from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. A. I. was supported by King's College London Overseas Research Studentship, D. M. was supported by a Wellcome VIP award, and C. M. was supported by a Federation of European Microbiological Societies Advanced Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Asin SN, 2004, J INFECT DIS, V190, P236, DOI 10.1086/421910; Baba TW, 1996, SCIENCE, V272, P1486, DOI 10.1126/science.272.5267.1486; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Berlier W, 2005, J MED VIROL, V77, P465, DOI 10.1002/jmv.20478; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Bhoopat L, 2001, MODERN PATHOL, V14, P1263, DOI 10.1038/modpathol.3880472; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; BREAU AP, 1984, CELL BIOL TOXICOL, V1, P21, DOI 10.1007/BF00125562; Challacombe S J, 2006, Adv Dent Res, V19, P29; Cohen MS, 2000, LANCET, V356, P272, DOI 10.1016/S0140-6736(00)02500-9; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Cutler C W, 2006, Adv Dent Res, V19, P49; Delezay O, 1997, AIDS, V11, P1311, DOI 10.1097/00002030-199711000-00004; Dezzutti CS, 2001, J INFECT DIS, V183, P1204, DOI 10.1086/319676; Dietrich EA, 2012, AIDS RES HUM RETROV, V28, P1574, DOI [10.1089/aid.2011.0069, 10.1089/AID.2011.0069]; Dorosko SM, 2010, J VIROL, V84, P10533, DOI 10.1128/JVI.01263-10; Dulioust E, 1998, J REPROD IMMUNOL, V41, P27, DOI 10.1016/S0165-0378(98)00047-3; Fanibunda SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028014; FURUTA Y, 1994, P NATL ACAD SCI USA, V91, P12559, DOI 10.1073/pnas.91.26.12559; GAFFNEY RA, 1995, J INFECT DIS, V172, P1528, DOI 10.1093/infdis/172.6.1528; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Giacaman RA, 2007, J IMMUNOL, V179, P2542, DOI 10.4049/jimmunol.179.4.2542; Giavedoni LD, 2013, J VIROL, V87, P1750, DOI 10.1128/JVI.02079-12; Goulston C, 1998, J INFECT DIS, V177, P1100, DOI 10.1086/517404; Greenhead P, 2000, J VIROL, V74, P5577, DOI 10.1128/JVI.74.12.5577-5586.2000; Han Y, 2000, ORAL MICROBIOL IMMUN, V15, P82, DOI 10.1034/j.1399-302x.2000.150203.x; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; Hernandez Rosa, 2009, V470, P105, DOI 10.1007/978-1-59745-204-5_10; Herz AM, 2002, J MED PRIMATOL, V31, P29, DOI 10.1034/j.1600-0684.2002.1o005.x; Herzberg M C, 2006, Adv Dent Res, V19, P158; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hocini H, 1999, J INFECT DIS, V179, pS448, DOI 10.1086/314802; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Howell AL, 1997, J VIROL, V71, P3498, DOI 10.1128/JVI.71.5.3498-3506.1997; Hu JJ, 1998, LAB INVEST, V78, P435; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Janoff EN, 2001, GASTROENTEROLOGY, V120, P607, DOI 10.1053/gast.2001.22427; Joag SV, 1997, J VIROL, V71, P4016, DOI 10.1128/JVI.71.5.4016-4023.1997; Jotwani R, 2004, J DENT RES, V83, P371, DOI 10.1177/154405910408300504; Kage A, 1998, J VIROL, V72, P4231, DOI 10.1128/JVI.72.5.4231-4236.1998; Kaldensjo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021344; Kazmi SH, 2006, CLIN VACCINE IMMUNOL, V13, P1111, DOI 10.1128/CDLI.00426-05; Khanna KV, 2002, J CLIN INVEST, V109, P205; KNUECHEL R, 1990, AM J PATHOL, V137, P725; Kumar RB, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-25; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; Liuzzi G, 1996, AIDS, V10, pF51, DOI 10.1097/00002030-199612000-00001; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maher D, 2004, J INFECT DIS, V190, P1989, DOI 10.1086/425423; Malamud D, 2010, AIDS, V24, P5, DOI 10.1097/QAD.0b013e328333525f; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Mbisa Jean L., 2009, V485, P55, DOI 10.1007/978-1-59745-170-3_5; Miller CJ, 1998, J REPROD IMMUNOL, V41, P331, DOI 10.1016/S0165-0378(98)00069-2; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; MILMAN G, 1994, AIDS RES HUM RETROV, V10, P1305, DOI 10.1089/aid.1994.10.1305; Milush JA, 2004, AIDS, V18, P2371; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Moore JS, 2002, VIROLOGY, V297, P89, DOI 10.1006/viro.2002.1469; Moore JS, 2003, VIROLOGY, V313, P343, DOI 10.1016/S0042-6822(03)00283-6; Moutsopoulos NM, 2007, AM J PATHOL, V171, P571, DOI 10.2353/ajpath.2007.061006; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Navarrete P, 2003, ANTIVIR THER, V8, P635; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Pang S, 2000, J VIROL, V74, P10994, DOI 10.1128/JVI.74.23.10994-11000.2000; Phillips David M., 1994, Trends in Microbiology, V2, P454, DOI 10.1016/0966-842X(94)90804-4; Phillips DM, 1998, AIDS RES HUM RETROV, V14, pS67; Pierson TC, 2003, CURR TOP MICROBIOL, V281, P1; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Qureshi M N, 1997, Oral Dis, V3 Suppl 1, pS73; QURESHI MN, 1995, J INFECT DIS, V171, P190, DOI 10.1093/infdis/171.1.190; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Rodriguez-Inigo E, 2005, J MED VIROL, V77, P17, DOI [10.1002/jmv.20409, 10.1002/JMV.20409]; Rothenberg RB, 1998, AIDS, V12, P2095, DOI 10.1097/00002030-199816000-00004; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Strus M., 2001, Medycyna Doswiadczalna i Mikrobiologia, V53, P253; TAN X, 1993, J VIROL, V67, P6447, DOI 10.1128/JVI.67.11.6447-6452.1993; Tugizov SM, 2012, J VIROL, V86, P2556, DOI 10.1128/JVI.06578-11; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Vacharaksa A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-66; Van Herrewege Y, 2007, ANTIVIR RES, V74, P111, DOI 10.1016/j.antiviral.2006.10.010; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Velarde G, 1999, TOXICOL IN VITRO, V13, P723, DOI 10.1016/S0887-2333(99)00048-X; WALSH LJ, 1990, J ORAL PATHOL MED, V19, P177, DOI 10.1111/j.1600-0714.1990.tb00820.x; Weinberg A, 2011, Adv Dent Res, V23, P122, DOI 10.1177/0022034511399917; Wilkinson J, 2006, CURR DRUG TARGETS, V7, P1563, DOI 10.2174/138945006779025482; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 1998, AIDS RES HUM RETROV, V14, pS57; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	104	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98077	10.1371/journal.pone.0098077	http://dx.doi.org/10.1371/journal.pone.0098077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857971	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400037
J	Takae, S; Kawamura, K; Sato, Y; Nishijima, C; Yoshioka, N; Sugishita, Y; Horage, Y; Tanaka, M; Ishizuka, B; Suzuki, N				Takae, Seido; Kawamura, Kazuhiro; Sato, Yorino; Nishijima, Chie; Yoshioka, Nobuhito; Sugishita, Yodo; Horage, Yuki; Tanaka, Mamoru; Ishizuka, Bunpei; Suzuki, Nao			Analysis of Late-Onset Ovarian Insufficiency after Ovarian Surgery: Retrospective Study with 75 Patients of Post-Surgical Ovarian Insufficiency	PLOS ONE			English	Article							LAPAROSCOPIC EXCISION; BILATERAL ENDOMETRIOMAS; FAILURE; CYSTS	The primary objectives of the present study are to determine the period of onset of ovarian insufficiency after surgery and to confirm potential risk factors for ovarian insufficiency after surgery for the removal of benign ovarian cysts. Data were obtained from 75 patients who underwent surgery for benign ovarian cysts prior to the onset of ovarian insufficiency. Our analysis included 835 ovarian insufficiency patients who were referred to our institution from July 2003 to July 2013. Several epidemiological parameters of ovarian insufficiency after surgery (age at operation, period of onset of ovarian insufficiency, operation procedure, and pathological diagnosis) were investigated. Of the 835 patients who had ovarian insufficiency, 75 patients (9.0%) underwent ovarian surgery before the onset of ovarian insufficiency. Of those 75 patients, 66 patients (88.0%) underwent cystectomy. For the majority of the 75 patients the surgical indication was the presence of endometriotic cysts (57 patients; 76.0%). Twelve patients (16.0%) underwent multiple surgeries (all bilateral cystectomies). The mean age of the patients at the time of surgery was 27.8 +/- 5.5 years-old, and the mean period of onset of ovarian insufficiency was 5.8 +/- 3.8 years. In patients with cystectomy, the patient's age at the time of surgery and period of onset of ovarian insufficiency was well-correlated (coefficient of correlation; hemilateral endometriotic cystectomy: -0.64, bilateral endometriotic cystectomy: -0.61, and multiple endimetriotic cystectomy: -0.40). We found that cystectomy of endometriotic cysts is the potential risk factor for ovarian insufficiency after surgery, at times, the onset of ovarian insufficiency long after cystectomy. Therefore, it is important to monitor ovarian reserve for an extended period of time after ovarian surgery. It is particularly important to monitor ovarian reserve long-term for patients who wish to conceive in the future and to suggest a variety of infertility treatments appropriate for their ovarian reserve.	[Takae, Seido; Kawamura, Kazuhiro; Sato, Yorino; Nishijima, Chie; Yoshioka, Nobuhito; Sugishita, Yodo; Horage, Yuki; Tanaka, Mamoru; Suzuki, Nao] St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan; [Ishizuka, Bunpei] St Marianna Univ, Sch Med, Dept Adv Reprod Med, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University	Kawamura, K (corresponding author), St Marianna Univ, Sch Med, Dept Obstet & Gynecol, Kawasaki, Kanagawa, Japan.	kawamurak@marianna-u.ac.jp		Sugishita, Yodo/0000-0003-4315-1370				Benaglia L, 2010, HUM REPROD, V25, P678, DOI 10.1093/humrep/dep464; Brosens IA, 1996, FERTIL STERIL, V66, P517, DOI 10.1016/S0015-0282(16)58561-6; Busacca M, 2006, AM J OBSTET GYNECOL, V195, P421, DOI 10.1016/j.ajog.2006.03.064; Coccia ME, 2011, HUM REPROD, V26, P3000, DOI 10.1093/humrep/der286; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Di Prospero F, 2009, REPROD BIOMED ONLINE, V18, P167, DOI 10.1016/S1472-6483(10)60251-9; Dogan E, 2011, INT J GYNECOL OBSTET, V114, P124, DOI 10.1016/j.ijgo.2011.04.002; Donnez J, 1996, HUM REPROD, V11, P641, DOI 10.1093/HUMREP/11.3.641; Iwase A, 2010, FERTIL STERIL, V94, P2846, DOI 10.1016/j.fertnstert.2010.06.010; Kitajima M, 2011, FERTIL STERIL, V96, P685, DOI 10.1016/j.fertnstert.2011.06.064; Lemos NA, 2008, FERTIL STERIL, V89, P1064, DOI 10.1016/j.fertnstert.2007.04.048; Li CZ, 2009, FERTIL STERIL, V92, P1428, DOI 10.1016/j.fertnstert.2008.08.071; Muzii L, 2002, FERTIL STERIL, V77, P609, DOI 10.1016/S0015-0282(01)03203-4; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x	14	11	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98174	10.1371/journal.pone.0098174	http://dx.doi.org/10.1371/journal.pone.0098174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858999	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400049
J	Banla, M; Tchalim, S; Karabou, PK; Gantin, RG; Agba, AI; Kere-Banla, A; Helling-Giese, G; Heuschkel, C; Schulz-Key, H; Soboslay, PT				Banla, Meba; Tchalim, Solim; Karabou, Potochoziou K.; Gantin, Richard G.; Agba, Aide I.; Kere-Banla, Abiba; Helling-Giese, Gertrud; Heuschkel, Christoph; Schulz-Key, Hartwig; Soboslay, Peter T.			Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study	PLOS ONE			English	Article							VISUAL IMPAIRMENT; ONCHODERMATITIS SOWDA; VOLVULUS INFECTION; AFRICA; DOXYCYCLINE; ELIMINATION; PREVALENCE; INTENSITY; BLINDNESS; THERAPY	The evolution and persistence of ocular pathology was assessed in a cohort of Onchocerca volvulus infected patients treated annually with ivermectin for 23 years. Patients were resident in rural Central and Kara Region of Togo and ocular examinations included testing of visual acuity, slit lamp examination of the anterior eye segment and the eye fundus by ophthalmoscopy. Before ivermectin treatment, vivid O. volvulus microfilariae (MF) were observed in the right and left anterior eye chamber in 52% and 42% of patients (n = 82), and dead MF were seen in the right and left cornea in 24% and 15% of cases, respectively. At 23 years post initial treatment (PIT), none of the patients (n = 82) presented with MF in the anterior chamber and cornea. A complete resolution of punctate keratitis (PK) lesions without observable corneal scars was present at 23 years PIT (p < 0.0001), and sclerosing keratitits (SK) lessened by half, but mainly in patients with lesions at early stage of evolution. Early-stage iridocyclitis diminished from 42%(rE) and 40%(lE) to 13% (rE + lE)(p < 0.0001), but advanced iridocyclitis augmented (p < 0.001) at 23 years PIT compared to before ivermectin. Advanced-stage papillitis and chorioretinitis did not regress, while early-stage papillitis present in 28%(rE) and 27%(lE) of patients at before ivermectin regressed to 17%(rE) and 18%(lE), and early-stage chorioretinitis present in 51%(rE + lE) of cases at before ivermectin was observed in 12%(rE) and 13%(lE) at 23 years PIT (p < 0.0001). Thus, regular annual ivermectin treatment eliminated and prevented the migration of O. volvulus microfilariae into the anterior eye chamber and cornea; keratitis punctata lesions resolved completely and early-stage sclerosing keratitits and iridocyclitis regressed, whilst advanced lesions of the anterior and posterior eye segment remained progressive. In conclusion, annual ivermectin treatments may prevent the emergence of ocular pathology in those populations still exposed to O. volvulus infection.	[Banla, Meba; Tchalim, Solim; Gantin, Richard G.; Kere-Banla, Abiba; Helling-Giese, Gertrud; Heuschkel, Christoph; Schulz-Key, Hartwig; Soboslay, Peter T.] Natl Inst Hyg, Onchocerciasis Reference Lab, Sokode, Togo; [Banla, Meba; Tchalim, Solim; Agba, Aide I.] Univ Lome, Lome, Togo; [Karabou, Potochoziou K.] Natl Onchocerciasis Control Programme, Kara, Togo; [Gantin, Richard G.; Helling-Giese, Gertrud; Heuschkel, Christoph; Schulz-Key, Hartwig; Soboslay, Peter T.] Univ Clin Tubingen, Inst Trop Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Soboslay, PT (corresponding author), Natl Inst Hyg, Onchocerciasis Reference Lab, Sokode, Togo.	peter.soboslay@uni-tuebingen.de			WHO/TDR [ID 930543]; Gesellschaft fur Internationale Zusammenarbeit (giz); Deutsche Forschungsgemeinschaft (DFG) [367/1-2]; Commission of the European Community [CEC-TS*-CT92-0057, 032321]; Togolese Ministry of Health [0407/2007/MS/CAB/DGS]	WHO/TDR(World Health Organization); Gesellschaft fur Internationale Zusammenarbeit (giz); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Commission of the European Community(European Commission); Togolese Ministry of Health	This work was supported by WHO/TDR (ID 930543), Gesellschaft fur Internationale Zusammenarbeit (giz), Deutsche Forschungsgemeinschaft (DFG grant no. 367/1-2), Commission of the European Community (CEC-TS*-CT92-0057 and FP6-INCO-SCOOTT contract no. 032321) and the Togolese Ministry of Health (Autorisation no. 0407/2007/MS/CAB/DGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIOSE A, 1993, LANCET, V341, P130, DOI 10.1016/0140-6736(93)90002-X; Abiose A, 1998, ANN TROP MED PARASIT, V92, pS11, DOI 10.1080/00034989859519; Adegbehingbe BO, 2007, AUST J RURAL HEALTH, V15, P269, DOI 10.1111/j.1440-1584.2007.00906.x; Babalola O E, 2011, West Afr J Med, V30, P104; Balo PK, 2000, J FR OPHTALMOL, V23, P459; BARAKA OZ, 1995, T ROY SOC TROP MED H, V89, P312, DOI 10.1016/0035-9203(95)90559-6; Bastawrous A, 2013, BRIT J OPHTHALMOL, V97, P1237, DOI 10.1136/bjophthalmol-2013-303135; Boatin B, 2008, ANN TROP MED PARASIT, V102, P13, DOI 10.1179/136485908X337427; Chippaux J P, 1999, Ophthalmic Epidemiol, V6, P229, DOI 10.1076/opep.6.4.229.4185; DADZIE KY, 1989, TROP MED PARASITOL, V40, P355; DADZIE KY, 1991, T ROY SOC TROP MED H, V85, P267, DOI 10.1016/0035-9203(91)90051-Y; Dadzie Yankum, 2003, Filaria J, V2, P2, DOI 10.1186/1475-2883-2-2; Darge K, 1995, TROP MED PARASITOL, V46, P206; DESOLE G, 1992, ACTA TROP, V52, P87, DOI 10.1016/0001-706X(92)90024-R; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Ejere H, 2001, COCHRANE DB SYST REV, V1; Fafowora OF, 1997, E AFR MED J, V74, P435; GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Katabarwa MN, 2011, AM J TROP MED HYG, V85, P1041, DOI 10.4269/ajtmh.2011.11-0333; Klager SL, 1996, TROP MED INT HEALTH, V1, P581; LARIVIERE M, 1985, LANCET, V2, P174; Mabey D, 1996, OPHTHALMOLOGY, V103, P1001, DOI 10.1016/S0161-6420(96)30574-5; Masud H, 2009, JCPSP-J COLL PHYSICI, V19, P34, DOI 01.2009/JCPSP.3438; NEWLAND HS, 1988, BRIT J OPHTHALMOL, V72, P561, DOI 10.1136/bjo.72.8.561; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; RODRIGUEZPEREZ MA, 1995, AM J TROP MED HYG, V52, P429; Seketeli A., 2002, Annals of Tropical Medicine and Parasitology, V96, pS15, DOI 10.1179/000349802125000628; SEMBA RD, 1990, OPHTHALMOLOGY, V97, P1334; TAYLOR HR, 1986, ARCH OPHTHALMOL-CHIC, V104, P863, DOI 10.1001/archopht.1986.01050180097039; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Umeh R E, 2010, Afr J Med Med Sci, V39, P267; Vieira JC, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-9; WHITWORTH JAG, 1991, LANCET, V338, P1100, DOI 10.1016/0140-6736(91)91963-U; Yameogo L, 2008, ANN TROP MED PARAS S	36	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98411	10.1371/journal.pone.0098411	http://dx.doi.org/10.1371/journal.pone.0098411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887413	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300064
J	Debevec, T; Simpson, EJ; Macdonald, IA; Eiken, O; Mekjavic, IB				Debevec, Tadej; Simpson, Elizabeth J.; Macdonald, Ian A.; Eiken, Ola; Mekjavic, Igor B.			Exercise Training during Normobaric Hypoxic Confinement Does Not Alter Hormonal Appetite Regulation	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; HIGH-ALTITUDE; WEIGHT-LOSS; PHYSICAL-EXERCISE; LEPTIN LEVELS; OPERATION EVEREST; OXIDATIVE STRESS; ACYLATED GHRELIN; BODY-COMPOSITION; ENERGY-INTAKE	Background: Both exposure to hypoxia and exercise training have the potential to modulate appetite and induce beneficial metabolic adaptations. The purpose of this study was to determine whether daily moderate exercise training performed during a 10-day exposure to normobaric hypoxia alters hormonal appetite regulation and augments metabolic health. Methods: Fourteen healthy, male participants underwent a 10-day hypoxic confinement at,4000 m simulated altitude (FIO2 = 0.139 +/- 0.003%) either combined with daily moderate intensity exercise (Exercise group; N = 8, Age = 25.8 +/- 2.4 yrs, BMI = 22.9 +/- 1.2 kg.m(-2)) or without any exercise (Sedentary group; N = 6 Age = 24.8 +/- 3.1 yrs, BMI = 22.3 +/- 2.5 kg.m(-2)). A meal tolerance test was performed before (Pre) and after the confinement (Post) to quantify fasting and postprandial concentrations of selected appetite-related hormones and metabolic risk markers. C-13-Glucose was dissolved in the test meal and (CO2)-C-13 determined in breath samples. Perceived appetite ratings were obtained throughout the meal tolerance tests. Results: While body mass decreased in both groups (-1.4 kg; p = 0.01) following the confinement, whole body fat mass was only reduced in the Exercise group (-1.5 kg; p = 0.01). At Post, postprandial serum insulin was reduced in the Sedentary group (-49%; p = 0.01) and postprandial plasma glucose in the Exercise group (-19%; p = 0.03). Fasting serum total cholesterol levels were reduced (-12%; p = 0.01) at Post in the Exercise group only, secondary to low-density lipoprotein cholesterol reduction (-16%; p = 0.01). No differences between groups or testing periods were noted in fasting and/or postprandial concentrations of total ghrelin, peptide YY, and glucagon-like peptide-1, leptin, adiponectin, expired (CO2)-C-13 as well as perceived appetite ratings (p>0.05). Conclusion: These findings suggest that performing daily moderate intensity exercise training during continuous hypoxic exposure does not alter hormonal appetite regulation but can improve the lipid profile in healthy young males.	[Debevec, Tadej; Mekjavic, Igor B.] Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia; [Simpson, Elizabeth J.; Macdonald, Ian A.] Univ Nottingham, Sch Med, Sch Life Sci,Queens Med Ctr, MRC,Arthrit Res UK Ctr Musculoskeletal Ageing Res, Nottingham, England; [Eiken, Ola] Royal Inst Technol, Swedish Aerosp Physiol Ctr, Dept Environm Physiol, Stockholm, Sweden	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Nottingham; Royal Institute of Technology	Debevec, T (corresponding author), Jozef Stefan Inst, Dept Automat Biocybernet & Robot, Ljubljana, Slovenia.	tadej.debevec@ijs.si	, Liz/M-7432-2019; Mekjavic, Igor/AAM-6962-2021; Debevec, Tadej/D-7917-2013	, Liz/0000-0001-9353-6258; Mekjavic, Igor/0000-0001-5930-2159; Debevec, Tadej/0000-0001-7053-3978; Macdonald, Ian/0000-0002-7540-9850	European union [284438]; European Space Agency (ESA) Programme for European Cooperating States (ESTEC) [40001043721/11/NL/KML]; Slovene Research Agency [L3-3654]	European union(European Commission); European Space Agency (ESA) Programme for European Cooperating States (ESTEC); Slovene Research Agency(Slovenian Research Agency - Slovenia)	The study was supported, in part, by the European union funding programme FP7 (PlanHab project; Grant no. 284438), the European Space Agency (ESA) Programme for European Cooperating States (ESTEC/Contract No. 40001043721/11/NL/KML: Planetary Habitat Simulation), and by the Slovene Research Agency (Contract no. L3-3654: Zero and reduced gravity simulation: The effect on the cardiovascular and musculoskeletal systems). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252; Bailey DM, 2001, J APPL PHYSIOL, V90, P105, DOI 10.1152/jappl.2001.90.1.105; Bailey DM, 2000, MED SCI SPORT EXER, V32, P1058, DOI 10.1097/00005768-200006000-00004; Benso A, 2007, EUR J ENDOCRINOL, V157, P733, DOI 10.1530/EJE-07-0355; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; BROOKS GA, 1991, J APPL PHYSIOL, V70, P919, DOI 10.1152/jappl.1991.70.2.919; Chen SM, 2013, CHIN J PHYSL, V56; Debevec T, 2014, MED SCI SPORT EXER, V46, P33, DOI 10.1249/MSS.0b013e31829f87ef; Debevec T, 2014, APPL PHYSIOL NUTR ME, V39, P386, DOI 10.1139/apnm-2013-0278; Debevec T, 2010, AVIAT SPACE ENVIR MD, V81, P387, DOI 10.3357/ASEM.2660.2010; DINMORE AJ, 1994, J APPL PHYSIOL, V76, P1903, DOI 10.1152/jappl.1994.76.5.1903; Faiss R, 2013, MED SCI SPORT EXER, V45, P253, DOI 10.1249/MSS.0b013e31826d5aa2; Forster CD, 1999, BIOMED CHROMATOGR, V13, P209, DOI 10.1002/(SICI)1099-0801(199905)13:3<209::AID-BMC820>3.0.CO;2-Z; Gibbons C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-57; Guelfi KJ, 2013, METABOLISM, V62, P235, DOI 10.1016/j.metabol.2012.08.002; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hamad N, 2006, EUR J GASTROEN HEPAT, V18, P5, DOI 10.1097/00042737-200601000-00002; Haufe S, 2008, MED SCI SPORT EXER, V40, P1939, DOI 10.1249/MSS.0b013e31817f1988; Hind K, 2011, EUR J CLIN NUTR, V65, P140, DOI 10.1038/ejcn.2010.190; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Kalson NS, 2010, EUR J CLIN INVEST, V40, P735, DOI 10.1111/j.1365-2362.2010.02324.x; Katayama K, 2010, METABOLISM, V59, P959, DOI 10.1016/j.metabol.2009.10.017; Kayser B, 2013, OBES REV, V14, P579, DOI 10.1111/obr.12034; King JA, 2011, J CLIN ENDOCR METAB, V96, P1114, DOI 10.1210/jc.2010-2735; Mackenzie R, 2012, J CLIN ENDOCR METAB, V97, pE546, DOI 10.1210/jc.2011-2829; Martins C, 2010, J CLIN ENDOCR METAB, V95, P1609, DOI 10.1210/jc.2009-2082; Martins C, 2007, J ENDOCRINOL, V193, P251, DOI 10.1677/JOE-06-0030; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Morishima T, 2014, CLIN PHYSIOL FUNCT I, V34, P90, DOI 10.1111/cpf.12069; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; Riepl RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044445; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; Russel RR, 2009, J SPORT SCI MED, V8, P574; Schubert MM, 2013, SPORTS MED; SEALS DR, 1991, J APPL PHYSIOL, V71, P1032, DOI 10.1152/jappl.1991.71.3.1032; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; Sierra-Johnson J, 2008, J APPL PHYSIOL, V105, P1684, DOI 10.1152/japplphysiol.01284.2007; Snyder EM, 2008, APPL PHYSIOL NUTR ME, V33, P929, DOI 10.1139/H08-079; Stensel D, 2010, ANN NUTR METAB, V57, P36, DOI 10.1159/000322702; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; Tschop M, 1998, LANCET, V352, P1119, DOI 10.1016/S0140-6736(05)79760-9; Tschop M, 2001, ADV EXP MED BIOL, V502, P237; Wasse LK, 2012, J APPL PHYSIOL, V112, P552, DOI 10.1152/japplphysiol.00090.2011; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wiesner S, 2010, OBESITY, V18, P116, DOI 10.1038/oby.2009.193; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	50	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98874	10.1371/journal.pone.0098874	http://dx.doi.org/10.1371/journal.pone.0098874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887106	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300116
J	Gurgel, SJT; El Dib, R; do Nascimento, P				Gurgel, Sanderland J. T.; El Dib, Regina; do Nascimento, Paulo, Jr.			Enhanced Recovery after Elective Open Surgical Repair of Abdominal Aortic Aneurysm: A Complementary Overview through a Pooled Analysis of Proportions from Case Series Studies	PLOS ONE			English	Article							ENDOVASCULAR REPAIR; PRACTICE GUIDELINES; STENT GRAFT; SURGERY; STAY; METAANALYSIS; OUTCOMES; ANESTHESIA; MANAGEMENT; CARE	Objectives: To evaluate the efficacy and safety of enhanced recovery after surgery (ERAS) programs in elective open surgical repair (OSR) of abdominal aortic aneurysm (AAA). Background: Open surgical repair of AAA is associated with high morbidity and mortality, prolonged hospital stay and high costs. ERAS programs contribute to the optimization of treatment by reducing hospital stay and improving clinical outcomes. Methods: A review of PubMed, EMBASE and LILACS databases was conducted. As only one randomized controlled trial was found, a pooled analysis of proportions from case series was conducted, considering it a complementary overview of the topic. Inclusion criteria were case series with more than five cases reported, adult patients who underwent an elective OSR of AAA and use of an ERAS program. ERAS was compared to conventional perioperative care. The pooled proportion and the confidence interval (CI) are shown for each outcome. The overlap of the CI suggests similar effect of the interventions studied. Results: Thirteen case series studies with ERAS involving 1,250 patients were compared to six case series with conventional care with a total of 1,429 patients. The pooled, respective proportions for ERAS and conventional care were: mortality, 1.51% [95% CI: 0.0091, 0.0226] and 3.0% [95% CI 0.0183, 0.0445]; and incidence of complications, 3.82% [95% CI 0.0259, 0.0528] and 4.0% [95% CI 0.03, 0.05]. Conclusion: This review shows that ERAS and conventional care therapies have similar mortality and complication rates in OSR of AAA.	[Gurgel, Sanderland J. T.; El Dib, Regina; do Nascimento, Paulo, Jr.] Univ Estadual Paulista, UNESP, Fac Med Botucatu, Dept Anesthesiol, Botucatu, SP, Brazil; [Gurgel, Sanderland J. T.] UNINGA Univ, Maringa, Parana, Brazil; [El Dib, Regina] McMaster Univ, McMaster Inst Urol, Hamilton, ON L8S 4L8, Canada	Universidade Estadual Paulista; Centro Universitario Inga (UNINGA); McMaster University	Gurgel, SJT (corresponding author), Univ Estadual Paulista, UNESP, Fac Med Botucatu, Dept Anesthesiol, Botucatu, SP, Brazil.	drsanderland@hotmail.com	Junior, Paulo do Nascimento/C-6966-2010; Dib, Regina El/ABC-8178-2020	Junior, Paulo do Nascimento/0000-0002-2323-9159; Dib, Regina El/0000-0002-4081-803X				Abularrage Christopher J, 2005, Vasc Endovascular Surg, V39, P229, DOI 10.1177/153857440503900303; Albrecht J, 2005, J CLIN EPIDEMIOL, V58, P1227, DOI 10.1016/j.jclinepi.2005.04.003; Albrecht J, 2009, J AM ACAD DERMATOL, V60, P412, DOI 10.1016/j.jaad.2008.10.023; Becquemin JP, 2011, J VASC SURG, V53, P1167, DOI 10.1016/j.jvs.2010.10.124; Bertin KC, 2005, CLIN ORTHOP RELAT R, P154, DOI 10.1097/01.blo.0000157173.22995.cf; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Brustia Piero, 2007, Interact Cardiovasc Thorac Surg, V6, P60; Callaghan CJ, 2005, EUR J VASC ENDOVASC, V30, P252, DOI 10.1016/j.ejvs.2005.03.004; Chaikof EL, 2009, J VASC SURG, V50, P880, DOI 10.1016/j.jvs.2009.07.001; Chang JK, 2003, J VASC SURG, V38, P335, DOI 10.1016/S0741-5214(03)00121-6; Dangas G, 2012, JACC-CARDIOVASC INTE, V5, P1071, DOI 10.1016/j.jcin.2012.06.015; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; Deeks J J, 2003, Health Technol Assess, V7, piii; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; El Dib R, 2013, ACTA CIR BRAS, V28, P870, DOI 10.1590/S0102-86502013001200010; El Dib R, 2012, BJU INT, V110, P510, DOI 10.1111/j.1464-410X.2011.10885.x; El Dib RP, 2007, J EVAL CLIN PRACT, V13, P689, DOI 10.1111/j.1365-2753.2007.00886.x; El Dib RP, 2012, 20 COCHR C NZ AUSTR; Firoozfard B, 2003, SCAND J UROL NEPHROL, V37, P305, DOI 10.1080/00365590310014742; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Hafez H, 2011, J VASC SURG, V53, P1514, DOI 10.1016/j.jvs.2011.02.013; Haynes R B, 1998, Stud Health Technol Inform, V52 Pt 1, P33; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Jenicek M, 2008, MED SCI MONITOR, V14, pRA149; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kehlet H, 2002, AM J SURG, V183, P630, DOI 10.1016/S0002-9610(02)00866-8; Kehlet H, 2008, LANCET, V371, P791, DOI 10.1016/S0140-6736(08)60357-8; Ko Po-Jen, 2004, Chang Gung Med J, V27, P210; Lassen K, 2009, ARCH SURG-CHICAGO, V144, P961, DOI 10.1001/archsurg.2009.170; Lederle FA, 1997, J VASC SURG, V26, P595, DOI 10.1016/S0741-5214(97)70057-0; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Lohr G, 2008, ZBL CHIR, V133, P344, DOI 10.1055/s-2008-1076864; Lottman PEM, 2004, J ENDOVASC THER, V11, P323, DOI 10.1583/03-1141.1; Moniaci D, 2011, VASCULAR, V19, P233, DOI 10.1258/vasc.2010.oa0271; Muehling B, 2009, WORLD J SURG, V33, P577, DOI 10.1007/s00268-008-9892-2; Mukherjee D, 2008, INT J ANGIOL, V17, P93; Murphy MA, 2007, EUR J VASC ENDOVASC, V34, P274, DOI 10.1016/j.ejvs.2007.04.018; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Norris EJ, 2001, ANESTHESIOLOGY, V95, P1054, DOI 10.1097/00000542-200111000-00006; Podore PC, 1999, J VASC SURG, V29, P787, DOI 10.1016/S0741-5214(99)70204-1; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Renghi A, 2001, Minerva Anestesiol, V67, P441; Rigberg DA, 2004, ARCH SURG-CHICAGO, V139, P941, DOI 10.1001/archsurg.139.9.941; Sahai A, 2005, BRIT J SURG, V92, P58, DOI 10.1002/bjs.4746; Soulez G, 2005, J VASC INTERV RADIOL, V16, P1093, DOI 10.1097/01.RVI.0000167858.16223.D5; Villas Boas PJ, 2013, J EVAL CLIN PRACT; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wilmore DW, 2001, BMJ-BRIT MED J, V322, P473, DOI 10.1136/bmj.322.7284.473	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98006	10.1371/journal.pone.0098006	http://dx.doi.org/10.1371/journal.pone.0098006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887022	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300033
J	Brandt, VC; Niessen, E; Ganos, C; Kahl, U; Baumer, T; Munchau, A				Brandt, Valerie Catherine; Niessen, Eva; Ganos, Christos; Kahl, Ursula; Baeumer, Tobias; Muenchau, Alexander			Altered Synaptic Plasticity in Tourette's Syndrome and Its Relationship to Motor Skill Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED ASSOCIATIVE STIMULATION; CORTEX EXCITABILITY; CORTICAL PLASTICITY; NEURONAL NETWORKS; COGNITIVE CONTROL; NMDA RECEPTORS; TIC SEVERITY; MODULATION; INHIBITION	Gilles de la Tourette syndrome is a neuropsychiatric disorder characterized by motor and phonic tics that can be considered motor responses to preceding inner urges. It has been shown that Tourette patients have inferior performance in some motor learning tasks and reduced synaptic plasticity induced by transcranial magnetic stimulation. However, it has not been investigated whether altered synaptic plasticity is directly linked to impaired motor skill acquisition in Tourette patients. In this study, cortical plasticity was assessed by measuring motor-evoked potentials before and after paired associative stimulation in 14 Tourette patients (13 male; age 18-39) and 15 healthy controls (12 male; age 18-33). Tic and urge severity were assessed using the Yale Global Tic Severity Scale and the Premonitory Urges for Tics Scale. Motor learning was assessed 45 minutes after inducing synaptic plasticity and 9 months later, using the rotary pursuit task. On average, long-term potentiation-like effects in response to the paired associative stimulation were present in healthy controls but not in patients. In Tourette patients, long-term potentiation-like effects were associated with more and long-term depression-like effects with less severe urges and tics. While motor learning did not differ between patients and healthy controls 45 minutes after inducing synaptic plasticity, the learning curve of the healthy controls started at a significantly higher level than the Tourette patients' 9 months later. Induced synaptic plasticity correlated positively with motor skills in healthy controls 9 months later. The present study confirms previously found long-term improvement in motor performance after paired associative stimulation in healthy controls but not in Tourette patients. Tourette patients did not show long-term potentiation in response to PAS and also showed reduced levels of motor skill consolidation after 9 months compared to healthy controls. Moreover, synaptic plasticity appears to be related to symptom severity.	[Brandt, Valerie Catherine; Ganos, Christos; Baeumer, Tobias; Muenchau, Alexander] Univ Lubeck, Inst Neurogenet, Lubeck, Schleswig Holst, Germany; [Brandt, Valerie Catherine; Ganos, Christos; Kahl, Ursula] Univ Clin Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Niessen, Eva] Res Ctr Julich, Inst Neurosci & Med, Julich, Nordrhein Westf, Germany; [Ganos, Christos] UCL, Sobell Dept Motor Neurosci & Movement Disorders, London, England	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Research Center Julich; University of London; University College London	Brandt, VC (corresponding author), Univ Lubeck, Inst Neurogenet, Lubeck, Schleswig Holst, Germany.	valerie.brandt@gmx.de	Niessen, Eva/H-8529-2017	Niessen, Eva/0000-0002-2801-0986; Kahl, Ursula/0000-0003-2096-9647; Ganos, Christos/0000-0001-8077-8530	"Else-Kroner-Stiftung'' [2011_A37]; Deutsche Forschungsgemeinschaft (DFG) [MU1692/2-1, MU 1692/3-1, SFB 936]; European Science Foundation; Actelion; Ipsen; Pharm Allergan; Merz Pharmaceuticals	"Else-Kroner-Stiftung''; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission); Actelion; Ipsen(Ipsen); Pharm Allergan(AbbVieAllergan); Merz Pharmaceuticals	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclosures for Brandt 20.1.2014: PhD grant from the "Else-Kroner-Stiftung'' Grant number: 2011_A37. Disclosures for Niessen 20.1.2014: None. Disclosures for Ganos 20.1.2014: Academic research support: Deutsche Forschungsgemeinschaft (DFG) Deutsche Forschungsgemeinschaft (MU1692/2-1) European Science Foundation. Commercial research support: Grants by Actelion, Ipsen, Pharm Allergan and Merz Pharmaceuticals. Disclosures for Kahl 20.1.2014: None. Disclosures for Baumer 20.1.2014: Commercial research support: Honoraria for lectures from Pharm Allergan, Ipsen, Merz Pharmaceuticals. Disclosures for Munchau 20.1.2014: Commercial research support: Grants by Pharm Allergan, Ipsen, Merz Pharmaceuticals. Honoraria for lectures from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline and Desitin. Support from non-profit foundations or societies: Possehl-Stiftung, Lubeck; Dystonia Coalition (USA); Tourette Syndrome Association (Germany); European Huntington Disease Network; N.E.MO. Charity supporting the research of paediatric movement disorders. Academic research support not attributed in the manuscript: Deutsche Forschungsgemeinschaft (MU 1692/3-1; SFB 936). Else Kroner-Fresenius-Stiftung. A. Munchau is employed at the University of Lubeck.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Bornstein R A, 1991, J Neuropsychiatry Clin Neurosci, V3, P157; Bornstein R A, 1990, J Neuropsychiatry Clin Neurosci, V2, P275; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Como PG, 2005, HDB TOURETTES SYNDRO, P237; Crossley E, 2014, BRAIN DEV-JPN, V36, P45, DOI 10.1016/j.braindev.2012.12.010; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; DOYERE V, 1992, HIPPOCAMPUS, V2, P39, DOI 10.1002/hipo.450020106; Elahi B, 2012, J NEUROPHYSIOL, V107, P1935, DOI 10.1152/jn.00202.2011; FAHN S, 1993, ARCH NEUROL-CHICAGO, V50, P1013; Frantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Heise KF, 2010, BRAIN, V133, P580, DOI 10.1093/brain/awp299; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; Jackson SR, 2011, CURR BIOL, V21, P580, DOI 10.1016/j.cub.2011.02.047; Jung J, 2013, NEUROSCI BIOBEHAV R, V37, P1016, DOI 10.1016/j.neubiorev.2012.08.009; Krivanekova L, 2011, EUR J NEUROSCI, V34, P1292, DOI 10.1111/j.1460-9568.2011.07849.x; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Marsh R, 2005, NEUROPSYCHOLOGIA, V43, P1456, DOI 10.1016/j.neuropsychologia.2004.12.012; MORRIS RGM, 1990, PHILOS T ROY SOC B, V329, P187, DOI 10.1098/rstb.1990.0164; Mueller ST., 2012, PEBL PURSUIT ROTOR T; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Muller-Dahlhaus F, 2010, FRONT SYNAPTIC NEURO, V2, P34, DOI DOI 10.3389/FNSYN.2010.00034; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Neuner I, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-120; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2005, BRAIN, V128, P1292, DOI 10.1093/brain/awh473; Orth M, 2008, BIOL PSYCHIAT, V64, P248, DOI 10.1016/j.biopsych.2007.12.009; Orth M, 2013, BEHAV NEUROL, V27, P57, DOI [10.1155/2013/349137, 10.3233/BEN-120289]; Park P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0131; Paszek J, 2010, MOVEMENT DISORD, V25, P1106, DOI 10.1002/mds.23053; Player MJ, 2012, CLIN NEUROPHYSIOL, V123, P2220, DOI 10.1016/j.clinph.2012.03.081; Potter-Nerger M, 2009, J NEUROPHYSIOL, V102, P3180, DOI 10.1152/jn.91046.2008; Rajji TK, 2011, BRAIN STIMUL, V4, P137, DOI 10.1016/j.brs.2010.09.007; Robertson MM, 2011, BRIT J HOSP MED, V72, P100, DOI 10.12968/hmed.2011.72.2.100; Robertson MM, 1999, NEUROLOGY, V53, P2108, DOI 10.1212/WNL.53.9.2108; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rossner V., 2010, TOURETTE SYNDROM AND, P242; Russmann H, 2009, CLIN NEUROPHYSIOL, V120, P1204, DOI 10.1016/j.clinph.2009.04.005; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Serrien DJ, 2002, BRAIN, V125, P290, DOI 10.1093/brain/awf024; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Suppa A, 2011, MOVEMENT DISORD, V26, P1703, DOI 10.1002/mds.23706; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Weise D, 2013, J PHYSIOL-LONDON, V591, P4903, DOI 10.1113/jphysiol.2013.253989; Weise D, 2011, NEUROBIOL DIS, V42, P171, DOI 10.1016/j.nbd.2010.11.009; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Woods DW, 2005, J DEV BEHAV PEDIATR, V26, P397, DOI 10.1097/00004703-200512000-00001; Wu SW, 2012, BRAIN STIMUL, V5, P315, DOI 10.1016/j.brs.2011.04.001; Yeates KO, 1994, NEUROPSYCHOLOGY, V8, P65, DOI 10.1037/0894-4105.8.1.65; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Ziemann U, 1997, AM J PSYCHIAT, V154, P1277; Ziemann Ulf, 2004, Suppl Clin Neurophysiol, V57, P702; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	66	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98417	10.1371/journal.pone.0098417	http://dx.doi.org/10.1371/journal.pone.0098417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878665	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500056
J	Endo, Y; Blinova, K; Romantseva, T; Golding, H; Zaitseva, M				Endo, Yukinori; Blinova, Ksenia; Romantseva, Tatiana; Golding, Hana; Zaitseva, Marina			Differences in PGE(2) Production between Primary Human Monocytes and Differentiated Macrophages: Role of IL-1 beta and TRIF/IRF3	PLOS ONE			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; FEBRILE RESPONSE; MOLECULAR-BIOLOGY; INTERFERON-BETA; GUINEA-PIGS; FEVER; ENDOTOXIN; CELLS; PROSTAGLANDIN	Prostaglandin E2 (PGE(2)) is induced in vivo by bacterial products including TLR agonists. To determine whether PGE(2) is induced directly or via IL-1 beta, human monocytes and macrophages were cultured with LPS or with Pam3CSK4 in presence of caspase-1 inhibitor, ZVAD, or IL-1R antagonist, Kineret. TLR agonists induced PGE(2) in macrophages exclusively via IL-1 beta-independent mechanisms. In contrast, ZVAD and Kineret reduced PGE2 production in LPS-treated (but not in Pam3CSK4-treated) monocytes, by 30-60%. Recombinant human IL-1 beta augmented COX-2 and mPGES-1 mRNA and PGE(2) production in LPS-pretreated monocytes but not in un-primed or Pam3CSK4-primed monocytes. This difference was explained by the finding that LPS but not Pam3CSK4 induced phosphorylation of IRF3 in monocytes suggesting activation of the TRIF signaling pathway. Knocking down TRIF, TRAM, or IRF3 genes by siRNA inhibited IL-1 beta-induced COX-2 and mPGES-1 mRNA. Blocking of TLR4 endocytosis during LPS priming prevented the increase in PGE(2) production by exogenous IL-1 beta. Our data showed that TLR2 agonists induce PGE(2) in monocytes independently from IL-1 beta. In the case of TLR4, IL-1 beta augments PGE(2) production in LPS-primed monocytes (but not in macrophages) through a mechanism that requires TLR4 internalization and activation of the TRIF/IRF3 pathway. These findings suggest a key role for blood monocytes in the rapid onset of fever in animals and humans exposed to bacterial products and some novel adjuvants.	[Endo, Yukinori; Blinova, Ksenia; Romantseva, Tatiana; Golding, Hana; Zaitseva, Marina] US FDA, CBER, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Zaitseva, M (corresponding author), US FDA, CBER, Bethesda, MD 20014 USA.	marina.zaitseva@fda.hhs.gov		BLINOVA, KSENIA/0000-0003-1123-3152	Federal fund from the Critical Path Initiative at CBER; Federal fund from the Critical Path Initiative at FDA; Biomedical Advanced Research and Development Authority (BARDA), HHS	Federal fund from the Critical Path Initiative at CBER; Federal fund from the Critical Path Initiative at FDA; Biomedical Advanced Research and Development Authority (BARDA), HHS	This project has been funded in part with Federal funds from the Critical Path Initiative at CBER, FDA and from the Biomedical Advanced Research and Development Authority (BARDA), HHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bezugla Y, 2006, PROSTAG OTH LIPID M, V79, P93, DOI 10.1016/j.prostaglandins.2005.11.001; Blatteis CM, 2007, PROG BRAIN RES, V162, P3, DOI 10.1016/S0079-6123(06)62001-3; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Campisi J, 2003, J APPL PHYSIOL, V95, P1873, DOI 10.1152/japplphysiol.00371.2003; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; Chi PL, 2011, ARTHRITIS RHEUM-US, V63, P2905, DOI 10.1002/art.30504; Davidson J, 2001, PFLUG ARCH EUR J PHY, V442, P526; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gatti S, 2002, AM J PHYSIOL-REG I, V282, pR702, DOI 10.1152/ajpregu.00393.2001; Goehler LE, 2005, BRAIN BEHAV IMMUN, V19, P334, DOI 10.1016/j.bbi.2004.09.002; Greis A, 2007, AM J PHYSIOL-REG I, V293, pR152, DOI 10.1152/ajpregu.00182.2007; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hubschle T, 2006, AM J PHYSIOL-REG I, V290, pR180, DOI 10.1152/ajpregu.00579.2005; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; JANSKY L, 1995, NEUROENDOCRINOLOGY, V62, P55, DOI 10.1159/000126988; Janssen E, 2014, J IMMUNOL, V192, P2651, DOI 10.4049/jimmunol.1300909; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kozak W, 2006, AM J PHYSIOL-REG I, V290, pR871, DOI 10.1152/ajpregu.00408.2005; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Lien E, 2001, J BIOL CHEM, V276, P1873, DOI 10.1074/jbc.M009040200; LONG NC, 1990, AM J PHYSIOL, V259, pR724, DOI 10.1152/ajpregu.1990.259.4.R724; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Netea MG, 1999, EUR J CLIN INVEST, V29, P351; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Perlik V, 2005, AM J PHYSIOL-REG I, V289, pR332, DOI 10.1152/ajpregu.00567.2004; RAZ A, 1988, J BIOL CHEM, V263, P3022; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sehic E, 1998, AM J PHYSIOL-REG I, V274, pR1594, DOI 10.1152/ajpregu.1998.274.6.R1594; Shimpo H, 2009, J ORTHOP SCI, V14, P611, DOI 10.1007/s00776-009-1370-7; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tapping RI, 1999, J IMMUNOL, V162, P5483; Zaitseva M, 2012, VACCINE, V30, P4859, DOI 10.1016/j.vaccine.2012.05.002; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	46	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98517	10.1371/journal.pone.0098517	http://dx.doi.org/10.1371/journal.pone.0098517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870145	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300051
J	Davidson, JO; Drury, PP; Green, CR; Nicholson, LF; Bennet, L; Gunn, AJ				Davidson, Joanne O.; Drury, Paul P.; Green, Colin R.; Nicholson, Louise F.; Bennet, Laura; Gunn, Alistair J.			Connexin Hemichannel Blockade Is Neuroprotective after Asphyxia in Preterm Fetal Sheep	PLOS ONE			English	Article							WHITE-MATTER INJURY; GAP-JUNCTIONAL HEMICHANNELS; SEVERE HYPOXIA; CELL-DEATH; CEREBRAL HYPOTHERMIA; CORTICAL ASTROCYTES; PERINATAL ASPHYXIA; NERVOUS-SYSTEM; CORD OCCLUSION; ISCHEMIA	Asphyxia around the time of preterm birth is associated with neurodevelopmental disability. In this study, we tested the hypothesis that blockade of connexin hemichannels would improve recovery of brain activity and reduce cell loss after asphyxia in preterm fetal sheep. Asphyxia was induced by 25 min of complete umbilical cord occlusion in preterm fetal sheep (103-104 d gestational age). Connexin hemichannels were blocked by intracerebroventricular infusion of mimetic peptide starting 90 min after asphyxia at a concentration of 50 mu M/h for one hour followed by 50 mM/24 hour for 24 hours (occlusion-peptide group, n = 6) or vehicle infusion for controls (occlusion-vehicle group, n = 7). Peptide infusion was associated with earlier recovery of electroencephalographic power after asphyxia compared to occlusion-vehicle (p<0.05), with reduced neuronal loss in the caudate and putamen (p<0.05), but not in the hippocampus. In the intragyral and periventricular white matter, peptide administration was associated with an increase in total oligodendrocyte numbers (p<0.05) and immature/mature oligodendrocytes compared to occlusion-vehicle (p<0.05), with a significant increase in proliferation (p<0.05). Connexin hemichannel blockade was neuroprotective and reduced oligodendrocyte death and improved recovery of oligodendrocyte maturation in preterm fetuses after asphyxia.	[Davidson, Joanne O.; Drury, Paul P.; Bennet, Laura; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Green, Colin R.] Univ Auckland, Dept Ophthalmol, Auckland 1, New Zealand; [Nicholson, Louise F.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Gunn, AJ (corresponding author), Univ Auckland, Dept Physiol, Auckland, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021; Green, Colin R/B-5663-2012	Green, Colin R/0000-0003-3459-6298; Nicholson, Louise/0000-0003-1737-7624; Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Bennet, Laura/0000-0002-4336-7596	Health Research Council of New Zealand; Lottery Health Board of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); Lottery Health Board of New Zealand	This study was funded by the Health Research Council of New Zealand and the Lottery Health Board of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BARKOVICH AJ, 1990, AM J NEURORADIOL, V11, P1087; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; Barrett RD, 2012, BRAIN RES, V1469, P35, DOI 10.1016/j.brainres.2012.06.018; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Behrman RE, 2007, PRETERM BIRTH CAUSES; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Bennet L, 2007, J NEUROPHYSIOL, V97, P572, DOI 10.1152/jn.00957.2006; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Danesh-Meyer HV, 2012, BRAIN, V135, P506, DOI 10.1093/brain/awr338; Davidson JO, 2013, EXP NEUROL, V248, P301, DOI 10.1016/j.expneurol.2013.06.026; Davidson JO, 2012, INT J MOL SCI, V13, P6303, DOI 10.3390/ijms13056303; Davidson JO, 2012, ANN NEUROL, V71, P121, DOI 10.1002/ana.22654; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Gajda Z, 2006, EPILEPSIA, V47, P1009, DOI 10.1111/j.1528-1167.2006.00573.x; Gomez-Gonzalo M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000352; GUNN AJ, 1992, PEDIATR RES, V31, P486, DOI 10.1203/00006450-199205000-00016; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Keogh MJ, 2012, PEDIATR RES, V71, P345, DOI 10.1038/pr.2011.80; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Murray DM, 2009, PEDIATRICS, V124, pE459, DOI 10.1542/peds.2008-2190; O'Carroll SJ, 2008, CELL COMMUN ADHES, V15, P27, DOI 10.1080/15419060802014164; Orellana JA, 2010, GLIA, V58, P329, DOI 10.1002/glia.20926; Quaedackers JS, 2004, AM J PHYSIOL-REG I, V286, pR576, DOI 10.1152/ajpregu.00592.2003; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; van Rooij LGM, 2005, ARCH DIS CHILD-FETAL, V90, P245, DOI 10.1136/adc.2004.064964; Volpe JJ, 2005, PEDIATRICS, V116, P221, DOI 10.1542/peds.2005-0191; Wang XY, 2013, CELL MOL NEUROBIOL, V33, P401, DOI 10.1007/s10571-013-9906-y; Wibbens B, 2005, AM J OBSTET GYNECOL, V193, P803, DOI 10.1016/j.ajog.2005.01.058; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	44	63	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96558	10.1371/journal.pone.0096558	http://dx.doi.org/10.1371/journal.pone.0096558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865217	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100007
J	Heude, E; Shaikho, S; Ekker, M				Heude, Eglantine; Shaikho, Sarah; Ekker, Marc			The dlx5a/dlx6a Genes Play Essential Roles in the Early Development of Zebrafish Median Fin and Pectoral Structures	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; LATE-STAGE ZEBRAFISH; HOMEOBOX GENES; DANIO-RERIO; PAIRED FINS; DISTAL-LESS; DLX GENES; LIMB DEVELOPMENT; NEURAL-TUBE; EXPRESSION PATTERNS	The Dlx5 and Dlx6 genes encode homeodomain transcription factors essential for the proper development of limbs in mammalian species. However, the role of their teleost counterparts in fin development has received little attention. Here, we show that dlx5a is an early marker of apical ectodermal cells of the pectoral fin buds and of the median fin fold, but also of cleithrum precursor cells during pectoral girdle development. We propose that early median fin fold establishment results from the medial convergence of dlx5a-expressing cells at the lateral edges of the neural keel. Expression analysis also shows involvement of dlx5a during appendage skeletogenesis. Using morpholino-mediated knock down, we demonstrate that disrupted dlx5a/6a function results in pectoral fin agenesis associated with misexpression of bmp4, fgf8a, and1 and msx genes. In contrast, the median fin fold presents defects in mesenchymal cell migration and actinotrichia formation, whereas the initial specification seems to occur normally. Our results demonstrate that the dlx5a/6a genes are essential for the induction of pectoral fin outgrowth, but are not required during median fin fold specification. The dlx5a/6a knock down also causes a failure of cleithrum formation associated with a drastic loss of runx2b and col10a1 expression. The data indicate distinct requirements for dlx5a/6a during median and pectoral fin development suggesting that initiation of unpaired and paired fin formation are not directed through the same molecular mechanisms. Our results refocus arguments on the mechanistic basis of paired appendage genesis during vertebrate evolution.	[Heude, Eglantine; Shaikho, Sarah; Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada	University of Ottawa	Ekker, M (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7221, Paris, France.	mekker@uottawa.ca	Heude, Eglantine/AAR-4334-2020	Heude, Eglantine/0000-0003-0563-9607	CIHR [MOP14460]; government of Canada	CIHR(Canadian Institutes of Health Research (CIHR)); government of Canada(CGIAR)	This work was supported by CIHR grant MOP14460. EH was a recipient of a postdoctoral fellowship from the government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe G, 2007, DEV BIOL, V304, P355, DOI 10.1016/j.ydbio.2006.12.040; Acampora D, 1999, DEVELOPMENT, V126, P3795; Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bendall AJ, 2003, INT J DEV BIOL, V47, P335; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Birnbaum RY, 2012, HUM MOL GENET, V21, P4930, DOI 10.1093/hmg/dds336; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; COATES MI, 1994, DEVELOPMENT, P169; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Crotwell PL, 2007, DEV DYNAM, V236, P3111, DOI 10.1002/dvdy.21352; Crotwell PL, 2001, DEV GENES EVOL, V211, P555, DOI 10.1007/s00427-001-0186-z; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Debiais-Thibaud M, 2008, EVOL DEV, V10, P464, DOI 10.1111/j.1525-142X.2008.00257.x; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Esterberg R, 2009, DEV BIOL, V325, P189, DOI 10.1016/j.ydbio.2008.10.017; Ferrari D, 2006, INT J DEV BIOL, V50, P709, DOI 10.1387/ijdb.062180df; Finckbeiner S, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-32; Fischer S, 2003, DEVELOPMENT, V130, P3515, DOI 10.1242/dev.00537; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Grandel H, 2002, DEVELOPMENT, V129, P2851; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Grandel H, 2000, DEVELOPMENT, V127, P4169; Harrington MJ, 2010, DEV DYNAM, V239, P747, DOI 10.1002/dvdy.22184; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Heude E, 2010, P NATL ACAD SCI USA, V107, P11441, DOI 10.1073/pnas.1001582107; Johanson Z, 2010, J EXP ZOOL PART B, V314B, P347, DOI 10.1002/jez.b.21343; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Mabee PM, 2002, J EXP ZOOL, V294, P77, DOI 10.1002/JEZ.10076; MacDonald RB, 2013, DEV BIOL, V381, P276, DOI 10.1016/j.ydbio.2013.05.025; MacDonald RB, 2010, DEV DYNAM, V239, P2298, DOI 10.1002/dvdy.22365; MacDonald RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-157; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Panganiban G, 2002, DEVELOPMENT, V129, P4371; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Quint E, 2000, J EXP ZOOL, V288, P235, DOI 10.1002/1097-010X(20001015)288:3&lt;235::AID-JEZ4&gt;3.0.CO;2-J; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Shearman RM, 2005, J MORPHOL, V264, P94, DOI 10.1002/jmor.10322; SIMEONE A, 1994, P NATL ACAD SCI USA, V91, P2250, DOI 10.1073/pnas.91.6.2250; Sleptsova-Friedrich I, 2001, MECH DEVELOP, V102, P213, DOI 10.1016/S0925-4773(01)00280-5; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tanaka M, 2012, EVOL DEV, V14, P412, DOI 10.1111/j.1525-142X.2012.00561.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tulenko FJ, 2013, P NATL ACAD SCI USA, V110, P11899, DOI 10.1073/pnas.1304210110; vanEeden FJM, 1996, DEVELOPMENT, V123, P255; Verreijdt L, 2006, DEV DYNAM, V235, P1371, DOI 10.1002/dvdy.20734; Vieux-Rochas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051700; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yang L, 1998, J NEUROSCI, V18, P8322; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Yonei-Tamura S, 2008, EVOL DEV, V10, P737, DOI 10.1111/j.1525-142X.2008.00288.x; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zerucha T, 2000, BIOCHEM CELL BIOL, V78, P593, DOI 10.1139/bcb-78-5-593; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137; Zhu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008097	80	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98505	10.1371/journal.pone.0098505	http://dx.doi.org/10.1371/journal.pone.0098505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858471	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400079
J	Boerkamp, KM; van Steenbeek, FG; Penning, LC; Koerkamp, MJAG; van Leenen, D; Vos-Loohuis, M; Grinwis, GCM; Rutteman, GR				Boerkamp, Kim M.; van Steenbeek, Frank G.; Penning, Louis C.; Koerkamp, Marian J. A. Groot; van Leenen, Dik; Vos-Loohuis, Manon; Grinwis, Guy C. M.; Rutteman, Gerard R.			The Two Main Forms of Histiocytic Sarcoma in the Predisposed Flatcoated Retriever Dog Display Variation in Gene Expression	PLOS ONE			English	Article							REAL-TIME PCR; GUIDELINES MINIMUM INFORMATION; FLAT-COATED RETRIEVERS; BREAST-CANCER; DENDRITIC CELLS; IDENTIFICATION; CLASSIFICATION; PUBLICATION; CHEMOKINES; LEUKEMIA	Examination of gene functions in specific tumor types improves insight in tumorigenesis and helps design better treatments. Due to the rarity of histiocytic/dendritic cell sarcoma in humans, it is difficult to accrue such knowledge. Therefore, comparative research of these cancers in predisposed dog breeds, such as the Flatcoated retriever, can be of value. Histiocytic sarcoma in the dog can be grouped into a soft tissue-and visceral form. The soft tissue form at first is localized, while the visceral form progresses more quickly to a terminal state, which might be related to variations in gene expression. Microarray analyses were performed on fresh-frozen tissue from Flatcoated retrievers with either soft tissue-or visceral histiocytic sarcoma. Expression differences of ten most significantly differentially expressed genes were validated with quantitative real-time PCR (q PCR) analyses. Q PCR analyses confirmed the significantly aberrant expression of three of the selected genes: C6 was up-regulated; CLEC12A and CCL5 were down-regulated in the visceral histiocytic sarcoma compared to the soft tissue form. The findings of our study indicate that these two forms of histiocytic sarcoma in the dog display a variation in gene expression and warrant analysis of functional changes in the expression of those genes in these rare sarcomas in man.	[Boerkamp, Kim M.; van Steenbeek, Frank G.; Penning, Louis C.; Vos-Loohuis, Manon; Rutteman, Gerard R.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; van Leenen, Dik] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Dept Pathobiol, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University	Boerkamp, KM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	K.M.Boerkamp@uu.nl	van Steenbeek, F.G./AFL-0046-2022; Penning, Louis/AAC-7524-2019	van Steenbeek, F.G./0000-0001-5460-6540; Grinwis, Guy/0000-0002-1583-9648; Groot Koerkamp, Marian JA/0000-0002-0867-0821	European Commission [LUPA-GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partly funded by the European Commission (LUPA-GA-201370). No external financers contributed to this experiment. Intervet International BV, that in later stage became part of Merck Sharp Dohme, provided a gift to this study in order to help finance the purchase of micro-arrays. The donation was provided without any obligation by authors to this company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie J, 2009, J HERED, V100, pS19, DOI 10.1093/jhered/esp039; Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; Baier PK, 2005, ANTICANCER RES, V25, P3581; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Boerkamp KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071094; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Constantino-Casas F, 2011, VET PATHOL, V48, P764, DOI 10.1177/0300985810385153; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Dobson J, 2009, VET COMP ONCOL, V7, P115, DOI 10.1111/j.1476-5829.2009.00181.x; Fidel J, 2006, VET COMP ONCOL, V4, P63, DOI 10.1111/j.1476-5810.2006.00090.x; Fulmer AK, 2007, CAN VET J, V48, P1041; GYAPAY G, 1991, COMPLEMENT INFLAMMAT, V8, P370, DOI 10.1159/000463208; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hoffman MM, 2007, MOL BIOL EVOL, V24, P522, DOI 10.1093/molbev/msl179; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kischel P, 2012, ANTICANCER RES, V32, P5211; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; MEUTEN DJ, 2002, TUMORS DOMESTIC ANIM, DOI DOI 10.1002/9780470376928.FMATTER; Mimori K, 2005, CLIN EXP METASTAS, V22, P59, DOI 10.1007/s10585-005-4417-y; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Moore PF, 2014, VET PATHOL, V51, P167, DOI 10.1177/0300985813510413; Mori M, 1998, CLIN CANCER RES, V4, P1507; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Rust R, 2006, J PATHOL, V209, P474, DOI 10.1002/path.2003; Schlotter YM, 2009, VET IMMUNOL IMMUNOP, V129, P115, DOI 10.1016/j.vetimm.2008.12.004; SHEARIN AL, 2012, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965; Skorupski KA, 2009, VET COMP ONCOL, V7, P139, DOI 10.1111/j.1476-5829.2009.00186.x; Swamydas M, 2013, CELL ADHES MIGR, V7, P315, DOI 10.4161/cam.25138; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tamburini BA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-619; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057973; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco-Velazquez M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23660; Wang SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035101; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	53	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98258	10.1371/journal.pone.0098258	http://dx.doi.org/10.1371/journal.pone.0098258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886914	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300051
J	Cheung, CHM; Fazier-Wood, AC; Asherson, P; Rijsdijk, F; Kuntsi, J				Cheung, Celeste H. M.; Fazier-Wood, Alexis C.; Asherson, Philip; Rijsdijk, Fruhling; Kuntsi, Jonna			Shared Cognitive Impairments and Aetiology in ADHD Symptoms and Reading Difficulties	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SUBSTANTIAL GENETIC OVERLAP; REACTION-TIME PERFORMANCE; WORKING-MEMORY; PSYCHIATRIC-DISORDERS; CRITERION VALIDITY; GENERAL-POPULATION; DELAY AVERSION; DISABILITY	Background: Twin studies indicate that the frequent co-occurrence of attention deficit hyperactivity disorder (ADHD) symptoms and reading difficulties (RD) is largely due to shared genetic influences. Both disorders are associated with multiple cognitive impairments, but it remains unclear which cognitive impairments share the aetiological pathway, underlying the co-occurrence of the symptoms. We address this question using a sample of twins aged 7-10 and a range of cognitive measures previously associated with ADHD symptoms or RD. Methods: We performed multivariate structural equation modelling analyses on parent and teacher ratings on the ADHD symptom domains of inattention and hyperactivity, parent ratings on RD, and cognitive data on response inhibition (commission errors, CE), reaction time variability (RTV), verbal short-term memory (STM), working memory (WM) and choice impulsivity, from a population sample of 1312 twins aged 7-10 years. Results: Three cognitive processes showed significant phenotypic and genetic associations with both inattention symptoms and RD: RTV, verbal WM and STM. While STM captured only 11% of the shared genetic risk between inattention and RD, the estimates increased somewhat for WM (21%) and RTV (28%); yet most of the genetic sharing between inattention and RD remained unaccounted for in each case. Conclusion: While response inhibition and choice impulsivity did not emerge as important cognitive processes underlying the co-occurrence between ADHD symptoms and RD, RTV and verbal memory processes separately showed significant phenotypic and genetic associations with both inattention symptoms and RD. Future studies employing longitudinal designs will be required to investigate the developmental pathways and direction of causality further.	[Cheung, Celeste H. M.; Asherson, Philip; Rijsdijk, Fruhling; Kuntsi, Jonna] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Fazier-Wood, Alexis C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Human Genet, Houston, TX 77030 USA	University of London; King's College London; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Kuntsi, J (corresponding author), Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.	jonna.kuntsi@kcl.ac.uk	Kuntsi, Jonna/G-9750-2011; Wood, Lekki/B-8053-2010	Kuntsi, Jonna/0000-0002-0113-8162; Rijsdijk, Fruhling/0000-0003-4762-2803; Asherson, Philip/0000-0003-2667-2254; Wood, Lekki/0000-0001-7616-2119	Wellcome Trust [GR070345MF]	Wellcome Trust(Wellcome TrustEuropean Commission)	The Study of Activity and Impulsivity Levels in children (SAIL) is funded by a project grant from the Wellcome Trust (GR070345MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou P, 2007, PSYCHOL MED, V37, P1703, DOI 10.1017/S0033291707000815; Astrom R., 2009, BEHAV GENET, V39, P634; Borger N, 2000, BIOL PSYCHOL, V51, P247, DOI 10.1016/S0301-0511(99)00040-X; Catts HW, 2002, J LEARN DISABIL-US, V35, P509; Cheung CHM, 2012, J CHILD PSYCHOL PSYC, V53, P864, DOI 10.1111/j.1469-7610.2012.02527.x; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Frazier-Wood AC, 2012, AM J MED GENET B, V159B, P131, DOI 10.1002/ajmg.b.32018; Greven CU, 2011, J ABNORM CHILD PSYCH, V39, P265, DOI 10.1007/s10802-010-9451-9; Greven CU, 2011, J CAN ACAD CHILD ADO, V20, P6; Jacobson LA, 2013, ARCH CLIN NEUROPSYCH, V28, P672, DOI 10.1093/arclin/act048; Kuntsi J, 2013, J ABNORM CHILD PSYCH; Kuntsi Jonna, 2006, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; Kuntsi J, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-40; Kuntsi J, 2006, PSYCHOL MED, V36, P1613, DOI 10.1017/S0033291706008580; Kuntsi J, 2014, J ABNORM CHILD PSYCH, V42, P127, DOI 10.1007/s10802-013-9771-7; Kuntsi J, 2010, ARCH GEN PSYCHIAT, V67, P1159, DOI 10.1001/archgenpsychiatry.2010.139; Li JJ, 2009, J CLIN EXP NEUROPSYC, V31, P877, DOI 10.1080/13803390802646973; Loehlin JC, 1996, BEHAV GENET, V26, P65, DOI 10.1007/BF02361160; Martin N.C., 2006, INT J DISABIL DEV ED, V53, P21, DOI [DOI 10.1080/10349120500509992, 10.1080/10349120500509992]; McGrath LM, 2011, J CHILD PSYCHOL PSYC, V52, P547, DOI 10.1111/j.1469-7610.2010.02346.x; McLoughlin G, 2007, J ABNORM CHILD PSYCH, V35, P999, DOI 10.1007/s10802-007-9149-9; Neale MC, 2006, TWIN RES HUM GENET, V9, P481; Paloyelis Y, 2010, J ABNORM CHILD PSYCH, V38, P1083, DOI 10.1007/s10802-010-9429-7; Paloyelis Y, 2009, J AM ACAD CHILD PSY, V48, P837, DOI 10.1097/CHI.0b013e3181ab8c97; Rietveld MJH, 2003, BEHAV GENET, V33, P247, DOI 10.1023/A:1023490307170; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Rommelse NNJ, 2009, J ABNORM CHILD PSYCH, V37, P793, DOI 10.1007/s10802-009-9312-6; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; RUTTER M, 1990, J CHILD PSYCHOL PSYC, V31, P39, DOI 10.1111/j.1469-7610.1990.tb02273.x; Sattler JM, 1992, ASSESSMENT CHILDHREN; Schmitz S, 1998, BEHAV GENET, V28, P357, DOI 10.1023/A:1021669602220; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Swanson HL, 2009, J LEARN DISABIL-US, V42, P548, DOI 10.1177/0022219409338742; Swanson HL, 2009, J LEARN DISABIL-US, V42, P260, DOI 10.1177/0022219409331958; Tamm L, 2014, J INT NEUROPSYCH SOC, V20, P292, DOI 10.1017/S1355617713001495; Trouton A, 2002, TWIN RES, V5, P444, DOI 10.1375/136905202320906255; van Leeuwen M, 2009, BEHAV GENET, V39, P245, DOI 10.1007/s10519-009-9264-1; Wang SM, 2013, J EXP CHILD PSYCHOL, V115, P188, DOI 10.1016/j.jecp.2012.11.015; Wechsler D., 1991, WECHLER INTELLIGENCE; Willcutt EG, 2005, DEV NEUROPSYCHOL, V27, P35, DOI 10.1207/s15326942dn2701_3; Willcutt EG, 2001, J ABNORM PSYCHOL, V110, P157, DOI 10.1037//0021-843X.1001.1.157; Willcutt EG, 2011, COLORADO LE IN PRESS; Willcutt EG, 2007, AM J MED GENET B, V144B, P709, DOI 10.1002/ajmg.b.30310; Willcutt EG, 2011, PSYCHOL ASSESSMENT, V23, P778, DOI 10.1037/a0023290; Willcutt EG, 2010, CORTEX, V46, P1345, DOI 10.1016/j.cortex.2010.06.009; Willcutt Erik G., 2008, V24, P195, DOI 10.1159/000118526; Wood AC, 2011, PSYCHOL MED, V41, P861, DOI 10.1017/S003329171000108X; Wood AC, 2010, PSYCHOL MED, V40, P1027, DOI 10.1017/S003329170999119X	49	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98590	10.1371/journal.pone.0098590	http://dx.doi.org/10.1371/journal.pone.0098590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24886915	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300091
J	Di Filippo, M; Marcais, C; Charriere, S; Marmontel, O; Broyer, M				Di Filippo, M.; Marcais, C.; Charriere, S.; Marmontel, O.; Broyer, M.			Post-Heparin LPL Activity Measurement Using VLDL As a Substrate: A New Robust Method for Routine Assessment of Plasma Triglyceride Lipolysis Defects (vol 9, e96482, 2014)	PLOS ONE			English	Correction													charriere, sybil/AAG-1603-2021; Di Filippo, Mathilde/C-2234-2016	Di Filippo, Mathilde/0000-0001-6206-5908; VALERO, RENE/0000-0002-2176-3280				Di Filippo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096482	1	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e99721	10.1371/journal.pone.0099721	http://dx.doi.org/10.1371/journal.pone.0099721			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886863	Green Published, gold			2022-12-27	WOS:000336956300130
J	Guerrini, M; Gennai, C; Panayides, P; Crabtree, A; Zuberogoitia, I; Copland, AS; Babushkina, O; Politi, PM; Giunchi, D; Barbanera, F				Guerrini, Monica; Gennai, Clizia; Panayides, Panicos; Crabtree, Alan; Zuberogoitia, Inigo; Copland, Alex S.; Babushkina, Olga; Politi, Paolo M.; Giunchi, Dimitri; Barbanera, Filippo			Large-Scale Patterns of Genetic Variation in a Female-Biased Dispersing Passerine: The Importance of Sex-Based Analyses	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; BARN SWALLOWS; MICROSATELLITE MARKERS; BREEDING DISPERSAL; MIGRATION PATTERNS; NEUTRALITY TESTS; HIRUNDO-RUSTICA; FLOW; EVOLUTION	Dispersal affects the distribution, dynamics and genetic structure of natural populations, and can be significantly different between sexes. However, literature records dealing with the dispersal of migratory birds are scarce, as migratory behaviour can notably complicate the study of dispersal. We used the barn swallow Hirundo rustica as model taxon to investigate patterns of genetic variability in males and in females of a migratory species showing sex-biased dispersal. We collected blood samples (n = 186) over the period 2006 to 2011 from adults (H. r. rustica subspecies) nesting in the same breeding site at either high (Ireland, Germany and Russia) or low (Spain, Italy and Cyprus) latitude across Europe. We amplified the Chromo Helicase DNA gene in all birds in order to warrant a sex-balanced sample size (92 males, 94 females). We investigated both uniparental (mitochondrial ND2 gene) and biparental (microsatellite DNA: 10 loci) genetic systems. The mtDNA provided evidence for demographic expansion yet no significant partition of the genetic variability was disclosed. Nevertheless, a comparatively distant Russian population investigated in another study, whose sequences were included in the present dataset, significantly diverged from all other ones. Different to previous studies, microsatellites highlighted remarkable genetic structure among the studied populations, and pointed to the occurrence of differences between male and female barn swallows. We produced evidence for non-random patterns of gene flow among barn swallow populations probably mediated by female natal dispersal, and we found significant variability in the philopatry of males of different populations. Our data emphasize the importance of taking into account the sex of sampled individuals in order to obtain reliable inferences on species characterized by different patterns of dispersal between males and females.	[Guerrini, Monica; Gennai, Clizia; Barbanera, Filippo] Univ Pisa, Zool & Anthropol Unit, Dept Biol, Pisa, Italy; [Panayides, Panicos] Minist Interior, Game & Fauna Serv, Nicosia, Cyprus; [Crabtree, Alan] BirdLife Cyprus, Nicosia, Cyprus; [Zuberogoitia, Inigo] Icarus Environm Studies, Logrono, Spain; [Copland, Alex S.] BirdWatch Ireland, Banagher, Ireland; [Babushkina, Olga] St Petersburg State Univ, Lab Avian Ecol & Bird Protect, St Petersburg 199034, Russia; [Politi, Paolo M.] World Wildlife Fund, Orti Bottagone Nat Reserve, Piombino, Italy; [Giunchi, Dimitri] Univ Pisa, Dept Biol, Ethol Unit, Pisa, Italy	University of Pisa; Saint Petersburg State University; University of Pisa	Barbanera, F (corresponding author), Univ Pisa, Zool & Anthropol Unit, Dept Biol, Pisa, Italy.	filippo.barbanera@unipi.it	Barbanera, Filippo/L-3109-2015; Babushkina, Olga/I-6326-2013; Giunchi, Dimitri/B-9642-2008; Iñigo, Zuberogoitia/H-5062-2019	Barbanera, Filippo/0000-0003-4225-1919; Babushkina, Olga/0000-0002-2277-2285; Giunchi, Dimitri/0000-0003-2753-8997; Zuberogoitia, Inigo/0000-0002-8945-7386	Anastasios G. Leventis Foundation (Nicosia, Cyprus)	Anastasios G. Leventis Foundation (Nicosia, Cyprus)	The Anastasios G. Leventis Foundation (Nicosia, Cyprus) funded this research with two grants (2008-2010, 2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Arguedas N, 2000, CONDOR, V102, P517, DOI 10.1650/0010-5422(2000)102[0517:SMAGPS]2.0.CO;2; Balbontin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1197, DOI 10.1007/s00265-009-0752-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbanera F, 2005, BIOL CONSERV, V122, P275, DOI 10.1016/j.biocon.2004.07.017; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Barbanera F, 2009, NATURWISSENSCHAFTEN, V96, P1203, DOI 10.1007/s00114-009-0586-x; Belliure J, 2000, J EVOLUTION BIOL, V13, P480; Blair ME, 2012, AM J PRIMATOL, V74, P37, DOI 10.1002/ajp.21007; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Borden WC, 2006, J GREAT LAKES RES, V32, P242, DOI 10.3394/0380-1330(2006)32[242:DPGSOS]2.0.CO;2; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Davis LA, 2006, MOL ECOL, V15, P2141, DOI 10.1111/j.1365-294X.2006.02914.x; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; Dor R, 2010, MOL PHYLOGENET EVOL, V56, P409, DOI 10.1016/j.ympev.2010.02.008; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Itonaga N, 2010, J ETHOL, V28, P393, DOI 10.1007/s10164-010-0204-6; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; Jones KL, 2005, MOL ECOL, V14, P2645, DOI 10.1111/j.1365-294X.2005.02622.x; Kahn NW, 1998, AUK, V115, P1074; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moller AP, 2011, J EVOLUTION BIOL, V24, P1744, DOI 10.1111/j.1420-9101.2011.02302.x; Moller AP., 1994, SEXUAL SELECTION BAR; Newton I., 2003, SPECIATION BIOGEOGRA; Nichols J., 2001, DISPERSAL; Ortego J, 2011, ANIM BEHAV, V82, P131, DOI 10.1016/j.anbehav.2011.04.007; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Palo JU, 2004, MOL ECOL, V13, P2865, DOI 10.1111/j.1365-294X.2004.02286.x; Paquette SR, 2010, J HERED, V101, P403, DOI 10.1093/jhered/esq020; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Piertney SB, 2000, EVOLUTION, V54, P279, DOI 10.1111/j.0014-3820.2000.tb00028.x; Pilkington MM, 2008, MOL BIOL EVOL, V25, P517, DOI 10.1093/molbev/msm279; PRIMMER CR, 1995, MOL ECOL, V4, P493, DOI 10.1111/j.1365-294X.1995.tb00243.x; Pritchard JK, 2000, GENETICS, V155, P945; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Randi E, 2003, MOL ECOL, V12, P2201, DOI 10.1046/j.1365-294X.2003.01899.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rockwell R.F., 1987, P223; Rodriguez-Ramilo ST, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-49; Roff DA, 2004, HEREDITY, V93, P8, DOI 10.1038/sj.hdy.6800404; Santure AW, 2010, BIOL J LINN SOC, V99, P306, DOI 10.1111/j.1095-8312.2009.01366.x; Schneider S, 1999, GENETICS, V152, P1079; Scribner KT, 2001, EVOLUTION, V55, P2105; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Spina F., 2008, ATLANTE MIGRAZIONE U; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsyusko OV, 2007, MOL ECOL NOTES, V7, P833, DOI 10.1111/j.1471-8286.2007.01719.x; Turner A., 2006, BARN SWALLOW; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zink RM, 2006, P ROY SOC B-BIOL SCI, V273, P1245, DOI 10.1098/rspb.2005.3414; [No title captured]	81	7	8	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98574	10.1371/journal.pone.0098574	http://dx.doi.org/10.1371/journal.pone.0098574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886720	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300088
J	Mammari, N; Vignoles, P; Halabi, MA; Darde, ML; Courtioux, B				Mammari, Nour; Vignoles, Philippe; Halabi, Mohamad Adnan; Darde, Marie Laure; Courtioux, Bertrand			In Vitro Infection of Human Nervous Cells by Two Strains of Toxoplasma gondii: A Kinetic Analysis of Immune Mediators and Parasite Multiplication	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTERCELLULAR-ADHESION MOLECULE-1; CHEMOTACTIC PROTEIN-1 SECRETION; MICROGLIAL CELLS; GENETIC DIVERSITY; DENDRITIC CELLS; HOST-RESISTANCE; CHEMOKINE; EXPRESSION; ASTROCYTES	The severity of toxoplasmic infection depends mainly on the immune status of the host, but also on the Toxoplasma gondii strains, which differ by their virulence profile. The relationship between the human host and T. gondii has not yet been elucidated because few studies have been conducted on human models. The immune mechanisms involved in the persistence of T. gondii in the brains of immunocompetent subjects and during the reactivation of latent infections are still unclear. In this study, we analyzed the kinetics of immune mediators in human nervous cells in vitro, infected with two strains of T. gondii. Human neuroblast cell line (SH SY5Y), microglial (CMH5) and endothelial cells (Hbmec) were infected separately by RH (type I) or PRU (type II) strains for 8 h, 14 h, 24 h and 48 h (ratio 1 cell: 2 tachyzoites). Pro-inflammatory protein expression was different between the two strains and among different human nervous cells. The cytokines IL-6, IL-8 and the chemokines MCP-1 and GRO alpha, and SERPIN E1 were significantly increased in CMH5 and SH SY5Y at 24 h pi. At this point of infection, the parasite burden declined in microglial cells and neurons, but remained high in endothelial cells. This differential effect on the early parasite multiplication may be correlated with a higher production of immune mediators by neurons and microglial cells compared to endothelial cells. Regarding strain differences, PRU strain, but not RH strain, stimulates all cells to produce pro-inflammatory growth factors, G-CSF and GM-CSF. These proteins could increase the inflammatory effect of this type II strain. These results suggest that the different protein expression profiles depend on the parasitic strain and on the human nervous cell type, and that this could be at the origin of diverse brain lesions caused by T. gondii.	[Mammari, Nour; Vignoles, Philippe; Darde, Marie Laure; Courtioux, Bertrand] Natl Inst Hlth & Med Res 1094, Trop Neuroepidemiol Inst, Limoges, France; [Mammari, Nour; Vignoles, Philippe; Darde, Marie Laure; Courtioux, Bertrand] Univ Limoges, Natl Ctr Sci Res, France 3503 Inst Genom Environm Immun Hlth & Ther, Limoges, France; [Halabi, Mohamad Adnan] Univ Limoges, Fac Pharm, France 3503 Inst Genom Environm Immun Hlth & Ther, Natl Ctr Sci Res France 7276, Limoges, France; [Darde, Marie Laure] Univ Hosp, Dept Parasitol, Biol Resource Ctr Toxoplasma, Limoges, France	Universite de Limoges; Universite de Limoges; CHU Limoges	Mammari, N (corresponding author), INSERM UMR1094, Trop Neuroepidemiol Inst, Limoges, France.	nour.mammari@unilim.fr	HALABI, Mohamad adnan/AAY-6996-2021; Mammari, Nour/AAY-7000-2021	HALABI, Mohamad adnan/0000-0001-8869-5385; Mammari, Nour/0000-0002-3075-110X	"3IS, infection et immunite sous immunosuppression'' from FR 3503 GEIST, Limoges, France; INSERM 1094 Tropical Neuroepidemiology Institute	"3IS, infection et immunite sous immunosuppression'' from FR 3503 GEIST, Limoges, France; INSERM 1094 Tropical Neuroepidemiology Institute	This work was supported by grants from "3IS, infection et immunite" sous immunosuppression'' from FR 3503 GEIST, Limoges, France, and INSERM 1094 Tropical Neuroepidemiology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2013, MOL CELL NEUROSCI; Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Ajzenberg D, 2002, INT J PARASITOL, V32, P27, DOI 10.1016/S0020-7519(01)00301-0; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Aviles H, 2008, J PARASITOL, V94, P1282, DOI 10.1645/GE-1309.1; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; BLEWETT DA, 1983, VET REC, V112, P98, DOI 10.1136/vr.112.5.98; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; BRACH MA, 1992, BLOOD, V80, P2920; Brenier-Pinchart MP, 2002, FEMS MICROBIOL LETT, V214, P45, DOI 10.1111/j.1574-6968.2002.tb11323.x; Brenier-Pinchart MP, 2004, ACTA NEUROPATHOL, V107, P245, DOI 10.1007/s00401-003-0804-0; Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006; Channon JY, 2002, INFECT IMMUN, V70, P6048, DOI 10.1128/IAI.70.11.6048-6057.2002; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; COLEMAN DL, 1988, BLOOD, V72, P573; de Gannes FMP, 1998, NEUROCHEM INT, V33, P61, DOI 10.1016/S0197-0186(05)80010-5; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Denney CF, 1999, INFECT IMMUN, V67, P1547; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; ERBE DV, 1991, J IMMUNOL, V146, P3145; Fagard R, 1999, PARASITOL TODAY, V15, P504, DOI 10.1016/S0169-4758(99)01568-9; Fischer HG, 1997, EUR J IMMUNOL, V27, P1539, DOI 10.1002/eji.1830270633; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Freund YR, 2001, INFECT IMMUN, V69, P765, DOI 10.1128/IAI.69.2.765-772.2001; Halonen SK, 1996, J NEUROPATH EXP NEUR, V55, P1150, DOI 10.1097/00005072-199611000-00006; Halonen SK, 1998, INT J PARASITOL, V28, P815, DOI 10.1016/S0020-7519(98)00035-6; Haroon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035516; Herrmann DC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-39; HULINSKA D, 1990, FOLIA PARASIT, V37, P207; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jebbari H, 1998, PARASITE IMMUNOL, V20, P231, DOI 10.1046/j.1365-3024.1998.00152.x; Kikumura A, 2012, BRIT J OPHTHALMOL, V96, P1259, DOI 10.1136/bjophthalmol-2012-301490; Knight BC, 2006, J NEUROIMMUNOL, V179, P126, DOI 10.1016/j.jneuroim.2006.06.002; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lieberman Linda A, 2002, Int Rev Immunol, V21, P373, DOI 10.1080/08830180213281; Liu ZY, 1997, BLOOD, V90, P2253, DOI 10.1182/blood.V90.6.2253.2253_2253_2259; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; Goncalves RM, 2007, ACTA OPHTHALMOL SCAN, V85, P871, DOI 10.1111/j.1600-0420.2007.00943.x; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Nagineni CN, 2000, INFECT IMMUN, V68, P407, DOI 10.1128/IAI.68.1.407-410.2000; Petersen E, 2012, OCUL IMMUNOL INFLAMM, V20, P68, DOI 10.3109/09273948.2012.661115; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; ROSS RA, 1983, J NATL CANCER I, V71, P741; Schuindt SHS, 2012, VET PARASITOL, V186, P207, DOI 10.1016/j.vetpar.2011.11.035; Schluter D, 2001, INFECT IMMUN, V69, P7889, DOI 10.1128/IAI.69.12.7889-7893.2001; SCHWEITZER CM, 1995, EXP HEMATOL, V23, P41; Schweitzer KM, 1997, LAB INVEST, V76, P25; Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Xiao JC, 2011, INFECT IMMUN, V79, P1363, DOI 10.1128/IAI.00947-10; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598	60	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98491	10.1371/journal.pone.0098491	http://dx.doi.org/10.1371/journal.pone.0098491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886982	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300072
J	Paulus-Hock, V; Cheung, EC; Roxburgh, P; Vousden, KH; Hock, AK				Paulus-Hock, Viola; Cheung, Eric C.; Roxburgh, Patricia; Vousden, Karen H.; Hock, Andreas K.			iRFP Is a Real Time Marker for Transformation Based Assays in High Content Screening	PLOS ONE			English	Article							GROWTH; CELLS	Anchorage independent growth is one of the hallmarks of oncogenic transformation. Here we show that infrared fluorescent protein (iRFP) based assays allow accurate and unbiased determination of colony formation and anchorage independent growth over time. This protocol is particularly compatible with high throughput systems, in contrast to traditional methods which are often labor-intensive, subjective to bias and do not allow further analysis using the same cells. Transformation in a single layer soft agar assay could be documented as early as 2 to 3 days in a 96 well format, which can be easily combined with standard transfection, infection and compound screening setups to allow for high throughput screening to identify therapeutic targets.	[Paulus-Hock, Viola; Cheung, Eric C.; Roxburgh, Patricia; Vousden, Karen H.; Hock, Andreas K.] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Roxburgh, Patricia] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow	Vousden, KH (corresponding author), Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk; a.hock@beatson.gla.ac.uk		Paulus-Hock, Viola/0000-0002-2891-5419	Cancer Research UK; Cancer Research UK [18274] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The authors would like to acknowledge funding from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1991, CANCER RES, V51, P1247; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Hock AK, 2014, CELL CYCLE, V13, P220, DOI 10.4161/cc.26985; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SIMONS PJ, 1967, NATURE, V214, P897, DOI 10.1038/214897a0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299	10	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98399	10.1371/journal.pone.0098399	http://dx.doi.org/10.1371/journal.pone.0098399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887316	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336956300061
J	Schmidt, BL; Kuczynski, J; Bhattacharya, A; Huey, B; Corby, PM; Queiroz, ELS; Nightingale, K; Kerr, AR; DeLacure, MD; Veeramachaneni, R; Olshen, AB; Albertson, DG				Schmidt, Brian L.; Kuczynski, Justin; Bhattacharya, Aditi; Huey, Bing; Corby, Patricia M.; Queiroz, Erica L. S.; Nightingale, Kira; Kerr, A. Ross; DeLacure, Mark D.; Veeramachaneni, Ratna; Olshen, Adam B.; Albertson, Donna G.			Changes in Abundance of Oral Microbiota Associated with Oral Cancer	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; BACTERIA PRESENT; NECK-CANCER; DIVERSITY; HEAD; PERIODONTITIS; MICROFLORA; EXPRESSION; CARCINOMA; SEQUENCES	Individual bacteria and shifts in the composition of the microbiome have been associated with human diseases including cancer. To investigate changes in the microbiome associated with oral cancers, we profiled cancers and anatomically matched contralateral normal tissue from the same patient by sequencing 16S rDNA hypervariable region amplicons. In cancer samples from both a discovery and a subsequent confirmation cohort, abundance of Firmicutes (especially Streptococcus) and Actinobacteria (especially Rothia) was significantly decreased relative to contralateral normal samples from the same patient. Significant decreases in abundance of these phyla were observed for pre-cancers, but not when comparing samples from contralateral sites (tongue and floor of mouth) from healthy individuals. Weighted UniFrac principal coordinates analysis based on 12 taxa separated most cancers from other samples with greatest separation of node positive cases. These studies begin to develop a framework for exploiting the oral microbiome for monitoring oral cancer development, progression and recurrence.	[Schmidt, Brian L.; Corby, Patricia M.; Queiroz, Erica L. S.; Nightingale, Kira] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY 10012 USA; [Schmidt, Brian L.] NYU, Coll Dent, Dept Oral & Maxillofacial Surg, New York, NY USA; [Kuczynski, Justin] Second Genome, Bioinformat Dept, San Bruno, CA USA; [Bhattacharya, Aditi; Huey, Bing; Veeramachaneni, Ratna; Olshen, Adam B.; Albertson, Donna G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kerr, A. Ross] NYU, Coll Dent, Dept Oral & Maxillofacial Pathol Radiol & Med, New York, NY USA; [DeLacure, Mark D.] NYU, Dept Otolaryngol, New York, NY 10016 USA; [DeLacure, Mark D.] NYU, Dept Plast Surg, New York, NY USA	New York University; New York University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; New York University; New York University; New York University	Albertson, DG (corresponding author), NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY 10012 USA.	da66@nyu.edu	Veeramachaneni, Ratna/N-1810-2015; Teh, Muy-Teck/B-9284-2016	Veeramachaneni, Ratna/0000-0003-2515-0120; Schmidt, Brian/0000-0002-2409-8984; Teh, Muy-Teck/0000-0002-7725-8355	Roche; National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director, National Institutes of Health, through University of San Francisco (UCSF)-CTSI [UL1 RR024129]; National Cancer Institute [R01 CA131286, R21 CA 941186215]; National Institute of Dental and Craniofacial Research [R01 DE019796]; NATIONAL CANCER INSTITUTE [R01CA131286] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	Roche(Roche Holding); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director, National Institutes of Health, through University of San Francisco (UCSF)-CTSI; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by an award of a GS Junior 454 Sequencing run from Roche, the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco (UCSF)-CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CA131286, R21 CA 941186215) and the National Institute of Dental and Craniofacial Research (R01 DE019796). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bebek G, 2012, HUM MOL GENET, V21, P1557, DOI 10.1093/hmg/ddr593; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bizzarro S, 2013, J CLIN PERIODONTOL, V40, P483, DOI 10.1111/jcpe.12087; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chang AH, 2010, CLIN MICROBIOL REV, V23, P837, DOI 10.1128/CMR.00012-10; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cheng Allen, 2008, Oral Maxillofac Surg Clin North Am, V20, P477, DOI 10.1016/j.coms.2008.02.002; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; CORREA P, 1975, LANCET, V2, P58; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Guan SM, 2011, FEMS IMMUNOL MED MIC, V62, P91, DOI 10.1111/j.1574-695X.2011.00789.x; Gursoy UK, 2010, J PERIODONTOL, V81, P1084, DOI 10.1902/jop.2010.090664; Hooper SJ, 2007, J MED MICROBIOL, V56, P1651, DOI 10.1099/jmm.0.46918-0; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kumar PS, 2011, INFECT IMMUN, V79, P4730, DOI 10.1128/IAI.05371-11; Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Markopoulos AK, 2010, OPEN DENT J, V4, P172, DOI 10.2174/1874210601004010172; Matthews AM, 2012, BRIT J ORAL MAXILLOF; Nagy KN, 1998, ORAL ONCOL, V34, P304, DOI 10.1016/S1368-8375(98)80012-2; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Nobbs AH, 2011, J DENT RES, V90, P1271, DOI 10.1177/0022034511399096; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Pushalkar S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-144; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Schmidt BL, 2004, J ORAL MAXIL SURG, V62, P1055, DOI 10.1016/j.joms.2004.03.010; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Stahringer SS, 2012, GENOME RES; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei JE, 2011, INT J CANCER, V129, P2207, DOI 10.1002/ijc.25881; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang G, 2011, J PERIODONTAL RES, V46, P558, DOI 10.1111/j.1600-0765.2011.01373.x; Zhang G, 2011, MOL ORAL MICROBIOL, V26, P150, DOI 10.1111/j.2041-1014.2010.00600.x	57	192	199	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98741	10.1371/journal.pone.0098741	http://dx.doi.org/10.1371/journal.pone.0098741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887397	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300102
J	Leal, MF; Cirilo, PDR; Mazzotti, TKF; Calcagno, DQ; Wisnieski, F; Demachki, S; Martinez, MC; Assumpcao, PP; Chammas, R; Burbano, RR; Smith, MC				Leal, Mariana Ferreira; Ramos Cirilo, Priscila Daniele; Furuya Mazzotti, Tatiane Katsue; Calcagno, Danielle Queiroz; Wisnieski, Fernanda; Demachki, Samia; Martinez, Margarita Cortes; Assumpcao, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodriguez; Smith, Marilia Cardoso			Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3 ' Untranslated Region 1630 C > T Polymorphism and Copy Number Variation	PLOS ONE			English	Article							CLINICOPATHOLOGICAL CHARACTERISTICS; NUMERICAL ABERRATIONS; YOUNG; IDENTIFICATION; CHROMOSOME-17; PROGNOSIS; CARCINOMA; BIOMARKER; DIFFUSE; PROTEIN	PHB is a reported oncogene and tumor suppressor in gastric cancer. Here, we evaluated whether the PHB copy number and the rs6917 polymorphism affect its expression in gastric cancer. Down-regulation and up-regulation of PHB were observed in the evaluated tumors. Reduced expression was associated with tumor dedifferentiation and cancer initiation. The T allele of the rs6917 polymorphism was associated with reduced PHB mRNA levels. Moreover, the up-regulation of PHB appeared to be regulated by the gain of additional gene copies. Thus, PHB copy number variation and differential expression of the rs6917 polymorphism may play a role in PHB transcriptional regulation.	[Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Wisnieski, Fernanda; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, Brazil; [Leal, Mariana Ferreira] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, Brazil; [Ramos Cirilo, Priscila Daniele; Furuya Mazzotti, Tatiane Katsue; Martinez, Margarita Cortes; Chammas, Roger] Univ Fed Sao Paulo, Fac Med, Dept Radiol, Lab Oncol Expt, Sao Paulo, Brazil; [Ramos Cirilo, Priscila Daniele; Furuya Mazzotti, Tatiane Katsue; Martinez, Margarita Cortes; Chammas, Roger] Inst Canc Estado Sao Paulo, Ctr Invest Translat Oncol, Sao Paulo, Brazil; [Calcagno, Danielle Queiroz; Demachki, Samia; Assumpcao, Paulo Pimentel] Fed Univ Para, Hosp Univ Joao Barros Barreto, BR-66059 Belem, Para, Brazil; [Burbano, Rommel Rodriguez] Fed Univ Para, Inst Ciencias Biol, Lab Citogenet Humana, BR-66059 Belem, Para, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Universidade Federal do Para	Leal, MF (corresponding author), Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, Brazil.	mariana.morf@epm.br	Chammas, Roger/A-8004-2011; Burbano, Rommel R/C-4149-2012; Furuya, Tatiane K/E-5543-2013; Leal, Mariana/C-4010-2012; Cirillo, Priscila Daniele Ramos/AAH-4246-2020; de A. C. Smith, Marilia/C-4397-2012; Furuya, Tatiane Katsue/B-5842-2015	Chammas, Roger/0000-0003-0342-8726; Burbano, Rommel R/0000-0002-4872-234X; Leal, Mariana/0000-0003-4375-2563; Cirillo, Priscila Daniele Ramos/0000-0001-5453-3978; de A. C. Smith, Marilia/0000-0002-1441-1033; Wisnieski, Fernanda/0000-0003-4963-3194	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; RC, MACS and RRB) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; MFL, PDRC and DQC) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Assumpcao PP, 2006, CANCER GENET CYTOGEN, V169, P45, DOI 10.1016/j.cancergencyto.2006.03.019; Buffart TE, 2007, J PATHOL, V211, P45, DOI 10.1002/path.2085; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Francisco G, 2013, MELANOMA RES, V23, P231, DOI 10.1097/CMR.0b013e3283612483; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Jupe ER, 1996, EXP CELL RES, V224, P128, DOI 10.1006/excr.1996.0120; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Kang XD, 2008, J GASTROENTEROL, V43, P618, DOI 10.1007/s00535-008-2208-3; Khayat AS, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-55; Kitamura K, 1996, BRIT J CANCER, V73, P798, DOI 10.1038/bjc.1996.139; Kitayama Y, 2003, LAB INVEST, V83, P1311, DOI 10.1097/01.LAB.0000087622.80751.C5; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042255; Leal MF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/631268; Leal MF, 2009, CANCER GENET CYTOGEN, V195, P85, DOI 10.1016/j.cancergencyto.2009.04.020; Li J, 2013, CANCER LETT, V337, P22, DOI 10.1016/j.canlet.2013.05.034; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Maehara Y, 1996, CANCER-AM CANCER SOC, V77, P1774, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1774::AID-CNCR3>3.0.CO;2-C; Manjeshwar S, 2004, J MOL HISTOL, V35, P639; Manjeshwar S, 2003, CANCER RES, V63, P5251; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Ren H, 2006, WORLD J GASTROENTERO, V12, P2789, DOI 10.3748/wjg.v12.i17.2789; Ryu JW, 2003, J KOREAN MED SCI, V18, P505, DOI 10.3346/jkms.2003.18.4.505; Takeno SS, 2009, CANCER GENET CYTOGEN, V190, P1, DOI 10.1016/j.cancergencyto.2008.09.007; Tang L, 2013, ONCOTARGETS THER, V6, P177, DOI 10.2147/OTT.S40997; Tavares A, 2013, PATHOL ONCOL RES, V19, P111, DOI 10.1007/s12253-012-9530-z; Terada R, 1999, J GASTROENTEROL, V34, P11, DOI 10.1007/s005350050210; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Wang KJ, 2004, WORLD J GASTROENTERO, V10, P2179; WARBURG O, 1956, SCIENCE, V124, P269; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Zhou TB, 2012, ASIAN PAC J CANCER P, V13, P3319, DOI 10.7314/APJCP.2012.13.7.3319	43	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98583	10.1371/journal.pone.0098583	http://dx.doi.org/10.1371/journal.pone.0098583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879411	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500069
J	Parker, M; Acland, A; Armstrong, HJ; Bellingham, JR; Bland, J; Bodmer, HC; Burall, S; Castell, S; Chilvers, J; Cleevely, DD; Cope, D; Costanzo, L; Dolan, JA; Doubleday, R; Feng, WY; Godfray, HCJ; Good, DA; Grant, J; Green, N; Groen, AJ; Guilliams, TT; Gupta, S; Hall, AC; Heathfield, A; Hotopp, U; Kass, G; Leeder, T; Lickorish, FA; Lueshi, LM; Magee, C; Mata, T; McBride, T; McCarthy, N; Mercer, A; Neilson, R; Ouchikh, J; Oughton, EJ; Oxenham, D; Pallett, H; Palmer, J; Patmore, J; Petts, J; Pinkerton, J; Ploszek, R; Pratt, A; Rocks, SA; Stansfield, N; Surkovic, E; Tyler, CP; Watkinson, AR; Wentworth, J; Willis, R; Wollner, PKA; Worts, K; Sutherland, WJ				Parker, Miles; Acland, Andrew; Armstrong, Harry J.; Bellingham, Jim R.; Bland, Jessica; Bodmer, Helen C.; Burall, Simon; Castell, Sarah; Chilvers, Jason; Cleevely, David D.; Cope, David; Costanzo, Lucia; Dolan, James A.; Doubleday, Robert; Feng, Wai Yi; Godfray, H. Charles J.; Good, David A.; Grant, Jonathan; Green, Nick; Groen, Arnoud J.; Guilliams, Tim T.; Gupta, Sunjai; Hall, Amanda C.; Heathfield, Adam; Hotopp, Ulrike; Kass, Gary; Leeder, Tim; Lickorish, Fiona A.; Lueshi, Leila M.; Magee, Chris; Mata, Tiago; McBride, Tony; McCarthy, Natasha; Mercer, Alan; Neilson, Ross; Ouchikh, Jackie; Oughton, Edward J.; Oxenham, David; Pallett, Helen; Palmer, James; Patmore, Jeff; Petts, Judith; Pinkerton, Jan; Ploszek, Richard; Pratt, Alan; Rocks, Sophie A.; Stansfield, Neil; Surkovic, Elizabeth; Tyler, Christopher P.; Watkinson, Andrew R.; Wentworth, Jonny; Willis, Rebecca; Wollner, Patrick K. A.; Worts, Kim; Sutherland, William J.			Identifying the Science and Technology Dimensions of Emerging Public Policy Issues through Horizon Scanning	PLOS ONE			English	Article							ADAPTATION; ENERGY; PARTICIPATION; QUESTIONS; THREATS; FUTURE; PLANT; POWER; RISK; FOOD	Public policy requires public support, which in turn implies a need to enable the public not just to understand policy but also to be engaged in its development. Where complex science and technology issues are involved in policy making, this takes time, so it is important to identify emerging issues of this type and prepare engagement plans. In our horizon scanning exercise, we used a modified Delphi technique [1]. A wide group of people with interests in the science and policy interface (drawn from policy makers, policy adviser, practitioners, the private sector and academics) elicited a long list of emergent policy issues in which science and technology would feature strongly and which would also necessitate public engagement as policies are developed. This was then refined to a short list of top priorities for policy makers. Thirty issues were identified within broad areas of business and technology; energy and environment; government, politics and education; health, healthcare, population and aging; information, communication, infrastructure and transport; and public safety and national security.	[Parker, Miles; Cleevely, David D.; Doubleday, Robert; Guilliams, Tim T.; Ouchikh, Jackie] Univ Cambridge, Ctr Sci & Policy, Cambridge, England; [Acland, Andrew; Mercer, Alan] Sciencewise, Didcot, Oxon, England; [Armstrong, Harry J.] Babraham Inst, Cambridge, England; [Bellingham, Jim R.] Univ Cambridge, Sch Phys Sci, Cambridge, England; [Bland, Jessica] Nesta, London, England; [Bodmer, Helen C.; Costanzo, Lucia; Pinkerton, Jan] Dept Business Innovat & Skills, London, England; [Burall, Simon] Involve, London, England; [Castell, Sarah] Ipsos MORI, London, England; [Chilvers, Jason; Pallett, Helen] Univ E Anglia, Sch Environm Sci, Sci Soc & Sustainabil Grp 3S, Norwich NR4 7TJ, Norfolk, England; [Cope, David] Clare Hall, Cambridge, England; [Dolan, James A.] Univ Cambridge, NanoDTC, Cambridge, England; [Feng, Wai Yi] Univ Cambridge, Fac Educ, Cambridge, England; [Godfray, H. Charles J.] Univ Oxford, Oxford Martin Programme Future Food, Oxford, England; [Good, David A.] Univ Cambridge, Dept Psychol, Cambridge, England; [Grant, Jonathan] RAND Europe, Cambridge, England; [Green, Nick] Royal Soc, London, England; [Groen, Arnoud J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Gupta, Sunjai] Publ Hlth England, London, England; [Hall, Amanda C.] Univ Bristol, Dept Geog Sci, Bristol, Avon, England; [Heathfield, Adam] Pfizer Ltd, Sandwich, Kent, England; [Hotopp, Ulrike; Worts, Kim] Dept Environm Food & Rural Affairs, London, England; [Kass, Gary] Nat England, London, England; [Leeder, Tim] Univ Bristol, Bristol, Avon, England; [Lickorish, Fiona A.; Rocks, Sophie A.] Cranfield Univ, Cranfield MK43 0AL, Beds, England; [Lueshi, Leila M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Magee, Chris] Understanding Anim Res, London, England; [Mata, Tiago] Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England; [McCarthy, Natasha; Ploszek, Richard] Royal Acad Engn, London, England; [Neilson, Ross] Cabinet Off, London, England; [Oughton, Edward J.] Univ Cambridge, Dept Land Econ, Cambridge Ctr Climate Change Mitigat Res 4CMR, Cambridge CB3 9EP, England; [Oxenham, David] Def Sci & Technol Lab, Salisbury, Wilts, England; [Palmer, James] Univ Oxford Keble Coll, Oxford OX1 3PG, England; [Patmore, Jeff] Univ Cambridge Pembroke Coll, Cambridge CB2 1RF, England; [Petts, Judith] Univ Southampton, Southampton, Hants, England; [Pratt, Alan] Home Off, London, England; [Stansfield, Neil] Minist Def, London, England; [Surkovic, Elizabeth] Govt Off Sci, London, England; [Tyler, Christopher P.; Wentworth, Jonny] Parliamentary Off Sci & Technol, London, England; [Watkinson, Andrew R.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Willis, Rebecca] Green Alliance, London, England; [Wollner, Patrick K. A.] Univ Cambridge, Dept Engn, Engn Design Ctr, Cambridge CB2 1PZ, England; [Sutherland, William J.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of East Anglia; University of Cambridge; University of Cambridge; University of Oxford; University of Cambridge; RAND Corporation; RAND Europe; University of Cambridge; Public Health England; University of Bristol; Pfizer; University of Bristol; Cranfield University; University of Cambridge; University of Cambridge; University of Cambridge; Defence Science & Technology Laboratory; University of Oxford; University of Cambridge; University of Southampton; University of East Anglia; University of Cambridge; University of Cambridge	Parker, M (corresponding author), Univ Cambridge, Ctr Sci & Policy, Cambridge, England.	miles.parker@csap.cam.ac.uk	Rocks, Sophie/A-3965-2010; Oughton, Edward/C-4376-2018; Grant, Jonathan C/K-4282-2012	Rocks, Sophie/0000-0002-4439-1299; Oughton, Edward/0000-0002-2766-008X; Grant, Jonathan C/0000-0002-1646-3486; Chilvers, Jason/0000-0001-9238-1653; Lickorish, Fiona/0000-0002-0696-202X; Pallett, Helen/0000-0001-5014-6356; Mata, Tiago/0000-0002-6423-299X; Tyler, Chris/0000-0001-5403-372X; Sutherland, William/0000-0002-6498-0437; Palmer, James/0000-0002-1151-1485; Dolan, James/0000-0001-5019-1544	UK Government through the Scienewise programme; EPSRC [EP/K005316/1, EP/I01344X/2, EP/I01344X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I01344X/1, EP/I01344X/2, 1208452, EP/K005316/1] Funding Source: researchfish	UK Government through the Scienewise programme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding for the work reported in this paper was provided by the UK Government through the Scienewise programme: http://www.sciencewise-erc.org. uk/cms/public-dialogue-sciencewise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acemoglu D, 2011, WORKING PAPERS; Adger WN, 2005, GLOBAL ENVIRON CHANG, V15, P77, DOI [10.1016/j.gloenvcha.2004.12.005, 10.1016/j.gloenvcha.2005.03.001]; Aerospace Aviation & Defence Knowledge Transfer Network, 2012, AUT SYST OPP CHALL U; Anderson C., 2012, MAKERS NEW IND REVOL; Anderson C., 2006, LONG TAIL WHY FUTURE; [Anonymous], 2012, 0703072009550687SERD; [Anonymous], DEF CRIT RAW MAT; Baker A, 2000, HLTH STAT Q, V7, P32; Basu N, 2013, FOREIGH POLICY J; Baylis M, 2006, T73 FOR OFF SCI INN; Bech M, 2011, EUR J HEALTH ECON, V12, P469, DOI 10.1007/s10198-010-0260-4; Beddington J., 2009, FOOD ENERGY WATER CL; Berdal M, 1997, MILLENNIUM-J INT ST, V26, P795, DOI 10.1177/03058298970260030401; Burgman MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022998; Cadogan RA, 2004, J BUSINESS EC RES, V2, P49; Carlet J, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-1; Cerami JR, 2001, US ARMY WAR COLL GUI, P19; Collingridge D, 1980, SOCIAL CONTROL TECHN; Council for Science and Technology, 2009, NAT INTR 21 CENT; CUSUMANO MA, 2013, COMMUN ACM, V56, P26; Czosseck C, 2012, 4 INT C CYB CONFL NA; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; De La Maisonneuve C, 2013, OECD EC POLICY PAPER, V6; Department for Business Innovation & Skills, 2011, CM8239; Department for Environment Food and Rural Affairs, 2011, GREENL 3 GUID ENV RI; Department for Environment Food and Rural Affairs, 2009, UK CLIM PROJ; Department for Environment Food and Rural Affairs, 2012, REV NAT RES STRAT RE; Department for Environment Food and Rural Affairs, 2012, SUMM KEY FIND UK CLI; Department for Transport, 2008, DEL SUST TRANSP SYST; Department of Business Innovation and Skills, 2011, STRAT UK LIF SCI; Department of Health, 2012, ANT RES POS AL THREA; Department of Health, 2012, PUBL HLTH OUTC FRAM; Diener E., 2003, WELL BEING FDN HEDON; DoH, 2013, UK 5 YEAR ANT RES ST; Douron M, 2010, J TOXICOL ENV HEAL A, V73, P181, DOI 10.1080/15287390903340450; Engineering and Physical Science Research Council, 2011, DET GRANT AUT POW SY; European Commission, 2012, SEC201272; Fao WFP. IFAD, 2014, STAT FOOD INS WORLD; FIORINO DJ, 1990, SCI TECHNOL HUM VAL, V15, P226, DOI 10.1177/016224399001500204; Fischer F., 2009, DEMOCRACY EXPERTISE; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foresight, 2011, FUT FOOD FARM; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gibbs A., 2012, RES METHODS METHODOL, V186, P192; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; GM Science Review Panel, 2003, GM SCI REV 1 REP OP; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Government Accountability Office, 2011, GAO1171 CTR SCI TECH; Government Office for Science, 2010, FOR LAND US PROJ MAK; Government Science and Engineering, 2013, REV SCI ENG PROF CIV; Haida H, 2012, GSDRC TOPIC GUIDE CO; Ham C., 2012, TRANSFORMING DELIVER; Hammond GP, 2013, ENERG POLICY, V52, P1, DOI 10.1016/j.enpol.2012.10.052; Hargreaves T, 2013, ENERG POLICY, V52, P126, DOI 10.1016/j.enpol.2012.03.027; Hathaway OA, 2012, CALIF LAW REV, V100, P817; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Hickman R, 2010, TRANSPORT POLICY, V17, P110, DOI 10.1016/j.tranpol.2009.12.002; HM Government, 2013, NAT AD PROGR; HM Government, 2012, CIV SERV REF PART 2; HM Government, 2012, CIV SERV REF; HM Government, UK RES COMM RISK GUI; HM Treasury, 2004, ORANG BOOK MAN RISK; HMGovernment, 2009, UK LOW CARB TRANS PL; Ho P, 2012, COPING COMPLEXITY, P82; Holt J., 1964, CHILDREN FAIL; House of Commons Public Administration Select Committee, 2012, 24 REP SESS 2010 12; House of Commons Science and Technology Committee, 2010, 5 REP SESS 2009 10 H; House of Lords Science and Technology Committee, 2011, 2 REP SESS 2010 12 B; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Infrastructure UK, 2011, NAT INFR PLAN 2011; Infrastructure UK, 2012, NAT INFR PLAN UPD 20; Institution of Engineering and Technology and Intelligent Transport Systems (UK), 2011, CAN WE REALL DO MOR; Involve, 2007, DEM TECHN FIN REP NA; Iyasu AA, 2013, CHINAS NONINTERFEREN; Jackson R, 2005, CRIT REV INT SOC POL, V8, P349, DOI 10.1080/13698230500187227; Jones H., 2011, 330 ODI; Koranyi D, 2011, TRANSATLANTIC ENERGY; Kshetri N, 2013, COMPUTER, V46, P86, DOI 10.1109/MC.2013.86; Lenton TM, 2013, CLIMATIC CHANGE, V117, P585, DOI 10.1007/s10584-012-0572-8; Lewis JA, 2010, NOTES LAWS WAR CYBER; Linstone H. A., 1975, DELPHI METHOD TECHNI; Lowe J, 2013, LWEC GEOENGINEERING; Lyons Inquiry, 2007, PLAC SHAP SHAR AMB F; MacLean D, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-2; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Matterson C., 2012, INFORMAL SCI LEARNIN; Meissner A, 2002, DES CHALL INT DIS MA; Mulcare C, 2013, BENEFITS RISKS DIGIT; N V, 2012, ECONOMIST       0909; National Endowment for Science and the Arts (Nesta), 2013, DYN DEM CHALL SHIFT; Natural Capital Committee, 2013, STAT NAT CAP FRAM ME; Nolte E, 2008, WHO EUROPEAN OBSERVA, V15; Nutt, 2012, DRUGS HOT AIR; O'Brien K, 2012, PROG HUM GEOG, V36, P667, DOI 10.1177/0309132511425767; Ofgem, 2010, PROJ DISC OPT DEL SE; Organization for Economic Cooperation and Development, 2013, OECD GUID MEAS SUBJ; Ostrom E., 2006, UNDERSTANDING KNOWLE; Owens S, 2000, ENVIRON PLANN A, V32, P1141, DOI 10.1068/a3330; Parliamentary Office of Science and Technology, 2009, INT TRANSP SYST; Pidgeon N, 2010, WRITTEN EVIDENCE MEM, p[42, 44]; Pretty J, 2010, INT J AGR SUSTAIN, V8, P219, DOI 10.3763/ijas.2010.0534; Pudjianto D, 2007, IET RENEW POWER GEN, V1, P10, DOI 10.1049/iet-rpg:20060023; Ramalingam B., 2008, EXPLORING SCI COMPLE; Risk and Regulation Advisory Council, 2009, RISK LANDSC INT SHAP; Rocks SA, 2009, ENV HUMAN HLTH IMPAC, P389; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosenhead J, 2001, WORKING PAPER SERIES; ROTHWELL R, 1994, INT J TECHNOL MANAGE, V9, P629; Roudometof V, 2005, CURR SOCIOL, V53, P113, DOI DOI 10.1177/0011392105048291; Rowe G, 2011, TECHNOL FORECAST SOC, V78, P1487, DOI 10.1016/j.techfore.2011.09.002; Royal Academy of Engineering, 2009, AUT SYST SOC LEG ETH; Royal Commission on Environmental Pollution, 2010, AD I CLIM CHANG; Royal Society, 2009, 1009 ROY SOC; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scrase I., 2009, TRANSFORMATIVE INNOV; Shared Practice, 2008, EV SCIENC; Sissons A., 2012, 3 DIMENSIONAL POLICY; Smith MS, 2011, PHILOS T R SOC A, V369, P196, DOI 10.1098/rsta.2010.0277; Snowden DJ, 2007, HARVARD BUS REV, V85, P68; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Stirling A, 2008, SCI TECHNOL HUM VAL, V33, P262, DOI 10.1177/0162243907311265; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Sutherland WJ, 2008, J APPL ECOL, V45, P821, DOI 10.1111/j.1365-2664.2008.01474.x; Sutherland WJ, 2013, NATURE, V503, P167, DOI 10.1038/503167a; Sutherland WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031824; Sutherland WJ, 2012, TRENDS ECOL EVOL, V27, P12, DOI 10.1016/j.tree.2011.10.011; Sutherland WJ, 2011, METHODS ECOL EVOL, V2, P238, DOI 10.1111/j.2041-210X.2010.00083.x; Sutherland WL, J POVERTY S IN PRESS; Swan K., 2002, ED COMMUNICATION INF, V2, P23, DOI DOI 10.1080/1463631022000005016; Swor T, 2011, ENVIRON IMPACT ASSES, V31, P506, DOI 10.1016/j.eiar.2011.01.014; Taylor CM, 2013, SCI TOTAL ENVIRON, V447, P488, DOI 10.1016/j.scitotenv.2012.12.073; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tuck CJ, 2008, INT J COMPUT INTEG M, V21, P245, DOI 10.1080/09511920701216238; Tyler C, 2013, FUTURE DIRECTIONS SC, P115; UKNEA, 2011, UK NAT EC ASS SYNTH; United Nations, 2013, CHART UN; White P., 2010, SOCIAL SUSTAINABILIT, P141; Wilks L, 2007, NEW TECH WORK EMPLOY, V22, P168, DOI 10.1111/j.1468-005X.2007.00191.x; Willetts D., 2013, 8 GREAT TECHNOLOGIES; Willetts D., 2011, PINCH BABY BOOMERS T; Willis R., 2011, DEMANDING LESS WHY W; Wilsdon J., 2004, SEE THROUGH SCI WHY; Woo Y., 2007, Internet and Higher Education, V10, P15, DOI 10.1016/j.iheduc.2006.10.005; World Health Organisation, 2013, DRUG RES; Wright C, 2012, PROCEDIA COMPUT SCI, V8, P45, DOI 10.1016/j.procs.2012.01.012	145	25	26	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96480	10.1371/journal.pone.0096480	http://dx.doi.org/10.1371/journal.pone.0096480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24879444	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000338101500007
J	Song, JL; Zhang, X; Liu, Q; Peng, JH; Liang, XJ; Shen, YY; Liu, HT; Li, HY				Song, Junlong; Zhang, Xiang; Liu, Qiang; Peng, Jianheng; Liang, Xinjie; Shen, Yuanyuan; Liu, Hongtao; Li, Hongyuan			Impact of Neoadjuvant Chemotherapy on Immediate Breast Reconstruction: A Meta-Analysis	PLOS ONE			English	Article							SKIN-SPARING MASTECTOMY; ADJUVANT TREATMENT; COMPLICATIONS; CANCER; REVASCULARIZATION; SURVIVAL; OUTCOMES	Objectives: The objective of this study was to perform a meta-analysis of published studies for evaluating the impact of neoadjuvant chemotherapy (NAC) on immediate breast reconstruction. Methods: We searched medical databases to identify appropriate studies that assessed the impact of NAC on immediate breast reconstruction from the inception of this technique through April 2013. We then performed a meta-analysis of these studies. Results: Our searches identified 11 studies among 1,840 citations. In the meta-analysis, NAC did not increase the overall rate of complications after immediate breast reconstruction (odds ratio [OR] = 0.59; 95% confidence interval[CI] = 0.38-0.91). The complication rate was also unaffected by NAC when we considered infections (OR = 0.82; 95% CI = 0.46-1.45), hematomas (OR = 1.35; 95% CI = 0.57-3.21), and seromas (OR = 0.77; 95% CI = 0.23-2.55). Additionally, expander or implant loss did not significantly increase in patients after NAC (OR = 1.59; 95% CI = 0.91-2.79). Only 2 studies (202 procedures) had reported total autologous flap loss, and they were included in our analysis; both studies found no association between NAC and total flap loss. Conclusion: Our analysis suggests that NAC does not increase the complication rate after immediate breast reconstruction. For appropriately selected patients, immediate breast reconstruction following NAC is a safe procedure. The best way to study this issue in the future is to conduct a multicenter prospective study with a longer follow-up period and more clearly defined parameters.	[Song, Junlong; Zhang, Xiang; Peng, Jianheng; Liang, Xinjie; Shen, Yuanyuan; Liu, Hongtao; Li, Hongyuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China; [Liu, Qiang] Peoples Hosp Dazu Cty, Dept Gen Surg, Chongqing, Peoples R China	Chongqing Medical University	Li, HY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China.	hongy_li@hotmail.com	Song, Junlong/AAI-4639-2020					Al-Ghazal SK, 2000, EUR J SURG ONCOL, V26, P17, DOI 10.1053/ejso.1999.0733; Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Azzawi K, 2010, PLAST RECONSTR SURG, V126, P1, DOI 10.1097/PRS.0b013e3181da8699; Chevray PM, 2008, CANCER J, V14, P223, DOI 10.1097/PPO.0b013e3181824e37; Decker MR, 2012, SURGERY, V152, P382, DOI 10.1016/j.surg.2012.05.001; Donker M, 2012, EJSO-EUR J SURG ONC, V38, P25, DOI 10.1016/j.ejso.2011.09.005; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; GODFREY PM, 1995, PLAST RECONSTR SURG, V95, P1039, DOI 10.1097/00006534-199505000-00013; Gouy S, 2005, ANN SURG ONCOL, V12, P161, DOI 10.1245/ASO.2005.04.003; Hu YY, 2011, CANCER-AM CANCER SOC, V117, P2833, DOI 10.1002/cncr.25872; Hultman CS, 2003, ANN PLAS SURG, V50, P249, DOI 10.1097/01.SAP.0000046784.70583.E1; JACQUILLAT C, 1990, PATHOL BIOL, V38, P851; Jimenez-Puente A, 2011, INT J TECHNOL ASSESS, V27, P298, DOI 10.1017/S026646231100047X; Langstein HN, 2003, PLAST RECONSTR SURG, V111, P712, DOI 10.1097/01.PRS.0000041441.42563.95; Liu Ying, 2009, Journal of Medical and Dental Sciences, V56, P55; Mehrara BJ, 2006, PLAST RECONSTR SURG, V118, P1100, DOI 10.1097/01.prs.0000236898.87398.d6; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mustonen P, 2004, EJSO-EUR J SURG ONC, V30, P817, DOI 10.1016/j.ejso.2004.06.003; NCCN Clinical Practice Guidelines in Oncology, 2012, NCCN CLIN PRACT GUID; Peled AW, 2010, ARCH SURG-CHICAGO, V145, P880, DOI 10.1001/archsurg.2010.163; Radovanovic Z, 2010, SCAND J SURG, V99, P115, DOI 10.1177/145749691009900302; Schaverien MV, 2013, EJSO-EUR J SURG ONC, V39, P430, DOI 10.1016/j.ejso.2013.02.015; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X; Taylor CW, 2005, BREAST, V14, P118, DOI 10.1016/j.breast.2004.08.006; Warren A, 2012, ANN SURG ONCOL, V19, P3402, DOI 10.1245/s10434-012-2362-y; Zweifel-Schlatter M, 2010, ANN SURG ONCOL, V17, P2945, DOI 10.1245/s10434-010-1195-9	28	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98225	10.1371/journal.pone.0098225	http://dx.doi.org/10.1371/journal.pone.0098225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878776	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500039
J	Trauth, S; Bischofs, IB				Trauth, Stephanie; Bischofs, Ilka B.			Ectopic Integration Vectors for Generating Fluorescent Promoter Fusions in Bacillus subtilis with Minimal Dark Noise	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN; TRANSCRIPTOME; VARIANTS; DNA	Fluorescent protein promoter reporters are important tools that are widely used for diverse purposes in microbiology, systems biology and synthetic biology and considerable engineering efforts are still geared at improving the sensitivity of the reporter systems. Here we focus on dark noise, i.e. the signal that is generated by the empty vector control. We quantitatively characterize the dark noise of a few common bacterial reporter systems by single cell microscopy. All benchmarked reporter systems generated significant amounts of dark noise that exceed the cellular autofluorescence to different extents. We then reengineered a multicolor set of fluorescent ectopic integration vectors for Bacillus subtilis by introducing a terminator immediately upstream of the promoter insertion site, resulting in an up to 2.7-fold reduction of noise levels. The sensitivity and dynamic range of the new high-performance pXFP_Star reporter system is only limited by cellular autofluorescence. Moreover, based on studies of the rapE promoter of B. subtilis we show that the new pXFP_Star reporter system reliably reports on the weak activity of the rapE promoter whereas the original reporter system fails because of transcriptional interference. Since the pXFP_Star reporter system properly isolates the promoter from spurious transcripts, it is a particularly suitable tool for quantitative characterization of weak promoters in B. subtilis.	[Trauth, Stephanie; Bischofs, Ilka B.] Univ Heidelberg ZMBH, Zentrum Mol Biol, Heidelberg, Germany; [Trauth, Stephanie; Bischofs, Ilka B.] Heidelberg Univ, Ctr Quantitat Anal Mol & Cellular Biosyst BioQuan, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bischofs, IB (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, Heidelberg, Germany.	i.bischofs@zmbh.uni-heidelberg.de		Bischofs, Ilka/0000-0001-5905-7106	European Research Council [ERC-StG ComMots-260860]; Deutsche Forschungsgemeinschaft [BI 1213/3-1,2, SPP1617 BE 5098/1-1]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Research Council by ERC-StG ComMots-260860 and the Deutsche Forschungsgemeinschaft [Emmy Noether Program, BI 1213/3-1,2 SPP1617 BE 5098/1-1, CellNetworks]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Bischofs IB, 2009, P NATL ACAD SCI USA, V106, P6459, DOI 10.1073/pnas.0810878106; Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; Blom EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027160; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; Ferguson ML, 2011, ANAL BIOCHEM, V419, P250, DOI 10.1016/j.ab.2011.08.017; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Green MR, 2012, MOL CLONING 4 EDI CO; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hentschel E, 2013, MICROB BIOTECHNOL, V6, P196, DOI 10.1111/j.1751-7915.2012.00360.x; Jiang M, 2000, J BACTERIOL, V182, P303, DOI 10.1128/JB.182.2.303-310.2000; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Schenborn E, 1999, MOL BIOTECHNOL, V13, P29, DOI 10.1385/MB:13:1:29; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van der Meer JR, 2010, NAT REV MICROBIOL, V8, P511, DOI 10.1038/nrmicro2392; Veening JW, 2004, APPL ENVIRON MICROB, V70, P6809, DOI 10.1128/AEM.70.11.6809-6815.2004; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	35	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98360	10.1371/journal.pone.0098360	http://dx.doi.org/10.1371/journal.pone.0098360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874808	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800035
J	Dettmann, HM; Zhang, Y; Wronna, N; Kraushaar, U; Guenther, E; Mohr, R; Neckel, PH; Mack, A; Fuchs, J; Just, L; Obermayr, F				Dettmann, Heike Monika; Zhang, Ying; Wronna, Nadine; Kraushaar, Udo; Guenther, Elke; Mohr, Roland; Neckel, Peter Helmut; Mack, Andreas; Fuchs, Joerg; Just, Lothar; Obermayr, Florian			Isolation, Expansion and Transplantation of Postnatal Murine Progenitor Cells of the Enteric Nervous System	PLOS ONE			English	Article							NEURAL STEM-CELLS; DEVELOPMENTAL DISTURBANCES; NITRIC-OXIDE; GUT; NEURONS; MOTILITY; FETAL; BOWEL; DIFFERENTIATE; THERAPY	Neural stem or progenitor cells have been proposed to restore gastrointestinal function in patients suffering from congenital or acquired defects of the enteric nervous system. Various, mainly embryonic cell sources have been identified for this purpose. However, immunological and ethical issues make a postnatal cell based therapy desirable. We therefore evaluated and quantified the potential of progenitor cells of the postnatal murine enteric nervous system to give rise to neurons and glial cells in vitro. Electrophysiological analysis and BrdU uptake studies provided direct evidence that generated neurons derive from expanded cells in vitro. Transplantation of isolated and expanded postnatal progenitor cells into the distal colon of adult mice demonstrated cell survival for 12 weeks (end of study). Implanted cells migrated within the gut wall and differentiated into neurons and glial cells, both of which were shown to derive from proliferated cells by BrdU uptake. This study indicates that progenitor cells isolated from the postnatal enteric nervous system might have the potential to serve as a source for a cell based therapy for neurogastrointestinal motility disorders. However, further studies are necessary to provide evidence that the generated cells are capable to positively influence the motility of the diseased gastrointestinal tract.	[Dettmann, Heike Monika; Fuchs, Joerg; Obermayr, Florian] Univ Childrens Hosp Tuebingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany; [Zhang, Ying; Mohr, Roland; Neckel, Peter Helmut; Mack, Andreas; Just, Lothar] Univ Tubingen, Inst Anat, Ctr Regenerat Biol & Med, Tubingen, Germany; [Wronna, Nadine; Kraushaar, Udo; Guenther, Elke] Univ Tubingen, Deptartment Electrophysiol, Nat & Med Sci Inst, Reutlingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Obermayr, F (corresponding author), Univ Childrens Hosp Tuebingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany.	florian.obermayr@med.uni-tuebingen.de		Mack, Andreas/0000-0001-7591-4374; Neckel, Peter/0000-0003-1976-0512; Dr. Guenther, Elke/0000-0002-8758-1607; Kraushaar, Udo/0000-0002-4660-1093	German Federal Ministry for Education and Research (BMBF) [01GN0967]; Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University	The project was supported by a grant from the German Federal Ministry for Education and Research (BMBF, Grant Number: 01GN0967). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; BREHMER A, 2006, ADV ANAT EMBRYOL CEL, V186, P1; Burns AJ, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00466.x; Dong YL, 2008, TRANSPL P, V40, P3646, DOI 10.1016/j.transproceed.2008.06.107; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Gariepy CE, 2004, J PEDIATR GASTR NUTR, V39, P5, DOI 10.1097/00005176-200407000-00003; Geisbauer CL, 2012, J SURG RES, V176, P20, DOI 10.1016/j.jss.2011.05.014; Geisbauer CL, 2012, J SURG RES, V174, P257, DOI 10.1016/j.jss.2010.12.016; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Gershon MD, 2007, GUT, V56, P459, DOI 10.1136/gut.2006.107748; Hanani M, 2000, AM J PHYSIOL-GASTR L, V278, pG644, DOI 10.1152/ajpgi.2000.278.4.G644; Hao MM, 2011, J NEUROSCI, V31, P15352, DOI 10.1523/JNEUROSCI.3053-11.2011; Harberson J, 2010, DIGEST DIS SCI, V55, P359, DOI 10.1007/s10620-009-1071-2; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hotta R, 2009, SEMIN PEDIATR SURG, V18, P263, DOI 10.1053/j.sempedsurg.2009.07.008; Jarvi K, 2010, ANN SURG, V252, P977, DOI 10.1097/SLA.0b013e3182018542; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Liu W, 2007, NEUROGASTROENT MOTIL, V19, P1001, DOI 10.1111/j.1365-2982.2007.00981.x; Martucciello G, 2007, EUR J PEDIATR SURG, V17, P34, DOI 10.1055/s-2007-964952; Metzger M, 2007, DEV DYNAM, V236, P128, DOI 10.1002/dvdy.20920; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Micci MA, 2005, GASTROENTEROLOGY, V129, P1817, DOI 10.1053/j.gastro.2005.08.055; Micci MA, 2001, GASTROENTEROLOGY, V121, P757, DOI 10.1053/gast.2001.28633; Natarajan D, 1999, DEVELOPMENT, V126, P157; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P224, DOI 10.1007/s10024-001-0142-y; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P329, DOI 10.1007/s10024-002-0002-4; Pan H, 2000, J NEUROSCI, V20, P3295, DOI 10.1523/JNEUROSCI.20-09-03295.2000; Pan WK, 2011, J SURG RES, V167, pE221, DOI 10.1016/j.jss.2011.01.016; Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Schafer KH, 2009, NEUROGASTROENT MOTIL, V21, P103, DOI 10.1111/j.1365-2982.2008.01257.x; Schemann M, 2005, J PEDIATR GASTR NUTR, V41, pS4, DOI 10.1097/01.scs.0000180285.51365.55; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Vogalis F, 2000, J NEUROPHYSIOL, V83, P1253, DOI 10.1152/jn.2000.83.3.1253; Wade PR, 2004, NEUROGASTROENT MOTIL, V16, P19, DOI 10.1111/j.1743-3150.2004.00469.x; Wood JD, 2004, GASTROENTEROLOGY, V127, P635, DOI 10.1053/j.gastro.2004.02.017; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212	44	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97792	10.1371/journal.pone.0097792	http://dx.doi.org/10.1371/journal.pone.0097792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871092	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300020
J	Huang, YMM; Chang, CEA				Huang, Yu-ming M.; Chang, Chia-en A.			Achieving Peptide Binding Specificity and Promiscuity by Loops: Case of the Forkhead-Associated Domain	PLOS ONE			English	Article							FHA DOMAIN; STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; FORCE-FIELD; PHOSPHOPEPTIDE RECOGNITION; MECHANISTIC INSIGHTS; MOLECULAR-DYNAMICS; SQ/TQ CLUSTER; BRCT REPEATS; PROTEIN	The regulation of a series of cellular events requires specific protein-protein interactions, which are usually mediated by modular domains to precisely select a particular sequence from diverse partners. However, most signaling domains can bind to more than one peptide sequence. How do proteins create promiscuity from precision ? Moreover, these complex interactions typically occur at the interface of a well-defined secondary structure, alpha helix and beta sheet. However, the molecular recognition primarily controlled by loop architecture is not fully understood. To gain a deep understanding of binding selectivity and promiscuity by the conformation of loops, we chose the forkhead-associated (FHA) domain as our model system. The domain can bind to diverse peptides via various loops but only interact with sequences containing phosphothreonine (pThr). We applied molecular dynamics (MD) simulations for multiple free and bound FHA domains to study the changes in conformations and dynamics. Generally, FHA domains share a similar folding structure whereby the backbone holds the overall geometry and the variety of sidechain atoms of multiple loops creates a binding surface to target a specific partner. FHA domains determine the specificity of pThr by well-organized binding loops, which are rigid to define a phospho recognition site. The broad range of peptide recognition can be attributed to different arrangements of the loop interaction network. The moderate flexibility of the loop conformation can help access or exclude binding partners. Our work provides insights into molecular recognition in terms of binding specificity and promiscuity and helpful clues for further peptide design.	[Huang, Yu-ming M.; Chang, Chia-en A.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Huang, YMM (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	yhuan022@ucr.edu; chiaenc@ucr.edu			US National Science Foundation (NSF) [MCB-0919586]; NSF supercomputer centers	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF supercomputer centers(National Science Foundation (NSF))	This research was supported by the US National Science Foundation (NSF; MCB-0919586) and the NSF supercomputer centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai R, 2010, J COMPUT AID MOL DES, V24, P819, DOI 10.1007/s10822-010-9376-y; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Ding ZF, 2005, BIOCHEMISTRY-US, V44, P10119, DOI 10.1021/bi050414a; Ding Z, 2007, BIOCHEMISTRY-US, V46, P2684, DOI 10.1021/bi061763n; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Gan WX, 2009, PROTEINS, V74, P996, DOI 10.1002/prot.22209; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YMM, 2012, J PHYS CHEM B, V116, P10247, DOI 10.1021/jp305028d; Huang YMM, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-12; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huggins DJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000880; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joughin BA, 2005, PROTEIN SCI, V14, P131, DOI 10.1110/ps.04964705; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kupfer Gary M., 2013, Yale Journal of Biology and Medicine, V86, P491; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Li HY, 2004, J MOL BIOL, V335, P371, DOI 10.1016/j.jmb.2003.10.032; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Liao H, 2000, J MOL BIOL, V304, P941, DOI 10.1006/jmbi.2000.4291; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Lokesh GL, 2007, J AM CHEM SOC, V129, P10658, DOI 10.1021/ja0739178; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Mahajan A, 2005, J AM CHEM SOC, V127, P14572, DOI 10.1021/ja054538m; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Munz M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002749; Nachman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011215; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Song YF, 2009, J MOL BIOL, V387, P840, DOI 10.1016/j.jmb.2009.01.038; Sudol Marius, 2005, V3, P185, DOI 10.1007/0-387-24532-4_9; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yaffe MB, 1999, NATURE, V402, P30; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yongkiettrakul S, 2004, BIOCHEMISTRY-US, V43, P3862, DOI 10.1021/bi036195f; Yuan CH, 2001, J MOL BIOL, V314, P563, DOI 10.1006/jmbi.2001.5140	74	3	3	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98291	10.1371/journal.pone.0098291	http://dx.doi.org/10.1371/journal.pone.0098291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870410	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300034
J	Jitkova, Y; Gronda, M; Hurren, R; Wang, XM; Goard, CA; Jhas, B; Schimmer, AD				Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Wang, Xiaoming; Goard, Carolyn A.; Jhas, Bozhena; Schimmer, Aaron D.			A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity	PLOS ONE			English	Article							REDUCING REAGENT OXYRASE; ACUTE MYELOID-LEUKEMIA; MITOCHONDRIAL TRANSLATION; IN-VITRO; INHIBITION; CELLS; GLYCYLCYCLINE; GAR-936; FRESH; ACID	Tigecycline is a broad-spectrum, first-in-class glycylcycline antibiotic currently used to treat complicated skin and intra-abdominal infections, as well as community-acquired pneumonia. In addition, we have demonstrated that tigecycline also has in vitro and in vivo activity against acute myeloid leukemia (AML) due to its ability to inhibit mitochondrial translation. Tigecycline is relatively unstable after reconstitution, and this instability may limit the use of the drug in ambulatory infusions for the treatment of infection and may prevent the development of optimal dosing schedules for the treatment of AML. This study sought to identify a formulation that improved the stability of the drug after reconstitution and maintained its antimicrobial and antileukemic activity. A panel of chemical additives was tested to identify excipients that enhanced the stability of tigecycline in solution at room temperature for up to one week. We identified a novel formulation containing the oxygen-reducing agents ascorbic acid (3 mg/mL) and pyruvate (60 mg/mL), in saline solution, pH 7.0, in which tigecycline (1 mg/mL) remained intact when protected from light for at least 7 days. This formulation also preserved the drug's antibacterial and antileukemic activity in vitro. Moreover, the novel formulation retained tigecycline's antileukemic activity in vivo. Thus, we identified and characterized a novel formulation for tigecycline that preserves its stability and efficacy after reconstitution.	[Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Wang, Xiaoming; Goard, Carolyn A.; Jhas, Bozhena; Schimmer, Aaron D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Schimmer, AD (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	aaron.schimmer@utoronto.ca		Schimmer, Aaron/0000-0003-4023-3899	Canadian Stem Cell Network; Leukemia and Lymphoma Society; National Institutes of Health (NCI) [1R01CA157456]; Princess Margaret Hospital Foundation; Ministry of Long Term Health and Planning in the Province of Ontario; NATIONAL CANCER INSTITUTE [R01CA157456] Funding Source: NIH RePORTER	Canadian Stem Cell Network; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Princess Margaret Hospital Foundation; Ministry of Long Term Health and Planning in the Province of Ontario; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Stem Cell Network, the Leukemia and Lymphoma Society, the National Institutes of Health (NCI 1R01CA157456), the Princess Margaret Hospital Foundation, and the Ministry of Long Term Health and Planning in the Province of Ontario. A. D. S. is a Leukemia and Lymphoma Society Scholar in clinical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer G, 2004, J ANTIMICROB CHEMOTH, V53, P592, DOI 10.1093/jac/dkh125; Bradford PA, 2005, ANTIMICROB AGENTS CH, V49, P3903, DOI 10.1128/AAC.49.9.3903-3909.2005; CHEN W, 1989, LEUKEMIA, V3, P264; Fawzi MB, 2011, US patent, Patent No. 7879828; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Giamarellou H, 2011, EXPERT OPIN DRUG MET, V7, P1459, DOI 10.1517/17425255.2011.623126; Hope R, 2005, J ANTIMICROB CHEMOTH, V56, P1042, DOI 10.1093/jac/dki386; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Kehrein K, 2013, ANTIOXID REDOX SIGNA; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Li CH, 2004, J CHROMATOGR B, V811, P225, DOI 10.1016/j.jchromb.2004.09.011; Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05; Petersen PJ, 1999, ANTIMICROB AGENTS CH, V43, P738, DOI 10.1128/AAC.43.4.738; Petersen PJ, 2005, ANTIMICROB AGENTS CH, V49, P3910, DOI 10.1128/AAC.49.9.3910-3918.2005; Pohanka M, 2012, MINI-REV MED CHEM, V12, P35, DOI 10.2174/138955712798868986; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Schimmer AD, 2012, EXPERT REV HEMATOL, V5, P117, DOI [10.1586/ehm.12.8, 10.1586/EHM.12.8]; Schimmer AD, 2006, CANCER RES, V66, P2367, DOI 10.1158/0008-5472.CAN-05-1061; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sum PE, 1999, BIOORG MED CHEM LETT, V9, P1459, DOI 10.1016/S0960-894X(99)00216-4; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Wenzel R, 2005, NAT REV DRUG DISCOV, V4, P809, DOI 10.1038/nrd1857; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wyeth Pharmaceuticals Inc, 2012, TYG FULL PRESCR INF	24	21	22	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e95281	10.1371/journal.pone.0095281	http://dx.doi.org/10.1371/journal.pone.0095281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871339	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300002
J	McCormick, AW; Abuelezam, NN; Rhode, ER; Hou, TG; Walensky, RP; Pei, PP; Becker, JE; DiLorenzo, MA; Losina, E; Freedberg, KA; Lipsitch, M; Seage, GR				McCormick, Alethea W.; Abuelezam, Nadia N.; Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Losina, Elena; Freedberg, Kenneth A.; Lipsitch, Marc; Seage, George R., III			Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SEXUAL RISK BEHAVIOR; COST-EFFECTIVENESS; POTENTIAL IMPACT; MALE CIRCUMCISION; DIFFERENT REGIONS; REFERENCE RANGES; CLINICAL IMPACT; INFECTED ADULTS; UNITED-STATES	Understanding HIV transmission dynamics is critical to estimating the potential population-wide impact of HIV prevention and treatment interventions. We developed an individual-based simulation model of the heterosexual HIV epidemic in South Africa and linked it to the previously published Cost-Effectiveness of Preventing AIDS Complications (CEPAC) International Model, which simulates the natural history and treatment of HIV. In this new model, the CEPAC Dynamic Model (CDM), the probability of HIV transmission per sexual encounter between short-term, long-term and commercial sex worker partners depends upon the HIV RNA and disease stage of the infected partner, condom use, and the circumcision status of the uninfected male partner. We included behavioral, demographic and biological values in the CDM and calibrated to HIV prevalence in South Africa pre-antiretroviral therapy. Using a multi-step fitting procedure based on Bayesian melding methodology, we performed 264,225 simulations of the HIV epidemic in South Africa and identified 3,750 parameter sets that created an epidemic and had behavioral characteristics representative of a South African population pre-ART. Of these parameter sets, 564 contributed 90% of the likelihood weight to the fit, and closely reproduced the UNAIDS HIV prevalence curve in South Africa from 1990-2002. The calibration was sensitive to changes in the rate of formation of short-duration partnerships and to the partnership acquisition rate among high-risk individuals, both of which impacted concurrency. Runs that closely fit to historical HIV prevalence reflect diverse ranges for individual parameter values and predict a wide range of possible steady-state prevalence in the absence of interventions, illustrating the value of the calibration procedure and utility of the model for evaluating interventions. This model, which includes detailed behavioral patterns and HIV natural history, closely fits HIV prevalence estimates.	[McCormick, Alethea W.; Abuelezam, Nadia N.; Lipsitch, Marc; Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	McCormick, AW (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	amccormi@hsph.harvard.edu	Abuelezam, Nadia/AAO-1952-2021	Abuelezam, Nadia/0000-0002-5459-8592; Walensky, Rochelle P./0000-0002-8795-379X; Becker, Jessica/0000-0003-0522-2836; Losina, ELENA/0000-0002-3424-0892	 [RO1-AI-058736];  [RO1-MH-087326];  [T32-AI-007535];  [T32-AI-007433]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007535, R01AI058736, R37AI042006, T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087328] Funding Source: NIH RePORTER	; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the following grants: RO1-AI-058736, RO1-MH-087326, T32-AI-007535 and T32-AI-007433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Abuelezam NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075624; Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Alkema L, 2007, ANN APPL STAT, V1, P229, DOI 10.1214/07-AOAS111; [Anonymous], 2002, WORLD MORTALITY 2000; Auvert B, 2000, COMPUT BIOMED RES, V33, P84, DOI 10.1006/cbmr.1999.1533; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Barlow D, 1997, AIDS, V11, P1039, DOI 10.1097/00002030-199708000-00013; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Bershteyn A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0613; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 2001, NAT MED, V7, P1016, DOI 10.1038/nm0901-1016; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Carael M, 2006, SEX TRANSM INFECT, V82, pIII26, DOI 10.1136/sti.2006.021196; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; Chou R, 2007, SCREENING HIV FOCUSE; Detsky A S, 1993, Pharmacoeconomics, V3, P354, DOI 10.2165/00019053-199303050-00003; Doherty IA, 2009, JAIDS-J ACQ IMM DEF, V52, P114, DOI 10.1097/QAI.0b013e3181ab5e10; Dunkle KL, 2005, INT J STD AIDS, V16, P256, DOI 10.1258/0956462053420220; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Eisenberg JNS, 2002, ENVIRON HEALTH PERSP, V110, P783, DOI 10.1289/ehp.02110783; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Gibson GJ, 2004, P NATL ACAD SCI USA, V101, P12120, DOI 10.1073/pnas.0400829101; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Harrison A, 2008, STUD FAMILY PLANN, V39, P295, DOI 10.1111/j.1728-4465.2008.00176.x; Hoare A, 2012, SEX HEALTH, V9, P144, DOI 10.1071/SH10145; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Hontelez JAC, 2011, VACCINE, V29, P6100, DOI 10.1016/j.vaccine.2011.06.059; Introcaso CE, 2013, SEX TRANSM DIS, V40, P521, DOI 10.1097/01.OLQ.0000430797.56499.0d; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Johnson LF, 2010, SEX TRANSM INFECT, V86, P169, DOI 10.1136/sti.2009.037341; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Lara AM, 2008, AIDS, V22, pS123, DOI 10.1097/01.aids.0000327633.85221.9a; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Levin BR, 1996, MATH BIOSCI, V132, P69, DOI 10.1016/0025-5564(95)00053-4; Losina E, 2006, SAMJ S AFR MED J, V96, P526; Losina E, 2007, ANTIVIR THER, V12, P543; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Maini MK, 1996, GENITOURIN MED, V72, P27; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; McCreesh N, 2012, SEX TRANSM DIS, V39, P407, DOI 10.1097/OLQ.0b013e318254c84a; Meekers D, 2000, INT J STD AIDS, V11, P21, DOI 10.1258/0956462001914850; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; National Department of Health ICF, 2019, S AFR DEM HLTH SURV; Ndase P, 2012, JAIDS-J ACQ IMM DEF, V59, P65, DOI 10.1097/QAI.0b013e318237b864; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Phair JP, 1997, J INFECT DIS, V175, P959, DOI 10.1086/514000; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; RAFTERY AE, 1995, J AM STAT ASSOC, V90, P402, DOI 10.2307/2291048; RICARD D, 1994, AIDS, V8, P977, DOI 10.1097/00002030-199407000-00016; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Sevcikova H, 2007, TRANSPORTATION RES B, V41, P652; Sevcikova H, 2007, TRANSPORT RES B-METH, V41, P652, DOI 10.1016/j.trb.2006.11.001; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Stover J, 2003, GOALS MODEL ESTIMATI; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; U.S Census Bureau, 2012, INT DAT BAS DEM OV S; UNAIDS, 2021, PREV HIV INF TIM NEW; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS/WHO, 2009, AIDS EP UPD NOV 2009; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vieira IT, 2010, ANN OPER RES, V178, P173, DOI 10.1007/s10479-009-0571-y; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; World Health Organization, 2006, ANT THER HIV INF AD; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	102	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98272	10.1371/journal.pone.0098272	http://dx.doi.org/10.1371/journal.pone.0098272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867402	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100044
J	Nandi, B; Pai, C; Huang, Q; Prabhala, RH; Munshi, NC; Gold, JS				Nandi, Bisweswar; Pai, Christine; Huang, Qin; Prabhala, Rao H.; Munshi, Nikhil C.; Gold, Jason S.			CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis	PLOS ONE			English	Article							INFLAMMATORY PROTEIN 3-ALPHA; EXPRESSION LEVEL; CELLS; TH17; PROLIFERATION; MACROPHAGES; HOMEOSTASIS; NEOPLASIA; MIGRATION; MUTATION	Interactions between the inflammatory chemokine CCL20 and its receptor CCR6 have been associated with colorectal cancer growth and metastasis, however, a causal role for CCL20 signaling through CCR6 in promoting intestinal carcinogenesis has not been demonstrated in vivo. In this study, we aimed to determine the role of CCL20-CCR6 interactions in spontaneous intestinal tumorigenesis. CCR6-deficient mice were crossed with mice heterozygous for a mutation in the adenomatous polyposis coli (APC) gene (APC(MIN/+) mice) to generate APC(MIN/+) mice with CCR6 knocked out (CCR6KO-APC(MIN/+) mice). CCR6KO-APC(MIN/+) mice had diminished spontaneous intestinal tumorigenesis. CCR6KO-APC(MIN/+) also had normal sized spleens as compared to the enlarged spleens found in APC(MIN/+) mice. Decreased macrophage infiltration into intestinal adenomas and non-tumor epithelium was observed in CCR6KO-APC(MIN/+) as compared to APC(MIN/+) mice. CCL20 signaling through CCR6 caused increased production of CCL20 by colorectal cancer cell lines. Furthermore, CCL20 had a direct mitogenic effect on colorectal cancer cells. Thus, interactions between CCL20 and CCR6 promote intestinal carcinogenesis. Our results suggest that the intestinal tumorigenesis driven by CCL20-CCR6 interactions may be driven by macrophage recruitment into the intestine as well as proliferation of neoplastic epithelial cells. This interaction could be targeted for the treatment or prevention of malignancy.	[Nandi, Bisweswar; Pai, Christine; Prabhala, Rao H.] VA Boston Healthcare Syst, Res Serv, West Roxbury, MA USA; [Nandi, Bisweswar; Huang, Qin; Prabhala, Rao H.; Munshi, Nikhil C.; Gold, Jason S.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Huang, Qin] VA Boston Healthcare Syst, Serv, Pathol, West Roxbury, MA USA; [Prabhala, Rao H.; Munshi, Nikhil C.] Dana Farber Canc Ctr, Boston, MA USA; [Munshi, Nikhil C.] VA Boston Healthcare Syst, Med Serv, West Roxbury, MA USA; [Gold, Jason S.] VA Boston Healthcare Syst, Surg Serv, West Roxbury, MA USA; [Gold, Jason S.] Brigham & Womens Hosp, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Dana-Farber Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Gold, JS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	jgold4@partners.org	Nandi, Bisweswar/N-5815-2019; Gold, Jason S./O-5112-2014; Munshi, Nikhil/ABE-2338-2021	Gold, Jason S./0000-0002-2925-4755; 	Department of Veterans Affairs Office of Research and Development	Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs)	This work is supported by the Department of Veterans Affairs Office of Research and Development through a Career Development Award-2 to JSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Beider K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005125; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Fenton JI, 2010, MOL CARCINOGEN, V49, P700, DOI 10.1002/mc.20644; Frick VO, 2013, SCAND J IMMUNOL, V78, P298, DOI 10.1111/sji.12087; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hausmann M, 2005, J IMMUNOL, V175, P1389, DOI 10.4049/jimmunol.175.3.1389; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Iwata T, 2013, J SURG ONCOL, V107, P160, DOI 10.1002/jso.23247; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Keates S, 2007, J IMMUNOL, V178, P8013, DOI 10.4049/jimmunol.178.12.8013; Kimsey TF, 2004, CANCER J, V10, P374, DOI 10.1097/00130404-200411000-00007; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; McClellan JL, 2012, AM J PHYSIOL-GASTR L, V303, pG1087, DOI 10.1152/ajpgi.00252.2012; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rao VP, 2006, CANCER RES, V66, P57, DOI 10.1158/0008-5472.CAN-05-3445; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; You SJ, 2006, INT J EXP PATHOL, V87, P227, DOI 10.1111/j.1365-2613.2006.00477.x	41	35	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97566	10.1371/journal.pone.0097566	http://dx.doi.org/10.1371/journal.pone.0097566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866282	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100017
J	Robins, JH; Tintinger, V; Aplin, KP; Hingston, M; Matisoo-Smith, E; Penny, D; Lavery, SD				Robins, Judith H.; Tintinger, Vernon; Aplin, Ken P.; Hingston, Melanie; Matisoo-Smith, Elizabeth; Penny, David; Lavery, Shane D.			Phylogenetic Species Identification in Rattus Highlights Rapid Radiation and Morphological Similarity of New Guinean Species	PLOS ONE			English	Article							ANCIENT DNA; CHROMOSOME EVOLUTION; BLACK RATS; MITOCHONDRIAL; DELIMITATION; SEQUENCE; REVEALS; EXTRACTION; SPECIATION; DIVERSITY	The genus Rattus is highly speciose, the taxonomy is complex, and individuals are often difficult to identify to the species level. Previous studies have demonstrated the usefulness of phylogenetic approaches to identification in Rattus but some species, especially among the endemics of the New Guinean region, showed poor resolution. Possible reasons for this are simple misidentification, incomplete gene lineage sorting, hybridization, and phylogenetically distinct lineages that are unrecognised taxonomically. To assess these explanations we analysed 217 samples, representing nominally 25 Rattus species, collected in New Guinea, Asia, Australia and the Pacific. To reduce misidentification problems we sequenced museum specimens from earlier morphological studies and recently collected tissues from samples with associated voucher specimens. We also reassessed vouchers from previously sequenced specimens. We inferred combined and separate phylogenies from two mitochondrial DNA regions comprising 550 base pair D-loop sequences and both long (655 base pair) and short (150 base pair) cytochrome oxidase I sequences. Our phylogenetic species identification for 17 species was consistent with morphological designations and current taxonomy thus reinforcing the usefulness of this approach. We reduced misidentifications and consequently the number of polyphyletic species in our phylogenies but the New Guinean Rattus clades still exhibited considerable complexity. Only three of our eight New Guinean species were monophyletic. We found good evidence for either incomplete mitochondrial lineage sorting or hybridization between species within two pairs, R. leucopus/R. cf. verecundus and R. steini/R. praetor. Additionally, our results showed that R. praetor, R. niobe and R. verecundus each likely encompass more than one species. Our study clearly points to the need for a revised taxonomy of the rats of New Guinea, based on broader sampling and informed by both morphology and phylogenetics. The remaining taxonomic complexity highlights the recent and rapid radiation of Rattus in the Australo-Papuan region.	[Robins, Judith H.; Hingston, Melanie; Lavery, Shane D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Robins, Judith H.; Tintinger, Vernon] Univ Auckland, Dept Anthropol, Auckland 1, New Zealand; [Aplin, Ken P.] Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DC 20560 USA; [Matisoo-Smith, Elizabeth] Univ Otago, Dept Anat, Dunedin, New Zealand; [Penny, David] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Lavery, Shane D.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Otago; Massey University; University of Auckland	Robins, JH (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	j.robins@auckland.ac.nz	Lavery, Shane/AFX-7929-2022	Lavery, Shane/0000-0003-3038-292X; Hingston, Melanie/0000-0002-2960-6212; Matisoo-Smith, Elizabeth/0000-0002-3500-8307	University of Auckland; Marsden Fund of New Zealand [UOA510]	University of Auckland; Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	The University of Auckland and the Marsden Fund of New Zealand, Project Number UOA510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin Ken P., 2003, ACIAR Monograph Series, V100, P1; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; Aplin KP, 2011, RAP B BIOL ASSESSMEN, V60; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Balakirev Alexander E., 2012, Russian Journal of Theriology, V11, P33; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; BAVERSTOCK PR, 1983, GENETICA, V60, P93, DOI 10.1007/BF00127495; BAVERSTOCK PR, 1986, GENETICA, V71, P11, DOI 10.1007/BF00123228; BAVERSTOCK PR, 1977, CHROMOSOMA, V61, P227, DOI 10.1007/BF00292807; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Chaimanee Y, 2000, HIST BIOL, V15, P181, DOI DOI 10.1080/10292380109380590; CLARK DA, 1981, BIOTROPICA, V13, P182, DOI 10.2307/2388123; Conroy CJ, 2013, BIOL INVASIONS, V15, P741, DOI 10.1007/s10530-012-0323-9; Cooper A, 2000, SCIENCE, V289, P1139; DENNIS E, 1978, AUST J ZOOL, V26, P197, DOI 10.1071/ZO9780197; FLANNERY T F, 1990, Records of the Australian Museum, V42, P173; Flannery TF, 1995, MAMMALS NEW GUINEA; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Galan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048374; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Homer E., 1965, CSIRO Wildlife Research, V10, P101; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; Innes J.G., 1990, P206; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Lack JB, 2012, MOL ECOL, V21, P3545, DOI 10.1111/j.1365-294X.2012.05620.x; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; MatisooSmith E, 1997, ELECTROPHORESIS, V18, P1534, DOI 10.1002/elps.1150180908; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Musser Guy G., 1993, P501; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; Pages M, 2013, MOL ECOL, V22, P1019, DOI 10.1111/mec.12149; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; Robins JH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-375; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rowe KC, 2011, SYST BIOL, V60, P188, DOI 10.1093/sysbio/syq092; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Simmons MP, 2014, MOL PHYLOGENET EVOL, V74, P1, DOI 10.1016/j.ympev.2014.01.030; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TAYLOR J M, 1973, Bulletin of the American Museum of Natural History, V150, P1; TAYLOR JM, 1983, J MAMMAL, V64, P463, DOI 10.2307/1380359; Taylor JM, 1982, B AM MUS NAT HIST, V173, P177; Verneau O, 1998, P NATL ACAD SCI USA, V95, P11284, DOI 10.1073/pnas.95.19.11284; WATTS CHS, 1994, AUST J ZOOL, V42, P711, DOI 10.1071/ZO9940711; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	57	17	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98002	10.1371/journal.pone.0098002	http://dx.doi.org/10.1371/journal.pone.0098002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865350	gold, Green Submitted, Green Published			2022-12-27	WOS:000336914100028
J	Guitart, M; Osorio-Conles, O; Pentinat, T; Cebria, J; Garcia-Villoria, J; Sala, D; Sebastian, D; Zorzano, A; Ribes, A; Jimenez-Chillaron, JC; Garcia-Martinez, C; Gomez-Foix, AM				Guitart, Maria; Osorio-Conles, Oscar; Pentinat, Thais; Cebria, Judith; Garcia-Villoria, Judit; Sala, David; Sebastian, David; Zorzano, Antonio; Ribes, Antonia; Jimenez-Chillaron, Josep C.; Garcia-Martinez, Celia; Gomez-Foix, Anna M.			Fatty Acid Transport Protein 1 (FATP1) Localizes in Mitochondria in Mouse Skeletal Muscle and Regulates Lipid and Ketone Body Disposal	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; IN-VIVO; EXPRESSION; CELLS; METABOLISM; OXIDATION; MEMBRANE; GLUCOSE; LIVER; MICE	FATP1 mediates skeletal muscle cell fatty acid import, yet its intracellular localization and metabolic control role are not completely defined. Here, we examine FATP1 localization and metabolic effects of its overexpression in mouse skeletal muscle. The FATP1 protein was detected in mitochondrial and plasma membrane fractions, obtained by differential centrifugation, of mouse gastrocnemius muscle. FATP1 was most abundant in purified mitochondria, and in the outer membrane and soluble intermembrane, but not in the inner membrane plus matrix, enriched subfractions of purified mitochondria. Immunogold electron microscopy localized FATP1-GFP in mitochondria of transfected C2C12 myotubes. FATP1 was overexpressed in gastrocnemius mouse muscle, by adenovirus-mediated delivery of the gene into hindlimb muscles of newborn mice, fed after weaning a chow or high-fat diet. Compared to GFP delivery, FATP1 did not alter body weight, serum fed glucose, insulin and triglyceride levels, and whole-body glucose tolerance, in either diet. However, fatty acid levels were lower and beta-hydroxybutyrate levels were higher in FATP1-than GFP-mice, irrespective of diet. Moreover, intramuscular triglyceride content was lower in FATP1-versus GFP-mice regardless of diet, and beta-hydroxybutyrate content was unchanged in high-fat-fed mice. Electroporation-mediated FATP1 overexpression enhanced palmitate oxidation to CO2, but not to acid-soluble intermediate metabolites, while CO2 production from beta-hydroxybutyrate was inhibited and that from glucose unchanged, in isolated mouse gastrocnemius strips. In summary, FATP1 was localized in mitochondria, in the outer membrane and intermembrane parts, of mouse skeletal muscle, what may be crucial for its metabolic effects. Overexpressed FATP1 enhanced disposal of both systemic fatty acids and intramuscular triglycerides. Consistently, it did not contribute to the high-fat diet-induced metabolic dysregulation. However, FATP1 lead to hyperketonemia, likely secondary to the sparing of ketone body oxidation by the enhanced oxidation of fatty acids.	[Guitart, Maria; Osorio-Conles, Oscar; Sala, David; Sebastian, David; Zorzano, Antonio; Gomez-Foix, Anna M.] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Inst Biomed, Barcelona, Spain; [Pentinat, Thais; Cebria, Judith; Jimenez-Chillaron, Josep C.] Hosp St Joan de Deu, Barcelona, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Serv Bioquim & Genet Mol, Secc Errores Congenitos Metab IBC, Barcelona, Spain; [Garcia-Villoria, Judit; Ribes, Antonia] Inst Salud Carlos III, CIBERER, Madrid, Spain; [Sala, David; Sebastian, David; Zorzano, Antonio] Inst Res Biomed, Barcelona, Spain; [Osorio-Conles, Oscar; Sala, David; Sebastian, David; Zorzano, Antonio; Gomez-Foix, Anna M.] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Garcia-Martinez, Celia] Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona	Guitart, M (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Inst Biomed, Barcelona, Spain.	maguita022002@yahoo.es	Osorio-Conles, Óscar/B-2064-2017; Martinez, Celia Garcia/G-9536-2017; Garcia, Judit/AAN-1753-2021; Zorzano, Antonio/R-5479-2018; Sebastián, David/ABH-1574-2020; Osorio-Conles, Óscar/ABC-7346-2021	Osorio-Conles, Óscar/0000-0002-0285-5526; Martinez, Celia Garcia/0000-0002-5267-0191; Osorio-Conles, Óscar/0000-0002-0285-5526; Ribes Rubio, Antonia/0000-0002-2249-246X; Garcia Villoria, Judit/0000-0003-2132-4138; Sebastian, David/0000-0002-7260-3869	Spanish Ministerio de Ciencia e Innovacion (MCI) [SAF2009-07559, SAF2012-37480]; CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas [PI 08/0733, PI08/1195, CB07/08/0012]	Spanish Ministerio de Ciencia e Innovacion (MCI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas	This study was supported by the following grants: SAF2009-07559 and SAF2012-37480 from the Spanish Ministerio de Ciencia e Innovacion (MCI); and PI 08/0733, PI08/1195, CIBERDEM de Diabetes y Enfermedades Metabolicas Asociadas (CB07/08/0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Cotter DG, 2013, AM J PHYSIOL-ENDOC M, V304, pE363, DOI 10.1152/ajpendo.00547.2012; CRETTAZ M, 1980, BIOCHEM J, V186, P525, DOI 10.1042/bj1860525; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; FINK G, 1988, J BIOL CHEM, V263, P18036; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hayasaki H, 2001, CELL MOL BIOL NOISY, V47; Holloway GP, 2011, DIABETOLOGIA, V54, P1457, DOI 10.1007/s00125-011-2114-8; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; HUARD J, 1995, GENE THER, V2, P107; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Jimenez-Chillaron JC, 2002, METABOLISM, V51, P121, DOI 10.1053/meta.2002.29028; Jimenez-Chillaron JC, 1999, FASEB J, V13, P2153, DOI 10.1096/fasebj.13.15.2153; Johnson M, 2006, HUM GENE THER, V17, P1262, DOI 10.1089/hum.2006.17.1262; Kazantzis M, 2012, BBA-MOL CELL BIOL L, V1821, P852, DOI 10.1016/j.bbalip.2011.09.010; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KOCH DD, 1987, CLIN CHEM, V33, P1761; Lanni A, 1996, INT J BIOCHEM CELL B, V28, P337, DOI 10.1016/1357-2725(95)00137-9; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Marotta M, 2004, METABOLISM, V53, P1032, DOI 10.1016/j.metabol.2004.03.011; MASCARO C, 1995, ARCH BIOCHEM BIOPHYS, V317, P385, DOI 10.1006/abbi.1995.1178; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Matsufuji T, 2012, BIOORG MED CHEM LETT, V22, P5067, DOI 10.1016/j.bmcl.2012.05.130; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; OKAMOTO H, 1970, J BIOL CHEM, V245, P3603; Peters SJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1151, DOI 10.1152/ajpendo.2001.281.6.E1151; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Puisac B, 2012, MOL BIOL REP, V39, P4777, DOI 10.1007/s11033-011-1270-8; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; RIBES A, 1992, J INHERIT METAB DIS, V15, P367, DOI 10.1007/BF02435978; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stefanyk LE, 2012, METABOLISM, V61, P1518, DOI 10.1016/j.metabol.2012.04.002; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; VANLAACK HLJM, 1988, CLIN CHIM ACTA, V171, P109; Walter G, 2000, P NATL ACAD SCI USA, V97, P5151, DOI 10.1073/pnas.97.10.5151; Wang YB, 2000, DRUG DISCOV TODAY, V5, P10, DOI 10.1016/S1359-6446(99)01433-6; WEIDEMANN MJ, 1969, BIOCHEM J, V112, P149, DOI 10.1042/bj1120149; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; Wiczer BM, 2009, J LIPID RES, V50, P2502, DOI 10.1194/jlr.M900218-JLR200; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087	59	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98109	10.1371/journal.pone.0098109	http://dx.doi.org/10.1371/journal.pone.0098109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858472	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400041
J	Rajput, NA; Zhang, MX; Ru, YY; Liu, TL; Xu, J; Liu, L; Mafurah, JJ; Dou, DL				Rajput, Nasir Ahmed; Zhang, Meixiang; Ru, Yanyan; Liu, Tingli; Xu, Jing; Liu, Li; Mafurah, Joseph Juma; Dou, Daolong			Phytophthora sojae Effector PsCRN70 Suppresses Plant Defenses in Nicotiana benthamiana	PLOS ONE			English	Article							CELL-DEATH; HYPERSENSITIVE RESPONSE; PROTEIN; LOCALIZATION; ACCUMULATION; EXPRESSION; INFESTANS	Phytophthora sojae, an oomycete pathogen, produces a large number of effector proteins that enter into host cells. The Crinklers (Crinkling and Necrosis, CRN) are cytoplasmic effectors that are conserved in oomycete pathogens and their encoding genes are highly expressed at the infective stages in P. sojae. However, their roles in pathogenesis are largely unknown. Here, we functionally characterized an effector PsCRN70 by transiently and stably overexpressing it in Nicotiana benthamiana. We demonstrated that PsCRN70 was localized to the plant cell nucleus and suppressed cell death elicited by all the tested cell death-inducing proteins, including BAX, PsAvh241, PsCRN63, PsojNIP and R3a/Avr3a. Overexpression of the PsCRN70 gene in N. benthamiana enhanced susceptibility to P. parasitica. The H2O2 accumulation in the PsCRN70-transgenic plants was reduced compared to the GFP-lines. The transcriptional levels of the defense-associated genes, including PR1b, PR2b, ERF1 and LOX, were also down-regulated in the PsCRN70-transgenic lines. Our results suggest that PsCRN70 may function as a universal suppressor of the cell death induced by many elicitors, the host H2O2 accumulation and the expression of defense-associated genes, and therefore promotes pathogen infection.	[Rajput, Nasir Ahmed; Zhang, Meixiang; Ru, Yanyan; Liu, Tingli; Xu, Jing; Liu, Li; Mafurah, Joseph Juma; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642	NSF of Jiangsu Province [BK2012027]; NSFC [31301613]; Youth Science and Technology Innovation Fund of NJAU [KJ2013005]	NSF of Jiangsu Province; NSFC(National Natural Science Foundation of China (NSFC)); Youth Science and Technology Innovation Fund of NJAU	NSF of Jiangsu Province (BK2012027); NSFC(31301613); Youth Science and Technology Innovation Fund of NJAU (KJ2013005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Gallois P, 1995, Methods Mol Biol, V49, P39; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hann DR, 2010, CURR OPIN PLANT BIOL, V13, P388, DOI 10.1016/j.pbi.2010.04.003; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kelley BS, 2010, PLANT J, V62, P357, DOI 10.1111/j.1365-313X.2010.04160.x; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P13142, DOI 10.1073/pnas.0907506106; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lee S, 2013, PEERJ, V1, DOI 10.7717/peerj.34; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; McLellan H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003670; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shen DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070036; Song TQ, 2013, MOL PLANT MICROBE IN, V26, P711, DOI 10.1094/MPMI-12-12-0289-R; Stam R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00387; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2001, TRENDS GENET, V17, P611, DOI 10.1016/S0168-9525(01)02517-3; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yu XL, 2012, NEW PHYTOL, V196, P247, DOI 10.1111/j.1469-8137.2012.04241.x; Zhang MX, 2012, FUNGAL BIOL-UK, V116, P1013, DOI 10.1016/j.funbio.2012.07.006	37	35	41	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98114	10.1371/journal.pone.0098114	http://dx.doi.org/10.1371/journal.pone.0098114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858571	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400042
J	Xiong, Y; Zhang, LS; Kebebew, E				Xiong, Yin; Zhang, Lisa; Kebebew, Electron			MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1	PLOS ONE			English	Article							BREAST-CANCER; MIR-17-92 CLUSTER; TUMOR-METASTASIS; PROSTATE-CANCER; CELL-LINE; MICRORNA; INVASION; EXPRESSION; KINASE; PROLIFERATION	Background: There have been conflicting reports regarding the function of miR-20a in a variety of cancer types and we previously found it to be dysregulated in sporadic versus familial papillary thyroid cancer. In this study, we studied the expression of miR-20a in normal, benign and malignant thyroid samples, and its effect on thyroid cancer cells in vitro and in vivo. Methodology/Principal Findings: The expression of miR-20a in normal, benign and malignant thyroid tissue was determined by quantitative RT-PCR. Thyroid cancer cells were transfected with miR-20a and the effect on cellular proliferation, tumor spheroid formation, and invasion was evaluated. Target genes of miR-20 were determined by genome-wide mRNA expression analysis with miR-20a overexpression in thyroid cancer cells and target prediction database. Target genes were validated by quantitative PCR and immunoblotting, and luciferase assays. MiR-20a expression was significantly higher in anaplastic thyroid cancer than in differentiated thyroid cancer, and benign and normal thyroid tissues. MiR-20a significantly inhibited thyroid cancer cell proliferation in vitro (p<0.01) and in vivo (p<0.01), tumor spheroid formation (p<0.05) and invasion (p<0.05) in multiple thyroid cancer cell lines. We found that LIMK1 was a target of miR-20a in thyroid cancer cell lines and direct knockdown of LIMK1 recapitulated the effect of miR-20a in thyroid cancer cells. Conclusions/Significance: To our knowledge, this is the first study to demonstrate that miR-20a plays a role as a tumor suppressor in thyroid cancer cells and targets LIMK1. Our findings suggest the upregulated expression of miR-20a in anaplastic thyroid cancer counteracts thyroid cancer progression and may have therapeutic potential.	[Xiong, Yin; Zhang, Lisa; Kebebew, Electron] NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kebebew, E (corresponding author), NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov			National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011275] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan XX, 2010, ACTA BIOCH BIOPH SIN, V42, P318, DOI 10.1093/abbs/gmq026; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu QL, 2013, BIOMATERIALS, V34, P2265, DOI 10.1016/j.biomaterials.2012.12.016; Huang GX, 2012, CANCER RES, V72, P908, DOI 10.1158/0008-5472.CAN-11-1460; Huang XM, 2013, CLIN CANCER RES, V19, P2355, DOI 10.1158/1078-0432.CCR-12-3191; Institute NC, 2011, THYR CANC; Kang HW, 2012, FEBS LETT, V586, P897, DOI 10.1016/j.febslet.2012.02.020; Kebebew E, 2008, WORLD J SURG, V32, P678, DOI 10.1007/s00268-007-9312-z; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Vriens MR, 2009, THYROID, V19, P1343, DOI 10.1089/thy.2009.1607; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024717; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475	34	114	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96103	10.1371/journal.pone.0096103	http://dx.doi.org/10.1371/journal.pone.0096103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858712	Green Submitted, gold, Green Published			2022-12-27	WOS:000336839400001
J	Liu, W; Li, W; He, QL; Daud, MK; Chen, JH; Zhu, SJ				Liu, Wei; Li, Wei; He, Qiuling; Daud, Muhammad Khan; Chen, Jinhong; Zhu, Shuijin			Genome-Wide Survey and Expression Analysis of Calcium-Dependent Protein Kinase in Gossypium raimondii	PLOS ONE			English	Article							ABIOTIC STRESS CONDITIONS; CALMODULIN-LIKE DOMAIN; GENE FAMILY; FUNCTIONAL-CHARACTERIZATION; COMPREHENSIVE ANALYSIS; REGULATORY NETWORKS; LOW-TEMPERATURE; ARABIDOPSIS; RICE; CDPK	Calcium-dependent protein kinases (CDPKs) are one of the largest protein kinases in plants and participate in different physiological processes through regulating downstream components of calcium signaling pathways. In this study, 41 CDPK genes, from GrCPK1 to GrCPK41, were identified in the genome of the diploid cotton, Gossypium raimondii. The phylogenetic analysis indicated that all these genes were divided into four subgroups and members within the same subgroup shared conserved exon-intron structures. The expansion of GrCPKs family in G. raimondii was due to the segmental duplication events, and the analysis of Ka/Ks ratios implied that the duplicated GrCPKs had mainly undergone strong purifying selection pressure with limited functional divergence. The cold-responsive elements in promoter regions were detected in the majority of GrCPKs. The expression analysis of 11 selected genes showed that GrCPKs exhibited tissue-specific expression patterns and the expression of GrCPKs were induced or repressed by cold treatment. These observations would lay an important foundation for functional and evolutionary analysis of CDPK gene family in Gossypium species.	[Liu, Wei; Li, Wei; He, Qiuling; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Daud, Muhammad Khan] Kohat Univ Sci & Technol, Dept Biotechnol & Genet Engn, Kohat, Pakistan	Zhejiang University; Kohat University of Science & Technology	Chen, JH (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	jinhongchen@zju.edu.cn; shjzhu@zju.edu.cn	Khan, Muhammad Daud/AAF-1011-2021		National Basic Research Program (973 program) [2010CB126006]; National High Technology Research and Development Program of China [2011AA10A102, 2013AA102601]	National Basic Research Program (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The works are support by the National Basic Research Program (973 program, No: 2010CB126006) and the National High Technology Research and Development Program of China (2011AA10A102, 2013AA102601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berberich T, 1997, MOL GEN GENET, V254, P275, DOI 10.1007/s004380050416; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chang WJ, 2009, BIOSCI BIOTECH BIOCH, V73, P2427, DOI 10.1271/bbb.90385; Chen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080818; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Giammaria V, 2011, PLANTA, V233, P593, DOI 10.1007/s00425-010-1319-2; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harmon AC, 2001, NEW PHYTOL, V151, P175, DOI 10.1046/j.1469-8137.2001.00171.x; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong Y, 1996, PLANT MOL BIOL, V30, P1259, DOI 10.1007/BF00019557; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hrabak EM, 1996, PLANT MOL BIOL, V31, P405, DOI 10.1007/BF00021802; Huang QS, 2008, PLANT CELL REP, V27, P1869, DOI 10.1007/s00299-008-0603-0; Ivashuta S, 2005, PLANT CELL, V17, P2911, DOI 10.1105/tpc.105.035394; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SS, 2003, PLANT J, V33, P825, DOI 10.1046/j.1365-313X.2003.01672.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li AL, 2008, PLANT MOL BIOL, V66, P429, DOI 10.1007/s11103-007-9281-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SX, 2013, PLANT MOL BIOL, V82, P267, DOI 10.1007/s11103-013-0061-0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma PD, 2013, APPL BIOCHEM BIOTECH, V169, P2111, DOI 10.1007/s12010-013-0125-2; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Mehlmer N, 2010, PLANT J; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Gargantini P, 2009, PLANT MOL BIOL, V70, P153, DOI 10.1007/s11103-009-9462-5; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Saijo Y, 2001, PLANT CELL PHYSIOL, V42, P1228, DOI 10.1093/pcp/pce158; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang CT, 2013, PLANT MOL BIOL REP, V31, P222, DOI 10.1007/s11105-012-0496-5; Wang H, 2011, ACTA BIOCH BIOPH SIN, V43, P654, DOI 10.1093/abbs/gmr056; Wei HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068435; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Yoon GM, 1999, PLANT MOL BIOL, V39, P991, DOI 10.1023/A:1006170512542; Zhang M, 2005, BBA-GENE STRUCT EXPR, V1729, P174, DOI 10.1016/j.bbaexp.2005.04.006; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	74	52	57	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98189	10.1371/journal.pone.0098189	http://dx.doi.org/10.1371/journal.pone.0098189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887436	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300044
J	Mou, B; Beltran, CJ; Park, SS; Olivier, KR; Furutani, KM				Mou, Benjamin; Beltran, Chris J.; Park, Sean S.; Olivier, Kenneth R.; Furutani, Keith M.			Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study	PLOS ONE			English	Article							BODY RADIATION-THERAPY; SBRT; CANCER	Stereotactic ablative radiotherapy is being increasingly adopted in the treatment of lung tumors. The use of proton beam therapy can further reduce dose to normal structures. However, uncertainty exists in proton-based treatment plans, including range uncertainties, large sensitivity to position uncertainty, and calculation of dose deposition in heterogeneous areas. This study investigated the feasibility of proton transmission beams, i.e. without the Bragg peak, to treat lung tumors with stereotactic ablative radiotherapy. We compared three representative treatment plans using proton transmission beams versus conformal static-gantry photon beams. It was found that proton treatment plans using transmission beams passing through the patient were feasible and demonstrated lower dose to normal structures and markedly reduced treatment times than photon plans. This is the first study to demonstrate the feasibility of proton-based stereotactic ablative radiotherapy planning for lung tumors using proton transmission beams alone. Further research using this novel approach for proton-based planning is warranted.	[Mou, Benjamin; Beltran, Chris J.; Park, Sean S.; Olivier, Kenneth R.; Furutani, Keith M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA	Mayo Clinic	Beltran, CJ (corresponding author), Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA.	Beltran.Chris@mayo.edu		Mou, Benjamin/0000-0002-5636-604X; Park, Sean/0000-0003-3814-853X				Bradley J, 2013, J CLIN ONCOL, V31, P7501; Georg D, 2008, RADIOTHER ONCOL, V88, P368, DOI 10.1016/j.radonc.2008.03.007; Hoppe BS, 2010, RADIOTHER ONCOL, V97, P425, DOI 10.1016/j.radonc.2010.09.006; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Macdonald OK, 2009, INT J RADIAT ONCOL, V75, P950, DOI 10.1016/j.ijrobp.2009.04.023; Paganetti H, 2012, PHYS MED BIOL, V57, pR99, DOI 10.1088/0031-9155/57/11/R99; Register SP, 2011, INT J RADIAT ONCOL, V80, P1015, DOI 10.1016/j.ijrobp.2010.03.012; Seco J, 2012, INT J RADIAT ONCOL, V83, P354, DOI 10.1016/j.ijrobp.2011.05.062; Videtic GM, 2013, INT J RADIAT ONCOL, V87, pS3, DOI 10.1016/j.ijrobp.2013.06.016; Westover KD, 2012, J THORAC ONCOL, V7, P1021, DOI 10.1097/JTO.0b013e31824de0bf	10	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98621	10.1371/journal.pone.0098621	http://dx.doi.org/10.1371/journal.pone.0098621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887068	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300094
J	Wang, KC; Lin, KH; Lee, TC; Lee, CL; Chen, SY; Chen, SJ; Chin, LT; Tsai, CP				Wang, Kai-Chen; Lin, Kuan-Hsiang; Lee, Tzu-Chi; Lee, Chao-Lin; Chen, Shao-Yuan; Chen, Shyi-Jou; Chin, Li-Te; Tsai, Ching-Piao			Poor Responses to Interferon-Beta Treatment in Patients with Neuromyelitis Optica and Multiple Sclerosis with Long Spinal Cord Lesions	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; JAPANESE; HETEROGENEITY; INVOLVEMENT; MRI	Interferon-beta (IFN-beta) treatment may not be effective in neuromyelitis optica (NMO). Whether the poor response to IFN-beta is related to long spinal cord lesions (LSCL) or the NMO disease entity itself is unclear. We evaluated the spinal cord involvement of patients with multiple sclerosis (MS) and NMO, as well as the response after receiving IFN-beta. Forty-nine MS and 21 NMO patients treated with IFN-beta for at least 2 years from 2002-2008 were enrolled in this study and the treatment response was analyzed 2 years post-treatment. In the study, spinal cord lesions were present in 57.1% (28/49) of the MS patients, of which 16.3% (8/49) presented spinal cord lesions longer than 3 vertebral segments (LSCL). Responses to IFN-beta treatment were seen in 69.3% (34/49) of all the MS cases, of which the appropriate response rates were 76.1% (16/21) in MS patients without spinal cord lesions and 37.5% (3/8) in patients with LSCL. Only 14.2% (3/21) of NMO patients responded to IFN-beta treatment. In conclusion, spinal cord lesion is common in MS patients in Taiwan. Both NMO and MS patients with LSCL had a poor response to IFN-beta treatment. NMO patients had a worse response to IFN-beta treatment than MS patients with LSCL, which shows that the crucial structural defect is something other than LSCL such as the elevated serum IL17 level in NMO compared to MS.	[Wang, Kai-Chen] Cheng Hsin Gen Hosp, Dept Neurol, Taipei, Taiwan; [Wang, Kai-Chen; Lin, Kuan-Hsiang; Tsai, Ching-Piao] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Wang, Kai-Chen; Lin, Kuan-Hsiang; Lee, Chao-Lin; Tsai, Ching-Piao] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lee, Tzu-Chi] Kaohsiung Med Univ, Fac Publ Hlth, Kaohsiung, Taiwan; [Lee, Chao-Lin] I Lan Hosp, Dept Neurol, Ilan, Taiwan; [Chen, Shao-Yuan] Cardinal Tien Hosp, Sect Hyperbar Oxygen Med, Taipei, Taiwan; [Chen, Shyi-Jou] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Chin, Li-Te] Natl Chayi Univ, Dept Microbiol & Immunol, Chayi, Taiwan	Cheng Hsin General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; National Defense Medical Center	Chin, LT (corresponding author), Natl Chayi Univ, Dept Microbiol & Immunol, Chayi, Taiwan.	litechin@yahoo.com.tw; cptsai@vghtpe.gov.tw						Balasa R, 2012, MULT SCLER; Bot JCJ, 2004, RADIOLOGY, V233, P531, DOI 10.1148/radiol.2332031572; Chon H. T., 2002, NEUROLOGY J S E ASIA, V7, P35; Chong HT, 2006, CAN J NEUROL SCI, V33, P95, DOI 10.1017/S0317167100004777; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Hutchinson M, 2009, PRACT NEUROL, V9, P144; Hutchinson Michael, 2009, Pract Neurol, V9, P133, DOI 10.1136/jnnp.2009.177212; KIDD D, 1993, NEUROLOGY, V43, P2632, DOI 10.1212/WNL.43.12.2632; MARAVILLA KR, 1985, AM J ROENTGENOL, V144, P381, DOI 10.2214/ajr.144.2.381; Matsuoka T, 2008, J NEUROL SCI, V266, P115, DOI 10.1016/j.jns.2007.09.010; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; O'Rourke KET, 2005, MULT SCLER J, V11, P46, DOI 10.1191/1352458505ms1131oa; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qiu W, 2011, J NEUROL SCI, V300, P114, DOI 10.1016/j.jns.2010.09.006; Saida T, 2005, NEUROLOGY, V64, P621, DOI 10.1212/01.WNL.0000151856.10387.E2; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Shimizu Y, 2011, TOHOKU J EXP MED, V223, P211, DOI 10.1620/tjem.223.211; Tanaka M, 2009, EUR NEUROL, V62, P167, DOI 10.1159/000227277; TARTAGLINO LM, 1995, RADIOLOGY, V195, P725, DOI 10.1148/radiology.195.3.7754002; ULDRY PA, 1993, J NEUROL, V240, P41, DOI 10.1007/BF00838445; Uzawa A, 2010, EUR J NEUROL, V17, P672, DOI 10.1111/j.1468-1331.2009.02897.x; Wang KC, 2011, EUR NEUROL, V65, P99, DOI 10.1159/000322740; Warabi Y, 2007, J NEUROL SCI, V252, P57, DOI 10.1016/j.jns.2006.10.008; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74	26	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98192	10.1371/journal.pone.0098192	http://dx.doi.org/10.1371/journal.pone.0098192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887452	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300045
J	Chen, W; DelProposto, Z; Liu, W; Kassir, M; Wang, ZY; Zhao, J; Xie, B; Wen, YM; Wang, J; Hu, JN				Chen, Wei; DelProposto, Zachary; Liu, Wei; Kassir, Mohammad; Wang, Zhiyuan; Zhao, Jun; Xie, Bing; Wen, Yaming; Wang, Jian; Hu, Jiani			Susceptibility-Weighted Imaging for the Noncontrast Evaluation of Hepatocellular Carcinoma: A Prospective Study with Histopathologic Correlation	PLOS ONE			English	Article							INTRATUMORAL HEMORRHAGE; MRI; DIAGNOSIS; PATHOLOGY; LIVER; CT; NODULES; LESIONS	Background: Specific morphologic features of hepatocellular carcinoma (HCC) on imaging have identifiable pathologic correlates as well as implications for altering surgical management and defining prognosis. In this study, we compared susceptibility-weighted imaging (SWI) to conventional techniques and correlated our findings with histopathology to determine the role of SWI in assessing morphologic features of HCC without using a contrast agent. Methods: 86 consecutive patients with suspected HCC were imaged with MRI (including T1, T2, T2*, and SWI) and subsequently CT. 59 histologically-proven HCC lesions were identified in 53 patients. Each lesion on each imaging sequence was evaluated by two radiologists, and classified with respect to lesion morphology, signal intensity relative to surrounding hepatic parenchyma, presence of a pseudocapsule, presence of venous invasion, and internal homogeneity. Results: Histopathology confirmed pseudocapsules in 41/59 lesions. SWI was able to detect a pseudocapsule in 34/41 lesions; compared to conventional T1/T2 imaging (12/41) and T2* (27/41). Mosaic pattern was identified in 25/59 lesions by histopathology; SWI confirmed this in all 25 lesions, compared to T1/T2 imaging (13/25) or T2* (18/25). Hemorrhage was confirmed by histopathology in 43/59 lesions, and visible on SWI in 41/43 lesions, compared to T1/T2 (7/43) and T2* (38/43). Venous invasion was confirmed by histopathology in 31/59 patients; SWI demonstrated invasion in 28/31 patients, compared to T1/T2 (7/31) and T2* (24/31). Conclusions: SWI is better at identifying certain morphologic features such as pseudocapsule and hemorrhage than conventional MRI without using a contrast agent in HCC patients.	[Chen, Wei; Zhao, Jun; Xie, Bing; Wen, Yaming; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [DelProposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Liu, Wei] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Kassir, Mohammad; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Wang, Zhiyuan] Cent S Univ, Xiangya Med Sch, Hunan Prov Tumor Hosp, Canc Biotherapy Ctr, Changsha, Hunan, Peoples R China	Army Medical University; Henry Ford Health System; Henry Ford Hospital; Army Medical University; Wayne State University; Central South University	Wang, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	wangjian811@gmail.com; jhu@med.wayne.edu			National Natural Science Foundation of China [81272442/H1608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (Project No: 81272442/H1608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; CHOI BI, 1993, AM J ROENTGENOL, V160, P1177, DOI 10.2214/ajr.160.6.8388618; Choi JH, 2004, J KOREAN MED SCI, V19, P895, DOI 10.3346/jkms.2004.19.6.895; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Earls JP, 1996, RADIOLOGY, V201, P207, DOI 10.1148/radiology.201.1.8816545; EBARA M, 1986, RADIOLOGY, V159, P371, DOI 10.1148/radiology.159.2.3008213; Grazioli L, 1999, EUR RADIOL, V9, P62, DOI 10.1007/s003300050629; Hardie AD, 2010, MAGN RESON IMAGING, V28, P281, DOI 10.1016/j.mri.2009.12.010; HONDA H, 1992, GASTROINTEST RADIOL, V17, P245, DOI 10.1007/BF01888559; Ito K, 2006, EUR J RADIOL, V58, P186, DOI 10.1016/j.ejrad.2005.11.039; KADOYA M, 1992, RADIOLOGY, V183, P819, DOI 10.1148/radiology.183.3.1316622; Lee JM, 2012, SEMIN ONCOL, V39, P399, DOI 10.1053/j.seminoncol.2012.05.010; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Mie MB, 2010, Z MED PHYS, V20, P143, DOI 10.1016/j.zemedi.2010.02.004; Miller G, 2007, SURG ONCOL CLIN N AM, V16, P343, DOI 10.1016/j.soc.2007.04.001; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; NAKASHIMA T, 1986, SEMIN LIVER DIS, V6, P259, DOI 10.1055/s-2008-1040608; Onaya H, 2000, Magn Reson Imaging Clin N Am, V8, P757; Perazella MA, 2008, CURR DRUG SAF, V3, P67, DOI 10.2174/157488608783333989; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Stevens WR, 1996, J COMPUT ASSIST TOMO, V20, P337, DOI 10.1097/00004728-199605000-00001; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Tan MGK, 2009, EXP BIOL MED, V234, P693, DOI 10.3181/0807-RM-227; Tao R, 2012, CLIN RADIOL, V67, pE91, DOI 10.1016/j.crad.2012.08.015	25	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98303	10.1371/journal.pone.0098303	http://dx.doi.org/10.1371/journal.pone.0098303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879409	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500048
J	Ferrero, R; Lima, M; Gonzalez-Andujar, JL				Ferrero, Rosana; Lima, Mauricio; Luis Gonzalez-Andujar, Jose			Spatio-Temporal Dynamics of Maize Yield Water Constraints under Climate Change in Spain	PLOS ONE			English	Article							TEMPERATURE; CROP; VARIABILITY; IRRIGATION; MINIMUM; MODELS; HEAT; GAPS; US	Many studies have analyzed the impact of climate change on crop productivity, but comparing the performance of water management systems has rarely been explored. Because water supply and crop demand in agro-systems may be affected by global climate change in shaping the spatial patterns of agricultural production, we should evaluate how and where irrigation practices are effective in mitigating climate change effects. Here we have constructed simple, general models, based on biological mechanisms and a theoretical framework, which could be useful in explaining and predicting crop productivity dynamics. We have studied maize in irrigated and rain-fed systems at a provincial scale, from 1996 to 2009 in Spain, one of the most prominent "hot-spots'' in future climate change projections. Our new approach allowed us to: (1) evaluate new structural properties such as the stability of crop yield dynamics, (2) detect nonlinear responses to climate change (thresholds and discontinuities), challenging the usual linear way of thinking, and (3) examine spatial patterns of yield losses due to water constraints and identify clusters of provinces that have been negatively affected by warming. We have reduced the uncertainty associated with climate change impacts on maize productivity by improving the understanding of the relative contributions of individual factors and providing a better spatial comprehension of the key processes. We have identified water stress and water management systems as being key causes of the yield gap, and detected vulnerable regions where efforts in research and policy should be prioritized in order to increase maize productivity.	[Ferrero, Rosana; Luis Gonzalez-Andujar, Jose] CSIC, Inst Agr Sostenible, Dept Protecc Cult, Cordoba, Spain; [Lima, Mauricio] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile; [Lima, Mauricio; Luis Gonzalez-Andujar, Jose] LINCG CSIC PUC, Lab Int Cambio Global, Santiago, Chile; [Ferrero, Rosana; Lima, Mauricio] Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Pontificia Universidad Catolica de Chile	Ferrero, R (corresponding author), CSIC, Inst Agr Sostenible, Dept Protecc Cult, Cordoba, Spain.	rferrero@ias.csic.es	GONZALEZ-ANDUJAR, JOSE L./G-5671-2013; Lima, Mauricio/F-2722-2013; Ferrero, Rosana/G-6435-2014	GONZALEZ-ANDUJAR, JOSE L./0000-0003-2356-4098; Lima, Mauricio/0000-0002-3700-2945; Ferrero, Rosana/0000-0002-2520-0231	Fundacion Carolina; FEDER (Fondo Europeo de Desarrollo Regional); Spanish Ministry of Economy and Competitiveness funds [AGL2012-33736]; Fondo Basal-CONICYT [FB-0002]; LINCGlobal (Laboratorio Internacional en Cambio Global)	Fundacion Carolina; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Spanish Ministry of Economy and Competitiveness funds(Spanish Government); Fondo Basal-CONICYT; LINCGlobal (Laboratorio Internacional en Cambio Global)	R. Ferrero gratefully acknowledges receipt of a grant from the Fundacion Carolina. J. L. Gonzalez-Andujar and R. Ferrero were supported by FEDER (Fondo Europeo de Desarrollo Regional) and the Spanish Ministry of Economy and Competitiveness funds (AGL2012-33736). R. Ferrero and M. Lima acknowledge financial support from Fondo Basal-CONICYT grant FB-0002. We are grateful to LINCGlobal (Laboratorio Internacional en Cambio Global) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Bates D.M., 1991, STAT MODELS S; Berryman A, 2001, OIKOS, V92, P265, DOI 10.1034/j.1600-0706.2001.920208.x; Berryman A., 1999, PRINCIPLES POPULATIO; Bivand R, 2013, SPEED SPATIAL DEPEND; Bivand RS, 2008, USE R, P1; Bosello F, 2009, SSRN ELECT J; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/NCLIMATE1585, 10.1038/nclimate1585]; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Chen CQ, 2011, AGR FOREST METEOROL, V151, P1580, DOI 10.1016/j.agrformet.2011.06.013; De La Maza M, 2009, GLOBAL CHANGE BIOL, V15, P1116, DOI 10.1111/j.1365-2486.2008.01796.x; Doll P, 2002, CLIMATIC CHANGE, V54, P269, DOI 10.1023/A:1016124032231; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; IGLESIAS A, 1995, ASA SPEC P, P259; Iglesias A, 2012, CLIMATIC CHANGE, V112, P29, DOI 10.1007/s10584-011-0338-8; Iglesias A, 2011, REG ENVIRON CHANGE, V11, pS159, DOI 10.1007/s10113-010-0187-4; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Lawrence JF, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007836; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu Z, 2012, GLOB CHANG BIOL, V86; Lobell D, 2009, J CLIMATE, V22, P2248, DOI 10.1175/2008JCLI2703.1; Lobell DB, 2007, AGR FOREST METEOROL, V145, P229, DOI 10.1016/j.agrformet.2007.05.002; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lobell DB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034145; Lobell DB, 2006, ECOL MODEL, V196, P173, DOI 10.1016/j.ecolmodel.2005.11.030; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; MAGRAMA, 2012, MAGRAMA STAT DAT; Medici LO, 2014, ENVIRON EXP BOT, V99, P38, DOI 10.1016/j.envexpbot.2013.10.019; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mohammed AR, 2011, GLOBAL WARMING IMPACTS - CASE STUDIES ON THE ECONOMY, HUMAN HEALTH, AND ON URBAN AND NATURAL ENVIRONMENTS, P153; MUCHOW RC, 1990, AGRON J, V82, P338, DOI 10.2134/agronj1990.00021962008200020033x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reidsma P, 2009, AGR SYST, V100, P51, DOI 10.1016/j.agsy.2008.12.009; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rodriguez-Puebla C, 2007, CLIM RES, V34, P223, DOI 10.3354/cr00700; Rosenzweig C, 1996, AGR FOREST METEOROL, V80, P215, DOI 10.1016/0168-1923(95)02299-6; Royama T., 1992, ANAL POPULATION ECOL; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Sun BJ, 2013, J AGR SCI, P1; Tokatlidis IS, 2013, AGRON SUSTAIN DEV, V33, P63, DOI 10.1007/s13593-012-0108-7; Turral H., 2011, CLIMATE CHANGE WATER, P204; WOLF J, 1995, CLIMATIC CHANGE, V29, P299, DOI 10.1007/BF01091866; Zou XX, 2012, MITIG ADAPT STRAT GL, V17, P111, DOI 10.1007/s11027-011-9316-8	51	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98220	10.1371/journal.pone.0098220	http://dx.doi.org/10.1371/journal.pone.0098220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878747	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500038
J	Han, JM; Kim, HG; Lee, JS; Choi, MK; Kim, YA; Son, CG				Han, Jong-Min; Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Kim, Young-Ae; Son, Chang-Gue			Repeated Sense of Hunger Leads to the Development of Visceral Obesity and Metabolic Syndrome in a Mouse Model	PLOS ONE			English	Article							MESSENGER-RNA; INSULIN-RESISTANCE; GLUCOSE-TRANSPORTER; EATING PATTERNS; ENERGY-BALANCE; LEPTIN LEVELS; ADIPOSITY; FAT; ADIPONECTIN; EXPRESSION	Obesity-related disorders, especially metabolic syndrome, contribute to 2.8 million deaths each year worldwide, with significantly increasing morbidity. Eating at regular times and proper food quantity are crucial for maintaining a healthy status. However, many people in developed countries do not follow a regular eating schedule due to a busy lifestyle. Herein, we show that a repeated sense of hunger leads to a high risk of developing visceral obesity and metabolic syndrome in a mouse model (both 3-week and 6-week-old age, 10 mice in each group). The ad libitum (AL) group (normal eating pattern) and the food restriction (FR) group (alternate-day partially food restriction by given only 1/3 of average amount) were compared after 8-week experimental period. The total food consumption in the FR group was lower than in the AL group, however, the FR group showed a metabolic syndrome-like condition with significant fat accumulation in adipose tissues. Consequently, the repeated sense of hunger induced the typical characteristics of metabolic syndrome in an animal model; a distinct visceral obesity, hyperlipidemia, hyperglycemia and hepatic steatosis. Furthermore, we found that specifically leptin, a major metabolic hormone, played a major role in the development of these pathological disorders. Our study indicated the importance of regular eating habits besides controlling calorie intake.	[Han, Jong-Min; Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Kim, Young-Ae; Son, Chang-Gue] Daejeon Univ, Inst Tradit Med & Biosci, Liver & Immunol Res Ctr, Taejon, South Korea	Daejeon University	Son, CG (corresponding author), Daejeon Univ, Inst Tradit Med & Biosci, Liver & Immunol Res Ctr, 22-5 Daeheung Dong, Taejon, South Korea.	ckson@dju.ac.kr	son, chang gue/ABC-2215-2021		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2001519]; Oriental Medicine Research and Development Project, Ministry of Health and Welfare [B120047]; Korea Institute of Oriental Medicine, Republic of Korea [K12101]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Oriental Medicine Research and Development Project, Ministry of Health and Welfare; Korea Institute of Oriental Medicine, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) founded by the Ministry of Education, Science and Technology (2012R1A1A2001519), the Oriental Medicine Research and Development Project, Ministry of Health and Welfare (B120047), and the "Study of aging-control by energy metabolism based on oriental medicine'' of Korea Institute of Oriental Medicine, Republic of Korea (K12101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait Saada D., 2008, ADV BIOL RES, V2, P111; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Bouguerra R, 2006, ANN ENDOCRINOL-PARIS, V67, P54, DOI 10.1016/S0003-4266(06)72541-0; Brietzke SA, 2007, MED CLIN N AM, V91, P1041, DOI 10.1016/j.mcna.2007.06.005; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738; Devlin MJ, 2000, AM J PSYCHIAT, V157, P854, DOI 10.1176/appi.ajp.157.6.854; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Harsch IA, 2007, J PHYSIOL PHARMACOL, V58, P65; Havel PJ, 1998, AM J CLIN NUTR, V67, P355, DOI 10.1093/ajcn/67.3.355; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Jaakkola J, 2013, NUTRITION, V29, P1209, DOI 10.1016/j.nut.2013.03.008; Johnson JB, 2006, MED HYPOTHESES, V67, P209, DOI 10.1016/j.mehy.2006.01.030; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Klempel MC, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-98; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Li LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066069; Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Martins MD, 2012, REV PORT CARDIOL, V31, P711, DOI 10.1016/j.repc.2012.08.002; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Monroe MB, 2000, INT J OBESITY, V24, P1183, DOI 10.1038/sj.ijo.0801364; Mozzanega B, 2004, ANN NY ACAD SCI, V1034, P364, DOI 10.1196/annals.1335.038; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Savino F, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/803985; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Segal KR, 1996, DIABETES, V45, P988, DOI 10.2337/diabetes.45.7.988; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Weissman C, 1999, CRIT CARE, V3, pR67, DOI 10.1186/cc360; Wilding JPH, 2002, DIABETIC MED, V19, P619, DOI 10.1046/j.1464-5491.2002.00790.x; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155; Yun JE, 2010, METABOLISM, V59, P424, DOI 10.1016/j.metabol.2009.08.012	50	4	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98276	10.1371/journal.pone.0098276	http://dx.doi.org/10.1371/journal.pone.0098276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879081	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500043
J	Levesque, C; Provost, C; Labrie, J; Reyes, YH; Nava, JAB; Gagnon, CA; Jacques, M				Levesque, Cynthia; Provost, Chantale; Labrie, Josee; Reyes, Yenney Hernandez; Burciaga Nava, Jorge A.; Gagnon, Carl A.; Jacques, Mario			Actinobacillus pleuropneumoniae Possesses an Antiviral Activity against Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							SWINE INFLUENZA-VIRUS; CELL-LINE; STREPTOCOCCUS-PNEUMONIAE; MYCOPLASMA-HYOPNEUMONIAE; EPITHELIAL-CELLS; SYNDROME PRRS; IN-VITRO; INFECTION; PIGS; REPLICATION	Pigs are often colonized by more than one bacterial and/or viral species during respiratory tract infections. This phenomenon is known as the porcine respiratory disease complex (PRDC). Actinobacillus pleuropneumoniae (App) and porcine reproductive and respiratory syndrome virus (PRRSV) are pathogens that are frequently involved in PRDC. The main objective of this project was to study the in vitro interactions between these two pathogens and the host cells in the context of mixed infections. To fulfill this objective, PRRSV permissive cell lines such as MARC-145, SJPL, and porcine alveolar macrophages (PAM) were used. A pre-infection with PRRSV was performed at 0.5 multiplicity of infection (MOI) followed by an infection with App at 10 MOI. Bacterial adherence and cell death were compared. Results showed that PRRSV pre-infection did not affect bacterial adherence to the cells. PRRSV and App co-infection produced an additive cytotoxicity effect. Interestingly, a pre-infection of SJPL and PAM cells with App blocked completely PRRSV infection. Incubation of SJPL and PAM cells with an App cell-free culture supernatant is also sufficient to significantly block PRRSV infection. This antiviral activity is not due to LPS but rather by small molecular weight, heat-resistant App metabolites(<1 kDa). The antiviral activity was also observed in SJPL cells infected with swine influenza virus but to a much lower extent compared to PRRSV. More importantly, the PRRSV antiviral activity of App was also seen with PAM, the cells targeted by the virus in vivo during infection in pigs. The antiviral activity might be due, at least in part, to the production of interferon c. The use of in vitro experimental models to study viral and bacterial co-infections will lead to a better understanding of the interactions between pathogens and their host cells, and could allow the development of novel prophylactic and therapeutic tools.	[Levesque, Cynthia; Provost, Chantale; Labrie, Josee; Reyes, Yenney Hernandez; Gagnon, Carl A.; Jacques, Mario] Univ Montreal, Fac Med Vet, CRIPA, St Hyacinthe, PQ J2S 7C6, Canada; [Levesque, Cynthia; Provost, Chantale; Labrie, Josee; Reyes, Yenney Hernandez; Gagnon, Carl A.; Jacques, Mario] Univ Montreal, Fac Med Vet, GREMIP, St Hyacinthe, PQ J2S 7C6, Canada; [Burciaga Nava, Jorge A.] Univ Juarez Estado Durango, Fac Med, Dept Bioquim, Durango, Mexico	Universite de Montreal; Universite de Montreal; Universidad Juarez del Estado de Durango	Jacques, M (corresponding author), Univ Montreal, Fac Med Vet, CRIPA, St Hyacinthe, PQ J2S 7C6, Canada.	mario.jacques@umontreal.ca	Jacques, Mario/D-4901-2015; Gagnon, Carl A/A-9239-2015	Provost, Chantale/0000-0002-6674-1157; Gagnon, Carl A./0000-0003-4528-541X	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche du Quebec nature et technologies (FRQNT); Canadian Swine Health Board (CSHB); NSERC-Alexander Graham Bell Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec nature et technologies (FRQNT); Canadian Swine Health Board (CSHB); NSERC-Alexander Graham Bell Canada Graduate Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grants (to CAG and MJ) and Fonds de recherche du Quebec nature et technologies (FRQNT) team research project program (to CAG and MJ). C. Provost was a recipient of a postdoctoral fellowship grant from the Canadian Swine Health Board (CSHB). Y. Hernandez Reyes was a recipient of a NSERC-Alexander Graham Bell Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET RES, V28, P305; Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Avadhanula V, 2007, J MED MICROBIOL, V56, P1133, DOI 10.1099/jmm.0.47086-0; Bautista EM, 1999, ARCH VIROL, V144, P1191, DOI 10.1007/s007050050578; BIKOUR MH, 1995, J GEN VIROL, V76, P2539, DOI 10.1099/0022-1317-76-10-2539; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Cafruny WA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-90; Chen Z, 2010, VIROLOGY, V398, P87, DOI 10.1016/j.virol.2009.11.033; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73, DOI 10.1017/S1466252300000074; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gagnon CA, 2003, ARCH VIROL, V148, P951, DOI 10.1007/s00705-002-0943-y; Gagnon CA, 2009, J CLIN MICROBIOL, V47, P796, DOI 10.1128/JCM.01228-08; Gagnon CA, 2008, J VET DIAGN INVEST, V20, P545, DOI 10.1177/104063870802000503; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063767; Golda A, 2011, J GEN VIROL, V92, P1358, DOI 10.1099/vir.0.028381-0; Ishizuka S, 2003, J INFECT DIS, V188, P1928, DOI 10.1086/379833; Jacques M, 2004, CAN J VET RES, V68, P81; Jiang YB, 2010, VET RES COMMUN, V34, P607, DOI 10.1007/s11259-010-9435-9; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Karuppannan AK, 2012, ANTIVIR RES, V94, P188, DOI 10.1016/j.antiviral.2012.03.008; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; Kheyar A, 2005, VACCINE, V23, P4016, DOI 10.1016/j.vaccine.2005.03.012; Kim Y, 2013, VIRUS RES, V171, P44, DOI 10.1016/j.virusres.2012.10.018; Liu CM, 2013, INT J BIOL MACROMOL, V52, P21, DOI 10.1016/j.ijbiomac.2012.09.020; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Music Nedzad, 2010, Animal Health Research Reviews, V11, P135, DOI 10.1017/S1466252310000034; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; PAYMENT P, 1989, MANUEL TECHNIQUES VI; Provost C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-267; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Rimar J M, 1986, MCN Am J Matern Child Nurs, V11, P413, DOI 10.1097/00005721-198611000-00013; ROSSOW KD, 1994, J VET DIAGN INVEST, V6, P3, DOI 10.1177/104063879400600102; Sang Yongming, 2011, BMC Proc, V5 Suppl 4, pS8, DOI 10.1186/1753-6561-5-S4-S8; Seo SH, 2001, J VIROL, V75, P9517, DOI 10.1128/JVI.75.19.9517-9525.2001; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Silversides DW, 2010, J VIROL, V84, P5454, DOI 10.1128/JVI.00042-10; SNELL NJC, 1990, LUNG, V168, P422, DOI 10.1007/BF02718160; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Sun N, 2012, J ASIAN NAT PROD RES, V14, P721, DOI 10.1080/10286020.2012.685727; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thacker EL, 2001, J CLIN MICROBIOL, V39, P2525, DOI 10.1128/JCM.39.7.2525-2530.2001; Thanawongnuwech R, 2000, VET PATHOL, V37, P143, DOI 10.1354/vp.37-2-143; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Xu M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-184; Yang Q, 2013, ANTIVIR RES, V97, P66, DOI 10.1016/j.antiviral.2012.11.004; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001	60	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98434	10.1371/journal.pone.0098434	http://dx.doi.org/10.1371/journal.pone.0098434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878741	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500058
J	Yadav, A; Desai, RS; Bhuta, BA; Singh, JS; Mehta, R; Nehete, AP				Yadav, Archana; Desai, Rajiv S.; Bhuta, Bansari A.; Singh, Jatinder S.; Mehta, Reema; Nehete, Akash P.			Altered Immunohistochemical Expression of Mast Cell Tryptase and Chymase in the Pathogenesis of Oral Submucous Fibrosis and Malignant Transformation of the Overlying Epithelium	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; FIBROBLAST PROLIFERATION; COLLAGEN; DENSITY; MYOFIBROBLASTS; INFLAMMATION; RELEVANCE; CLEAVAGE; CANCER	Mast cells (MCs) expressing serine proteases; tryptase and chymase, are associated with fibrosis in various diseases. However, little is known about their involvement in oral submucous fibrosis (OSF). Our goal was to evaluate the role of MC tryptase and chymase in the pathogenesis of OSF and its malignant transformation. Immunohistochemical expression of MC tryptase and chymase was evaluated in 20 cases of OSF, 10 cases of oral squamous cell carcinoma (OSCC) and 10 cases of healthy controls. Subepithelial zone of Stage 1 and 2 while deep zone of Stage 3 and 4 OSF demonstrated increased tryptase positive MCs. OSCC revealed a proportionate increase in tryptase and chymase positive MCs irrespective of areas of distribution. An altered balance in the subepithelial and deep distribution of tryptase and chymase positive MCs play an important role in the pathogenesis of OSF and its malignant transformation.	[Yadav, Archana; Desai, Rajiv S.; Bhuta, Bansari A.; Singh, Jatinder S.; Mehta, Reema; Nehete, Akash P.] Nair Hosp, Coll Dent, Dept Oral Pathol, Bombay, Maharashtra, India		Desai, RS (corresponding author), Nair Hosp, Coll Dent, Dept Oral Pathol, Bombay, Maharashtra, India.	nansrd@hotmail.com	MEHTA, REEMA V./AAS-5718-2021	singh, Jatinder/0000-0003-4869-1210				Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Akimoto S, 1998, BRIT J DERMATOL, V138, P399; Algermissen B, 1994, Exp Dermatol, V3, P290, DOI 10.1111/j.1600-0625.1994.tb00291.x; Angadi PV, 2011, J ORAL PATHOL MED, V40, P208, DOI 10.1111/j.1600-0714.2010.00995.x; Ankle M. R., 2007, J ORAL MAXILLOFACIAL, V11, P18, DOI [10.4103/0973-029X.33959, DOI 10.4103/0973-029X.33959]; Artuc M, 2002, J INVEST DERMATOL, V118, P391, DOI 10.1046/j.0022-202x.2001.01705.x; Benitez-Bribiesca L, 2001, J HISTOCHEM CYTOCHEM, V49, P1061, DOI 10.1177/002215540104900816; Bhatt AP, 1997, J IND DENT ASS, V49, P187; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bishen KA, 2008, J ORAL PATHOL MED, V37, P402, DOI 10.1111/j.1600-0714.2008.00649.x; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chen Ching-Charng, 1995, Kaohsiung Journal of Medical Sciences, V11, P604; CHOI KL, 1987, IMMUNOL RES, V6, P145, DOI 10.1007/BF02918088; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Desai RS, 2010, ORAL ONCOL, V46, P553, DOI 10.1016/j.oraloncology.2010.04.004; Desai RS, 2012, CURRENT ANGIOGENESIS, V1, P347; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1985, ADV CANCER RES, V43, P203; Folkman J., 2000, CANC MED, V5, P13; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Fukushima H, 2006, HISTOPATHOLOGY, V49, P498, DOI 10.1111/j.1365-2559.2006.02534.x; Gruber BL, 1997, J IMMUNOL, V158, P2310; Haque MF, 1997, J ORAL PATHOL MED, V26, P75, DOI 10.1111/j.1600-0714.1997.tb00025.x; Haque MF, 1998, CYTOKINE, V10, P713, DOI 10.1006/cyto.1997.0342; Iamaroon A, 2003, J ORAL PATHOL MED, V32, P195, DOI 10.1034/j.1600-0714.2003.00128.x; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Kale AD, 2013, MED ORAL PATOL ORAL, V18, pE12, DOI 10.4317/medoral.18226; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khan I, 2011, GROWTH FACTORS, V29, P119, DOI 10.3109/08977194.2011.582839; Khatri MJ, 2013, ISRN PATHOLOGY; Kofford MW, 1997, J BIOL CHEM, V272, P7127, DOI 10.1074/jbc.272.11.7127; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kumar KK, 2007, INDIAN J DENT RES, V18, P106, DOI DOI 10.4103/0970-9290.33785; Kyzas PA, 2005, J CANCER RES CLIN, V131, P624, DOI 10.1007/s00432-005-0003-6; Lingstedt KA, 2001, FASEB J, V15, P1377; Longley BJ, 1997, P NATL ACAD SCI USA, V94, P9017, DOI 10.1073/pnas.94.17.9017; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pujari R, 2013, INT J HEALTH SCI-IJH, V7, P23, DOI 10.12816/0006017; Punnya V, 2011, ORAL MAXILLOFAC SURG, V15, P1; Rajalalitha P, 2005, J ORAL PATHOL MED, V34, P321, DOI 10.1111/j.1600-0714.2005.00325.x; Roberts ISD, 2000, J CLIN PATHOL, V53, P858, DOI 10.1136/jcp.53.11.858; Rojas IG, 2005, J ORAL PATHOL MED, V34, P268, DOI 10.1111/j.1600-0714.2004.00297.x; Rojas IG, 2012, J ORAL PATHOL MED, V41, P27, DOI 10.1111/j.1600-0714.2011.01057.x; RUOKONEN H, 1993, J ORAL PATHOL MED, V22, P30, DOI 10.1111/j.1600-0714.1993.tb00116.x; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; Sabarinath B, 2011, Indian J Dent Res, V22, P116, DOI 10.4103/0970-9290.80009; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Surekha Chavan, 2013, Al Ameen Journal of Medical Sciences, V6, P144; Tanigawa N, 1997, J CLIN ONCOL, V15, P826, DOI 10.1200/JCO.1997.15.2.826; Thode C, 2011, J ORAL PATHOL MED, V40, P201, DOI 10.1111/j.1600-0714.2010.00999.x; Trautmann A, 1998, J IMMUNOL, V160, P5053; Tsai Chi-Cheng, 1999, Kaohsiung Journal of Medical Sciences, V15, P513; TUAN TL, 1994, J CELL SCI, V107, P2285; WALSH LJ, 1995, J ORAL PATHOL MED, V24, P266, DOI 10.1111/j.1600-0714.1995.tb01180.x; Walsh LJ, 2003, CRIT REV ORAL BIOL M, V14, P188, DOI 10.1177/154411130301400304; Wang HW, 2005, EXP DERMATOL, V14, P295, DOI 10.1111/j.0906-6705.2005.00315.x; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yoshiji H, 1996, CANCER RES, V56, P2013	64	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98719	10.1371/journal.pone.0098719	http://dx.doi.org/10.1371/journal.pone.0098719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874976	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800056
J	Han, XL; Zhang, W; Gu, J; Zhao, H; Ni, L; Han, JJ; Zhou, Y; Gu, YN; Zhu, XS; Sun, J; Hou, XL; Yang, HL; Dai, JW; Shi, Q				Han, Xinglong; Zhang, Wen; Gu, Jun; Zhao, Huan; Ni, Li; Han, Jiajun; Zhou, Yun; Gu, Yannan; Zhu, Xuesong; Sun, Jie; Hou, Xianglin; Yang, Huilin; Dai, Jianwu; Shi, Qin			Accelerated Postero-Lateral Spinal Fusion by Collagen Scaffolds Modified with Engineered Collagen-Binding Human Bone Morphogenetic Protein-2 in Rats	PLOS ONE			English	Article							LONG-TERM DELIVERY; RABBIT MODEL; RHBMP-2; MATRIX; REGENERATION; BMP-2; CARRIER; GRAFT; OSTEOGENESIS; ARTHRODESIS	Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive cytokine that plays a critical role in bone regeneration and repair. However, its distribution and side effects are major barriers to its success as therapeutic treatment. The improvement of therapy using collagen delivery matrices has been reported. To investigate a delivery system on posterolateral spinal fusion, both engineered human BMP-2 with a collagen binding domain (CBD-BMP-2) and collagen scaffolds were developed and their combination was implanted into Sprague-Dawley (SD) rats to study Lumbar 4-5 (L4-L5) posterolateral spine fusion. We divided SD rats into three groups, the sham group (G1, n = 20), the collagen scaffold-treated group (G2, n = 20) and the BMP-2-loaded collagen scaffolds group (G3, n = 20). 16 weeks after surgery, the spines of the rats were evaluated by X-radiographs, high-resolution micro-computed tomography (micro-CT), manual palpation and hematoxylin and eosin (H&E) staining. The results showed that spine L4-L5 fusions occurred in G2(40%) and G3(100%) group, while results from the sham group were inconsistent. Moreover, G3 had better results than G2, including higher fusion efficiency (X score, G2 = 2.4 +/- 0.163, G3 = 3.0 +/- 0, p<0.05), higher bone mineral density (BMD, G2: 0.3337 +/- 0.0025g/cm3, G3: 0.4353 +/- 0.0234g/cm3, p<0.05) and more bone trabecular formation. The results demonstrated that with site-specific collagen binding domain, a dose of BMP-2 as low as 0.02mg CBD-BMP-2/cm(3) collagen scaffold could enhance the posterolateral intertransverse process fusion in rats. It suggested that combination delivery could be an alternative in spine fusion with dramatically decreased side effects caused by high dose of BMP-2.	[Han, Xinglong; Zhao, Huan; Ni, Li; Han, Jiajun; Zhou, Yun; Gu, Yannan; Zhu, Xuesong; Yang, Huilin; Shi, Qin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Peoples R China; [Zhang, Wen] Soochow Univ, Inst Orthoped, Suzhou, Peoples R China; [Gu, Jun] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Peoples R China; [Sun, Jie] Chinese Acad Sci, Suzhou Inst Nanotech & Nanob, Div Nanobiomed, Suzhou, Peoples R China; [Hou, Xianglin; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dai, JW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn; shiqin@suda.edu.cn	ZHU, XUESONG/AAI-1933-2020	Zhu, Xuesong/0000-0003-3579-2741	National Nature Science Foundation of China [81101369]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01030000]; SRF for ROCS of SEM; Jiangsu Provincial Special Program of Medical Science [BL2012004, BK2011264]; State Key Laboratory Cultivation Base of Stem Cell and Bio-medical Materials; Program Foundation of SEM [20113201110013]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); SRF for ROCS of SEM; Jiangsu Provincial Special Program of Medical Science; State Key Laboratory Cultivation Base of Stem Cell and Bio-medical Materials; Program Foundation of SEM	This work was supported by National Nature Science Foundation of China (81101369), the "Strategic Priority Research Program of the Chinese Academy of Sciences'' (Grant No. XDA01030000), SRF for ROCS of SEM (QS), PH.D. Program Foundation of SEM (20113201110013), Jiangsu Provincial Special Program of Medical Science (BL2012004, BK2011264), and the State Key Laboratory Cultivation Base of Stem Cell and Bio-medical Materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh KA, 2012, SPINE, V37, P993; Bae HW, 2012, J BONE JOINT SURG AM, V94A, P1845, DOI 10.2106/JBJS.K.00469; Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035; Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063; Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900; Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013; Crandall DG, 2013, SPINE, V38, P1137, DOI 10.1097/BRS.0b013e3182880298; Devine John G, 2012, Evid Based Spine Care J, V3, P35, DOI 10.1055/s-0031-1298616; Dewan AK, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-58; Dmitriev AE, 2010, SPINE J, V10, P16, DOI 10.1016/j.spinee.2009.10.003; Drespe Inneke H, 2005, Spine J, V5, p209S, DOI 10.1016/j.spinee.2005.02.013; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Glassman SD, 2008, SPINE J, V8, P443, DOI 10.1016/j.spinee.2007.03.004; Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381; Gupta MC, 2005, CYTOKINE GROWTH F R, V16, P347, DOI 10.1016/j.cytogfr.2005.02.004; Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4; Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012; Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Kettler A, 2011, EUR SPINE J, V20, P578, DOI 10.1007/s00586-010-1635-z; Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x; Lee JW, 2011, ACTA ORTHOP, V82, P756, DOI 10.3109/17453674.2011.636675; Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005; Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6; Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862; Lopez MJ, 2009, J ORTHOP RES, V27, P366, DOI 10.1002/jor.20735; Lu J, 2008, SPINE, V33, P242, DOI 10.1097/BRS.0b013e318162451b; Miyazaki M, 2009, SPINE J, V9, P22, DOI 10.1016/j.spinee.2008.08.009; Park BH, 2011, BONE, V49, P447, DOI 10.1016/j.bone.2011.05.020; Park DK, 2013, SPINE, V38, pE738, DOI 10.1097/BRS.0b013e31828fd23c; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Rao RD, 2008, SPINE J, V8, P563, DOI 10.1016/j.spinee.2007.04.017; Reid JJ, 2011, J BIOMECH, V44, P213, DOI 10.1016/j.jbiomech.2010.10.021; SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023; Shi Q, 2012, BIOMATERIALS, V33, P6644, DOI 10.1016/j.biomaterials.2012.05.071; Zhao H, 2013, CHINESE MED J-PEKING, V126, P729, DOI 10.3760/cma.j.issn.0366-6999.20122566; Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821	39	16	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98480	10.1371/journal.pone.0098480	http://dx.doi.org/10.1371/journal.pone.0098480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869484	gold, Green Published, Green Submitted			2022-12-27	WOS:000336858300047
J	Alvarez, CL; Schachter, J; Pinheiro, AAD; Silva, LD; Verstraeten, SV; Persechini, PM; Schwarzbaum, PJ				Alvarez, Cora Lilia; Schachter, Julieta; de Sa Pinheiro, Ana Acacia; Silva, Leandro de Souza; Viviana Verstraeten, Sandra; Persechini, Pedro Muanis; Julio Schwarzbaum, Pablo			Regulation of Extracellular ATP in Human Erythrocytes Infected with Plasmodium falciparum	PLOS ONE			English	Article							RED-BLOOD-CELLS; SIGNAL-TRANSDUCTION PATHWAY; PANNEXIN 1 CHANNELS; G-PROTEIN; NITRIC-OXIDE; MEMBRANE-PERMEABILITY; MALARIA; RELEASE; CAMP; NUCLEOTIDES	In human erythrocytes (h-RBCs) various stimuli induce increases in [cAMP] that trigger ATP release. The resulting pattern of extracellular ATP accumulation (ATPe kinetics) depends on both ATP release and ATPe degradation by ectoATPase activity. In this study we evaluated ATPe kinetics from primary cultures of h-RBCs infected with P. falciparum at various stages of infection (ring, trophozoite and schizont stages). A "3V'' mixture containing isoproterenol (beta-adrenergic agonist), forskolin (adenylate kinase activator) and papaverine (phosphodiesterase inhibitor) was used to induce cAMP-dependent ATP release. ATPe kinetics of r-RBCs (ring-infected RBCs), t-RBCs (trophozoite-infected RBCs) and s-RBCs (schizont-infected RBCs) showed [ATPe] to peak acutely to a maximum value followed by a slower time dependent decrease. In all intraerythrocytic stages, values of Delta ATP(1) (difference between [ATPe] measured 1 min post-stimulus and basal [ATPe]) increased nonlinearly with parasitemia (from 2 to 12.5%). Under 3V exposure, t-RBCs at parasitemia 94% (t94-RBCs) showed 3.8-fold higher Delta ATP(1) values than in h-RBCs, indicative of upregulated ATP release. Pre-exposure to either 100 mu M carbenoxolone, 100 nM mefloquine or 100 mM NPPB reduced Delta ATP(1) to 83-87% for h-RBCs and 63-74% for t94-RBCs. EctoATPase activity, assayed at both low nM concentrations (300-900 nM) and 500 mM exogenous ATPe concentrations increased approx. 400-fold in t94-RBCs, as compared to h-RBCs, while intracellular ATP concentrations of t94-RBCs were 65% that of h-RBCs. In t94-RBCs, production of nitric oxide (NO) was approx. 7-fold higher than in h-RBCs, and was partially inhibited by L-NAME pretreatment. In media with L-NAME, Delta ATP(1) values were 2.7-times higher in h-RBCs and 4.2-times higher in t94-RBCs, than without L-NAME. Results suggest that P. falciparum infection of h-RBCs strongly activates ATP release via Pannexin 1 in these cells. Several processes partially counteracted ATPe accumulation: an upregulated ATPe degradation, an enhanced NO production, and a decreased intracellular ATP concentration.	[Alvarez, Cora Lilia; Viviana Verstraeten, Sandra; Julio Schwarzbaum, Pablo] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Alvarez, Cora Lilia; Schachter, Julieta; de Sa Pinheiro, Ana Acacia; Silva, Leandro de Souza; Persechini, Pedro Muanis] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Alvarez, Cora Lilia; Schachter, Julieta; Persechini, Pedro Muanis] INPeTAm Inst Nacl Ciencia & Tecnol Pesquisa Trans, Rio De Janeiro, Brazil	University of Buenos Aires; Universidade Federal do Rio de Janeiro	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina.	pjs@qb.ffyb.uba.ar	Verstraeten, Sandra/H-7612-2019; Sila, Leandro/B-1381-2018; Persechini, Pedro/A-9477-2009; Schachter, Julieta/GLR-1361-2022	Verstraeten, Sandra/0000-0001-5760-6271; Sila, Leandro/0000-0001-8720-0088; Persechini, Pedro/0000-0002-3278-1951; Schachter, Julieta/0000-0001-7704-4958; schwarzbaum, pablo/0000-0002-5176-089X; Pinheiro, Ana Acacia/0000-0002-3894-1645	CAPES-MINCYT [197/11]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 639]; Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires [20020100100090]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [0151]; Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-INPeTAm/CNPq/MCT) of Brasil	CAPES-MINCYT(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires(University of Buenos AiresSecretaria de Ciencia y Tecnologia (SECYT)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-INPeTAm/CNPq/MCT) of Brasil	This work was supported by the following agencies and organisations: CAPES-MINCYT (197/11), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 639, Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires Grant 20020100100090, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior (CAPES), Agencia Nacional de Promocion Cientifica y Tecnologica Grant 0151 of Argentina and Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (INCT-INPeTAm/CNPq/MCT) of Brasil. CLA, SVV, PJS are career researchers from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya C, 2009, PFLUG ARCH EUR J PHY, V457, P1035, DOI 10.1007/s00424-008-0572-8; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Brown A., 1982, ATP ATPASE DETERMINA, P223; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Cerutti C, 1999, J INFECT DIS, V180, P2077, DOI 10.1086/315141; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Dahl G, 2012, BRAIN RES, V1487, P150, DOI 10.1016/j.brainres.2012.04.058; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; Egee S, 2002, J PHYSIOL-LONDON, V542, P795, DOI 10.1113/jphysiol.2002.022970; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Essien EM, 1998, THROMB HAEMOSTASIS, V80, P867; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GHIGO D, 1995, J EXP MED, V182, P677, DOI 10.1084/jem.182.3.677; Glenister FK, 2009, BLOOD, V113, P919, DOI 10.1182/blood-2008-05-157735; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Gorman MW, 2007, CLIN CHEM, V53, P318, DOI 10.1373/clinchem.2006.076364; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hanson MS, 2010, EXP BIOL MED, V235, P256, DOI 10.1258/ebm.2009.009206; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Huber SM, 2004, J BIOL CHEM, V279, P41444, DOI 10.1074/jbc.M407618200; Huber SM, 2002, EMBO J, V21, P22, DOI 10.1093/emboj/21.1.22; Iglesias R, 2009, CELL COMMUN ADHES, V16, P131, DOI 10.3109/15419061003642618; Kitchen LW, 2006, CLIN INFECT DIS, V43, P67, DOI 10.1086/504873; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Koka S, 2008, CELL PHYSIOL BIOCHEM, V21, P481, DOI 10.1159/000129641; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; KUTNER S, 1982, BIOCHIM BIOPHYS ACTA, V687, P113, DOI 10.1016/0005-2736(82)90178-X; KWANT W O, 1970, Journal of General Physiology, V55, P208, DOI 10.1085/jgp.55.2.208; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Denis MFL, 2013, BBA-GEN SUBJECTS, V1830, P4692, DOI 10.1016/j.bbagen.2013.05.033; Levano-Garcia J, 2010, PURINERG SIGNAL, V6, P365, DOI 10.1007/s11302-010-9202-y; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Maia J.C., 1983, GENES ANTIGENS PARAS, P144; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mehta M, 2005, FEBS LETT, V579, P6151, DOI 10.1016/j.febslet.2005.09.088; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Miles AM, 1996, METHOD ENZYMOL, V268, P105; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nicolay JP, 2008, PFLUG ARCH EUR J PHY, V456, P293, DOI 10.1007/s00424-007-0393-1; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V286, pH940, DOI 10.1152/ajpheart.00677.2003; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; PLESNER L, 1995, INT REV CYTOL, V158, P141; Raththagala M, 2010, EUR J PHARMACOL, V645, P32, DOI 10.1016/j.ejphar.2010.07.012; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Saraiva VB, 2011, PLOS ONE, V18, P1; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Sprague RS, 2002, J PHYSIOL PHARMACOL, V53, P667; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Strehler B L, 1968, Methods Biochem Anal, V16, P99, DOI 10.1002/9780470110348.ch2; Tanneur V, 2005, FASEB J, V19, P133, DOI 10.1096/fj.04-3371fje; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Uhlemann A.-C., 2000, MACS MORE, V4, P7; WHO, 2013, WORLD MALARIA REPORT 2013, P1	71	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96216	10.1371/journal.pone.0096216	http://dx.doi.org/10.1371/journal.pone.0096216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858837	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400003
J	Arunasri, K; Adil, M; Khan, PAA; Shivaji, S				Arunasri, Kotakonda; Adil, Mohammed; Khan, Pathan Akbar Ali; Shivaji, Sisinthy			Global Gene Expression Analysis of Long-Term Stationary Phase Effects in E. coli K12 MG1655	PLOS ONE			English	Article							RIBOSOME MODULATION FACTOR; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; GROWTH; RNA; PHYSIOLOGY; EVOLUTION; CELL; IDENTIFICATION; CHANNELS	Global gene expression was monitored in long-term stationary phase (LSP) cells of E. coli K12 MG1655 and compared with stationary phase (SP) cells that were sub-cultured without prolonged delay to get an insight into the survival strategies of LSP cells. The experiments were carried out using both LB medium and LB supplemented with 10% of glycerol. In both the media the LSP cells showed decreased growth rate compared to SP cells. DNA microarray analysis of LSP cells in both the media resulted in the up-and down-regulation of several genes in LSP cells compared to their respective SP cells in the corresponding media. In LSP cells grown in LB 204 genes whereas cells grown in LB plus glycerol 321 genes were differentially regulated compared to the SP cells. Comparison of these differentially regulated genes indicated that irrespective of the medium used for growth in LSP cells expression of 95 genes (22 genes up-regulated and 73 down-regulated) were differentially regulated. These 95 genes could be associated with LSP status of the cells and are likely to influence survival and growth characteristics of LSP cells. This is indeed so since the up-and down-regulated genes include genes that protect E. coli LSP cells from stationary phase stress and genes that would help to recover from stress when transferred into fresh medium. The growth phenotype in LSP cells could be attributed to up-regulation of genes coding for insertion sequences that confer beneficial effects during starvation, genes coding for putative transposases and simultaneous down-regulation of genes coding for ribosomal protein synthesis, transport-related genes, non-coding RNA genes and metabolic genes. As yet we still do not know the role of several unknown genes and genes coding for hypothetical proteins which are either up-or down-regulated in LSP cells compared to SP cells.	[Arunasri, Kotakonda; Adil, Mohammed; Khan, Pathan Akbar Ali; Shivaji, Sisinthy] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Shivaji, S (corresponding author), LV Prasad Eye Inst, Jhaveri Microbiol Ctr, LV Prasad Marg,Banjara Hills, Hyderabad, Andhra Pradesh, India.	shivas@ccmb.res.in	PATHAN, AKBAR ALI KHAN/ABC-8189-2021	PATHAN, AKBAR ALI KHAN/0000-0002-6516-7587; Kotakonda, Arunasri/0000-0001-6870-2541; shivaji, sisinthy/0000-0003-0376-4658	ISRO, India	ISRO, India	The authors would also like to state that this project was funded by ISRO, India up to March 2012 and the authors do not have any current funding sources for this study for paying the publication charges. Further the authors would also like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio V, 2014, COMP BIOCHEM PHYS D, V9, P40, DOI 10.1016/j.cbd.2013.12.001; ANTONUCCI T K, 1986, Proteins Structure Function and Genetics, V1, P125, DOI 10.1002/prot.340010204; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arunasri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057860; Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Bremer H, 1996, ESCHERICHIA COLI SAL; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; BROWN S, 1984, J MOL BIOL, V178, P533, DOI 10.1016/0022-2836(84)90237-7; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Bylund GO, 1998, J BACTERIOL, V180, P73, DOI 10.1128/JB.180.1.73-82.1998; Calhoun LN., 2011, INT J MICROBIOL RES, V3, P136, DOI [10.9735/0975-5276.3.3.136-147, DOI 10.9735/0975-5276.3.3.136-147]; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; de Visser JAGM, 2004, GENETICS, V168, P1145, DOI 10.1534/genetics.104.032136; Dhavan GM, 2002, J MOL BIOL, V315, P1027, DOI 10.1006/jmbi.2001.5303; Ekaza E, 2000, MICROBIOL-UK, V146, P1605, DOI 10.1099/00221287-146-7-1605; El-Sharoud Walid M., 2004, Science Progress, V87, P137, DOI 10.3184/003685004783238517; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; HEYDE M, 1988, FEMS MICROBIOL LETT, V52, P59; HOGARTH BG, 1983, J BACTERIOL, V153, P1548, DOI 10.1128/JB.153.3.1548-1551.1983; HSU D, 1994, J BACTERIOL, V176, P4761, DOI 10.1128/JB.176.15.4761-4765.1994; IKENAKA K, 1986, J BIOL CHEM, V261, P9316; John E, 1968, J BACTERIOL, V95, P2054; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Kaji A, 2001, COLD SPRING HARB SYM, V66, P515, DOI 10.1101/sqb.2001.66.515; Kalinin A, 2002, J BIOMOL NMR, V23, P335, DOI 10.1023/A:1020279728394; Kinne RKH, 2001, AM ZOOL, V41, P728, DOI 10.1668/0003-1569(2001)041[0728:OOCITR]2.0.CO;2; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maaloe O., 1979, BIOL REGUL DEV, P487; MCCARTHY BJ, 1960, BIOCHIM BIOPHYS ACTA, V39, P563, DOI 10.1016/0006-3002(60)90221-3; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Pin C, 2008, APPL ENVIRON MICROB, V74, P2534, DOI 10.1128/AEM.02402-07; PRAMANIK A, 1986, J BACTERIOL, V168, P746, DOI 10.1128/jb.168.2.746-751.1986; RAK B, 1984, EMBO J, V3, P807, DOI 10.1002/j.1460-2075.1984.tb01889.x; Repoila F, 2009, BIOL CELL, V101, P117, DOI 10.1042/BC20070137; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHEPS R, 1972, EUR J BIOCHEM, V29, P319, DOI 10.1111/j.1432-1033.1972.tb01991.x; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SIEGELE DA, 1992, J BACTERIOL, V174, P345, DOI 10.1128/jb.174.2.345-348.1992; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; THOMAS AD, 1992, J GEN MICROBIOL, V138, P1829, DOI 10.1099/00221287-138-9-1829; Towle DW, 2001, AM ZOOL, V41, P770, DOI 10.1668/0003-1569(2001)041[0770:OBGOEC]2.0.CO;2; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weerasinghe JP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-14; YAMAGISHI M, 1993, EMBO J, V12, P625, DOI 10.1002/j.1460-2075.1993.tb05695.x; YANG WP, 1993, P NATL ACAD SCI USA, V90, P5796, DOI 10.1073/pnas.90.12.5796; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zambrano MM, 1996, CELL, V86, P181, DOI 10.1016/S0092-8674(00)80089-6; Zinser ER, 2004, RES MICROBIOL, V155, P328, DOI 10.1016/j.resmic.2004.01.014	64	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96701	10.1371/journal.pone.0096701	http://dx.doi.org/10.1371/journal.pone.0096701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858919	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400006
J	Kohler, D; Devanathan, V; Franz, CBD; Eldh, T; Novakovic, A; Roth, JM; Granja, T; Birnbaumer, L; Rosenberger, P; Beer-Hammer, S; Nurnberg, B				Koehler, David; Devanathan, Vasudharani; Franz, Claudia Bernardo de Oliveira; Eldh, Therese; Novakovic, Ana; Roth, Judith M.; Granja, Tiago; Birnbaumer, Lutz; Rosenberger, Peter; Beer-Hammer, Sandra; Nuernberg, Bernd			G alpha(i2)- and G alpha(i3)- Deficient Mice Display Opposite Severity of Myocardial Ischemia Reperfusion Injury	PLOS ONE			English	Article							G-PROTEIN; PERTUSSIS TOXIN; INHIBITION; MIGRATION; CYCLASE	G-protein-coupled receptors (GPCRs) are the most abundant receptors in the heart and therefore are common targets for cardiovascular therapeutics. The activated GPCRs transduce their signals via heterotrimeric G-proteins. The four major families of G-proteins identified so far are specified through their alpha-subunit: G alpha(i), G alpha(s), G alpha(q) and G(12/13). G alpha(i)-proteins have been reported to protect hearts from ischemia reperfusion injury. However, determining the individual impact of G alpha(i2) or G alpha(i3) on myocardial ischemia injury has not been clarified yet. Here, we first investigated expression of G alpha(i2) and G alpha(i3) on transcriptional level by quantitative PCR and on protein level by immunoblot analysis as well as by immunofluorescence in cardiac tissues of wild-type, G alpha(i2), and G alpha(i3)-deficient mice. G alpha(i2) was expressed at higher levels than G alpha(i3) in murine hearts, and irrespective of the isoform being knocked out we observed an up regulation of the remaining G alpha i-protein. Myocardial ischemia promptly regulated cardiac mRNA and with a slight delay protein levels of both G alpha(i2) and G alpha(i3), indicating important roles for both G alpha(i) isoforms. Furthermore, ischemia reperfusion injury in G alpha(i2)- and G alpha(i3)-deficient mice exhibited opposite outcomes. Whereas the absence of G alpha(i2) significantly increased the infarct size in the heart, the absence of G alpha(i3) or the concomitant upregulation of G alpha(i2) dramatically reduced cardiac infarction. In conclusion, we demonstrate for the first time that the genetic ablation of G alpha(i) proteins has protective or deleterious effects on cardiac ischemia reperfusion injury depending on the isoform being absent.	[Koehler, David; Franz, Claudia Bernardo de Oliveira; Roth, Judith M.; Granja, Tiago; Rosenberger, Peter] Eberhard Karls Univ Hosp & Clin, Dept Anesthesiol & Intens Care Med, Inst Expt & Clin Pharmacol & Toxicol, Tubingen, Germany; [Koehler, David; Devanathan, Vasudharani; Franz, Claudia Bernardo de Oliveira; Eldh, Therese; Novakovic, Ana; Roth, Judith M.; Granja, Tiago; Rosenberger, Peter; Beer-Hammer, Sandra; Nuernberg, Bernd] Interfac Ctr Pharmacogen & Drug Res, Tubingen, Germany; [Devanathan, Vasudharani; Eldh, Therese; Novakovic, Ana; Beer-Hammer, Sandra; Nuernberg, Bernd] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Tubingen, Germany; [Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Div Intramural Res, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Beer-Hammer, S (corresponding author), Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Tubingen, Germany.	sandra.beer-hammer@uni-tuebingen.de; bernd.nuernberg@uni-tuebingen.de	Beer-Hammer, Sandra/AAK-4516-2020; Granja, Tiago/O-2597-2019; Granja, Tiago/D-8426-2014	Beer-Hammer, Sandra/0000-0001-6049-0257; Granja, Tiago/0000-0002-8137-1449; Granja, Tiago/0000-0002-8137-1449; Nurnberg, Bernd/0000-0002-5995-6555	Deutsche Forschungsgemeinschaft [SFB 612, MO2252/1]; Tuebingen University; NIH [Z01-ES-101643]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, Z01ES101643] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (SFB 612 to B.N. and MO2252/1 to D. K.), the Open Access Publishing Fund of Tuebingen University and the Intramural Research Program of the NIH (project Z01-ES-101643 to L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarran-Juarez J, 2009, J PHARMACOL EXP THER, V331, P35, DOI 10.1124/jpet.109.157230; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; DeWire SM, 2011, CIRC RES, V109, P205, DOI 10.1161/CIRCRESAHA.110.231308; Dizayee S, 2013, PLOS ONE, V8, DOI [10.1371/annotation/7be097c0-9075-41ae-91e9-d2209de952cc, DOI 10.1371/ANNOTATION/7BE097C0-9075-41AE-91E9-D2209DE952CC]; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eisen A, 2004, ATHEROSCLEROSIS, V172, P201, DOI 10.1016/S0021-9150(03)00238-7; Exner T, 1999, P NATL ACAD SCI USA, V96, P1327, DOI 10.1073/pnas.96.4.1327; Ezan J, 2013, NAT CELL BIOL, V15, P1107, DOI 10.1038/ncb2819; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Hippe HJ, 2013, N-S ARCH PHARMACOL, V386, P459, DOI 10.1007/s00210-013-0876-x; Huang XY, 2006, MOL CELL BIOL, V26, P6870, DOI 10.1128/MCB.00314-06; Jantzen HM, 2001, J CLIN INVEST, V108, P477; Jin YZ, 2008, EUR J IMMUNOL, V38, P1988, DOI 10.1002/eji.200737738; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; Minetti GC, 2014, MOL CELL BIOL, V34, P619, DOI 10.1128/MCB.00957-13; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; Nagata K, 2000, CIRC RES, V87, P903, DOI 10.1161/01.RES.87.10.903; Plummer NW, 2012, P NATL ACAD SCI USA, V109, P21366, DOI 10.1073/pnas.1219810110; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Salazar NC, 2007, BBA-BIOMEMBRANES, V1768, P1006, DOI 10.1016/j.bbamem.2007.02.010; Schultz JE, 1998, AM J PHYSIOL-HEART C, V275, pH495, DOI 10.1152/ajpheart.1998.275.2.H495; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Waterson RE, 2011, CARDIOVASC RES, V91, P45, DOI 10.1093/cvr/cvr054; Wiege K, 2013, J IMMUNOL, V190, P324, DOI 10.4049/jimmunol.1201398; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]	29	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98325	10.1371/journal.pone.0098325	http://dx.doi.org/10.1371/journal.pone.0098325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858945	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400066
J	Liang, S; Varrecchia, M; Ishida, K; Jolly, ER				Liang, Shuang; Varrecchia, Melissa; Ishida, Kenji; Jolly, Emmitt R.			Evaluation of Schistosome Promoter Expression for Transgenesis and Genetic Analysis	PLOS ONE			English	Article							RNA INTERFERENCE; CMV PROMOTER; CYCLIN B1; BLOOD FLUKE; MANSONI; OVEREXPRESSION; APOPTOSIS; ACTIN; DNA; TRANSFECTION	Schistosome worms of the genus Schistosoma are the causative agents of schistosomiasis, a devastating parasitic disease affecting more than 240 million people worldwide. Schistosomes have complex life cycles, and have been challenging to manipulate genetically due to the dearth of molecular tools. Although the use of gene overexpression, gene knockouts or knockdowns are straight-forward genetic tools applied in many model systems, gene misexpression and genetic manipulation of schistosome genes in vivo has been exceptionally challenging, and plasmid based transfection inducing gene expression is limited. We recently reported the use of polyethyleneimine (PEI) as a simple and effective method for schistosome transfection and gene expression. Here, we use PEI-mediated schistosome plasmid transgenesis to define and compare gene expression profiles from endogenous and nonendogenous promoters in the schistosomula stage of schistosomes that are potentially useful to misexpress (underexpress or overexpress) gene product levels. In addition, we overexpress schistosome genes in vivo using a strong promoter and show plasmid-based misregulation of genes in schistosomes, producing a clear and distinct phenotype-death. These data focus on the schistosomula stage, but they foreshadow strong potential for genetic characterization of schistosome molecular pathways, and potential for use in overexpression screens and drug resistance studies in schistosomes using plasmid-based gene expression.	[Liang, Shuang; Varrecchia, Melissa; Ishida, Kenji; Jolly, Emmitt R.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Jolly, ER (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.	emmitt.jolly@case.edu	Jolly, Emmitt R/I-6646-2012	Jolly, Emmitt R/0000-0002-7141-2307	Case Western Reserve University; NIH-NIAID [1 R21 AI107147 01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107147] Funding Source: NIH RePORTER	Case Western Reserve University; NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Case Western Reserve University startup funds provided to ERJ and in part by NIH-NIAID grant 1 R21 AI107147 01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzese Ronald V, 2002, Methods Mol Med, V69, P109; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Alrefaei YN, 2011, MEM I OSWALDO CRUZ, V106, P785, DOI 10.1590/S0074-02762011000700002; BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632; Beckmann S, 2007, EXP PARASITOL, V117, P292, DOI 10.1016/j.exppara.2007.04.007; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bhardwaj R, 2011, METHODS MOL BIOL, V764, P223, DOI 10.1007/978-1-61779-188-8_15; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Correnti JA, 2005, MOL BIOCHEM PARASIT, V143, P209, DOI 10.1016/j.molbiopara.2005.06.007; Correnti JM, 2007, INT J PARASITOL, V37, P1107, DOI 10.1016/j.ijpara.2007.02.011; Cursio R, 1999, FASEB J, V13, P253, DOI 10.1096/fasebj.13.2.253; Davis RE, 1999, P NATL ACAD SCI USA, V96, P8687, DOI 10.1073/pnas.96.15.8687; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dubois F, 2009, MOL BIOCHEM PARASIT, V168, P7, DOI 10.1016/j.molbiopara.2009.06.001; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gomez LA, 2007, MOL CANCER THER, V6, P1534, DOI 10.1158/1535-7163.MCT-06-0727; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; He SJ, 2010, PARASITOL RES, V107, P955, DOI 10.1007/s00436-010-1960-5; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Heyers O, 2003, EXP PARASITOL, V105, P174, DOI 10.1016/j.exppara.2003.11.001; HOLLAND JP, 1980, J BIOL CHEM, V255, P2596; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Jolly ER, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r65; Kalinna BH, 2007, TRENDS PARASITOL, V23, P197, DOI 10.1016/j.pt.2007.03.007; Kerr LE, 2004, CELL DEATH DIFFER, V11, P1102, DOI 10.1038/sj.cdd.4401449; Kines KJ, 2006, EXP PARASITOL, V112, P209, DOI 10.1016/j.exppara.2006.02.003; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KOSTER B, 1994, ARCH BIOCHEM BIOPHYS, V310, P108, DOI 10.1006/abbi.1994.1146; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; LEE KW, 1995, EXP PARASITOL, V80, P155, DOI 10.1006/expr.1995.1018; Liang S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002332; LIU HP, 1992, GENETICS, V132, P665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD C, 1992, J CELL BIOL, V117, P787, DOI 10.1083/jcb.117.4.787; Lu CF, 2007, APPL ENVIRON MICROB, V73, P6072, DOI 10.1128/AEM.00955-07; MACGREGOR AN, 1990, INT J PARASITOL, V20, P279, DOI 10.1016/0020-7519(90)90141-9; Marcelli M, 2000, J UROLOGY, V164, P518, DOI 10.1016/S0022-5347(05)67416-2; Mecozzi B, 2000, MOL BIOCHEM PARASIT, V110, P333, DOI 10.1016/S0166-6851(00)00287-5; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Milligan JN, 2011, JOVE-J VIS EXP, DOI 10.3791/3191; Morales ME, 2007, FASEB J, V21, P3479, DOI 10.1096/fj.07-8726com; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759; Peckham M, 2001, J CELL SCI, V114, P1367; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Rinaldi G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002820; Rossi A, 2003, MOL BIOCHEM PARASIT, V130, P133, DOI 10.1016/S0166-6851(03)00158-0; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Tchoubrieva EB, 2010, CELL MOL LIFE SCI, V67, P3739, DOI 10.1007/s00018-010-0345-3; Teschendorf C, 2002, ANTICANCER RES, V22, P3325; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Wang J, 2000, J CELL SCI, V113, P753; Wippersteg V, 2002, INT J PARASITOL, V32, P1219, DOI 10.1016/S0020-7519(02)00092-9; Wippersteg V, 2002, MOL BIOCHEM PARASIT, V120, P141, DOI 10.1016/S0166-6851(01)00446-7; Wippersteg V, 2005, INT J PARASITOL, V35, P583, DOI 10.1016/j.ijpara.2005.02.002; Zhou XY, 2002, CANCER RES, V62, P1598	67	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98302	10.1371/journal.pone.0098302	http://dx.doi.org/10.1371/journal.pone.0098302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858918	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400064
J	Bertin, Y; Deval, C; de la Foye, A; Masson, L; Gannon, V; Harel, J; Martin, C; Desvaux, M; Forano, E				Bertin, Yolande; Deval, Christiane; de la Foye, Anne; Masson, Luke; Gannon, Victor; Harel, Josee; Martin, Christine; Desvaux, Mickael; Forano, Evelyne			The Gluconeogenesis Pathway Is Involved in Maintenance of Enterohaemorrhagic Escherichia coli O157:H7 in Bovine Intestinal Content	PLOS ONE			English	Article							STATIONARY-PHASE; GROWTH ADVANTAGE; AMINO-ACIDS; O157-H7; BACTERIA; COLONIZATION; UREASE; GENES; NORMALIZATION; GLYCEROL	Enterohaemorrhagic Escherichia coli (EHEC) are responsible for outbreaks of food- and water-borne illness. The bovine gastrointestinal tract (GIT) is thought to be the principle reservoir of EHEC. Knowledge of the nutrients essential for EHEC growth and survival in the bovine intestine may help in developing strategies to limit their shedding in bovine faeces thus reducing the risk of human illnesses. To identify specific metabolic pathways induced in the animal GIT, the transcriptome profiles of EHEC O157:H7 EDL933 during incubation in bovine small intestine contents (BSIC) and minimal medium supplemented with glucose were compared. The transcriptome analysis revealed that genes responsible for the assimilation of ethanolamine, urea, agmatine and amino acids (Asp, Thr, Gly, Ser and Trp) were strongly up-regulated suggesting that these compounds are the main nitrogen sources for EHEC in BSIC. A central role for the gluconeogenesis pathway and assimilation of gluconeogenic substrates was also pinpointed in EHEC incubated in BSIC. Our results suggested that three amino acids (Asp, Ser and Trp), glycerol, glycerol 3-phosphate, L-lactate and C4-dicarboxylates are important carbon sources for EHEC in BSIC. The ability to use gluconeogenic substrates as nitrogen sources (amino acids) and/or carbon sources (amino acids, glycerol and lactate) may provide a growth advantage to the bacteria in intestinal fluids. Accordingly, aspartate (2.4 mM), serine (1.9 mM), glycerol (5.8 mM) and lactate (3.6 mM) were present in BSIC and may represent the main gluconeogenic substrates potentially used by EHEC. A double mutant of E. coli EDL933 defective for phosphoenolpyruvate synthase (PpsA) and phosphoenolpyruvate carboxykinase (PckA), unable to utilize tricarboxylic acid (TCA) intermediates was constructed. Growth competition experiments between EHEC EDL933 and the isogenic mutant strain in BSIC clearly showed a significant competitive growth advantage of the wild-type strain further illustrating the importance of the gluconeogenesis pathway in maintaining EHEC in the bovine GIT.	[Bertin, Yolande; Martin, Christine; Desvaux, Mickael; Forano, Evelyne] INRA, Microbiol UR454, St Genes Champanelle, France; [Deval, Christiane] INRA, UMR 1019, Unite Nutr Humaine, Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France; [Deval, Christiane] Clermont Univ, Univ Auvergne, Unite Nutr Humaine, Clermont Ferrand, France; [de la Foye, Anne] INRA, Herbivores UMR1213, St Genes Champanelle, France; [Masson, Luke] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Gannon, Victor] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada; [Harel, Josee] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada	INRAE; INRAE; Universite Clermont Auvergne (UCA); INRAE; VetAgro Sup; National Research Council Canada; Public Health Agency of Canada; Universite de Montreal	Bertin, Y (corresponding author), INRA, Microbiol UR454, St Genes Champanelle, France.	yolande.bertin@clermont.inra.fr	DESVAUX, Mickael/A-8333-2008; Harel, Josée/H-1933-2011; FORANO, Evelyne/C-9976-2009	DESVAUX, Mickael/0000-0003-2986-6417; Harel, Josée/0000-0002-7822-3795; FORANO, Evelyne/0000-0002-7450-3466	EU [Food-CT-2006-32241]	EU(European Commission)	Funding provided by EU project ProsafeBeef within the 6th Framework Programme (Food-CT-2006-32241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Amer AE, 2004, J BACTERIOL, V186, P1879, DOI 10.1128/JB.186.6.1879-1889.2004; AbuGhazaleh AA, 2011, J ANIM PHYSIOL AN N, V95, P313, DOI 10.1111/j.1439-0396.2010.01056.x; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Bacun-Druzina V, 2011, FOOD TECHNOL BIOTECH, V49, P13; Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergholz TM, 2009, APPL ENVIRON MICROB, V75, P3542, DOI 10.1128/AEM.02841-08; Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chagnot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059386; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHAO YP, 1993, J BACTERIOL, V175, P6939, DOI 10.1128/jb.175.21.6939-6944.1993; Chaucheyras-Durand F, 2006, APPL ENVIRON MICROB, V72, P4136, DOI 10.1128/AEM.02600-05; Chaucheyras-Durand F, 2010, APPL ENVIRON MICROB, V76, P640, DOI 10.1128/AEM.02054-09; Christophe G, 2009, BIOPROC BIOSYST ENG, V32, P123, DOI 10.1007/s00449-008-0230-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Vaux A, 2002, APPL ENVIRON MICROB, V68, P519, DOI 10.1128/AEM.68.2.519-524.2002; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; Delmar P, 2005, BIOINFORMATICS, V21, P502, DOI 10.1093/bioinformatics/bti023; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Dougherty MJ, 2006, J BIOL CHEM, V281, P33892, DOI 10.1074/jbc.M604429200; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; ENGEL P, 1992, J BACTERIOL, V174, P5533, DOI 10.1128/JB.174.17.5533-5539.1992; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Friedrich AW, 2005, J CLIN MICROBIOL, V43, P546, DOI 10.1128/JCM.43.2.546-550.2005; Heimer SR, 2002, INFECT IMMUN, V70, P1027, DOI 10.1128/IAI.70.2.1027-1031.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; McEvoy JM, 2003, J APPL MICROBIOL, V95, P256, DOI 10.1046/j.1365-2672.2003.01981.x; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Molderings GJ, 2003, ANN NY ACAD SCI, V1009, P44, DOI 10.1196/annals.1304.005; MONDINO A, 1972, J CHROMATOGR, V74, P255, DOI 10.1016/S0021-9673(01)86154-9; Montagne L, 2000, J DAIRY SCI, V83, P507, DOI 10.3168/jds.S0022-0302(00)74910-1; OLUKOYA DK, 1986, J GEN MICROBIOL, V132, P3231; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; PANAGIOTIDIS CA, 1987, P NATL ACAD SCI USA, V84, P4423, DOI 10.1073/pnas.84.13.4423; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Pradhan S, 2010, J BACTERIOL, V192, P955, DOI 10.1128/JB.01180-09; Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073/pnas.190329997; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Steyert SR, 2012, INFECT IMMUN, V80, P2589, DOI 10.1128/IAI.00210-12; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Trabue S, 2007, J AGR FOOD CHEM, V55, P7043, DOI 10.1021/jf071076i; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	58	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98367	10.1371/journal.pone.0098367	http://dx.doi.org/10.1371/journal.pone.0098367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887187	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300059
J	Dias, CB; Milanski, M; Portovedo, M; Horita, V; Ayrizono, MDS; Planell, N; Coy, CSR; Velloso, LA; Meirelles, LR; Leal, RF				Dias, Cilene Bicca; Milanski, Marciane; Portovedo, Mariana; Horita, Vivian; Setsuko Ayrizono, Maria de Lourdes; Planell, Nuria; Rodrigues Coy, Claudio Saddy; Velloso, Licio Augusto; Meirelles, Luciana Rodrigues; Leal, Raquel Franco			Defective Apoptosis in Intestinal and Mesenteric Adipose Tissue of Crohn's Disease Patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; CREEPING FAT; EXPRESSION; ADIPONECTIN; MACROPHAGES; ADIPOCYTES; PROTEIN; LEPTIN; PATHOGENESIS	Background: Crohn's disease (CD) is associated with complex pathogenic pathways involving defects in apoptosis mechanisms. Recently, mesenteric adipose tissue (MAT) has been associated with CD ethiopathology, since adipose thickening is detected close to the affected intestinal area. However, the potential role of altered apoptosis in MAT of CD has not been addressed. Aims: To evaluate apoptosis in the intestinal mucosa and MAT of patients with CD. Methods: Samples of intestinal mucosa and MAT from patients with ileocecal CD and from non-inflammatory bowel diseases patients (controls) were studied. Apoptosis was assessed by TUNEL assay and correlated with the adipocytes histological morphometric analysis. The transcriptional and protein analysis of selected genes and proteins related to apoptosis were determined. Results: TUNEL assay showed fewer apoptotic cells in CD, when compared to the control groups, both in the intestinal mucosa and in MAT. In addition, the number of apoptotic cells (TUNEL) correlated significantly with the area and perimeter of the adipose cells in MAT. Transcriptomic and proteomic analysis reveal a significantly lower transcript and protein levels of Bax in the intestinal mucosa of CD, compared to the controls; low protein levels of Bax were found localized in the lamina propria and not in the epithelium of this tissue. Furthermore, higher level of Bcl-2 and low level of Caspase 3 were seen in the MAT of CD patients. Conclusion: The defective apoptosis in MAT may explain the singular morphological characteristics of this tissue in CD, which may be implicated in the pathophysiology of the disease.	[Dias, Cilene Bicca; Setsuko Ayrizono, Maria de Lourdes; Rodrigues Coy, Claudio Saddy; Leal, Raquel Franco] Univ Campinas UNICAMP, Dept Surg, Coloproctol Unit, Sch Med, Sao Paulo, Brazil; [Dias, Cilene Bicca; Milanski, Marciane; Portovedo, Mariana; Velloso, Licio Augusto; Leal, Raquel Franco] Univ Campinas UNICAMP, Sch Med, Dept Internal Med, Lab Cell Signaling, Sao Paulo, Brazil; [Dias, Cilene Bicca] Univ Estadual Campinas, Fac Med Sch, Post Grad Program Surg Sci, Sao Paulo, Brazil; [Horita, Vivian; Meirelles, Luciana Rodrigues] Univ Campinas UNICAMP, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Planell, Nuria] CIBERehd, Dept Gastroenterol & Bioinformat Platform, Barcelona, Spain	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Leal, RF (corresponding author), Univ Campinas UNICAMP, Dept Surg, Coloproctol Unit, Sch Med, Sao Paulo, Brazil.	rafranco.unicamp@gmail.com	Velloso, Licio/AAJ-3778-2020; Milanski, Marciane/F-5410-2012; Leal, Raquel/W-7997-2019; Planell, Núria/H-6807-2015	Milanski, Marciane/0000-0002-6322-5368; Leal, Raquel/0000-0003-4285-4402; Planell, Núria/0000-0001-7550-2433; Portovedo, Mariana/0000-0001-6417-8252	FAPESP (Foundation for Research Support of the Sao Paulo State); CAPES-Brazil	FAPESP (Foundation for Research Support of the Sao Paulo State)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	FAPESP (Foundation for Research Support of the Sao Paulo State) for financial support and CAPES-Brazil for research fellowship (C.B. Dias). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Barbier M, 2005, GASTROENTEROL CLIN B, V27, P1; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Batra A, 2009, INFLAMM BOWEL DIS, V15, P1897, DOI 10.1002/ibd.20937; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Coffey JC, 2001, J SURG RES, V98, P27, DOI 10.1006/jsre.2001.6129; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Deveraux Quinn L., 2001, Cardiology Clinics, V19, P57; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Drouet M, 2012, NUTRITION, V28, P113, DOI 10.1016/j.nut.2011.09.009; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; Itoh J, 2001, GUT, V49, P35, DOI 10.1136/gut.49.1.35; Jung SH, 2013, CYTOKINE, V61, P459, DOI 10.1016/j.cyto.2012.11.021; Karmiris K, 2005, INFLAMM BOWEL DIS, V11, P847, DOI 10.1097/01.mib.0000178915.54264.8f; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Leal RF, 2012, CELL TISSUE RES, V350, P549, DOI 10.1007/s00441-012-1491-8; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Olivier I, 2011, INFLAMM BOWEL DIS, V17, P747, DOI 10.1002/ibd.21413; Palmer CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007787; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Pietsch J, 2006, ANN NY ACAD SCI, V1072, P407, DOI 10.1196/annals.1326.021; Rodrigues VS, 2012, CLIN EXP IMMUNOL, V170, P358, DOI 10.1111/j.1365-2249.2012.04660.x; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Sanders EJ, 1996, HISTOCHEM J, V28, P275, DOI 10.1007/BF02409015; Santaolalla R, 2011, INFLAMM BOWEL DIS, V17, P1490, DOI 10.1002/ibd.21507; Schaffler A, 2009, GUT, V58, P317, DOI 10.1136/gut.2008.159210; Schaffler A, 2005, GUT, V54, P742, DOI 10.1136/gut.2004.061531; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SHEEHAN AL, 1992, BRIT J SURG, V79, P955, DOI 10.1002/bjs.1800790934; Sitaraman S, 2004, FASEB J, V18, P696, DOI 10.1096/fj.03-0422fje; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Ueyama H, 1998, GUT, V43, P48, DOI 10.1136/gut.43.1.48; Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Wang C.H., 1999, FLORA REIPUBLICAE PO, V6, P1; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004; Zulian A, 2012, GUT, V61, P86, DOI 10.1136/gutjnl-2011-300391	49	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98547	10.1371/journal.pone.0098547	http://dx.doi.org/10.1371/journal.pone.0098547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887376	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300080
J	Eftekhar, A; Juffali, W; El-Imad, J; Constandinou, TG; Toumazou, C				Eftekhar, Amir; Juffali, Walid; El-Imad, Jamil; Constandinou, Timothy G.; Toumazou, Christofer			Ngram-Derived Pattern Recognition for the Detection and Prediction of Epileptic Seizures	PLOS ONE			English	Article							TIME; LONG; TERM	This work presents a new method that combines symbol dynamics methodologies with an Ngram algorithm for the detection and prediction of epileptic seizures. The presented approach specifically applies Ngram-based pattern recognition, after data pre-processing, with similarity metrics, including the Hamming distance and Needlman-Wunsch algorithm, for identifying unique patterns within epochs of time. Pattern counts within each epoch are used as measures to determine seizure detection and prediction markers. Using 623 hours of intracranial electrocorticogram recordings from 21 patients containing a total of 87 seizures, the sensitivity and false prediction/detection rates of this method are quantified. Results are quantified using individual seizures within each case for training of thresholds and prediction time windows. The statistical significance of the predictive power is further investigated. We show that the method presented herein, has significant predictive power in up to 100% of temporal lobe cases, with sensitivities of up to 70-100% and low false predictions (dependant on training procedure). The cases of highest false predictions are found in the frontal origin with 0.31-0.61 false predictions per hour and with significance in 18 out of 21 cases. On average, a prediction sensitivity of 93.81% and false prediction rate of approximately 0.06 false predictions per hour are achieved in the best case scenario. This compares to previous work utilising the same data set that has shown sensitivities of up to 40-50% for a false prediction rate of less than 0.15/hour.	[Eftekhar, Amir; Juffali, Walid; El-Imad, Jamil; Constandinou, Timothy G.; Toumazou, Christofer] Univ London Imperial Coll Sci Technol & Med, Ctr Bioinspired Technol, London, England	Imperial College London	Eftekhar, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Bioinspired Technol, South Kensington Campus, London, England.	a.eftekhar@imperial.ac.uk		Constandinou, Timothy/0000-0001-9778-1162	Engineering and Physical Sciences Research Council [EP/K009842/1]; EPSRC [EP/I000569/1, EP/K009842/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000569/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge the support received from Engineering and Physical Sciences Research Council grant number EP/K009842/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2006, CLIN NEUROPHYSIOLOGY, V117; Aarabi A, 2012, CLIN NEUROPHYSIOL, V123, P1111, DOI 10.1016/j.clinph.2012.01.014; al Naqeeb N, 1999, PEDIATRICS, V103, P1263, DOI 10.1542/peds.103.6.1263; [Anonymous], 2007, TRENT NEON SURV REP; ASCHENBRENNERSC.R, 2003, BRAIN, V126, P1; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Banerjee S, 2003, P INT TEXT PROC COMP; Bengio Y., 2003, J MACHINE LEARNING R; Cohen P, 2002, ESF EXPL WORKSH PATT, P99; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Daw CS, 2003, REV SCI INSTRUMENTS, V74; Eftaxias K, 2011, PHYS GEOPHYS, V1; Eftekhar A, 2013, J SIGNAL PROCESSING; Faul S, 2005, CLIN NEUROPHYSIOLOGY, V116; Feldwisch-Drentrup H, 2011, EPILEPSY BEHAV, V22, pS119, DOI 10.1016/j.yebeh.2011.08.023; Feldwisch-Drentrup H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066704; Gadhoumi K, 2013, CLIN NEUROPHISIOLOGY; Gailey PC, 1999, P EXP CHAOS; Gupta S, 2006, ISA T, V45, P477, DOI 10.1016/S0019-0578(07)60226-2; Hill WM, 2000, EPILEPSIA, V41; Hively LM, 2005, J CLIN NEUROPHYSIOL, V22, P402; Jain A, 2000, IEEE T PATTERN ANAL, P22; Juffali W, 2010, BIOMED CIRC SYST C, P45, DOI 10.1109/BIOCAS.2010.5709567; Keller K., 2007, CHAOS COMPLEXITY LET, V2, P247; Klatt J, 2012, EPILEPSIA, V53, P1669, DOI 10.1111/j.1528-1167.2012.03564.x; Logesparan L, 2012, MED BIOL ENG COMPUT, V50, P659, DOI 10.1007/s11517-012-0904-x; Maiwald T, 2004, PHYSICA D, V194, P357, DOI 10.1016/j.physd.2004.02.013; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Osorio I, 2000, ANN NEUROLOGY, V57; Paraskevopoulou SE, 2013, J NEUROSCI METH, V215, P29, DOI 10.1016/j.jneumeth.2013.01.012; PETROSIAN A, 1995, COMP MED SY, P212, DOI 10.1109/CBMS.1995.465426; Rennie JM, 2004, ARCH DIS CHILD FETAL; Schelter B, 2006, CHAOS, V16, DOI 10.1063/1.2137623; Schelter B, 2006, EPILEPSIA, V47, P2058, DOI 10.1111/j.1528-1167.2006.00848.x; Schindler K, 2011, EPILEPSIA, V52, P1771, DOI 10.1111/j.1528-1167.2011.03202.x; Schulze-Bonhage A, 2011, EPILEPSY BEHAV, V22, pS88, DOI 10.1016/j.yebeh.2011.08.030; Stein GA, 2000, EPILEPSY RES, V39; Takens F., 1981, LECT NOTES MATH, V898, DOI [10.1007/BF02368233, 10.1007/bfb0091924]; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; Williamson JR, 2012, EPILEPSY BEHAV, V25, P230, DOI 10.1016/j.yebeh.2012.07.007; Winterhalder M, 2003, EPILEPSY BEHAV, V4, P318, DOI 10.1016/S1525-5050(03)00105-7; Yadav R, 2012, IEEE T BIO-MED ENG, V59, P1871, DOI 10.1109/TBME.2012.2190601; Zandi AS, 2013, IEEE T BIO-MED ENG, V60, P1401, DOI 10.1109/TBME.2012.2237399; Zhou W, 2013, IEEE T BIOMEDICAL EN	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e96235	10.1371/journal.pone.0096235	http://dx.doi.org/10.1371/journal.pone.0096235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886714	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300008
J	Ruan, Z; Liu, SQ; Zhou, Y; Mi, SM; Liu, G; Wu, X; Yao, K; Assaad, H; Deng, ZY; Hou, YQ; Wu, GY; Yin, YL				Ruan, Zheng; Liu, Shiqiang; Zhou, Yan; Mi, Shumei; Liu, Gang; Wu, Xin; Yao, Kang; Assaad, Houssein; Deng, Zeyuan; Hou, Yongqing; Wu, Guoyao; Yin, Yulong			Chlorogenic Acid Decreases Intestinal Permeability and Increases Expression of Intestinal Tight Junction Proteins in Weaned Rats Challenged with LPS	PLOS ONE			English	Article							MUCOSAL BARRIER FUNCTION; AMINO-ACIDS; OCCLUDIN; SUPPLEMENTATION; PIGS; INFLAMMATION; ANTIOXIDANT; POLYPHENOLS; DISRUPTION; MODULATION	Chlorogenic acid, a natural phenolic acid present in fruits and plants, provides beneficial effects for human health. The objectives of this study were to investigate whether chlorogenic acid (CHA) could improve the intestinal barrier integrity for weaned rats with lipopolysaccharide (LPS) challenge. Thirty-two weaned male Sprague Dawley rats (21 +/- 1 d of age; 62.26 +/- 2.73 g) were selected and randomly allotted to four treatments, including weaned rat control, LPS-challenged and chlorogenic acid (CHA) supplemented group (orally 20 mg/kg and 50 mg/kg body). Dietary supplementation with CHA decreased (P < 0.05) the concentrations of urea and albumin in the serum, compared to the LPS-challenged group. The levels of IFN-gamma and TNF-alpha were lower (P < 0.05) in the jejunal and colon of weaned rats receiving CHA supplementation, in comparison with the control group. CHA supplementation increased (P < 0.05) villus height and the ratio of villus height to crypt depth in the jejunal and ileal mucosae under condictions of LPS challenge. CHA supplementation decreased (P < 0.05) intestinal permeability, which was indicated by the ratio of lactulose to mannitol and serum DAO activity, when compared to weaned rats with LPS challenge. Immunohistochemical analysis of tight junction proteins revealed that ZO-1 and occludin protein abundances in the jejunum and colon were increased (P < 0.05) by CHA supplementation. Additionally, results of immunoblot analysis revealed that the amount of occludin in the colon was also increased (P < 0.05) in CHA-supplemented rats. In conclusion, CHA decreases intestinal permeability and increases intestinal expression of tight junction proteins in weaned rats challenged with LPS.	[Ruan, Zheng; Liu, Shiqiang; Zhou, Yan; Mi, Shumei; Deng, Zeyuan; Yin, Yulong] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Liu, Gang; Wu, Xin; Yao, Kang; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Assaad, Houssein] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Hou, Yongqing] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Wuhan, Hubei, Peoples R China; [Hou, Yongqing; Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Nanchang University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Texas A&M University System; Texas A&M University College Station; Wuhan Polytechnic University; Texas A&M University System; Texas A&M University College Station	Wu, GY (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	g-wu@tamu.edu; yinyulong@isa.ac.cn	Deng, zeyuan/P-1933-2014; Liu, Gang/G-5283-2017	Deng, zeyuan/0000-0001-5650-1507; Liu, Gang/0000-0002-9475-5134; Ruan, Zheng/0000-0001-9638-1466	National Basic Research Program of China [2013CB12730]; National Natural Science Foundation of China [31001014, 530901040, 31110103909, 30928018, 31101729]; Dr. Li Jieshou (Academician of CAS) Research Fund for Intestinal Barrier [LJS_201006]; Research Foundation [SKLF-TS-201108, SKLF-TS-200817]; Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University [SKLF-KF-201005, SKLF-KF-201216]; Texas A&M AgriLife Research [H-8200]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant [2011T2S15]; National Cancer Institute [R25T-CA090301]; NATIONAL CANCER INSTITUTE [R25CA090301] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dr. Li Jieshou (Academician of CAS) Research Fund for Intestinal Barrier; Research Foundation; Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University; Texas A&M AgriLife Research; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was jointly supported by the National Basic Research Program of China (2013CB12730), the National Natural Science Foundation of China (31001014, 530901040, 31110103909, 30928018, and 31101729), the Dr. Li Jieshou (Academician of CAS) Research Fund for Intestinal Barrier (LJS_201006), the Research Foundation (SKLF-TS-201108 and SKLF-TS-200817) and the Open Project Program (SKLF-KF-201005 and SKLF-KF-201216) of State Key Laboratory of Food Science and Technology, Nanchang University, and Texas A&M AgriLife Research (H-8200). GW was funded by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant (No. 2011T2S15). HA was supported by a postdoctoral training grant (R25T-CA090301) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bergmann H, 2009, MOL NUTR FOOD RES, V53, P1211, DOI 10.1002/mnfr.200800498; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Chiang LC, 2003, PLANTA MED, V69, P600, DOI 10.1055/s-2003-41113; Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI [10.1002/(SICI)1097-0010(19990301)79:3&lt;362::AID-JSFA256&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D]; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Gong J, 2004, IMMUNOL INVEST, V33, P295, DOI 10.1081/IMM-120037603; Han J, 2009, AMINO ACIDS, V37, P643, DOI 10.1007/s00726-008-0184-9; Hou YQ, 2013, AMINO ACIDS, V45, P513, DOI 10.1007/s00726-012-1295-x; Hou YQ, 2011, AMINO ACIDS, V41, pS57, DOI 10.1007/s00726-011-1191-9; Hou YQ, 2011, FRONT BIOSCI-LANDMRK, V16, P1186, DOI 10.2741/3783; Hou YQ, 2010, AMINO ACIDS, V39, P555, DOI 10.1007/s00726-010-0473-y; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Ma L, 2008, HERALD MED, V10, P1168; Marsilio R, 1998, CLIN CHEM, V44, P1685; Martel F, 2010, NUTR RES REV, V23, P47, DOI 10.1017/S0954422410000053; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H; Noth R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-109; Oswald IP, 2001, PARASITOLOGY, V122, P299, DOI 10.1017/S0031182001007399; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Peng X, 2004, BURNS, V30, P135, DOI 10.1016/j.burns.2003.09.032; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Rogoll D, 2010, J APPL BOT FOOD QUAL, V83, P110; Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Tatefuji T, 1996, BIOL PHARM BULL, V19, P966, DOI 10.1248/bpb.19.966; THOMPSON JS, 1987, JPEN-PARENTER ENTER, V11, P28, DOI 10.1177/014860718701100128; Wang HF, 2011, ANIM FEED SCI TECH, V170, P141, DOI 10.1016/j.anifeedsci.2011.08.004; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Xu XD, 2013, FOOD CONTROL, V32, P678, DOI 10.1016/j.foodcont.2013.02.007; Yang CM, 2012, J ANIM SCI, V90, P2671, DOI 10.2527/jas.2011-4699; Yang Y, 2011, NUTRITION, V27, P227, DOI 10.1016/j.nut.2009.11.024; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhang Y, 2011, WORLD J GASTROENTERO, V17, P254, DOI 10.3748/wjg.v17.i2.254; Zhao JH, 2011, EUR J PHARMACOL, V654, P289, DOI 10.1016/j.ejphar.2010.12.032; Zhao Y, 2011, INT J MOL SCI, V12, P8502, DOI 10.3390/ijms12128502; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017	54	71	78	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97815	10.1371/journal.pone.0097815	http://dx.doi.org/10.1371/journal.pone.0097815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887396	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300022
J	Suh, HS; Lo, YT; Choi, N; Letendre, S; Lee, SC				Suh, Hyeon-Sook; Lo, Yungtai; Choi, Namjong; Letendre, Scott; Lee, Sunhee C.			Evidence of the Innate Antiviral and Neuroprotective Properties of Progranulin	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVATED MICROGLIA; UP-REGULATION; EXPRESSION; INFECTION; INDUCTION; BRAIN; GAMMA; MUTATIONS; RECEPTORS	Background: Compelling data exist that show that normal levels of progranulin (PGRN) are required for successful CNS aging. PGRN production is also modulated by inflammation and infection, but no data are available on the production and role of PGRN during CNS HIV infection. Methods: To determine the relationships between PGRN and HIV disease, neurocognition, and inflammation, we analyzed 107 matched CSF and plasma samples from CHARTER, a well-characterized HIV cohort. Levels of PGRN were determined by ELISA and compared to levels of several inflammatory mediators (IFN gamma, IL-6, IL-10, IP-10, MCP-1, TNF alpha, IL-1 beta, IL-4 and IL-13), as well as clinical, virologic and demographic parameters. The relationship between HIV infection and PGRN was also examined in HIV-infected primary human microglial cultures. Results: In plasma, PGRN levels correlated with the viral load (VL, p < 0.001). In the CSF of subjects with undetectable VL, lower PGRN was associated with neurocognitive impairment (p = 0.046). CSF PGRN correlated with CSF IP-10, TNF alpha and IL-10, and plasma PGRN correlated with plasma IP-10. In vitro, microglial HIV infection increased PGRN production and PGRN knockdown increased HIV replication, demonstrating that PGRN is an innate antiviral protein. Conclusions: We propose that PGRN plays dual roles in people living with HIV disease. With active HIV replication, PGRN is induced in infected macrophages and microglia and functions as an antiviral protein. In individuals without active viral replication, decreased PGRN production contributes to neurocognitive dysfunction, probably through a diminution of its neurotrophic functions. Our results have implications for the pathogenesis, biomarker studies and therapy for HIV diseases including HIV-associated neurocognitive dysfunction (HAND).	[Suh, Hyeon-Sook; Choi, Namjong; Lee, Sunhee C.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Lo, Yungtai] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Letendre, Scott] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego	Suh, HS (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	hyeon-sook.suh@einstein.yu.edu; sunhee.lee@einstein.yu.edu	Letendre, Scott L./GLU-6874-2022		NIH [KO1 MH084705, RO1 MH55477, 1S10RR031646, N01 MH22005, HHSN271201000036C, HHSN271201000030C]; Einstein CFAR [P30AI051519]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH084705, R01MH055477, N01MH022005, P30MH062512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein CFAR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the NIH awards KO1 MH084705 (HS), RO1 MH55477 (SCL), 1S10RR031646 (SL), the Einstein CFAR P30AI051519. The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) was supported by the NIH awards N01 MH22005, HHSN271201000036C and HHSN271201000030C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; ARKINS S, 1995, MOL ENDOCRINOL, V9, P350, DOI 10.1210/me.9.3.350; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Cassol E, 2013, J NEUROIMMUNE PHARM, V8, P1087, DOI 10.1007/s11481-013-9512-2; Chantry D, 1998, J LEUKOCYTE BIOL, V64, P49, DOI 10.1002/jlb.64.1.49; Chihara T, 2012, J IMMUNOL, V188, P3620, DOI 10.4049/jimmunol.1101593; Clerici M, 1996, BLOOD, V88, P574, DOI 10.1182/blood.V88.2.574.bloodjournal882574; Clutton G, 2013, EUR J IMMUNOL, V43, P2875, DOI 10.1002/eji.201343646; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; De ML, 2011, J MOL NEUROSCI; De Riz M, 2010, NEUROSCI LETT, V469, P234, DOI 10.1016/j.neulet.2009.12.002; Eisfeld C, 2013, CNS DRUGS, V27, P31, DOI 10.1007/s40263-012-0018-x; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fenoglio C, 2009, J ALZHEIMERS DIS, V18, P603, DOI 10.3233/JAD-2009-1170; Fields J, 2014, J NEUROIMMUNE PHARM; Galimberti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032164; Gelman BB, 2012, J ACQUIR IMMUNE DEFI; Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Johnson RT, 1996, ANN NEUROL, V39, P392, DOI 10.1002/ana.410390319; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; LEE SHC, 1992, LAB INVEST, V67, P465; LEE SHC, 1993, AM J PATHOL, V143, P1032; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Marcotte TD, 2013, J NEUROIMMUNE PHARM; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Meeker RB, 2011, J NEUROVIROL, V17, P258, DOI 10.1007/s13365-011-0034-5; Moore DJ, 2011, J NEUROVIROL, V17, P50, DOI 10.1007/s13365-010-0009-y; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ong CHP, 2006, AM J PHYSIOL-REG I, V291, pR1602, DOI 10.1152/ajpregu.00616.2005; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Perry SW, 2005, NEUROTOX RES, V8, P161, DOI 10.1007/BF03033827; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Philips T, 2010, J NEUROPATH EXP NEUR, V69, P1191, DOI 10.1097/NEN.0b013e3181fc9aea; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Si QS, 2002, VIROLOGY, V301, P342, DOI 10.1006/viro.2002.1613; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Suh HS, 2013, J NEUROIMMUNE PHARM; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Suh HS, 2010, AM J PATHOL, V177, P2446, DOI 10.2353/ajpath.2010.100399; Suh HS, 2009, CURR TOP MICROBIOL, V336, P63, DOI 10.1007/978-3-642-00549-7_4; Suh HS, 2009, VIROLOGY, V392, P246, DOI 10.1016/j.virol.2009.07.001; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Vercellino M, 2011, MULT SCLER J, V17, P1194, DOI 10.1177/1352458511406164; Wang HY, 2011, FEMS IMMUNOL MED MIC, V63, P82, DOI 10.1111/j.1574-695X.2011.00833.x; Wex T, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-63; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565; Wynes MW, 2003, J IMMUNOL, V171, P3550, DOI 10.4049/jimmunol.171.7.3550; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	69	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98184	10.1371/journal.pone.0098184	http://dx.doi.org/10.1371/journal.pone.0098184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878635	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500035
J	Xie, CQ; Wang, QN; He, Y				Xie, Chuanqi; Wang, Qiaonan; He, Yong			Identification of Different Varieties of Sesame Oil Using Near-Infrared Hyperspectral Imaging and Chemometrics Algorithms	PLOS ONE			English	Article							SUCCESSIVE PROJECTIONS ALGORITHM; SPECTROSCOPY; DISCRIMINATION; CLASSIFICATION; QUALITY; LEAVES	This study investigated the feasibility of using near infrared hyperspectral imaging (NIR-HSI) technique for non-destructive identification of sesame oil. Hyperspectral images of four varieties of sesame oil were obtained in the spectral region of 8741734 nm. Reflectance values were extracted from each region of interest (ROI) of each sample. Competitive adaptive reweighted sampling (CARS), successive projections algorithm (SPA) and x-loading weights (x-LW) were carried out to identify the most significant wavelengths. Based on the sixty-four, seven and five wavelengths suggested by CARS, SPA and x-LW, respectively, two classified models (least squares-support vector machine, LS-SVM and linear discriminant analysis, LDA) were established. Among the established models, CARS-LS-SVM and CARS-LDA models performed well with the highest classification rate (100%) in both calibration and prediction sets. SPA-LS-SVM and SPA-LDA models obtained better results (95.59% and 98.53% of classification rate in prediction set) with only seven wavelengths (938, 1160, 1214, 1406, 1656, 1659 and 1663 nm). The x-LW-LS-SVM and x-LW-LDA models also obtained satisfactory results (>80% of classification rate in prediction set) with the only five wavelengths (921, 925, 995, 1453 and 1663 nm). The results showed that NIR-HSI technique could be used to identify the varieties of sesame oil rapidly and non-destructively, and CARS, SPA and x-LW were effective wavelengths selection methods.	[Xie, Chuanqi; Wang, Qiaonan; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yhe@zju.edu.cn	He, Yong/E-3218-2010	He, Yong/0000-0001-6752-1757	863 National High-Tech Research and Development Plan [2012AA101903]; Ningbo Department of Science and Technology [2011C11024]; Fundamental Research Funds for the Central Universities of China [2012FZA6005, 2013QNA6011]	863 National High-Tech Research and Development Plan(National High Technology Research and Development Program of China); Ningbo Department of Science and Technology; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by 863 National High-Tech Research and Development Plan (Project No: 2012AA101903), Ningbo Department of Science and Technology (2011C11024) and the Fundamental Research Funds for the Central Universities of China (2012FZA6005, 2013QNA6011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Azeez MA, 2011, EUR J LIPID SCI TECH, V113, P238, DOI 10.1002/ejlt.201000080; Barbin DF, 2012, ANAL CHIM ACTA, V719, P30, DOI 10.1016/j.aca.2012.01.004; Chen XJ, 2011, FOOD BIOPROCESS TECH, V4, P753, DOI 10.1007/s11947-009-0199-6; Criado M, 2010, EUR J LIPID SCI TECH, V112, P246, DOI 10.1002/ejlt.200900159; ElMasry G, 2012, J FOOD ENG, V110, P127, DOI 10.1016/j.jfoodeng.2011.11.028; ElMasry G, 2011, J FOOD ENG, V103, P333, DOI 10.1016/j.jfoodeng.2010.10.031; Galvao RKH, 2008, CHEMOMETR INTELL LAB, V92, P83, DOI 10.1016/j.chemolab.2007.12.004; Kamruzzaman M, 2011, J FOOD ENG, V104, P332, DOI 10.1016/j.jfoodeng.2010.12.024; Li HD, 2009, ANAL CHIM ACTA, V648, P77, DOI 10.1016/j.aca.2009.06.046; Li XL, 2012, SENSORS-BASEL, V12, P9847, DOI 10.3390/s120709847; Lin P, 2012, FOOD BIOPROCESS TECH, V5, P235, DOI 10.1007/s11947-009-0302-z; Liu F, 2009, ANAL CHIM ACTA, V635, P45, DOI 10.1016/j.aca.2009.01.017; Liu F, 2008, FOOD RES INT, V41, P562, DOI 10.1016/j.foodres.2008.03.011; Luna AS, 2013, SPECTROCHIM ACTA A, V100, P115, DOI 10.1016/j.saa.2012.02.085; Mondal N, 2010, J AM OIL CHEM SOC, V87, P1263, DOI 10.1007/s11746-010-1615-9; Pizarro C, 2013, FOOD CHEM, V138, P915, DOI 10.1016/j.foodchem.2012.11.087; Riovanto R, 2011, J AGR FOOD CHEM, V59, P10356, DOI 10.1021/jf202578f; Sharmila V, 2007, GENET MOL BIOL, V30, P80, DOI 10.1590/S1415-47572007000100015; Sowmya M, 2009, FOOD HYDROCOLLOID, V23, P1827, DOI 10.1016/j.foodhyd.2009.02.008; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Wei X, 2014, FOOD BIOPROCESS TECH, V7, P1371, DOI 10.1007/s11947-013-1164-y; Wei X, 2014, FOOD BIOPROCESS TECH, V7, P184, DOI 10.1007/s11947-013-1053-4; Wu D, 2013, FOOD BIOPROCESS TECH, V6, P2943, DOI 10.1007/s11947-012-0928-0; Wu D, 2013, TALANTA, V111, P39, DOI 10.1016/j.talanta.2013.03.041; Wu D, 2012, FOOD CHEM, V135, P2147, DOI 10.1016/j.foodchem.2012.07.011; Wu D, 2009, J AGR FOOD CHEM, V57, P1697, DOI 10.1021/jf8030343; Xie CQ, 2012, SPECTROSC SPECT ANAL, V32, P3324, DOI 10.3964/j.issn.1000-0593(2012)12-3324-05; Zhang XL, 2012, SENSORS-BASEL, V12, P17234, DOI 10.3390/s121217234; Zhang XL, 2013, IND CROP PROD, V42, P416, DOI 10.1016/j.indcrop.2012.06.021	30	19	20	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98522	10.1371/journal.pone.0098522	http://dx.doi.org/10.1371/journal.pone.0098522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879306	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500066
J	Weber-Chrysochoou, C; Crisafulli, D; Kemp, AS; Britton, WJ; Marks, GB				Weber-Chrysochoou, Christina; Crisafulli, Daniele; Kemp, Andrew Stewart; Britton, Warwick John; Marks, Guy Barrington		CAPS Investigators	Allergen-Specific IL-5 Responses in Early Childhood Predict Asthma at Age Eight	PLOS ONE			English	Article							HOUSE-DUST MITE; BRONCHIAL HYPERRESPONSIVENESS; AUSTRALIAN SCHOOLCHILDREN; CYTOKINE PRODUCTION; 2 POPULATIONS; IGE LEVELS; ATOPY; ASSOCIATION; MEPOLIZUMAB; PREVENTION	Background: The pattern of development of allergen-specific T cell cytokine responses in early childhood and their relation to later disease is poorly understood. Here we describe longitudinal changes in allergen-stimulated T cell cytokine responses and their relation to asthma and allergic disease during the first 8 years of life. Methods: Subjects with a family history of asthma, who were enrolled antenatally in the Childhood Asthma Prevention Study (public trials registration number ACTRN12605000042640), had skin prick tests, clinical evaluation for asthma and eczema, and in vitro assessment of T cell cytokine responses to HDM extract performed at ages 18 months (n = 281), 3 years (n = 349), 5 years (n = 370) and 8 years (n = 275). We measured interleukin (IL-) 13 at 3, 5 and 8 years, and IL-5, IL-10, and interferon-gamma (IFN-gamma), at 18 months, 3, 5 and 8 years by ELISA. A cohort analysis was undertaken. Independent effects of cytokine responses at each age on the risk of asthma and allergic outcomes at age 8 years were estimated by multivariable logistic regression. Results: HDM-specific IL-5 responses increased with age. HDM-specific IL-13 and IL-10 responses peaked at age 5 years. HDM-specific IL-5 responses at 3 years, 5 years and 8 years were significantly associated with the presence of asthma and atopy at 8 years. IL-13 responses at 3 years, 5 years and 8 years were significantly associated with atopy at 8 years, but this association was not independent of the effect of IL-5. Other HDM-specific cytokine responses were not independently related to asthma or eczema at 8 years. Conclusion: HDM-specific IL-5 responses at age 3 years or later are the best measure of T cell function for predicting asthma at age 8 years.	[Weber-Chrysochoou, Christina; Crisafulli, Daniele; Marks, Guy Barrington] Woolcock Inst Med Res, Sydney, NSW, Australia; [Kemp, Andrew Stewart; Britton, Warwick John; Marks, Guy Barrington] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Marks, Guy Barrington] Univ New S Wales, South Western Sydney Clin Sch, Liverpool Hlth Serv Hosp, Dept Resp Med, Sydney, NSW, Australia; [Weber-Chrysochoou, Christina; Britton, Warwick John] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Dept Immunol, Sydney, NSW 2006, Australia; [Kemp, Andrew Stewart] Childrens Hosp Westmead, Dept Allergy & Immunol, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of New South Wales Sydney; University of Sydney; Centenary Institute; University of Sydney	Marks, GB (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	guy.marks@sydney.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Garden, Frances/0000-0003-1653-3031; Britton, Warwick/0000-0001-6721-9646	National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma; New South Wales Department of Health; Children's Hospital Westmead; Swiss National Science Foundation [PBZHB-114742]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); New South Wales Department of Health; Children's Hospital Westmead; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma; New South Wales Department of Health; Children's Hospital Westmead; Swiss National Science Foundation, PBZHB-114742 (funding for CW); contributions of goods and services were made by Allergopharma Joachim Ganzer KG Germany, John Sands Australia, Hasbro, Toll Refrigerated, AstraZeneca Australia, and Nu-Mega Ingredients Pty Ltd. Goods were provided at reduced cost by Auspharm, Allersearch and Meadow Lea Foods. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush RK, 2008, ALLERGY ASTHMA PROC, V29, P575, DOI 10.2500/aap.2008.29.3172; Crestani E, 2007, J ALLERGY CLIN IMMUN, V120, P820, DOI 10.1016/j.jaci.2007.05.033; Guerra S, 2004, AM J RESP CRIT CARE, V169, P70, DOI 10.1164/rccm.200304-499OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Marks GB, 2002, CLIN EXP ALLERGY, V32, P355, DOI 10.1046/j.1365-2222.2002.01292.x; Mihrshahi S, 2001, CONTROL CLIN TRIALS, V22, P333, DOI 10.1016/S0197-2456(01)00112-X; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Niggemann B, 2006, ALLERGY, V61, P855, DOI 10.1111/j.1398-9995.2006.01068.x; PEAT JK, 1987, CLIN ALLERGY, V17, P291, DOI 10.1111/j.1365-2222.1987.tb02017.x; PEAT JK, 1987, CLIN ALLERGY, V17, P283, DOI 10.1111/j.1365-2222.1987.tb02016.x; Peat JK, 1996, ALLERGY, V51, P804, DOI 10.1111/j.1398-9995.1996.tb00026.x; Prescott SL, 2003, ALLERGY, V58, P1187, DOI 10.1034/j.1398-9995.2003.00263.x; SALOME CM, 1987, CLIN ALLERGY, V17, P271, DOI 10.1111/j.1365-2222.1987.tb02015.x; Toelle BG, 2010, J ALLERGY CLIN IMMUN, V126, P388, DOI 10.1016/j.jaci.2010.04.031; Turner SW, 2007, CLIN EXP ALLERGY, V37, P371, DOI 10.1111/j.1365-2222.2007.02668.x; van der Velden VHJ, 2001, CLIN EXP ALLERGY, V31, P997, DOI 10.1046/j.1365-2222.2001.01176.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weber-Chrysochoou C, 2007, J ALLERGY CLIN IMMUN, V120, P286, DOI 10.1016/j.jaci.2007.06.034; Wolfe R, 2000, AM J RESP CRIT CARE, V162, P2177, DOI 10.1164/ajrccm.162.6.9812019; Xu Y, 2009, BUILD ENVIRON, V45, P330; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97995	10.1371/journal.pone.0097995	http://dx.doi.org/10.1371/journal.pone.0097995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875149	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800019
J	Choi, YH; Kim, K				Choi, Yoon-Hyeong; Kim, KyooSang			Noise-Induced Hearing Loss in Korean Workers: Co-Exposure to Organic Solvents and Heavy Metals in Nationwide Industries	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; OCCUPATIONAL-EXPOSURE; INDUCED OTOTOXICITY; LEAD-EXPOSURE; BRAIN-STEM; INNER-EAR; CADMIUM; TOLUENE; SURVEILLANCE; IMPAIRMENT	Background: Noise exposure is a well-known contributor to work-related hearing loss. Recent biological evidence suggests that exposure to ototoxic chemicals such as organic solvents and heavy metals may be additional contributors to hearing loss. However, in industrial settings, it is difficult to determine the risks of hearing loss due to these chemicals in workplaces accompanied by excessive noise exposure. A few studies suggest that the effect of noise may be enhanced by ototoxic chemicals. Therefore, this study investigated whether co-exposure to organic solvents and/or heavy metals in the workplace modifies the risk of noise exposure on hearing loss in a background of excessive noise. Methods: We examined 30,072 workers nationwide in a wide range of industries from the Korea National Occupational Health Surveillance 2009. Data on industry-based exposure (e.g., occupational noise, heavy metals, and organic solvents) and subject-specific health outcomes (e.g., audiometric examination) were collected. Noise was measured as the daily 8-h time-weighted average level. Air conduction hearing thresholds were measured from 0.5 to 6 kHz, and pure-tone averages (PTA) (i.e., means of 2, 3, and 4 kHz) were computed. Results: In the multivariate linear model, PTA increment with occupational noise were 1.64-fold and 2.15-fold higher in individuals exposed to heavy metals and organic solvents than in unexposed individuals, respectively. Conclusion: This study provides nationwide evidence that co-exposure to heavy metals and/or organic solvents may exacerbate the effect of noise exposure on hearing loss in workplaces. These findings suggest that workers in industries dealing with heavy metals or organic solvents are susceptible to such risks.	[Choi, Yoon-Hyeong] Gachon Univ, Grad Sch Med, Dept Prevent Med, Inchon, South Korea; [Kim, KyooSang] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Inchon, South Korea	Gachon University	Kim, K (corresponding author), Seoul Med Ctr, Dept Occupat Environm Med, Seoul, South Korea.	kyoosang@daum.net						ABBATE C, 1993, INT ARCH OCC ENV HEA, V64, P389, DOI 10.1007/BF00517943; Beckett WS, 2003, J OCCUP ENVIRON MED, V45, P1029, DOI 10.1097/01.jom.0000088878.64921.1e; Campo P, 2001, HEARING RES, V154, P170, DOI 10.1016/S0378-5955(01)00218-0; Cappaert NLM, 2001, HEARING RES, V162, P67, DOI 10.1016/S0378-5955(01)00373-2; CDC, 2013, OCC HEAR LOSS SURV; CDC, 2001, WORK REL HEAR LOSS; Choi Y-H, 2012, ENV HLTH PE IN PRESS; Choi YH, 2012, ENVIRON HEALTH PERSP, V120, P1544, DOI 10.1289/ehp.1104863; Choi YH, 2012, OCCUP ENVIRON MED, V69, P176, DOI 10.1136/oem.2011.064758; Chuang HY, 2007, SCI TOTAL ENVIRON, V387, P79, DOI 10.1016/j.scitotenv.2007.07.032; CROFTON KM, 1994, HEARING RES, V80, P25, DOI 10.1016/0378-5955(94)90005-1; DISCALZI G, 1993, INT J PSYCHOPHYSIOL, V14, P21, DOI 10.1016/0167-8760(93)90080-9; European Agency for Safety and Health at Work (EU-OSHA), 2009, COMB EXP NOIS OT SUB; Fuente A, 2006, INT J AUDIOL, V45, P367, DOI 10.1080/14992020600753205; Fuente A, 2009, J OCCUP ENVIRON MED, V51, P1202, DOI 10.1097/JOM.0b013e3181bae17c; JACOBSEN P, 1993, OCCUP MED-OXFORD, V43, P180, DOI 10.1093/occmed/43.4.180; Johnson AC, 2010, ARBETE HALSA, V44, p177p; Jones LG, 2008, J COMP NEUROL, V506, P1003, DOI 10.1002/cne.21563; Kim K-S, 2007, AUDIOLOGY, V3, P9; Kim SJ, 2008, ENVIRON HEALTH PERSP, V116, P854, DOI 10.1289/ehp.10467; LASKY RE, 1995, NEUROTOXICOL TERATOL, V17, P633, DOI 10.1016/0892-0362(95)02006-3; Maguin K, 2009, TOXICOL SCI, V107, P473, DOI 10.1093/toxsci/kfn242; Meyer JD, 2002, OCCUP MED-OXFORD, V52, P75, DOI 10.1093/occmed/52.2.75; MORATA TC, 1993, SCAND J WORK ENV HEA, V19, P245, DOI 10.5271/sjweh.1477; Morata TC, 2003, J OCCUP ENVIRON MED, V45, P676, DOI 10.1097/01.jom.0000071507.96740.70; Morata TC, 1997, SCAND J WORK ENV HEA, V23, P289, DOI 10.5271/sjweh.222; OSHRI, 2010, RES OCC EXP REL DIS; OSHRI, 2009, OCC HLTH SURV STAND; OSHRI, 2009, STAND METH MAN PUR T; Ozcaglar HU, 2001, ACTA OTO-LARYNGOL, V121, P393; Palmer KT, 2002, OCCUP ENVIRON MED, V59, P634, DOI 10.1136/oem.59.9.634; Park J, 1999, INT ARCH OCC ENV HEA, V72, P411, DOI 10.1007/s004200050394; Park SK, 2010, HEARING RES, V269, P48, DOI 10.1016/j.heares.2010.07.004; Rabinowitz PM, 2006, EAR HEARING, V27, P742, DOI 10.1097/01.aud.0000240544.79254.bc; Sabolic I, 2006, NEPHRON PHYSIOL, V104, P107, DOI 10.1159/000095539; Sass-Kortsak Andrea M., 1995, Annals of Epidemiology, V5, P15, DOI 10.1016/1047-2797(94)00036-S; Shargorodsky J, 2011, ARCH OTOLARYNGOL, V137, P1177, DOI 10.1001/archoto.2011.202; Sliwinska-Kowalska M, 2005, ENVIRON TOXICOL PHAR, V19, P547, DOI 10.1016/j.etap.2004.12.018; Sliwinska-Kowalska M, 2004, J OCCUP ENVIRON MED, V46, P30, DOI 10.1097/01.jom.0000105912.29242.5b; Sliwinska-Kowalska M, 2003, J OCCUP ENVIRON MED, V45, P15, DOI 10.1097/01.jom.0000048169.87707.c2; Sliwinska-Kowalska M, 2001, SCAND J WORK ENV HEA, V27, P335, DOI 10.5271/sjweh.622; Sliwinska-Kowalska Mariola, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P215, DOI 10.2478/v10001-007-0021-5; Sliwinska-Kowalska M, 2008, OCCUP ENVIRON MED, V65, P222, DOI 10.1136/oem.2007.035907; SPANDOW O, 1988, AM J OTOLARYNG, V9, P327, DOI 10.1016/S0196-0709(88)80041-3; Stanbury M, 2008, J OCCUP ENVIRON MED, V50, P72, DOI 10.1097/JOM.0b013e31815b568c; Varney NR, 1998, CLIN NEUROPSYCHOL, V12, P107, DOI 10.1076/clin.12.1.107.1729; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wallhagen MI, 1997, AM J PUBLIC HEALTH, V87, P440, DOI 10.2105/AJPH.87.3.440; Wu TN, 1998, PREV MED, V27, P65, DOI 10.1006/pmed.1997.0238; YAMAMURA K, 1989, FUND APPL TOXICOL, V13, P509, DOI 10.1016/0272-0590(89)90287-X	50	24	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97538	10.1371/journal.pone.0097538	http://dx.doi.org/10.1371/journal.pone.0097538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870407	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300014
J	Kim, HG; Lee, JS; Choi, MK; Han, JM; Son, CG				Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Han, Jong-Min; Son, Chang-Gue			Ethanolic Extract of Astragali Radix and Salviae Radix Prohibits Oxidative Brain Injury by Psycho-Emotional Stress in Whisker Removal Rat Model	PLOS ONE			English	Article							KAPPA-B; INFLAMMATION; DISORDERS; MYELOPHIL; RESPONSES; MICE; DEPRESSION; DISEASE; DAMAGE; CELLS	Myelophil, an ethanolic extract of Astragali Radix and Salviae Radix, has been clinically used to treat chronic fatigue and stress related disorders in South Korea. In this study, we investigated the protective effects of Myelophil on a whisker removal-induced psycho-emotional stress model. SD rats were subjected to whisker removal after oral administration of Myelophil or ascorbic acid for consecutive 4 days. Whisker removal considerably increased total reactive oxygen species in serum levels as well as cerebral cortex and hippocampal regions in brain tissues. Lipidperoxidation levels were also increased in the cerebral cortex, hippocampus regions, and brain tissue injuries as shown in histopathology and immunohistochemistry. However, Myelophil significantly ameliorated these alterations, and depletion of glutathione contents in both cerebral cortex and hippocampus regions respectively. Serum levels of corticosterone and adrenaline were notably altered after whisker removal stress, whereas these abnormalities were significantly normalized by pre-treatment with Myelophil. The NF-kappa B was notably activated in both cerebral cortex and hippocampus after whisker removal stress, while it was efficiently blocked by pre-treatment with Myelophil. Myelophil also significantly normalizes alterations of tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6 and interferon-gamma in both gene expressions and protein levels. These results suggest that Myelophil has protective effects on brain damages in psycho-emotional stress, and the underlying mechanisms involve regulation of inflammatory proteins, especially NF-kappa B modulation.	[Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Han, Jong-Min; Son, Chang-Gue] Daejeon Univ, Oriental Med Coll, Daejeon Oriental Hosp, Liver & Immunol Res Ctr, Taejon, South Korea	Daejeon University	Son, CG (corresponding author), Daejeon Univ, Oriental Med Coll, Daejeon Oriental Hosp, Liver & Immunol Res Ctr, Taejon, South Korea.	ckson@dju.ac.kr	son, chang gue/ABC-2215-2021		Oriental Medicine R&D Project, Ministry of Health Welfare [B100045]; KM-Based Herbal Drug Research Group of Korea Institute of Oriental Medicine, Rep. of Korea [K13101]	Oriental Medicine R&D Project, Ministry of Health Welfare; KM-Based Herbal Drug Research Group of Korea Institute of Oriental Medicine, Rep. of Korea	This study was supported by a grant (B100045) from the Oriental Medicine R&D Project, Ministry of Health & Welfare, and a grant (K13101) from KM-Based Herbal Drug Research Group of Korea Institute of Oriental Medicine, Rep. of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcraft KA, 2008, BRAIN BEHAV IMMUN, V22, P1231, DOI 10.1016/j.bbi.2008.06.008; Braun S, 2000, NEUROSCI LETT, V295, P101, DOI 10.1016/S0304-3940(00)01603-7; Busciglio J, 1998, ANN NY ACAD SCI, V851, P429, DOI 10.1111/j.1749-6632.1998.tb09021.x; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cho JH, 2009, COMPLEMENT THER MED, V17, P141, DOI 10.1016/j.ctim.2008.11.003; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; Dimitrijevic M, 2012, IMMUNOL RES, V52, P64, DOI 10.1007/s12026-012-8275-9; Dinkel K, 2002, J NEUROVIROL, V8, P513, DOI 10.1080/13550280290100914; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Hayashi I, 2007, MUTAT RES-GEN TOX EN, V631, P55, DOI 10.1016/j.mrgentox.2007.04.006; HERBERT V, 1994, STEM CELLS, V12, P289, DOI 10.1002/stem.5530120305; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050764; Ishiwata H, 2005, NEUROSCIENCE, V133, P893, DOI 10.1016/j.neuroscience.2005.03.048; Jaremka LM, 2013, DEPRESS ANXIETY, V30, P288, DOI 10.1002/da.22078; KAMAL AAM, 1989, ENVIRON RES, V49, P173, DOI 10.1016/S0013-9351(89)80062-3; Kambayashi Y, 2009, J CLIN BIOCHEM NUTR, V44, P46, DOI 10.3164/jcbn.08-162; Kim HG, 2013, J ETHNOPHARMACOL, V148, P505, DOI 10.1016/j.jep.2013.04.046; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Lederbogen F, 2012, NERVENARZT, V83, P1448, DOI 10.1007/s00115-012-3666-7; Lee JS, 2012, PROG NEURO-PSYCHOPH, V39, P339, DOI 10.1016/j.pnpbp.2012.07.006; Oka T, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-7; Rahman MM, 2008, J AGR FOOD CHEM, V56, P7545, DOI 10.1021/jf800930s; Rinwa P, 2013, ARCH PHARM RES, DOI 10.1007/s12272-013-0205-4; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Sinha R, 2003, PSYCHOPHARMACOLOGY, V170, P62, DOI 10.1007/s00213-003-1525-8; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Traeger L, 2013, ONCOL NURS FORUM, V40, pE327, DOI 10.1188/13.ONF.E327-E336; Videbech P, 2001, UGESKRIFT LAEGER, V163, P6568; Wang L, 2007, EVID-BASED COMPL ALT, V4, P195, DOI 10.1093/ecam/nel080; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Wong DL, 2008, ANN NY ACAD SCI, V1148, P249, DOI 10.1196/annals.1410.048; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136	36	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98329	10.1371/journal.pone.0098329	http://dx.doi.org/10.1371/journal.pone.0098329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870587	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300036
J	Kang, WX; Liu, Y; Wu, QX; Yue, XS				Kang, Wenxiong; Liu, Yang; Wu, Qiuxia; Yue, Xishun			Contact-Free Palm-Vein Recognition Based on Local Invariant Features	PLOS ONE			English	Article							ILLUMINATION NORMALIZATION; FEATURE-EXTRACTION; GRAY-SCALE; PATTERNS	Contact-free palm-vein recognition is one of the most challenging and promising areas in hand biometrics. In view of the existing problems in contact-free palm-vein imaging, including projection transformation, uneven illumination and difficulty in extracting exact ROIs, this paper presents a novel recognition approach for contact-free palm-vein recognition that performs feature extraction and matching on all vein textures distributed over the palm surface, including finger veins and palm veins, to minimize the loss of feature information. First, a hierarchical enhancement algorithm, which combines a DOG filter and histogram equalization, is adopted to alleviate uneven illumination and to highlight vein textures. Second, RootSIFT, a more stable local invariant feature extraction method in comparison to SIFT, is adopted to overcome the projection transformation in contact-free mode. Subsequently, a novel hierarchical mismatching removal algorithm based on neighborhood searching and LBP histograms is adopted to improve the accuracy of feature matching. Finally, we rigorously evaluated the proposed approach using two different databases and obtained 0.996% and 3.112% Equal Error Rates (EERs), respectively, which demonstrate the effectiveness of the proposed approach.	[Kang, Wenxiong; Liu, Yang; Yue, Xishun] S China Univ Technol, Coll Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Qiuxia] S China Univ Technol, Guangzhou Inst Modern Ind Technol, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Kang, WX (corresponding author), S China Univ Technol, Coll Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China.	auwxkang@scut.edu.cn			National Natural Science Foundation of China [61105019]; Science and Technology Planning Project of Guangdong Province [2012B010100021]; Fundamental Research Funds for the Central Universities, SCUT [2014ZG0041, 2013ZB0006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (No. 61105019), the Science and Technology Planning Project of Guangdong Province (No. 2012B010100021), and the Fundamental Research Funds for the Central Universities, SCUT (No. 2014ZG0041, No. 2013ZB0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ELECTR POW SYST RES; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Choi JH, 2009, SPIE IS T ELECT IMAG; Chum O, 2005, PROC CVPR IEEE, P220, DOI 10.1109/cvpr.2005.221; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Han WY, 2012, EXPERT SYST APPL, V39, P13225, DOI 10.1016/j.eswa.2012.05.079; Hao Y, 2008, IEEE IMAGE PROC, P281, DOI 10.1109/ICIP.2008.4711746; Juan Luo, 2009, INT J IMAGE PROCESSI, V3, P143, DOI DOI 10.1007/S11270-006-2859-8; Kang BJ, 2011, OPT ENG, V50, DOI 10.1117/1.3530023; Kang WX, 2012, PATTERN RECOGN LETT, V33, P1916, DOI 10.1016/j.patrec.2012.02.020; Kang WX, 2010, SCI CHINA INFORM SCI, V53, P2062, DOI 10.1007/s11432-010-4064-z; Kim HG, 2012, LECT NOTES COMPUT SC, V7432, P21, DOI 10.1007/978-3-642-33191-6_3; Ladoux PO, 2009, LECT NOTES COMPUT SC, V5558, P1290, DOI 10.1007/978-3-642-01793-3_130; Lee EC, 2011, SENSORS-BASEL, V11, P2319, DOI 10.3390/s110302319; Lee EC, 2009, INT J IMAG SYST TECH, V19, P179, DOI 10.1002/ima.20193; Lee JC, 2012, PATTERN RECOGN LETT, V33, P1520, DOI 10.1016/j.patrec.2012.04.007; Li Xiuyan, 2011, Chinese Journal of Scientific Instrument, V32, P831; Li Xueyan, 2007, 2007 1st International Conference on Bioinformatics and Biomedical Engineering, P612, DOI 10.1109/ICBBE.2007.160; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mirmohamadsadeghi L., 2011, P 5 INT C BIOM WASH, P1, DOI DOI 10.1109/IJCB.2011.6117804; Miura N, 2004, MACH VISION APPL, V15, P194, DOI 10.1007/s00138-004-0149-2; Miura N, 2007, IEICE T INF SYST, VE90D, P1185, DOI 10.1093/ietisy/e90-d.8.1185; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pan M, 2011, LECT NOTES COMPUT SC, V7098, P116, DOI 10.1007/978-3-642-25449-9_15; Qian X., 2009, P INT C COMP INT SOF, P1, DOI [DOI 10.1109/CISE.2009.5366021, DOI 10.1109/TENCON.2009.5396125]; Rosdi BA, 2011, SENSORS-BASEL, V11, P11357, DOI 10.3390/s111211357; Song W, 2011, PATTERN RECOGN LETT, V32, P1541, DOI 10.1016/j.patrec.2011.04.021; Tan XY, 2007, LECT NOTES COMPUT SC, V4778, P168; Wang B, 2011, IEEE SIGNAL PROC LET, V18, P462, DOI 10.1109/LSP.2011.2158998; Wang L, 2007, IET COMPUT VIS, V1, P113, DOI 10.1049/iet-cvi:20070009; Wang L, 2008, PATTERN RECOGN, V41, P920, DOI 10.1016/j.patcog.2007.07.012; Wang YD, 2010, INT CONF SIGN PROCES, P1671, DOI 10.1109/ICOSP.2010.5656717; Yang J, 2013, INFORM SCI IN PRESS; Yang JF, 2012, PATTERN RECOGN LETT, V33, P1569, DOI 10.1016/j.patrec.2012.04.018; Yang W, 2013, INFORM SCI IN PRESS; Zhang D, 2010, IEEE T INSTRUM MEAS, V59, P480, DOI 10.1109/TIM.2009.2028772; Zhang YB, 2007, LECT NOTES COMPUT SC, V4781, P154; Zhou YB, 2011, IEEE T INF FOREN SEC, V6, P1259, DOI 10.1109/TIFS.2011.2158423	42	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97548	10.1371/journal.pone.0097548	http://dx.doi.org/10.1371/journal.pone.0097548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866176	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100016
J	Kiwanuka, N; Ssetaala, A; Nalutaaya, A; Mpendo, J; Wambuzi, M; Nanvubya, A; Sigirenda, S; Kitandwe, PK; Nielsen, LE; Balyegisawa, A; Kaleebu, P; Nalusiba, J; Sewankambo, NK				Kiwanuka, Noah; Ssetaala, Ali; Nalutaaya, Annet; Mpendo, Juliet; Wambuzi, Matthias; Nanvubya, Annet; Sigirenda, Simon; Kitandwe, Paul Kato; Nielsen, Leslie Elizabeth; Balyegisawa, Apolo; Kaleebu, Pontiano; Nalusiba, Josephine; Sewankambo, Nelson Kaulukusi			High Incidence of HIV-1 Infection in a General Population of Fishing Communities around Lake Victoria, Uganda	PLOS ONE			English	Article							RISK-FACTORS; SEXUAL-BEHAVIOR; TRUCK DRIVERS; PREVALENCE; FISHERFOLK; ALCOHOL	Background: High HIV-1 incidence rates were reported among persons in fisherfolk communities (FFC) in Uganda who were selected for high risk behaviour. We assessed the incidence of HIV-1 and associated risk factors in a general population FFC to determine population-wide HIV rates. Methods: A community-based cohort study was conducted among a random sample of 2191 participants aged 18-49 years. At baseline and 12 months post-baseline, data were collected on socio-demographic characteristics and risky behaviors (including number of partners, new partners, condom use, use of alcohol and illicit drug use). Venous blood was collected for HIV serological testing. HIV incidence was calculated per 100 person years at-risk (pyar) and adjusted incidence rate ratios (Adj.IRR) were estimated by multivariable Poisson regression. Results: Overall follow up at 12 months was 76.9% (1685/2191) and was significantly higher among HIV uninfected persons and those with at least 1 year duration of stay in community. Overall HIV-1 incidence was 3.39/100 pyar (95% CI: 2.55-4.49). Among the 25-29 years who drank alcohol, HIV incidence was 7.67/100pyar (95% CI; 4.62-12.7) while it was 5.67/100pyar (95% CI; 3.14-10.2) for 18-24 year olds who drank alcohol. The risk of HIV infection was higher among 25-29 years (adj.IRR = 3.36; 95% CI: 1.48-7.65) and 18-24 years (adj.IRR = 2.65; 95% CI: 1.05-6.70) relative to 30+ years. Compared to nondrinkers, HIV incidence increased by frequency CI: 1.91-12.8). Conclusion: HIV-1 incidence in general fisherfolk population along L. Victoria, Uganda, is high and is mainly associated with young age and alcohol drinking. HIV prevention and control strategies are urgently needed in this population.	[Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Kiwanuka, Noah; Ssetaala, Ali; Nalutaaya, Annet; Mpendo, Juliet; Wambuzi, Matthias; Nanvubya, Annet; Sigirenda, Simon; Kitandwe, Paul Kato] Uganda Virus Res Inst, Int AIDS Vaccine Initiate HIV Vaccine Program, Entebbe, Uganda; [Nielsen, Leslie Elizabeth; Balyegisawa, Apolo] IAVI, New York, NY USA; [Kaleebu, Pontiano] Uganda Virus Res Insitute, Uganda Res Unit AIDS, MRC, Entebbe, Uganda; [Nalusiba, Josephine; Sewankambo, Nelson Kaulukusi] Makerere Univ, Coll Hlth Sci, Sch Med, Clin Epidemiol Unit, Kampala, Uganda	Makerere University; International AIDS Vaccine Initiative; Uganda Virus Research Institute; International AIDS Vaccine Initiative; Makerere University	Kiwanuka, N (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda.	nkiwanuka@gmail.com	Ssetaala, Ali/AAB-3832-2020	Ssetaala, Ali/0000-0003-2156-3024; Sewankambo, Nelson/0000-0001-9362-053X	United States Agency for International Development (USAID) through the International AIDS Vaccine Initiative, USA; Training Health Researchers into Vocational Excellence in East Africa Project (THRiVE) of Wellcome Trust, UK [087540]; Canada-Africa Prevention Trials Network (CAPTN) [1063357-001]	United States Agency for International Development (USAID) through the International AIDS Vaccine Initiative, USA(United States Agency for International Development (USAID)); Training Health Researchers into Vocational Excellence in East Africa Project (THRiVE) of Wellcome Trust, UK; Canada-Africa Prevention Trials Network (CAPTN)	This work was made possible in part by the generous support of the American people through the United States Agency for International Development (USAID) through the International AIDS Vaccine Initiative, USA, and the Training Health Researchers into Vocational Excellence in East Africa Project (THRiVE), Grant Number 087540 of Wellcome Trust, UK, and the Canada-Africa Prevention Trials Network (CAPTN) grant number 1063357-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; Camlin CS, 2013, AIDS EDUC PREV, V25, P216, DOI 10.1521/aeap.2013.25.3.216; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Chersich MF, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-16; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Gazi Rukhsana, 2008, Confl Health, V2, P5, DOI 10.1186/1752-1505-2-5; Gysels M, 2001, AIDS CARE, V13, P373, DOI 10.1080/09540120120044026; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; KIPP W, 1995, TROP MED PARASITOL, V46, P141; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Kwena ZA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054523; MacPherson EE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17364; McArthur M, 2013, QUAL HEALTH RES, V23, P1125, DOI 10.1177/1049732313495327; Ministry of Health (MoH) Uganda, 2003, UG NAT POL GUID HIV; Mojola SA, 2011, SOC SCI MED, V72, P149, DOI 10.1016/j.socscimed.2010.11.006; Nunan F, 2012, ENVIRON MANAGE, V50, P204, DOI 10.1007/s00267-012-9881-y; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Tanser F, 2014, CURR OPIN HIV AIDS, V9, P115, DOI 10.1097/COH.0000000000000034; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; Uganda AIDS Commission, 2008, MOD TRANM STUD UG CO; Uganda Ministry of Health, 2012, UNAIDS UNAIDS REP GL; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	31	66	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e94932	10.1371/journal.pone.0094932	http://dx.doi.org/10.1371/journal.pone.0094932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866840	Green Published, gold			2022-12-27	WOS:000336914100001
J	Dorland, A; Rytwinski, T; Fahrig, L				Dorland, Alexandra; Rytwinski, Trina; Fahrig, Lenore			Do Roads Reduce Painted Turtle (Chrysemys picta) Populations?	PLOS ONE			English	Article							FRESH-WATER TURTLES; LANDSCAPE COMPOSITION; EMYDOIDEA-BLANDINGII; GOPHERUS-AGASSIZII; PSEUDEMYS-SCRIPTA; HABITAT FEATURES; SPATIAL SCALES; SEX-RATIO; MORTALITY; PREDATION	Road mortality is thought to be a leading cause of turtle population decline. However, empirical evidence of the direct negative effects of road mortality on turtle population abundance is lacking. The purpose of this study was to provide a strong test of the prediction that roads reduce turtle population abundance. While controlling for potentially confounding variables, we compared relative abundance of painted turtles (Chrysemys picta) in 20 ponds in Eastern Ontario, 10 as close as possible to high traffic roads (Road sites) and 10 as far as possible from any major roads (No Road sites). There was no significant effect of roads on painted turtle relative abundance. Furthermore, our data do not support other predictions of the road mortality hypothesis; we observed neither a higher relative frequency of males to females at Road sites than at No Road sites, nor a lower average body size of turtles at Road than at No Road sites. We speculate that, although roads can cause substantial adult mortality in turtles, other factors, such as release from predation on adults and/or nests close to roads counter the negative effect of road mortality in some populations. We suggest that road mitigation for painted turtles can be limited to locations where turtles are forced to migrate across high traffic roads due, for example, to destruction of local nesting habitat or seasonal drying of ponds. This conclusion should not be extrapolated to other species of turtles, where road mortality could have a larger population-level effect than on painted turtles.	[Dorland, Alexandra; Rytwinski, Trina; Fahrig, Lenore] Carleton Univ, Dept Biol, Geomat & Landscape Ecol Res Lab, Ottawa, ON K1S 5B6, Canada	Carleton University	Rytwinski, T (corresponding author), Carleton Univ, Dept Biol, Geomat & Landscape Ecol Res Lab, Ottawa, ON K1S 5B6, Canada.	trytwinski@hotmail.com	Fahrig, Lenore/C-6494-2012	Fahrig, Lenore/0000-0002-3841-0342	Natural Sciences and Engineering Research Council of Canada [OGP197309]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (Grant #:OGP197309). http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresco MJ, 2005, BIOL CONSERV, V123, P37, DOI 10.1016/j.biocon.2004.10.006; Aresco MJ, 2004, J HERPETOL, V38, P249, DOI 10.1670/169-03A; Aresco MJ, 2003, N CAR STAT U RAL P I, P433; Ashley EP, 1996, CAN FIELD NAT, V110, P403; Baldwin EA, 2004, NORTHEAST NAT, V11, P41, DOI 10.1656/1092-6194(2004)011[0041:THUBNP]2.0.CO;2; Beaudry F, 2008, BIOL CONSERV, V141, P2550, DOI 10.1016/j.biocon.2008.07.016; Boarman WI, 2006, J ARID ENVIRON, V65, P94, DOI 10.1016/j.jaridenv.2005.06.020; Bowne DR, 2004, ANIM BEHAV, V68, P1401, DOI 10.1016/j.anbehav.2004.01.018; Bulte G, 2010, AQUAT CONSERV, V20, P31, DOI [10.1002/aqc.1063, 10.1002/aqc.1089]; Bulte G, 2009, ECOSCIENCE, V16, P175, DOI 10.2980/16-2-3243; Burke VJ, 1995, CONSERV BIOL, V9, P1365, DOI 10.1046/j.1523-1739.1995.09061365.x; Bury RB, 2011, J WILDLIFE MANAGE, V75, P3, DOI 10.1002/jwmg.31; Caldwell IR, 2006, CAN J ZOOL, V84, P1129, DOI 10.1139/Z06-102; Carr LW, 2001, CONSERV BIOL, V15, P1071, DOI 10.1046/j.1523-1739.2001.0150041071.x; CHRISTENS E, 1987, HERPETOLOGICA, V43, P55; Congdon JD, 2003, EXP GERONTOL, V38, P765, DOI 10.1016/S0531-5565(03)00106-2; Congdon Justin D., 1996, P137, DOI 10.1016/B978-012178075-3/50007-6; Crawford BA, 2014, J APPL ECOL, V51, P359, DOI 10.1111/1365-2664.12194; Dorcas ME, 2007, BIOL CONSERV, V137, P334, DOI 10.1016/j.biocon.2007.02.014; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Ernst CH, 2009, TURTLES US CANADA; Fahrig L, 2009, ECOL SOC, V14; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Findlay CS, 2000, CONSERV BIOL, V14, P86, DOI 10.1046/j.1523-1739.2000.99086.x; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fowle SC, 1996, THESIS U MONTANA MIS, P55; FRAZER NB, 1993, AM MIDL NAT, V130, P314, DOI 10.2307/2426130; Galois P, 2007, CHELONIAN CONSERV BI, V6, P288, DOI 10.2744/1071-8443(2007)6[288:TIIESS]2.0.CO;2; GARBER SD, 1995, ECOL APPL, V5, P1151, DOI 10.2307/2269362; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gibbs JP, 2005, CONSERV BIOL, V19, P552, DOI 10.1111/j.1523-1739.2005.000155.x; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Janzen FJ, 2001, ANIM BEHAV, V62, P73, DOI 10.1006/anbe.2000.1732; Jones MT, 2012, HERPETOL CONSERV BIO, V7, P89; Kolbe JJ, 2002, OIKOS, V99, P538, DOI 10.1034/j.1600-0706.2002.11853.x; Langen TA, 2009, AM05405 MOU NEW YORK; Larocque SM, 2012, ANIM CONSERV, V15, P53, DOI 10.1111/j.1469-1795.2011.00487.x; MAHMOUD I Y, 1968, Herpetologica, V24, P158; Marchand MA, 2002, WILDLIFE SOC B, V30, P1092; Marchand MN, 2004, CONSERV BIOL, V18, P758, DOI 10.1111/j.1523-1739.2004.00019.x; Marchand MN, 2004, BIOL CONSERV, V117, P243, DOI 10.1016/j.biocon.2003.07.003; MITCHELL J.C, 1988, HERPETOL MONOGR, V2, P40, DOI DOI 10.2307/1467026; MOLL E O, 1973, Herpetologica, V29, P307; MORREALE SJ, 1984, CAN J ZOOL, V62, P1038, DOI 10.1139/z84-148; Nafus MG, 2013, BIOL CONSERV, V162, P100, DOI 10.1016/j.biocon.2013.04.009; PARKER WS, 1984, AM MIDL NAT, V112, P280, DOI 10.2307/2425435; Patrick DA, 2010, LANDSCAPE ECOL, V25, P791, DOI 10.1007/s10980-010-9459-0; Proulx CL, 2014, J HERPETOL, V48, P267, DOI 10.1670/12-176; Refsnider JM, 2012, HERPETOL CONSERV BIO, V7, P185; Roe JH, 2011, J WILDLIFE MANAGE, V75, P1544, DOI 10.1002/jwmg.219; Rowe JW, 2003, J HERPETOL, V37, P342, DOI 10.1670/0022-1511(2003)037[0342:AAMOMP]2.0.CO;2; Rytwinski T, 2013, OECOLOGIA, V173, P1143, DOI 10.1007/s00442-013-2684-x; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Rytwinski T, 2011, ECOL APPL, V21, P589, DOI 10.1890/10-0968.1; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; SHINE R, 1995, OIKOS, V72, P343, DOI 10.2307/3546119; Steen DA, 2006, ANIM CONSERV, V9, P269, DOI 10.1111/j.1469-1795.2006.00032.x; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; TEMPLE SA, 1987, COPEIA, P250, DOI 10.2307/1446069; TINKLE DW, 1981, ECOLOGY, V62, P1426, DOI 10.2307/1941498; WILBUR HM, 1975, ECOLOGY, V56, P64, DOI 10.2307/1935300; Wood RC, 1997, P CONSERVATION RESTO, V1, P46	62	15	16	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98414	10.1371/journal.pone.0098414	http://dx.doi.org/10.1371/journal.pone.0098414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858065	Green Published, gold			2022-12-27	WOS:000336839400076
J	Queiroz, EAIF; Puukila, S; Eichler, R; Sampaio, SC; Forsyth, HL; Lees, SJ; Barbosa, AM; Dekker, RFH; Fortes, ZB; Khaper, N				Queiroz, Eveline A. I. F.; Puukila, Stephanie; Eichler, Rosangela; Sampaio, Sandra C.; Forsyth, Heidi L.; Lees, Simon J.; Barbosa, Aneli M.; Dekker, Robert F. H.; Fortes, Zuleica B.; Khaper, Neelam			Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IN-VIVO; INSULIN-RESISTANCE; TUMOR SUPPRESSORS; GROWTH; INHIBITION; OBESITY; AUTOPHAGY; PROSTATE; AKT	Recent studies have demonstrated that the anti-diabetic drug, metformin, can exhibit direct antitumoral effects, or can indirectly decrease tumor proliferation by improving insulin sensitivity. Despite these recent advances, the underlying molecular mechanisms involved in decreasing tumor formation are not well understood. In this study, we examined the antiproliferative role and mechanism of action of metformin in MCF-7 cancer cells treated with 10 mM of metformin for 24, 48, and 72 hours. Using BrdU and the MTT assay, it was found that metformin demonstrated an antiproliferative effect in MCF-7 cells that occurred in a time-and concentration-dependent manner. Flow cytometry was used to analyze markers of cell cycle, apoptosis, necrosis and oxidative stress. Exposure to metformin induced cell cycle arrest in G(0)-G(1) phase and increased cell apoptosis and necrosis, which were associated with increased oxidative stress. Gene and protein expression were determined in MCF-7 cells by real time RT-PCR and western blotting, respectively. In MCF-7 cells metformin decreased the activation of IRb, Akt and ERK1/2, increased p-AMPK, FOXO3a, p27, Bax and cleaved caspase-3, and decreased phosphorylation of p70S6K and Bcl-2 protein expression. Co-treatment with metformin and H2O2 increased oxidative stress which was associated with reduced cell number. In the presence of metformin, treating with SOD and catalase improved cell viability. Treatment with metformin resulted in an increase in p-p38 MAPK, catalase, MnSOD and Cu/Zn SOD protein expression. These results show that metformin has an antiproliferative effect associated with cell cycle arrest and apoptosis, which is mediated by oxidative stress, as well as AMPK and FOXO3a activation. Our study further reinforces the potential benefit of metformin in cancer treatment and provides novel mechanistic insight into its antiproliferative role.	[Queiroz, Eveline A. I. F.; Eichler, Rosangela; Sampaio, Sandra C.; Fortes, Zuleica B.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil; [Queiroz, Eveline A. I. F.] Univ Estadual Londrina, Dept Physiol Sci, Londrina, Parana, Brazil; [Barbosa, Aneli M.; Dekker, Robert F. H.] Lakehead Univ, Biorefining Res Inst, Thunder Bay, ON P7B 5E1, Canada; [Forsyth, Heidi L.; Lees, Simon J.; Khaper, Neelam] Lakehead Univ, Northern Ontario Sch Med, Thunder Bay, ON P7B 5E1, Canada; [Puukila, Stephanie; Lees, Simon J.; Khaper, Neelam] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada	Universidade de Sao Paulo; Universidade Estadual de Londrina; Lakehead University; Lakehead University; Northern Ontario School of Medicine; Lakehead University	Fortes, ZB (corresponding author), Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Sao Paulo, Brazil.	zbfortes@icb.usp.br; nkhaper@nosm.ca	Sampaio, Sandra/D-1585-2012; Vessoni, Sandra/AAA-5380-2021; Barbosa-Dekker, Aneli/F-9936-2013; Eichler, Rosangela/Q-4967-2019; Dekker, Robert/AAM-1597-2020	Vessoni, Sandra/0000-0001-6257-3531; Barbosa-Dekker, Aneli/0000-0002-2339-8985; Eichler, Rosangela/0000-0002-7629-0089; Dekker, Robert F. H./0000-0002-3787-6917; Isquierdo Fonseca de Queiroz, Eveline Aparecida/0000-0002-8094-1585	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo (Brazil); NSERC-Research Capacity Development - Canada; NOSM	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSERC-Research Capacity Development - Canada; NOSM	E.A.I.F. Queiroz is grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; Z.B. Fortes) Sao Paulo (Brazil) for a doctoral scholarship at USP (Brazil), and to study in Canada at Lakehead University. This project was conducted by E. A. I. F. Queiroz while a Visiting Scholar at the Biorefining Research Institute (BRI) and Northern Ontario School of Medicine (NOSM) under the supervision of N. Khaper, and funded by a grant from NSERC-Research Capacity Development - Canada (R. F. H. Dekker) and NOSM (N. Khaper). The authors are grateful to the BRI and NOSM for the conduct of this work and Dr. S. Gupta for critical reading of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; [Anonymous], 2008, GLOBOCAN DATABASE; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Berstein LM, 2011, BREAST CANCER RES TR, V128, P109, DOI 10.1007/s10549-010-1072-z; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Chiacchiera F, 2009, CELL DEATH DIFFER, V16, P1203, DOI 10.1038/cdd.2009.36; Chiacchiera F, 2009, AUTOPHAGY, V5, P1030, DOI 10.4161/auto.5.7.9252; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giannarelli R, 2003, DIABETES METAB, V29, pS28; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Gruning NM, 2011, NATURE, V480, P190, DOI 10.1038/480190a; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; HULL RN, 1953, SCIENCE, V117, P223, DOI 10.1126/science.117.3035.223; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Fonseca EAI, 2011, LIFE SCI, V88, P846, DOI 10.1016/j.lfs.2011.03.005; Jagani Z, 2008, BBA-REV CANCER, V1785, P63, DOI 10.1016/j.bbcan.2007.10.003; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Kaaks R, 1996, CANCER CAUSE CONTROL, V7, P605, DOI 10.1007/BF00051703; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osorio-Costa F, 2009, ARQ BRAS ENDOCRINOL, V53, P213, DOI 10.1590/S0004-27302009000200013; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232; Pollak MN, 2007, AM J CLIN NUTR, V86, p820S, DOI 10.1093/ajcn/86.3.820S; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Ropelle ER, 2007, ENDOCRINOLOGY, V148, P5220, DOI 10.1210/en.2007-0381; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seufert J, 2004, CLIN THER, V26, P805, DOI 10.1016/S0149-2918(04)90125-7; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Youle RJ, 2008, NATURE REV, V9, P4759; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	74	182	194	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98207	10.1371/journal.pone.0098207	http://dx.doi.org/10.1371/journal.pone.0098207			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858012	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400055
J	Rainero, E; Cianflone, C; Porporato, PE; Chianale, F; Malacarne, V; Bettio, V; Ruffo, E; Ferrara, M; Benecchia, F; Capello, D; Paster, W; Locatelli, I; Bertoni, A; Filigheddu, N; Sinigaglia, F; Norman, JC; Baldanzi, G; Graziani, A				Rainero, Elena; Cianflone, Cristina; Porporato, Paolo Ettore; Chianale, Federica; Malacarne, Valeria; Bettio, Valentina; Ruffo, Elisa; Ferrara, Michele; Benecchia, Fabio; Capello, Daniela; Paster, Wolfgang; Locatelli, Irene; Bertoni, Alessandra; Filigheddu, Nicoletta; Sinigaglia, Fabiola; Norman, Jim C.; Baldanzi, Gianluca; Graziani, Andrea			The Diacylglycerol Kinase alpha/Atypical PKC/beta 1 Integrin Pathway in SDF-1 alpha Mammary Carcinoma Invasiveness	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANCHORAGE-INDEPENDENT GROWTH; CHRONIC LYMPHOCYTIC-LEUKEMIA; ATYPICAL PKC-ZETA; MATRIX METALLOPROTEINASES; RAC ACTIVATION; ALPHA-4-BETA-1 INTEGRIN; TUMOR MICROENVIRONMENT; LUNG-CANCER; IN-VIVO	Diacylglycerol kinase a (DGK alpha), by phosphorylating diacylglycerol into phosphatidic acid, provides a key signal driving cell migration and matrix invasion. We previously demonstrated that in epithelial cells activation of DGK alpha activity promotes cytoskeletal remodeling and matrix invasion by recruiting atypical PKC at ruffling sites and by promoting RCP-mediated recycling of alpha 5 beta 1 integrin to the tip of pseudopods. In here we investigate the signaling pathway by which DGK alpha mediates SDF-1 alpha-induced matrix invasion of MDA-MB-231 invasive breast carcinoma cells. Indeed we showed that, following SDF-1 alpha stimulation, DGKa is activated and localized at cell protrusion, thus promoting their elongation and mediating SDF-1 alpha induced MMP-9 metalloproteinase secretion and matrix invasion. Phosphatidic acid generated by DGK alpha promotes localization at cell protrusions of atypical PKCs which play an essential role downstream of DGK alpha by promoting Rac-mediated protrusion elongation and localized recruitment of beta 1 integrin and MMP-9. We finally demonstrate that activation of DGK alpha, atypical PKCs signaling and beta 1 integrin are all essential for MDA-MB-231 invasiveness. These data indicates the existence of a SDF-1 alpha induced DGK alpha - atypical PKC - beta 1 integrin signaling pathway, which is essential for matrix invasion of carcinoma cells.	[Rainero, Elena; Norman, Jim C.; Baldanzi, Gianluca; Graziani, Andrea] Beatson Inst Canc Res, Integrin Biol Lab, Glasgow G61 1BD, Lanark, Scotland; [Cianflone, Cristina; Porporato, Paolo Ettore; Chianale, Federica; Malacarne, Valeria; Bettio, Valentina; Ruffo, Elisa; Ferrara, Michele; Benecchia, Fabio; Capello, Daniela; Locatelli, Irene; Bertoni, Alessandra; Filigheddu, Nicoletta; Sinigaglia, Fabiola] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Paster, Wolfgang] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Beatson Institute; University of Eastern Piedmont Amedeo Avogadro; University of Oxford	Baldanzi, G (corresponding author), Beatson Inst Canc Res, Integrin Biol Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	gianluca.baldanzi@med.unipmn.it	Porporato, Paolo E./A-9932-2018; Graziani, Andrea/AAB-6301-2022; Locatelli, Irene/ABH-4738-2020; Capello, Daniela/J-4110-2012; Bettio, Valentina/AFT-9834-2022; graziani, andrea/B-2554-2009; Locatelli, Irene/AAN-3168-2020; Baldanzi, Gianluca/AAO-7673-2021; Ferrara, Michele/I-8849-2018; Filigheddu, Nicoletta/N-7219-2015	Porporato, Paolo E./0000-0001-8519-1552; Graziani, Andrea/0000-0002-6302-2317; Capello, Daniela/0000-0001-9157-8753; graziani, andrea/0000-0002-6302-2317; Baldanzi, Gianluca/0000-0002-1370-9903; Filigheddu, Nicoletta/0000-0002-3848-611X; Locatelli, Irene/0000-0002-8467-2132; Malacarne, Valeria/0000-0001-5893-8606; Ferrara, Michele/0000-0002-3142-483X; NORMAN, Jim/0000-0002-0098-3014; Paster, Wolfgang/0000-0002-5537-2886; Rainero, Elena/0000-0003-1402-8701; Ruffo, Elisa/0000-0003-1990-7377	AIRC, Italian Association for Cancer Research [IG 13524, IG 5392]; CARIPLO Foundation [2010-0737]; mobility grant of CIB, Consorzio Interuniversitario Biotecnologie; EMBO; University Piemonte Orientale; Compagnia di San Paolo; Fondo Di Solidarieta' Edo Tempia Valenta Per Lotta Contro I Tumori; Cancer Research UK [18277] Funding Source: researchfish	AIRC, Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); CARIPLO Foundation(Fondazione Cariplo); mobility grant of CIB, Consorzio Interuniversitario Biotecnologie; EMBO(European Molecular Biology Organization (EMBO)); University Piemonte Orientale; Compagnia di San Paolo(Compagnia di San Paolo); Fondo Di Solidarieta' Edo Tempia Valenta Per Lotta Contro I Tumori; Cancer Research UK(Cancer Research UK)	This work was supported by: AIRC, Italian Association for Cancer Research, (IG 13524 and IG 5392 grants) www.airc.it, and CARIPLO Foundation (2010-0737 grant) www.fondazionecariplo.it. CC was supported by a mobility grant of CIB, Consorzio Interuniversitario Biotecnologie www.cibiotech.it. GB was supported by EMBO (short term fellowships) www.embo.org and University Piemonte Orientale (Young Investigators) www.unipmn.it. VM was supported by Compagnia di San Paolo www.compagnia.torino.it/. DC was supported by Fondo Di Solidarieta' Edo Tempia Valenta Per Lotta Contro I Tumori www.fondoedotempia.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; BALDANZI G, 2011, CANC SCI; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Chianale F, 2007, MOL BIOL CELL, V18, P4859, DOI 10.1091/mbc.E07-02-0177; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Cutrupi S, 2000, EMBO J, V19, P4614, DOI 10.1093/emboj/19.17.4614; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Filigheddu N, 2007, ANTICANCER RES, V27, P1489; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; Flores I, 1999, J IMMUNOL, V163, P708; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kang H, 2005, INT J ONCOL, V26, P1429; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kumar A, 2011, J IMMUNOL, V186, P951, DOI 10.4049/jimmunol.1002019; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; MERIDA I, 2009, ADV ENZYME REGUL; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Sato M, 2013, PHARMACOLOGY, V92, P99, DOI 10.1159/000351849; SCHAAP D, 1990, FEBS LETT, V275, P151, DOI 10.1016/0014-5793(90)81461-V; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Takeishi K, 2012, J HEPATOL, V57, P77, DOI 10.1016/j.jhep.2012.02.026; Taulli R, 2005, CANCER GENE THER, V12, P456, DOI 10.1038/sj.cgt.7700815; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yanagisawa K, 2007, BBA-MOL CELL BIOL L, V1771, P462, DOI 10.1016/j.bbalip.2006.12.008; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Yu YC, 2007, EUR J CANCER PREV, V16, P430, DOI 10.1097/01.cej.0000236259.88146.a4	54	26	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97144	10.1371/journal.pone.0097144	http://dx.doi.org/10.1371/journal.pone.0097144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887021	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300013
J	Tseng, CN; Karlof, E; Chang, YT; Lengquist, M; Rotzius, P; Berggren, PO; Hedin, U; Eriksson, EE				Tseng, Chi-Nan; Karlof, Eva; Chang, Ya-Ting; Lengquist, Mariette; Rotzius, Pierre; Berggren, Per-Olof; Hedin, Ulf; Eriksson, Einar E.			Contribution of Endothelial Injury and Inflammation in Early Phase to Vein Graft Failure: The Causal Factors Impact on the Development of Intimal Hyperplasia in Murine Models	PLOS ONE			English	Article							P-SELECTIN; NEOINTIMAL HYPERPLASIA; ARTERIAL INJURY; DEFICIENT; SUSCEPTIBILITY; PLATELET; CELLS	Objectives: Autologous veins are preferred conduits in by-pass surgery. However, long-term results are hampered by limited patency due to intimal hyperplasia. Although mechanisms involved in development of intimal hyperplasia have been established, the role of inflammatory processes is still unclear. Here, we studied leukocyte recruitment and intimal hyperplasia in inferior vena cava grafts transferred to abdominal aorta in mice. Methods and Results: Several microscopic techniques were used to study endothelium denudation and regeneration and leukocyte recruitment on endothelium. Scanning electron microscopy demonstrated denudation of vein graft endothelium 7 days post-transfer and complete endothelial regeneration by 28 days. Examination of vein grafts transferred to mice transgenic for green fluorescent protein under Tie2 promoter in endothelial cells showed regeneration of graft endothelium from the adjacent aorta. Intravital microscopy revealed recruitment of leukocytes in vein grafts at 7 days in wild type mice, which had tapered off by 28 days. At 28 and 63 days there was significant development of intimal hyperplasia. In contrast; no injury, leukocyte recruitment nor intimal hyperplasia occurred in arterial grafts. Leukocyte recruitment was reduced in vein grafts in mice deficient in E-and P-selectin. In parallel, intimal hyperplasia was reduced in vein grafts in mice deficient in E-and P-selectin and in wild type mice receiving P-selectin/E-selectin function-blocking antibodies. Conclusion: The results show that early phase endothelial injury and inflammation are crucial processes in intimal hyperplasia in murine vein grafts. The data implicate endothelial selectins as targets for intervention of vein graft disease.	[Tseng, Chi-Nan; Karlof, Eva; Chang, Ya-Ting; Lengquist, Mariette; Rotzius, Pierre; Hedin, Ulf; Eriksson, Einar E.] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden; [Berggren, Per-Olof] Karolinska Inst, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tseng, CN (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden.	neon1995.tw@gmail.com		Berggren, Per-Olof/0000-0001-8991-413X; Hedin, Ulf/0000-0001-9212-3945; Tseng, Chi-Nan/0000-0003-2069-3636	Swedish Heart-Lung Foundation [20060691, 20080365, 20080606, 20090701]; Swedish Research Council [K2009-65X-2233-01-3]; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Heart-Lung Foundation (project number: 20060691, 20080365, 20080606 and 20090701), the Swedish Research Council (project number: K2009-65X-2233-01-3), and Karolinska Institutet. The sponsors had no role in the study design, data collection, data analysis, and interpretation of data. The sponsors were not involve in the writing of the manuscript or in the decision to submit the manuscript for publication.	Anggrahini DW, 2009, CARDIOVASC RES, V82, P143, DOI 10.1093/cvr/cvp026; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Cooley BC, 1998, MICROSURG, V18, P234, DOI 10.1002/(SICI)1098-2752(1998)18:4<234::AID-MICR3>3.0.CO;2-J; Deb S, 2012, J AM COLL CARDIOL, V60, P28, DOI 10.1016/j.jacc.2012.03.037; Ehsan A, 2002, CIRCULATION, V105, P1686, DOI 10.1161/01.CIR.0000013775.02396.93; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GRONDIN CM, 1984, J THORAC CARDIOV SUR, V87, P161; Itoh Y, 2010, ARTERIOSCL THROM VAS, V30, P1725, DOI 10.1161/ATVBAHA.110.207365; Jeremy JY, 2011, PHARMACOL RES, V63, P483, DOI 10.1016/j.phrs.2010.10.018; Jung U, 1999, J IMMUNOL, V162, P6755; Liehn EA, 2004, ARTERIOSCL THROM VAS, V24, P1891, DOI 10.1161/01.ATV.0000143135.71440.75; Nakao A, 2011, CARDIOVASC RES, V89, P457, DOI 10.1093/cvr/cvq298; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Salzberg SP, 2006, CIRCULATION, V114, pI302, DOI 10.1161/CIRCULATIONAHA.105.001339; Sata M, 2004, ARTERIOSCL THROM VAS, V24, P1147, DOI 10.1161/01.ATV.0000134296.22448.eb; Schachner T, 2004, ANN THORAC SURG, V77, P1580, DOI 10.1016/j.athoracsur.2003.10.008; Shyu KG, 2006, CARDIOVASC RES, V72, P359, DOI 10.1016/j.cardiores.2006.09.017; Soehnlein O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002531; Sterpetti AV, 1996, J VASC SURG, V23, P568, DOI 10.1016/S0741-5214(96)80034-6; Thatte HS, 2001, ANN THORAC SURG, V72, pS2245, DOI 10.1016/S0003-4975(01)03272-6; Wang K, 2005, ARTERIOSCL THROM VAS, V25, P1584, DOI 10.1161/01.ATV.0000172687.01179.d4; Westerband A, 2001, J VASC SURG, V33, P561, DOI 10.1067/mva.2001.112230; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Yu P, 2010, J VASC SURG, V52, P444, DOI 10.1016/j.jvs.2010.03.048; Zhang LS, 2004, ARTERIOSCL THROM VAS, V24, P2277, DOI 10.1161/01.ATV.0000147766.68987.0d; Zou YP, 2000, CIRC RES, V86, P434, DOI 10.1161/01.RES.86.4.434; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	29	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98904	10.1371/journal.pone.0098904	http://dx.doi.org/10.1371/journal.pone.0098904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887332	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300121
J	Woltmann, A; Chen, BW; Lascorz, J; Johansson, R; Eyfjord, JE; Hamann, U; Manjer, J; Enquist-Olsson, K; Henriksson, R; Herms, S; Hoffmann, P; Hemminki, K; Lenner, P; Forsti, A				Woltmann, Andrea; Chen, Bowang; Lascorz, Jesus; Johansson, Robert; Eyfjord, Jorunn E.; Hamann, Ute; Manjer, Jonas; Enquist-Olsson, Kerstin; Henriksson, Roger; Herms, Stefan; Hoffmann, Per; Hemminki, Kari; Lenner, Per; Forsti, Asta			Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients' Clinical Outcome	PLOS ONE			English	Article							METASTASIS; SIGNATURE; RISK	Genome-wide association studies (GWASs) may help to understand the effects of genetic polymorphisms on breast cancer (BC) progression and survival. However, they give only a focused view, which cannot capture the tremendous complexity of this disease. Therefore, we investigated data from a previously conducted GWAS on BC survival for enriched pathways by different enrichment analysis tools using the two main annotation databases Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The goal was to identify the functional categories (GO terms and KEGG pathways) that are consistently overrepresented in a statistically significant way in the list of genes generated from the single nucleotide polymorphism (SNP) data. The SNPs with allelic p-value cut-offs 0.005 and 0.01 were annotated to the genes by excluding or including a 20 kb up-and down-stream sequence of the genes and analyzed by six different tools. We identified eleven consistently enriched categories, the most significant ones relating to cell adhesion and calcium ion binding. Moreover, we investigated the similarity between our GWAS and the enrichment analyses of twelve published gene expression signatures for breast cancer prognosis. Five of them were commonly used and commercially available, five were based on different aspects of metastasis formation and two were developed from meta-analyses of published prognostic signatures. This comparison revealed similarities between our GWAS data and the general and the specific brain metastasis gene signatures as well as the Oncotype DX signature. As metastasis formation is a strong indicator of a patient's prognosis, this result reflects the survival aspect of the conducted GWAS and supports cell adhesion and calcium signaling as important pathways in cancer progression.	[Woltmann, Andrea; Chen, Bowang; Lascorz, Jesus; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Johansson, Robert; Henriksson, Roger; Lenner, Per] Umea Univ, Dept Radiat Sci & Oncol, Umea, Sweden; [Eyfjord, Jorunn E.] Univ Iceland, Fac Med, Canc Res Lab, Reykjavik, Iceland; [Hamann, Ute] German Canc Res Ctr, Heidelberg, Germany; [Manjer, Jonas] Lund Univ, Malmo Diet & Canc Study, Malmo, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Plast Surg, Malmo, Sweden; [Manjer, Jonas] Lund Univ, Malmo, Sweden; [Enquist-Olsson, Kerstin] Umea Univ, Dept Publ Hlth & Clin Med Nutr, Umea, Sweden; [Henriksson, Roger] Canc Ctr Stockholm Gotland, Stockholm, Sweden; [Herms, Stefan; Hoffmann, Per] Univ Bonn, Inst Human Genet, Dept Genom, Bonn, Germany; [Herms, Stefan; Hoffmann, Per] Univ Basel, Div Med Genet, Basel, Switzerland; [Herms, Stefan; Hoffmann, Per] Univ Basel, Dept Biomed, Basel, Switzerland; [Hemminki, Kari; Forsti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Umea University; University of Iceland; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Lund University; Skane University Hospital; Lund University; Umea University; University of Bonn; University of Basel; University of Basel; Lund University	Woltmann, A (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	a.woltmann@dkfz-heidelberg.de	Herms, Stefan/J-1949-2014; Hoffmann, Per/A-5149-2010; Henriksson, Roger/AAI-8608-2020	Herms, Stefan/0000-0002-2786-8200; Hoffmann, Per/0000-0002-6573-983X; 	EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (CCPRB) [LSHC-CT-2004-503465]	EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (CCPRB)	The genome-wide association study was supported by the EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (CCPRB, LSHC-CT-2004-503465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Azzato EM, 2010, J NATL CANCER I, V102, P650, DOI 10.1093/jnci/djq057; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Hemminki K, 2008, BREAST CANCER RES TR, V110, P177, DOI 10.1007/s10549-007-9692-7; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lascorz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018867; Lauss M, 2008, BREAST CANCER RES TR, V110, P235, DOI 10.1007/s10549-007-9716-3; Li SF, 2008, ADV CANCER RES, V101, P45, DOI 10.1016/S0065-230X(08)00403-X; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pukkala E, 2007, ACTA ONCOL, V46, P286, DOI 10.1080/02841860701203545; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tryggvadottir L, 2006, JNCI-J NATL CANCER I, V98, P116, DOI 10.1093/jnci/djj012; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	34	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98229	10.1371/journal.pone.0098229	http://dx.doi.org/10.1371/journal.pone.0098229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886783	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300049
J	Chuang, YW; Chang, WM; Chen, KH; Hong, CZ; Chang, PJ; Hsu, HC				Chuang, Yi-Wen; Chang, Wen-Ming; Chen, Kai-Hua; Hong, Chang-Zern; Chang, Pey-Jium; Hsu, Hung-Chih			Lysophosphatidic Acid Enhanced the Angiogenic Capability of Human Chondrocytes by Regulating Gi/NF-kappa B-Dependent Angiogenic Factor Expression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; OVARIAN-CANCER CELLS; ENDOTHELIAL-CELLS; INTERLEUKIN-8; PATHWAY; LYSOPHOSPHOLIPIDS; TRANSACTIVATION; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS	Lysophosphatidic acid (LPA) has been found to mediate myeloid differentiation, stimulate osteogenesis, alter cell proliferation and migration, and inhibit apoptosis in chondrocytes. The effect of LPA on the angiogenic capability of chondrocytes is not clear. This study aimed to investigate its effect on the angiogenic capability of human chondrocytes and the underlying mechanism of these effects. Human chondrocyte cell line, CHON-001, commercialized human chondrocytes (HC) derived from normal human articular cartilage, and human vascular endothelial cells (HUVECs) were used as cell models in this study. The angiogenic capability of chondrocytes was determined by capillary tube formation, monolayer permeability, cell migration, and cell proliferation. An angiogenesis protein array kit was used to evaluate the secretion of angiogenic factors in conditioned medium. Angiogenin, insulin-like growth factor-binding protein 1 (IGFBP-1), interleukin (IL)-8, monocyte chemoattractant protein-1 (MCP-1), matrix metalloproteinase (MMP)-9, and vascular endothelial growth factor (VEGF) mRNA and protein expressions were evaluated by Q-RT-PCR and EIA, respectively. LPA receptor (LPAR) expression was determined by RT-PCR. Signaling pathways were clarified using inhibitors, Western blot analysis, and reporter assays. The LPA treatment promoted the angiogenic capability of CHON-001 cells and HC, resulting in enhanced HUVEC capillary tube formation, monolayer permeability, migration, and cell growth. Angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF mRNA and protein expressions were significantly enhanced in LPA-treated chondrocytes. LPA2, 3, 4 and 6 were expressed in CHON-001 and HC cells. Pretreatment with the Gi/o type G protein inhibitor, pertussis toxin (PTX), and the NF-kappa B inhibitor, PDTC, significantly inhibited LPA-induced angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF expressions in chondrocytes. The PTX pretreatment also inhibited LPA-mediated NF-kappa B activation, suggesting the presence of active Gi/NF-kappa B signaling in CHON-001 and HC cells. The effect of LPA on the angiogenesis-inducing capacity of chondrocytes may be due to the increased angiogenesis factor expression via the Gi/NF-kappa B signaling pathway.	[Chuang, Yi-Wen; Chang, Wen-Ming; Chen, Kai-Hua; Hsu, Hung-Chih] Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Chuang, Yi-Wen; Chang, Wen-Ming; Chen, Kai-Hua; Hsu, Hung-Chih] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Hong, Chang-Zern] HungKuang Univ, Dept Phys Therapy, Taichung, Taiwan; [Chang, Pey-Jium; Hsu, Hung-Chih] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Hungkuang University; Chang Gung University	Hsu, HC (corresponding author), Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan.	dr.tonyhsu@gmail.com		Chang, Pey-Jium/0000-0002-6492-0346	Chang Gung Memorial Hospital [CMRPG6B0481]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The funding was from the research grant of Chang Gung Memorial Hospital ( Grant Number: CMRPG6B0481, website:www.cgmh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi M, 2009, OSTEOARTHR CARTILAGE, V17, P271, DOI 10.1016/j.joca.2008.06.019; Aki Y, 2008, ARCH ORAL BIOL, V53, P207, DOI 10.1016/j.archoralbio.2007.08.006; Burke SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046986; Cecil DL, 2005, ARTHRITIS RHEUM-US, V52, P144, DOI 10.1002/art.20748; Chen RJ, 2012, INT J CANCER, V131, P789, DOI 10.1002/ijc.26476; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Chou CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066268; DeNiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059021; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Evseenko D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063718; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; Gschwind A, 2002, CANCER RES, V62, P6329; Hurst-Kennedy J, 2010, J STEROID BIOCHEM, V122, P264, DOI 10.1016/j.jsbmb.2010.05.010; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kim KW, 2009, SPINE J, V9, P323, DOI 10.1016/j.spinee.2008.05.003; Kim MK, 2005, BIOCHEM PHARMACOL, V70, P1764, DOI 10.1016/j.bcp.2005.09.015; KING TV, 1991, J BONE JOINT SURG BR, V73, P587, DOI 10.1302/0301-620X.73B4.1712788; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Nadra R, 2003, J CELL BIOCHEM, V88, P911, DOI 10.1002/jcb.10396; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Segar CE, 2013, CURR PHARM DESIGN, V19, P3403, DOI 10.2174/1381612811319190007; Strakova Z, 2000, ENDOCRINOLOGY, V141, P4664, DOI 10.1210/en.141.12.4664; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; Tseng HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057955; Xu XY, 2010, CANCER-AM CANCER SOC, V116, P1739, DOI 10.1002/cncr.24907; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zelzer E, 2002, DEVELOPMENT, V129, P1893	42	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e95180	10.1371/journal.pone.0095180	http://dx.doi.org/10.1371/journal.pone.0095180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879414	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500002
J	Seo, AN; Kwak, Y; Kim, DW; Kang, SB; Choe, G; Kim, WH; Lee, HS				Seo, An Na; Kwak, Yoonjin; Kim, Duck-Woo; Kang, Sung-Bum; Choe, Gheeyoung; Kim, Woo Ho; Lee, Hye Seung			HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CETUXIMAB PLUS IRINOTECAN; PHASE-II TRIAL; BREAST-CANCER; GASTRIC-CANCER; MONOCLONAL-ANTIBODIES; PROGNOSTIC-FACTOR; RECTAL-CANCER; NEU ONCOGENE; SURVIVAL	This study aimed at determining the incidence and clinical implications of HER2 status in primary colorectal cancer (CRC). HER2 status was investigated in two retrospective cohorts of 365 consecutive CRC patients (cohort 1) and 174 advanced CRC patients with synchronous or metachronous distant metastasis (cohort 2). HER2 status was determined by performing dual-color silver in-situ hybridization (SISH), mRNA in-situ hybridization (ISH), and immunohistochemistry (IHC). The incidence of HER2 protein overexpression (IHC 2+/3+) was approximately 6% (22 of 365 in cohort 1; 10 of 174 in cohort 2). HER2 gene amplification was observed in 5.8% of the patients from cohort 1 and 6.3% of the patients from cohort 2. HER2 gene amplification was more frequently observed in CRCs located in the rectum than in the right and left colon (P = 0.013 in cohort 1; P = 0.009 in cohort 2). HER2 status, determined by IHC, ISH, and dual-color SISH, was not significantly associated with aggressive CRC behaviour or patients' prognosis in both the cohorts. Of the combined cohort with a total of 539 cases, the concordance rate was 95.5% between dual-color SISH and IHC detection methods. On excluding equivocally immunostained cases (IHC 2+), the concordance rate was 97.7%. HER2 mRNA overtranscription, detected by ISH, significantly correlated with protein overexpression and gene amplification (P<0.001). HER2 gene amplification was identified in a minority of CRC patients with high concordance rates between dual-color SISH and IHC detection methods. Although HER2 status did not predict patients' prognosis, our findings may serve as a basis for future studies on patient selection for HER2 targeted therapy.	[Seo, An Na] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Pathol, Taegu, South Korea; [Kwak, Yoonjin; Choe, Gheeyoung; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea; [Choe, Gheeyoung; Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea	Kyungpook National University; Kyungpook National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	Seoul National University Bundang Hospital Research Fund [02-2013-041]	Seoul National University Bundang Hospital Research Fund	This study was supported by grant number 02-2013-041 from the Seoul National University Bundang Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Blok EJ, 2013, CLIN MED INSIGHTS-ON, V7, P41, DOI 10.4137/CMO.S10811; Boers JE, 2011, HISTOPATHOLOGY, V58, P383, DOI 10.1111/j.1365-2559.2011.03760.x; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Clark JW, 2003, P AM SOC CLIN ONCOL, V22; Conradi LC, 2013, AM J SURG PATHOL, V37, P522, DOI 10.1097/PAS.0b013e318272ff4d; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Edge S, 2010, AJCC CANC STAGING MA, V7th; Essapen S, 2004, INT J ONCOL, V24, P241; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kavanagh DO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-1; Kim MA, 2013, HUM PATHOL, V44, P487, DOI 10.1016/j.humpath.2012.06.022; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Kruszewski WJ, 2010, DIS MARKERS, V29, P207, DOI [10.1155/2010/109063, 10.3233/DMA-2010-0742]; Langer R, 2011, MODERN PATHOL, V24, P908, DOI 10.1038/modpathol.2011.52; Lech G, 2014, NEOPLASMA, V61, P1, DOI 10.4149/neo_2014_003; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Marsoni S, 2013, J CLIN ONCOL, V31; Marx AH, 2010, HUM PATHOL, V41, P1577, DOI 10.1016/j.humpath.2010.02.018; Mojarad EN, 2013, IMMUNOTHERAPY-UK, V5, P1267, DOI 10.2217/imt.13.131; Oh JR, 2012, FAM CANCER, V11, P459, DOI 10.1007/s10689-012-9536-4; Osako T, 1998, ONCOLOGY-BASEL, V55, P548, DOI 10.1159/000011911; Park DI, 2007, INT J COLORECTAL DIS, V22, P491, DOI 10.1007/s00384-006-0192-8; Prins MJD, 2013, ANN ONCOL, V24, P1290, DOI 10.1093/annonc/mds640; Ramanathan RK, 2004, CANCER INVEST, V22, P858, DOI 10.1081/CNV-200039645; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rossi HA, 2002, CANCER J, V8, P268, DOI 10.1097/00130404-200205000-00011; Schoppmann SF, 2010, AM J SURG PATHOL, V34, P1868, DOI 10.1097/PAS.0b013e3181f8be17; Sclafani F, 2013, ANN ONCOL, V24, P3123, DOI 10.1093/annonc/mdt408; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tafe LJ, 2011, ARCH PATHOL LAB MED, V135, P1460, DOI 10.5858/arpa.2010-0541-OA; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	41	106	117	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98528	10.1371/journal.pone.0098528	http://dx.doi.org/10.1371/journal.pone.0098528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879338	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500067
J	Pereira, ACF; Fonseca, FSA; Mota, GR; Fernandes, AKC; Fagundes, M; Reis-Junior, R; Faria, ML				Pereira, Anielle C. F.; Fonseca, Francine S. A.; Mota, Gleicielle R.; Fernandes, Ane K. C.; Fagundes, Marcilio; Reis-Junior, Ronaldo; Faria, Mauricio L.			Ecological Interactions Shape the Dynamics of Seed Predation in Acrocomia aculeata (Arecaceae)	PLOS ONE			English	Article							INSECT HERBIVORES; FUNGI; BEETLES; COMMUNITY; IMPACT; PLANTS; ANTS; COLONIZATION; POPULATIONS; DISPERSERS	Background: The complex network of direct and indirect relationships determines not only the species abundances but also the community characteristics such as diversity and stability. In this context, seed predation is a direct interaction that affects the reproductive success of the plant. For Acrocomia aculeata, the seed predation by Pachymerus cardo and Speciomerus revoili in post-dispersal may destroy more than 70% of the propagules and is influenced by the herbivory of the fruits during pre-dispersal. Fruits of plants with a higher level of herbivory during pre-dispersal are less attacked by predators in post-dispersal. We proposed a hypothesis that describes this interaction as an indirect defense mediated by fungi in a multitrophic interaction. As explanations, we proposed the predictions: i) injuries caused by herbivores in the fruits of A. aculeata favor fungal colonization and ii) the colonization of A. acuelata fruit by decomposing fungi reduces the selection of the egg-laying site by predator. Methodology/Principal Findings: For prediction (i), differences in the fungal colonization in fruits with an intact or damaged epicarp were evaluated in fruits exposed in the field. For prediction (ii), we performed fruit observations in the field to determine the number of eggs of P. cardo and/or S. revoili per fruit and the amount of fungal colonization in the fruits. In another experiment, in the laboratory, we use P. cardo females in a triple-choice protocol. Each insect to choose one of the three options: healthy fruits, fruits with fungus, or an empty pot. The proposed hypothesis was corroborated. Fruits with injuries in the epicarp had a higher fungal colonization, and fruits colonized by fungi were less attractive for egg-laying by seed predators. Conclusion/Significance: This study emphasizes the importance of exploring the networks of interactions between multitrophic systems to understand the dynamics and maintenance of natural populations.	[Pereira, Anielle C. F.; Mota, Gleicielle R.; Fernandes, Ane K. C.; Fagundes, Marcilio; Reis-Junior, Ronaldo; Faria, Mauricio L.] Univ Estadual Montes Claros, Dept Gen Biol, Montes Claros, MG, Brazil; [Fonseca, Francine S. A.] Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil; [Fonseca, Francine S. A.] Univ Fed Minas Gerais, Inst Agr Sci, Montes Claros, MG, Brazil	Universidade Estadual de Montes Claros; Universidade Estadual de Campinas; Universidade Federal de Minas Gerais	Pereira, ACF (corresponding author), Univ Estadual Montes Claros, Dept Gen Biol, Montes Claros, MG, Brazil.	aniellecristina@gmail.com	Fagundes, Marcilio/Y-7784-2019; Reis Junior, Ronaldo/E-2353-2016; Faria, Mauricio L/E-2415-2016; Fonseca, Francine/AAQ-1528-2020; de Faria, Maurício/AAS-5253-2020	Fagundes, Marcilio/0000-0001-5915-6331; de Faria, Maurício/0000-0003-4976-1874	Petroleo Brasileiro SA (Petrobras); intervention Foundation Arthur Bernardes (Funarbe) [0050.0061571.10.9.]	Petroleo Brasileiro SA (Petrobras); intervention Foundation Arthur Bernardes (Funarbe)	This paper was funded by Petroleo Brasileiro SA (Petrobras), with the intervention Foundation Arthur Bernardes (Funarbe), through the project: Desenvolvimento tecnologico para exploracao sustentavel da macauba (Acrocomia aculeata) - Subproject I, grant number 0050.0061571.10.9. Website:http://www.petrobras.com.br/pt/ The funders had role in decision to publish. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Agarwal VM, 2007, J APPL ENTOMOL, V131, P493, DOI 10.1111/j.1439-0418.2007.01197.x; Almeida S. P., 1998, CERRADO APROVEITAMEN; Amarasekare P, 2003, J ANIM ECOL, V72, P713, DOI 10.1046/j.1365-2656.2003.00744.x; ANDERSEN AN, 1989, OECOLOGIA, V81, P310, DOI 10.1007/BF00377076; ANDERSON RC, 1986, NEW PHYTOL, V102, P523, DOI 10.1111/j.1469-8137.1986.tb00828.x; Begon M, 2006, ECOLGY INDIVIDUALS E; Bennett AE, 2006, AM NAT, V167, P141, DOI 10.1086/499379; Birch ANE, 1989, POLSKIE PISMO ENTOMO, V57, P3; Carrenho Rosilaine, 2007, Acta Bot. Bras., V21, P723, DOI 10.1590/S0102-33062007000300018; CENTER TD, 1974, ECOLOGY, V55, P1096, DOI 10.2307/1940359; CHRISTENSEN M, 1989, MYCOLOGIA, V81, P1, DOI 10.2307/3759446; Clement CR, 2005, AGROCIENCIAS, V9, P67; Cornelissen TG, 2001, AUSTRAL ECOL, V26, P246, DOI 10.1046/j.1442-9993.2001.01109.x; Crawley M. J, 2002, STAT COMPUTING INTRO; CRIST TO, 1993, ECOLOGY, V74, P2231, DOI 10.2307/1939576; DasSilva F. R., 2007, REV BRASILEIRA BIOCI, V5, P681; Del-Claro K, 2004, NEOTROP ENTOMOL, V33, P665, DOI 10.1590/S1519-566X2004000600002; Delobel A, 1995, AMAZONIANA, V13, P209; Donatti CI, 2009, ECOL RES, V24, P1187, DOI 10.1007/s11284-009-0601-x; Dostal P, 2010, BASIC APPL ECOL, V11, P676, DOI 10.1016/j.baae.2010.10.001; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Fagundes M, 2005, ECOL ENTOMOL, V30, P28, DOI 10.1111/j.0307-6946.2005.00668.x; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; GUIMARAES D. P., 2010, INDICES PLUVIOMETRIC; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Horn BW, 2006, CAN J MICROBIOL, V52, P951, DOI 10.1139/W06-050; HUANG CF, 1991, OECOLOGIA, V85, P530, DOI 10.1007/BF00323765; Instituto Nacional de Metereologia, 2013, BANC DAD MET ENS PES; JANZEN D H, 1971, Principes, V15, P89; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Johnson Clarence Dan, 1995, Principes, V39, P25; Karimzadeh J, 2013, J INSECT BEHAV, V26, P35, DOI 10.1007/s10905-012-9331-y; KREMER RJ, 1993, ECOL APPL, V3, P42, DOI 10.2307/1941791; Kruess A, 2002, OECOLOGIA, V130, P563, DOI 10.1007/s00442-001-0829-9; Lee Eun-Hwa, 2012, Mycobiology, V40, P168, DOI 10.5941/MYCO.2012.40.3.168; Leishman M. R., 2000, SEEDS ECOLOGY REGENE, P31, DOI [DOI 10.1126/science.1156831, DOI 10.1079/9780851994321.0031]; Lorenzi G.M.A.C., 2006, VISAO ACAD, V7; MADEJ CW, 1991, OECOLOGIA, V88, P296, DOI 10.1007/BF00320825; Miller T.E., 1987, P33; MILLER TE, 1994, AM NAT, V143, P1007, DOI 10.1086/285646; MILLS JT, 1983, PHYTOPATHOLOGY, V73, P330, DOI 10.1094/Phyto-73-330; Miranda IPA, 2001, FRUTOS PALMEIRAS AMA, P7; Mooney KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034403; Mordecai EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039083; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; NAKAMURA RR, 1995, OECOLOGIA, V102, P324, DOI 10.1007/BF00329799; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Paris CI, 2011, PLANT SIGNAL BEHAV, V6, P547, DOI 10.4161/psb.6.4.14839; Pires TP, 2013, IND CROP PROD, V44, P200, DOI 10.1016/j.indcrop.2012.09.029; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Ramirez N, 2010, PERSPECT PLANT ECOL, V12, P193, DOI 10.1016/j.ppees.2010.04.001; Ramos F. A., 2001, Brazilian Journal of Biology, V61, P449, DOI 10.1590/S1519-69842001000300014; Ribeiro SP, 2006, J ECOL, V94, P932, DOI 10.1111/j.1365-2745.2006.01133.x; Saari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009845; SCARIOT A, 1995, BIOTROPICA, V27, P168, DOI 10.2307/2388992; Scariot Aldicir, 1998, Principes, V42, P5; SCARIOT AO, 1991, BIOTROPICA, V23, P12, DOI 10.2307/2388683; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; SCHOWALTER T. D., 2006, INSECT ECOLOGY ECOSY; Secretaria Municipal de Desenvolvimento Economico Turismo Ciencia e Tecnologia, 2013, COL INF MUN MONT CLA; Shepherd VE, 1998, J TROP ECOL, V14, P199, DOI 10.1017/S0266467498000169; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; STANFORD N. P., 2005, ECOLOGIA MANEJO PATO, P61; Steffler Carla Elisabete, 2008, Palms, V52, P133; STRAUSS SY, 1991, TRENDS ECOL EVOL, V6, P206, DOI 10.1016/0169-5347(91)90023-Q; Tack AJM, 2013, FUNCT ECOL, V27, P633, DOI 10.1111/1365-2435.12087; Tariq M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069013; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Torres-Alruiz MD, 2013, ECOL MODEL, V250, P363, DOI 10.1016/j.ecolmodel.2012.11.024; Tscharntke T., 2002, MULTITROPHIC LEVEL I; WEBBER J, 1981, NATURE, V292, P449, DOI 10.1038/292449a0; Wicklow DT, 1983, FUNGAL COMMUNITY ITS; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461; WRIGHT SJ, 1990, OIKOS, V58, P272, DOI 10.2307/3545217	79	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98026	10.1371/journal.pone.0098026	http://dx.doi.org/10.1371/journal.pone.0098026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875386	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800021
J	Schulte, EC; Schramm, K; Schurmann, C; Lichtner, P; Herder, C; Roden, M; Gieger, C; Peters, A; Trenkwalder, C; Hogl, B; Frauscher, B; Berger, K; Fietze, I; Gross, N; Stiasny-Kolster, K; Oertel, W; Bachmann, CG; Paulus, W; Zimprich, A; Volzke, H; Schminke, U; Nauck, M; Illig, T; Meitinger, T; Muller-Myhsok, B; Prokisch, H; Winkelmann, J				Schulte, Eva C.; Schramm, Katharina; Schurmann, Claudia; Lichtner, Peter; Herder, Christian; Roden, Michael; Gieger, Christian; Peters, Annette; Trenkwalder, Claudia; Hoegl, Birgit; Frauscher, Birgit; Berger, Klaus; Fietze, Ingo; Gross, Nadine; Stiasny-Kolster, Karin; Oertel, Wolfgang; Bachmann, Cornelius G.; Paulus, Walter; Zimprich, Alexander; Voelzke, Henry; Schminke, Ulf; Nauck, Matthias; Illig, Thomas; Meitinger, Thomas; Mueller-Myhsok, Bertram; Prokisch, Holger; Winkelmann, Juliane			Blood cis-eQTL Analysis Fails to Identify Novel Association Signals among Sub-Threshold Candidates from Genome-Wide Association Studies in Restless Legs Syndrome	PLOS ONE			English	Article							GENE-EXPRESSION; RISK; POPULATION; DISEASE; HEALTH; KORA; VARIANTS; LINKAGE; TRAITS; COHORT	Restless legs syndrome (RLS) is a common neurologic disorder characterized by nightly dysesthesias affecting the legs primarily during periods of rest and relieved by movement. RLS is a complex genetic disease and susceptibility factors in six genomic regions have been identified by means of genome-wide association studies (GWAS). For some complex genetic traits, expression quantitative trait loci (eQTLs) are enriched among trait-associated single nucleotide polymorphisms (SNPs). With the aim of identifying new genetic susceptibility factors for RLS, we assessed the 332 best-associated SNPs from the genome-wide phase of the to date largest RLS GWAS for cis-eQTL effects in peripheral blood from individuals of European descent. In 740 individuals belonging to the KORA general population cohort, 52 cis-eQTLs with p(nominal) < 10(-3) were identified, while in 976 individuals belonging to the SHIP-TREND general population study 53 cis-eQTLs with p(nominal) < 10(-3) were present. 23 of these cis-eQTLs overlapped between the two cohorts. Subsequently, the twelve of the 23 cis-eQTL SNPs, which were not located at an already published RLS-associated locus, were tested for association in 2449 RLS cases and 1462 controls. The top SNP, located in the DET1 gene, was nominally significant (p < 0.05) but did not withstand correction for multiple testing (p = 0.42). Although a similar approach has been used successfully with regard to other complex diseases, we were unable to identify new genetic susceptibility factor for RLS by adding this novel level of functional assessment to RLS GWAS data.	[Schulte, Eva C.; Gross, Nadine; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany; [Schulte, Eva C.; Schramm, Katharina; Meitinger, Thomas; Prokisch, Holger; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, Munich, Germany; [Schramm, Katharina; Lichtner, Peter; Meitinger, Thomas; Prokisch, Holger; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, D-80290 Munich, Germany; [Trenkwalder, Claudia] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Herder, Christian; Roden, Michael] German Ctr Diabet Res DZD eV, Dusseldorf, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Univ Clin Endocrinol & Diabetol, Dusseldorf, Germany; [Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Trenkwalder, Claudia] Paracelsus Elena Klin, Kassel, Germany; [Trenkwalder, Claudia] Univ Gottingen, Univ Med Ctr, Dept Neurosurg, D-37073 Gottingen, Germany; [Hoegl, Birgit; Frauscher, Birgit] Med Univ Innsbruck, Neurol Klin, A-6020 Innsbruck, Austria; [Berger, Klaus] Univ Munster, Inst Epidemiol & Sozialmed, D-48149 Munster, Germany; [Fietze, Ingo] Charite, Zentrum Schlafmed, D-13353 Berlin, Germany; [Stiasny-Kolster, Karin; Oertel, Wolfgang] Univ Marburg, Neurol Klin, Marburg, Germany; [Stiasny-Kolster, Karin] Somnomar Inst Med Forsch & Schlafmed, Marburg, Germany; [Bachmann, Cornelius G.] Paracelsus Klin Osnabruck, Abt Neurol, Osnabruck, Germany; [Paulus, Walter] Univ Gottingen, Univ Med Ctr, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Zimprich, Alexander] Med Univ Wien, Neurol Klin, Vienna, Austria; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Schminke, Ulf] Univ Med Greifswald, Inst Neurol, Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany; [Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Mueller-Myhsok, Bertram; Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ernst Moritz Arndt Universitat Greifswald; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen; Medical University of Innsbruck; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; University of Gottingen; Medical University of Vienna; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; University of Munich	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany.	winkelmann@lrz.tum.de	Roden, Michael/AAD-3843-2019; Peters, Annette/A-6117-2011; Meitinger, Thomas/O-1318-2015; Schurmann, Claudia/L-1204-2016; Paulus, Walter/A-3544-2009; Schulte, Eva C./AAT-2410-2021; Trenkwalder, Claudia/AHD-1232-2022; Trenkwalder, Claudia/ABD-6559-2021; Zimprich, Alexander/A-5232-2017	Peters, Annette/0000-0001-6645-0985; Schurmann, Claudia/0000-0003-4158-9192; Paulus, Walter/0000-0001-5549-8377; Trenkwalder, Claudia/0000-0001-6407-1199; Zimprich, Alexander/0000-0002-1668-5177; Schulte, Eva Christina/0000-0003-3105-5672; Prokisch, Holger/0000-0003-2379-6286; Hogl, Birgit/0000-0003-1894-7641; Gieger, Christian/0000-0001-6986-9554; Meitinger, Thomas/0000-0002-8838-8403; Winkelmann, Juliane/0000-0003-2667-9691; Fietze, Ingo/0000-0001-5567-5206	Helmholtz Zentrum Munchen, Munich, Germany from the German Bundesministerium fur Bildung und Forschung [03.2007-02.2011 FKZ 01ET0713]; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Deutsche Forschungsgemeinschaft [DFG GRK840-D2]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [03IS2061A]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg, West Pomerania	Helmholtz Zentrum Munchen, Munich, Germany from the German Bundesministerium fur Bildung und Forschung; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg, West Pomerania	Recruitment of the KORA cohort was supported by institutional (Helmholtz Zentrum Munchen, Munich, Germany) and government funding from the German Bundesministerium fur Bildung und Forschung (03.2007-02.2011 FKZ 01ET0713). SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Deutsche Forschungsgemeinschaft (DFG GRK840-D2), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED), which is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A). Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg, West Pomerania. Whole-body MR imaging was supported by a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG and the Cache Campus program of the InterSystems GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Mehta D, 2012, EUR J HUM GENET; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Spieler D, 2014, GENOME RES, V24, P592, DOI 10.1101/gr.166751.113; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Winkelmann J, 2005, J NEUROL, V252, P67, DOI 10.1007/s00415-005-0604-7; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171	28	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98092	10.1371/journal.pone.0098092	http://dx.doi.org/10.1371/journal.pone.0098092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875634	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800023
J	Werner, EE; Davis, CJ; Skelly, DK; Relyea, RA; Benard, MF; McCauley, SJ				Werner, Earl E.; Davis, Christopher J.; Skelly, David K.; Relyea, Rick A.; Benard, Michael F.; McCauley, Shannon J.			Cross-Scale Interactions and the Distribution-Abundance Relationship	PLOS ONE			English	Article							OCCUPANCY RELATIONSHIPS; SPECIES ABUNDANCE; RANGE SIZE; METAPOPULATION DYNAMICS; ECOLOGICAL THRESHOLDS; REGIONAL DISTRIBUTION; POPULATION-DYNAMICS; LARVAL AMPHIBIANS; LOCAL ABUNDANCE; HABITAT	Positive interspecific relationships between local abundance and extent of regional distribution are among the most ubiquitous patterns in ecology. Although multiple hypotheses have been proposed, the mechanisms underlying distribution-abundance (d-a) relationships remain poorly understood. We examined the intra- and interspecific distribution-abundance relationships for a metacommunity of 13 amphibian species sampled for 15 consecutive years. Mean density of larvae in occupied ponds was positively related to number of ponds occupied by species; employing the fraction of ponds uniquely available to each species this same relationship sharply decelerates. The latter relationship suggested that more abundant species inhabited most available habitats annually, whereas rarer species were dispersal limited. We inferred the mechanisms responsible for this pattern based on the dynamics of one species, Pseudacris triseriata, which transitioned between a rare, narrowly distributed species to a common, widely distributed species and then back again. Both transitions were presaged by marked changes in mean local densities driven by climatic effects on habitat quality. We identified threshold densities separating these population regime shifts that differed with landscape configuration. Our data suggest that these transitions were caused by strong cross-scale interactions between local resource/niche processes and larger scale metapopulation processes. The patterns we observed have relevance for understanding the mechanisms of interspecific d-a relationships and critical thresholds associated with habitat fragmentation.	[Werner, Earl E.; Davis, Christopher J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Skelly, David K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Relyea, Rick A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Benard, Michael F.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [McCauley, Shannon J.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Michigan System; University of Michigan; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; University of Toronto; University Toronto Mississauga	Werner, EE (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	eewerner@umich.edu		McCauley, Shannon/0000-0001-9649-6693; Benard, Michael/0000-0002-8585-3816	NSF LTREB [DEB-9727014, DEB-0454519]	NSF LTREB(National Science Foundation (NSF))	NSF LTREB grants DEB-9727014 and DEB-0454519 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; BEISWENGER R E, 1975, Herpetologica, V31, P222; Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Borregaard MK, 2010, Q REV BIOL, V85, P3, DOI 10.1086/650265; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Delzell DE, 1958, SPATIAL MOVEMENT GRO; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Freckleton RP, 2005, J ANIM ECOL, V74, P353, DOI 10.1111/j.1365-2656.2005.00931.x; Freckleton RP, 2006, AM NAT, V167, P260, DOI 10.1086/498655; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GASTON KJ, 1990, OIKOS, V58, P329, DOI 10.2307/3545224; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; GYLLENBERG M, 1992, THEOR POPUL BIOL, V42, P35, DOI 10.1016/0040-5809(92)90004-D; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski Ilkka, 1993, P108; Harte J, 2001, AM NAT, V157, P374, DOI 10.1086/319323; Hillis DM, 2005, MOL PHYLOGENET EVOL, V34, P299, DOI 10.1016/j.ympev.2004.10.007; Holt RD, 1997, OIKOS, V78, P183, DOI 10.2307/3545815; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lawton JH, 1996, BIRD STUDY, V43, P3, DOI 10.1080/00063659609460991; Leibold MA, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P439; McCauley SJ, 2007, OIKOS, V116, P121, DOI 10.1111/j.2006.0030-1299.15105.x; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mullins ML, 2004, J HERPETOL, V38, P166, DOI 10.1670/67-03A; OOSTERBAAN RJ, 1990, P S LAND DRAIN SAL C, V3, P373; Oosterbaan RJ, 2005, STAT SIGN SEGM LIN R; Ostman O, 2011, OECOLOGIA, V165, P687, DOI 10.1007/s00442-010-1752-8; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Rodionov S, 2005, ICES J MAR SCI, V62, P328, DOI 10.1016/j.icesjms.2005.01.013; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schoener T.W., 1986, P91; SegReg, 2008, SEGM LIN REGR BREAKP; SHAFFER HB, 1991, SYST ZOOL, V40, P284, DOI 10.2307/2992323; Skelly DK, 1996, COPEIA, P599; Skelly DK, 2002, ECOLOGY, V83, P983, DOI 10.1890/0012-9658(2002)083[0983:FCATPO]2.0.CO;2; SKELLY DK, 1995, ECOLOGY, V76, P150, DOI 10.2307/1940638; SMITH DC, 1995, AM NAT, V145, P211, DOI 10.1086/285737; Smith MA, 2005, ECOGRAPHY, V28, P110; Spencer WA, 1964, RELATIONSHIP DISPERS; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Team RDC, 2019, R LANG ENV STAT COMP; Venier LA, 1996, OIKOS, V76, P564, DOI 10.2307/3546349; Venier LA, 1998, OIKOS, V82, P483, DOI 10.2307/3546369; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Werner EE, 2009, ECOL MONOGR, V79, P503, DOI 10.1890/08-1047.1; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Zuckerberg B, 2009, J ANIM ECOL, V78, P172, DOI 10.1111/j.1365-2656.2008.01463.x	65	9	9	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97387	10.1371/journal.pone.0097387	http://dx.doi.org/10.1371/journal.pone.0097387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875899	Green Published, gold			2022-12-27	WOS:000336790800006
J	Azmi, AM; Al-Ssulami, A				Azmi, Aqil M.; Al-Ssulami, Abdulrakeeb			Encoded Expansion: An Efficient Algorithm to Discover Identical String Motifs	PLOS ONE			English	Article							GIBBS SAMPLING METHOD; DNA; IDENTIFICATION; SEQUENCES; SIGNALS; SITES; MEME; WEB	A major task in computational biology is the discovery of short recurring string patterns known as motifs. Most of the schemes to discover motifs are either stochastic or combinatorial in nature. Stochastic approaches do not guarantee finding the correct motifs, while the combinatorial schemes tend to have an exponential time complexity with respect to motif length. To alleviate the cost, the combinatorial approach exploits dynamic data structures such as trees or graphs. Recently (Karci (2009) Efficient automatic exact motif discovery algorithms for biological sequences, Expert Systems with Applications 36: 7952-7963) devised a deterministic algorithm that finds all the identical copies of string motifs of all sizes >= 2 in theoretical time complexity of O(n(2)L+L-2), and a space complexity of O(nL(2)), where n is the length of the input sequence and L is the length of the longest possible string motif. In this paper, we present a significant improvement on Karci's original algorithm. The algorithm that we propose reports all identical string motifs of sizes >= 2 that occur at least tau times. Our algorithm starts with string motifs of size 2, and at each iteration it expands the candidate string motifs by one symbol throwing out those that occur less than t times in the entire input sequence. We use a simple array and data encoding to achieve theoretical worst-case time complexity of O(nL), and a space complexity of O(n): Encoding of the substrings can speed up the process of comparison between string motifs. Experimental results on random and real biological sequences confirm that our algorithm has indeed a linear time complexity and it is more scalable in terms of sequence length than the existing algorithms.	[Azmi, Aqil M.; Al-Ssulami, Abdulrakeeb] King Saud Univ, Dept Comp Sci, Coll Comp & Informat Sci, Riyadh, Saudi Arabia	King Saud University	Azmi, AM (corresponding author), King Saud Univ, Dept Comp Sci, Coll Comp & Informat Sci, Riyadh, Saudi Arabia.	aqil@ksu.edu.sa	Azmi, Aqil M/L-3780-2019; Azmi, Aqil M/AAR-2299-2020	Azmi, Aqil M/0000-0002-0983-2861; Azmi, Aqil M/0000-0002-0983-2861	Research Center of the College of Computer and Information Sciences (CCIS) at King Saud University	Research Center of the College of Computer and Information Sciences (CCIS) at King Saud University	This work was supported by a special fund of the Research Center of the College of Computer and Information Sciences (CCIS) at King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1007/BF00993379; Brown P, 2013, BIOINFORMATICS, V29, P1696, DOI 10.1093/bioinformatics/btt248; Crochemore M., 1994, TEXT ALGORITHMS; Defrance M, 2009, BIOINFORMATICS, V25, P2715, DOI 10.1093/bioinformatics/btp490; Fauteux F, 2008, BIOINFORMATICS, V24, P2303, DOI 10.1093/bioinformatics/btn444; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Gusfield D., 1997, ALGORITHMS STRINGS T; Huang CW, 2011, IEEE ACM T COMPUT BI, V8, P959, DOI 10.1109/TCBB.2010.92; Karci A, 2009, EXPERT SYST APPL, V36, P7952, DOI 10.1016/j.eswa.2008.10.087; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Marschall T, 2009, BIOINFORMATICS, V25, pI356, DOI 10.1093/bioinformatics/btp188; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Riviere R, 2008, J DISCRET ALGORITHMS, V6, P192, DOI 10.1016/j.jda.2007.06.001; Shida K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-486; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sze SH, 2006, LECT NOTES BIOINFORM, P198; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Vanet A, 1999, RES MICROBIOL, V150, P779, DOI 10.1016/S0923-2508(99)00115-1; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yu Q, 2013, INT J BIOL SCI, V9, P412, DOI 10.7150/ijbs.5786; Yu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048442	28	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e95148	10.1371/journal.pone.0095148	http://dx.doi.org/10.1371/journal.pone.0095148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871320	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300001
J	Bouwer, FL; Van Zuijen, TL; Honing, H				Bouwer, Fleur L.; Van Zuijen, Titia L.; Honing, Henkjan			Beat Processing Is Pre-Attentive for Metrically Simple Rhythms with Clear Accents: An ERP Study	PLOS ONE			English	Article							MISMATCH NEGATIVITY; NEURONAL ENTRAINMENT; COMPARING MUSICIANS; METER; DISCRIMINATION; PREDICTION; DYNAMICS; HUMANS; SOUNDS; MODEL	The perception of a regular beat is fundamental to music processing. Here we examine whether the detection of a regular beat is pre-attentive for metrically simple, acoustically varying stimuli using the mismatch negativity (MMN), an ERP response elicited by violations of acoustic regularity irrespective of whether subjects are attending to the stimuli. Both musicians and non-musicians were presented with a varying rhythm with a clear accent structure in which occasionally a sound was omitted. We compared the MMN response to the omission of identical sounds in different metrical positions. Most importantly, we found that omissions in strong metrical positions, on the beat, elicited higher amplitude MMN responses than omissions in weak metrical positions, not on the beat. This suggests that the detection of a beat is pre-attentive when highly beat inducing stimuli are used. No effects of musical expertise were found. Our results suggest that for metrically simple rhythms with clear accents beat processing does not require attention or musical expertise. In addition, we discuss how the use of acoustically varying stimuli may influence ERP results when studying beat processing.	[Bouwer, Fleur L.; Honing, Henkjan] Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands; [Bouwer, Fleur L.; Honing, Henkjan] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Van Zuijen, Titia L.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	Bouwer, FL (corresponding author), Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands.	bouwer@uva.nl	van Zuijen, Titia/F-5063-2012; Honing, Henkjan/A-1362-2012	Honing, Henkjan/0000-0001-7046-7923; Bouwer, Fleur/0000-0001-7064-7481; van Zuijen, Titia/0000-0002-2578-4396	Research Priority Area "Brain & Cognition" at the University of Amsterdam; Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW)	Research Priority Area "Brain & Cognition" at the University of Amsterdam; Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW)	The research of FB and HH is supported by the Research Priority Area "Brain & Cognition" at the University of Amsterdam. HH is supported by the Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; CARLYON RP, 1988, HEARING RES, V32, P65, DOI 10.1016/0378-5955(88)90147-5; Carpenter S, 2012, SCIENCE, V335, P1558, DOI 10.1126/science.335.6076.1558; Chapin HL, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00224; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cooper G., 1960, RHYTHMIC STRUCTURE M; Dau T, 1996, J ACOUST SOC AM, V99, P3623, DOI 10.1121/1.414960; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Geiser E, 2009, CORTEX, V45, P93, DOI 10.1016/j.cortex.2007.09.010; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Honing H, 2014, NEUROBIOLOG IN PRESS; Honing H, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P369, DOI 10.1016/B978-0-12-381460-9.00009-2; Honing H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051369; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; Ladinig O, 2011, MUSIC PERCEPT, V28, P444; Ladinig O, 2009, MUSIC PERCEPT, V26, P377, DOI 10.1525/MP.2009.26.4.377; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; London J., 2012, HEARING TIME; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Sabri M, 2001, COGNITIVE BRAIN RES, V12, P171, DOI 10.1016/S0926-6410(01)00026-X; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Tierney A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00014; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; van Zuijen TL, 2005, COGNITIVE BRAIN RES, V23, P270, DOI 10.1016/j.cogbrainres.2004.10.007; van Zuijen TL, 2004, J COGNITIVE NEUROSCI, V16, P331, DOI 10.1162/089892904322984607; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; ZWICKER E, 1984, J ACOUST SOC AM, V75, P219, DOI 10.1121/1.390398	43	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97467	10.1371/journal.pone.0097467	http://dx.doi.org/10.1371/journal.pone.0097467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870123	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300011
J	Rahman, S; Alexanderson, K; Jokinen, J; Mittendorfer-Rutz, E				Rahman, Syed; Alexanderson, Kristina; Jokinen, Jussi; Mittendorfer-Rutz, Ellenor			Risk Factors for Suicidal Behaviour in Individuals on Disability Pension Due to Common Mental Disorders - A Nationwide Register-Based Prospective Cohort Study in Sweden	PLOS ONE			English	Article							POPULATION-BASED COHORT; ANXIETY DISORDERS; SOCIODEMOGRAPHIC FACTORS; EMPLOYMENT STATUS; FOLLOW-UP; MORTALITY; HEALTH; RETIREMENT; DEPRESSION; IDEATION	Background: Common mental disorders (CMD) have become one of the leading causes for disability pension (DP). Studies on predictors of adverse health outcome following DP are sparse. This study aimed to examine the association of different socio-demographic factors and health care consumption with subsequent suicidal behaviour among individuals on DP due to CMD. Method: This is a population-based prospective cohort study based on register data. All individuals aged 18-64 years, living in Sweden on 31-Dec-2004 who in 2005 were on DP due to CMD (N = 46 745) were followed regarding suicide attempt and suicide (2006-10). Univariate and multivariate hazard ratios (HR) and 95% confidence intervals (CI) for suicidal behaviour were estimated by Cox regression. Results: During the five-year follow-up, 1 046 (2.2%) and 210 (0.4%) individuals attempted and committed suicide, respectively. Multivariate analyses showed that young age (18-24 years) and low education predicted suicide attempt, while living alone was associated with both higher suicide attempt and suicide (range of HRs 1.23 to 1.68). Combined prescription of antidepressants with anxiolytics during 2005 and inpatient care due to mental diagnoses or suicide attempt (2001-05) were strongly associated with suicide attempt and suicide (range of HRs 1.3 to 4.9), while inpatient care due to somatic diagnoses and specialized outpatient care due to mental diagnoses during 2001-05 only predicted suicide attempt (HR 1.45; 95% CI: 1.3-1.7; HR 1.30; 95% CI: 1.1-1.7). Conclusions: Along with socio-demographic factors, it is very important to consider type of previous healthcare use and medication history when designing further research or intervention aiming at individuals on DP due to CMD. Further research is warranted to investigate both characteristics of disability pension due to CMD, like duration, diagnoses and grade as well as mechanisms to subsequent suicidal behavior, taking potential gender differences into consideration.	[Rahman, Syed; Alexanderson, Kristina; Mittendorfer-Rutz, Ellenor] Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden; [Jokinen, Jussi] Karolinska Inst, Karolinska Univ Hosp, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Rahman, S (corresponding author), Karolinska Inst, Div Insurance Med, Dept Clin Neurosci, Stockholm, Sweden.	syed.rahman@ki.se	Rahman, Syed Ghulam/J-2118-2019	Rahman, Syed Ghulam/0000-0002-4006-3327; Alexanderson, Kristina/0000-0002-9313-3413	Swedish Research Council; Karolinska Institutet's	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet's(Karolinska Institutet)	The study was funded by the Swedish Research Council and Karolinska Institutet's funding for doctoral students. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Ahs AMH, 2006, SCAND J PUBLIC HEALT, V34, P159, DOI 10.1080/14034940510032374; Alexanderson A.T., 2004, J PUBLIC HLTH, V63, P12; ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; Anguiano L, 2012, CANCER NURS, V35, pE14, DOI 10.1097/NCC.0b013e31822fc76c; Boden JM, 2007, PSYCHOL MED, V37, P431, DOI 10.1017/S0033291706009147; Bomyea J, 2013, PSYCHIAT RES; Bowers L, 2010, J NERV MENT DIS, V198, P315, DOI 10.1097/NMD.0b013e3181da47e2; Brown J, 2009, J PUBLIC HEALTH-UK, V31, P74, DOI 10.1093/pubmed/fdn098; Carlsten A, 2003, SCAND J PUBLIC HEALT, V31, P224, DOI 10.1080/14034940210167966; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Crump C, 2014, PSYCHOL MED, V44, P279, DOI 10.1017/S0033291713000810; Deverill C, 2009, ADULT PSYCHIAT MORBI, P25; Forsakringskassan, 2013, SOC INS FIG 2013; Friis K, 2008, SCAND J CARING SCI, V22, P241, DOI 10.1111/j.1471-6712.2007.00521.x; Gjesdal S, 2009, SCAND J PUBLIC HEALT, V37, P168, DOI 10.1177/1403494808100937; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Ishtiak-Ahmed K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-492; JARVISALO J., 2005, MENTAL DISORDERS MAJ; Jonsson U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002286; Karlsson NE, 2007, SCAND J PUBLIC HEALT, V35, P341, DOI 10.1080/14034940601159229; Khan A, 2002, J AFFECT DISORDERS, V68, P183, DOI 10.1016/S0165-0327(01)00354-8; Koopmans PC, 2011, INT ARCH OCC ENV HEA, V84, P193, DOI 10.1007/s00420-010-0540-4; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lauber C, 2008, EPIDEMIOL PSICHIAT S, V17, P10, DOI 10.1017/S1121189X0000261X; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; National Board of Health and Welfare, 2012, CAUS DEATH REG; National Collaborating Centre for Mental Health, 2011, COMM MENT HLTH DIS I; Neutel CI, 1997, ANN EPIDEMIOL, V7, P568, DOI 10.1016/S1047-2797(97)00126-9; NIMH, 2009, ANXIETY DISORDERS; OECD, 2003, TRANSF DIS AB POL PR; OECD, 2009, SICKN DIS WORK KEEP; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Quaade T, 2002, SCAND J PUBLIC HEALT, V30, P216, DOI 10.1080/14034940210134022; Ramberg IL, 2000, PSYCHOL MED, V30, P1189, DOI 10.1017/S003329179900238X; Rihmer Z, 2007, CURR OPIN PSYCHIATR, V20, P17, DOI 10.1097/YCO.0b013e3280106868; Andres AR, 2010, EUR J PUBLIC HEALTH, V20, P265, DOI 10.1093/eurpub/ckp183; Rutz EM, 2004, EUR CHILD ADOLES PSY, V13, P321, DOI 10.1007/s00787-004-0406-y; Samuelsson A, 2012, SOC PSYCH PSYCH EPID, V47, P1999, DOI 10.1007/s00127-012-0498-5; Sareen J, 2005, ARCH GEN PSYCHIAT, V62, P1249, DOI 10.1001/archpsyc.62.11.1249; Schneider B, 2011, PSYCHIAT RES, V190, P265, DOI 10.1016/j.psychres.2011.07.037; Shih HI, 2013, PSYCHOPHARMACOLOGY, V229, P665, DOI 10.1007/s00213-013-3127-4; Shrivastava Amresh, 2012, Mens Sana Monogr, V10, P70, DOI 10.4103/0973-1229.90181; Social Insurance Agency, 2012, SOC INS FIG 2012; ten Have M, 2009, CAN J PSYCHIAT, V54, P824, DOI 10.1177/070674370905401205; Thong JY, 2008, AUST NZ J PSYCHIAT, V42, P509, DOI 10.1080/00048670802050553; Vingard E, 2004, SCAND J PUBLIC HEALT, V32, P207, DOI 10.1080/14034950410021899; Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103; Wasserman D, 2012, EUR PSYCHIAT, V27, P129, DOI 10.1016/j.eurpsy.2011.06.003; Weissman MM, 1995, BRIT J PSYCHIAT, V167, P819, DOI 10.1192/bjp.167.6.819	57	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98497	10.1371/journal.pone.0098497	http://dx.doi.org/10.1371/journal.pone.0098497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24869674	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300048
J	Vinson, MR; Angradi, TR				Vinson, Mark R.; Angradi, Ted R.			Muskie Lunacy: Does the Lunar Cycle Influence Angler Catch of Muskellunge (Esox masquinongy)?	PLOS ONE			English	Article							MOON PHASE; FISH; PERIODICITY; BEHAVIOR; SALMON; RATES; REGRESSION; MIGRATION; FISHERIES; LANDINGS	We analyzed angling catch records for 341,959 muskellunge (Esox masquinongy) from North America to test for a cyclic lunar influence on the catch. Using periodic regression, we showed that the number caught was strongly related to the 29-day lunar cycle, and the effect was consistent across most fisheries. More muskellunge were caught around the full and new moon than at other times. At night, more muskellunge were caught around the full moon than the new moon. The predicted maximum relative effect was approximate to 5% overall. Anglers fishing exclusively on the peak lunar day would, on average, catch 5% more muskellunge than anglers fishing on random days. On some lakes and at night, the maximum relative effect was higher. We obtained angler effort data for Wisconsin, Mille Lacs (MN), and Lake Vermilion (MN). For Lake Vermilion there was a significant effect of the lunar cycle on angler effort. We could therefore not conclude that the lunar effect on catch was due to an effect on fish behavior alone. Several factors affected the amount of variation explained by the lunar cycle. The lunar effect was stronger for larger muskellunge (> 102 cm) than for smaller fish, stronger in midsummer than in June or October, and stronger for fish caught at high latitudes (>48 degrees N) than for fish caught further south. There was no difference in the lunar effect between expert and novice muskellunge anglers. We argue that this variation is evidence that the effect of the lunar cycle on catch is mediated by biological factors and is not due solely to angler effort and reflects lunar synchronization in feeding. This effect has been attributed to variation among moon phases in lunar illumination, but our results do not support that hypothesis for angler-caught muskellunge.	[Vinson, Mark R.] US Geol Survey, Great Lakes Sci Ctr, Lake Super Biol Stn, Ashland, WI 54806 USA; [Angradi, Ted R.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA	United States Department of the Interior; United States Geological Survey; United States Environmental Protection Agency	Vinson, MR (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Lake Super Biol Stn, Ashland, WI 54806 USA.	mvinson@usgs.gov	Callahan, Charles D/L-1641-2013		U.S. Geological Survey; U.S. Environmental Protection Agency	U.S. Geological Survey(United States Geological Survey); U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the U.S. Geological Survey and the U.S. Environmental Protection Agency. The views expressed in this paper are the authors' and do not necessarily reflect U.S. Geological Survey or U.S. Environmental Protection Agency policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], HALF MILLION MUSKIE; [Anonymous], 2011, PROTECTING RESTORING; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Bucher J, 2013, REAL SCOOP MOON PHAS; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; Crossman E.J., 1986, American Fisheries Society Special Publication, P1; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Dettloff J, 2004, TOPWATER TACTICS TAL; DeVries P, 2004, T AM FISH SOC, V133, P1379, DOI 10.1577/T03-173.1; Donabauer S, 2011, HIST REV NO PIKE ESO; Gaudreau N, 2000, CAN J FISH AQUAT SCI, V57, P581, DOI 10.1139/cjfas-57-3-581; GRAU EG, 1982, AQUACULTURE, V28, P49, DOI 10.1016/0044-8486(82)90007-2; Hanson KC, 2008, FISHERIES MANAG ECOL, V15, P357, DOI 10.1111/j.1365-2400.2008.00634.x; Hernandez-Leon S, 2008, FISH FISH, V9, P138, DOI 10.1111/j.1467-2979.2008.00272.x; Heting S, 2013, PIECES BIG MUSKIE PU; Horky P, 2006, FOLIA ZOOL, V55, P411; Jason, 2013, MUSKIES MOON PHASES; Jepsen N, 2001, ECOL FRESHW FISH, V10, P26, DOI 10.1034/j.1600-0633.2001.100104.x; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Kerr, 2011, DISTRIBUTION MANAGEM; Kerr SJ, 2007, ENVIRON BIOL FISH, V79, P61, DOI 10.1007/s10641-006-9120-6; Knight JA, 1936, MODERN ANGLER INCLUD; Kobler A, 2009, OECOLOGIA, V161, P837, DOI 10.1007/s00442-009-1415-9; Kuparinen A, 2009, J FISH BIOL, V74, P2401, DOI 10.1111/j.1095-8649.2009.02255.x; Kuparinen A, 2010, FISH RES, V105, P111, DOI 10.1016/j.fishres.2010.03.011; Landsman S, 2011, THESIS CARLETON U OT; Libini CL, 2012, INDIAN J FISH, V59, P81; LOBEL PS, 1978, PAC SCI, V32, P193; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; LUECKE C, 1993, T AM FISH SOC, V122, P112, DOI 10.1577/1548-8659(1993)122<0112:EOMADO>2.3.CO;2; Madrid JAB T, 2008, FOOD INTAKE FISH; Moore MV, 2001, INT VER THEOR ANGEW, V27, P779; Mosindy TE, 2007, ENVIRON BIOL FISH, V79, P71, DOI 10.1007/s10641-006-9167-4; Ortega-Garcia S, 2008, FISH RES, V93, P190, DOI 10.1016/j.fishres.2008.04.005; PALOMARES ML, 1989, AUST J MAR FRESH RES, V40, P259, DOI 10.1071/MF9890259; Ritter Erich, 2013, Open Fish Science Journal, V6, P71; ROSSITER A, 1991, NATURWISSENSCHAFTEN, V78, P182, DOI 10.1007/BF01136210; Samoilys MA, 1997, MAR ECOL PROG SER, V160, P149, DOI 10.3354/meps160149; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Simonson T. D., 2012, WISCONSIN DEP NATURA, VFH-508-2012; Stevenson BC, 2013, ENVIRON ECOL STAT, P1; TAYLOR MH, 1984, T AM FISH SOC, V113, P484, DOI 10.1577/1548-8659(1984)113<484:LSOFR>2.0.CO;2; Thomas MH, 2011, STATUS FISHERIES MIC; Younk JA, 2007, ENVIRON BIOL FISH, V79, P125, DOI 10.1007/s10641-006-9168-3; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	47	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98046	10.1371/journal.pone.0098046	http://dx.doi.org/10.1371/journal.pone.0098046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871329	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300023
J	Paoletta, S; Tosh, DK; Salvemini, D; Jacobson, KA				Paoletta, Silvia; Tosh, Dilip K.; Salvemini, Daniela; Jacobson, Kenneth A.			Structural Probing of Off-Target G Protein-Coupled Receptor Activities within a Series of Adenosine/Adenine Congeners	PLOS ONE			English	Article							SEROTONIN RECEPTORS; DRUG DESIGN; NUCLEOSIDES; AGONISTS; 2-ARYLETHYNYL; SUBSTITUTIONS; PROMISCUITY; SELECTIVITY; ANTAGONISTS; ACTIVATION	We studied patterns of off-target receptor interactions, mostly at G protein-coupled receptors (GPCRs) in the mu M range, of nucleoside derivatives that are highly engineered for nM interaction with adenosine receptors (ARs). Because of the considerable interest of using AR ligands for treating diseases of the CNS, we used the Psychoactive Drug Screening Program (PDSP) for probing promiscuity of these adenosine/adenine congeners at 41 diverse receptors, channels and a transporter. The step-wise truncation of rigidified, trisubstituted (at N degrees, C2, and 5' positions) nucleosides revealed unanticipated interactions mainly with biogenic amine receptors, such as adrenergic receptors and serotonergic receptors, with affinities as high as 61 nM. The unmasking of consistent sets of structure activity relationship (SAR) at novel sites suggested similarities between receptor families in molecular recognition. Extensive molecular modeling of the GPCRs affected suggested binding modes of the ligands that supported the patterns of SAR at individual receptors. In some cases, the ligand docking mode closely resembled AR binding and in other cases the ligand assumed different orientations. The recognition patterns for different GPCRs were clustered according to which substituent groups were tolerated and explained in light of the complementarity with the receptor binding site. Thus, some likely off-target interactions, a concern for secondary drug effects, can be predicted for analogues of this set of substructures, aiding the design of additional structural analogues that either eliminate or accentuate certain off-target activities. Moreover, similar analyses could be performed for unrelated structural families for other GPCRs.	[Paoletta, Silvia; Tosh, Dilip K.; Jacobson, Kenneth A.] NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Saint Louis University	Jacobson, KA (corresponding author), NIDDK, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA.	kajacobs@helix.nih.gov	Jacobson, Kenneth Alan/A-1530-2009	Jacobson, Kenneth Alan/0000-0001-8104-1493	National Institutes of Health (Intramural Research Program of the NIDDK); National Institutes of Health [R01HL077707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126, ZIADK031115, ZIADK031117] Funding Source: NIH RePORTER	National Institutes of Health (Intramural Research Program of the NIDDK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Institutes of Health (Intramural Research Program of the NIDDK and R01HL077707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; [Anonymous], MOL OP ENV MOE VERS; [Anonymous], 2012, SCHROD SUIT 2012; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen ZM, 2012, FASEB J, V26, P1855, DOI 10.1096/fj.11-201541; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Costanzi S., 2007, FRONT DRUG DES DISCO, V3, P63; Dimova D, 2012, J MED CHEM, V55, P10220, DOI 10.1021/jm301292a; Fishman P, 2012, DRUG DISCOV TODAY, V17, P359, DOI 10.1016/j.drudis.2011.10.007; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GALLORODRIGUEZ C, 1994, J MED CHEM, V37, P636, DOI 10.1021/jm00031a014; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Haupt VJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065894, 10.1371/journal.pone.0059937]; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Huggins DJ, 2012, J MED CHEM, V55, P1424, DOI 10.1021/jm2010332; Jensen NH, 2008, COMB CHEM HIGH T SCR, V11, P420, DOI 10.2174/138620708784911483; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Klotz KN, 2003, N-S ARCH PHARMACOL, V367, P629, DOI 10.1007/s00210-003-0749-9; Kolb P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049910; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Melman A, 2008, BIOORGAN MED CHEM, V16, P8546, DOI 10.1016/j.bmc.2008.08.007; Peprah K, 2012, BIOORGAN MED CHEM, V20, P1291, DOI 10.1016/j.bmc.2011.12.019; Peters JU, 2012, DRUG DISCOV TODAY, V17, P325, DOI 10.1016/j.drudis.2012.01.001; Pinna A, 2010, NEUROPHARMACOLOGY, V58, P613, DOI 10.1016/j.neuropharm.2009.11.012; Tosh DK, 2012, J MED CHEM, V55, P8075, DOI 10.1021/jm300965a; Tosh DK, 2012, ACS MED CHEM LETT, V3, P596, DOI 10.1021/ml300107e; Tosh DK, 2012, J MED CHEM, V55, P4847, DOI 10.1021/jm300396n; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhu CB, 2011, MOL PHARMACOL, V80, P458, DOI 10.1124/mol.111.071399	40	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97858	10.1371/journal.pone.0097858	http://dx.doi.org/10.1371/journal.pone.0097858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859150	Green Submitted, gold, Green Published			2022-12-27	WOS:000336839400028
J	van Gestel, MA; Boender, AJ; de Vrind, VAJ; Garner, KM; Luijendijk, MCM; Adan, RAH				van Gestel, Margriet A.; Boender, Arjen J.; de Vrind, Veronne A. J.; Garner, Keith M.; Luijendijk, Mieneke C. M.; Adan, Roger A. H.			Recombinant Adeno-Associated Virus: Efficient Transduction of the Rat VMH and Clearance from Blood	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-TRANSFER; NONHUMAN-PRIMATES; SIALIC-ACID; DELIVERY; TYPE-2; EXPRESSION; NEURONS; HYPOTHALAMUS; CORECEPTOR	To promote the efficient and safe application of adeno-associated virus (AAV) vectors as a gene transfer tool in the central nervous system (CNS), transduction efficiency and clearance were studied for serotypes commonly used to transfect distinct areas of the brain. As AAV2 was shown to transduce only small volumes in several brain regions, this study compares the transduction efficiency of three AAV pseudotyped vectors, namely AAV2/1, AAV2/5 and AAV2/8, in the ventromedial nucleus of the hypothalamus (VMH). No difference was found between AAV2/1 and AAV2/5 in transduction efficiency. Both AAV2/1 and AAV2/5 achieved a higher transduction rate than AAV2/8. One hour after virus administration to the brain, no viral particles could be traced in blood, indicating that no or negligible numbers of virions crossed the blood-brain barrier. In order to investigate survival of AAV in blood, clearance was determined following systemic AAV administration. The half-life of AAV2/1, AAV2/2, AAV2/5 and AAV2/8 was calculated by determining virus clearance rates from blood after systemic injection. The half-life of AAV2/2 was 4.2 minutes, which was significantly lower than the half-lives of AAV2/1, AAV2/5 and AAV2/8. With a half-life of more than 11 hours, AAV2/8 particles remained detectable in blood significantly longer than AAV2/5. We conclude that application of AAV in the CNS is relatively safe as no AAV particles are detectable in blood after injection into the brain. With a half-life of 1.67 hours of AAV2/5, a systemic injection with 1x10(9) genomic copies of AAV would be fully cleared from blood after 2 days.	[van Gestel, Margriet A.; Boender, Arjen J.; de Vrind, Veronne A. J.; Garner, Keith M.; Luijendijk, Mieneke C. M.; Adan, Roger A. H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Adan, RAH (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	r.a.h.adan@umcutrecht.nl		Boender, Arjen/0000-0002-6018-3588	TI Pharma [T5-210-1]	TI Pharma	This work was supported by TI Pharma, project T5-210-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Chen SF, 2005, HUM GENE THER, V16, P235, DOI 10.1089/hum.2005.16.235; Ciron C, 2009, HUM GENE THER, V20, P350, DOI 10.1089/hum.2008.155; Colle MA, 2010, HUM MOL GENET, V19, P147, DOI 10.1093/hmg/ddp475; Cunningham J, 2008, MOL THER, V16, P1267, DOI 10.1038/mt.2008.111; de Backer MWA, 2010, J MOL ENDOCRINOL, V45, P341, DOI 10.1677/JME-10-0057; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fitzsimons HL, 2010, J GENE MED, V12, P385, DOI 10.1002/jgm.1449; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Hauck B, 2004, J VIROL, V78, P13678, DOI 10.1128/JVI.78.24.13678-13686.2004; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kashiwakura Y, 2005, J VIROL, V79, P609, DOI 10.1128/JVI.79.1.609-614.2005; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Kotchey NM, 2011, MOL THER, V19, P1079, DOI 10.1038/mt.2011.3; MATHEWS D, 1977, HORM BEHAV, V8, P40, DOI 10.1016/0018-506X(77)90019-8; McCown TJ, 1996, BRAIN RES, V713, P99, DOI 10.1016/0006-8993(95)01488-8; McFarland NR, 2009, J NEUROCHEM, V109, P838, DOI 10.1111/j.1471-4159.2009.06010.x; Miyake N, 2011, BRAIN RES, V1389, P19, DOI 10.1016/j.brainres.2011.03.014; Negishi A, 2004, GLYCOBIOLOGY, V14, P969, DOI 10.1093/glycob/cwh118; Qing K, 1999, NAT MED, V5, P71, DOI 10.1038/4758; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Reimsnider S, 2007, MOL THER, V15, P1504, DOI 10.1038/sj.mt.6300227; Satoh N, 1997, ENDOCRINOLOGY, V138, P947, DOI 10.1210/en.138.3.947; Summerford C, 1999, NAT MED, V5, P78, DOI 10.1038/4768; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Trogrlic L, 2011, LEARN MEMORY, V18, P678, DOI 10.1101/lm.2314311; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Zhang HW, 2011, MOL THER, V19, P1440, DOI 10.1038/mt.2011.98; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	40	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97639	10.1371/journal.pone.0097639	http://dx.doi.org/10.1371/journal.pone.0097639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858547	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400022
J	Gagne-Sansfacon, J; Allaire, JM; Jones, C; Boudreau, F; Perreault, N				Gagne-Sansfacon, Jessica; Allaire, Joannie M.; Jones, Christine; Boudreau, Francois; Perreault, Nathalie			Loss of Sonic Hedgehog Leads to Alterations in Intestinal Secretory Cell Maturation and Autophagy	PLOS ONE			English	Article							STEM-CELLS; PROMOTES AUTOPHAGY; SIGNALING PATHWAY; MULTIPLE ASPECTS; TENSIN HOMOLOG; HUMAN COLON; HOMEOSTASIS; GENE; EXPRESSION; DIFFERENTIATION	Background: Intestinal epithelial cells express the Sonic and Indian hedgehog ligands. Despite the strong interest in gut hedgehog signaling in GI diseases, no studies have specifically addressed the singular role of intestinal epithelial cell Sonic hedgehog signaling. The aim of this study was to investigate the specific role of Sonic hedgehog in adult ileal epithelial homeostasis. Methodology/Principal Findings: A Sonic hedgehog intestinal epithelial conditional knockout mouse model was generated. Assessment of ileal histological abnormalities, crypt epithelial cell proliferation, epithelial cell fate, junctional proteins, signaling pathways, as well as ultrastructural analysis of intracellular organelles were performed in control and mutant mice. Mice lacking intestinal epithelial Sonic Hedgehog displayed decreased ileal crypt/villus length, decreased crypt proliferation as well as a decrease in the number of ileal mucin-secreting goblet cells and antimicrobial peptide-secreting Paneth cells during adult life. These secretory cells also exhibited disruption of their secretory products in mutant mice. Ultrastructural microscopy analysis revealed a dilated ER lumen in secretory cells. This phenotype was also associated with a decrease in autophagy. Conclusions/Significance: Altogether, these findings indicate that the loss of Sonic hedgehog can lead to ileal secretory cell modifications indicative of endoplasmic reticulum stress, accompanied by a significant reduction in autophagy.	[Gagne-Sansfacon, Jessica; Allaire, Joannie M.; Jones, Christine; Boudreau, Francois; Perreault, Nathalie] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Perreault, N (corresponding author), Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Nathalie.Perreault@USherbrooke.ca		Allaire, Joannie/0000-0002-2665-5617	Canadian Institutes of Health Research (CIHR) [MOP-111104]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (CIHR) MOP-111104 to NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire JM, 2011, AM J PHYSIOL-GASTR L, V300, pG586, DOI 10.1152/ajpgi.00041.2010; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; FALK P, 1994, AM J PHYSIOL, V266, pG987, DOI 10.1152/ajpgi.1994.266.6.G987; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maloum F, 2011, AM J PHYSIOL-GASTR L, V300, pG1065, DOI 10.1152/ajpgi.00176.2010; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Milla LA, 2012, BIOL RES, V45, P223, DOI 10.4067/S0716-97602012000300004; Nielsen CM, 2004, LAB INVEST, V84, P1631, DOI 10.1038/labinvest.3700197; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Petralia RS, 2013, BIOL OPEN, V2, P499, DOI 10.1242/bio.20134275; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Roy SAB, 2012, WORLD J GASTROENTERO, V18, P1579, DOI 10.3748/wjg.v18.i14.1579; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Stappenbeck TS, 2010, MUCOSAL IMMUNOL, V3, P8, DOI 10.1038/mi.2009.121; Stappenbeck TS, 2009, GASTROENTEROLOGY, V137, P30, DOI 10.1053/j.gastro.2009.05.013; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; Traber Peter G., 1995, P21; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; van den Brink GR, 2006, GUT, V55, P912, DOI 10.1136/gut.2005.085902; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Van Dop WA, 2010, GASTROENTEROLOGY, V138, P426, DOI 10.1053/j.gastro.2009.12.013; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Varnat F, 2010, MECH DEVELOP, V127, P73, DOI 10.1016/j.mod.2009.10.005; Wang Y, 2013, HEPATOLOGY, V58, P995, DOI 10.1002/hep.26394; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	59	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98751	10.1371/journal.pone.0098751	http://dx.doi.org/10.1371/journal.pone.0098751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887421	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300104
J	Wang, WY; Wu, XM; Wang, L; Meng, QG; Liu, WH				Wang, Wenyan; Wu, Xiangmeng; Wang, Li; Meng, Qingguo; Liu, Wanhui			Stereoselective Property of 20(S)-Protopanaxadiol Ocotillol Type Epimers Affects Its Absorption and Also the Inhibition of P-Glycoprotein	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; IN-VITRO; RAT PLASMA; 20(S)-GINSENOSIDE RH2; LIQUID-CHROMATOGRAPHY; MULTIDRUG-RESISTANCE; GINSENOSIDE RG(3); RG3; TRANSPORTERS; METABOLITES	Stereoselectivity has been proved to be tightly related to drug action including pharmacodynamics and pharmacokinetics. (20S, 24R)-epoxy-dammarane-3,12,25-triol (24R-epimer) and (20S, 24S)-epoxy-dammarane-3,12,25-triol (24S-epimer), a pair of 20(S)-protopanaxadiol (PPD) ocotillol type epimers, were the main metabolites of PPD. Previous studies have shown that 24R-epimer and 24S-epimer had stereoselectivity in pharmacological action and pharmacokinetics. In the present study, the aim was to further study the pharmacokinetic characteristics of both epimers, investigate their absorption mechanism and analyze the selectivity effects of ocotillol type side chain and C24 stereo-configuration on P-glycoprotein (P-gp) in vivo and in vitro. Results showed that the absolute bioavailability of 24R-epimer was about 14-fold higher than that of 24S-epimer, and a linear kinetic characteristic was acquired in doses of 5-20 mg/kg for both epimers after oral administration. Furthermore, the apparent permeability coefficients of 24R-epimer were 5-7 folds higher than that of 24S-epimer having lower efflux ratios in Caco-2 cell models. Moreover, both 24R-epimer and 24S-epimer had similar inhibitory effects on P-gp by increasing cellular retention of rhodamine 123 in Caco-2 cells and decreasing efflux of digoxin across Caco-2 cell monolayers. In situ in vivo experiments showed that the inhibition of 24R-epimer on P-gp was stronger than that of 24S-epimer by single-pass intestinal perfusion of rhodamine 123 in rats. Western blot analyses demonstrated that both epimers had no action on P-gp expression in Caco-2 cells. In conclusion, with respect to the stereoselectivity, C24 S-configuration of the ocotillol type epimers processed a poor transmembrane permeability and could be distinguished by P-gp. Sharing a dammarane skeleton, both 24R-epimer and 24S-epimer were potent inhibitors of P-gp. This study provides a new case of stereoselective pharmacokinetics of chiral compounds which contributes to know the chiral characteristics of P-gp and structure-action relationship of PPD type and ocotillol type ginsenosides as a P-gp inhibitor.	[Wang, Wenyan; Wu, Xiangmeng; Wang, Li; Meng, Qingguo; Liu, Wanhui] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Yantai University	Meng, QG (corresponding author), Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China.	qinggmeng@163.com; wanhui@luye.cn	Wu, Xiangmeng/ABB-9299-2021; Wu, Xiangmeng/AAW-3149-2021	Wu, Xiangmeng/0000-0001-5767-7555	National Natural Science Foundation of China [81102880]; Research Awards Fund for Excellent Young Scientists of Shandong Province [BS2011YY062]; Natural Science Foundation of Shandong Province [ZR2012HM036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Awards Fund for Excellent Young Scientists of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China No. 81102880 (WW), Research Awards Fund for Excellent Young Scientists of Shandong Province No. BS2011YY062 (WW), and Natural Science Foundation of Shandong Province No. ZR2012HM036 (QM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bae EA, 2002, BIOL PHARM BULL, V25, P58, DOI 10.1248/bpb.25.58; Bae SH, 2013, J SEP SCI, V36, P1904, DOI 10.1002/jssc.201300107; Bhatia P, 2008, XENOBIOTICA, V38, P656, DOI [10.1080/00498250802109207, 10.1080/00498250802109207 ]; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Fei XF, 2002, ACTA PHARMACOL SIN, V23, P315; Gu Y, 2010, XENOBIOTICA, V40, P602, DOI 10.3109/00498254.2010.500744; He Y, 2010, CHIRALITY, V22, P684, DOI 10.1002/chir.20815; Hutt Andrew J., 2007, Drug Metabolism and Drug Interactions, V22, P79; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jia WWG, 2004, CAN J PHYSIOL PHARM, V82, P431, DOI 10.1139/Y04-049; Jin J, 2006, BIOCHEM BIOPH RES CO, V345, P1308, DOI 10.1016/j.bbrc.2006.04.152; Kasai R, 2000, CHEM PHARM BULL, V48, P1226; Kawase A, 2014, J NAT MED-TOKYO, V68, P395, DOI 10.1007/s11418-013-0791-y; Kim HS, 2004, ARCH PHARM RES, V27, P429, DOI 10.1007/BF02980085; Kim SW, 2003, BIOCHEM PHARMACOL, V65, P75, DOI 10.1016/S0006-2952(02)01446-6; Kwak JO, 2010, EUR J PHARMACOL, V627, P92, DOI 10.1016/j.ejphar.2009.11.008; Kwok HH, 2012, BIOCHEM PHARMACOL, V83, P893, DOI 10.1016/j.bcp.2011.12.039; Lancet JE, 2009, LEUKEMIA RES, V33, P1055, DOI 10.1016/j.leukres.2008.09.015; Lee HU, 2005, BIOL PHARM BULL, V28, P1992, DOI 10.1248/bpb.28.1992; Li LA, 2011, DRUG METAB DISPOS, V39, P472, DOI 10.1124/dmd.110.036723; Li Xiao, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P217; Liu J, 2010, FITOTERAPIA, V81, P902, DOI 10.1016/j.fitote.2010.05.020; Liu J, 2009, BIOORG MED CHEM LETT, V19, P3320, DOI 10.1016/j.bmcl.2009.04.054; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Maki N, 2003, J BIOL CHEM, V278, P18132, DOI 10.1074/jbc.M210413200; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Popovich DG, 2004, CAN J PHYSIOL PHARM, V82, P183, DOI 10.1139/Y04-001; Prueksaritanont T, 2003, XENOBIOTICA, V33, P1125, DOI 10.1080/00498250310001609174; Qi LW, 2011, NAT PROD REP, V28, P467, DOI 10.1039/c0np00057d; Shinkai K, 1996, JPN J CANCER RES, V87, P357, DOI 10.1111/j.1349-7006.1996.tb00230.x; Sun SY, 2012, XENOBIOTICA, V42, P1197, DOI 10.3109/00498254.2012.702247; Thomas Hilary, 2003, Cancer Control, V10, P159; Tian JW, 2005, NEUROSCI LETT, V374, P92, DOI 10.1016/j.neulet.2004.10.030; Wang TA, 2010, FITOTERAPIA, V81, P783, DOI 10.1016/j.fitote.2010.04.005; Wang WY, 2012, J CHROMATOGR B, V887, P19, DOI 10.1016/j.jchromb.2011.12.032; Wei XJ, 2012, INT IMMUNOL, V24, P465, DOI 10.1093/intimm/dxs043; Xie HT, 2005, J CHROMATOGR B, V818, P167, DOI 10.1016/j.jchromb.2004.12.028; Xie XW, 2006, J UROLOGY, V175, P1926, DOI 10.1016/S0022-5347(05)00891-8; Zhang H, 2007, PHYTOCHEMISTRY, V68, P2523, DOI 10.1016/j.phytochem.2007.05.028; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035768; Zhang JW, 2010, DRUG METAB DISPOS, V38, P2179, DOI 10.1124/dmd.110.034793; Zhang Rui, 2008, Zhongguo Yaolixue Tongbao, V24, P1504; Zhao Y, 2009, PLANTA MED, V75, P1124, DOI 10.1055/s-0029-1185477; Zhu S, 2004, CHEM PHARM BULL, V52, P995, DOI 10.1248/cpb.52.995	45	19	22	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98887	10.1371/journal.pone.0098887	http://dx.doi.org/10.1371/journal.pone.0098887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887182	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300118
J	Zhang, HF; Wang, F; Ding, L; Zhang, ZY; Sun, DR; Feng, XM; An, JL; Zhu, Y				Zhang, Haifei; Wang, Feng; Ding, Lin; Zhang, Zhiyu; Sun, Deri; Feng, Xinmin; An, Jiuli; Zhu, Yue			A Meta Analysis of Lumbar Spinal Fusion Surgery Using Bone Morphogenetic Proteins and Autologous Iliac Crest Bone Graft	PLOS ONE			English	Article							PROTEIN-2/COMPRESSION RESISTANT MATRIX; INSTRUMENTED POSTEROLATERAL FUSIONS; OSTEOGENIC PROTEIN-1; RADIOGRAPHIC OUTCOMES; PUBLICATION BIAS; SITE MORBIDITY; AUTOGRAFT; RHBMP-2; SAFETY; METAANALYSIS	Background: Bone morphogenetic protein (BMPs) as a substitute for iliac crest bone graft (ICBG) has been increasingly widely used in lumbar fusion. The purpose of this study is to systematically compare the effectiveness and safety of fusion with BMPs for the treatment of lumbar disease. Methods: Cochrane review methods were used to analyze all relevant randomized controlled trials (RCTs) published up to nov 2013. Results: 19 RCTs (1,852 patients) met the inclusion criteria. BMPs group significantly increased fusion rate (RR: 1.13; 95% CI 1.05-1.23, P = 0.001), while there was no statistical difference in overall success of clinical outcomes (RR: 1.04; 95% CI 0.95-1.13, P = 0.38) and complications (RR: 0.96; 95% CI 0.85-1.09, p = 0.54). A significant reduction of the reoperation rate was found in BMPs group (RR: 0.57; 95% CI 0.42-0.77, p = 0.0002). Significant difference was found in the operating time (MD-0.32; 95% CI-0.55, -0.08; P = 0.009), but no significant difference was found in the blood loss, the hospital stay, patient satisfaction, and work status. Conclusion: Compared with ICBG, BMPs in lumbar fusion can increase the fusion rate, while reduce the reoperation rate and operating time. However, it doesn't increase the complication rate, the amount of blood loss and hospital stay. No significant difference was found in the overall success of clinical outcome of the two groups.	[Zhang, Haifei; Wang, Feng; Zhang, Zhiyu; Sun, Deri; Feng, Xinmin; An, Jiuli] China Med Univ, Affiliated Hosp 4, Dept Orthoped, Shenyang, Peoples R China; [Ding, Lin] China Med Univ, Ctr Comp, Shenyang, Peoples R China; [Zhu, Yue] China Med Univ, Affiliated Hosp 1, Dept Orthoped, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Zhu, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Orthoped, Shenyang, Peoples R China.	zhuyuedr@163.com						Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669; Ahlmann E, 2002, J BONE JOINT SURG AM, V84A, P716, DOI 10.2106/00004623-200205000-00003; An H, 2003, SPINE, V28, pS24, DOI 10.1097/00007632-200308011-00005; Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Assiri I, 2004, CAN J SURG S, V47, P7; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; BLUMENTHAL SL, 1993, SPINE, V18, P1186, DOI 10.1097/00007632-199307000-00010; Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; Burkus JK, 2005, J BONE JOINT SURG AM, V87A, P1205, DOI 10.2106/JBJS.D.02532; Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012; Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001; Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/00007632-200211010-00015; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Chen ZG, 2012, ARCH ORTHOP TRAUM SU, V132, P1725, DOI 10.1007/s00402-012-1607-3; Dawson E, 2009, J BONE JOINT SURG AM, V91A, P1604, DOI 10.2106/JBJS.G.01157; Delawi D, 2010, SPINE, V35, P1185, DOI 10.1097/BRS.0b013e3181d3cf28; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimar JR, 2006, SPINE, V31, P2534, DOI 10.1097/01.brs.0000240715.78657.81; Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Donell S, 2011, BONE MORPHOGENETIC P; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Glassman SD, 2005, SPINE, V30, P1694, DOI 10.1097/01.brs.0000172157.39513.80; Glassman SD, 2008, SPINE, V33, P2843, DOI 10.1097/BRS.0b013e318190705d; Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; HUTCHINSON MR, 1994, SPINE, V19, P62, DOI 10.1097/00007632-199401000-00013; Johnsson R, 2002, SPINE, V27, P2654, DOI 10.1097/00007632-200212010-00004; Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Michielsen J, 2013, J BONE JOINT SURG AM, V95A, P873, DOI 10.2106/JBJS.L.00137; Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2; Mussano F, 2007, SPINE, V32, P824, DOI 10.1097/01.brs.0000259227.51180.ca; Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaccaro AR, 2008, SPINE, V33, P2850, DOI 10.1097/BRS.0b013e31818a314d; Vaccaro AR, 2005, SPINE, V30, P2709, DOI 10.1097/01.brs.0000190812.08447.ba; Viera AJ, 2005, FAM MED, V37, P360; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002	52	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97049	10.1371/journal.pone.0097049	http://dx.doi.org/10.1371/journal.pone.0097049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886911	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300011
J	Arreola, A; Cowey, CL; Coloff, JL; Rathmell, JC; Rathmell, WK				Arreola, Alexandra; Cowey, C. Lance; Coloff, Jonathan L.; Rathmell, Jeffrey C.; Rathmell, W. Kimryn			HIF1 alpha and HIF2 alpha Exert Distinct Nutrient Preferences in Renal Cells	PLOS ONE			English	Article							HYPOXIA; HIF-2-ALPHA; GLUTAMINE; HIF-1; IDENTIFICATION; ADAPTATION; BINDING; GENES; LEADS	Background: Hypoxia Inducible Factors (HIF1 alpha and HIF2 alpha) are commonly stabilized and play key roles related to cell growth and metabolic programming in clear cell renal cell carcinoma. The relationship of these factors to discretely alter cell metabolic activities has largely been described in cancer cells, or in hypoxic conditions, where other confounding factors undoubtedly compete. These transcription factors and their specific roles in promoting cancer metabolic phenotypes from the earliest stages are poorly understood in pre-malignant cells. Methods: We undertook an analysis of SV40-transformed primary kidney epithelial cells derived from newborn mice genetically engineered to express a stabilized HIF1 alpha or HIF2 alpha transgene. We examined the metabolic profile in relation to each gene. Results: Although the cells proliferated similarly, the metabolic profile of each genotype of cell was markedly different and correlated with altered gene expression of factors influencing components of metabolic signaling. HIF1 alpha promoted high levels of glycolysis as well as increased oxidative phosphorylation in complete media, but oxidative phosphorylation was suppressed when supplied with single carbon source media. HIF2 alpha, in contrast, supported oxidative phosphorylation in complete media or single glucose carbon source, but these cells were not responsive to glutamine nutrient sources. This finding correlates to HIF2 alpha-specific induction of Glul, effectively reducing glutamine utilization by limiting the glutamate pool, and knockdown of Glul allows these cells to perform oxidative phosphorylation in glutamine media. Conclusion: HIF1 alpha and HIF2 alpha support highly divergent patterns of kidney epithelial cell metabolic phenotype. Expression of these factors ultimately alters the nutrient resource utilization and energy generation strategy in the setting of complete or limiting nutrients.	[Arreola, Alexandra; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Arreola, Alexandra; Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Cowey, C. Lance; Rathmell, W. Kimryn] Univ N Carolina, Div Hematol & Oncol, Dept Med, Chapel Hill, NC USA; [Coloff, Jonathan L.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	rathmell@med.unc.edu			NIH NRSA [F31CA154080];  [R01-CA121781]; NATIONAL CANCER INSTITUTE [P30CA014236, F31CA154080, R01CA121781, P30CA016086, K24CA172355] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AA was funded by NIH NRSA Grant F31CA154080. WKR was funded by R01-CA121781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BELL CL, 1988, AM J HUM GENET, V43, P293; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Davidson A. J, 2009, MOUSE KIDNEY DEV; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lai YL, 2011, J PROTEOME RES, V10, P5175, DOI 10.1021/pr200642c; Linehan WM, 2013, SEMIN CANCER BIOL, V23, P46, DOI 10.1016/j.semcancer.2012.06.002; Lutz MS, 2006, CANCER RES, V66, P6903, DOI 10.1158/0008-5472.CAN-06-0501; Maxwell PH, 1995, DEVELOPMENT, V121, P4005; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; SHERIDAN AM, 1993, AM J PHYSIOL, V265, pF342, DOI 10.1152/ajprenal.1993.265.3.F342; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; White NMA, 2013, COLD SPRING HARBOR P, P1; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105	43	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98705	10.1371/journal.pone.0098705	http://dx.doi.org/10.1371/journal.pone.0098705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879016	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500081
J	Caulfield, F; Ewing, L; Burton, N; Avard, E; Rhodes, G				Caulfield, Frances; Ewing, Louise; Burton, Nichola; Avard, Eleni; Rhodes, Gillian			Facial Trustworthiness Judgments in Children with ASD Are Modulated by Happy and Angry Emotional Cues	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; SOCIAL COGNITION; FACE PERCEPTION; EXPRESSIONS; IMPRESSIONS; BEHAVIOR; AMYGDALA; BRAIN; ATTRACTIVENESS; SCHIZOPHRENIA	Appearance-based trustworthiness inferences may reflect the misinterpretation of emotional expression cues. Children and adults typically perceive faces that look happy to be relatively trustworthy and those that look angry to be relatively untrustworthy. Given reports of atypical expression perception in children with Autism Spectrum Disorder (ASD), the current study aimed to determine whether the modulation of trustworthiness judgments by emotional expression cues in children with ASD is also atypical. Cognitively-able children with and without ASD, aged 6-12 years, rated the trustworthiness of faces showing happy, angry and neutral expressions. Trust judgments in children with ASD were significantly modulated by overt happy and angry expressions, like those of typically-developing children. Furthermore, subtle emotion cues in neutral faces also influenced trust ratings of the children in both groups. These findings support a powerful influence of emotion cues on perceived trustworthiness, which even extends to children with social cognitive impairments.	[Caulfield, Frances; Ewing, Louise; Burton, Nichola; Avard, Eleni; Rhodes, Gillian] Univ Western Australia, Sch Psychol, Australian Res Council, Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia	University of Western Australia	Ewing, L (corresponding author), Univ Western Australia, Sch Psychol, Australian Res Council, Ctr Excellence Cognit & Its Disorders, Perth, WA 6009, Australia.	louise.ewing@uwa.edu.au	Ewing, Louise/H-9158-2014	Ewing, Louise/0000-0001-5263-1267; Rhodes, Gillian/0000-0002-3631-8518; Burton, Nichola/0000-0003-4470-4846	Australian Research Council Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC Professional Fellowship [DP0877379]; ARC Discovery Outstanding Researcher Award [DP130102300]	Australian Research Council Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC Professional Fellowship(Australian Research Council); ARC Discovery Outstanding Researcher Award(Australian Research Council)	This research was supported by the Australian Research Council Centre of Excellence in Cognition and its Disorders (CE110001021), an ARC Professional Fellowship to Rhodes (DP0877379) and an ARC Discovery Outstanding Researcher Award to Rhodes (DP130102300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Castelli F, 2005, AUTISM, V9, P428, DOI 10.1177/1362361305056082; Caulfield F, 2014, JUDGING TRUSTW UNPUB; Celani G, 1999, J AUTISM DEV DISORD, V29, P57, DOI 10.1023/A:1025970600181; Chang LJ, 2010, COGNITIVE PSYCHOL, V61, P87, DOI 10.1016/j.cogpsych.2010.03.001; Cooper PA, 2006, DEVELOPMENTAL SCI, V9, P530, DOI 10.1111/j.1467-7687.2006.00520.x; Corsello C, 2007, J CHILD PSYCHOL PSYC, V48, P932, DOI 10.1111/j.1469-7610.2007.01762.x; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Couture SM, 2010, PSYCHOL MED, V40, P569, DOI 10.1017/S003329170999078X; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; DAVIES S, 1994, J CHILD PSYCHOL PSYC, V35, P1033, DOI 10.1111/j.1469-7610.1994.tb01808.x; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Evers Kris, 2014, Autism Res Treat, V2014, P345878, DOI 10.1155/2014/345878; Field A.P., 2020, DISCOVERING STAT USI, V4th; Franklin RG, 2013, J NONVERBAL BEHAV, V37, P139, DOI 10.1007/s10919-013-0150-4; Frith U, 2008, AUTISM VERY SHORT IN; Gaigg SB, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00113; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Gao XQ, 2009, J EXP CHILD PSYCHOL, V102, P503, DOI 10.1016/j.jecp.2008.11.002; Hamilton AFDC, 2007, CURR BIOL, V17, pR641, DOI 10.1016/j.cub.2007.06.009; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Haynes S, 2011, JUDGMENTS TRUSTWORTH; Hirschfeld L, 2007, CURR BIOL, V17, pR451, DOI 10.1016/j.cub.2007.04.051; HOBSON RP, 1986, J CHILD PSYCHOL PSYC, V27, P321, DOI 10.1111/j.1469-7610.1986.tb01836.x; Jones CRG, 2011, J CHILD PSYCHOL PSYC, V52, P275, DOI 10.1111/j.1469-7610.2010.02328.x; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Lacroix A, 2009, RES DEV DISABIL, V30, P976, DOI 10.1016/j.ridd.2009.02.002; Lord C., 2012, ADOS 2 MANUAL PART I, DOI DOI 10.1016/j.specom.2006.10.003; Losh M, 2009, ARCH GEN PSYCHIAT, V66, P518, DOI 10.1001/archgenpsychiatry.2009.34; Mathersul D, 2013, INT J PSYCHOPHYSIOL, V87, P88, DOI 10.1016/j.ijpsycho.2012.11.005; MCARTHUR LZ, 1983, PSYCHOL REV, V90, P215, DOI 10.1037/0033-295X.90.3.215; Nuske HJ, 2013, COGNITION EMOTION, V27, P1042, DOI 10.1080/02699931.2012.762900; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Pellicano E, 2014, CAMBRIDGE FACE UNPUB; Piggot J, 2004, J AM ACAD CHILD PSY, V43, P473, DOI 10.1097/00004583-200404000-00014; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Ramachandran R, 2009, J CHILD PSYCHOL PSYC, V50, P871, DOI 10.1111/j.1469-7610.2009.02053.x; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rotenberg KJ, 2005, BRIT J DEV PSYCHOL, V23, P271, DOI 10.1348/026151005X26192; ROTHENBERG KJ, 1994, J SOC CLIN PSYCHOL, V13, P152; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Rule NO, 2013, J PERS SOC PSYCHOL, V104, P409, DOI 10.1037/a0031050; Rutter M., 2003, SOCIAL COMMUNICATION; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Secord PF., 1958, PERSON PERCEPTION IN, P300; SILVER NC, 1987, J APPL PSYCHOL, V72, P146, DOI 10.1037/0021-9010.72.1.146; Skinner AL, 2010, PSYCHOL SCI, V21, P1248, DOI 10.1177/0956797610380702; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Uljarevic M, 2013, J AUTISM DEV DISORD, V43, P1517, DOI 10.1007/s10803-012-1695-5; Webb S. J., 2011, OXFORD HDB FACE PERC, P839; Wechsler D., 2011, WASI 2 WECHSLER ABBR; White S, 2006, BRAIN COGNITION, V61, P69, DOI 10.1016/j.bandc.2005.12.007; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 2008, SOC PERSONAL PSYCHOL, V2, P1497, DOI 10.1111/j.1751-9004.2008.00109.x; Zebrowitz LA, 2007, PERS SOC PSYCHOL B, V33, P648, DOI 10.1177/0146167206297399	65	25	28	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97644	10.1371/journal.pone.0097644	http://dx.doi.org/10.1371/journal.pone.0097644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878763	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500020
J	Medina-Martinez, I; Barron, V; Roman-Bassaure, E; Juarez-Torres, E; Guardado-Estrada, M; Espinosa, AM; Bermudez, M; Fernandez, F; Venegas-Vega, C; Orozco, L; Zenteno, E; Kofman, S; Berumen, J				Medina-Martinez, Ingrid; Barron, Valeria; Roman-Bassaure, Edgar; Juarez-Torres, Eligia; Guardado-Estrada, Mariano; Espinosa, Ana Maria; Bermudez, Miriam; Fernandez, Fernando; Venegas-Vega, Carlos; Orozco, Lorena; Zenteno, Edgar; Kofman, Susana; Berumen, Jaime			Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study	PLOS ONE			English	Article							MOLECULAR CYTOGENETIC CHARACTERIZATION; HUMAN-PAPILLOMAVIRUS TYPE-16; NF-KAPPA-B; CHROMOSOMAL-ABERRATIONS; GLUCOSE-METABOLISM; RECURRENT PATTERN; MITOTIC PATHWAY; HYBRIDIZATION; GAIN; CARCINOMA	We investigated the role of tumor copy number (CN)-altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays-31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1 +/- 8.9). Tumors were classified as low (mean = 0.5 +/- 0.6, n = 11), medium (mean = 5.4 +/- 2.4, n = 10), or high (mean = 19.2 +/- 6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r(2) = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated.	[Medina-Martinez, Ingrid; Barron, Valeria; Juarez-Torres, Eligia; Guardado-Estrada, Mariano; Espinosa, Ana Maria; Bermudez, Miriam; Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Unidad Med Genom, Mexico City 04510, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Fernandez, Fernando; Venegas-Vega, Carlos; Kofman, Susana] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Serv Genet, Mexico City 04510, DF, Mexico; [Orozco, Lorena] Inst Nacl Med Genom, Lab Genom Enfermedades Complejas, Mexico City, DF, Mexico; [Zenteno, Edgar] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Unidad Med Genom, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Berumen, Jaime/F-7914-2018; Fernández-Ramírez, Fernando/GPK-5724-2022; Berumen, Jaime/AAL-5577-2020	Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; Orozco, Lorena/0000-0002-5801-9180; Fernandez-Ramirez, Fernando/0000-0002-7016-1948; Zenteno, Edgar/0000-0001-5603-4072; ESPINOSA GARCIA, ANA MARIA/0000-0003-3255-4051; VENEGAS-VEGA, CARLOS ALBERTO/0000-0001-5609-418X	National Council of Science and Technology (CONACYT) [8135/A1, 24341, 80680, 133273]; National University of Mexico [SDI.PTID.05.2]	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 (to JB), 80680 (to SK) and 133273 (to FF) and the National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2 (to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz M, 2006, GENE CHROMOSOME CANC, V45, P829, DOI 10.1002/gcc.20343; Alameda F, 2009, HUM PATHOL, V40, P1474, DOI 10.1016/j.humpath.2009.03.013; Allen DG, 2000, BRIT J CANCER, V83, P1659, DOI 10.1054/bjoc.2000.1509; Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Atkin NB, 2000, CYTOGENET CELL GENET, V91, P44, DOI 10.1159/000056816; Belloni E, 2011, ONCOGENE, V30, P1117, DOI 10.1038/onc.2010.478; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dowen SE, 2003, ONCOGENE, V22, P2531, DOI 10.1038/sj.onc.1206296; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kirchhoff M, 1999, GENE CHROMOSOME CANC, V24, P144, DOI 10.1002/(SICI)1098-2264(199902)24:2<144::AID-GCC7>3.0.CO;2-9; Kloth JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-53; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Macville M, 1999, CANCER RES, V59, P141; Manos MM, 1989, USE POLYMERASE CHAIN, P209; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Matthews CP, 2000, P SOC EXP BIOL MED, V223, P316, DOI 10.1046/j.1525-1373.2000.22345.x; MITRA AB, 1995, J NATL CANCER I, V87, P742, DOI 10.1093/jnci/87.10.742; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Patel D, 2010, J VIROL, V84, P10956, DOI 10.1128/JVI.00259-10; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; Teissier S, 2007, J VIROL, V81, P9368, DOI 10.1128/JVI.00427-07; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; Vazquez Mena O, 2012, PLOS ONE, V7; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Yang YC, 2001, CANCER GENET CYTOGEN, V131, P48, DOI 10.1016/S0165-4608(01)00510-6; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	54	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97842	10.1371/journal.pone.0097842	http://dx.doi.org/10.1371/journal.pone.0097842			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879114	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500025
J	Merali, Z; Gao, MM; Bowes, T; Chen, J; Evans, K; Kassner, A				Merali, Zamir; Gao, Meah MingYang; Bowes, Tim; Chen, Jian; Evans, Kenneth; Kassner, Andrea			Neuroproteome Changes after Ischemia/Reperfusion Injury and Tissue Plasminogen Activator Administration in Rats: A Quantitative iTRAQ Proteomics Study	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; CEREBRAL-CORTEX; GLUTAMATE RELEASE; ISCHEMIC-INJURY; KAPPA-B; STROKE; BRAIN; EXPRESSION; STRATEGIES; UPDATE	The thrombolytic, recombinant tissue plasminogen activator (rt-PA) is the only approved therapy for acute ischemic stroke (AIS). When administered after AIS, rt-PA has many adverse pleiotropic actions, which are currently poorly understood. The identification of proteins showing differential expression after rt-PA administration may provide insight into these pleiotropic actions. In this study we used a 2D-LC MS/MS iTRAQ proteomic analysis, western blotting, and pathway analysis to analyze changes in protein expression 24-hours after rt-PA administration in the cortical brain tissue of 36 rats that underwent a sham or transient middle cerebral artery occlusion surgery. After rt-PA administration we reported alterations in the expressions of 18 proteins, many of which were involved in excitatory neurotransmitter function or cytoskeletal structure. The expression changes of GAD2 and EAAT1 were validated with western blot. The interactions between the identified proteins were analyzed with the IPA pathway analysis tool and three proteins: DPYSL2, RTN4, and the NF-kappa B complex, were found to have characteristics of being key proteins in the network. The differential protein expressions we observed may reflect pleiotropic actions of rt-PA after experimental stroke, and shine light on the mechanisms of rt-PA's adverse effects. This may have important implications in clinical settings where thrombolytic therapy is used to treat AIS.	[Gao, Meah MingYang; Bowes, Tim; Kassner, Andrea] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Merali, Zamir; Kassner, Andrea] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Chen, Jian; Evans, Kenneth] Ontario Canc Biomarker Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kassner, A (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON, Canada.	Andrea.kassner@utoronto.ca			Canada Research Chair Program; Canadian Institutes of Health Research [94383, 111113]	Canada Research Chair Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canada Research Chair Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and the Canadian Institutes of Health Research (94383, 111113) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambauer KZ, 2006, ARCH NEUROL-CHICAGO, V63, P661, DOI 10.1001/archneur.63.5.661; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Beschorner R, 2007, HISTOPATHOLOGY, V50, P897, DOI 10.1111/j.1365-2559.2007.02703.x; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Brown DL, 2005, ANN EMERG MED, V46, P56, DOI 10.1016/j.annemergmed.2004.12.025; Carrol JE, 2000, NEUROREPORT, V11, pR1; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; Datta A, 2010, J PROTEOME RES, V9, P472, DOI 10.1021/pr900829h; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Muller GDES, 2013, J MOL NEUROSCI, V50, P154, DOI 10.1007/s12031-012-9888-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Douen AG, 2000, J NEUROCHEM, V75, P812, DOI 10.1046/j.1471-4159.2000.0750812.x; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Focking M, 2006, ACTA NEUROBIOL EXP, V66, P273; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Inagaki N, 2000, J BIOL CHEM, V275, P27165; Indraswari F, 2009, NEUROCHEM INT, V55, P235, DOI 10.1016/j.neuint.2009.03.005; Iwakuma M, 2003, NEUROSCI RES, V45, P285, DOI 10.1016/S0168-0102(02)00233-X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jeyaseelan K, 2008, EXPERT OPIN PHARMACO, V9, P887, DOI 10.1517/14656566.9.6.887; Jia ZY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/617539; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Kern F, 2013, BIOCHEM J, V455, P217, DOI 10.1042/BJ20130579; Kiran M, 2013, J PROTEOME RES, V12, P5436, DOI 10.1021/pr4002788; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lee TYJ, 2003, MICROSC RES TECHNIQ, V60, P115, DOI 10.1002/jemt.10250; Lin L, 2012, J AM SOC NEPHROL, V23, P1329, DOI 10.1681/ASN.2011111123; Liu T., 2009, METHODS MOL BIOL, V566, P201, DOI 10.1007/978-1-59745-562-6_14; Matthews CC, 2007, J NEUROSCI RES, V85, P855, DOI 10.1002/jnr.21187; McDowell GS, 2013, J PROTEOME RES, V12, P3809, DOI 10.1021/pr400032m; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitka M, 2003, JAMA-J AM MED ASSOC, V289, P1363, DOI 10.1001/jama.289.11.1363; NAG S, 1995, ACTA NEUROPATHOL, V90, P454; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Sung JH, 2009, J PINEAL RES, V46, P300, DOI 10.1111/j.1600-079X.2008.00661.x; Ueno Y, 2012, STROKE, V43, P2221, DOI 10.1161/STROKEAHA.111.646224; Uluc K, 2011, FOCUS CEREBRAL ISCHE, pe1978; White CN, 2004, CLIN BIOCHEM, V37, P636, DOI 10.1016/j.clinbiochem.2004.05.004; Winiewski JR, 2009, NATURE METHODS, V6; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhou Y, 2008, J PROTEOME RES, V7, P2507, DOI 10.1021/pr800108k	50	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98706	10.1371/journal.pone.0098706	http://dx.doi.org/10.1371/journal.pone.0098706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879061	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500082
J	Silva, ED; de Abreu, CB; Orlando, TC; Wisniewski, C; dos Santos-Wisniewski, MJ				Silva, Erika dos Santos; de Abreu, Cinthia Bruno; Orlando, Tereza Cristina; Wisniewski, Celio; dos Santos-Wisniewski, Maria Jose			Alona iheringula Sinev & Kotov, 2004 (Crustacea, Anomopoda, Chydoridae, Aloninae): Life Cycle and DNA Barcode with Implications for the Taxonomy of the Aloninae Subfamily	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; CLADOCERA; BRANCHIOPODA; HISTORY; TEMPERATURE; DIVERSITY; PREDATION; RESERVOIR; BIOMASS; GROWTH	Knowledge of reproductive rates and life cycle of the Cladocera species is essential for population dynamic studies, secondary production and food webs, as well as the management and preservation of aquatic ecosystems. The present study aimed to understand the life cycle and growth of Alona iheringula Kotov & Sinev, 2004 (Crustacea, Anomopoda, Chydoridae), a Neotropical species, as well as its DNA barcoding, providing new information on the Aloninae taxonomy. The specimens were collected in the dammed portion of the Cabo Verde River (21 degrees 26'05" S and 46 degrees 10'57" W), in the Furnas Reservoir, Minas Gerais State, Brazil. Forty neonates were observed individually two or three times a day under controlled temperature (25 +/- 1 degrees C), photoperiod (12 h light/12 h dark) and feeding (Pseudokirchneriella subcapitata at a concentration of 10(5) cells.mL(-1) and a mixed suspension of yeast and fish feed in equal proportion). Individual body growth was measured daily under optical microscope using a micrometric grid and 40x magnification. The species had a mean size of 413(+/- 29) mu m, a maximum size of 510 mu m and reached maturity at 3.24(+/- 0.69) days of age. Mean fecundity was 2 eggs per female per brood and the mean number of eggs produced per female during the entire life cycle was 47.6(+/- 6.3) eggs per female. The embryonic development time was 1.79(+/- 0.23) days and the maximum longevity was 54 days. The species had eight instars throughout its life cycle and four instars between neonate and primipara stage. The present study using molecular data (a 461 bp smaller COI fragment) demonstrated a deep divergence in the Aloninae subfamily.	[Silva, Erika dos Santos; de Abreu, Cinthia Bruno; Orlando, Tereza Cristina; dos Santos-Wisniewski, Maria Jose] Univ Fed Alfenas UNIFAL MG, Inst Ciencias Nat, Alfenas, MG, Brazil; [Wisniewski, Celio] Univ Fed Alfenas UNIFAL MG, Inst Ciencias Exatas, Alfenas, MG, Brazil	Universidade Federal de Alfenas; Universidade Federal de Alfenas	dos Santos-Wisniewski, MJ (corresponding author), Univ Fed Alfenas UNIFAL MG, Inst Ciencias Nat, Gabriel Monteiro da Silva 700, Alfenas, MG, Brazil.	zeze.wisniewski@unifal-mg.edu.br	Abreu, Cínthia/ABD-8213-2021; Orlando, Tereza/GPX-8165-2022	Bruno de Abreu, Cinthia/0000-0002-2782-8268	Eletrobras Furnas (Programa de PD Aneel); FAPEMIG (Biota Minas) [APQ-03549-09]; FAPEMIG (Universal APQ) [01518-09]; PIBICT/FAPEMIG Program 029	Eletrobras Furnas (Programa de PD Aneel); FAPEMIG (Biota Minas)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG (Universal APQ)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PIBICT/FAPEMIG Program 029	Funding for this research was provided by Eletrobras Furnas (Programa de P&D Aneel) and FAPEMIG (Biota Minas APQ-03549-09 and Universal APQ 01518-09) grants and an undergraduate fellowship to C. B. A. (PIBICT/FAPEMIG Program 029/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNT, 2009, ASS BRAS NORM TECN N; ALLAN JD, 1976, AM NAT, V110, P165, DOI 10.1086/283056; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Bekker EI, 2012, ZOOTAXA, P1; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; BOTTRELL HH, 1975, OECOLOGIA, V19, P129, DOI 10.1007/BF00369097; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Bucklin A., 2000, P533, DOI 10.1016/B978-012327645-2/50012-8; CETESB, 1992, AG MET AV TOX POL OR; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; De Lima IHAG, 1997, ACTA LIMNOL BRAS, V9, P149; dos Santos-Wisniewski MJ, 2011, BIOTA NEOTROP, V11, P287, DOI 10.1590/S1676-06032011000300024; Duggan IC, 2012, AQUAT INVASIONS, V7, P585, DOI 10.3391/ai.2012.7.4.015; Durigan JG, 1994, REV UNIMAR, V16, P229; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; Elmoor-Loureiro L. M. A., 1997, MANUAL IDENTIFICACAO; Elmoor-Loureiro LMA, 2004, ZOOTAXA, P1; Elmoor-Loureiro LMA, 2007, REV BRAS ZOOL, V24, P344, DOI 10.1590/S0101-81752007000200012; Eskinazi-Sant'Anna E.M., 2005, Acta Limnologica Brasiliensia, V17, P199; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Fryer G, 1993, FRESHWATER CRUSTACEA; Golterman HL, 1978, METHODS PHYS CHEM AN; Hardy E. R., 1994, Acta Amazonica, V24, P119; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hwang JS, 2009, ZOOL STUD, V48, P738; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jeffery NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018364; Kotov AA, 1997, HYDROBIOLOGIA, V354, P83, DOI 10.1023/A:1003063407127; Kotov AA, 2006, ENTOMOL REV, V86, P210, DOI [10.1134/S0013873806110157, DOI 10.1134/S0013873806110157]; Kotov Alexey A., 2004, Arthropoda Selecta, V13, P95; Lowe-McConnell RH, 1980, IBP HDB, V22; LYNCH M, 1980, Q REV BIOL, V55, P23, DOI 10.1086/411614; Martinez-Jeronimo F, 2011, CRUSTACEANA, V84, P187, DOI 10.1163/001121610X551827; Matsumura-Tundisi T, 2005, HYDROBIOLOGIA, V542, P367, DOI 10.1007/s10750-004-9461-0; Matsumura-Tundisi T, 2006, ACTA LIMNOL BRAS, V18, P305; Melao MG, 2006, ACTA LIMNOL BRAS, V18, P433; MUNRO IG, 1975, OECOLOGIA, V20, P157, DOI 10.1007/BF00369028; MURUGAN N, 1982, HYDROBIOLOGIA, V89, P9, DOI 10.1007/BF00017533; Nogueira MG, 2005, ECOLOGIA RESERVATORI, V2005; Pompeo M. L. M., 1999, PERSPECTIVAS LIMNOLO, P45; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rietzler AC, 1998, ANAIS DO VI SEMINARI, V8, P1159; ROBERTSON AL, 1988, FRESHWATER BIOL, V20, P75, DOI 10.1111/j.1365-2427.1988.tb01719.x; Rocha O, 2000, INVERTEBRADOS AGUA D, V4, P109; Rocha Odete, 2011, Biota Neotropica, V11, P1; Sacherova V, 2003, BIOL J LINN SOC, V79, P629, DOI 10.1046/j.1095-8312.2003.00216.x; Santos RM, 2010, BRAZ J BIOL, V70, P879, DOI 10.1590/S1519-69842010000400019; Shan R. K.c., 1969, Hydrobiologia, V34, P513; Sharma S, 1998, INDIAN J ANIM SCI, V68, P101; Sinev Artem Y., 1999, Arthropoda Selecta, V8, P131; Sinev AY, 2010, ZOOTAXA, P1; Sinev AY, 2001, HYDROBIOLOGIA, V464, P113, DOI 10.1023/A:1013935100483; Smirnov NN, 1971, CRUSTACEA, V1, P1; Smirnov NN, 1974, PROGRAM SCI TRANSLAT, V1, P1; Sousa Francisco Diogo Rocha, 2008, Biota Neotrop., V8, P159, DOI 10.1590/S1676-06032008000100019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomaz SM, 2003, ECOLOGIA MANEJO MACR, P19; Toledo AP, 1983, C BRAS ENG SAN CAMB, P1; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Van Damme K, 2010, ZOOTAXA, P1; Venkataraman K, 1990, J ANDAMAN SCI ASS, V6, P127; Viti T, 2013, IHERINGIA SER ZOOL, V103, P110, DOI 10.1590/S0073-47212013000200005; Young SS, 2012, ZOOL STUD, V51, P222	65	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97050	10.1371/journal.pone.0097050	http://dx.doi.org/10.1371/journal.pone.0097050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878503	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500011
J	Will, M; Bader, GD; Conard, NJ				Will, Manuel; Bader, Gregor D.; Conard, Nicholas J.			Characterizing the Late Pleistocene MSA Lithic Technology of Sibudu, KwaZulu-Natal, South Africa	PLOS ONE			English	Article							MIDDLE-STONE-AGE; DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; POST-HOWIESONS POORT; WESTERN-CAPE; BLOMBOS CAVE; STILL BAY; KLASIES RIVER; ARCHAEOLOGICAL APPLICATION; BEDDING CONSTRUCTION	Studies of the African Middle Stone Age (MSA) have become central for defining the cultural adaptations that accompanied the evolution of modern humans. While much of recent research in South Africa has focused on the Still Bay and Howiesons Poort (HP), periods following these technocomplexes were often neglected. Here we examine lithic assemblages from Sibudu that post-date the HP to further the understanding of MSA cultural variability during the Late Pleistocene. Sibudu preserves an exceptionally thick, rich, and high-resolution archaeological sequence that dates to similar to 58 ka, which has recently been proposed as type assemblage for the "Sibudan''. This study presents a detailed analysis of the six uppermost lithic assemblages from these deposits (BM-BSP) that we excavated from 2011-2013. We define the key elements of the lithic technology and compare our findings to other assemblages post-dating the HP. The six lithic assemblages provide a distinct and robust cultural signal, closely resembling each other in various technological, techno-functional, techno-economic, and typological characteristics. These results refute assertions that modern humans living after the HP possessed an unstructured and unsophisticated MSA lithic technology. While we observed several parallels with other contemporaneous MSA sites, particularly in the eastern part of southern Africa, the lithic assemblages at Sibudu demonstrate a distinct and so far unique combination of techno-typological traits. Our findings support the use of the Sibudan to help structuring this part of the southern African MSA and emphasize the need for further research to identify the spatial and temporal extent of this proposed cultural unit.	[Will, Manuel; Bader, Gregor D.; Conard, Nicholas J.] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Conard, Nicholas J.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Will, M (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.	manuel.will@uni-tuebingen.de		Will, Manuel/0000-0001-8116-2543; Conard, Nicholas/0000-0002-4633-0385; Bader, Gregor/0000-0003-0621-9209	Heidelberger Akademie der Wissenschaft; Tubingen Senckenberg Center for Human Evolution and Paleoecology; Deutsche Forschungsgemeinschaft [CO 226/27-1]; Doctoral Dissertation Grant of the Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft; Tuebingen University	Heidelberger Akademie der Wissenschaft; Tubingen Senckenberg Center for Human Evolution and Paleoecology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Doctoral Dissertation Grant of the Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The excavation and research at Sibudu was funded by the Heidelberger Akademie der Wissenschaft, the Tubingen Senckenberg Center for Human Evolution and Paleoecology, and the Deutsche Forschungsgemeinschaft grant (CO 226/27-1). MW's work on this study was supported by a Doctoral Dissertation Grant of the Studienstiftung des deutschen Volkes. We acknowledge support by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperson-Afil N., 2007, PALEOANTHROPOLOGY, V2007, P1; Ambrose S.H., 2002, ARCHEOLOGICAL PAPERS, V12, P9; Andrefsky W., 1998, LITHICS MACROSCOPIC; [Anonymous], J ARCHAEOLOGICAL MET, DOI DOI 10.1007/BF02229424; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Bishop WW, 1966, CURR ANTHROPOL, V7, P253; Bisson MS, 2000, J ARCHAEOL METHOD TH, V7, P1, DOI 10.1023/A:1009578011590; BLEED P, 2011, PALEOANTHROPOLOGY, P297, DOI DOI 10.4207/PA.2011.ART60; Boeda E, 2013, QUATERN INT, V295, P191, DOI 10.1016/j.quaint.2012.07.020; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI [10.3406/bspf.1993.9669, DOI 10.3406/BSPF.1993.9669]; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E., 2001, IND OUTILS BIFACIAUX, P51; Bonilauri S., 2010, THESIS U PARIS OUEST; Braun D. R., 2003, OLDOWAN RATHER MORE, P132; Braun DR, 2005, LITHIC TECHNOL, V30, P107, DOI 10.1080/01977261.2005.11721029; Brew J.O., 1946, PAPERS PEABODY MUSEU, V21, P44; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Cain C.R., 2006, SOUTH AFR HUMANIT, V18, P241; Cain CR, 2004, S AFR J SCI, V100, P195; Clark G.A., 1983, HUNTER GATHERER EC P, P131; Clark J.D., 1966, S AFRICAN ARCHAEOLOG, V21, P114, DOI [https://doi.org/10.2307/3888427, DOI 10.2307/3888427]; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; Cochrane G.W.G., 2008, S AFRICAN ARCHAEOLOG, V10, P157; Conard NJ, 2012, S AFR ARCHAEOL BULL, V67, P180; Conard NJ, 2010, P NATL ACAD SCI USA, V107, P7621, DOI 10.1073/pnas.1001458107; Conard NJ, 1997, J ANTHROPOL RES, V53, P147, DOI 10.1086/jar.53.2.3631275; Conard NJ, 2004, S AFR ARCHAEOL BULL, V59, P12, DOI 10.2307/3889318; Conard NJ, 2008, S AFR ARCHAEOL SOC G, V10, P175; Conard NJ, 2005, TOOLS SYMBOLS EARLY, P294; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; Deacon H.J., 1988, S AFR ARCHAEOL B, V43, P5, DOI [DOI 10.2307/3887608, 10.2307/3887608]; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Dibble H. L, 1992, MIDDLE PALEOLITHIC A, P1; DIBBLE HL, 1987, AM ANTIQUITY, V52, P109, DOI 10.2307/281062; Dibble HL, 2005, AM ANTIQUITY, V70, P545, DOI 10.2307/40035313; Douglass MJ, 2008, AM ANTIQUITY, V73, P513, DOI 10.2307/25470502; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Goodwin A., 1929, STONE AGE CULTURES S, V27; Harper PTN, 1997, S AFR J SCI, V93, P470; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS, 2005, TOOLS SYMBOLS EARLY, P451; Hodgskiss T, 2013, J AFR ARCHAEOL, V11, P75, DOI 10.3213/2191-5784-10232; Holdaway S.J., 2004, RECORD STONE STUDY A; HULL KL, 1987, AM ANTIQUITY, V52, P772, DOI 10.2307/281385; Inizan ML, 1995, TECHNOLOGIE PIERRE T, V4; Jacobs Z, 2008, S AFRICAN ARCHAEOLOG, V10, P9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Zenobia, 2009, Commun Integr Biol, V2, P191; Kaplan J, 1990, SOUTH AFR HUMANIT, P94; Kaplan JM., 1989, GOODWIN SERIES, V6, P7, DOI DOI 10.2307/3858128; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Krukowski S., 1939, ENCYKLOPEDIA POLSKA, V4, P1; Langejans GHJ, 2012, J ARCHAEOL SCI, V39, P1694, DOI 10.1016/j.jas.2011.12.036; Lepot M., 1993, THESIS U PARIS 10; Lombard M, 2004, S AFR ARCHAEOL BULL, V59, P37, DOI 10.2307/3889241; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P57; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2012, S AFR ARCHAEOL BULL, V67, P123; Lombard M, 2012, QUATERN INT, V270, P140, DOI 10.1016/j.quaint.2012.02.033; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Lombard M, 2010, S AFR ARCHAEOL BULL, V65, P224; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; Lombard M, 2009, S AFR ARCHAEOL BULL, V64, P4; Mackay A, 2014, J HUM EVOL IN PRESS; Mackay A., 2009, THESIS AUSTR NATL U; Mackay A, 2008, J ARCHAEOL SCI, V35, P614, DOI 10.1016/j.jas.2007.05.013; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mackay A, 2010, S AFR ARCHAEOL BULL, V65, P132; Mackay A, 2011, J ARCHAEOL SCI, V38, P1430, DOI 10.1016/j.jas.2011.02.006; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; McCall GS, 2011, S AFR ARCHAEOL BULL, V66, P89; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P. A., 2007, RETHINKING HUMAN REV, P1; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Miller CE, 2013, J ARCHAEOL SCI, V40, P3432, DOI 10.1016/j.jas.2013.02.014; Miller CE, 2012, J ARCHAEOL SCI, V39, P3039, DOI 10.1016/j.jas.2012.02.007; Minichillo T, 2006, J HUM EVOL, V50, P359, DOI 10.1016/j.jhevol.2005.08.013; Mitchell P., 2008, S AFRICAN ARCHAEOLOG, V10, P52; Mohapi M, 2013, SOUTH AFR HUMANIT, V25, P25; Mohapi M, 2012, S AFR ARCHAEOL BULL, V67, P5; Odell H.G., 2004, LITHIC ANAL; Orton J, 2008, J ARCHAEOL SCI, V35, P1090, DOI 10.1016/j.jas.2007.08.002; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Peresani M., PALEO, V10, P123, DOI [10.3406/pal.1998.1133, DOI 10.3406/PAL.1998.1133]; PORRAZ G, 2005, THESIS U PROVENCE; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Rito T, 2013, PLOS ONE; Roth BJ, 1998, AM ANTIQUITY, V63, P47, DOI 10.2307/2694775; Roussel M, 2009, BULL SOC PREHIST FR, V106, P219, DOI 10.3406/bspf.2009.13846; Schiegl S., 2006, SOUTH AFR HUMANIT, V18, P149; Schiffer M.B., 1987, FORMATION PROCESSES; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Singer R., 1982, MIDDLE STONE AGE KLA; Soressi M., 2011, PALEOANTHROPOLOGY, V334, P334, DOI DOI 10.4207/PA.2011.ART63; Soriano S., 2001, IND OUTILS BIFACIAUX, V98, P77; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; SULLIVAN AP, 1985, AM ANTIQUITY, V50, P755, DOI 10.2307/280165; Texier PJ, 2013, J ARCHAEOL SCI, V40, P3412, DOI 10.1016/j.jas.2013.02.021; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Torrence R., 1989, TIME ENERGY STONE TO; Tostevin GB., 2003, STRANSKA SKALA ORIGI, P77; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Tribolo C., 2003, THESIS U BORDEAUX 1; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; VILLA P, 1991, J ANTHROPOL RES, V47, P193, DOI 10.1086/jar.47.2.3630325; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Volman T., 1981, THESIS U CHICAGO; Volman T.P., 1984, P169; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2004, S AFR J SCI, V100, P145; Wadley L., 2006, SN HUMANITIES, V18, P315; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L, 2006, S AFR HUMANIT, V18; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2013, S AFR ARCHAEOL BULL, V68, P41; Wadley L, 2011, SOUTH AFR HUMANIT, V23, P87; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Will M, 2013, J HUM EVOL, V64, P518, DOI 10.1016/j.jhevol.2013.02.012; Wurz S, 2002, J ARCHAEOL SCI, V29, P1001, DOI 10.1006/jasc.2001.0799; Wurz S., 2000, THESIS U STELLENBOSC; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	153	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98359	10.1371/journal.pone.0098359	http://dx.doi.org/10.1371/journal.pone.0098359			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878544	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500052
J	Adam, T; Evans, DB; Ying, B; Murray, CJL				Adam, Taghreed; Evans, David B.; Ying, Bian; Murray, Christopher J. L.			Variability in Costs across Hospital Wards. A Study of Chinese Hospitals	PLOS ONE			English	Article								Introduction: Analysts estimating the costs or cost-effectiveness of health interventions requiring hospitalization often cut corners because they lack data and the costs of undertaking full step-down costing studies are high. They sometimes use the costs taken from a single hospital, sometimes use simple rules of thumb for allocating total hospital costs between general inpatient care and the outpatient department, and sometimes use the average cost of an inpatient bed-day instead of a ward-specific cost. Purpose: In this paper we explore for the first time the extent and the causes of variation in ward-specific costs across hospitals, using data from China. We then use the resulting model to show how ward-specific costs for hospitals outside the data set could be estimated using information on the determinants identified in the paper. Methodology: Ward-specific costs estimated using step-down costing methods from 41 hospitals in 12 provinces of China were used. We used seemingly unrelated regressions to identify the determinants of variability in the ratio of the costs of specific wards to that of the outpatient department, and explain how this can be used to generate ward-specific unit costs. Findings: Ward-specific unit costs varied considerably across hospitals, ranging from 1 to 24 times the unit cost in the outpatient department - average unit costs are not a good proxy for costs at specialty wards in general. The most important sources of variability were the number of staff and the level of capacity utilization. Practice Implications: More careful hospital costing studies are clearly needed. In the meantime, we have shown that in China it is possible to estimate ward-specific unit costs taking into account key determinants of variability in costs across wards. This might well be a better alternative than using simple rules of thumb or using estimates from a single study.	[Adam, Taghreed] WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland; [Evans, David B.] WHO, CH-1211 Geneva, Switzerland; [Ying, Bian] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	World Health Organization; World Health Organization; University of Macau; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Adam, T (corresponding author), WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva, Switzerland.	adamt@who.int	bian, ying/ABI-8040-2020	bian, ying/0000-0002-1716-2925	WHO	WHO(World Health Organization)	The data used in the model was collected with financial support from WHO. WHO as an agency had no role in the design, data collection, data analysis, decision to publish or preparation of the manuscript. Taghreed Adam and David B. Evans as technical staff of WHO were part of the study team and contributed as technical experts in the area.	Adam T, 2006, SOC SCI MED, V63, P1700, DOI 10.1016/j.socscimed.2006.04.023; Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Barnum H., 1993, PUBLIC HOSP DEV COUN; BARTEN AP, 1969, EUR ECON REV, V1, P7, DOI 10.1016/0014-2921(69)90017-8; Bewley R., 1986, ALLOCATION MODELS SP; Billheimer D, 1998, STAT ANAL INTERPRETA; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Greene W.H., 2007, ECONOMETRIC ANAL; Gutierrez JP, 2004, LANCET, V364, P63, DOI 10.1016/S0140-6736(04)16590-2; Haupt P., 2000, EC SOC WORLD C 2000; Johns B, 2007, B WORLD HEALTH ORGAN, V85, P256, DOI 10.2471/BLT.06.032037; Katz JN, 1999, AM POLIT SCI REV, V93, P15, DOI 10.2307/2585758; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; LOMBARD CJ, 1991, S AFR MED J, V80, P508; POWELL A, 1969, J AM STAT ASSOC, V64, P913, DOI 10.2307/2283472; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Shanahan M, 1999, MED CARE, V37, pJS101, DOI 10.1097/00005650-199906001-00011; Shepard DS., 2000, ANAL HOSP COSTS MANU; Smith M, 2000, J ECONOMETRICS, V98, P257, DOI 10.1016/S0304-4076(00)00018-X; *STAT CORP, 2003, STAT STAT SOFTW REL; Stenberg K, 2007, B WORLD HEALTH ORGAN, V85, P305, DOI 10.2471/BLT.06.032052; Stevenson M., 2006, WOMENS HLTH, V3, P149, DOI [10.1383/wohm.2006.3.4.149, DOI 10.1383/wohm.2006.3.4.149]; World Bank, 2002, WORLD DEV IND 2002, DOI [10.1596/0-8213-5088-9, DOI 10.1596/0-8213-5088-9]	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97874	10.1371/journal.pone.0097874	http://dx.doi.org/10.1371/journal.pone.0097874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874566	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800013
J	Aguilar, X; Blomberg, J; Brannstrom, K; Olofsson, A; Schleucher, J; Bjorklund, S				Aguilar, Ximena; Blomberg, Jeanette; Brannstrom, Kristoffer; Olofsson, Anders; Schleucher, Jurgen; Bjorklund, Stefan			Interaction Studies of the Human and Arabidopsis thaliana Med25-ACID Proteins with the Herpes Simplex Virus VP16-and Plant-Specific Dreb2a Transcription Factors	PLOS ONE			English	Article							RNA-POLYMERASE-II; RESPONSIVE GENE-EXPRESSION; 9-AMINO-ACID TRANSACTIVATION DOMAIN; HUMAN MEDIATOR COMPLEX; ACTIVATION DOMAIN; LIGAND-BINDING; FLOWERING TIME; SUBUNIT MED25; NMR STRUCTURE; P53	Mediator is an evolutionary conserved multi-protein complex present in all eukaryotes. It functions as a transcriptional coregulator by conveying signals from activators and repressors to the RNA polymerase II transcription machinery. The Arabidopsis thaliana Med25 (aMed25) ACtivation Interaction Domain (ACID) interacts with the Dreb2a activator which is involved in plant stress response pathways, while Human Med25-ACID (hMed25) interacts with the herpes simplex virus VP16 activator. Despite low sequence similarity, hMed25-ACID also interacts with the plant-specific Dreb2a transcriptional activator protein. We have used GST pull-down-, surface plasmon resonance-, isothermal titration calorimetry and NMR chemical shift experiments to characterize interactions between Dreb2a and VP16, with the hMed25 and aMed25-ACIDs. We found that VP16 interacts with aMed25-ACID with similar affinity as with hMed25-ACID and that the binding surface on aMed25-ACID overlaps with the binding site for Dreb2a. We also show that the Dreb2a interaction region in hMed25-ACID overlaps with the earlier reported VP16 binding site. In addition, we show that hMed25-ACID/Dreb2a and aMed25-ACID/Dreb2a display similar binding affinities but different binding energetics. Our results therefore indicate that interaction between transcriptional regulators and their target proteins in Mediator are less dependent on the primary sequences in the interaction domains but that these domains fold into similar structures upon interaction.	[Aguilar, Ximena] Umea Univ, Dept Chem, Umea, Sweden; [Blomberg, Jeanette; Brannstrom, Kristoffer; Olofsson, Anders; Schleucher, Jurgen; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden	Umea University; Umea University	Bjorklund, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	stefan.bjorklund@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020		Swedish Research Council; Swedish Cancer Society; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Kempe Foundation	S.B., J.S. and A.O. were supported by grants from the the Swedish Research Council, and S. B. was supported by grants from Swedish Cancer Society and the Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Blomberg J, 2012, NUCLEIC ACIDS RES, V40, P5938, DOI 10.1093/nar/gks265; Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Eletsky Alexander, 2011, Journal of Structural and Functional Genomics, V12, P159, DOI 10.1007/s10969-011-9115-1; Elfving N, 2011, P NATL ACAD SCI USA, V108, P8245, DOI 10.1073/pnas.1002981108; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Han EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044007; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ikeda K, 2002, GENES CELLS, V7, P49, DOI 10.1046/j.1356-9597.2001.00492.x; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KLEMM RD, 1995, P NATL ACAD SCI USA, V92, P5788, DOI 10.1073/pnas.92.13.5788; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Langlois C, 2008, J AM CHEM SOC, V130, P10596, DOI 10.1021/ja800975h; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mills JL, 2009, BIOCHEMISTRY-US, V48, P7411, DOI 10.1021/bi900535j; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sela D, 2013, J BIOL CHEM, V288, P26179, DOI 10.1074/jbc.M113.496968; Shen F, 1996, J BIOL CHEM, V271, P4827; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Verger A, 2013, NUCLEIC ACIDS RES, V41, P4847, DOI 10.1093/nar/gkt199; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Yamamoto S, 2009, J VIROL, V83, P6300, DOI 10.1128/JVI.00054-09; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yang M, 2008, J VIROL, V82, P12154, DOI 10.1128/JVI.01693-08; ZHU H, 1994, J BIOL CHEM, V269, P3489; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	69	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98575	10.1371/journal.pone.0098575	http://dx.doi.org/10.1371/journal.pone.0098575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874105	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800049
J	Beck-Cormier, S; Escande, M; Souilhol, C; Vandormael-Pournin, S; Sourice, S; Pilet, P; Babinet, C; Cohen-Tannoudji, M				Beck-Cormier, Sarah; Escande, Marie; Souilhol, Celine; Vandormael-Pournin, Sandrine; Sourice, Sophie; Pilet, Paul; Babinet, Charles; Cohen-Tannoudji, Michel			Notchless Is Required for Axial Skeleton Formation in Mice	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; SIGNALING PATHWAY; GENE; EXPRESSION; PROTEIN; SEGMENTATION; EPIBLAST; MORPHOGENESIS; MAINTENANCE; APOPTOSIS	Maintenance of cell survival is essential for proper embryonic development. In the mouse, Notchless homolog 1 (Drosophila) (Nle1) is instrumental for survival of cells of the inner cell mass upon implantation. Here, we analyze the function of Nle1 after implantation using the Meox2(tm1(cre)Sor) mouse that expresses the Cre recombinase specifically in the epiblast at E5.5. First, we find that NLE1 function is required in epiblast cells, as Nle1-deficient cells are rapidly eliminated. In this report, we also show that the Meox2(Cre) transgene is active in specific tissues during organogenesis. In particular, we detect high Cre expression in the vertebral column, ribs, limbs and tailbud. We took advantage of this dynamic expression profile to analyze the effects of inducing mosaic deletion of Nle1 in the embryo. We show that Nle1 deletion in this context, results in severe developmental anomalies leading to lethality at birth. Mutant embryos display multiple developmental defects in particular during axial skeletal formation. We also provide evidence that axial defects are due to an increase in apoptotic cell death in the somite at E9.5. These data demonstrate an essential role for Nle1 during organogenesis and in particular during axial development.	[Beck-Cormier, Sarah; Escande, Marie; Souilhol, Celine; Vandormael-Pournin, Sandrine; Babinet, Charles; Cohen-Tannoudji, Michel] Inst Pasteur, Dept Dev Stem Cell Biol, Mouse Funct Genet, Paris, France; [Beck-Cormier, Sarah; Vandormael-Pournin, Sandrine; Babinet, Charles; Cohen-Tannoudji, Michel] Inst Pasteur, Ctr Natl Rech Scientif, URA 2578, Paris, France; [Beck-Cormier, Sarah; Sourice, Sophie] Inst Natl Sante & Rech Med, STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, Nantes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm)	Beck-Cormier, S (corresponding author), Inst Natl Sante & Rech Med, STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, Nantes, France.	m-cohen@pasteur.fr	Paul, Pilet/A-3755-2015; Beck-Cormier, Sarah/P-3091-2014	Beck-Cormier, Sarah/0000-0001-5258-1933; Cohen-Tannoudji, Michel/0000-0002-6405-2657	Centre National de la Recherche Scientifique; Institut Pasteur; Agence Nationale de la Recherche [JC05_41835]; Centre National de la Recherche Scientifique (Bourse de Doctorat pour les Ingenieurs)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (Bourse de Doctorat pour les Ingenieurs)	This work was supported by the Centre National de la Recherche Scientifique, the Institut Pasteur and the Agence Nationale de la Recherche (contract no JC05_41835). CS received grants from the Centre National de la Recherche Scientifique (Bourse de Doctorat pour les Ingenieurs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Clark AL, 2013, NAT REV CARDIOL, V10, P156, DOI 10.1038/nrcardio.2012.191; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cormier S, 2006, MOL CELL BIOL, V26, P3541, DOI 10.1128/MCB.26.9.3541-3549.2006; Davis S, 2004, DEV BIOL, V270, P47, DOI 10.1016/j.ydbio.2004.01.048; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Delgado I, 2008, DEV DYNAM, V237, P649, DOI 10.1002/dvdy.21452; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Douville JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029099; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Le Bouteiller M, 2013, J EXPT MED; Le Bouteiller M, 2013, J EXP MED, V210, P2351, DOI 10.1084/jem.20122019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lossie AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-106; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Shim M, 2010, J BIOL CHEM, V285, P16206, DOI 10.1074/jbc.M109.078576; Skopicki HA, 1997, CIRC RES, V80, P452, DOI 10.1161/01.RES.80.4.452; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Trainor PA, 2013, BIOCHIM BIOPHYS ACTA, V842, P769; Watkins-Chow DE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003094; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zucker RM, 1998, CYTOMETRY, V33, P348, DOI 10.1002/(SICI)1097-0320(19981101)33:3<348::AID-CYTO9>3.0.CO;2-C	45	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98507	10.1371/journal.pone.0098507	http://dx.doi.org/10.1371/journal.pone.0098507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875805	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800045
J	Paljarvi, T; Martikainen, P; Leinonen, T; Pensola, T; Makela, P				Paljarvi, Tapio; Martikainen, Pekka; Leinonen, Taina; Pensola, Tiina; Makela, Pia			Non-Employment Histories of Middle-Aged Men and Women Who Died from Alcohol-Related Causes: A Longitudinal Retrospective Study	PLOS ONE			English	Article							DISORDERS; DRINKING; HEALTH; UNEMPLOYMENT; DISABILITY; EMPLOYMENT; IMPACT; CONSUMPTION; DEPENDENCE; CHILDHOOD	Background: Long-term patterning of non-employment among problem drinkers is poorly understood. We determined the level and timing of non-employment, and the relative contribution of various types of non-employment among middle-aged persons who died of alcohol-related causes. Methods: We conducted a longitudinal retrospective register-based study of Finnish men and women aged 45-64 years who died of alcohol-related causes (n = 15 552) or other causes (n = 39 166) in the period 2000-07, or who survived (n = 204 422) until the end of 2007. We traced back the number of days in employment and non-employment for up to 17 years before death or before the end of the study period for the survivors. Results: The majority (>= 56%) of persons who died of alcohol-related causes were in employment up to ten years before death. Over the 17-year period before death, those who died of alcohol-related causes were in employment on average two years less (mean 6.3 years, 95% CI 6.2-6.4) than those dying of other causes (8.2, 8.1-8.3), and five years less than survivors (11.6, 11.5-11.7), when sex and age were adjusted for. The relative role of various types of non-employment differed markedly across the two mortality groups. Among those who died of alcohol-related causes, unemployment accounted for 54% of the total burden of non-employment, in comparison with 29% among those who died of other causes. In contrast, disability pension accounted for 41% of the total burden of non-employment among those who died of alcohol-related causes, but 65% among those who died of other causes. Conclusions: The results indicate the feasibility of preventing movement out of employment among middle-aged men and women with severe alcohol-related harm, provided that they are identified early on during their working careers and offered effective interventions.	[Paljarvi, Tapio; Makela, Pia] Natl Inst Hlth & Welf, Alcohol & Drugs Unit, Helsinki, Finland; [Martikainen, Pekka; Leinonen, Taina] Univ Helsinki, Populat Res Unit, Helsinki, Finland; [Pensola, Tiina] Finnish Inst Occupat Hlth, Hlth & Work Abil, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Finnish Institute of Occupational Health	Paljarvi, T (corresponding author), Natl Inst Hlth & Welf, Alcohol & Drugs Unit, Helsinki, Finland.	tapio.paljarvi@thl.fi	Mäkelä, Pia/C-5679-2015	Mäkelä, Pia/0000-0002-3343-2139; Paljarvi, Tapio/0000-0002-5324-9825; Martikainen, Pekka/0000-0001-9374-1438	Academy of Finland [259289]; Commission of the European Communities Seventh Framework Programme [278511]	Academy of Finland(Academy of Finland); Commission of the European Communities Seventh Framework Programme	This work was supported by a grant from the Academy of Finland (grant no. 259289) and the Commission of the European Communities Seventh Framework Programme (grant no. 278511). This study is part of the DEMETRIQ project. The study does not necessarily reflect the Commission's views and in no way anticipates the Commission's future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2011, J AFFECT DISORDERS, V134, P365, DOI 10.1016/j.jad.2011.05.028; Ahs A, 2012, INT J BEHAV MED, V19, P29, DOI 10.1007/s12529-010-9129-2; Bauld L, 2013, POLICY STUD-UK, V34, P360, DOI 10.1080/01442872.2013.804303; Cloud W, 2008, SUBST USE MISUSE, V43, P1971, DOI 10.1080/10826080802289762; Durkin A, 2010, ALCOHOL ALCOHOLISM, V45, P374, DOI 10.1093/alcalc/agq025; Edlund MJ, 2009, PSYCHIAT SERV, V60, P1618, DOI 10.1176/ps.2009.60.12.1618; Grant BF, 1997, J STUD ALCOHOL, V58, P365, DOI 10.15288/jsa.1997.58.365; Halme JT, 2008, ALCOHOL CLIN EXP RES, V32, P1615, DOI 10.1111/j.1530-0277.2008.00740.x; Harris E, 2009, MED J AUSTRALIA, V191, P119, DOI 10.5694/j.1326-5377.2009.tb02709.x; Hay G, 2010, 94 HM GOVT DEP WORK; Hedden SL, 2011, ADDICT BEHAV, V36, P1213, DOI 10.1016/j.addbeh.2011.07.026; Henkel Dieter, 2011, Curr Drug Abuse Rev, V4, P4; Hermansson U, 2010, ALCOHOL ALCOHOLISM, V45, P252, DOI 10.1093/alcalc/agq021; Herttua K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001094; Home Office, 2010, DRUG STRAT 2010 RED; Johansson E, 2007, HEALTH ECON, V16, P739, DOI 10.1002/hec.1201; John U, 2013, ALCOHOL CLIN EXP RES, V37, P156, DOI 10.1111/j.1530-0277.2012.01863.x; Kokko K, 2000, DEV PSYCHOL, V36, P463, DOI 10.1037/0012-1649.36.4.463; MacDonald Z, 2004, HEALTH ECON, V13, P139, DOI 10.1002/hec.816; Makela P, 2011, ADDICTION, V106, P1239, DOI 10.1111/j.1360-0443.2010.03356.x; Mansson NO, 1999, ANN EPIDEMIOL, V9, P341, DOI 10.1016/S1047-2797(99)00014-9; Maurage P, 2012, NEUROPSYCHOPHARMACOL, V37, P2067, DOI 10.1038/npp.2012.54; McCormack RP, 2013, LANCET, V382, P995, DOI 10.1016/S0140-6736(12)62206-5; Mullahy J, 1996, J HEALTH ECON, V15, P409, DOI 10.1016/S0167-6296(96)00489-4; Osler M, 2006, AM J EPIDEMIOL, V163, P654, DOI 10.1093/aje/kwj084; Paljarvi T, 2005, ADDICTION, V100, P1851, DOI 10.1111/j.1360-0443.2005.01258.x; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x; Roman PM, 1996, AM J HEALTH PROMOT, V11, P136, DOI 10.4278/0890-1171-11.2.136; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Selvik R., 2004, J EMPLOYEE ASSISTANC, V34, P18; Sidorchuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042083; Skogen JC, 2012, ADDICTION, V107, P98, DOI 10.1111/j.1360-0443.2011.03551.x; Thoma P, 2013, NEUROSCI BIOBEHAV R, V37, P448, DOI 10.1016/j.neubiorev.2013.01.024; United Nations, 2013, WORLD POP AG 2013; Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	37	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98620	10.1371/journal.pone.0098620	http://dx.doi.org/10.1371/journal.pone.0098620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874518	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000336790800052
J	Seubert, J; Gregory, KM; Chamberland, J; Dessirier, JM; Lundstrom, JN				Seubert, Janina; Gregory, Kristen M.; Chamberland, Jessica; Dessirier, Jean-Marc; Lundstroem, Johan N.			Odor Valence Linearly Modulates Attractiveness, but Not Age Assessment, of Invariant Facial Features in a Memory-Based Rating Task	PLOS ONE			English	Article							AMYGDALA ACTIVATION; EMOTION; INTEGRATION; FACES; RECOGNITION; EXPRESSIONS; PERCEPTION; SYSTEMS	Scented cosmetic products are used across cultures as a way to favorably influence one's appearance. While cross-modal effects of odor valence on perceived attractiveness of facial features have been demonstrated experimentally, it is unknown whether they represent a phenomenon specific to affective processing. In this experiment, we presented odors in the context of a face battery with systematic feature manipulations during a speeded response task. Modulatory effects of linear increases of odor valence were investigated by juxtaposing subsequent memory-based ratings tasks - one predominantly affective (attractiveness) and a second, cognitive (age). The linear modulation pattern observed for attractiveness was consistent with additive effects of face and odor appraisal. Effects of odor valence on age perception were not linearly modulated and may be the result of cognitive interference. Affective and cognitive processing of faces thus appear to differ in their susceptibility to modulation by odors, likely as a result of privileged access of olfactory stimuli to affective brain networks. These results are critically discussed with respect to potential biases introduced by the preceding speeded response task.	[Seubert, Janina; Gregory, Kristen M.; Lundstroem, Johan N.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Chamberland, Jessica; Dessirier, Jean-Marc] Unilever R&D, Sensat Percept & Behav, Trumbull, CT USA; [Seubert, Janina; Lundstroem, Johan N.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundstroem, Johan N.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Unilever; Karolinska Institutet; University of Pennsylvania	Seubert, J (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	jseubert@monell.org	Lundström, Johan N/E-9482-2014; Seubert, Janina/G-8775-2014	Lundström, Johan N/0000-0002-3529-8981; Seubert, Janina/0000-0001-9630-9261	Unilever Corporation; Knut and Alice Wallenberg Foundation [KAW 2012.0141]; Swedish Research Council [VRHS2009-2337]; German Research Foundation (DFG) [SE 2147-1]	Unilever Corporation(Unilever); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded in part by an investigator-initiated grant from the Unilever Corporation. JNL is funded by the Knut and Alice Wallenberg Foundation (KAW 2012.0141) and a grant from the Swedish Research Council (VRHS2009-2337). JS is funded by a research fellowship by the German Research Foundation (DFG, SE 2147-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Banks SJ, 2012, NEUROSCI LETT, V514, P71, DOI 10.1016/j.neulet.2012.02.059; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; BAUML KH, 1994, PERCEPT PSYCHOPHYS, V56, P163, DOI 10.3758/BF03213895; Boesveldt S, 2010, BIOL PSYCHOL, V84, P313, DOI 10.1016/j.biopsycho.2010.03.006; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bzdok D, 2012, CEREB CORTEX, V22, P951, DOI 10.1093/cercor/bhr166; Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; Classen C., 1994, AROMA CULTURAL HIST; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Forscher EC, 2012, J NEUROSCI, V32, P2159, DOI 10.1523/JNEUROSCI.5094-11.2012; Habel U, 2007, NEUROPSYCHOLOGIA, V45, P2369, DOI 10.1016/j.neuropsychologia.2007.01.023; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; KIRKSMITH MD, 1990, CHEM SIGNAL, V5, P48; Kristjansson A, 2013, J EXP PSYCHOL HUMAN, V39, P298, DOI 10.1037/a0028683; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Lundstrom JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00597; Lundstrom JN, 2010, INT J PSYCHOPHYSIOL, V78, P179, DOI 10.1016/j.ijpsycho.2010.07.007; MCGRAW KO, 1989, J GENET PSYCHOL, V150, P251, DOI 10.1080/00221325.1989.9914595; Miller SS, 2013, CHEM SENSES, V38, P167, DOI 10.1093/chemse/bjs086; Mitro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038110; Olofsson JK, 2012, PSYCHOL SCI, V23, P1224, DOI 10.1177/0956797612441951; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pollatos O, 2007, CHEM SENSES, V32, P583, DOI 10.1093/chemse/bjm027; Quinn KA, 2005, J PERS SOC PSYCHOL, V88, P467, DOI 10.1037/0022-3514.88.3.467; Rach S, 2011, PSYCHOL RES-PSYCH FO, V75, P77, DOI 10.1007/s00426-010-0289-0; Rolls ET, 2004, ANAT REC PART A, V281A, P1212, DOI 10.1002/ar.a.20126; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Small DM, 2012, NEURAL BASES MULTISE; Stein BE., 1993, MERGING SENSES; Townsend J.T., 1978, COGNITIVE THEORY, V3, P200; Townsend J. T., 1983, STOCHASTIC MODELING; van Reekum CM, 1999, COGNITION EMOTION, V13, P831, DOI 10.1080/026999399379104; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Walla P, 2010, SENSORS-BASEL, V10, P8185, DOI 10.3390/s100908185; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	45	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98347	10.1371/journal.pone.0098347	http://dx.doi.org/10.1371/journal.pone.0098347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874703	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800034
J	Smith, CT; Dwan, K; Altman, DG; Clarke, M; Riley, R; Williamson, PR				Smith, Catrin Tudur; Dwan, Kerry; Altman, Douglas G.; Clarke, Mike; Riley, Richard; Williamson, Paula R.			Sharing Individual Participant Data from Clinical Trials: An Opinion Survey Regarding the Establishment of a Central Repository	PLOS ONE			English	Article							PATIENT DATA METAANALYSIS; EPILEPSY; TIME; DRUG; LAMOTRIGINE; TOPIRAMATE; ACCESS; SANAD	Background: Calls have been made for increased access to individual participant data (IPD) from clinical trials, to ensure that complete evidence is available. However, despite the obvious benefits, progress towards this is frustratingly slow. In the meantime, many systematic reviews have already collected IPD from clinical trials. We propose that a central repository for these IPD should be established to ensure that these datasets are safeguarded and made available for use by others, building on the strengths and advantages of the collaborative groups that have been brought together in developing the datasets. Objective: Evaluate the level of support, and identify major issues, for establishing a central repository of IPD. Design: On-line survey with email reminders. Participants: 71 reviewers affiliated with the Cochrane Collaboration's IPD Meta-analysis Methods Group were invited to participate. Results: 30 (42%) invitees responded: 28 (93%) had been involved in an IPD review and 24 (80%) had been involved in a randomised trial. 25 (83%) agreed that a central repository was a good idea and 25 (83%) agreed that they would provide their IPD for central storage. Several benefits of a central repository were noted: safeguarding and standardisation of data, increased efficiency of IPD meta-analyses, knowledge advancement, and facilitating future clinical, and methodological research. The main concerns were gaining permission from trial data owners, uncertainty about the purpose of the repository, potential resource implications, and increased workload for IPD reviewers. Restricted access requiring approval, data security, anonymisation of data, and oversight committees were highlighted as issues under governance of the repository. Conclusion: There is support in this community of IPD reviewers, many of whom are also involved in clinical trials, for storing IPD in a central repository. Results from this survey are informing further work on developing a repository of IPD which is currently underway by our group.	[Smith, Catrin Tudur; Dwan, Kerry; Williamson, Paula R.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Clarke, Mike] Queens Univ, Belfast, Antrim, North Ireland; [Riley, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	University of Liverpool; University of Oxford; Queens University Belfast; University of Birmingham	Smith, CT (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	cat1@liverpool.ac.uk	Williamson, Paula R/B-6425-2016; Dwan, Kerry/AFK-6469-2022; Riley, Richard David/ABE-5877-2020; Dwan, Kerry/AAG-4726-2022	Williamson, Paula R/0000-0001-9802-6636; Dwan, Kerry/0000-0001-6918-1215; Riley, Richard David/0000-0001-8699-0735; Dwan, Kerry/0000-0001-6918-1215; Tudur Smith, Catrin/0000-0003-3051-1445	MRC North West Hub for Trials Methodology Research [G0800792]; Midlands Hub for Trials Methodology Research at the University of Birmingham [G0800808]; All Ireland Hub for Trials Methodology Research at the Queen's University of Belfast [G0901530]; Cancer Research UK [C5529]; MRC [G0800792, MR/K025635/1, G0901530, G0800808] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [G0901530, G0800808, MR/K025635/1, G0800792] Funding Source: researchfish	MRC North West Hub for Trials Methodology Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Midlands Hub for Trials Methodology Research at the University of Birmingham; All Ireland Hub for Trials Methodology Research at the Queen's University of Belfast; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by the MRC North West Hub for Trials Methodology Research (G0800792). RR is supported by funding from the Midlands Hub for Trials Methodology Research (G0800808), at the University of Birmingham. MC is supported by funding from the All Ireland Hub for Trials Methodology Research (G0901530), at the Queen's University of Belfast. DGA is supported by a programme grant from Cancer Research UK (C5529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; Bhattacharjee Y, 2012, SCIENCE, V338; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chodacki J, 2013, IMPROVING DATA ACCES; Donegan S, 2013, STAT MED, V32, P914, DOI 10.1002/sim.5584; Donegan S, 2012, STAT MED, V31, P3840, DOI 10.1002/sim.5470; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; European Medicines Agency, 2013, EMA2408102013; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Kirwan JR, 1997, J RHEUMATOL, V24, P822; Marsella AJ, 2000, COCHRANE LIB, P3; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Medical Research Council, MRC POL RES DAT SHAR; Muller M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003615.pub2; National Institute for Health and Clinical Excellence, 2012, EPILEPSIES DIAGNOSIS; National Institutes of Health, FIN NIH STAT SHAR RE; Nature publishing group, AUTH REF POL AV DAT; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Sandercock PAG, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-101; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Smith CT, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-34; Smith CT, 2007, CLIN TRIALS, V4, P621, DOI 10.1177/1740774507085276; Smith CT, 2005, STAT MED, V24, P1307, DOI 10.1002/sim.2050; Taylor S, 2003, COCHRANE DB SYST REV; The Cochrane Collaboration, 2014, COCHR COLL SUPP FREE; Trials, AB TRIALS ED POL DAT; Tudur Smith C, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001911, DOI 10.1002/14651858.CD001911]; Vickers A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001957.pub4; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Williamson P, 2006, EPILEPSIA, V47, P12; Williamson PR, 2000, J EVAL CLIN PRACT, V6, P205, DOI 10.1046/j.1365-2753.2000.00236.x; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Williamson PR, 2002, STAT MED, V21, P2613, DOI 10.1002/sim.1044; [No title captured]	39	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97886	10.1371/journal.pone.0097886	http://dx.doi.org/10.1371/journal.pone.0097886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874700	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800014
J	Chang, WT; Chen, JS; Hung, YK; Tsai, WC; Juang, JN; Liu, PY				Chang, Wei-Ting; Chen, Jung-San; Hung, Yung-Kung; Tsai, Wei-Chuan; Juang, Jer-Nan; Liu, Ping-Yen			Characterization of Aging-Associated Cardiac Diastolic Dysfunction	PLOS ONE			English	Article							LEFT-VENTRICULAR RELAXATION; INTACT LEFT-VENTRICLE; HEART-FAILURE; ELASTIC-MODULUS; DOPPLER-ECHOCARDIOGRAPHY; MODEL; HEALTH	Aims: Diastolic dysfunction is common in geriatric heart failure. A reliable parameter to predict myocardium stiffness and relaxation under similar end-diastolic pressure is being developed. We propose a material and mathematical model for calculating myocardium stiffness based on the concept of linear correlation between e/e' and wedge pressure. Methods and Results: We enrolled 919 patients (male: 52.6% [484/919]). Compared with the younger population of controls (mean age: 43.9 +/- 11.7 years; n= 211; male: 62.1% [131/211]), the elderly (mean age: 76.3 +/- 6.2; n= 708; male: 52.6% [484/708]) had a greater prevalence of hypertension, diabetes mellitus, and coronary artery disease (all p <0.05). We collected their M-mode and 2-D echocardiographic volumetric parameters, intraventricular filling pressure, and speckle tracking images to establish a mathematical model. The feasibility of this model was validated. The average early diastolic velocity of the mitral annulus assessed using tissue Doppler imaging was significantly attenuated in the elderly (e': 0.09 +/- 0.02 vs. 0.08 +/- 0.02; p = 0.02) and corresponded to the higher estimated wedge (e/e') pressure (7.76 +/- 2.44 vs. 8.35 +/- 2.64; p = 0.02) in that cohort. E (Young's modulus) was calculated to describe the tensile elasticity of the myocardium. With the same intraventricular filling pressure, E was significantly higher in the elderly, especially those with e/e' values >9. Compared with diastolic dysfunction parameters, E also presented sentinel characteristics more sensitive for detecting early myocardial relaxation impairment, which indicates stiffer myocardium in aging hearts. Conclusion: Our material and geometric mathematical model successfully described the stiffer myocardium in aging hearts with higher intraventricular pressure. Additional studies that compare individual differences, especially in health status, are needed to validate its application for detecting diastolic heart failure.	[Chang, Wei-Ting; Tsai, Wei-Chuan; Liu, Ping-Yen] Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan 70428, Taiwan; [Chang, Wei-Ting; Liu, Ping-Yen] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chen, Jung-San; Hung, Yung-Kung; Juang, Jer-Nan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University	Juang, JN (corresponding author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan.	jjuang@mail.ncku.edu.tw; larry@mail.ncku.edu.tw			Headquarters of University Advancement at the National Cheng Kung University - Ministry of Education, Taiwan, ROC; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC [NSC101-2314-B-006-075-MY2]; Ministry of Science and Technology, Taiwan, ROC; A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center in National Cheng Kung University Hospital, Ministry of Health and Welfare, Taiwan	Headquarters of University Advancement at the National Cheng Kung University - Ministry of Education, Taiwan, ROC; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center in National Cheng Kung University Hospital, Ministry of Health and Welfare, Taiwan	This research was supported in part by the Headquarters of University Advancement at the National Cheng Kung University, which is sponsored by the Ministry of Education, Taiwan, ROC. The research was also granted from Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC and the grant from NSC101-2314-B-006-075-MY2, sponsored by the Ministry of Science and Technology, Taiwan, ROC. The investigator (PY Liu) was granted by ''A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center in National Cheng Kung University Hospital, Ministry of Health and Welfare, Taiwan.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7; ARTS T, 1979, ANN BIOMED ENG, V7, P299, DOI 10.1007/BF02364118; Bertini M, 2012, CIRC-CARDIOVASC IMAG, V5, P383, DOI 10.1161/CIRCIMAGING.111.970434; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Butler J, 2008, CIRC-HEART FAIL, V1, P125, DOI 10.1161/CIRCHEARTFAILURE.108.768457; CHADWICK RS, 1982, BIOPHYS J, V39, P279, DOI 10.1016/S0006-3495(82)84518-9; Chang CL, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-60; Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874; DUMESNIL JG, 1979, CIRCULATION, V59, P1024, DOI 10.1161/01.CIR.59.5.1024; Fung YC, 1990, BIOMECHANICS MOTION; Galderisi Maurizio, 2005, Cardiovasc Ultrasound, V3, P9; GHISTA DN, 1975, MED BIOL ENG, V13, P151, DOI 10.1007/BF02477722; GHISTA DN, 1975, MED BIOL ENG, V13, P162, DOI 10.1007/BF02477723; Horne SG, 2000, CAN J CARDIOL, V16, P607; Huang XP, 2004, ACTA PHARMACOL SIN, V25, P1569; ISNARD RN, 1989, J AM COLL CARDIOL, V13, P399, DOI 10.1016/0735-1097(89)90518-4; Jaarsma T, 1999, EUR J HEART FAIL, V1, P151, DOI 10.1016/S1388-9842(99)00007-0; Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8; LAFFERTY JF, 1972, J BASIC ENG-T ASME, V94, P912, DOI 10.1115/1.3425589; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lin J, 2008, EXP GERONTOL, V43, P296, DOI 10.1016/j.exger.2007.12.005; Liu YW, 2009, J CARD FAIL, V15, P782, DOI 10.1016/j.cardfail.2009.05.006; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; MYRENG Y, 1990, CIRCULATION, V81, P260, DOI 10.1161/01.CIR.81.1.260; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pawlik P, 1980, ELASTICITY THEORY AP; Perk G, 2009, ECHOCARDIOGR-J CARD, V26, P299, DOI 10.1111/j.1540-8175.2008.00863.x; Taber LA, 1998, J THEOR BIOL, V193, P201, DOI 10.1006/jtbi.1997.0618; Tei C, 1995, J Cardiol, V26, P357; TRESCH DD, 1995, J AM GERIATR SOC, V43, P1035, DOI 10.1111/j.1532-5415.1995.tb05570.x; von Lukowicz T, 2005, EUR J HEART FAIL, V7, P525, DOI 10.1016/j.ejheart.2004.12.010; WARREN SE, 1991, HERZ, V16, P324; Yang T, 2012, BMC SYST BIOL, V6, P1; Yettram AL, 1992, J ENG MED, V208, P1	36	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97455	10.1371/journal.pone.0097455	http://dx.doi.org/10.1371/journal.pone.0097455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869961	gold, Green Published, Green Submitted			2022-12-27	WOS:000336858300010
J	Libraty, DH; Zhang, L; Obcena, A; Brion, JD; Capeding, RZ				Libraty, Daniel H.; Zhang, Lei; Obcena, AnaMae; Brion, Job D.; Capeding, Rosario Z.			Circulating Levels of Soluble MICB in Infants with Symptomatic Primary Dengue Virus Infections	PLOS ONE			English	Article							SERUM-LEVELS; NKG2D	Dengue is the most prevalent arthropod-borne viral illness in humans. A MHC class I polypeptide-related sequence B (MICB) single nucleotide polymorphism (SNP) was previously associated with symptomatic dengue compared to non-dengue causes of acute febrile illnesses in infants. We measured circulating levels of soluble (s)MICB in the sera of infants with symptomatic primary dengue virus infections. We found that serum levels of sMICB increased between pre-infection and acute illness among infants with symptomatic primary dengue virus infections. The likelihood of being hospitalized with an acute primary DENV infection during infancy also tended to be higher with increasing acute illness sMICB levels. The elevation of sMICB during acute primary DENV infections in infants likely represents an immune evasion strategy and contributes to the severity of the acute illness.	[Libraty, Daniel H.; Zhang, Lei] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Obcena, AnaMae; Capeding, Rosario Z.] Res Inst Trop Med, Dept Med, Manila, Philippines; [Brion, Job D.] San Pablo City Hlth Off, San Pablo, Philippines; [Capeding, Rosario Z.] Res Inst Trop Med, Dept Microbiol, Manila, Philippines	University of Massachusetts System; University of Massachusetts Worcester; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.	daniel.libraty@umassmed.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01 AI091820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091820] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health/National Institute of Allergy and Infectious Diseases R01 AI091820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; Chung HW, 2011, CANCER SCI, V102, P1673, DOI 10.1111/j.1349-7006.2011.01989.x; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Tamaki S, 2010, ANTICANCER RES, V30, P4097; Whitehorn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059067	10	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98509	10.1371/journal.pone.0098509	http://dx.doi.org/10.1371/journal.pone.0098509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869966	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300050
J	Solem, CT; Snedecor, SJ; Khachatryan, A; Nedrow, K; Tawadrous, M; Chambers, R; Haider, S; Simpson, K				Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit			Cost of Treatment in a US Commercially Insured, HIV-1-Infected Population	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; HEALTH-CARE; HIV; ADHERENCE; OUTCOMES	Objective: Recent treatment patterns and cost data associated with HIV in the United States are limited. This study assessed first-line persistence and healthcare costs of HIV-1 in patients by treatment line and CD4 cell count. Methods: MarketScan Commercial Claims and Encounters Database (2007-2011) and Lab Database (2007-2010) were used to construct two HIV-1 cohorts: 1) newly treated HIV-1-infected patients with >= 6 months' continuous enrollment prior to first third-agent drug claim (Newly Treated Cohort) and 2) CD4 cell count test results (CD4 Measurements Cohort). All patients were >= 18 years old and without hepatitis co-infection. The Kaplan-Meier method was used to measure treatment switch rates. Generalized linear models (gamma distribution, log link) were used to compare healthcare costs by treatment line and CD4 cell count controlling for potential confounders. Results: Newly treated patients (n = 8,617) had mean age of 41, 82% were male, and 20% had experienced AIDS-defining events at baseline. Over 20% of newly treated patients switched initial treatment regimen within 2 years. Average unadjusted (and covariate-adjusted) total healthcare cost/year was $33,674 ($28,861) for first-line, $39,191 ($35,805) for second-line, and $39,882 ($40,804) for third-line treatment. Covariate-adjusted costs of care on second-and third-line treatments were significantly more expensive than first-line treatment (24% [p<0.001] and 41% [p=0.006] higher, respectively). The CD4 Measurements Cohort included 803 CD4 measurements (mean age 49, 76% male, 8% experienced an AIDS-defining event). Costs associated with CD4 measurements <100 cells/mu L were 92% higher than those with >350 cells/mu L (p<0.001). For higher CD4 cell counts, the majority of expenditures were for antiretrovirals (64% of total for CD4 > 350 cells/mu L). Conclusions: Despite modern advances in antiretroviral therapy and medical care, direct medical costs of HIV-1-infected patients increase after treatment switch and with lower CD4 counts, consistent with previous costing studies.	[Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra] Pharmerit Int, Bethesda, MD 20814 USA; [Nedrow, Katherine; Tawadrous, Margaret; Haider, Seema] Pfizer Inc, Groton, CT 06340 USA; [Chambers, Richard] Pfizer Inc, Philadelphia, PA USA; [Simpson, Kit] Med Univ S Carolina, Charleston, SC 29425 USA	Pfizer; Pfizer; Medical University of South Carolina	Snedecor, SJ (corresponding author), Pharmerit Int, Bethesda, MD 20814 USA.	ssnedecor@pharmerit.com	Tawadrous, Margaret/AAY-3551-2020	Solem, Caitlyn/0000-0002-4914-8052	ViiV Healthcare	ViiV Healthcare	The study was sponsored by ViiV Healthcare, who also funded editorial assistance during the development of this manuscript. All authors participated in study design, data collection and analysis, decision to publish, and preparation and review of manuscript.	Centers for Disease Control and Prevention, 2014, CTR DIS CONTR PREV H; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, pRR; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fong R, 2013, SEX HEALTH, V10, P442, DOI 10.1071/SH13043; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hogg R, 2013, 7 IAS C HIV PATH TRE; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Martin S, 2007, 4 IAS C HIV PATH TRE; Meenan RT, 2010, CLIN MED RES, V8, P52, DOI [DOI 10.3121/CMR.8.1.52-A, 10.3121/cmr.8.1.52-a]; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Snedecor SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072784; Stansell J, 2000, 7 C RETR OPP INF SAN	19	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98152	10.1371/journal.pone.0098152	http://dx.doi.org/10.1371/journal.pone.0098152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866200	gold, Green Submitted, Green Published			2022-12-27	WOS:000336914100036
J	Beaumont, PE; McHugh, B; Findlay, EG; Mackellar, A; Mackenzie, KJ; Gallo, RL; Govan, JRW; Simpson, AJ; Davidson, DJ				Beaumont, Paula E.; McHugh, Brian; Findlay, Emily Gwyer; Mackellar, Annie; Mackenzie, Karen J.; Gallo, Richard L.; Govan, John R. W.; Simpson, A. John; Davidson, Donald J.			Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo	PLOS ONE			English	Article							LUNG MUCOSAL IMMUNITY; ANTIMICROBIAL-PEPTIDE; CYSTIC-FIBROSIS; ANTIBACTERIAL PEPTIDES; ACTIN BUNDLES; LL-37; RECEPTOR; CELLS; GENE; DIFFERENTIATION	Cathelicidins are multifunctional cationic host-defence peptides (CHDP; also known as antimicrobial peptides) and an important component of innate host defence against infection. In addition to microbicidal potential, these peptides have properties with the capacity to modulate inflammation and immunity. However, the extent to which such properties play a significant role during infection in vivo has remained unclear. A murine model of acute P. aeruginosa lung infection was utilised, demonstrating cathelicidin-mediated enhancement of bacterial clearance in vivo. The delivery of exogenous synthetic human cathelicidin LL-37 was found to enhance a protective pro-inflammatory response to infection, effectively promoting bacterial clearance from the lung in the absence of direct microbicidal activity, with an enhanced early neutrophil response that required both infection and peptide exposure and was independent of native cathelicidin production. Furthermore, although cathelicidin-deficient mice had an intact early cellular inflammatory response, later phase neutrophil response to infection was absent in these animals, with significantly impaired clearance of P. aeruginosa. These findings demonstrate the importance of the modulatory properties of cathelicidins in pulmonary infection in vivo and highlight a key role for cathelicidins in the induction of protective pulmonary neutrophil responses, specific to the infectious milieu. In additional to their physiological roles, CHDP have been proposed as future antimicrobial therapeutics. Elucidating and utilising the modulatory properties of cathelicidins has the potential to inform the development of synthetic peptide analogues and novel therapeutic approaches based on enhancing innate host defence against infection with or without direct microbicidal targeting of pathogens.	[Beaumont, Paula E.; McHugh, Brian; Findlay, Emily Gwyer; Mackellar, Annie; Mackenzie, Karen J.; Simpson, A. John; Davidson, Donald J.] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland; [Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA; [Gallo, Richard L.] VA San Diego Hlth Care Syst, San Diego, CA USA; [Govan, John R. W.] Univ Edinburgh, New Royal Infirm, Edinburgh Infect Dis, Edinburgh, Midlothian, Scotland; [Simpson, A. John] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Edinburgh; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Edinburgh; Newcastle University - UK	Davidson, DJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland.	donald.davidson@ed.ac.uk	Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Mackenzie, Karen/0000-0002-5441-1476; Simpson, John/0000-0003-4731-7294; McHugh, Brian/0000-0003-4747-0643	Asthma UK/MRC Joint PhD Studentship [S08/001]; MRC Clinical Research Training Fellowship [G0701350]; NIH [R01-AR052728, R01-AI052453, R01 AI0833358]; MRC Senior Non-clinical Fellowship [G1002046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI083358, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; MRC [G0701350, G0901697, G1002046] Funding Source: UKRI; Medical Research Council [G1002046, G0701350, G0901697] Funding Source: researchfish; Asthma UK [S08/001] Funding Source: researchfish	Asthma UK/MRC Joint PhD Studentship; MRC Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC Senior Non-clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	PEB was supported by an Asthma UK/MRC Joint PhD Studentship (S08/001). KJM was supported by a MRC Clinical Research Training Fellowship (G0701350). RLG was supported by NIH grants R01-AR052728, R01-AI052453 and R01 AI0833358. DJD was supported by a MRC Senior Non-clinical Fellowship (G1002046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Beaumont PE, 2013, ANTIMICROBIAL PEPTID, P97; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; British Thoracic Society, 2006, BURD LUNG DIS STAT R; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Davidson DJ, 2003, P C C I D, V7, P71; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hermes DM, 2013, J MED MICROBIOL, V62, P1184, DOI 10.1099/jmm.0.059220-0; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HN, 2009, J LEUKOCYTE BIOL, V86, P891, DOI 10.1189/jlb.0209050; Lipsky BA, 2008, CLIN INFECT DIS, V47, P1537, DOI 10.1086/593185; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Mansbach JM, 2012, J ALLERGY CLIN IMMUN, V130, P1007, DOI 10.1016/j.jaci.2012.07.044; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Pompilio A, 2011, PEPTIDES, V32, P1807, DOI 10.1016/j.peptides.2011.08.002; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Rivas-Santiago B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059119; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; van der Does AM, 2012, J LEUKOCYTE BIOL, V92, P735, DOI 10.1189/jlb.0412178; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wang YQ, 1998, J PROTEIN CHEM, V17, P522; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	57	61	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e99029	10.1371/journal.pone.0099029	http://dx.doi.org/10.1371/journal.pone.0099029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887410	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300123
J	Goud, PT; Goud, AP; Najafi, T; Gonik, B; Diamond, MP; Saed, GM; Zhang, XJ; Abu-Soud, HM				Goud, Pravin T.; Goud, Anuradha P.; Najafi, Tohid; Gonik, Bernard; Diamond, Michael P.; Saed, Ghassan M.; Zhang, Xueji; Abu-Soud, Husam M.			Direct Real-Time Measurement of Intra-Oocyte Nitric Oxide Concentration In Vivo	PLOS ONE			English	Article							NO; RELEASE; TARGETS; CORTEX; BRAIN	Nitric oxide (NO) is reported to play significant a role in oocyte activation and maturation, implantation, and early embryonic development. Previously we have shown that NO forms an important component of the oocyte microenvironment, and functions effectively to delay oocyte aging. Thus, precise information about intra-oocyte NO concentrations [NO] will result in designing more accurate treatment plans in assisted reproduction. In this work, the direct, real-time and quantitative intra-oocyte [NO] was measured utilizing an L-shaped amperometric integrated NO-selective electrode. This method not only provides an elegant and convenient approach to real-time the measurement of NO in physiological environments, but also mimics the loss of NO caused by rapid NO diffusion combined with its reactivity in the biological milieu. This experiment suggests that the NO levels of oocytes obtained from young animals are significantly higher than those of oocytes obtained from old animals. Additionally the NO levels stay constant during the measurements; however, the intra-oocyte [NO] is reduced significantly (70-75% reduction) in response to L-NAME incubation, suggesting that NO measurements are truly NOS based rather than caused by an unknown interfering substance in our system. We believe this first demonstration of the direct quantitative measurement of [NO] in situ in an intact cellular complex should be useful in tracking real-time and rapid changes at nanomolar levels. Moreover, this finding confirms and extends our previous work showing that supplementation with NO delays the oocyte aging process.	[Goud, Pravin T.; Najafi, Tohid; Gonik, Bernard; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA; [Goud, Pravin T.] Univ Calif Davis, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Sacramento, CA 95817 USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Davis, CA USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Sacramento, CA USA; [Goud, Anuradha P.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Diamond, Michael P.] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Zhang, Xueji] World Precis Instruments, Sarasota, FL USA; [Zhang, Xueji] Univ Sci & Technol, Res Ctr Bioengn & Sensing Technol, Beijing, Peoples R China; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Wayne State University; University of California System; University of California Davis; University of California System; University of California Davis; University System of Georgia; Augusta University; University of Science & Technology Beijing; Wayne State University	Abu-Soud, HM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA.	habusoud@med.wayne.edu	zhang, xueji/B-1904-2010; zhang, xueji/ABE-6497-2020	zhang, xueji/0000-0002-0035-3821; Diamond, Michael/0000-0001-6353-4489	National Institutes of Health [RO1 HL066367]; Children's Hospital of Michigan; National Nature Science Foundation of China [21127007, 21005037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1 HL066367, a grant from Children's Hospital of Michigan (H.M.A-S) and National Nature Science Foundation of China (Grant No. 21127007, 21005037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; ABUSOUD HM, 1993, J BIOL CHEM, V268, P7699; ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Bates J. N., 1992, NEUROPROTOCOLS, V1, P141; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Ciszewski A, 2003, ELECTROCHEMICAL DETE; Gainutdinov KL, 2013, B EXP BIOL MED+, V154, P635, DOI 10.1007/s10517-013-2018-3; Goud AP, 2005, BIOCHEMISTRY-US, V44, P11361, DOI 10.1021/bi050711f; Goud AP, 2005, REPROD BIOMED ONLINE, V11, P43, DOI 10.1016/S1472-6483(10)61297-7; Goud P, 1997, FERTIL STERIL, V67, P979, DOI 10.1016/S0015-0282(97)90147-3; Goud PT, 2008, FREE RADICAL BIO MED, V45, P453, DOI 10.1016/j.freeradbiomed.2008.04.035; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Hetrick EM, 2009, ANNU REV ANAL CHEM, V2, P409, DOI 10.1146/annurev-anchem-060908-155146; Hrbac J, 2007, BIOELECTROCHEMISTRY, V71, P46, DOI 10.1016/j.bioelechem.2006.09.007; Hunter RA, 2013, ANAL CHEM, V85, P1957, DOI 10.1021/ac303787p; ICHIMORI K, 1994, REV SCI INSTRUM, V65, P2714, DOI 10.1063/1.1144674; Khorram Omid, 2002, Rev Endocr Metab Disord, V3, P145, DOI 10.1023/A:1015459029397; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; LARFARS G, 1995, J IMMUNOL METHODS, V184, P53, DOI 10.1016/0022-1759(95)00074-K; Laver JR, 2008, METHOD ENZYMOL, V436, P113, DOI 10.1016/S0076-6879(08)36007-8; Levine DZ, 2001, AM J PHYSIOL-RENAL, V281, pF189, DOI 10.1152/ajprenal.2001.281.1.F189; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Noack E., 1992, NEUROPROTOCOLS, V1, P133; Palm F, 2005, DIABETES, V54, P3282, DOI 10.2337/diabetes.54.11.3282; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; Pittner J, 2005, KIDNEY INT, V67, P227, DOI 10.1111/j.1523-1755.2005.00073.x; Saed GM, 2005, FERTIL STERIL, V84, P235, DOI 10.1016/j.fertnstert.2005.01.105; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Wakatsuki H, 1998, J PHYSIOL-LONDON, V513, P71, DOI 10.1111/j.1469-7793.1998.071by.x; Xiangji Z, 1996, ANAL CHEM, V68, P1748; Zhang XJ, 2004, FRONT BIOSCI-LANDMRK, V9, P3434, DOI 10.2741/1492; Zhang XJ, 2000, ELECTROANALYSIS, V12	34	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98720	10.1371/journal.pone.0098720	http://dx.doi.org/10.1371/journal.pone.0098720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887331	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300101
J	Kellner, R; Hanschke, C; Begerow, D				Kellner, Ronny; Hanschke, Christian; Begerow, Dominik			Patterns of Variation at Ustilago maydis Virulence Clusters 2A and 19A Largely Reflect the Demographic History of Its Populations	PLOS ONE			English	Article							SMUT FUNGI; MAIZE DOMESTICATION; GENOME; EVOLUTION; SEQUENCES; PROTEINS; GENETICS; INSIGHTS	The maintenance of an intimate interaction between plant-biotrophic fungi and their hosts over evolutionary times involves strong selection and adaptative evolution of virulence-related genes. The highly specialised maize pathogen Ustilago maydis is assigned with a high evolutionary capability to overcome host resistances due to its high rates of sexual recombination, large population sizes and long distance dispersal. Unlike most studied fungus-plant interactions, the U. maydis - Zea mays pathosystem lacks a typical gene-for-gene interaction. It exerts a large set of secreted fungal virulence factors that are mostly organised in gene clusters. Their contribution to virulence has been experimentally demonstrated but their genetic diversity within U. maydis remains poorly understood. Here, we report on the intraspecific diversity of 34 potential virulence factor genes of U. maydis. We analysed their sequence polymorphisms in 17 isolates of U. maydis from Europe, North and Latin America. We focused on gene cluster 2A, associated with virulence attenuation, cluster 19A that is crucial for virulence, and the cluster-independent effector gene pep1. Although higher compared to four house-keeping genes, the overall levels of intraspecific genetic variation of virulence clusters 2A and 19A, and pep1 are remarkably low and commensurate to the levels of 14 studied non-virulence genes. In addition, each gene is present in all studied isolates and synteny in cluster 2A is conserved. Furthermore, 7 out of 34 virulence genes contain either no polymorphisms or only synonymous substitutions among all isolates. However, genetic variation of clusters 2A and 19A each resolve the large scale population structure of U. maydis indicating subpopulations with decreased gene flow. Hence, the genetic diversity of these virulence-related genes largely reflect the demographic history of U. maydis populations.	[Kellner, Ronny] Max Planck Inst Terr Microbiol, MPRG Fungal Biodivers, D-35043 Marburg, Germany; [Kellner, Ronny; Hanschke, Christian; Begerow, Dominik] Ruhr Univ Bochum, Dept Geobot, Bochum, Germany	Max Planck Society; Ruhr University Bochum	Kellner, R (corresponding author), Max Planck Inst Terr Microbiol, MPRG Fungal Biodivers, D-35043 Marburg, Germany.	ronny.kellner@mpi-marburg.mpg.de	Kellner, Ronny/H-3106-2019	Kellner, Ronny/0000-0002-4618-0110; Begerow, Dominik/0000-0002-8286-1597	Deutsche Forschungsgemeinschaft (DFG) [BE 2201/8-1]; Ruhr-University Bochum	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruhr-University Bochum	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 2201/8-1) and the Ruhr-University Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CW, 2004, MYCOLOGIA, V96, P1236, DOI 10.2307/3762140; Basse CW, 2000, MOL CELL BIOL, V20, P329, DOI 10.1128/MCB.20.1.329-339.2000; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; BAUER R, 1995, CAN J BOT, V73, P867, DOI 10.1139/b95-095; Baumgarten AM, 2007, THEOR APPL GENET, V114, P1229, DOI 10.1007/s00122-007-0513-5; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; FU YX, 1993, GENETICS, V133, P693; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kellner R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002436; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kirkman T. W., 1996, STAT USE; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Kumar Nei, 2000, MOL EVOLUTION PHYLOG; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Librado P, 2009, DNASP V5 SOFTWARE CO, P5; Liu KJ, 2003, GENETICS, V165, P2117; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Munkacsi AB, 2008, P ROY SOC B-BIOL SCI, V275, P1037, DOI 10.1098/rspb.2007.1636; Munkacsi AB, 2007, EVOLUTION, V61, P388, DOI 10.1111/j.1558-5646.2007.00036.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pierce JV, 2012, MBIO, V3, DOI 10.1128/mBio.00117-12; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stock J, 2012, J BIOTECHNOL, V161, P80, DOI 10.1016/j.jbiotec.2012.03.004; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stukenbrock EH, 2011, GENOME RES, V21, P2157, DOI 10.1101/gr.118851.110; Stukenbrock EH, 2009, MOL PLANT MICROBE IN, V22, P371, DOI 10.1094/MPMI-22-4-0371; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vollmeister E, 2010, CURR OPIN MICROBIOL, V13, P693, DOI 10.1016/j.mib.2010.08.013; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yang Z, 1997, MOL BIOL EVOL, V15, P568; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	49	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98837	10.1371/journal.pone.0098837	http://dx.doi.org/10.1371/journal.pone.0098837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887029	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300113
J	Weiss, K; Parzefall, C; Herzner, G				Weiss, Katharina; Parzefall, Christopher; Herzner, Gudrun			Multifaceted Defense against Antagonistic Microbes in Developing Offspring of the Parasitoid Wasp Ampulex compressa (Hymenoptera, Ampulicidae)	PLOS ONE			English	Article							COCKROACHES PERIPLANETA-AMERICANA; METARHIZIUM-ANISOPLIAE; SECONDARY METABOLITES; POTENTIAL VECTORS; ENDOPHYTIC FUNGUS; PATHOGENIC FUNGI; GLAND SECRETION; BACTERIA; NAPHTHALENE; LARVAE	Effective antimicrobial strategies are essential adaptations of insects to protect themselves, their offspring, and their foods from microbial pathogens and decomposers. Larvae of the emerald cockroach wasp, Ampulex compressa, sanitize their cockroach hosts, Periplaneta americana, with a cocktail of nine antimicrobials comprising mainly (R)-(-)-mellein and micromolide. The blend of these antimicrobials has broad-spectrum antimicrobial activity. Here we explore the spatio-temporal pattern of deployment of antimicrobials during the development from egg to adult as well as their physico-chemical properties to assess how these aspects may contribute to the success of the antimicrobial strategy. Using gas chromatography/mass spectrometry (GC/MS) we show that larvae start sanitizing their food as soon as they have entered their host to feed on its tissue. Subsequently, they impregnate the cockroach carcass with antimicrobials to create a hygienic substrate for cocoon spinning inside the host. Finally, the antimicrobials are incorporated into the cocoon. The antimicrobial profiles on cockroach and wasp cocoon differed markedly. While micromolide persisted on the cockroaches until emergence of the wasps, solid-phase microextraction sampling and GC/MS analysis revealed that (R)-(-)-mellein vaporized from the cockroaches and accumulated in the enclosed nest. In microbial challenge assays (R)-(-)-mellein in the headspace of parasitized cockroaches inhibited growth of entomopathogenic and opportunistic microbes (Serratia marcescens, Aspergillus sydowii, Metarhizium brunneum). We conclude that, in addition to food sanitation, A. compressa larvae enclose themselves in two defensive walls by impregnating the cocoon and the cockroach cuticle with antimicrobials. On top of that, they use vaporous (R)-(-)-mellein to sanitize the nest by fumigation. This multifaceted antimicrobial defense strategy involving the spatially and temporally coordinated deployment of several antimicrobials in solution and vapor form has apparently evolved to reliably protect the larvae themselves and their food against a broad range of antagonistic microbes.	[Weiss, Katharina; Parzefall, Christopher; Herzner, Gudrun] Univ Regensburg, Inst Zool, Evolutionary Ecol Grp, D-93053 Regensburg, Germany	University of Regensburg	Herzner, G (corresponding author), Univ Regensburg, Inst Zool, Evolutionary Ecol Grp, Univ Str 31, D-93053 Regensburg, Germany.	gudrun.herzner@biologie.uni-regensburg.de			Forschungsrat of the University of Regensburg	Forschungsrat of the University of Regensburg	Gudrun Herzner gratefully acknowledges financial support from the Forschungsrat of the University of Regensburg (http://www.uni-regensburg.de/forschung/forschungsrat/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang-Kucuker M, 1999, ZBL BAKT, V289, P781; BATRA SWT, 1969, SCIENCE, V165, P607, DOI 10.1126/science.165.3893.607; Baumholtz MA, 1997, INT J DERMATOL, V36, P90, DOI 10.1046/j.1365-4362.1997.00077.x; Beckage NE, 2008, INSECT IMMUNOLOGY, P1; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Cardoza YJ, 2006, ECOL ENTOMOL, V31, P636, DOI 10.1111/j.1365-2311.2006.00829.x; Chaichanawongsaroj Nuntaree, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P681; Chen J, 1998, NATURE, V392, P558, DOI 10.1038/33305; Chen J, 1998, J AGR FOOD CHEM, V46, P2337, DOI 10.1021/jf9709717; Chouvenc T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1885; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cotter SC, 2010, ECOL LETT, V13, P1114, DOI 10.1111/j.1461-0248.2010.01500.x; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dai JR, 2001, J NAT PROD, V64, P125, DOI 10.1021/np000381u; Degenkolb T, 2011, J CHEM ECOL, V37, P724, DOI 10.1007/s10886-011-9978-4; El-Mehalawy A. A., 2005, International Journal of Agriculture and Biology, V7, P188; Fakoorziba MR, 2010, ANN TROP MED PARASIT, V104, P521, DOI 10.1179/136485910X12786389891326; Feng Z, 2010, J MICROBIOL BIOTECHN, V20, P985, DOI 10.4014/jmb.1002.02012; FUHRER E, 1986, J INSECT PHYSIOL, V32, P361, DOI 10.1016/0022-1910(86)90049-1; Fuhrer E, 2001, J APPL ENTOMOL, V125, P235, DOI 10.1046/j.1439-0418.2001.00529.x; Gasch T, 2013, J INSECT PHYSIOL, V59, P1186, DOI 10.1016/j.jinsphys.2013.09.006; GOCHNAUER TA, 1979, J INVERTEBR PATHOL, V34, P57, DOI 10.1016/0022-2011(79)90053-3; Griffiths HM, 2010, ECOL ENTOMOL, V35, P529, DOI 10.1111/j.1365-2311.2010.01212.x; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Gross J, 2009, RES CHRYSOMELIDAE, V2, P177; Gross J, 2010, J CHEM ECOL, V36, P1180, DOI 10.1007/s10886-010-9867-2; Haak U, 1996, CHEMOECOLOGY, V7, P85, DOI 10.1007/BF01239485; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heitmans Wijnand R.B., 1990, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V1, P13; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Herzner G, 2007, CURR BIOL, V17, pR46, DOI 10.1016/j.cub.2006.11.060; Herzner G, 2013, P NATL ACAD SCI USA, V110, P1369, DOI 10.1073/pnas.1213384110; Herzner G, 2011, ANIM BEHAV, V82, P321, DOI 10.1016/j.anbehav.2011.05.006; Herzner G, 2011, ZOOLOGY, V114, P36, DOI 10.1016/j.zool.2010.10.002; Holler U, 1999, J NAT PROD, V62, P114, DOI 10.1021/np980341e; Iranshahi M, 2004, Z NATURFORSCH C, V59, P506; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Keasar T, 2006, ETHOLOGY, V112, P699, DOI 10.1111/j.1439-0310.2006.01214.x; Koehler S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-3; Krohn K, 1997, PHYTOCHEMISTRY, V45, P313, DOI 10.1016/S0031-9422(96)00854-0; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Legendre P., 2012, NUMERICAL ECOLOGY; Lemos AA, 2006, MYCOSES, V49, P23, DOI 10.1111/j.1439-0507.2005.01179.x; Li B, 2011, BRAZ J MICROBIOL, V42, P96, DOI 10.1590/S1517-83822011000100013; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; Ma CY, 2005, PLANTA MED, V71, P261, DOI 10.1055/s-2005-837826; Muneer M, 2005, J MOL CATAL A-CHEM, V234, P151, DOI 10.1016/j.molcata.2005.02.025; Oliveira CM, 2011, PHYTOCHEM LETT, V4, P93, DOI 10.1016/j.phytol.2010.11.003; Pai HH, 2005, ACTA TROP, V93, P259, DOI 10.1016/j.actatropica.2004.11.006; Pai HH, 2004, INFECT CONT HOSP EP, V25, P979, DOI 10.1086/502330; Prado Marinésia Aparecida, 2006, Braz J Infect Dis, V10, P26, DOI 10.1590/S1413-86702006000100006; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reynolds S., 2009, INSECT INFECT IMMUNI; Rohrich CR, 2012, BIOL LETTERS, V8, P308, DOI 10.1098/rsbl.2011.0760; Rosengaus RB, 2000, J CHEM ECOL, V26, P21, DOI 10.1023/A:1005481209579; Rosengaus RB, 2004, INSECT SOC, V51, P259, DOI 10.1007/s00040-004-0749-x; Rosengaus RB, 2013, NATURWISSENSCHAFTEN, V100, P1051, DOI 10.1007/s00114-013-1110-x; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Rukachaisirikul V, 2009, TETRAHEDRON, V65, P10590, DOI 10.1016/j.tet.2009.10.084; Schmidtberg H, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0006; SCHULZ B, 1995, MYCOL RES, V99, P1007, DOI 10.1016/S0953-7562(09)80766-1; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Secil ES, 2012, BIOLOGIA, V67, P767, DOI 10.2478/s11756-012-0070-5; Sikorowski P. P., 2001, American Entomologist, V47, P51; SUN CM, 1993, J NAT PROD, V56, P953, DOI 10.1021/np50096a024; Suwannarach N, 2013, CROP PROT, V45, P63, DOI 10.1016/j.cropro.2012.11.015; THOMPSON PR, 1978, J COMP PHYSIOL, V126, P257, DOI 10.1007/BF00688935; Tragust S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-225; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; Tunc S, 2007, INT J FOOD MICROBIOL, V113, P263, DOI 10.1016/j.ijfoodmicro.2006.07.004; Vanninen I, 1997, ENTOMOPHAGA, V42, P377, DOI 10.1007/BF02769831; Vilcinskas Andreas, 2013, Proc Biol Sci, V280, P20122113, DOI 10.1098/rspb.2012.2113; Wang L, 2008, ANN MICROBIOL, V58, P579, DOI 10.1007/BF03175561; Williams FX, 1942, P HAWAII ENTOMOL SOC, V11, P221; Wiltz BA, 1998, ENVIRON ENTOMOL, V27, P936, DOI 10.1093/ee/27.4.936; Wright MS, 2000, MYCOLOGIA, V92, P42, DOI 10.2307/3761448; Yek SH, 2012, P ROY SOC B-BIOL SCI, V279, P4215, DOI 10.1098/rspb.2012.1458; Yuan H, 2008, BIOORG MED CHEM LETT, V18, P5311, DOI 10.1016/j.bmcl.2008.08.027; Zhao JH, 2012, WORLD J MICROB BIOT, V28, P2107, DOI 10.1007/s11274-012-1015-4	83	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98784	10.1371/journal.pone.0098784	http://dx.doi.org/10.1371/journal.pone.0098784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886721	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300108
J	Yang, QP; Li, Z; Cao, JJ; Zhang, SD; Zhang, HJ; Wu, XY; Zhang, QW; Liu, XX				Yang, Qingpo; Li, Zhen; Cao, Jinjun; Zhang, Songdou; Zhang, Huaijiang; Wu, Xiaoyun; Zhang, Qingwen; Liu, Xiaoxia			Selection and Assessment of Reference Genes for Quantitative PCR Normalization in Migratory Locust Locusta migratoria (Orthoptera: Acrididae)	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE CHAIN-REACTION; POTENTIAL REFERENCE GENES; SUITABLE REFERENCE GENES; ACETYL-COA HYDROLASE; ACTIN MESSENGER-RNA; RT-PCR; HOUSEKEEPING GENES; BETA-ACTIN; RIBOSOMAL-RNA	Locusta migratoria is a classic hemimetamorphosis insect and has caused widespread economic damage to crops as a migratory pest. Researches on the expression pattern of functional genes in L. migratoria have drawn focus in recent years, especially with the release of genome information. Real-time quantitative PCR is the most reproducible and sensitive approach for detecting transcript expression levels of target genes, but optimal internal standards are key factors for its accuracy and reliability. Therefore, it's necessary to provide a systematic stability assessment of internal control for well-performed tests of target gene expression profile. In this study, twelve candidate genes (Ach, Act, Cht2, EF1 alpha, RPL32, Hsp70, Tub, RP49, SDH, GAPDH, 18S, and His) were analyzed with four statistical methods: the delta Ct approach, geNorm, Bestkeeper and NormFinder. The results from these analyses aimed to choose the best suitable reference gene across different experimental situations for gene profile study in L. migratoria. The result demonstrated that for different developmental stages, EF1 alpha, Hsp70 and RPL32 exhibited the most stable expression status for all samples; EF1 alpha and RPL32 were selected as the best reference genes for studies involving embryo and larvae stages, while SDH and RP49 were identified for adult stage. The best-ranked reference genes across different tissues are RPL32, Hsp70 and RP49. For abiotic treatments, the most appropriate genes we identified were as follows: Act and SDH for larvae subjected to different insecticides; RPL32 and Ach for larvae exposed to different temperature treatments; and Act and Ach for larvae suffering from starvation. The present report should facilitate future researches on gene expression in L. migratoria with accessibly optimal reference genes under different experimental contexts.	[Yang, Qingpo; Li, Zhen; Cao, Jinjun; Zhang, Songdou; Zhang, Huaijiang; Wu, Xiaoyun; Zhang, Qingwen; Liu, Xiaoxia] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Wu, Xiaoyun] Beijing Vocat Coll Agr, Dept Hort, Beijing, Peoples R China	China Agricultural University	Liu, XX (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	liuxiaoxia611@cau.edu.cn			National "973" Project [2012CB114103]	National "973" Project(National Basic Research Program of China)	This study was supported by grants from the National "973" Project (No. 2012CB114103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bear A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011563; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen Yong-Lin, 2000, Entomological Knowledge, V37, P50; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Docimo T, 2013, F1000RESEARCH; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Guo W, 2010, J INSECT PHYSIOL, V56, P943, DOI 10.1016/j.jinsphys.2010.05.007; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; HUNTER T, 1977, CELL, V12, P767, DOI 10.1016/0092-8674(77)90276-8; Infante C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-28; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Keeley L.L., 1985, P211; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Lee FJS, 1996, BBA-PROTEIN STRUCT M, V1297, P105, DOI 10.1016/0167-4838(96)00109-4; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; MOSHIER JA, 1993, EXP GERONTOL, V28, P249, DOI 10.1016/0531-5565(93)90032-9; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piana C, 2008, EUR J PHARM BIOPHARM, V69, P1187, DOI 10.1016/j.ejpb.2008.03.008; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Qin WS, 2003, CELL STRESS CHAPERON, V8, P144, DOI 10.1379/1466-1268(2003)008<0144:CACOAM>2.0.CO;2; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; SCHULZ WA, 1991, FEBS LETT, V292, P264, DOI 10.1016/0014-5793(91)80880-C; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Serazin-Leroy V, 1998, MOL CELL PROBE, V12, P283, DOI 10.1006/mcpr.1998.0182; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Steenkamp ET, 1999, APPL ENVIRON MICROB, V65, P3401; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Suematsu N, 2002, ACTA BIOCHIM POL, V49, P937; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Ullmannova V, 2003, FOLIA BIOL-PRAGUE, V49, P211; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Wang XH, 2003, CRYOLETTERS, V24, P331; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Zhang CB, 2009, CURR GENET, V55, P399, DOI 10.1007/s00294-009-0254-x; Zhang JZ, 2010, INSECT BIOCHEM MOLEC, V40, P824, DOI 10.1016/j.ibmb.2010.08.001; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhou XX, 2009, PESTIC BIOCHEM PHYS, V93, P77, DOI 10.1016/j.pestbp.2008.11.007; Zhu E.L., 1999, OCCURRENCE MANAGEMEN; Zimoch L, 2002, CELL TISSUE RES, V308, P287, DOI 10.1007/s00441-002-0546-7	79	48	53	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98164	10.1371/journal.pone.0098164	http://dx.doi.org/10.1371/journal.pone.0098164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887329	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300041
J	Lou, YF; Zou, ZZ; Chen, PJ; Huang, GB; Li, B; Zheng, DQ; Yu, XR; Luo, XY				Lou, Yun-feng; Zou, Zheng-zhi; Chen, Pin-jia; Huang, Guo-bin; Li, Bin; Zheng, De-qing; Yu, Xiu-rong; Luo, Xiao-yong			Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells	PLOS ONE			English	Article							XIAP-ASSOCIATED FACTOR-1; GASTRIC-CANCER; IN-VITRO; EGFR; GROWTH; XAF1; RESISTANCE; EXPRESSION; THERAPY; KINASE	Despite recent advances in the treatment of human colon cancer, the chemotherapy efficacy against colon cancer is still unsatisfactory. In the present study, effects of concomitant inhibition of the epidermal growth factor receptor (EGFR) and DNA methyltransferase were examined in human colon cancer cells. We demonstrated that decitabine (a DNA methyltransferase inhibitor) synergized with gefitinib (an EGFR inhibitor) to reduce cell viability and colony formation in SW1116 and LOVO cells. However, the combination of the two compounds displayed minimal toxicity to NCM460 cells, a normal human colon mucosal epithelial cell line. The combination was also more effective at inhibiting the AKT/mTOR/S6 kinase pathway. In addition, the combination of decitabine with gefitinib markedly inhibited colon cancer cell migration. Furthermore, gefitinib synergistically enhanced decitabine-induced cytotoxicity was primarily due to apoptosis as shown by Annexin V labeling that was attenuated by z-VAD-fmk, a pan caspase inhibitor. Concomitantly, cell apoptosis resulting from the co-treatment of gefitinib and decitabine was accompanied by induction of BAX, cleaved caspase 3 and cleaved PARP, along with reduction of Bcl-2 compared to treatment with either drug alone. Interestingly, combined treatment with these two drugs increased the expression of XIAP-associated factor 1 (XAF1) which play an important role in cell apoptosis. Moreover, small interfering RNA (siRNA) depletion of XAF1 significantly attenuated colon cancer cells apoptosis induced by the combination of the two drugs. Our findings suggested that gefitinib in combination with decitabine exerted enhanced cell apoptosis in colon cancer cells were involved in mitochondrial-mediated pathway and induction of XAF1 expression. In conclusion, based on the observations from our study, we suggested that the combined administration of these two drugs might be considered as a novel therapeutic regimen for treating colon cancer.	[Lou, Yun-feng; Chen, Pin-jia; Li, Bin; Yu, Xiu-rong; Luo, Xiao-yong] Zhengzhou Univ, Affiliated Luoyang Cent Hosp, Dept Oncol, Luoyang, Peoples R China; [Zou, Zheng-zhi] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Zou, Zheng-zhi] S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Guo-bin; Zheng, De-qing] Sun Yat Sen Univ, Affiliated Donghua Hosp, Dept Gastroenterol, Dongguan, Peoples R China	Zhengzhou University; South China Normal University; South China Normal University; Sun Yat Sen University	Luo, XY (corresponding author), Zhengzhou Univ, Affiliated Luoyang Cent Hosp, Dept Oncol, Luoyang, Peoples R China.	xiaoyongluo68@163.com	bin, li/AAK-6880-2020		South China Normal University Science Fund for Young Scholars [13KJ19]; Bureau of Dongguan city science and Technology key project Fund [201028]	South China Normal University Science Fund for Young Scholars; Bureau of Dongguan city science and Technology key project Fund	The work was supported by the South China Normal University Science Fund for Young Scholars (Grant No. 13KJ19 to Zheng-zhi Zou), the Bureau of Dongguan city science and Technology 2010 key project Fund (Grant No. 201028 to Xiao-yong Luo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin K, 2014, ONCOL LETT, V7, P255, DOI 10.3892/ol.2013.1662; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6; Bender CM, 1998, CANCER RES, V58, P95; Braun AH, 2005, ANTI-CANCER DRUG, V16, P1099, DOI 10.1097/00001813-200511000-00009; Byun DS, 2003, CANCER RES, V63, P7068; Carr TD, 2012, CANCER PREV RES, V5, P1394, DOI 10.1158/1940-6207.CAPR-12-0272-T; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Correale P, 2010, EUR J CANCER, V46, P1703, DOI 10.1016/j.ejca.2010.03.005; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Flageng MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074618; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Giannopoulou E, 2009, CANCER CHEMOTH PHARM, V63, P973, DOI 10.1007/s00280-008-0820-9; Griffiths EA, 2013, ADV EXP MED BIOL, V754, P253, DOI 10.1007/978-1-4419-9967-2_13; Haraldsdottir S, 2013, J GASTROINTEST ONCOL, V4, P285, DOI 10.3978/j.issn.2078-6891.2013.028; Hsiao SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083266; Huang S, 2013, MOL CANCER THER, V12, P2772, DOI 10.1158/1535-7163.MCT-13-0587; Issa JP, 2008, CANCER PREV RES, V1, P219, DOI 10.1158/1940-6207.CAPR-08-0029; Jones HE, 2006, BRIT J CANCER, V95, P172, DOI 10.1038/sj.bjc.6603237; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kim DJ, 2011, CANCER PREV RES, V4, P1842, DOI 10.1158/1940-6207.CAPR-11-0158; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rajput S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061342; Schneider BG, 2013, CANCER PREV RES, V6, P253, DOI 10.1158/1940-6207.CAPR-13-0067; Schwartz PA, 2013, P NATL ACAD SCI US; Shen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081628; Smith DL, 2014, ARCH PATHOL LAB MED, V138, P371, DOI 10.5858/arpa.2013-0002-OA; Toda D, 2006, ANTICANCER RES, V26, P129; Toker A, 2008, MOL CELL, V31, P6, DOI 10.1016/j.molcel.2008.06.007; Troiani T, 2006, MOL CANCER THER, V5, P1883, DOI 10.1158/1535-7163.MCT-06-0055; van Laarhoven HWM, 2004, EUR J GASTROEN HEPAT, V16, P283, DOI 10.1097/01.meg.0000108279.74393.52; Wang JD, 2006, GASTROENTEROLOGY, V130, P747, DOI 10.1053/j.gastro.2005.12.017; Wang J, 2009, CARCINOGENESIS, V30, P1507, DOI 10.1093/carcin/bgp155; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213; Wang K, 2007, BIOORG MED CHEM LETT, V17, P1455, DOI 10.1016/j.bmcl.2006.11.056; Wang LS, 2013, NUTR CANCER, V65, P118, DOI 10.1080/01635581.2013.741759; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037572; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031601; Yao JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037197; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	52	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97719	10.1371/journal.pone.0097719	http://dx.doi.org/10.1371/journal.pone.0097719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874286	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800011
J	Xiong, J; Bing, ZT; Su, YL; Deng, DF; Peng, XN				Xiong, Jie; Bing, Zhitong; Su, Yanlin; Deng, Defeng; Peng, Xiaoning			An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis	PLOS ONE			English	Article							REGULARIZATION PATHS; PREDICTING SURVIVAL; MALIGNANT GLIOMA; GRADE; BIOCONDUCTOR; TEMOZOLOMIDE; INHIBITOR; CONTAINS; BIOLOGY; MARKERS	Although patients with Glioblastoma multiforme (GBM) have grave prognosis, significant variability in patient outcome is observed. The objective of this study is to identify a molecular signature for GBM prognosis. We subjected 355 mRNA and microRNA expression profiles to elastic net-regulated Cox regression for identification of an integrated RNA signature for GBM prognosis. A prognostic index (PI) was generated for patient stratification. Survival comparison was conducted by Kaplan-Meier method and a general multivariate Cox regression procedure was applied to evaluate the independence of the PI. The abilities and efficiencies of signatures to predict GBM patient outcome was assessed and compared by the area under the curve (AUC) of the receiver-operator characteristic (ROC). An integrated RNA prognostic signature consisted by 4 protective mRNAs, 12 risky mRNAs, and 1 risky microRNA was identified. Decreased survival was associated with being in the high-risk group (hazard ratio = 2.864, P<0.0001). The prognostic value of the integrated signature was validated in five independent GBM expression datasets (n = 201, hazard ratio = 2.453, P<0.0001). The PI outperformed the known clinical factors, mRNA-only, and miRNA-only prognostic signatures for GBM prognosis (area under the ROC curve for the integrated RNA, mRNA-only, and miRNA-only signatures were 0.828, 0.742, and 0.757 at 3 years of overall survival, respectively, P<0.0001 by permutation test). We describe the first, to our knowledge, robust transcriptome-based integrated RNA signature that improves the current GBM prognosis based on clinical variables, mRNA-only, and miRNA-only signatures.	[Xiong, Jie; Peng, Xiaoning] Hunan Normal Univ, Coll Math & Comp Sci, Dept Stat, Changsha, Hunan, Peoples R China; [Xiong, Jie; Su, Yanlin; Peng, Xiaoning] Hunan Normal Univ, Dept Mol Epidemiol, Coll Med, Changsha, Hunan, Peoples R China; [Bing, Zhitong] Chinese Acad Sci, Inst Modern Phys, Dept Computat Phys, Lanzhou, Peoples R China; [Deng, Defeng] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Hunan Normal University; Hunan Normal University; Chinese Academy of Sciences; Institute of Modern Physics, CAS; University of Texas System; UTMD Anderson Cancer Center	Peng, XN (corresponding author), Hunan Normal Univ, Coll Math & Comp Sci, Dept Stat, Changsha, Hunan, Peoples R China.	pxiaoning@hunnu.edu.cn			National Natural Science Foundation of China [81071628]; Natural Science Foundation of Hunan [11JJ2013]; Graduate Student Innovation Project of Hunan [CX2013B224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan(Natural Science Foundation of Hunan Province); Graduate Student Innovation Project of Hunan	This work is supported by the following grants: 1, Grants from the National Natural Science Foundation of China (No. 81071628). 2, Grants from the Natural Science Foundation of Hunan (No. 11JJ2013). 3, Grants from the Graduate Student Innovation Project of Hunan (CX2013B224). All of the above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimappamagan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Cameron A, 2000, FEBS LETT, V473, P135, DOI 10.1016/S0014-5793(00)01511-8; Cheng WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034705; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hua DS, 2012, OMICS, V16, P690, DOI 10.1089/omi.2012.0069; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Kawaguchi A, 2013, CANCER SCI, V104, P1205, DOI 10.1111/cas.12214; Kawaguchi A, 2012, INT J ONCOL, V40, P721, DOI 10.3892/ijo.2011.1240; Kim H, 2012, BIOINF BIOM WORKSH B, P872; Kim J ZY, 2012, P 103 ANN M AM ASS C, P3165; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Marimuthu A, 2013, PROTEOM CLIN APPL, V7, P355, DOI 10.1002/prca.201200069; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Ohka F, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/878425; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; SHINOURA N, 1995, BRIT J CANCER, V72, P627, DOI 10.1038/bjc.1995.384; Simon N, 2011, J STAT SOFTW, V39, P1; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun S, 2013, NEURO-ONCOLOGY, V15, P562, DOI 10.1093/neuonc/not005; Taminelli GL, 2008, BIOCHEM BIOPH RES CO, V365, P856, DOI 10.1016/j.bbrc.2007.11.076; Varki A, 2009, GLYCOSYLATION CHANGE; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006274	48	16	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98419	10.1371/journal.pone.0098419	http://dx.doi.org/10.1371/journal.pone.0098419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871302	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300042
J	Yu, W; Zha, WL; Guo, S; Cheng, HK; Wu, JL; Liu, C				Yu, Wei; Zha, Wenliang; Guo, Shuang; Cheng, Hongke; Wu, Jiliang; Liu, Chao			Flos Puerariae Extract Prevents Myocardial Apoptosis via Attenuation Oxidative Stress in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CARDIAC DYSFUNCTION; HIGH GLUCOSE; IN-VITRO; CARDIOMYOPATHY; RATS; PATHWAY; KINASE; ACTIVATION; DAMAGE	Background: Diabetic cardiomyopathy (DCM) suggests a direct cellular insult to myocardium. Apoptosis is considered as one of the hallmarks of DCM. Oxidative stress plays a key role in the pathogenesis of DCM. In this study, we explored the prevention of myocardial apoptosis by crude extract from Flos Puerariae (FPE) in experimental diabetic mice. Methods: Experimental diabetic model was induced by intraperitoneally injection of streptozotocin (STZ, 50 mg/kg/day) for five consecutive days in C57BL/6J mice. FPE (100, 200 mg/kg) was orally administrated once a day for ten weeks. Cardiac structure changes, apoptosis, superoxide production, NADPH oxidase subunits expression (gp91(phox), p47(phox), and p67(phox)), and related regulatory factors were assessed in the heart of mice. Results: Diabetic mice were characterized by high blood glucose (>= 11.1 mmol/L) and reduced body weight. In the end of the experiment, aberrant myofilament structure, as well as TUNEL positive cardiac cells coupled with increased Bax/Bcl-2 ratio and Caspase-3 expression was found in diabetic mice. Moreover, ROS formation, the ratio of NADP(+)/NADPH and NADPH oxidase subunits expression of gp91(phox) and p47(phox), lipid peroxidation level was significantly increased, while antioxidant enzyme SOD and GSH-Px activity were reduced in the myocardial tissue of diabetic mice. In contrast, treatment with FPE resulted in a normalized glucose and weight profile. FPE administration also preserved myocardial structure and reduced apoptotic cardiac cell death in diabetic mice. The elevated markers of oxidative stress were significantly reversed by FPE supplementation. Further, FPE treatment markedly inhibited the increased Bax/Bcl-2 ratio and Caspase-3 expression, as well as suppressed JNK and P38 MAPK activation in the heart of diabetic mice. Conclusions: Our data demonstrate for the first time that FPE may have therapeutic potential for STZ-induced diabetic cardiomyopathy through preventing myocardial apoptosis via attenuation oxidative stress. And this effect is probably mediated by JNK and P38 MAPK signaling pathway.	[Yu, Wei; Zha, Wenliang; Guo, Shuang; Cheng, Hongke; Wu, Jiliang; Liu, Chao] Hubei Univ Sci & Technol, Hubei Prov Key Lab Cardiovasc Cerebrovasc & Metab, Xianning, Peoples R China	Hubei University of Science & Technology	Wu, JL (corresponding author), Hubei Univ Sci & Technol, Hubei Prov Key Lab Cardiovasc Cerebrovasc & Metab, Xianning, Peoples R China.	xywjl@163.com; xn_liuchao@163.com			National Natural Science Foundation of China [31101026]; Hubei Universities of outstanding young scientific and technological innovation team plans [T201213]; Hubei Province Natural Science Fund Project of outstanding youth project [2012FFA005]; Young talent project of Hubei Province Education Office [Q20122804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Universities of outstanding young scientific and technological innovation team plans; Hubei Province Natural Science Fund Project of outstanding youth project; Young talent project of Hubei Province Education Office	This work was supported by grants from the National Natural Science Foundation of China to Dr. Chao Liu (No. 31101026), Hubei Universities of outstanding young scientific and technological innovation team plans to Dr. Chao Liu (No. T201213), Hubei Province Natural Science Fund Project of outstanding youth project to Dr. Chao Liu (No. 2012FFA005), Young talent project of Hubei Province Education Office to Dr. Wei Yu (No. Q20122804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Berry C, 2008, HEART, V94, P296, DOI 10.1136/hrt.2006.110999; Bloomgarden ZT, 2008, DIABETES CARE, V31, P1913, DOI 10.2337/dc08-zb09; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Cai Fei, 2014, African Journal of Pharmacy and Pharmacology, V8, P1; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cai Lu, 2003, Cardiovasc Toxicol, V3, P219, DOI 10.1385/CT:3:3:219; Chang Sheng-Huang, 2011, Evid Based Complement Alternat Med, V2011, P950150, DOI 10.1093/ecam/neq075; Chavali V, 2013, DIABET METAB SYND OB, V6, P151, DOI 10.2147/DMSO.S30968; Engel D, 2004, AM J PHYSIOL-HEART C, V287, pH1303, DOI 10.1152/ajpheart.00053.2004; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Han T, 2012, FOOD CHEM TOXICOL, V50, P409, DOI 10.1016/j.fct.2011.10.066; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Jie BZ, 2012, MOL CELL BIOCHEM, V370, P35, DOI 10.1007/s11010-012-1395-7; Kuo WW, 2013, INT J CARDIOL, V168, P270, DOI 10.1016/j.ijcard.2012.09.080; Lakshmanan AP, 2012, BIOCHEM PHARMACOL, V83, P653, DOI 10.1016/j.bcp.2011.11.018; Lee KT, 2000, ARCH PHARM RES, V23, P461, DOI 10.1007/BF02976573; Lee MK, 2001, AM J CHINESE MED, V29, P343, DOI 10.1142/S0192415X01000368; Li CJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-73; Li D, 2013, MOL VIS, V19, P1999; Li ZH, 2007, J CLIN BIOCHEM NUTR, V41, P58, DOI 10.3164/jcbn.2007008; Litwin SE, 2013, DIABETES, V62, P3329, DOI 10.2337/db13-0683; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Rajamani U, 2010, AM J PHYSIOL-CELL PH, V299, pC139, DOI 10.1152/ajpcell.00020.2010; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Reinking BE, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-43; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Soetikno V, 2012, EUR J PHARM SCI, V47, P604, DOI 10.1016/j.ejps.2012.04.018; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; Yong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073428; Yu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052013	39	28	36	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98044	10.1371/journal.pone.0098044	http://dx.doi.org/10.1371/journal.pone.0098044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865768	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100031
J	Campbell, MD; Walker, M; Trenell, MI; Luzio, S; Dunseath, G; Tuner, D; Bracken, RM; Bain, SC; Russell, M; Stevenson, EJ; West, DJ				Campbell, Matthew D.; Walker, Mark; Trenell, Michael I.; Luzio, Steven; Dunseath, Gareth; Tuner, Daniel; Bracken, Richard M.; Bain, Stephen C.; Russell, Mark; Stevenson, Emma J.; West, Daniel J.			Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE; EXERCISE; CHILDREN; HYPERGLYCEMIA; RESPONSES; IL-6; BLOOD; INTERLEUKIN-6; CARBOHYDRATE; INDIVIDUALS	Aim: To examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients. Methods: This was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (2462 years, HbA1c 7.7 +/- 0.4%/61 +/- 4 mmol.l(-1)) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at similar to 08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg(-1)BM; 380 +/- 10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1 +/- 0.9% VO2peak. At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate. kg(-1)BM; 660 +/- 21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, beta-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-alpha concentrations were measured for 180 minutes post-meal. Results: All participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p, <0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose >= 8.0 mmol. l(-1); 50% n = 6, Full n = 3). beta-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-alpha concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = -0.484, p = 0.017). Conclusions: Heavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-alpha and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances.	[Campbell, Matthew D.; Russell, Mark; Stevenson, Emma J.; West, Daniel J.] Northumbria Univ, Fac Hlth & Life Sci, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Walker, Mark] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Trenell, Michael I.] Newcastle Univ, Fac Med, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Luzio, Steven; Dunseath, Gareth; Bain, Stephen C.] Swansea Univ, Coll Med, Diabet Res Grp, Swansea, W Glam, Wales; [Tuner, Daniel; Bracken, Richard M.] Swansea Univ, Coll Engn, Appl Sports Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales	Northumbria University; Newcastle University - UK; Newcastle University - UK; Swansea University; Swansea University	West, DJ (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	d.j.west@northumbria.ac.uk	Campbell, Matthew/AAZ-2997-2021; Russell, Mark/M-1652-2019; Bracken, Rich/AAC-2586-2021; Luzio, Stephen/AAD-8038-2020; West, Daniel/O-4127-2014	Russell, Mark/0000-0002-7305-1090; Bracken, Rich/0000-0002-6986-6449; Luzio, Stephen/0000-0002-7206-6530; West, Daniel/0000-0003-2246-4925; Dunseath, Gareth/0000-0001-6022-862X; Trenell, Michael/0000-0001-8253-5620; Campbell, Matthew/0000-0001-5883-5041	Diabetes UK; MRC [MC_G0802536] Funding Source: UKRI; Diabetes UK [11/0004334] Funding Source: researchfish; Medical Research Council [MC_G0802536] Funding Source: researchfish; National Institute for Health Research [SRF-2011-04-017] Funding Source: researchfish; NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish	Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Newcastle Biomedical Research Centre	This study was funded by Diabetes UK (www.diabetesorg.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALASSE EO, 1989, DIABETES METAB REV, V5, P247, DOI 10.1002/dmr.5610050304; Bracken RM, 2011, DIABETIC MED, V28, P218, DOI 10.1111/j.1464-5491.2010.03162.x; Brown RJ, 2008, DIABETES CARE, V31, P1403, DOI 10.2337/dc08-0575; Campbell MD, 2013, DIABETES CARE, V36, P2217, DOI 10.2337/dc12-2467; Chu LS, 2011, PHYSICIAN SPORTSMED, V39, P64, DOI 10.3810/psm.2011.05.1896; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; de Rekeneire N, 2006, DIABETES CARE, V29, P1902, DOI 10.2337/dc05-2327; DIAMOND MP, 1989, FERTIL STERIL, V52, P204; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; DRENTH JPH, 1995, J APPL PHYSIOL, V79, P1497, DOI 10.1152/jappl.1995.79.5.1497; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Febbraio MA, 2005, EXERC SPORT SCI REV, V33, P114, DOI 10.1097/00003677-200507000-00003; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Galassetti PR, 2006, PEDIATR DIABETES, V7, P16, DOI 10.1111/j.1399-543X.2006.00140.x; Galassetti PR, 2006, AM J PHYSIOL-ENDOC M, V290, pE833, DOI 10.1152/ajpendo.00445.2005; Hopkins W., 2006, SPORTSCIENCE, V10, P63; Jentjens R, 2003, SPORTS MED, V33, P117, DOI 10.2165/00007256-200333020-00004; Kalra PR, 2002, INT J CARDIOL, V85, P125, DOI 10.1016/S0167-5273(02)00241-3; Karavanaki K, 2012, CLIN BIOCHEM, V45, P1383, DOI 10.1016/j.clinbiochem.2012.05.003; Karavanaki K, 2011, ENDOCR J, V58, P1045, DOI 10.1507/endocrj.EJ11-0024; Khani S, 2001, CLIN SCI, V101, P739, DOI 10.1042/cs1010739; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; McGarry J, 1996, JAMA-J AM MED ASSOC, P19; NehlsenCannarella SL, 1997, J APPL PHYSIOL, V82, P1662, DOI 10.1152/jappl.1997.82.5.1662; Nemet D, 2002, PEDIATRICS, V110, P681, DOI 10.1542/peds.110.4.681; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Rabasa-Lhoret R, 2001, DIABETES CARE, V24, P625, DOI 10.2337/diacare.24.4.625; Rosa JS, 2008, PEDIATR DIABETES, V9, P9, DOI 10.1111/j.1399-5448.2007.00243.x; Rosa JS, 2011, PEDIATR DIABETES, V12, P464, DOI 10.1111/j.1399-5448.2010.00724.x; Rosa JS, 2010, J APPL PHYSIOL, V108, P334, DOI 10.1152/japplphysiol.01083.2009; SPRENGER H, 1992, CLIN IMMUNOL IMMUNOP, V63, P188, DOI 10.1016/0090-1229(92)90012-D; STOUTHARD JML, 1995, AM J PHYSIOL-ENDOC M, V268, pE813, DOI 10.1152/ajpendo.1995.268.5.E813; Targher G, 2001, DIABETES CARE, V24, P956, DOI 10.2337/diacare.24.5.956; Tonoli C, 2012, SPORTS MED, V42, P1059, DOI 10.2165/11635380-000000000-00000; Viardot A, 2007, ENDOCRINOLOGY, V148, P346, DOI 10.1210/en.2006-0686; Walter R, 2010, ACSMS GUIDELINES EXE; West DJ, 2011, J SPORT SCI, V29, P279, DOI 10.1080/02640414.2010.531753; West DJ, 2010, J SPORT SCI, V28, P781, DOI 10.1080/02640411003734093	43	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97143	10.1371/journal.pone.0097143	http://dx.doi.org/10.1371/journal.pone.0097143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858952	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336839400009
J	Miller, AH; Jones, JF; Drake, DF; Tian, H; Unger, ER; Pagnoni, G				Miller, Andrew H.; Jones, James F.; Drake, Daniel F.; Tian, Hao; Unger, Elizabeth R.; Pagnoni, Giuseppe			Decreased Basal Ganglia Activation in Subjects with Chronic Fatigue Syndrome: Association with Symptoms of Fatigue	PLOS ONE			English	Article							INTERFERON-ALPHA; FUNCTIONAL-ANATOMY; REWARD; BRAIN; DISORDERS; PATHOGENESIS; ANHEDONIA; RESPONSES; CIRCUITS; DISEASE	Reduced basal ganglia function has been associated with fatigue in neurologic disorders, as well as in patients exposed to chronic immune stimulation. Patients with chronic fatigue syndrome (CFS) have been shown to exhibit symptoms suggestive of decreased basal ganglia function including psychomotor slowing, which in turn was correlated with fatigue. In addition, CFS patients have been found to exhibit increased markers of immune activation. In order to directly test the hypothesis of decreased basal ganglia function in CFS, we used functional magnetic resonance imaging to examine neural activation in the basal ganglia to a reward-processing (monetary gambling) task in a community sample of 59 male and female subjects, including 18 patients diagnosed with CFS according to 1994 CDC criteria and 41 non-fatigued healthy controls. For each subject, the average effect of winning vs. losing during the gambling task in regions of interest (ROI) corresponding to the caudate nucleus, putamen, and globus pallidus was extracted for group comparisons and correlational analyses. Compared to non-fatigued controls, patients with CFS exhibited significantly decreased activation in the right caudate (p = 0.01) and right globus pallidus (p = 0.02). Decreased activation in the right globus pallidus was significantly correlated with increased mental fatigue (r(2) = 0.49, p = 0.001), general fatigue (r(2) = 0.34, p = 0.01) and reduced activity (r(2) = 0.29, p = 0.02) as measured by the Multidimensional Fatigue Inventory. No such relationships were found in control subjects. These data suggest that symptoms of fatigue in CFS subjects were associated with reduced responsivity of the basal ganglia, possibly involving the disruption of projections from the globus pallidus to thalamic and cortical networks.	[Miller, Andrew H.; Drake, Daniel F.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Jones, James F.; Tian, Hao; Unger, Elizabeth R.] Ctr Dis Control & Prevent, Chron Viral Dis Branch, Atlanta, GA USA; [Pagnoni, Giuseppe] Univ Modena & Reggio Emilia, Dept Neurosci, Modena, Italy	Emory University; Centers for Disease Control & Prevention - USA; Universita di Modena e Reggio Emilia	Miller, AH (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	amill02@emory.edu	Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091; Unger, Elizabeth/0000-0002-2925-5635	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Bruck A, 2001, NEUROSCI LETT, V311, P81, DOI 10.1016/S0304-3940(01)02124-3; Bryclon L, 2008, BIOL PSYCHIAT, V63, P1022, DOI 10.1016/j.biopsych.2007.12.007; Cannon JG, 1999, J CLIN IMMUNOL, V19, P414, DOI 10.1023/A:1020558917955; Capuron L, 2012, ARCH GEN PSYCHIAT, V69, P1044, DOI 10.1001/archgenpsychiatry.2011.2094; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chaudhuri A, 2004, PROSTAG LEUKOTR ESS, V71, P181, DOI 10.1016/j.plefa.2004.03.009; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Eisenberger NI, 2010, BIOL PSYCHIAT, V68, P748, DOI 10.1016/j.biopsych.2010.06.010; Farrar AM, 2008, NEUROSCIENCE, V152, P321, DOI 10.1016/j.neuroscience.2007.12.034; Felger JC, 2013, NEUROPSYCHOPHARMACOL, V38, P2179, DOI 10.1038/npp.2013.115; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; First M. B., 1997, STRUCTURED CLIN INTE; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Fritz-French C, 2012, CYTOKINE GROWTH F R, V23, P7, DOI 10.1016/j.cytogfr.2012.01.001; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; GLICK SD, 1982, BRAIN RES, V234, P53, DOI 10.1016/0006-8993(82)90472-3; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kirsch-Darrow L, 2011, PARKINSONISM RELAT D, V17, P182, DOI 10.1016/j.parkreldis.2010.12.011; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lou JS, 2001, MOVEMENT DISORD, V16, P190, DOI 10.1002/mds.1042; Maes M, 2012, J AFFECT DISORDERS, V136, P933, DOI 10.1016/j.jad.2011.09.004; Majer M, 2008, PSYCHOSOM MED, V70, P829, DOI 10.1097/PSY.0b013e31817b9793; Miller JM, 2006, AM J PSYCHIAT, V163, P786, DOI 10.1176/appi.ajp.163.5.786; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Patarca-Montero R, 2001, Appl Neuropsychol, V8, P51, DOI 10.1207/S15324826AN0801_7; PETERSON BS, 1993, MAGN RESON IMAGING, V11, P493, DOI 10.1016/0730-725X(93)90468-S; Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19; Reeves William C, 2007, Popul Health Metr, V5, P5; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Rho MB, 1995, BRAIN BEHAV IMMUN, V9, P366, DOI 10.1006/brbi.1995.1034; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith KS, 2011, P NATL ACAD SCI USA, V108, pE255, DOI 10.1073/pnas.1101920108; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Stern RA, 2000, NEUROPSYCHIATRIC MAN; Wagner David L., 2005, P8; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	51	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98156	10.1371/journal.pone.0098156	http://dx.doi.org/10.1371/journal.pone.0098156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858857	Green Published, gold			2022-12-27	WOS:000336839400047
J	Tomita, T; Yasui-Furukori, N; Nakagami, T; Tsuchimine, S; Ishioka, M; Kaneda, A; Sugawara, N; Kaneko, S				Tomita, Tetsu; Yasui-Furukori, Norio; Nakagami, Taku; Tsuchimine, Shoko; Ishioka, Masamichi; Kaneda, Ayako; Sugawara, Norio; Kaneko, Sunao			The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; CLINICAL PHARMACOKINETICS; TRICYCLIC ANTIDEPRESSANTS; SERUM CONCENTRATIONS; REUPTAKE INHIBITORS; TREATMENT RESPONSE; POLYMORPHISM; PROMOTER; EFFICACY; PHARMACOGENETICS	Introduction: The efficacy of treatment with selective serotonin reuptake inhibitors in patients with major depressive disorder (MDD) can differ depending on the patient's serotonin transporter-linked polymorphic region (5-HTTLPR) genotype, and the effects of varying plasma concentrations of drugs can also vary. We investigated the association between the paroxetine plasma concentration and clinical response in patients with different 5-HTTLPR genotypes. Methods: Fifty-one patients were enrolled in this study. The Montgomery-Asberg Depression Rating Scale (MADRS) was used to evaluate patients at 0, 1, 2, 4, and 6 weeks. The patients' paroxetine plasma concentrations at week 6 were measured using high-performance liquid chromatography. Additionally, their 5-HTTLPR polymorphisms (alleles S and L) were analyzed using a polymerase chain reaction with specific primers. We divided the participants into two groups based on their L haplotype: the SS group and the SL and LL group. We performed single and multiple regression analyses to investigate the associations between MADRS improvement and paroxetine plasma concentrations or other covariates for each group. Results: There were no significant differences between the two groups with regard to demographic or clinical data. In the SS group, the paroxetine plasma concentration was significantly negatively correlated with improvement in MADRS at week 6. In the SL and LL group, the paroxetine plasma concentration was significantly positively correlated with improvement in MADRS at week 6 according to the results of the single regression analysis; however, it was not significantly correlated with improvement in MADRS at week 6 according to the results of the multiple regression analysis. Conclusion: Among patients with MDD who do not respond to paroxetine, a lower plasma concentration or a lower oral dose of paroxetine might be more effective in those with the SS genotype, and a higher plasma concentration might be more effective in those with the SL or LL genotype.	[Tomita, Tetsu; Yasui-Furukori, Norio; Nakagami, Taku; Tsuchimine, Shoko; Ishioka, Masamichi; Kaneda, Ayako; Sugawara, Norio; Kaneko, Sunao] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan	Hirosaki University	Yasui-Furukori, N (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.	yasufuru@cc.hirosaki-u.ac.jp	Tomita, Tetsu/G-4806-2014		Japan Society for the Promotion of Research (JSPS) [24590652]; Mitsubishi Pharma Research Foundation	Japan Society for the Promotion of Research (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Pharma Research Foundation	This study was funded by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Research (JSPS, #24590652) and Mitsubishi Pharma Research Foundation. The funding sources played no role in the study design, in the collection, analysis, or interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.	Abela JRZ, 2005, J PERS DISORD, V19, P68, DOI 10.1521/pedi.19.1.68.62177; AMDISEN A, 1980, THER DRUG MONIT, V2, P73, DOI 10.1097/00007691-198001000-00009; AMDISEN A, 1977, CLIN PHARMACOKINET, V2, P73, DOI 10.2165/00003088-197702020-00001; AMSTERDAM J, 1980, AM J PSYCHIAT, V137, P653; Andersen B, 1990, J AFFECT DISORDERS, V18, P289; Antonijevic IA, 2006, PSYCHONEUROENDOCRINO, V31, P1, DOI 10.1016/j.psyneuen.2005.04.004; Arias B, 2001, MOL PSYCHIATR, V6, P239, DOI 10.1038/sj.mp.4000818; Baffa A, 2010, NEUROPSYCHOBIOLOGY, V62, P121, DOI 10.1159/000317285; Bonvicini C, 2010, PROG NEURO-PSYCHOPH, V34, P934, DOI 10.1016/j.pnpbp.2010.04.020; BROWNE TR, 1978, AM J HOSP PHARM, V35, P1048, DOI 10.1093/ajhp/35.9.1048; BURROWS GD, 1988, J CLIN PSYCHIAT, V49, P18; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Dreimuller N, 2012, PHARMACOPSYCHIATRY, V45, P108, DOI 10.1055/s-0031-1291347; Eggart V, 2011, PSYCHOPHARMACOLOGY, V217, P297, DOI 10.1007/s00213-011-2319-z; Freeman DJ, 1997, CLIN PHARMACOKINET, V32, P93, DOI 10.2165/00003088-199732020-00001; Gex-Fabry M, 2007, PROG NEURO-PSYCHOPH, V31, P892, DOI 10.1016/j.pnpbp.2007.02.003; Gilles M, 2005, PHARMACOPSYCHIATRY, V38, P118, DOI 10.1055/s-2005-864121; GLASSMAN AH, 1985, AM J PSYCHIAT, V142, P155; Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7; Gunasekara NS, 1998, DRUGS, V55, P85, DOI 10.2165/00003495-199855010-00007; HADDOCK RE, 1989, ACTA PSYCHIAT SCAND, V80, P24, DOI 10.1111/j.1600-0447.1989.tb07163.x; Heils A, 1996, J NEUROCHEM, V66, P2621; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Huezo-Diaz P, 2009, BRIT J PSYCHIAT, V195, P30, DOI 10.1192/bjp.bp.108.062521; Illi A, 2011, EUR ARCH PSY CLIN N, V261, P95, DOI 10.1007/s00406-010-0126-x; KAYE CM, 1989, ACTA PSYCHIAT SCAND, V80, P60, DOI 10.1111/j.1600-0447.1989.tb07176.x; Kunugi H, 1997, MOL PSYCHIATR, V2, P457, DOI 10.1038/sj.mp.4000334; Laje G, 2009, PSYCHIAT SERV, V60, P1446, DOI 10.1176/appi.ps.60.11.1446; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lieberman R, 1996, THER DRUG MONIT, V18, P423, DOI 10.1097/00007691-199608000-00019; LIEBERMAN R, 1993, THER DRUG MONIT, V15, P498, DOI 10.1097/00007691-199312000-00008; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Lundmark J, 2000, ACTA PSYCHIAT SCAND, V101, P354, DOI 10.1034/j.1600-0447.2000.101005354.x; Maron E, 2009, EUR NEUROPSYCHOPHARM, V19, P451, DOI 10.1016/j.euroneuro.2009.01.010; Min WJ, 2009, PSYCHOPHARMACOLOGY, V205, P409, DOI 10.1007/s00213-009-1550-3; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Muller MJ, 2003, PHARMACOPSYCHIATRY, V36, P98; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Niitsu T, 2013, PROG NEURO-PSYCHOPH, V45, P183, DOI 10.1016/j.pnpbp.2013.05.011; Normann C, 2004, PHARMACOPSYCHIATRY, V37, P123, DOI 10.1055/s-2004-818990; PERRY PJ, 1987, CLIN PHARMACOKINET, V13, P381, DOI 10.2165/00003088-198713060-00003; PERRY PJ, 1994, J CLIN PSYCHOPHARM, V14, P230; Pfuhlmann B, 2007, J NEURAL TRANSM-SUPP, P287; RODIGHIERO V, 1989, CLIN PHARMACOKINET, V16, P27, DOI 10.2165/00003088-198916010-00002; Serretti A, 2007, MOL PSYCHIATR, V12, P247, DOI 10.1038/sj.mp.4001926; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Takahashi N, 2004, HUM PSYCHOPHARM CLIN, V19, P187, DOI 10.1002/hup.576; TASKER TCG, 1989, ACTA PSYCHIAT SCAND, V80, P152, DOI 10.1111/j.1600-0447.1989.tb07201.x; Umene-Nakano W, 2010, J PSYCHOPHARMACOL, V24, P1764, DOI 10.1177/0269881109106899; van Praag HM, 2008, EUR ARCH PSY CLIN N, V258, P29, DOI 10.1007/s00406-008-2006-1; VANHARTEN J, 1993, CLIN PHARMACOKINET, V24, P203, DOI 10.2165/00003088-199324030-00003; Wilkie MJV, 2009, PHARMACOGENOMICS J, V9, P61, DOI 10.1038/sj.tpj.6500491; Won ES, 2012, NEUROPSYCHOBIOLOGY, V66, P221, DOI 10.1159/000341876; Yasui-Furukori N, 2007, THER DRUG MONIT, V29, P45, DOI 10.1097/FTD.0b013e31802bb20d; Yasui-Furukori N, 2007, EUR J CLIN PHARMACOL, V63, P51, DOI 10.1007/s00228-006-0217-9; Yasui-Furukori N, 2011, HUM PSYCHOPHARM CLIN, V26, P602, DOI 10.1002/hup.1252	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98099	10.1371/journal.pone.0098099	http://dx.doi.org/10.1371/journal.pone.0098099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858363	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400040
J	Vallejo, G; La Greca, AD; Tarifa-Reischle, IC; Mestre-Citrinovitz, AC; Ballare, C; Beato, M; Saragueta, P				Vallejo, Griselda; La Greca, Alejandro D.; Tarifa-Reischle, Inti C.; Mestre-Citrinovitz, Ana C.; Ballare, Cecilia; Beato, Miguel; Saragueeta, Patricia			CDC2 Mediates Progestin Initiated Endometrial Stromal Cell Proliferation: A PR Signaling to Gene Expression Independently of Its Binding to Chromatin	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; CYCLIN D1; STEROID-HORMONES; CROSS-TALK; IN-VIVO; ACTIVATION; PROMOTER; RAT; ESTRADIOL; KINASES	Although non-genomic steroid receptor pathways have been studied over the past decade, little is known about the direct gene expression changes that take place as a consequence of their activation. Progesterone controls proliferation of rat endometrial stromal cells during the peri-implantation phase of pregnancy. We showed that picomolar concentration of progestin R5020 mimics this control in UIII endometrial stromal cells via ERK1-2 and AKT activation mediated by interaction of Progesterone Receptor (PR) with Estrogen Receptor beta (ERb) and without transcriptional activity of endogenous PR and ER. Here we identify early downstream targets of cytoplasmic PR signaling and their possible role in endometrial stromal cell proliferation. Microarray analysis of global gene expression changes in UIII cells treated for 45 min with progestin identified 97 up-and 341 down-regulated genes. The most over-represented molecular functions were transcription factors and regulatory factors associated with cell proliferation and cell cycle, a large fraction of which were repressors down-regulated by hormone. Further analysis verified that progestins regulate Ccnd1, JunD, Usf1, Gfi1, Cyr61, and Cdkn1b through PR-mediated activation of ligand-free ER, ERK1-2 or AKT, in the absence of genomic PR binding. ChIP experiments show that progestin promoted the interaction of USF1 with the proximal promoter of the Cdc2 gene. Usf1 knockdown abolished Cdc2 progestin-dependent transcriptional regulation and cell proliferation, which also blocked Cdc2 knockdown. We conclude that progestin-induced proliferation of endometrial stromal cells is mediated by ERK1-2 and AKT dependent early regulation of USF1, which directly induces Cdc2. To our knowledge, this is the first description of early target genes of progestin-activated classical PR via crosstalk with protein kinases and independently of hormone receptor binding to the genomic targets.	[Vallejo, Griselda; La Greca, Alejandro D.; Tarifa-Reischle, Inti C.; Mestre-Citrinovitz, Ana C.; Saragueeta, Patricia] IByME Conicet, Inst Biol & Med Expt, Buenos Aires, DF, Argentina; [Ballare, Cecilia; Beato, Miguel] CRG, Barcelona, Spain; [Beato, Miguel] UPF, Barcelona, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Saragueta, P (corresponding author), IByME Conicet, Inst Biol & Med Expt, Buenos Aires, DF, Argentina.	sarag@dna.uba.ar	Beato, Miguel/B-5564-2015; Ballare, Cecilia/F-2593-2016	Beato, Miguel/0000-0002-2878-2222; Ballare, Cecilia/0000-0002-9442-807X; Mestre, Ana Cecilia/0000-0001-8027-3487	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 5-34086, PID 88]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP); Ministerio de Educacion y Ciencia (MEC) [BMC 2003-02902]; Consolider [CSD2006-00049]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants to P. S. from Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 5-34086 and PID 88) Argentina and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2005-2006); and to M. B. from the Ministerio de Educacion y Ciencia (MEC) BMC 2003-02902, Consolider (CSD2006-00049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Breitkreutz BJ, 2001, GENOME BIOL, V2; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Clarkl DE, 2001, EMBO J, V20, P3484, DOI 10.1093/emboj/20.13.3484; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; COHEN H, 1993, EUR J CELL BIOL, V61, P116; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gazel A, 2008, J CELL PHYSIOL, V215, P292, DOI 10.1002/jcp.21394; Gerstein M, 2012, NATURE, V489, P208, DOI 10.1038/489208b; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; GRUMMER R, 1994, BIOL REPROD, V51, P1109, DOI 10.1095/biolreprod51.6.1109; Hu X, 2011, CELL PROLIFERAT, V44, P205, DOI 10.1111/j.1365-2184.2011.00753.x; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; North S, 1999, ONCOGENE, V18, P1945, DOI 10.1038/sj.onc.1202506; PARR MB, 1989, J REPROD FERTIL, V85, P105, DOI 10.1530/jrf.0.0850105; Psychoyos A, 1973, Vitam Horm, V31, P201; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Said TK, 1997, ENDOCRINOLOGY, V138, P3933, DOI 10.1210/en.138.9.3933; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Strutt H, 1999, METH MOL B, V119, P455; Vallejo G, 2005, MOL ENDOCRINOL, V19, P3023, DOI 10.1210/me.2005-0016; Vallejo G, 2010, J CELL PHYSIOL, V222, P127, DOI 10.1002/jcp.21929; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; ZHANG ZM, 1994, ENDOCRINOLOGY, V135, P1256, DOI 10.1210/en.135.3.1256	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97311	10.1371/journal.pone.0097311	http://dx.doi.org/10.1371/journal.pone.0097311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859236	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400012
J	Beiser, KU; Glaser, A; Kleinschmidt, K; Scholl, I; Roth, R; Li, L; Gretz, N; Mechtersheimer, G; Karperien, M; Marchini, A; Richter, W; Rappold, GA				Beiser, Katja U.; Glaser, Anne; Kleinschmidt, Kerstin; Scholl, Isabell; Roeth, Ralph; Li, Li; Gretz, Norbert; Mechtersheimer, Gunhild; Karperien, Marcel; Marchini, Antonio; Richter, Wiltrud; Rappold, Gudrun A.			Identification of Novel SHOX Target Genes in the Developing Limb Using a Transgenic Mouse Model	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; HOMEOBOX GENE; LERI-WEILL; CHONDROCYTE PROLIFERATION; TURNER-SYNDROME; EXPRESSION; PHENOTYPES; MUTATIONS; FAMILY; DYSCHONDROSTEOSIS	Deficiency of the human short stature homeobox-containing gene (SHOX) has been identified in several disorders characterized by reduced height and skeletal anomalies such as Turner syndrome, Leri-Weill dyschondrosteosis and Langer mesomelic dysplasia as well as isolated short stature. SHOX acts as a transcription factor during limb development and is expressed in chondrocytes of the growth plates. Although highly conserved in vertebrates, rodents lack a SHOX orthologue. This offers the unique opportunity to analyze the effects of human SHOX expression in transgenic mice. We have generated a mouse expressing the human SHOXa cDNA under the control of a murine Col2a1 promoter and enhancer (Tg(Col2a1-SHOX)). SHOX and marker gene expression as well as skeletal phenotypes were characterized in two transgenic lines. No significant skeletal anomalies were found in transgenic compared to wildtype mice. Quantitative and in situ hybridization analyses revealed that Tg(Col2a1-SHOX), however, affected extracellular matrix gene expression during early limb development, suggesting a role for SHOX in growth plate assembly and extracellular matrix composition during long bone development. For instance, we could show that the connective tissue growth factor gene Ctgf, a gene involved in chondrogenic and angiogenic differentiation, is transcriptionally regulated by SHOX in transgenic mice. This finding was confirmed in human NHDF and U2OS cells and chicken micromass culture, demonstrating the value of the SHOX-transgenic mouse for the characterization of SHOX-dependent genes and pathways in early limb development.	[Beiser, Katja U.; Glaser, Anne; Scholl, Isabell; Roeth, Ralph; Marchini, Antonio; Rappold, Gudrun A.] Univ Heidelberg Hosp, Dept Human Mol Genet, Heidelberg, Germany; [Kleinschmidt, Kerstin; Richter, Wiltrud] Orthopaed Univ Hosp, Div Expt Orthopaed, Heidelberg, Germany; [Li, Li; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr ZMF, Mannheim, Germany; [Mechtersheimer, Gunhild] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Karperien, Marcel] Univ Twente, Dept Dev Bioengn, NL-7500 AE Enschede, Netherlands; [Marchini, Antonio] German Canc Res Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Twente; Helmholtz Association; German Cancer Research Center (DKFZ)	Rappold, GA (corresponding author), Univ Heidelberg Hosp, Dept Human Mol Genet, Heidelberg, Germany.	gudrun.rappold@med.uni-heidelberg.de	Marchini, Antonio/AAG-7151-2019; Marchini, Antonio/ABD-3328-2020; Richter, Wiltrud/V-3217-2017; Karperien, Marcel/R-3270-2018	Richter, Wiltrud/0000-0003-4694-2768; Karperien, Marcel/0000-0003-0751-0604; Marchini, Antonio/0000-0003-3157-4552	Deutsche Forschungsgemeinschaft [RA 380/13-2]; Baden-Wurttemberg Foundation [1.1601.07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (grant number RA 380/13-2; URL: www.dfg.de) and the Baden-Wurttemberg Foundation (grant number 1.1601.07; URL: www.bwstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benito-Sanz S, 2012, EUR J HUM GENET, V20, P125, DOI 10.1038/ejhg.2011.210; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blum WF, 2007, J CLIN ENDOCR METAB, V92, P219, DOI 10.1210/jc.2006-1409; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Chen J, 2009, J MED GENET, V46, P834, DOI 10.1136/jmg.2009.067785; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Decker E, 2011, HUM MOL GENET, V20, P1524, DOI 10.1093/hmg/ddr030; Dhar A., 2010, Experimental Oncology, V32, P2; Durand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018115; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jorge AAL, 2007, CLIN ENDOCRINOL, V66, P130, DOI 10.1111/j.1365-2265.2006.02698.x; Kanaka-Gantenbein Christina, 2004, Horm Res, V61, P205, DOI 10.1159/000076532; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Long FX, 2001, DEVELOPMENT, V128, P541; Marchini A, 2004, J BIOL CHEM, V279, P37103, DOI 10.1074/jbc.M307006200; Marchini A, 2007, HUM MOL GENET, V16, P3081, DOI 10.1093/hmg/ddm266; Minina E, 2001, DEVELOPMENT, V128, P4523; Munns C F, 2001, Hand Surg, V6, P13, DOI 10.1142/S0218810401000424; Munns CJF, 2004, J CLIN ENDOCR METAB, V89, P4130, DOI 10.1210/jc.2003-032230; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rappold GA, 2002, UNDERSTANDING SHOX D; Rappold G, 2007, J MED GENET, V44, P306, DOI 10.1136/jmg.2006.046581; Rosilio M, 2012, J CLIN ENDOCR METAB, V97, pE1257, DOI 10.1210/jc.2011-3460; Ross JL, 2001, J CLIN ENDOCR METAB, V86, P5674, DOI 10.1210/jc.86.12.5674; Sabherwal N, 2004, J CELL SCI, V117, P3041, DOI 10.1242/jcs.01152; Schneider KU, 2005, HUM MUTAT, V26, P44, DOI 10.1002/humu.20187; Schneider KU, 2005, AM J HUM GENET, V77, P89, DOI 10.1086/431655; Shears DJ, 2002, AM J MED GENET, V110, P153, DOI 10.1002/ajmg.10421; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Soucek O, 2011, CLIN ENDOCRINOL, V74, P445, DOI 10.1111/j.1365-2265.2010.03955.x; Stahl PD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe59; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226; Vickerman L, 2011, DEV BIOL, V350, P323, DOI 10.1016/j.ydbio.2010.11.031; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518	44	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98543	10.1371/journal.pone.0098543	http://dx.doi.org/10.1371/journal.pone.0098543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887312	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300079
J	Okada, K; Na-Ubol, M; Natakuathung, W; Roobthaisong, A; Maruyama, F; Nakagawa, I; Chantaroj, S; Hamada, S				Okada, Kazuhisa; Na-Ubol, Mathukorn; Natakuathung, Wirongrong; Roobthaisong, Amonrattana; Maruyama, Fumito; Nakagawa, Ichiro; Chantaroj, Siriporn; Hamada, Shigeyuki			Comparative Genomic Characterization of a Thailand-Myanmar Isolate, MS6, of Vibrio cholerae O1 El Tor, Which Is Phylogenetically Related to a "US Gulf Coast" Clone	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; PHAGE INTEGRATION; GENE; EPIDEMIC; ISLAND; VIBRIO-CHOLERAE-O1; IDENTIFICATION; HYBRID; STRAIN; XERC	Background: The cholera outbreaks in Thailand during 2007-2010 were exclusively caused by the Vibrio cholerae O1 El Tor variant carrying the cholera toxin gene of the classical biotype. We previously isolated a V. cholerae O1 El Tor strain from a patient with diarrhea and designated it MS6. Multilocus sequence-typing analysis revealed that MS6 is most closely related to the U. S. Gulf Coast clone with the exception of two novel housekeeping genes. Methodology/Principal Findings: The nucleotide sequence of the genome of MS6 was determined and compared with those of 26 V. cholerae strains isolated from clinical and environmental sources worldwide. We show here that the MS6 isolate is distantly related to the ongoing seventh pandemic V. cholerae O1 El Tor strains. These strains differ with respect to polymorphisms in housekeeping genes, seventh pandemic group-specific markers, CTX phages, two genes encoding predicted transmembrane proteins, the presence of metY (MS6_A0927) or hchA/luxR in a highly conserved region of the V. cholerae O1 serogroup, and a superintegron (SI). We found that V. cholerae species carry either hchA/luxR or metY and that the V. cholerae O1 clade commonly possesses hchA/luxR, except for MS6 and U. S. Gulf Coast strains. These findings illuminate the evolutionary relationships among V. cholerae O1 strains. Moreover, the MS6 SI carries a quinolone-resistance gene cassette, which was closely related with those present in plasmid-borne integrons of other gram-negative bacteria. Conclusions/Significance: Phylogenetic analysis reveals that MS6 is most closely related to a U. S. Gulf Coast clone, indicating their divergence before that of the El Tor biotype strains from a common V. cholerae O1 ancestor. We propose that MS6 serves as an environmental aquatic reservoir of V. cholerae O1.	[Okada, Kazuhisa; Na-Ubol, Mathukorn; Natakuathung, Wirongrong; Roobthaisong, Amonrattana; Hamada, Shigeyuki] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand; [Okada, Kazuhisa; Hamada, Shigeyuki] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Maruyama, Fumito; Nakagawa, Ichiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Chantaroj, Siriporn] Minist Publ Hlth, Dept Med Sci DMSc, Natl Inst Hlth, Nonthaburi, Thailand	Osaka University; Tokyo Medical & Dental University (TMDU); Ministry of Public Health - Thailand	Okada, K (corresponding author), Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand.	kazuhisa@biken.osaka-u.ac.jp	Maruyama, Fumito/AAK-5928-2020; Maruyama, Fumito/F-6875-2016	Maruyama, Fumito/0000-0003-2347-616X; Okada, Kazuhisa/0000-0002-1225-7933	program of Japan Initiative for Global Research Network on Infectious Diseases by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan [22710252]; Oyama Health foundation; Department of Medical Sciences; Ministry of Public Health, Thailand	program of Japan Initiative for Global Research Network on Infectious Diseases by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Oyama Health foundation; Department of Medical Sciences; Ministry of Public Health, Thailand	This work was supported by the program of Japan Initiative for Global Research Network on Infectious Diseases by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by Grant-in-Aid for Young Scientists (B) (No. 22710252) from the MEXT of Japan, by the Oyama Health foundation, and by the Department of Medical Sciences, the Ministry of Public Health, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Belfaiza J, 1998, J BACTERIOL, V180, P250, DOI 10.1128/JB.180.2.250-255.1998; Chatterjee SN, 2004, BBA-MOL BASIS DIS, V1690, P93, DOI 10.1016/j.bbadis.2004.06.006; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; DEPAOLA A, 1992, LANCET, V339, P624, DOI 10.1016/0140-6736(92)90917-R; Dittmer JB, 2012, J BACTERIOL, V194, P5255, DOI 10.1128/JB.00952-12; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fonseca Erica L, 2008, Emerg Infect Dis, V14, P1129, DOI 10.3201/eid1407.080132; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Grim CJ, 2010, OMICS, V14, P1, DOI 10.1089/omi.2009.0087; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jermyn WS, 2002, MICROBIOL-SGM, V148, P3681, DOI 10.1099/00221287-148-11-3681; KAPER JB, 1982, J CLIN MICROBIOL, V16, P129, DOI 10.1128/JCM.16.1.129-134.1982; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; Merrell DS, 1999, MOL MICROBIOL, V34, P836, DOI 10.1046/j.1365-2958.1999.01650.x; Mujacic M, 2007, APPL ENVIRON MICROB, V73, P1014, DOI 10.1128/AEM.02429-06; Na-Ubol M, 2011, INDIAN J MED RES, V133, P387; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; Nandi B, 2005, MICROBIOL-SGM, V151, P2975, DOI 10.1099/mic.0.27995-0; O'Shea YA, 2004, J CLIN MICROBIOL, V42, P4657, DOI 10.1128/JCM.42.10.4657-4671.2004; Okada K, 2013, EMERG INFECT DIS, V19, P1015, DOI 10.3201/eid1906.120345; Okada K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030863; Okada K, 2010, AM J TROP MED HYG, V82, P875, DOI 10.4269/ajtmh.2010.09-0537; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rasouly A, 2007, J BACTERIOL, V189, P5779, DOI 10.1128/JB.00453-07; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Rowe-Magnus DA, 2002, MOL MICROBIOL, V43, P1657, DOI 10.1046/j.1365-2958.2002.02861.x; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Salim A, 2005, EMERG INFECT DIS, V11, P1758, DOI 10.3201/eid1111.041170; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; STAMATAKIS A, 2011, CURR PROTOC MOL BIOL, pch19; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; WACHSMUTH IK, 1991, LANCET, V337, P1097; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Xia RR, 2010, ANTIMICROB AGENTS CH, V54, P3471, DOI 10.1128/AAC.01668-09; Zhao YM, 2012, J CRANIOMAXILLOFAC S, V28, P28	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98120	10.1371/journal.pone.0098120	http://dx.doi.org/10.1371/journal.pone.0098120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887199	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300039
J	Tilley, LD; Krishnamurthy, S; Westwood, NJ; Ward, GE				Tilley, Lucas D.; Krishnamurthy, Shruthi; Westwood, Nicholas J.; Ward, Gary E.			Identification of TgCBAP, a Novel Cytoskeletal Protein that Localizes to Three Distinct Subcompartments of the Toxoplasma gondii Pellicle	PLOS ONE			English	Article							MEMBRANE COMPLEX; COMPONENT; PARASITE; GENE	The cytoskeletons of Toxoplasma gondii and related apicomplexan parasites are highly polarized, with apical and basal regions comprised of distinct protein complexes. Components of these complexes are known to play important roles in parasite shape, cell division, and host cell invasion. During an effort to discover the biologically relevant target of a small-molecule inhibitor of T. gondii invasion (Conoidin A), we discovered a novel cytoskeletal protein that we named TgCBAP (Conserved Basal Apical Peripheral protein). Orthologs of TgCBAP are only found in the genomes of other apicomplexans; they contain no identifiable domains or motifs and their function(s) is unknown. As a first step toward elucidating the function of this highly conserved family of proteins, we disrupted the TgCBAP gene by double homologous recombination. Parasites lacking TgCBAP are as sensitive to the effects of Conoidin A as wild-type parasites, demonstrating that TgCBAP is not the biologically relevant target of Conoidin A. However, Delta TgCBAP parasites are significantly shorter than wild-type parasites and have a growth defect in culture. Furthermore, TgCBAP has an unusual subcellular localization, forming small rings at the apical and basal ends of the parasite and localizing to punctate, ring-like structures around the parasite periphery. These data identify a new marker of the apical and basal subcompartments of T. gondii, reveal a potentially novel compartment along the parasite periphery, and identify TgCBAP as a determinant of parasite size that is required for a maximally efficient lytic cycle.	[Tilley, Lucas D.; Krishnamurthy, Shruthi; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Westwood, Nicholas J.] Univ St Andrews, Sch Chem, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] Univ St Andrews, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	University of Vermont; University of St Andrews; University of St Andrews; University of St Andrews	Ward, GE (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	Gary.Ward@uvm.edu		Ward, Gary/0000-0003-4138-3055; Westwood, Nicholas/0000-0003-0630-0138	US Public Health Service grant [AI054961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US Public Health Service grant AI054961 (GEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Barkhuff WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023977; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Boothroyd John C., 1995, MBL (Marine Biology Laboratory) Lectures in Biology, V12, P211; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Haraldsen JD, 2009, ORG BIOMOL CHEM, V7, P3040, DOI 10.1039/b901735f; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Lorestani A, 2012, CYTOSKELETON, V69, P1069, DOI 10.1002/cm.21077; Lorestani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012302; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2007, CURR OPIN MICROBIOL, V10, P349, DOI 10.1016/j.mib.2007.07.006; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Mital J, 2007, MOL MECH PARASITE IN; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; PORCHET E, 1977, Z PARASITENKD, V54, P101, DOI 10.1007/BF00380795; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Soldati D, 1996, FEBS LETT, V389, P80, DOI 10.1016/0014-5793(96)00572-8; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; VIVIER E, 1969, J CELL BIOL, V43, P329, DOI 10.1083/jcb.43.2.312	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98492	10.1371/journal.pone.0098492	http://dx.doi.org/10.1371/journal.pone.0098492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887026	Green Published, gold			2022-12-27	WOS:000336956300073
J	Zhou, L; Shi, YH; Guo, R; Liang, MG; Zhu, XY; Wang, CZ				Zhou, Lu; Shi, Yinghua; Guo, Rui; Liang, Minggen; Zhu, Xiaoyan; Wang, Chengzhang			Digital Gene-Expression Profiling Analysis of the Cholesterol-Lowering Effects of Alfalfa Saponin Extract on Laying Hens	PLOS ONE			English	Article							EGG-YOLK CHOLESTEROL; PEA APHID; RNA-SEQ; PERFORMANCE; METABOLISM; RATS; IDENTIFICATION; STEROLS; PATHWAY; CHICKEN	Background: To prevent cardiovascular disease, people are advised to limit their intake of dietary cholesterol to less than 300 mg/day. Egg consumption has been seriously reduced because of the high levels of cholesterol. The purpose of the present study was to evaluate the cholesterol-lowering effects of alfalfa saponin extract (ASE) in yolk and the molecular mechanisms underlying these effects using digital gene-expression profiling analysis. Liver and ovary tissues were isolated from laying hens fed with ASE for RNA sequencing. Results: The cholesterol content of the yolks of eggs from hens fed 120 mg/kg ASE declined considerably on day 60. Other groups (60, 240, 480 mg/kg ASE group) also showed decreases, but they were not significant. Digital gene expression generated over nine million reads per sample, producing expression data for least 12,384 genes. Among these genes, 110 genes showed greater than normal expression in the liver and 107 genes showed greater than normal expression in the ovary. Cholesterol 7 alpha-hydroxylase (Cyp7a1) and apolipoprotein H (Apoh), which act in the synthesis of bile acid and cholesterol efflux, showed more expression in the livers of hens given dietary ASE supplementation. In the ovary, levels of very low density lipoprotein receptor (Vldlr), apolipoprotein B (Apob), apovitellenin 1 (ApovldlII) and vitellogenin (VtgI, VtgII and VtgIII) in ovary decreased with dietary ASE supplementation. Conclusion: Transcriptome analysis revealed that the molecular mechanisms underlying the cholesterol-lowering effects of ASE were partially mediated by enhancement of cholesterol efflux in the liver and this reduced of cholesterol deposition in the ovary.	[Zhou, Lu; Shi, Yinghua; Guo, Rui; Liang, Minggen; Zhu, Xiaoyan; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wangcz@henau.edu.cn			China Forage and Grass Research System [CARS-35-20]	China Forage and Grass Research System	This research was supported by China Forage and Grass Research System (CARS-35-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrose S, 2010, BRIT POULTRY SCI, V51, P797, DOI 10.1080/00071668.2010.526924; Afrose S, 2011, J ANIM PHYSIOL AN N, V95, P693, DOI 10.1111/j.1439-0396.2010.01098.x; Anders S., 2010, HTSEQ ANAL HIGH THRO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Avato P, 2006, PHYTOTHER RES, V20, P454, DOI 10.1002/ptr.1876; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chowdhury SR, 2002, POULTRY SCI, V81, P1856, DOI 10.1093/ps/81.12.1856; COULSON CB, 1960, BRIT J NUTR, V14, P121, DOI 10.1079/BJN19600019; De Geyter E, 2012, PEST MANAG SCI, V68, P164, DOI 10.1002/ps.2235; Deng W, 2012, J ANIM PHYSIOL AN N, V96, P85, DOI 10.1111/j.1439-0396.2010.01125.x; Dong XF, 2007, POULTRY SCI, V86, P1955, DOI 10.1093/ps/86.9.1955; Elkin RG, 2006, WORLD POULTRY SCI J, V62, P665, DOI 10.1017/S0043933906001206; Golawska S, 2008, ENTOMOL EXP APPL, V128, P147, DOI 10.1111/j.1570-7458.2008.00709.x; GRIFFIN HD, 1992, WORLD POULTRY SCI J, V48, P101, DOI 10.1079/WPS19920010; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARGIS PS, 1988, WORLD POULTRY SCI J, V44, P17, DOI 10.1079/WPS19880002; Kaya S, 2003, J VET MED A, V50, P14, DOI 10.1046/j.1439-0442.2003.00487.x; Kim JH, 2004, POULTRY SCI, V83, P1539, DOI 10.1093/ps/83.9.1539; Klita PT, 1996, J ANIM SCI, V74, P1144; KUKSIS A, 1992, BIOCHIM BIOPHYS ACTA, V1124, P205, DOI 10.1016/0005-2760(92)90132-F; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lin KY, 2001, LIFE SCI, V69, P707, DOI 10.1016/S0024-3205(01)01164-X; LU CD, 1987, J NUTR, V117, P919, DOI 10.1093/jn/117.5.919; MALINOW MR, 1981, J CLIN INVEST, V67, P156, DOI 10.1172/JCI110008; MALINOW MR, 1977, AM J CLIN NUTR, V30, P2061, DOI 10.1093/ajcn/30.12.2061; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McDerment NA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-494; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKAUE HS, 1980, POULTRY SCI, V59, P2744, DOI 10.3382/ps.0592744; OLESZEK W, 1993, J CHEM ECOL, V19, P1063, DOI 10.1007/BF00987369; Pan J, 2007, THESIS HENAN AGR U Z; Pesti GM, 1998, POULTRY SCI, V77, P1540, DOI 10.1093/ps/77.10.1540; Ponte PIP, 2004, POULTRY SCI, V83, P810, DOI 10.1093/ps/83.5.810; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sam LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017305; SIM JS, 1984, CAN J ANIM SCI, V64, P977, DOI 10.4141/cjas84-110; Smith MF, 1999, J REPROD FERTIL, P367; Song YB, 2012, J SCI FOOD AGR, V92, P388, DOI 10.1002/jsfa.4589; Spence JD, 2012, ATHEROSCLEROSIS; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WASHBURN KW, 1974, POULTRY SCI, V53, P109, DOI 10.3382/ps.0530109; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Wu JT, 2011, AFR J PHARM PHARMACO, V5, P2444, DOI 10.5897/AJPP11.185; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Young M. D., 2010, METHOD GENE ONTOLOGY; Yu CH, 2011, J HEALTH SCI, V57, P401, DOI 10.1248/jhs.57.401; Zhang RZ, 1999, J FOOD BIOCHEM, V23, P351, DOI 10.1111/j.1745-4514.1999.tb00025.x	52	15	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98578	10.1371/journal.pone.0098578	http://dx.doi.org/10.1371/journal.pone.0098578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886784	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300089
J	Bredart, S; Cornet, A; Rakic, JM				Bredart, Serge; Cornet, Alyssa; Rakic, Jean-Marie			Recognition Memory for Colored and Black-and-White Scenes in Normal and Color Deficient Observers (Dichromats)	PLOS ONE			English	Article							VISUAL MEMORY	Color deficient (dichromat) and normal observers' recognition memory for colored and black-and-white natural scenes was evaluated through several parameters: the rate of recognition, discrimination (A'), response bias (B '' D), response confidence, and the proportion of conscious recollections (Remember responses) among hits. At the encoding phase, 36 images of natural scenes were each presented for 1 sec. Half of the images were shown in color and half in black-and-white. At the recognition phase, these 36 pictures were intermixed with 36 new images. The participants' task was to indicate whether an image had been presented or not at the encoding phase, to rate their level of confidence in his her/his response, and in the case of a positive response, to classify the response as a Remember, a Know or a Guess response. Results indicated that accuracy, response discrimination, response bias and confidence ratings were higher for colored than for black-and-white images; this advantage for colored images was similar in both groups of participants. Rates of Remember responses were not higher for colored images than for black-and-white ones, whatever the group. However, interestingly, Remember responses were significantly more often based on color information for colored than for black-and-white images in normal observers only, not in dichromats.	[Bredart, Serge; Cornet, Alyssa] Univ Liege, Dept Psychol, Liege, Belgium; [Rakic, Jean-Marie] Univ Hosp, Dept Ophthalmol, Liege, Belgium	University of Liege; University of Liege	Bredart, S (corresponding author), Univ Liege, Dept Psychol, Liege, Belgium.	serge.bredart@ulg.ac.be		Bredart, Serge/0000-0002-2250-5603	University of Liege [OTP PSYCEPCO01-01]	University of Liege(University of Liege)	The research was funded by the University of Liege (OTP PSYCEPCO01-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeman R., 1986, OBSERVING INTERACTIO, DOI [10.1017/cbo9780511527685, DOI 10.1017/CBO9780511527685]; Bonnardel V, 2014, ENCY COLOR SCI TECHN; Bonnardel V, 2006, VISUAL NEUROSCI, V23, P637, DOI 10.1017/S0952523806233558; Bosten JM, 2005, CURR BIOL, V15, pR950, DOI 10.1016/j.cub.2005.11.031; Gardiner JM, 1998, CONSCIOUS COGN, V7, P1, DOI 10.1006/ccog.1997.0321; Gardiner JM, 2000, OXFORD HDB MEMORY PP, P229; Gegenfurtner KR, 1998, VISION RES, V38, P1041, DOI 10.1016/S0042-6989(97)00200-9; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; JAMESON D, 1978, SENS PROCESS, V2, P146; Lillo J, 2014, COLOR RES A IN PRESS, DOI [10.1002/col.21802, DOI 10.1002/COL.21802]; Lillo J, 2011, NEW DIRECTIONS IN COLOUR STUDIES, P293; Simunovic MP, 2010, EYE, V24, P747, DOI 10.1038/eye.2009.251; Spence I, 2006, PSYCHOL SCI, V17, P1, DOI 10.1111/j.1467-9280.2005.01656.x; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; Wixted JT, 2010, PSYCHOL REV, V117, P1025, DOI 10.1037/a0020874	16	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98757	10.1371/journal.pone.0098757	http://dx.doi.org/10.1371/journal.pone.0098757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24879303	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500084
J	Chen, C; Wei, XT; Xiao, HJ; He, HM; Xia, QW; Xue, FS				Chen, Chao; Wei, XiaoTang; Xiao, HaiJun; He, HaiMin; Xia, QinWen; Xue, FangSen			Diapause Induction and Termination in Hyphantria cunea (Drury) (Lepidoptera: Arctiinae)	PLOS ONE			English	Article							FALL WEBWORM; INSECT PHOTOPERIODISM; REPRODUCTIVE DIAPAUSE; GEOGRAPHIC-VARIATION; CLOCK MECHANISM; PUPAL DIAPAUSE; TEMPERATURE; MOTH; INTENSITY; JAPAN	The fall webworm, Hyphantria cunea (Drury), enters facultative diapause as a pupa in response to short-day conditions during autumn. Photoperiodic response curves showed that the critical day length for diapause induction was 14 h 30 min, 14 h 25 min and 13 h 30 min at 22, 25 and 28 degrees C, respectively. The photoperiodic responses under non-24 h light-dark cycles demonstrated that night length played an essential role in the determination of diapause. Experiments using a short day length interrupted by a 1-h light pulse exhibited two troughs of diapause inhibition and the effect of diapause inhibition was greater in the early scotophase than in the late scotophase. The diapause-inducing short day lengths of 8, 10 and 12 h evoked greater intensities of diapause than did 13 and 14 h. Diapause can be terminated without exposure to chilling, but chilling at 5 degrees C for 90 and 120 d significantly accelerated diapause development, reduced mortality, and synchronized adult emergence. Additionally, the potential for H. cunea from the temperate region (Qingdao) to emerge and overwinter under field conditions in subtropical regions (Nanchang) of China was evaluated. Pupae that were transferred to Nanchang in early July showed a 60% survival rate and extremely dispersed pupal period (from 12 to 82 days), suggesting that some pupae may undergo summer diapause. Diapausing temperate region pupae that were moved out-of-doors in Nanchang during October showed approximately 20% overwintering survival; moreover, those pupae that overwintered successfully emerged the next spring during a period when their host plants would be available. The results indicate that this moth has the potential to expand its range into subtropical regions of China.	[Chen, Chao; Xiao, HaiJun; He, HaiMin; Xia, QinWen; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Wei, XiaoTang] Qingdao Entry Exit Inspect & Quarantine Bur, Qingdao, Shandong, Peoples R China	Jiangxi Agricultural University	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com	XIAO, Haijun/AAJ-5321-2021; Xiao, Haijun/HGE-3088-2022	XIAO, Haijun/0000-0002-0832-0493; Xiao, Haijun/0000-0002-0832-0493	National Natural Science Foundation of P. R. China [31260430]; Administration of Quality Supervision, Inspection and Quarantine of the P. R. China China (AQSIQ) Science and Technology Project [2012IK282]	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Administration of Quality Supervision, Inspection and Quarantine of the P. R. China China (AQSIQ) Science and Technology Project	The research was supported by grants from National Natural Science Foundation of P. R. China (31260430) and Administration of Quality Supervision, Inspection and Quarantine of the P. R. China China (AQSIQ) Science and Technology Project (2012IK282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKISSON PL, 1964, AM NAT, V98, P357, DOI 10.1086/282332; Beck S.D., 1980, INSECT PHOTOPERIODIS, DOI 10.1016/b978-0-120-84380-0.x5001-7; BECK SD, 1989, J INSECT PHYSIOL, V35, P75, DOI 10.1016/0022-1910(89)90039-5; Broufas GD, 2006, ENVIRON ENTOMOL, V35, P1216, DOI 10.1603/0046-225X(2006)35[1216:EOCEAP]2.0.CO;2; Chen C, 2014, B ENTOMOL RES, V104, P12, DOI 10.1017/S0007485313000266; Damos PT, 2010, PHYSIOL ENTOMOL, V35, P64, DOI 10.1111/j.1365-3032.2009.00715.x; Danks HV, 1987, INSECT DORMANCY ECOL; Gomi T, 1997, OECOLOGIA, V111, P160, DOI 10.1007/s004420050220; Gomi T, 1996, EXPERIENTIA, V52, P273, DOI 10.1007/BF01920722; Gomi T, 1996, FUNCT ECOL, V10, P384, DOI 10.2307/2390287; Gomi T, 2007, ECOL RES, V22, P855, DOI 10.1007/s11284-006-0327-y; Goryshin N. I., 1968, P192; Han R, 2005, J APPL ENTOMOL, V129, P105, DOI 10.1111/j.1439-0418.2005.00941.x; He HM, 2009, J INSECT PHYSIOL, V55, P1003, DOI 10.1016/j.jinsphys.2009.07.004; HODEK I, 1988, ENTOMOL EXP APPL, V49, P153, DOI 10.1007/BF00188248; Hodek I, 2002, EUR J ENTOMOL, V99, P163, DOI 10.14411/eje.2002.024; Ji R, 2003, CHINESE J APPL ENTOM, V10, P13; KIMURA MT, 1990, J INSECT PHYSIOL, V36, P147, DOI 10.1016/0022-1910(90)90115-V; KIMURA MT, 1983, PHYSIOL ENTOMOL, V8, P181, DOI 10.1111/j.1365-3032.1983.tb00347.x; KIMURA Y, 1993, PHYSIOL ENTOMOL, V18, P240, DOI 10.1111/j.1365-3032.1993.tb00594.x; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Li SX, 2009, CHINESE AGR SCI B, V25, P202; Li YP, 2001, J INSECT PHYSIOL, V47, P1181, DOI 10.1016/S0022-1910(01)00099-3; MASAKI S, 1968, Applied Entomology and Zoology, V3, P55; MASAKI S, 1984, CIBA F SYMP, V104, P7; MASAKI S, 1977, ADAPTATION SPECIATIO, P31; Mironidis GK, 2012, B ENTOMOL RES, V102, P139, DOI 10.1017/S0007485311000484; PETERSON DM, 1968, J INSECT PHYSIOL, V14, P519, DOI 10.1016/0022-1910(68)90067-X; Roditakis NE, 2001, PHYSIOL ENTOMOL, V26, P329, DOI 10.1046/j.0307-6962.2001.00253.x; Saunders DS, 2013, J INSECT PHYSIOL, V59, P1, DOI 10.1016/j.jinsphys.2012.11.003; SAUNDERS DS, 1987, EXPERIENTIA, V43, P935, DOI 10.1007/BF01951677; Saunders DS, 2002, INSECT CLOCKS; Takeda M, 2005, ENTOMOL SCI, V8, P211, DOI 10.1111/j.1479-8298.2005.00117.x; TAKEDA M, 1979, ENTOMOL EXP APPL, V25, P317, DOI 10.1007/BF00302794; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Wang XP, 2009, PHYSIOL ENTOMOL, V34, P158, DOI 10.1111/j.1365-3032.2008.00668.x; Wang XP, 2004, J INSECT PHYSIOL, V50, P373, DOI 10.1016/j.jinsphys.2004.01.002; WARREN LO, 1970, ARKANSAS AGR EXPT ST, V759, P1; Wei XT, 2001, J INSECT PHYSIOL, V47, P1367, DOI 10.1016/S0022-1910(01)00125-1; Wei XT, 2006, PLANT QUARANTINE, V20, P14; Xiao HJ, 2010, J INSECT PHYSIOL, V56, P1558, DOI 10.1016/j.jinsphys.2010.05.012; Xiao HJ, 2009, J INSECT PHYSIOL, V55, P488, DOI 10.1016/j.jinsphys.2008.12.012; XUE FS, 1993, J APPL ENTOMOL, V116, P170; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z; Zhang S.F., 1985, HYPHANTRIA CUNEA	45	18	21	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98145	10.1371/journal.pone.0098145	http://dx.doi.org/10.1371/journal.pone.0098145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878546	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500032
J	Hashimoto, M; Fujii, T; Hamaguchi, M; Furu, M; Ito, H; Terao, C; Yamamoto, K; Yamamoto, W; Matsuo, T; Mori, M; Ohmura, K; Kawabata, H; Mimori, T				Hashimoto, Motomu; Fujii, Takao; Hamaguchi, Masahide; Furu, Moritoshi; Ito, Hiromu; Terao, Chikashi; Yamamoto, Keiichi; Yamamoto, Wataru; Matsuo, Takashi; Mori, Masato; Ohmura, Koichiro; Kawabata, Hiroshi; Mimori, Tsuneyo			Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis	PLOS ONE			English	Article							ANEMIA; HEPCIDIN; INFLAMMATION; DISEASE; INTERLEUKIN-6; GOLIMUMAB; MEDIATOR	Objective: To compare the effect of tocilizumab (TCZ) with other biologic therapies in improving anemia of rheumatoid arthritis (RA) patients. Methods: We compared the change of hemoglobin (Hb) levels in a cohort of 147 consecutive RA patients who were treated with biologics for more than 12 weeks. Twenty eight patients were treated with TCZ, and 119 patients were treated with biologics other than TCZ (87 with TNF inhibitors and 32 with abatacept). The change of Hb levels from baseline to week 12 was compared between the TCZ and the non-TCZ groups. We performed univariate and multivariate analyses with adjustment of potential confounders such as baseline characteristics, concomitant treatment, and the clinical response to treatment. Results: Hb levels generally increased after biologic therapies both in the TCZ and the non-TCZ groups. The increase of Hb levels was greater in the TCZ group than in the non-TCZ groups (1.1 g/dL in the TCZ group vs 0.3 g/dL in the non-TCZ group, p = 0.009). Univariate analysis revealed that increase of Hb levels was also significantly associated with lower Hb, higher Low Hemoglobin Density, and higher CRP levels at baseline and greater reduction in the clinical disease activity index. TCZ therapy was significantly associated with the increase of Hb levels even after adjustment for these factors by multivariate analysis (p < 0.001, effect size 0.08-0.12). Conclusion: TCZ therapy is an independent factor associated with the increase of Hb level after biologic therapies in RA patients. It will help in selecting appropriate biologics for RA patients with anemia.	[Hashimoto, Motomu; Fujii, Takao; Furu, Moritoshi; Ito, Hiromu; Yamamoto, Wataru] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Fujii, Takao; Matsuo, Takashi; Mori, Masato; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hamaguchi, Masahide] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Osaka, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Yamamoto, Keiichi] Natl Cerebral & Cardiovasc Ctr, Dept Informat Governance, Div Clin & Epidemiol Database, Osaka, Japan; [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan; [Kawabata, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan	Kyoto University; Kyoto University; Osaka University; Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University	Hashimoto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan.	mohashim@kuhp.kyoto-u.ac.jp	Yamamoto, Keiichi/AFQ-9006-2022	Yamamoto, Keiichi/0000-0003-3278-5001; Hamaguchi, Masahide/0000-0002-8651-4445	Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co., Ltd.; AbbVie GK.; Eisai Co., Ltd.; Astellas Pharma Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Co.; Santen Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corporation; Daiichi Sankyo Co., Ltd; Bristol-Myers Squibb K.K.; Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceutical Co., Ltd.	Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co., Ltd.; AbbVie GK.; Eisai Co., Ltd.(Eisai Co Ltd); Astellas Pharma Inc.(Astellas Pharmaceuticals); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Co.(Takeda Pharmaceutical Company Ltd); Santen Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corporation; Daiichi Sankyo Co., Ltd(Daiichi Sankyo Company Limited); Bristol-Myers Squibb K.K.(Bristol-Myers Squibb); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd)	The authors have read the journal's policy and have the following conflicts: M. Hashimoto, T.F., M.F., H.I., and T. Mimori are affiliated with a department that is supported financially by five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Bristol-Myers K.K., Chugai Pharmaceutical Co., Ltd., AbbVie GK., Eisai Co., Ltd.). M.H. and M.F. has received grant and research support from Astellas Pharma Inc. and Pfizer Japan Inc. H.I. has received grant and research support from Astellas Pharma Inc., Pfizer Japan Inc., NTT communications, and Takeda Pharmaceutical Co., Ltd. T.F. has received grant and research support from Takeda Pharmaceutical Co., Santen Pharmaceutical Co., Ltd., Astellas Pharma Inc., Asahi Kasei Pharma Corporation, and Daiichi Sankyo Co., Ltd. T.M. has received grant and research support from Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Santen Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., and speakers bureau from AbbVie GK., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd. K.O. has received grant and research support from AbbVie GK., Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and speakers bureau from AbbVie GK., Astellas Pharma, Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors declare that although they are affiliated with a department that is supported financially by pharmaceutical companies, the authors received no current funding for this study and this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Demirag MD, 2009, INTERNAL MED, V48, P421, DOI 10.2169/internalmedicine.48.1578; Doyle MK, 2013, RHEUMATOLOGY, V52, P1214, DOI 10.1093/rheumatology/kes381; Doyle MK, 2009, SEMIN ARTHRITIS RHEU, V39, P123, DOI 10.1016/j.semarthrit.2008.08.002; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; Furst DE, 2013, RHEUMATOLOGY, V52, P1845, DOI 10.1093/rheumatology/ket233; Furu M, 2014, SCAND J RHE IN PRESS; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Han CL, 2007, J RHEUMATOL, V34, P2177; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Maccio A, 2005, BLOOD, V106, P362, DOI 10.1182/blood-2005-01-0160; Matsuyama M, 2007, INTERNAL MED, V46, P771, DOI 10.2169/internalmedicine.46.6262; Moller B, 2014, ANN RHEUM DIS, V73, P691, DOI 10.1136/annrheumdis-2012-202709; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nikolaisen C, 2008, J RHEUMATOL, V35, P380; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; Raj DSC, 2009, SEMIN ARTHRITIS RHEU, V38, P382, DOI 10.1016/j.semarthrit.2008.01.006; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Thomas DW, 2013, BRIT J HAEMATOL, V161, P639, DOI 10.1111/bjh.12311; Urrechaga E, 2012, INT J LAB HEMATOL, V34, P47, DOI 10.1111/j.1751-553X.2011.01355.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wolfe F, 2006, J RHEUMATOL, V33, P1516	27	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98202	10.1371/journal.pone.0098202	http://dx.doi.org/10.1371/journal.pone.0098202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878740	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500037
J	Manning, EN; Barnes, J; Cash, DM; Bartlett, JW; Leung, KK; Ourselin, S; Fox, NC				Manning, Emily N.; Barnes, Josephine; Cash, David M.; Bartlett, Jonathan W.; Leung, Kelvin K.; Ourselin, Sebastien; Fox, Nick C.		Alzheimers Dis NeuroImaging Initia	APOE epsilon 4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD	PLOS ONE			English	Article							APOLIPOPROTEIN-E EPSILON-4; TEMPORAL-LOBE ATROPHY; ALZHEIMERS-DISEASE; BRAIN ATROPHY; VOLUME LOSS; E GENOTYPE; LONGITUDINAL CHANGE; MRI; RATES; MATTER	Objectives: To investigate whether APOE epsilon 4 carriers have higher hippocampal atrophy rates than non-carriers in Alzheimer's disease (AD), mild cognitive impairment (MCI) and controls, and if so, whether higher hippocampal atrophy rates are still observed after adjusting for concurrent whole-brain atrophy rates. Methods: MRI scans from all available visits in ADNI (148 AD, 307 MCI, 167 controls) were used. MCI subjects were divided into "progressors'' (MCI-P) if diagnosed with AD within 36 months or "stable'' (MCI-S) if a diagnosis of MCI was maintained. A joint multi-level mixed-effect linear regression model was used to analyse the effect of epsilon 4 carrier-status on hippocampal and whole-brain atrophy rates, adjusting for age, gender, MMSE and brain-to-intracranial volume ratio. The difference in hippocampal rates between epsilon 4 carriers and non-carriers after adjustment for concurrent whole-brain atrophy rate was then calculated. Results: Mean adjusted hippocampal atrophy rates in epsilon 4 carriers were significantly higher in AD, MCI-P and MCI-S (p <= 0.011, all tests) compared with epsilon 4 non-carriers. After adjustment for whole-brain atrophy rate, the difference in mean adjusted hippocampal atrophy rate between epsilon 4 carriers and non-carriers was reduced but remained statistically significant in AD and MCI-P. Conclusions: These results suggest that the APOE epsilon 4 allele drives atrophy to the medial-temporal lobe region in AD.	[Manning, Emily N.; Barnes, Josephine; Cash, David M.; Leung, Kelvin K.; Ourselin, Sebastien; Fox, Nick C.] UCL Inst Neurol, Dementia Res Ctr, London, England; [Cash, David M.; Leung, Kelvin K.; Ourselin, Sebastien] UCL, Ctr Med Image Comp, London, England; [Bartlett, Jonathan W.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Manning, EN (corresponding author), UCL Inst Neurol, Dementia Res Ctr, London, England.	e.manning@ucl.ac.uk	Barnes, Josesphine/P-5698-2014; Cash, David/V-3617-2019; Fox, Nick C/B-1319-2009	Cash, David/0000-0001-7833-616X; Fox, Nick C/0000-0002-6660-657X; Manning, Emily Ndakola/0000-0002-4505-3611; Bartlett, Jonathan/0000-0001-7117-0195	Alzheimer's Research UK; Brain Research Trust; Wolfson Foundation; AVID; Bristol-Myers Squibb; Elan Pharmaceuticals; Eisai; Lilly Research Laboratories; GE Healthcare; IXICO; Janssen Alzheimer Immunotherapy; Johnson Johnson; Janssen-Cilig; Lundbeck; Neurochem Inc; Novartis Pharma AG; Pfizer Inc; Sanofi-Aventis and Wyeth Pharmaceuticals; NIHR Biomedical Research Unit (Dementia) at UCL; EPSRC; NIA; EPSRC [EP/H046410/1, EP/J020990/1, EP/K005278]; EU-FP7 project VPH-DARE@IT [FP7-ICT-2011-9-601055]; National Institute for Health Research University College London Hospitals Biomedical Research Centre (High Impact Initiative); IXICO Ltd.; Siemens Molecular Imaging; MIRADA Medical Solution; General Electric Healthcare; National Institute for Health Research Queen Square Dementia Biomedical Research Unit - Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Alzheimers Research UK [ARUK-SRF2013-5, ARUK-PG2014-25] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046410/1, EP/J020990/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10134, NF-SI-0508-10123] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P30AG010129, K01AG030514, U01AG024904, U24AG021886] Funding Source: NIH RePORTER	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Brain Research Trust; Wolfson Foundation; AVID; Bristol-Myers Squibb(Bristol-Myers Squibb); Elan Pharmaceuticals; Eisai(Eisai Co Ltd); Lilly Research Laboratories(Eli Lilly); GE Healthcare(General ElectricGE Healthcare); IXICO; Janssen Alzheimer Immunotherapy; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Janssen-Cilig; Lundbeck(Lundbeck Corporation); Neurochem Inc; Novartis Pharma AG; Pfizer Inc(Pfizer); Sanofi-Aventis and Wyeth Pharmaceuticals; NIHR Biomedical Research Unit (Dementia) at UCL; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU-FP7 project VPH-DARE@IT; National Institute for Health Research University College London Hospitals Biomedical Research Centre (High Impact Initiative)(General Electric); IXICO Ltd.; Siemens Molecular Imaging; MIRADA Medical Solution; General Electric Healthcare(General ElectricGE Healthcare); National Institute for Health Research Queen Square Dementia Biomedical Research Unit - Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Dementia Research Centre is supported by Alzheimer's Research UK, Brain Research Trust, and The Wolfson Foundation. Professor Fox's research group has received payment for consultancy or for conducting studies from AVID, Bristol-Myers Squibb, Elan Pharmaceuticals, Eisai, Lilly Research Laboratories, GE Healthcare, IXICO, Janssen Alzheimer Immunotherapy, Johnson & Johnson, Janssen-Cilig, Lundbeck, Neurochem Inc, Novartis Pharma AG, Pfizer Inc, Sanofi-Aventis and Wyeth Pharmaceuticals. NCF has an NIHR Senior Investigator award and receives support from the Wolfson Foundation; NIHR Biomedical Research Unit (Dementia) at UCL; the EPSRC; Alzheimer's Research UK and the NIA. NCF receives no personal compensation for the activities mentioned above. Prof. Ourselin receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the EU-FP7 project VPH-DARE@IT (FP7-ICT-2011-9-601055), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (High Impact Initiative). SO has received personal compensation for activities and research support from IXICO Ltd. Dr. Ourselin also received financial support for his research from Siemens Molecular Imaging, MIRADA Medical Solution, General Electric Healthcare and equipment support from Medtronic Navigation, Inc. Dr. Barnes is supported by an Alzheimer's Research UK senior fellowship and received honoraria for reviewing grants for Fundacao para a Ciencia e a Tecnologia-Portugal in 2011. Dr. Cash is supported by a grant from an anonymous charitable foundation. This research was supported by the National Institute for Health Research Queen Square Dementia Biomedical Research Unit Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www. fnih. org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, Rev October 16, 2012 San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Barnes J, 2004, NEUROIMAGE, V23, P574, DOI 10.1016/j.neuroimage.2004.06.028; Chiang GC, 2010, NEUROLOGY, V75, P1976, DOI 10.1212/WNL.0b013e3181ffe4d1; Chiang Gloria C, 2011, Alzheimers Dement, V7, P514, DOI 10.1016/j.jalz.2010.12.010; Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Hashimoto M, 2001, NEUROLOGY, V57, P1461, DOI 10.1212/WNL.57.8.1461; Hashimoto R, 2009, GENES BRAIN BEHAV, V8, P43, DOI 10.1111/j.1601-183X.2008.00440.x; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Khan W, 2013, J ALZHEIMERS DIS; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Lu PH, 2011, J ALZHEIMERS DIS, V23, P433, DOI 10.3233/JAD-2010-101398; Moffat SD, 2000, NEUROLOGY, V55, P134, DOI 10.1212/WNL.55.1.134; Mori E, 2002, ANN NEUROL, V51, P209, DOI 10.1002/ana.10093; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; NARAYANA PA, 1988, MAGN RESON IMAGING, V6, P271, DOI 10.1016/0730-725X(88)90401-8; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Pievani M, 2009, NEUROIMAGE, V45, P1090, DOI 10.1016/j.neuroimage.2009.01.009; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spampinato MV, 2011, RADIOLOGY, V258, P843, DOI 10.1148/radiol.10100307; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96; van der Flier WM, 2009, NAT REV NEUROL, V5, P361, DOI 10.1038/nrneurol.2009.94; van Es MA, 2009, NAT GENET, V41, P1047, DOI 10.1038/ng1009-1047; Wang PN, 2009, PSYCHIAT RES-NEUROIM, V171, P221, DOI 10.1016/j.pscychresns.2008.05.002; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE	39	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97608	10.1371/journal.pone.0097608	http://dx.doi.org/10.1371/journal.pone.0097608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878738	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338101500018
J	Wu, L; Chen, XP; Cui, ZL; Zhang, WF; Zhang, FS				Wu, Liang; Chen, Xinping; Cui, Zhenling; Zhang, Weifeng; Zhang, Fusuo			Establishing a Regional Nitrogen Management Approach to Mitigate Greenhouse Gas Emission Intensity from Intensive Smallholder Maize Production	PLOS ONE			English	Article							CROP SYSTEM MANAGEMENT; NUTRIENT MANAGEMENT; FERTILIZER; CHINA; AGRICULTURE; YIELD	The overuse of Nitrogen (N) fertilizers on smallholder farms in rapidly developing countries has increased greenhouse gas (GHG) emissions and accelerated global N consumption over the past 20 years. In this study, a regional N management approach was developed based on the cost of the agricultural response to N application rates from 1,726 on-farm experiments to optimize N management across 12 agroecological subregions in the intensive Chinese smallholder maize belt. The grain yield and GHG emission intensity of this regional N management approach was investigated and compared to field-specific N management and farmers' practices. The regional N rate ranged from 150 to 219 kg N ha(-1) for the 12 agroecological subregions. Grain yields and GHG emission intensities were consistent with this regional N management approach compared to field-specific N management, which indicated that this regional N rate was close to the economically optimal N application. This regional N management approach, if widely adopted in China, could reduce N fertilizer use by more than 1.4 MT per year, increase maize production by 31.9 MT annually, and reduce annual GHG emissions by 18.6 MT. This regional N management approach can minimize net N losses and reduce GHG emission intensity from over-and underapplications, and therefore can also be used as a reference point for regional agricultural extension employees where soil and/or plant N monitoring is lacking.	[Wu, Liang; Chen, Xinping; Cui, Zhenling; Zhang, Weifeng; Zhang, Fusuo] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Cui, ZL (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	cuizl@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021		National Basic Research Program of China (973, Program) [2009CB118606]; Special Fund for Agro-scientific Research in the Public Interest [201103003]	National Basic Research Program of China (973, Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	The work has been funded by the National Basic Research Program of China (973, Program: 2009CB118606) (website: http://www.973.gov.cn/AreaAppl.aspx). National Maize Production System in China (CARS-02-24)(website: http://119.253.58.231/). Special Fund for Agro-scientific Research in the Public Interest (201103003)(website: http://www.hymof.net.cn/webapp/login.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barning R, 2008, THESIS U HOHENHEIM; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; CHEN XP, 2003, THESIS U HOHENHEIM; Conant RT, 2011, FRONT ECOL ENVIRON, V9, P169, DOI 10.1890/090153; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cui Z. L., 2005, THESIS CHINA AGR U; Cui ZL, 2008, AGRON J, V100, P517, DOI 10.2134/agronj2007.0194; Cui ZL, 2013, GLOBAL CHANGE BIOL, V19, P2467, DOI 10.1111/gcb.12213; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; De Klein C., 2006, 2006 IPCC GUIDELINES; Dobermann A, 2003, AGRON J, V95, P924, DOI 10.2134/agronj2003.0924; Etim N. A. A., 2010, Journal of Agriculture and Social Sciences, V6, P24; Forster P., 2007, PHYS SCI BASIS CONTR; Gebbers R, 2010, SCIENCE, V327, P828, DOI 10.1126/science.1183899; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Grassini P, 2012, P NATL ACAD SCI USA, V109, P1074, DOI 10.1073/pnas.1116364109; Heffer P., 2009, ASSESSMENT FERTILIZE; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Hou P, 2012, FIELD CROP RES, V129, P1, DOI 10.1016/j.fcr.2012.01.006; Huang JK, 2008, J SOIL WATER CONSERV, V63, p165A, DOI 10.2489/jswc.63.5.165A; IFA, IFA IFA STAT; Khan SA, 2001, SOIL SCI SOC AM J, V65, P1751, DOI 10.2136/sssaj2001.1751; Lu YY, 2006, CHEMOSPHERE, V65, P1915, DOI 10.1016/j.chemosphere.2006.07.035; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Meng Q F, 2012, THESIS CHINA AGR U; National Bureau of Statistics of China (Various years), CHIN STAT YB; OECE, ENV IND AGR METH RES; Richards LA., 1954, DIAGNOSIS IMPROVEMEN; Sawyer J, 2006, CONCEPTS RATIONALE R, P15; Smith P., 2007, CONTRIBUTION WORKING; SOPER RJ, 1963, CAN J SOIL SCI, V43, P350, DOI DOI 10.4141/CJSS63-041; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; VAN REEUWIJK L., 1993, PROCEDURES SOIL ANAL, V4th; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wallach D, 1949, APPL STAT, P641; Wang J., 2004, THESIS CHINA AGR U B; Wehrmann J., 1988, Nitrogen efficiency in agricultural soils. Proceedings Symposium Edinburgh, 16-18 Sept. 1987., P38; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	43	41	44	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98481	10.1371/journal.pone.0098481	http://dx.doi.org/10.1371/journal.pone.0098481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875747	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800044
J	Edler, D; Bestgen, AK; Kuchinke, L; Dickmann, F				Edler, Dennis; Bestgen, Anne-Kathrin; Kuchinke, Lars; Dickmann, Frank			Grids in Topographic Maps Reduce Distortions in the Recall of Learned Object Locations	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; SEX-DIFFERENCES; COGNITIVE LOAD; MEMORY; SCENE; ORGANIZATION; HIERARCHIES; PERCEPTION; COMPLEXITY	To date, it has been shown that cognitive map representations based on cartographic visualisations are systematically distorted. The grid is a traditional element of map graphics that has rarely been considered in research on perception-based spatial distortions. Grids do not only support the map reader in finding coordinates or locations of objects, they also provide a systematic structure for clustering visual map information ("spatial chunks''). The aim of this study was to examine whether different cartographic kinds of grids reduce spatial distortions and improve recall memory for object locations. Recall performance was measured as both the percentage of correctly recalled objects (hit rate) and the mean distance errors of correctly recalled objects (spatial accuracy). Different kinds of grids (continuous lines, dashed lines, crosses) were applied to topographic maps. These maps were also varied in their type of characteristic areas (LANDSCAPE) and different information layer compositions (DENSITY) to examine the effects of map complexity. The study involving 144 participants shows that all experimental cartographic factors (GRID, LANDSCAPE, DENSITY) improve recall performance and spatial accuracy of learned object locations. Overlaying a topographic map with a grid significantly reduces the mean distance errors of correctly recalled map objects. The paper includes a discussion of a square grid's usefulness concerning object location memory, independent of whether the grid is clearly visible (continuous or dashed lines) or only indicated by crosses.	[Edler, Dennis; Dickmann, Frank] Ruhr Univ Bochum, Dept Geog, Bochum, Germany; [Bestgen, Anne-Kathrin; Kuchinke, Lars] Ruhr Univ Bochum, Dept Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Edler, D (corresponding author), Ruhr Univ Bochum, Dept Geog, Univ Str 150, Bochum, Germany.	dennis.edler@rub.de	Dickmann, Frank/AAC-3002-2020	Dickmann, Frank/0000-0002-9012-9419; Edler, Dennis/0000-0002-2260-9103	German Research Foundation (DFG) [DI 771/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG, DI 771/7-1; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdV, 2010, AMTL TOP KART INF AT; Barkowsky T., 2002, MENTAL REPRESENTATIO; BAYLIS GC, 1993, J EXP PSYCHOL HUMAN, V19, P451, DOI 10.1037/0096-1523.19.3.451; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; Bestgen A, 2013, P COGSCI 2013 35 ANN; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Bollmann J, 1981, ASPEKTE KARTOGRAPHIS; Bunch RL, 2000, CARTOGR GEOGR INF SC, V27, P15; Chai XJ, 2009, BEHAV NEUROSCI, V123, P276, DOI 10.1037/a0014722; Chandler P, 1996, APPL COGNITIVE PSYCH, V10, P151, DOI 10.1002/(SICI)1099-0720(199604)10:2<151::AID-ACP380>3.0.CO;2-U; Clements-Stephens AM, 2011, VIS COGN, V19, P886, DOI 10.1080/13506285.2011.595742; COREN S, 1980, J EXP PSYCHOL HUMAN, V6, P404, DOI 10.1037/0096-1523.6.3.404; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Crampton JW, 2009, PROG HUM GEOG, V33, P91, DOI 10.1177/0309132508094074; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; Davies C., 2007, EMERGING SPATIAL MIN, P219, DOI DOI 10.1093/ACPROF:OSO/9780195189223.003.0010; DeLeeuw KE, 2008, J EDUC PSYCHOL, V100, P223, DOI 10.1037/0022-0663.100.1.223; Dickmann F, 2013, KARTOGRAPHISCHE NACH, V63, P174, DOI DOI 10.1007/BF03546131; Dickmann F, 2012, CARTOGR J, V49, P62, DOI 10.1179/1743277411Y.0000000018; Donderi DC, 2005, DISPLAYS, V26, P71, DOI 10.1016/j.displa.2005.02.002; EASTMAN J. R., 1985, CARTOGR J, V22, P95; Eastman R.J., 1985, CARTOGRAPHICA, V22, P1, DOI DOI 10.3138/FJK4-2776-485N-6464; Evans G.W., 1984, J ENVIRON PSYCHOL, V4, P323, DOI [10.1016/S0272-4944(84)80003-1, DOI 10.1016/S0272-4944(84)80003-1]; Fabrikant SI., 2009, CARTOGRAPHICA, V44, P129, DOI 10.3138/carto.44.3.139; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Gartner G., 2007, CARTOGR GEOGR INF SC, V34, P247, DOI [10.1559/152304007782382963, DOI 10.1559/152304007782382963]; Golledge R.G., 1991, ENV COGNITION ACTION; Goodenough W, 1933, GEOGR J, V82, P47; Griffin AL, 2012, CARTOGR J, V49, P298, DOI 10.1179/0008704112Z.00000000049; Hake G., 2002, KARTOGRAPHIE; Harrie L, 2010, ISPRS J PHOTOGRAMM, V65, P266, DOI 10.1016/j.isprsjprs.2009.05.004; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; HEKKERT P, 1990, BRIT J PSYCHOL, V81, P483, DOI 10.1111/j.2044-8295.1990.tb02374.x; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM, 2009, J VISION, V9, DOI 10.1167/9.1.32; HIRTLE SC, 1985, MEM COGNITION, V13, P208, DOI 10.3758/BF03197683; Hommel B, 2000, PSYCHOL RES-PSYCH FO, V64, P1, DOI 10.1007/s004260000032; Hurts K., 2005, P HUM FACT ERG SOC A, V49, P1593, DOI [10.1177/154193120504901720, DOI 10.1177/154193120504901720]; Kaplan S., 1973, IMAGE ENV; Kent A., 2013, CARTOGR PERSPECT, V73, P39; Kettunen P, 2012, J SPAT INT SCI, P75, DOI 10.5311/JOSIS.2012.5.85; Klippel A, 2004, LECT NOTES COMPUT SC, V3343, P204; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Landesvermessungsamt NRW, 2005, AUSZ ZEICH DTK10 V N; Lawton CA, 1999, SEX ROLES, V40, P73, DOI 10.1023/A:1018830401088; Leifert S., 2011, P 2011 ANN C HUM FAC, P941, DOI 10.1145/1979742.1979522; LLOYD R, 1987, ANN ASSOC AM GEOGR, V77, P191, DOI 10.1111/j.1467-8306.1987.tb00153.x; Lloyd R., 2005, CARTOGR GEOGR INF SC, V32, P33, DOI [DOI 10.1559/1523040053270774, 10.1559/1523040053270774]; Lloyd R.E., 2010, CARTOGRAPHICA INT J, V45, P169, DOI [https://doi.org/10.3138/carto.45.3.169, DOI 10.3138/CARTO.45.3.169]; Lloyd RE, 2008, CARTOGR GEOGR INF SC, V35, P171, DOI DOI 10.1559/152304008784864677; Maling D. H., 1992, COORDINATE SYSTEMS M; Mark DM, 1999, INT J GEOGR INF SCI, V13, P747, DOI 10.1080/136588199241003; Martin R, 2008, NEUROPSYCHOLOGIA, V46, P576, DOI 10.1016/j.neuropsychologia.2007.10.010; Matthews M. H., 1985, J ENVIRON PSYCHOL, V5, P261, DOI DOI 10.1016/S0272-4944(85)80026-8; MCNAMARA TP, 1984, J EXP PSYCHOL LEARN, V10, P723, DOI 10.1037/0278-7393.10.4.723; McNamara TP, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P3; MCNAMARA TP, 1989, J EXP PSYCHOL LEARN, V15, P211, DOI 10.1037/0278-7393.15.2.211; MCNAMARA TP, 1986, COGNITIVE PSYCHOL, V18, P87, DOI 10.1016/0010-0285(86)90016-2; Meng L, 2013, KARTOGRAPHISCHE NACH, V63, P115; Montello DR, 1998, Z SEMIOTIK, V20, P91; Montello DR, 1999, ANN ASSOC AM GEOGR, V89, P515, DOI 10.1111/0004-5608.00160; Montello DR, 1994, CARTOGRAPHICA, V31, P18, DOI DOI 10.3138/W806-5127-7W41-12H8; Neider MB, 2011, J VISION, V11, DOI 10.1167/11.14.7; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKABAYASHI H, 1984, J GEN PSYCHOL, V111, P271, DOI 10.1080/00221309.1984.9921116; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Rahman Q, 2003, J INT NEUROPSYCH SOC, V9, P376, DOI 10.1017/S1355617703930037; Robinson A.H., 1995, ELEMENTS CARTOGRAPHY, V6th ed.; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Schnur S, 2010, P 6 INT C GEOGR INF; Skiles MD, 2012, CARTOGR J, V49, P312, DOI 10.1179/1743277412Y.0000000020; Speake J, 2012, CARTOGR J, V49, P326, DOI 10.1179/1743277412Y.0000000021; Stachon Z., 2013, KARTOGRAPHISCHE NACH, V63, P216, DOI [10.1007/BF03546137, DOI 10.1007/BF03546137]; Stainer MJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00624; STEVENS A, 1978, COGNITIVE PSYCHOL, V10, P422, DOI 10.1016/0010-0285(78)90006-3; Strobl J., 2000, ANGEW GEOGRAPHISCHE, P12; Tottenham LS, 2003, BRAIN COGNITION, V53, P381, DOI 10.1016/S0278-2626(03)00149-0; Tversky B, 2003, ENVIRON BEHAV, V35, P66, DOI 10.1177/0013916502238865; TVERSKY B, 1992, GEOFORUM, V23, P131, DOI 10.1016/0016-7185(92)90011-R; TVERSKY B, 1981, COGNITIVE PSYCHOL, V13, P407, DOI 10.1016/0010-0285(81)90016-5; Tversky B., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P14; Tversky B, 2006, MODEL BASED REASONIN, P1; Uttal DH, 2000, DEVELOPMENTAL SCI, V3, P247, DOI 10.1111/1467-7687.00119; Voyer D, 2007, PSYCHON B REV, V14, P23, DOI 10.3758/BF03194024; Waller D, 2000, J EXP PSYCHOL-APPL, V6, P307, DOI 10.1037//1076-898X.6.4.307; Weninger B, 2013, P 26 INT CART C ICC; Wessel G, 2013, P 6 INT C ADV COMP H; Westerbeek H, 2013, APPL COGNITIVE PSYCH, V27, P297, DOI 10.1002/acp.2907; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Wolf N, 2011, P 2011 RSPSOC ANN C; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001	92	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98148	10.1371/journal.pone.0098148	http://dx.doi.org/10.1371/journal.pone.0098148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24869486	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300027
J	Gao, Y; Hamers, N; Rakhshandehroo, M; Berger, R; Lough, J; Kalkhoven, E				Gao, Yuan; Hamers, Nicole; Rakhshandehroo, Maryam; Berger, Ruud; Lough, John; Kalkhoven, Eric			Allele Compensation in Tip60(+/-) Mice Rescues White Adipose Tissue Function In Vivo	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; DNA-DAMAGE RESPONSE; ACETYLTRANSFERASE TIP60; ENERGY-BALANCE; GAMMA; ADIPOGENESIS; HOMEOSTASIS; P300; ADIPOCYTES; EXPRESSION	Adipose tissue is a key regulator of energy homestasis. The amount of adipose tissue is largely determined by adipocyte differentiation (adipogenesis), a process that is regulated by the concerted actions of multiple transcription factors and cofactors. Based on in vitro studies in murine 3T3-L1 preadipocytes and human primary preadipocytes, the transcriptional cofactor and acetyltransferase Tip60 was recently identified as an essential adipogenic factor. We therefore investigated the role of Tip60 on adipocyte differentiation and function, and possible consequences on energy homeostasis, in vivo. Because homozygous inactivation results in early embryonic lethality, Tip60(+/-) mice were used. Heterozygous inactivation of Tip60 had no effect on body weight, despite slightly higher food intake by Tip60(+/-) mice. No major effects of heterozygous inactivation of Tip60 were observed on adipose tissue and liver, and Tip60(+/-) displayed normal glucose tolerance, both on a low fat and a high fat diet. While Tip60 mRNA was reduced to 50% in adipose tissue, the protein levels were unaltered, suggesting compensation by the intact allele. These findings indicate that the in vivo role of Tip60 in adipocyte differentiation and function cannot be properly addressed in Tip60(+/-) mice, but requires the generation of adipose tissue-specific knock out animals or specific knock-in mice.	[Gao, Yuan; Hamers, Nicole; Rakhshandehroo, Maryam; Berger, Ruud; Kalkhoven, Eric] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Gao, Yuan; Hamers, Nicole; Berger, Ruud; Kalkhoven, Eric] Netherlands Metab Ctr, Leiden, Netherlands; [Lough, John] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Lough, John] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA	Utrecht University; Utrecht University Medical Center; Medical College of Wisconsin; Medical College of Wisconsin	Kalkhoven, E (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.	E.Kalkhoven@umcutrecht.nl			research programme of The Netherlands Metabolomics Centre; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)	research programme of The Netherlands Metabolomics Centre; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugge A, 2009, MOL ENDOCRINOL, V23, P794, DOI 10.1210/me.2008-0236; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fisher JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031569; Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gronniger E, 2010, CELL BIOL INT, V34, P737, DOI 10.1042/CBI20090299; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schipper HS, 2012, J CLIN INVESTIGATION; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98343	10.1371/journal.pone.0098343	http://dx.doi.org/10.1371/journal.pone.0098343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870614	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300037
J	Horliana, ACRT; Chambrone, L; Foz, AM; Artese, HPC; Rabelo, MD; Pannuti, CM; Romito, GA				Ratto Tempestini Horliana, Anna Carolina; Chambrone, Leandro; Foz, Adriana Moura; Carillo Artese, Hilana Paula; Rabelo, Mariana de Sousa; Pannuti, Claudio Mendes; Romito, Giuseppe Alexandre			Dissemination of Periodontal Pathogens in the Bloodstream after Periodontal Procedures: A Systematic Review	PLOS ONE			English	Article							ODONTOGENIC BACTEREMIA; SUBGINGIVAL PLAQUE; LYSIS-FILTRATION; MICROORGANISMS; ENDOCARDITIS; IRRIGATION; MOUTHRINSE; SAMPLE	Background: To date, there is no compilation of evidence-based information associating bacteremia and periodontal procedures. This systematic review aims to assess magnitude, duration, prevalence and nature of bacteremia caused by periodontal procedures. Study Design: Systematic Review Types of Studies Reviewed: MEDLINE, EMBASE and LILACS databases were searched in duplicate through August, 2013 without language restriction. Observational studies were included if blood samples were collected before, during or after periodontal procedures of patients with periodontitis. The methodological quality was assessed in duplicate using the modified Newcastle-Ottawa scale (NOS). Results: Search strategy identified 509 potentially eligible articles and nine were included. Only four studies demonstrated high methodological quality, whereas five were of medium or low methodological quality. The study characteristics were considered too heterogeneous to conduct a meta-analysis. Among 219 analyzed patients, 106 (49.4%) had positive bacteremia. More frequent bacteria were S. viridans, A. actinomycetemcomitans P. gingivalis, M. micros and species Streptococcus and Actinomyces, although identification methods of microbiologic assays were different among studies. Clinical Implications: Although half of the patients presented positive bacteremia after periodontal procedures, accurate results regarding the magnitude, duration and nature of bacteremia could not be confidentially assessed.	[Ratto Tempestini Horliana, Anna Carolina; Chambrone, Leandro; Foz, Adriana Moura; Carillo Artese, Hilana Paula; Rabelo, Mariana de Sousa; Pannuti, Claudio Mendes; Romito, Giuseppe Alexandre] Univ Sao Paulo, Sch Dent, Dept Stomatol, Sao Paulo, Brazil	Universidade de Sao Paulo	Romito, GA (corresponding author), Univ Sao Paulo, Sch Dent, Dept Stomatol, Sao Paulo, Brazil.	garomito@usp.br	Horliana, Anna/ABH-9640-2020; Horliana, Anna Carolina Ratto Tempestini/J-3257-2015; Artese, Hilana/C-8773-2013; Rabelo, Mariana/AAP-7698-2020; Romito, Giuseppe Alexandre/C-3592-2012; Pannuti, Cláudio/B-8972-2011; Rabelo, Mariana/AAT-9257-2020	Horliana, Anna Carolina Ratto Tempestini/0000-0003-3476-9064; Artese, Hilana/0000-0001-8421-9592; Romito, Giuseppe Alexandre/0000-0001-5669-912X; Pannuti, Cláudio/0000-0003-4181-3975; Rabelo, Mariana/0000-0003-1385-8471				Allison C, 1993, J CAN DENT ASSOC, V59, P6; [Anonymous], 2001, GLOSS PER TERMS; APPLEMAN MD, 1982, J PERIODONTOL, V53, P319, DOI 10.1902/jop.1982.53.5.319; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bahrani-Mougeot FK, 2008, J CLIN MICROBIOL, V46, P2129, DOI 10.1128/JCM.02004-07; BALTCH AL, 1982, AM HEART J, V104, P1335, DOI 10.1016/0002-8703(82)90164-8; BANDT CL, 1964, J PERIODONTOL, V35, P214, DOI 10.1902/jop.1964.35.3.214; BAYLISS R, 1983, BRIT HEART J, V50, P506, DOI 10.1136/hrt.50.6.506; Belstrom D, 2011, INFECT IMMUN, V79, P1559, DOI 10.1128/IAI.01036-10; Carlos PE, 2007, REV MED CHILE, V135, P1118; CATES KL, 1983, AM J MED, V75, P19, DOI 10.1016/0002-9343(83)90068-2; Chambrone L, 2011, J CLIN PERIODONTOL, V38, P795, DOI 10.1111/j.1600-051X.2011.01755.x; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P1110, DOI 10.1111/j.1600-051X.2010.01634.x; Chambrone L, 2010, J CLIN PERIODONTOL, V37, P675, DOI 10.1111/j.1600-051X.2010.01587.x; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; CONNER HD, 1967, J PERIODONTOL, V38, P466, DOI 10.1902/jop.1967.38.6_part1.466; Daly C, 1997, AUST DENT J, V42, P77, DOI 10.1111/j.1834-7819.1997.tb00100.x; Daly CG, 2001, J PERIODONTOL, V72, P210, DOI 10.1902/jop.2001.72.2.210; Deshpande Rajashri G., 1998, Invasion and Metastasis, V18, P57, DOI 10.1159/000024499; Ewart N P, 1971, Bull N Z Soc Periodontol, P15; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Fine DH, 2010, J CLIN PERIODONTOL, V37, P840, DOI 10.1111/j.1600-051X.2010.01599.x; Fisher MA, 2008, J PERIODONTOL, V79, P1670, DOI 10.1902/jop.2008.070569 ; Font Buxo J., 1985, REV ACTUAL ESTOMATOL, V45, P58; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Gendron R, 2000, MICROBES INFECT, V2, P897, DOI 10.1016/S1286-4579(00)00391-9; HEIMDAHL A, 1990, J CLIN MICROBIOL, V28, P2205, DOI 10.1128/JCM.28.10.2205-2209.1990; Herzberg M C, 1998, Ann Periodontol, V3, P151, DOI 10.1902/annals.1998.3.1.151; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; Kinane DF, 2005, J CLIN PERIODONTOL, V32, P708, DOI 10.1111/j.1600-051X.2005.00741.x; KORN NA, 1962, J PERIODONTOL, V33, P226, DOI 10.1902/jop.1962.33.3.226; Kraal J H, 1970, Ned Tijdschr Tandheelkd, V77, P5; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Lafaurie GI, 2007, J CLIN PERIODONTOL, V34, P873, DOI 10.1111/j.1600-051X.2007.01125.x; LAZANSKY JP, 1949, J DENT RES, V28, P533, DOI 10.1177/00220345490280060201; Lieberman M B, 1992, J Calif Dent Assoc, V20, P37; LINEBERGER LT, 1973, J PERIODONTOL, V44, P757, DOI 10.1902/jop.1973.44.12.757; Lockhart PB, 1999, INFECT DIS CLIN N AM, V13, P833, DOI 10.1016/S0891-5520(05)70111-2; Lockhart PB, 2000, PERIODONTOL 2000, V23, P127, DOI 10.1034/j.1600-0757.2000.2230113.x; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; LOFTHUS JE, 1991, J PERIODONTOL, V62, P602, DOI 10.1902/jop.1991.62.10.602; Lucas VS, 2002, J CLIN MICROBIOL, V40, P3416, DOI [10.1128/JCM.40.9.3482-3484.2002, 10.1128/JCM.40.9.3416-3420.2002]; MADSEN KL, 1974, SCAND J DENT RES, V82, P1; Vera JRM, 2008, REV ESP QUIM, V21, P153; Castillo DM, 2011, J CLIN PERIODONTOL, V38, P418, DOI 10.1111/j.1600-051X.2011.01717.x; Millar BC, 2004, EMERG INFECT DIS, V10, P1110; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Montanari G, 1967, Mondo Odontostomatol, V9, P570; Morozumi T, 2010, J PERIODONTOL, V81, P1555, DOI 10.1902/jop.2010.100163; Murphy AM, 2006, J CLIN PERIODONTOL, V33, P730, DOI 10.1111/j.1600-051X.2006.00980.x; Olsen I, 2008, TRANSFUS APHER SCI, V39, P173, DOI 10.1016/j.transci.2008.06.008; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI 10.1128/CMR.00028-08; Perez-Chaparro PJ, 2008, J CLIN PERIODONTOL, V35, P748, DOI 10.1111/j.1600-051X.2008.01296.x; Pizzo G, 2010, EUR J INTERN MED, V21, P496, DOI 10.1016/j.ejim.2010.07.011; Que YA, 2011, NAT REV CARDIOL, V8, P322, DOI 10.1038/nrcardio.2011.43; Raetzke P, 1981, Dtsch Zahnarztl Z, V36, P121; REINHARDT RA, 1982, J PERIODONTOL, V53, P96, DOI 10.1902/jop.1982.53.2.96; ROGOSA M., 1960, JOUR AMER DENTAL ASSOC, V60, P171; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Trivedi D N, 1984, J Indian Dent Assoc, V56, P447; WANK HA, 1976, J PERIODONTOL, V47, P683, DOI 10.1902/jop.1976.47.12.683; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; WINSLOW M B, 1960, J Am Dent Assoc, V61, P69; WITZENBERGER T, 1982, J PERIODONTOL, V53, P172, DOI 10.1902/jop.1982.53.3.172; Zanatta FB, 2007, J PERIODONTOL, V78, P2127, DOI 10.1902/jop.2007.070090; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001; Zhang W, 2013, J CLIN PERIODONTOL, V40, P41, DOI 10.1111/jcpe.12029	71	71	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98271	10.1371/journal.pone.0098271	http://dx.doi.org/10.1371/journal.pone.0098271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870125	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300031
J	Sondhi, S; Sharma, P; Saini, S; Puri, N; Gupta, N				Sondhi, Sonica; Sharma, Prince; Saini, Shilpa; Puri, Neena; Gupta, Naveen			Purification and Characterization of an Extracellular, Thermo-Alkali-Stable, Metal Tolerant Laccase from Bacillus tequilensis SN4	PLOS ONE			English	Article							BACTERIAL LACCASE; SUBSTRATE	A novel extracellular thermo-alkali-stable laccase from Bacillus tequilensis SN4 (SN4LAC) was purified to homogeneity. The laccase was a monomeric protein of molecular weight 32 KDa. UV-visible spectrum and peptide mass fingerprinting results showed that SN4LAC is a multicopper oxidase. Laccase was active in broad range of phenolic and non-phenolic substrates. Catalytic efficiency (k(cat)/K-m) showed that 2, 6-dimethoxyphenol was most efficiently oxidized by the enzyme. The enzyme was inhibited by conventional inhibitors of laccase like sodium azide, cysteine, dithiothreitol and beta-mercaptoethanol. SN4LAC was found to be highly thermostable, having temperature optimum at 85 degrees C and could retain more than 80% activity at 70 degrees C for 24 h. The optimum pH of activity for 2, 6-dimethoxyphenol, 2, 2'-azino bis[3-ethylbenzthiazoline-6-sulfonate], syringaldazine and guaiacol was 8.0, 5.5, 6.5 and 8.0 respectively. Enzyme was alkali-stable as it retained more than 75% activity at pH 9.0 for 24 h. Activity of the enzyme was significantly enhanced by Cu2+, Co2+, SDS and CTAB, while it was stable in the presence of halides, most of the other metal ions and surfactants. The extracellular nature and stability of SN4LAC in extreme conditions such as high temperature, pH, heavy metals, halides and detergents makes it a highly suitable candidate for biotechnological and industrial applications.	[Sondhi, Sonica; Sharma, Prince; Saini, Shilpa; Gupta, Naveen] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Puri, Neena] Guru Nanak Khalsa Coll, Dept Ind Microbiol, Yamunanagar, Haryana, India	Panjab University	Gupta, N (corresponding author), Panjab Univ, Dept Microbiol, BMS Block, Chandigarh 160014, India.	gupta27_naveen@yahoo.com	Gupta, Naveen/AAR-9410-2020; Sondhi, Sonica/AAC-3809-2021	Sondhi, Sonica/0000-0002-5919-1345				Adamafio N. A., 2012, Asian Journal of Biochemistry, V7, P143; Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; Baldrian P, 2002, FEMS MICROBIOL LETT, V206, P69, DOI 10.1111/j.1574-6968.2002.tb10988.x; Brijwani K., 2010, Enzyme Research, V2010, P149748, DOI 10.4061/2010/149748; Chauhan P.S., 2014, INT J PHARM BIO SCI, V5, P176; Degerli N, 2001, ANAL BIOCHEM, V297, P192, DOI 10.1006/abio.2001.5335; DEGRYSE E, 1978, ARCH MICROBIOL, V117, P189, DOI 10.1007/BF00402307; Deng Y, 2011, J BACTERIOL, V193, P2070, DOI 10.1128/JB.00129-11; Diamantidis G, 2000, SOIL BIOL BIOCHEM, V32, P919, DOI 10.1016/S0038-0717(99)00221-7; Gomes J, 1998, Adv Biochem Eng Biotechnol, V59, P1; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Kaushik G, 2013, APPL BIOCHEM MICRO+, V49, P352, DOI 10.1134/S0003683813040169; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; MOORE BM, 1990, J BIOL CHEM, V265, P4982; Murugesan K, 2009, J HAZARD MATER, V168, P523, DOI 10.1016/j.jhazmat.2009.02.075; Niladevi KN, 2008, BIORESOURCE TECHNOL, V99, P4583, DOI 10.1016/j.biortech.2007.06.056; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Robles A, 2002, ENZYME MICROB TECH, V31, P516, DOI 10.1016/S0141-0229(02)00142-4; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Ryan S, 2003, ENZYME MICROB TECH, V33, P766, DOI 10.1016/S0141-0229(03)00162-5; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shraddha, 2011, Enzyme Res, V2011, P217861, DOI 10.4061/2011/217861; Sondhi S, 2015, 3 BIOTECH, V5, P175, DOI 10.1007/s13205-014-0207-z; Telke AA, 2011, BIORESOURCE TECHNOL, V102, P1752, DOI 10.1016/j.biortech.2010.08.086; van Wezel GP, 2006, APPL ENVIRON MICROB, V72, P6863, DOI 10.1128/AEM.01853-06; Zhang C, 2013, J AGR FOOD CHEM, V61, P5468, DOI 10.1021/jf4010498	33	107	114	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e96951	10.1371/journal.pone.0096951	http://dx.doi.org/10.1371/journal.pone.0096951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871763	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300006
J	Saradalekshmi, KR; Neetha, NV; Sathyan, S; Nair, IV; Nair, CM; Banerjee, M				Saradalekshmi, Koramannil Radha; Neetha, Nanoth Vellichiramal; Sathyan, Sanish; Nair, Indu V.; Nair, Chandrasekharan M.; Banerjee, Moinak			DNA Methyl Transferase (DNMT) Gene Polymorphisms Could Be a Primary Event in Epigenetic Susceptibility to Schizophrenia	PLOS ONE			English	Article							BIPOLAR DISORDER; LEUKOCYTE DNA; MESSENGER-RNA; PROMOTER; EXPRESSION; RISK; HYPERMETHYLATION; HYPOMETHYLATION; PSYCHOSIS; SUICIDE	DNA methylation has been implicated in the etiopathology of various complex disorders. DNA methyltransferases are involved in maintaining and establishing new methylation patterns. The aim of the present study was to investigate the inherent genetic variations within DNA methyltransferase genes in predisposing to susceptibility to schizophrenia. We screened for polymorphisms in DNA methyltransferases, DNMT1, DNMT3A, DNMT3B and DNMT3L in 330 schizophrenia patients and 302 healthy controls for association with Schizophrenia in south Indian population. These polymorphisms were also tested for subgroup analysis with patient's gender, age of onset and family history. DNMT1 rs2114724 (genotype P = .004, allele P = 0.022) and rs2228611 (genotype P = 0.004, allele P = 0.022) were found to be significantly associated at genotypic and allelic level with Schizophrenia in South Indian population. DNMT3B rs2424932 genotype (P = 0.023) and allele (P = 0.0063) increased the risk of developing schizophrenia in males but not in females. DNMT3B rs1569686 (genotype P = 0.027, allele P = 0.033) was found to be associated with early onset of schizophrenia and also with family history and early onset (genotype P = 0.009). DNMT3L rs2070565 (genotype P = 0.007, allele P = 0.0026) confers an increased risk of developing schizophrenia at an early age in individuals with family history. In-silico prediction indicated functional relevance of these SNPs in regulating the gene. These observations might be crucial in addressing and understanding the genetic control of methylation level differences from ethnic viewpoint. Functional significance of genotype variations within the DNMTs indeed suggest that the genetic nature of methyltransferases should be considered while addressing epigenetic events mediated by methylation in Schizophrenia.	[Saradalekshmi, Koramannil Radha; Neetha, Nanoth Vellichiramal; Sathyan, Sanish; Banerjee, Moinak] Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Thiruvananthapuram, Kerala, India; [Nair, Indu V.] Mental Hlth Ctr, Thiruvananthapuram, Kerala, India; [Nair, Chandrasekharan M.] Nairs Hosp, Ernakulam, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Banerjee, M (corresponding author), Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Thiruvananthapuram, Kerala, India.	mbanerjee@rgcb.res.in	RADHA, SARADALEKSHMI KORAMANNIL/AAV-7061-2021; Banerjee, Moinak/X-4471-2018; SATHYAN, SANISH/CAF-8167-2022	Banerjee, Moinak/0000-0002-0842-0398; Nair, Chandrasekharan/0000-0001-7879-1023; Nanoth Vellichirammal, Neetha/0000-0002-5740-7093; K R, Saradalekshmi/0000-0003-1414-4315	Council for Scientific and Industrial Research (CSIR) New Delhi; Rajiv Gandhi Center for Biotechnology (RGCB)	Council for Scientific and Industrial Research (CSIR) New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Rajiv Gandhi Center for Biotechnology (RGCB)(Department of Biotechnology (DBT) India)	KRS was supported by Council for Scientific and Industrial Research (CSIR) New Delhi through a research fellowship. MB was supported through intramural project support from Rajiv Gandhi Center for Biotechnology (RGCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Bromberg A, 2008, SCHIZOPHR RES, V101, P50, DOI 10.1016/j.schres.2008.01.009; Carrard A, 2011, J AFFECT DISORDERS, V132, P450, DOI 10.1016/j.jad.2011.03.018; Chen YB, 2012, HUM GENET, V131, P1081, DOI 10.1007/s00439-011-1131-5; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Dempster EL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-10; Gabriel O, 2008, SCHIZOPHR B, V34, P1122; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Guidotti A, 2007, NEUROREPORT, V18, P57, DOI 10.1097/WNR.0b013e32800fefd7; Inoue-Choi M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-389; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji-Yong C, 2009, BMB REP, V42, P834; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mohammad Bakhtiar H, 2012, ENV HLTH PERSPECT, V120, P879; Murphy TM, 2013, GENES BRAIN BEHAV, V12, P125, DOI 10.1111/j.1601-183X.2012.00865.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Petronis A, 2004, BIOL PSYCHIAT, V55, P965, DOI 10.1016/j.biopsych.2004.02.005; Ronald SD, 2007, BIOL PSYCHIAT, V62, P1; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Selten JP, 2007, CURR OPIN PSYCHIATR, V20, P111, DOI 10.1097/YCO.0b013e328017f68e; Shimabukuro M, 2007, J PSYCHIATR RES, V41, P1042, DOI 10.1016/j.jpsychires.2006.08.006; Sipos A, 2004, BMJ-BRIT MED J, V329, P1070, DOI 10.1136/bmj.38243.672396.55; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Thomas R, 2006, TISSUE ANTIGENS, V68, P225, DOI 10.1111/j.1399-0039.2006.00652.x; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Weiser Mark, 2005, Dialogues Clin Neurosci, V7, P81; Zhubi A, 2009, SCHIZOPHR RES, V111, P115, DOI 10.1016/j.schres.2009.03.020	33	56	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98182	10.1371/journal.pone.0098182	http://dx.doi.org/10.1371/journal.pone.0098182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859147	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400050
J	Gracanin, A; Timmermans-Sprang, EPM; van Wolferen, ME; Rao, NAS; Grizelj, J; Vince, S; Hellmen, E; Mol, JA				Gracanin, Ana; Timmermans-Sprang, Elpetra P. M.; van Wolferen, Monique E.; Rao, Nagesha A. S.; Grizelj, Juraj; Vince, Silvijo; Hellmen, Eva; Mol, Jan A.			Ligand-Independent Canonical Wnt Activity in Canine Mammary Tumor Cell Lines Associated with Aberrant LEF1 Expression	PLOS ONE			English	Article							POLYPOSIS-COLI PROTEIN; BETA-CATENIN; BREAST-CANCER; E-CADHERIN; GENE-EXPRESSION; PATHWAY; PROLIFERATION; TRANSCRIPTION; APC; METHYLATION	Pet dogs very frequently develop spontaneous mammary tumors and have been suggested as a good model organism for breast cancer research. In order to obtain an insight into underlying signaling mechanisms during canine mammary tumorigenesis, in this study we assessed the incidence and the mechanism of canonical Wnt activation in a panel of 12 canine mammary tumor cell lines. We show that a subset of canine mammary cell lines exhibit a moderate canonical Wnt activity that is dependent on Wnt ligands, similar to what has been described in human breast cancer cell lines. In addition, three of the tested canine mammary cell lines have a high canonical Wnt activity that is not responsive to inhibitors of Wnt ligand secretion. Tumor cell lines with highly active canonical Wnt signaling often carry mutations in key members of the Wnt signaling cascade. These cell lines, however, carry no mutations in the coding regions of intracellular Wnt pathway components (APC, beta-catenin, GSK3 beta, CK1 alpha and Axin1) and have a functional beta-catenin destruction complex. Interestingly, however, the cell lines with high canonical Wnt activity specifically overexpress LEF1 mRNA and the knock-down of LEF1 significantly inhibits TCF-reporter activity. In addition, LEF1 is overexpressed in a subset of canine mammary carcinomas, implicating LEF1 in ligand-independent activation of canonical Wnt signaling in canine mammary tumors. We conclude that canonical Wnt activation may be a frequent event in canine mammary tumors both through Wnt ligand-dependent and novel ligand-independent mechanisms.	[Gracanin, Ana; Timmermans-Sprang, Elpetra P. M.; van Wolferen, Monique E.; Mol, Jan A.] Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Rao, Nagesha A. S.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Grizelj, Juraj; Vince, Silvijo] Fac Vet Med, Clin Obestr & Reprod, Zagreb, Croatia; [Hellmen, Eva] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Utrecht University; Radboud University Nijmegen; University of Zagreb; Swedish University of Agricultural Sciences	Mol, JA (corresponding author), Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	j.a.mol@uu.nl		Vince, Silvijo/0000-0002-1883-3225; Grizelj, Juraj/0000-0001-5963-3409	Dutch Society for Scientific Research (NWO) [017.004.081]	Dutch Society for Scientific Research (NWO)	This work was supported by the Mozaiek Grant 017.004.081 (to A.G.) from the Dutch Society for Scientific Research (NWO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Benhaj K, 2006, ONCOL REP, V15, P701; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Browne SJ, 1998, CELL DEATH DIFFER, V5, P206, DOI 10.1038/sj.cdd.4400331; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doleschall M, 2007, DEV COMP IMMUNOL, V31, P945, DOI 10.1016/j.dci.2006.12.007; Easwaran V, 1999, J BIOL CHEM, V274, P16641, DOI 10.1074/jbc.274.23.16641; De Matos AJF, 2007, APMIS, V115, P327, DOI 10.1111/j.1600-0463.2007.apm_544.x; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gama A, 2008, VET J, V177, P45, DOI 10.1016/j.tvjl.2007.05.024; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; HELLMEN E, 1992, IN VITRO CELL DEV-AN, V28A, P309, DOI 10.1007/BF02877054; Hollestelle A, 2010, BREAST CANCER RES TR, V122, P125, DOI 10.1007/s10549-009-0545-4; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsieh TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042750; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Klarmann GJ, 2008, EPIGENETICS-US, V3, P59, DOI 10.4161/epi.3.2.5899; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; MISDORP W, 1988, VET QUART, V10, P26, DOI 10.1080/01652176.1988.9694142; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Restucci B, 2007, ANTICANCER RES, V27, P3083; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; SCHNEIDER R, 1969, JNCI-J NATL CANCER I, V43, P1249; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Uyama R, 2006, VET COMP ONCOL, V4, P104, DOI 10.1111/j.1476-5810.2006.00098.x; van de Wetering M, 2001, CANCER RES, V61, P278; vanLeeuwen IS, 1996, ANTICANCER RES, V16, P3737; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Virmani AK, 2001, CLIN CANCER RES, V7, P1998; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145	44	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98698	10.1371/journal.pone.0098698	http://dx.doi.org/10.1371/journal.pone.0098698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887235	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300099
J	Li, J; Zhao, L; Yang, T; Zeng, YJ; Yang, K				Li, Jun; Zhao, Li; Yang, Ting; Zeng, Yi-Jun; Yang, Kang			c-Ski Inhibits Autophagy of Vascular Smooth Muscle Cells Induced by oxLDL and PDGF	PLOS ONE			English	Article							FINE-STRUCTURE; LYSOSOMES; ATHEROSCLEROSIS; DEATH; 7-KETOCHOLESTEROL; EXPRESSION; REPRESSOR; RECEPTOR	Autophagy is increasingly being recognized as a critical determinant of vascular smooth muscle cell (VSMC) biology. Previously, we have demonstrated that c-Ski inhibits VSMC proliferation stimulated by transforming growth factor beta (TGF-beta), but it is not clear whether c-Ski has the similar protective role against other vascular injury factors and whether regulation of autophagy is involved in its protective effects on VSMC. Accordingly, in this study, rat aortic A10 VSMCs were treated with 40 mu g/ml oxidized low-density lipoprotein (oxLDL) or 20 ng/ml platelet-derived growth factor (PDGF), both of which were autophagy inducers and closely related to the abnormal proliferation of VSMCs. Overexpression of c-Ski in A10 cells significantly suppressed the oxLDL- and PDGF-induced autophagy. This action of c-Ski resulted in inhibiting the cell proliferation, the decrease of contractile phenotype marker alpha-SMA expression while the increase of synthetic phenotype marker osteopontin expression stimulated by oxLDL or PDGF. Inversely, knockdown of c-Ski by RNAi enhanced the stimulatory effects of oxLDL or PDGF on A10 cell growth and phenotype transition. And further investigation found that inhibition of AKT phosphorylation to downregulate proliferating cell nuclear antigen (PCNA) expression, was involved in the regulation of autophagy and associated functions by c-Ski in the oxLDL- and PDGF-stimulated VSMCs. Collectively, c-Ski may play an important role in inhibiting autophagy to protect VSMCs against some harsh stress including oxLDL and PDGF.	[Li, Jun; Yang, Kang] Third Mil Med Univ, Southwest Hosp, Dept Cardiothorac Surg, Chongqing, Peoples R China; [Zhao, Li; Yang, Ting; Zeng, Yi-Jun] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Cardiothorac Surg, Chongqing, Peoples R China.	tmmubiodss@aliyun.com			National Natural Science Foundation of China [81172817]; Natural Science Foundation of Chongqing, China [CSTC2009BB5317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	This work is supported by National Natural Science Foundation of China (No. 81172817), Natural Science Foundation of Chongqing, China (No. CSTC2009BB5317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z; Bowen-Pope DF, 2011, ARTERIOSCL THROM VAS, V31, P2397, DOI 10.1161/ATVBAHA.108.179556; BUCK RC, 1962, BRIT J EXP PATHOL, V43, P236; Bundy RE, 2000, GEN PHARMACOL-VASC S, V34, P73, DOI 10.1016/S0306-3623(00)00047-1; Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482; Damiani E, 1998, FEBS LETT, V425, P123, DOI 10.1016/S0014-5793(98)00212-9; Ding ZF, 2013, INT J CARDIOL, V168, P1378, DOI 10.1016/j.ijcard.2012.12.045; GEER JC, 1961, AM J PATHOL, V38, P263; GEER JC, 1968, AM J PATHOL, V52, P265; GOLDFISCHER S, 1975, AM J PATHOL, V78, P497; GOLDFISCHER S, 1975, HUM PATHOL, V6, P633, DOI 10.1016/S0046-8177(75)80047-5; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; He CY, 2013, AM J PATHOL, V183, P626, DOI 10.1016/j.ajpath.2013.04.028; Hill BG, 2008, BIOCHEM J, V410, P525, DOI 10.1042/BJ20071063; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Li J, 2014, CELL SIGNAL, V26, P724; Li J, 2013, CELL SIGNAL, V25, P159, DOI 10.1016/j.cellsig.2012.09.001; Li J, 2012, CELL PHYSIOL BIOCHEM, V30, P1059, DOI 10.1159/000341482; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marcelain K, 2012, J CELL PHYSIOL, V227, P278, DOI 10.1002/jcp.22733; Martinet W, 2008, BRIT J PHARMACOL, V154, P1236, DOI 10.1038/bjp.2008.181; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Maziere C, 2010, FREE RADICAL BIO MED, V48, P1382, DOI 10.1016/j.freeradbiomed.2010.02.022; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Orford JL, 2000, AM J CARDIOL, V86, p6H, DOI 10.1016/S0002-9149(00)01094-8; PARKER F, 1966, AM J PATHOL, V48, P451; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Salabei JK, 2013, FREE RADICAL BIO MED, V65, P693, DOI 10.1016/j.freeradbiomed.2013.08.003; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; SHIO H, 1974, AM J PATHOL, V76, P1; TAPP RL, 1969, BRIT J EXP PATHOL, V50, P356; WOLINSKY H, 1974, CIRC RES, V34, P233, DOI 10.1161/01.RES.34.2.233; Xu KD, 2010, J LIPID RES, V51, P2581, DOI 10.1194/jlr.M005702; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709	45	8	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98902	10.1371/journal.pone.0098902	http://dx.doi.org/10.1371/journal.pone.0098902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887307	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300120
J	Strauss, AS; Wang, D; Stock, M; Gretscher, RR; Groth, M; Boland, W; Burse, A				Strauss, Anja S.; Wang, Ding; Stock, Magdalena; Gretscher, Rene R.; Groth, Marco; Boland, Wilhelm; Burse, Antje			Tissue-Specific Transcript Profiling for ABC Transporters in the Sequestering Larvae of the Phytophagous Leaf Beetle Chrysomela populi	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; P-GLYCOPROTEIN ATPASE; MULTIDRUG-RESISTANCE; DROSOPHILA-MELANOGASTER; MOLECULAR-BASIS; GENE FAMILY; SUBCELLULAR-LOCALIZATION; HELICOVERPA-ARMIGERA; CONFERS RESISTANCE; CHEMICAL DEFENSE	Background: Insects evolved ingenious adaptations to use extraordinary food sources. Particularly, the diet of herbivores enriched with noxious plant secondary metabolites requires detoxification mechanisms. Sequestration, which involves the uptake, transfer, and concentration of occasionally modified phytochemicals into specialized tissues or hemolymph, is one of the most successful detoxification strategies found in most insect orders. Due to the ability of ATP-binding cassette (ABC) carriers to transport a wide range of molecules including phytochemicals and xenobiotics, it is highly likely that they play a role in this sequestration process. To shed light on the role of ABC proteins in sequestration, we describe an inventory of putative ABC transporters in various tissues in the sequestering juvenile poplar leaf beetle, Chrysomela populi. Results: In the transcriptome of C. populi, we predicted 65 ABC transporters. To link the proteins with a possible function, we performed comparative phylogenetic analyses with ABC transporters of other insects and of humans. While tissue-specific profiling of each ABC transporter subfamily suggests that ABCB, C and G influence the plant metabolite absorption in the gut, ABCC with 14 members is the preferred subfamily responsible for the excretion of these metabolites via Malpighian tubules. Moreover, salicin, which is sequestered from poplar plants, is translocated into the defensive glands for further deterrent production. In these glands and among all identified ABC transporters, an exceptionally high transcript level was observed only for Cpabc35 (Cpmrp). RNAi revealed the deficiency of other ABC pumps to compensate the function of CpABC35, demonstrating its key role during sequestration. Conclusion: We provide the first comprehensive phylogenetic study of the ABC family in a phytophagous beetle species. RNA-seq data from different larval tissues propose the importance of ABC pumps to achieve a homeostasis of plant-derived compounds and offer a basis for future analyses of their physiological function in sequestration processes.	[Strauss, Anja S.; Wang, Ding; Stock, Magdalena; Gretscher, Rene R.; Boland, Wilhelm; Burse, Antje] Max Planck Inst Chem Ecol, D-07745 Jena, Thuringia, Germany; [Groth, Marco] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Thuringia, Germany	Max Planck Society; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Burse, A (corresponding author), Max Planck Inst Chem Ecol, Beutenberg Campus,Hans Knoell Str 8, D-07745 Jena, Thuringia, Germany.	aburse@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534; Groth, Marco/0000-0002-9199-8990; Gretscher, Rene/0000-0002-0249-4978; Strauss, Anja/0000-0003-2528-4735	Deutsche Forschungsgemeinschaft [BU 1862/2-1]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work has been supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp; grant number, BU 1862/2-1) and the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Aung T, 2011, P NATL ACAD SCI USA, V108, P15336, DOI 10.1073/pnas.1102855108; Aurade RM, 2012, ARCH INSECT BIOCHEM, V79, P47, DOI 10.1002/arch.21004; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Bangert I, 2011, BIOL CHEM, V392, P61, DOI 10.1515/BC.2011.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BAUER LS, 1993, J EUKARYOT MICROBIOL, V40, P135, DOI 10.1111/j.1550-7408.1993.tb04893.x; Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Begun DJ, 2000, HEREDITY, V85, P184, DOI 10.1046/j.1365-2540.2000.00729.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bodemann RR, 2012, P ROY SOC B-BIOL SCI, V279, P4126, DOI 10.1098/rspb.2012.1342; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chavan H, 2013, J BIOL CHEM, V288, P22658, DOI 10.1074/jbc.M113.485284; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Chloupkova M, 2003, J MOL BIOL, V331, P155, DOI 10.1016/S0022-2836(03)00666-1; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dassa E, 2011, ESSAYS BIOCHEM, V50, P19, DOI [10.1042/BSE0500019, 10.1042/bse0500019]; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Discher S, 2009, CHEMBIOCHEM, V10, P2223, DOI 10.1002/cbic.200900226; Dong JS, 2005, MOL CELL BIOL, V25, P9859, DOI 10.1128/MCB.25.22.9859-9873.2005; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Evans JM, 2008, J EXP BIOL, V211, P890, DOI 10.1242/jeb.014837; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Gross J, 2002, J CHEM ECOL, V28, P317, DOI 10.1023/A:1017934124650; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Hock T, 2000, P NATL ACAD SCI USA, V97, P9519, DOI 10.1073/pnas.160271797; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Hunt JF, 2013, COLD SPRING HARB PER, V3; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Itoh TQ, 2011, GENES CELLS, V16, P1159, DOI 10.1111/j.1365-2443.2011.01559.x; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawanobe T, 2012, BIOCHEM BIOPH RES CO, V418, P736, DOI 10.1016/j.bbrc.2012.01.090; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy P, 2011, CURR PHARM BIOTECHNO, V12, P647, DOI 10.2174/138920111795163995; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; LANDER E S, 1988, Genomics, V2, P231; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lanning CL, 1996, BBA-GEN SUBJECTS, V1291, P155, DOI 10.1016/0304-4165(96)00060-8; Li JW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003596; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Michalski C, 2008, J BIOL CHEM, V283, P19219, DOI 10.1074/jbc.M802236200; Moitra Karobi, 2011, Drug Metabolism and Drug Interactions, V26, P105, DOI 10.1515/DMDI.2011.015; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Overbeck TR, 2013, ONCOLOGY-BASEL, V84, P362, DOI 10.1159/000348884; PASTEELS JM, 1990, J CHEM ECOL, V16, P211, DOI 10.1007/BF01021280; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petschenka G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3089; Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185; Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Popovic M, 2010, MAR ENVIRON RES, V69, pS11, DOI 10.1016/j.marenvres.2009.10.016; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Roth CW, 2003, MOL CELLS, V15, P150; RYALL RL, 1974, INSECT BIOCHEM, V4, P47, DOI 10.1016/0020-1790(74)90041-9; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; SMILEY JT, 1985, SCIENCE, V229, P649, DOI 10.1126/science.229.4714.649; Sorensen JS, 2006, J CHEM ECOL, V32, P1181, DOI 10.1007/s10886-006-9079-y; Srinivas R, 2004, COMP BIOCHEM PHYS C, V137, P261, DOI 10.1016/j.cca.2004.02.002; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Stock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084461; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; SULLIVAN DT, 1974, J EXP ZOOL, V188, P225, DOI 10.1002/jez.1401880210; SULLIVAN DT, 1975, BIOCHEM GENET, V13, P603, DOI 10.1007/BF00484918; Sumitani M, 2005, INSECT BIOCHEM MOLEC, V35, P231, DOI 10.1016/j.ibmb.2004.12.006; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tamaki A, 2011, ESSAYS BIOCHEM, V50, P209, DOI [10.1042/BSE0500209, 10.1042/bse0500209]; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Tian Y, 2012, IUBMB LIFE, V64, P795, DOI 10.1002/iub.1071; Toguebaye B.S., 1988, Series Entomologica (Dordrecht), V42, P399; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Xie XD, 2012, MOL BIOL REP, V39, P7281, DOI 10.1007/s11033-012-1558-3; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zarubica A, 2007, PFLUG ARCH EUR J PHY, V453, P569, DOI 10.1007/s00424-006-0108-z; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 ; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	144	26	27	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98637	10.1371/journal.pone.0098637	http://dx.doi.org/10.1371/journal.pone.0098637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887102	Green Published, gold			2022-12-27	WOS:000336956300096
J	Vokhshoori, NL; McCarthy, MD				Vokhshoori, Natasha L.; McCarthy, Matthew D.			Compound-Specific delta N-15 Amino Acid Measurements in Littoral Mussels in the California Upwelling Ecosystem: A New Approach to Generating Baseline delta N-15 Isoscapes for Coastal Ecosystems	PLOS ONE			English	Article							PACIFIC SUBTROPICAL GYRE; TROPHIC POSITION; NITROGEN; PATTERNS; ZOOPLANKTON; DYNAMICS; CARBON; FRACTIONATION; ISOTOPES; DIET	We explored delta N-15 compound-specific amino acid isotope data (CSI-AA) in filter-feeding intertidal mussels (Mytilus californianus) as a new approach to construct integrated isoscapes of coastal primary production. We examined spatial delta N-15 gradients in the California Upwelling Ecosystem (CUE), determining bulk delta N-15 values of mussel tissue from 28 sites between Port Orford, Oregon and La Jolla, California, and applying CSI-AA at selected sites to decouple trophic effects from isotopic values at the base of the food web. Bulk delta N-15 values showed a strong linear trend with latitude, increasing from North to South (from similar to 7 parts per thousand to similar to 12 parts per thousand, R-2 = 0.759). In contrast, CSI-AA trophic position estimates showed no correlation with latitude. The delta N-15 trend is therefore most consistent with a baseline delta N-15 gradient, likely due to the mixing of two source waters: low delta N-15 nitrate from the southward flowing surface California Current, and the northward transport of the California Undercurrent (CUC), with N-15-enriched nitrate. This interpretation is strongly supported by a similar linear gradient in delta N-15 values of phenylalanine (delta N-15(Phe)), the best AA proxy for baseline delta N-15 values. We hypothesize delta N-15(Phe) values in intertidal mussels can approximate annual integrated delta N-15 values of coastal phytoplankton primary production. We therefore used delta N-15(Phe) values to generate the first compound-specific nitrogen isoscape for the coastal Northeast Pacific, which indicates a remarkably linear gradient in coastal primary production delta N-15 values. We propose that delta N-15(Phe) isoscapes derived from filter feeders can directly characterize baseline delta N-15 values across major biochemical provinces, with potential applications for understanding migratory and feeding patterns of top predators, monitoring effects of climate change, and study of paleoarchives.	[Vokhshoori, Natasha L.; McCarthy, Matthew D.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Vokhshoori, NL (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	nvokhsho@ucsc.edu; mccarthy@pmc.ucsc.edu		vokhshoori, natasha/0000-0003-3412-7934	Friends of Long Marine Lab; Myers Oceanographic Trust; University of California, Santa Cruz, Open Access Fund	Friends of Long Marine Lab; Myers Oceanographic Trust; University of California, Santa Cruz, Open Access Fund	Sources of funding that have supported this work were awards received from Friends of Long Marine Lab (http://seymourcenter.ucsc.edu/about-us/people/board/; http://seymourcenter.ucsc.edu/wp-content/uploads/2013/10/SREA-2013-2014-guidelines.pdf) and from the Myers Oceanographic Trust. Funding for Open Access provided by the University of California, Santa Cruz, Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 2009, LIMNOL OCEANOGR, V54, P1272, DOI 10.4319/lo.2009.54.4.1272; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ASMUS RM, 1991, J EXP MAR BIOL ECOL, V148, P215, DOI 10.1016/0022-0981(91)90083-9; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bracken MES, 2012, MAR ECOL PROG SER, V459, P53, DOI 10.3354/meps09764; Brandes JA, 2007, CHEM REV, V107, P577, DOI 10.1021/cr050377t; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Choy CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050133; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; CODISPOTI LA, 1976, LIMNOL OCEANOGR, V21, P379, DOI 10.4319/lo.1976.21.3.0379; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Decima M, 2013, LIMNOL OCEANOGR, V58, P624, DOI 10.4319/lo.2013.58.2.0624; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Ford HL, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001677; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Graham B.S., 2009, USING ISOSCAPES TRAC, P299, DOI DOI 10.1007/978-90-481-3354-3_14; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hannides CCS, 2013, LIMNOL OCEANOGR, V58, P1931, DOI 10.4319/lo.2013.58.6.1931; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kahru M, 2000, GEOPHYS RES LETT, V27, P2937, DOI 10.1029/2000GL011486; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Larsen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073441; Liu ZH, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002044; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McCarthy MD, 2013, GEOCHIM COSMOCHIM AC, V103, P104, DOI 10.1016/j.gca.2012.10.037; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McKinnell SM, 2010, PICES SPECIAL PUBLIC, V4, P393; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Olson RJ, 2010, PROG OCEANOGR, V86, P124, DOI 10.1016/j.pocean.2010.04.026; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Raikow DF, 2001, LIMNOL OCEANOGR, V46, P514, DOI 10.4319/lo.2001.46.3.0514; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Ruiz-Cooley RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059651; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Rykaczewski RR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045019; Schwing FB, 1996, NOAA TECH REP NMFS S, V231, P144; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Sherwood OA, 2013, NATURE, P1; Sigman DM, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000384; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Sigman DM, 2009, ENCY OCEAN SCI; Somes CJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044537; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vokhshoori N, 2013, THESIS U CALIFORNIA; Vokhshoori NL, 2014, MAR ECOL PROG SER, V504, P59, DOI 10.3354/meps10746; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Waser N, 2010, LIMNOL OCEANOGR, V43, P215; White AE, 2013, PROG OCEANOGR, V109, P1, DOI 10.1016/j.pocean.2012.09.002	59	49	49	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98087	10.1371/journal.pone.0098087	http://dx.doi.org/10.1371/journal.pone.0098087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887109	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300037
J	Halphen, I; Elie, C; Brousse, V; Le Bourgeois, M; Allali, S; Bonnet, D; de Montalembert, M				Halphen, Isabelle; Elie, Caroline; Brousse, Valentine; Le Bourgeois, Muriel; Allali, Slimane; Bonnet, Damien; de Montalembert, Mariane			Severe Nocturnal and Postexercise Hypoxia in Children and Adolescents with Sickle Cell Disease	PLOS ONE			English	Article							REGURGITANT JET VELOCITY; HEMOGLOBIN OXYGEN DESATURATION; 6-MINUTE WALK TEST; PULMONARY-HYPERTENSION; PULSE OXIMETRY; OXYHEMOGLOBIN DESATURATION; LUNG-FUNCTION; EXERCISE; SATURATION; HYPOXEMIA	Hypoxia is a common feature in children with sickle cell disease (SCD) that is inconsistently associated with painful crises and acute chest syndrome. To assess the prevalence and risk factors of hypoxia, we recorded daytime, nocturnal, and postexercise pulse oximetry (SpO(2)) values in 39 SCD patients with a median age of 10.8 years. Median daytime SpO2 was 97% (range, 89%-100%), and 36% of patients had daytime hypoxia defined as SpO(2)< 96%. Median nocturnal SpO(2) was 94.7% (range, 87.7%-99.5%), 50% of patients had nocturnal hypoxia defined as SpO(2)<= 93%, and 11(37%) patients spent more than 10% of their total sleep time with SpO(2)< 90%. Median postexercise SpO(2) was 94% (range, 72%-100%) and 44.7% of patients had postexercise hypoxia defined as an SpO(2) decrease >= 3% after a 6-minute walk test. Among patients with normal daytime SpO(2), 35% had nocturnal and 42% postexercise hypoxia. Compared to 9 patients without daytime, nocturnal, or postexercise hypoxia, 25 patients with hypoxia under at least one of these three conditions had greater anemia severity (P = 0.01), lower HbF levels (P = 0.04), and higher aspartate aminotransferase levels (P = 0.03). Males predominated among patients with postexercise hypoxia (P = 0.004). Hypoxia correlated neither with painful crises nor with acute chest syndrome. Of 32 evaluable patients, 6 (18.8%) had a tricuspid regurgitation velocity >= 2.6 m/s, and this feature was associated with anemia (P = 0.044). Median percentage of the predicted distance covered during a 6-minute walk test was 86% [46-120]; the distance was negatively associated with LDH (P = 0.044) and with a past history of acute chest syndrome (P = 0.009). In conclusion, severe episodes of nocturnal and postexercise hypoxia are common in children with SCD, even those with normal daytime SpO(2).	[Halphen, Isabelle] Hop Necker Enfants Malad, AP HP, Pediat Emergency Dept, Paris, France; [Elie, Caroline; Bonnet, Damien; de Montalembert, Mariane] Paris Descartes Univ, Paris, France; [Elie, Caroline] Hop Necker Enfants Malad, AP HP, Dept Biostat, Paris, France; [Brousse, Valentine; Allali, Slimane; de Montalembert, Mariane] Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France; [Brousse, Valentine; Allali, Slimane; de Montalembert, Mariane] Hop Necker Enfants Malad, AP HP, Sickle Cell Clin, Paris, France; [Le Bourgeois, Muriel] Hop Necker Enfants Malad, AP HP, Pediat Pneumol & Allergol Dept, Paris, France; [Bonnet, Damien] Paris Descartes Univ, Necker M3C, AP HP, Dept Pediat Cardiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	de Montalembert, M (corresponding author), Paris Descartes Univ, Paris, France.	mariane.demontal@nck.aphp.fr	Allali, Slimane/AGW-0037-2022	Allali, Slimane/0000-0001-7068-4530				Ambrusko SJ, 2006, PEDIATR BLOOD CANCER, V47, P907, DOI 10.1002/pbc.20791; Campbell A, 2009, BRIT J HAEMATOL, V147, P352, DOI 10.1111/j.1365-2141.2009.07854.x; Chapusette R, 2013, BLOOD, V122; Chaudry RA, 2011, ARCH DIS CHILD, V96, P131, DOI 10.1136/adc.2010.184028; Colombatti R, 2011, HEMATOL REP, V3, P34, DOI 10.4081/hr.2011.e12; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; Cox SE, 2013, ISRN HEMATOLOGY, DOI DOI 10.1155/2013/472909; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dahoui HA, 2010, PEDIATR BLOOD CANCER, V54, P398, DOI 10.1002/pbc.22306; Fitzgerald RK, 2001, CRIT CARE MED, V29, P1803, DOI 10.1097/00003246-200109000-00025; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Gordeuk VR, 2011, HAEMATOL-HEMATOL J, V96, P33, DOI 10.3324/haematol.2010.030767; Gulmans VAM, 1996, PEDIATR PULM, V22, P85, DOI 10.1002/(SICI)1099-0496(199608)22:2<85::AID-PPUL1>3.0.CO;2-I; Hagar RW, 2008, BRIT J HAEMATOL, V140, P104, DOI 10.1111/j.1365-2141.2007.06822.x; Hargrave DR, 2003, BLOOD, V101, P846, DOI 10.1182/blood-2002-05-1392; Hassan J, 2010, BRIT J SPORT MED, V44, P270, DOI 10.1136/bjsm.2008.048512; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kirkham FJ, 2001, LANCET, V357, P1656, DOI 10.1016/S0140-6736(00)04821-2; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; Liem RI, 2009, PEDIATR PULM, V44, P281, DOI 10.1002/ppul.20996; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Marshall MJ, 2009, HAEMATOL-HEMATOL J, V94, P1006, DOI 10.3324/haematol.2008.005215; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; MILNER PF, 1974, ARCH INTERN MED, V133, P565, DOI 10.1001/archinte.133.4.565; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; Mullin JE, 2010, PEDIATR BLOOD CANCER, V54, P1017, DOI 10.1002/pbc.22420; Needleman JP, 1999, PEDIATR PULM, V28, P418, DOI 10.1002/(SICI)1099-0496(199912)28:6<418::AID-PPUL6>3.0.CO;2-D; Nelson SC, 2007, J PEDIAT HEMATOL ONC, V29, P334, DOI 10.1097/MPH.0b013e31805d8f32; Onyekwere OC, 2008, PEDIATR CARDIOL, V29, P309, DOI 10.1007/s00246-007-9018-x; Ortiz FO, 1999, AM J RESP CRIT CARE, V159, P447, DOI 10.1164/ajrccm.159.2.9806108; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; Pashankar FD, 2009, BRIT J HAEMATOL, V144, P736, DOI 10.1111/j.1365-2141.2008.07501.x; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira FM, 2011, J BRAS PNEUMOL, V37, P735, DOI 10.1590/S1806-37132011000600006; Quinn CT, 2005, BRIT J HAEMATOL, V131, P129, DOI 10.1111/j.1365-2141.2005.05738.x; RACKOFF WR, 1993, BLOOD, V81, P3422; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; Singh SA, 2008, PEDIATR BLOOD CANCER, V50, P1258, DOI 10.1002/pbc.21480; Uong EC, 2006, J PEDIATR-US, V149, P707, DOI 10.1016/j.jpeds.2006.06.038; Waltz X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077830; Waltz X, 2013, HAEMATOLOGICA, V98, P1039, DOI 10.3324/haematol.2013.083576	47	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97462	10.1371/journal.pone.0097462	http://dx.doi.org/10.1371/journal.pone.0097462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878576	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500014
J	Hedegaard, J; Thorsen, K; Lund, MK; Hein, AMK; Hamilton-Dutoit, SJ; Vang, S; Nordentoft, I; Birkenkamp-Demtroder, K; Kruhoffer, M; Hager, H; Knudsen, B; Andersen, CL; Sorensen, KD; Pedersen, JS; Orntoft, TF; Dyrskjot, L				Hedegaard, Jakob; Thorsen, Kasper; Lund, Mette Katrine; Hein, Anne-Mette K.; Hamilton-Dutoit, Stephen Jacques; Vang, Soren; Nordentoft, Iver; Birkenkamp-Demtroder, Karin; Kruhoffer, Mogens; Hager, Henrik; Knudsen, Bjarne; Andersen, Claus Lindbjerg; Sorensen, Karina Dalsgaard; Pedersen, Jakob Skou; Orntoft, Torben Falck; Dyrskjot, Lars			Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHROMATIN IMMUNOPRECIPITATION; PATHOLOGY TISSUE; COPY-NUMBER; CARCINOMA; SPECIMENS; RESOLUTION; ARTIFACTS; SIGNATURE; PCR	Formalin-fixed, paraffin-embedded (FFPE) tissues are an invaluable resource for clinical research. However, nucleic acids extracted from FFPE tissues are fragmented and chemically modified making them challenging to use in molecular studies. We analysed 23 fresh-frozen (FF), 35 FFPE and 38 paired FF/FFPE specimens, representing six different human tissue types (bladder, prostate and colon carcinoma; liver and colon normal tissue; reactive tonsil) in order to examine the potential use of FFPE samples in next-generation sequencing (NGS) based retrospective and prospective clinical studies. Two methods for DNA and three methods for RNA extraction from FFPE tissues were compared and were found to affect nucleic acid quantity and quality. DNA and RNA from selected FFPE and paired FF/FFPE specimens were used for exome and transcriptome analysis. Preparations of DNA Exome-Seq libraries was more challenging (29.5% success) than that of RNA-Seq libraries, presumably because of modifications to FFPE tissue-derived DNA. Libraries could still be prepared from RNA isolated from two-decade old FFPE tissues. Data were analysed using the CLC Bio Genomics Workbench and revealed systematic differences between FF and FFPE tissue-derived nucleic acid libraries. In spite of this, pairwise analysis of DNA Exome-Seq data showed concordance for 70-80% of variants in FF and FFPE samples stored for fewer than three years. RNA-Seq data showed high correlation of expression profiles in FF/FFPE pairs (Pearson Correlations of 0.90 +/- 0.05), irrespective of storage time (up to 244 months) and tissue type. A common set of 1,494 genes was identified with expression profiles that were significantly different between paired FF and FFPE samples irrespective of tissue type. Our results are promising and suggest that NGS can be used to study FFPE specimens in both prospective and retrospective archive-based studies in which FF specimens are not available.	[Hedegaard, Jakob; Thorsen, Kasper; Vang, Soren; Nordentoft, Iver; Birkenkamp-Demtroder, Karin; Andersen, Claus Lindbjerg; Sorensen, Karina Dalsgaard; Pedersen, Jakob Skou; Orntoft, Torben Falck; Dyrskjot, Lars] Aarhus Univ Hosp, Mol Diagnost Lab, Dept Mol Med MOMA, DK-8000 Aarhus, Denmark; [Lund, Mette Katrine; Kruhoffer, Mogens] AROS Appl Biotechnol AS, Aarhus, Denmark; [Hein, Anne-Mette K.; Knudsen, Bjarne] CLC Bio, Aarhus, Denmark; [Hamilton-Dutoit, Stephen Jacques; Hager, Henrik] Aarhus Univ Hosp, Inst Pathol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Hedegaard, J (corresponding author), Aarhus Univ Hosp, Mol Diagnost Lab, Dept Mol Med MOMA, DK-8000 Aarhus, Denmark.	Jakob.Hedegaard@ki.au.dk	Birkenkamp-Demtröder, Karin/AAN-1764-2021; Nordentoft, Iver/C-6345-2017; Pedersen, Jakob/G-3382-2012; Andersen, Claus L/C-1477-2017; Birkenkamp-Demtröder, Karin/C-1981-2017; Andersen, Claus Lindbjerg/A-9217-2012	Birkenkamp-Demtröder, Karin/0000-0001-8057-6277; Pedersen, Jakob/0000-0002-7236-4001; Sorensen, Karina Dalsgaard/0000-0002-4902-5490; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Nordentoft, Iver Kristiansen/0000-0003-4856-4086; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Dyrskjot, Lars/0000-0001-7061-9851; Vang, Soren/0000-0002-1899-4205	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Cancer Society; The Danish Cancer Society [R72-A4591] Funding Source: researchfish	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Cancer Society(Danish Cancer Society); The Danish Cancer Society(Danish Cancer Society)	This work was supported by grants from The Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk/), The John and Birthe Meyer Foundation and The Danish Cancer Society (http://www.cancer.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; [Anonymous], 2014, R LANG ENV STAT COMP; Babraham Bioinformatics, 2014, FASTQC; Boeckx C, 2011, DIAGN MOL PATHOL, V20, P203, DOI 10.1097/PDM.0b013e3182230937; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do HD, 2012, ONCOTARGET, V3, P546; Dyrskjot L, 2005, CLIN CANCER RES, V11, P4029, DOI 10.1158/1078-0432.CCR-04-2095; Dyrskjot L, 2012, BRIT J CANCER, V107, P1392, DOI 10.1038/bjc.2012.412; Fanelli M, 2011, NAT PROTOC, V6, P1905, DOI 10.1038/nprot.2011.406; Fanelli M, 2010, P NATL ACAD SCI USA, V107, P21535, DOI 10.1073/pnas.1007647107; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Norton N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081925; Oster B, 2013, INT J CANCER, V132, P2303, DOI 10.1002/ijc.27921; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Sinicropi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040092; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907	29	221	225	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98187	10.1371/journal.pone.0098187	http://dx.doi.org/10.1371/journal.pone.0098187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878701	gold, Green Published			2022-12-27	WOS:000338101500036
J	Lee, G; Sparks, R; Ali, S; Shih, NNC; Feldman, MD; Spangler, E; Rebbeck, T; Tomaszewski, JE; Madabhushi, A				Lee, George; Sparks, Rachel; Ali, Sahirzeeshan; Shih, Natalie N. C.; Feldman, Michael D.; Spangler, Elaine; Rebbeck, Timothy; Tomaszewski, John E.; Madabhushi, Anant			Co-Occurring Gland Angularity in Localized Subgraphs: Predicting Biochemical Recurrence in Intermediate-Risk Prostate Cancer Patients	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; POSTOPERATIVE NOMOGRAM; CELL-GRAPHS; PROBABILITY; PROGRESSION; VALIDATION; DEATH	Quantitative histomorphometry (QH) refers to the application of advanced computational image analysis to reproducibly describe disease appearance on digitized histopathology images. QH thus could serve as an important complementary tool for pathologists in interrogating and interpreting cancer morphology and malignancy. In the US, annually, over 60,000 prostate cancer patients undergo radical prostatectomy treatment. Around 10,000 of these men experience biochemical recurrence within 5 years of surgery, a marker for local or distant disease recurrence. The ability to predict the risk of biochemical recurrence soon after surgery could allow for adjuvant therapies to be prescribed as necessary to improve long term treatment outcomes. The underlying hypothesis with our approach, co-occurring gland angularity (CGA), is that in benign or less aggressive prostate cancer, gland orientations within local neighborhoods are similar to each other but are more chaotically arranged in aggressive disease. By modeling the extent of the disorder, we can differentiate surgically removed prostate tissue sections from (a) benign and malignant regions and (b) more and less aggressive prostate cancer. For a cohort of 40 intermediate-risk (mostly Gleason sum 7) surgically cured prostate cancer patients where half suffered biochemical recurrence, the CGA features were able to predict biochemical recurrence with 73% accuracy. Additionally, for 80 regions of interest chosen from the 40 studies, corresponding to both normal and cancerous cases, the CGA features yielded a 99% accuracy. CGAs were shown to be statistically signicantly (p<0.05) better at predicting BCR compared to state-of-the-art QH methods and postoperative prostate cancer nomograms.	[Lee, George; Ali, Sahirzeeshan; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Sparks, Rachel] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Shih, Natalie N. C.; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Spangler, Elaine; Rebbeck, Timothy] Univ Penn, Dept Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Tomaszewski, John E.] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA	Case Western Reserve University; Rutgers State University New Brunswick; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, G (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	george.lee@case.edu; anant.madabhushi@case.edu	Sparks, Rachel/AAM-5586-2020; Rebbeck, Timothy/GLU-8348-2022; Madabhushi, Anant/AAG-2908-2019	Sparks, Rachel/0000-0003-1553-7903; Rebbeck, Timothy/0000-0002-4799-1900; Madabhushi, Anant/0000-0002-5741-0399	Department of Defense [W81XWH-12-1-0171, W81XWH-11-1-0179]; National Cancer Institute of the National Institutes of Health [R01CA136535-01, R01CA140772-01, R21CA167811-01]; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R43EB015199-01]; National Science Foundation [IIP-1248316]; QED award from the University City Science Center; Rutgers University; NATIONAL CANCER INSTITUTE [R21CA167811, P30CA016520, R01CA140772, R01CA136535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R43EB015199] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); QED award from the University City Science Center; Rutgers University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Department of Defense (W81XWH-12-1-0171); Department of Defense (W81XWH-11-1-0179); National Cancer Institute of the National Institutes of Health under award numbers R01CA136535-01, R01CA140772-01, and R21CA167811-01; the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award number R43EB015199-01; the National Science Foundation under award number IIP-1248316; and the QED award from the University City Science Center and Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2013, P SPIE 8676, V8676; Ali S, 2012, IEEE T MED IMAGING, V31, P1448, DOI 10.1109/TMI.2012.2190089; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; ChristensBarry WA, 1997, J HOPKINS APL TECH D, V18, P226; Cooperberg MR, 2006, CANCER, V107, P2384, DOI 10.1002/cncr.22262; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Demir C, 2005, BIOINFORMATICS, V21, P7, DOI 10.1093/bioinformatics/bti1100; Doyle S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-282; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Fagerland MW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-78; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gunduz-Demir C, 2007, MATH BIOSCI, V209, P514, DOI 10.1016/j.mbs.2007.03.005; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hinev AI, 2011, J BUON, V16, P316; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jafari-Khouzani K, 2003, IEEE T BIO-MED ENG, V50, P697, DOI 10.1109/TBME.2003.812194; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; LEE G, 2013, BIOMEDICAL IMAGING I, P113; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Monaco JP, 2010, MED IMAGE ANAL, V14, P617, DOI 10.1016/j.media.2010.04.007; Pinto F, 2006, UROL INT, V76, P202, DOI 10.1159/000091619; Stark JR, 2009, J CLIN ONCOL, V27, P3459, DOI 10.1200/JCO.2008.20.4669; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Veltri RW, 2010, PROSTATE, V70, P1333, DOI 10.1002/pros.21168	31	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97954	10.1371/journal.pone.0097954	http://dx.doi.org/10.1371/journal.pone.0097954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875018	Green Published, gold			2022-12-27	WOS:000336790800018
J	Sauvage, E; Derouaux, A; Fraipont, C; Joris, M; Herman, R; Rocaboy, M; Schloesser, M; Dumas, J; Kerff, F; Nguyen-Disteche, M; Charlier, P				Sauvage, Eric; Derouaux, Adeline; Fraipont, Claudine; Joris, Marine; Herman, Raphael; Rocaboy, Mathieu; Schloesser, Marie; Dumas, Jacques; Kerff, Frederic; Nguyen-Disteche, Martine; Charlier, Paulette			Crystal Structure of Penicillin-Binding Protein 3 (PBP3) from Escherichia coli	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; CELL-DIVISION; LYTIC TRANSGLYCOSYLASE; MEMBRANE-PROTEINS; GLOBULAR-PROTEINS; COMPLEX; LOCALIZATION; INHIBITOR; MACHINERY; MECHANISM	In Escherichia coli, penicillin-binding protein 3 (PBP3), also known as FtsI, is a central component of the divisome, catalyzing cross-linking of the cell wall peptidoglycan during cell division. PBP3 is mainly periplasmic, with a 23 residues cytoplasmic tail and a single transmembrane helix. We have solved the crystal structure of a soluble form of PBP3 (PBP3(57-577)) at 2.5 angstrom revealing the two modules of high molecular weight class B PBPs, a carboxy terminal module exhibiting transpeptidase activity and an amino terminal module of unknown function. To gain additional insight, the PBP3 Val88-Ser165 subdomain (PBP3(88-165)), for which the electron density is poorly defined in the PBP3 crystal, was produced and its structure solved by SAD phasing at 2.1 angstrom. The structure shows a three dimensional domain swapping with a beta-strand of one molecule inserted between two strands of the paired molecule, suggesting a possible role in PBP3(57-577) dimerization.	[Sauvage, Eric; Derouaux, Adeline; Fraipont, Claudine; Joris, Marine; Herman, Raphael; Rocaboy, Mathieu; Schloesser, Marie; Kerff, Frederic; Nguyen-Disteche, Martine; Charlier, Paulette] Univ Liege, Ctr Ingn Prot, Inst Phys B5a, Liege, Belgium; [Sauvage, Eric; Derouaux, Adeline; Fraipont, Claudine; Joris, Marine; Herman, Raphael; Rocaboy, Mathieu; Schloesser, Marie; Kerff, Frederic; Nguyen-Disteche, Martine; Charlier, Paulette] Inst Chim B6a, Liege, Belgium; [Dumas, Jacques] Sanofi R&D, Prot Prod, F-94403 Vitry Sur Seine, France	University of Liege; Sanofi-Aventis; Sanofi France	Sauvage, E (corresponding author), Univ Liege, Ctr Ingn Prot, Inst Phys B5a, Liege, Belgium.	Eric.Sauvage@ulg.ac.be			Belgian Program on Interuniversity Poles of Attraction; Fonds de la Recherche Scientifique [IISN 4.4505.09, IISN 4.4509.11, FRFC 2.4511.06F]; University of Liege (Fonds speciaux) [C-06/19, C-09/75]; FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture) fellowship (F.R.S.-FNRS, Brussels, Belgium)	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); University of Liege (Fonds speciaux)(University of Liege); FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture) fellowship (F.R.S.-FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by the Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy programming (IAP no. P6/19), the Fonds de la Recherche Scientifique, (IISN 4.4505.09, IISN 4.4509.11, FRFC 2.4511.06F), the University of Liege (Fonds speciaux, Credit classique, C-06/19 and C-09/75), and a return grant to AD. M. J. is recipient of a FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture) fellowship (F.R.S.-FNRS, Brussels, Belgium). FK is research associates of the FRS-FNRS, Belgium. Jacques Dumas is employed by Sanofi-Aventis. Sanofi-Aventis provided support in the form of salary for author JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Dzhekieva L, 2010, BIOCHEMISTRY-US, V49, P6411, DOI 10.1021/bi100757c; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Fedarovich A, 2010, J MOL BIOL, V398, P54, DOI 10.1016/j.jmb.2010.02.046; FRAIPONT C, 1994, BIOCHEM J, V298, P189, DOI 10.1042/bj2980189; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Han S, 2011, J AM CHEM SOC, V133, P20536, DOI 10.1021/ja208835z; Jennings GT, 2002, EUR J BIOCHEM, V269, P3722, DOI 10.1046/j.1432-1033.2002.03064.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kishida H, 2006, BIOCHEMISTRY-US, V45, P783, DOI 10.1021/bi051533t; Leimanis S, 2006, J BACTERIOL, V188, P6298, DOI 10.1128/JB.00334-06; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lovering AL, 2008, J MOL BIOL, V383, P167, DOI 10.1016/j.jmb.2008.08.020; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGASAWA H, 1989, J BACTERIOL, V171, P5890, DOI 10.1128/jb.171.11.5890-5893.1989; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Sauvage E, 2007, J MOL BIOL; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; TASCHNER PEM, 1988, J BACTERIOL, V170, P4828, DOI 10.1128/jb.170.10.4828-4837.1988; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Yoshida H, 2012, J MOL BIOL, V423, P351, DOI 10.1016/j.jmb.2012.07.012; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	58	40	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98042	10.1371/journal.pone.0098042	http://dx.doi.org/10.1371/journal.pone.0098042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875494	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800022
J	Ding, XH; Yang, SG; Li, WJ; Liu, Y; Li, ZG; Zhang, Y; Li, LJ; Liu, SJ				Ding, Xinghua; Yang, Shuguang; Li, Wuju; Liu, Yong; Li, Zhiguo; Zhang, Yan; Li, Lingjiang; Liu, Shaojun			The Potential Biomarker Panels for Identification of Major Depressive Disorder (MDD) Patients with and without Early Life Stress (ELS) by Metabonomic Analysis	PLOS ONE			English	Article							FATTY-ACID DEPRIVATION; CHILDHOOD TRAUMA; METABOLOMIC ANALYSIS; BIPOLAR DISORDER; MODEL; RISK; ABUSE; PSYCHOPATHOLOGY; ABNORMALITIES; VULNERABILITY	Objective: The lack of the disease biomarker to support objective laboratory tests still constitutes a bottleneck in the clinical diagnosis and evaluation of major depressive disorder (MDD) and its subtypes. We used metabonomic techniques to screen the diagnostic biomarker panels from the plasma of MDD patients with and without early life stress (ELS) experience. Methods: Plasma samples were collected from 25 healthy adults and 46 patients with MDD, including 23 patients with ELS and 23 patients without ELS. Furthermore, gas chromatography/mass spectrometry (GC/MS) coupled with multivariate statistical analysis was used to identify the differences in global plasma metabolites among the 3 groups. Results: The distinctive metabolic profiles exist either between healthy subjects and MDD patients or between the MDD patients with ELS experience (ELS/MDD patients) and the MDD patients without it (non-ELS/MDD patients), and some diagnostic panels of feature metabolites' combination have higher predictive potential than the diagnostic panels of differential metabolites. Conclusions: These findings in this study have high potential of being used as novel laboratory diagnostic tool for MDD patients and it with ELS or not in clinical application.	[Ding, Xinghua; Yang, Shuguang; Liu, Yong; Li, Zhiguo; Liu, Shaojun] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Prote, Beijing 100730, Peoples R China; [Ding, Xinghua; Yang, Shuguang; Liu, Yong; Li, Zhiguo; Liu, Shaojun] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Neurobiol, Beijing 100730, Peoples R China; [Li, Wuju] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Computat Biol, Beijing 100730, Peoples R China; [Zhang, Yan; Li, Lingjiang] Cent South Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Central South University	Liu, SJ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Prote, Beijing 100730, Peoples R China.	liusj@bmi.ac.cn	Li, Wu/AHA-4320-2022	Li, Wuju/0000-0003-4613-9692	Chinese National Key Project of Basic Research [2009CB918301, 2009CB918303]; Chinese National Natural Science Foundation [81370051]	Chinese National Key Project of Basic Research(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National Key Project of Basic Research (2009CB918301 and 2009CB918303) and the Chinese National Natural Science Foundation (81370051). The funders had no role in study design, data collection and analysis, decision to publish, or perparation of the manuscript.	Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; ASHCROFT GW, 1966, LANCET, V2, P1049; Bertram HC, 2009, METABOLISM, V58, P1039, DOI 10.1016/j.metabol.2009.03.011; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Chen LS, 2000, J AFFECT DISORDERS, V59, P1, DOI 10.1016/S0165-0327(99)00132-9; Das UN, 2004, MED SCI MONITOR, V10, pHY19; de Kivit S, 2011, EUR J PHARMACOL, V668, pS124, DOI 10.1016/j.ejphar.2011.05.086; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Feng B, 2007, J PROTEOME RES, V6, P2161, DOI 10.1021/pr0606326; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; First MB, 1996, PSYCHIAT CLIN N AM, V19, P29, DOI 10.1016/S0193-953X(05)70271-9; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; Jow GM, 2006, J AFFECT DISORDERS, V90, P21, DOI 10.1016/j.jad.2005.09.015; Kaufman D, 2007, DIABETES, V56, P1382, DOI 10.2337/db06-1409; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; Koh YT, 2010, J CHROMATOGR A, V1217, P8308, DOI 10.1016/j.chroma.2010.10.101; Krall L, 2009, J CHROMATOGR B, V877, P2952, DOI 10.1016/j.jchromb.2009.07.006; Kraneveld AD, 2014, BASIC CLIN PHARMACOL, V114, P128, DOI 10.1111/bcpt.12154; Ladd CO, 2000, PROG BRAIN RES, V122, P81; Laugeray A, 2010, BEHAV BRAIN RES, V210, P84, DOI 10.1016/j.bbr.2010.02.014; Logue JA, 2000, LIPIDS, V35, P745, DOI 10.1007/s11745-000-0581-3; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; McNamara RK, 2010, J AFFECT DISORDERS, V126, P303, DOI 10.1016/j.jad.2010.03.015; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Mitani H, 2006, PROG NEURO-PSYCHOPH, V30, P1155, DOI 10.1016/j.pnpbp.2006.03.036; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Ni Y, 2008, FEBS LETT, V582, P2627, DOI 10.1016/j.febslet.2008.06.040; Olusi SO, 1996, BIOL PSYCHIAT, V40, P1128, DOI 10.1016/S0006-3223(95)00599-4; Paige LA, 2007, INT J GERIATR PSYCH, V22, P418, DOI 10.1002/gps.1690; Pasikanti KK, 2008, J CHROMATOGR B, V871, P202, DOI 10.1016/j.jchromb.2008.04.033; Sakaguchi M, 2012, DEV NEUROBIOL, V72, P1059, DOI 10.1002/dneu.22023; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sharp LK, 2002, AM FAM PHYSICIAN, V66, P1001; Shin T, 2013, ACTA HISTOCHEM, V115, P407, DOI 10.1016/j.acthis.2012.11.010; Simon GE, 2003, BIOL PSYCHIAT, V54, P208, DOI 10.1016/S0006-3223(03)00420-7; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Sun B, 2009, RAPID COMMUN MASS SP, V23, P1221, DOI 10.1002/rcm.3992; Wang L, 2007, FASEB J, V21, P1227, DOI 10.1096/fj.06-7495com; Wittchen HU, 2001, INT CLIN PSYCHOPHARM, V16, P121, DOI 10.1097/00004850-200105000-00001; Wu BL, 2007, BIOCHEM BIOPH RES CO, V354, P498, DOI 10.1016/j.bbrc.2007.01.002; Wuju L, 2002, BIOINFORMATICS, V18, P325, DOI 10.1093/bioinformatics/18.2.325; WURTMAN RJ, 1980, PHARMACOL REV, V32, P315; Xiao T, 2005, MOL CELL PROTEOMICS, V4, P1480, DOI 10.1074/mcp.M500055-MCP200; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Zhang FX, 2010, MOL BIOSYST, V6, P852, DOI 10.1039/b914751a; Zheng P, 2012, J PROTEOME RES, V11, P1741, DOI 10.1021/pr2010082; Zheng SN, 2010, CLIN CHIM ACTA, V411, P204, DOI 10.1016/j.cca.2009.11.003; Zung W W, 1974, Mod Probl Pharmacopsychiatry, V7, P170; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	63	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97479	10.1371/journal.pone.0097479	http://dx.doi.org/10.1371/journal.pone.0097479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870353	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300012
J	Morishita, M; Nabeka, H; Shimokawa, T; Miyawaki, K; Doihara, T; Saito, S; Kobayashi, N; Matsuda, S				Morishita, Midori; Nabeka, Hiroaki; Shimokawa, Tetsuya; Miyawaki, Kyojy; Doihara, Takuya; Saito, Shouichiro; Kobayashi, Naoto; Matsuda, Seiji			Temporal Changes in Prosaposin Expression in the Rat Dentate Gyrus after Birth	PLOS ONE			English	Article							FACIAL-NERVE NUCLEUS; ACTIVATOR PROTEIN; BETA-GLUCOSIDASE; MESSENGER-RNA; SAPOSIN-C; IN-VITRO; ADULT; NEUROGENESIS; IDENTIFICATION; PRECURSOR	Neurogenesis in the hippocampal dentate gyrus occurs constitutively throughout postnatal life. Adult neurogenesis includes a multistep process that ends with the formation of a postmitotic and functionally integrated new neuron. During adult neurogenesis, various markers are expressed, including GFAP, nestin, Pax6, polysialic acid-neural cell adhesion molecule (PSA-NCAM), neuronal nuclei (NeuN), doublecortin, TUC-4, Tuj-1, and calretinin. Prosaposin is the precursor of saposins A-D; it is found in various organs and can be excreted. Strong prosaposin expression has been demonstrated in the developing brain including the hippocampus, and its neurotrophic activity has been proposed. This study investigated changes in prosaposin in the dentate gyrus of young and adult rats using double immunohistochemistry with antibodies to prosaposin, PSA-NCAM, and NeuN. Prosaposin immunoreactivity was intense in the dentate gyrus at postnatal day 3 (P3) and P7, but decreased gradually after P14. In the dentate gyrus at P28, immature PSA-NCAM-positive neurons localized exclusively in the subgranular zone were prosaposin-negative, whereas mature Neu-N-positive neurons were positive for prosaposin. Furthermore, these prosaposin-negative immature neurons were saposin B-positive, suggesting that the neurons take up and degrade prosaposin. In situ hybridization assays showed that prosaposin in the adult dentate gyrus is dominantly the Pro+9 type, a secreted type of prosaposin. These results imply that prosaposin secreted from mature neurons stimulates proliferation and maturation of immature neurons in the dentate gyrus.	[Morishita, Midori; Nabeka, Hiroaki; Shimokawa, Tetsuya; Miyawaki, Kyojy; Doihara, Takuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Miyawaki, Kyojy] Shikokuchuoh Med Welf Gen Coll, Shikokuchuoh, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Gifu, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan	Ehime University; Gifu University; Ehime University	Shimokawa, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	tshimo@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, of Japan [25450466, 24590254, 25462295]	Ministry of Education, Culture, Sports, Science and Technology, of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants to TS (No. 25450466), NK (No. 24590254), and SM (No. 25462295), from the Ministry of Education, Culture, Sports, Science and Technology, of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Campana WM, 2000, J PERIPHER NERV SYST, V5, P126, DOI 10.1046/j.1529-8027.2000.00019.x; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; Cohen T, 2004, MOL BRAIN RES, V129, P8, DOI 10.1016/j.molbrainres.2004.06.027; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; Dai CF, 2000, AM J OTOL, V21, P115, DOI 10.1016/S0196-0709(00)80084-8; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FU Q, 1994, J MOL NEUROSCI, V5, P59, DOI 10.1007/BF02736694; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Henseler M, 1996, AM J HUM GENET, V58, P65; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; HOLTSCHMIDT H, 1991, J BIOL CHEM, V266, P7556; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; Hozumi I, 1999, NEUROSCI LETT, V267, P73, DOI 10.1016/S0304-3940(99)00325-0; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LAMONTAGNE S, 1994, J BIOL CHEM, V269, P20528; Madar-Shapiro L, 1999, BIOCHEM J, V337, P433, DOI 10.1042/0264-6021:3370433; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Morita F, 2001, J CEREBR BLOOD F MET, V21, P1295, DOI 10.1097/00004647-200111000-00005; Morris MA, 2001, FASEB J, V15, pA1026, DOI 10.1096/fj.00-0603fje; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Shimokawa T, 2013, CELL TISSUE RES, V352, P685, DOI 10.1007/s00441-013-1575-0; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Sun LP, 2010, ARCH BIOCHEM BIOPHYS, V502, P130, DOI 10.1016/j.abb.2010.08.007; Terashita T, 2013, ACTA OTO-LARYNGOL, V133, P462, DOI 10.3109/00016489.2012.750430; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; WEILER S, 1995, PROTEIN SCI, V4, P756; Xue B, 2011, NEUROSCI RES, V71, P22, DOI 10.1016/j.neures.2011.06.001; Yokota N, 2001, STROKE, V32, P168, DOI 10.1161/01.STR.32.1.168; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Q, 1997, MOL REPROD DEV, V48, P1, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;1::AID-MRD1&gt;3.0.CO;2-N	52	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e95883	10.1371/journal.pone.0095883	http://dx.doi.org/10.1371/journal.pone.0095883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871372	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300003
J	Arakaki, R; Eguchi, H; Yamada, A; Kudo, Y; Iwasa, A; Enkhmaa, T; Hotta, F; Mitamura-Aizawa, S; Mitamura, Y; Hayashi, Y; Ishimaru, N				Arakaki, Rieko; Eguchi, Hiroshi; Yamada, Akiko; Kudo, Yasusei; Iwasa, Akihiko; Enkhmaa, Tserennadmid; Hotta, Fumika; Mitamura-Aizawa, Sayaka; Mitamura, Yoshinori; Hayashi, Yoshio; Ishimaru, Naozumi			Anti-Inflammatory Effects of Rebamipide Eyedrop Administration on Ocular Lesions in a Murine Model of Primary Sjogren's Syndrome	PLOS ONE			English	Article							AUTOIMMUNE EXOCRINOPATHY; HARDERIAN-GLAND; MOUSE MODEL; LACTOFERRIN; EXPRESSION; AUTOANTIGEN; DISRUPTION; CELLS; SERUM	Background: Topical therapy is effective for dry eye, and its prolonged effects should help in maintaining the quality of life of patients with dry eye. We previously reported that the oral administration of rebamipide (Reb), a mucosal protective agent, had a potent therapeutic effect on autoimmune lesions in a murine model of Sjogren's syndrome (SS). However, the effects of topical treatment with Reb eyedrops on the ocular lesions in the murine model of SS are unknown. Methods and Finding: Reb eyedrops were administered to the murine model of SS aged 4-8 weeks four times daily. Inflammatory lesions of the extraorbital and intraorbital lacrimal glands and Harderian gland tissues were histologically evaluated. The direct effects of Reb on the lacrimal glands were analyzed using cultured lacrimal gland cells. Tear secretions of Reb-treated mice were significantly increased compared with those of untreated mice. In addition to the therapeutic effect of Reb treatment on keratoconjunctivitis, severe inflammatory lesions of intraorbital lacrimal gland tissues in this model of SS were resolved. The mRNA expression levels of IL-10 and mucin 5Ac in conjunctival tissues from Reb-treated mice was significantly increased compared with those of control mice. Moreover, lactoferrin production from lacrimal gland cells was restored by Reb treatment. Conclusion: Topical Reb administration had an anti-inflammatory effect on the ocular autoimmune lesions in the murine model of SS and a protective effect on the ocular surfaces.	[Arakaki, Rieko; Yamada, Akiko; Kudo, Yasusei; Iwasa, Akihiko; Hayashi, Yoshio; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Eguchi, Hiroshi; Enkhmaa, Tserennadmid; Hotta, Fumika; Mitamura-Aizawa, Sayaka; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 770, Japan	Tokushima University; Tokushima University	Ishimaru, N (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan.	ishimaru.n@tokushima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720	Funding Program for Next Generation World-Leading Researchers in Japan [LS090]; Ministry of Education, Science, Sport, and Culture of Japan [21792077, 23659946]	Funding Program for Next Generation World-Leading Researchers in Japan; Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Funding Program for Next Generation World-Leading Researchers in Japan (LS090), a Grant-in-Aid for Scientific Research (no. 21792077 and 23659946) from the Ministry of Education, Science, Sport, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Balasubramanian SA, 2012, EXP EYE RES, V96, P132, DOI 10.1016/j.exer.2011.12.010; Bamba R, 2009, LARYNGOSCOPE, V119, P1922, DOI 10.1002/lary.20292; Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009; Choi HS, 2013, LIFE SCI, V93, P69, DOI 10.1016/j.lfs.2013.05.019; DOANE MG, 1978, AM J OPHTHALMOL, V85, P383, DOI 10.1016/S0002-9394(14)77735-9; Dogru M, 2007, OPHTHALMOLOGY, V114, P2366, DOI 10.1016/j.ophtha.2007.06.027; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Fujihara T, 1998, J OCUL PHARMACOL TH, V14, P99, DOI 10.1089/jop.1998.14.99; Gesase AP, 1996, CELL TISSUE RES, V285, P501, DOI 10.1007/s004410050666; Goren MB, 1997, CORNEA, V16, P501, DOI 10.1097/00003226-199707000-00023; HANEJI N, 1994, J IMMUNOL, V153, P2769; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Iijima K, 2009, DIGEST DIS SCI, V54, P1500, DOI 10.1007/s10620-008-0507-4; Ishimaru N, 1999, AM J PATHOL, V155, P173, DOI 10.1016/S0002-9440(10)65111-5; Ishimaru N, 2000, AM J PATHOL, V156, P1557, DOI 10.1016/S0002-9440(10)65027-4; Ishimaru N, 2009, J IMMUNOL, V182, P6576, DOI 10.4049/jimmunol.0802289; Ishimaru N, 2008, J EXP MED, V205, P2915, DOI 10.1084/jem.20080174; JABS DA, 1994, ADV EXP MED BIOL, V350, P623; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033148; Kinoshita S, 2014, AM J OPHTHALMOL, V157, P576, DOI 10.1016/j.ajo.2013.11.010; Kohashi M, 2008, ARTHRITIS RHEUM, V58, P389, DOI 10.1002/art.23163; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lee BH, 2012, CLIN REV ALLERG IMMU, V42, P35, DOI 10.1007/s12016-011-8288-5; Mavragani CP, 2013, CURR OPIN RHEUMATOL, V25, P623, DOI 10.1097/BOR.0b013e328363eaa5; Naito Y, 2006, REDOX REP, V11, P243, DOI 10.1179/135100006X155021; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; NETO ERV, 1992, J ANAT, V180, P75; Nielsen SM, 2010, J GASTROENTEROL, V45, P1121, DOI 10.1007/s00535-010-0271-z; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Quinto GG, 2012, CORNEA, V31, P424, DOI 10.1097/ICO.0b013e31823f0a64; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Saegusa K, 2000, J IMMUNOL, V165, P2251, DOI 10.4049/jimmunol.165.4.2251; SAKAI T, 1981, ARCH HISTOL JAPON, V44, P299, DOI 10.1679/aohc1950.44.299; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; SATOH Y, 1992, ACTA ANAT, V143, P7; Tanaka H, 2013, BRIT J OPHTHALMOL, V97, P912, DOI 10.1136/bjophthalmol-2012-302868; Tei M, 2000, INVEST OPHTH VIS SCI, V41, P82; Tsubota K, 2001, INVEST OPHTH VIS SCI, V42, P101; Urashima H, 2012, J OCUL PHARMACOL TH, V28, P264, DOI 10.1089/jop.2011.0147; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004	40	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98390	10.1371/journal.pone.0098390	http://dx.doi.org/10.1371/journal.pone.0098390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866156	gold, Green Submitted, Green Published			2022-12-27	WOS:000336914100055
J	Yang, XR; Guo, YA; Du, YN; Yang, JM; Li, SC; Liu, SN; Li, K; Zhang, DC				Yang, Xiaorong; Guo, Yanan; Du, Yane; Yang, Jinmei; Li, Shichao; Liu, Shengnan; Li, Ke; Zhang, Dechun			Serum MicroRNA-21 as a Diagnostic Marker for Lung Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EXPRESSION; CANCER; BIOMARKERS; SIGNATURE	Objectives: MicroRNA-21 in serum is a promising marker for the diagnosis of lung carcinoma. A meta-analysis was performed to assess the diagnostic accuracy and clinical value of serum microRNA-21 in patients with lung carcinoma. Methods: PubMed, EMBASE, Web of Knowledge (ISI), the Cochrane Library, Scopus, BioMed Central, Science Direct, China National Knowledge Infrastructure (CNKI), Wan Fang data and Technology of Chongqing (VIP) databases were searched to identify studies in English and Chinese that assessed the diagnostic value of serum miR-21 for lung carcinoma, from inception to 9 April 2014. Two independent investigators identified and extracted the study characteristics from all articles according to defined inclusion and exclusion criteria. Quality assessment of diagnostic accuracy studies (QUADAS) was used to score the quality of the eligible studies. Stata12 and Meta-DiSc software were used to test the heterogeneity and to perform the meta-analysis. Results: Our search returned 1008 articles, of which seven fulfilled the inclusion criteria, accounting for 500 patients and 386 controls. Using random-effect model analysis, the summary assessments revealed that the mean sensitivity was 0.71% (95% CI: 57-82%) and specificity was 0.84% (95% CI: 76-89%). The area under the receiver operating characteristic curve was 0.86 (95% CI: 0.83-0.89). In addition, heterogeneity was clearly apparent but was not caused by the threshold effect, as shown by Meta-DiSc analysis. Conclusion: The current evidence suggests that serum miR-21 can be rapidly measured in lung carcinoma patients and has potential diagnostic value with moderate sensitivity and specificity. Further prospective studies to assess the early stage diagnostic value are needed in the future.	[Yang, Xiaorong; Guo, Yanan; Du, Yane; Yang, Jinmei; Li, Shichao; Liu, Shengnan; Li, Ke; Zhang, Dechun] Chong Qing Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China	Chongqing Medical University	Zhang, DC (corresponding author), Chong Qing Med Univ, Dept Pathogen Biol, Chongqing, Peoples R China.	zhangdechun46@sohu.com						Abdel-Aziz Amira, 2013, Case-Based Reasoning Research and Development. 21st International Conference, ICCBR 2013. Proceedings, P1, DOI 10.1007/978-3-642-39056-2_1; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Ciglenecki UJ, 2008, J VIROL METHODS, V147, P257, DOI 10.1016/j.jviromet.2007.09.017; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Guo SJ, 2013, MED J W CHIAN, V25, P8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Le HB, 2012, MED ONCOL, V29, P3190, DOI 10.1007/s12032-012-0303-z; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li YZ, 2011, ONCOL LETT, V2, P991, DOI 10.3892/ol.2011.351; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Liu XG, 2012, MED ONCOL, V29, P618, DOI 10.1007/s12032-011-9923-y; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rotkrua P, 2013, BRIT J CANCER, V108, P932, DOI 10.1038/bjc.2013.30; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tang DF, 2013, EUR J CANCER PREV, V22, P540, DOI 10.1097/CEJ.0b013e32835f3be9; Wang B, 2012, J CANCER RES CLIN, V138, P1659, DOI 10.1007/s00432-012-1244-9; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Wei j, 2011, IDENTIFICATION PLASM; Wei Juan, 2011, Chin J Cancer, V30, P407; Wei J, 2011, CHINESE J CANCER RES, V23, P123, DOI 10.1007/s11670-011-0123-2; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yang XR, 2013, CLIN BIOCHEM, V46, P1377, DOI 10.1016/j.clinbiochem.2013.05.064; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang H, 2012, STUDY PLASMA MIR 145	38	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97460	10.1371/journal.pone.0097460	http://dx.doi.org/10.1371/journal.pone.0097460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865991	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100013
J	Blackburne, LK; Eddy, MD; Kalra, P; Yee, D; Sinha, P; Gabrieli, JDE				Blackburne, Liwei King; Eddy, Marianna D.; Kalra, Priya; Yee, Debbie; Sinha, Pawan; Gabrieli, John D. E.			Neural Correlates of Letter Reversal in Children and Adults	PLOS ONE			English	Article							MENTAL ROTATION; HUMAN BRAIN; RECOGNITION; CORTEX; FACE; CATEGORIZATION; SPECIALIZATION; ORGANIZATION; PERCEPTION; MECHANISMS	Children often make letter reversal errors when first learning to read and write, even for letters whose reversed forms do not appear in normal print. However, the brain basis of such letter reversal in children learning to read is unknown. The present study compared the neuroanatomical correlates (via functional magnetic resonance imaging) and the electrophysiological correlates (via event-related potentials or ERPs) of this phenomenon in children, ages 5-12, relative to young adults. When viewing reversed letters relative to typically oriented letters, adults exhibited widespread occipital, parietal, and temporal lobe activations, including activation in the functionally localized visual word form area (VWFA) in left occipito-temporal cortex. Adults exhibited significantly greater activation than children in all of these regions; children only exhibited such activation in a limited frontal region. Similarly, on the P1 and N170 ERP components, adults exhibited significantly greater differences between typical and reversed letters than children, who failed to exhibit significant differences between typical and reversed letters. These findings indicate that adults distinguish typical and reversed letters in the early stages of specialized brain processing of print, but that children do not recognize this distinction during the early stages of processing. Specialized brain processes responsible for early stages of letter perception that distinguish between typical and reversed letters may develop slowly and remain immature even in older children who no longer produce letter reversals in their writing.	[Blackburne, Liwei King; Eddy, Marianna D.; Yee, Debbie; Sinha, Pawan; Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Kalra, Priya] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Blackburne, LK (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	lking@post.harvard.edu	Gabrieli, John/AAJ-2869-2020		Ellison Medical Foundation; NIH [UL1RR025758]; MIT Class Funds for Dyslexia Research; National Science Foundation;  [F32HD061180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD061180] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Class Funds for Dyslexia Research; National Science Foundation(National Science Foundation (NSF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Author MDE was supported by F32HD061180. The project was supported by grants from the Ellison Medical Foundation, NIH grant UL1RR025758, and the MIT Class of 1976 Funds for Dyslexia Research. LB was supported by a National Science Foundation graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Beaucousin V, 2011, NEUROPSYCHOLOGIA, V49, P1258, DOI 10.1016/j.neuropsychologia.2011.01.039; BLACK FW, 1973, PERCEPT MOTOR SKILL, V36, P895, DOI 10.2466/pms.1973.36.3.895; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Brown TT, 2005, CEREB CORTEX, V15, P275, DOI 10.1093/cercor/bhh129; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Church JA, 2008, CEREB CORTEX, V18, P2054, DOI 10.1093/cercor/bhm228; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; CORBALLIS MC, 1985, J CHILD PSYCHOL PSYC, V26, P929, DOI 10.1111/j.1469-7610.1985.tb00607.x; CORNELL JM, 1985, CAN J PSYCHOL, V39, P174, DOI 10.1037/h0080122; Danziger E., 1998, WRIT LANG LIT, V1, P153, DOI [10.1075/wll.1.2.02dan, DOI 10.1075/WLL.1.2.02DAN]; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S., 2009, READING IN THE BRAIN; Dehaene S, 2010, NEUROIMAGE, V49, P1837, DOI 10.1016/j.neuroimage.2009.09.024; Eger E, 2004, J NEUROPHYSIOL, V92, P1241, DOI 10.1152/jn.00206.2004; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; GROSSER GS, 1981, PERCEPT MOTOR SKILL, V53, P991, DOI 10.2466/pms.1981.53.3.991; Hamm JP, 2004, NEUROPSYCHOLOGIA, V42, P810, DOI 10.1016/j.neuropsychologia.2003.11.009; Hazan V, 2000, J PHONETICS, V28, P377, DOI 10.1006/jpho.2000.0121; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; HOLCOMB PJ, 1992, DEV NEUROPSYCHOL, V8, P203, DOI 10.1080/87565649209540525; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Jordan K, 2001, NEUROIMAGE, V13, P143, DOI 10.1006/nimg.2000.0677; Kang HC, 2003, NEUROIMAGE, V19, P16, DOI 10.1016/S1053-8119(03)00038-7; Kaufman A. S., 1997, KAUFMAN BRIEF INTELL; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lachmann T., 2003, PSYCHOL SCI, V45, P50; Lachmann T, 2007, DEV NEUROPSYCHOL, V31, P61, DOI 10.1207/s15326942dn3101_4; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Milivojevic B, 2011, NEUROPSYCHOLOGIA, V49, P3758, DOI 10.1016/j.neuropsychologia.2011.09.034; Nunez-Pena MI, 2009, BRAIN COGNITION, V69, P180, DOI 10.1016/j.bandc.2008.07.003; Pederson E, 2003, WRITTEN LANGUAGE LIT, V6, P71, DOI [10.1075/wll.6.1.04ped., DOI 10.1075/WLL.6.1.04PED]; Pegado F, 2011, NEUROIMAGE, V55, P742, DOI 10.1016/j.neuroimage.2010.11.043; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Proverbio AM, 2009, NEUROSCI LETT, V463, P228, DOI 10.1016/j.neulet.2009.08.001; Rauschecker AM, 2012, PROCEEDINGS OF THE N; REICHER GM, 1969, J EXP PSYCHOL, V81, P275, DOI 10.1037/h0027768; Rosazza C, 2009, BRAIN RES, V1272, P32, DOI 10.1016/j.brainres.2009.03.033; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Terepocki M, 2002, J LEARN DISABIL-US, V35, P214, DOI 10.1177/002221940203500304; Tisdall MD, 2012, MAGN RESON MED, V68, P389, DOI 10.1002/mrm.23228; Torgesen JK, 1999, TEST OF WORD READING; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Wagner RK, 1999, COMPREHENSIVE TEST O; WHEELER DD, 1970, COGNITIVE PSYCHOL, V1, P59, DOI 10.1016/0010-0285(70)90005-8; Wolff PH, 1996, READ WRIT, V8, P341, DOI 10.1007/BF00395113; Woodcock R.W., 2011, WOODCOCK READING MAS; Zacks JM, 2008, J COGNITIVE NEUROSCI, V20, P1, DOI 10.1162/jocn.2008.20013	61	20	22	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98386	10.1371/journal.pone.0098386	http://dx.doi.org/10.1371/journal.pone.0098386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859328	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400074
J	Cheney, JA; Ton, D; Konow, N; Riskin, DK; Breuer, KS; Swartz, SM				Cheney, Jorn A.; Ton, Daniel; Konow, Nicolai; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.			Hindlimb Motion during Steady Flight of the Lesser Dog-Faced Fruit Bat, Cynopterus brachyotis	PLOS ONE			English	Article							MEMBRANE WINGS; KINEMATICS; BIOMECHANICS; CHIROPTERA; STRENGTH	In bats, the wing membrane is anchored not only to the body and forelimb, but also to the hindlimb. This attachment configuration gives bats the potential to modulate wing shape by moving the hindlimb, such as by joint movement at the hip or knee. Such movements could modulate lift, drag, or the pitching moment. In this study we address: 1) how the ankle translates through space during the wingbeat cycle; 2) whether amplitude of ankle motion is dependent upon flight speed; 3) how tension in the wing membrane pulls the ankle; and 4) whether wing membrane tension is responsible for driving ankle motion. We flew five individuals of the lesser dog-faced fruit bat, Cynopterus brachyotis (Family: Pteropodidae), in a wind tunnel and documented kinematics of the forelimb, hip, ankle, and trailing edge of the wing membrane. Based on kinematic analysis of hindlimb and forelimb movements, we found that: 1) during downstroke, the ankle moved ventrally and during upstroke the ankle moved dorsally; 2) there was considerable variation in amplitude of ankle motion, but amplitude did not correlate significantly with flight speed; 3) during downstroke, tension generated by the wing membrane acted to pull the ankle dorsally, and during upstroke, the wing membrane pulled laterally when taut and dorsally when relatively slack; and 4) wing membrane tension generally opposed dorsoventral ankle motion. We conclude that during forward flight in C. brachyotis, wing membrane tension does not power hindlimb motion; instead, we propose that hindlimb movements arise from muscle activity and/or inertial effects.	[Cheney, Jorn A.; Ton, Daniel; Konow, Nicolai; Riskin, Daniel K.; Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Breuer, Kenneth S.; Swartz, Sharon M.] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University; Brown University	Cheney, JA (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Jorn_Cheney@Brown.edu	Breuer, Kenneth/P-7753-2016; Swartz, Sharon/B-9309-2011	Breuer, Kenneth/0000-0002-5122-2231; Swartz, Sharon/0000-0001-5762-7435; Riskin, Daniel K./0000-0001-8742-8509; Cheney, Jorn/0000-0002-9952-2612	National Science Foundation [IOS-0723392, IOS-1145549]; Air Force Office of Scientific Research [F49620-01-1-0335, FA9550-12-1-0301]; Direct For Biological Sciences [1145549] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS-0723392, IOS-1145549) and the Air Force Office of Scientific Research (F49620-01-1-0335, FA9550-12-1-0301) monitored by W. Larkin, D. Smith, and P. Bradshaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IH., 1959, THEORY WING SECTIONS; Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; Adams RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032074; CROWLEY GV, 1994, AUST J ZOOL, V42, P215, DOI 10.1071/ZO9940215; Gardiner JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018214; Hedrick TL, 2002, J EXP BIOL, V205, P1389; HOEVE CAJ, 1959, J AM CHEM SOC, V80, P6523, DOI 10.1021/ja01557a016; HOLBROOK KA, 1978, J ANAT, V126, P21; HOWELL DJ, 1977, J THEOR BIOL, V69, P625, DOI 10.1016/0022-5193(77)90371-X; Hubner JP, 2011, AEROSP SCI TECHNOL, V15, P670, DOI 10.1016/j.ast.2011.01.004; Leishman J. G., 2005, PRINCIPLES HELICOPTE; Lillie MA, 2002, INT J BIOL MACROMOL, V30, P119, DOI 10.1016/S0141-8130(02)00008-9; NORBERG U M, 1970, Bijdragen tot de Dierkunde, V40, P62; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; Riskin DK, 2008, J THEOR BIOL, V254, P604, DOI 10.1016/j.jtbi.2008.06.011; Riskin DK, 2010, J EXP BIOL, V213, P4110, DOI 10.1242/jeb.043091; Riskin DK, 2009, J EXP BIOL, V212, P945, DOI 10.1242/jeb.026161; Riskin DK, 2005, J EXP BIOL, V208, P1309, DOI 10.1242/jeb.01522; Simmons Nancy B., 1994, American Museum Novitates, V3103, P1; Song A, 2008, AIAA J, V46, P2096, DOI 10.2514/1.36694; Stanford B, 2008, PROG AEROSP SCI, V44, P258, DOI 10.1016/j.paerosci.2008.03.001; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; von Busse R, 2012, BIOL OPEN, V1, P1226, DOI 10.1242/bio.20122964; Waldman R M, 2013, P 43 AIAA FLUID DYN, P1; Wolf M, 2010, J EXP BIOL, V213, P2142, DOI 10.1242/jeb.029777	26	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98093	10.1371/journal.pone.0098093	http://dx.doi.org/10.1371/journal.pone.0098093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858194	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400039
J	Consonni, SV; Brouwer, PM; van Slobbe, ES; Bos, JL				Consonni, Sarah V.; Brouwer, Patricia M.; van Slobbe, Eleonora S.; Bos, Johannes L.			The PDZ Domain of the Guanine Nucleotide Exchange Factor PDZGEF Directs Binding to Phosphatidic Acid during Brush Border Formation	PLOS ONE			English	Article							RAP1; POLARIZATION; ACTIVATION; PROTEINS; EZRIN; PAR-3; GEFS	PDZGEF is a guanine nucleotide exchange factor for the small G protein Rap. It was recently found that PDZGEF contributes to establishment of intestinal epithelial polarity downstream of the kinase Lkb1. By binding to phosphatidic acid enriched at the apical membrane, PDZGEF locally activates Rap2a resulting in induction of brush border formation via a pathway that includes the polarity players TNIK, Mst4 and Ezrin. Here we show that the PDZ domain of PDZGEF is essential and sufficient for targeting PDZGEF to the apical membrane of polarized intestinal epithelial cells. Inhibition of PLD and consequently production of phosphatidic acid inhibitis targeting of PDZGEF to the plasma membrane. Furthermore, localization requires specific positively charged residues within the PDZ domain. We conclude that local accumulation of PDZGEF at the apical membrane during establishment of epithelial polarity is mediated by electrostatic interactions between positively charged side chains in the PDZ domain and negatively charged phosphatidic acid.	[Consonni, Sarah V.; Brouwer, Patricia M.; van Slobbe, Eleonora S.; Bos, Johannes L.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bos, JL (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Utrecht, Netherlands.	j.l.bos@umcutrecht.nl			Chemical Sciences and the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (NWO)	Chemical Sciences and the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research (NWO)	This work is supported by Chemical Sciences (S. V. C.) and the Netherlands Genomics Initiative (J.L.B.) of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Gallardo R, 2010, CHEMBIOCHEM, V11, P456, DOI 10.1002/cbic.200900616; Gloerich M, 2012, NAT CELL BIOL, V14, P793, DOI 10.1038/ncb2537; Hodgkin MN, 2000, CURR BIOL, V10, P43, DOI 10.1016/S0960-9822(99)00264-X; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Ross SH, 2011, J CELL SCI, V124, P1808, DOI 10.1242/jcs.079830; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yu CG, 2012, MOL BIOL CELL, V23, P3743, DOI 10.1091/mbc.E12-03-0196; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98253	10.1371/journal.pone.0098253	http://dx.doi.org/10.1371/journal.pone.0098253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858808	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400061
J	Meng, FQ; Olesen, JE; Sun, XP; Wu, WL				Meng, Fanqiao; Olesen, Jorgen E.; Sun, Xiangping; Wu, Wenliang			Inorganic Nitrogen Leaching from Organic and Conventional Rice Production on a Newly Claimed Calciustoll in Central Asia	PLOS ONE			English	Article							USE-EFFICIENCY; SOIL-WATER; NITRATE; DENITRIFICATION; NITRIFICATION; DYNAMICS; LOSSES; MINERALIZATION; IRRIGATION; MANAGEMENT	Characterizing the dynamics of nitrogen (N) leaching from organic and conventional paddy fields is necessary to optimize fertilization and to evaluate the impact of these contrasting farming systems on water bodies. We assessed N leaching in organic versus conventional rice production systems of the Ili River Valley, a representative aquatic ecosystem of Central Asia. The N leaching and overall performance of these systems were measured during 2009, using a randomized block experiment with five treatments. PVC pipes were installed at soil depths of 50 and 180 cm to collect percolation water from flooded organic and conventional paddies, and inorganic N (NH4-N+NO3-N) was analyzed. Two high-concentration peaks of NH4-N were observed in all treatments: one during early tillering and a second during flowering. A third peak at the mid-tillering stage was observed only under conventional fertilization. NO3-N concentrations were highest at transplant and then declined until harvest. At the 50 cm soil depth, NO3-N concentration was 21-42% higher than NH4-N in percolation water from organic paddies, while NH4-N and NO3-N concentrations were similar for the conventional and control treatments. At the depth of 180 cm, NH4-N and NO3-N were the predominant inorganic N for organic and conventional paddies, respectively. Inorganic N concentrations decreased with soil depth, but this attenuation was more marked in organic than in conventional paddies. Conventional paddies leached a higher percentage of applied N (0.78%) than did organic treatments (0.32-0.60%), but the two farming systems leached a similar amount of inorganic N per unit yield (0.21-0.34 kg N Mg-1 rice grains). Conventional production showed higher N utilization efficiency compared to fertilized organic treatments. These results suggest that organic rice production in the Ili River Valley is unlikely to reduce inorganic N leaching, if high crop yields similar to conventional rice production are to be maintained.	[Meng, Fanqiao; Sun, Xiangping; Wu, Wenliang] China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Olesen, Jorgen E.] Aarhus Univ, Fac Agr Sci, Dept Agroecol & Environm, Tjele, Denmark	China Agricultural University; Aarhus University	Meng, FQ (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	mengfq@cau.edu.cn	Olesen, Jørgen/Y-2857-2019; Olesen, Jørgen E/C-2905-2016; MENG, Fanqiao/J-1514-2014	Olesen, Jørgen/0000-0002-6639-1273; Olesen, Jørgen E/0000-0002-6639-1273; MENG, Fanqiao/0000-0002-0172-7776	National Natural Science Foundation of China [30970533]; National Key Science and Technology Project-Organic Farming Development in the Ili River Valley [2007BAC15B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Project-Organic Farming Development in the Ili River Valley	The study was funded by National Natural Science Foundation of China (No. 30970533) and the National Key Science and Technology Project-Organic Farming Development in the Ili River Valley (No. 2007BAC15B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askegaard M, 2011, AGR ECOSYST ENVIRON, V142, P149, DOI 10.1016/j.agee.2011.04.014; BAUDER JW, 1980, AGRON J, V72, P593, DOI 10.2134/agronj1980.00021962007200040005x; BIJAYSINGH, 1991, FERT RES, V28, P179, DOI 10.1007/BF01049748; Cassman KG, 1998, FIELD CROP RES, V56, P7, DOI 10.1016/S0378-4290(97)00140-8; Chhabra A, 2010, INT J APPL EARTH OBS, V12, P190, DOI 10.1016/j.jag.2010.02.007; Chowdary VM, 2004, AGR ECOSYST ENVIRON, V103, P425, DOI 10.1016/j.agee.2003.12.001; Devkota KP, 2013, EUR J AGRON, V47, P65, DOI 10.1016/j.eja.2013.01.009; Gao JS, 2002, TILLAGE CULTIVATION, V2, P31; GEORGE T, 1993, SOIL SCI SOC AM J, V57, P1526, DOI 10.2136/sssaj1993.03615995005700060022x; Ghosh BC, 1998, ENVIRON POLLUT, V102, P123, DOI 10.1016/S0269-7491(98)80024-9; Guan J., 2009, CHINESE AGR SCI B, V25, P88; Hansen B, 2000, EUR J AGRON, V13, P65, DOI 10.1016/S1161-0301(00)00060-5; Islam MM, 1998, COMMUN SOIL SCI PLAN, V29, P971, DOI 10.1080/00103629809370000; JEMISON JM, 1994, J ENVIRON QUAL, V23, P337, DOI 10.2134/jeq1994.00472425002300020018x; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; KEENEY DR, 1986, FERT RES, V9, P15, DOI 10.1007/BF01048694; Kirchmann H, 2001, COMMUN SOIL SCI PLAN, V32, P997, DOI 10.1081/CSS-100104101; Kirchmann Holger, 2008, P89, DOI 10.1007/978-1-4020-9316-6_5; Li CF, 2008, PLANT SOIL, V307, P207, DOI 10.1007/s11104-008-9597-1; Li FD, 2008, ENVIRON GEOL, V55, P1109, DOI 10.1007/s00254-007-1059-1; Li X, 2010, HUNAN AGR SCI, V5, P64; Luo LG, 1999, CHINESE J APPL ECOLO, V10, P301; Luo LG, 2011, ENVIRON MONIT ASSESS, V177, P141, DOI 10.1007/s10661-010-1624-z; Ma JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051894; Ou YangHong, 2009, Jiangsu Journal of Agricultural Sciences, V25, P106; Qian C, 2007, PLANT SOIL, V300, P197, DOI 10.1007/s11104-007-9404-4; REDDY KR, 1986, FERT RES, V9, P99, DOI 10.1007/BF01048697; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Rodrigues MA, 2006, EUR J AGRON, V25, P328, DOI 10.1016/j.eja.2006.07.002; STANFORD G, 1972, SOIL SCI SOC AM PRO, V36, P465, DOI 10.2136/sssaj1972.03615995003600030029x; Sun XP, 2011, T CSAE, V27, P158; Tian YH, 2007, PEDOSPHERE, V17, P445, DOI 10.1016/S1002-0160(07)60054-X; UHEL C, 1989, PLANT SOIL, V116, P197, DOI 10.1007/BF02214548; Wang XT, 2011, PLANT SOIL, V343, P195, DOI 10.1007/s11104-010-0648-z; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Xi YunGuan, 2007, Acta Agriculturae Shanghai, V23, P28; Xing GX, 2001, SCI CHINA SER B, V44, P304, DOI 10.1007/BF02879621; Xiong ZQ, 2010, PEDOSPHERE, V20, P209, DOI 10.1016/S1002-0160(10)60008-2; Yang L, 2008, WATER SAVING IRRIGAT, V3, P34; Zhou S, 2011, ECOL ENG, V37, P685, DOI 10.1016/j.ecoleng.2010.04.032; Zhu JG, 2000, NUTR CYCL AGROECOSYS, V57, P75, DOI 10.1023/A:1009712404335	41	35	39	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98138	10.1371/journal.pone.0098138	http://dx.doi.org/10.1371/journal.pone.0098138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858826	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400045
J	Bill, A; Rosethorne, EM; Kent, TC; Fawcett, L; Burchell, L; van Diepen, MT; Marelli, A; Batalov, S; Miraglia, L; Orth, AP; Renaud, NA; Charlton, SJ; Gosling, M; Gaither, LA; Groot-Kormelink, PJ				Bill, Anke; Rosethorne, Elizabeth M.; Kent, Toby C.; Fawcett, Lindsay; Burchell, Lynn; van Diepen, Michiel T.; Marelli, Anthony; Batalov, Sergey; Miraglia, Loren; Orth, Anthony P.; Renaud, Nicole A.; Charlton, Steven J.; Gosling, Martin; Gaither, L. Alex; Groot-Kormelink, Paul J.			High Throughput Mutagenesis for Identification of Residues Regulating Human Prostacyclin (hIP) Receptor Expression and Function	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIRECTED PROTEIN EVOLUTION; DNA-POLYMERASE; SYNTHETIC MUTATIONS; CYSTEINE RESIDUES; LIGAND-BINDING; MICE LACKING; IN-VITRO; FIDELITY; ACTIVATION	The human prostacyclin receptor (hIP receptor) is a seven-transmembrane G protein-coupled receptor (GPCR) that plays a critical role in vascular smooth muscle relaxation and platelet aggregation. hIP receptor dysfunction has been implicated in numerous cardiovascular abnormalities, including myocardial infarction, hypertension, thrombosis and atherosclerosis. Genomic sequencing has discovered several genetic variations in the PTGIR gene coding for hIP receptor, however, its structure-function relationship has not been sufficiently explored. Here we set out to investigate the applicability of high throughput random mutagenesis to study the structure-function relationship of hIP receptor. While chemical mutagenesis was not suitable to generate a mutagenesis library with sufficient coverage, our data demonstrate error-prone PCR (epPCR) mediated mutagenesis as a valuable method for the unbiased screening of residues regulating hIP receptor function and expression. Here we describe the generation and functional characterization of an epPCR derived mutagenesis library compromising >4000 mutants of the hIP receptor. We introduce next generation sequencing as a useful tool to validate the quality of mutagenesis libraries by providing information about the coverage, mutation rate and mutational bias. We identified 18 mutants of the hIP receptor that were expressed at the cell surface, but demonstrated impaired receptor function. A total of 38 non-synonymous mutations were identified within the coding region of the hIP receptor, mapping to 36 distinct residues, including several mutations previously reported to affect the signaling of the hIP receptor. Thus, our data demonstrates epPCR mediated random mutagenesis as a valuable and practical method to study the structure-function relationship of GPCRs.	[Bill, Anke; Renaud, Nicole A.; Gaither, L. Alex] Novartis Inst Biomed Res, Cambridge, MA USA; [Rosethorne, Elizabeth M.; Kent, Toby C.; Fawcett, Lindsay; Burchell, Lynn; van Diepen, Michiel T.; Charlton, Steven J.; Gosling, Martin; Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, Resp Dis Area, Horsham, W Sussex, England; [Marelli, Anthony; Batalov, Sergey; Miraglia, Loren; Orth, Anthony P.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, Musculoskeletal Dis Area, Basel, Switzerland	Novartis; Novartis; Novartis; Novartis	Groot-Kormelink, PJ (corresponding author), Novartis Inst Biomed Res, Resp Dis Area, Horsham, W Sussex, England.	paul.groot-kormelink@novartis.com		Batalov, Sergey/0000-0002-0925-0554; van Diepen, Michiel/0000-0001-8156-4294; Bill, Anke/0000-0003-1244-7574; Charlton, Steven/0000-0001-8841-2752; Rosethorne, Elizabeth/0000-0001-6877-2320	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	The work was funded by Novartis Institutes for Biomedical Research. The authors contributed to the manuscript as follows: PJGK, AM, APO, and LM designed and made the IPR mutant library as well as contributed to the overall design and conclusions of the study and the writing of the paper. AB, TCK, ER, LF, LB, and MTvD designed the functional screen, screened the IPR mutant library and followed up on the resulting mutants as well as contributed to the overall design and conclusions of the study and the writing of the paper. AB and NAR designed and executed the NGS dataset and analyzed the NGS results. PJGK and SB created the mutation rate program. PJGK, AB, TCK, ER, APO, SJC, MG and LAG all had considerable input in the design of the study, the conclusions made from the study and the writing of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Eckert K A, 1991, PCR Methods Appl, V1, P17; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Giguere V, 2004, EUR J PHARMACOL, V494, P11, DOI 10.1016/j.ejphar.2004.04.041; KADONAGA JT, 1985, NUCLEIC ACIDS RES, V13, P1733, DOI 10.1093/nar/13.5.1733; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kuwano K, 2007, J PHARMACOL EXP THER, V322, P1181, DOI 10.1124/jpet.107.124248; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91, DOI 10.2174/138920310790274617; Martin KA, 2009, PROG MOL BIOL TRANSL, V89, P133, DOI 10.1016/S1877-1173(09)89006-6; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Saito S, 2003, J HUM GENET, V48, P461, DOI 10.1007/s10038-003-0062-y; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Selifonova O, 2001, APPL ENVIRON MICROB, V67, P3645, DOI 10.1128/AEM.67.8.3645-3649.2001; SHORTLE D, 1978, P NATL ACAD SCI USA, V75, P2170, DOI 10.1073/pnas.75.5.2170; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; Stitham J, 2002, J BIOL CHEM, V277, P15439, DOI 10.1074/jbc.M201187200; Stitham J, 2002, MOL PHARMACOL, V61, P1202, DOI 10.1124/mol.61.5.1202; Stitham J, 2007, GENE, V396, P180, DOI 10.1016/j.gene.2007.03.016; Stitham J, 2007, PROSTAG OTH LIPID M, V82, P95, DOI 10.1016/j.prostaglandins.2006.05.010; Stitham J, 2006, J BIOL CHEM, V281, P37227, DOI 10.1074/jbc.M604042200; Stitham J, 2011, J BIOL CHEM, V286, P7060, DOI 10.1074/jbc.M110.124933; STOLARSKI R, 1987, BIOCHEMISTRY-US, V26, P4332, DOI 10.1021/bi00388a022; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Wang D, 2000, J COMPUT BIOL, V7, P143, DOI 10.1089/10665270050081423; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; Wong TS, 2006, COMB CHEM HIGH T SCR, V9, P271, DOI 10.2174/138620706776843192; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Zhang ZB, 2001, MOL PHARMACOL, V60, P480	42	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97973	10.1371/journal.pone.0097973	http://dx.doi.org/10.1371/journal.pone.0097973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886841	Green Published, Green Accepted, gold			2022-12-27	WOS:000336956300030
J	Gong, WZ; Qi, PF; Du, JB; Sun, X; Wu, XL; Song, C; Liu, WG; Wu, YS; Yu, XB; Yong, TW; Wang, XC; Yang, F; Yan, YH; Yang, WY				Gong, Wanzhuo; Qi, Pengfei; Du, Junbo; Sun, Xin; Wu, Xiaoling; Song, Chun; Liu, Weiguo; Wu, Yushan; Yu, Xiaobo; Yong, Taiwen; Wang, Xiaochun; Yang, Feng; Yan, Yanhong; Yang, Wenyu			Transcriptome Analysis of Shade-Induced Inhibition on Leaf Size in Relay Intercropped Soybean	PLOS ONE			English	Article							GENE-EXPRESSION; GLUCOSE PYROPHOSPHORYLASE; LIGHT IRRADIANCE; CELL-DIVISION; CO2 DIFFUSION; ARABIDOPSIS; AUXIN; COMPLEX; GROWTH; AVOIDANCE	Multi-species intercropping is a sustainable agricultural practice worldwide used to utilize resources more efficiently. In intercropping systems, short crops often grow under vegetative shade of tall crops. Soybean, one important legume, is often planted in intercropping. However, little is known about the mechanisms of shade inhibition effect on leaf size in soybean leaves at the transcriptome level. We analyzed the transcriptome of shaded soybean leaves via RNA-Seq technology. We found that transcription 1085 genes in mature leaves and 1847 genes in young leaves were significantly affected by shade. Gene ontology analyses showed that expression of genes enriched in polysaccharide metabolism was down-regulated, but genes enriched in auxin stimulus were up-regulated in mature leaves; and genes enriched in cell cycling, DNA-replication were down-regulated in young leaves. These results suggest that the inhibition of higher auxin content and shortage of sugar supply on cell division and cell expansion contribute to smaller and thinner leaf morphology, which highlights potential research targets such as auxin and sugar regulation on leaves for crop adaptation to shade in intercropping.	[Gong, Wanzhuo; Du, Junbo; Sun, Xin; Wu, Xiaoling; Liu, Weiguo; Wu, Yushan; Yu, Xiaobo; Yong, Taiwen; Wang, Xiaochun; Yang, Feng; Yang, Wenyu] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China; [Gong, Wanzhuo; Du, Junbo; Sun, Xin; Wu, Xiaoling; Song, Chun; Liu, Weiguo; Wu, Yushan; Yu, Xiaobo; Yong, Taiwen; Wang, Xiaochun; Yang, Feng; Yang, Wenyu] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China; [Qi, Pengfei] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Song, Chun] Sichuan Agr Univ, Coll Resource & Environm, Chengdu, Peoples R China; [Yan, Yanhong] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Yang, WY (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China.	wenyu.yang@263.net	Song, Chun/B-8298-2019	Song, Chun/0000-0001-9927-2599; Wu, Yushan/0000-0003-4190-0294	National Natural Science Foundation of China [31171476, 531071373]; National Program on Key Basic Research Project [1 2011CB100402]; China Agriculture Research System [CARS-04-PS19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project(National Basic Research Program of China); China Agriculture Research System	This work was supported by National Natural Science Foundation of China (No. 31171476 & 531071373), National Program on Key Basic Research Project (1 2011CB100402), and the China Agriculture Research System (CARS-04-PS19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YO, 2010, CARBOHYD RES, V345, P55, DOI 10.1016/j.carres.2009.08.025; Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; Beemster GTS, 2005, PLANT PHYSIOL, V138, P734, DOI 10.1104/pp.104.053884; Bolon YT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-41; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Casal JJ, 2012, SHADE AVOIDANCE ARAB, pe0157; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Chen H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-122; Cleland RE, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P204; Cookson SJ, 2006, ANN BOT-LONDON, V97, P443, DOI 10.1093/aob/mcj047; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Echarte L, 2011, FIELD CROP RES, V121, P423, DOI 10.1016/j.fcr.2011.01.011; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Evans JR, 2013, PLANT PHYSIOL, V162, P1780, DOI 10.1104/pp.113.219006; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Francis C.A., 1989, ADV AGRON, V42, P1; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Gao Y, 2010, AGR WATER MANAGE, V98, P199, DOI 10.1016/j.agwat.2010.08.021; Ghosh PK, 2009, EUR J AGRON, V31, P43, DOI 10.1016/j.eja.2009.03.002; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Granier C, 2000, J PLANT GROWTH REGUL, V19, P45, DOI 10.1007/s003440000006; Halliday KJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001586; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; Horiguchi G, 2006, J PLANT RES, V119, P37, DOI 10.1007/s10265-005-0232-4; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Kadowaki M, 2001, J AGRON CROP SCI, V186, P37, DOI 10.1046/j.1439-037x.2001.00451.x; Keller CP, 2007, PHYSIOL PLANTARUM, V130, P580, DOI 10.1111/j.1399-3054.2007.00916.x; Keller CP, 2011, PLANT SIGNAL BEHAV, V6, P1997, DOI 10.4161/psb.6.12.18026; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kozuka T, 2005, PLANT CELL PHYSIOL, V46, P213, DOI 10.1093/pcp/pci016; Kurepin LV, 2007, J EXP BOT, V58, P2145, DOI 10.1093/jxb/erm068; Kurepin LV, 2011, PLANT GROWTH REGUL, V65, P255, DOI 10.1007/s10725-011-9596-8; Langeveld SMJ, 2002, PLANT PHYSIOL, V129, P278, DOI 10.1104/pp.010720; Lerouxel O, 2006, CURR OPIN PLANT BIOL, V9, P621, DOI 10.1016/j.pbi.2006.09.009; Libault M, 2009, PLANT PHYSIOL, V151, P1207, DOI 10.1104/pp.109.144030; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Matsye PD, 2011, PLANT MOL BIOL, V77, P513, DOI 10.1007/s11103-011-9828-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murchie EH, 2005, J EXP BOT, V56, P449, DOI 10.1093/jxb/eri100; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Nagano AJ, 2012, CELL, V151, P1358, DOI 10.1016/j.cell.2012.10.048; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sasidharan R, 2010, PLANT PHYSIOL, V154, P978, DOI 10.1104/pp.110.162057; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Scarpella E, 2010, COLD SPRING HARBOR P, V2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Terashima I, 2001, J PLANT RES, V114, P93, DOI 10.1007/PL00013972; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Tholen D, 2012, PLANT SCI, V197, P92, DOI 10.1016/j.plantsci.2012.09.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Van Volkenburgh E, 1999, PLANT CELL ENVIRON, V22, P1463, DOI 10.1046/j.1365-3040.1999.00514.x; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Vandenbussche F, 2003, PLANT PHYSIOL, V133, P517, DOI 10.1104/pp.103.022665; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wang J.W., 2009, PLANT QUARANTINE, V1, P1, DOI DOI 10.1371/J0URNAL.PGEN.1000350; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	79	40	49	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98465	10.1371/journal.pone.0098465	http://dx.doi.org/10.1371/journal.pone.0098465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886785	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300069
J	Jafari, B; Elias, JA; Mohsenin, V				Jafari, Behrouz; Elias, Jack A.; Mohsenin, Vahid			Increased Plasma YKL-40/Chitinase-3-Like-Protein-1 Is Associated with Endothelial Dysfunction in Obstructive Sleep Apnea	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ALL-CAUSE MORTALITY; GROWTH-FACTOR; YKL-40 LEVELS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; ATHEROSCLEROSIS; HYPERTENSION; PROTEINS; GP38K	Purpose: Obstructive sleep apnea (OSA) is a common disorder affecting 15-24% of the adults and is associated with increased risk of hypertension and atherosclerosis. The exact mechanisms underlying hypertension in OSA are not entirely clear. YKL-40/Chitinase-3-like protein-1 is a circulating moiety with roles in injury, repair and angiogenesis that is dysregulated in atherosclerosis and a number of other diseases. We sought to determine the role of YKL-40 in endothelial dysfunction and hypertension in OSA. Methods: We studies 23 normotensive OSA (N-OSA) and 14 hypertensive OSA (H-OSA) without diabetes and apparent cardiovascular disease. Endothelial-dependent nitric oxide-mediated vasodilatory capacity was assessed by flow-mediated vasodilation (FMD). YKL-40, vascular endothelial growth factor (VEGF) and the soluble form of VEGF receptor-1 or sFlt-1 were measured in plasma using ELISA methodology. Results: N-OSA subjects aged 49.1 +/- 2.3 years and H-OSA aged 51.3 +/- 1.9 years with BMI 36.1 +/- 1.6 and 37.6 +/- 1.9 kg/m(2), respectively. The apnea-hypopnea index (AHI) was 41 +/- 5 events/hr in N-OSA and 46 +/- 6 in H-OSA with comparable degree of oxygen desaturations during sleep. FMD was markedly impaired in H-OSA (8.3%+/- 0.8) compared to N-OSA (13.2%+/- 0.6, P < 0.0001). Plasma YKL-40 was significantly elevated in H-OSA (55.2 +/- 7.9 ng/ml vs. 35.6 +/- 4.2 ng/ml in N-OSA, P = 0.02) and had an inverse relationship with FMD (r = -0.52, P = 0.013). There was a significant positive correlation between sFlt-1/VEGF, a measure of decreased VEGF availability, and YKL-40 (r = 0.42, P = 0.04). Conclusion: The levels of plasma YKL-40 were elevated in H-OSA group and inversely correlated with the endothelial-dependent vasodilatory capacity whereas there was a positive correlation between sFlt-1/VEGF and YKL-40. These findings suggest that YKL-40 is dysregulated, in part, due to perturbation of VEGF signaling, and may contribute to endothelial dysfunction and hypertension in OSA.	[Jafari, Behrouz] Univ Calif Irvine, Sect Pulm Crit Care & Sleep Med, Irvine, CA USA; [Elias, Jack A.] Warren Alpert Sch Med, Providence, RI USA; [Mohsenin, Vahid] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA; John B Pierce Lab, New Haven, CT USA	University of California System; University of California Irvine; Yale University; Yale University; The John B Pierce Laboratory, Inc	Mohsenin, V (corresponding author), Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA.	Vahid.mohsenin@yale.edu	Jafari, Behrouz/W-9280-2019	Jafari, Behrouz/0000-0003-3463-8558	National Institutes of Health [5T32HL07778, HL093017]; Yale University;  [U01-HL-108638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108638, R01HL093017, T32HL007778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health to BJ (5T32HL07778) and JAE (HL093017), as well as by Yale University, Section of Pulmonary, Critical Care and Sleep Medicine intramural grant and U01-HL-108638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkeson A, 2009, PROG CARDIOVASC DIS, V51, P351, DOI 10.1016/j.pcad.2008.08.002; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Ferrara N, 2001, Am J Physiol Cell Physiol, V280, pC1358; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harutyunyan M, 2013, IMMUNOBIOLOGY, V218, P945, DOI 10.1016/j.imbio.2012.10.015; Harutyunyan M, 2012, IMMUNOBIOLOGY, V217, P652, DOI 10.1016/j.imbio.2011.11.003; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Jafari B, 2012, AM J HYPERTENS, V25, P854, DOI 10.1038/ajh.2012.56; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Karumanchi SA, 2006, METH MOLEC MED, V122, P393; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW; Lu FX, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.024; Ma Wei-hong, 2012, BMC Cardiovasc Disord, V12, P35, DOI 10.1186/1471-2261-12-35; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mohsenin V, 2011, RESP MED, V105, P801, DOI 10.1016/j.rmed.2011.01.001; Mohsenin V, 2009, SLEEP MED, V10, P759, DOI 10.1016/j.sleep.2008.09.005; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Rondbjerg AK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-54; Rossi R, 2004, J AM COLL CARDIOL, V44, P1636, DOI 10.1016/j.jacc.2004.07.027; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shah NA, 2010, SLEEP BREATH, V14, P131, DOI 10.1007/s11325-009-0298-7; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Valipour A, 2004, RESP MED, V98, P1180, DOI 10.1016/j.rmed.2004.04.009; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	38	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98629	10.1371/journal.pone.0098629	http://dx.doi.org/10.1371/journal.pone.0098629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878721	Green Published, gold			2022-12-27	WOS:000338101500076
J	Wu, IC; Lin, MY; Yu, FJ; Hsieh, HM; Chiu, KF; Wu, MT				Wu, I-Chen; Lin, Ming-Yen; Yu, Fang-Jung; Hsieh, Hui-Min; Chiu, Kuei-Fen; Wu, Ming-Tsang			A Short-Term Effect of Low-Dose Aspirin on Major Hemorrhagic Risks in Primary Prevention: A Case-Crossover Design	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; LUNG-CANCER; EVENTS; STROKE; ASSOCIATION; BENEFITS; DRUGS	Background: Very few studies have examined the risk of short-term adverse hemorrhage of low-dose aspirin use in primary prevention. This case-crossover study examined the transient effect of low-dose aspirin use on major hemorrhagic risks. Methods: A representative database of 1,000,000 patients randomly sampled from the Taiwan's National Health Insurance Research Database in 2000 was analyzed. The study cohort consisted of a total of 501,946 individuals, aged 30-95 years old, at risk of a major bleeding event in 2000. A case-crossover study was used to retrieve data on 10,905 incident patients with major hemorrhagic complications (3,781 cerebral and 7,124 gastrointestinal) and prescribed low-dose aspirin (<= 300 mg/day) from 2000-2008. A 56-day time window (similar to 2 months) was used as the case period for which the odds ratio (OR) was estimated using the ratio of patients exposed during the 56-day case period only (1-56 days before the index date) compared to its corresponding 56-day control period only (57-112 days before the index date). Results: Four hundred eighty-nine (4.5%) of the 10,905 hemorrhagic patients had used low-dose aspirin during the 56-day case only period; 294 (2.7%) of the same patients had used low-dose aspirin during control only period. Low-dose aspirin use increase the risk of developing a major hemorrhage 1.33-fold (95% CI = 1.13-1.55, P<0.0001). Significance was found prominent in 4,453 non-hypertensive and non-diabetic subjects (Adjusted odds ratio = 1.88, 95% CI = 1.21-2.91). Conclusion: Transient low-dose aspirin use increases risk for major hemorrhagic events in Han Chinese.	[Wu, I-Chen; Lin, Ming-Yen; Yu, Fang-Jung; Hsieh, Hui-Min; Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Wu, I-Chen; Yu, Fang-Jung; Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chiu, Kuei-Fen] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.	960021@cc.kmuh.org.tw	Wu, Ming-Tsang/G-5637-2012; Lin, Ming Yen/A-8637-2010	Wu, Ming-Tsang/0000-0001-7307-7816; Lin, Ming Yen/0000-0002-8194-4833	Kaohsiung Medical University Hospital [KMUH97-7G65]; National Science Council [NSC 101-2314-B-037-037-MY3]; Taiwan's National Health Research Institutes [NHRI-EX102-10209PI]	Kaohsiung Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Taiwan's National Health Research Institutes	This study was supported by grants from Kaohsiung Medical University Hospital (KMUH97-7G65), the National Science Council (NSC 101-2314-B-037-037-MY3), and Taiwan's National Health Research Institutes (NHRI-EX102-10209PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042; Calonge N, 2009, ANN INTERN MED, V150, P396; Caso V, 2012, EUR J INTERN MED, V23, P580, DOI 10.1016/j.ejim.2012.04.010; Chan AT, 2012, LANCET, V379, P1569, DOI 10.1016/S0140-6736(11)61654-1; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; DiNicolantonio JJ, 2012, JAMA-J AM MED ASSOC, V308, P1088, DOI 10.1001/2012.jama.10717; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Lai CH, 2011, STROKE, V42, P2615, DOI 10.1161/STROKEAHA.111.617076; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lee SM, 2013, STROKE, V44, P2139, DOI 10.1161/STROKEAHA.111.674077; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin JS, 2010, BEHAV COUNSELING PRO; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Meade Tom, 2012, Handb Exp Pharmacol, P565, DOI 10.1007/978-3-642-29423-5_23; Morimoto T, 2004, AM J MED, V117, P459, DOI 10.1016/j.amjmed.2004.04.017; Nemerovski CW, 2012, PHARMACOTHERAPY, V32, P1020, DOI 10.1002/phar.1127; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raju NC, 2012, CURR OPIN CARDIOL, V27, P499, DOI 10.1097/HCO.0b013e328356ae95; Rembold CM, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-12-201206190-02003; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Schneeweiss S, 1997, PHARMACOEPIDEM DR S, V6, pS51, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J; Siller-Matula JM, 2012, JAMA-J AM MED ASSOC, V307, P2318, DOI 10.1001/jama.2012.6152; Tantry US, 2005, EXPERT OPIN PHARMACO, V6, P2027, DOI 10.1517/14656566.6.12.2027; The Medical Research Council's General Practice Research Framework, 1988, LANCET, V351, P233; Thornley S, 2012, INTERN MED J, V42, P46, DOI 10.1111/j.1445-5994.2012.02902.x; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; US Centers for Diseases Control and Prevention, INT CLASS DIS 9 REV; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Yamane K, 2012, J ATHEROSCLER THROMB, V19, P1142, DOI 10.5551/jat.14100	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98326	10.1371/journal.pone.0098326	http://dx.doi.org/10.1371/journal.pone.0098326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879431	Green Submitted, gold, Green Published			2022-12-27	WOS:000338101500050
J	Christiaen, SEA; Motherway, MO; Bottacini, F; Lanigan, N; Casey, PG; Huys, G; Nelis, HJ; van Sinderen, D; Coenye, T				Christiaen, Steven E. A.; Motherway, Mary O'Connell; Bottacini, Francesca; Lanigan, Noreen; Casey, Pat G.; Huys, Geert; Nelis, Hans J.; van Sinderen, Douwe; Coenye, Tom			Autoinducer-2 Plays a Crucial Role in Gut Colonization and Probiotic Functionality of Bifidobacterium breve UCC2003	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COMMENSAL-HOST INTERACTION; DNA-MICROARRAY DATA; QUORUM-SENSING ROLE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; IMMUNE MODULATION; IRON ACQUISITION; LUXS; LACTOBACILLUS	In the present study we show that luxS of Bifidobacterium breve UCC2003 is involved in the production of the interspecies signaling molecule autoinducer-2 (AI-2), and that this gene is essential for gastrointestinal colonization of a murine host, while it is also involved in providing protection against Salmonella infection in Caenorhabditis elegans. We demonstrate that a B. breve luxS-insertion mutant is significantly more susceptible to iron chelators than the WT strain and that this sensitivity can be partially reverted in the presence of the AI-2 precursor DPD. Furthermore, we show that several genes of an iron starvation-induced gene cluster, which are downregulated in the luxS-insertion mutant and which encodes a presumed iron-uptake system, are transcriptionally upregulated under in vivo conditions. Mutation of two genes of this cluster in B. breve UCC2003 renders the derived mutant strains sensitive to iron chelators while deficient in their ability to confer gut pathogen protection to Salmonella-infected nematodes. Since a functional luxS gene is present in all tested members of the genus Bifidobacterium, we conclude that bifidobacteria operate a LuxS-mediated system for gut colonization and pathogen protection that is correlated with iron acquisition.	[Christiaen, Steven E. A.; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Motherway, Mary O'Connell; Bottacini, Francesca; Lanigan, Noreen; Casey, Pat G.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Motherway, Mary O'Connell; Bottacini, Francesca; Lanigan, Noreen; Casey, Pat G.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Huys, Geert] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium; [Huys, Geert] Univ Ghent, BCCM LMG Bacteria Collect, B-9000 Ghent, Belgium	Ghent University; University College Cork; University College Cork; Ghent University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Coenye@UGent.be	Huys, Geert R.B./V-8633-2019; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Van Sinderen, Douwe/A-6778-2015; Huys, Geert/M-6781-2019; Bottacini, Francesca/AAO-2431-2021	Huys, Geert R.B./0000-0002-7092-4837; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Van Sinderen, Douwe/0000-0003-1823-7957; Bottacini, Francesca/0000-0002-0142-2956; O'Connell Motherway, Mary/0000-0001-9164-9320	IWT Vlaanderen (Instituut voor Innovatie door Wetenschap en Technologie Vlaanderen); Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office; HRB postdoctoral fellowship [PDTM/20011/9]; IRCSET postgraduate fellowship; Science Foundation Ireland (SFI) [07/CE/B1368, SFI/12/RC/2273]	IWT Vlaanderen (Instituut voor Innovatie door Wetenschap en Technologie Vlaanderen); Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office; HRB postdoctoral fellowship; IRCSET postgraduate fellowship; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was financially supported by IWT Vlaanderen (Instituut voor Innovatie door Wetenschap en Technologie Vlaanderen), and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. This publication has emanated from research conducted with the financial support of a HRB postdoctoral fellowship (Grant no. PDTM/20011/9) awarded to MOCM and Science Foundation Ireland (SFI) awards under Grant Numbers 07/CE/B1368 and SFI/12/RC/2273; FB acknowledges financial assistance through an IRCSET postgraduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martin P, 2007, APPL MICROBIOL BIOT, V76, P1395, DOI 10.1007/s00253-007-1115-5; Barrett E, 2013, ARCH DIS CHILD-FETAL, V98, pF334, DOI 10.1136/archdischild-2012-303035; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Buck BL, 2009, J APPL MICROBIOL, V107, P269, DOI 10.1111/j.1365-2672.2009.04204.x; Butler CC, 2012, BMJ CLIN RES ED, V344, pe682; Cabana MD, 2010, J PEDIATR-US, V157, P864, DOI 10.1016/j.jpeds.2010.09.023; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; Chen CC, 2013, SEMIN PEDIATR SURG, V22, P94, DOI 10.1053/j.sempedsurg.2013.01.006; Choi J, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0983-5; Clark LC, 2014, CELL MICROBIOL, V16, P27, DOI 10.1111/cmi.12234; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; Cronin M, 2012, BIOENGINEERED, V3, P157, DOI 10.4161/bbug.18985; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; de la Nava JG, 2003, BIOINFORMATICS, V19, P2328, DOI 10.1093/bioinformatics/btg318; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Fanning S, 2012, GUT MICROBES, V3, P420, DOI 10.4161/gmic.20630; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Hodgkinson JT, 2007, ACS CHEM BIOL, V2, P715, DOI 10.1021/cb700227k; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Isolauri E, 2002, CURR OPIN ALLERGY CL, V2, P263, DOI 10.1097/00130832-200206000-00018; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Janssens J C A, 2007, Commun Agric Appl Biol Sci, V72, P35; Jonkers D, 2012, DRUGS, V72, P803, DOI 10.2165/11632710-000000000-00000; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lebeer S, 2008, APPL ENVIRON MICROB, V74, P4711, DOI 10.1128/AEM.00133-08; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Li D, 2013, J CLIN PHARM THER, V38, P445, DOI 10.1111/jcpt.12084; Li L, 2011, MICROB PATHOGENESIS, V50, P293, DOI 10.1016/j.micpath.2011.02.002; Lin HY, 2013, J FORM MED ASS; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Masco L, 2003, SYST APPL MICROBIOL, V26, P557, DOI 10.1078/072320203770865864; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Motherway MO, 2009, MICROB BIOTECHNOL, V2, P321, DOI 10.1111/j.1751-7915.2008.00071.x; Mshvildadze M, 2010, EARLY HUM DEV, V86, pS67, DOI 10.1016/j.earlhumdev.2010.01.018; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Pollumaa L, 2012, SENSORS-BASEL, V12, P3327, DOI 10.3390/s120303327; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Reid G, 2006, FEMS IMMUNOL MED MIC, V46, P149, DOI 10.1111/j.1574-695X.2005.00026.x; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Shlomai NO, 2014, NEONATOLOGY, V105, P64, DOI 10.1159/000354891; Siciliano RA, 2012, CURR OPIN MICROBIOL, V15, P390, DOI 10.1016/j.mib.2012.03.006; Sivamaruthi BS, 2011, J BASIC MICROB, V51, P540, DOI 10.1002/jobm.201000377; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Soni KA, 2008, FOODBORNE PATHOG DIS, V5, P147, DOI 10.1089/fpd.2007.0050; Stiernagle Theresa, 2006, WormBook, P1; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Sun ZK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088328, 10.1371/journal.pone.0088260]; Surette MG, 1999, MOL MICROBIOL, V31, P585, DOI 10.1046/j.1365-2958.1999.01199.x; Turovskiy Y, 2007, ADV APPL MICROBIOL, V62, P191, DOI 10.1016/S0065-2164(07)62007-3; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; van der Vinne AN, 2005, VET MICROBIOL, V110, P53, DOI 10.1016/j.vetmic.2005.06.011; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wilson CM, 2012, J BACTERIOL, V194, P1743, DOI 10.1128/JB.06318-11; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005	81	51	80	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98111	10.1371/journal.pone.0098111	http://dx.doi.org/10.1371/journal.pone.0098111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871429	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300025
J	Liao, JY; Zhang, Q; Liao, Y; Cai, B; Chen, J; Li, LX; Wang, LL				Liao, Jingyu; Zhang, Qi; Liao, Yun; Cai, Bei; Chen, Jie; Li, Lixin; Wang, Lanlan			Association of T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms with Susceptibility and Disease Progression of HBV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; ANTITUMOR IMMUNITY; VIRUS-INFECTION; EXPRESSION; BLOCKADE; DYSFUNCTION; EXHAUSTION; AUTOIMMUNE; INDUCTION	Purpose: T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) plays an important role in regulating T cells in hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). However, few researches have reported the association of Tim-3 genetic variants with susceptibility and progression of HBV infection. In this study, we focused on the association of Tim-3 polymorphisms with HBV infection, HBsAg seroclearance and hepatocellular carcinoma. Methods: A total of 800 subjects were involved in this study. Four groups were studied here, including HBV, HBsAg seroclearance, HBV-associated HCC and healthy controls. Three single-nucleotide polymorphisms (SNPs) of Tim-3, rs246871, rs25855 and rs31223 were genotyped to analyze the association of Tim-3 polymorphisms with susceptibility and disease progression of HBV infection. Results: Our study found that rs31223 and rs246871 were associated with disease progression of HBV infection, while none of the three SNPs was relevant to HBV susceptibility. The minor allele "C'' of rs31223 was found to be associated with an increased probability of HBsAg seroclearance (P = 0.033) and genotype "CC'' of rs246871 to be associated with an increased probability of HBV-associated HCC (P = 0.007). In accordance, haplotypic analysis of the three polymorphisms also showed that the haplotype block CGC* and TGC* were significantly associated with HBsAg seroclearance (P<0.05) while haplotype block CAT*, CGT*, TAC* and TGT* were significantly associated with HBV-associated HCC (all P<0.05). Conclusions: Genetic variants of Tim-3 have an important impact on disease progression of HBV infection. With specific Tim-3 polymorphisms, patients infected with HBV could be potential candidates of HCC and HBsAg seroclearance.	[Liao, Jingyu; Zhang, Qi; Liao, Yun; Cai, Bei; Chen, Jie; Li, Lixin; Wang, Lanlan] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	wanglanlan85@126.com			National Natural Science Foundation of China [81072443, 81273256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (No. 81072443 and 81273256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Wu W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-113; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058006; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	31	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98280	10.1371/journal.pone.0098280	http://dx.doi.org/10.1371/journal.pone.0098280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867713	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100046
J	Yamane, K; Indalao, IL; Chida, J; Yamamoto, Y; Hanawa, M; Kido, H				Yamane, Kazuhiko; Indalao, Irene L.; Chida, Junji; Yamamoto, Yoshikazu; Hanawa, Masaaki; Kido, Hiroshi			Diisopropylamine Dichloroacetate, a Novel Pyruvate Dehydrogenase Kinase 4 Inhibitor, as a Potential Therapeutic Agent for Metabolic Disorders and Multiorgan Failure in Severe Influenza	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE-II; PROLIFERATOR-ACTIVATED RECEPTOR; BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; TRYPSIN-I; A VIRUS; PROTEIN-KINASE; RAT LUNGS; IDENTIFICATION; INFLAMMATION	Severe influenza is characterized by cytokine storm and multiorgan failure with metabolic energy disorders and vascular hyperpermeability. In the regulation of energy homeostasis, the pyruvate dehydrogenase (PDH) complex plays an important role by catalyzing oxidative decarboxylation of pyruvate, linking glycolysis to the tricarboxylic acid cycle and fatty acid synthesis, and thus its activity is linked to energy homeostasis. The present study tested the effects of diisopropylamine dichloroacetate (DADA), a new PDH kinase 4 (PDK4) inhibitor, in mice with severe influenza. Infection of mice with influenza A PR/8/34(H1N1) virus resulted in marked down-regulation of PDH activity and ATP level, with selective up-regulation of PDK4 in the skeletal muscles, heart, liver and lungs. Oral administration of DADA at 12-h intervals for 14 days starting immediately after infection significantly restored PDH activity and ATP level in various organs, and ameliorated disorders of glucose and lipid metabolism in the blood, together with marked improvement of survival and suppression of cytokine storm, trypsin up-regulation and viral replication. These results indicate that through PDK4 inhibition, DADA effectively suppresses the host metabolic disorder-cytokine cycle, which is closely linked to the influenza virus-cytokine-trypsin cycle, resulting in prevention of multiorgan failure in severe influenza.	[Yamane, Kazuhiko; Indalao, Irene L.; Chida, Junji; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan; [Yamamoto, Yoshikazu; Hanawa, Masaaki] Daiichi Sankyo Healthcare Co Ltd, R&D Dept, Tokyo, Japan	Tokushima University; Daiichi Sankyo Company Limited	Kido, H (corresponding author), Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 770, Japan.	kido@ier.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24249059]; Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan [12103307]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan	This research was funded in part by Grants-in-Aid (#24249059) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by Health and Labor Sciences Research Grants (Grant #12103307) from the Ministry of Health, Labor and Welfare of Japan. The funding agencies have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler Christopher F., 2007, Infectious Disorders - Drug Targets, V7, P282, DOI 10.2174/187152607783018745; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Chida J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060561; Chida J, 2012, ANAL CHIM ACTA, V727, P8, DOI 10.1016/j.aca.2012.03.022; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Close TE, 2013, MICROCIRCULATION, V20, P534, DOI 10.1111/micc.12053; da Rocha  LF, 2013, PPAR RES, V2013, DOI 10.1155/2013/519724; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; DELORME L, 1979, AM J DIS CHILD, V133, P822, DOI 10.1001/archpedi.1979.02130080062011; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Gallagher D, 1998, AM J PHYSIOL-ENDOC M, V275, pE249, DOI 10.1152/ajpendo.1998.275.2.E249; Hardaway AL, 2013, FUTURE MED CHEM, V5, P1089, DOI [10.4155/FMC.13.90, 10.4155/fmc.13.90]; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Henderson GN, 1997, BIOCHEM BIOPH RES CO, V235, P695, DOI 10.1006/bbrc.1997.6868; HERBERT V, 1979, AM J CLIN NUTR, V32, P1534, DOI 10.1093/ajcn/32.7.1534; Hunt JM, 2012, CURR MOL MED, V12, P827; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kelly DP, 2003, CIRC RES, V92, P482, DOI 10.1161/01.RES.0000064382.46274.95; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; Kim YD, 2012, DIABETES, V61, P2484, DOI 10.2337/db11-1665; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Koshiba T, 2013, BBA-MOL CELL RES, V1833, P225, DOI 10.1016/j.bbamcr.2012.03.005; Le TQ, 2006, BIOL CHEM, V387, P467, DOI 10.1515/BC.2006.062; Lee H, 2013, PEDIATR GASTROENTERO, V16, P143, DOI 10.5223/pghn.2013.16.3.143; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Lu Lun Geng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P92; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; McAinch AJ, 2009, DIABETES OBES METAB, V11, P721, DOI 10.1111/j.1463-1326.2009.01042.x; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Moseley CE, 2010, INFLUENZA OTHER RESP, V4, P307, DOI 10.1111/j.1750-2659.2010.00155.x; NAITO E, 1989, BRAIN DEV-JPN, V11, P195, DOI 10.1016/S0387-7604(89)80098-1; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; OLDENDORF WH, 1977, ANN NEUROL, V1, P409, DOI 10.1002/ana.410010502; Pan HY, 2011, J MED INVESTIG, V58, P19, DOI 10.2152/jmi.58.19; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Planavila A, 2005, BBA-MOL CELL BIOL L, V1736, P120, DOI 10.1016/j.bbalip.2005.08.001; PLATEEL M, 1995, J NEUROCHEM, V65, P2138; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Towatari T, 2002, EUR J BIOCHEM, V269, P2613, DOI 10.1046/j.1432-1033.2002.02937.x; Ushikai M, 2011, MOL GENET METAB, V102, P349, DOI 10.1016/j.ymgme.2010.11.167; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Witt KA, 2003, AM J PHYSIOL-HEART C, V285, pH2820, DOI 10.1152/ajpheart.00589.2003; Yamada H, 2006, ARCH VIROL, V151, P2529, DOI 10.1007/s00705-006-0807-y; Yang B, 2002, EUR RESPIR J, V19, P952, DOI 10.1183/09031936.02.00253302; Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717; Yao DB, 2011, J MED INVESTIG, V58, P210, DOI 10.2152/jmi.58.210; Yao M, 2011, MOL GENET METAB, V104, P265, DOI 10.1016/j.ymgme.2011.07.009	61	42	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98032	10.1371/journal.pone.0098032	http://dx.doi.org/10.1371/journal.pone.0098032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865588	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100030
J	Franklin, MT; Myers, JH; Cory, JS				Franklin, Michelle T.; Myers, Judith H.; Cory, Jenny S.			Genetic Similarity of Island Populations of Tent Caterpillars during Successive Outbreaks	PLOS ONE			English	Article							HARE LEPUS-AMERICANUS; CYCLIC POPULATIONS; WINTER MOTH; SIZE; FLOW; LEPIDOPTERA; VARIABILITY; DIVERSITY; MIGRATION; PROGRAM	Cyclic or fluctuating populations experience regular periods of low population density. Genetic bottlenecks during these periods could give rise to temporal or spatial genetic differentiation of populations. High levels of movement among increasing populations, however, could ameliorate any differences and could also synchronize the dynamics of geographically separated populations. We use microsatellite markers to investigate the genetic differentiation of four island and one mainland population of western tent caterpillars, Malacosoma californicum pluviale, in two periods of peak or pre-peak density separated by 8 years. Populations showed high levels of genetic variation and little genetic differentiation either temporally between peaks or spatially among sites. Mitochondrial haplotypes were also shared between one island population and one mainland population in the two years studied. An isolation-by-distance analysis showed the F-ST values of the two geographically closest populations to have the highest level of differentiation in both years. We conclude that high levels of dispersal among populations maintain both synchrony of population dynamics and override potential genetic differentiation that might occur during population troughs. As far we are aware, this is the first time that genetic similarity between temporally separated population outbreaks in insects has been investigated. A review of genetic data for both vertebrate and invertebrate species of cyclic animals shows that a lack of spatial genetic differentiation is typical, and may result from high levels of dispersal associated with fluctuating dynamics.	[Franklin, Michelle T.; Cory, Jenny S.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Franklin, Michelle T.; Myers, Judith H.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Franklin, Michelle T.; Myers, Judith H.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of British Columbia; University of British Columbia	Cory, JS (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jsc21@sfu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to JSC and JHM. Additional support was provided by a President's Research Start-up Grant to JSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; BROWN CE, 1965, CAN ENTOMOL, V97, P1073, DOI 10.4039/Ent971073-10; Burton C, 2002, MOL ECOL, V11, P1689, DOI 10.1046/j.1365-294X.2002.01566.x; Chapuis MP, 2011, P ROY SOC B-BIOL SCI, V278, P3152, DOI 10.1098/rspb.2010.2605; Chapuis MP, 2009, MOL ECOL, V18, P792, DOI 10.1111/j.1365-294X.2008.04072.x; Chitty D, 1971, NATURAL REGULATION A, P136; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; COSTA JT, 1994, EVOLUTION, V48, P1158, DOI 10.1111/j.1558-5646.1994.tb05302.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ehrich D, 2005, J MAMMAL, V86, P380, DOI 10.1644/BER-126.1; Elton CS, 1924, BR J EXP BIOL, V2, P119; EMELIANOV I, 1995, HEREDITY, V75, P416, DOI 10.1038/hdy.1995.154; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franklin MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037472; Franklin MT, 2010, MOL ECOL, V19, P1122, DOI 10.1111/j.1365-294X.2010.04548.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ingvarsson PK, 2000, P ROY SOC B-BIOL SCI, V267, P1321, DOI 10.1098/rspb.2000.1145; Jakobsson M, 2007, CLUMPP CLUSTER MATCH; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Krebs CJ, 2013, CAN J ZOOL, V91, P562, DOI 10.1139/cjz-2013-0012; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Leggett HC, 2011, ECOL ENTOMOL, V36, P318, DOI 10.1111/j.1365-2311.2011.01275.x; Liebhold AM, 2012, INSECT OUTBREAKS REV, P114; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Myers JH, 2000, POPUL ECOL, V42, P231, DOI 10.1007/PL00012002; Myers JH, 2013, ANNU REV ECOL EVOL S, V44, P565, DOI 10.1146/annurev-ecolsys-110512-135858; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1981, GENETICS, V98, P625; Noren K, 2013, BIOL REV; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pilot M, 2010, MOL ECOL, V19, P2800, DOI 10.1111/j.1365-294X.2010.04692.x; Pritchard JK, 2000, GENETICS, V155, P945; Rikalainen K, 2012, ECOL EVOL, V2, P1491, DOI 10.1002/ece3.277; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Tenow O, 2013, J ANIM ECOL, V82, P84, DOI 10.1111/j.1365-2656.2012.02023.x; Van Dongen S, 1998, HEREDITY, V80, P92, DOI 10.1046/j.1365-2540.1998.00278.x; Waite TA, 1997, EVOLUTION, V51, P620, DOI 10.1111/j.1558-5646.1997.tb02450.x; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; WELLINGTON W. G., 1960, CANADIAN JOUR ZOOL, V38, P289, DOI 10.1139/z60-036; Wheat CW, 2011, MOL ECOL, V20, P1813, DOI 10.1111/j.1365-294X.2011.05062.x	48	12	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e96679	10.1371/journal.pone.0096679	http://dx.doi.org/10.1371/journal.pone.0096679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858905	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400005
J	Gomes-Santos, IL; Fernandes, T; Couto, GK; Ferreira, JCA; Salemi, VMC; Fernandes, FB; Casarini, DE; Brum, PC; Rossoni, LV; de Oliveira, EM; Negrao, CE				Gomes-Santos, Igor Lucas; Fernandes, Tiago; Couto, Gisele Kruger; Ayres Ferreira-Filho, Julio Cesar; Cury Salemi, Vera Maria; Fernandes, Fernanda Barrinha; Casarini, Dulce Elena; Brum, Patricia Chakur; Rossoni, Luciana Venturini; de Oliveira, Edilamar Menezes; Negrao, Carlos Eduardo			Effects of Exercise Training on Circulating and Skeletal Muscle Renin-Angiotensin System in Chronic Heart Failure Rats	PLOS ONE			English	Article							ENZYME-RELATED CARBOXYPEPTIDASE; CONVERTING ENZYME; MYOCARDIAL-INFARCTION; BAROREFLEX SENSITIVITY; DEPENDENT MECHANISM; RECEPTOR BLOCKER; IN-VIVO; ANG-II; ACTIVATION; ACE2	Background: Accumulated evidence shows that the ACE-AngII-AT1 axis of the renin-angiotensin system (RAS) is markedly activated in chronic heart failure (CHF). Recent studies provide information that Angiotensin (Ang)-(1-7), a metabolite of AngII, counteracts the effects of AngII. However, this balance between AngII and Ang-(1-7) is still little understood in CHF. We investigated the effects of exercise training on circulating and skeletal muscle RAS in the ischemic model of CHF. Methods/Main Results: Male Wistar rats underwent left coronary artery ligation or a Sham operation. They were divided into four groups: 1) Sedentary Sham (Sham-S), 2) exercise-trained Sham (Sham-Ex), sedentary CHF (CHF-S), and exercise-trained CHF (CHF-Ex). Angiotensin concentrations and ACE and ACE2 activity in the circulation and skeletal muscle (soleus and plantaris) were quantified. Skeletal muscle ACE and ACE2 protein expression, and AT1, AT2, and Mas receptor gene expression were also evaluated. CHF reduced ACE2 serum activity. Exercise training restored ACE2 and reduced ACE activity in CHF. Exercise training reduced plasma AngII concentration in both Sham and CHF rats and increased the Ang-(1-7)/AngII ratio in CHF rats. CHF and exercise training did not change skeletal muscle ACE and ACE2 activity and protein expression. CHF increased AngII levels in both soleus and plantaris muscle, and exercise training normalized them. Exercise training increased Ang-(1-7) in the plantaris muscle of CHF rats. The AT1 receptor was only increased in the soleus muscle of CHF rats, and exercise training normalized it. Exercise training increased the expression of the Mas receptor in the soleus muscle of both exercise-trained groups, and normalized it in plantaris muscle. Conclusions: Exercise training causes a shift in RAS towards the Ang-(1-7)-Mas axis in skeletal muscle, which can be influenced by skeletal muscle metabolic characteristics. The changes in RAS circulation do not necessarily reflect the changes occurring in the RAS of skeletal muscle.	[Gomes-Santos, Igor Lucas; Ayres Ferreira-Filho, Julio Cesar; Cury Salemi, Vera Maria; Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Med, Heart Inst InCor HCFMUSP, Sao Paulo, Brazil; [Fernandes, Tiago; Brum, Patricia Chakur; de Oliveira, Edilamar Menezes; Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Couto, Gisele Kruger; Rossoni, Luciana Venturini] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Fernandes, Fernanda Barrinha; Casarini, Dulce Elena] Univ Fed Sao Paulo, Kidney & Hypertens Hosp, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Negrao, CE (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor HCFMUSP, Sao Paulo, Brazil.	cndnegrao@incor.usp.br	Salemi, Vera MC/C-9104-2013; Negrao, Carlos E/C-4281-2012; Brum, Patricia C/E-6605-2011; Oliveira, Edilamar M/AAG-1082-2019; Fernandes, Tiago/I-7891-2014; Salemi, Vera/AAY-5024-2020; Ferreira, Julio/L-4687-2019; Rossoni, Luciana Venturini/AFR-0021-2022; Gomes dos Santos, Igor Lucas/H-3706-2013; Fernandes, Fernanda B/N-8202-2013; Rossoni, Luciana Venturini/C-7226-2012	Salemi, Vera MC/0000-0002-7152-1810; Brum, Patricia C/0000-0002-4750-6506; Oliveira, Edilamar M/0000-0002-7101-312X; Fernandes, Tiago/0000-0002-9057-3878; Gomes dos Santos, Igor Lucas/0000-0001-5946-8300; Fernandes, Fernanda B/0000-0002-7919-6098; Rossoni, Luciana Venturini/0000-0002-0944-9483; Casarini, Dulce/0000-0003-1912-4292; Negrao, Carlos Eduardo/0000-0003-4652-1226	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-2010/50048-1]; Fundacao Zerbini; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Zerbini; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-2010/50048-1) and, in part, by Fundacao Zerbini. IL Gomes-Santos was supported by Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). PC Brum, DE Casarini, LV Rossoni, EM Oliveira and CE Negrao are research fellows at Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi ZA, 1997, CIRCULATION, V96, P3655; Agata J, 2006, HYPERTENS RES, V29, P865, DOI 10.1291/hypres.29.865; Akasu M, 1998, HYPERTENSION, V32, P514, DOI 10.1161/01.HYP.32.3.514; Barretto ACP, 2009, INT J CARDIOL, V135, P302, DOI 10.1016/j.ijcard.2008.03.056; Braith RW, 1999, J AM COLL CARDIOL, V34, P1170, DOI 10.1016/S0735-1097(99)00339-3; BROOKS GA, 1978, J APPL PHYSIOL, V45, P1009, DOI 10.1152/jappl.1978.45.6.1009; Burniston JG, 2005, EXP PHYSIOL, V90, P755, DOI 10.1113/expphysiol.2005.030908; Dalla Libera L, 2001, CIRCULATION, V103, P2195; Franco FGD, 2006, EUR J HEART FAIL, V8, P851, DOI 10.1016/j.ejheart.2006.02.009; Dimitrijevic I, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-40; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Fernandes T, 2010, BRAZ J MED BIOL RES, V43, P837, DOI 10.1590/S0100-879X2010000900005; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferreira JCB, 2008, AM J PHYSIOL-REG I, V294, pR26, DOI 10.1152/ajpregu.00424.2007; Filho AG, 2008, EXP PHYSIOL, V93, P589, DOI 10.1113/expphysiol.2007.014293; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Johnston APW, 2011, J RENIN-ANGIO-ALDO S, V12, P75, DOI 10.1177/1470320310381795; Kar S, 2010, J APPL PHYSIOL, V108, P923, DOI 10.1152/japplphysiol.00840.2009; Kato M, 1996, J Card Fail, V2, P103, DOI 10.1016/S1071-9164(96)80028-5; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Liu JL, 2000, CIRCULATION, V102, P1854; Malendowicz SL, 2000, CIRCULATION, V102, P2210; Mariappan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046568; Mousa TM, 2008, J APPL PHYSIOL, V104, P616, DOI 10.1152/japplphysiol.00601.2007; Munoz MC, 2012, REGUL PEPTIDES, V177, P1, DOI 10.1016/j.regpep.2012.04.001; Negrao CE, 2008, HEART FAIL REV, V13, P51, DOI 10.1007/s10741-007-9057-7; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; OSTERZIEL KJ, 1995, BRIT HEART J, V73, P517; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; Prasannarong M, 2012, BIOCHEM BIOPH RES CO, V426, P369, DOI 10.1016/j.bbrc.2012.08.093; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Rondon E, 2006, AM J PHYSIOL-HEART C, V291, pH2801, DOI 10.1152/ajpheart.01352.2005; Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3; Russell ST, 2007, CELL SIGNAL, V19, P1797, DOI 10.1016/j.cellsig.2007.04.003; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; SCHUNKERT H, 1992, J CLIN INVEST, V90, P1523, DOI 10.1172/JCI116020; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; SIGURDSSON A, 1993, AM HEART J, V126, P1068, DOI 10.1016/0002-8703(93)90656-T; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Uehara Y, 2013, CURR PHARM DESIGN, V19, P3054; vanKats JP, 1997, HYPERTENSION, V30, P42, DOI 10.1161/01.HYP.30.1.42; Vescovo G, 2000, HEART, V84, P431, DOI 10.1136/heart.84.4.431; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; WARD PE, 1995, PEPTIDES, V16, P1073, DOI 10.1016/0196-9781(95)00082-U; Xu XH, 2008, CARDIOVASC RES, V78, P523, DOI 10.1093/cvr/cvn028; Zhang GX, 2007, J MOL CELL CARDIOL, V42, P804, DOI 10.1016/j.yjmcc.2007.01.012	51	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98012	10.1371/journal.pone.0098012	http://dx.doi.org/10.1371/journal.pone.0098012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859374	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400034
J	Latus, J; Tenner-Racz, K; Racz, P; Kitterer, D; Cadar, D; Ott, G; Alscher, MD; Schmidt-Chanasit, J; Braun, N				Latus, Joerg; Tenner-Racz, Klara; Racz, Paul; Kitterer, Daniel; Cadar, Daniel; Ott, German; Alscher, M. Dominik; Schmidt-Chanasit, Jonas; Braun, Niko			Detection of Puumala Hantavirus Antigen in Human Intestine during Acute Hantavirus Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; NEPHROPATHIA-EPIDEMICA; VIRUS-INFECTION; GERMANY; DIAGNOSIS; OUTBREAKS; KIDNEYS; MODELS	Background: Puumala virus (PUUV) is the most important hantavirus species in Central Europe. Nephropathia epidemica (NE), caused by PUUV, is characterized by acute renal injury (AKI) with thrombocytopenia and frequently gastrointestinal symptoms. Methods: 456 patients with serologically and clinically confirmed NE were investigated at time of follow-up in a single clinic. The course of the NE was investigated using medical reports. We identified patients who had endoscopy with intestinal biopsy during acute phase of NE. Histopathological, immunohistochemical and molecular analyses of the biopsies were performed. Results: Thirteen patients underwent colonoscopy or gastroscopy for abdominal pain, diarrhea, nausea and vomiting during acute phase of NE. Immunohistochemistry (IHC) revealed PUUV nucleocapsid antigen in 11 biopsies from 8 patients; 14 biopsies from 5 patients were negative for PUUV nucleocapsid antigen. IHC localized PUUV nucleocapsid antigen in endothelial cells of capillaries or larger vessels in the lamina propria. Rate of AKI was not higher and severity of AKI was not different in the PUUV-positive compared to the PUUV-negative group. All IHC positive biopsies were positive for PUUV RNA using RT-PCR. Phylogenetic reconstruction revealed clustering of all PUUV strains from this study with viruses previously detected from the South-West of Germany. Long-term outcome was favorable in both groups. Conclusions: In patients with NE, PUUV nucleocapsid antigen and PUUV RNA was detected frequently in the intestine. This finding could explain frequent GI-symptoms in NE patients, thus demonstration of a more generalized PUUV infection. The RT-PCR was an effective and sensitive method to detect PUUV RNA in FFPE tissues. Therefore, it can be used as a diagnostic and phylogenetic approach also for archival materials. AKI was not more often present in patients with PUUV-positive IHC. This last finding should be investigated in larger numbers of patients with PUUV infection.	[Latus, Joerg; Kitterer, Daniel; Alscher, M. Dominik; Braun, Niko] Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany; [Tenner-Racz, Klara; Racz, Paul; Cadar, Daniel; Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemmorrhag Fev, Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Div Pathol, Dept Diagnost Med, Stuttgart, Germany; [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Hamburg, Germany	Bosch; Robert Bosch Krankenhaus; Bernhard Nocht Institut fur Tropenmedizin; Bosch; Robert Bosch Krankenhaus; German Center for Infection Research	Kitterer, D (corresponding author), Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Auerbachstr 110, Stuttgart, Germany.	Daniel.Kitterer@rbk.de	Daniel, Cadar/AAN-2658-2021	Cadar, Daniel/0000-0002-8063-2766				Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Braun N, 2010, NEPHROL DIAL TRANSPL, V25, P2997, DOI 10.1093/ndt/gfq118; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Clement J, 2010, NEPHROL DIAL TRANSPL, V25, P1740, DOI 10.1093/ndt/gfq122; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Essbauer SS, 2007, EMERG INFECT DIS, V13, P1271, DOI 10.3201/eid1308.061425; Ettinger J, 2012, EMERG INFECT DIS, V18, P1461, DOI 10.3201/eid1809.111447; Groen J, 1996, CLIN NEPHROL, V46, P379; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hautala T, 2002, CLIN INFECT DIS, V35, P96, DOI 10.1086/340859; Heyman P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00237; Hofmann J, 2008, EMERG INFECT DIS, V14, P850, DOI 10.3201/eid1405.071533; HUNG T, 1992, ARCH VIROL, V122, P187, DOI 10.1007/BF01321127; KIM SG, 1993, AM J CLIN PATHOL, V100, P398, DOI 10.1093/ajcp/100.4.398; Klempa B, 2004, J CLIN MICROBIOL, V42, P1322, DOI 10.1128/JCM.42.3.1322-1325.2004; Klempa B, 2003, J CLIN MICROBIOL, V41, P4894, DOI 10.1128/JCM.41.10.4894-4897.2003; Krautkramer E, 2013, KIDNEY INT, V83, P23, DOI 10.1038/ki.2012.360; Krautkramer E, 2011, J VIROL, V85, P9811, DOI 10.1128/JVI.00568-11; Kruger DH, 2013, DTSCH ARZTEBL INT, V110, P461, DOI 10.3238/arztebl.2013.0461; Kruger DH, 2011, HUM VACCINES, V7, P685, DOI 10.4161/hv.7.6.15197; Latus J, 2012, J CLIN VIROL, V53, P156, DOI 10.1016/j.jcv.2011.11.003; LEE HW, 1989, PROG MED VIROL, V36, P62; Maes P, 2004, VIRAL IMMUNOL, V17, P481, DOI 10.1089/vim.2004.17.481; Mertens M, 2009, MED MICROBIOL IMMUN, V198, P83, DOI 10.1007/s00430-009-0106-9; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; Muranyi W, 2005, J AM SOC NEPHROL, V16, P3669, DOI 10.1681/ASN.2005050561; MUSTONEN J, 1994, CLIN NEPHROL, V41, P121; NUUTINEN H, 1992, GASTROINTEST ENDOSC, V38, P476, DOI 10.1016/S0016-5107(92)70480-5; Peters CJ, 1999, ANNU REV MED, V50, P531, DOI 10.1146/annurev.med.50.1.531; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; SCHMALJOHN CS, 1983, VIROLOGY, V131, P482, DOI 10.1016/0042-6822(83)90514-7; SCHWAB SJ, 1987, ARCH INTERN MED, V147, P943, DOI 10.1001/archinte.147.5.943; Sironen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003035; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; Ulrich RG, 2013, BERL MUNCH TIERARZTL, V126, P514, DOI 10.2376/0005-9366-126-514; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Zeier M, 1996, INTERNIST, V37, P1092; ZOLLER LG, 1993, J CLIN MICROBIOL, V31, P1194	39	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98397	10.1371/journal.pone.0098397	http://dx.doi.org/10.1371/journal.pone.0098397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24857988	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400075
J	Kim, S; Hwang, J; Xuan, J; Jung, YH; Cha, HS; Kim, KH				Kim, Sooah; Hwang, Jiwon; Xuan, Jinhua; Jung, Young Hoon; Cha, Hoon-Suk; Kim, Kyoung Heon			Global Metabolite Profiling of Synovial Fluid for the Specific Diagnosis of Rheumatoid Arthritis from Other Inflammatory Arthritis	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; ANTI-GAMMA-GLOBULIN; TRANSCRIPTOME ANALYSIS; METABOLOMICS; ANTIBODIES; DISEASE; TESTS; CELLS	Currently, reliable biomarkers that can be used to distinguish rheumatoid arthritis (RA) from other inflammatory diseases are unavailable. To find possible distinctive metabolic patterns and biomarker candidates for RA, we performed global metabolite profiling of synovial fluid samples. Synovial fluid samples from 38 patients with RA, ankylosing spondylitis, Behcet's disease, and gout were analyzed by gas chromatography/time-of-flight mass spectrometry (GC/TOF MS). Orthogonal partial least-squares discriminant and hierarchical clustering analyses were performed for the discrimination of RA and non-RA groups. Variable importance for projection values were determined, and the Wilcoxon-Mann-Whitney test and the breakdown and one-way analysis of variance were conducted to identify potential biomarkers for RA. A total of 105 metabolites were identified from synovial fluid samples. The score plot of orthogonal partial least squares discriminant analysis showed significant discrimination between the RA and non-RA groups. The 20 metabolites, including citrulline, succinate, glutamine, octadecanol, isopalmitic acid, and glycerol, were identified as potential biomarkers for RA. These metabolites were found to be associated with the urea and TCA cycles as well as fatty acid and amino acid metabolism. The metabolomic analysis results demonstrated that global metabolite profiling by GC/TOF MS might be a useful tool for the effective diagnosis and further understanding of RA.	[Kim, Sooah; Xuan, Jinhua; Jung, Young Hoon; Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea; [Hwang, Jiwon; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Cha, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.	hoonsuk.cha@samsung.com; khekim@korea.ac.kr	Kim, Kyoung Heon/F-1059-2013; Jung, Young Hoon/F-1703-2013	Kim, Kyoung Heon/0000-0003-4600-8668; Jung, Young Hoon/0000-0002-0781-3608	Advanced Biomass R&D Center of Korea - Korean Government [2011-0031353]; National Foundation of Research - Korean Government [2013059103]	Advanced Biomass R&D Center of Korea - Korean Government; National Foundation of Research - Korean Government	This work was supported by the Advanced Biomass R&D Center of Korea (2011-0031353) and the National Foundation of Research (2013059103), both funded by the Korean Government. Experiments were performed by using the facilities of the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas S, 2002, RHEUMATOLOGY, V41, P809, DOI 10.1093/rheumatology/41.7.809; BELL JD, 1991, MAGN RESON MED, V17, P414, DOI 10.1002/mrm.1910170213; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; BORENSTEIN DG, 1982, ARTHRITIS RHEUM, V25, P947, DOI 10.1002/art.1780250806; CAMMARATA RJ, 1967, J AMER MED ASSOC, V199, P455, DOI 10.1001/jama.199.7.455; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Huang ZZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007922; Hugle T, 2012, CLIN EXP RHEUMATOL, V30, P240; Humphreys JH, 2013, CURR OPIN RHEUMATOL, V25, P157, DOI 10.1097/BOR.0b013e32835cfc41; Hutschenreuther A, 2012, ANAL METHODS-UK, V4, P1953, DOI 10.1039/c2ay25046b; JETTEN MSM, 1994, APPL MICROBIOL BIOT, V41, P47, DOI 10.1007/s002530050105; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; KREMER JM, 1990, ARTHRITIS RHEUM, V33, P810, DOI 10.1002/art.1780330607; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lauridsen MB, 2010, J PROTEOME RES, V9, P4545, DOI 10.1021/pr1002774; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; LITWIN SD, 1965, ARTHRITIS RHEUM, V8, P538, DOI 10.1002/art.1780080408; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tanino M, 2009, BIOCHEM BIOPH RES CO, V387, P261, DOI 10.1016/j.bbrc.2009.06.149; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Umetrics A. B., 2005, USERS GUIDE SIMCA P; Villas-Boas SG., 2007, METABOLOME ANAL INTR, DOI [10.1002/0470105518, DOI 10.1002/0470105518]; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Xie GX, 2012, METABOLOMICS, V8, P220, DOI 10.1007/s11306-011-0302-7; Zhai G, 2010, ANN RHEUM DIS, V69, P1227, DOI 10.1136/ard.2009.120857; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181	39	95	104	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97501	10.1371/journal.pone.0097501	http://dx.doi.org/10.1371/journal.pone.0097501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887281	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300020
J	Kodama, N; Kimura, T; Yonemura, S; Kaneda, S; Ohashi, M; Ikeno, H				Kodama, Naomi; Kimura, Toshifumi; Yonemura, Seiichiro; Kaneda, Satoshi; Ohashi, Mizue; Ikeno, Hidetoshi			Automated Analysis of Two-Dimensional Positions and Body Lengths of Earthworms (Oligochaeta); MimizuTrack	PLOS ONE			English	Article							REPRODUCTION; INDIVIDUALS; TRACKING; ECOLOGY; GROWTH	Earthworms are important soil macrofauna inhabiting almost all ecosystems. Their biomass is large and their burrowing and ingestion of soils alters soil physicochemical properties. Because of their large biomass, earthworms are regarded as an indicator of "soil heath''. However, primarily because the difficulties in quantifying their behavior, the extent of their impact on soil material flow dynamics and soil health is poorly understood. Image data, with the aid of image processing tools, are a powerful tool in quantifying the movements of objects. Image data sets are often very large and time-consuming to analyze, especially when continuously recorded and manually processed. We aimed to develop a system to quantify earthworm movement from video recordings. Our newly developed program successfully tracked the two-dimensional positions of three separate parts of the earthworm and simultaneously output the change in its body length. From the output data, we calculated the velocity of the earthworm's movement. Our program processed the image data three times faster than the manual tracking system. To date, there are no existing systems to quantify earthworm activity from continuously recorded image data. The system developed in this study will reduce input time by a factor of three compared with manual data entry and will reduce errors involved in quantifying large data sets. Furthermore, it will provide more reliable measured values, although the program is still a prototype that needs further testing and improvement. Combined with other techniques, such as measuring metabolic gas emissions from earthworm bodies, this program could provide continuous observations of earthworm behavior in response to environmental variables under laboratory conditions. In the future, this standardized method will be applied to other animals, and the quantified earthworm movement will be incorporated into models of soil material flow dynamics or behavior in response to chemical substances present in the soil.	[Kodama, Naomi; Yonemura, Seiichiro; Kaneda, Satoshi] Natl Inst Agroenvironm Sci NIAES, Tsukuba, Ibaraki, Japan; [Kimura, Toshifumi; Ohashi, Mizue; Ikeno, Hidetoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan	University of Hyogo	Kodama, N (corresponding author), Natl Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki, Japan.	naomi.kodama@googlemail.com	Ikeno, Hidetoshi/O-3034-2018	Ikeno, Hidetoshi/0000-0002-5134-5485	Sumitomo Foundation [123225]	Sumitomo Foundation	This work was supported by Grant for Environmental Research Projects from the Sumitomo Foundation (Contract nr.:123225.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Bartlett MD, 2010, EUR J SOIL BIOL, V46, P67, DOI 10.1016/j.ejsobi.2009.11.006; Blakemore R. J., 2006, ASSESSMENT CONTROL B, P173; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; D'Souza D., 2010, APPL ENVIRON SOIL SC, V2010, P1, DOI [DOI 10.1155/2010/678360, 10.1155/2010/678360]; Darwin C., 1892, FORMATION VEGETABLE; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Feldman A, 2003, AUTOMATIC IDENTIFICA, P53; Helling B, 2000, ECOTOX ENVIRON SAFE, V46, P108, DOI 10.1006/eesa.1999.1880; Hilditch C.J., 1969, MACH INTELL, P403; Ishizuka K, 2001, B SEIKEI U, V33, P1; JOSCHKO M, 1993, GEODERMA, V56, P209, DOI 10.1016/0016-7061(93)90111-W; KIMURA T, 2012, TRACKING MULTIPLE HO, P36; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084656; Kimura T, 2011, APIDOLOGIE, V42, P607, DOI 10.1007/s13592-011-0060-6; Lavelle P., 2001, SOIL ECOLOGY; LIGTHART TN, 1993, GEODERMA, V57, P129, DOI 10.1016/0016-7061(93)90151-A; Lubbers IM, 2013, NAT CLIM CHANGE, V3, P187, DOI [10.1038/NCLIMATE1692, 10.1038/nclimate1692]; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Michaelsen W, 1891, OLIGOCHAETEN NATURHI; Nakano A, 2012, J PLANT NUTR SOIL SC, V175, P775, DOI 10.1002/jpln.201100316; NEUHAUSER EF, 1990, SOIL BIOL BIOCHEM, V22, P175, DOI 10.1016/0038-0717(90)90083-C; Rizvandi NB, 2008, SKELETON ANAL POPULA; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Uchida T, 2004, APPL SOIL ECOL, V27, P153, DOI 10.1016/j.apsoil.2004.04.003; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Yamaguchi E, 1965, ILLUSTRATED ENCY FAU, V1, P547	29	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97986	10.1371/journal.pone.0097986	http://dx.doi.org/10.1371/journal.pone.0097986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886977	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300032
J	Lourenco, JD; Neves, LP; Olivo, CR; Duran, A; Almeida, FM; Arantes, PMM; Prado, CM; Leick, EA; Tanaka, AS; Martins, MA; Sasaki, SD; Lopes, FDTQS				Lourenco, Juliana D.; Neves, Luana P.; Olivo, Clarice R.; Duran, Adriana; Almeida, Francine M.; Arantes, Petra M. M.; Prado, Carla M.; Leick, Edna Aparecida; Tanaka, Aparecida S.; Martins, Milton A.; Sasaki, Sergio D.; Lopes, Fernanda D. T. Q. S.			A Treatment with a Protease Inhibitor Recombinant from the Cattle Tick (Rhipicephalus Boophilus microplus) Ameliorates Emphysema in Mice	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; ELASTASE INHIBITOR; LUNG; EXPRESSION; MECHANICS; PRESSURE; MODEL	Aims: To determine whether a serine protease inhibitor treatment can prevent or minimize emphysema in mice. Methods: C57BL/6 mice were subjected to porcine pancreatic elastase (PPE) nasal instillation to induce emphysema and were treated with a serine protease inhibitor (rBmTI-A) before (Protocol 1) and after (Protocol 2) emphysema development. In both protocols, we evaluated lung function to evaluate the airway resistance (Raw), tissue damping (Gtis) and tissue elastance (Htis). The inflammatory profile was analyzed in the bronchoalveolar lavage (BALF) and through the use of morphometry; we measured the mean linear intercept (Lm) (to verify alveolar enlargement), the volume proportion of collagen and elastic fibers, and the numbers of macrophages and metalloprotease 12 (MMP-12) positive cells in the parenchyma. We showed that at both time points, even after the emphysema was established, the rBmTI-A treatment was sufficient to reverse the loss of elastic recoil measured by Htis, the alveolar enlargement and the increase in the total number of cells in the BALF, with a primary decrease in the number of macrophages. Although, the treatment did not control the increase in macrophages in the lung parenchyma, it was sufficient to decrease the number of positive cells for MMP-12 and reduce the volume of collagen fibers, which was increased in PPE groups. These findings attest to the importance of MMP-12 in PPE-induced emphysema and suggest that this metalloprotease could be an effective therapeutic target.	[Lourenco, Juliana D.; Olivo, Clarice R.; Almeida, Francine M.; Arantes, Petra M. M.; Leick, Edna Aparecida; Martins, Milton A.; Lopes, Fernanda D. T. Q. S.] Univ Sao Paulo, Dept Med, Sao Paulo, Brazil; [Prado, Carla M.] Univ Fed Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil; [Tanaka, Aparecida S.] UNIFESP EPM, Dept Bioquim, Sao Paulo, Brazil; [Neves, Luana P.; Duran, Adriana; Sasaki, Sergio D.] UFABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Lopes, FDTQS (corresponding author), Univ Sao Paulo, Dept Med, Sao Paulo, Brazil.	fernandadtqsl@gmail.com	Lourenço, Juliana D./C-5326-2013; Martins, Milton A/L-7541-2017; Prado, Carla M/G-3327-2012; Sasaki, Sergio Daishi/AAR-2928-2021; Tanaka, Aparecida/ADF-5338-2022; Tanaka, Aparecida S/L-8754-2017; de Almeida, Francine Maria/S-2314-2019; Almeida, Francine Maria/H-3733-2013; Martins, Milton A/D-6658-2012; Leick, Edna/C-6432-2012; Olivo, Clarice Rosa/K-2236-2012	Lourenço, Juliana D./0000-0002-9291-5237; Prado, Carla M/0000-0003-1160-0442; Sasaki, Sergio Daishi/0000-0002-6233-3316; Tanaka, Aparecida S/0000-0001-9407-805X; de Almeida, Francine Maria/0000-0001-9755-5034; Almeida, Francine Maria/0000-0001-9755-5034; DTQS Lopes, Fernanda/0000-0002-6402-3055	Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da USP (LIM/HC); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)	Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da USP (LIM/HC); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da USP (LIM/HC) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2000, J STRUCTURAL BIOL S2, P189; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BATES JHT, 1989, J APPL PHYSIOL, V67, P488, DOI 10.1152/jappl.1989.67.1.488; Boyle JR, 1998, J VASC SURG, V27, P354, DOI 10.1016/S0741-5214(98)70367-2; Faria AC, 2010, CLINICS, P443; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Global Initiative for Chronic Obstructive Lung Disease, 2013, GLOBAL STRATEGY DIAG; Gomes RFM, 2000, J APPL PHYSIOL, V89, P908, DOI 10.1152/jappl.2000.89.3.908; GROSS P, 1965, ARCH ENVIRON HEALTH, V11, P50, DOI 10.1080/00039896.1965.10664169; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Keatings VM, 1997, THORAX, V52, P372, DOI 10.1136/thx.52.4.372; Kuraki T, 2002, AM J RESP CRIT CARE, V166, P496, DOI 10.1164/rccm.2103118; Lopes FDTQS, 2013, HISTOL HISTOPATHOL, V28, P269, DOI 10.14670/HH-28.269; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; MARTIN TR, 1985, AM REV RESPIR DIS, V132, P254; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Robbesom AA, 2008, MODERN PATHOL, V21, P297, DOI 10.1038/modpathol.3801004; Sasaki SD, 2008, VET PARASITOL, V155, P133, DOI 10.1016/j.vetpar.2008.03.031; Senior RM, 1998, AM J RESP CRIT CARE, V157, pS139, DOI 10.1164/ajrccm.157.4.nhlbi-12; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Stockley RA, 1998, CLIN PULM MED, V5, P203; Takayama M, 2001, J APPL PHYSIOL, V91, P1800, DOI 10.1152/jappl.2001.91.4.1800; Tanaka AS, 1999, IMMUNOPHARMACOLOGY, V45, P171, DOI 10.1016/S0162-3109(99)00074-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Willadsen P, 1999, PARASITOL TODAY, V15, P258, DOI 10.1016/S0169-4758(99)01472-6; Wright JL, 2002, AM J RESP CRIT CARE, V166, P954, DOI 10.1164/rccm.200202-098OC; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73	35	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98216	10.1371/journal.pone.0098216	http://dx.doi.org/10.1371/journal.pone.0098216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886716	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300048
J	Pires, R; Jelinek, HF; Wainer, J; Valle, E; Rocha, A				Pires, Ramon; Jelinek, Herbert F.; Wainer, Jacques; Valle, Eduardo; Rocha, Anderson			Advancing Bag-of-Visual-Words Representations for Lesion Classification in Retinal Images	PLOS ONE			English	Article							COLOR FUNDUS PHOTOGRAPHS; DIABETIC-RETINOPATHY; MICROANEURYSM DETECTION; AUTOMATED DETECTION; IDENTIFICATION; DIAGNOSIS; SYSTEM	Diabetic Retinopathy (DR) is a complication of diabetes that can lead to blindness if not readily discovered. Automated screening algorithms have the potential to improve identification of patients who need further medical attention. However, the identification of lesions must be accurate to be useful for clinical application. The bag-of-visual-words (BoVW) algorithm employs a maximum-margin classifier in a flexible framework that is able to detect the most common DR-related lesions such as microaneurysms, cotton-wool spots and hard exudates. BoVW allows to bypass the need for pre- and post-processing of the retinographic images, as well as the need of specific ad hoc techniques for identification of each type of lesion. An extensive evaluation of the BoVW model, using three large retinograph datasets (DR1, DR2 and Messidor) with different resolution and collected by different healthcare personnel, was performed. The results demonstrate that the BoVW classification approach can identify different lesions within an image without having to utilize different algorithms for each lesion reducing processing time and providing a more flexible diagnostic system. Our BoVW scheme is based on sparse low-level feature detection with a Speeded-Up Robust Features (SURF) local descriptor, and mid-level features based on semi-soft coding with max pooling. The best BoVW representation for retinal image classification was an area under the receiver operating characteristic curve (AUC-ROC) of 97.8% (exudates) and 93.5% (red lesions), applying a cross-dataset validation protocol. To assess the accuracy for detecting cases that require referral within one year, the sparse extraction technique associated with semi-soft coding and max pooling obtained an AUC of 94.2 +/- 2.0%, outperforming current methods. Those results indicate that, for retinal image classification tasks in clinical practice, BoVW is equal and, in some instances, surpasses results obtained using dense detection (widely believed to be the best choice in many vision problems) for the low-level descriptors.	[Pires, Ramon; Wainer, Jacques; Rocha, Anderson] Univ Campinas Unicamp, Inst Comp, Sao Paulo, Brazil; [Jelinek, Herbert F.] Khalifa Univ, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Jelinek, Herbert F.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia; [Valle, Eduardo] Univ Campinas UNICAMP, Sch Elect & Comp Engn, Sao Paulo, Brazil	Universidade Estadual de Campinas; Khalifa University of Science & Technology; Macquarie University; Universidade Estadual de Campinas	Pires, R (corresponding author), Univ Campinas Unicamp, Inst Comp, Sao Paulo, Brazil.	pires.ramon@ic.unicamp.br	Jelinek, Herbert F/S-6779-2019; Wainer, Jacques/B-4241-2012; Wainer, Jacques/AAQ-6029-2021; Jelinek, Herbert/AAQ-6825-2020	Jelinek, Herbert F/0000-0001-5457-6193; Wainer, Jacques/0000-0001-5201-1244; Wainer, Jacques/0000-0001-5201-1244; Pires, Ramon/0000-0002-0023-1971; Alves do Valle Jr, Eduardo/0000-0001-5396-9868	Sao Paulo Research Foundation FAPESP [2010/05647-4, 2011/15349-3]; National Counsel of Technological and Scientific Development (CNPq) [307018/2010-5, 304352/2012-8]; Microsoft Research; Samsung Eletronica da Amazonia	Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Microsoft Research(Microsoft); Samsung Eletronica da Amazonia(Samsung)	This work was supported in part by Sao Paulo Research Foundation FAPESP (http://www.fapesp.br) under Grant 2010/05647-4 and Grant 2011/15349-3, National Counsel of Technological and Scientific Development (CNPq) (http://www.cnpq.br) under Grant 307018/2010-5 and Grant 304352/2012-8, Microsoft Research (http://research.microsoft.com) and Samsung Eletronica da Amazonia (http://www.samsung.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2013, JAMA OPHTHALMOL, V131, P351, DOI 10.1001/jamaophthalmol.2013.1743; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Acharya UR, 2009, P I MECH ENG H, V223, P545, DOI 10.1243/09544119JEIM486; Ahmed J, 2006, DIABETES CARE, V29, P2205, DOI 10.2337/dc06-0295; [Anonymous], 1991, Ophthalmology, V98, P786; Antal B, 2012, IEEE T BIO-MED ENG, V59, P1720, DOI 10.1109/TBME.2012.2193126; Avila S, 2013, COMPUT VIS IMAGE UND, V117, P453, DOI 10.1016/j.cviu.2012.09.007; Baeza-Yates R, 1999, MODERN INFORM RETRIE, V1; Barriga ES, 2010, I S BIOMED IMAGING, P1349, DOI 10.1109/ISBI.2010.5490247; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Boureau Y. L., 2010, IEEE INT C COMP VIS; Boureau Y-L., 2010, P 27 INT C MACH LEAR, P111, DOI DOI 10.5555/3104322.3104338; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chew EY, 2003, OPHTHALMOLOGY, V110, P1675, DOI 10.1016/S0161-6420(03)00815-7; Cornforth D., 2005, P WDIC2005 ARPS WORK, P163; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Decenciere E, 2013, TELEOPHTA MACHINE LE; Deepak KS, 2012, IEEE T MED IMAGING, V31, P766, DOI 10.1109/TMI.2011.2178856; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Fleming AD, 2007, PHYS MED BIOL, V52, P7385, DOI 10.1088/0031-9155/52/24/012; Fleming AD, 2006, IEEE T MED IMAGING, V25, P1223, DOI 10.1109/TMI.2006.879953; Fleming AD, 2010, BRIT J OPHTHALMOL, V94, P706, DOI 10.1136/bjo.2008.149807; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Giancardo L, 2011, IEEE ENG MED BIO, P5939, DOI 10.1109/IEMBS.2011.6091562; Giancardo L, 2010, SPIE MED IMAGING; Giancardo L, 2012, MED IMAGE ANAL, V16, P216, DOI 10.1016/j.media.2011.07.004; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Jelinek HF, 2009, IFMBE PROC, V25, P127, DOI 10.1007/978-3-642-03891-4_34; Jelinek H.F., 2012, P 25 IEEE INT S COMP, P1, DOI [10.1109/CBMS.2012.6266342, DOI 10.1109/CBMS.2012.6266342]; Jelinek HF, 2011, IEEE ENG MED BIO, P5951, DOI 10.1109/IEMBS.2011.6091471; Jelinek HJ, 2006, CLIN EXP OPTOM, V89, P299, DOI 10.1111/j.1444-0938.2006.00071.x; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P237, DOI 10.1001/archopht.1989.01070010243030; Lazar I, 2013, IEEE T MED IMAGING, V32, P400, DOI 10.1109/TMI.2012.2228665; Li YQ, 2011, TELEMED E-HEALTH, V17, P627, DOI 10.1089/tmj.2011.0004; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mitchell P., 2008, GUIDELINES MANAGEMEN; Nayak J, 2008, J MED SYST, V32, P107, DOI 10.1007/s10916-007-9113-9; Nemenyi P., 1963, DISTRIBUTION FREE MU; Niemeijer M, 2007, INVEST OPHTH VIS SCI, V48, P2260, DOI 10.1167/iovs.06-0996; Perronnin F., 2012, P IEEE C COMP VIS PA, P1, DOI [DOI 10.1109/CVPR, 10.1109/CVPR]; Phillips PJ, 2012, MED TODAY, V5, P83; Pires R, 2012, INT C GRAPH PATT IM; Pires R, 2013, IEEE T BIO-MED ENG, V60, P3391, DOI 10.1109/TBME.2013.2278845; Precioso F, 2012, SPRINGERBRIEFS COMPU, P21; Rocha A, 2012, IEEE T BIO-MED ENG, V59, P2244, DOI 10.1109/TBME.2012.2201717; Sanchez CI, 2009, SPIE MED IMAGING; Sanchez CI, 2009, MED IMAGE ANAL, V13, P650, DOI 10.1016/j.media.2009.05.005; Sinthanayothin C, 2002, DIABETIC MED, V19, P105, DOI 10.1046/j.1464-5491.2002.00613.x; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sopharak A, 2008, COMPUTERIZED MED IMA, V32, P8; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Welfer D, 2010, COMPUT MED IMAG GRAP, V34, P228, DOI 10.1016/j.compmedimag.2009.10.001; World Health Organization, 2013, DIAB PROGR; Yun WL, 2008, INFORM SCIENCES, V178, P106, DOI 10.1016/j.ins.2007.07.020; Zhang B, 2009, SPIE MED IMAGING	57	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e96814	10.1371/journal.pone.0096814	http://dx.doi.org/10.1371/journal.pone.0096814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886780	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300009
J	Ravona-Springer, R; Heymann, A; Schmeidler, J; Moshier, E; Godbold, J; Sano, M; Leroith, D; Johnson, S; Preiss, R; Koifman, K; Hoffman, H; Silverman, JM; Beeri, MS				Ravona-Springer, Ramit; Heymann, Anthony; Schmeidler, James; Moshier, Erin; Godbold, James; Sano, Mary; Leroith, Derek; Johnson, Sterling; Preiss, Rachel; Koifman, Keren; Hoffman, Hadas; Silverman, Jeremy M.; Beeri, Michal Schnaider			Trajectories in Glycemic Control over Time Are Associated with Cognitive Performance in Elderly Subjects with Type 2 Diabetes	PLOS ONE			English	Article							ALZHEIMER-DISEASE; BLOOD-PRESSURE; OLDER-ADULTS; DEMENTIA; RISK; DEPRESSION; SCALE; HYPOGLYCEMIA; MORTALITY; MELLITUS	Objective: To study the relationships of long-term trajectories of glycemic control with cognitive performance in cognitively normal elderly with type 2 diabetes (T2D). Methods: Subjects (n = 835) pertain to a diabetes registry (DR) established in 1998 with an average of 18 HbA1c measurements per subject, permitting identification of distinctive trajectory groups of HbA1c and examining their association with cognitive function in five domains: episodic memory, semantic categorization, attention/working memory, executive function, and overall cognition. Analyses of covariance compared cognitive function among the trajectory groups adjusting for sociodemographic, cardiovascular, diabetes-related covariates and depression. Results: Subjects averaged 72.8 years of age. Six trajectories of HbA1c were identified, characterized by HbA1c level at entry into the DR (Higher/Lower), and trend over time (Stable/Decreasing/Increasing). Both groups with a trajectory of decreasing HbA1c levels had high HbA1c levels at entry into the DR (9.2%, 10.7%), and high, though decreasing, HbA1c levels over time. They had the worst cognitive performance, particularly in overall cognition (p < 0.02) and semantic categorization (p < 0.01), followed by that of subjects whose HbA1c at entry into the DR was relatively high (7.2%, 7.8%) and increased over time. Subjects with stable HbA1c over time had the lowest HbA1c levels at entry (6.0%, 6.8%) and performed best in cognitive tests. Conclusion: Glycemic control trajectories, which better reflect chronicity of T2D than a single HbA1c measurement, predict cognitive performance. A trajectory of stable HbA1c levels over time is associated with better cognitive function.	[Ravona-Springer, Ramit; Koifman, Keren] Sheba Med Ctr, Memory Clin, Ramat Gan, Israel; [Heymann, Anthony] Tel Aviv Univ, Dept Family Med, IL-69978 Tel Aviv, Israel; [Schmeidler, James; Sano, Mary; Silverman, Jeremy M.; Beeri, Michal Schnaider] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Moshier, Erin; Godbold, James] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY USA; [Leroith, Derek] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA; [Johnson, Sterling] Univ Wisconsin, Ctr Geriatr Res Educ & Clin, Madison VA Hosp, Madison, WI 53706 USA; [Johnson, Sterling] Univ Wisconsin, Alzheimers Dis Res Ctr, Dept Med, Madison, WI 53706 USA; [Preiss, Rachel; Hoffman, Hadas] Maccabi Hlth Serv, Tel Aviv, Israel; [Beeri, Michal Schnaider] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Chaim Sheba Medical Center	Ravona-Springer, R (corresponding author), Sheba Med Ctr, Memory Clin, Ramat Gan, Israel.	ramit.ravona@sheba.health.gov.il	Silverman, Jeremy M./AAO-4268-2020	heymann, anthony/0000-0003-2353-9933	American Federation for Aging Research (AFAR); Alzheimer's Association [NIRG-11-205083]; NIA grant [R01 AG034087]; VH [NIA-AG02219]; Helen Bader Foundation; Irma T. Hirschl Scholar Award; Leroy Schecter Foundation Award; National Institute of Aging from the United States Department of Veterans Affairs [P01-AG02219]	American Federation for Aging Research (AFAR); Alzheimer's Association(Alzheimer's Association); NIA grant; VH; Helen Bader Foundation; Irma T. Hirschl Scholar Award; Leroy Schecter Foundation Award; National Institute of Aging from the United States Department of Veterans Affairs	This study was supported by the American Federation for Aging Research (AFAR), Young investigator award 2011 and NIRG-11-205083 Alzheimer's Association, 2012 to RRS, NIA grant R01 AG034087 to MSB, NIA-AG02219 (VH), the Helen Bader Foundation and the Irma T. Hirschl Scholar Award as well as the Leroy Schecter Foundation Award to MSB. National Institute of Aging grant P01-AG02219, a Merit Award to JMS from the United States Department of Veterans Affairs; Berkman Charitable Trust. The funders have no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Ahren B, 2013, VASC HEALTH RISK MAN, V9, P155, DOI 10.2147/VHRM.S33934; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Beeri MS, 2004, NEUROLOGY, V63, P1902, DOI 10.1212/01.WNL.0000144278.79488.DD; Bellelli G, 2002, ARCH INTERN MED, V162, P483, DOI 10.1001/archinte.162.4.483; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Chen YC, 2010, ARCH GERONTOL GERIAT, V50, pS48, DOI 10.1016/S0167-4943(10)70013-3; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Conradsson M, 2013, AGING MENT HEALTH, V17, P638, DOI 10.1080/13607863.2012.758231; Cooray G, 2011, PSYCHONEUROENDOCRINO, V36, P77, DOI 10.1016/j.psyneuen.2010.06.009; Crane PK, 2013, NEW ENGL J MED, V369, P1863; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fillenbaum GG, 1996, AGING-CLIN EXP RES, V8, P379, DOI 10.1007/BF03339599; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gebregziabher M, 2010, AM J EPIDEMIOL, V171, P1090, DOI 10.1093/aje/kwq070; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Heymann AD, 2006, DIABETES RES CLIN PR, V71, P290, DOI 10.1016/j.diabres.2005.07.002; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jones BL, 2001, SOCIOL METHOD RES, V29; Kishore P, 2012, CURR DIABETES REP, V12, P255, DOI 10.1007/s11892-012-0268-5; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; Mokini Zhirajr, 2006, Pediatr Endocrinol Rev, V4, P138; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Rajala U, 2005, J HUM HYPERTENS, V19, P85, DOI 10.1038/sj.jhh.1001779; Ravona-Springer R, 2013, DIABETES CARE, V36, P3139, DOI 10.2337/dc12-2250; Ravona-Springer R, 2012, J ALZHEIMERS DIS, V30, P299, DOI 10.3233/JAD-2012-120106; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Spreen O., 1977, NEUROSENSORY CTR COM; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TURNER RC, 1995, DIABETES, V44, P1249; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhong Y, 2012, BIOMED ENVIRON SCI, V25, P1, DOI 10.3967/0895-3988.2012.01.001	47	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97384	10.1371/journal.pone.0097384	http://dx.doi.org/10.1371/journal.pone.0097384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887092	Green Published, gold			2022-12-27	WOS:000336956300016
J	Bhattarai, GP; Cronin, JT				Bhattarai, Ganesh P.; Cronin, James T.			Hurricane Activity and the Large-Scale Pattern of Spread of an Invasive Plant Species	PLOS ONE			English	Article							REED PHRAGMITES-AUSTRALIS; COMMON REED; CLIMATE-CHANGE; BIOLOGICAL INVASIONS; CHESAPEAKE BAY; TROPICAL CYCLONES; CRYPTIC INVASION; UNITED-STATES; NORTH-AMERICA; SALT MARSHES	Disturbances are a primary facilitator of the growth and spread of invasive species. However, the effects of large-scale disturbances, such as hurricanes and tropical storms, on the broad geographic patterns of invasive species growth and spread have not been investigated. We used historical aerial imagery to determine the growth rate of invasive Phragmites australis patches in wetlands along the Atlantic and Gulf Coasts of the United States. These were relatively undisturbed wetlands where P. australis had room for unrestricted growth. Over the past several decades, invasive P. australis stands expanded in size by 6-35% per year. Based on tropical storm and hurricane activity over that same time period, we found that the frequency of hurricane-force winds explained 81% of the variation in P. australis growth over this broad geographic range. The expansion of P. australis stands was strongly and positively correlated with hurricane frequency. In light of the many climatic models that predict an increase in the frequency and intensity of hurricanes over the next century, these results suggest a strong link between climate change and species invasion and a challenging future ahead for the management of invasive species.	[Bhattarai, Ganesh P.; Cronin, James T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bhattarai, GP (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	gbhatt2@tigers.lsu.edu	Cronin, James/V-2781-2019	Cronin, James/0000-0001-7111-6412; Bhattarai, Ganesh/0000-0003-1285-0531	National Science Foundation [DEB-1050084]; Louisiana Environmental Education Commission Grant; Louisiana State University-Biograds; Carrie Lynn Yoder Memorial Fellowships	National Science Foundation(National Science Foundation (NSF)); Louisiana Environmental Education Commission Grant; Louisiana State University-Biograds; Carrie Lynn Yoder Memorial Fellowships	Financial support provided by National Science Foundation Grant DEB-1050084 to JTC, and Louisiana Environmental Education Commission Grant, Louisiana State University-Biograds and Carrie Lynn Yoder Memorial Fellowships to GPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; Bart David, 2006, Wetlands Ecology and Management, V14, P53, DOI 10.1007/s11273-005-2566-z; Bellingham PJ, 2005, J VEG SCI, V16, P675; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; BLOOD ER, 1991, BIOTROPICA, V23, P348, DOI 10.2307/2388251; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; CHABRECK RH, 1973, ECOLOGY, V54, P1118, DOI 10.2307/1935578; Chambers RM, 2008, WETLANDS, V28, P1097, DOI 10.1672/07-61.1; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dibble KL, 2013, BIOL INVASIONS, V15, P1725, DOI 10.1007/s10530-012-0404-9; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2007, J CLIMATE, V20, P5497, DOI 10.1175/2007JCLI1571.1; Guo WY, 2013, GLOBAL CHANGE BIOL, V19, P3406, DOI 10.1111/gcb.12295; Hazelton ELG, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu001; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holdredge C, 2010, OIKOS, V119, P1776, DOI 10.1111/j.1600-0706.2010.18647.x; Holland GJ, 2010, MON WEATHER REV, V138, P4393, DOI 10.1175/2010MWR3317.1; Howard RJ, 2006, ENVIRON EXP BOT, V56, P301, DOI 10.1016/j.envexpbot.2005.03.003; Hsu SA, 1998, J COASTAL RES, V14, P667; Hsu SA., 2005, NATL WEATHER ASS ELE, V6, P1; Kettenring KM, 2011, J APPL ECOL, V48, P1305, DOI 10.1111/j.1365-2664.2011.02024.x; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lambert AM, 2007, ENVIRON ENTOMOL, V36, P451, DOI 10.1603/0046-225X(2007)36[451:SONANC]2.0.CO;2; Lambertini C, 2012, AM J BOT, V99, P538, DOI 10.3732/ajb.1100396; Lelong B, 2007, DIVERS DISTRIB, V13, P430, DOI 10.1111/j.1472-4642.2007.00351.x; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; Meyerson LA, 2010, INVAS PLANT SCI MANA, V3, P515, DOI 10.1614/IPSM-D-09-00052.1; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Minchinton TE, 2006, J ECOL, V94, P342, DOI 10.1111/j.1365-2745.2006.01099.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; NIERING W A, 1977, Connecticut Arboretum Bulletin, V22, P2; Paerl HW, 2001, P NATL ACAD SCI USA, V98, P5655, DOI 10.1073/pnas.101097398; Pielke RA, 2005, B AM METEOROL SOC, V86, P1571, DOI 10.1175/BAMS-86-11-1571; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P73; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Rice D, 2000, WETLANDS, V20, P280, DOI 10.1672/0277-5212(2000)020[0280:CAEOPA]2.0.CO;2; Rosso Pablo H., 2008, Proceedings of the SPIE - The International Society for Optical Engineering, V7110, DOI 10.1117/12.800269; Ruiz GM, 1997, AM ZOOL, V37, P621; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Shearer JF, 2012, TN121 USACE ERDC EL; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; Vasquez EA, 2005, MAR ECOL PROG SER, V298, P1, DOI 10.3354/meps298001; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Williams DA, 2012, J AQUAT PLANT MANAGE, V50, P69; Windham L, 2003, ECOL APPL, V13, P883, DOI 10.1890/02-5005	59	34	35	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98478	10.1371/journal.pone.0098478	http://dx.doi.org/10.1371/journal.pone.0098478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878928	gold, Green Published			2022-12-27	WOS:000338101500062
J	Cheng, XQ; Sherman, J; Murphy, W; Ratovitski, E; Canady, J; Keidar, M				Cheng, Xiaoqian; Sherman, Jonathan; Murphy, William; Ratovitski, Edward; Canady, Jerome; Keidar, Michael			The Effect of Tuning Cold Plasma Composition on Glioblastoma Cell Viability	PLOS ONE			English	Article							ATMOSPHERIC PLASMA; MELANOMA-CELLS; IN-VIVO; CANCER; PEROXYNITRITE; EXPRESSION; APOPTOSIS; THERAPY; NEEDLE; DEATH	Previous research in cold atmospheric plasma (CAP) and cancer cell interaction has repeatedly proven that the cold plasma induced cell death. It is postulated that the reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a major role in the CAP cancer therapy. In this paper, we seek to determine a mechanism of CAP therapy on glioblastoma cells (U87) through an understanding of the composition of the plasma, including treatment time, voltage, flow-rate and plasma-gas composition. In order to determine the threshold of plasma treatment on U87, normal human astrocytes (E6/E7) were used as the comparison cell line. Our data showed that the 30 sec plasma treatment caused 3-fold cell death in the U87 cells compared to the E6/E7 cells. All the other compositions of cold plasma were performed based on this result: plasma treatment time was maintained at 30 s per well while other plasma characteristics such as voltage, flow rate of source gas, and composition of source gas were changed one at a time to vary the intensity of the reactive species composition in the plasma jet, which may finally have various effect on cells reflected by cell viability. We defined a term "plasma dosage'' to summarize the relationship of all the characteristics and cell viability.	[Cheng, Xiaoqian; Ratovitski, Edward; Keidar, Michael] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA; [Sherman, Jonathan] George Washington Univ, Dept Neurosurg, Washington, DC USA; [Murphy, William] George Washington Univ, Dept Elect & Comp Engn, Washington, DC USA; [Ratovitski, Edward] Johns Hopkins Univ, Sch Med, Head & Neck Canc Res Div, Baltimore, MD USA; [Canady, Jerome] USMI, Inst Adv Biol & Tech Sci, Takoma Pk, MD USA	George Washington University; George Washington University; George Washington University; Johns Hopkins University	Keidar, M (corresponding author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.	keidar@gwu.edu		Cheng, Xiaoqian/0000-0002-2544-4260	Katzen Research Grant	Katzen Research Grant	Support was provided by a Katzen Research Grant (http://www.katzencancer.org/index.php/research/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Barekzi N, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/42/422002; Beckman J, 1996, AM J PHYSL SOC; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Chen W, 2012, J APPL PHYS, V112, DOI 10.1063/1.4732135; Dunnbier M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435203; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2013, PLASMA ENGINEERING: APPLICATIONS FROM AEROSPACE TO BIO- AND NANOTECHNOLOGY, P1; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Liu DW, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186073; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Morris Angela D, 2009, J Dent Hyg, V83, P55; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nehra V, 2008, INT J ENG-IRAN, V2, P53; Nersisyan G, 2004, PLASMA SOURCES SCI T, V13, P582, DOI 10.1088/0963-0252/13/4/005; Nie QY, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115015; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Pearse R. W. B., 1976, IDENTIFICATION MOL S; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Walk RM, 2013, J PEDIATR SURG, V48, P67, DOI 10.1016/j.jpedsurg.2012.10.020; Walsh JL, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982497; Winter J, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/29/295401; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08; Yousfi M, 2014, FUND CLIN PHARMACOL, V28, P123, DOI 10.1111/fcp.12018; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735; Zirnheld JL, 2010, IEEE T PLASMA SCI, V38, P948, DOI 10.1109/TPS.2010.2041470; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	43	131	132	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98652	10.1371/journal.pone.0098652	http://dx.doi.org/10.1371/journal.pone.0098652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878760	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500078
J	Nadrowski, K; Pietsch, K; Baruffol, M; Both, S; Gutknecht, J; Bruelheide, H; Heklau, H; Kahl, A; Kahl, T; Niklaus, P; Krober, W; Liu, XJ; Mi, XC; Michalski, S; von Oheimb, G; Purschke, O; Schmid, B; Fang, T; Welk, E; Wirth, C				Nadrowski, Karin; Pietsch, Katherina; Baruffol, Martin; Both, Sabine; Gutknecht, Jessica; Bruelheide, Helge; Heklau, Heike; Kahl, Anja; Kahl, Tiemo; Niklaus, Pascal; Kroeber, Wenzel; Liu, Xiaojuan; Mi, Xiangcheng; Michalski, Stefan; von Oheimb, Goddert; Purschke, Oliver; Schmid, Bernhard; Fang, Teng; Welk, Erik; Wirth, Christian			Tree Species Traits but Not Diversity Mitigate Stem Breakage in a Subtropical Forest following a Rare and Extreme Ice Storm	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; GLOBAL PATTERNS; DAMAGE; DISTURBANCE; PLANTATIONS; ECONOMICS; DYNAMICS; IMPACT; LEAF	Future climates are likely to include extreme events, which in turn have great impacts on ecological systems. In this study, we investigated possible effects that could mitigate stem breakage caused by a rare and extreme ice storm in a Chinese subtropical forest across a gradient of forest diversity. We used Bayesian modeling to correct stem breakage for tree size and variance components analysis to quantify the influence of taxon, leaf and wood functional traits, and stand level properties on the probability of stem breakage. We show that the taxon explained four times more variance in individual stem breakage than did stand level properties; trees with higher specific leaf area (SLA) were less susceptible to breakage. However, a large part of the variation at the taxon scale remained unexplained, implying that unmeasured or undefined traits could be used to predict damage caused by ice storms. When aggregated at the plot level, functional diversity and wood density increased after the ice storm. We suggest that for the adaption of forest management to climate change, much can still be learned from looking at functional traits at the taxon level.	[Nadrowski, Karin; Pietsch, Katherina; Kahl, Anja; Wirth, Christian] Univ Leipzig, D-04109 Leipzig, Germany; [Baruffol, Martin; Niklaus, Pascal; Schmid, Bernhard] Univ Zurich, Zurich, Switzerland; [Both, Sabine; Bruelheide, Helge; Heklau, Heike; Kroeber, Wenzel; Welk, Erik] Univ Halle Wittenberg, D-06108 Halle, Germany; [Gutknecht, Jessica] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Kahl, Tiemo] Univ Freiburg, Waldbau Inst, D-79106 Freiburg, Germany; [Liu, Xiaojuan; Mi, Xiangcheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Michalski, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [von Oheimb, Goddert] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Purschke, Oliver] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Fang, Teng] Gutianshan Natl Nat Reserve, Kaihua, Peoples R China	Leipzig University; University of Zurich; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg; Chinese Academy of Sciences; Institute of Botany, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leuphana University Luneburg	Nadrowski, K (corresponding author), Univ Leipzig, D-04109 Leipzig, Germany.	nadrowski@uni-leipzig.de	Niklaus, Pascal A/G-5786-2010; von Oheimb, Goddert/O-9483-2015; Liu, Xiaojuan/B-4947-2017; Both, Sabine/GRO-4210-2022; Gutknecht, Jessica/AAI-3682-2021; Schmid, Bernhard/C-8625-2009; Bruelheide, Helge/G-3907-2013; Michalski, Stefan G/O-5774-2015; Wirth, Christian/A-4446-2016; WELK, Erik/AGL-4971-2022; Baruffol, Martin/A-2406-2014	Niklaus, Pascal A/0000-0002-2360-1357; von Oheimb, Goddert/0000-0001-7408-425X; Schmid, Bernhard/0000-0002-8430-3214; Bruelheide, Helge/0000-0003-3135-0356; Michalski, Stefan G/0000-0002-8969-7355; Kahl, Anja/0000-0001-5497-8520; Purschke, Oliver/0000-0003-0444-0882; Nadrowski, Karin/0000-0001-5358-5469; Both, Sabine/0000-0003-4437-5106; Baruffol, Martin/0000-0001-9358-5885	German Science Foundation [DFG FOR 891/1, DFG FOR 891/2]; National Science Foundation of China [NSFC 30710103907, 30930005]	German Science Foundation(German Research Foundation (DFG)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the German Science Foundation (http://www.dfg.de, DFG FOR 891/1 & 2) and by the National Science Foundation of China (http://www.nsfc.gov.cn, NSFC 30710103907 and 30930005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Barrufol M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081246; Bates D, 2012, LME4 LINEAR MIXED EF; Bohnke M, 2014, J VEG SCI, V25, P897, DOI 10.1111/jvs.12114; Bohnke M, 2012, TREES-STRUCT FUNCT, V26, P641, DOI 10.1007/s00468-011-0632-0; Bohnke M, 2012, LEAF TRAITS CHEM 130; Bohnke M, 2010, XYLEM TRAITS TREE SP; Bolker B., 2007, ECOLOGICAL MODELS DA; Bragg DC, 2003, FOREST ECOL MANAG, V186, P99, DOI 10.1016/S0378-1127(03)00230-5; Bruelheide H, 2013, METHODS ECOL EVOL, DOI 10.1111/2041-210X.12126; Bruelheide H, 2013, COMP STUDY PLOT CSP; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cain M. D., 2002, General Technical Report - Southern Research Station, USDA Forest Service, P579; Duguay SM, 2001, ENVIRON MONIT ASSESS, V67, P97, DOI 10.1023/A:1006464511158; Field C.B., 2011, INTERGOVERNMENTAL PA; Geissler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049618; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; He Qian, 2010, Chinese Journal of Plant Ecology, V34, P195, DOI 10.3773/j.issn.1005-264x.2010.02.011; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017434; Holzwarth F, 2013, J ECOL, V101, P220, DOI 10.1111/1365-2745.12015; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; King DJ, 2005, NAT HAZARDS, V35, P321, DOI 10.1007/s11069-004-1795-4; Kraemer MJ, 2010, NRS60 USDA FOR SERV; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Lafon CW, 2004, J VEG SCI, V15, P267, DOI 10.1111/j.1654-1103.2004.tb02261.x; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lang AC, 2012, ECOL RES, V27, P181, DOI 10.1007/s11284-011-0887-3; Lang AC, 2010, FOREST ECOL MANAG, V260, P1708, DOI 10.1016/j.foreco.2010.08.015; Lou LuHuan, 2000, Journal of Beijing Forestry University, V22, P33; Ma Ze-Qing, 2010, Chinese Journal of Plant Ecology, V34, P204, DOI 10.3773/j.issn.1005-264x.2010.02.012; Man XingXing, 2011, Biodiversity Science, V19, P197, DOI 10.3724/SP.J.1003.2011.09220; Michalski S., 2013, PHYLOGENETIC TREE WO; Nadrowski K., 2013, DEVIATIONS STEM BREA; Nadrowski K, 2009, CORE WOOD DENSITY PA; Nadrowski K, 2013, LIVING KILLED TREES; Nadrowski K, 2013, METHODS ECOL EVOL, V4, P201, DOI 10.1111/2041-210x.12009; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Plummer M, 2012, RJAGS BAYESIAN GRAPH; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Research Institute of Wood Industry of the Chinese Academy of Forestry, 1982, PHYS MECH PROP PRIM; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stueve KM, 2007, AREA, V39, P20, DOI 10.1111/j.1475-4762.2007.00722.x; Su Zhi-Yao, 2010, Chinese Journal of Plant Ecology, V34, P213, DOI 10.3773/j.issn.1005-264x.2010.02.013; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang X, 2009, SCI SILVAE SIN, V45, P42; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Yu MingJian, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P375; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zhang Lei, 2011, Biodiversity Science, V19, P206, DOI 10.3724/SP.J.1003.2011.10237; Zhou BZ, 2011, B AM METEOROL SOC, V92, P47, DOI 10.1175/2010BAMS2857.1; Zhou BZ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2009JG001234	55	6	6	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96022	10.1371/journal.pone.0096022	http://dx.doi.org/10.1371/journal.pone.0096022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879434	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000338101500004
J	Hosoda, K; Habuchi, M; Suzuki, S; Miyazaki, M; Takikawa, G; Sakurai, T; Kashiwagi, A; Sueyoshi, M; Matsumoto, Y; Kiuchi, A; Mori, K; Yomo, T				Hosoda, Kazufumi; Habuchi, Masumi; Suzuki, Shingo; Miyazaki, Mikako; Takikawa, Go; Sakurai, Takahiro; Kashiwagi, Akiko; Sueyoshi, Makoto; Matsumoto, Yusuke; Kiuchi, Ayako; Mori, Kotaro; Yomo, Tetsuya			Adaptation of a Cyanobacterium to a Biochemically Rich Environment in Experimental Evolution as an Initial Step toward a Chloroplast-Like State	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; SP PCC 6803; SELECTION; MUTATION; CHLAMYDOMONAS; FITNESS; GENE; ACCUMULATION; DYNAMICS; PCC-6803	Chloroplasts originated from cyanobacteria through endosymbiosis. The original cyanobacterial endosymbiont evolved to adapt to the biochemically rich intracellular environment of the host cell while maintaining its photosynthetic function; however, no such process has been experimentally demonstrated. Here, we show the adaptation of a model cyanobacterium, Synechocystis sp. PCC 6803, to a biochemically rich environment by experimental evolution. Synechocystis sp. PCC 6803 does not grow in a biochemically rich, chemically defined medium because several amino acids are toxic to the cells at approximately 1 mM. We cultured the cyanobacteria in media with the toxic amino acids at 0.1 mM, then serially transferred the culture, gradually increasing the concentration of the toxic amino acids. The cells evolved to show approximately the same specific growth rate in media with 0 and 1 mM of the toxic amino acid in approximately 84 generations and evolved to grow faster in the media with 1 mM than in the media with 0 mM in approximately 181 generations. We did not detect a statistically significant decrease in the autotrophic growth of the evolved strain in an inorganic medium, indicating the maintenance of the photosynthetic function. Whole-genome resequencing revealed changes in the genes related to the cell membrane and the carboxysome. Moreover, we quantitatively analyzed the evolutionary changes by using simple mathematical models, which evaluated the evolution as an increase in the half-maximal inhibitory concentration (IC50) and estimated quantitative characteristics of the evolutionary process. Our results clearly demonstrate not only the potential of a model cyanobacterium to adapt to a biochemically rich environment without a significant decrease in photosynthetic function but also the properties of its evolutionary process, which sheds light of the evolution of chloroplasts at the initial stage.	[Hosoda, Kazufumi] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Habuchi, Masumi; Mori, Kotaro; Yomo, Tetsuya] Osaka Univ, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Suzuki, Shingo] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan; [Miyazaki, Mikako; Kiuchi, Ayako] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan; [Takikawa, Go; Sakurai, Takahiro; Sueyoshi, Makoto; Matsumoto, Yusuke; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Kashiwagi, Akiko] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, ERATO, Suita, Osaka, Japan	Osaka University; Osaka University; RIKEN; Osaka University; Osaka University; Hirosaki University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Shingo/O-3651-2014	Suzuki, Shingo/0000-0003-1332-3194	JSPS KAKENHI [25650147]; "Global COE Program" of MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "Global COE Program" of MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by JSPS KAKENHI grant number 25650147, and the "Global COE Program" of MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018877; Bell G, 1997, HEREDITY, V78, P498, DOI 10.1038/hdy.1997.78; Bell GAC, 1997, HEREDITY, V78, P490, DOI 10.1038/sj.hdy.6881220; Bergman B, 2008, PLANT BIOTECHNOL-NAR, V25, P213, DOI 10.5511/plantbiotechnology.25.213; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; CHAUVAT F, 1989, MOL GEN GENET, V216, P51, DOI 10.1007/BF00332230; Drake JW, 1998, GENETICS, V148, P1667; Eisenhut M, 2007, FEMS MICROBIOL LETT, V277, P232, DOI 10.1111/j.1574-6968.2007.00960.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Fisher RA, 1930, GENETICAL THEORY NAT; FLORES E, 1990, ARCH MICROBIOL, V154, P521; Gorelova OA, 2003, MICROBIOLOGY+, V72, P318, DOI 10.1023/A:1024252116667; HAN K, 1988, BIOTECHNOL BIOENG, V32, P430, DOI 10.1002/bit.260320404; Hihara Y, 1997, PHOTOSYNTH RES, V53, P243, DOI 10.1023/A:1005879905365; Hosoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017105; IWASA Y, 1988, J THEOR BIOL, V135, P265, DOI 10.1016/S0022-5193(88)80243-1; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; KINGMAN JFC, 1978, J APPL PROBAB, V15, P1, DOI 10.2307/3213231; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; LABARRE J, 1987, J BACTERIOL, V169, P4668, DOI 10.1128/jb.169.10.4668-4673.1987; Margulis L., 1993, SYMBIOSIS CELL EVOLU; Martin W, 1999, EUR J PHYCOL, V34, P287, DOI 10.1017/S0967026299002231; Mereschkovsky K.S, 1905, BIOL ZBL, V85, P593, DOI DOI 10.1017/S0967026299002231; Mori K, 2011, J EUKARYOT MICROBIOL, V58, P37, DOI 10.1111/j.1550-7408.2010.00517.x; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Nilsson M, 2002, NEW PHYTOL, V156, P517, DOI 10.1046/j.1469-8137.2002.00534.x; OGAWA T, 1994, J BACTERIOL, V176, P2374, DOI 10.1128/JB.176.8.2374-2378.1994; Qiao JJ, 2013, GENE, V512, P6, DOI 10.1016/j.gene.2012.10.004; Raven JA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-209; Reboud X, 1997, HEREDITY, V78, P507, DOI 10.1038/hdy.1997.79; Srivastava A. K., 2013, STRESS BIOL CYANOBAC; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Taiz L., 2018, FUNDAMENTALS PLANT P; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Whitton B., 2012, ECOLOGY CYANOBACTERI, DOI [DOI 10.1007/978-94-007-3855-3, DOI 10.1007/978-94-007-3855-3_24]; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766	40	5	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98337	10.1371/journal.pone.0098337	http://dx.doi.org/10.1371/journal.pone.0098337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874568	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800033
J	Li, R; Yuan, MX; Ma, KS; Li, XW; Tang, CL; Zhang, XH; Guo, DY; Yan, XC				Li, Rui; Yuan, Meng-Xia; Ma, Kuan-sheng; Li, Xiao-Wu; Tang, Chun-Lin; Zhang, Xiao-Hang; Guo, De-Yu; Yan, Xiao-Chu			Detailed Analysis of Temporal Features on Contrast Enhanced Ultrasound May Help Differentiate Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma in Cirrhosis	PLOS ONE			English	Article							CLINICAL-PRACTICE RECOMMENDATIONS; FOCAL LIVER-LESIONS; DIAGNOSTIC-ACCURACY; SURVEILLANCE; GUIDELINES; MISDIAGNOSIS; MANAGEMENT; RISK; CEUS; MRI	Aim: To verify if detailed analysis of temporal enhancement patterns on contrast enhanced ultrasound (CEUS) may help differentiate intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) in cirrhosis. Methods: Thirty three ICC and fifty HCC in cirrhosis were enrolled in this study. The contrast kinetics of ICC and HCC was analyzed and compared. Results: Statistical analysis did not reveal significant difference between ICC and HCC in the time of contrast first appearance and arterial peak maximum time. ICC displayed much earlier washout than that of HCC (47.93 +/- 26.45 seconds vs 90.86 +/- 31.26 seconds) in the portal phase, and most ICC (87.9%) showed washout before 60 seconds than HCC (16.0%). Much more ICC (78.8%) revealed marked washout than HCC (12.0%) while most HCC (88.0%) showed mild washout or no washout in late part of the portal phase (90-120 seconds). Twenty six out of thirty three ICC (78.8%) demonstrated both early washout(<60seconds) and marked washout in late part of the portal phase, whereas, only six of fifty HCC (12.0%) showed these temporal enhancement features (p = 0.000). When both early washout and marked washout in the portal phase are taken as diagnostic criterion for ICC, the diagnostic sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 78.8%, 88.0%, 81.3%, 86.3%, and 84.3% respectively by CEUS. Conclusions: Analysis of detailed temporal enhancement features on CEUS is helpful differentiate ICC from HCC in cirrhosis. If a nodule in cirrhotic liver displays hyper-enhancement in the arterial phase followed by early and marked washout in the portal phase, the nodule is highly suspicious of ICC rather than HCC.	[Li, Rui; Yuan, Meng-Xia; Tang, Chun-Lin; Zhang, Xiao-Hang] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Ma, Kuan-sheng; Li, Xiao-Wu] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China; [Guo, De-Yu; Yan, Xiao-Chu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China.	raylee7991@163.com	Li, Xiaowu/AAF-2769-2020					[Anonymous], 2011, HEPATOLOGY, V54, P1898; Barreiros AP, 2012, J HEPATOL, V57, P930, DOI 10.1016/j.jhep.2012.04.018; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bolondi L, 2007, DIGEST LIVER DIS, V39, P187, DOI 10.1016/j.dld.2006.08.008; Boozari B, 2011, DIGEST LIVER DIS, V43, P484, DOI 10.1016/j.dld.2011.01.001; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen LD, 2010, EUR RADIOL, V20, P743, DOI 10.1007/s00330-009-1599-8; Claudon M, 2008, ULTRASCHALL MED, V29, P28, DOI 10.1055/s-2007-963785; Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Dietrich CF, 2006, WORLD J GASTROENTERO, V12, P1699, DOI 10.3748/wjg.v12.i11.1699; Galassi M, 2013, LIVER INT, V33, P771, DOI 10.1111/liv.12124; Iavarone M, 2013, J HEPATOL, V58, P1188, DOI 10.1016/j.jhep.2013.02.013; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Lencioni R, 2008, J HEPATOL, V48, P848, DOI 10.1016/j.jhep.2008.02.005; Li R, 2013, ABDOM IMAGING, V38, P112, DOI 10.1007/s00261-012-9854-x; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Rimola J, 2012, J HEPATOL, V56, P1317, DOI 10.1016/j.jhep.2012.01.004; Rimola J, 2009, HEPATOLOGY, V50, P791, DOI 10.1002/hep.23071; Sangiovanni A, 2010, GUT, V59, P638, DOI 10.1136/gut.2009.187286; Serste T, 2012, HEPATOLOGY, V55, P800, DOI 10.1002/hep.24746; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Strobel D, 2008, ULTRASCHALL MED, V29, P499, DOI 10.1055/s-2008-1027806; Tranquart F, 2009, J RADIOL, V90, P109, DOI 10.1016/S0221-0363(09)70089-7; Vilana R, 2010, HEPATOLOGY, V51, P2020, DOI 10.1002/hep.23600; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027	28	44	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98612	10.1371/journal.pone.0098612	http://dx.doi.org/10.1371/journal.pone.0098612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874413	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800051
J	Ng, FL; Phang, SM; Periasamy, V; Yunus, K; Fisher, AC				Ng, Fong-Lee; Phang, Siew-Moi; Periasamy, Vengadesh; Yunus, Kamran; Fisher, Adrian C.			Evaluation of Algal Biofilms on Indium Tin Oxide (ITO) for Use in Biophotovoltaic Platforms Based on Photosynthetic Performance	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; LIGHT EXPOSURE; PHOTOPROTECTION; MICROALGAE; RESPONSES; DIATOMS; PROTEIN; ENERGY	In photosynthesis, a very small amount of the solar energy absorbed is transformed into chemical energy, while the rest is wasted as heat and fluorescence. This excess energy can be harvested through biophotovoltaic platforms to generate electrical energy. In this study, algal biofilms formed on ITO anodes were investigated for use in the algal biophotovoltaic platforms. Sixteen algal strains, comprising local isolates and two diatoms obtained from the Culture Collection of Marine Phytoplankton (CCMP), USA, were screened and eight were selected based on the growth rate, biochemical composition and photosynthesis performance using suspension cultures. Differences in biofilm formation between the eight algal strains as well as their rapid light curve (RLC) generated using a pulse amplitude modulation (PAM) fluorometer, were examined. The RLC provides detailed information on the saturation characteristics of electron transport and overall photosynthetic performance of the algae. Four algal strains, belonging to the Cyanophyta (Cyanobacteria) Synechococcus elongatus (UMACC 105), Spirulina platensis. (UMACC 159) and the Chlorophyta Chlorella vulgaris (UMACC 051), and Chlorella sp. (UMACC 313) were finally selected for investigation using biophotovoltaic platforms. Based on power output per Chl-a content, the algae can be ranked as follows: Synechococcus elongatus (UMACC 105) (6.38x10(-5) Wm(-2)/mu gChl-a)>Chlorella vulgaris UMACC 051 (2.24x10(-5) Wm(-2)/mu gChl-a)>Chlorella sp.(UMACC 313) (1.43x10(-5) Wm(-2)/mu gChl-a)>Spirulina platensis (UMACC 159) (4.90x10(-6) Wm(-2)/mu gChl-a). Our study showed that local algal strains have potential for use in biophotovoltaic platforms due to their high photosynthetic performance, ability to produce biofilm and generation of electrical power.	[Ng, Fong-Lee; Phang, Siew-Moi] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Ng, Fong-Lee; Phang, Siew-Moi] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Periasamy, Vengadesh] Univ Malaya, Dept Phys, Fac Sci, Low Dimens Mat Res Ctr, Kuala Lumpur, Malaysia; [Yunus, Kamran; Fisher, Adrian C.] Univ Cambridge, Dept Chem Engn & Biotechnol, CREST, Cambridge, England	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Cambridge	Phang, SM (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	phang@um.edu.my	Ng, Fong Lee/V-2267-2017; PERIASAMY, VENGADESH/B-9993-2010; Phang, Siew Moi/A-7653-2008	PERIASAMY, VENGADESH/0000-0002-0435-4944; 	University of Malaya Research Grant [J-21002-73823]; University of Malaya Postgraduate Research Fund [PG051-2012B]; IOES-Cambridge Biophotovoltaic Cell Research Grant [TC004-2010A]; Fundamental Research Grant [KPT1059-2012]; Malaysian Palm Oil Board (MPOB) Grant [55-02-03-1054]; Knowledge Management Grant [RP001O-13SUS]; High Impact Research Grant; EPSRC [EP/F006586/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F006586/1] Funding Source: researchfish	University of Malaya Research Grant; University of Malaya Postgraduate Research Fund(Universiti Malaya); IOES-Cambridge Biophotovoltaic Cell Research Grant; Fundamental Research Grant; Malaysian Palm Oil Board (MPOB) Grant; Knowledge Management Grant; High Impact Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the High Impact Research Grant, University of Malaya Research Grant (J-21002-73823), University of Malaya Postgraduate Research Fund (PG051-2012B), IOES-Cambridge Biophotovoltaic Cell Research Grant (TC004-2010A), Fundamental Research Grant (KPT1059-2012), Malaysian Palm Oil Board (MPOB) Grant (55-02-03-1054) and Knowledge Management Grant (RP001O-13SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Blatti JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042949; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bombelli Paolo, 2011, Commun Agric Appl Biol Sci, V76, P89; Bonnineau C, 2012, ECOTOXICOLOGY, V21, P1208, DOI 10.1007/s10646-012-0876-5; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartaxana P, 2008, LIMNOL OCEANOGR-METH, V6, P466, DOI 10.4319/lom.2008.6.466; Chu WL, 2009, J APPL PHYCOL, V21, P641, DOI 10.1007/s10811-008-9396-3; Consalvey M, 2004, PHOTOSYNTH RES, V81, P91, DOI 10.1023/B:PRES.0000028397.86495.b5; Daroch M, 2013, APPL ENERG, V102, P1371, DOI 10.1016/j.apenergy.2012.07.031; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Ferreira T, 2010, IMAGE J USER GUIDE; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hwang J, 2006, ORG ELECTRON, V7, P387, DOI 10.1016/j.orgel.2006.04.005; Inglesby AE, 2013, PHYS CHEM CHEM PHYS, V15, P6903, DOI 10.1039/c3cp51076j; Jackson DD, 1896, REP MASS STATE BOARD, P410; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Jordan L, 2009, J MAR BIOL ASSOC UK, P1; Keng FSL, 2013, J APPL PHYCOL, V25, P1377, DOI 10.1007/s10811-013-9990-x; Kochert A. G., 1978, HDB PHYCOLOGICAL MET; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Lim SL, 2010, BIORESOURCE TECHNOL, V101, P7314, DOI 10.1016/j.biortech.2010.04.092; Luimstra VM, 2014, J APPL PHYCOL, V26, P15, DOI 10.1007/s10811-013-0051-2; Mao LF, 2013, INT J ENERGY ENVIR E, V4, DOI 10.1186/2251-6832-4-17; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCormick AJ, 2011, ENERG ENVIRON SCI, V4, P4699, DOI 10.1039/c1ee01965a; McMinn A, 2010, POLAR BIOL, V33, P1547, DOI 10.1007/s00300-010-0844-6; McMinn Andrew, 2006, Polar Bioscience, P30; Mustafa EM, 2012, J APPL PHYCOL, V24, P953, DOI 10.1007/s10811-011-9716-x; Ng FL, 2013, ADV MAT RES, V895, P116; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Nishio K, 2010, APPL MICROBIOL BIOT, V86, P957, DOI 10.1007/s00253-009-2400-2; Ozkan A, 2013, BIOFOULING, V29, P469, DOI 10.1080/08927014.2013.782397; Ozkan A, 2012, BIORESOURCE TECHNOL, V114, P542, DOI 10.1016/j.biortech.2012.03.055; Pankowski A, 2009, AQUAT BIOL, V4, P273, DOI 10.3354/ab00116; Perkins RG, 2001, MAR ECOL PROG SER, V223, P101, DOI 10.3354/meps223101; PHANG SM, 1988, BIOL WASTE, V25, P177, DOI 10.1016/0269-7483(88)90078-X; Phang SM., 1999, CATALOGUE STRAINS U; PLATT T, 1980, J MAR RES, V38, P687; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Reeves S, 2011, POLAR BIOL, V34, P1019, DOI 10.1007/s00300-011-0961-x; Rismani-Yazdi H, 2008, J POWER SOURCES, V180, P683, DOI 10.1016/j.jpowsour.2008.02.074; Roeselers G, 2006, FEMS MICROBIOL ECOL, V58, P169, DOI 10.1111/j.1574-6941.2006.00172.x; Sauer K., 2007, MICROBE AM SOC MICRO, V2, P347, DOI [10.1128/microbe.2.347.1, DOI 10.1128/MICR0BE.2.347.1]; Serodio J, 2006, PHOTOSYNTH RES, V90, P29, DOI [10.1007/s11120-006-9105-5, 10.1007/s11120-006-9101-9]; Strickland J.D.H., 1968, FISH RES BD CAN B, V167, P311; van Leeuwenhoek A, 1684, PHIL T, V14, P568; Vejeysri V, 2013, J APPL PHYCOL, DOI [10.1007/s10811-013-0160, DOI 10.1007/S10811-013-0160]; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; Wiltshire KH, 1997, J SEDIMENT RES, V67, P977, DOI 10.1306/D4268694-2B26-11D7-8648000102C1865D; Wong CY, 2007, J APPL PHYCOL, V19, P689, DOI 10.1007/s10811-007-9214-3; Yagishita T, 1997, SOL ENERGY, V61, P347, DOI 10.1016/S0038-092X(97)00069-8	55	43	43	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97643	10.1371/journal.pone.0097643	http://dx.doi.org/10.1371/journal.pone.0097643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874081	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800009
J	Urquhart, EA; Zaitchik, BF; Waugh, DW; Guikema, SD; Del Castillo, CE				Urquhart, Erin A.; Zaitchik, Benjamin F.; Waugh, Darryn W.; Guikema, Seth D.; Del Castillo, Carlos E.			Uncertainty in Model Predictions of Vibrio vulnificus Response to Climate Variability and Change: A Chesapeake Bay Case Study	PLOS ONE			English	Article							SEASONAL DYNAMICS; COASTAL WATERS; PARAHAEMOLYTICUS; SALINITY; CHOLERAE; INFECTIONS; OYSTERS; ECOLOGY	The effect that climate change and variability will have on waterborne bacteria is a topic of increasing concern for coastal ecosystems, including the Chesapeake Bay. Surface water temperature trends in the Bay indicate a warming pattern of roughly 0.3-0.4 degrees C per decade over the past 30 years. It is unclear what impact future warming will have on pathogens currently found in the Bay, including Vibrio spp. Using historical environmental data, combined with three different statistical models of Vibrio vulnificus probability, we explore the relationship between environmental change and predicted Vibrio vulnificus presence in the upper Chesapeake Bay. We find that the predicted response of V. vulnificus probability to high temperatures in the Bay differs systematically between models of differing structure. As existing publicly available datasets are inadequate to determine which model structure is most appropriate, the impact of climatic change on the probability of V. vulnificus presence in the Chesapeake Bay remains uncertain. This result points to the challenge of characterizing climate sensitivity of ecological systems in which data are sparse and only statistical models of ecological sensitivity exist.	[Urquhart, Erin A.; Zaitchik, Benjamin F.; Waugh, Darryn W.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Guikema, Seth D.] Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA; [Del Castillo, Carlos E.] NASA, Ocean Ecol Lab, Goddard Space Flight Ctr, Greenbelt, MD USA	Johns Hopkins University; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Urquhart, EA (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	erinu@jhu.edu	Zaitchik, Benjamin/AAB-3298-2020; Urquhart, Erin/A-2336-2015; Waugh, Darryn W/K-3688-2016	Zaitchik, Benjamin/0000-0002-0698-0658; Urquhart, Erin/0000-0001-7141-9499; Waugh, Darryn W/0000-0001-7692-2798	Johns Hopkins University Department of Earth and Planetary Sciences	Johns Hopkins University Department of Earth and Planetary Sciences	This work was financially supported by the Johns Hopkins University Department of Earth and Planetary Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin HM, 2002, AM FISH S S, V32, P155; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Breiman L, 1996, TECHNICAL REPORT; Cantet F, 2013, RES MICROBIOLOGY; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; de Magny GC, 2009, ECOHEALTH, V6, P378, DOI 10.1007/s10393-009-0273-6; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Deepanjali A, 2005, APPL ENVIRON MICROB, V71, P3575, DOI 10.1128/AEM.71.7.3575-3580.2005; Ebi KL, 2008, CLIMATIC CHANGE, V88, P5, DOI 10.1007/s10584-006-9233-0; Eiler A, 2006, APPL ENVIRON MICROB, V72, P6004, DOI 10.1128/AEM.00917-06; Faraway J.J., 2004, EXTENDING LINEAR MOD; Gibson JR, 2000, LIMNOL OCEANOGR, V45, P1764, DOI 10.4319/lo.2000.45.8.1764; Hastie T., 1986, STAT SCI, V1, P297; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5488, DOI 10.1128/AEM.68.11.5488-5497.2002; Hofstra N, 2011, CURR OPIN ENV SUST, V3, P471, DOI 10.1016/j.cosust.2011.10.006; Jacobs J, 2010, NOAA TECHNICAL MEMOR, V112, P1; Johnson CN, 2012, APPL ENVIRON MICROB, V78, P7249, DOI 10.1128/AEM.01296-12; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; KAPER JB, 1981, ESTUARIES, V4, P321, DOI 10.2307/1352156; KLONTZ KC, 1988, ANN INTERN MED, V109, P318, DOI 10.7326/0003-4819-109-4-318; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lipp EK, 2001, HYDROBIOLOGIA, V460, P165, DOI 10.1023/A:1013127517860; Louis VR, 2003, APPL ENVIRON MICROB, V69, P2773, DOI 10.1128/AEM.69.5.2773-2785.2003; Maryland Department of Health, 2013, CAS SEL NOT COND REP; Najjar R, 2009, CLIMATIC CHANGE, V95, P139, DOI 10.1007/s10584-008-9521-y; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Oberbeckmann S, 2012, MICROB ECOL, V63, P543, DOI 10.1007/s00248-011-9990-9; Schets FM, 2004, J WATER HEALTH, V2, P191, DOI 10.2166/wh.2004.0017; Secor D, 2008, 69 YEAR RECORD WARMI; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; Urquhart EA, 2014, J ENV INFOR IN PRESS; Urquhart EA, 2013, REMOTE SENS ENVIRON, V135, P167, DOI 10.1016/j.rse.2013.03.034; Urquhart EA, 2012, REMOTE SENS ENVIRON, V123, P522, DOI 10.1016/j.rse.2012.04.008; Virginia Department of Health, 2013, VIRG REP DIS SURV DA; Wright AC, 1996, APPL ENVIRON MICROB, V62, P717, DOI 10.1128/AEM.62.2.717-724.1996	37	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98256	10.1371/journal.pone.0098256	http://dx.doi.org/10.1371/journal.pone.0098256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874082	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800029
J	Zimmerman, DL; Ruzicka, M; Hebert, P; Fergusson, D; Touyz, RM; Burns, KD				Zimmerman, Deborah L.; Ruzicka, Marcel; Hebert, Paul; Fergusson, Dean; Touyz, Rhian M.; Burns, Kevin D.			Short Daily versus Conventional Hemodialysis for Hypertensive Patients: A Randomized Cross-Over Study	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; LEFT-VENTRICULAR HYPERTROPHY; OXIDATIVE STRESS; NITRIC-OXIDE; DRY-WEIGHT; DYSFUNCTION; MANAGEMENT; REDUCTION; TIME	Background: Treatment of end stage renal disease patients with short daily hemodialysis has been associated with an improvement in blood pressure. It is unclear from these studies if anti-hypertensive management had been optimized prior to starting short daily hemodialysis. Also, the potential mechanism(s) of blood pressure improvement remain to be fully elucidated. Study Design, Setting and Participants: We undertook a randomized cross-over trial in adult hypertensive patients with ESRD treated with conventional hemodialysis to determine: 1) if short-daily hemodialysis is associated with a reduction in systolic blood pressure after a 3-month blood pressure optimization period and; 2) the potential mechanism(s) of blood pressure reduction. Blood pressure was measured using Canadian Hypertension Education Program guidelines. Extracellular fluid volume (ECFV) was assessed with bioimpedance. Serum catecholamines were used to assess the sympathetic nervous system. Interleukin-6 (IL-6) and thiobarbituric acid reactive substances (T-BARS) were used as markers of inflammation and oxidative stress respectively. Results: After a 3-month run-in phase in which systolic blood pressure improved, there was no significant difference in pre-dialysis systolic pressure between short-daily and conventional hemodialysis (p = 0.39). However, similar blood pressures were achieved on fewer anti-hypertensive medications with short daily hemodialysis compared to conventional hemodialysis (p = 0.01). Short daily hemodialysis, compared to conventional hemodialysis, was not associated with a difference in dry weight or ECFV (p = 0.77). Sympathetic nervous system activity as assessed by plasma epinephrine (p = 1.0) and norepinephrine (p = 0.52) was also not different. Markers of inflammation (p = 0.42) and oxidative stress (p = 0.83) were also similar between the two treatment arms. Conclusions: Patients treated with short daily, compared to conventional hemodialysis, have similar blood pressure control on fewer anti-hypertensive medications. The mechanism(s) by which short daily hemodialysis allows for decreased antihypertensive medication use remains unclear but effects on sodium balance and changes in peripheral vascular resistance require further study.	[Zimmerman, Deborah L.; Ruzicka, Marcel] Univ Ottawa, Ottawa Hosp, Res Inst, Div Nephrol,Kidney Res Ctr, Ottawa, ON, Canada; [Hebert, Paul] Univ Ottawa, Ottawa, ON, Canada; [Hebert, Paul] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Fergusson, Dean] Ottawa Hosp, Res Inst, Dept Med, Ottawa, ON, Canada; [Fergusson, Dean] Ottawa Hosp, Res Inst, Dept Surg, Ottawa, ON, Canada; [Fergusson, Dean] Ottawa Hosp, Res Inst, Dept Epidemiol, Ottawa, ON, Canada; [Fergusson, Dean] Ottawa Hosp, Res Inst, Dept Community Med, Ottawa, ON, Canada; [Fergusson, Dean] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Touyz, Rhian M.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Burns, Kevin D.] Univ Ottawa, Div Nephrol, Ottawa, ON, Canada; [Burns, Kevin D.] Univ Ottawa, Ottawa Hosp, Res Inst, Kidney Res Ctr, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Glasgow; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Zimmerman, DL (corresponding author), Univ Ottawa, Ottawa Hosp, Res Inst, Div Nephrol,Kidney Res Ctr, Ottawa, ON, Canada.	dzimmerman@toh.on.ca	Touyz, Rhian/AAM-3564-2020	Touyz, Rhian/0000-0003-0670-0887; Fergusson, Dean/0000-0002-3389-2485	Ontario Heart and Stroke Foundation; Ottawa Hospital Department of Medicine	Ontario Heart and Stroke Foundation(Heart & Stroke Foundation of Ontario); Ottawa Hospital Department of Medicine	This study was funded by the Ontario Heart and Stroke Foundation and the Ottawa Hospital Department of Medicine. The funders had no role in study design, data collection and analysis, decison to publish, or preparation of the manuscript.	Agarwal R, 2003, AM J MED, V115, P291, DOI 10.1016/S0002-9343(03)00366-8; Agarwal R, 2009, HYPERTENSION, V53, P500, DOI 10.1161/HYPERTENSIONAHA.108.125674; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Chan CT, 2003, HYPERTENSION, V42, P925, DOI 10.1161/01.HYP.0000097605.35343.64; Chan CT, 2002, KIDNEY INT, V61, P2235, DOI 10.1046/j.1523-1755.2002.00362.x; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cox-Reijven PL, 2001, AM J KIDNEY DIS, V38, P832, DOI 10.1053/ajkd.2001.27703; de Paula FM, 2004, KIDNEY INT, V66, P1232, DOI 10.1111/j.1523-1755.2004.00876.x; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Fagugli RM, 2001, AM J KIDNEY DIS, V38, P371, DOI 10.1053/ajkd.2001.26103; FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024; Hirooka Y, 2011, AM J PHYSIOL-REG I, V300, pR818, DOI 10.1152/ajpregu.00426.2010; Horl MP, 2002, AM J KIDNEY DIS, V39, P227, DOI 10.1053/ajkd.2002.30542; Jefferies HJ, 2011, CLIN J AM SOC NEPHRO, V6, P1326, DOI 10.2215/CJN.05200610; Katzarski KS, 1999, NEPHROL DIAL TRANSPL, V14, P369, DOI 10.1093/ndt/14.2.369; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Luik AJ, 2001, AM J NEPHROL, V21, P471, DOI 10.1159/000046651; Montezano AC, 2012, CAN J CARDIOL, V28, P288, DOI 10.1016/j.cjca.2012.01.017; Nesrallah G, 2003, AM J KIDNEY DIS, V42, pS13, DOI 10.1016/S0272-6386(03)00532-8; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Penne EL, 2010, BLOOD PURIFICAT, V30, P71, DOI 10.1159/000317124; Ponnuchamy B, 2009, AM J PHYSIOL-REG I, V296, pR1001, DOI 10.1152/ajpregu.90960.2008; Rocco MV, 2011, KIDNEY INT, V80, P1080, DOI 10.1038/ki.2011.213; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Song JH, 2002, AM J KIDNEY DIS, V40, P291, DOI 10.1053/ajkd.2002.34507; Thein H, 2007, NEPHROL DIAL TRANSPL, V22, P2630, DOI 10.1093/ndt/gfm220; Virdis A, 2002, HYPERTENSION, V40, P504, DOI 10.1161/01.HYP.0000034738.79310.06; White M, 2006, CLIN SCI, V110, P483, DOI 10.1042/CS20050317; Yoon JW, 2007, KIDNEY INT, V71, P167, DOI 10.1038/sj.ki.5002019; Yuen D, 2005, CLIN NEPHROL, V64, P364; Zilch O, 2007, J HYPERTENS, V25, P1285, DOI 10.1097/HJH.0b013e3280f9df85; Zimmerman DL, 2003, ASAIO J, V49, P426, DOI 10.1097/01.MAT.0000073969.50918.59; Zoccali C, 1991, J HYPERTENS, V17, P355	33	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97135	10.1371/journal.pone.0097135	http://dx.doi.org/10.1371/journal.pone.0097135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875804	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336790800004
J	Gao, CX; Sang, N; Huang, R				Gao, Changxin; Sang, Nong; Huang, Rui			Biologically Inspired Scene Context for Object Detection Using a Single Instance	PLOS ONE			English	Article							ATTENDED OBJECTS; ATTENTION; ROTATION; FAILURE; FIELDS	This paper presents a novel object detection method using a single instance from the object category. Our method uses biologically inspired global scene context criteria to check whether every individual location of the image can be naturally replaced by the query instance, which indicates whether there is a similar object at this location. Different from the traditional detection methods that only look at individual locations for the desired objects, our method evaluates the consistency of the entire scene. It is therefore robust to large intra-class variations, occlusions, a minor variety of poses, low-revolution conditions, background clutter etc., and there is no off-line training. The experimental results on four datasets and two video sequences clearly show the superior robustness of the proposed method, suggesting that global scene context is important for visual detection/localization.	[Gao, Changxin; Sang, Nong; Huang, Rui] Huazhong Univ Sci & Technol, Sch Automat, Key Lab, Minist Educ Image Proc & Intelligent Control, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Gao, CX (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Key Lab, Minist Educ Image Proc & Intelligent Control, Wuhan 430074, Peoples R China.	cgao@hust.edu.cn	Huang, Rui/AAC-8207-2022; Gao, Changxin/L-4841-2016	Huang, Rui/0000-0002-7950-1662; Gao, Changxin/0000-0003-2736-3920	Project of the National Natural Science Foundation of China [61105014]; Fundamental Research Funds for the Central Universities [HUST:2013TS132]	Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the Project of the National Natural Science Foundation of China (No. 61105014), and the Fundamental Research Funds for the Central Universities (No. HUST:2013TS132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, IEEE T PATTERN ANAL, V26, P1475, DOI 10.1109/TPAMI.2004.108; BARM, 2005, J VISION, V5, pA88; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Biederman I., 1995, INVITATION COGNITIVE, P121; Biederman I., 1988, COMPUTATIONAL PROCES; CALLEGUILLOS C, 2010, COMPUTER VISION IMAG, V114, P712; Carbonetto P, 2004, LECT NOTES COMPUT SC, V3021, P350; Choi MS, 2002, PATTERN RECOGN, V35, P119, DOI 10.1016/S0031-3203(01)00025-5; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Dinh TB, 2011, PROC CVPR IEEE, P1177, DOI 10.1109/CVPR.2011.5995733; Gao CX, 2012, OPT LETT, V37, P76, DOI 10.1364/OL.37.000076; Gao C, 2011, CURR ORG CHEM, V15, P1, DOI 10.2174/138527211793797846; Greene M. R., 2005, J VISION, V5, p70a; He XM, 2004, PROC CVPR IEEE, P695; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hochberg Julian, 1968, CONT THEORY RES VISU, P309; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; KRATTENTHALER W, 1994, IEEE IMAGE PROC, P208, DOI 10.1109/ICIP.1994.413305; Levin DT, 1997, PSYCHON B REV, V4, P501, DOI 10.3758/BF03214339; Mitroff SR, 2004, PERCEPT PSYCHOPHYS, V66, P1268, DOI 10.3758/BF03194997; Murphy K, 2004, ADV NEUR IN, V16, P1499; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Rabinovich A, 2007, IEEE I CONF COMP VIS, P1237, DOI 10.1109/iccv.2007.4408986; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Russell B. C., 2005, TECHNICAL REPORT; Sanocki T, 1997, PSYCHOL SCI, V8, P374, DOI 10.1111/j.1467-9280.1997.tb00428.x; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Shechtman E, 2007, IEEE T PATTERN ANAL, V29, P2045, DOI 10.1109/TPAMI.2007.1119; Shotton J, 2007, INT J COMPUT VISION, V81, P2, DOI DOI 10.1007/S11263-007-0109-1; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; Torralba A, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P273; Torralba A, 2003, INT J COMPUT VISION, V53, P169, DOI 10.1023/A:1023052124951; Ullah F, 2004, PATTERN RECOGN, V37, P201, DOI 10.1016/S0031-3203(03)00184-5; VANDERBRUG GJ, 1977, IEEE T COMPUT, V26, P384, DOI 10.1109/TC.1977.1674847; Wu Y, 2009, PROC CVPR IEEE, P33, DOI 10.1109/CVPRW.2009.5206719; Yeo CH, 2008, IEEE T CIRC SYST VID, V18, P1006, DOI 10.1109/TCSVT.2008.927112; YOSHIMURA S, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P2086, DOI 10.1109/IROS.1994.407577	44	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98447	10.1371/journal.pone.0098447	http://dx.doi.org/10.1371/journal.pone.0098447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24871350	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300045
J	Nahrgang, J; Varpe, O; Korshunova, E; Murzina, S; Hallanger, IG; Vieweg, I; Berge, J				Nahrgang, Jasmine; Varpe, Oystein; Korshunova, Ekaterina; Murzina, Svetlana; Hallanger, Ingeborg G.; Vieweg, Ireen; Berge, Jorgen			Gender Specific Reproductive Strategies of an Arctic Key Species (Boreogadus saida) and Implications of Climate Change	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; LIFE-HISTORY STRATEGIES; POLAR COD; CALANUS-FINMARCHICUS; ICE; LEPECHIN; GLACIALIS; SHIFTS; FJORD; BIODIVERSITY	The Arctic climate is changing at an unprecedented rate. What consequences this may have on the Arctic marine ecosystem depends to a large degree on how its species will respond both directly to elevated temperatures and more indirectly through ecological interactions. But despite an alarming recent warming of the Arctic with accompanying sea ice loss, reports evaluating ecological impacts of climate change in the Arctic remain sparse. Here, based upon a large-scale field study, we present basic new knowledge regarding the life history traits for one of the most important species in the entire Arctic, the polar cod (Boreogadus saida). Furthermore, by comparing regions of contrasting climatic influence (domains), we present evidence as to how its growth and reproductive success is impaired in the warmer of the two domains. As the future Arctic is predicted to resemble today's Atlantic domains, we forecast changes in growth and life history characteristics of polar cod that will lead to alteration of its role as an Arctic keystone species. This will in turn affect community dynamics and energy transfer in the entire Arctic food chain.	[Nahrgang, Jasmine; Korshunova, Ekaterina; Hallanger, Ingeborg G.; Vieweg, Ireen; Berge, Jorgen] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Nahrgang, Jasmine; Varpe, Oystein; Berge, Jorgen] Univ Ctr Svalbard, Longyearbyen, Norway; [Varpe, Oystein; Korshunova, Ekaterina] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Murzina, Svetlana] Russian Acad Sci, Karelian Res Ctr, Inst Biol, Petrozavodsk, Russia	UiT The Arctic University of Tromso; University Centre Svalbard (UNIS); Akvaplan-niva; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS	Nahrgang, J (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.	jasmine.m.nahrgang@uit.no	Varpe, Øystein/B-9693-2008; Berge, Jørgen/E-7544-2015; Nahrgang, Jasmine/AAQ-3594-2020; Murzina, Svetlana A./A-7624-2014	Varpe, Øystein/0000-0002-5895-6983; Berge, Jørgen/0000-0003-0900-5679; Nahrgang, Jasmine/0000-0002-4202-5922; Murzina, Svetlana A./0000-0002-9705-2741; Vieweg, Ireen/0000-0003-1983-5211; Hallanger, Ingeborg G./0000-0002-9476-4401	Norwegian Research Council through the EWMA [195160]; Polarisation [nr 214184/F20]; UiT - The Arctic University of Norway (Tromso); Svalbard Science Forum [RiS 5148]; Barents secretariat; Akvaplan-niva; President of the Russian Federation [NSh-1410.2014.4]; NFR - project CircA [214271/F20]	Norwegian Research Council through the EWMA; Polarisation; UiT - The Arctic University of Norway (Tromso); Svalbard Science Forum; Barents secretariat; Akvaplan-niva(Akvaplan-niva); President of the Russian Federation; NFR - project CircA	The work is partly financed by the Norwegian Research Council through the EWMA (nr 195160) and Polarisation (nr 214184/F20) projects, UiT - The Arctic University of Norway (Tromso), Arctic Field Grant (RiS 5148, Svalbard Science Forum), Barents secretariat, Akvaplan-niva and the President of the Russian Federation (Grant NSh-1410.2014.4). Fieldwork and the time allocated for JB and OV was supported by the NFR funded project CircA (nr 214271/F20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2013, REMOTE SENS ENVIRON, V132, P195, DOI 10.1016/j.rse.2013.01.014; Andriashev A.P., 1954, FISHES NO SEAS USSR; Anisimov OA, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P653; Arnkvaern G, 2005, POLAR BIOL, V28, P528, DOI 10.1007/s00300-005-0715-8; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Benoit D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004276; Bjorge A, 2010, NAMMCO SCI PUBLICATI, V8, P7, DOI [DOI 10.7557/3.2668, 10.7557/3.2668]; Bluhm BA, 2011, OCEANOGRAPHY, V24, P232, DOI 10.5670/oceanog.2011.75; Bouchard C, 2011, PROG OCEANOGR, V90, P105, DOI 10.1016/j.pocean.2011.02.008; BRADSTREET MSW, 1982, ARCTIC, V35, P28; Christiansen JS, 2008, J EXP MAR BIOL ECOL, V360, P47, DOI 10.1016/j.jembe.2008.04.003; Christiansen JS, 2012, POLAR BIOL, V35, P1247, DOI 10.1007/s00300-012-1170-y; Cottier F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002757; CRAIG PC, 1982, CAN J FISH AQUAT SCI, V39, P395, DOI 10.1139/f82-057; Crawley MJ, 2007, R LANG ENV STAT COMP; Dalpadado P, 2012, ICES J MAR SCI, V69, P1303, DOI 10.1093/icesjms/fss063; Dolgov AV, 2011, BARENTS SEA ECOSYSTE, P193; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; FALKPETERSEN IB, 1986, SARSIA, V71, P235, DOI 10.1080/00364827.1986.10419693; Ferguson Steven H, 2012, Aquat Biosyst, V8, P3, DOI 10.1186/2046-9063-8-3; Fevolden SE, 1999, SARSIA, V84, P99, DOI 10.1080/00364827.1999.10420437; FORTIER L, 1995, MAR ECOL PROG SER, V120, P11, DOI 10.3354/meps120011; Gillispie J.G., 1997, American Fisheries Society Symposium, V19, P81; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; GJOSAETER H, 1994, ICES J MAR SCI, V51, P115, DOI 10.1006/jmsc.1994.1011; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; HOP H, 1995, CAN J FISH AQUAT SCI, V52, P541, DOI 10.1139/f95-055; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huse G, 1998, CAN J FISH AQUAT SCI, V55, P631, DOI 10.1139/cjfas-55-3-631; Jonsson H, 2010, MAR POLLUT BULL, V60, P390, DOI 10.1016/j.marpolbul.2009.10.014; Kjellerup S, 2012, MAR ECOL PROG SER, V447, P87, DOI 10.3354/meps09551; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Kovacs KM, 2012, MAR MAMMAL SCI, V28, P414, DOI 10.1111/j.1748-7692.2011.00479.x; Lear WH, 1979, CAFSAC RES DOC, V79, P17; LEGGETT WC, 1978, J FISH RES BOARD CAN, V35, P1469, DOI 10.1139/f78-230; LONNE OJ, 1989, POLAR BIOL, V9, P187, DOI 10.1007/BF00297174; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Nahrgang J, 2010, MAR POLLUT BULL, V60, P1336, DOI 10.1016/j.marpolbul.2010.03.004; Nilsen F, 2008, CONT SHELF RES, V28, P1838, DOI 10.1016/j.csr.2008.04.015; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Renaud PE, 2012, POLAR BIOL, V35, P401, DOI 10.1007/s00300-011-1085-z; REZNICK DN, 1987, OECOLOGIA, V73, P401, DOI 10.1007/BF00385257; Sameoto DD, 1984, REV CURRENT INFORM A; Skjaeraasen JE, 2012, P NATL ACAD SCI USA, V109, P8995, DOI 10.1073/pnas.1200223109; Slagstad D, 2011, PROG OCEANOGR, V90, P117, DOI 10.1016/j.pocean.2011.02.009; Stearns S.C., 1992, pi; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wienerroither R, 2011, IMR PINRO JOINT REPO, V1-2011; YOUNG TP, 1981, AM NAT, V118, P27, DOI 10.1086/283798	56	48	48	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98452	10.1371/journal.pone.0098452	http://dx.doi.org/10.1371/journal.pone.0098452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871481	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300046
J	Rohlmann, A; Pohl, D; Bender, A; Graichen, F; Dymke, J; Schmidt, H; Bergmann, G				Rohlmann, Antonius; Pohl, David; Bender, Alwina; Graichen, Friedmar; Dymke, Joern; Schmidt, Hendrik; Bergmann, Georg			Activities of Everyday Life with High Spinal Loads	PLOS ONE			English	Article							VERTEBRAL BODY REPLACEMENT; MEASURED IN-VIVO; INTRADISCAL PRESSURE; LUMBAR SPINE; DISK PRESSURE; IMPLANT; ELEMENT; WALKING; WEIGHT; HEIGHT	Activities with high spinal loads should be avoided by patients with back problems. Awareness about these activities and knowledge of the associated loads are important for the proper design and pre-clinical testing of spinal implants. The loads on an instrumented vertebral body replacement have been telemetrically measured for approximately 1000 combinations of activities and parameters in 5 patients over a period up to 65 months postoperatively. A database containing, among others, extreme values for load components in more than 13,500 datasets was searched for 10 activities that cause the highest resultant force, bending moment, torsional moment, or shear force in an anatomical direction. The following activities caused high resultant forces: lifting a weight from the ground, forward elevation of straight arms with a weight in hands, moving a weight laterally in front of the body with hanging arms, changing the body position, staircase walking, tying shoes, and upper body flexion. All activities have in common that the center of mass of the upper body was moved anteriorly. Forces up to 1650 N were measured for these activities of daily life. However, there was a large intra-and inter-individual variation in the implant loads for the various activities depending on how exercises were performed. Measured shear forces were usually higher in the posterior direction than in the anterior direction. Activities with high resultant forces usually caused high values of other load components.	[Rohlmann, Antonius; Pohl, David; Bender, Alwina; Graichen, Friedmar; Dymke, Joern; Schmidt, Hendrik; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohlmann, A (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	antonius.rohlmann@charite.de	Rohlmann, Antonius/E-4778-2011	Rohlmann, Antonius/0000-0002-0083-2793; Schmidt, Hendrik/0000-0003-3300-8685; Bender, Alwina/0000-0002-4444-6309	Deutsche Forschungsgemeinschaft [Ro 581/18-1, Ro 581/20-1, Schm 2572/3-1]; Deutsche Arthrose-Hilfe, Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe, Frankfurt	Funding for this study was obtained from the Deutsche Forschungsgemeinschaft [Ro 581/18-1, Ro 581/20-1 and Schm 2572/3-1] and the Deutsche Arthrose-Hilfe, Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON GBJ, 1977, CLIN ORTHOP RELAT R, P156; BRINCKMANN P, 1991, SPINE, V16, P641, DOI 10.1097/00007632-199106000-00008; CHOLEWICKI J, 1994, J BIOMECH, V27, P1287, DOI 10.1016/0021-9290(94)90282-8; Dreischarf M, 2013, MED ENG PHYS, V35, P1385, DOI 10.1016/j.medengphy.2013.03.007; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Han KS, 2013, MED ENG PHYS, V35, P969, DOI 10.1016/j.medengphy.2012.09.009; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Marras WS, 2009, ERGONOMICS, V52, P384, DOI 10.1080/00140130802376075; McGill SM, 2013, ERGONOMICS, V56, P293, DOI 10.1080/00140139.2012.752528; NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Rohlmann A, 1997, J BIOMECH, V30, P41, DOI 10.1016/S0021-9290(96)00103-0; Rohlmann A, 2014, GAIT POSTURE, V39, P750, DOI 10.1016/j.gaitpost.2013.10.010; Rohlmann A, 2013, EUR SPINE J, V22, P2575, DOI 10.1007/s00586-013-3057-1; Rohlmann A, 2012, CLIN BIOMECH, V27, P754, DOI 10.1016/j.clinbiomech.2012.04.006; Rohlmann A, 2001, ERGONOMICS, V44, P781, DOI 10.1080/00140130120943; Rohlmann A, 2000, J BIOMECH, V33, P1099, DOI 10.1016/S0021-9290(00)00075-0; Rohlmann A, 2007, MED ENG PHYS, V29, P580, DOI 10.1016/j.medengphy.2006.06.012; Rohlmann A, 2013, J BIOMECH, V46, P511, DOI 10.1016/j.jbiomech.2012.10.022; Rohlmann A, 2011, SPINE J, V11, P870, DOI 10.1016/j.spinee.2011.06.017; Rohlmann A, 2010, EUR SPINE J, V19, P1129, DOI 10.1007/s00586-010-1346-5; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; SCHULTZ AB, 1981, SPINE, V6, P76, DOI 10.1097/00007632-198101000-00017; Shirazi-Adl A, 2006, J BIOMECH, V39, P267, DOI 10.1016/j.jbiomech.2004.11.022; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0	26	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98510	10.1371/journal.pone.0098510	http://dx.doi.org/10.1371/journal.pone.0098510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866883	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100062
J	Garderes, J; Henry, J; Bernay, B; Ritter, A; Zatylny-Gaudin, C; Wiens, M; Muller, WEG; Le Pennec, G				Garderes, Johan; Henry, Joel; Bernay, Benoit; Ritter, Andres; Zatylny-Gaudin, Celine; Wiens, Matthias; Mueller, Werner E. G.; Le Pennec, Gael			Cellular Effects of Bacterial N-3-Oxo-Dodecanoyl-(L)-Homoserine Lactone on the Sponge Suberites domuncula (Olivi, 1792): Insights into an Intimate Inter-Kingdom Dialogue	PLOS ONE			English	Article							INNATE IMMUNE DEFENSE; N-3-OXODODECANOYL HOMOSERINE LACTONE; SENSING SIGNAL MOLECULE; N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; RETINA COGNIN; QUORUM; COFILIN; EXPRESSION; INDUCTION; EVOLUTION	Sponges and bacteria have lived together in complex consortia for 700 million years. As filter feeders, sponges prey on bacteria. Nevertheless, some bacteria are associated with sponges in symbiotic relationships. To enable this association, sponges and bacteria are likely to have developed molecular communication systems. These may include molecules such as N-acyl-(L)-homoserine lactones, produced by Gram-negative bacteria also within sponges. In this study, we examined the role of N-3-oxododecanoyl-(L)-homoserine lactone (3-oxo-C-12-HSL) on the expression of immune and apoptotic genes of the host sponge Suberites domuncula. This molecule seemed to inhibit the sponge innate immune system through a decrease of the expression of genes coding for proteins sensing the bacterial membrane: a Toll-Like Receptor and a Toll-like Receptor Associated Factor 6 and for an anti-bacterial perforin-like molecule. The expression of the pro-apoptotic caspase-like 3/7 gene decreased as well, whereas the level of mRNA of anti-apoptotic genes Bcl-2 Homolog Proteins did not change. Then, we demonstrated the differential expression of proteins in presence of this 3-oxo-C-12-HSL using 3D sponge cell cultures. Proteins involved in the first steps of the endocytosis process were highlighted using the 2D electrophoresis protein separation and the MALDI-TOF/TOF protein characterization: alpha and beta subunits of the lysosomal ATPase, a cognin, cofilins-related proteins and cytoskeleton proteins actin, alpha tubulin and alpha actinin. The genetic expression of some of these proteins was subsequently followed. We propose that the 3-oxo-C-12-HSL may participate in the tolerance of the sponge apoptotic and immune systems towards the presence of bacteria. Besides, the sponge may sense the 3-oxo-C-12-HSL as a molecular evidence of the bacterial presence and/or density in order to regulate the populations of symbiotic bacteria in the sponge. This study is the first report of a bacterial secreted molecule acting on sponge cells and regulating the symbiotic relationship.	[Garderes, Johan; Le Pennec, Gael] Univ Bretagne Sud, Lab Biotechnol & Chim Marines, EA 3884, Inst Univ Europeen Mer, Lorient, France; [Henry, Joel; Zatylny-Gaudin, Celine] Univ Caen Basse Normandie, CNRS INEE FRE 3484, Lab Mollusques Marins & Ecosyst Associes, Caen, France; [Bernay, Benoit] Univ Caen Basse Normandie, SF ICORE 4206, Post Genom Platform PROTEOGEN, Caen, France; [Ritter, Andres] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Wiens, Matthias; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, European Res Council Adv Investigator Grant Res G, D-55122 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Caen Normandie; Universite de Caen Normandie; Pontificia Universidad Catolica de Chile; Johannes Gutenberg University of Mainz	Le Pennec, G (corresponding author), Univ Bretagne Sud, Lab Biotechnol & Chim Marines, EA 3884, Inst Univ Europeen Mer, Lorient, France.	gael.le-pennec@univ-ubs.fr	Müller, W. E. G./AAR-8651-2020	Müller, W. E. G./0000-0002-8223-3689; Wiens, Matthias/0000-0001-9219-0478; Zatylny-Gaudin, Celine/0000-0001-9258-9876; Ritter, Andres/0000-0001-7011-6824; GARDERES, Johan/0000-0002-0934-8041	Ministere de la Recherche et de l'Enseignement Superieur, France; Axis 1 (Genomics and Blue Chemistry) of the GIS Europole Mer; Region Bretagne; European FEDER	Ministere de la Recherche et de l'Enseignement Superieur, France; Axis 1 (Genomics and Blue Chemistry) of the GIS Europole Mer; Region Bretagne(Region Bretagne); European FEDER(European Commission)	JG was the recipient of a PhD fellowship from the Ministere de la Recherche et de l'Enseignement Superieur, France. This project was funded by the Axis 1 (Genomics and Blue Chemistry) of the GIS Europole Mer. The LBCM is supported by the Region Bretagne and European FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 1997, J CELL SCI, V110, P2333; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Bamburg JR, 2011, MOL MICROBIOL, V81, P851, DOI 10.1111/j.1365-2958.2011.07759.x; Bohm M, 2001, MAR BIOL, V139, P1037; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Bryan A, 2010, MICROBES INFECT, V12, P1042, DOI 10.1016/j.micinf.2010.07.006; Chantzoura E, 2010, BIOCHEM BIOPH RES CO, V403, P335, DOI 10.1016/j.bbrc.2010.11.029; de Bary HA, 1879, ERSCHEINUNG SYMBIOSE; Fu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-600; Garderes J, 2012, MAR BIOL, V159, P1685, DOI 10.1007/s00227-012-1956-z; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463-6470.2004; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lawrence RN, 1999, BRIT J PHARMACOL, V128, P845, DOI 10.1038/sj.bjp.0702870; Le Pennec G, 2003, J BIOTECHNOL, V100, P93, DOI 10.1016/S0168-1656(02)00259-6; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; May RC, 2001, J CELL SCI, V114, P1061; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P75, DOI 10.1111/j.1462-2920.2007.01431.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller Werner E. G., 2009, V47, P55, DOI 10.1007/978-3-540-88552-8_3; Muller WEG, 2004, PROG MOL SUBCELL BIO, V34, P103; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Pariser HP, 1998, DEV BRAIN RES, V111, P1, DOI 10.1016/S0165-3806(98)00113-8; Pariser HP, 2000, EXP CELL RES, V258, P42, DOI 10.1006/excr.2000.4931; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Tang L, 2011, ARCH ORAL BIOL, V56, P1064, DOI 10.1016/j.archoralbio.2011.02.020; Taylor MW, 2004, APPL ENVIRON MICROB, V70, P4387, DOI 10.1128/AEM.70.7.4387-4389.2004; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Thakur NL, 2005, MAR BIOL, V146, P271, DOI 10.1007/s00227-004-1438-z; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Vikstrom E, 2005, MICROBES INFECT, V7, P1512, DOI 10.1016/j.micinf.2005.05.012; Vikstrom E, 2006, FEBS LETT, V580, P6921, DOI 10.1016/j.febslet.2006.11.057; Wagner C, 2007, ANAL BIOANAL CHEM, V387, P481, DOI 10.1007/s00216-006-0698-5; Wiens M, 2005, J BIOL CHEM, V280, P27949, DOI 10.1074/jbc.M504049200; Wiens M, 2004, IMMUNOGENETICS, V56, P597, DOI 10.1007/s00251-004-0718-6; Wiens M, 2007, MOL BIOL EVOL, V24, P792, DOI 10.1093/molbev/msl208; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Zan JD, 2012, MOL MICROBIOL, V85, P916, DOI 10.1111/j.1365-2958.2012.08149.x; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; Zhang XY, 2004, BIOTECHNOL PROGR, V20, P151, DOI 10.1021/bp0341601	51	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97662	10.1371/journal.pone.0097662	http://dx.doi.org/10.1371/journal.pone.0097662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858701	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400023
J	Croci, I; Borrani, F; Byrne, N; Wood, R; Hickman, I; Cheneviere, X; Malatesta, D				Croci, Ilaria; Borrani, Fabio; Byrne, Nuala; Wood, Rachel; Hickman, Ingrid; Cheneviere, Xavier; Malatesta, Davide			Reproducibility of Fat(max) and Fat Oxidation Rates during Exercise in Recreationally Trained Males	PLOS ONE			English	Article							SUBSTRATE UTILIZATION; WIDE-RANGE; BODY FAT; INTENSITY; RELIABILITY; CARBOHYDRATE; METABOLISM; OVERWEIGHT; KINETICS; VALIDITY	Aerobic exercise training performed at the intensity eliciting maximal fat oxidation (Fat(max)) has been shown to improve the metabolic profile of obese patients. However, limited information is available on the reproducibility of Fat(max) and related physiological measures. The aim of this study was to assess the intra-individual variability of: a) Fat(max) measurements determined using three different data analysis approaches and b) fat and carbohydrate oxidation rates at rest and at each stage of an individualized graded test. Fifteen healthy males [body mass index 23.1 +/- 0.6 kg/m(2), maximal oxygen consumption ((V) over dotO(2max)) 52.0 +/- 2.0 ml/kg/min] completed a maximal test and two identical submaximal incremental tests on ergocycle (30-min rest followed by 5-min stages with increments of 7.5% of the maximal power output). Fat and carbohydrate oxidation rates were determined using indirect calorimetry. Fat(max) was determined with three approaches: the sine model (SIN), measured values (MV) and 3rd polynomial curve (P3). Intra-individual coefficients of variation (CVs) and limits of agreement were calculated. CV for Fat(max) determined with SIN was 16.4% and tended to be lower than with P3 and MV (18.6% and 20.8%, respectively). Limits of agreement for Fat(max) were -2 +/- 27% of (V) over dotO(2max) with SIN, -4 +/- 32 with P3 and -4 +/- 28 with MV. CVs of oxygen uptake, carbon dioxide production and respiratory exchange rate were <10% at rest and <5% during exercise. Conversely, CVs of fat oxidation rates (20% at rest and 24-49% during exercise) and carbohydrate oxidation rates (33.5% at rest, 8.5-12.9% during exercise) were higher. The intra-individual variability of Fat(max) and fat oxidation rates was high (CV>15%), regardless of the data analysis approach employed. Further research on the determinants of the variability of Fat(max) and fat oxidation rates is required.	[Croci, Ilaria; Hickman, Ingrid] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Croci, Ilaria] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia; [Borrani, Fabio; Cheneviere, Xavier; Malatesta, Davide] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland; [Borrani, Fabio; Malatesta, Davide] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Byrne, Nuala; Wood, Rachel] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Byrne, Nuala] Bond Univ, Bond Inst ofHealth & Sport, Robina, Australia; [Hickman, Ingrid] Princess Alexandra Hosp, Dept Nutr & Dietet, Brisbane, Qld 4102, Australia; [Hickman, Ingrid] Mater Mothers Hosp, Mater Med Res Inst, Brisbane, Qld, Australia; [Cheneviere, Xavier] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	University of Queensland; University of Queensland; University of Lausanne; University of Lausanne; Queensland University of Technology (QUT); Bond University; Mater Research; University of Fribourg	Croci, I (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia.	ilaria.croci@uqconnect.edu.au	Croci, Ilaria/M-4452-2013; Malatesta, Davide/G-5812-2012; Hickman, Ingrid J/P-8364-2016; Wood, Rachel/O-1410-2017	Malatesta, Davide/0000-0003-3905-5642; Croci, Ilaria/0000-0002-3661-2290; Hickman, Ingrid J/0000-0003-3205-9165; Byrne, Nuala/0000-0001-5310-6640; Wood, Rachel/0000-0001-7053-6319; Cheneviere, Xavier/0000-0003-4755-840X; Wood, Rachel/0000-0003-0208-6330				Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231; Achten J, 2003, INT J SPORTS MED, V24, P603, DOI 10.1055/s-2003-43265; Achten J, 2003, METABOLISM, V52, P747, DOI 10.1016/S0026-0495(03)00068-4; Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Aucouturier J, 2009, EUR J APPL PHYSIOL, V105, P325, DOI 10.1007/s00421-008-0907-3; Brandou F, 2005, DIABETES METAB, V31, P327, DOI 10.1016/S1262-3636(07)70201-X; Brandou F, 2003, DIABETES METAB, V29, P20, DOI 10.1016/S1262-3636(07)70003-4; Carter J, 2002, EUR J APPL PHYSIOL, V86, P435, DOI 10.1007/s00421-001-0572-2; Cheneviere X, 2010, EUR J APPL PHYSIOL, V109, P1037, DOI 10.1007/s00421-010-1443-5; Cheneviere X, 2009, MED SCI SPORT EXER, V41, P1615, DOI 10.1249/MSS.0b013e31819e2f91; Crisp NA, 2012, EUR J APPL PHYSIOL, V112, P2557, DOI 10.1007/s00421-011-2232-5; Croci I, 2013, GUT, V62, P1625, DOI 10.1136/gutjnl-2012-302789; Dumortier M, 2003, DIABETES METAB, V29, P509, DOI 10.1016/S1262-3636(07)70065-4; DURNIN JVG, 1973, P NUTR SOC, V32, pA45; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gasic S, 1997, HORM METAB RES, V29, P12, DOI 10.1055/s-2007-978972; Gmada N, 2012, DIABETES METAB, V38, P40, DOI 10.1016/j.diabet.2011.07.004; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Kang J, 2009, EUR J APPL PHYSIOL, V107, P43, DOI 10.1007/s00421-009-1100-z; MACRAE HSH, 1995, EUR J APPL PHYSIOL O, V71, P523, DOI 10.1007/BF00238555; Maurie J, 2011, SCI SPORT, V26, P92, DOI 10.1016/j.scispo.2010.12.002; Meyer T, 2009, SCAND J MED SCI SPOR, V19, P213, DOI 10.1111/j.1600-0838.2008.00775.x; Michallet AS, 2008, DIABETES METAB, V34, P514, DOI 10.1016/j.diabet.2008.04.004; Perez-Martin A, 2001, DIABETES METAB, V27, P466; Roffey DM, 2006, JPEN-PARENTER ENTER, V30, P426, DOI 10.1177/0148607106030005426; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Schwindling S, 2013, INT J SPORTS MED; Stisen AB, 2006, EUR J APPL PHYSIOL, V98, P497, DOI 10.1007/s00421-006-0290-x; Takagi S, 2014, J SPORT SCI, V32, P175, DOI 10.1080/02640414.2013.815360; Tolfrey K, 2010, EUR J APPL PHYSIOL, V109, P1145, DOI 10.1007/s00421-010-1453-3; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003; Venables MC, 2008, MED SCI SPORT EXER, V40, P495, DOI 10.1249/MSS.0b013e31815f256f; Wood RE, 2010, MED SCI SPORT EXER, V42, P470, DOI 10.1249/MSS.0b013e3181b666ad	35	38	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97930	10.1371/journal.pone.0097930	http://dx.doi.org/10.1371/journal.pone.0097930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886715	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300028
J	Minervini, G; Panizzoni, E; Giollo, M; Masiero, A; Ferrari, C; Tosatto, SCE				Minervini, Giovanni; Panizzoni, Elisabetta; Giollo, Manuel; Masiero, Alessandro; Ferrari, Carlo; Tosatto, Silvio C. E.			Design and Analysis of a Petri Net Model of the Von Hippel-Lindau (VHL) Tumor Suppressor Interaction Network	PLOS ONE			English	Article							EXPRESSION; HIF-1-ALPHA; MUTATION; GLUCOSE; CANCER; PVHL; CELL; IDENTIFICATION; HIF-1; P53	Von Hippel-Lindau (VHL) syndrome is a hereditary condition predisposing to the development of different cancer forms, related to germline inactivation of the homonymous tumor suppressor pVHL. The best characterized function of pVHL is the ubiquitination dependent degradation of Hypoxia Inducible Factor (HIF) via the proteasome. It is also involved in several cellular pathways acting as a molecular hub and interacting with more than 200 different proteins. Molecular details of pVHL plasticity remain in large part unknown. Here, we present a novel manually curated Petri Net (PN) model of the main pVHL functional pathways. The model was built using functional information derived from the literature. It includes all major pVHL functions and is able to credibly reproduce VHL syndrome at the molecular level. The reliability of the PN model also allowed in silico knockout experiments, driven by previous model analysis. Interestingly, PN analysis suggests that the variability of different VHL manifestations is correlated with the concomitant inactivation of different metabolic pathways.	[Minervini, Giovanni; Panizzoni, Elisabetta; Giollo, Manuel; Masiero, Alessandro; Tosatto, Silvio C. E.] Univ Padua, Dept Biomed Sci, Padua, Italy; [Giollo, Manuel; Ferrari, Carlo] Univ Padua, Dept Informat Engn, Padua, Italy	University of Padua; University of Padua	Tosatto, SCE (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	silvio.tosatto@unipd.it	Ferrari, Carlo/AAU-8107-2021; Tosatto, Silvio/B-2840-2009; Minervini, Giovanni/D-1200-2013	Tosatto, Silvio/0000-0003-4525-7793; Minervini, Giovanni/0000-0001-7013-5785; FERRARI, CARLO/0000-0003-3665-0446	Associazione Italiana per la Ricerca sul Cancro(AIRC) [MFAG 12740]	Associazione Italiana per la Ricerca sul Cancro(AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro(AIRC) Grant MFAG 12740 to ST. GM is an AIRC research fellow (http://www.airc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Berndt JD, 2009, TRENDS BIOCHEM SCI, V34, P101, DOI 10.1016/j.tibs.2008.12.002; Bortfeldt Ralf H, 2011, Stud Health Technol Inform, V162, P244; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Stefanie G, 2008, BIOSYSTEMS, V92, P189, DOI 10.1016/j.biosystems.2008.02.005; Heather LC, 2013, CIRC-HEART FAIL, V6, P1058, DOI 10.1161/CIRCHEARTFAILURE.112.000342; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Heiner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008600; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim BY, 2008, EXP MOL MED, V40, P71, DOI 10.3858/emm.2008.40.1.71; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Leonardi E, 2009, FEBS LETT, V583, P3704, DOI 10.1016/j.febslet.2009.10.070; Leonardi E, 2011, ANN HUM GENET, V75, P483, DOI 10.1111/j.1469-1809.2011.00647.x; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Minervini G, 2013, FEBS LETT, V587, P2996, DOI 10.1016/j.febslet.2013.07.019; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Okabe T, 1998, Nihon Rinsho, V56, P1734; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Roe JS, 2006, CELL CYCLE, V5, P2054, DOI 10.4161/cc.5.18.3247; Rohr C, 2010, BIOINFORMATICS, V26, P974, DOI 10.1093/bioinformatics/btq050; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; TAKEDA J, 1993, DIABETES, V42, P773, DOI 10.2337/diabetes.42.5.773; Tang N, 2006, MOL CELL, V26, DOI [10.1128/MCB.26.7.2519, DOI 10.1128/MCB.26.7.2519]; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Thomas JG, 2001, GENOME RES, V11, P1227, DOI 10.1101/gr.165101; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vortmeyer A, 2002, ONCOGENE, V21, P1167, DOI 10.1038/sj.onc.1205121; Weitz JS, 2007, PLOS BIOL, V5, P10, DOI 10.1371/journal.pbio.0050011; Wu M, 2013, BIOINFORMATICS, V29, P1541, DOI 10.1093/bioinformatics/btt186; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; Zhu JL, 2000, MOL CELL ENDOCRINOL, V164, P205, DOI 10.1016/S0303-7207(00)00207-0	53	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e96986	10.1371/journal.pone.0096986	http://dx.doi.org/10.1371/journal.pone.0096986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886840	Green Published, gold			2022-12-27	WOS:000336956300010
J	Vilhelmsen, L; Zimmermann, D				Vilhelmsen, Lars; Zimmermann, Dominique			Baltorussus Total Makeover: Rejuvenation and Sex Change in an Ancient Parasitoid Wasp Lineage	PLOS ONE			English	Article							HYMENOPTERA INSECTA; ORUSSIDAE INSECTA; PHYLOGENY; MORPHOLOGY; EVOLUTION; FOSSILS; WAIST; AMBER; TREE	The Orussidae is a small and rare but phylogenetically important family of parasitoid wasps. The fossil record of the family is also very poor. Baltorussus velteni was described from Baltic amber from an allegedly female specimen. This and another recently discovered specimen are examined with microCT scanning and standard microscopy. We reveal that both the holotype and the new specimen are actually males. Furthermore, the results of the microCT scanning allow us to integrate the fossils in a morphological data set assembled for extant Orussidae. Phylogenetic analyses consistently retrieve Baltorussus as a separate basal lineage within the crown group, whereas two Cretaceous fossils are placed as stem group orussids and a Dominican amber fossil in an extant genus. Based on the positions of the fossils, we estimate that the extant Orussidae radiated in the mid-Cretaceous (approx. 100 Ma ago). This is considerably younger than a previously suggested Early Jurassic date (180 Ma ago), which was primarily based on biogeographic evidence.	[Vilhelmsen, Lars] Nat Hist Museum Denmark, Copenhagen, Denmark; [Zimmermann, Dominique] Nat Hist Museum Vienna, Zool Dept 2, Vienna, Austria		Vilhelmsen, L (corresponding author), Nat Hist Museum Denmark, Copenhagen, Denmark.	lbvilhelmsen@snm.ku.dk	Vilhelmsen, Lars/A-3396-2013; Vilhelmsen, Lars/AAC-6747-2020	Vilhelmsen, Lars/0000-0002-5593-5722; Vilhelmsen, Lars/0000-0002-5593-5722	University of Copenhagen; Natural History Museum Vienna	University of Copenhagen; Natural History Museum Vienna	The only funding going into this work is the salaries of the people involved, provided from the University of Copenhagen and the Natural History Museum Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basibuyuk Hasan H., 2000, P305; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Engel Michael S., 2008, Transactions of the Kansas Academy of Science, V111, P39, DOI 10.1660/0022-8443(2008)111[39:AOWWIA]2.0.CO;2; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grimaldi David, 2005, pi; KLEINTEICH T., 2008, P SPIE D, V7078D, P1; Klopfstein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069344; Maddison W. P., 2011, MESQUITE 2 75; Rasnitsyn A.P., 1969, T PALEONTOL I ACAD S, V123, P1; RASNITSYN AP, 1988, ORIENT INSECTS, V22, P115, DOI 10.1080/00305316.1988.11835485; Rasnitsyn AP, 1977, PALEONTOL J+, V11, P349; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross HH, 1937, ILLINOIS BIOL MONOGR, V15, P1, DOI DOI 10.5962/BHL.TITLE.50339; Schedl Wolfgang, 2011, Zeitschrift der Arbeitsgemeinschaft Oesterreichischer Entomologen, V63, P33; Schulmeister S, 2003, ORG DIVERS EVOL, V3, P253, DOI 10.1078/1439-6092-00078; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; SNODGRASS R. E., 1941, SMITHSONIAN MISC COLL, V99, P1; Vilhelmsen L, 2000, ZOOMORPHOLOGY, V119, P185, DOI 10.1007/PL00008493; Vilhelmsen L, 2004, BIOL J LINN SOC, V82, P139, DOI 10.1111/j.1095-8312.2004.00327.x; Vilhelmsen L, 2003, ZOOL J LINN SOC-LOND, V139, P337, DOI 10.1046/j.1096-3642.2003.00080.x; Vilhelmsen L, 2002, INSECT SYST EVOL, V33, P387, DOI 10.1163/187631202X00217; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; Vilhelmsen L, 1996, ZOOL SCR, V25, P143, DOI 10.1111/j.1463-6409.1996.tb00156.x; Vilhelmsen L, 2013, INVERTEBR SYST, V27, P450, DOI 10.1071/IS13006; Vilhelmsen L, 2011, ARTHROPOD STRUCT DEV, V40, P2, DOI 10.1016/j.asd.2010.10.001; Vilhelmsen L, 2010, ZOOL J LINN SOC-LOND, V159, P22, DOI 10.1111/j.1096-3642.2009.00576.x	29	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98412	10.1371/journal.pone.0098412	http://dx.doi.org/10.1371/journal.pone.0098412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887435	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300065
J	Helbo, S; Gow, AJ; Jamil, A; Howes, BD; Smulevich, G; Fago, A				Helbo, Signe; Gow, Andrew J.; Jamil, Amna; Howes, Barry D.; Smulevich, Giulietta; Fago, Angela			Oxygen-Linked S-Nitrosation in Fish Myoglobins: A Cysteine-Specific Tertiary Allosteric Effect	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTROSCOPY; AMINO-ACID-SEQUENCE; RAINBOW-TROUT; NITRIC-OXIDE; FUNCTIONAL-PROPERTIES; NITROSOHEMOGLOBIN; HEMOGLOBIN; BINDING; MODULATION; AFFINITY	The discovery that cysteine (Cys) S-nitrosation of trout myoglobin (Mb) increases heme O-2 affinity has revealed a novel allosteric effect that may promote hypoxia-induced nitric oxide (NO) delivery in the trout heart and improve myocardial efficiency. To better understand this allosteric effect, we investigated the functional effects and structural origin of S-nitrosation in selected fish Mbs differing by content and position of reactive cysteine (Cys) residues. The Mbs from the Atlantic salmon and the yellowfin tuna, containing two and one reactive Cys, respectively, were S-nitrosated in vitro by reaction with Cys-NO to generate Mb-SNO to a similar yield (similar to 0.50 SH/ heme), suggesting reaction at a specific Cys residue. As found for trout, salmon Mb showed a low O2 affinity (P-50 = 2.7 torr) that was increased by S-nitrosation (P-50 = 1.7 torr), whereas in tuna Mb, O-2 affinity (P-50 = 0.9 torr) was independent of S-nitrosation. O-2 dissociation rates (K-off) of trout and salmon Mbs were not altered when Cys were in the SNO or N-ethylmaleimide (NEM) forms, suggesting that S-nitrosation should affect O-2 affinity by raising the O-2 association rate (kon). Taken together, these results indicate that O-2-linked Snitrosation may occur specifically at Cys107, present in salmon and trout Mb but not in tuna Mb, and that it may relieve protein constraints that limit O-2 entry to the heme pocket of the unmodified Mb by a yet unknown mechanism. UV-Vis and resonance Raman spectra of the NEM-derivative of trout Mb (functionally equivalent to Mb-SNO and not photolabile) were identical to those of the unmodified Mb, indicating that S-nitrosation does not affect the extent or nature of heme-ligand stabilization of the fully ligated protein. The importance of S-nitrosation of Mb in vivo is confirmed by the observation that Mb-SNO is present in trout hearts and that its level can be significantly reduced by anoxic conditions.	[Helbo, Signe; Fago, Angela] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Gow, Andrew J.; Jamil, Amna] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Howes, Barry D.; Smulevich, Giulietta] Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, FI, Italy	Aarhus University; Rutgers State University New Brunswick; University of Florence	Fago, A (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	angela.fago@biology.au.dk	Fago, Angela/J-5946-2013; Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013	Fago, Angela/0000-0001-7315-2628; Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Smulevich, Giulietta/0000-0003-3021-8919	Danish Council for Independent Research, Natural Sciences [10-084565]; Lundbeck foundation; Local Italian grants; National Institute of Health (NIH) [HL086621]; Summer Undergraduate Research Fellowship (SURF) Program at Rutgers University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R25ES020721] Funding Source: NIH RePORTER	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck foundation(Lundbeckfonden); Local Italian grants; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Undergraduate Research Fellowship (SURF) Program at Rutgers University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Danish Council for Independent Research, Natural Sciences (grant 10-084565 to AF) the Lundbeck foundation (to AF), by the Local Italian grants (ex 60%) (to GS), by the National Institute of Health (NIH grant HL086621 to AJG), and the Summer Undergraduate Research Fellowship (SURF) Program at Rutgers University (to AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2013, BBA-PROTEINS PROTEOM, V1834, P1750, DOI 10.1016/j.bbapap.2013.02.012; Bonaventura C, 1999, J BIOL CHEM, V274, P24742, DOI 10.1074/jbc.274.35.24742; BOUTILIER RG, 1984, FISH PHYSIOL, V10, P403; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Fago A, 2013, BBA-PROTEINS PROTEOM, V1834, P1894, DOI 10.1016/j.bbapap.2013.04.017; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Giardina B, 1996, J BIOL CHEM, V271, P16999, DOI 10.1074/jbc.271.29.16999; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Gros G, 2010, J EXP BIOL, V213, P2713, DOI 10.1242/jeb.043075; HARTMUND T, 1995, J COMP PHYSIOL B, V165, P219, DOI 10.1007/BF00260813; Helbo S, 2013, BBA-PROTEINS PROTEOM, V1834, P1832, DOI 10.1016/j.bbapap.2013.01.037; Helbo S, 2013, COMP BIOCHEM PHYS A, V165, P40, DOI 10.1016/j.cbpa.2013.01.020; Helbo S, 2012, J EXP BIOL, V215, P3403, DOI 10.1242/jeb.073726; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; Helbo S, 2011, AM J PHYSIOL-REG I, V300, pR101, DOI 10.1152/ajpregu.00374.2010; Howes BD, 2012, J INORG BIOCHEM, V109, P1, DOI 10.1016/j.jinorgbio.2012.01.007; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Madden PW, 2004, COMP BIOCHEM PHYS B, V137, P341, DOI 10.1016/j.cbpc.2003.12.008; MAEDA N, 1981, J BIOL CHEM, V256, P4301; Marcinek DJ, 2001, AM J PHYSIOL-REG I, V280, pR1123, DOI 10.1152/ajpregu.2001.280.4.R1123; Patel RP, 1999, J BIOL CHEM, V274, P15487, DOI 10.1074/jbc.274.22.15487; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Pedersen CL, 2010, J EXP BIOL, V213, P2755, DOI 10.1242/jeb.041624; Rayner BS, 2005, J BIOL CHEM, V280, P9985, DOI 10.1074/jbc.M410564200; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; SPIRO TG, 1985, ADV PROTEIN CHEM, V37, P111, DOI 10.1016/S0065-3233(08)60064-9; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; WATTS DA, 1983, BIOCHIM BIOPHYS ACTA, V742, P310, DOI 10.1016/0167-4838(83)90316-3; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97012	10.1371/journal.pone.0097012	http://dx.doi.org/10.1371/journal.pone.0097012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879536	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500010
J	Kim, A; Im, M; Yim, NH; Kim, T; Ma, JY				Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Kim, Taesoo; Ma, Jin Yeul			A Novel Herbal Medicine, KIOM-C, Induces Autophagic and Apoptotic Cell Death Mediated by Activation of JNK and Reactive Oxygen Species in HT1080 Human Fibrosarcoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CANCER-CELLS; NONCANONICAL AUTOPHAGY; INDUCTION; PATHWAYS; CHEMOTHERAPY; INHIBITION; CROSSTALK; SURVIVAL; GROWTH	KIOM-C was recently demonstrated to have anti-metastatic activity in highly malignant cancer cells via suppression of NF-kappa B-mediated MMP-9 activity. In addition, it was reported to be effective for clearance of the influenza virus by increasing production of anti-viral cytokines, such as TNF-alpha and IFN-gamma, and efficacious in the treatment of pigs suffering from porcine circovirus-associated disease (PCVAD). In this study, we investigated whether KIOM-C induces cancer cell death and elucidated the underlying anti-cancer mechanisms. In addition, we examined whether KIOM-C oral administration suppresses in vivo tumor growth of HT1080 cells in athymic nude mice. We initially found that KIOM-C at concentrations of 500 and 1000 mu g/ml caused dose- and time-dependent cell death in cancer cells, but not normal hepatocytes, to approximately 50% of control levels. At the early stage of KIOM-C treatment (12 h), cells were arrested in G(1) phase, which was accompanied by up-regulation of p21 and p27, down-regulation of cyclin D1, and subsequent increases in apoptotic and autophagic cells. Following KIOM-C treatment, the extent of caspase-3 activation, PARP cleavage, Beclin-1 expression, and LC3-II conversion was remarkably up-regulated, but p62 expression was down-regulated. Phosphorylation of AMPK, ULK, JNK, c-jun, and p53 was increased significantly in response to KIOM-C treatment. The levels of intracellular ROS and CHOP expression were also increased. In particular, the JNK-specific inhibitor SP600125 blocked KIOM-C-induced ROS generation and CHOP expression almost completely, which consequently almost completely rescued cell death, indicating that JNK activation plays a critical role in KIOM-C-induced cell death. Furthermore, daily oral administration of 85 and 170 mg/kg KIOM-C efficiently suppressed the tumorigenic growth of HT1080 cells, without systemic toxicity. These results collectively suggest that KIOM-C efficiently induces cancer cell death by both autophagy and apoptosis via activation of JNK signaling pathways, and KIOM-C represents a safe and potent herbal therapy for treating malignancies.	[Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Kim, Taesoo; Ma, Jin Yeul] KIOM, KM Based Herbal Drug Dev Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ma, JY (corresponding author), KIOM, KM Based Herbal Drug Dev Grp, Taejon, South Korea.	jyma@kiom.re.kr			Ministry of Education, Science and Technology (MEST), Republic of Korea [K13050]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by a Grant K13050 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Chung TaeHo, 2012, Journal of Medicinal Plants Research, V6, P4456, DOI 10.5897/JMPR10.691; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Duan WJ, 2010, J PHARMACOL SCI, V113, P48, DOI 10.1254/jphs.09315FP; Evans T, 2005, SEM RESP CRIT CARE M, V26, P304, DOI 10.1055/s-2005-871989; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; GIOVARELLI M, 1986, INT J CANCER, V37, P141, DOI 10.1002/ijc.2910370122; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Haberzettl P, 2013, REDOX BIOL, V1, P56, DOI 10.1016/j.redox.2012.10.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kim A, 2014, ONCOL REP, V31, P287, DOI 10.3892/or.2013.2822; Kim EH, 2013, ANTIVIR RES, V98, P386, DOI 10.1016/j.antiviral.2013.04.006; Kiyohara H, 2004, EVID-BASED COMPL ALT, V1, P83, DOI 10.1093/ecam/neh004; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Liu YL, 2010, AUTOPHAGY, V6, P1057, DOI 10.4161/auto.6.8.13365; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Park SH, 2013, FOOD CHEM TOXICOL, V56, P100, DOI 10.1016/j.fct.2013.02.022; Petrylak DP, 2005, UROLOGY, V65, P3, DOI 10.1016/j.urology.2005.03.053; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tan ML, 2009, PHARM RES-DORDR, V26, P1547, DOI 10.1007/s11095-009-9895-1; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Trejo-Solis C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-156; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Zhang YH, 2009, ARCH BIOCHEM BIOPHYS, V489, P25, DOI 10.1016/j.abb.2009.07.017; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	41	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98703	10.1371/journal.pone.0098703	http://dx.doi.org/10.1371/journal.pone.0098703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878898	Green Submitted, gold, Green Published			2022-12-27	WOS:000338101500080
J	Mei, PJ; Bai, J; Shi, ML; Liu, QH; Li, ZL; Fan, YC; Zheng, JN				Mei, Pengjin; Bai, Jin; Shi, Meilin; Liu, Qinghua; Li, Zhonglin; Fan, Yuechao; Zheng, Junnian			RETRACTED: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							BREAST-CANCER-METASTASIS; CARCINOMA METASTASIS; MESSENGER-RNA; HUMAN-MELANOMA; EXPRESSION; GENE; PROLIFERATION; TRANSCRIPTION	Breast cancer metastasis suppressor 1 (BRMS1) is a metastasis suppressor gene in several solid tumors. However, the expression and function of BRMS1 in glioma have not been reported. In this study, we investigated whether BRMS1 play a role in glioma pathogenesis. Using the tissue microarray technology, we found that BRMS1 expression is significantly decreased in glioma compared with tumor adjacent normal brain tissue (P<0.01, chi(2) test) and reduced BRMS1 staining is associated with WHO stages (P<0.05, chi(2) test). We also found that BRMS1 was significantly downregulated in glioma cell lines compared to normal human astrocytes (P<0.01, chi(2) test). Furthermore, we demonstrated that BRMS1 overexpression inhibited glioma cell invasion by suppressing uPA, NF-kappa B, MMP-2 expression and MMP-2 enzyme activity. Moreover, our data showed that overexpression of BRMS1 inhibited glioma cell migration and adhesion capacity compared with the control group through the Src-FAK pathway. Taken together, this study suggested that BRMS1 has a role in glioma development and progression by regulating invasion, migration and adhesion activities of cancer cells.	[Mei, Pengjin; Li, Zhonglin; Fan, Yuechao] Xuzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China; [Mei, Pengjin; Bai, Jin; Shi, Meilin; Liu, Qinghua; Zheng, Junnian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou, Jiangsu, Peoples R China; [Zheng, Junnian] Xuzhou Med Coll, Affiliated Hosp, Dept Med Oncol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Fan, YC (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China.	fanyuechaoxyfy@163.com; jnzheng@xzmc.edu.cn			National Natural Science Foundation of China [81372460]; Science and Technology Department of Jiangsu province [BK20131120]; Health Department Foundation of Jiangsu province [H201019]; Key University Science Research Project of Jiangsu Province [11KJA320002, 12KJA320001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jiangsu province; Health Department Foundation of Jiangsu province; Key University Science Research Project of Jiangsu Province	This project is supported by grants from the National Natural Science Foundation of China (No. 81372460), the Science and Technology Department of Jiangsu province (No. BK20131120), the Health Department Foundation of Jiangsu province (No. H201019) and the Key University Science Research Project of Jiangsu Province (Nos. 11KJA320002, 12KJA320001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 1998, Pathol Oncol Res, V4, P230; Bai J, 2012, J CANCER RES CLIN, V138, P991, DOI 10.1007/s00432-012-1172-8; Bianchi-Smiraglia A, 2012, ONCOGENE; Chen XP, 2011, INT J BIOL MARKER, V26, P1, DOI 10.5301/JBM.2011.6267; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2009, CLIN EXP METASTAS, V26, P229, DOI 10.1007/s10585-009-9235-1; Cui RX, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-376; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DeWald DB, 2005, CANCER RES, V65, P713; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Hecker TP, 2002, CANCER RES, V62, P2699; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Lamszus K, 2001, INT J CANCER, V91, P803, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1134>3.0.CO;2-P; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Li J, 2011, ONCOGENE, V30, P896, DOI 10.1038/onc.2010.470; Liu JL, 2013, J NEURO-ONCOL, V111, P245, DOI 10.1007/s11060-012-1018-x; Lombardi G, 2007, INT J CANCER, V120, P1169, DOI 10.1002/ijc.22379; Mei PJ, 2011, J CANCER RES CLIN, V137, P1823, DOI 10.1007/s00432-011-1063-4; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Oliveira-Ferrer L, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-86; Radner H, 2002, PATHOLOGE, V23, P260, DOI 10.1007/s00292-002-0530-8; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Seraj MJ, 2000, CANCER RES, V60, P2764; Seraj MJ, 2001, CLIN EXP METASTAS, V18, P519, DOI 10.1023/A:1011819621859; Sheng XJ, 2012, ONCOL REP, V27, P1011, DOI 10.3892/or.2011.1596; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Slanina H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039613; Slipicevic A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-73; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Stark AM, 2005, J CANCER RES CLIN, V131, P191, DOI 10.1007/s00432-004-0629-9; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sun Zeng-feng, 2012, Zhonghua Zhong Liu Za Zhi, V34, P26; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tomkiewicz C, 2012, ONCOGENE; Wang Q, 2013, J NEURO-ONCOL, V112, P73, DOI 10.1007/s11060-013-1045-2; Wu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042976; Xiao-Bao J, 2013, BIOL PHARM B; Zainabadi K, 2005, GENOMICS, V85, P704, DOI 10.1016/j.ygeno.2005.02.014; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x; Zhang ZH, 2006, CLIN CANCER RES, V12, P6410, DOI 10.1158/1078-0432.CCR-06-1347; Zhao Xiao-lan, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P82; Zhao XL, 2011, SICHUAN DA XUE XUE B, V42, P105	43	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98544	10.1371/journal.pone.0098544	http://dx.doi.org/10.1371/journal.pone.0098544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879377	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500068
J	Pereira, JL; Queiroz, RML; Charneau, SO; Felix, CR; Ricart, CAO; da Silva, FL; Steindorff, AS; Ulhoa, CJ; Noronha, EF				Pereira, Jackeline L.; Queiroz, Rayner M. L.; Charneau, Sebastien O.; Felix, Carlos R.; Ricart, Carlos A. O.; da Silva, Francilene Lopes; Steindorff, Andrei Stecca; Ulhoa, Cirano J.; Noronha, Eliane F.			Analysis of Phaseolus vulgaris Response to Its Association with Trichoderma harzianum (ALL-42) in the Presence or Absence of the Phytopathogenic Fungi Rhizoctonia solani and Fusarium solani	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CINNAMOYL-COA REDUCTASE; ARABIDOPSIS-THALIANA; PROTEOMIC ANALYSIS; SYSTEMIC RESISTANCE; DIFFERENTIAL EXPRESSION; PSEUDOMONAS-SYRINGAE; BIOCONTROL ACTIVITY; DEFENSE RESPONSES; GENE-EXPRESSION	The present study was carried out to evaluate the ability of Trichoderma harzianum (ALL 42-isolated from Brazilian Cerrado soil) to promote common bean growth and to modulate its metabolism and defense response in the presence or absence of the phytopathogenic fungi Rhizoctonia solani and Fusarium solani using a proteomic approach. T. harzianum was able to promote common bean plants growth as shown by the increase in root/foliar areas and by size in comparison to plants grown in its absence. The interaction was shown to modulate the expression of defense-related genes (Glu1, pod3 and lox1) in roots of P. vulgaris. Proteomic maps constructed using roots and leaves of plants challenged or unchallenged by T. harzianum and phytopathogenic fungi showed differences. Reference gels presented differences in spot distribution (absence/presence) and relative volumes of common spots (up or down-regulation). Differential spots were identified by peptide fingerprinting MALDI-TOF mass spectrometry. A total of 48 identified spots (19 for leaves and 29 for roots) were grouped into protein functional classes. For leaves, 33%, 22% and 11% of the identified proteins were categorized as pertaining to the groups: metabolism, defense response and oxidative stress response, respectively. For roots, 17.2%, 24.1% and 10.3% of the identified proteins were categorized as pertaining to the groups: metabolism, defense response and oxidative stress response, respectively.	[Pereira, Jackeline L.; Queiroz, Rayner M. L.; Charneau, Sebastien O.; Felix, Carlos R.; Ricart, Carlos A. O.; da Silva, Francilene Lopes; Steindorff, Andrei Stecca; Noronha, Eliane F.] Univ Brasilia UNB, Dept Cellular Biol, Brasilia, DF, Brazil; [Ulhoa, Cirano J.] Fed Univ Goias UFG, Inst Biol Sci, Goiania, Go, Brazil	Universidade de Brasilia; Universidade Federal de Goias	Ulhoa, CJ (corresponding author), Fed Univ Goias UFG, Inst Biol Sci, Goiania, Go, Brazil.	ulhoa@icb.ufg.br	Ulhoa, CIRANO/AAV-9374-2020; Noronha, Eliane F./D-4812-2016; Steindorff, Andrei Stecca/I-3084-2013; Charneau, Sébastien/AAD-1145-2019	Steindorff, Andrei Stecca/0000-0002-2052-2848; Charneau, Sébastien/0000-0002-9364-7289; Noronha, Eliane Ferreira/0000-0002-4081-4979; Ulhoa, Cirano/0000-0002-4171-6465	Research and Projects Financing (FINEP); National Council for Scientific and Technological Development (CNPq) [FINEP/CT-AGRO AGRO/Acao Transversal - 01.07.0551.00/Ref. 0845/07]; FAPDF; FAPEGO. (Foundation for research support fromGoias state, Brazil)	Research and Projects Financing (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEGO. (Foundation for research support fromGoias state, Brazil)	This work was funded by Research and Projects Financing (FINEP), National Council for Scientific and Technological Development (CNPq) ( FINEP/CT-AGRO AGRO/Acao Transversal - 01.07.0551.00/Ref. 0845/07) and FAPDF. C.J.U. is supported by a biotechnology research grant from FAPEGO. (Foundation for research support fromGoias state, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Muniz CH, 2012, PHYSIOL PLANTARUM, V144, P59, DOI 10.1111/j.1399-3054.2011.01522.x; ALSCHER RG, 1989, PHYSIOL PLANTARUM, V77, P457, DOI 10.1111/j.1399-3054.1989.tb05667.x; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Bart RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001123; Rubio MB, 2012, MICROBIOL-SGM, V158, P119, DOI 10.1099/mic.0.052118-0; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Almeida FBDR, 2007, BIOTECHNOL LETT, V29, P1189, DOI 10.1007/s10529-007-9372-z; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Chacon MR, 2007, INT MICROBIOL, V10, P19, DOI 10.2436/20.1501.01.4; Carvalho DDC, 2011, PESQUI AGROPECU BRAS, V46, P822, DOI 10.1590/S0100-204X2011000800006; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Djonovic S, 2007, MOL PLANT PATHOL, V8, P469, DOI [10.1111/j.1364-3703.2007.00407.x, 10.1111/J.1364-3703.2007.00407.X]; Geraldine AM, 2012, THESIS U FEDERAL GOI; Gonzalez-Fernandez R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/932527; Guerrero-Gonzalez ML, 2011, PLANT CELL REP, V30, P1465, DOI 10.1007/s00299-011-1055-5; Hagedorn DJ, 1986, HDB BEAN DIS, pA3374; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Hu R, 2010, BMC PLANT BIOL, V15, P145; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; KEEN NT, 1979, PHYSIOL PLANT PATHOL, V14, P265, DOI 10.1016/0048-4059(79)90048-1; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Lieberherr D, 2003, PLANT CELL PHYSIOL, V44, P750, DOI 10.1093/pcp/pcg093; Marra R, 2006, APPL ENVIRON MICROB, V65, P1061; Marsolais F, 2010, J PROTEOMICS, V73, P1587, DOI 10.1016/j.jprot.2010.03.013; Martinez-Medina A, 2011, PHYTOCHEMISTRY, V72, P223, DOI 10.1016/j.phytochem.2010.11.008; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Monteiro VN, 2010, CURR MICROBIOL, V61, P298, DOI 10.1007/s00284-010-9611-8; Montero-Barrientos M, 2011, APPL ENVIRON MICROB, V77, P3009, DOI 10.1128/AEM.02486-10; Moran-Diez E, 2009, MOL PLANT MICROBE IN, V22, P1021, DOI 10.1094/MPMI-22-8-1021; Mukherjee AK, 2010, J PROTEOMICS, V73, P709, DOI 10.1016/j.jprot.2009.10.005; Natarajan S, 2005, ANAL BIOCHEM, V342, P214, DOI 10.1016/j.ab.2005.04.046; Oh SK, 2005, PLANTA, V222, P876, DOI 10.1007/s00425-005-0030-1; Paba J, 2004, J PROTEOME RES, V3, P517, DOI 10.1021/pr034075o; Palmieri MC, 2012, J EXP BOT, V63, P6237, DOI 10.1093/jxb/ers279; Perazzolli M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-660; Punja ZK, 2003, TRENDS BIOTECHNOL, V21, P400, DOI 10.1016/S0167-7799(03)00193-8; Qualhato TF, 2013, BIOTECHNOL LETT, V35, P1461, DOI 10.1007/s10529-013-1225-3; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Shibu MA, 2012, J AGR FOOD CHEM, V60, P10723, DOI 10.1021/jf3025634; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; Shoresh M, 2008, PLANT PHYSIOL, V147, P2147, DOI 10.1104/pp.108.123810; Shoresh M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-136; Silva OF, 2011, DADOS CONJUNTURA PRO; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sun LJ, 2010, MOL PLANT MICROBE IN, V23, P1470, DOI 10.1094/MPMI-01-10-0029; Toledo-Souza ED, 2009, PESQUI AGROPECU TROP, V39, P13; Torres AR, 2009, BRAZ J MICROBIOL, V40, P852, DOI 10.1590/S1517-838220090004000016; Tucci M, 2011, MOL PLANT PATHOL, V12, P341, DOI 10.1111/j.1364-3703.2010.00674.x; Vallad G, 2001, THEOR APPL GENET, V103, P1046, DOI 10.1007/s001220100705; Valledor L, 2008, J PROTEOME RES, V7, P2616, DOI 10.1021/pr7006285; Vargas WA, 2009, PLANT PHYSIOL, V151, P792, DOI 10.1104/pp.109.141291; Wang XH, 2006, CHIN J CHROMATOGR, V24, P486; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wegulo SN, 2005, CAN J PLANT SCI, V85, P749, DOI 10.4141/P04-076; Xiao S, 2011, PLANT PHYSIOL, V156, P2069, DOI 10.1104/pp.111.176933; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Xiao S, 2009, PLANT PHYSIOL BIOCH, V47, P479, DOI 10.1016/j.plaphy.2008.12.002; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220; [No title captured]	64	33	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98234	10.1371/journal.pone.0098234	http://dx.doi.org/10.1371/journal.pone.0098234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878929	Green Submitted, gold, Green Published			2022-12-27	WOS:000338101500041
J	Azhar, A; El-Bassossy, HM				Azhar, Ahmad; El-Bassossy, Hany M.			Pentoxifylline Alleviates Cardiac Ischemia and Dysfunction Following Experimental Angina in Insulin Resistance	PLOS ONE			English	Article							INHIBITOR; RESPONSES; MODELS; ACID	We have previously shown that pentoxifylline (PTX) protects from vascular complications associated with insulin resistance (IR). Here, we investigated the protective effect of PTX against cardiac ischemia and dysfunction following experimental angina in IR. IR, along with its accompanying cardiac dysfunction, was induced in rats by a high-fructose (10% in drinking water) high-fat diet for 12 weeks. PTX was administered daily (30 mu g.kg(-1)) during the last 4 weeks of the study. Experimental angina was induced by isoproterenol (10 mu g.kg(-1)) administered by intravenous injection. Both before (baseline) and after the experimental angina, cardiac contractility was assessed by continuous recording in anesthetized rats via a microtip catheter inserted in the left ventricle, and cardiac conductivity was determined by a surface electrocardiograph. Serum glucose, insulin, tumor necrosis factor-alpha (TNF alpha), and adiponectin levels and lipid profile were also determined. Feeding the rats a high-fructose high-fat diet produced IR, as evidenced by significant hyperinsulinemia and hyperglycemia, and PTX administration did not affect this IR. When subjected to experimental angina, IR hearts were less resistant to the ischemia following induction of angina (reflected by the large ST height depression) compared with controls, and PTX completely prevented the excessive ST height depression in IR animals. In addition, left ventricular pressure development was largely attenuated during and after induction of angina in IR animals compared with controls. PTX administration prevented the excessive attenuation in ventricular pressure development in IR animals. IR was associated with elevated levels of the inflammatory cytokine TNF alpha, whereas PTX treatment elevated the serum level of the anti-inflammatory cytokine adiponectin. PTX alleviates cardiac ischemia and dysfunction following experimental angina in IR directly through inhibition of the low-grade inflammation that accompanies IR.	[Azhar, Ahmad] King Abdulaziz Univ, Dept Pediat, Fac Med, Jeddah 21413, Saudi Arabia; [El-Bassossy, Hany M.] King Abdulaziz Univ, Dept Pharmacol, Fac Pharm, Jeddah 21413, Saudi Arabia; [El-Bassossy, Hany M.] Zagazig Univ, Fac Pharm, Dept Pharmacol, Zagazig, Egypt	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University	Azhar, A (corresponding author), King Abdulaziz Univ, Dept Pediat, Fac Med, Jeddah 21413, Saudi Arabia.	azcardio@hotmail.com	Azhar, Ahmad/K-4257-2013; El-Bassossy, Hany/O-2242-2019; El-Bassossy, Hany M/I-1576-2012	El-Bassossy, Hany/0000-0002-6838-6945; El-Bassossy, Hany M/0000-0002-6838-6945	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [45-140-1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (45-140-1433). The authors, therefore, acknowledge with thanks DSR technical and financial support. DSR did not have any role in in study design; in the collection, analysis or interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Busija DW, 2006, ANTIOXID REDOX SIGN, V8, P1131, DOI 10.1089/ars.2006.8.1131; Chen H, 2006, PHARMACOL RES, V53, P469, DOI 10.1016/j.phrs.2006.03.003; DeFronzo RA, 1996, J DIABETES COMPLICAT, V10, P243, DOI 10.1016/1056-8727(96)00046-3; DHURANDH.RW, 1972, AM J CARDIOL, V30, P902, DOI 10.1016/0002-9149(72)90018-5; El-Bassossy HM, 2011, N-S ARCH PHARMACOL, V384, P277, DOI 10.1007/s00210-011-0669-z; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Loganathan R, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-7; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Marks JB, 2000, J DIABETES COMPLICAT, V14, P108, DOI 10.1016/S1056-8727(00)00065-9; Maslov LN, 2006, B EXP BIOL MED+, V142, P557, DOI 10.1007/s10517-006-0417-4; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; MORI T, 1995, BRIT J PHARMACOL, V116, P1668, DOI 10.1111/j.1476-5381.1995.tb16389.x; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Osadchii O, 2005, EUR J PHARMACOL, V514, P201, DOI 10.1016/j.ejphar.2005.03.022; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Radovits T, 2009, BRIT J PHARMACOL, V156, P909, DOI 10.1111/j.1476-5381.2008.00098.x; Radovits T, 2009, AM J PHYSIOL-HEART C, V297, pH125, DOI 10.1152/ajpheart.00165.2009; RASKIN P, 1994, J DIABETES COMPLICAT, V8, P195, DOI 10.1016/1056-8727(94)90043-4; Robinson DA, 1996, J SURG RES, V66, P51, DOI 10.1006/jsre.1996.0371; Schafer S, 2006, EUR J HEART FAIL, V8, P2, DOI 10.1016/j.ejheart.2005.04.011; SEIFFGE D, 1984, IRCS MED SCI-BIOCHEM, V12, P91; Shaw SM, 2009, EUR J HEART FAIL, V11, P113, DOI 10.1093/eurjhf/hfn040; Soliman EZ, 2011, HEART, V97, P1597, DOI 10.1136/hrt.2010.215871; Williams IL, 2003, BRIT J DIABETES VASC, V3, P18; Yamamoto S, 2000, JPN J PHARMACOL, V84, P196, DOI 10.1254/jjp.84.196; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yasue H, 1983, CIRC RES, V52, pI; Zhang Ming, 2008, Zhongguo Yaolixue Tongbao, V24, P937	28	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98281	10.1371/journal.pone.0098281	http://dx.doi.org/10.1371/journal.pone.0098281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874295	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800031
J	Rodrigues-Sousa, T; Ladeirinha, AF; Santiago, AR; Carvalheiro, H; Raposo, B; Alarcao, A; Cabrita, A; Holmdahl, R; Carvalho, L; Souto-Carneiro, MM				Rodrigues-Sousa, Tiago; Ladeirinha, Ana Filipa; Santiago, Ana Raquel; Carvalheiro, Helena; Raposo, Bruno; Alarcao, Ana; Cabrita, Antonio; Holmdahl, Rikard; Carvalho, Lina; Margarida Souto-Carneiro, M.			Deficient Production of Reactive Oxygen Species Leads to Severe Chronic DSS-Induced Colitis in Ncf1/p47(phox)-Mutant Mice	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SODIUM-SULFATE; REGULATORY T-CELLS; INTESTINAL INFLAMMATION; NITRIC-OXIDE; ULCERATIVE-COLITIS; DENDRITIC CELLS; CROHNS-DISEASE; MACROPHAGES	Background: Colitis is a common clinical complication in chronic granulomatous disease (CGD), a primary immunodeficiency caused by impaired oxidative burst. Existing experimental data from NADPH-oxidase knockout mice propose contradictory roles for the involvement of reactive oxygen species in colitis chronicity and severity. Since genetically controlled mice with a point-mutation in the Ncf1 gene are susceptible to chronic inflammation and autoimmunity, we tested whether they presented increased predisposition to develop chronic colitis. Methods: Colitis was induced in Ncf1-mutant and wild-type mice by a 1st 7-days cycle of dextran sulfate sodium (DSS), intercalated by a 7-days resting period followed by a 2nd 7-days DSS-cycle. Cytokines were quantified locally in the colon inflammatory infiltrates and in the serum. Leukocyte infiltration and morphological alterations of the colon mucosa were assessed by immunohistochemistry. Results: Clinical scores demonstrated a more severe colitis in Ncf1-mutant mice than controls, with no recovery during the resting period and a severe chronic colitis after the 2nd cycle, confirmed by histopathology and presence of infiltrating neutrophils, macrophages, plasmocytes and lymphocytes in the colon. Severe colitis was mediated by increased local expression of cytokines (IL-6, IL-10, TNF-alpha, IFN-gamma and IL-17A) and phosphorylation of Leucine-rich repeat kinase 2 (LRRK2). Serological cytokine titers of those inflammatory cytokines were more elevated in Ncf1-mutant than control mice, and were accompanied by systemic changes in functional subsets of monocytes, CD4(+)T and B cells. Conclusion: This suggests that an ineffective oxidative burst leads to severe chronic colitis through local accumulation of peroxynitrites, pro-inflammatory cytokines and lymphocytes and systemic immune deregulation similar to CGD.	[Rodrigues-Sousa, Tiago; Carvalheiro, Helena; Margarida Souto-Carneiro, M.] Univ Coimbra, CNC Ctr Neurociencias & Biol Celular, ImmunoMetabol Pharmacol Grp, Coimbra, Portugal; [Ladeirinha, Ana Filipa; Alarcao, Ana; Carvalho, Lina] Univ Coimbra, Fac Med, Dept Anat Patol, Coimbra, Portugal; [Santiago, Ana Raquel] Univ Coimbra, Fac Med, Inst Biomed Invest Luz & Imagem, Coimbra, Portugal; [Raposo, Bruno; Holmdahl, Rikard] Karolinska Inst, Stockholm, Sweden; [Cabrita, Antonio] Univ Coimbra, Fac Med, Dept Patol Expt, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Karolinska Institutet; Universidade de Coimbra	Souto-Carneiro, MM (corresponding author), Univ Coimbra, CNC Ctr Neurociencias & Biol Celular, ImmunoMetabol Pharmacol Grp, Coimbra, Portugal.	margarida.carneiro@cnc.uc.pt	Souto-Carneiro, Margarida/C-4386-2016; Raposo, Bruno RA/C-5265-2013; Holmdahl, Rikard/AAI-7682-2020; Carvalho, Lina/AAC-6810-2020; Santiago, Ana Raquel/I-6566-2013; Carvalheiro, Helena/N-2179-2014	Souto-Carneiro, Margarida/0000-0001-6923-0590; Carvalho, Lina/0000-0001-8349-4488; Santiago, Ana Raquel/0000-0002-7541-7041; Carvalheiro, Helena/0000-0003-0698-818X; Cabrita, Antonio/0000-0001-5165-5849; Rodrigues de Sousa, Tiago Joao/0000-0003-0355-5944	Fundacao para a Ciencia e Tecnologia [SFRH/BD/60467/2009]; Marie Curie grant [PERG-GA-2008-239422]; Swedish Research Council; EU; FEDER/COMPETE/Fundacao para a Ciencia e Tecnologia [Pest/C-SAU/LA0001/2013-2014]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie grant(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); FEDER/COMPETE/Fundacao para a Ciencia e Tecnologia	H. Carvalheiro was funded by Fundacao para a Ciencia e Tecnologia grant SFRH/BD/60467/2009. This work was funded by the Marie Curie grant PERG-GA-2008-239422 to M. M. Souto-Carneiro, by the Swedish Research Council and the EU FP7 project Neurinox to R. Holmdahl and by the FEDER/COMPETE/Fundacao para a Ciencia e Tecnologia project Pest/C-SAU/LA0001/2013-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bento AF, 2012, BIOCH PHARM; Bleesing JJ, 2006, J IMMUNOL, V176, P7096, DOI 10.4049/jimmunol.176.11.7096; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; COOPER HS, 1993, LAB INVEST, V69, P238; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; Deffert C, 2012, J PATHOLOGY; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Falcone EL, 2012, CURR OPIN INFECT DIS; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Lewis CJ, 2011, EUR J IMMUNOL, V41, P2562, DOI 10.1002/eji.201141396; Liu S, 2009, INFLAMM BOWEL DIS, V15, P1213, DOI 10.1002/ibd.20890; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mori M, 2005, AM J PHYSIOL-GASTR L, V289, pG1024, DOI 10.1152/ajpgi.00247.2005; Naito Y, 2004, INT J MOL MED, V14, P191; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schappi MG, 2003, J PEDIATR GASTR NUTR, V36, P623, DOI 10.1097/00005176-200305000-00006; Shih TC, 2008, WORLD J GASTROENTERO, V14, P1759, DOI 10.3748/wjg.14.1759; Smeekens SP, 2012, J INTERF CYTOK RES, V32, P159, DOI 10.1089/jir.2011.0046; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Vasilevsky S, 2011, AM J PATHOL, V178, P2774, DOI 10.1016/j.ajpath.2011.02.038; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494; Yasukawa K, 2012, FREE RADICAL RES, V46, P1427, DOI 10.3109/10715762.2012.732698; Yu JE, 2011, CLIN IMMUNOL, V138, P14, DOI 10.1016/j.clim.2010.08.003	41	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97532	10.1371/journal.pone.0097532	http://dx.doi.org/10.1371/journal.pone.0097532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873968	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800008
J	Jones, EA; Kananurak, A; Bevins, CL; Hollox, EJ; Bakaletz, LO				Jones, Eric A.; Kananurak, Anchasa; Bevins, Charles L.; Hollox, Edward J.; Bakaletz, Lauren O.			Copy Number Variation of the Beta Defensin Gene Cluster on Chromosome 8p Influences the Bacterial Microbiota within the Nasopharynx of Otitis-Prone Children	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TYMPANOSTOMY TUBES; MEDIA; COLONIZATION; EXPRESSION; BETA-DEFENSIN-2; DISEASE; POLYMORPHISMS; ASSOCIATIONS; EFFUSION	As there is increasing evidence that aberrant defensin expression is related to susceptibility for infectious disease and inflammatory disorders, we sought to determine if copy number of the beta-defensin gene cluster located on chromosome 8p23.1 (DEFB107, 106, 105, 104, 103, DEFB4 and SPAG11), that shows copy number variation as a block, was associated with susceptibility to otitis media (OM). The gene DEFB103 within this complex encodes human beta defensin-3 (hBD-3), an antimicrobial peptide (AP) expressed by epithelial cells that line the mammalian airway, important for defense of mucosal surfaces and previously shown to have bactericidal activity in vitro against multiple human pathogens, including the three that predominate in OM. To this end, we conducted a retrospective case-control study of 113 OM prone children and 267 controls aged five to sixty months. We identified the copy number of the above defined beta-defensin gene cluster (DEFB-CN) in each study subject by paralogue ratio assays. The mean DEFB-CN was indistinguishable between subjects classified as OM prone based on a recent history of multiple episodes of OM and control subjects who had no history of OM (4.4 +/- 0.96 versus 4.4 +/- 1.08, respectively: Odds Ratio [OR]: 1.16 (95% CI: 0.61, 2.20). Despite a lack of direct association, we observed a statistically significant correlation between DEFB-CN and nasopharyngeal bacterial colonization patterns. Collectively, our findings suggested that susceptibility to OM might be mediated by genetic variation among individuals, wherein a DEFB-CN less than 4 exerts a marked influence on the microbiota of the nasopharynx, specifically with regard to colonization by the three predominant bacterial pathogens of OM.	[Jones, Eric A.; Bakaletz, Lauren O.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Microbial Pathogenesis,Dept Pediat,Res Inst, Columbus, OH 43210 USA; [Kananurak, Anchasa; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of California System; University of California Davis; University of Leicester	Bakaletz, LO (corresponding author), Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Microbial Pathogenesis,Dept Pediat,Res Inst, Columbus, OH 43210 USA.	Lauren.Bakaletz@NationwideChildrens.org	Bevins, Charles L/P-4438-2015; Bakaletz, Lauren/GMW-8490-2022	Bevins, Charles L/0000-0003-2725-2622; Hollox, Edward/0000-0002-0115-2298	National Institutes of Health [R01 DC005847, R01 DC003915, N01-AI-30040]; Medical Research Council [GO801123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, N01AI030040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003915, R01DC005847] Funding Source: NIH RePORTER; Medical Research Council [G0801123] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Institutes of Health (www.nih.gov), R01 DC005847 and R01 DC003915 to LOB, subcontract on N01-AI-30040 to LOB and Medical Research Council (www.mrc.ac.uk/index.htm) New Investigator Grant, GO801123 to EJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Alsarraf R, 1999, ARCH OTOLARYNGOL, V125, P12, DOI 10.1001/archotol.125.1.12; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; BALDWIN RL, 1993, AM J OTOL, V14, P601; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boruk M, 2007, OTOLARYNG HEAD NECK, V136, P159, DOI 10.1016/j.otohns.2006.09.005; BRIGHT RA, 1993, AM J PUBLIC HEALTH, V83, P1026, DOI 10.2105/AJPH.83.7.1026; Cantsilieris S, 2013, HUM MUTAT, V34, P1, DOI 10.1002/humu.22172; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Casselbrant ML, 2005, CURR OPIN ALLERGY CL, V5, P1, DOI 10.1097/00130832-200502000-00002; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1991, ANN OTO RHINOL LARYN, V100, P612, DOI 10.1177/000348949110000802; Faden H, 2001, EUR J PEDIATR, V160, P407, DOI 10.1007/s004310100754; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fernandez-Jimenez N, 2010, HUM IMMUNOL, V71, P833, DOI 10.1016/j.humimm.2010.05.012; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Fujimori I, 1996, EUR ARCH OTO-RHINO-L, V253, P260; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Haggard M, 2008, VACCINE, V26, pG20, DOI 10.1016/j.vaccine.2008.11.009; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Ilia S, 2008, PEDIATR INFECT DIS J, V27, P929, DOI 10.1097/INF.0b013e318174e0b0; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Jenke ACW, 2012, PEDIATR RES, V72, P513, DOI 10.1038/pr.2012.110; Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Marom T, 2012, CURR ALLERGY ASTHM R, V12, P551, DOI 10.1007/s11882-012-0303-2; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Revai K, 2008, CLIN INFECT DIS, V46, pE34, DOI 10.1086/525856; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, pS1, DOI 10.1177/0194599813487302; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Sassen ML, 1997, AM J OTOLARYNG, V18, P324, DOI 10.1016/S0196-0709(97)90027-2; Shin DJ, 2006, ACTA OTO-LARYNGOL, V126, P1040, DOI 10.1080/00016480600672626; Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618; Taudien Stefan, 2012, BMC Res Notes, V5, P629, DOI 10.1186/1756-0500-5-629; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Wain LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084192; WILLIAMS RL, 1993, JAMA-J AM MED ASSOC, V270, P1344, DOI 10.1001/jama.270.11.1344	53	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98269	10.1371/journal.pone.0098269	http://dx.doi.org/10.1371/journal.pone.0098269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867293	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100043
J	Roullier-Gall, C; Lucio, M; Noret, L; Schmitt-Kopplin, P; Gougeon, RD				Roullier-Gall, Chloe; Lucio, Marianna; Noret, Laurence; Schmitt-Kopplin, Philippe; Gougeon, Regis D.			How Subtle Is the "Terroir'' Effect? Chemistry-Related Signatures of Two "Climats de Bourgogne''	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; VITIS-VINIFERA L.; GEOGRAPHICAL ORIGIN; MULTIVARIATE DISCRIMINATION; GRAPE VARIETIES; PINOT-NOIR; WINE; H-1-NMR; RESVERATROL; VINTAGE	The chemical composition of grape berries is influenced by various environmental conditions often considered to be representative of a "terroir''. If grapes from a given terroir are assumed to reflect this origin in their chemical compositions, the corresponding wine should also reflect it. The aim of this work was therefore to reveal the "terroir'' expression within the chemodiversity of grapes and related wines, using ultrahigh-resolution mass spectrometry. Grapes and corresponding wines, from two distinct - though very proximate - terroirs of Burgundy were analyzed over three vintages (2010, 2011 and 2012). Ultrahigh-resolution mass spectrometry and ultra-high performance liquid chromatography were used as untargeted and targeted approaches to discriminate complex chemical fingerprints for vintages, classes (wines, skins or musts), and terroirs. Statistical analyses revealed that even if vintages have the most significant impact on fingerprints, the most significant terroir differences are seen in the grapes of a given vintage.	[Roullier-Gall, Chloe; Noret, Laurence; Gougeon, Regis D.] Univ Bourgogne, AgroSupDijon, Equipe Proc Alimentaires & Phys Chim, Inst Univ Vigne & Vin,UMR Proc Alimentaires & Mic, Dijon, France; [Roullier-Gall, Chloe; Lucio, Marianna; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Freising Weihenstephan, Germany	Institut Agro; AgroSup Dijon; Universite de Bourgogne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Schmitt-Kopplin, P (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Analyt BioGeoChem, Neuherberg, Germany.	schmitt-kopplin@helmholtz-muenchen.de; regis.gougeon@u-bourgogne.fr	Gougeon, Régis D/T-4069-2017; Schmitt-Kopplin, Philippe/H-6271-2011	Gougeon, Régis D/0000-0002-5371-5523; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098	Regional Council of Burgundy; Interprofessionnals of Burgundy; Interprofessionnals of Champagne	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Interprofessionnals of Burgundy; Interprofessionnals of Champagne	Fundings were from the Regional Council of Burgundy, the Interprofessionnals of Burgundy, and the Interprofessionnals of Champagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2011, J BIOMOL NMR, V49, P255, DOI 10.1007/s10858-011-9487-3; [Anonymous], PROGR AUTHENTICATION; Boutegrabet L, 2012, APPROCHE METABOLOMIQ; Boutegrabet L, 2012, CHEM-EUR J, V18, P13059, DOI 10.1002/chem.201103788; Boutegrabet L, 2011, ANAL BIOANAL CHEM, V401, P1513, DOI 10.1007/s00216-011-4879-5; Brescia MA, 2002, ANAL CHIM ACTA, V458, P177, DOI 10.1016/S0003-2670(01)01532-X; Capron X, 2007, FOOD CHEM, V101, P1585, DOI 10.1016/j.foodchem.2006.04.019; Catharino RR, 2006, J MASS SPECTROM, V41, P185, DOI 10.1002/jms.976; Charlton AJ, 2010, EUR FOOD RES TECHNOL, V231, P733, DOI 10.1007/s00217-010-1299-2; Chira K, 2011, FOOD CHEM, V126, P1971, DOI 10.1016/j.foodchem.2010.12.056; Cooper HJ, 2001, J AGR FOOD CHEM, V49, P5710, DOI 10.1021/jf0108516; Cortell JM, 2005, J AGR FOOD CHEM, V53, P5798, DOI 10.1021/jf0504770; Cuadros-Inostroza A, 2010, ANAL CHEM, V82, P3573, DOI 10.1021/ac902678t; Fischer U, 1999, FOOD QUAL PREFER, V10, P281, DOI 10.1016/S0950-3293(99)00008-7; Forcisi S, 2013, J CHROMATOGR A, V1292, P51, DOI 10.1016/j.chroma.2013.04.017; Godelmann R, 2013, J AGR FOOD CHEM, V61, P5610, DOI 10.1021/jf400800d; GOLDBERG DM, 1995, J CHROMATOGR A, V708, P89, DOI 10.1016/0021-9673(95)00368-W; Gougeon RD, 2009, P NATL ACAD SCI USA, V106, P9174, DOI 10.1073/pnas.0901100106; He F, 2010, AUST J GRAPE WINE R, V16, P464, DOI 10.1111/j.1755-0238.2010.00107.x; Sawaya ACHF, 2011, CIENCIA TECNOL ALIME, V31, P730, DOI 10.1590/S0101-20612011000300027; Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4; JEANDET P, 1995, AM J ENOL VITICULT, V46, P1; Koundouras S, 2006, J AGR FOOD CHEM, V54, P5077, DOI 10.1021/jf0605446; Kumsta M, 2012, HORTIC SCI, V39, P38, DOI 10.17221/126/2010-HORTSCI; Lee JEY, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/074003; Leeuwen C. van, 2010, Bulletin de l'OIV, V83, P13; Liger-Belair G, 2009, P NATL ACAD SCI USA, V106, P16545, DOI 10.1073/pnas.0906483106; Lopez-Rituerto E, 2012, J AGR FOOD CHEM, V60, P3452, DOI 10.1021/jf204361d; Lund ST, 2006, SCIENCE, V311, P804, DOI 10.1126/science.1118962; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Morlat R, 2006, PLANT SOIL, V281, P55, DOI 10.1007/s11104-005-3769-z; Muller C, 2013, ANAL BIOANAL CHEM; Pereira GE, 2006, ANAL CHIM ACTA, V563, P346, DOI 10.1016/j.aca.2005.11.007; Pereira GE, 2005, J AGR FOOD CHEM, V53, P6382, DOI 10.1021/jf058058q; Pereira GE, 2007, J INT SCI VIGNE VIN, V41, P103; Pineiro Z, 2011, J AGR FOOD CHEM, V59, P11683, DOI 10.1021/jf202254t; Riou C., 1995, Bulletin de l'OIV, V68, P93; Rodriguez-Delgado MA, 2002, FOOD CHEM, V76, P371, DOI 10.1016/S0308-8146(01)00258-8; Romisch U, 2009, EUR FOOD RES TECHNOL, V230, P31, DOI 10.1007/s00217-009-1141-x; Roullier-Gall C, 2014, FOOD CHEM, V152, P100, DOI 10.1016/j.foodchem.2013.11.056; Russell K, 2005, J FOOD QUALITY, V28, P377, DOI 10.1111/j.1745-4557.2005.00041.x; Schmitt-Kopplin P, 2012, BIOGEOSCIENCES; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; SEGUIN G, 1986, EXPERIENTIA, V42, P861, DOI 10.1007/BF01941763; Smeyers-Verbeke J, 2009, EUR FOOD RES TECHNOL, V230, P15, DOI 10.1007/s00217-009-1142-9; Son HS, 2008, J AGR FOOD CHEM, V56, P8007, DOI 10.1021/jf801424u; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; Tarr PT, 2013, METABOLOMICS, V9, pS170, DOI 10.1007/s11306-013-0497-x; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Tziotis D, 2011, EUR J MASS SPECTROM, V17, P415, DOI 10.1255/ejms.1135; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Vaudour E, 2003, TERROIRS VITICOLES E, V5, P91; Vilanova M, 2007, J SCI FOOD AGR, V87, P1252, DOI 10.1002/jsfa.2833; Villagra E, 2012, FOOD CHEM, V131, P692, DOI 10.1016/j.foodchem.2011.08.078; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Zheng SF, 2012, EXPERT SYST APPL, V39, P1687, DOI 10.1016/j.eswa.2011.06.060	56	49	51	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97615	10.1371/journal.pone.0097615	http://dx.doi.org/10.1371/journal.pone.0097615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858426	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400021
J	Chang, CC; Wu, TH; Chen, CY; Wang, JD; Lin, CY				Chang, Chih-Cheng; Wu, Tsung-Hsien; Chen, Chih-Yin; Wang, Jung-Der; Lin, Chung-Ying			Psychometric Evaluation of the Internalized Stigma of Mental Illness Scale for Patients with Mental Illnesses: Measurement Invariance across Time	PLOS ONE			English	Article							SELF-ESTEEM; CONSEQUENCES; PEOPLE; DISCRIMINATION; SCHIZOPHRENIA; RELIABILITY; VERSION	Background: The current investigation examined the psychometric properties of the Internalized Stigma of Mental Illness (ISMI) scale in a sample of patients with mental illness. In addition to the internal consistency, test-retest reliability, and concurrent validity that previous studies have tested for the ISMI, we extended the evaluation to its construct validity and measurement invariance using confirmatory factor analysis (CFA). Methods: Three hundred forty-seven participants completed two questionnaires (i.e., the ISMI and the Depression and Somatic Symptoms Scale [DSSS]), and 162 filled out the ISMI again after 50.23 +/- 31.18 days. Results: The results of this study confirmed the frame structure of the ISMI; however, the Stigma Resistance subscale in the ISMI seemed weak. In addition, internal consistency, test-retest reliability, and concurrent validity were all satisfactory for all subscales and the total score of the ISMI, except for Stigma Resistance (alpha = 0.66; ICC = 0.52, and r = 0.02 to 0.06 with DSSS). Therefore, we hypothesize that Stigma Resistance is a new concept rather than a concept in internalized stigma. The acceptable fit indices supported the measurement invariance of the ISMI across time, and suggested that people with mental illness interpret the ISMI items the same at different times. Conclusion: The clinical implication of our finding is that clinicians, when they design interventions, may want to use the valid and reliable ISMI without the Stigma Resistance subscale to evaluate the internalized stigma of people with mental illness.	[Chang, Chih-Cheng; Wu, Tsung-Hsien] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Chang, Chih-Cheng] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Chang, Chih-Cheng; Chen, Chih-Yin] Chia Nan Univ Pharm & Sci, Coll Recreat & Hlth Management, Dept Senior Citizen Serv Management, Tainan, Taiwan; [Chen, Chih-Yin] Chang Jung Christian Univ, Coll Hlth Sci, Dept Nursing, Tainan, Taiwan; [Wang, Jung-Der; Lin, Chung-Ying] Natl Cheng Kung Univ, Coll Med, Deparment Publ Hlth, Tainan, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan	Chi Mei Hospital; University of London; King's College London; Chia Nan University of Pharmacy & Science; Chang Jung Christian University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Lin, CY (corresponding author), Natl Cheng Kung Univ, Coll Med, Deparment Publ Hlth, Tainan, Taiwan.	cylin36933@gmail.com	Lin, Chung-Ying/I-5434-2016	Lin, Chung-Ying/0000-0002-2129-4242	Chi Mei Medical Center, Liouying, Taiwan [CLFHR10028]; Ministry of Education, Taiwan, R.O.C.; Aim for the Top University Project	Chi Mei Medical Center, Liouying, Taiwan; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); Aim for the Top University Project	This study was supported by grant CLFHR10028 from the Chi Mei Medical Center, Liouying, Taiwan. This research was, in part, supported by the Ministry of Education, Taiwan, R.O.C.; and the Aim for the Top University Project to the National Cheng Kung University (NCKU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Boyd JE, 2014, COMPR PSYCHIAT, V55, P221, DOI 10.1016/j.comppsych.2013.06.005; Brohan E, 2010, SCHIZOPHR RES, V122, P232, DOI 10.1016/j.schres.2010.02.1065; Brohan E, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-80; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Chan Y H, 2003, Singapore Med J, V44, P614; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Ersoy MA, 2007, TURK PSIKIYATR DERG, V18, P163; Hoyle R.H., 1995, STRUCTURAL EQUATION, P158; Hung CI, 2006, PSYCHIAT CLIN NEUROS, V60, P700, DOI 10.1111/j.1440-1819.2006.01585.x; HWANG TAE-YEON, 2006, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V45, P418; Jacobsson L, 2013, OJPSYCH, V3, P370, DOI DOI 10.4236/ojpsych.2013.34039; Lin CY, 2014, EUR J PSYCHOL ASSESS, V30, P100, DOI 10.1027/1015-5759/a000175; Lin CY, 2013, CHILD PSYCHIAT HUM D, V44, P583, DOI 10.1007/s10578-012-0352-8; Lin CY, 2012, QUAL LIFE RES, V21, P177, DOI 10.1007/s11136-011-9928-1; Link BG, 2001, PSYCHIATR SERV, V52, P1621, DOI 10.1176/appi.ps.52.12.1621; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424; LINK BG, 1991, J HEALTH SOC BEHAV, V32, P302, DOI 10.2307/2136810; Motl RW, 2002, STRUCT EQU MODELING, V9, P562, DOI 10.1207/S15328007SEM0904_6; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rensen C, 2011, DISABIL REHABIL, V33, P711, DOI 10.3109/09638288.2010.506942; Revheim N., 2002, DEALING COGNITIVE DY; Ritsher JB, 2003, PSYCHIAT RES, V121, P31, DOI 10.1016/j.physchres.2003.08.008; Schweizer K, 2010, EUR J PSYCHOL ASSESS, V26, P1, DOI 10.1027/1015-5759/a000001; Sibitz I, 2011, EUR PSYCHIAT, V26, P28, DOI 10.1016/j.eurpsy.2010.08.010; Sibitz I., 2006, INTERNALISIERTES STI; Sibitz I, 2013, PSYCHIAT PRAX, V40, P83, DOI 10.1055/s-0032-1332878; Sibitz I, 2011, SCHIZOPHRENIA BULL, V37, P316, DOI 10.1093/schbul/sbp048; Stevelink S., 2012, STIGMA RES ACTION, V2, P100, DOI [10.5463/sra.v1i3.35, DOI 10.5463/SRA.V1I1.11, 10.5463/sra.v1i1.11]; Tang I-C, 2009, J DISABILITY RES, V7, P230; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002	33	40	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98767	10.1371/journal.pone.0098767	http://dx.doi.org/10.1371/journal.pone.0098767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24887440	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300106
J	Chawla, S; Rahar, B; Singh, M; Bansal, A; Saraswat, D; Saxena, S				Chawla, Sonam; Rahar, Babita; Singh, Mrinalini; Bansal, Anju; Saraswat, Deepika; Saxena, Shweta			Exogenous Sphingosine-1-Phosphate Boosts Acclimatization in Rats Exposed to Acute Hypobaric Hypoxia: Assessment of Haematological and Metabolic Effects	PLOS ONE			English	Article							FACILITATES ACCLIMATIZATION; OXIDATIVE STRESS; SUPPLEMENTATION; EXPRESSION; TOLERANCE; ALTITUDE; KINASE; MICE; ATP	Background: The physiological challenges posed by hypobaric hypoxia warrant exploration of pharmacological entities to improve acclimatization to hypoxia. The present study investigates the preclinical efficacy of sphingosine-1-phosphate (S1P) to improve acclimatization to simulated hypobaric hypoxia. Experimental Approach: Efficacy of intravenously administered S1P in improving haematological and metabolic acclimatization was evaluated in rats exposed to simulated acute hypobaric hypoxia (7620 m for 6 hours) following S1P pre-treatment for three days. Major Findings: Altitude exposure of the control rats caused systemic hypoxia, hypocapnia (plausible sign of hyperventilation) and respiratory alkalosis due to suboptimal renal compensation indicated by an overt alkaline pH of the mixed venous blood. This was associated with pronounced energy deficit in the hepatic tissue along with systemic oxidative stress and inflammation. S1P pre-treatment improved blood oxygen-carrying-capacity by increasing haemoglobin, haematocrit, and RBC count, probably as an outcome of hypoxia inducible factor-1 alpha mediated erythropoiesis and renal S1P receptor 1 mediated haemoconcentation. The improved partial pressure of oxygen in the blood could further restore aerobic respiration and increase ATP content in the hepatic tissue of S1P treated animals. S1P could also protect the animals from hypoxia mediated oxidative stress and inflammation. Conclusion: The study findings highlight S1P's merits as a preconditioning agent for improving acclimatization to acute hypobaric hypoxia exposure. The results may have long term clinical application for improving physiological acclimatization of subjects venturing into high altitude for occupational or recreational purposes.	[Chawla, Sonam; Rahar, Babita; Singh, Mrinalini; Bansal, Anju; Saraswat, Deepika; Saxena, Shweta] Minist Def, Def Res & Dev Org, Inst Physiol & Allied Sci, Expt Biol Div, Delhi, India	Defence Research & Development Organisation (DRDO)	Saxena, S (corresponding author), Minist Def, Def Res & Dev Org, Inst Physiol & Allied Sci, Expt Biol Div, Lucknow Rd, Delhi, India.	shweta.dipas@gmail.com	Chawla, Sonam/AAV-5929-2020	Chawla, Sonam/0000-0002-6187-4778; , shweta/0000-0001-8171-4264	Defence Research and Development Organization, India [S&T-09 DIP-251 A 2.3]	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO))	This work was funded by the Defence Research and Development Organization, India (www.drdo.gov.in) Project Grant No. S&T-09 DIP-251 A 2.3 to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Chawla S, 2014, LIPIDS, V49, P191, DOI 10.1007/s11745-013-3860-9; DOUSSET JC, 1983, CLIN CHIM ACTA, V129, P319, DOI 10.1016/0009-8981(83)90035-9; Dumont Lionel, 2005, Travel Med Infect Dis, V3, P183, DOI 10.1016/j.tmaid.2004.12.001; Elliott S, 2008, BRIT J PHARMACOL, V154, P529, DOI 10.1038/bjp.2008.89; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fagan K A, 2001, Respir Res, V2, P306, DOI 10.1186/rr74; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Graham R, 2012, IRON PHYSIOLOGY AND, P126; Guyton AC, 2005, TEXTBOOK OF MEDICAL; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Ilavazhagan G, 2001, AVIAT SPACE ENVIR MD, V72, P899; Jung HJ, 2010, CURR NEUROVASC RES, V7, P201; Katz A, 1990, Exerc Sport Sci Rev, V18, P1; Keul P, 2007, HEART FAIL REV, V12, P301, DOI 10.1007/s10741-007-9038-x; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; KORNBERG A, 1955, METHOD ENZYMOL, V1, P441, DOI 10.1016/0076-6879(55)01072-0; Laursen BE, 2008, VASC PHARMACOL, V49, P71, DOI 10.1016/j.vph.2008.03.001; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lopez V, 2009, HIGH ALT MED BIOL, V10, P373, DOI 10.1089/ham.2008.1072; Luks AM, 2012, HIGH ALT MED BIOL, V13, P147, DOI 10.1089/ham.2012.1055; Magalhaes J, 2004, AVIAT SPACE ENVIR MD, V75, P16; OKAMURA JM, 1990, J CLIN LAB ANAL, V4, P231, DOI 10.1002/jcla.1860040316; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; PUGH L G, 1962, Br Med J, V2, P621; Reynafarje C, 1966, LIFE HIGH ALTITUDES, V140, P32; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; SHEPHERD D, 1966, BIOCHEM BIOPH RES CO, V22, P89, DOI 10.1016/0006-291X(66)90607-3; SHIMIZU S, 1989, JPN J PHYSIOL, V39, P833, DOI 10.2170/jjphysiol.39.833; Shrivastava K, 2008, HIGH ALT MED BIOL, V9, P63, DOI 10.1089/ham.2008.1046; Singh M, 2010, J PHARM PHARMACOL, V62, P1729, DOI 10.1111/j.2042-7158.2010.01163.x; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; SUPOWIT SC, 1976, BIOCHIM BIOPHYS ACTA, V422, P48, DOI 10.1016/0005-2744(76)90007-3; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Taylor AT, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10022; Veeger C., 1969, METHODS ENZYMOLOGY, VXIII, P81, DOI [https://doi.org/10.1016/0076-6879(69)13020-7, DOI 10.1016/0076-6879(69)13020-7]; Wacker BK, 2012, J NEUROCHEM, V123, P954, DOI 10.1111/jnc.12047; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wright A, 2008, EXPERT OPIN PHARMACO, V9, P119, DOI 10.1517/14656566.9.1.119; Yang JF, 2005, J IMMUNOL, V175, P6580, DOI 10.4049/jimmunol.175.10.6580; Yasuo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053927; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhu Q, 2011, AM J PHYSIOL-RENAL, V301, pF35, DOI 10.1152/ajprenal.00014.2011	45	12	12	13	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98025	10.1371/journal.pone.0098025	http://dx.doi.org/10.1371/journal.pone.0098025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887065	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300034
J	Giri, S; Rattan, R; Deshpande, M; Maguire, JL; Johnson, Z; Graham, RP; Shridhar, V				Giri, Shailendra; Rattan, Ramandeep; Deshpande, Mandar; Maguire, Jacie L.; Johnson, Zachary; Graham, Rondell P.; Shridhar, Viji			Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer	PLOS ONE			English	Article							NF-KAPPA-B; S-NITROSYLATION; IN-VITRO; CONSTITUTIVE ACTIVATION; SIGNAL TRANSDUCERS; STAT 3; GROWTH; CISPLATIN; INHIBITION; TRANSCRIPTION-3	This study examines the role of s-nitrosylation in the growth of ovarian cancer using cell culture based and in vivo approaches. Using the nitrosylating agent, S-nitrosoglutathione (GSNO), a physiological nitric oxide molecule, we show that GSNO treatment inhibited proliferation of chemoresponsive and chemoresistant ovarian cancer cell lines (A2780, C200, SKVO3, ID8, OVCAR3, OVCAR4, OVCAR5, OVCAR7, OVCAR8, OVCAR10, PE01 and PE04) in a dose dependent manner. GSNO treatment abrogated growth factor (HB-EGF) induced signal transduction including phosphorylation of Akt, p42/44 and STAT3, which are known to play critical roles in ovarian cancer growth and progression. To examine the therapeutic potential of GSNO in vivo, nude mice bearing intra-peritoneal xenografts of human A2780 ovarian carcinoma cell line (2 x 10(-6)) were orally administered GSNO at the dose of 1 mg/kg body weight. Daily oral administration of GSNO significantly attenuated tumor mass (p < 0.001) in the peritoneal cavity compared to vehicle (phosphate buffered saline) treated group at 4 weeks. GSNO also potentiated cisplatin mediated tumor toxicity in an A2780 ovarian carcinoma nude mouse model. GSNO's nitrosylating ability was reflected in the induced nitrosylation of various known proteins including NF kappa B p65, Akt and EGFR. As a novel finding, we observed that GSNO also induced nitrosylation with inverse relationship at tyrosine 705 phosphorylation of STAT3, an established player in chemoresistance and cell proliferation in ovarian cancer and in cancer in general. Overall, our study underlines the significance of S-nitrosylation of key cancer promoting proteins in modulating ovarian cancer and proposes the therapeutic potential of nitrosylating agents (like GSNO) for the treatment of ovarian cancer alone or in combination with chemotherapeutic drugs.	[Giri, Shailendra; Maguire, Jacie L.; Johnson, Zachary; Shridhar, Viji] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN USA; [Graham, Rondell P.] Mayo Clin, Coll Med, Dept Anat Clin Pathol, Rochester, MN USA; [Rattan, Ramandeep] Henry Ford Hlth Syst, Womens Hlth Serv, Detroit, MI USA; [Giri, Shailendra; Deshpande, Mandar] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA	Mayo Clinic; Mayo Clinic; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Giri, S (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	SGiri1@hfhs.org; shridhar.vijayalakshmi@mayo.edu	Seal, Sudipta/A-7698-2012	Graham, Rondell/0000-0002-8686-4867; Rattan, Ramandeep/0000-0002-3532-6057; Giri, Shailendra/0000-0002-7123-829X	Marsha Rivkin Scholar grant; Department of Defense OCRP award [W81XWH-12-1-0270]	Marsha Rivkin Scholar grant; Department of Defense OCRP award(United States Department of Defense)	This work is supported by Marsha Rivkin Scholar grant and Department of Defense OCRP award W81XWH-12-1-0270 to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Anttila MA, 2007, GYNECOL ONCOL, V105, P97, DOI 10.1016/j.ygyno.2006.10.049; Bratasz A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-9; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Cabrales P, 2009, RESUSCITATION, V80, P707, DOI 10.1016/j.resuscitation.2009.03.001; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chattopadhyay M, 2010, CANCER LETT, V298, P204, DOI 10.1016/j.canlet.2010.07.006; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Estrada C, 1997, BIOCHEM J, V326, P369, DOI 10.1042/bj3260369; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054578; Hao M, 2009, J OBSTET GYNAECOL RE, V35, P918, DOI 10.1111/j.1447-0756.2009.01045.x; Haq E, 2007, J OCUL PHARMACOL TH, V23, P221, DOI 10.1089/jop.2007.0023; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Huang F, 2008, ACTA BIOCH BIOPH SIN, V40, P519, DOI 10.1111/j.1745-7270.2008.00424.x; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Ikuta K, 2005, ONCOL REP, V13, P217; Jiang QY, 2013, J OBSTET GYNAECOL RE, V39, P701, DOI 10.1111/j.1447-0756.2012.02007.x; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kato K, 2000, BBA-GENE STRUCT EXPR, V1493, P91, DOI 10.1016/S0167-4781(00)00168-8; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Klimp AH, 2001, CANCER RES, V61, P7305; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Liu M, 2014, CANCER INVEST, V32, P8, DOI 10.3109/07357907.2013.861471; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Meyer T, 2007, EXPERT OPIN THER TAR, V11, P1355, DOI 10.1517/14728222.11.10.1355; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nomelini RS, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/186584; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Prasad R, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-14; Rath KS, 2014, CANC RES; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Savarese TM, 2002, CYTOKINE, V17, P324, DOI 10.1006/cyto.2002.1022; Selvendiran K, 2008, CELL CYCLE, V7, P81, DOI 10.4161/cc.7.1.5103; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Song H, 2004, INT J ONCOL, V24, P1017; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Stevens EV, 2010, MOL PHARMACEUT, V7, P775, DOI 10.1021/mp9002865; Sun ZL, 2013, ASIAN PAC J CANCER P, V14, P4823, DOI 10.7314/APJCP.2013.14.8.4823; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhao SH, 2011, RADIOL ONCOL, V45, P196, DOI 10.2478/v10019-011-0013-8	68	15	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97897	10.1371/journal.pone.0097897	http://dx.doi.org/10.1371/journal.pone.0097897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887420	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300024
J	Graham, DB; Osborne, DG; Piotrowski, JT; Gomez, TS; Gmyrek, GB; Akilesh, HM; Dani, A; Billadeau, DD; Swat, W				Graham, Daniel B.; Osborne, Douglas G.; Piotrowski, Joshua T.; Gomez, Timothy S.; Gmyrek, Grzegorz B.; Akilesh, Holly M.; Dani, Adish; Billadeau, Daniel D.; Swat, Wojciech			Dendritic Cells Utilize the Evolutionarily Conserved WASH and Retromer Complexes to Promote MHCII Recycling and Helper T Cell Priming	PLOS ONE			English	Article							CLASS-II TRANSPORT; SUBSETS IN-VIVO; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; DOWN-REGULATION; PEPTIDE COMPLEXES; PROTEIN; TRAFFICKING; RECEPTOR; UBIQUITINATION	Immature dendritic cells (DCs) maintain a highly dynamic pool of recycling MHCII that promotes sampling of environmental antigens for presentation to T helper cells. However, the molecular basis of MHCII recycling and the cellular machinery that orchestrates MHCII trafficking are incompletely understood. Using a mouse model we show that WASH, an actin regulatory protein that facilitates retromer function, is essential for MHCII recycling and efficient priming of T helper cells. We further demonstrate that WASH deficiency results in impaired MHCII surface levels, recycling, and an accumulation of polyubiquitinated MHCII complexes, which are subsequently slated for premature lysosomal degradation. Consequently, conditional deletion of the Wash gene in DCs impairs priming of both conventional and autoimmune T helper cells in vivo and attenuates disease progression in a model of experimental autoimmune encephalitis (EAE). Thus, we identify a novel mechanism in which DCs employ the evolutionarily conserved WASH and retromer complex for MHCII recycling in order to regulate T helper cell priming.	[Graham, Daniel B.; Gmyrek, Grzegorz B.; Akilesh, Holly M.; Dani, Adish; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Immunobiol, St Louis, MO USA; [Osborne, Douglas G.; Piotrowski, Joshua T.; Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Div Oncol Res, Dept Immunol, Rochester, MN 55905 USA; [Osborne, Douglas G.; Piotrowski, Joshua T.; Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Schulze Ctr Novel Therapeut, Rochester, MN USA	Washington University (WUSTL); Mayo Clinic; Mayo Clinic	Billadeau, DD (corresponding author), Mayo Clin, Coll Med, Div Oncol Res, Dept Immunol, Rochester, MN 55905 USA.	billadeau.daniel@mayo.edu; swat@wustl.edu			National Institutes of Health [R01AI061077, R01AI065474]; Allergic Diseases Training grant [T32 AI07047]; MSTP [5T32-GM065841]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007047, R01AI061077, R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergic Diseases Training grant; MSTP; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01AI061077 to W. S., R01AI065474 to D. D. B., Allergic Diseases Training grant T32 AI07047 to T. S. G. and D.G.O., MSTP Training grant program 5T32-GM065841 to J.T.P., Leukemia and Lymphoma Society Scholar awards to W. S. and D. D. B., and Special Fellowship award to D. B. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Derivery E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039774; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gomez TS, 2012, MOL BIOL CELL, V23, P3215, DOI 10.1091/mbc.E12-02-0101; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Graham DB, 2010, BLOOD, V116, P3208, DOI 10.1182/blood-2009-10-250415; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Jia D, 2012, MOL BIOL CELL, V23, P2352, DOI 10.1091/mbc.E11-12-1059; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Piotrowski JT, 2013, MOL CELL BIOL, V33, P958, DOI 10.1128/MCB.01288-12; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Santambrogio L, 2006, IMMUNITY, V25, P857, DOI 10.1016/j.immuni.2006.11.007; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Sullivan BM, 2008, J VIROL, V82, P602, DOI 10.1128/JVI.01571-07; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Thery C, 1998, J IMMUNOL, V161, P2106; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986	47	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98606	10.1371/journal.pone.0098606	http://dx.doi.org/10.1371/journal.pone.0098606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886983	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300092
J	Houbraken, M; Demeyer, S; Michoel, T; Audenaert, P; Colle, D; Pickavet, M				Houbraken, Maarten; Demeyer, Sofie; Michoel, Tom; Audenaert, Pieter; Colle, Didier; Pickavet, Mario			The Index-Based Subgraph Matching Algorithm with General Symmetries (ISMAGS): Exploiting Symmetry for Faster Subgraph Enumeration	PLOS ONE			English	Article							NETWORK	Subgraph matching algorithms are used to find and enumerate specific interconnection structures in networks. By enumerating these specific structures/subgraphs, the fundamental properties of the network can be derived. More specifically in biological networks, subgraph matching algorithms are used to discover network motifs, specific patterns occurring more often than expected by chance. Finding these network motifs yields information on the underlying biological relations modelled by the network. In this work, we present the Index-based Subgraph Matching Algorithm with General Symmetries (ISMAGS), an improved version of the Index-based Subgraph Matching Algorithm (ISMA). ISMA quickly finds all instances of a predefined motif in a network by intelligently exploring the search space and taking into account easily identifiable symmetric structures. However, more complex symmetries (possibly involving switching multiple nodes) are not taken into account, resulting in superfluous output. ISMAGS overcomes this problem by using a customised symmetry analysis phase to detect all symmetric structures in the network motif subgraphs. These structures are then converted to symmetry-breaking constraints used to prune the search space and speed up calculations. The performance of the algorithm was tested on several types of networks (biological, social and computer networks) for various subgraphs with a varying degree of symmetry. For subgraphs with complex (multi-node) symmetric structures, high speed-up factors are obtained as the search space is pruned by the symmetry-breaking constraints. For subgraphs with no or simple symmetric structures, ISMAGS still reduces computation times by optimising set operations. Moreover, the calculated list of subgraph instances is minimal as it contains no instances that differ by only a subgraph symmetry. An implementation of the algorithm is freely available at https://github.com/mhoubraken/ISMAGS.	[Houbraken, Maarten; Audenaert, Pieter; Colle, Didier; Pickavet, Mario] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Demeyer, Sofie; Michoel, Tom] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH8 9YL, Midlothian, Scotland	Ghent University; IMEC; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Houbraken, M (corresponding author), Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium.	Maarten.Houbraken@intec.ugent.be	Pickavet, Mario J/E-9530-2019	Pickavet, Mario J/0000-0001-5817-7886; Demeyer, Sofie/0000-0002-8193-5734; Michoel, Tom/0000-0003-4749-4725; Colle, Didier/0000-0002-1428-0301	Research Foundation - Flanders (FWO-Vlaanderen); Roslin Institute; Ghent University	Research Foundation - Flanders (FWO-Vlaanderen)(FWO); Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ghent University(Ghent University)	Funded by the Research Foundation - Flanders (FWO-Vlaanderen), Ghent University and the Roslin Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, P 2 ACM S SYMBOLIC A; [Anonymous], 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526809; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Cook S. A., 1971, Proceedings of the 3rd annual ACM symposium on theory of computing, P151; Cordella L. P., 1999, Proceedings 10th International Conference on Image Analysis and Processing, P1172, DOI 10.1109/ICIAP.1999.797762; Cordella L. P., 2001, 3 IAPR TC15 WORKSH G, P149; Darga PT, 2004, DES AUT CON, P530; Demeyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061183; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Grochow JA, 2007, LECT NOTES COMPUT SC, V4453, P92; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kashtan N., 2002, TECHNICAL REPORT; Katebi H, 2012, TURING 100 EPIC, P181; LUBIW A, 1981, SIAM J COMPUT, V10, P11, DOI 10.1137/0210002; McKay B.D., 1981, PRACTICAL GRAPH ISOM; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Petersen J, 1898, INTERMED MATH, V5, P225; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Puget JF, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P272; Ribeiro P, 2010, P 2010 ACM S APPL CO, P1559, DOI DOI 10.1145/1774088.1774422; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2005, LECT NOTES COMPUT SC, V3692, P165	25	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97896	10.1371/journal.pone.0097896	http://dx.doi.org/10.1371/journal.pone.0097896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879305	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500026
J	Massilamany, C; Marciano-Cabral, F; da Rocha-Azevedo, B; Jamerson, M; Gangaplara, A; Steffen, D; Zabad, R; Illes, Z; Sobel, RA; Reddy, J				Massilamany, Chandirasegaran; Marciano-Cabral, Francine; da Rocha-Azevedo, Bruno; Jamerson, Melissa; Gangaplara, Arunakumar; Steffen, David; Zabad, Rana; Illes, Zsolt; Sobel, Raymond A.; Reddy, Jay			SJL Mice Infected with Acanthamoeba castellanii Develop Central Nervous System Autoimmunity through the Generation of Cross-Reactive T Cells for Myelin Antigens	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; FREE-LIVING AMEBAS; PROTEOLIPID PROTEIN; BASIC-PROTEIN; CEREBROSPINAL-FLUID; BYSTANDER ACTIVATION; DISEASE; IDENTIFICATION	We recently reported that Acanthamoeba castellanii (ACA), an opportunistic pathogen of the central nervous system (CNS) possesses mimicry epitopes for proteolipid protein (PLP) 139-151 and myelin basic protein 89-101, and that the epitopes induce experimental autoimmune encephalomyelitis (EAE) in SJL mice reminiscent of the diseases induced with their corresponding cognate peptides. We now demonstrate that mice infected with ACA also show the generation of crossreactive T cells, predominantly for PLP 139-151, as evaluated by T cell proliferation and IA(s)/dextramer staining. We verified that PLP 139-151-sensitized lymphocytes generated in infected mice contained a high proportion of T helper 1 cytokineproducing cells, and they can transfer disease to naive animals. Likewise, the animals first primed with suboptimal dose of PLP 139-151 and later infected with ACA, developed EAE, suggesting that ACA infection can trigger CNS autoimmunity in the presence of preexisting repertoire of autoreactive T cells. Taken together, the data provide novel insights into the pathogenesis of Acanthamoeba infections, and the potential role of infectious agents with mimicry epitopes to self-antigens in the pathogenesis of CNS diseases such as multiple sclerosis.	[Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Steffen, David; Reddy, Jay] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Marciano-Cabral, Francine; Jamerson, Melissa] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [da Rocha-Azevedo, Bruno] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zabad, Rana] Univ Nebraska, Med Ctr, Omaha, NE USA; [Illes, Zsolt] Univ Pecs, Pecs, Hungary; [Illes, Zsolt] Univ Southern Denmark, Odense, Denmark; [Sobel, Raymond A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Sobel, Raymond A.] VA Hlth Care Syst, Palo Alto, CA USA	University of Nebraska System; University of Nebraska Lincoln; Virginia Commonwealth University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Medical Center; University of Pecs; University of Southern Denmark; Stanford University	Reddy, J (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	nreddy2@unl.edu	da Rocha-Azevedo, Bruno/N-6385-2014; Steffen, David/ABI-5565-2020; Reddy, Jay/K-7200-2014; Gangaplara, Arunakumar/K-5922-2019; Driemeier, David/H-3461-2012; ZABAD, RANA/AAD-3895-2022; da+Rocha-Azevedo, Bruno/K-5348-2019; Zabad, Rana Khalil/AAX-7285-2021; Massilamany, Chandirasegaran/D-9305-2016	da Rocha-Azevedo, Bruno/0000-0002-4684-161X; Steffen, David/0000-0002-5166-2296; Reddy, Jay/0000-0003-4082-9254; Gangaplara, Arunakumar/0000-0001-6307-9391; Driemeier, David/0000-0003-3766-0654; ZABAD, RANA/0000-0003-3170-7108; Massilamany, Chandirasegaran/0000-0002-0205-282X; Illes, Zsolt/0000-0001-9655-0450; Sobel, Raymond/0000-0002-0477-9002	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065494] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50-HG002790] Funding Source: Medline; NIGMS NIH HHS [5R01-GM065494] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Brindley N, 2009, EXP PARASITOL, V121, P254, DOI 10.1016/j.exppara.2008.11.009; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Cabral GA, 2004, J NEUROIMMUNOL, V147, P127, DOI 10.1016/j.jneuroim.2003.10.027; Chappell CL, 2001, CLIN DIAGN LAB IMMUN, V8, P724, DOI 10.1128/CDLI.8.4.724-730.2001; Cirone M, 2002, J MED VIROL, V68, P268, DOI 10.1002/jmv.10190; Claerhout I, 1999, Bull Soc Belge Ophtalmol, V274, P71; CULBERTSON C, 1961, AM J CLIN PATHOL, V35, P195, DOI 10.1093/ajcp/35.3.195; CULBERTSON C. G., 1959, AMER JOUR PATHOL, V35, P185; CULBERTSON CG, 1958, SCIENCE, V127, P1506, DOI 10.1126/science.127.3313.1506; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Ferber IA, 1996, J IMMUNOL, V156, P5; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; FORGHANI B, 1978, J CLIN MICROBIOL, V7, P63; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Greer JM, 1996, J IMMUNOL, V156, P371; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Khan N. A., 2005, American Journal of Immunology, V1, P24; Khan NA, 2003, MICROB PATHOGENESIS, V34, P277, DOI 10.1016/S0882-4010(03)00061-5; Khan NA, 2008, J MED MICROBIOL, V57, P1051, DOI 10.1099/jmm.0.2008/000976-0; Kidney DD, 1998, AM J ROENTGENOL, V171, P809, DOI 10.2214/ajr.171.3.9725321; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; LEINIKKI P, 1982, J NEUROL SCI, V57, P249, DOI 10.1016/0022-510X(82)90031-4; Mancuso R, 2010, J MED VIROL, V82, P1051, DOI 10.1002/jmv.21764; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marciano-Cabral F, 2001, J EUKARYOT MICROBIOL, p4S; Marciano-Cabral F, 2000, J EUKARYOT MICROBIOL, V47, P29, DOI 10.1111/j.1550-7408.2000.tb00007.x; MARTINEZ AJ, 1985, INFECTION, V13, P251, DOI 10.1007/BF01645432; Massilamany C, 2011, NON-FLAVIVIRUS ENCEPHALITIS, P307; Massilamany C, 2011, INT IMMUNOL, V23, P729, DOI 10.1093/intimm/dxr084; Massilamany C, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-40; Massilamany C, 2011, J NEUROIMMUNOL, V230, P95, DOI 10.1016/j.jneuroim.2010.09.011; Massilamany C, 2010, J NEUROIMMUNOL, V219, P17, DOI 10.1016/j.jneuroim.2009.11.006; McClellan K, 2002, EXP EYE RES, V75, P285, DOI [10.1016/S0014-4835(02)92015-4, 10.1006/exer.2002.2015]; MEINL E, 1993, J CLIN INVEST, V92, P2633, DOI 10.1172/JCI116879; Moore FGA, 2002, ACTA NEUROL SCAND, V106, P63, DOI 10.1034/j.1600-0404.2002.01251.x; Nogai A, 2005, J IMMUNOL, V175, P959, DOI 10.4049/jimmunol.175.2.959; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Olsen JK, 2001, J CLIN INVEST, V108, P311; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; Segal BM, 1997, J IMMUNOL, V158, P5087; Shadidi KR, 2001, RHEUMATOLOGY, V40, P1120, DOI 10.1093/rheumatology/40.10.1120; SOBEL RA, 1990, J NEUROPATH EXP NEUR, V49, P468, DOI 10.1097/00005072-199009000-00002; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sowka J. W., 2001, HDB OCULAR DIS MANAG; TANAKA Y, 1994, PARASITOL RES, V80, P549, DOI 10.1007/BF00933001; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; WICHER V, 1979, CLIN EXP IMMUNOL, V37, P114; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhang Y, 2004, INVEST OPHTH VIS SCI, V45, P1904, DOI 10.1167/iovs.03-1073	61	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98506	10.1371/journal.pone.0098506	http://dx.doi.org/10.1371/journal.pone.0098506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879066	Green Published, gold			2022-12-27	WOS:000338101500064
J	Moors, P; Wagemans, J; de-Wit, L				Moors, Pieter; Wagemans, Johan; de-Wit, Lee			Moving Stimuli Are Less Effectively Masked Using Traditional Continuous Flash Suppression (CFS) Compared to a Moving Mondrian Mask (MMM): A Test Case for Feature-Selective Suppression and Retinotopic Adaptation	PLOS ONE			English	Article							BINOCULAR-RIVALRY; AWARENESS; PERCEPTION; ATTENTION; DEPENDS; MOTION; CELLS; LOAD; FACE	Continuous flash suppression (CFS) is a powerful interocular suppression technique, which is often described as an effective means to reliably suppress stimuli from visual awareness. Suppression through CFS has been assumed to depend upon a reduction in (retinotopically specific) neural adaptation caused by the continual updating of the contents of the visual input to one eye. In this study, we started from the observation that suppressing a moving stimulus through CFS appeared to be more effective when using a mask that was actually more prone to retinotopically specific neural adaptation, but in which the properties of the mask were more similar to those of the to-be-suppressed stimulus. In two experiments, we find that using a moving Mondrian mask (i.e., one that includes motion) is more effective in suppressing a moving stimulus than a regular CFS mask. The observed pattern of results cannot be explained by a simple simulation that computes the degree of retinotopically specific neural adaptation over time, suggesting that this kind of neural adaptation does not play a large role in predicting the differences between conditions in this context. We also find some evidence consistent with the idea that the most effective CFS mask is the one that matches the properties (speed) of the suppressed stimulus. These results question the general importance of retinotopically specific neural adaptation in CFS, and potentially help to explain an implicit trend in the literature to adapt one's CFS mask to match one's to-be-suppressed stimuli. Finally, the results should help to guide the methodological development of future research where continuous suppression of moving stimuli is desired.	[Moors, Pieter; Wagemans, Johan; de-Wit, Lee] Univ Leuven KU Leuven, Expt Psychol Lab, Leuven, Belgium	KU Leuven	Moors, P (corresponding author), Univ Leuven KU Leuven, Expt Psychol Lab, Leuven, Belgium.	Pieter.Moors@ppw.kuleuven.be	Moors, Pieter/H-8638-2019; Wagemans, Johan/M-3878-2019	Moors, Pieter/0000-0002-4667-1235; Wagemans, Johan/0000-0002-7970-1541	Research Foundation - Flanders (FWO); Flemish Government [METH/08/02]; FWO postdoctoral fellowship	Research Foundation - Flanders (FWO)(FWO); Flemish Government(European Commission); FWO postdoctoral fellowship(FWO)	PM is a research assistant supported by the Research Foundation - Flanders (FWO), JW is supported by a Methusalem grant from the Flemish Government (METH/08/02), and LDW by a FWO postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Alais D, 2006, NEURON, V52, P911, DOI 10.1016/j.neuron.2006.10.027; Alais D, 2012, WIRES COGN SCI, V3, P87, DOI 10.1002/wcs.151; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Bahrami B, 2010, PSYCHOL SCI, V21, P224, DOI 10.1177/0956797609360664; Bahrami B, 2008, J VISION, V8, DOI 10.1167/8.3.12; Bahrami B, 2008, PERCEPTION, V37, P1520, DOI 10.1068/p5999; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Faivre N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00129; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Hesselmann G, 2011, CEREB CORTEX, V21, P2829, DOI 10.1093/cercor/bhr085; Hesselmann G, 2011, J NEUROSCI, V31, P12936, DOI 10.1523/JNEUROSCI.1556-11.2011; Hong SW, 2009, ATTEN PERCEPT PSYCHO, V71, P403, DOI 10.3758/APP.71.2.403; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Kawabe T, 2009, CONSCIOUS COGN, V18, P168, DOI 10.1016/j.concog.2008.12.004; Krekelberg B, 2006, J NEUROPHYSIOL, V95, P255, DOI 10.1152/jn.00750.2005; Krekelberg B, 2006, TRENDS NEUROSCI, V29, P250, DOI 10.1016/j.tins.2006.02.008; Kruschke J. K, 2010, DOING BAYESIAN DATA; Kruschke JK, 2010, TRENDS COGN SCI, V14, P293, DOI 10.1016/j.tics.2010.05.001; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Maehara G, 2009, VISION RES, V49, P1838, DOI 10.1016/j.visres.2009.04.020; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Porta IB, 1593, REFRACTIONE OPTICES; Raio CM, 2012, CURR BIOL, V22, pR477, DOI 10.1016/j.cub.2012.04.023; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rolfs M, 2013, CURR BIOL, V23, P250, DOI 10.1016/j.cub.2012.12.017; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; ROZEBOOM WW, 1960, PSYCHOL BULL, V57, P416, DOI 10.1037/h0042040; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Shimaoka D, 2011, VISION RES, V51, P521, DOI 10.1016/j.visres.2011.01.009; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stuit SM, 2009, J VISION, V9, DOI 10.1167/9.11.17; Sweeny TD, 2011, PSYCHOL SCI, V22, P943, DOI 10.1177/0956797611413292; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040106; Wilson HR, 2007, VISION RES, V47, P2741, DOI 10.1016/j.visres.2007.07.007; Xu S, 2011, VISION RES, V51, P2048, DOI 10.1016/j.visres.2011.07.023; Yamada Y, 2012, JPN PSYCHOL RES, V54, P348, DOI 10.1111/j.1468-5884.2012.00512.x; Yamada Y, 2011, CONSCIOUS COGN, V20, P1835, DOI 10.1016/j.concog.2011.06.016; Yan XD, 2009, ADDICT BIOL, V14, P478, DOI 10.1111/j.1369-1600.2009.00172.x; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24; Zito Tiziano, 2008, Front Neuroinform, V2, P8, DOI 10.3389/neuro.11.008.2008	57	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98298	10.1371/journal.pone.0098298	http://dx.doi.org/10.1371/journal.pone.0098298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24879378	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500047
J	van Bergen, APL; Hoff, SJM; van Ameijden, EJC; van Hemert, AM				van Bergen, Addi P. L.; Hoff, Stella J. M.; van Ameijden, Erik J. C.; van Hemert, Albert M.			Measuring Social Exclusion in Routine Public Health Surveys: Construction of a Multidimensional Instrument	PLOS ONE			English	Article							MENTAL-HEALTH	Introduction: Social exclusion is considered a major factor in the causation and maintenance of health inequalities, but its measurement in health research is still in its infancy. In the Netherlands the Institute for Social Research (SCP) developed an instrument to measure the multidimensional concept of social exclusion in social and economic policy research. Here, we present a method to construct a similar measure of social exclusion using available data from public health surveys. Methods: Analyses were performed on data from the health questionnaires that were completed by 20,877 adults in the four largest cities in the Netherlands. From each of the four questionnaires we selected the items that corresponded to those of the SCP-instrument. These were entered into a nonlinear canonical correlation analysis. The measurement properties of the resulting indices and dimension scales were assessed and compared to the SCP-instrument. Results: The internal consistency of the indices and most of the dimension scales were adequate and the internal structure of the indices was as expected. Both generalisabiliy and construct validity were good: in all datasets strong associations were found between the index and a number of known risk factors of social exclusion. A limitation of content validity was that the dimension "lack of normative integration'' could not be measured, because no relevant items were available. Conclusions: Our findings indicate that a measure for social exclusion can be constructed with available health questionnaires. This provides opportunities for application in public health surveillance systems in the Netherlands and elsewhere in the world.	[van Bergen, Addi P. L.; van Ameijden, Erik J. C.] Municipal Hlth Serv Utrecht, Utrecht, Netherlands; [Hoff, Stella J. M.] Netherlands Inst Social Research, SCP, The Hague, Netherlands; [van Bergen, Addi P. L.; van Hemert, Albert M.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Bergen, APL (corresponding author), Municipal Hlth Serv Utrecht, Utrecht, Netherlands.	a.van.bergen@utrecht.nl	van Bergen, Adriana/AAS-2414-2020	van Bergen, Adriana/0000-0002-9526-2649				[Anonymous], 2010, WELLBEING NETHERLAND; [Anonymous], 2010, POV SOC EXCL HLTH SY; Boardman J, 2011, MENT HEALTH SOC INCL, V15, P112, DOI 10.1108/20428301111165690; Curran C, 2007, SOC POLICY ADMIN, V41, P289, DOI 10.1111/j.1467-9515.2007.00553.x; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Dirven H, 2005, ARMOEDEMONITOR 2005, P103; Engbersen G, 2000, BALANS ARMOEDEBELEID, P53; Escorel S, 2008, REV LIT; Garson G, 2012, CANONICAL CORRELATIO; Guiaux M., 2011, VOORBESTEMD ACHTERST; Hoff S., 2011, DIMENSIES SOCIALE UI; Jehoel-Gijsbers G., 2008, SOCIAL EXCLUSION ELD; Jehoel-Gijsbers G., 2007, EXPLAINING SOCIAL EX; Jehoel-Gijsbers G., 2004, SOCIALE UITSLUITING; Khan S., 2012, TOPIC GUIDE SOCIAL E; Klaus-Meijs W, 2010, G4 OP GEZONDHEID UIT; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Minardi V, 2011, INT J PUBLIC HEALTH, V56, P359, DOI 10.1007/s00038-011-0241-0; Morgan C, 2007, BRIT J PSYCHIAT, V191, P477, DOI 10.1192/bjp.bp.106.034942; Popay J., 2008, UNDERSTANDING TACKLI; Popay J, 2011, IMPROVING EQUITY HLT, P88; Renahy E, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-4; Roest A, 2012, SOCIALE UITSLUITING; Scutella R., 2009, MEASURING POVERTY SO; Silver H., 2003, INDICATORS, V2, P5, DOI DOI 10.1080/15357449.2003.11069166; Stoop I.A.L., 2005, HUNT LAST RESPONDENT; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Van den Brink C, 2011, TIJDSCHRIFT GEZONDHE, V89, P83, DOI [10.1007/s12508-011-0030-4, DOI 10.1007/S12508-011-0030-4]; Vrooman JC, 2013, SOC INDIC RES, V113, P1261, DOI 10.1007/s11205-012-0138-1; Wilkinson R., 2003, Social determinants of health: the solid facts; Wright N, 2012, J PSYCHIATR MENT HLT, DOI 10/1111/j.1365.2850.2012.01889.x	31	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98680	10.1371/journal.pone.0098680	http://dx.doi.org/10.1371/journal.pone.0098680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878842	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500079
J	Gagnon, JA; Valen, E; Thyme, SB; Huang, P; Ahkmetova, L; Pauli, A; Montague, TG; Zimmerman, S; Richter, C; Schier, AF				Gagnon, James A.; Valen, Eivind; Thyme, Summer B.; Huang, Peng; Ahkmetova, Laila; Pauli, Andrea; Montague, Tessa G.; Zimmerman, Steven; Richter, Constance; Schier, Alexander F.			Efficient Mutagenesis by Cas9 Protein-Mediated Oligonucleotide Insertion and Large-Scale Assessment of Single-Guide RNAs	PLOS ONE			English	Article							CRISPR-CAS9 SYSTEM; HUMAN GENOME; ZEBRAFISH; CRISPR/CAS; POLYMERASE; DNA; NUCLEASES; MICE	The CRISPR/Cas9 system has been implemented in a variety of model organisms to mediate site-directed mutagenesis. A wide range of mutation rates has been reported, but at a limited number of genomic target sites. To uncover the rules that govern effective Cas9-mediated mutagenesis in zebrafish, we targeted over a hundred genomic loci for mutagenesis using a streamlined and cloning-free method. We generated mutations in 85% of target genes with mutation rates varying across several orders of magnitude, and identified sequence composition rules that influence mutagenesis. We increased rates of mutagenesis by implementing several novel approaches. The activities of poor or unsuccessful single-guide RNAs (sgRNAs) initiating with a 59 adenine were improved by rescuing 59 end homogeneity of the sgRNA. In some cases, direct injection of Cas9 protein/sgRNA complex further increased mutagenic activity. We also observed that low diversity of mutant alleles led to repeated failure to obtain frame-shift mutations. This limitation was overcome by knock-in of a stop codon cassette that ensured coding frame truncation. Our improved methods and detailed protocols make Cas9-mediated mutagenesis an attractive approach for labs of all sizes.	[Gagnon, James A.; Valen, Eivind; Thyme, Summer B.; Huang, Peng; Ahkmetova, Laila; Pauli, Andrea; Montague, Tessa G.; Zimmerman, Steven; Richter, Constance; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Huang, Peng] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; University of Calgary; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Gagnon, JA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	james.gagnon@gmail.com; schier@fas.harvard.edu	Richter, Constance/P-8714-2019; Valen, Eivind/A-8617-2011; Huang, Peng/U-8384-2019	Huang, Peng/0000-0001-7954-8869; Schier, Alexander Franz/0000-0001-7645-5325; Montague, Tessa/0000-0002-5918-6327; Valen, Eivind/0000-0003-1840-6108; Richter, Constance/0000-0003-3312-0941; Thyme, Summer/0000-0003-3593-4148; Gagnon, James/0000-0003-3978-6058	American Cancer Society; Human Frontier Science Program; Damon Runyon Cancer Research Foundation; EMBO; NSDEG; Life Sciences Research Foundation; NIH [R01 GM056211, R01 HL109525, R21 HD072733]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076935, R21HD072733] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); Damon Runyon Cancer Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); NSDEG; Life Sciences Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the American Cancer Society (JAG), Human Frontier Science Program (EV, AP), Damon Runyon Cancer Research Foundation (SBT), EMBO(CR), NSDEG (TGM), Life Sciences Research Foundation (CR), and NIH grants R01 GM056211, R01 HL109525, and R21 HD072733 (JAG, EV, SBT, PH, LA, AP, TGM, SZ, CR, AFS). All authors supported by these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll D, 2014, ANN REV BIOCH; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Helm M, 1999, RNA, V5, P618, DOI 10.1017/S1355838299982328; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Sander JD, 2014, NAT BIOTECHNOL; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUMP WT, 1993, NUCLEIC ACIDS RES, V21, P5480, DOI 10.1093/nar/21.23.5480; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	25	526	561	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98186	10.1371/journal.pone.0098186	http://dx.doi.org/10.1371/journal.pone.0098186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873830	gold, Green Published			2022-12-27	WOS:000336790800027
J	Wang, DM; Wu, SH; Yao, YJ				Wang, Dong-Mei; Wu, Sheng-Hua; Yao, Yi-Jian			Clarification of the Concept of Ganoderma orbiforme with High Morphological Plasticity	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SUBUNIT RIBOSOMAL DNA; OIL PALM; SEQUENCE; POLYPORES; TAXONOMY; LUCIDUM; DISEASE; FUNGI; RDNA	Ganoderma has been considered a very difficult genus among the polypores to classify and is currently in a state of taxonomic chaos. In a study of Ganoderma collections including numerous type specimens, we found that six species namely G. cupreum, G. densizonatum, G. limushanense, G. mastoporum, G. orbiforme, G. subtornatum, and records of G. fornicatum from Mainland China and Taiwan are very similar to one another in basidiocarp texture, pilear cuticle structure, context color, pore color and basidiospore characteristics. Further, we sequenced the nrDNA ITS region (ITS1 and ITS2) and partial mtDNA SSU region of the studied materials, and performed phylogenetic analyses based on these sequence data. The nrDNA ITS sequence analysis results show that the eight nrDNA ITS sequences derived from this study have single-nucleotide polymorphisms in ITS1 and/or ITS2 at inter- and intra- individual levels. In the nrDNA ITS phylogenetic trees, all the sequences from this study are grouped together with those of G. cupreum and G. mastoporum retrieved from GenBank to form a distinct clade. The mtDNA SSU sequence analysis results reveal that the five mtDNA SSU sequences derived from this study are clustered together with those of G. cupreum retrieved from GenBank and also form a distinct clade in the mtDNA SSU phylogenetic trees. Based on morphological and molecular data, we conclude that the studied taxa are conspecific. Among the names assigned to this species, G. fornicatum given to Asian collections has nomenclatural priority over the others. However, the type of G. fornicatum from Brazil is probably lost and a modern description based on the type lacks. The identification of the Asian collections to G. fornicatum therefore cannot be confirmed. To the best of our knowledge, G. orbiforme is the earliest valid name for use.	[Wang, Dong-Mei; Yao, Yi-Jian] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Wang, Dong-Mei; Wu, Sheng-Hua] Natl Museum Nat Sci, Dept Bot, Taichung, Taiwan	Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, DM (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wangdmwendy@gmail.com	WANG, DONG-MEI/K-5799-2016		National Science Council (ROC) [NSC96-2816-B-178-001]; National Natural Science Foundation of China [30270006]	National Science Council (ROC)(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Postdoctoral Fellowship Grant of National Science Council (ROC), NO. NSC96-2816-B-178-001, and the National Natural Science Foundation of China (30270006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corner EJH, 1983, BEIH NOV HEDW, V75, P1; Dai YC, 2007, FOREST PATHOL, V37, P105, DOI 10.1111/j.1439-0329.2007.00485.x; Dai YC, 2009, INT J MED MUSHROOMS, V11, P287, DOI 10.1615/IntJMedMushr.v11.i3.80; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flood J, 2000, GANODERMA DIS PERENN; Fries E, 1836, EPICRISIS SYSTEMATIS, Vi-xii; Fries E. M., 1830, LINNAEA, V5, P497; Gottlieb AM, 2000, MYCOL RES, V104, P1033, DOI 10.1017/S095375620000304X; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HOLMGREN PK, 1998, INDEX HERBARIORUM GL; Hong SG, 2004, MYCOLOGIA, V96, P742, DOI 10.2307/3762108; Hong SG, 2002, MYCOLOGIA, V94, P823, DOI 10.2307/3761697; Hseu RS, 1990, THESIS NATL TAIWAN U; HUMPHREY C. J., 1931, Philipp. J. of Sci, V45, P483; IMAZEKI R., 1939, BULL TOKYO SCI MUS, V1, P29; Isaka M, 2013, PHYTOCHEMISTRY, V87, P133, DOI 10.1016/j.phytochem.2012.11.022; Kinge TR, 2011, MYCOSPHERE, V2, P179; Kirk PM, 2008, AINSWORTH BISBYS DIC; Lin ZB, 2009, LINGZHI MYSTERY SCI; Lloyd CG, 1912, MYCOL WRIT, V3, P95; Moncalvo J. M., 2000, Ganoderma diseases of perennial crops, P23, DOI 10.1079/9780851993881.0023; Moncalvo J.M., 1995, GANODERMA SYSTEMATIC, V59, P31; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Moncalvo JM., 1997, SYNOPSIS FUNGORUM, V11; Murrill WA, 1902, B TORREY BOT CLUB, V29, P599, DOI DOI 10.2307/2478682; Murrill WA, 1973, BIBL MYCOL, V40, P1; Murrill WA, 1907, B TORREY BOT CLUB, V34, P465; Murrill WA, 1908, N AM FLORA, V9, P113; Park Young-Jin, 2012, Mycobiology, V40, P71, DOI 10.5941/MYCO.2012.40.1.071; Patouillard NT, 1889, BULL SOC MYCOL FR, V5, P64; Ryvarden L, 2000, MYCOLOGIA, V92, P180, DOI 10.2307/3761462; RYVARDEN L, 1995, P CONTRIB S A, V59, P19; Ryvarden L., 1991, SYNOPSIS FUNGORUM, V5, DOI DOI 10.2307/3760304; Sankaran KV, 2005, MYCOPATHOLOGIA, V159, P143, DOI 10.1007/s11046-004-4437-1; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith BJ, 2000, MYCOL RES, V104, P943, DOI 10.1017/S0953756200002458; Smith BJ, 2003, AUST SYST BOT, V16, P487, DOI 10.1071/SB02001; STEYAERT R L, 1980, Bulletin du Jardin Botanique National de Belgique, V50, P135, DOI 10.2307/3667780; STEYAERT R. L., 1967, Bull. Jard. bot. Nat. Belg., V37, P465, DOI 10.2307/3667472; Steyaert RL, 1972, PERSOONIA, V7, P55; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Utomo C, 2005, MYCOPATHOLOGIA, V159, P159, DOI 10.1007/s11046-004-4439-z; Wang DM, 2005, MYCOTAXON, V93, P61; Wang DM, 2005, CAN J MICROBIOL, V51, P113, DOI 10.1139/W04-118; Wang DM, 2008, MYCOTAXON, V104, P297; Wang DM, 2007, MYCOTAXON, V102, P373; Wang DM, 2009, BOT STUD, V50, P451; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu SH, 2007, MYCOLOGIA, V99, P302, DOI 10.3852/mycologia.99.2.302; Zhao J.-D., 1979, Acta Microbiologica Sinica, V19, P265; Zhao JD, 1995, GANODERMA SYSTEMATIC, P1; Zhao JD, 2000, FLORA FUNGORUM SINIC; Zhao JD, 1986, ACTA MYCOLOGICA SINI, V5, P219	54	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98733	10.1371/journal.pone.0098733	http://dx.doi.org/10.1371/journal.pone.0098733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875218	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800058
J	Lu, Y; Wang, Q; Wang, DH; Zhou, H; Hu, YJ; Yang, WX				Lu, Yang; Wang, Qi; Wang, Da-Hui; Zhou, Hong; Hu, Yan-Jun; Yang, Wan-Xi			Functional Analysis of KIF3A and KIF3B during Spermiogenesis of Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							HETEROTRIMERIC KINESIN; SUPERFAMILY PROTEINS; MOLECULAR MOTORS; I-TASSER; TESTIS; GENE; TRANSPORT; SPERMATOGENESIS; IDENTIFICATION; EXPRESSION	Background: Spermatogenesis represents the transformation process at the level of cellular development. KIF3A and KIF3B are believed to play some roles in the assembly and maintenance of flagella, intracellular transport of materials including organelles and proteins, and other unknown functions during this process. During spermatogenesis in Eriocheir sinensis, if the sperm shaping machinery is dependent on KIF3A and KIF3B remains unknown. Methodology/Principal Findings: The cDNA of KIF3A and KIF3B were obtained by designing degenerate primers, 3'RACE, and 5'RACE. We detected the genetic presence of kif3a and kif3b in the heart, muscle, liver, gill, and testis of E. sinensis through RT-PCR. By western blot analysis, the protein presence of KIF3A and KIF3B in heart, muscle, gill, and testis reflected the content in protein level. Using in situ hybridization and immunofluorescence, we could track the dynamic location of KIF3A and KIF3B during different developmental phases of sperm. KIF3A and KIF3B were found surrounding the nucleus in early spermatids. In intermediate spermatids, these proteins expressed at high levels around the nucleus and extended to the final phase. During the nuclear shaping period, KIF3A and KIF3B reached their maximum in the late spermatids and were located around the nucleus and concentrated in the acrosome to some extent. Conclusions/Significance: Our results revealed that KIF3A and KIF3B were involved in the nuclear and cellular morphogenesis at the levels of mRNA and protein. These proteins can potentially facilitate the intracellular transport of organelles, proteins, and other cargoes. The results represent the functions of KIF3A and KIF3B in the spermatogenesis of Crustacea and clarify phylogenetic relationships among the Decapoda.	[Lu, Yang; Wang, Qi; Wang, Da-Hui; Zhou, Hong; Yang, Wan-Xi] Zhejiang Univ, Sperm Lab, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Yan-Jun] Zhejiang Univ, Dept Reprod Endocrinol, Womens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, H (corresponding author), Zhejiang Univ, Sperm Lab, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhouhong@zuaa.zju.edu.cn; hyj101@163.com; wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [41276151, 31072198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/tab131/) (No. 41276151 and 31072198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Chennathukuzhi V, 2003, P NATL ACAD SCI USA, V100, P15566, DOI 10.1073/pnas.2536695100; Christensen GL, 2006, MOL HUM REPROD, V12, P257, DOI 10.1093/molehr/gal006; Dang R, 2012, MOL BIOL REP, V39, P5589, DOI 10.1007/s11033-011-1363-4; Du Nanshan, 1988, Oceanologia et Limnologia Sinica, V19, P71; Garcia EBG, 2009, LANCET ONCOL, V10, P727, DOI 10.1016/S1470-2045(09)70167-6; Henson JH, 1997, CELL MOTIL CYTOSKEL, V38, P29, DOI 10.1002/(SICI)1097-0169(1997)38:1<29::AID-CM4>3.0.CO;2-C; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Ho NY, 2008, MAR POLLUT BULL, V57, P425, DOI 10.1016/j.marpolbul.2008.02.044; Hu JR, 2012, MOL BIOL REP, V39, P4207, DOI 10.1007/s11033-011-1206-3; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kotaja N, 2005, J BIOL CHEM, V280, P31739, DOI 10.1074/jbc.M505971200; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Marszalek JR, 2000, BBA-MOL CELL RES, V1496, P142, DOI 10.1016/S0167-4889(00)00015-X; Medina PMB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003054; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Ramalho-Santos J, 2002, BIOL REPROD, V67, P1043, DOI 10.1095/biolreprod67.4.1043; RASHID DJ, 1995, J MOL BIOL, V252, P157, DOI 10.1006/jmbi.1995.0484; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saade M, 2007, EXP CELL RES, V313, P614, DOI 10.1016/j.yexcr.2006.11.011; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Shimizu K, 1996, J BIOL CHEM, V271, P27013, DOI 10.1074/jbc.271.43.27013; Simeo CG, 2010, J MORPHOL, V271, P394, DOI 10.1002/jmor.10805; Sun X, 2011, MOL BIOL REP, V38, P3993, DOI 10.1007/s11033-010-0517-0; Sun XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012738; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tang EI, 2013, J ENDOCRINOL, V217, pR13, DOI 10.1530/JOE-12-0586; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagner MK, 2000, CURR BIOL, V10, pR149, DOI 10.1016/S0960-9822(00)00328-6; Wang DH, 2010, COMP BIOCHEM PHYS A, V157, P123, DOI 10.1016/j.cbpa.2010.05.015; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Wang W, 2010, COMP BIOCHEM PHYS A, V157, P237, DOI 10.1016/j.cbpa.2010.07.004; Wang WK, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/695750; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yang Wan-Xi, 1999, Acta Zoologica Sinica, V45, P178; Yang Wanxi, 2000, Yingyong Shengtai Xuebao, V11, P763; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zama U, 2004, TISSUE CELL, V36, P29, DOI 10.1016/j.tice.2003.08.003; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zou Y, 2002, BIOL REPROD, V66, P843, DOI 10.1095/biolreprod66.3.843	55	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97645	10.1371/journal.pone.0097645	http://dx.doi.org/10.1371/journal.pone.0097645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870586	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300016
J	Bouwsema, H; van der Sluis, CK; Bongers, RM				Bouwsema, Hanneke; van der Sluis, Corry K.; Bongers, Raoul M.			Effect of Feedback during Virtual Training of Grip Force Control with a Myoelectric Prosthesis	PLOS ONE			English	Article							SENSORY FEEDBACK; TACTILE DISPLAY; CONTROL STRATEGIES; LIMB; REALITY; OBJECT; VARIABILITY; KNOWLEDGE; STROKE; SYSTEM	The aim of this study was to determine whether virtual training improves grip force control in prosthesis use, and to examine which type of augmented feedback facilitates its learning most. Thirty-two able-bodied participants trained grip force with a virtual ball-throwing game for five sessions in a two-week period, using a myoelectric simulator. They received either feedback on movement outcome or on movement execution. Sixteen controls received training that did not focus on force control. Variability over learning was examined with the Tolerance-Noise-Covariation approach, and the transfer of grip force control was assessed in five test-tasks that assessed different aspects of force control in a pretest, a posttest and a retention test. During training performance increased while the variability in performance was decreased, mainly by reduction in noise. Grip force control only improved in the test-tasks that provided information on performance. Starting the training with a task that required low force production showed no transfer of the learned grip force. Feedback on movement execution was detrimental to grip force control, whereas feedback on movement outcome enhanced transfer of grip force control to tasks other than trained. Clinical implications of these results regarding virtual training of grip force control are discussed.	[Bouwsema, Hanneke; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Bouwsema, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464	Otto Bock Healthcare GmbH, Vienna, Austria	Otto Bock Healthcare GmbH, Vienna, Austria	This research is performed while Hanneke Bouwsema was financially supported by Otto Bock Healthcare GmbH, Vienna, Austria. By legal contract, Otto Bock had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; AGNEW PJ, 1981, AM J OCCUP THER, V35, P722, DOI 10.5014/ajot.35.11.722; Anderson F, 2012, PROC 9 INT C DIS VIR; Antfolk C, 2013, EXPERT REV MED DEVIC, V10, P45, DOI [10.1586/erd.12.68, 10.1586/ERD.12.68]; Antfolk C, 2010, J MED BIOL ENG, V30, P355, DOI 10.5405/jmbe.766; Antfolk C, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-50; Antfolk C, 2010, J PLAST SURG HAND SU, V44, P50, DOI 10.3109/02844310903259090; Bernstein N.A., 1996, RES ECOL PS; Blank A, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1773965.1773966; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; Chappell P. H., 2011, Journal of Medical Engineering & Technology, V35, P1, DOI 10.3109/03091902.2010.526983; Chatterjee A., 2008, J PROSTHETICS ORTHOT, V20, P27, DOI [10.1097/01.JPO.0000311041.61628.be, DOI 10.1097/01.JP0.0000311041.61628.BE]; Chatterjee A, 2008, 2008 IEEE REGION 5 CONFERENCE, P75; Cirstea AC, 2007, NEUROREHAB NEURAL RE, V21, P398, DOI 10.1177/1545968306298414; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Dakpa R, 1997, CURR ORTHOPAED, V11, P193, DOI 10.1016/S0268-0890(97)90034-7; Dawson Michael R, 2012, Open Biomed Eng J, V6, P5, DOI 10.2174/1874230001206010005; Dawson MR, 2011, EXPERT REV MED DEVIC, V8, P581, DOI [10.1586/erd.11.23, 10.1586/ERD.11.23]; Dingwell JB, 2004, J NEUROPHYSIOL, V91, P1158, DOI 10.1152/jn.00704.2003; Engeberg ED, 2012, PROSTHET ORTHOT INT, V36, P423, DOI 10.1177/0309364612440077; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Gilmore P.E., 2001, PHYS OCCUP THER GERI, V20, P1, DOI [10.1080/J148v20n01_01, DOI 10.1080/J148V20N01_01, DOI 10.1080/J148V20N01_]; Goodman JS, 2004, J APPL PSYCHOL, V89, P248, DOI 10.1037/0021-9010.89.2.248; Gordon K, 2004, EXP BRAIN RES, V159, P478, DOI 10.1007/s00221-004-1970-6; Hebert JS, 2012, J REHABIL RES DEV, V49, P1163, DOI 10.1682/JRRD.2011.10.0207; Heckathorne C. W., 1992, ATLAS LIMB PROSTHETI, V2nd, P151; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; KRIZ G, 1995, ARCH PHYS MED REHAB, V76, P653, DOI 10.1016/S0003-9993(95)80635-0; Kurillo G, 2004, CLIN BIOMECH, V19, P1014, DOI 10.1016/j.clinbiomech.2004.07.003; Kurillo Gregorij, 2005, Technol Health Care, V13, P137; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Mah CD, 2003, BIOL CYBERN, V88, P60, DOI 10.1007/s00422-002-0347-9; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MEEK S G, 1989, Journal of Rehabilitation Research and Development, V26, P53; Melendez-Calderon A, 2011, IEEE T NEUR SYS REH, V19, P298, DOI 10.1109/TNSRE.2011.2125990; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Park JH, 2000, J MOTOR BEHAV, V32, P287, DOI 10.1080/00222890009601379; Peerdeman B, 2011, J REHABIL RES DEV, V48, P719, DOI 10.1682/JRRD.2010.08.0161; Proteau L, 2005, EXP BRAIN RES, V161, P441, DOI 10.1007/s00221-004-2090-z; Pylatiuk C, 2006, J PROSTHET ORTHOT, V18, P57, DOI DOI 10.1097/00008526-200604000-00007; Ranganathan R, 2009, J MOTOR BEHAV, V41, P317, DOI 10.3200/JMBR.41.4.317-330; Resnik L, 2011, J REHABIL RES DEV, V48, P707, DOI 10.1682/JRRD.2010.07.0127; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; Saunders I, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-60; SCHMIDT RA, 1989, J EXP PSYCHOL LEARN, V15, P352, DOI 10.1037/0278-7393.15.2.352; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Sebelius F., 2005, TECHNOL DISABIL, V17, P131, DOI [10.3233/TAD-2005-17301, DOI 10.3233/TAD-2005-17301]; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Subramanian SK, 2013, NEUROREHAB NEURAL RE, V27, P13, DOI 10.1177/1545968312449695; Van Vliet PM, 2006, DISABIL REHABIL, V28, P831, DOI 10.1080/09638280500534937; Weeks DL, 2000, EXP BRAIN RES, V132, P404, DOI 10.1007/s002210000337; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Zafar M, 2000, MED BIOL ENG COMPUT, V38, P267, DOI 10.1007/BF02347046	63	26	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98301	10.1371/journal.pone.0098301	http://dx.doi.org/10.1371/journal.pone.0098301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865570	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100050
J	Kassavetis, GA; Kadonaga, JT				Kassavetis, George A.; Kadonaga, James T.			The Annealing Helicase and Branch Migration Activities of Drosophila HARP	PLOS ONE			English	Article							GENOME STABILITY; RNA-DNA; REPLICATION STRESS; TRANSCRIPTION; PROTEIN; IDENTIFICATION; CHROMATIN; PCNA	HARP (SMARCAL1, MARCAL1) is an annealing helicase that functions in the repair and restart of damaged DNA replication forks through its DNA branch migration and replication fork regression activities. HARP is conserved among metazoans. HARP from invertebrates differs by the absence of one of the two HARP-specific domain repeats found in vertebrates. The annealing helicase and branch migration activity of invertebrate HARP has not been documented. We found that HARP from Drosophila melanogaster retains the annealing helicase activity of human HARP, the ability to disrupt D-loops and to branch migrate Holliday junctions, but fails to regress model DNA replication fork structures. A comparison of human and Drosophila HARP on additional substrates revealed that both HARPs are competent in branch migrating a bidirectional replication bubble composed of either DNA:DNA or RNA:DNA hybrid. Human, but not Drosophila, HARP is also capable of regressing a replication fork structure containing a highly stable poly rG:dC hybrid. Persistent RNA:DNA hybrids in vivo can lead to replication fork arrest and genome instability. The ability of HARP to strand transfer hybrids may signify a hybrid removal function for this enzyme, in vivo.	[Kassavetis, George A.; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kassavetis, GA (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.	gkassavetis@ucsd.edu			National Institute of General Medical Sciences/National Institutes of Health [R01 GM058272]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058272] Funding Source: NIH RePORTER	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences/National Institutes of Health to JTK (R01 GM058272). This was our sole source of funding for the research submitted in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, HUM MOL GENET, V21, P2572, DOI 10.1093/hmg/dds083; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Betous R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063149; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; CASEY J, 1977, NUCLEIC ACIDS RES, V4, P1539, DOI 10.1093/nar/4.5.1539; Chakraborty P, 2010, NUCLEIC ACIDS RES, V38, P4722, DOI 10.1093/nar/gkq240; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Ghosal G, 2011, EMBO REP, V12, P574, DOI 10.1038/embor.2011.74; Grierson PM, 2012, HUM MOL GENET, V21, P1172, DOI 10.1093/hmg/ddr545; Huang C, 2010, DEV BIOL, V339, P89, DOI 10.1016/j.ydbio.2009.12.018; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; SILVEIRA MH, 1995, NUCLEIC ACIDS RES, V23, P1083, DOI 10.1093/nar/23.6.1083; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; WHITEHALL SK, 1995, GENE DEV, V9, P2974, DOI 10.1101/gad.9.23.2974; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2010, P NATL ACAD SCI USA, V107, P20970, DOI 10.1073/pnas.1011196107; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98173	10.1371/journal.pone.0098173	http://dx.doi.org/10.1371/journal.pone.0098173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866343	Green Published, gold			2022-12-27	WOS:000336914100037
J	Peterson, A; Hanberger, L; Akesson, K; Bojestig, M; Gare, BA; Samuelsson, U				Peterson, Anette; Hanberger, Lena; Akesson, Karin; Bojestig, Mats; Gare, Boel Andersson; Samuelsson, Ulf			Improved Results in Paediatric Diabetes Care Using a Quality Registry in an Improvement Collaborative: A Case Study in Sweden	PLOS ONE			English	Article							METABOLIC-CONTROL; GLYCEMIC CONTROL; ADOLESCENTS; CHILDREN; HYPOGLYCEMIA; COMPLICATIONS; MANAGEMENT	Background: Several studies show that good metabolic control is important for children and adolescents with type 1 diabetes. In Sweden, there are large differences in mean haemoglobin A1c (HbA1c) in different hospitals and difficulties implementing national guidelines in everyday practice. This study shows how the participation in an improvement collaborative could facilitate improvements in the quality of care by paediatric diabetes teams. The Swedish paediatric diabetes quality registry, SWEDIABKIDS was used as a tool and resource for feedback and outcome measures. Methods: Twelve teams at paediatric diabetes centres, caring for 30% (2302/7660) of patients in Sweden, participated in an 18-month quality improvement program. Each team defined treatment targets, areas needing improvement, and action plans. The main outcome was the centre patients' mean HbA1c levels, but other clinical variables and change concepts were also studied. Data from the previous six months were compared with the first six months after starting the program, and the long-term follow up after another eleven months. Results: All centres reduced mean HbA1c during the second and third periods compared with the first. The mean reduction for all was 3.7 mmol/mol (p<0.001), compared with non-participating centres who improved their mean HbA1c with 1.7 mmol/mol during the same period. Many of the participating centres reduced the frequency of severe hypoglycaemia and/or ketoacidosis, and five centres reached their goal of ensuring that all patients had some sort of physical activity at least once weekly. Change concepts were, for example, improved guidelines, appointment planning, informing the patients, improving teamwork and active use of the registry, and health promotion activities. Conclusions: By involving paediatric diabetes teams in a quality improvement collaborative together with access to a quality register, the quality of paediatric diabetes care can improve, thereby contributing to a reduced risk of late complications for children and adolescents with diabetes.	[Hanberger, Lena; Samuelsson, Ulf] Linkoping Univ Hosp, Res Ctr, Div Pediat & Diabetes, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Akesson, Karin] Cty Hosp Ryhov, Dept Pediat, Jonkoping, Sweden; [Peterson, Anette; Akesson, Karin; Bojestig, Mats; Gare, Boel Andersson] Jonkoping Univ, Sch Hlth Sci, Jonkoping Acad Improvement Hlth & Welf, Jonkoping, Sweden; [Peterson, Anette; Akesson, Karin; Bojestig, Mats; Gare, Boel Andersson] Jonkoping Cty Council, Jonkoping, Sweden; [Hanberger, Lena] Linkoping Univ, Dept Med & Hlth Sci, Div Nursing Sci, Linkoping, Sweden	Linkoping University; Jonkoping University; Linkoping University	Peterson, A (corresponding author), Jonkoping Univ, Sch Hlth Sci, Jonkoping Acad Improvement Hlth & Welf, Jonkoping, Sweden.	anette.peterson@lj.se			Swedish Association of Local Authorities and Regions (SALAR)	Swedish Association of Local Authorities and Regions (SALAR)	This work was supported by the Swedish Association of Local Authorities and Regions (SALAR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson P, 2008, BARN UNGDOMSDIABETES, P163; [Anonymous], 1993, NEW ENGL J MED, V329, P977; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Batalden P B, 1993, Jt Comm J Qual Improv, V19, P424; Berwick DM, 2003, MED CARE, V41, pI30; Carlhed R, 2009, CIRC-CARDIOVASC QUAL, V2, P458, DOI 10.1161/CIRCOUTCOMES.108.842146; Danne T, 2001, DIABETES CARE, V24, P1342, DOI 10.2337/diacare.24.8.1342; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; Godfrey M.M., 2013, J NURSING MANAGEMENT; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hanberger L, 2012, DIABETES RES CLIN PR, V96, P331, DOI 10.1016/j.diabres.2012.01.016; Hanberger L, 2008, DIABETES CARE, V31, P927, DOI 10.2337/dc07-1863; Hansen LO, 2010, QUAL SAF HEALTH CARE, V19, P275, DOI 10.1136/qshc.2009.036087; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Nelson EC, 1996, JOINT COMM J QUAL IM, V22, P243, DOI 10.1016/S1070-3241(16)30228-0; Nordfeldt S, 2001, ACTA PAEDIATR, V90, P137; Nordwall M, 2009, PEDIATR DIABETES, V10, P168, DOI 10.1111/j.1399-5448.2008.00472.x; Olsen BS, 2004, J DIABETES COMPLICAT, V18, P160, DOI 10.1016/S1056-8727(03)00073-4; Peterson Anette, 2007, Qual Manag Health Care, V16, P25; Riddell MC, 2006, PEDIATR DIABETES, V7, P60, DOI 10.1111/j.1399-543X.2006.00146.x; Swift PGF, 2010, PEDIATR DIABETES, V11, P271, DOI 10.1111/j.1399-5448.2009.00596.x; Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85	25	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97875	10.1371/journal.pone.0097875	http://dx.doi.org/10.1371/journal.pone.0097875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24867418	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100025
J	Wilson, T				Wilson, Tom			New Population and Life Expectancy Estimates for the Indigenous Population of Australia's Northern Territory, 1966-2011	PLOS ONE			English	Article								Background: The Indigenous population of Australia suffers considerable disadvantage across a wide range of socioeconomic indicators, and is therefore the focus of many policy initiatives attempting to 'close the gap' between Indigenous and non-Indigenous Australians. Unfortunately, past population estimates have proved unreliable as denominators for these indicators. The aim of the paper is to contribute more robust estimates for the Northern Territory Indigenous population for the period 1966-2011, and hence estimate one of the most important of socio-economic indicators, life expectancy at birth. Method: A consistent time series of population estimates from 1966 to 2011, based off the more reliable 2011 official population estimates, was created by a mix of reverse and forward cohort survival. Adjustments were made to ensure sensible sex ratios and consistency with recent birth registrations. Standard life table methods were employed to estimate life expectancy. Drawing on an approach from probabilistic forecasting, confidence intervals surrounding population numbers and life expectancies were estimated. Results: The Northern Territory Indigenous population in 1966 numbered between 23,800 and 26,100, compared to between 66,100 and 73,200 in 2011. In 1966-71 Indigenous life expectancy at birth lay between 49.1 and 56.9 years for males and between 49.7 and 57.9 years for females, whilst by 2006-11 it had increased to between 60.5 and 66.2 years for males and between 65.4 and 70.8 for females. Over the last 40 years the gap with all-Australian life expectancy has not narrowed, fluctuating at about 17 years for both males and females. Whilst considerable progress has been made in closing the gap in under-five mortality, at most other ages the mortality rate differential has increased. Conclusions: A huge public health challenge remains. Efforts need to be redoubled to reduce the large gap in life expectancy between Indigenous and non-Indigenous Australians.	Univ Queensland, Queensland Ctr Populat Res, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia	University of Queensland	Wilson, T (corresponding author), Univ Queensland, Queensland Ctr Populat Res, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	tom.wilson@uq.edu.au		Wilson, Tom/0000-0001-8812-7556	University of Queensland ResTeach grant	University of Queensland ResTeach grant	Funding was provided by a University of Queensland ResTeach grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2008, AUSTR HIST POP STAT; ABS, 2008, EXP EST AB TORR STRA; ABS, 2013, AUSTR CENS LONG DAT; ABS, 2012, CENS POP HOUS DET UN; Abs, 2013, BIRTHS AUSTR 2012; ABS, 2013, LIF TABL AB TORR STR; ABS, 2004, EXP EST PROJ AB TORR; Altman JC, 2009, AUST ECON HIST REV, V49, P225, DOI 10.1111/j.1467-8446.2009.00264.x; Andreev KF, 1999, THESIS U SO DENMARK; Australian Bureau of Statistics (ABS), 1994, EXP EST AB TORR STRA; Australian Bureau of Statistics (ABS), 1998, EXP EST AB TORR STRA; Australian Bureau of Statistics (ABS), 2013, UND INCR AB TORR STR; Australian Bureau of Statistics (ABS), 1993, CENS CHAR NO TERR; Australian Bureau of Statistics (ABS), 1983, CROSS CLASS CHAR PER; Australian Bureau of Statistics (ABS), 2013, EST AB TORR ISL AUST; Australian Bureau of Statistics (ABS), 1979, POP DWELL CROSS C TO; Australian Bureau of Statistics (ABS), CROSS CLASS CHAR PER; Australian Bureau of Statistics (ABS), 2013, EST AB TORR STRA ISL; Australian Bureau of Statistics (ABS), 2013, DEATH REG CENS LINK; Australian Institute of Health and Welfare (AIHW), 2011, HLTH WELF AUSTR AB T; Barbi E., 2004, INVERSE PROJECTION T; Chiang CL, 1984, LIFE TABLE ITS APPL; COAG, 2008, CLOS GAP IND DIS; Commonwealth Bureau of Census and Statistics (CBCS), 1973, 291 CBCS; Commonwealth Bureau of Census and Statistics (CBCS), 1969, 223 CBCS; Condon JR, 2004, DEMOGRAPHIC CHARACTE; Council of Australian Governments [COAG], 2012, NAT IND REF AGR CLOS; Gray A, 1983, AUSTR ABORIGINAL STU, V1, P2; Gray A, 1993, 521993 AUSTR NAT U C; Kinfu Y, 2005, AUST GEOGR, V36, P233, DOI 10.1080/00049180500150027; Luther N Y, 1995, J Aust Popul Assoc, V12, P147; Madden R, 2012, J POPUL RES, V29, P269, DOI 10.1007/s12546-012-9085-6; Newbold Bruce, 2004, POPULATION MOBILITY, P117; Preston S., 2000, DEMOGRAPHY MEASURING; Productivity Commission, 2019, REP GOV SERV 2019; Rees P., 1986, MIGRATION SETTLEMENT, P19; Smith Len R, 1980, ABORIGINAL POPULATIO; Tay E. L., 2013, MORTALITY NO TERRITO; Taylor J, 2004, POPULATION MOBILITY, P13; Terblanche W, 2014, UNDERSTANDING GROWTH; Thatcher AR., 2002, DEMOGR RES, V6, P1, DOI [10.4054/DemRes.2002.6.1, DOI 10.4054/DEMRES.2002.6.1]; Toson B, 2003, LIFE EXPECTANCY BIRT; Vincent P, 1951, POPULATION, V6, P181, DOI 10.2307/1524149; Wilson T, 2007, PEOPLE PLACE, V15, P12; Wilson T, 2007, AUST NZ J PUBL HEAL, V31, P184, DOI 10.1111/j.1753-6405.2007.00039.x; Wilson T, 2013, APPL GEOGR, V42, P108, DOI 10.1016/j.apgeog.2013.05.006; Wilson T, 2009, ENVIRON PLANN A, V41, P230, DOI 10.1068/a402	47	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97576	10.1371/journal.pone.0097576	http://dx.doi.org/10.1371/journal.pone.0097576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866421	Green Published, gold			2022-12-27	WOS:000336914100018
J	Aci-Seche, S; Sawma, P; Hubert, P; Sturgis, JN; Bagnard, D; Jacob, L; Genest, M; Garnier, N				Aci-Seche, Samia; Sawma, Paul; Hubert, Pierre; Sturgis, James N.; Bagnard, Dominique; Jacob, Laurent; Genest, Monique; Garnier, Norbert			Transmembrane Recognition of the Semaphorin Co-Receptors Neuropilin 1 and Plexin A1: Coarse-Grained Simulations	PLOS ONE			English	Article							HELIX-HELIX INTERACTIONS; GLYCOPHORIN-A; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; STRUCTURAL BASIS; ALPHA-HELICES; MODEL MEMBRANES; EGF RECEPTOR; FORCE-FIELD; FREE-ENERGY	The cancer associated class 3 semaphorins require direct binding to neuropilins and association to plexins to trigger cell signaling. Here, we address the role of the transmembrane domains of neuropilin 1 and plexin A1 for the dimerization of the two receptors by characterizing the assembly in lipid bilayers using coarse-grained molecular dynamics simulations. From experimental evidence using a two-hybrid system showing the biochemical association of the two receptors transmembrane domains, we performed molecular simulations in DOPC and POPC demonstrating spontaneously assembly to form homodimers and heterodimers with a very high propensity for right-handed packing of the helices. Inversely, left-handed packing was observed with a very low propensity. This mode of packing was observed uniquely when the plexin A1 transmembrane domain was involved in association. Potential of mean force calculations were used to predict a hierarchy of self-association for the monomers: the two neuropilin 1 transmembrane domains strongly associated, neuropilin 1 and plexin A1 transmembrane domains associated less and the two plexin A1 transmembrane domains weakly but significantly associated. We demonstrated that homodimerization and heterodimerization are driven by GxxxG motifs, and that the sequence context modulates the packing mode of the plexin A1 transmembrane domains. This work presents major advances towards our understanding of membrane signaling platforms assembly through membrane domains and provides exquisite information for the design of antagonist drugs defining a novel class of therapeutic agents.	[Aci-Seche, Samia; Genest, Monique; Garnier, Norbert] Univ Orleans, Ctr Natl Rech Sci UPR, Ctr Biophys Mol, Orleans, France; [Sawma, Paul; Hubert, Pierre; Sturgis, James N.] Univ Aix Marseille, Lab Ingn Syst Macromol UMR, Marseille, France; [Bagnard, Dominique; Jacob, Laurent] Univ Strasbourg, Inst Natl Sante & Rech Med, Strasbourg, France	Universite de Orleans; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Genest, M (corresponding author), Univ Orleans, Ctr Natl Rech Sci UPR, Ctr Biophys Mol, Orleans, France.	monique.genest@cnrs-orleans.fr; norbert.garnier@cnrs-orleans.fr	Bagnard, Dominique/I-6535-2013; Sturgis, James/AAU-8103-2020	Bagnard, Dominique/0000-0002-5261-902X; Sturgis, James/0000-0001-5125-7699; JACOB, Laurent/0000-0003-4767-0442; Garnier, Norbert/0000-0003-1941-1814	French Agence Nationale de la Recherche (InterferenceTM project) [ANR-10-BLAN-1507]	French Agence Nationale de la Recherche (InterferenceTM project)(French National Research Agency (ANR))	This work was supported by a grant from the French Agence Nationale de la Recherche (InterferenceTM project; ANR-10-BLAN-1507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Beevers AJ, 2010, CHEM SOC REV, V39, P2146, DOI 10.1039/b912944h; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; Bordag N, 2010, CHEM PHYS LIPIDS, V163, P1, DOI 10.1016/j.chemphyslip.2009.07.009; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cebecauer M, 2010, J CELL SCI, V123, P309, DOI 10.1242/jcs.061739; Chaudhary B, 2013, CANC IMMUNOL IMMUNOT; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Cymer F, 2011, BIOCHIM BIOPHYS ACTA, V1818, P963; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; Domanski J, 2012, BBA-BIOMEMBRANES, V1818, P984, DOI 10.1016/j.bbamem.2011.08.021; Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fink A, 2011, BIOCHIM BIOPHYS ACTA, V1818, P974; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Hall BA, 2011, BIOPHYS J, V100, P1940, DOI 10.1016/j.bpj.2011.02.041; Henin J, 2005, J AM CHEM SOC, V127, P8478, DOI 10.1021/ja050581y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hubert P, 2010, CELL ADHES MIGR, V4, P313, DOI 10.4161/cam.4.2.12430; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janosi L, 2010, BIOPHYS J, V99, P284, DOI 10.1016/j.bpj.2010.04.005; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mineev KS, 2010, J MOL BIOL, V400, P231, DOI 10.1016/j.jmb.2010.05.016; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Nasarre C, 2010, ONCOGENE, V29, P2381, DOI 10.1038/onc.2010.9; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Psachoulia E, 2008, BIOCHEMISTRY-US, V47, P10503, DOI 10.1021/bi800678t; Psachoulia E, 2010, ACCOUNTS CHEM RES, V43, P388, DOI 10.1021/ar900211k; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Roth L, 2008, MOL BIOL CELL, V19, P646, DOI 10.1091/mbc.E07-06-0625; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schafer LV, 2011, P NATL ACAD SCI USA, V108, P1343, DOI 10.1073/pnas.1009362108; Sengupta D, 2010, PHYS CHEM CHEM PHYS, V12, P12987, DOI 10.1039/c0cp00101e; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	77	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97779	10.1371/journal.pone.0097779	http://dx.doi.org/10.1371/journal.pone.0097779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858828	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400025
J	Chen, TD; Chen, DP; Wang, WT; Sun, CF				Chen, Tai-Di; Chen, Ding-Ping; Wang, Wei-Ting; Sun, Chien-Feng			MNSs Blood Group Glycophorin Variants in Taiwan: A Genotype- Serotype Correlation Study of 'Mi(a)' and St(a) with Report of Two New Alleles for St(a)	PLOS ONE			English	Article							POPULATION; STA; GENE; IDENTIFICATION; STONES	Background: Glycophorin variants of the MNSs blood group are important in Taiwan. For more than 20 years, screening for the most frequent irregular antibody, anti-'Mi(a)', has been conducted by using 'Mi(a)'(+) RBCs, with a significant success. However, the sensitivity and the specificity of this screening strategy have never been validated, and the true incidences of different glycophorin variants in Taiwan have been in controversy. Also, the significance of another less frequent and usually separately reported variant, St(a), has never been evaluated. Methodology/Principal Findings: We ran a population-based screening (from unselected patients in our hospital) for MNSs blood group glycophorin variants by PCR-sequencing method. GP.Mur (Mil.III) was confirmed by sequence from 57 out of 1027 samples (5.6%), and there was no other Miltenberger subtype glycophorin variant found. Glycophorin variant St(a) was found from 35 out of 1027 samples (3.4%). In contrast to anti-'Mi(a)', which is the most frequently identified irregular antibody in Taiwan, the prevalence of anti-St(a) was only 0.13% as determined by serologic method. In addition, two new alleles for St(a) were found and reported. Conclusion/Significance: We confirm the long-standing assumption that GP.Mur is the only prevalent Miltenberger subtype in Taiwan. The current anti-'Mi(a)' screening method used in Taiwan, although neither sensitive nor specific, is still a suitable practice. Although St(a) antigen has a high prevalence in Taiwan, routine screening for anti-St(a) is not warranted based on current evidence.	[Chen, Tai-Di; Sun, Chien-Feng] Chang Gung Mem Hosp, Dept Anat Pathol, Gueishan, Taoyuan County, Taiwan; [Chen, Ding-Ping; Wang, Wei-Ting; Sun, Chien-Feng] Chang Gung Mem Hosp, Dept Lab Med, Gueishan, Taoyuan County, Taiwan; [Chen, Ding-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Gueishan, Taoyuan County, Taiwan; [Sun, Chien-Feng] Chang Gung Univ, Sch Med, Dept Pathol, Gueishan, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Sun, CF (corresponding author), Chang Gung Mem Hosp, Dept Anat Pathol, Gueishan, Taoyuan County, Taiwan.	suncgj@adm.cgmh.org.tw		Chen, Tai-Di/0000-0002-4231-7677	Chang Gung Memorial Hospital, Taiwan [CMRPG300091-93]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by the Grant CMRPG300091-93 from the Chang Gung Memorial Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broadberry RE, 1996, TRANSFUSION MED, V6, P145, DOI 10.1046/j.1365-3148.1996.d01-64.x; Broadberry RE, 1998, TRANSFUSION MED, V8, P57; Broadberry RE, 1994, TRANSFUSION, V34, P238; CLEGHORN TE, 1962, NATURE, V195, P297, DOI 10.1038/195297b0; Daniels G, 2002, HUMAN BLOOD GROUPS, P99; Hsu K, 2013, TRANSFUSION, V53, P962, DOI 10.1111/j.1537-2995.2012.03861.x; HUANG CH, 1991, J BIOL CHEM, V266, P23306; LIN M, 1994, VOX SANG, V67, P320, DOI 10.1111/j.1423-0410.1994.tb01262.x; Lin M, 1998, TRANSFUS MED REV, V12, P56, DOI 10.1016/S0887-7963(98)80090-4; MADDEN HJ, 1964, VOX SANG, V9, P502, DOI 10.1111/j.1423-0410.1964.tb03319.x; Palacajornsuk P, 2007, TRANSFUSION MED, V17, P169, DOI 10.1111/j.1365-3148.2007.00747.x; REARDEN A, 1990, J BIOL CHEM, V265, P9259; Shih MC, 2000, TRANSFUSION, V40, P54, DOI 10.1046/j.1537-2995.2000.40010054.x; Suchanowska A, 2010, TRANSFUSION, V50, P514, DOI 10.1111/j.1537-2995.2009.02475.x; TIPPETT P, 1992, Transfusion Medicine Reviews, V6, P170, DOI 10.1016/S0887-7963(92)70167-9	15	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98166	10.1371/journal.pone.0098166	http://dx.doi.org/10.1371/journal.pone.0098166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858913	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400048
J	Chhatre, VE; Rajora, OP				Chhatre, Vikram E.; Rajora, Om P.			Genetic Divergence and Signatures of Natural Selection in Marginal Populations of a Keystone, Long-Lived Conifer, Eastern White Pine (Pinus strobus) from Northern Ontario	PLOS ONE			English	Article							MATING SYSTEM; PERIPHERAL-POPULATIONS; LOCAL ADAPTATION; RED SPRUCE; DIVERSITY; RANGE; CLIMATE; EVOLUTION; MIGRATION; CORE	Marginal populations are expected to provide the frontiers for adaptation, evolution and range shifts of plant species under the anticipated climate change conditions. Marginal populations are predicted to show genetic divergence from central populations due to their isolation, and divergent natural selection and genetic drift operating therein. Marginal populations are also expected to have lower genetic diversity and effective population size (N-e) and higher genetic differentiation than central populations. We tested these hypotheses using eastern white pine (Pinus strobus) as a model for keystone, long-lived widely-distributed plants. All 614 eastern white pine trees, in a complete census of two populations each of marginal old-growth, central old-growth, and central second-growth, were genotyped at 11 microsatellite loci. The central populations had significantly higher allelic and genotypic diversity, latent genetic potential (LGP) and N-e than the marginal populations. However, heterozygosity and fixation index were similar between them. The marginal populations were genetically diverged from the central populations. Model testing suggested predominant north to south gene flow in the study area with curtailed gene flow to northern marginal populations. Signatures of natural selection were detected at three loci in the marginal populations; two showing divergent selection with directional change in allele frequencies, and one balancing selection. Contrary to the general belief, no significant differences were observed in genetic diversity, differentiation, LGP, and Ne between old-growth and second-growth populations. Our study provides information on the dynamics of migration, genetic drift and selection in central versus marginal populations of a keystone long-lived plant species and has broad evolutionary, conservation and adaptation significance.	[Chhatre, Vikram E.; Rajora, Om P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Rajora, Om P.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada	Dalhousie University; University of New Brunswick	Rajora, OP (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Om.Rajora@unb.ca	Chhatre, Vikram/B-6649-2016; Chhatre, Vikram/O-2459-2019	Chhatre, Vikram/0000-0001-6627-2832; Chhatre, Vikram/0000-0001-6627-2832	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 170651]; Dalhousie University; Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB; Canada Research Chair Program [CRC950-201869]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University; Stora Enso Port Hawkesbury Ltd.; Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB; Canada Research Chair Program(Canada Research Chairs)	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN 170651) to Om P. Rajora. Vikram E. Chhatre was financially supported from the NSERC Discovery grant funds to Om P. Rajora and a graduate scholarship at Dalhousie University. Om P. Rajora held the Stora Enso Senior Chair in Forest Genetics and Biotechnology at Dalhousie University, which was supported by Stora Enso Port Hawkesbury Ltd., and the Senior Canada Research Chair in Forest and Conservation Genomics and Biotechnology at UNB, which was supported by the Canada Research Chair Program (CRC950-201869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; [Anonymous], 1975, EVOLUTION, DOI DOI 10.1111/j.1558-5646.1975.tb00807.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Atkins KE, 2010, J THEOR BIOL, V266, P449, DOI 10.1016/j.jtbi.2010.07.014; BEAULIEU J, 1995, CAN J FOREST RES, V25, P1697, DOI 10.1139/x95-183; BEAULIEU J, 1994, CAN J FOREST RES, V24, P1726, DOI 10.1139/x94-223; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BERGMANN F, 1990, GENETICA, V82, P1, DOI 10.1007/BF00057667; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Buchert GP, 1997, CONSERV BIOL, V11, P747, DOI 10.1046/j.1523-1739.1997.96074.x; BUCHERT GP, 1994, FOREST CHRON, V70, P427, DOI 10.5558/tfc70427-4; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Crins WJ., 2009, TR01 SIB TER IMA; DAVIS MB, 1980, QUATERNARY RES, V14, P240, DOI 10.1016/0033-5894(80)90051-4; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edelist C, 2006, MOL ECOL, V15, P4623, DOI 10.1111/j.1365-294X.2006.03112.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gapare WJ, 2005, BIOL CONSERV, V123, P113, DOI 10.1016/j.biocon.2004.11.002; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Holliday JA, 2012, P ROY SOC B-BIOL SCI, V279, P1675, DOI 10.1098/rspb.2011.1805; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; LESICA P, 1992, CONSERV BIOL, V6, P135, DOI 10.1046/j.1523-1739.1992.610135.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Marquardt PE, 2004, MOL ECOL, V13, P3305, DOI 10.1111/j.1365-294X.2004.02341.x; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Mehes M, 2009, J PLANT ECOL-UK, V2, P143, DOI 10.1093/jpe/rtp016; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Mosseler A, 2003, THEOR APPL GENET, V106, P931, DOI 10.1007/s00122-002-1156-1; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nijensohn SE, 2005, CAN J FOREST RES, V35, P1041, DOI 10.1139/X05-029; O'Connell LM, 2006, HEREDITY, V97, P418, DOI 10.1038/sj.hdy.6800886; Oksanen J, 2009, COMMUNITY ECOLOGY PA; Pandey M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-48; Pandey M, 2012, AM J BOT, V99, P690, DOI 10.3732/ajb.1100116; Parisod C, 2010, ANN BOT-LONDON, V105, P655, DOI 10.1093/aob/mcq014; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rajora OP, 2000, CAN J BOT, V78, P941, DOI 10.1139/cjb-78-7-941; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 2002, CAN J BOT, V80, P1173, DOI [10.1139/b02-105, 10.1139/B02-105]; Rajora OP, 1998, CAN J BOT, V76, P500, DOI 10.1139/cjb-76-3-500; Ritchie J.C., 1987, POSTGLACIAL VEGETATI; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sezen UU, 2005, SCIENCE, V307, P891, DOI 10.1126/science.1105034; Slatkin M, 1991, GENETICS, V139, P457; STEBBINS GL, 1988, P NATL ACAD SCI USA, V85, P5141, DOI 10.1073/pnas.85.14.5141; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Thomas MK, 1953, CLIMATOLOGICAL ATLAS; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wendel G.W., 1990, SILVICS N AM, V654, P476; [No title captured]	69	20	21	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97291	10.1371/journal.pone.0097291	http://dx.doi.org/10.1371/journal.pone.0097291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859159	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400011
J	Leonard, AV; Thornton, E; Vink, R				Leonard, Anna Victoria; Thornton, Emma; Vink, Robert			NK1 Receptor Blockade Is Ineffective in Improving Outcome following a Balloon Compression Model of Spinal Cord Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBSTANCE-P ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; EDEMA FORMATION; PROTEIN EXTRAVASATION; ISCHEMIC-STROKE; BLOOD-FLOW; RAT; BARRIER; RELEASE	The neuropeptide substance P (SP) is a well-known mediator of neurogenic inflammation following a variety of CNS disorders. Indeed, inhibition of SP through antagonism of its receptor, the tachykinin NK1 receptor, has been shown to be beneficial following both traumatic brain injury and stroke. Such studies demonstrated that administration of an NK1 receptor antagonist reduced blood-brain-barrier permeability, edema development and improved functional outcome. Furthermore, our recent studies have demonstrated a potential role for SP in mediating neurogenic inflammation following traumatic spinal cord injury (SCI). Accordingly, the present study investigates whether inhibition of SP may similarly play a neuroprotective role following traumatic SCI. A closed balloon compression injury was induced at T10 in New Zealand White rabbits. At 30 minutes post-injury an NK1 receptor antagonist was administered intravenously. Animals were thereafter assessed for blood spinal cord barrier (BSCB) permeability, spinal water content (edema), intrathecal pressure (ITP), and histological and functional outcome from 5 hours to 2 weeks post-SCI. Administration of an NK1 receptor antagonist was not effective in reducing BSCB permeability, edema, ITP, or functional deficits following SCI. We conclude that SP mediated neurogenic inflammation does not seem to play a major role in BSCB disruption, edema development and consequential tissue damage seen in acute traumatic SCI. Rather it is likely that the severe primary insult and subsequent hemorrhage may be the key contributing factors to ongoing SCI injury.	[Leonard, Anna Victoria; Thornton, Emma] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Vink, Robert] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia	University of Adelaide; University of South Australia	Leonard, AV (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia.	anna.leonard@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Leonard, Anna/0000-0002-9430-3314	Neil Sachse Foundation; University of Adelaide	Neil Sachse Foundation; University of Adelaide	The study was funded by the Neil Sachse Foundation (http://www.nsf.org.au/) and the University of Adelaide. AVL is the Neil Sachse Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Barry CM, 2011, BRAIN RES, V1389, P143, DOI 10.1016/j.brainres.2011.02.082; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Caberlotto L, 2003, EUR J NEUROSCI, V17, P1736, DOI 10.1046/j.1460-9568.2003.02600.x; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Demediuk P, 1990, Adv Neurol, V52, P225; DIETL MM, 1991, BRAIN RES, V539, P211, DOI 10.1016/0006-8993(91)91623-9; Donkin J. D., 2006, EFFECTS NEUROPEPTIDE; Donkin JJ, 2009, J CEREB BLOOD FLOW M; Flanders AE, 1999, AM J NEURORADIOL, V20, P926; FREEDMAN J, 1988, NEUROSCIENCE, V27, P267, DOI 10.1016/0306-4522(88)90236-9; Fukuda S, 2005, BRAIN RES PROTOC, V14, P171, DOI 10.1016/j.brainresprot.2005.01.001; GOODMAN JH, 1976, J NEUROSURG, V44, P418, DOI 10.3171/jns.1976.44.4.0418; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Jiang MH, 2012, NEUROREPORT, V23, P786, DOI 10.1097/WNR.0b013e3283572206; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; KOYANAGI I, 1989, PARAPLEGIA, V27, P190, DOI 10.1038/sc.1989.28; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Leonard AV, 2013, J NEUROTRAUMA; Lever IJ, 2003, NEUROPHARMACOLOGY, V45, P1101, DOI 10.1016/S0028-3908(03)00298-3; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; MALCANGIO M, 1994, BRIT J PHARMACOL, V113, P635, DOI 10.1111/j.1476-5381.1994.tb17037.x; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; Nyberg F, 2002, AMINO ACIDS, V23, P231, DOI 10.1007/s00726-001-0134-2; OSHAUGHNESSY CT, 1993, EUR J PHARMACOL, V236, P319, DOI 10.1016/0014-2999(93)90605-H; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SHARMA HS, 1993, NEUROSCIENCE, V57, P443, DOI 10.1016/0306-4522(93)90076-R; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; Shepard MJ, 1999, SPINAL CORD, V37, P833, DOI 10.1038/sj.sc.3100927; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042630, 10.1371/journal.pone.0034138]; Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Vink R, 2003, ACT NEUR S, V86, P257; WANG R, 1993, SURG NEUROL, V39, P348, DOI 10.1016/0090-3019(93)90198-A; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WINKLER T, 1994, NEUROSCI RES, V21, P91, DOI 10.1016/0168-0102(94)90072-8; YASHON D, 1973, J NEUROSURG, V38, P693, DOI 10.3171/jns.1973.38.6.0693	52	6	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98364	10.1371/journal.pone.0098364	http://dx.doi.org/10.1371/journal.pone.0098364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859234	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400069
J	Mazur, G; Butrym, A; Kryczek, I; Dlubek, D; Jaskula, E; Lange, A; Kuliczkowski, K; Jelen, M				Mazur, Grzegorz; Butrym, Aleksandra; Kryczek, Ilona; Dlubek, Dorota; Jaskula, Emilia; Lange, Andrzej; Kuliczkowski, Kazimierz; Jelen, Michal			Decreased Expression of CXCR4 Chemokine Receptor in Bone Marrow after Chemotherapy in Patients with Non-Hodgkin Lymphomas Is a Good Prognostic Factor	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NODE METASTASIS; TUMOR-GROWTH; CANCER; MICROENVIRONMENT; PROGRESSION; MIGRATION; CELLS	Background: CXCR4 chemokine receptor is constitutively expressed on normal and malignant B lymphocytes derived from patients with B-cell lymphoproliferative disorders and has a significant role in cell migration to lymph nodes and bone marrow. Non-Hodgkin's lymphomas (NHL) constitute a heterogeneous group of lymphoproliferative diseases, which can localize not only to lymph nodes, but also can migrate to peripheral blood and metastase to other organs, including bone marrow. Aim: The purpose of this study was to determine CXCR4 gene expression in peripheral blood and bone marrow of NHL patients before and after treatment. Methods: Samples of lymphoma lymph nodes, peripheral blood and bone marrow aspirates of patients with B-cell NHL were taken at diagnosis and after chemotherapy. Gene expression was determined by the reverse transcription (RT)polymerase chain reaction method. Expression was estimated from 0 AU (no amplificate signal) to 3 AU (maximal amplificate signal). Results: No significant difference in the level of CXCR4 expression was found in reactive lymph nodes compared to lymphoma samples We observed high level of CXCR4 expression in most patients before treatment: in bone marrow: 3 AU-10 pts, 2 AU-8 pts, 1 AU-2 pts. In peripheral blood: 3 AU-14 pts, 2 AU-4 pts, 1 AU-1 pts, 0 AU-1 pts. After chemotherapy, significant decrease in CXCR4 expression was observed. Bone marrow: 3 AU-5 pts, 2 AU-7 pts, 1 AU-5 pts, 0 AU-3 pts (p = 0.03). Peripheral blood: 3 AU-2 pts, 2 AU-6 pts, 1 AU-10 pts, 0 AU-2 pts (p = 0.0002). There was a good response to treatment in patients with significant decrease of CXCR4 expression in the bone marrow after treatment with 10-fold lower risk of death (p = 0.03). Conclusions: Decrease in CXCR4 expression in the bone marrow of NHL patients after chemotherapy may be a good prognostic factor.	[Mazur, Grzegorz] Wroclaw Med Univ, Dept Internal & Occupat Dis & Hypertens, Wroclaw, Poland; [Butrym, Aleksandra; Kuliczkowski, Kazimierz] Wroclaw Med Univ, Dept Haematol Blood Neoplasms & Bone Marrow Trans, Wroclaw, Poland; [Butrym, Aleksandra] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland; [Kryczek, Ilona; Dlubek, Dorota; Jaskula, Emilia; Lange, Andrzej] Polish Acad Sci, L Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Wroclaw, Poland; [Jelen, Michal] Wroclaw Med Univ, Div Pathomorphol & Oncol Cytol, Div Pathomorphol & Oncol Cytol, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University	Butrym, A (corresponding author), Wroclaw Med Univ, Dept Haematol Blood Neoplasms & Bone Marrow Trans, Wroclaw, Poland.	aleksandra.butrym@gmail.com	Jaskuła, Emilia/AAA-4515-2020; Lange, Andrzej/AAR-3247-2021; Butrym, Aleksandra/T-6582-2018	Jaskuła, Emilia/0000-0002-4894-7522; Lange, Andrzej/0000-0003-3544-1853; Butrym, Aleksandra/0000-0002-8199-2018; Mazur, Grzegorz/0000-0001-6610-2008; Kuliczkowski, Kazimierz/0000-0001-6812-1421	Wroclaw Medical University [ST-338]	Wroclaw Medical University	The study was supported by Wroclaw Medical University grant No: ST-338, www.umed.wroc.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Arya Manit, 2004, J Exp Ther Oncol, V4, P291; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beider K, 2013, CLIN CANCER RES, V19, P3495, DOI 10.1158/1078-0432.CCR-12-3015; Berghuis D, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-24; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Corcione A, 2004, CLIN CANCER RES, V10, P964, DOI 10.1158/1078-0432.CCR-1182-3; Corcione A, 2000, J NATL CANCER I, V92, P628, DOI 10.1093/jnci/92.8.628; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Deutsch AJA, 2013, MODERN PATHOL, V26, P182, DOI 10.1038/modpathol.2012.134; Durig J, 2001, LEUKEMIA, V15, P752, DOI 10.1038/sj.leu.2402107; Ghobrial IM, 2004, MAYO CLIN PROC, V79, P318, DOI 10.4065/79.3.318; Guo MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090518; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Juarez JG, 2009, BRIT J HAEMATOL, V145, P491, DOI 10.1111/j.1365-2141.2009.07648.x; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Mancuso P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-644; Mazur G, 2013, CYTOKINE, V64, P422, DOI 10.1016/j.cyto.2013.05.004; Mazur Grzegorz, 2005, Acta Haematologica Polonica, V36, P113; Moser B, 2003, IMMUNOL LETT, V85, P105, DOI 10.1016/S0165-2478(02)00233-X; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ngo HT, 2008, BLOOD, V112, P150, DOI 10.1182/blood-2007-12-129395; Peled A, 2013, THERANOSTICS, V3, P34, DOI 10.7150/thno.5150; Ratajczak MZ, 2012, SCI WORLD J, DOI 10.1100/2012/758512; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Tesfai Y, 2012, LEUKEMIA RES, V36, P299, DOI 10.1016/j.leukres.2011.08.001; Wong SWJ, 2004, LEUKEMIA LYMPHOMA, V45, P2491, DOI 10.1080/10428190410001723449; Yasuoka H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-340	31	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98194	10.1371/journal.pone.0098194	http://dx.doi.org/10.1371/journal.pone.0098194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859274	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400053
J	Hasselberg, M; Beer, N; Blom, L; Wallis, LA; Laflamme, L				Hasselberg, Marie; Beer, Netta; Blom, Lisa; Wallis, Lee A.; Laflamme, Lucie			Image-Based Medical Expert Teleconsultation in Acute Care of Injuries. A Systematic Review of Effects on Information Accuracy, Diagnostic Validity, Clinical Outcome, and User Satisfaction	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PLASTIC SURGICAL TRAUMA; MOBILE CAMERA-PHONE; COST-EFFECTIVENESS; E-HEALTH; TELEMEDICINE; TELERADIOLOGY; EMERGENCY; MANAGEMENT; ACCIDENT	Objective: To systematically review the literature on image-based telemedicine for medical expert consultation in acute care of injuries, considering system, user, and clinical aspects. Design: Systematic review of peer-reviewed journal articles. Data sources: Searches of five databases and in eligible articles, relevant reviews, and specialized peer-reviewed journals. Eligibility criteria: Studies were included that covered teleconsultation systems based on image capture and transfer with the objective of seeking medical expertise for the diagnostic and treatment of acute injury care and that presented the evaluation of one or several aspects of the system based on empirical data. Studies of systems not under routine practice or including real-time interactive video conferencing were excluded. Method: The procedures used in this review followed the PRISMA Statement. Predefined criteria were used for the assessment of the risk of bias. The DeLone and McLean Information System Success Model was used as a framework to synthesise the results according to system quality, user satisfaction, information quality and net benefits. All data extractions were done by at least two reviewers independently. Results: Out of 331 articles, 24 were found eligible. Diagnostic validity and management outcomes were often studied; fewer studies focused on system quality and user satisfaction. Most systems were evaluated at a feasibility stage or during small-scale pilot testing. Although the results of the evaluations were generally positive, biases in the methodology of evaluation were concerning selection, performance and exclusion. Gold standards and statistical tests were not always used when assessing diagnostic validity and patient management. Conclusions: Image-based telemedicine systems for injury emergency care tend to support valid diagnosis and influence patient management. The evidence relates to a few clinical fields, and has substantial methodological shortcomings. As in the case of telemedicine in general, user and system quality aspects are poorly documented, both of which affect scale up of such programs.	[Hasselberg, Marie; Beer, Netta; Blom, Lisa; Laflamme, Lucie] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Wallis, Lee A.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Emergency Med, Cape Town, South Africa; [Laflamme, Lucie] Univ S Africa, ZA-0001 Pretoria, South Africa	Karolinska Institutet; Stellenbosch University; University of South Africa	Wallis, LA (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Emergency Med, Cape Town, South Africa.	marie.hasselberg@ki.se	Laflamme, Lucie/T-2953-2019	Laflamme, Lucie/0000-0002-6443-1307; Wallis, Lee/0000-0003-2711-3139; Blom, Lisa/0000-0002-3538-7159	Swedish International Development Agency (Sida); Stellenbosch Institute for Advanced Studies (STIAS)	Swedish International Development Agency (Sida); Stellenbosch Institute for Advanced Studies (STIAS)	This study was supported by the Swedish International Development Agency (Sida) and the Stellenbosch Institute for Advanced Studies (STIAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tout YA, 2010, ANN CHIR PLAST ESTH, V55, P8, DOI 10.1016/j.anplas.2008.10.002; Archbold HAP, 2005, INJURY, V36, P560, DOI 10.1016/j.injury.2004.08.027; Benger J, 2000, J ACCID EMERG MED, V17, P157; Benger J, 1999, J TELEMED TELECARE, V5, P5, DOI 10.1258/1357633991933666; Brebner JA, 2006, J TELEMED TELECARE, V12, P5, DOI 10.1258/135763306777978542; Chandhanayingyong C, 2007, J TELEMED TELECARE, V13, P193, DOI 10.1258/135763307780908049; Currell R., 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002098; D Whited J, 2006, J TELEMED TELECARE, V12, P271, DOI 10.1258/135763306778558114; DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9, DOI 10.1080/07421222.2003.11045748; Diver Andrew J, 2009, Ulster Med J, V78, P113; Egol Kenneth A, 2003, Am J Orthop (Belle Mead NJ), V32, P356; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Goh KYC, 1997, CAN J NEUROL SCI, V24, P235, DOI 10.1017/S0317167100021867; GUYATT G, 1986, SOC SCI MED, V22, P393, DOI 10.1016/0277-9536(86)90046-8; Hailey D, 2002, J TELEMED TELECARE, V8, P1; Hersh W, 2002, J TELEMED TELECARE, V8, P197, DOI 10.1258/135763302320272167; Hersh WR, 2006, J TELEMED TELECARE, V12, P3, DOI 10.1258/135763306778393117; Hsieh CH, 2005, J TRAUMA, V58, P1208, DOI 10.1097/01.TA.0000175098.52974.FA; Hsieh CH, 2004, PLAST RECONSTR SURG, V114, P1776, DOI 10.1097/01.PRS.0000142402.07896.21; Jacobs MJE, 2002, BRIT J ORAL MAX SURG, V40, P156, DOI 10.1054/bjom.2001.0751; Jones SM, 2004, ANN ROY COLL SURG, V86, P239, DOI 10.1308/147870804344; Kayingo Gerald, 2012, Yale Journal of Biology and Medicine, V85, P424; Keane MG, 2009, J TELEMED TELECARE, V15, P132, DOI 10.1258/jtt.2009.003008; Kim YS, 2004, YONSEI MED J, V45, P761, DOI 10.3349/ymj.2004.45.5.761; Krupinski E, 2000, TELEMED J E-HEALTH, V6, P297, DOI 10.1089/153056200750040156; Laflamme L, 2009, ADDRESSING SOCIOECON; Larson A, 1998, AM J ROENTGENOL, V170, P19, DOI 10.2214/ajr.170.1.9423590; Latifi Rifat, 2004, Stud Health Technol Inform, V104, P193; Lemaire J., 2011, SCALING MOBILE HLTH; Lewis ER, 2012, TELEMED E-HEALTH, V18, P434, DOI 10.1089/tmj.2011.0199; Lewis T, 2012, B WORLD HEALTH ORGAN, V90, P332, DOI 10.2471/BLT.11.099820; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mair F, 2011, J TELEMED TELECARE, V17, P427, DOI 10.1258/jtt.2011.110318; Mechael P., 2010, BARRIERS GAPS AFFECT; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moya M, 2010, TELEMED J E-HEALTH, V16, P245, DOI 10.1089/tmj.2010.0044; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pap SA, 2002, PLAST RECONSTR SURG, V110, P452, DOI 10.1097/00006534-200208000-00012; Piette JD, 2012, B WORLD HEALTH ORGAN, V90, P365, DOI 10.2471/BLT.11.099069; Poca MA, 2004, NEUROCIRUGIA, V15, P17; Raikin SM, 1999, J ORTHOP TRAUMA, V13, P516, DOI 10.1097/00005131-199909000-00012; Reid JG, 1997, J AM MED INFORM ASSN, P403; Ricci WM, 2002, J ORTHOP TRAUMA, V16, P1, DOI 10.1097/00005131-200201000-00001; Roine R, 2001, CAN MED ASSOC J, V165, P765; SCOTT WW, 1993, RADIOLOGY, V187, P811, DOI 10.1148/radiology.187.3.8497636; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Wallace DL, 2008, J PLAST RECONSTR AES, V61, P31, DOI 10.1016/j.bjps.2006.03.045; Wallace DL, 2012, BURNS, V38, P465, DOI 10.1016/j.burns.2011.09.024; Wallace DL, 2007, J TELEMED TELECARE, V13, P282, DOI 10.1258/135763307781644933; Whitten PS, 2002, BRIT MED J, V324, P1434, DOI 10.1136/bmj.324.7351.1434; WILSON AJ, 1995, RADIOLOGY, V196, P565, DOI 10.1148/radiology.196.2.7617878; Wootton R, 2012, J TELEMED TELECARE, V18, P305, DOI 10.1258/jtt.2012.120315; World Health Organization mHealth, 2011, GLOBAL OBSERVATORY E, V3, P1; YOSHINO MT, 1992, INVEST RADIOL, V27, P55, DOI 10.1097/00004424-199201000-00011	54	21	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98539	10.1371/journal.pone.0098539	http://dx.doi.org/10.1371/journal.pone.0098539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887257	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300078
J	Leech, R; Scott, G; Carhart-Harris, R; Turkheimer, F; Taylor-Robinson, SD; Sharp, DJ				Leech, Robert; Scott, Gregory; Carhart-Harris, Robin; Turkheimer, Federico; Taylor-Robinson, Simon D.; Sharp, David J.			Spatial Dependencies between Large-Scale Brain Networks	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; NEURONAL AVALANCHES; RESTING-STATE; COMPETITION; ECHOES; ENERGY	Functional neuroimaging reveals both increases (task-positive) and decreases (task-negative) in neural activation with many tasks. Many studies show a temporal relationship between task positive and task negative networks that is important for efficient cognitive functioning. Here we provide evidence for a spatial relationship between task positive and negative networks. There are strong spatial similarities between many reported task negative brain networks, termed the default mode network, which is typically assumed to be a spatially fixed network. However, this is not the case. The spatial structure of the DMN varies depending on what specific task is being performed. We test whether there is a fundamental spatial relationship between task positive and negative networks. Specifically, we hypothesize that the distance between task positive and negative voxels is consistent despite different spatial patterns of activation and deactivation evoked by different cognitive tasks. We show significantly reduced variability in the distance between within-condition task positive and task negative voxels than across-condition distances for four different sensory, motor and cognitive tasks - implying that deactivation patterns are spatially dependent on activation patterns (and vice versa), and that both are modulated by specific task demands. We also show a similar relationship between positively and negatively correlated networks from a third 'rest' dataset, in the absence of a specific task. We propose that this spatial relationship may be the macroscopic analogue of microscopic neuronal organization reported in sensory cortical systems, and that this organization may reflect homeostatic plasticity necessary for efficient brain function.	[Leech, Robert; Scott, Gregory; Carhart-Harris, Robin; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, London, England; [Turkheimer, Federico] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Taylor-Robinson, Simon D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Imperial College London; University of London; King's College London; Imperial College London	Leech, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, London, England.	r.leech@imperial.ac.uk	Leech, Robert/AAE-8254-2019; Sharp, David J/A-2119-2013; Turkheimer, Federico E/B-9485-2012	Leech, Robert/0000-0002-5801-6318; Turkheimer, Federico E/0000-0002-3766-3815; Scott, Gregory/0000-0001-8063-5871	Human Connectome Project, WUMinn Consortium - 16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; MRC [G1100809, G0701951, MR/K015192/1] Funding Source: UKRI; Medical Research Council [G0701951, G1100809, MR/K015192/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-048] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Human Connectome Project, WUMinn Consortium - 16 NIH Institutes and Centers; McDonnell Center for Systems Neuroscience at Washington University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	One of the three datasets analyzed was provided by the Human Connectome Project, WUMinn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Daugman J.G., 1990, COMPUTATIONAL NEUROS, P403; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Glasser M.F., 2013, NEUROIMAGE; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; McPhail MJW, 2013, NEUROLOGY, V80, P1041, DOI 10.1212/WNL.0b013e31828726e1; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Seghier ML, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00281; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Tagliazucchi E, 2012, FRONTIERS PHYSL; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98500	10.1371/journal.pone.0098500	http://dx.doi.org/10.1371/journal.pone.0098500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887067	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300074
J	Liu, CY; Ward, PJ; English, AW				Liu, Caiyue; Ward, Patricia J.; English, Arthur W.			The Effects of Exercise on Synaptic Stripping Require Androgen Receptor Signaling	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; RAT SPINAL-CORD; VESICULAR GLUTAMATE TRANSPORTERS; HAMSTER FACIAL MOTONEURONS; ELECTRICAL-STIMULATION; SKELETAL-MUSCLE; SCIATIC-NERVE; DIFFERENTIAL REGULATION; INDUCED ACCELERATION; AXON REGENERATION	Following peripheral nerve injury, synapses are withdrawn from axotomized motoneurons. Moderate daily treadmill exercise, which promotes axon regeneration of cut peripheral nerves, also influences this synaptic stripping. Different exercise protocols are required to promote axon regeneration in male and female animals, but the sex requirements for an effect of exercise on synaptic stripping are unknown. In male and female C57BL/6 mice, the sciatic nerve was transected in the mid-thigh. Mice were then exercised five days per week for two weeks, beginning on the third post-transection day. Half of the exercised mice were trained by walking slowly (10 M/min) on a level treadmill for one hour per day (continuous training). Other mice were interval trained; four short (two min) sprints at 20 M/min separated by five minute rest periods. A third group was untrained. The extent of synaptic contacts made by structures immunoreactive to vesicular glutamate transporter 1 and glutamic acid decarboxylase 67 onto axotomized motoneurons was studied in confocal images of retrogradely labeled cells. Both types of presumed synaptic contacts were reduced markedly in unexercised mice following nerve transection, relative to intact mice. No significant reduction was found in continuous trained males or interval trained females. Reductions in these contacts in interval trained males and continuous trained females were identical to that observed in untrained mice. Treatments with the anti-androgen, flutamide, blocked the effect of sex-appropriate exercise on synaptic contacts in both males and females. Moderate daily exercise has a potent effect on synaptic inputs to axotomized motoneurons. Successful effects of exercise have different requirements in males and females, but require androgen receptor signaling in both sexes.	[Liu, Caiyue] Second Mil Med Univ, Changzheng Hosp, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Ward, Patricia J.; English, Arthur W.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Naval Medical University; Emory University	English, AW (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	medae@emory.edu		Ward, Patricia/0000-0002-5379-3644	NIH from the USPHS [NS057190, HD032571]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057190] Funding Source: NIH RePORTER	NIH from the USPHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH Grants NS057190 and HD032571 from the USPHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2008, J APPL PHYSIOL, V104, P67, DOI 10.1152/japplphysiol.00558.2007; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059647; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Brown TJ, 2001, RESTOR NEUROL NEUROS, V18, P191; Brown TJ, 1999, RESTOR NEUROL NEUROS, V15, P289; Brown TJ, 2013, RESTOR NEUROL NEUROS, V31, P169, DOI 10.3233/RNN-120287; Coirini H, 2002, NEUROSCIENCE, V113, P883, DOI 10.1016/S0306-4522(02)00224-5; COPE TC, 1993, J NEUROPHYSIOL, V70, P1787, DOI 10.1152/jn.1993.70.5.1787; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; English AW, 2011, ANN ANAT, V193, P354, DOI 10.1016/j.aanat.2011.02.013; Fargo KN, 2008, J NEUROTRAUM, V25, P561, DOI 10.1089/neu.2007.0466; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gottfried-Blackmore A, 2008, J STEROID BIOCHEM, V109, P96, DOI 10.1016/j.jsbmb.2007.12.013; GRAEBER MB, 1986, J NEUROCYTOL, V15, P363; GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104; Hoke A, 2013, EXP NEUROL, V239, pA1, DOI 10.1016/j.expneurol.2012.12.011; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Jones KJ, 1999, J NEUROSCI RES, V57, P817, DOI 10.1002/(SICI)1097-4547(19990915)57:6<817::AID-JNR6>3.0.CO;2-Q; Jones KJ, 1997, J NEUROCYTOL, V26, P257, DOI 10.1023/A:1018596316465; Jones SL, 2012, ENDOCRINOLOGY, V153, P5928, DOI 10.1210/en.2012-1578; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Krakowiak JR, 2010, ABSTR SOC NEUROSCI; KUJAWA KA, 1995, EXP NEUROL, V133, P138, DOI 10.1006/exnr.1995.1016; KUJAWA KA, 1989, EXP NEUROL, V105, P80, DOI 10.1016/0014-4886(89)90174-X; Lenth RV., 2006, JAVA APPLETS POWER S; Matsumoto A, 2005, STRESS, V8, P133, DOI 10.1080/10253890500140642; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Montero F, 2010, J PHYSIOL-LONDON, V588, P3425, DOI 10.1113/jphysiol.2010.195396; Moreno-Lopez B, 2011, MOL NEUROBIOL, V43, P41, DOI 10.1007/s12035-010-8159-8; OLIVEIRA A, 2008, PNAS, V101, P17843; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Patte-Mensah C, 2004, J COMP NEUROL, V477, P286, DOI 10.1002/cne.20251; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Rakotoarivelo C, 2004, NEUROENDOCRINOLOGY, V80, P284, DOI 10.1159/000083611; Rotterman TM, 2014, J NEUROSCI, V34, P3475, DOI 10.1523/JNEUROSCI.4768-13.2014; Sabatier MJ, 2008, EXP NEUROL, V211, P489, DOI 10.1016/j.expneurol.2008.02.013; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529; Sharma N, 2010, EXP NEUROL, V223, P183, DOI 10.1016/j.expneurol.2009.04.031; Smith E. R., 1977, METHOD PSYCHOBIOL, VIII, P259, DOI [10. 1016/B978-0-12-461003-3. 50014-3, DOI 10.1016/B978-0-12-461003-3.50014-3]; Sunico CR, 2010, J NEUROSCI, V30, P973, DOI 10.1523/JNEUROSCI.3911-09.2010; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Thompson NJ, 2014, DEV NEUROBIOL, V74, P531, DOI 10.1002/dneu.22147; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Udina E, 2011, MUSCLE NERVE, V43, P500, DOI 10.1002/mus.21912; Wang Y, 2006, EUR J NEUROSCI, V23, P141, DOI 10.1111/j.1460-9568.2005.04547.x; Wilhelm JC, 2012, J NEUROSCI, V32, P5002, DOI 10.1523/JNEUROSCI.1411-11.2012; Wood K, 2012, DEV NEUROBIOL, V72, P688, DOI 10.1002/dneu.20960; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186	63	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98633	10.1371/journal.pone.0098633	http://dx.doi.org/10.1371/journal.pone.0098633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887087	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300095
J	Shin, H; Cho, Y; Choe, DH; Jeong, Y; Cho, S; Kim, SC; Cho, BK				Shin, HyeonSeok; Cho, Yoobok; Choe, Dong-hui; Jeong, Yujin; Cho, Suhyung; Kim, Sun Chang; Cho, Byung-Kwan			Exploring the Functional Residues in a Flavin-Binding Fluorescent Protein Using Deep Mutational Scanning	PLOS ONE			English	Article							DIRECTED EVOLUTION; REPORTER PROTEINS; LIGHT; OXYGEN; IDENTIFICATION; GENERATION; MUTANTS; DOMAINS	Flavin mononucleotide (FMN)-based fluorescent proteins are versatile reporters that can monitor various cellular processes in both aerobic and anaerobic conditions. However, the understanding of the role of individual amino acid residues on the protein function has been limited and has restricted the development of better functional variants. Here we examine the functional amino acid residues of Escherichia coli flavin mononucleotide binding fluorescent protein (EcFbFP) using the application of high-throughput sequencing of functional variants, termed deep mutational scanning. The variants were classified into 329 function-retained (FR) and 259 function-loss (FL) mutations, and further the mutational enrichment in each amino acid residues was weighed to find the functionally important residues of EcFbFP. We show that the crucial amino acid residues of EcFbFP lie among the FMN-binding pocket, turns and loops of the protein where conformation changes occur, and spatially clustered residues near the E56-K97 salt bridges. In addition, the mutational sensitivity of the critical residues was confirmed by site-directed mutagenesis. The deep mutational scanning of EcFbFP has demonstrated important implications for constructing better functioning protein variants.	[Shin, HyeonSeok; Cho, Yoobok; Choe, Dong-hui; Jeong, Yujin; Cho, Suhyung; Kim, Sun Chang; Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Shin, HyeonSeok; Cho, Yoobok; Choe, Dong-hui; Jeong, Yujin; Cho, Suhyung; Kim, Sun Chang; Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Taejon, South Korea; [Kim, Sun Chang; Cho, Byung-Kwan] Intelligent Synthet Biol Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Cho, BK (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	bcho@kaist.ac.kr	Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022; Cho, Byung-Kwan/C-1830-2011	Choe, Donghui/0000-0003-1107-7380; Shin, HyeonSeok/0000-0001-7618-035X	Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031957, 2011-0031962]; Basic Core Technology Development Program for the Oceans and the Polar Regions - Ministry of Education, Science and Technology [2011-0021053]	Intelligent Synthetic Biology Center of Global Frontier Project; Basic Core Technology Development Program for the Oceans and the Polar Regions - Ministry of Education, Science and Technology	The authors acknowledge financial support from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031957, 2011-0031962) and the Basic Core Technology Development Program for the Oceans and the Polar Regions (2011-0021053) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Golovin A, 2005, PROTEINS, V58, P190, DOI 10.1002/prot.20288; Hao N, 2011, NUCLEIC ACIDS RES, V39, P3695, DOI 10.1093/nar/gkq1336; HODEL AC, 1995, PROTEIN SCI, V4, P484; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Lengauer T, 1996, CURR OPIN STRUC BIOL, V6, P402, DOI 10.1016/S0959-440X(96)80061-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Metz S, 2012, NUCLEIC ACIDS RES, V40, P5901, DOI 10.1093/nar/gks243; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Mukherjee A, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-20; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Song XF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003129; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; URFER R, 1992, PROTEIN SCI, V1, P31; Walter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043921; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wu NC, 2013, J VIROL, V87, P1193, DOI 10.1128/JVI.01658-12	30	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97817	10.1371/journal.pone.0097817	http://dx.doi.org/10.1371/journal.pone.0097817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887409	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300023
J	DiSantostefano, RL; Sampson, T; Le, HV; Hinds, D; Davis, KJ; Bakerly, ND				DiSantostefano, Rachael L.; Sampson, Tim; Hoa Van Le; Hinds, David; Davis, Kourtney J.; Bakerly, Nawar Diar			Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study	PLOS ONE			English	Article							DIAGNOSED COPD; DOUBLE-BLIND; MORTALITY; HOSPITALIZATIONS; EXACERBATIONS; VALIDATION; TIME	Observational studies using case-control designs have showed an increased risk of pneumonia associated inhaled corticosteroid (ICS)-containing medications in patients with chronic obstructive pulmonary disease (COPD). New-user observational cohort designs may minimize biases associated with previous case-control designs. Objective: To estimate the association between ICS and pneumonia among new users of ICS relative to inhaled long-acting bronchodilator (LABD) monotherapy. Methods: Pneumonia events in COPD patients >= 45 years old were compared among new users of ICS medications (n = 11,555; ICS, ICS/long-acting beta(2)-agonist [LABA] combination) and inhaled LABD monotherapies (n = 6,492; LABA, longacting muscarinic antagonists) using Cox proportional hazards models, with propensity scores to adjust for confounding. Setting: United Kingdom electronic medical records with linked hospitalization and mortality data (2002-2010). New users were censored at earliest of: pneumonia event, death, changing/discontinuing treatment, or end of follow-up. Outcomes: severe pneumonia (primary) and any pneumonia (secondary). Results: Following adjustment, new use of ICS-containing medications was associated with an increased risk of pneumonia hospitalization (n = 322 events; HR = 1.55, 95% CI: 1.14, 2.10) and any pneumonia (n = 702 events; HR = 1.49, 95% CI: 1.22, 1.83). Crude incidence rates of any pneumonia were 48.7 and 30.9 per 1000 person years among the ICS-containing and LABD cohorts, respectively. Excess risk of pneumonia with ICS was reduced when requiring >= 1 month or >= 6 months of new use. There was an apparent dose-related effect, with greater risk at higher daily doses of ICS. There was evidence of channeling bias, with more severe patients prescribed ICS, for which the analysis may not have completely adjusted. Conclusions: The results of this new-user cohort study are consistent with published findings; ICS were associated with a 20-50% increased risk of pneumonia in COPD, which reduced with exposure time. This risk must be weighed against the benefits when prescribing ICS to patients with COPD.	[DiSantostefano, Rachael L.; Sampson, Tim; Hoa Van Le; Hinds, David; Davis, Kourtney J.] GlaxoSmithKline, Worldwide Epidemiol, Res Triangle Pk, NC 27709 USA; [Bakerly, Nawar Diar] Salford Royal NHS Fdn Trust, Manchester, Lancs, England; [Bakerly, Nawar Diar] Univ Manchester, Manchester, Lancs, England	GlaxoSmithKline; Salford Royal NHS Foundation Trust; University of Manchester	DiSantostefano, RL (corresponding author), GlaxoSmithKline, Worldwide Epidemiol, Res Triangle Pk, NC 27709 USA.	Rachael.L.DiSantostefano@gsk.com		Diar Bakerly, Nawar/0000-0003-2102-1997	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors RLD, TS, HVL, DH and KJD, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The decision to submit for publication is required by GSK policy as part of being transparent regarding research activities. The specific roles of these authors are articulated in the ` author contributions' section. Editorial support in the form of development of the manuscript first draft in consultation with the authors, editorial suggestions to draft versions of this paper, assembling tables and figures, collating author comments, copyediting, fact checking, referencing and graphic services was provided by David Cutler, PhD and Laura Maguire, MChem at Gardiner-Caldwell Communications (Macclesfield, UK), and was funded by GlaxoSmithKline. The open-access charge was paid for by GlaxoSmithKline.	Andrejak C, 2013, THORAX, V68, P256, DOI 10.1136/thoraxjnl-2012-201772; [Anonymous], 2013, QUAL OUTC FRAM QOF G; Arai T, 2005, NEUROLOGY, V64, P573, DOI 10.1212/01.WNL.0000150897.14961.0F; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Communities and Local Government, 2008, ENGLISH INDICES DEPR; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Davis KJ, 2013, EUR RESPIR J S57, P1005; Dong YH, 2014, CHEST, V145, P1286, DOI 10.1378/chest.13-2137; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, WEUSKOP6416 EVALUATI; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; GOLD, 2011, GLOB STRAT DIAGN MAN; Guess HA, 2006, PHARMACOEPIDEM DR S, V15, P81, DOI 10.1002/pds.1164; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Health & Social Care Information Centre, HOSP EP STAT; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; Janson C, 2013, BMJ-BRIT MED J, V346, pf3306; Jara M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000841; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Joo MJ, 2010, RESP MED, V104, P246, DOI 10.1016/j.rmed.2009.10.002; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lambert BL, 2005, J CLIN PSYCHOPHARM, V25, P12, DOI 10.1097/01.jcp.0000150224.38630.ae; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mannino DM, 2009, RESP MED, V103, P224, DOI 10.1016/j.rmed.2008.09.005; Meropol SB, 2012, PHARMACOEPIDEM DR S, V21, P659, DOI 10.1002/pds.3207; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Molinos L, 2009, J INFECTION, V58, P417, DOI 10.1016/j.jinf.2009.03.003; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Office for National Statistics, 21 CENT MORT FIL 200; Pereira JM, 2012, SEMIN RESP CRIT CARE, V33, P272, DOI 10.1055/s-0032-1315639; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Restrepo MI, 2006, EUR RESPIR J, V28, P346, DOI 10.1183/09031936.06.00131905; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Robins JM, 1998, 1997 P AM STAT ASS S, P1, DOI DOI 10.1097/EDE.0B013E318245847E; Rossi SE, 2000, RADIOGRAPHICS, V20, P1245, DOI 10.1148/radiographics.20.5.g00se081245; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Schneider C, 2010, EUR J EPIDEMIOL, V25, P253, DOI 10.1007/s10654-010-9435-7; Sharafkhaneh A, 2012, RESP MED, V106, P257, DOI 10.1016/j.rmed.2011.07.020; Simon L, 2001, JAMA-J AM MED ASSOC, V286, P2398; Singh S, 2010, CURR OPIN PULM MED, V16, P118, DOI 10.1097/MCP.0b013e328334c085; Snider JT, 2012, CURR MED RES OPIN, V28, P1959, DOI 10.1185/03007995.2012.743459; Soriano JB, 2001, EUR J EPIDEMIOL, V17, P1075, DOI 10.1023/A:1021235123382; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Spencer S, 2011, COCHRANE DB SYST REV, V12; Strom B, 2002, PHARMACOEPIDEM DR S, P375; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Tamim H, 2007, PHARMACOEPIDEM DR S, V16, P250, DOI 10.1002/pds.1360; Toy EL, 2011, RESP MED, V105, P435, DOI 10.1016/j.rmed.2010.09.006; Yawn BP, 2013, INT J CHRONIC OBSTR, V8, P295, DOI 10.2147/COPD.S42366	56	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97149	10.1371/journal.pone.0097149	http://dx.doi.org/10.1371/journal.pone.0097149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878543	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500012
J	Iacobucci, GJ; Rahman, NA; Valtuena, AA; Nayak, TK; Gunawardena, S				Iacobucci, Gary J.; Rahman, Noura Abdel; Valtuena, Aida Andrades; Nayak, Tapan Kumar; Gunawardena, Shermali			Spatial and Temporal Characteristics of Normal and Perturbed Vesicle Transport	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; KINESIN-HEAVY-CHAIN; TUMOR-SUPPRESSOR GENE; FAST AXONAL-TRANSPORT; CHOLINE-ACETYLTRANSFERASE; SYNAPTIC-TRANSMISSION; DROSOPHILA NEURONS; MICROTUBULE ORGANIZATION; CULTURED HIPPOCAMPAL; CYTOPLASMIC DYNEIN	Efficient intracellular transport is essential for healthy cellular function and structural integrity, and problems in this pathway can lead to neuronal cell death and disease. To spatially and temporally evaluate how transport defects are initiated, we adapted a primary neuronal culture system from Drosophila larval brains to visualize the movement dynamics of several cargos/organelles along a 90 micron axonal neurite over time. All six vesicles/organelles imaged showed robust bidirectional motility at both day 1 and day 2. Reduction of motor proteins decreased the movement of vesicles/organelles with increased numbers of neurite blocks. Neuronal growth was also perturbed with reduction of motor proteins. Strikingly, we found that all blockages were not fixed, permanent blocks that impeded transport of vesicles as previously thought, but that some blocks were dynamic clusters of vesicles that resolved over time. Taken together, our findings suggest that non-resolving blocks may likely initiate deleterious pathways leading to death and degeneration, while resolving blocks may be benign. Therefore evaluating the spatial and temporal characteristics of vesicle transport has important implications for our understanding of how transport defects can affect other pathways to initiate death and degeneration.	[Iacobucci, Gary J.; Rahman, Noura Abdel; Valtuena, Aida Andrades; Gunawardena, Shermali] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Nayak, Tapan Kumar] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gunawardena, S (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sg99@buffalo.edu	Iacobucci, Gary/GQH-4517-2022	Nayak, Tapan/0000-0002-3054-5867; gunawardena, shermali/0000-0001-8776-9397; Nayak, Tapan/0000-0002-3706-6092; Andrades Valtuena, Aida/0000-0002-1737-2228	John R. Oishei Foundation; NIH/NINDS [R03-NS084386-01]; University at Buffalo (UB) Center for Undergraduate Research; UB Department of Biological Sciences Alumni Undergraduate Research Fellowship; Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America; Fundacio Joan Riera i Gubau (Santa Coloma de Farners, Spain); Itaca-Banc Santander from Barcelona, Spain at UB; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS084386] Funding Source: NIH RePORTER	John R. Oishei Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University at Buffalo (UB) Center for Undergraduate Research; UB Department of Biological Sciences Alumni Undergraduate Research Fellowship; Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America; Fundacio Joan Riera i Gubau (Santa Coloma de Farners, Spain); Itaca-Banc Santander from Barcelona, Spain at UB; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the John R. Oishei Foundation and partially by funds from NIH/NINDS (R03-NS084386-01) to SG. GJI was supported by a University at Buffalo (UB) Center for Undergraduate Research and Creative Activities fellowship, the UB Department of Biological Sciences Alumni Undergraduate Research Fellowship and the Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America. AAV was supported by Fundacio Joan Riera i Gubau (Santa Coloma de Farners, Spain) and beca salari Itaca-Banc Santander from Barcelona, Spain, while at UB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andlauer Till F M, 2012, Cold Spring Harb Protoc, V2012, P481, DOI 10.1101/pdb.prot068593; Baqri R, 2006, J NEUROBIOL, V66, P378, DOI 10.1002/neu.20230; Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Bowman AB, 1999, J CELL BIOL, V146, P165; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Darya K, 2009, BRAIN RES, V1280, P1, DOI 10.1016/j.brainres.2009.05.026; De Strooper B, 2000, J CELL SCI, V113, P1857; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Djagaeva I, 2012, GENETICS, V192, P173, DOI 10.1534/genetics.112.140798; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fretham SJB, 2012, HIPPOCAMPUS, V22, P1691, DOI 10.1002/hipo.22004; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Fye S, 2010, J VIS EXP; Gardzinski P, 2007, J PHYSIOL-LONDON, V581, P75, DOI 10.1113/jphysiol.2006.127472; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; GHOSH RN, 1995, J CELL BIOL, V128, P549, DOI 10.1083/jcb.128.4.549; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gorczyca D, 2007, J NEUROSCI, V27, P1033, DOI 10.1523/JNEUROSCI.3160-06.2007; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; HAYASHI I, 1994, IN VITRO CELL DEV-AN, V30A, P202; Hemar A, 1997, J NEUROSCI, V17, P9026; Henthorn KS, 2011, MOL BIOL CELL, V22, P4038, DOI 10.1091/mbc.E10-07-0572; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Hong Zheng K, 2013, HUM MOL GENET; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hurd DD, 1996, GENETICS, V144, P1075; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KATZ F, 1988, EMBO J, V7, P3471, DOI 10.1002/j.1460-2075.1988.tb03222.x; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kraft R, 1998, J NEUROSCI, V18, P8886; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Lee D, 2003, J NEUROSCI, V23, P4625; Lee D, 1999, J NEUROSCI, V19, P5311; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Liu ZH, 2011, J NEUROSCI, V31, P2052, DOI 10.1523/JNEUROSCI.3278-10.2011; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Magrane J, 2013, HUM MOL GENET; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Mukherjee A, 2011, MED IMAGE ANAL, V15, P354, DOI 10.1016/j.media.2010.12.005; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; ODOWD DK, 1995, J NEUROBIOL, V27, P113, DOI 10.1002/neu.480270111; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Pathak R, 2013, SMALL GTPASES, P4; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Reis GF, 2012, MOL BIOL CELL, V23, P1700, DOI 10.1091/mbc.E11-11-0938; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Sadananda A, 2012, TRAFFIC, V13, P979, DOI 10.1111/j.1600-0854.2012.01361.x; Sandstrom DJ, 2008, ANESTHESIOLOGY, V108, P434, DOI 10.1097/ALN.0b013e318164cfda; Sandstrom DJ, 2004, J PHYSIOL-LONDON, V558, P489, DOI 10.1113/jphysiol.2004.065748; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schmidt MR, 2007, BIOL CELL, V99, P333, DOI 10.1042/BC20070007; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sheng JS, 2012, NEURON, V74, P6, DOI 10.1016/j.neuron.2012.03.013; SNOW PM, 1987, J NEUROSCI, V7, P4137; Stone MC, 2008, MOL BIOL CELL, V19, P4122, DOI 10.1091/mbc.E07-10-1079; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Torroja L, 1996, J NEUROSCI, V16, P4638; Torroja L, 1999, J NEUROSCI, V19, P7793; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weaver C, 2013, TRAFFIC, V14, P295, DOI 10.1111/tra.12037; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WU CF, 1983, J NEUROSCI, V3, P1888; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; YAMAMOTO D, 1989, J EXP BIOL, V145, P173; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zhang Y, 2011, JOVE-J VIS EXP, DOI 10.3791/2331; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	120	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97237	10.1371/journal.pone.0097237	http://dx.doi.org/10.1371/journal.pone.0097237			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878565	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500013
J	Moorin, RE; Gibson, DAJ; Forsyth, RK; Fox, R				Moorin, Rachael E.; Gibson, David A. J.; Forsyth, Rene K.; Fox, Richard			Demonstration of the Effect of Generic Anatomical Divisions versus Clinical Protocols on Computed Tomography Dose Estimates and Risk Burden	PLOS ONE			English	Article							RADIATION-EXPOSURE; CANCER-RISKS; CT; SCANS; STATEMENT; CHILDHOOD	Objective: Choosing to undertake a CT scan relies on balancing risk versus benefit, however risks associated with CT scanning have generally been limited to broad anatomical locations, which do not provided adequate information to evaluate risk against benefit. Our study aimed to determine differences in radiation dose and risk estimates associated with modern CT scanning examinations when computed for clinical protocols compared with those using anatomical area. Methods: Technical data were extracted from a tertiary hospital Picture Archiving Communication System for random samples of 20-40 CT examinations per adult clinical CT protocol. Organ and whole body radiation dose were calculated using ImPACT Monte Carlo simulation software and cancer incidence and mortality estimated using BEIR VII age and gender specific lifetime attributable risk weights. Results: Thirty four unique CT protocols were identified by our study. When grouped according to anatomic area the radiation dose varied substantially, particularly for abdominal protocols. The total estimated number of incident cancers and cancer related deaths using the mean dose of anatomical area were 86 and 69 respectively. Using more specific protocol doses the estimates rose to 214 and 138 incident cancers and cancer related deaths, at least doubling the burden estimated. Conclusions: Modern CT scanning produces a greater diversity of effective doses than much of the literature describes; where a lack of focus on actual scanning protocols has produced estimates that do not reflect the range and complexity of modern CT practice. To allow clinicians, patients and policy makers to make informed risk versus benefit decisions the individual and population level risks associated with modern CT practices are essential.	[Moorin, Rachael E.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Moorin, Rachael E.; Gibson, David A. J.] Univ Western Australia, Ctr Hlth Serv Res, Sch Populat Hlth, Perth, WA 6009, Australia; [Forsyth, Rene K.] Curtin Univ, Dept Med Imaging Sci, Perth, WA 6845, Australia; [Fox, Richard] Univ Western Australia, Sch Phys, Perth, WA 6009, Australia	Curtin University; University of Western Australia; Curtin University; University of Western Australia	Moorin, RE (corresponding author), Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia.	r.moorin@curtin.edu.au	Moorin, Rachael/AAQ-3650-2020	Moorin, Rachael/0000-0001-8742-7151	National Medical and Research Council [APP 1008394]	National Medical and Research Council	This study was supported by a National Medical and Research Council (http://www.nhmrc.gov.au/) project grant (APP 1008394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brink JA, 2012, RADIOLOGY, V265, P666, DOI 10.1148/radiol.12121919; Christner JA, 2012, RADIOLOGY, V265, P841, DOI 10.1148/radiol.12112365; Clarke JC, 2001, BRIT J RADIOL, V74, P926, DOI 10.1259/bjr.74.886.740926; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; European Commission: Dose Datamed Project, 2008, EUR GUID EST POP DOS; Golding SJ, 2002, BRIT J RADIOL, V75, P1, DOI 10.1259/bjr.75.889.750001; Hendee WR, 2013, RADIOLOGY, V267, P326, DOI 10.1148/radiol.13130567; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Imaging and Performance and Assessment of CT scanners (ImPACT), 2001, CT PAT DOS EXC SPREA; International Commission on Radiological Protection, 2000, INT COMM RAD PROT PU, V87; International Commission on Radiological Protection, 2007, REC INT COMM RAD PRO; Little MP, 2009, RADIOLOGY, V251, P6, DOI [10.1148/radiol.2511081686, 10.1148/radiol.1.2511081686]; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mayo JR, 2003, RADIOLOGY, V228, P15, DOI 10.1148/radiol.2281020874; Moorin RE, 2013, J RADIOL PROT, V33, P295, DOI 10.1088/0952-4746/33/2/295; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Redberg RF, 2009, ARCH INTERN MED, V169, P2049, DOI 10.1001/archinternmed.2009.453; Schroeder AR, 2013, JAMA PEDIAT, V2013, pE1; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; SHRIMPTON PC, 1995, RADIAT PROT DOSIM, V57, P413; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sodickson A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3102; Sodickson A, 2012, RADIOLOGY, V264, P397, DOI 10.1148/radiol.12111822; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD; Wall BF, 2005, RADIAT PROT DOSIM, V114, P183, DOI 10.1093/rpd/nch505; Zweifel P, 1992, HLTH EC WORLDWIDE	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97691	10.1371/journal.pone.0097691	http://dx.doi.org/10.1371/journal.pone.0097691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878841	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500021
J	Haller, S; Eckmanns, T; Benzler, J; Tolksdorf, K; Claus, H; Gilsdorf, A; Abu Sin, M				Haller, Sebastian; Eckmanns, Tim; Benzler, Justus; Tolksdorf, Kristin; Claus, Hermann; Gilsdorf, Andreas; Abu Sin, Muna			Results from the First 12 Months of the National Surveillance of Healthcare Associated Outbreaks in Germany, 2011/2012	PLOS ONE			English	Article							DIFFICILE-ASSOCIATED DISEASE; SURGICAL SITE INFECTIONS; NOSOCOMIAL INFECTIONS; ENTEROBACTER-CLOACAE; CONTROL PROGRAM; HOSPITALS; BAUMANNII; EVENTS; UNITS	Background: In August 2011, the German Protection against Infection Act was amended, mandating the reporting of healthcare associated infection (HAI) outbreak notifications by all healthcare workers in Germany via local public health authorities and federal states to the Robert Koch Institute (RKI). Objective: To describe the reported HAI-outbreaks and the surveillance system's structure and capabilities. Methods: Information on each outbreak was collected using standard paper forms and notified to RKI. Notifications were screened daily and regularly analysed. Results: Between November 2011 and November 2012, 1,326 paper forms notified 578 HAI-outbreaks, between 7 and 116 outbreaks per month. The main causative agent was norovirus (n = 414/578; 72%). Among the 108 outbreaks caused by bacteria, the most frequent pathogens were Clostridium difficile (25%) Klebsiella spp. (19%) and Staphylococcus spp. (19%). Multidrug-resistant bacteria were responsible for 54/108 (50%) bacterial outbreaks. Hospitals were affected most frequently (485/578; 84%). Hospital outbreaks due to bacteria were mostly reported from intensive care units (ICUs) (45%), followed by internal medicine wards (16%). Conclusion: The mandatory HAI-outbreak surveillance system describes common outbreaks. Pathogens with a particular high potential to cause large or severe outbreaks may be identified, enabling us to further focus research and preventive measures. Increasing the sensitivity and reliability of the data collection further will facilitate identification of outbreaks able to increase in size and severity, and guide specific control measures to interrupt their propagation.	[Haller, Sebastian; Eckmanns, Tim; Benzler, Justus; Tolksdorf, Kristin; Claus, Hermann; Gilsdorf, Andreas; Abu Sin, Muna] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Haller, Sebastian] European Ctr Dis Prevent & Control, European Programme Intervent Epidemiol Training, Stockholm, Sweden	Robert Koch Institute; European Centre for Disease Prevention & Control	Haller, S (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	HallerS@rki.de	Haller, Sebastian/P-1634-2014	Haller, Sebastian/0000-0001-8242-711X; Claus, Hermann/0000-0002-0120-1846; Tolksdorf, Kristin/0000-0002-8712-6399; Gilsdorf, Andreas/0000-0001-8572-2798				Ammon A, 2007, KRANKENHAUSHYGIENE U, V2, P217; Armbrust Sven, 2009, BMC Res Notes, V2, P96, DOI 10.1186/1756-0500-2-96; Bernard H., 2014, EURO SURVEILL, V19; Choi WS, 2010, J KOREAN MED SCI, V25, P999, DOI 10.3346/jkms.2010.25.7.999; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Faensen D, 2006, Euro Surveill, V11, P7, DOI 10.2807/esm.11.04.00614-en; Gastmeier P, 2008, DEUT MED WOCHENSCHR, V133, P1111, DOI 10.1055/s-2008-1077224; Gastmeier P, 2005, INFECT CONT HOSP EP, V26, P357, DOI 10.1086/502552; Gastmeier P, 2009, INFECT CONT HOSP EP, V30, P993, DOI 10.1086/605720; Gastmeier P, 2008, J HOSP INFECT, V70, P11, DOI 10.1016/S0195-6701(08)60005-5; Geubbels ELPE, 2006, INT J QUAL HEALTH C, V18, P127, DOI 10.1093/intqhc/mzi103; Gortner L, 2000, LANCET, V356, P2015, DOI 10.1016/S0140-6736(05)72992-5; Graf K, 2009, EUR J CLIN MICROBIOL, V28, P543, DOI 10.1007/s10096-008-0655-7; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Hauri AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017341; Hermes J, 2011, GESUNDHEITSWESEN, V73, P778, DOI 10.1055/s-0031-1291260; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hosoglu S, 2012, INFECTION, V40, P11, DOI 10.1007/s15010-011-0180-y; Jang TN, 2009, J HOSP INFECT, V73, P143, DOI 10.1016/j.jhin.2009.06.007; Kruse EB, 2010, J HOSP INFECT, V75, P33, DOI 10.1016/j.jhin.2010.01.015; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mohr O, 2010, BUNDESGESUNDHEITSBLA, V53, P903, DOI 10.1007/s00103-010-1122-z; Nubel U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054898; Ostrosky-Zeichner L, 2000, INFECT CONT HOSP EP, V21, P527, DOI 10.1086/501800; Reiss I, 2000, LANCET, V356, P310, DOI 10.1016/S0140-6736(00)02509-5; Rhinehart E, 2012, AM J INFECT CONTROL, V40, P2, DOI 10.1016/j.ajic.2011.10.003; Rioux C, 2007, J HOSP INFECT, V66, P217, DOI 10.1016/j.jhin.2007.04.005; Robert Koch-Institut, 2012, EPIDEMIOL B, V26, P239; Robert Koch-Institut, 2013, INF JB MELD KRANKH 2; Robert-Koch-Institut, 2002, BUNDESGESUNDHEITSBLA, V2, P180; Robert-Koch-Institut, 2012, EPIDEMIOLOGISCHES B, V2, P2; Said MA, 2008, CLIN INFECT DIS, V47, P1202, DOI 10.1086/592299; Statistisches-Bundesamt, 2012, GRUNDD KRANK; Vonberg RP, 2011, INFECTION, V39, P29, DOI 10.1007/s15010-010-0064-6	36	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98100	10.1371/journal.pone.0098100	http://dx.doi.org/10.1371/journal.pone.0098100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875674	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800024
J	Horibe, H; Murakami, M; Iohara, K; Hayashi, Y; Takeuchi, N; Takei, Y; Kurita, K; Nakashima, M				Horibe, Hiroshi; Murakami, Masashi; Iohara, Koichiro; Hayashi, Yuki; Takeuchi, Norio; Takei, Yoshifumi; Kurita, Kenichi; Nakashima, Misako			Isolation of a Stable Subpopulation of Mobilized Dental Pulp Stem Cells (MDPSCs) with High Proliferation, Migration, and Regeneration Potential Is Independent of Age	PLOS ONE			English	Article							SIDE POPULATION CELLS; MARROW STROMAL CELLS; PLURIPOTENTIAL CAPACITY; TRANSCRIPTION FACTOR; TELOMERE LENGTH; SENESCENCE; DIFFERENTIATION; TRANSPLANTATION	Insights into the understanding of the influence of the age of MSCs on their cellular responses and regenerative potential are critical for stem cell therapy in the clinic. We have isolated dental pulp stem cells (DPSCs) subsets based on their migratory response to granulocyte-colony stimulating factor (G-CSF) (MDPSCs) from young and aged donors. The aged MDPSCs were efficiently enriched in stem cells, expressing high levels of trophic factors with high proliferation, migration and anti-apoptotic effects compared to young MDPSCs. In contrast, significant differences in those properties were detected between aged and young colony-derived DPSCs. Unlike DPSCs, MDPSCs showed a small age-dependent increase in senescence-associated beta-galactosidase (SA-beta-gal) production and senescence markers including p16, p21, Interleukin (IL)-1 beta, -6, -8, and Groa in long-term culture. There was no difference between aged and young MDPSCs in telomerase activity. The regenerative potential of aged MDPSCs was similar to that of young MDPSCs in an ischemic hindlimb model and an ectopic tooth root model. These results demonstrated that the stem cell properties and the high regenerative potential of MDPSCs are independent of age, demonstrating an immense utility for clinical applications by autologous cell transplantation in dental pulp regeneration and ischemic diseases.	[Horibe, Hiroshi; Murakami, Masashi; Iohara, Koichiro; Hayashi, Yuki; Takeuchi, Norio; Nakashima, Misako] Natl Ctr Geriatr & Gerontol, Res Inst, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi, Japan; [Horibe, Hiroshi; Kurita, Kenichi] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 464, Japan; [Hayashi, Yuki] Aichi Gakuin Univ, Sch Dent, Dept Pediat Dent, Nagoya, Aichi 464, Japan; [Takeuchi, Norio] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi 464, Japan; [Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Dept Biochem, Nagoya, Aichi 4648601, Japan; [Takei, Yoshifumi] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Dis Models, Nagoya, Aichi 4648601, Japan	National Center for Geriatrics & Gerontology; Aichi Gakuin University; Aichi Gakuin University; Aichi Gakuin University; Nagoya University; Nagoya University	Nakashima, M (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi, Japan.	misako@ncgg.go.jp	TAKEI, Yoshifumi/I-7260-2014		Research Grant for Longevity Sciences from the Ministry of Health, Labour and Welfare [23-10]	Research Grant for Longevity Sciences from the Ministry of Health, Labour and Welfare	The work was supported by Research Grant for Longevity Sciences (23-10) from the Ministry of Health, Labour and Welfare to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Bajek A, 2012, AGING CLIN EXP RES, V24, P404, DOI 10.3275/8424; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Bressan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049146; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chang HX, 2011, ORTHOPEDICS, V34, P593, DOI 10.3928/01477447-20110627-06; Chen CS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-21; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Gala K, 2011, CELL BIOL INT, V35, P1055, DOI 10.1042/CBI20100586; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Iida K, 2010, ARCH ORAL BIOL, V55, P648, DOI 10.1016/j.archoralbio.2010.06.005; Inukai T, 2013, BIOCHEM BIOPH RES CO, V430, P763, DOI 10.1016/j.bbrc.2012.11.074; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.tea.2010.0615, 10.1089/ten.TEA.2010.0615]; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Ishizaka R, 2013, BIOMATERIALS, V34, P1888, DOI 10.1016/j.biomaterials.2012.10.045; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Ksiazek K, 2009, REJUV RES, V12, P105, DOI 10.1089/rej.2009.0830; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Lepperdinger G, 2011, CURR OPIN IMMUNOL, V23, P518, DOI 10.1016/j.coi.2011.05.007; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Murakami M, 2013, BIOMATERIALS, V34, P9036, DOI 10.1016/j.biomaterials.2013.08.011; Murray PE, 2002, ORAL SURG ORAL MED O, V93, P474, DOI 10.1067/moe.2002.120974; NAKASHIMA M, 1991, ARCH ORAL BIOL, V36, P655, DOI 10.1016/0003-9969(91)90018-P; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Roura S, 2006, EUR J HEART FAIL, V8, P555, DOI 10.1016/j.ejheart.2005.11.006; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Zhang J, 2012, BIOMATERIALS, V33, P6974, DOI 10.1016/j.biomaterials.2012.06.032; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	47	42	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98553	10.1371/journal.pone.0098553	http://dx.doi.org/10.1371/journal.pone.0098553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870376	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300053
J	Lu, F; Xue, JX; Hu, YC; Gan, L; Shi, Y; Yang, HS; Wei, YQ				Lu, Fang; Xue, Jian-xin; Hu, Yu-chang; Gan, Lu; Shi, Yi; Yang, Han-shuo; Wei, Yu-quan			CARP Is a Potential Tumor Suppressor in Gastric Carcinoma and a Single-Nucleotide Polymorphism in CARP Gene Might Increase the Risk of Gastric Carcinoma	PLOS ONE			English	Article							CELL-CYCLE KINASES; CANCER; P27; EPIDEMIOLOGY; DEGRADATION; INHIBITORS; P27(KIP1); ROLES; P53; EXPRESSION	Background: The caspase-associated recruitment domain-containing protein (CARP) is expressed in almost all tissues. Recently, the tumor-suppressive function of CARP was discovered and attracted increasing attention. This study aimed to investigate the role of CARP in the carcinogenesis of human gastric carcinoma. Methodology/Principal Findings: Compared with normal gastric tissue, the downregulation of CARP expression was observed in gastric carcinoma tissue by cDNA array and tissue microarray assay. In vitro, the gastric carcinoma cell line (BGC823) was stably transfected with pcDNA3.1B-CARP or plus CARP siRNA, and we used MTT, flow cytometry, cell migration on type I collagen, cell-matrix adhesion assay and western blot analysis to investigate the potential anti-tumor effects of CARP. The data showed that overexpressing CARP suppressed the malignancy of gastric carcinoma BGC-823 cell line, including significant increases in apoptosis, as well as obvious decreases in cell proliferation, migration, adhesion ability, and tumor growth. The tumor-suppressive effects of CARP were almost restored by siRNA-directed CARP silence. In addition, overexpression of CARP induced G1 arrest, decreased the expressions of cyclin E and CDK2, and increased the expressions of p27, p53 and p21. In vivo, the tumor-suppressive effect of CARP was also verified. A single-nucleotide polymorphism (SNP) genotype of CARP (rs2297882) was located in the Kozak sequence of the CARP gene. The reporter gene assay showed that rs2297882 TT caused an obvious downregulation of activity of CARP gene promoter in BGC-823 cells. Furthermore, the association between rs2297882 and human gastric carcinoma susceptibility was analyzed in 352 cases and 889 controls. It displayed that the TT genotype of rs2297882 in the CARP gene was associated with an increased risk of gastric carcinoma. Conclusions/Significance: CARP is a potential tumor suppressor of gastric carcinoma and the rs2297882 C. T phenotype of CARP may serve as a predictor of gastric carcinoma.	[Lu, Fang; Gan, Lu; Yang, Han-shuo; Wei, Yu-quan] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Peoples R China; [Lu, Fang; Shi, Yi] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Lu, Fang; Shi, Yi] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Xue, Jian-xin] Sichuan Univ, Dept Thorac Oncol, Ctr Canc, West China Hosp, Chengdu 610064, Peoples R China; [Xue, Jian-xin] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Peoples R China; [Hu, Yu-chang] China Three Gorges Univ, Inst Pathol, Yichang, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University; China Three Gorges University	Yang, HS (corresponding author), Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Peoples R China.	yangyanshuo13@163.com			National Natural Science Foundation of China [81101698, 81272216]; China Postdoctoral Science Foundation [2012T50722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was financially supported by grants from the National Natural Science Foundation of China (81101698 to Xue Jianxin and 81272216 to Yang Hanshou), and China Postdoctoral Science Foundation (2012T50722 to Xue Jianxin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M., 2013, CURR OPIN PHARM; Berg JP, 2007, HUM PATHOL, V38, P1621, DOI 10.1016/j.humpath.2007.03.007; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Damiano JS, 2004, CURR DRUG TARGETS, V5, P367, DOI 10.2174/1389450043345470; Daw EW, 2007, HUM MOL GENET, V16, P2463, DOI 10.1093/hmg/ddm202; Fan B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-316; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; HARPER JW, 1993, CELL, V75, P805; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lee EW, 2006, MOL CELLS, V22, P133; Liu BH, 2002, BIOCHEM BIOPH RES CO, V293, P1396, DOI 10.1016/S0006-291X(02)00379-0; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Philipp-Staheli J, 2004, ONCOGENE, V23, P905, DOI 10.1038/sj.onc.1207220; Qin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076486; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi Y, 2011, ONCOGENE, V30, P4107, DOI 10.1038/onc.2011.116; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stadtlander CTKH, 1999, CARCINOGENESIS, V20, P2195, DOI 10.1093/carcin/20.12.2195; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Stone Andrew, 2012, Critical Reviews in Oncogenesis, V17, P175; Tang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074527; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504	33	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97743	10.1371/journal.pone.0097743	http://dx.doi.org/10.1371/journal.pone.0097743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870804	gold, Green Published, Green Submitted			2022-12-27	WOS:000336858300018
J	Ahn, M; Bajsarowicz, K; Oehler, A; Lemus, A; Bankiewicz, K; DeArmond, SJ				Ahn, Misol; Bajsarowicz, Krystyna; Oehler, Abby; Lemus, Azucena; Bankiewicz, Krystof; DeArmond, Stephen J.			Convection-Enhanced Delivery of AAV2-PrPshRNA in Prion-Infected Mice	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; PROLONGS SURVIVAL; DISEASE; QUINACRINE; PROTEIN; BRAIN; PRP; MODEL; DEGENERATION; TRANSDUCTION	Prion disease is caused by a single pathogenic protein (PrPSc), an abnormal conformer of the normal cellular prion protein PrPC. Depletion of PrPC in prion knockout mice makes them resistant to prion disease. Thus, gene silencing of the Prnp gene is a promising effective therapeutic approach. Here, we examined adeno-associated virus vector type 2 encoding a short hairpin RNA targeting Prnp mRNA (AAV2-PrP-shRNA) to suppress PrPC expression both in vitro and in vivo. AAV2-PrP-shRNA treatment suppressed PrP levels and prevented dendritic degeneration in RML-infected brain aggregate cultures. Infusion of AAV2-PrP-shRNA-eGFP into the thalamus of CD-1 mice showed that eGFP was transported to the cerebral cortex via anterograde transport and the overall PrPC levels were reduced by similar to 70% within 4 weeks. For therapeutic purposes, we treated RML-infected CD-1 mice with AAV2-PrP-shRNA beginning at 50 days post inoculation. Although AAV2-PrP-shRNA focally suppressed PrPSc formation in the thalamic infusion site by similar to 75%, it did not suppress PrPSc formation efficiently in other regions of the brain. Survival of mice was not extended compared to the untreated controls. Global suppression of PrPC in the brain is required for successful therapy of prion diseases.	[Ahn, Misol; Bajsarowicz, Krystyna; Oehler, Abby; Lemus, Azucena; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Bankiewicz, Krystof] Univ Calif San Francisco, Dept Neurosurg & Neurol, San Francisco, CA 94143 USA; [Ahn, Misol; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	DeArmond, SJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	stephen.dearmond@ucsf.edu		Ahn, Misol/0000-0002-6088-8481	National institute on Aging of the National Institutes of Health [K01AG039386]; UCSF SOM REAC; UCSF Bridge fund; Stephen C & Patricia A Schott foundation; NATIONAL INSTITUTE ON AGING [K01AG039386] Funding Source: NIH RePORTER	National institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UCSF SOM REAC; UCSF Bridge fund; Stephen C & Patricia A Schott foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National institute on Aging of the National Institutes of Health under award number K01AG039386, the UCSF SOM REAC award (Mainprice Memorial Foundation and Cox J Fund) and the UCSF Bridge fund as well as by a gift from the Stephen C & Patricia A Schott foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039112; Bajsarowicz K, 2012, J NEUROPATH EXP NEUR, V71, P449, DOI 10.1097/NEN.0b013e3182544680; Bartus RT, 2011, NEUROBIOL DIS, V44, P38, DOI 10.1016/j.nbd.2011.05.026; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bouzamondo-Bernstein E, 2004, J NEUROPATH EXP NEUR, V63, P882, DOI 10.1093/jnen/63.8.882; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; Chiu TL, 2009, INT J ONCOL, V35, P1361, DOI 10.3892/ijo_00000454; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Cunningham J, 2008, MOL THER, V16, P1267, DOI 10.1038/mt.2008.111; DeArmond S.J., 2002, GREENFIELDS NEUROPAT, V7th, P273; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P205, DOI 10.1023/B:CEMN.0000018617.21378.95; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gayrard V, 2005, BRIT J PHARMACOL, V144, P386, DOI 10.1038/sj.bjp.0706072; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghaemmaghami S, 2010, J BIOL CHEM, V285, P10415, DOI 10.1074/jbc.M109.045112; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Hadaczek P, 2006, HUM GENE THER, V17, P291, DOI 10.1089/hum.2006.17.291; Hadaczek P, 2009, HUM GENE THER, V20, P225, DOI 10.1089/hum.2008.151; Haviv Y, 2008, ARCH NEUROL-CHICAGO, V65, P762, DOI 10.1001/archneur.65.6.762; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MORRISON PF, 1994, AM J PHYSIOL, V266, pR292, DOI 10.1152/ajpregu.1994.266.1.R292; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Prusiner SB, 2001, HARRISONS PRINCIPLES, P2486; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Su XM, 2010, MOL THER, V18, P1490, DOI 10.1038/mt.2010.114; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Vetrugno V, 2009, J GEN VIROL, V90, P1775, DOI 10.1099/vir.0.009936-0; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98496	10.1371/journal.pone.0098496	http://dx.doi.org/10.1371/journal.pone.0098496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866748	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100061
J	Meli, M; Pagano, K; Ragona, L; Colombo, G				Meli, Massimiliano; Pagano, Katiuscia; Ragona, Laura; Colombo, Giorgio			Investigating the Dynamic Aspects of Drug-Protein Recognition through a Combination of MD and NMR Analyses: Implications for the Development of Protein-Protein Interaction Inhibitors	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BACKBONE DYNAMICS; SPECTROSCOPY; FLEXIBILITY; RELAXATION; SIMULATION; DISCOVERY; SELECTION; DESIGN	In this paper, we investigate the dynamic aspects of the molecular recognition between a small molecule ligand and a flat, exposed protein surface, representing a typical target in the development of protein-protein interaction inhibitors. Specifically, we analyze the complex between the protein Fibroblast Growth Factor 2 (FGF2) and a recently discovered small molecule inhibitor, labeled sm27 for which the binding site and the residues mainly involved in small molecule recognition have been previously characterized. We have approached this problem using microsecond MD simulations and NMR-based characterizations of the dynamics of the apo and holo states of the system. Using direct combination and cross-validation of the results of the two techniques, we select the set of conformational states that best recapitulate the principal dynamic and structural properties of the complex. We then use this information to generate a multi-structure representation of the sm27-FGF2 interaction. We propose this kind of representation and approach as a useful tool in particular for the characterization of systems where the mutual dynamic influence between the interacting partners is expected to play an important role. The results presented can also be used to generate new rules for the rational expansion of the chemical diversity space of FGF2 inhibitors.	[Meli, Massimiliano; Colombo, Giorgio] CNR, Ist Chim Riconoscimento, I-20133 Milan, Italy; [Pagano, Katiuscia; Ragona, Laura] CNR, Ist Studio Macromol, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR)	Colombo, G (corresponding author), CNR, Ist Chim Riconoscimento, I-20133 Milan, Italy.	g.colombo@icrm.cnr.it	Pagano, Katiuscia/AAB-9495-2020; Meli, Massimiliano/AAY-8570-2020; Ragona, Laura/AAB-9691-2020; Colombo, Giorgio/A-2730-2012	Meli, Massimiliano/0000-0003-3304-6104; Ragona, Laura/0000-0003-3893-7117; Colombo, Giorgio/0000-0002-1318-668X; pagano, katiuscia/0000-0002-0462-2056	AIRC (Associazione Italiana Ricerca sul Cancro) [IG.11775]	AIRC (Associazione Italiana Ricerca sul Cancro)	GC acknowledges a grant from AIRC (Associazione Italiana Ricerca sul Cancro), Grant IG.11775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Carlson HA, 2002, CURR OPIN CHEM BIOL, V6, P447, DOI 10.1016/S1367-5931(02)00341-1; Case DA, 2012, AMBER 12; Colombo G, 2010, J BIOL CHEM, V285, P8733, DOI 10.1074/jbc.M109.085605; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; DALVIT C, 1995, J BIOMOL NMR, V5, P306, DOI 10.1007/BF00211757; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dibenedetto D, 2013, BIOCHEMISTRY-US, V52, P6672, DOI 10.1021/bi400367r; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KEELER J, 1994, METHOD ENZYMOL, V239, P145; Keskin O, 2007, PROTEIN PROTEIN INTE, p222A; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moroni E, 2014, J CHEM INF MODEL; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Niccolai N, 2001, J BIOL CHEM, V276, P42455, DOI 10.1074/jbc.M107387200; Nieto L, 2013, CHEMBIOCHEM, V14, P1732, DOI 10.1002/cbic.201300313; Pagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036990; Panjkovich A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-273; Prompers JJ, 2002, J AM CHEM SOC, V124, P4522, DOI 10.1021/ja012750u; Schroder C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2198802; Taraboletti G, 2010, ONCOTARGET, V1, P662; van Gunsteren WF, 2008, CURR OPIN STRUC BIOL, V18, P149, DOI 10.1016/j.sbi.2007.12.007; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhuravleva A, 2007, J MOL BIOL, V367, P1079, DOI 10.1016/j.jmb.2007.01.051	38	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97153	10.1371/journal.pone.0097153	http://dx.doi.org/10.1371/journal.pone.0097153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865844	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100012
J	Liu, C; Du, WB; Wang, WX				Liu, Chen; Du, Wen-Bo; Wang, Wen-Xu			Particle Swarm Optimization with Scale-Free Interactions	PLOS ONE			English	Article							ECONOMIC-DISPATCH; ALGORITHM; NETWORKS; SYSTEM	The particle swarm optimization (PSO) algorithm, in which individuals collaborate with their interacted neighbors like bird flocking to search for the optima, has been successfully applied in a wide range of fields pertaining to searching and convergence. Here we employ the scale-free network to represent the inter-individual interactions in the population, named SF-PSO. In contrast to the traditional PSO with fully-connected topology or regular topology, the scale-free topology used in SF-PSO incorporates the diversity of individuals in searching and information dissemination ability, leading to a quite different optimization process. Systematic results with respect to several standard test functions demonstrate that SF-PSO gives rise to a better balance between the convergence speed and the optimum quality, accounting for its much better performance than that of the traditional PSO algorithms. We further explore the dynamical searching process microscopically, finding that the cooperation of hub nodes and non-hub nodes play a crucial role in optimizing the convergence process. Our work may have implications in computational intelligence and complex networks.	[Liu, Chen; Du, Wen-Bo] Beihang Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Wang, Wen-Xu] Beijing Normal Univ, Sch Management, Beijing 100875, Peoples R China	Beihang University; Beijing Normal University	Du, WB (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing, Peoples R China.	wenbodu@buaa.edu.cn	Armstrong, Jonathan K/A-3069-2008		National Natural Science Foundation of China [61201314, 61231013]; Ministry of Science and Technology of China [2011CB707004, 2012BAG04B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was funded by National Natural Science Foundation of China (Grant Nos. 61201314 and 61231013, http://www.nsfc.gov.cn/) and Ministry of Science and Technology of China (Grant Nos. 2011CB707004 and 2012BAG04B01, http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barradas NP, 1997, APPL PHYS LETT, V71, P291, DOI 10.1063/1.119524; Benedetti M, 2006, IEEE ANTENN WIREL PR, V5, P545, DOI 10.1109/LAWP.2006.887553; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bratton D, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P120, DOI 10.1109/SIS.2007.368035; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Gaing ZL, 2003, IEEE T POWER SYST, V18, P1187, DOI 10.1109/TPWRS.2003.814889; Grimaccia F, 2007, IEEE T ANTENN PROPAG, V55, P781, DOI 10.1109/TAP.2007.891561; Ho SL, 2006, IEEE T MAGN, V42, P1107, DOI 10.1109/TMAG.2006.871426; Jin NB, 2005, IEEE T ANTENN PROPAG, V53, P3459, DOI 10.1109/TAP.2005.858842; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1931, DOI 10.1109/CEC.1999.785509; Kennedy J, 2002, IEEE C EVOL COMPUTAT, P1671, DOI 10.1109/CEC.2002.1004493; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI [10.1109/TEVC.2004.826074, 10.1109/tevc.2004.826074]; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Park JB, 2005, IEEE T POWER SYST, V20, P34, DOI 10.1109/TPWRS.2004.831275; Parpinelli RS, 2002, IEEE T EVOLUT COMPUT, V6, P321, DOI 10.1109/TEVC.2002.802452; Peram T, 2003, PROCEEDINGS OF THE 2003 IEEE SWARM INTELLIGENCE SYMPOSIUM (SIS 03), P174, DOI 10.1109/SIS.2003.1202264; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Selvan SE, 2006, IEEE T INF TECHNOL B, V10, P685, DOI 10.1109/TITB.2006.874197; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Veeramachaneni K, 2005, IEEE T SYST MAN CY C, V35, P344, DOI 10.1109/TSMCC.2005.848191; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wai RJ, 2011, IEEE T IND ELECTRON, V58, P629, DOI 10.1109/TIE.2010.2046004; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Zwickl DJ., 2006, THESIS	37	132	133	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97822	10.1371/journal.pone.0097822	http://dx.doi.org/10.1371/journal.pone.0097822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859007	Green Published, gold			2022-12-27	WOS:000336839400027
J	Bellas, C; Garcia, D; Vicente, Y; Kilany, L; Abraira, V; Navarro, B; Provencio, M; Martin, P				Bellas, Carmen; Garcia, Diego; Vicente, Yolanda; Kilany, Linah; Abraira, Victor; Navarro, Belen; Provencio, Mariano; Martin, Paloma			Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							GERMINAL CENTER PHENOTYPE; PARAFFIN-EMBEDDED TISSUE; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; CHOP CONSORTIUM PROGRAM; NON-HODGKINS-LYMPHOMAS; GENE-EXPRESSION; PROTEIN EXPRESSION; RISK STRATIFICATION; CLINICAL-RELEVANCE; MYC TRANSLOCATION	Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic heterogeneity. We analyzed 100 cases of DLBCL to evaluate the prognostic value of immunohistochemical markers derived from the gene expression profiling-defined cell origin signature, including MYC, BCL2, BCL6, and FOXP1 protein expression. We also investigated genetic alterations in BCL2, BCL6, MYC and FOXP1 using fluorescence in situ hybridization and assessed their prognostic significance. BCL6 rearrangements were detected in 29% of cases, and BCL6 gene alteration (rearrangement and/or amplification) was associated with the non-germinal center B subtype (non-GCB). BCL2 translocation was associated with the GCB phenotype, and BCL2 protein expression was associated with the translocation and/or amplification of 18q21. MYC rearrangements were detected in 15% of cases, and MYC protein expression was observed in 29% of cases. FOXP1 expression, mainly of the non-GCB subtype, was demonstrated in 37% of cases. Co-expression of the MYC and BCL2 proteins, with non-GCB subtype predominance, was observed in 21% of cases. We detected an association between high FOXP1 expression and a high proliferation rate as well as a significant positive correlation between MYC overexpression and FOXP1 overexpression. MYC, BCL2 and FOXP1 expression were significant predictors of overall survival. The co-expression of MYC and BCL2 confers a poorer clinical outcome than MYC or BCL2 expression alone, whereas cases negative for both markers had the best outcomes. Our study confirms that DLBCL, characterized by the co-expression of MYC and BCL2 proteins, has a poor prognosis and establishes a significant positive correlation with MYC and FOXP1 over-expression in this entity.	[Bellas, Carmen; Garcia, Diego; Vicente, Yolanda; Kilany, Linah; Martin, Paloma] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Lab Mol Pathol, Madrid, Spain; [Abraira, Victor] Hosp Univ Ramon & Cajal, CIBER Epidemiol & Salud Publ CIBERESP, Unidad Bioestadist Clin, Madrid, Spain; [Navarro, Belen] Hosp Univ Puerta de Hierro Majadahonda, Dept Hematol, Madrid, Spain; [Provencio, Mariano] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Oncohematol Res Unit, Med Oncol Serv, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda	Martin, P (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Lab Mol Pathol, Madrid, Spain.	pmartin@idiphim.org	Acosta, Paloma Martin/AAF-7998-2021; Provencio, Mariano/ABE-8586-2020	Acosta, Paloma Martin/0000-0002-3274-4595; Provencio, Mariano/0000-0001-9053-9197; Provencio Pulla, Mariano/0000-0001-6315-7919	Fondo de Investigaciones Sanitarias [RETIC RD 06/0020/0047]; Fundacion Mutua Madrilena; Miguel Servet contract from the Fondo de Investigaciones Sanitarias	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Miguel Servet contract from the Fondo de Investigaciones Sanitarias	This work was supported by grants from the Fondo de Investigaciones Sanitarias (RETIC RD 06/0020/0047) and Fundacion Mutua Madrilena. PM is supported by a Miguel Servet contract from the Fondo de Investigaciones Sanitarias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Banham AH, 2005, CLIN CANCER RES, V11, P1065; Barrans SL, 2004, BLOOD, V104, P2933, DOI 10.1182/blood-2004-03-1209; Barrans SL, 2003, CLIN CANCER RES, V9, P2133; Barrans SL, 2002, BLOOD, V99, P1136, DOI 10.1182/blood.V99.4.1136; Barrans SL, 2002, BRIT J HAEMATOL, V117, P322, DOI 10.1046/j.1365-2141.2002.03435.x; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Copie-Bergman C, 2009, J CLIN ONCOL, V27, P5573, DOI 10.1200/JCO.2009.22.7058; Craig VJ, 2011, BLOOD, V117, P6227, DOI 10.1182/blood-2010-10-312231; Gascoyne RD, 1997, BLOOD, V90, P244; Goatly A, 2008, MODERN PATHOL, V21, P902, DOI 10.1038/modpathol.2008.74; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Gutierrez-Garcia G, 2011, BLOOD, V117, P4836, DOI 10.1182/blood-2010-12-322362; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Haralambieva E, 2006, LEUKEMIA, V20, P1300, DOI 10.1038/sj.leu.2404244; Haralambieva E, 2002, J PATHOL, V198, P163, DOI 10.1002/path.1197; Hoeller S, 2010, HISTOPATHOLOGY, V57, P73, DOI 10.1111/j.1365-2559.2010.03600.x; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Huang JZ, 2002, BLOOD, V99, P2285, DOI 10.1182/blood.V99.7.2285; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Jais JP, 2008, LEUKEMIA, V22, P1917, DOI 10.1038/leu.2008.188; Jerkeman M, 2002, INT J ONCOL, V20, P161; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Kluk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033813; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Kusumoto S, 2005, AM J SURG PATHOL, V29, P1067; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Meyer PN, 2011, J CLIN ONCOL, V29, P200, DOI 10.1200/JCO.2010.30.0368; MILLER TP, 1994, BLOOD, V83, P1460, DOI 10.1182/blood.V83.6.1460.1460; Moskowitz CH, 2005, BLOOD, V106, P3383, DOI 10.1182/blood-2005-04-1603; Muris JJF, 2006, J PATHOL, V208, P714, DOI 10.1002/path.1924; Natkunam Y, 2008, J CLIN ONCOL, V26, P447, DOI 10.1200/JCO.2007.13.0690; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; Niitsu N, 2007, LEUKEMIA RES, V31, P1191, DOI 10.1016/j.leukres.2006.11.004; Niitsu N, 2009, CANCER SCI, V100, P233, DOI 10.1111/j.1349-7006.2008.01035.x; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sagaert X, 2006, J CLIN ONCOL, V24, P2490, DOI 10.1200/JCO.2006.05.6150; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Stein H, 2008, WHO CLASSIFICATION T, V4th, P233; Valera A, 2013, HAEMATOLOGICA, V98, P1554, DOI 10.3324/haematol.2013.086173; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Visco C, 2013, HAEMATOLOGICA, V98, P255, DOI 10.3324/haematol.2012.066209; Vitolo U, 1998, ANN ONCOL, V9, P55, DOI 10.1023/A:1008201729596; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Zhang HW, 2011, HEMATOL ONCOL, V29, P185, DOI 10.1002/hon.991	55	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98169	10.1371/journal.pone.0098169	http://dx.doi.org/10.1371/journal.pone.0098169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887414	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300043
J	Martin, RNA; McGeehan, JE; Kneale, G				Martin, Richard N. A.; McGeehan, John E.; Kneale, Geoff			Structural and Mutagenic Analysis of the RM Controller Protein C.Esp1396I	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; TRANSCRIPTION REGULATION; EXPRESSION; ENDONUCLEASE; RECOGNITION; PROMOTER; SYMMETRY; C.AHDL; PVUII	Bacterial restriction-modification (RM) systems are comprised of two complementary enzymatic activities that prevent the establishment of foreign DNA in a bacterial cell: DNA methylation and DNA restriction. These two activities are tightly regulated to prevent over-methylation or auto-restriction. Many Type II RM systems employ a controller (C) protein as a transcriptional regulator for the endonuclease gene (and in some cases, the methyltransferase gene also). All high-resolution structures of C-protein/DNA-protein complexes solved to date relate to C.Esp1396I, from which the interactions of specific amino acid residues with DNA bases and/or the phosphate backbone could be observed. Here we present both structural and DNA binding data for a series of mutations to the key DNA binding residues of C.Esp1396I. Our results indicate that mutations to the backbone binding residues (Y37, S52) had a lesser affect on DNA binding affinity than mutations to those residues that bind directly to the bases (T36, R46), and the contributions of each side chain to the binding energies are compared. High-resolution X-ray crystal structures of the mutant and native proteins showed that the fold of the proteins was unaffected by the mutations, but also revealed variation in the flexible loop conformations associated with DNA sequence recognition. Since the tyrosine residue Y37 contributes to DNA bending in the native complex, we have solved the structure of the Y37F mutant protein/DNA complex by X-ray crystallography to allow us to directly compare the structure of the DNA in the mutant and native complexes.	[Martin, Richard N. A.; McGeehan, John E.; Kneale, Geoff] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Labs, Portsmouth, Hants, England	University of Portsmouth	Kneale, G (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Labs, Portsmouth, Hants, England.	geoff.kneale@port.ac.uk		McGeehan, John/0000-0002-6750-1462	Biotechnology and Biological Sciences Research Council [BB/H00680X/1]; University of Portsmouth; BBSRC [BB/H00680X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Portsmouth; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) for funding this research (research grant number BB/H00680X/1 to G. G. K. and J.E.M. and the University of Portsmouth for an IBBS studentship to N.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball N, 2009, ACTA CRYSTALLOGR D, V65, P900, DOI 10.1107/S0907444909020514; Ball NJ, 2012, NUCLEIC ACIDS RES, V40, P10532, DOI 10.1093/nar/gks718; Bogdanova E, 2008, NUCLEIC ACIDS RES, V36, P1429, DOI 10.1093/nar/gkm1116; Bogdanova E, 2009, NUCLEIC ACIDS RES, V37, P3354, DOI 10.1093/nar/gkp210; Cesnaviciene E, 2003, NUCLEIC ACIDS RES, V31, P743, DOI 10.1093/nar/gkg135; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; IVES CL, 1992, J BACTERIOL, V174, P7194, DOI 10.1128/jb.174.22.7194-7201.1992; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knowle D, 2005, J BACTERIOL, V187, P488, DOI 10.1128/JB.187.2.488-497.2005; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Leslie AGW, 1992, RECENT CHANGES MOSFL; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Martin RNA, 2013, ACTA CRYSTALLOGR F, V69, P962, DOI 10.1107/S174430911302126X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGeehan JE, 2012, NUCLEIC ACIDS RES, V40, P4158, DOI 10.1093/nar/gkr1250; McGeehan JE, 2006, J MOL BIOL, V358, P523, DOI 10.1016/j.jmb.2006.02.003; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; McGeehan JE, 2008, NUCLEIC ACIDS RES, V36, P4778, DOI 10.1093/nar/gkn448; Mruk I, 2008, NUCLEIC ACIDS RES, V36, P2581, DOI 10.1093/nar/gkn097; Mruk I, 2007, NUCLEIC ACIDS RES, V35, P6935, DOI 10.1093/nar/gkm837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; RIMSELIENE R, 1995, GENE, V157, P217; Streeter SD, 2004, NUCLEIC ACIDS RES, V32, P6445, DOI 10.1093/nar/gkh975; TAKEDA Y, 1992, P NATL ACAD SCI USA, V89, P8180, DOI 10.1073/pnas.89.17.8180; TAO T, 1991, J BACTERIOL, V173, P1367, DOI 10.1128/jb.173.4.1367-1375.1991; Vijesurier RM, 2000, J BACTERIOL, V182, P477, DOI 10.1128/JB.182.2.477-487.2000; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98365	10.1371/journal.pone.0098365	http://dx.doi.org/10.1371/journal.pone.0098365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887147	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300058
J	Sharma, N; Baron, JC				Sharma, Nikhil; Baron, Jean-Claude			Effects of Healthy Ageing on Activation Pattern within the Primary Motor Cortex during Movement and Motor Imagery: An fMRI Study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; SUBCORTICAL STROKE; HUMAN BRAIN; AREAS; MECHANISMS; SYSTEM; ADULTS; ACQUISITION; OPPOSITION; EXECUTION	The increase in older adults over the coming decades will be accompanied by a greater burden of chronic neurological diseases affecting the motor system. The motor system adapts to maintain motor performance with the primary motor cortex (BA4) emerging as a pivotal node within this neuroplastic process. Studies of ageing often consider BA4 a homogenous area but cytoarchitectonic studies have revealed two subdivisions, an anterior (BA4a) and posterior subdivision (BA4p). Here we focus upon the effects of ageing on the involvement of BA4a and BA4p during movement and motor imagery (MI). Thirty-one right-handed healthy volunteers were recruited and screened for their ability to perform imagery (5 subjects excluded). The sample was split into an older group (n = 13, mean age 56.4 SD 9.4) and a younger group (n = 13, mean age 27.4 SD 5.3). We used an fMRI block-design (auditory-paced [1 Hz] right hand finger-thumb opposition sequence [2,3,4,5, 2...]) with MI & rest and actual movement & rest. We explored the distribution-based clustering and weighted laterality index within BA4a and BA4p. The involvement of BA4p during MI (measured with distribution-based clustering) was significantly greater in the older group (p < 0.05) than in the younger group. Hemispheric balance of BA4p decreased with age during MI (Spearman rho 20.371; p < 0.05), whereas that of BA4a decreased with age during actual movement (Spearman rho = -0.458 p < 0.01). Irrespective of age, we found BA4 is involved during motor imagery, strengthening the rationale for its potential use in older subjects. These findings suggest that the functions of the subdivisions of BA4 are differentially affected by ageing and have implications regarding how ageing affects the cognitive processes underlying motor functions.	[Sharma, Nikhil; Baron, Jean-Claude] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Baron, Jean-Claude] Univ Paris, Hop St Anne, Ctr Psychiat & Neurosci, INSERM, F-75252 Paris, France	University of Cambridge; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sharma, N (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	ns358@cam.ac.uk		Sharma, Nikhil/0000-0001-8903-2938; baron, jean-claude/0000-0002-5264-2588	Brain Entry Scholarship; Stroke Association [TSA 2003/10]; Sackler Fellowship; Medical Research Council [MRC G0001219]; MRC [G0500874] Funding Source: UKRI; Medical Research Council [G0500874] Funding Source: researchfish	Brain Entry Scholarship; Stroke Association; Sackler Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NS is supported by a Brain Entry Scholarship, The Stroke Association (TSA 2003/10) & Sackler Fellowship. JCB is supported by the Medical Research Council (MRC G0001219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calautti C, 2001, STROKE, V32, P139, DOI 10.1161/01.STR.32.1.139; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1013, DOI 10.1016/S0197-4580(03)00030-7; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; DORFMAN LJ, 1979, NEUROLOGY, V29, P38, DOI 10.1212/WNL.29.1.38; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Friston KJ, 2006, STAT PARAMETRIC MAPP, P656; Gabbard C, 2011, ARCH GERONTOL GERIAT, V53, P206, DOI 10.1016/j.archger.2010.10.006; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Heremans E, 2011, NEUROREHAB NEURAL RE, V25, P168, DOI 10.1177/1545968310370750; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Hovington CL, 2010, NEUROREHAB NEURAL RE, V24, P851, DOI 10.1177/1545968310374190; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Malouin F, 2010, ARCH PHYS MED REHAB, V91, P1122, DOI 10.1016/j.apmr.2010.03.007; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Mulder T, 2007, HUM MOVEMENT SCI, V26, P203, DOI 10.1016/j.humov.2007.01.001; Naccarato M, 2006, NEUROIMAGE, V32, P1250, DOI 10.1016/j.neuroimage.2006.05.003; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sharma N, 2012, DEV PSYCHOBIOL, V54, P254, DOI 10.1002/dev.20508; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Simmons L, 2008, NEUROREHAB NEURAL RE, V22, P458, DOI 10.1177/1545968308315597; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Zapparoli L, 2013, EXP BRAIN RES, V224, P519, DOI 10.1007/s00221-012-3331-1; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	52	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e88443	10.1371/journal.pone.0088443	http://dx.doi.org/10.1371/journal.pone.0088443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887402	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300001
J	Wang, CH; Wang, JS; Liu, YQ; Guo, XL; Zhang, CQ				Wang, Chenghua; Wang, Jinshen; Liu, Yiqing; Guo, Xueliang; Zhang, Chunqing			MUC5AC Upstream Complex Repetitive Region Length Polymorphisms Are Associated with Susceptibility and Clinical Stage of Gastric Cancer	PLOS ONE			English	Article							TANDEM REPEATS POLYMORPHISM; VARIABLE NUMBER; MICROSATELLITE INSTABILITY; INSULIN GENE; MINISATELLITE; RISK; EXPRESSION; DNA; DEFICIENT; PROMOTER	MUC5AC was deemed to be involved in gastric carcinogenesis since aberrant MUC5AC expression has been repeatedly detected in patients with gastric cancer (GC). In this study, length polymorphisms in a complicated repetitive region adjacent to MUC5AC promoter were assessed in 230 patients with GC and 328 cancer-free controls. Alleles of 1.4 and 1.8 kb were significantly more prevalent in GC group than in controls. In contrast, 2.3 and 2.8 kb alleles occurred at significantly lower frequencies in patients than in controls. Alleles were then classified into susceptible (S; 1.4 and 1.8 kb), protective (P; 2.3 and 2.8 kb) and null (N; all other alleles) categories with respect to their linkage with the susceptibility to GC. Individuals with genotype SS had a 2.7-fold increased risk of GC occurrence, but PN genotype was associated with a significantly reduced risk of this cancer. Moreover, homozygous or heterozygous individuals with one or two copies of 1.4 kb allele showed an earlier age of onset and more advanced metastasis stage compared with patients without this allele (Bonferroni corrected p = 1.35 x 10(-4) and 6.60 x 10(-4) accordingly), whereas homozygous patients with two copies of 1.8 kb allele were linked to less advanced GC TNM stage. Our results suggest that certain genetic variations in MUC5AC upstream repetitive region are associated with the susceptibility and progression of GC.	[Wang, Chenghua] Shandong Univ, Dept Emergency Ctr, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Jinshen] Shandong Univ, Dept Gen Surg, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Liu, Yiqing] Shandong Univ, Dept Lab Med, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Guo, Xueliang] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Zhang, Chunqing] Shandong Univ, Dept Gastroenterol, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of North Carolina; University of North Carolina Chapel Hill; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhang, CQ (corresponding author), Shandong Univ, Dept Gastroenterol, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China.	zhangchunqing_sdu@163.com			National Natural Science Foundation of China [81370590]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China to Innovation Research Group (No. 81370590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour JAL, 2006, MUTAT RES-FUND MOL M, V598, P6, DOI 10.1016/j.mrfmmm.2006.01.013; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Coleman MG, 2001, BRIT J CANCER, V85, P1486, DOI 10.1054/bjoc.2001.2058; CORREA P, 1994, CANCER RES, V54, pS1941; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Guo X, 2013, AM J RESP CELL MOL B; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; HO SB, 1995, CANCER RES, V55, P2681; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Inamori H, 2002, JPN J CANCER RES, V93, P382, DOI 10.1111/j.1349-7006.2002.tb01268.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001163; Jin GA, 2011, CANCER SCI, V102, P144, DOI 10.1111/j.1349-7006.2010.01782.x; Kim SM, 2014, INT J CANCER, V134, P114, DOI 10.1002/ijc.28345; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; Kocer B, 2004, DIGEST DIS SCI, V49, P954, DOI 10.1023/B:DDAS.0000034554.96191.66; Lee HS, 2001, CANCER, V92, P1427, DOI 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lopes J, 2002, EMBO J, V21, P3201, DOI 10.1093/emboj/cdf310; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Ninomiya H, 2006, BRIT J CANCER, V94, P1485, DOI 10.1038/sj.bjc.6603121; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; THEIN SL, 1987, BRIT J CANCER, V55, P353, DOI 10.1038/bjc.1987.71; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wang HJ, 2008, CANCER SCI, V99, P787, DOI 10.1111/j.1349-7006.2008.00729.x; Wang JY, 2003, J SURG ONCOL, V83, P253, DOI 10.1002/jso.10222; Waterworth DM, 1997, LANCET, V349, P986, DOI 10.1016/S0140-6736(96)08368-7; Xiang C, 2012, CANCER SCI, V103, P1121, DOI 10.1111/j.1349-7006.2012.02266.x	34	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98327	10.1371/journal.pone.0098327	http://dx.doi.org/10.1371/journal.pone.0098327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887023	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300053
J	Zheng, Y; Wang, QH; Yun, CX; Wang, YJ; Smith, WW; Leng, J				Zheng, Yu; Wang, Qihui; Yun, Chenxia; Wang, Yingjun; Smith, Wanli W.; Leng, Jing			Identification of Glyceraldehyde 3-Phosphate Dehydrogenase Sequence and Expression Profiles in Tree Shrew (Tupaia belangeri)	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HOUSEKEEPING GENES; ANIMAL-MODELS; IN-VITRO; INFECTION; NORMALIZATION; TIMESCALE	The tree shrews (Tupaia belangeri) diverged from the primate order (Primates) and are classified as Scandentia, a separate taxonomic group of mammals. The tree shrew has been suggested to use an animal model to study human disease but the genomic sequences of tree shrew is largely unidentified. Here we identified the full-length cDNA sequence of a housekeeping gene, Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH), in tree shrew. We further constructed a phylogenetic family tree base on GAPDH molecules of various organisms and compared GAPDH sequences with human and other small experimental animals. These study revealed that tree shrew was closer to human than mouse, rat, rabbit and guinea pig. The Quantitative Reverse Transcription PCR and western blot analysis further demonstrated that GAPDH expressed in various tissues in tree shrew as a general conservative housekeeping proteins as in human. Our findings provide the novel genetic knowledge of the tree shrew and strong evidences that tree shrew can be an experimental model system to study human disorders.	[Zheng, Yu; Yun, Chenxia; Leng, Jing] Guangxi Univ Chinese Med, Dept Microbiol & Immunol, Nanning, Guangxi, Peoples R China; [Wang, Qihui; Wang, Yingjun] Guangxi Med Univ, Dept Immunol, Nanning, Guangxi, Peoples R China; [Leng, Jing] Guangxi Univ Chinese Med, Nanning, Guangxi, Peoples R China; [Smith, Wanli W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Guangxi University of Chinese Medicine; Guangxi Medical University; Guangxi University of Chinese Medicine; University System of Maryland; University of Maryland Baltimore	Leng, J (corresponding author), Guangxi Univ Chinese Med, Dept Microbiol & Immunol, Nanning, Guangxi, Peoples R China.	jingleng.gx@hotmail.com	Zheng, Yu/ABE-4364-2020	Zheng, Yu/0000-0003-0400-3615	National Natural Science Foundation of China [31160190]; Guangxi Department of Science and Technology [GKG1140003B51, GKG13470036]; Guangxi Department of Education [GJKY[2003]8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Department of Science and Technology; Guangxi Department of Education	Grant number: 31160190, the National Natural Science Foundation of China, http://www.nsfc.gov.cn; Grant number: GKG1140003B51, the Guangxi Department of Science and Technology, http://www.gxst.gov.cn; Grant number: GKG13470036, the Guangxi Department of Science and Technology, http://www.gxst.gov.cn; Grant number: GJKY[2003]8, the Guangxi Department of Education, http://www.gxedu.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao J, 2003, J MED PRIMATOL, V32, P123, DOI 10.1034/j.1600-0684.2003.00022.x; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Flugge P, 2002, IMMUNOGENETICS, V53, P984, DOI 10.1007/s00251-001-0401-0; Fuchs E., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P262; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Kimball S, 1995, GIMP GNU IMAGE MANIP; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lu HZ, 2002, MOL THER, V6, P783, DOI 10.1006/mthe.2002.0813; MacArthur KL, 2012, WORLD J GASTROENTERO, V18, P2909, DOI 10.3748/wjg.v18.i23.2909; Mendiburu F, 2013, AGRICOLAE STAT PROCE; Palamalai V, 2010, PROTEIN SCI, V19, P255, DOI 10.1002/pro.311; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts TE, 2011, MOL PHYLOGENET EVOL, V60, P358, DOI 10.1016/j.ympev.2011.04.021; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; SCHWAIER A, 1979, RES EXP MED, V176, P15, DOI 10.1007/BF01852107; Shimada A., 1973, Experimental Anim, V22, P351; Song SY, 1999, J MOL BIOL, V287, P719, DOI 10.1006/jmbi.1999.2628; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; The Inkscape Team, 2012, INKSC OP SOURC VECT; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Walter E, 1996, HEPATOLOGY, V24, P1, DOI 10.1002/hep.510240101; Wickham H., 2012, SCALES SCALE FUNCTIO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie ZC, 1998, VIROLOGY, V244, P513, DOI 10.1006/viro.1998.9127; Yan RQ, 1996, J CANCER RES CLIN, V122, P283, DOI 10.1007/BF01261404; Yang EB, 2005, HEPATO-GASTROENTEROL, V52, P613; Yang ZX, 2013, J APPL MATH, DOI 10.1155/2013/367107; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zhang XH, 2013, GENE, V522, P147, DOI 10.1016/j.gene.2013.03.113	38	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98552	10.1371/journal.pone.0098552	http://dx.doi.org/10.1371/journal.pone.0098552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887411	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300081
J	Lai, DM; Wang, FY; Dong, ZL; Zhang, QW				Lai, Dongmei; Wang, Fangyuan; Dong, Zhangli; Zhang, Qiuwan			Skin-Derived Mesenchymal Stem Cells Help Restore Function to Ovaries in a Premature Ovarian Failure Mouse Model	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; BONE-MARROW; PORCINE SKIN; GENE-EXPRESSION; GERM-CELLS; CHEMOTHERAPY; FERTILITY; OOCYTES; MARKER; MICE	Skin-derived mesenchymal stem cells (SMSCs) can differentiate into the three embryonic germ layers. For this reason, they are considered a powerful tool for therapeutic cloning and offer new possibilities for tissue therapy. Recent studies showed that skin-derived stem cells can differentiate into cells expressing germ-cell specific markers in vitro and form oocytes in vivo. The idea that SMSCs may be suitable for the treatment of intractable diseases or traumatic tissue damage has attracted attention. To determine the ability of SMSCs to reactivate injured ovaries, a mouse model with ovaries damaged by busulfan and cyclophosphamide was developed and is described here. Female skin-derived mesenchymal stem cells (F-SMSCs) and male skin-derived mesenchymal stem cells (M-SMSCs) from red fluorescence protein (RFP) transgenic adult mice were used to investigate the restorative effects of SMSCs on ovarian function. Significant increases in total body weight and the weight of reproductive organs were observed in the treated animals. Both F-SMSCs and M-SMSCs were shown to be capable of partially restoring fertility in chemotherapy-treated females. Immunostaining with RFP and anti-Mullerian hormone (AMH) antibodies demonstrated that the grafted SMSCs survived, migrated to the recipient ovaries. After SMSCs were administered to the treated mice, real-time PCR showed that the expression levels of pro-inflammatory cytokines TNF-alpha, TGF-beta, IL-8, IL-6, IL-1 beta, and IFN gamma were significantly lower in the ovaries than in the untreated controls. Consistent with this observation, expression of oogenesis marker genes Nobox, Nanos3, and Lhx8 increased in ovaries of SMSCs-treated mice. These findings suggest that SMSCs may play a role within the ovarian follicle microenvironment in restoring the function of damaged ovaries and could be useful in reproductive health.	[Lai, Dongmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Ctr Res Lab, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Gynecol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lai, DM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Ctr Res Lab, Shanghai 200030, Peoples R China.	laidongmei@hotmail.com			Shanghai Municipal Health Bureau, Shanghai, China [XBR2011069]; NSFC (National Natural Science Foundation of China) [81070533, 81370678]; Shanghai Municipal Council for Science and Technology [12431902201]	Shanghai Municipal Health Bureau, Shanghai, China; NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Council for Science and Technology	This work was supported by grants from Shanghai Municipal Health Bureau, Shanghai, China (No. XBR2011069), the NSFC (National Natural Science Foundation of China, No. 81070533 & No. 81370678), Shanghai Municipal Council for Science and Technology (No. 12431902201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenfeld Z, 2012, BEST PRACT RES CL OB, V26, P379, DOI 10.1016/j.bpobgyn.2011.11.008; Bukovsky A, 2011, ANAT REC, V294, P1284, DOI 10.1002/ar.21422; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Dyce PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020339; Dyce PW, 2011, STEM CELLS DEV, V20, P809, DOI 10.1089/scd.2010.0395; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Flaws JA, 2001, BIOL REPROD, V64, P1153, DOI 10.1095/biolreprod64.4.1153; Fleischer RT, 2011, OBSTET GYNECOL SURV, V66, P248, DOI 10.1097/OGX.0b013e318224e97b; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hoffman GE, 2012, J HISTOCHEM CYTOCHEM, V60, P439, DOI 10.1369/0022155412441002; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kroeze KL, 2009, J INVEST DERMATOL, V129, P1569, DOI 10.1038/jid.2008.405; Lai DM, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-34; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Liu X, 2013, DEV GENES EVOL, V223, P269, DOI 10.1007/s00427-013-0441-0; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Park MR, 2013, SCI REP, V3, P1; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Qiu ZF, 2010, STEM CELLS DEV, V19, P259, DOI 10.1089/scd.2009.0058; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Russell DL, 2007, HUM REPROD UPDATE, V13, P289, DOI 10.1093/humupd/dml062; Santiquet N, 2012, CELL REPROGRAM, V14, P123, DOI 10.1089/cell.2011.0066; Takehara Y, 2013, LAB INVEST, V93, P181, DOI 10.1038/labinvest.2012.167; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Utsunomiya T, 2008, INT J ONCOL, V32, P991; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071	33	56	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98749	10.1371/journal.pone.0098749	http://dx.doi.org/10.1371/journal.pone.0098749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879098	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500083
J	Li, C; Yang, XL; He, J; Hixson, JE; Gu, DF; Rao, DC; Shimmin, LC; Huang, JF; Gu, CC; Chen, JC; Li, JX; Kelly, TN				Li, Changwei; Yang, Xueli; He, Jiang; Hixson, James E.; Gu, Dongfeng; Rao, Dabeeru C.; Shimmin, Lawrence C.; Huang, Jianfeng; Gu, Charles C.; Chen, Jichun; Li, Jianxin; Kelly, Tanika N.			A Gene-Based Analysis of Variants in the Serum/Glucocorticoid Regulated Kinase (SGK) Genes with Blood Pressure Responses to Sodium Intake: The GenSalt Study	PLOS ONE			English	Article							SERUM; HERITABILITY	Background: Serum and glucocorticoid regulated kinase (SGK) plays a critical role in the regulation of renal sodium transport. We examined the association between SGK genes and salt sensitivity of blood pressure (BP) using single-marker and gene-based association analysis. Methods: A 7-day low-sodium (51.3 mmol sodium/day) followed by a 7-day high-sodium intervention (307.8 mmol sodium/day) was conducted among 1,906 Chinese participants. BP measurements were obtained at baseline and each intervention using a random-zero sphygmomanometer. Additive associations between each SNP and salt-sensitivity phenotypes were assessed using a mixed linear regression model to account for family dependencies. Gene-based analyses were conducted using the truncated p-value method. The Bonferroni-method was used to adjust for multiple testing in all analyses. Results: In single-marker association analyses, SGK1 marker rs2758151 was significantly associated with diastolic BP (DBP) response to high-sodium intervention (P = 0.0010). DBP responses (95% confidence interval) to high-sodium intervention for genotypes C/C, C/T, and T/T were 2.04 (1.57 to 2.52), 1.79 (1.42 to 2.16), and 0.85 (0.30 to 1.41) mmHg, respectively. Similar trends were observed for SBP and MAP responses although not significant (P= 0.15 and 0.0026, respectively). In addition, gene-based analyses demonstrated significant associations between SGK1 and SBP, DBP and MAP responses to high sodium intervention (P= 0.0002, 0.0076, and 0.00001, respectively). Neither SGK2 nor SGK3 were associated with the salt-sensitivity phenotypes in single-maker or gene-based analyses. Conclusions: The current study identified association of the SGK1 gene and BP salt-sensitivity in the Han Chinese population. Further studies are warranted to identify causal SGK1 gene variants.	[Li, Changwei; He, Jiang; Kelly, Tanika N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Yang, Xueli; Gu, Dongfeng; Huang, Jianfeng; Chen, Jichun; Li, Jianxin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yang, Xueli; Gu, Dongfeng; Huang, Jianfeng; Chen, Jichun; Li, Jianxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Hixson, James E.; Shimmin, Lawrence C.] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Rao, Dabeeru C.; Gu, Charles C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA	Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tulane University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Washington University (WUSTL)	Kelly, TN (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	tkelly@tulane.edu	He, Jiang/AAF-5303-2020; Li, Changwei/S-5615-2016; Yang, Xueli/AAW-4792-2021; Gu, C. Charles/A-7934-2010	He, Jiang/0000-0002-8286-9652; Li, Changwei/0000-0002-9203-304X; Gu, C. Charles/0000-0002-8527-8145; Hixson, James/0000-0002-0849-9315	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD [U01HL072507, R01HL087263, R01HL090682]; American Heart Association [11SDG5130026]; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090682, U01HL072507, R01HL087263] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) is supported by a cooperative agreement project grant (U01HL072507, R01HL087263, and R01HL090682) from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD. https://www.nhlbi.nih.gov/Drs Tanika Kelly and Changwei Li are supported by American Heart Association award number 11SDG5130026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Faresse N, 2012, AM J PHYSIOL-RENAL, V302, pF977, DOI 10.1152/ajprenal.00535.2011; Gu DF, 2007, HYPERTENSION, V50, P116, DOI 10.1161/HYPERTENSIONAHA.107.088310; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; Kelly TN, 2012, J HYPERTENS, V30, P861, DOI 10.1097/HJH.0b013e3283524949; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Luft FC, 1997, AM J CLIN NUTR, V65, P612; McCormick JA, 2004, MOL BIOL CELL, V15, P4278, DOI 10.1091/mbc.E04-01-0027; MILLER JZ, 1987, AM J EPIDEMIOL, V126, P822, DOI 10.1093/oxfordjournals.aje.a114719; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Pao AC, 2012, CURR OPIN NEPHROL HY, V21, P534, DOI 10.1097/MNH.0b013e32835571be; Perkins EA, 2012, ARTHRITIS RHEUM-US, V64, P1355, DOI 10.1002/art.33464; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Quiroz Y, 2012, NEPHROL DIAL TRANSPL, V27, piv2, DOI 10.1093/ndt/gfs421; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V295, pF1440, DOI 10.1152/ajprenal.90239.2008; Rao AD, 2013, J HUM HYPERTENS, V27, P176, DOI 10.1038/jhh.2012.22; Schnackenberg CG, 2007, FASEB J, V21, pA508; Sheng X, 2012, OXF B EC ST IN PRESS; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang YZ, 2011, MOL ENDOCRINOL, V25, P72, DOI 10.1210/me.2010-0294; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393	33	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98432	10.1371/journal.pone.0098432	http://dx.doi.org/10.1371/journal.pone.0098432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878720	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500057
J	Peace, JM; Ter-Zakarian, A; Aparicio, OM				Peace, Jared M.; Ter-Zakarian, Anna; Aparicio, Oscar M.			Rif1 Regulates Initiation Timing of Late Replication Origins throughout the S-cerevisiae Genome	PLOS ONE			English	Article							CONTROLS DNA-REPLICATION; PROTEIN PHOSPHATASE 1; CELL-CYCLE; TELOMERE LENGTH; S-PHASE; YEAST; PHOSPHORYLATION; HETEROCHROMATIN; KINASE; ACTIVATION	Chromosomal DNA replication involves the coordinated activity of hundreds to thousands of replication origins. Individual replication origins are subject to epigenetic regulation of their activity during S-phase, resulting in differential efficiencies and timings of replication initiation during S-phase. This regulation is thought to involve chromatin structure and organization into timing domains with differential ability to recruit limiting replication factors. Rif1 has recently been identified as a genome-wide regulator of replication timing in fission yeast and in mammalian cells. However, previous studies in budding yeast have suggested that Rif1' s role in controlling replication timing may be limited to subtelomeric domains and derives from its established role in telomere length regulation. We have analyzed replication timing by analyzing BrdU incorporation genome-wide, and report that Rif1 regulates the timing of late/ dormant replication origins throughout the S. cerevisiae genome. Analysis of pfa4 Delta cells, which are defective in palmitoylation and membrane association of Rif1, suggests that replication timing regulation by Rif1 is independent of its role in localizing telomeres to the nuclear periphery. Intra-S checkpoint signaling is intact in rif1 Delta cells, and checkpoint-defective mec1 Delta cells do not comparably deregulate replication timing, together indicating that Rif1 regulates replication timing through a mechanism independent of this checkpoint. Our results indicate that the Rif1 mechanism regulates origin timing irrespective of proximity to a chromosome end, and suggest instead that telomere sequences merely provide abundant binding sites for proteins that recruit Rif1. Still, the abundance of Rif1 binding in telomeric domains may facilitate Rif1-mediated repression of non-telomeric origins that are more distal from centromeres.	[Peace, Jared M.; Aparicio, Oscar M.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Ter-Zakarian, Anna] Univ So Calif, Keck Sch Med, Program Global Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Aparicio, OM (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	oaparici@usc.edu		Aparicio, Oscar/0000-0002-5591-0277	National Institutes of Health grant [5R01-GM065494];  [P50-HG002790]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065494] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grant 5R01-GM065494 (to OMA) and JMP received support from P50-HG002790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Bell SP, 2013, COLD SPRING HARB PER, V5; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; Dunham Joseph P, 2013, Cold Spring Harb Protoc, V2013, P820, DOI 10.1101/pdb.prot074187; Gibson DG, 2004, MOL CELL BIOL, V24, P10208, DOI 10.1128/MCB.24.23.10208-10222.2004; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Herrick J, 2011, EVOLUTION, V65, P3031, DOI 10.1111/j.1558-5646.2011.01407.x; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Knott SRV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-305; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Kumar R, 2014, DNA REPAIR AMST; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PC, 2011, CELL CYCLE, V10, P323, DOI 10.4161/cc.10.2.14552; Lian HY, 2011, MOL BIOL CELL, V22, P1753, DOI 10.1091/mbc.E10-06-0549; Marcand S, 1998, CIBA F SYMP, V211, P76; Marcand S, 1997, CIBA F SYMP, V211, P93103; Mattarocci S, 2014, CELL REP, V7, P62, DOI 10.1016/j.celrep.2014.03.010; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Park S, 2011, P NATL ACAD SCI USA, V108, P14572, DOI 10.1073/pnas.1105262108; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pohl TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002677; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Siow CC, 2012, NUCLEIC ACIDS RES, V40, pD682, DOI 10.1093/nar/gkr1091; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Stark R., 2011, R PACKAGE VERSION; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Viggiani CJ, 2010, COLD SPRING HARB PRO, V2010; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xue Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002417; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	54	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98501	10.1371/journal.pone.0098501	http://dx.doi.org/10.1371/journal.pone.0098501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879017	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500063
J	Sluka, SHM; Akhmedov, A; Vogel, J; Unruh, D; Bogdanov, VY; Camici, GG; Luscher, TF; Ruf, W; Tanner, FC				Sluka, Susanna H. M.; Akhmedov, Alexander; Vogel, Johannes; Unruh, Dusten; Bogdanov, Vladimir Y.; Camici, Giovanni G.; Luescher, Thomas F.; Ruf, Wolfram; Tanner, Felix C.			Alternatively Spliced Tissue Factor Is Not Sufficient for Embryonic Development	PLOS ONE			English	Article							THROMBIN RECEPTOR; MICE; ANGIOGENESIS; COAGULATION; PROCOAGULANT; CONTRIBUTES; ACTIVATION; MECHANISMS; LETHALITY; GROWTH	Tissue factor (TF) triggers blood coagulation and is translated from two mRNA splice isoforms, encoding membrane-anchored full-length TF (flTF) and soluble alternatively-spliced TF (asTF). The complete knockout of TF in mice causes embryonic lethality associated with failure of the yolk sac vasculature. Although asTF plays roles in postnatal angiogenesis, it is unknown whether it activates coagulation sufficiently or makes previously unrecognized contributions to sustaining integrity of embryonic yolk sac vessels. Using gene knock-in into the mouse TF locus, homozygous asTF knock-in (asTFKI) mice, which express murine asTF in the absence of flTF, exhibited embryonic lethality between day 9.5 and 10.5. Day 9.5 homozygous asTFKI embryos expressed asTF protein, but no procoagulant activity was detectable in a plasma clotting assay. Although the alpha-smooth-muscle-actin positive mesodermal layer as well as blood islands developed similarly in day 8.5 wild-type or homozygous asTFKI embryos, erythrocytes were progressively lost from disintegrating yolk sac vessels of asTFKI embryos by day 10.5. These data show that in the absence of flTF, asTF expressed during embryonic development has no measurable procoagulant activity, does not support embryonic vessel stability by non-coagulant mechanisms, and fails to maintain a functional vasculature and embryonic survival.	[Sluka, Susanna H. M.; Akhmedov, Alexander; Camici, Giovanni G.; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Sluka, Susanna H. M.; Akhmedov, Alexander; Vogel, Johannes; Camici, Giovanni G.; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Vogel, Johannes] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Unruh, Dusten; Bogdanov, Vladimir Y.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA; [Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University System of Ohio; University of Cincinnati; University of Zurich; University Zurich Hospital; Scripps Research Institute	Tanner, FC (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	felix.tanner@access.uzh.ch	Camici, Giovanni/H-1631-2018; Akhmedov, Anvarjon Akhatjonovich/AGR-5386-2022	Camici, Giovanni/0000-0002-0523-0695; Akhmedov, Anvarjon Akhatjonovich/0000-0002-4307-7281; Unruh, Dusten/0000-0003-1027-1982; Sluka, Susanna/0000-0001-9051-8492; Bogdanov, Vladimir/0000-0003-4968-1129; Vogel, Johannes/0000-0003-4181-4521	Swiss National Research Foundation [SNF 3100-06811802/1]; Swiss Heart Foundation; NIH [HL-60742]; Pfizer, Inc., New York, United States of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060742] Funding Source: NIH RePORTER	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss Heart Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer, Inc., New York, United States of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Swiss National Research Foundation (SNF 3100-06811802/1 to TFL), the Swiss Heart Foundation (to FCT), NIH grant HL-60742 (to WR), and a strategic research alliance with Pfizer, Inc., New York, United States of America (to TFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boing AN, 2009, J THROMB HAEMOST, V7, P1423, DOI 10.1111/j.1538-7836.2009.03521.x; Bogdanov VY, 2006, J THROMB HAEMOST, V4, P158, DOI 10.1111/j.1538-7836.2005.01680.x; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Censarek P, 2007, THROMB HAEMOSTASIS, V97, P11, DOI 10.1160/TH06-09-0524; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Godby RC, 2012, MOL MED, V18, P771, DOI 10.2119/molmed.2011.00416; Mackman N, 2007, THROMB HAEMOSTASIS, V97, P5, DOI 10.1160/TH06-11-0670; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2002, P NATL ACAD SCI USA, V99, P15333, DOI 10.1073/pnas.242501899; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Signaevsky M, 2008, SEMIN THROMB HEMOST, V34, P161, DOI 10.1055/s-2008-1079256; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Szotowski B, 2005, CIRC RES, V96, P1233, DOI 10.1161/01.RES.0000171805.24799.fa; Toomey JR, 1996, BLOOD, V88, P1583; Unruh D, 2014, INT J CANCER, V134, P9, DOI 10.1002/ijc.28327; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; van den Berg YW, 2009, P NATL ACAD SCI USA, V106, P19497, DOI 10.1073/pnas.0905325106; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Zhu T, 2011, AM J PHYSIOL-REG I, V300, pR577, DOI 10.1152/ajpregu.00137.2010	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97793	10.1371/journal.pone.0097793	http://dx.doi.org/10.1371/journal.pone.0097793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879059	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000338101500024
J	Curran, SA; Hollan, I; Erridge, C; Lappin, DF; Murray, CA; Sturfelt, G; Mikkelsen, K; Forre, OT; Almdahl, SM; Fagerhol, MK; Goodyear, CS; Riggio, MP				Curran, Samuel A.; Hollan, Ivana; Erridge, Clett; Lappin, David F.; Murray, Colin A.; Sturfelt, Gunnar; Mikkelsen, Knut; Forre, Oystein T.; Almdahl, Sven M.; Fagerhol, Magne K.; Goodyear, Carl S.; Riggio, Marcello P.			Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis	PLOS ONE			English	Article							STENOTROPHOMONAS-MALTOPHILIA; ATHEROSCLEROTIC LESIONS; PSEUDOMONAS-MESOPHILICA; SYSTEMIC INFLAMMATION; CORONARY-ARTERIES; INFECTION; METHYLOBACTERIUM; PROTEIN; PATHOGEN; RISK	The incidence of atherosclerosis is significantly increased in rheumatoid arthritis (RA). Infection is one factor that may be involved in the pathogenesis of both diseases. The cause of RA and atherosclerosis is unknown, and infection is one of the factors that may be involved in the pathogenesis of both diseases. The aims of this study were to identify bacteria in the aortic adventitia of patients with cardiovascular disease (CVD) in the presence and absence of RA, and to determine the effect of identified candidate pathogens on Toll-like receptor (TLR)-dependent signalling and the proinflammatory response. The aortic adventitia of 11 CVD patients with RA (RA+CVD) and 11 CVD patients without RA (CVD) were collected during coronary artery bypass graft surgery. Bacteria were detected in four samples from CVD patients and three samples from RA+CVD patients and identified by 16S rRNA gene sequencing. Methylobacterium oryzae was identified in all three RA+CVD samples, representing 44.1% of the bacterial flora. The effect of M. oryzae on TLR-dependent signalling was determined by transfection of HEK-293 cells. Although mild TLR2 signalling was observed, TLR4 was insensitive to M. oryzae. Human primary macrophages were infected with M. oryzae, and a TLDA qPCR array targeting 90 genes involved in inflammation and immune regulation was used to profile the transcriptional response. A significant proinflammatory response was observed, with many of the up-regulated genes encoding proinflammatory cytokines (IL-1 alpha, IL-1 beta, IL-6, TNF-alpha) and chemokines (CCR7, IL-8). The aortic adventitia of CVD patients contains a wide range of bacterial species, and the bacterial flora is significantly less diverse in RA+CVD than CVD patients. M. oryzae may stimulate an proinflammatory response that may aggravate and perpetuate the pathological processes underlying atherosclerosis in RA patients.	[Curran, Samuel A.; Lappin, David F.; Murray, Colin A.; Riggio, Marcello P.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Hollan, Ivana] Hosp Rheumat Dis, Lillehammer, Norway; [Hollan, Ivana] Feiring Heart Clin, Feiring, Norway; [Erridge, Clett] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Sturfelt, Gunnar] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden; [Mikkelsen, Knut] Hosp Rheumat Dis, Lillehammer, Norway; [Forre, Oystein T.] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway; [Almdahl, Sven M.] Univ Hosp North Norway, Dept Surg, Tromso, Norway; [Fagerhol, Magne K.] Ullevaal Univ Hosp, Dept Immunol & Transfus Med, Oslo, Norway; [Goodyear, Carl S.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Lund University; Skane University Hospital; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Glasgow	Goodyear, CS (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Carl.Goodyear@glasgow.ac.uk; Marcello.Riggio@glasgow.ac.uk		Erridge, Clett/0000-0003-2978-346X; Goodyear, Carl/0000-0001-5926-5941; Fagerhol, Magne Kristoffer/0000-0002-5103-6981	Medical Research Council (United Kingdom); Versus Arthritis [19701] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	This study was funded a PhD scholarship from Medical Research Council (United Kingdom) and administered through the University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Au K, 2011, ANN RHEUM DIS, V70, P785, DOI 10.1136/ard.2010.128637; Aubry MC, 2004, CARDIOVASC PATHOL, V13, P233, DOI 10.1016/j.carpath.2004.02.005; BRUN JG, 1992, J RHEUMATOL, V19, P859; Chiu B, 1997, CIRCULATION, V96, P2144; da Silva RM, 2006, J VASC SURG, V44, P1055, DOI 10.1016/j.jvs.2006.07.021; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Deniset JF, 2010, AM J PATHOL, V176, P1028, DOI 10.2353/ajpath.2010.090645; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Eue I, 2000, ATHEROSCLEROSIS, V151, P593, DOI 10.1016/S0021-9150(00)00476-7; GILARDI GL, 1984, J CLIN MICROBIOL, V20, P626, DOI 10.1128/JCM.20.4.626-629.1984; GILCHRIST MJR, 1986, J CLIN MICROBIOL, V23, P1052, DOI 10.1128/JCM.23.6.1052-1055.1986; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hollan I, 2007, ARTHRITIS RHEUM, V56, P2072, DOI 10.1002/art.22690; Jonsson G, 2007, RHEUMATOLOGY, V46, P1133, DOI 10.1093/rheumatology/kem023; KAYE KM, 1992, CLIN INFECT DIS, V14, P1010, DOI 10.1093/clinids/14.5.1010; Lehtiniemi J, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01440.x; Liu JW, 1997, CLIN INFECT DIS, V24, P1008, DOI 10.1093/clinids/24.5.1008; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Madhaiyan M, 2007, INT J SYST EVOL MICR, V57, P326, DOI 10.1099/ijs.0.64603-0; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Park YS, 2008, AM J INFECT CONTROL, V36, P29, DOI 10.1016/j.ajic.2006.12.013; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rolston KVI, 2005, DIAGN MICR INFEC DIS, V51, P215, DOI 10.1016/j.diagmicrobio.2004.11.002; Sanders JW, 2000, CLIN INFECT DIS, V30, P936, DOI 10.1086/313815; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Scher JU, 2011, ARTHRITIS RHEUM-US, V63, pS985; Shah PK, 2001, CIRCULATION, V103, P5; Snow MH, 2005, CURR OPIN RHEUMATOL, V17, P234; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Toyofuku T, 2011, SURG TODAY, V41, P1395, DOI 10.1007/s00595-010-4496-5; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Weyand Cornelia M., 1999, Current Opinion in Rheumatology, V11, P210, DOI 10.1097/00002281-199905000-00010; Windhorst S, 2002, J BIOL CHEM, V277, P11042, DOI 10.1074/jbc.M109525200; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Young JL, 2002, THROMB HAEMOSTASIS, V88, P554, DOI 10.1055/s-0037-1613256	41	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98627	10.1371/journal.pone.0098627	http://dx.doi.org/10.1371/journal.pone.0098627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874661	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000336790800053
J	Kuc, S; Koster, MPH; Pennings, JLA; Hankemeier, T; Berger, R; Harms, AC; Dane, AD; Schielen, PCJI; Visser, GHA; Vreeken, RJ				Kuc, Sylwia; Koster, Maria P. H.; Pennings, Jeroen L. A.; Hankemeier, Thomas; Berger, Ruud; Harms, Amy C.; Dane, Adrie D.; Schielen, Peter C. J. I.; Visser, Gerard H. A.; Vreeken, Rob J.			Metabolomics Profiling for Identification of Novel Potential Markers in Early Prediction of Preeclampsia	PLOS ONE			English	Article							AMINO-ACID-CONCENTRATIONS; LOW-PROTEIN DIET; ASYMMETRIC DIMETHYLARGININE; 1ST-TRIMESTER PREDICTION; PLASMA HOMOCYSTEINE; BLOOD-PRESSURE; TAURINE; HYPERTENSION; CANCER; WOMEN	Objective: The first aim was to investigate specific signature patterns of metabolites that are significantly altered in first-trimester serum of women who subsequently developed preeclampsia (PE) compared to healthy pregnancies. The second aim of this study was to examine the predictive performance of the selected metabolites for both early onset [EO-PE] and late onset PE [LO-PE]. Methods: This was a case-control study of maternal serum samples collected between 8+0 and 13+6 weeks of gestation from 167 women who subsequently developed EO-PE n = 68; LO-PE n = 99 and 500 controls with uncomplicated pregnancies. Metabolomics profiling analysis was performed using two methods. One has been optimized to target eicosanoids/oxylipins, which are known inflammation markers and the other targets compounds containing a primary or secondary biogenic amine group. Logistic regression analyses were performed to predict the development of PE using metabolites alone and in combination with first trimester mean arterial pressure (MAP) measurements. Results: Two metabolites were significantly different between EO-PE and controls (taurine and asparagine) and one in case of LO-PE (glycylglycine). Taurine appeared the most discriminative biomarker and in combination with MAP predicted EO-PE with a detection rate (DR) of 55%, at a false-positive rate (FPR) of 10%. Conclusion: Our findings suggest a potential role of taurine in both PE pathophysiology and first trimester screening for EO-PE.	[Kuc, Sylwia; Koster, Maria P. H.; Visser, Gerard H. A.] UMCU, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands; [Pennings, Jeroen L. A.] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands; [Hankemeier, Thomas; Berger, Ruud; Vreeken, Rob J.] Leiden Univ, Div Analyt Biosci, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Hankemeier, Thomas; Berger, Ruud; Harms, Amy C.; Dane, Adrie D.; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening LIS, Bilthoven, Netherlands	Unilever; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment	Kuc, S (corresponding author), UMCU, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands.	S.Kuc@umcutrecht.nl	Vreeken, Rob/AAA-4563-2021; Hankemeier, Thomas/V-5407-2019; Schielen, Peter/AAP-4539-2020	Hankemeier, Thomas/0000-0001-7871-2073; Vreeken, Rob/0000-0003-3568-1371; Harms, Amy/0000-0002-2931-4295; Pennings, Jeroen L.A./0000-0002-9188-6358	Netherlands Metabolomics Centre (NMC) part of The Netherlands Genomics Initiative/Netherlands; Organization for Scientific Research	Netherlands Metabolomics Centre (NMC) part of The Netherlands Genomics Initiative/Netherlands; Organization for Scientific Research	This project was founded by Alexandre Suerman MD/PhD Stipendium, University Medical Center Utrecht, the Netherlands and (co-)financed by the Netherlands Metabolomics Centre (NMC) which is a part of The Netherlands Genomics Initiative/Netherlands; Organization for Scientific Research. No sponsor or funder had any role in the study design, the experiments or analysis of the data in this manuscript.	BAGLEY PJ, 1995, J NUTR, V125, P933; Bahado-Singh RO, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.003; Bahado-Singh RO, 2012, J MATERN-FETAL NEO M, V25, P1840, DOI 10.3109/14767058.2012.680254; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; CETIN I, 1990, AM J OBSTET GYNECOL, V162, P253, DOI 10.1016/0002-9378(90)90860-A; Cuckle H, 2000, ANTENATAL NEONATAL S, V2nd, P3; Dawson R, 2000, AMINO ACIDS, V19, P643, DOI 10.1007/s007260070014; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Desforges M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.81; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1219, DOI 10.1016/0002-9378(89)90670-4; Evans RW, 2003, REPRODUCTION, V125, P785, DOI 10.1530/rep.0.1250785; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Glew RH, 2004, CLIN CHIM ACTA, V342, P179, DOI 10.1016/j.cccn.2003.12.028; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Horie R, 1987, J Hypertens Suppl, V5, pS223; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Ingec M, 2005, TOHOKU J EXP MED, V206, P225, DOI 10.1620/tjem.206.225; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Kaymaz C, 2011, PRENATAL DIAG, V31, P1246, DOI 10.1002/pd.2874; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Khosrowbeygi A, 2011, Bangladesh Med Res Counc Bull, V37, P106; Kuc S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063546; Kupferminc MJ, 1999, AM J PERINAT, V16, P203, DOI 10.1055/s-2007-993859; Leichtle AB, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13801; Liesenfeld DB, 2013, CANCER EPIDEM BIOMAR, V22, P2182, DOI 10.1158/1055-9965.EPI-13-0584; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Makedos Georgios, 2007, Archives of Gynecology and Obstetrics, V275, P121, DOI 10.1007/s00404-006-0223-2; Mao DW, 2010, ARCH GYNECOL OBSTET, V282, P371, DOI 10.1007/s00404-009-1234-6; MELDRUM MJ, 1994, ADV EXP MED BIOL, V359, P207; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Odibo AO, 2011, PRENATAL DIAG, V31, P990, DOI 10.1002/pd.2822; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Savvidis A, 2011, CLIN EXP OBSTET GYN, V38, P134; SCHOENGOLD DM, 1978, AM J OBSTET GYNECOL, V131, P490, DOI 10.1016/0002-9378(78)90108-4; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1	51	50	53	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98540	10.1371/journal.pone.0098540	http://dx.doi.org/10.1371/journal.pone.0098540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873829	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800047
J	Navas, JM; Miller, PL; Henry, LA; Hennige, SJ; Roberts, JM				Navas, Juan Moreno; Miller, Peter L.; Henry, Lea-Anne; Hennige, Sebastian J.; Roberts, J. Murray			Ecohydrodynamics of Cold-Water Coral Reefs: A Case Study of the Mingulay Reef Complex (Western Scotland)	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; FOOD-SUPPLY MECHANISMS; ROCKALL TROUGH MARGIN; PHYTOPLANKTON DISTRIBUTIONS; OCEAN ACIDIFICATION; DEEP; HYDROGRAPHY; HYDRODYNAMICS; RADIOCESIUM; HEBRIDES	Ecohydrodynamics investigates the hydrodynamic constraints on ecosystems across different temporal and spatial scales. Ecohydrodynamics play a pivotal role in the structure and functioning of marine ecosystems, however the lack of integrated complex flow models for deep-water ecosystems beyond the coastal zone prevents further synthesis in these settings. We present a hydrodynamic model for one of Earth's most biologically diverse deep-water ecosystems, cold-water coral reefs. The Mingulay Reef Complex (western Scotland) is an inshore seascape of cold-water coral reefs formed by the scleractinian coral Lophelia pertusa. We applied single-image edge detection and composite front maps using satellite remote sensing, to detect oceanographic fronts and peaks of chlorophyll a values that likely affect food supply to corals and other suspension-feeding fauna. We also present a high resolution 3D ocean model to incorporate salient aspects of the regional and local oceanography. Model validation using in situ current speed, direction and sea elevation data confirmed the model's realistic representation of spatial and temporal aspects of circulation at the reef complex including a tidally driven current regime, eddies, and downwelling phenomena. This novel combination of 3D hydrodynamic modelling and remote sensing in deep-water ecosystems improves our understanding of the temporal and spatial scales of ecological processes occurring in marine systems. The modelled information has been integrated into a 3D GIS, providing a user interface for visualization and interrogation of results that allows wider ecological application of the model and that can provide valuable input for marine biodiversity and conservation applications.	[Navas, Juan Moreno; Henry, Lea-Anne; Hennige, Sebastian J.; Roberts, J. Murray] Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland; [Miller, Peter L.] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Roberts, J. Murray] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Roberts, J. Murray] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	Heriot Watt University; Plymouth Marine Laboratory; University of North Carolina; University of North Carolina Wilmington; UHI Millennium Institute	Navas, JM (corresponding author), Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland.	J.Moreno_Navas@hw.ac.uk; j.m.roberts@hw.ac.uk	Miller, Peter I./E-4525-2013; Roberts, Murray/D-8299-2013; Hennige, Sebastian/D-9369-2013	Miller, Peter I./0000-0002-5292-8789; Roberts, Murray/0000-0003-1688-5133; Hennige, Sebastian/0000-0002-3059-604X	European Commission [226354, 211384]; UK Ocean Acidification programme (NERC grant) [NE/H017305/1]; Heriot-Watt University's Environment & Climate Change theme; Technical University of Lisbon; Natural Environment Research Council [NE/K009028/1, NE/H017305/1, pml010008] Funding Source: researchfish; NERC [NE/H017305/1, NE/K009028/1, pml010008] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Ocean Acidification programme (NERC grant); Heriot-Watt University's Environment & Climate Change theme; Technical University of Lisbon(Istanbul Technical University); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is a contribution towards the European Commission FP7 projects HERMIONE (grant 226354) and EPOCA (grant 211384) and the UK Ocean Acidification programme (NERC grant NE/H017305/1). JMN and JMR acknowledge support from Heriot-Watt University's Environment & Climate Change theme and Javier Campuzano from the Technical University of Lisbon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa A., 1977, METHODS COMPUTATIONA, V17, P173, DOI DOI 10.1016/B978-0-12-460817-7.50009-4; BLACK KP, 1993, CORAL REEFS, V12, P43, DOI 10.1007/BF00303783; Burchard H., 1999, GOTM GEN OCEAN TURBU; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Craig RE, 1959, MARINE RES, V1958, P30; Danish Hydraulic Institute DHI, 1995, MIKE 21 HD HYDR MOD; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Dawson CW, 2007, ENVIRON MODELL SOFTW, V22, P1034, DOI 10.1016/j.envsoft.2006.06.008; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Dorschel B, 2007, MAR GEOL, V244, P184, DOI 10.1016/j.margeo.2007.06.010; Douarin M, 2013, EARTH PLANET SC LETT, V375, P176, DOI 10.1016/j.epsl.2013.05.023; Duineveld GCA, 2012, MAR ECOL PROG SER, V444, P97, DOI 10.3354/meps09430; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; ELLETT DJ, 1979, P ROY SOC EDINB B, V77, P61, DOI 10.1017/S026972700001263X; ELLETT DJ, 1983, P ROY SOC EDINB B, V83, P143, DOI 10.1017/S0269727000013385; FEARNHEAD PG, 1975, DEEP-SEA RES, V22, P311, DOI 10.1016/0011-7471(75)90072-8; Fehling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034098; Findlay HS, 2013, GLOBAL CHANGE BIOL, V19, P2708, DOI 10.1111/gcb.12256; Gillibrand PA, 2003, 0803 FRS MAR LAB; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hearn CJ, 2011, SPRINGER VERLAG EA 8, P563; Henry LA, 2013, BIOGEOSCIENCES, V10, P2737, DOI 10.5194/bg-10-2737-2013; Henry LA, 2013, BIOL CONSERV, V161, P67, DOI 10.1016/j.biocon.2013.03.002; Henry LA, 2010, CORAL REEFS, V29, P427, DOI 10.1007/s00338-009-0577-6; Hill AE, 1997, ESTUAR COAST SHELF S, V45, P473, DOI 10.1006/ecss.1996.0198; Leendertse J.J., 1978, HYDRODYNAMICS ESTUAR, P387; Long D, 2003, IR03149 BRIT GEOL SU; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Martins F., 2001, OCEANOLOGICA ACTA S, V24, P51, DOI [DOI 10.1016/S0399-1784(01)00092-5, 10.1016/s0399- 1784(01)00092-5]; Martins FA, 1998, HYDROINFORMATICS '98, VOLS 1 AND 2, P1403; Mauchline J, 1987, 144 SCOTT MAR BIOL A; MCKAY WA, 1986, J ENVIRON RADIOACTIV, V4, P205, DOI 10.1016/0265-931X(86)90011-1; MCKINLEY IG, 1981, ESTUAR COAST SHELF S, V13, P69, DOI 10.1016/S0302-3524(81)80106-5; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Mienis F, 2009, DEEP-SEA RES PT I, V56, P1026, DOI 10.1016/j.dsr.2009.01.006; Miller P, 2009, J MARINE SYST, V78, P327, DOI 10.1016/j.jmarsys.2008.11.019; Miller PI, 2014, MAR POLICY, V45, P318, DOI 10.1016/j.marpol.2013.09.009; Miller PI, 2014, 538 SCOTT NAT HER, P33; Mohn C, 2014, PROGR OCEAN IN PRESS; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Nihoul J. C. J, 1981, ECOHYDRODYNAMICS, P1; Nihoul JCJ, 1991, EARTH-SCI REV, V26, P163; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PINGREE RD, 1978, DEEP-SEA RES, V25, P1011, DOI 10.1016/0146-6291(78)90584-2; PINGREE RD, 1989, PROG OCEANOGR, V23, P303, DOI 10.1016/0079-6611(89)90003-7; Proctor R, 1996, J MARINE SYST, V7, P43, DOI 10.1016/0924-7963(94)00036-0; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Roberts JM, 2009, MAR ECOL PROG SER, V397, P139, DOI 10.3354/meps08112; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; SANTOS AJP, 1995, THESIS IST LISBON; SAVIDGE G, 1987, CONT SHELF RES, V7, P45, DOI 10.1016/0278-4343(87)90063-X; Simpson J. H., 1986, ROLE FRESHWATER OUTF, P295, DOI DOI 10.1007/978-3-642-70886-2_21; SIMPSON JH, 1979, ESTUAR COAST MAR SCI, V9, P713, DOI 10.1016/S0302-3524(79)80005-5; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Walstra DJR, 2001, P COAST DYN 2001 C L, pD41; WARWICK RM, 1980, MAR ECOL PROG SER, V3, P97, DOI 10.3354/meps003097; Watmough T, 2008, MAPPING MINGULAY REE; Wheeler AJ, 2005, COLD WATER CORALS EC, P503; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Xing JX, 1996, J MARINE SYST, V8, P191, DOI 10.1016/0924-7963(96)00006-1	66	16	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98218	10.1371/journal.pone.0098218	http://dx.doi.org/10.1371/journal.pone.0098218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873971	Green Published, gold			2022-12-27	WOS:000336790800028
J	Wu, J; Hu, YF; Jia, YJ; Su, YY; Cui, HX; Liu, HX; Wang, N				Wu, Jing; Hu, Yifei; Jia, Yujiang; Su, Yingying; Cui, Huixia; Liu, Huixin; Wang, Ning			Prevalence of Unprotected Anal Intercourse among Men Who Have Sex with Men in China: An Updated Meta-Analysis	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; CROSS-SECTIONAL SURVEY; HIV-INFECTION; RISK-FACTORS; UNITED-STATES; SYPHILIS PREVALENCE; TESTING BEHAVIORS; HOMOSEXUAL-MEN; CONDOM USE; TRANSMISSION	Objective: The purpose of this review was to assess the prevalence of unprotected anal intercourse (UAI) among men who have sex with men (MSM) in China. Methods: A comprehensive search was conducted including online databases like "Wanfang'', Chinese National Knowledge Infrastructure, PubMed and manual searches. Analyses using random-effects models were performed to estimate the prevalence of UAI among MSM in China. Results: Sixty-two articles reporting eighty-two studies were selected. The pooled prevalence rates of UAI with any male partner, with regular male partners, with non-regular male partners, with casual male partners, and with commercial male partners among MSM were 53%(95% CI: 51-56%), 45%(95% CI: 39-51%), 34%(95% CI: 24-45%), 33%(95% CI: 30-36%), 12% (95% CI: 5-26%), respectively. A cumulative meta-analysis found that the pooled UAI prevalence decreased over time. Conclusions: Although the prevalence of UAI with male partners among MSM in China presents a decreasing trend over the past decade, the concomitant rise in HIV prevalence and incidence indicates that current prevention intervention efforts are insufficient to effectively contain the spread of HIV. Therefore, the persistently high prevalence of risky sexual behaviors underscores the need for innovative and effective prevention strategies among MSM.	[Wu, Jing; Hu, Yifei; Su, Yingying; Liu, Huixin; Wang, Ning] China Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Jia, Yujiang] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Cui, Huixia] Liaoning Med Univ, Coll Nursing, Jinzhou, Liaoning, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Vanderbilt University; Jinzhou Medical University	Wang, N (corresponding author), China Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com	Hu, Yifei/GQO-8848-2022; Hu, Yifei/AAW-4389-2020	Hu, Yifei/0000-0002-4611-2206; Hu, Yifei/0000-0002-4611-2206	National Megaprojects of Science Research for the 12th Five-Year Plan [2012ZX10001-001]	National Megaprojects of Science Research for the 12th Five-Year Plan	This study is supported by the National Megaprojects of Science Research for the 12th Five-Year Plan (2012ZX10001-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen EJ, 2004, EPIDEMIOL INFECT, V132, P1139, DOI 10.1017/S0950268804002997; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bai HL, 2011, J BIOMED RES, V25, P17, DOI 10.1016/S1674-8301(11)60002-X; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Berry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043071; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Blais M, 2006, CULT HEALTH SEX, V8, P31, DOI 10.1080/13691050500391232; Boyle MH, 1998, EVID-BASED MENT HEAL, V1, P37; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Chen AD, 2012, S CHINA J PREV MED, V38, P1; [陈鑫 Chen Xin], 2012, [中国公共卫生, China Public Health], V28, P1549; Cheng WB, 2012, CHIN J DIS CONTROL P, V16, P1064; Cheng Wei-bin, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1027; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Chow EPF, 2013, AIDS BEHAV, V17, P2387, DOI 10.1007/s10461-012-0300-4; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Chow EPF, 2011, SEX TRANSM DIS, V38, P845, DOI 10.1097/OLQ.0b013e31821a4f43; Chow EPF, 2010, JAIDS-J ACQ IMM DEF, V55, pE32, DOI 10.1097/QAI.0b013e3181f3d3c1; Clements MS, 2004, JAIDS-J ACQ IMM DEF, V35, P401, DOI 10.1097/00126334-200404010-00010; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Dong XF, 2013, J NINGXIA MED U, V35, P277; Dong ZhengQuan, 2012, Disease Surveillance, V27, P623; Duan YW, 2013, AIDS EDUC PREV, V25, P38, DOI 10.1521/aeap.2013.25.1.38; Dubois-Arber F, 2012, ARCH SEX BEHAV, V41, P1263, DOI 10.1007/s10508-011-9868-4; Fan S, 2012, AIDS PATIENT CARE ST, V26, P148, DOI 10.1089/apc.2011.0277; Fang C, 2005, SEX TRANSM INFECT; Feng LG, 2010, J TROPICAL MED, V10, P78; Feng LianGui, 2010, Acta Academiae Medicinae Militaris Tertiae, V32, P2644; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; [高彦杰 Gao Yanjie], 2012, [中国公共卫生, China Public Health], V28, P451; Grov C, 2013, J SEX MED, V10, P2285, DOI 10.1111/jsm.12227; Hao C, 2014, AIDS BEHAV, V18, P99, DOI 10.1007/s10461-013-0492-2; Hao C, 2012, AIDS BEHAV, V16, P1138, DOI 10.1007/s10461-012-0141-1; He Huan, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P976; He Q, 2012, SEX TRANSM INFECT, V88, P229, DOI 10.1136/sextrans-2011-050230; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; He Q, 2011, SE ASIAN J TROP MED, V42, P616; Hirshfield S, 2004, J MED INTERNET RES, V6, P42, DOI 10.2196/jmir.6.4.e41; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Huan X, 2013, ASIA PAC J PUBLIC HL; Huan XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069740; Huang ZH, 2013, AIDS RES HUM RETROV, V29, P441, DOI [10.1089/aid.2012.0151, 10.1089/AID.2012.0151]; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Lau JTF, 2012, AIDS CARE, V24, P59, DOI 10.1080/09540121.2011.592813; [李春梅 Li Chunmei], 2011, [中国公共卫生, China Public Health], V27, P351; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Li JianJun, 2011, Chinese Preventive Medicine, V12, P666; Li Xinxu, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P99; Lim SH, 2013, SEX TRANSM INFECT, V89, P642, DOI 10.1136/sextrans-2012-050995; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050493; Liu L, 2009, CURR HIV RES, V7, P390, DOI 10.2174/157016209788680642; Liu PL, 2010, CHINESE J DIS CONTRO, V14, P917; Liu X. X., 2012, CHINESE J DIS CONTRO, V16, P1024; Liu ZY, 2011, CHIN J AIDS STD, V17, P646; Lou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S10; Luo Y, 2013, ANHUI J PREV MED, V19, P83; Luo Y, 2013, ANHUI J PREV MED, V19, P93; Ma GY, 2012, ANHUI J PREV MED, V18, P332; Ma XY, 2007, CHIN J AIDS STD, V13, P311; [马小燕 MA Xiaoyan], 2007, [中华流行病学杂志, Chinese Journal of Epidemiology], V28, P851; McDaid LM, 2012, SEX TRANSM DIS, V39, P735, DOI 10.1097/OLQ.0b013e31825a3a3c; Meng XJ, 2013, SEX HEALTH, V10, P211, DOI 10.1071/SH12093; Ministry of Health of China UNAIDS WHO, 2011, 2011 EST HIV AIDS EP; Ministry of Health of China UNAIDS WHO, 2010, 2009 EST HIV AIDS EP; Ministry of Health of China UNAIDS WHO, 2006, 2005 HIV AIDS EP WOR; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ouyang Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1001; Pappas G, 2011, MEDSCAPE PUBLIC HLTH; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Prestage GP, 2009, AIDS BEHAV, V13, P724, DOI 10.1007/s10461-008-9460-7; Qu L, 2013, PRACTICAL PREVENTIVE, V20, P145; Qu SQ, 2002, CHIN J STD AIDS PREV, V8, p[338, 370]; Rao XM, 2008, CHONGQING MED, V37, P2335; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Shao YM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-87; Song DD, 2013, AIDS BEHAV, V17, P2395, DOI 10.1007/s10461-012-0334-7; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Suarez T, 2001, ARCH SEX BEHAV, V30, P287, DOI 10.1023/A:1002700130455; Sun X, 2013, BIOMED RES INT; Tang Wei-ming, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P448; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Tsui HY, 2014, J SEX MARITAL THER, V40, P139, DOI 10.1080/0092623X.2012.702339; Tucker JD, 2011, SEX TRANSM INFECT, V87, pII16, DOI 10.1136/sti.2010.048314; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; van Sighem A, 2012, AIDS, V26, P1840, DOI 10.1097/QAD.0b013e3283574df9; van Wijngaarden JWD, 2009, SEX TRANSM DIS, V36, P319, DOI 10.1097/OLQ.0b013e318195c302; Vu L, 2013, SEX TRANSM INFECT, V89, P659, DOI 10.1136/sextrans-2013-051065; Wang KL, 2012, INT J EPIDEMIOL, V41, P423, DOI 10.1093/ije/dyr182; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Wang Y, 2013, PRACTICAL PREVENTIVE, V20, P260; Wang Y., 2012, CHINESE J AIDS STD, V18, P180; [王毅 Wang Yi], 2013, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V22, P364; Wang ZX, 2013, AIDS CARE, V25, P1010, DOI 10.1080/09540121.2012.748166; Wen F., 2010, S CHINA J PREV MED, V36, P19; Wim VB, 2014, AIDS BEHAV, V18, P50, DOI 10.1007/s10461-013-0516-y; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; Wu D, 2013, CHIN J AIDS STD, V19, P127; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu Jing, 2011, Journal of Tropical Medicine (Guangzhou), V11, P1199; [许娟 Xu Juan], 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P975; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Xu XX, 2013, MATH METHOD APPL SCI, V36, P234, DOI 10.1002/mma.2599; Yan HM, 2009, CHIN J AIDS STD, V15, P288; Yan HongJing, 2010, Chinese Preventive Medicine, V11, P1249; Yang Xu, 2007, Academic Journal of Second Military Medical University, V28, P1223; Zablotska IB, 2010, AIDS, V24, P1955, DOI 10.1097/QAD.0b013e32833bf74a; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang DD, 2010, ZHEJIANG PREVENTIVE, V22, P1; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhao J, 2013, ARCH SEX BEHAV; Zheng JD, 2012, AIDS EDUC PREV, V24, P78, DOI 10.1521/aeap.2012.24.1.78; Zheng WenBin, 2013, China Tropical Medicine, V13, P175; Zhong F, 2011, AIDS BEHAV, V15, P1058, DOI 10.1007/s10461-009-9619-x; [周金玲 Zhou Jinling], 2012, [中国公共卫生, China Public Health], V28, P806; Zhu JL, 2008, CHIN J PUBLIC HLTH, V24, P400; 张秋平, 2011, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V33, P318	127	29	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98366	10.1371/journal.pone.0098366	http://dx.doi.org/10.1371/journal.pone.0098366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874882	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800036
J	Jeong, S; Park, S; Park, BW; Park, Y; Kwon, OJ; Kim, HS				Jeong, Seri; Park, Seho; Park, Byeong-Woo; Park, Younhee; Kwon, Oh-Joong; Kim, Hyon-Suk			Human Leukocyte Antigen-G (HLA-G) Polymorphism and Expression in Breast Cancer Patients	PLOS ONE			English	Article							G GENE; BRAZILIAN POPULATION; CELLS; SUSCEPTIBILITY; CARCINOMA; RECEPTOR; ESOPHAGEAL; MOLECULES; APOPTOSIS	Human leukocyte antigen-G (HLA-G) is known to be implicated in a tumor-driven immune escape mechanism in malignancies. The purpose of this study was to investigate HLA-G polymorphism and expression in breast cancer. HLA-G alleles were determined by direct DNA sequencing procedures from blood samples of 80 breast cancer patients and 80 healthy controls. Soluble HLA-G (sHLA-G) was measured by enzyme-linked immunosorbent assay (ELISA) from serum specimens. HLA-G expression in breast cancer lesions was also analyzed by immunohistochemistry staining. The presence of HLA-G 3' untranslated region (UTR) 14-bp sequence was analyzed and found to be associated with reduced risk of breast cancer susceptibility based on HLA-G expression in tissues (P = 0.0407). Levels of sHLA-G were higher in the breast cancer group (median 117.2 U/mL) compared to the control group (median 10.1 U/mL, P<0.001). The area under the receiver operating characteristic curve (AU-ROC) values of sHLA-G for differentiating breast cancer from normal controls and for detecting metastasis from other stages of breast cancer were 0.89 and 0.79, respectively. HLA-G polymorphism and expression may be involved in breast carcinogenesis and sHLA-G concentrations could be used as a diagnostic marker for detecting breast cancer.	[Jeong, Seri; Kim, Hyon-Suk] Yonsei Univ, Coll Med, Severance Hosp, Dept Lab Med, Seoul, South Korea; [Park, Seho; Park, Byeong-Woo] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Park, Younhee] Kwandong Univ, Dept Lab Med, Coll Med, Goyang, South Korea; [Kwon, Oh-Joong] Konkuk Univ, Coll Anim Biosci & Technol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Catholic Kwandong University; Konkuk University	Kim, HS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Lab Med, Seoul, South Korea.	kimhs54@yuhs.ac	Kim, Hyon-Suk/R-4113-2017	Kim, Hyon-Suk/0000-0001-5662-7740; Park, Byeong-Woo/0000-0003-1353-2607; Park, Seho/0000-0001-8089-2755				Barrier BF, 2006, GYNECOL ONCOL, V103, P25, DOI 10.1016/j.ygyno.2006.01.045; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2008, TISSUE ANTIGENS, V72, P149, DOI 10.1111/j.1399-0039.2008.01091.x; Castelli EC, 2007, TISSUE ANTIGENS, V70, P62, DOI 10.1111/j.1399-0039.2007.00855.x; Chen HX, 2010, HUM IMMUNOL, V71, P892, DOI 10.1016/j.humimm.2010.06.009; Chen Y, 2012, BIOMARKERS, V17, P9, DOI 10.3109/1354750X.2011.633242; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; de Kruijf EM, 2010, J IMMUNOL, V185, P7452, DOI 10.4049/jimmunol.1002629; Elliott RL, 2011, CANCER BIOTHER RADIO, V26, P153, DOI 10.1089/cbr.2010.0924; Ferguson R, 2011, INT J CANC; Gaddy VT, 2004, CLIN CANCER RES, V10, P5215, DOI 10.1158/1078-0432.CCR-03-0637; He X, 2010, ANN SURG ONCOL, V17, P1459, DOI 10.1245/s10434-009-0891-9; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Jiang YT, 2011, DNA CELL BIOL, V30, P1027, DOI 10.1089/dna.2011.1238; Lau DT, 2011, TISSUE ANTIGENS, V78, P421, DOI 10.1111/j.1399-0039.2011.01781.x; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Lin A, 2007, TISSUE ANTIGENS, V70, P427, DOI 10.1111/j.1399-0039.2007.00926.x; Matte C, 2000, HUM IMMUNOL, V61, P1150, DOI 10.1016/S0198-8859(00)00200-7; Park GM, 2004, BIOCHEM BIOPH RES CO, V313, P606, DOI 10.1016/j.bbrc.2003.11.153; Provatopoulou X, 2012, ANTICANCER RES, V32, P1021; Rahimi R, 2010, INT J IMMUNOGENET, V37, P269, DOI 10.1111/j.1744-313X.2010.00919.x; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rebmann V, 2003, HUM IMMUNOL, V64, P1017, DOI 10.1016/j.humimm.2003.08.354; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Sayed D, 2010, TISSUE ANTIGENS, V75, P40, DOI 10.1111/j.1399-0039.2009.01393.x; van der Ven K, 1998, HUM IMMUNOL, V59, P302, DOI 10.1016/S0198-8859(98)00021-4; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Yan WH, 2011, CANCER LETT, V311, P123, DOI 10.1016/j.canlet.2011.07.019; Zheng N, 2011, TISSUE ANTIGENS, V77, P218, DOI 10.1111/j.1399-0039.2010.01607.x	35	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98284	10.1371/journal.pone.0098284	http://dx.doi.org/10.1371/journal.pone.0098284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870375	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300033
J	Kleijn, A; Kloezeman, J; Treffers-Westerlaken, E; Fulci, G; Leenstra, S; Dirven, C; Debets, R; Lamfers, M				Kleijn, Anne; Kloezeman, Jenneke; Treffers-Westerlaken, Elike; Fulci, Giulia; Leenstra, Sieger; Dirven, Clemens; Debets, Reno; Lamfers, Martine			The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity	PLOS ONE			English	Article							CONDITIONALLY REPLICATIVE ADENOVIRUS; VESICULAR STOMATITIS-VIRUS; PHASE I/II TRIAL; INFLAMMATORY RESPONSE; ANTITUMOR IMMUNITY; MALIGNANT GLIOMAS; CANCER-PATIENTS; CELL-DEATH; GLIOBLASTOMA; VECTORS	The oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for patients with a malignant glioma and is currently under investigation in clinical phase I/II trials. Earlier preclinical studies showed that Delta24-RGD is able to effectively lyse tumor cells, yielding promising results in various immune-deficient glioma models. However, the role of the immune response in oncolytic adenovirus therapy for glioma has never been explored. To this end, we assessed Delta24-RGD treatment in an immune-competent orthotopic mouse model for glioma and evaluated immune responses against tumor and virus. Delta24-RGD treatment led to long-term survival in 50% of mice and this effect was completely lost upon administration of the immunosuppressive agent dexamethasone. Delta24-RGD enhanced intra-tumoral infiltration of F4/80+ macrophages, CD4+ and CD8+ T-cells, and increased the local production of pro-inflammatory cytokines and chemokines. In treated mice, T cell responses were directed to the virus as well as to the tumor cells, which was reflected in the presence of protective immunological memory in mice that underwent tumor rechallenge. Together, these data provide evidence that the immune system plays a vital role in the therapeutic efficacy of oncolytic adenovirus therapy of glioma, and may provide angles to future improvements on Delta24-RGD therapy.	[Kleijn, Anne; Kloezeman, Jenneke; Leenstra, Sieger; Dirven, Clemens; Lamfers, Martine] ErasmusMC, Dept Neurosurg, Brain Tumor Ctr, Rotterdam, Netherlands; [Treffers-Westerlaken, Elike; Debets, Reno] ErasmusMC, Dept Med Oncol, Lab Expt Tumor Immunol, Rotterdam, Netherlands; [Fulci, Giulia] Massachusetts Gen Hosp, Dept Neurosurg, Mol Neurosurg Lab, Brain Tumor Res Ctr, Boston, MA 02114 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital	Lamfers, M (corresponding author), ErasmusMC, Dept Neurosurg, Brain Tumor Ctr, Rotterdam, Netherlands.	m.lamfers@erasmusmc.nl	Lamfers, Martine/C-6246-2016	Lamfers, Martine/0000-0001-7745-9029				Allen C, 2012, GENE THER; Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Altomonte J, 2008, MOL THER, V16, P146, DOI 10.1038/sj.mt.6300343; Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Badie B, 2000, J NEUROSURG, V93, P634, DOI 10.3171/jns.2000.93.4.0634; Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bauerschmitz GJ, 2004, INT J CANCER, V111, P303, DOI 10.1002/ijc.20217; Blackham AU, 2012, SURGERY; Cartmell T, 1999, J NEUROSCI, V19, P1517; Chiocca EA, 2004, MOL THER, V10, P958, DOI 10.1016/j.ymthe.2004.07.021; Datta SC, 2008, J NEUROSCI METH, V175, P119, DOI 10.1016/j.jneumeth.2008.08.007; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; Galanis E, 2005, GENE THER, V12, P437, DOI 10.1038/sj.gt.3302436; GOODWIN JS, 1986, J CLIN INVEST, V77, P1244, DOI 10.1172/JCI112427; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Grote D, 2003, CANCER RES, V63, P6463; Gujar SA, 2010, MOL CANCER THER, V9, P2924, DOI 10.1158/1535-7163.MCT-10-0590; Huang PY, 2012, MOL THER, V20, P298, DOI 10.1038/mt.2011.245; Idema S, 2007, J GENE MED, V9, P1046, DOI 10.1002/jgm.1113; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kanerva A, 2013, CLIN CANCER RES, V19, P2734, DOI 10.1158/1078-0432.CCR-12-2546; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Kiang A, 2006, MOL THER, V14, P588, DOI 10.1016/j.ymthe.2006.03.024; Kimball KJ, 2010, CLIN CANCER RES, V16, P5277, DOI 10.1158/1078-0432.CCR-10-0791; Kleijn A, 2011, CLIN CANCER RES, V17, P4484, DOI 10.1158/1078-0432.CCR-11-0575; Lamfers MLM, 2007, CLIN CANCER RES, V13, P7451, DOI 10.1158/1078-0432.CCR-07-1265; Lamfers MLM, 2006, MOL THER, V14, P779, DOI 10.1016/j.ymthe.2006.08.008; Lamfers MLM, 2002, CANCER RES, V62, P5736; Lesniak MS, 2004, J NEURO-ONCOL, V70, P23, DOI 10.1023/B:NEON.0000040821.50347.c5; Liikanen I, 2013, MOL THER, V21, P1212, DOI 10.1038/mt.2013.51; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Pouw N, 2010, CANCER IMMUNOL IMMUN, V59, P921, DOI 10.1007/s00262-010-0818-0; Reid TR, 2005, CANCER GENE THER, V12, P673, DOI 10.1038/sj.cgt.7700819; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Sebestyen Z, 2007, CANCER RES, V67, P11309, DOI 10.1158/0008-5472.CAN-07-0739; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Thomas MA, 2008, MOL THER, V16, P1665, DOI 10.1038/mt.2008.162; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Witlox AM, 2004, CLIN CANCER RES, V10, P61, DOI 10.1158/1078-0432.CCR-0609-03; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116	54	47	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97495	10.1371/journal.pone.0097495	http://dx.doi.org/10.1371/journal.pone.0097495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866126	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100014
J	Nayduch, D; Lee, MB; Saski, CA				Nayduch, Dana; Lee, Matthew B.; Saski, Christopher A.			The Reference Transcriptome of the Adult Female Biting Midge (Culicoides sonorensis) and Differential Gene Expression Profiling during Teneral, Blood, and Sucrose Feeding Conditions	PLOS ONE			English	Article							RNA-SEQ; DIPTERA-CERATOPOGONIDAE; ANOPHELES-GAMBIAE; VITELLOGENESIS; BLUETONGUE; PROTEIN; RESOURCE; DISEASE; AGBASE; TOPHAT	Unlike other important vectors such as mosquitoes and sandflies, genetic and genomic tools for Culicoides biting midges are lacking, despite the fact that they vector a large number of arboviruses and other pathogens impacting humans and domestic animals world-wide. In North America, female Culicoides sonorensis midges are important vectors of bluetongue virus (BTV) and epizootic hemorrhagic disease virus (EHDV), orbiviruses that cause significant disease in livestock and wildlife. Libraries of tissue-specific transcripts expressed in response to feeding and oral orbivirus challenge in C. sonorensis have previously been reported, but extensive genome-wide expression profiling in the midge has not. Here, we successfully used deep sequencing technologies to construct the first adult female C. sonorensis reference transcriptome, and utilized genome-wide expression profiling to elucidate the genetic response to blood and sucrose feeding over time. The adult female midge unigene consists of 19,041 genes, of which less than 7% are differentially expressed during the course of a sucrose meal, while up to 52% of the genes respond significantly in blood-fed midges, indicating hematophagy induces complex physiological processes. Many genes that were differentially expressed during blood feeding were associated with digestion (e.g. proteases, lipases), hematophagy (e.g., salivary proteins), and vitellogenesis, revealing many major metabolic and biological factors underlying these critical processes. Additionally, key genes in the vitellogenesis pathway were identified, which provides the first glimpse into the molecular basis of anautogeny for C. sonorensis. This is the first extensive transcriptome for this genus, which will serve as a framework for future expression studies, RNAi, and provide a rich dataset contributing to the ultimate goal of informing a reference genome assembly and annotation. Moreover, this study will serve as a foundation for subsequent studies of genome-wide expression analyses during early orbivirus infection and dissecting the molecular mechanisms behind vector competence in midges.	[Nayduch, Dana; Lee, Matthew B.] USDA ARS, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Saski, Christopher A.] Clemson Univ, Genom Inst, Clemson, SC 29634 USA	United States Department of Agriculture (USDA); Clemson University	Saski, CA (corresponding author), Clemson Univ, Genom Inst, Clemson, SC 29634 USA.	saski@clemson.edu		Nayduch, Dana/0000-0002-9258-6066	USDA-ARS National Program 104 [5430-32000-003]; Clemson University [58-5430-2-313]	USDA-ARS National Program 104; Clemson University	This work was funded by USDA-ARS National Program 104, Project number 5430-32000-003, and a Specific Cooperative Agreement with Clemson University, Agreement 58-5430-2-313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atallah J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084160; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Campbell CL, 2005, INSECT MOL BIOL, V14, P121, DOI 10.1111/j.1365-2583.2004.00537.x; Campbell CL, 2002, INSECT MOL BIOL, V11, P595, DOI 10.1046/j.1365-2583.2002.00370.x; Cardoso AF, 2010, MEM I OSWALDO CRUZ, V105, P254, DOI 10.1590/S0074-02762010000300003; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; FOSTER NM, 1977, J WILDLIFE DIS, V13, P9, DOI 10.7589/0090-3558-13.1.9; Fujikawa K, 2006, FEBS J, V273, P4311, DOI 10.1111/j.1742-4658.2006.05422.x; Gerry AC, 2009, J MED ENTOMOL, V46, P615, DOI 10.1603/033.046.0329; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; JONES RH, 1978, AM J TROP MED HYG, V27, P178, DOI 10.4269/ajtmh.1978.27.178; JONES RH, 1977, J WILDLIFE DIS, V13, P2, DOI 10.7589/0090-3558-13.1.2; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936; McCarthy FM, 2011, NUCLEIC ACIDS RES, V39, pD497, DOI 10.1093/nar/gkq1115; Nayduch D, 2014, VIRUS RES, V182, P43, DOI 10.1016/j.virusres.2013.12.009; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Philimonova S A, 2005, Zh Evol Biokhim Fiziol, V41, P176; Previte D, 2014, INSECT MOL BIOL, V23, P244, DOI 10.1111/imb.12077; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Ramalho-Ortigao M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-300; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969; Schmidtmann ET, 2011, J MED ENTOMOL, V48, P634, DOI 10.1603/ME10231; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Walton TE, 2004, VETER ITAL SER, V40, P31; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P544, DOI 10.1073/pnas.0235695100	48	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98123	10.1371/journal.pone.0098123	http://dx.doi.org/10.1371/journal.pone.0098123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866149	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100034
J	Tao, YX; van Peer, AF; Chen, BZ; Chen, ZH; Zhu, J; Deng, YJ; Jiang, YJ; Li, SJ; Wu, TJ; Xie, BG				Tao, Yongxin; van Peer, Arend F.; Chen, Bingzhi; Chen, Zhihong; Zhu, Jian; Deng, Youjin; Jiang, Yuji; Li, Shaojie; Wu, Taju; Xie, Baogui			Gene Expression Profiling Reveals Large Regulatory Switches between Succeeding Stipe Stages in Volvariella volvacea	PLOS ONE			English	Article							CELL-POPULATION DYNAMICS; EDIBLE STRAW MUSHROOM; COPRINUS-CINEREUS; BASIDIOCARP MATURATION; MOLECULAR-CLONING; GROWTH-REGULATION; FRUIT BODIES; PROTEIN; ELONGATION; FAMILY	The edible mushroom Volvariella volvacea is an important crop in Southeast Asia and is predominantly harvested in the egg stage. One of the main factors that negatively affect its yield and value is the rapid transition from the egg to the elongation stage, which has a decreased commodity value and shelf life. To improve our understanding of the changes during stipe development and the transition from egg to elongation stage in particular, we analyzed gene transcription in stipe tissue of V. volvacea using 3'-tag based digital expression profiling. Stipe development turned out to be fairly complex with high numbers of expressed genes, and regulation of stage differences is mediated mainly by changes in expression levels of genes, rather than on/off modulation. Most explicit is the strong up-regulation of cell division from button to egg, and the very strong down-regulation hereof from egg to elongation, that continues in the maturation stage. Button and egg share cell division as means of growth, followed by a major developmental shift towards rapid stipe elongation based on cell extension as demonstrated by inactivation of cell division throughout elongation and maturation. Examination of regulatory genes up-regulated from egg to elongation identified three potential high upstream regulators for this switch. The new insights in stipe dynamics, together with a series of new target genes, will provide a sound base for further studies on the developmental mechanisms of mushroom stipes and the switch from egg to elongation in V. volvacea in particular.	[Tao, Yongxin; Zhu, Jian] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China; [Tao, Yongxin; van Peer, Arend F.; Chen, Bingzhi; Chen, Zhihong; Zhu, Jian; Deng, Youjin; Xie, Baogui] Fujian Agr & Forestry Univ, Coll Life Sci, Mycol Res Ctr, Fuzhou, Fujian, Peoples R China; [Jiang, Yuji] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China; [Li, Shaojie; Wu, Taju] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	van Peer, AF (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Mycol Res Ctr, Fuzhou, Fujian, Peoples R China.	arendvanpeer@gmail.com; mrcfafu@163.com	Li, Shaojie/AAH-2077-2020	van Peer, Arend/0000-0001-7023-0045	National Key Basic Research Program of China [2014CB138302]; China Agriculture Research System [CARS24]; Scientific Research Foundation of Graduate School of Fujian Agriculture and Forestry University [1122yb007]	National Key Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System; Scientific Research Foundation of Graduate School of Fujian Agriculture and Forestry University	This work was supported by grants from the National Key Basic Research Program of China (2014CB138302), the China Agriculture Research System (CARS24), and the Scientific Research Foundation of Graduate School of Fujian Agriculture and Forestry University (1122yb007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima T, 2004, FUNGAL GENET BIOL, V41, P805, DOI 10.1016/j.fgb.2004.04.003; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bussink HJ, 1999, FEMS MICROBIOL LETT, V173, P117, DOI 10.1016/S0378-1097(99)00060-9; CHANG ST, 1971, AM J BOT, V58, P552, DOI 10.2307/2441038; CHANG ST, 1977, ECON BOT, V31, P374, DOI 10.1007/BF02866890; CHAPMAN ES, 1973, MYCOPATH MYCOL APPL, V51, P315, DOI 10.1007/BF02057802; Chen SC, 2004, FEMS MICROBIOL LETT, V230, P171, DOI 10.1016/S0378-1097(03)00878-4; COX RJ, 1975, ARCH MICROBIOL, V105, P257, DOI 10.1007/BF00447144; CRAIG GD, 1977, J GEN MICROBIOL, V102, P337, DOI 10.1099/00221287-102-2-337; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Dickman MB, 1999, FUNGAL GENET BIOL, V26, P99, DOI 10.1006/fgbi.1999.1118; Ding SJ, 2007, FEMS MICROBIOL LETT, V267, P221, DOI 10.1111/j.1574-6968.2006.00550.x; EILERS FI, 1974, ARCH MICROBIOL, V96, P353, DOI 10.1007/BF00590190; GOODAY GW, 1974, T BRIT MYCOL SOC, V62, P391, DOI 10.1016/S0007-1536(74)80047-1; GRUEN HE, 1963, PLANT PHYSIOL, V38, P652, DOI 10.1104/pp.38.6.652; HAMMAD F, 1993, MYCOL RES, V97, P275, DOI 10.1016/S0953-7562(09)81120-9; HAMMAD F, 1993, MYCOL RES, V97, P269, DOI 10.1016/S0953-7562(09)81119-2; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; KAMADA T, 1977, PLANT CELL PHYSIOL, V18, P831; KAMADA T, 1983, J GEN MICROBIOL, V129, P703; KAMADA T, 1977, PLANT CELL PHYSIOL, V18, P1291, DOI 10.1093/oxfordjournals.pcp.a075551; KAMADA T, 1982, J GEN MICROBIOL, V128, P1041; KHER K, 1992, MYCOL RES, V96, P817, DOI 10.1016/S0953-7562(09)81028-9; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [Luo Lianzhong 罗联忠], 2004, [华中农业大学学报, Journal of Huazhong Agricultural University], V23, P61; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Mau JL, 1997, J AGR FOOD CHEM, V45, P4726, DOI 10.1021/jf9703314; Maurer-Stroh S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-212; MONTGOMERY GWG, 1984, J GEN MICROBIOL, V130, P291; MONZER J, 1994, EXP MYCOL, V18, P7, DOI 10.1006/emyc.1994.1002; MOORE D, 1979, NEW PHYTOL, V83, P695, DOI 10.1111/j.1469-8137.1979.tb02301.x; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muraguchi H, 2000, FUNGAL GENET BIOL, V29, P49, DOI 10.1006/fgbi.2000.1184; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Purschwitz J, 2006, CURR OPIN MICROBIOL, V9, P566, DOI 10.1016/j.mib.2006.10.011; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; Sakamoto Y, 2005, CURR GENET, V48, P195, DOI 10.1007/s00294-005-0002-9; Sakamoto Y, 2012, FOOD QUALITY; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; SCHWALB MN, 1974, J GEN MICROBIOL, V82, P209, DOI 10.1099/00221287-82-2-209; Shelest E, 2008, FEMS MICROBIOL LETT, V286, P145, DOI 10.1111/j.1574-6968.2008.01293.x; Shioya T, 2013, FUNGAL GENET BIOL, V58-59, P80, DOI 10.1016/j.fgb.2013.08.007; STEPHENSON NA, 1984, T BRIT MYCOL SOC, V82, P531, DOI 10.1016/S0007-1536(84)80017-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tao YX, 2013, GENE, V527, P154, DOI 10.1016/j.gene.2013.05.071; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Wang J, 2008, BIORESOURCE TECHNOL, V99, P8524, DOI 10.1016/j.biortech.2008.03.007; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Zhang ZF, 2010, NUCLEIC ACIDS RES, V38, pW743, DOI 10.1093/nar/gkq538	58	10	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97789	10.1371/journal.pone.0097789	http://dx.doi.org/10.1371/journal.pone.0097789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867220	gold, Green Submitted, Green Published			2022-12-27	WOS:000336914100023
J	Zarecki, R; Oberhardt, MA; Yizhak, K; Wagner, A; Segal, ES; Freilich, S; Henry, CS; Gophna, U; Ruppin, E				Zarecki, Raphy; Oberhardt, Matthew A.; Yizhak, Keren; Wagner, Allon; Segal, Ella Shtifman; Freilich, Shiri; Henry, Christopher S.; Gophna, Uri; Ruppin, Eytan			Maximal Sum of Metabolic Exchange Fluxes Outperforms Biomass Yield as a Predictor of Growth Rate of Microorganisms	PLOS ONE			English	Article							ESCHERICHIA-COLI; OPTIMIZATION; CONSTRAINT; OPTIMALITY; EXPRESSION; COMMUNITY; PHENOTYPE; BACTERIA; MODEL; PH	Growth rate has long been considered one of the most valuable phenotypes that can be measured in cells. Aside from being highly accessible and informative in laboratory cultures, maximal growth rate is often a prime determinant of cellular fitness, and predicting phenotypes that underlie fitness is key to both understanding and manipulating life. Despite this, current methods for predicting microbial fitness typically focus on yields [e. g., predictions of biomass yield using GEnome-scale metabolic Models (GEMs)] or notably require many empirical kinetic constants or substrate uptake rates, which render these methods ineffective in cases where fitness derives most directly from growth rate. Here we present a new method for predicting cellular growth rate, termed SUMEX, which does not require any empirical variables apart from a metabolic network (i.e., a GEM) and the growth medium. SUMEX is calculated by maximizing the SUM of molar EXchange fluxes (hence SUMEX) in a genome-scale metabolic model. SUMEX successfully predicts relative microbial growth rates across species, environments, and genetic conditions, outperforming traditional cellular objectives (most notably, the convention assuming biomass maximization). The success of SUMEX suggests that the ability of a cell to catabolize substrates and produce a strong proton gradient enables fast cell growth. Easily applicable heuristics for predicting growth rate, such as what we demonstrate with SUMEX, may contribute to numerous medical and biotechnological goals, ranging from the engineering of faster-growing industrial strains, modeling of mixed ecological communities, and the inhibition of cancer growth.	[Zarecki, Raphy; Oberhardt, Matthew A.; Yizhak, Keren; Wagner, Allon; Ruppin, Eytan] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Zarecki, Raphy; Oberhardt, Matthew A.; Yizhak, Keren; Wagner, Allon; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Oberhardt, Matthew A.; Segal, Ella Shtifman; Gophna, Uri] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Freilich, Shiri] Agr Res Org, Newe Yaar Res Ctr, Ramat Yishay, Israel; [Henry, Christopher S.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; United States Department of Energy (DOE); Argonne National Laboratory	Oberhardt, MA (corresponding author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.	mattoby@gmail.com; ruppin@post.tau.ac.il	Gophna, Uri/AAS-8376-2020; Ruppin, Eytan/R-9698-2017	Gophna, Uri/0000-0001-5129-5652; Ruppin, Eytan/0000-0002-7862-3940; Wagner, Allon/0000-0001-5095-6009	Whitaker Foundation; Dan David Fellowship; EU; Israeli Science Foundation (ISF); Israeli Centers of Research Excellence (I-CORE); McDonnell foundation; Israeli Ministry of Health; German-Israeli Project Cooperation (DIP)	Whitaker Foundation; Dan David Fellowship; EU(European Commission); Israeli Science Foundation (ISF)(Israel Science Foundation); Israeli Centers of Research Excellence (I-CORE); McDonnell foundation; Israeli Ministry of Health; German-Israeli Project Cooperation (DIP)	MO gratefully acknowledges funding from the Whitaker Foundation (Whitaker International Scholars Program) and the Dan David Fellowship; ER gratefully acknowledges support from the EU FP7 Microme project, the Israeli Science Foundation (ISF), the Israeli Centers of Research Excellence (I-CORE), and the McDonnell foundation. UG is supported by the McDonnell foundation, the Israeli Ministry of Health and the German-Israeli Project Cooperation (DIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Groeneveld P, 2009, FEBS J, V276, P254, DOI 10.1111/j.1742-4658.2008.06778.x; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Knorr AL, 2006, BIOINFORMATICS; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oh YK, 2007, J BIOL CHEM; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Soga N, 2012, J BIOL CHEM, V287, P9633, DOI 10.1074/jbc.M111.335356; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Vazquez A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-7; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Whiteley M, 2001, ENVIRON MICROBIOL, V3, P43, DOI 10.1046/j.1462-2920.2001.00158.x; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]	29	7	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98372	10.1371/journal.pone.0098372	http://dx.doi.org/10.1371/journal.pone.0098372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866123	Green Submitted, Green Published, gold			2022-12-27	WOS:000336914100054
J	Erion, DM; Lapworth, A; Amor, PA; Bai, GY; Vera, NB; Clark, RW; Yan, QY; Zhu, YM; Ross, TT; Purkal, J; Gorgoglione, M; Zhang, GD; Bonato, V; Baker, L; Barucci, N; D'Aquila, T; Robertson, A; Aiello, RJ; Yan, JL; Trimmer, J; Rolph, TP; Pfefferkorn, JA				Erion, Derek M.; Lapworth, Amanda; Amor, Paul A.; Bai, Guoyun; Vera, Nicholas B.; Clark, Ronald W.; Yan, Qingyun; Zhu, Yimin; Ross, Trenton T.; Purkal, Julie; Gorgoglione, Matthew; Zhang, Guodong; Bonato, Vinicius; Baker, Levenia; Barucci, Nicole; D'Aquila, Theresa; Robertson, Alan; Aiello, Robert J.; Yan, Jiangli; Trimmer, Jeff; Rolph, Timothy P.; Pfefferkorn, Jeffrey A.			The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats	PLOS ONE			English	Article							PLASMA-GLUCOSE; FATTY LIVER; HIGH-YIELD; INSULIN; EXPRESSION; HYPOGLYCEMIA; HOMEOSTASIS; METABOLISM; DISCOVERY; MK-0941	Hyperglycemia resulting from type 2 diabetes mellitus (T2DM) is the main cause of diabetic complications such as retinopathy and neuropathy. A reduction in hyperglycemia has been shown to prevent these associated complications supporting the importance of glucose control. Glucokinase converts glucose to glucose-6-phosphate and determines glucose flux into the beta-cells and hepatocytes. Since activation of glucokinase in beta-cells is associated with increased risk of hypoglycemia, we hypothesized that selectively activating hepatic glucokinase would reduce fasting and postprandial glucose with minimal risk of hypoglycemia. Previous studies have shown that hepatic glucokinase overexpression is able to restore glucose homeostasis in diabetic models; however, these overexpression experiments have also revealed that excessive increases in hepatic glucokinase activity may also cause hepatosteatosis. Herein we sought to evaluate whether liver specific pharmacological activation of hepatic glucokinase is an effective strategy to reduce hyperglycemia without causing adverse hepatic lipids changes. To test this hypothesis, we evaluated a hepatoselective glucokinase activator, PF-04991532, in Goto-Kakizaki rats. In these studies, PF-04991532 reduced plasma glucose concentrations independent of changes in insulin concentrations in a dose-dependent manner both acutely and after 28 days of sub-chronic treatment. During a hyperglycemic clamp in Goto-Kakizaki rats, the glucose infusion rate was increased approximately 5-fold with PF-04991532. This increase in glucose infusion can be partially attributed to the 60% reduction in endogenous glucose production. While PF-04991532 induced dose-dependent increases in plasma triglyceride concentrations it had no effect on hepatic triglyceride concentrations in Goto-Kakizaki rats. Interestingly, PF-04991532 decreased intracellular AMP concentrations and increased hepatic futile cycling. These data suggest that hepatoselective glucokinase activation may offer glycemic control without inducing hepatic steatosis supporting the evaluation of tissue specific activators in clinical trials.	[Erion, Derek M.; Lapworth, Amanda; Amor, Paul A.; Vera, Nicholas B.; Clark, Ronald W.; Yan, Qingyun; Zhu, Yimin; Ross, Trenton T.; Purkal, Julie; Gorgoglione, Matthew; Bonato, Vinicius; Baker, Levenia; Barucci, Nicole; D'Aquila, Theresa; Robertson, Alan; Aiello, Robert J.; Trimmer, Jeff; Rolph, Timothy P.; Pfefferkorn, Jeffrey A.] Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis Res Unit, Cambridge, MA USA; [Bai, Guoyun; Zhang, Guodong; Yan, Jiangli] Pfizer Worldwide Res & Dev, Groton Ctr Chem, Groton, CT USA	Pfizer; Pfizer	Erion, DM (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis Res Unit, Cambridge, MA USA.	derek.erion@pfizer.com	Bonato, Vinicius/G-5818-2010	Bonato, Vinicius/0000-0003-2807-5859	Pfizer	Pfizer(Pfizer)	Pfizer provided funding for this study. The funder provided support in the form of salaries for authors DME, AL, PAA, GB, NBV, RWC, QY, YZ, TTR, JP, MG, GZ, VB, LB, NB, TD, AR, RJA, JY, JT, TPR, and JAP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; AIELLO RJ, 1984, J DAIRY SCI, V67, P1707, DOI 10.3168/jds.S0022-0302(84)81496-4; Bebernitz GR, 2009, J MED CHEM, V52, P6142, DOI 10.1021/jm900839k; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; CARO JF, 1995, HORM METAB RES, V27, P19, DOI 10.1055/s-2007-979899; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; FOLCH J, 1957, J BIOL CHEM, V226, P497; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Futamura M, 2012, DIABETOLOGIA, V55, P1071, DOI 10.1007/s00125-011-2439-3; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; HEALEY EC, 2013, CHRONIC DOSING LIVER; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kazierad D., 2013, 73 AM DIAB C CHIC IL; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KIYOSUE A, 2013, DIABETES OBES METAB; Kozian DH, 2010, HORM METAB RES, V42, P502, DOI 10.1055/s-0030-1249637; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Massa ML, 2011, IUBMB LIFE, V63, P1, DOI 10.1002/iub.411; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; MILLS SE, 1981, J DAIRY SCI, V64, P1719, DOI 10.3168/jds.S0022-0302(81)82752-X; MOOKHTIEAR KA, 2012, 72 AM DIAB ASS M PHI; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Pfefferkorn JA, 2013, EXPERT OPIN DRUG DIS, V8, P319, DOI 10.1517/17460441.2013.748744; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; SHULMAN GI, 1985, J CLIN INVEST, V76, P757, DOI 10.1172/JCI112032; SMITH D, 1987, METABOLISM, V36, P1167, DOI 10.1016/0026-0495(87)90244-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Torres TP, 2009, DIABETES, V58, P78, DOI 10.2337/db08-1119; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; Waring MJ, 2011, MEDCHEMCOMM, V2, P771, DOI 10.1039/c1md00090j; WILDING JP, 2013, DIABETES OBES METAB; Winzell MS, 2011, EUR J PHARMACOL, V663, P80, DOI 10.1016/j.ejphar.2011.05.009; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b	53	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97139	10.1371/journal.pone.0097139	http://dx.doi.org/10.1371/journal.pone.0097139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858947	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400008
J	Brodowski, L; Burlakov, J; Myerski, AC; von Kaisenberg, CS; Grundmann, M; Hubel, CA; von Versen-Hoynck, F				Brodowski, Lars; Burlakov, Jennifer; Myerski, Ashley C.; von Kaisenberg, Constantin S.; Grundmann, Magdalena; Hubel, Carl A.; von Versen-Hoeynck, Frauke			Vitamin D Prevents Endothelial Progenitor Cell Dysfunction Induced by Sera from Women with Preeclampsia or Conditioned Media from Hypoxic Placenta	PLOS ONE			English	Article							COLONY-FORMING CELLS; 1,25-DIHYDROXYVITAMIN D-3; INHIBITS ANGIOGENESIS; D SUPPLEMENTATION; D-RECEPTOR; IN-VITRO; EXPRESSION; RISK; OXYGEN; PROLIFERATION	Context: Placenta-derived circulating factors contribute to the maternal endothelial dysfunction underlying preeclampsia. Endothelial colony forming cells (ECFC), a sub-population of endothelial progenitor cells (EPCs), are thought to be involved in vasculogenesis and endothelial repair. Low vitamin D concentrations are associated with an increased risk for preeclampsia. Objective: We hypothesized that the function of human fetal ECFCs in culture would be suppressed by exposure to preeclampsia-related factors-preeclampsia serum or hypoxic placental conditioned medium-in a fashion reversed by vitamin D. Design, Setting, Patients: ECFCs were isolated from cord blood of uncomplicated pregnancies and expanded in culture. Uncomplicated pregnancy villous placenta in explant culture were exposed to either 2% (hypoxic), 8% (normoxic) or 21% (hyperoxic) O-2 for 48 h, after which the conditioned media (CM) was collected. Outcome Measures: ECFC tubule formation (Matrigel assay) and migration were examined in the presence of either maternal serum from preeclampsia cases or uncomplicated pregnancy controls, or pooled CM, in the presence or absence of 1,25(OH)(2) vitamin D-3. Results: 1,25(OH)(2) vitamin D-3 reversed the adverse effects of preeclampsia serum or CM from hypoxic placenta on ECFCs capillary-tube formation and migration. Silencing of VDR expression by VDR siRNA, VDR blockade, or VEGF pathway blockade reduced ECFC functional abilities. Effects of VDR or VEGF blockade were partially prevented by vitamin D. Conclusion: Vitamin D promotes the capillary-like tubule formation and migration of ECFCs in culture, minimizing the negative effects of exposure to preeclampsia-related factors. Further evaluation of the role of vitamin D in ECFC regulation and preeclampsia is warranted.	[Brodowski, Lars; Burlakov, Jennifer; von Kaisenberg, Constantin S.; Grundmann, Magdalena; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany; [Myerski, Ashley C.; Hubel, Carl A.] Univ Pittsburgh, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA	Hannover Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Hubel, CA (corresponding author), Univ Pittsburgh, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA.	chubel@mwri.magee.edu; vonVersen-Hoynck.Frauke@mh-hannover.de	von Versen-Höynck, Frauke/H-3719-2019; von Kaisenberg, Constantin/AAR-2756-2021	von Versen-Höynck, Frauke/0000-0002-1924-5695; 	National Institutes of Health [P01HD030367, UL1RR024153, UL1TR000005]; HiLF - Hannover Medical School; Boehringer Ingelheim Fonds travel grant program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HiLF - Hannover Medical School; Boehringer Ingelheim Fonds travel grant program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by National Institutes of Health P01HD030367 (CAH), UL1RR024153 and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute), and a HiLF grant by Hannover Medical School. LB was supported by the Boehringer Ingelheim Fonds travel grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Asahara T, 2002, J HEMATOTH STEM CELL, V11, P171, DOI 10.1089/152581602753658385; Bainbridge SA, 2009, AM J PHYSIOL-CELL PH, V297, pC440, DOI 10.1152/ajpcell.00593.2008; Barrera D, 2012, CYTOKINE, V57, P316, DOI 10.1016/j.cyto.2011.11.020; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Cardus A, 2009, ATHEROSCLEROSIS, V204, P85, DOI 10.1016/j.atherosclerosis.2008.08.020; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Dunn WB, 2009, PLACENTA, V30, P974, DOI 10.1016/j.placenta.2009.08.008; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Halhali A, 2004, J STEROID BIOCHEM, V89-90, P553, DOI 10.1016/j.jsbmb.2004.03.069; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hypponen E, 2007, EUR J CLIN NUTR, V61, P1136, DOI 10.1038/sj.ejcn.1602625; Ilekis JV, 2007, REPROD SCI, V14, P508, DOI 10.1177/1933719107306232; Ingram DA, 2008, DIABETES, V57, P724, DOI 10.2337/db07-1507; Lin C, 2009, AM J HYPERTENS, V22, P1014, DOI 10.1038/ajh.2009.101; Liu NQ, 2013, ENDOCRINOLOGY, V154, P2270, DOI 10.1210/en.2012-2270; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reynolds J, 2014, LANCET, V383, P89; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Robinson CJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.03.022; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sipos PI, 2013, J CLIN ENDOCR METAB, V98, P4953, DOI 10.1210/jc.2013-2580; Sipos PI, 2013, STEM CELLS, V31, P1363, DOI 10.1002/stem.1385; SIPOS PI, 2009, PLACENTA; Smarason AK, 1996, AM J OBSTET GYNECOL, V174, P787, DOI 10.1016/S0002-9378(96)70466-0; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; Tare M, 2011, J PHYSIOL-LONDON, V589, P4777, DOI 10.1113/jphysiol.2011.214726; von Versen-Hoynck F, 2009, PLACENTA, V30, P434, DOI 10.1016/j.placenta.2009.02.004; Wang YP, 2004, AM J OBSTET GYNECOL, V190, P817, DOI 10.1016/j.ajog.2003.09.049	49	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98527	10.1371/journal.pone.0098527	http://dx.doi.org/10.1371/journal.pone.0098527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887145	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300076
J	Eden, AS; Zwitserlood, P; Keuper, K; Junghofer, M; Laeger, I; Zwanzger, P; Dobel, C				Eden, Annuschka Salima; Zwitserlood, Pienie; Keuper, Katharina; Junghoefer, Markus; Laeger, Inga; Zwanzger, Peter; Dobel, Christian			All in Its Proper Time: Monitoring the Emergence of a Memory Bias for Novel, Arousing-Negative Words in Individuals with High and Low Trait Anxiety	PLOS ONE			English	Article							IMPLICIT MEMORY; CONDITIONED FEAR; AUDITORY-CORTEX; EXPLICIT MEMORY; EMOTIONAL WORDS; FREE-RECALL; LONG-TERM; SLEEP; CONSOLIDATION; DISORDERS	The well-established memory bias for arousing-negative stimuli seems to be enhanced in high trait-anxious persons and persons suffering from anxiety disorders. We monitored the emergence and development of such a bias during and after learning, in high and low trait anxious participants. A word-learning paradigm was applied, consisting of spoken pseudowords paired either with arousing-negative or neutral pictures. Learning performance during training evidenced a short-lived advantage for arousing-negative associated words, which was not present at the end of training. Cued recall and valence ratings revealed a memory bias for pseudowords that had been paired with arousing-negative pictures, immediately after learning and two weeks later. This held even for items that were not explicitly remembered. High anxious individuals evidenced a stronger memory bias in the cued-recall test, and their ratings were also more negative overall compared to low anxious persons. Both effects were evident, even when explicit recall was controlled for. Regarding the memory bias in anxiety prone persons, explicit memory seems to play a more crucial role than implicit memory. The study stresses the need for several time points of bias measurement during the course of learning and retrieval, as well as the employment of different measures for learning success.	[Eden, Annuschka Salima; Keuper, Katharina; Junghoefer, Markus; Dobel, Christian] Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Zwitserlood, Pienie] Univ Munster, Inst Psychol, D-48149 Munster, Germany; [Laeger, Inga; Zwanzger, Peter] Univ Hosp Munster, Dept Psychiat, Munster, Germany	University of Munster; University of Munster; University of Munster	Eden, AS (corresponding author), Univ Hosp Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	Annuschka.Eden@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986; Roesmann (Keuper), Kati/0000-0001-6940-3551	Interdisziplinares Zentrums fur Klinische Forschung Munster, IZKF (Interdisciplinary Center for Clinical Research of Muenster) [Do3/021/10]	Interdisziplinares Zentrums fur Klinische Forschung Munster, IZKF (Interdisciplinary Center for Clinical Research of Muenster)	This work was supported by Interdisziplinares Zentrums fur Klinische Forschung Munster, IZKF (Interdisciplinary Center for Clinical Research of Muenster) (http://campus.uni-muenster.de/3855.html) project number: Do3/021/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012131; BAAYEN R, 1995, CELEX DATABASE; BAEYENS F, 1990, COGNITION EMOTION, V4, P3, DOI 10.1080/02699939008406760; BAEYENS F, 1988, ADV BEHAV RES THER, V10, P179, DOI 10.1016/0146-6402(88)90014-8; Barlow DH, 2002, ANXIETY ITS DISORDER; Betsch T, 2001, PERS SOC PSYCHOL B, V27, P242, DOI 10.1177/0146167201272009; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Breitenstein C, 2007, RESTOR NEUROL NEUROS, V25, P493; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CALVO MG, 1994, COGNITION EMOTION, V8, P127, DOI 10.1080/02699939408408932; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; Davis MH, 2009, J COGNITIVE NEUROSCI, V21, P803, DOI 10.1162/jocn.2009.21059; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; DEUTSCH JA, 1971, SCIENCE, V174, P788, DOI 10.1126/science.174.4011.788; Dienes Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033400; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Dobel C, 2009, PHILOS T R SOC B, V364, P3697, DOI 10.1098/rstb.2009.0158; Dowens MG, 2003, COGNITION EMOTION, V17, P843, DOI 10.1080/02699930244000381; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; EYSENCK MW, 1994, COGNITION EMOTION, V8, P415, DOI 10.1080/02699939408408950; Flaisch T, 2011, SOC COGN AFFECT NEUR, V6, P109, DOI 10.1093/scan/nsq022; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friedman BH, 2001, BEHAV THER, V31, P745; Fritsch N, 2013, BRAIN LANG, V124, P75, DOI 10.1016/j.bandl.2012.12.001; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; Galvan VV, 2002, NEUROBIOL LEARN MEM, V77, P78, DOI 10.1006/nlme.2001.4044; Graves L, 2001, TRENDS NEUROSCI, V24, P237, DOI 10.1016/S0166-2236(00)01744-6; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; HEUER F, 1990, MEM COGNITION, V18, P496, DOI 10.3758/BF03198482; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kaestner EJ, 2013, J COGNITIVE NEUROSCI, V25, P1597, DOI 10.1162/jocn_a_00433; Keuper K, 2012, HUM BRAIN MAPP; Keuper K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070788; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; Lang P. J., 1999, INT AFFECTIVE PICTUR; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux JE, 2011, MEMORY PROCESS NEURO, P153; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2010, Z PSYCHOL, V218, P146, DOI 10.1027/0044-3409/a000022; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Mac Macmillan NA, 1991, DETECTION THEORY USE; McCabe RE, 1999, COGNITIVE THER RES, V23, P21, DOI 10.1023/A:1018706607051; Mineka S, 1996, Nebr Symp Motiv, V43, P135; Mitte K, 2008, PSYCHOL BULL, V134, P886, DOI 10.1037/a0013343; Muhlberger A, 2009, J NEURAL TRANSM, V116, P735, DOI 10.1007/s00702-008-0108-6; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Norton G. R., 1988, J ANXIETY DIORD, V2, P169, DOI DOI 10.1016/0887-6185(88)90023-0; Olson MA, 2001, PSYCHOL SCI, V12, P413, DOI 10.1111/1467-9280.00376; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Russo R, 2006, MEMORY, V14, P393, DOI 10.1080/09658210500343166; Russo R, 1999, COGNITION EMOTION, V13, P435, DOI 10.1080/026999399379258; SCHEICH H, 1992, NATO ADV SCI I D-BEH, V68, P447; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Sharot T, 2004, COGN AFFECT BEHAV NE, V4, P294, DOI 10.3758/CABN.4.3.294; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STARR A, 1970, NEUROPSYCHOLOGIA, V8, P75, DOI 10.1016/0028-3932(70)90027-8; Steinberg C, 2012, J COGNITIVE NEUROSCI, V24, P17, DOI 10.1162/jocn_a_00067; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Touryan SR, 2007, MEMORY, V15, P154, DOI 10.1080/09658210601151310; Waldhauser GT, 2011, SCAND J PSYCHOL, V52, P21, DOI 10.1111/j.1467-9450.2010.00845.x; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yegiyan NS, 2011, COGNITION EMOTION, V25, P1255, DOI 10.1080/02699931.2010.540821; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	87	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98339	10.1371/journal.pone.0098339	http://dx.doi.org/10.1371/journal.pone.0098339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24887093	Green Published, gold			2022-12-27	WOS:000336956300056
J	Kirkby, NS; Lundberg, MH; Wright, WR; Warner, TD; Paul-Clark, MJ; Mitchell, JA				Kirkby, Nicholas S.; Lundberg, Martina H.; Wright, William R.; Warner, Timothy D.; Paul-Clark, Mark J.; Mitchell, Jane A.			COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks	PLOS ONE			English	Article							E-KNOCKOUT MOUSE; GASTROINTESTINAL TOXICITY; CYCLOOXYGENASE INHIBITION; ANTIINFLAMMATORY DRUGS; ATHEROGENESIS; BIOSYNTHESIS; EXPRESSION; MODEL; CYCLO-OXYGENASE-2; THROMBOXANE	Cyxlo-oxygenase (COX)-2 inhibitors, including traditional nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with increased cardiovascular side effects, including myocardial infarction. We and others have shown that COX-1 and not COX-2 drives vascular prostacyclin in the healthy cardiovascular system, re-opening the question of how COX-2 might regulate cardiovascular health. In diseased, atherosclerotic vessels, the relative contribution of COX-2 to prostacyclin formation is not clear. Here we have used apoE(-/-)/COX-2(-/-) mice to show that, whilst COX-2 profoundly limits atherosclerosis, this protection is independent of local prostacyclin release. These data further illustrate the need to look for new explanations, targets and pathways to define the COX/NSAID/cardiovascular risk axis. Gene expression profiles in tissues from apoE(-/-)/COX-2(-/-) mice showed increased lymphocyte pathways that were validated by showing increased T-lymphocytes in plaques and elevated plasma Th1-type cytokines. In addition, we identified a novel target gene, rgl1, whose expression was strongly reduced by COX-2 deletion across all examined tissues. This study is the first to demonstrate that COX-2 protects vessels against atherosclerotic lesions independently of local vascular prostacyclin and uses systems biology approaches to identify new mechanisms relevant to development of next generation NSAIDs.	[Kirkby, Nicholas S.; Lundberg, Martina H.; Wright, William R.; Paul-Clark, Mark J.; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kirkby, Nicholas S.; Lundberg, Martina H.; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England	Imperial College London; University of London; Queen Mary University London	Kirkby, NS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	n.kirkby@imperial.ac.uk; j.a.mitchell@imperial.ac.uk	Warner, Timothy D/A-1980-2009; Slingsby, Martina H/B-1476-2015	Warner, Timothy D/0000-0003-3988-4408; Kirkby, Nicholas/0000-0003-3509-8549; Slingsby, Martina H/0000-0002-2620-7582	Wellcome Trust [0852551Z108/Z]; National Institutes of Health	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Wellcome Trust program grant 0852551Z108/Z. This forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Baker CSR, 1999, ARTERIOSCL THROM VAS, V19, P646, DOI 10.1161/01.ATV.19.3.646; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Belton OA, 2003, CIRCULATION, V108, P3017, DOI 10.1161/01.CIR.0000104565.78013.AD; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Chan ESL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2109; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; De Beer MC, 2014, ARTERIOSCL THROM VAS, V34, P255, DOI 10.1161/ATVBAHA.113.302247; Egan KM, 2005, CIRCULATION, V111, P334, DOI 10.1161/01.CIR.0000153386.95356.78; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Rodriguez LAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016780; Gitlin JM, 2009, CARDIOVASC RES, V81, P400, DOI 10.1093/cvr/cvn286; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; GRYGLEWSKI RJ, 1978, ATHEROSCLEROSIS, V31, P385, DOI 10.1016/0021-9150(78)90133-8; Hernandez-Presa MA, 2002, ATHEROSCLEROSIS, V160, P49, DOI 10.1016/S0021-9150(01)00547-0; Hui YQ, 2010, CIRCULATION, V121, P2654, DOI 10.1161/CIRCULATIONAHA.109.910687; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Kirkby NS, 2013, FASEB J, V27, P3938, DOI 10.1096/fj.12-215533; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; Kirkby NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016906; Klingenberg R, 2007, ARTERIOSCL THROM VAS, V27, P2392, DOI 10.1161/ATVBAHA.107.149476; Koki A, 2002, ADV EXP MED BIOL, V507, P177; Liu B., 2012, FOOD BIOPROCESS TECH, V1, P1; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; MATTSSON E, 1993, EUR J SURG, V159, P15; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; MEHTA JL, 1988, P NATL ACAD SCI USA, V85, P4511, DOI 10.1073/pnas.85.12.4511; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Narasimha A, 2007, PROSTAG OTH LIPID M, V84, P24, DOI 10.1016/j.prostaglandins.2007.03.004; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Olesen M, 2002, SCAND CARDIOVASC J, V36, P362, DOI 10.1080/140174302762659094; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rocca B, 2002, EUR J IMMUNOL, V32, P1482, DOI 10.1002/1521-4141(200205)32:5<1482::AID-IMMU1482>3.0.CO;2-O; Rott D, 2003, J AM COLL CARDIOL, V41, P1812, DOI 10.1016/S0735-1097(03)00304-8; Stemme V, 2000, EUR J VASC ENDOVASC, V20, P146, DOI 10.1053/ejvs.2000.1145; Tang SY, 2014, CIRCULATION; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2008, LANCET, V371, P270, DOI 10.1016/S0140-6736(08)60137-3; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wong E, 2001, ATHEROSCLEROSIS, V157, P393, DOI 10.1016/S0021-9150(00)00756-5; Yu Z, 2012, P NATL ACAD SCI USA, V109, P6727, DOI 10.1073/pnas.1115313109; Zhou Y, 2013, EXPT PHYSL	52	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98165	10.1371/journal.pone.0098165	http://dx.doi.org/10.1371/journal.pone.0098165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887395	Green Submitted, gold, Green Published			2022-12-27	WOS:000336956300042
J	Beg, MS; Dwivedi, AK; Ahmad, SA; Ali, S; Olowokure, O				Beg, Muhammad Shaalan; Dwivedi, Alok Kumar; Ahmad, Syed Arif; Ali, Sadia; Olowokure, Olugbenga			Impact of Diabetes Mellitus on the Outcome of Pancreatic Cancer	PLOS ONE			English	Article							GLUCOSE-METABOLISM; ADENOCARCINOMA; SURVIVAL; CACHEXIA; RESECTION; INSULIN; METAANALYSIS; METFORMIN; WORSENS; OBESITY	Diabetes mellitus (DM) has the potential to impact the pathogenesis, treatment, and outcome of pancreatic cancer. This study evaluates the impact of DM on pancreatic cancer survival. Methods: We conducted a retrospective cohort study from the Veterans Affairs (VA) Central Cancer Registry (VACCR) for pancreatic cancer cases between 1995 and 2008. DM and no-DM cases were identified from comorbidity data. Univariate and multivariable analysis was performed. Multiple imputation method was employed to account for missing variables. Results: Of 8,466 cases of pancreatic cancer DM status was known in 4728 cases that comprised this analysis. Males accounted for 97.7% cases, and 78% were white. Overall survival was 4.2 months in DM group and 3.6 months in the no-DM group. In multivariable analysis, DM had a HR = 0.91 (0.849-0.974). This finding persisted after accounting for missing variables using multiple imputations method with the HR in DM group of 0.93 (0.867-0.997). Conclusions: Our data suggest DM is associated with a reduction in risk of death in pancreatic cancer. Future studies should be directed towards examining this association, specifically impact of DM medications on cancer outcome.	[Beg, Muhammad Shaalan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Dwivedi, Alok Kumar] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Div Biostat & Epidemiol, El Paso, TX USA; [Ahmad, Syed Arif] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Ali, Sadia] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA; [Olowokure, Olugbenga] Univ Cincinnati, Coll Med, Div Hematol Oncol, Cincinnati, OH USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Tech University System; Texas Tech University; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati	Beg, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA.	Muhammad.Beg@UTSouthwestern.edu			National Institutes of Health (NIH) [KL2TR00103]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was conducted with support from a National Institutes of Health (NIH) grant (KL2TR00103) awarded to MSB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; Baracos VE, 2001, CANCER, V92, P1669, DOI 10.1002/1097-0142(20010915)92:6+<1669::AID-CNCR1495>3.0.CO;2-S; BASSO D, 1995, INT J CLIN LAB RES, V25, P40, DOI 10.1007/BF02592575; Ben QW, 2012, DIABETES-METAB RES, V28, P169, DOI 10.1002/dmrr.1284; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Bowker SL, 2006, DIABETES CARE, V29, P1990, DOI 10.2337/dc06-0997; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Busaidy NL, 2006, J CLIN ONCOL, V24, p202S; Call R, 2010, POSTGRAD MED, V122, P158, DOI 10.3810/pgm.2010.05.2153; Cannon RM, 2012, HPB, V14, P228, DOI 10.1111/j.1477-2574.2011.00432.x; Chagpar RB, 2011, J GASTROINTEST SURG, V15, P551, DOI 10.1007/s11605-011-1448-3; Chu CK, 2010, J AM COLL SURGEONS, V210, P463, DOI 10.1016/j.jamcollsurg.2009.12.029; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dehayem YM, 2011, ANN ENDOCRINOL-PARIS, V72, P24, DOI 10.1016/j.ando.2010.10.001; Hsu CC, 2012, J GASTROINTEST SURG, V16, P753, DOI 10.1007/s11605-011-1811-4; Huizinga Mary Margaret, 2007, Diabetes Care, V30, pe85, DOI 10.2337/dc07-0650; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Little R. J. A., 1987, STAT ANAL MISSING DA; Pausch T, 2012, SURGERY, V152, pS81, DOI 10.1016/j.surg.2012.05.028; PERMERT J, 1993, BRIT J SURG, V80, P1047, DOI 10.1002/bjs.1800800841; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Syrigos KN, 1996, INT J CANCER, V66, P624, DOI 10.1002/(SICI)1097-0215(19960529)66:5<624::AID-IJC7>3.0.CO;2-V; Talar-Wojnarowska R, 2003, NEOPLASMA, V50, P383; TAYEK JA, 1992, J AM COLL NUTR, V11, P445; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Wakasugi Hideyuki, 2001, International Journal of Clinical Oncology, V6, P50, DOI 10.1007/PL00012080	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98511	10.1371/journal.pone.0098511	http://dx.doi.org/10.1371/journal.pone.0098511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879130	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500065
J	Paz, FPC; Batista, JD; Porto, JIR				Castro Paz, Francis Paola; Batista, Jacqueline da Silva; Rebelo Porto, Jorge Ivan			DNA Barcodes of Rosy Tetras and Allied Species (Characiformes: Characidae: Hyphessobrycon) from the Brazilian Amazon Basin	PLOS ONE			English	Article							FRESH-WATER FISHES; DIVERSITY; DIVERGENCE	DNA barcoding can be an effective tool for fast and accurate species-level identification based on sequencing of the mitochondrial cytochrome c oxidase subunit (COI) gene. The diversity of this fragment can be used to estimate the richness of the respective species. In this study, we explored the use of DNA barcoding in a group of ornamental freshwater fish of the genus Hyphessobrycon. We sequenced the COI from 10 species of Hyphessobrycon belonging to the "Rosy Tetra Clade'' collected from the Amazon and Negro River basins and combined our results with published data. The average conspecific and congeneric Kimura 2-parameter distances were 2.3% and 19.3%, respectively. Six of the 10 species were easily distinguishable by DNA barcoding (H. bentosi, H. copelandi, H. eques, H. epicharis, H. pulchrippinis, and H. sweglesi), whereas the remaining species (H. erythrostigma, H. pyrrhonotus, H. rosaceus and H. socolofi) lacked reciprocal monophyly. Although the COI gene was not fully diagnostic, the discovery of distinct evolutionary units in certain Hyphessobrycon species under the same specific epithet as well as haplotype sharing between different species suggest that DNA barcoding is useful for species identification in this speciose genus.	[Castro Paz, Francis Paola] Univ Ricardo Palma, Fac Ciencias Biol, Surco, Peru; [Batista, Jacqueline da Silva] Inst Nacl de Pesquisas da Amazonia, Lab Temat Biol Mol Coordenacao Biodiversidade, Manaus, AM, Brazil; [Rebelo Porto, Jorge Ivan] Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim Coordenacao Biodiversidade, Manaus, AM, Brazil	Universidad Ricardo Palma; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Paz, FPC (corresponding author), Univ Ricardo Palma, Fac Ciencias Biol, Surco, Peru.	francispcpaz@gmail.com	da Silva Batista, Jacqueline/AAD-4349-2020; Porto, Jorge/K-1441-2014; Porto, Jorge/T-4694-2019	da Silva Batista, Jacqueline/0000-0002-6649-6200; Porto, Jorge/0000-0003-1393-6492; 	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FPCP received a scholarship from the CNPq. Lab research has been continuously supported by the CNPq, CAPES and FAPEAM to JSB and JIRP. This work is part of the Brazilian Barcode of Life (BrBOL) initative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Amaral CRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074397; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Asgharian H, 2011, MOL ECOL RESOUR, V11, P461, DOI 10.1111/j.1755-0998.2011.02989.x; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Carvalho FR, 2013, NEOTROP ICHTHYOL, V11, P525, DOI 10.1590/S1679-62252013000300006; Colatreli Olavo Pinhatti, 2012, International Journal of Evolutionary Biology, P1; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; de Carvalho Daniel C, 2011, Mitochondrial DNA, V22 Suppl 1, P80, DOI 10.3109/19401736.2011.588214; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eigenmann C. H., 1918, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge Mass, V43; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Eigenmann CH, 1908, B MUS COMP ZOOL HARV, V52, P93; Eschmeyer WN, 2012, SPECIES FISHES FAMIL; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Froese R, 2013, FISHBASE WORLD WIDE; Garcia-Alzate CA, 2011, REV BIOL TROP, V59, P709; Gery J., 1977, CHARACOIDS WORLD; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hillis DM, 1997, REV ECOL SYST, V18, P23; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Kadarusman, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040627; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lima FCT, 1993, CHECKLIST FRESHWATER, P106; Lima Flavio C.T., 2001, Ichthyological Exploration of Freshwaters, V12, P105; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Roxo FF, 2012, ZOOTAXA, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toffoli D, 2008, GENET MOL BIOL, V31, P324, DOI 10.1590/S1415-47572008000200028; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; WEITZMAN S H, 1983, Bulletin of the Museum of Comparative Zoology, V150, P339; Weitzman SH, 1997, ICHTHYOL EXPLOR FRES, V10, P1; Weitzman Stanley H., 1998, P161; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	55	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98603	10.1371/journal.pone.0098603	http://dx.doi.org/10.1371/journal.pone.0098603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878569	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500073
J	Gil-Lopez, MJ; Segarra-Moragues, JG; Ojeda, F				Gil-Lopez, Manuel Jesus; Segarra-Moragues, Jose Gabriel; Ojeda, Fernando			Population Genetic Structure of a Sandstone Specialist and a Generalist Heath Species at Two Levels of Sandstone Patchiness across the Strait of Gibraltar	PLOS ONE			English	Article							HABITAT FRAGMENTATION; DIVERSITY; PLANT; SOFTWARE; DISTANCE; DIFFERENTIATION; CONSEQUENCES; DETERMINANTS; BIODIVERSITY; RESPROUTER	Many habitat specialist species are originally composed of small, discontinuous populations because their habitats are naturally fragmented or patchy. They may have suffered the long-term effects of natural patchiness. Mediterranean heathlands, a representative habitat in the Strait of Gibraltar region, are associated with nutrient-poor, acidic sandstone soils. Sandstone soil patches in the African side of the Strait (Tangier) are, in general, smaller and more scattered than in the European side (Algeciras). In this study, we analyze the effect of this sandstone patchiness on the population genetic diversity and structure of two Erica species from these Mediterranean heathlands that differ in their edaphic specificity, E. australis, sandstone specialist, and E. arborea, generalist. Average levels of within-population genetic diversity and gene flow between populations were significantly lower in Tangier (high sandstone patchiness) than in Algeciras (low patchiness) for the sandstone specialist, whereas no differences between both sides of the Strait were detected in the edaphic generalist. Since most endemic species in Mediterranean heathlands of the Strait of Gibraltar are sandstone specialists, these results highlight an increased vulnerability to loss of genetic diversity and local extinction of the heathland endemic flora in the Tangier side of the Strait of Gibraltar.	[Gil-Lopez, Manuel Jesus; Ojeda, Fernando] Univ Cadiz, Dept Biol, Puerto Real, Cadiz, Spain; [Segarra-Moragues, Jose Gabriel] Consejo Super Invest Cientif, Ctr Invest Desertificac, Valencia, Spain	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Ojeda, F (corresponding author), Univ Cadiz, Dept Biol, Puerto Real, Cadiz, Spain.	fernando.ojeda@uca.es	Ojeda, Fernando/L-1626-2014; Segarra-Moragues, José Gabriel/I-7352-2012	Ojeda, Fernando/0000-0001-5480-0925; Segarra-Moragues, José Gabriel/0000-0003-0061-8647; Gil-Lopez, Manuel-Jesus/0000-0002-4567-4725	Project BREATHAL [CGL2011-28759/BOS]; Spanish Ministerio de Ciencia e Innovacion	Project BREATHAL; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Project BREATHAL (CGL2011-28759/BOS) was financed by the Spanish Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARROYO J, 1988, Lagascalia, V15, P615; Avise J.C., 2000, PHYLOGEOGRAPHY; Bayer E, 1993, FLORA IBERICA, V485-506; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Bossuyt B, 2007, CONSERV BIOL, V21, P832, DOI 10.1111/j.1523-1739.2006.00645.x; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Couvet D, 2002, CONSERV BIOL, V16, P369, DOI 10.1046/j.1523-1739.2002.99518.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ellstrand Norman C., 1992, New Forests, V6, P241, DOI 10.1007/BF00120647; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundez J, 2004, ISR J PLANT SCI, V52, P341, DOI 10.1560/WWNL-TQ7X-PDVM-E6KM; Fagundez J, 2010, PLANT SYST EVOL, V284, P65, DOI 10.1007/s00606-009-0240-2; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Segarra-Moragues JG, 2013, EVOL ECOL, V27, P117, DOI 10.1007/s10682-012-9586-y; Segarra-Moragues JG, 2010, EVOLUTION, V64, P3511, DOI 10.1111/j.1558-5646.2010.01064.x; Galan de Mera A, 2003, LAGASCALIA, V23, P27; Gibbs JP, 2001, BIOL CONSERV, V100, P15, DOI 10.1016/S0006-3207(00)00203-2; Goudet J, 2001, FSTAT V 2 9 3 2 PROG; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; Jules ES, 1998, ECOLOGY, V79, P1645, DOI 10.1890/0012-9658(1998)079[1645:HFADCF]2.0.CO;2; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Langella O, 2000, POPULATIONS LOGICIEL; Lowe A., 2004, ECOLOGICAL GENETICS; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Ludwig D, 1996, AM NAT, V147, P506, DOI 10.1086/285863; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McGuire AF, 2005, INT J PLANT SCI, V166, P311, DOI 10.1086/427478; Medrano M, 2008, ANN BOT-LONDON, V102, P183, DOI 10.1093/aob/mcn086; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1978, GENETICS, V89, P583; Ojeda F, 1998, J BIOGEOGR, V25, P165, DOI 10.1046/j.1365-2699.1998.251141.x; Ojeda F, 1996, J VEG SCI, V7, P63, DOI 10.2307/3236417; Ojeda F, 2000, ECOGRAPHY, V23, P148, DOI 10.1034/j.1600-0587.2000.230116.x; Ojeda F, 2001, J VEG SCI, V12, P867, DOI 10.2307/3236875; Palop-Esteban M, 2007, MOL ECOL, V16, P3814, DOI 10.1111/j.1365-294X.2007.03449.x; Paula S, 2006, PLANT ECOL, V183, P329, DOI 10.1007/s11258-005-9043-x; Pirie MD, 2011, MOL PHYLOGENET EVOL, V61, P593, DOI 10.1016/j.ympev.2011.06.007; Pluess AR, 2004, CONSERV GENET, V5, P145, DOI 10.1023/B:COGE.0000029999.10808.c2; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Rohlf FJ, 2002, USER GUIDE; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Segarra-Moragues JG, 2009, CONSERV GENET, V10, P1815, DOI 10.1007/s10592-009-9823-2; SLATKIN M, 1995, GENETICS, V139, P457; Soga M, 2013, J INSECT CONSERV, V17, P421, DOI 10.1007/s10841-012-9524-x; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wolf AT, 2000, AM J BOT, V87, P1138, DOI 10.2307/2656650; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	63	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98602	10.1371/journal.pone.0098602	http://dx.doi.org/10.1371/journal.pone.0098602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878545	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500072
J	Eberle, J; Myburgh, R; Ahrens, D				Eberle, Jonas; Myburgh, Renier; Ahrens, Dirk			The Evolution of Morphospace in Phytophagous Scarab Chafers: No Competition - No Divergence?	PLOS ONE			English	Article							MORPHOLOGICAL EVOLUTION; PHENOTYPIC EVOLUTION; PHYLOGENETIC SIGNAL; BEETLES COLEOPTERA; DUNG BEETLES; ECOLOGY; RATES; CONSEQUENCES; ASSEMBLAGES; SERICINI	Body shape reflects species' evolution and mediates its role in the environment as it integrates gene expression, life style, and structural morphology. Its comparative analysis may reveal insight on what shapes shape, being a useful approach when other evidence is lacking. Here we investigated evolutionary patterns of body shape in the highly diverse phytophagous chafers (Scarabaeidae: Pleurosticti), a polyphagous group utilizing different parts of angiosperms. Because the reasons of their successful diversification are largely unknown, we used a phylogenetic tree and multivariate analysis on twenty linear measurements of body morphology including all major Pleurosticti lineages to infer patterns of morphospace covariation and divergence. The chafer's different feeding types resulted to be not distinguishable in the described morphospace which was largely attributed to large occupancy of the morphospace of some feeding types and to multiple convergences of feeding behavior (particularly of anthophagy). Low correlation between molecular and morphological rates of evolution, including significant rate shifts for some lineages, indicated directed selection within feeding types. This is supported by morphospace divergence within feeding types and convergent evolution in Australian Melolonthinae. Traits driving morphospace divergence were extremities and traits linked with locomotion behavior, but also body size. Being highly adaptive for burrowing and locomotion these traits showed major changes in the evolution of pleurostict scarabs. These activities also affected another trait, the metacoxal length, which is highly influenced by key innovations of the metacoxa (extended mesal process, secondary closure) particularly in one lineage, the Sericini. Significant shape divergence between major lineages and a lack of strong differentiation among closely related lineages indicated that the question about the presence or absence of competition-derived directed selection needs to be addressed for different time scales. Striking divergence between some sister lineages at their origin revealed strong driven selection towards morphospace divergence, possibly linked with resource partitioning.	[Eberle, Jonas; Myburgh, Renier; Ahrens, Dirk] Ctr Taxon & Evolutionary Res, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Ahrens, Dirk] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Myburgh, Renier] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland; [Myburgh, Renier] Univ Zurich Hosp, Hosp Epidemiol, CH-8091 Zurich, Switzerland	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Natural History Museum London; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Ahrens, D (corresponding author), Ctr Taxon & Evolutionary Res, Zool Forsch Museum Alexander Koenig, Bonn, Germany.	ahrens.dirk_col@gmx.de	Ahrens, Dirk/AAR-1310-2021	Eberle, Jonas/0000-0003-2519-0640	German Science Foundation [AH175-1, AH175-3]	German Science Foundation(German Research Foundation (DFG))	This research was supported by the German Science Foundation (AH175-1, AH175-3) www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Ahrens D, 2006, SYST ENTOMOL, V31, P113, DOI 10.1111/j.1365-3113.2005.00307.x; Ahrens D, 2008, MOL PHYLOGENET EVOL, V47, P783, DOI 10.1016/j.ympev.2008.02.010; Ahrens D, 2011, MOL PHYLOGENET EVOL, V60, P408, DOI 10.1016/j.ympev.2011.04.011; Ahrens D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-234; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balthasar V, 1963, MONOGRAPHIE SCARABAE, pI; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bocak L, 2014, SYST ENTOMOL, V39, P97, DOI 10.1111/syen.12037; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; Claude J, 2008, MORPHOMETRICS R; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cooper N, 2009, J EVOLUTION BIOL, V22, P1024, DOI 10.1111/j.1420-9101.2009.01714.x; DOUGLAS ME, 1992, OIKOS, V65, P213, DOI 10.2307/3545012; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ERICHSON WF, 1847, NATURGESCHICHTE INSE, V3; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferrario VF, 1995, J ANAT, V187, P593; Finn JA, 2003, ECOL ENTOMOL, V28, P1, DOI 10.1046/j.1365-2311.2002.00487.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1992, AM NAT, V140, P509, DOI 10.1086/285424; GAUCH HG, 1982, ECOLOGY, V63, P1643, DOI 10.2307/1940105; GILLER PS, 1994, J ANIM ECOL, V63, P629, DOI 10.2307/5229; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanski I., 1991, P305; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heard Stephen B., 1995, Historical Biology, V10, P151; HOLM S, 1979, SCAND J STAT, V6, P65; Horgan FG, 2005, ECOL ENTOMOL, V30, P182, DOI 10.1111/j.0307-6946.2005.00673.x; Hugall AF, 2007, EVOLUTION, V61, P2293, DOI 10.1111/j.1558-5646.2007.00188.x; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; Inward DJG, 2011, J BIOGEOGR, V38, P1668, DOI 10.1111/j.1365-2699.2011.02509.x; JERMY T, 1985, Z ZOOL SYST EVOL, V23, P275; JOLICOEUR P, 1984, SYST ZOOL, V33, P14, DOI 10.2307/2413129; JOLICOEUR P, 1963, BIOMETRICS, V19, P497, DOI 10.2307/2527939; JOLICOEUR PIERRE, 1960, GROWTH, V24, P339; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Leal WS, 1998, ANNU REV ENTOMOL, V43, P39, DOI 10.1146/annurev.ento.43.1.39; Leal WS, 1998, ANN NY ACAD SCI, V855, P301, DOI 10.1111/j.1749-6632.1998.tb10586.x; Leal WS, 1999, ENV ENTOMLOLOGY BEHA, P464; Levinton J. S., 1988, GENETICS PALEONTOLOG; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1457, DOI 10.1007/BF02035145; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; MCPEEK MA, 1995, AM NAT, V145, P686, DOI 10.1086/285763; MCPEEK MA, 1995, EVOLUTION, V49, P749, DOI 10.1111/j.1558-5646.1995.tb02311.x; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; MEINECKE CC, 1975, ZOOMORPHOLOGIE, V82, P1, DOI 10.1007/BF00995905; Melville J, 2006, P ROY SOC B-BIOL SCI, V273, P557, DOI 10.1098/rspb.2005.3328; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Polly PD, 2001, GENETICA, V112, P339, DOI 10.1023/A:1013395907225; Potter DA, 1996, ENTOMOL EXP APPL, V80, P209, DOI 10.1007/BF00194759; R Development Core Team, 2012, R LANG ENV STAT COMP; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Ribera I, 1999, ANN ZOOL FENN, V36, P21; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Ricklefs R. E., 1994, ECOLOGICAL MORPHOLOG; RICKLEFS RE, 1980, AUK, V97, P321; RICKLEFS RE, 1981, ECOLOGY, V62, P1474, DOI 10.2307/1941504; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Scholtz C.H., 1995, P355; Scholtz C. H., 2005, COLEOPTERA BEETLES V, P367, DOI DOI 10.1515/9783110904550.367; SMITH ABT, 2006, COLEOPT SOC MONO DEC, P144, DOI DOI 10.1649/0010-065X(2006)60[; Springer Mark S., 1997, P129; Teissier G., 1960, PHYSL CRUSTACEA, P537; TRAVIS J, 1983, OIKOS, V41, P434, DOI 10.2307/3544103; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	87	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98536	10.1371/journal.pone.0098536	http://dx.doi.org/10.1371/journal.pone.0098536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875856	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800046
J	Inger, R; Bennie, J; Davies, TW; Gaston, KJ				Inger, Richard; Bennie, Jonathan; Davies, Thomas W.; Gaston, Kevin J.			Potential Biological and Ecological Effects of Flickering Artificial Light	PLOS ONE			English	Article							WHITE FLUORESCENT LIGHT; FUSION FREQUENCY; TEMPORAL RESOLUTION; INTERMITTENT ILLUMINATION; EYE; ELECTRORETINOGRAM; SENSITIVITY; ATTRACTIVENESS; MODULATION; RESPONSES	Organisms have evolved under stable natural lighting regimes, employing cues from these to govern key ecological processes. However, the extent and density of artificial lighting within the environment has increased recently, causing widespread alteration of these regimes. Indeed, night-time electric lighting is known significantly to disrupt phenology, behaviour, and reproductive success, and thence community composition and ecosystem functioning. Until now, most attention has focussed on effects of the occurrence, timing, and spectral composition of artificial lighting. Little considered is that many types of lamp do not produce a constant stream of light but a series of pulses. This flickering light has been shown to have detrimental effects in humans and other species. Whether a species is likely to be affected will largely be determined by its visual temporal resolution, measured as the critical fusion frequency. That is the frequency at which a series of light pulses are perceived as a constant stream. Here we use the largest collation to date of critical fusion frequencies, across a broad range of taxa, to demonstrate that a significant proportion of species can detect such flicker in widely used lamps. Flickering artificial light thus has marked potential to produce ecological effects that have not previously been considered.	[Inger, Richard; Bennie, Jonathan; Davies, Thomas W.; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Exeter	Inger, R (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	richinger@gmail.com	Davies, Thomas W/H-8103-2013; Inger, Richard/D-3445-2009	Davies, Thomas W/0000-0002-4673-9893; Inger, Richard/0000-0003-1660-3706; Gaston, Kevin J./0000-0002-7235-7928; Bennie, Jonathan/0000-0003-4394-2041	European Research Council under the European Union [268504]	European Research Council under the European Union(European Research Council (ERC))	The research leading to this paper received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268504 to K.J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1928, J PHYSIOL-LONDON, V65, P273, DOI 10.1113/jphysiol.1928.sp002475; Ali MA, 1985, VISION VERTEBRATES; AULT S J, 1987, Journal of Raptor Research, V21, P147; AUTRUM H, 1951, Z VERGL PHYSIOL, V33, P407; AUTRUM H, 1950, Z VERGL PHYSIOL, V32, P176, DOI 10.1007/BF00344524; AUTRUM H, 1950, Z NATURFORSCH B, V5, P38, DOI 10.1515/znb-1950-0107; BARTON K, 2011, MODEL SELECTION MODE; Bates D., 2013, LME4 LINEAR MIXED EF; BERMAN SM, 1991, OPTOMETRY VISION SCI, V68, P645, DOI 10.1097/00006324-199108000-00012; BERNHOLZ CD, 1975, VISION RES, V15, P733, DOI 10.1016/0042-6989(75)90292-8; BINNIE CD, 1979, EPILEPSIA, V20, P725, DOI 10.1111/j.1528-1157.1979.tb04856.x; Bird BL, 2004, CONSERV BIOL, V18, P1435, DOI 10.1111/j.1523-1739.2004.00349.x; BORNSCHEIN H, 1961, EXPERIENTIA, V17, P185, DOI 10.1007/BF02160375; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; BURNS SA, 1992, OPTOMETRY VISION SCI, V69, P95, DOI 10.1097/00006324-199202000-00002; Callahan TL, 2000, VISION RES, V40, P455, DOI 10.1016/S0042-6989(99)00194-7; Carvalho PSM, 2002, ANIM BEHAV, V64, P1, DOI 10.1006/anbe.2002.3028; Chu CC, 2006, SOUTHWEST ENTOMOL, V31, P77; Chu CC, 2004, SOUTHWEST ENTOMOL, V29, P111; COILE DC, 1989, PHYSIOL BEHAV, V45, P1087, DOI 10.1016/0031-9384(89)90092-9; Crevier DW, 1998, J NEUROPHYSIOL, V79, P1869, DOI 10.1152/jn.1998.79.4.1869; Crozier WJ, 1939, J GEN PHYSIOL, V22, P463, DOI 10.1085/jgp.22.4.463; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; DEVOE RD, 1963, J GEN PHYSIOL, V47, P13, DOI 10.1085/jgp.47.1.13; DODT E, 1953, ACTA PHYSIOL SCAND, V30, P80; DOUGLAS RH, 1990, VISUAL SYSTEM FISH, P279; Evans JE, 2006, ANIM BEHAV, V72, P393, DOI 10.1016/j.anbehav.2005.10.031; Evans JE, 2012, ANIM BEHAV, V83, P25, DOI 10.1016/j.anbehav.2011.10.002; Ferry ES, 1892, AM J SCI, V44, P192; FLEISHMAN LJ, 1995, COPEIA, P422; FORSTER LM, 1985, NEUROBIOLOGY ARACHNI, P250; Frank TM, 1999, BIOL BULL, V196, P137, DOI 10.2307/1542559; Frank TM, 2003, INTEGR COMP BIOL, V43, P559, DOI 10.1093/icb/43.4.559; Fritsches KA, 2005, CURR BIOL, V15, P55, DOI 10.1016/j.cub.2004.12.064; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Gaston KJ, 2012, J APPL ECOL, V49, P1256, DOI 10.1111/j.1365-2664.2012.02212.x; Granit R, 1934, J PHYSIOL-LONDON, V81, P1; GREEN DG, 1975, SCIENCE, V188, P1120, DOI 10.1126/science.1215989; Greenwood VJ, 2004, APPL ANIM BEHAV SCI, V86, P145, DOI 10.1016/j.applanim.2003.11.008; Gruber SH, 1969, THESIS U MIAMI CORAL; Hammer DX, 2001, COMP BIOCHEM PHYS A, V128, P805, DOI 10.1016/S1095-6433(00)00322-6; HANYU I, 1964, J CELL COMPAR PHYSL, V63, P309, DOI 10.1002/jcp.1030630306; Harding G., 1994, PHOTOSENSITIVE EPILE; HAZELL J, 1990, PSYCHOL MED, V20, P591, DOI 10.1017/S0033291700017098; Healy K, 2013, ANIM BEHAV, V86, P685, DOI 10.1016/j.anbehav.2013.06.018; Hecht S, 1933, J GEN PHYSIOL, V17, P237, DOI 10.1085/jgp.17.2.237; HENDRICKS J, 1966, J EXP ANAL BEHAV, V9, P501, DOI 10.1901/jeab.1966.9-501; Jarvis JR, 2002, VISION RES, V42, P99, DOI 10.1016/S0042-6989(01)00268-1; JENSSEN TA, 1974, VISION RES, V14, P965, DOI 10.1016/0042-6989(74)90164-3; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Kennedy A, 1998, Q J EXP PSYCHOL-A, V51, P135, DOI 10.1080/713755746; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; LALITHA R, 1988, Indian Journal of Physiology and Pharmacology, V32, P182; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; LOOP MS, 1975, VISION RES, V15, P555, DOI 10.1016/0042-6989(75)90302-8; Lu SN, 2012, CONSCIOUS COGN, V21, P928, DOI 10.1016/j.concog.2012.03.012; Lythgoe J.N., 1979, ECOLOGY VISION; Maddocks SA, 2001, GEN COMP ENDOCR, V124, P315, DOI 10.1006/gcen.2001.7718; McComb DM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P299, DOI 10.1086/648394; Meyer-Rochow V.B., 1984, Zoologica (Stuttgart), V45, P1; Meyer-Rochow VB, 1997, 3 INT C PHYS SCI ST; MIALL RC, 1978, PHYSIOL ENTOMOL, V3, P99, DOI 10.1111/j.1365-3032.1978.tb00139.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NOWAK LM, 1983, VISION RES, V23, P845, DOI 10.1016/0042-6989(83)90051-2; NUBOER JFW, 1992, BRIT POULTRY SCI, V33, P123, DOI 10.1080/00071669208417449; Orbach DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013912; PORCIATTI V, 1989, VISION RES, V29, P1693, DOI 10.1016/0042-6989(89)90151-X; Porter TC, 1902, P R SOC LONDON, V70, P313, DOI 10.1098/rspl.1902.0032; R Core Team, 2012, R LANG ENV STAT COMP; RENNER M, 1957, Z VERGL PHYSIOL, V40, P85, DOI 10.1007/BF00298152; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rubene D, 2010, J EXP BIOL, V213, P3357, DOI 10.1242/jeb.042424; RUCK P, 1954, J GEN PHYSIOL, V37, P825, DOI 10.1085/jgp.37.6.825; RYDELL J, 1991, HOLARCTIC ECOL, V14, P203; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Sandstrom M, 1997, J OCCUP ENVIRON MED, V39, P15, DOI 10.1097/00043764-199701000-00006; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sekular R., 2002, PERCEPTION; SHIELDS EJ, 1980, ANN ENTOMOL SOC AM, V73, P74, DOI 10.1093/aesa/73.1.74; SHUMAKE SA, 1968, PSYCHOL REC, V18, P537, DOI 10.1007/BF03393804; Smith EL, 2005, VET REC, V157, P148, DOI 10.1136/vr.157.5.148; SRINIVASAN MV, 1984, J COMP PHYSIOL, V155, P297, DOI 10.1007/BF00610583; SYMMES D, 1962, SCIENCE, V136, P714, DOI 10.1126/science.136.3517.714; SYMS PR, 1987, ENTOMOL EXP APPL, V43, P81, DOI 10.1007/BF00350379; TANSLEY K, 1961, J CELL COMPAR PHYSL, V57, P11, DOI 10.1002/jcp.1030570104; Van Praagh JP, 1975, J APICULT RES, V11, P77; Veitch J. A., 1995, Lighting Research and Technology, V27, P243; WALLS G. L, 1934, AM J OPHTHALMOL, V17, P892, DOI DOI 10.1016/S0002-9394(34)93309-2; Waterman T.H., 1981, HDB SENSORY PHYSL, P281; WATTS FN, 1989, PSYCHOL MED, V19, P875, DOI 10.1017/S0033291700005596; WILKINS A, 1986, HUM FACTORS, V28, P75, DOI 10.1177/001872088602800108; Wilkins A. J., 1989, Lighting Research and Technology, V21, P11; WILLIAMS RA, 1985, PHYSIOL BEHAV, V34, P259, DOI 10.1016/0031-9384(85)90114-3; Woo K, 2009, NATURWISSENSCHAFTEN, V96, P415, DOI 10.1007/s00114-008-0491-8; Yu Y, 2011, OPHTHALMIC RES, V46, P80, DOI 10.1159/000323179	99	43	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98631	10.1371/journal.pone.0098631	http://dx.doi.org/10.1371/journal.pone.0098631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874801	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800054
J	Kawashita, E; Kanno, Y; Ikeda, K; Kuretake, H; Matsuo, O; Matsuno, H				Kawashita, Eri; Kanno, Yosuke; Ikeda, Kanako; Kuretake, Hiromi; Matsuo, Osamu; Matsuno, Hiroyuki			Altered Behavior in Mice with Deletion of the Alpha2-Antiplasmin Gene	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; LONG-TERM POTENTIATION; MAJOR SITE; LATE-PHASE; DEGRADATION; STRESS; ALPHA-2-ANTIPLASMIN; CONTRIBUTES; INHIBITOR; FIBROSIS	Background: The alpha 2-antiplasmin (alpha 2AP) protein is known to be a principal physiological inhibitor of plasmin, and is expressed in various part of the brain, including the hippocampus, cortex, hypothalamus and cerebellum, thus suggesting a potential role for alpha 2AP in brain functions. However, the involvement of alpha 2AP in brain functions is currently unclear. Objectives: The goal of this study was to investigate the effects of the deletion of the alpha 2AP gene on the behavior of mice. Methods: The motor function was examined by the wire hang test and rotarod test. To evaluate the cognitive function, a repeated rotarod test, Y-maze test, Morris water maze test, passive or shuttle avoidance test and fear conditioning test were performed. An open field test, dark/light transition test or tail suspension test was performed to determine the involvement of alpha 2AP in anxiety or depression-like behavior. Results and Conclusions: The alpha 2AP knockout (alpha 2AP(-/-)) mice exhibited impaired motor function compared with alpha 2AP(+/+) mice. The alpha 2AP(-/-) mice also exhibited impairments in motor learning, working memory, spatial memory and fear conditioning memory. Furthermore, the deletion of alpha 2AP induced anxiety-like behavior, and caused an anti-depression-like effect in tail suspension. Therefore, our findings suggest that alpha 2AP is a crucial mediator of motor function, cognitive function, anxiety-like behavior and depression-like behavior, providing new insights into the role of alpha 2AP in the brain functions.	[Kawashita, Eri; Kanno, Yosuke; Ikeda, Kanako; Kuretake, Hiromi; Matsuno, Hiroyuki] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pathol Biochem, Kyotanabe, Kyoto, Japan; [Matsuo, Osamu] Kinki Univ, Sch Med, Dept Physiol 2, Osakasayama, Osaka, Japan	Kindai University (Kinki University)	Kawashita, E (corresponding author), Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pathol Biochem, Kyotanabe, Kyoto, Japan.	ekawashi@dwc.doshisha.ac.jp	MATSUO, OSAMU/AAM-9703-2020	Matsuo, Osamu/0000-0002-9806-2204	Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science [25830057]	Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science	This study was supported by Grants-in-Aid for Young Scientists (B, Grant Number 25830057), provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2012, J NEUROSCI, V32, P2002, DOI 10.1523/JNEUROSCI.1144-11.2012; Bahi A, 2012, EUR NEUROPSYCHOPHARM, V22, P672, DOI 10.1016/j.euroneuro.2012.01.008; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; COLLEN D, 1976, EUR J BIOCHEM, V69, P209, DOI 10.1111/j.1432-1033.1976.tb10875.x; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; Freeman R, 2014, BRAIN RES IN PRESS; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Ho-Tin-Noe B, 2009, MOL CELL NEUROSCI, V42, P288, DOI 10.1016/j.mcn.2009.08.001; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Kanno Y, 2007, J THROMB HAEMOST, V5, P2266, DOI 10.1111/j.1538-7836.2007.02745.x; Kanno Y, 2013, ARTHRITIS RHEUM-US, V65, P492, DOI 10.1002/art.37767; Kanno Y, 2010, AM J PATHOL, V176, P238, DOI 10.2353/ajpath.2010.090150; Kawashita E, 2013, J NEUROCHEM, V126, P58, DOI 10.1111/jnc.12281; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li J, 2013, P NATL ACAD IN PRESS, V110; Lu BGC, 2011, J BIOL CHEM, V286, P24544, DOI 10.1074/jbc.M111.229013; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mannaioni G, 2008, J BIOL CHEM, V283, P20600, DOI 10.1074/jbc.M803015200; Menoud PA, 1996, J CLIN INVEST, V97, P2478, DOI 10.1172/JCI118694; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Okada K, 1997, THROMB HAEMOSTASIS, V78, P1104; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; SAITO H, 1982, P NATL ACAD SCI-BIOL, V79, P5684, DOI 10.1073/pnas.79.18.5684; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Stout RW, 1996, AGE AGEING, V25, P256, DOI 10.1093/ageing/25.3.256; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Yuan HJ, 2009, J BIOL CHEM, V284, P12862, DOI 10.1074/jbc.M805123200	37	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97947	10.1371/journal.pone.0097947	http://dx.doi.org/10.1371/journal.pone.0097947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874880	gold, Green Published, Green Submitted			2022-12-27	WOS:000336790800016
J	Muscatello, DJ; Amin, J; MacIntyre, CR; Newall, AT; Rawlinson, WD; Sintchenko, V; Gilmour, R; Thackway, S				Muscatello, David J.; Amin, Janaki; MacIntyre, C. Raina; Newall, Anthony T.; Rawlinson, William D.; Sintchenko, Vitali; Gilmour, Robin; Thackway, Sarah			Inaccurate Ascertainment of Morbidity and Mortality due to Influenza in Administrative Databases: A Population-Based Record Linkage Study	PLOS ONE			English	Article							NEW-SOUTH-WALES; SEASONAL INFLUENZA; RESPIRATORY-INFECTIONS; SURVEILLANCE; BURDEN; VACCINATION; DIAGNOSIS; HEALTH; ADULTS; DETERMINANTS	Background: Historically, counting influenza recorded in administrative health outcome databases has been considered insufficient to estimate influenza attributable morbidity and mortality in populations. We used database record linkage to evaluate whether modern databases have similar limitations. Methods: Person-level records were linked across databases of laboratory notified influenza, emergency department (ED) presentations, hospital admissions and death registrations, from the population (similar to 6.9 million) of New South Wales (NSW), Australia, 2005 to 2008. Results: There were 2568 virologically diagnosed influenza infections notified. Among those, 25% of 40 who died, 49% of 1451 with a hospital admission and 7% of 1742 with an ED presentation had influenza recorded on the respective database record. Compared with persons aged >= 65 years and residents of regional and remote areas, respectively, children and residents of major cities were more likely to have influenza coded on their admission record. Compared with older persons and admitted patients, respectively, working age persons and non-admitted persons were more likely to have influenza coded on their ED record. On both ED and admission records, persons with influenza type A infection were more likely than those with type B infection to have influenza coded. Among death registrations, hospital admissions and ED presentations with influenza recorded as a cause of illness, 15%, 28% and 1.4%, respectively, also had laboratory notified influenza. Time trends in counts of influenza recorded on the ED, admission and death databases reflected the trend in counts of virologically diagnosed influenza. Conclusions: A minority of the death, hospital admission and ED records for persons with a virologically diagnosed influenza infection identified influenza as a cause of illness. Few database records with influenza recorded as a cause had laboratory confirmation. The databases have limited value for estimating incidence of influenza outcomes, but can be used for monitoring variation in incidence over time.	[Muscatello, David J.; Gilmour, Robin; Thackway, Sarah] New South Wales Minist Hlth, Ctr Epidemiol & Evidence, Sydney, NSW, Australia; [Muscatello, David J.; MacIntyre, C. Raina; Newall, Anthony T.] Univ New S Wales, Sch Publ Hlth & Community Med, Kensington, NSW 2033, Australia; [Amin, Janaki] Univ New S Wales, Kirby Inst, Coogee, NSW, Australia; [Rawlinson, William D.] Prince Wales Hosp, South East Area Lab Serv, Randwick, NSW 2031, Australia; [Rawlinson, William D.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Sintchenko, Vitali] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Sintchenko, Vitali] Ctr Infect Dis & Microbiol, Pathol West Inst Clin Pathol & Med Res, Westmead, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Sydney	Muscatello, DJ (corresponding author), New South Wales Minist Hlth, Ctr Epidemiol & Evidence, Sydney, NSW, Australia.	dmusc@doh.health.nsw.gov.au	Muscatello, David/AAD-9134-2019; Muscatello, David/HDO-2537-2022	Newall, Anthony/0000-0003-0836-1065; Sintchenko, Vitali/0000-0002-9261-3650; MacIntyre, C Raina/0000-0002-3060-0555; Amin, Janaki/0000-0003-2161-9366; Rawlinson, William/0000-0003-0988-7827	New South Wales Ministry of Health	New South Wales Ministry of Health	This work was supported by the New South Wales Ministry of Health (www.health.nsw.gov.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2010, 4390 0 PRIV HOSP AUS; Australian Bureau of Statistics, 2010, 1338 1 NSW STAT REG; Australian Bureau of Statistics, 2007, 1259 0 30 004 AUSTR; Australian Bureau of Statistics, 2010, 3218 0 REG POP GROWT; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention, 2013, OV INFL SURV US; Centre for Health Record Linkage, 2013, REC LINK WORKS; Cox B, 2010, INT J PUBLIC HEALTH, V55, P251, DOI 10.1007/s00038-010-0135-6; Doshi P, 2008, AM J PUBLIC HEALTH, V98, P939, DOI 10.2105/AJPH.2007.119933; FARR W, 1885, VITAL STATISTICS, P330; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hampson AW, 2006, MED J AUSTRALIA, V185, pS39; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Harris MF, 2012, AUST HEALTH REV, V36, P325, DOI 10.1071/AH11080; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Horby PW, 2005, AUST NZ J PUBL HEAL, V29, P35, DOI 10.1111/j.1467-842X.2005.tb00745.x; Howard PF, 2013, INFLUENZA OTHER RESP, V7, P330, DOI 10.1111/j.1750-2659.2012.00395.x; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Macintyre CR, 2013, HEART; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Moore HC, 2013, J PEDIAT INFECT DIS; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Muscatello DJ, 2008, COMMUN DIS INTELL, V32, P435; Muscatello DJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-141; Mytton OT, 2012, EURO SURVEILL, V17, P20139; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nicoll A, 2012, EURO SURVEILL, V3, P17; NSW Ministry of Health, 2013, NSW MIN HLTH ANN REP; Orsted I, 2013, INFLUENZA OTHER RESP, V7, P776, DOI 10.1111/irv.12093; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Schanzer DL, 2013, INFLUENZA OTHER RESP, V7, P799, DOI 10.1111/irv.12011; Schindeler SK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-190; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Takeuchi M, 2012, PEDIATR INFECT DIS J, V31, P368, DOI 10.1097/INF.0b013e318241ad06; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Williamson DA, 2012, INFECT CONT HOSP EP, V33, P1064, DOI 10.1086/667742; Zambon Maria, 2014, Medicine (Abingdon), V42, P45, DOI 10.1016/j.mpmed.2013.10.017; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	49	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98446	10.1371/journal.pone.0098446	http://dx.doi.org/10.1371/journal.pone.0098446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24875306	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800040
J	Anderson, RC; Klofstad, CA; Mayew, WJ; Venkatachalam, M				Anderson, Rindy C.; Klofstad, Casey A.; Mayew, William J.; Venkatachalam, Mohan			Vocal Fry May Undermine the Success of Young Women in the Labor Market	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; VOICE PITCH; ATTRACTIVENESS; DOMINANCE; MEN; PREFERENCES; PERCEPTION; SPEAKERS; QUALITY	Vocal fry is speech that is low pitched and creaky sounding, and is increasingly common among young American females. Some argue that vocal fry enhances speaker labor market perceptions while others argue that vocal fry is perceived negatively and can damage job prospects. In a large national sample of American adults we find that vocal fry is interpreted negatively. Relative to a normal speaking voice, young adult female voices exhibiting vocal fry are perceived as less competent, less educated, less trustworthy, less attractive, and less hirable. The negative perceptions of vocal fry are stronger for female voices relative to male voices. These results suggest that young American females should avoid using vocal fry speech in order to maximize labor market opportunities.	[Anderson, Rindy C.; Klofstad, Casey A.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Klofstad, Casey A.] Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA; [Mayew, William J.; Venkatachalam, Mohan] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA	Duke University; University of Miami; Duke University	Klofstad, CA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	klofstad@gmail.com	Mayew, William/AAF-9570-2021	Mayew, William/0000-0001-7059-122X	Duke University; Fuqua School of Business; National Science Foundation [IOS-11-44991]	Duke University; Fuqua School of Business; National Science Foundation(National Science Foundation (NSF))	Duke University and the Fuqua School of Business provided financial and logistical support. R.C.A. was also supported by a grant from the National Science Foundation (IOS-11-44991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051216; Bertrand M, 2010, AM ECON J-APPL ECON, V2, P228, DOI 10.1257/app.2.3.228; Boersma P., 2013, PRAAT DOING PHONETIC; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Carney J, 2012, WALL STREET WOMEN IN; Chappelow C, 2012, VERBAL TICK DOOM WHY; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P2394, DOI 10.1121/1.402044; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fraccaro PJ, 2013, ANIM BEHAV, V85, P127, DOI 10.1016/j.anbehav.2012.10.016; Hageman William, 2013, CHICAGO TRIBUNE; Harnsberger JD, 2010, J VOICE, V24, P523, DOI 10.1016/j.jvoice.2009.01.003; HOLLIEN H, 1966, J SPEECH HEAR RES, V9, P245, DOI 10.1044/jshr.0902.245; Hollien H, 1968, J ACOUST SOC AM, V3, P506; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Lepore M, 2012, COULD VOCAL FRY GIVE; Mayew WJ, 2013, EVOL HUM BEHAV, V34, P243, DOI 10.1016/j.evolhumbehav.2013.03.001; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Redi L, 2001, J PHONETICS, V29, P407, DOI 10.1006/jpho.2001.0145; Shorten K, 2013, WOMEN USING VOCAL FR; Stulp G, 2013, LEADERSHIP QUART, V24, P159, DOI 10.1016/j.leaqua.2012.09.002; Tillotson K, 2012, SOME WOMEN VOCAL FRY; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; Wolk L, 2012, J VOICE, V26, pE111, DOI 10.1016/j.jvoice.2011.04.007; Yuasa IP, 2010, AM SPEECH, V85, P315, DOI 10.1215/00031283-2010-018	31	52	52	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97506	10.1371/journal.pone.0097506	http://dx.doi.org/10.1371/journal.pone.0097506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24870387	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300013
J	Katzenberger, M; Hammond, J; Duarte, H; Tejedo, M; Calabuig, C; Relyea, RA				Katzenberger, Marco; Hammond, John; Duarte, Helder; Tejedo, Miguel; Calabuig, Cecilia; Relyea, Rick A.			Swimming with Predators and Pesticides: How Environmental Stressors Affect the Thermal Physiology of Tadpoles	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; REACTION NORMS; CLIMATE-CHANGE; ANURAN AMPHIBIANS; LIMITS DEPEND; TOLERANCE; ACCLIMATION; TEMPERATURE; MORPHOLOGY; IMPACT	To forecast biological responses to changing environments, we need to understand how a species's physiology varies through space and time and assess how changes in physiological function due to environmental changes may interact with phenotypic changes caused by other types of environmental variation. Amphibian larvae are well known for expressing environmentally induced phenotypes, but relatively little is known about how these responses might interact with changing temperatures and their thermal physiology. To address this question, we studied the thermal physiology of grey treefrog tadpoles (Hyla versicolor) by determining whether exposures to predator cues and an herbicide (Roundup) can alter their critical maximum temperature (CTmax) and their swimming speed across a range of temperatures, which provides estimates of optimal temperature (T-opt) for swimming speed and the shape of the thermal performance curve (TPC). We discovered that predator cues induced a 0.4 degrees C higher CTmax value, whereas the herbicide had no effect. Tadpoles exposed to predator cues or the herbicide swam faster than control tadpoles and the increase in burst speed was higher near T-opt. In regard to the shape of the TPC, exposure to predator cues increased T-opt by 1.5 degrees C, while exposure to the herbicide marginally lowered T-opt by 0.4 degrees C. Combining predator cues and the herbicide produced an intermediate T-opt that was 0.5 degrees C higher than the control. To our knowledge this is the first study to demonstrate a predator altering the thermal physiology of amphibian larvae (prey) by increasing CTmax, increasing the optimum temperature, and producing changes in the thermal performance curves. Furthermore, these plastic responses of CTmax and TPC to different inducing environments should be considered when forecasting biological responses to global warming.	[Katzenberger, Marco; Duarte, Helder; Tejedo, Miguel] Spanish Council Sci Res, Donana Biol Stn, Dept Evolutionary Ecol, Seville, Spain; [Hammond, John] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Calabuig, Cecilia] Fed Rural Univ Semiarid Reg, Dept Anim Sci, Mossoro, RN, Brazil; [Relyea, Rick A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of New Mexico; Universidade Federal Rural do Semi-Arido (UFERSA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Katzenberger, M (corresponding author), Spanish Council Sci Res, Donana Biol Stn, Dept Evolutionary Ecol, Seville, Spain.	katzenberger@ebd.csic.es	calabuig, cecilia/AAG-6495-2021	calabuig, cecilia/0000-0002-1243-1700	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/60271/2009]; U.S. National Science Foundation (NSF)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); U.S. National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by a Fundacao para a Ciencia e Tecnologia (FCT; www.fct.pt) PhD fellowship (SFRH/BD/60271/2009) to MK and a U.S. National Science Foundation (NSF; www.nsf.gov) grant to RAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Arendt J, 2010, J MORPHOL, V271, P1044, DOI 10.1002/jmor.10851; Arendt JD, 2009, OECOLOGIA, V159, P455, DOI 10.1007/s00442-008-1210-z; Arnqvist G, 1998, ECOLOGY, V79, P1847, DOI 10.2307/176693; Barry MJ, 1998, J PLANKTON RES, V20, P1219, DOI 10.1093/plankt/20.7.1219; Barry MJ, 2000, J PLANKTON RES, V22, P1705, DOI 10.1093/plankt/22.9.1705; Barry MJ, 1999, ENVIRON POLLUT, V104, P217, DOI 10.1016/S0269-7491(98)00188-2; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Buckley LB, 2008, AM NAT, V171, pE1, DOI 10.1086/523949; CARRIER R, 1988, WATER RES, V22, P511, DOI 10.1016/0043-1354(88)90048-6; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Condon CH, 2010, J EXP BIOL, V213, P3705, DOI 10.1242/jeb.046979; David JR, 1997, J THERM BIOL, V22, P441, DOI 10.1016/S0306-4565(97)00063-6; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Glennemeier KA, 2002, GEN COMP ENDOCR, V127, P16, DOI 10.1016/S0016-6480(02)00015-1; Gosner K. L., 1960, Herpetologica, V16, P183; Gvozdik L, 2008, J THERM BIOL, V33, P395, DOI 10.1016/j.jtherbio.2008.06.004; Gvozdik L, 2007, BIOL J LINN SOC, V90, P627, DOI 10.1111/j.1095-8312.2006.00752.x; Gvozdik L, 2006, EVOLUTION, V60, P2110; HANAZATO T, 1991, FRESHWATER BIOL, V26, P419, DOI 10.1111/j.1365-2427.1991.tb01408.x; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Heath AG, 1997, ECOTOX ENVIRON SAFE, V37, P280, DOI 10.1006/eesa.1997.1563; Helmuth B, 2010, J EXP BIOL, V213, P995, DOI 10.1242/jeb.038463; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hopkins WA, 2005, ENVIRON POLLUT, V133, P531, DOI 10.1016/j.envpol.2004.06.014; Hua J, 2013, EVOL APPL, V6, P1028, DOI 10.1111/eva.12083; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; HUTCHISON VICTOR H., 1961, PHYSIOL ZOOL, V34, P92; Izem R, 2005, AM NAT, V166, P277, DOI 10.1086/431314; Jones DK, 2011, ENVIRON TOXICOL CHEM, V30, P446, DOI 10.1002/etc.384; Jones DK, 2010, ENVIRON TOXICOL CHEM, V29, P2016, DOI 10.1002/etc.240; KATS LB, 1988, ECOLOGY, V69, P1865, DOI 10.2307/1941163; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kingsolver JG, 1998, AM ZOOL, V38, P545; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Learning in Motion Inc, 2004, MEAS MOT SOFTW V3 0; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; LYDY MJ, 1988, AQUAT TOXICOL, V12, P311, DOI 10.1016/0166-445X(88)90059-8; MAHONEY JJ, 1969, OECOLOGIA, V2, P143, DOI 10.1007/BF00379157; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Navas CA, 2008, COMP BIOCHEM PHYS A, V151, P344, DOI 10.1016/j.cbpa.2007.07.003; Oda S, 2011, ENVIRON TOXICOL CHEM, V30, P232, DOI 10.1002/etc.378; Patra RW, 2007, ENVIRON TOXICOL CHEM, V26, P1454, DOI 10.1897/06-156R1.1; PETRANKA JW, 1987, ANIM BEHAV, V35, P420, DOI 10.1016/S0003-3472(87)80266-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Relyea RA, 2005, ECOLOGY, V86, P1723, DOI 10.1890/04-1920; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Relyea RA, 2012, ECOL APPL, V22, P634, DOI 10.1890/11-0189.1; Relyea RA, 2009, ENVIRON TOXICOL CHEM, V28, P2004, DOI 10.1897/09-021.1; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rohlf FJ, 2010, TPSDIG2 DIGITIZE LAN; Sakamoto M, 2006, FRESHWATER BIOL, V51, P1974, DOI 10.1111/j.1365-2427.2006.01628.x; SHERMAN E, 1980, COMP BIOCHEM PHYS A, V65, P227, DOI 10.1016/0300-9629(80)90229-7; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; The MathWorks Inc, 2009, MATLAB V7 8 STAT TOO; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Van Damme R, 1999, ANIM BEHAV, V57, P347, DOI 10.1006/anbe.1998.0980; Wagner N, 2013, ENVIRON TOXICOL CHEM, V32, P1688, DOI 10.1002/etc.2268	83	29	30	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98265	10.1371/journal.pone.0098265	http://dx.doi.org/10.1371/journal.pone.0098265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869960	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000336858300030
J	Rutherford, JN; Demartelly, VA; Colon, DGL; Ross, CN; Tardif, SD				Rutherford, Julienne N.; Demartelly, Victoria A.; Colon, Donna G. Layne; Ross, Corinna N.; Tardif, Suzette D.			Developmental Origins of Pregnancy Loss in the Adult Female Common Marmoset Monkey (Callithrix jacchus)	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CATCH-UP GROWTH; LITTER SIZE; INTRAUTERINE POSITION; METABOLIC SYNDROME; POSTNATAL-GROWTH; REDUCED UTERINE; BLOOD-PRESSURE; OVARIAN SIZE; BODY-WEIGHT	Background: The impact of the intrauterine environment on the developmental programming of adult female reproductive success is still poorly understood and potentially underestimated. Litter size variation in a nonhuman primate, the common marmoset monkey (Callithrix jacchus), allows us to model the effects of varying intrauterine environments (e.g. nutrient restriction, exposure to male womb-mates) on the risk of losing fetuses in adulthood. Our previous work has characterized the fetuses of triplet pregnancies as experiencing intrauterine nutritional restriction. Methodology/Principal Findings: We used over a decade of demographic data from the Southwest National Primate Research Center common marmoset colony. We evaluated differences between twin and triplet females in the number of pregnancies they produce and the proportion of those pregnancies that ended in fetal loss. We found that triplet females produced the same number of total offspring as twin females, but lost offspring during pregnancy at a significantly higher rate than did twins (38% vs. 13%, p = 0.02). Regardless of their own birth weight or the sex ratio of the litter the experienced as fetuses, triplet females lost more fetuses than did twins. Females with a male littermate experienced a significant increase in the proportion of stillbirths. Conclusions/Significance: These striking findings anchor pregnancy loss in the mother's own fetal environment and development, underscoring a "Womb to Womb" view of the lifecourse and the intergenerational consequences of development. This has important translational implications for understanding the large proportion of human stillbirths that are unexplained. Our findings provide strong evidence that a full understanding of mammalian life history and reproductive biology requires a developmental foundation.	[Rutherford, Julienne N.; Demartelly, Victoria A.] Univ Illinois, Coll Nursing, Dept Women Children & Family Hlth, Chicago, IL 60612 USA; [Rutherford, Julienne N.] Univ Illinois, Dept Anthropol, Chicago, IL USA; [Demartelly, Victoria A.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Colon, Donna G. Layne; Ross, Corinna N.] Texas Biomed Res Inst, Southwest Natl Primate Res Center, San Antonio, TX USA; [Ross, Corinna N.] Texas A&M Univ, San Antonio, TX USA; [Ross, Corinna N.; Tardif, Suzette D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Emory University; Rollins School Public Health; Texas Biomedical Research Institute; Texas A&M University System; University of Texas System; University of Texas Health San Antonio	Rutherford, JN (corresponding author), Univ Illinois, Coll Nursing, Dept Women Children & Family Hlth, Chicago, IL 60612 USA.	ruther4d@uic.edu		deMartelly, Victoria/0000-0002-4381-2418; Rutherford, Julienne/0000-0001-6536-6888	National Institutes of Health [R01-HD076018, R01-RR02022, R01-DK77639]; Office of Research Infrastructure Programs [P51 OD011133]; Southwest National Primate Research Center [P51-RR13986]; National Institute of Child Health and Human Development [K12HD055892]; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076018, K12HD055892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR002022, P51RR013986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077639] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs; Southwest National Primate Research Center; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The design, execution, and writing of the study was funded by National Institutes of Health grants R01-HD076018 (Rutherford), R01-RR02022 (Tardif), R01-DK77639 (Tardif & Power), Office of Research Infrastructure Programs/OD P51 OD011133 (previously P51-RR13986; Southwest National Primate Research Center), and K12HD055892 (Rutherford), a University of Illinois at Chicago Building Interdisciplinary Research Careers in Women's Health (BIRCWH) faculty scholarship from the National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT DH, 1978, J REPROD FERTIL, V53, P155; Abbott DH, 2003, COMPARATIVE MED, V53, P339; Adair L, 2005, ANNU REV NUTR, V25, P407, DOI 10.1146/annurev.nutr.25.050304.092538; Adair LS, 2001, CIRCULATION, V104, P1034, DOI 10.1161/hc3401.095037; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Bales K, 2001, AM J PRIMATOL, V54, P211, DOI 10.1002/ajp.1031; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Birnie AK, 2012, HORM BEHAV, V62, P136, DOI 10.1016/j.yhbeh.2012.05.014; Burton G., 2011, PLACENTA HUMAN DEV P; CAMERON GN, 1973, J MAMMAL, V54, P489, DOI 10.2307/1379133; deKeyser N, 2012, HUM REPROD, V27, P1170, DOI 10.1093/humrep/der478; DIXSON AF, 1992, PATERNITY IN PRIMATES : GENETIC TESTS AND THEORIES, P192; Drickamer LC, 1996, ANIM BEHAV, V51, P925, DOI 10.1006/anbe.1996.0096; Drickamer LC, 1997, J ANIM SCI, V75, P2192; Emanuel I, 1997, AM J EPIDEMIOL, V146, P820; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; French JA, 2010, GEN COMP ENDOCR, V165, P309, DOI 10.1016/j.ygcen.2009.07.015; GAMA LT, 1991, J ANIM SCI, V69, P2727, DOI 10.2527/1991.6972727x; Godfrey K M, 2001, Public Health Nutr, V4, P611; Goldschmidt B., 2005, Israel Journal of Veterinary Medicine, V60, P86; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hoet JJ, 1999, J PHYSIOL-LONDON, V514, P617, DOI 10.1111/j.1469-7793.1999.617ad.x; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ibanez L, 2003, HUM REPROD, V18, P1565, DOI 10.1093/humrep/deg351; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Isachenko EF, 2002, J MED PRIMATOL, V31, P350, DOI 10.1034/j.1600-0684.2002.t01-1-02002.x; JAQUISH CE, 1991, AM J PHYS ANTHROPOL, V84, P291, DOI 10.1002/ajpa.1330840306; Jaquish CE, 1997, AM J PRIMATOL, V42, P269, DOI 10.1002/(SICI)1098-2345(1997)42:4<269::AID-AJP2>3.0.CO;2-V; Lu KD, 2011, J PERINATOL, V31, P504, DOI 10.1038/jp.2010.198; LUKE B, 1992, J REPROD MED, V37, P661; Lumey LH, 1997, AM J PUBLIC HEALTH, V87, P1962, DOI 10.2105/AJPH.87.12.1962; Mellado M, 2011, ANIM PROD SCI, V51, P144, DOI 10.1071/AN10112; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ostendorf ALG, 2013, INT J LEGAL MED, V127, P447, DOI 10.1007/s00414-012-0727-1; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Power ML, 2006, AM J PRIMATOL, V68, P181, DOI 10.1002/ajp.20215; Price KC, 2000, HUM REPROD, V15, P452, DOI 10.1093/humrep/15.2.452; Rutherford JN, 2009, PLACENTA, V30, P105, DOI 10.1016/j.placenta.2008.10.010; Rutherford JN, 2008, AM J PHYS ANTHROPOL, V137, P60, DOI 10.1002/ajpa.20846; Rutherford JN, 2009, AM J HUM BIOL, V21, P745, DOI 10.1002/ajhb.20923; Rutherford JN, 2009, AM J PRIMATOL, V71, P969, DOI 10.1002/ajp.20739; SAAL FSV, 1985, BIOL REPROD, V32, P1116, DOI 10.1095/biolreprod32.5.1116; Sanchez-Morgado JM, 2003, COMPARATIVE MED, V53, P539; Savage A, 2009, AM J PRIMATOL, V71, P707, DOI 10.1002/ajp.20696; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smith A, 2013, BUILDING BABIES PRIM; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smucny DA, 2004, AM J PRIMATOL, V64, P107, DOI 10.1002/ajp.20065; Stearns S.C., 1992, pi; Tardif S, 2012, AM J PHYS A IN PRESS; Tardif SD, 1997, AM J PRIMATOL, V42, P323, DOI 10.1002/(SICI)1098-2345(1997)42:4<323::AID-AJP7>3.0.CO;2-Z; Tardif SD, 2004, AM J PRIMATOL, V62, P83, DOI 10.1002/ajp.20009; Tardif SD, 2003, COMPARATIVE MED, V53, P364; Tardif SD, 2002, ETHOLOGY, V108, P825, DOI 10.1046/j.1439-0310.2002.00815.x; TARDIF SD, 1994, ANN NY ACAD SCI, V709, P214, DOI 10.1111/j.1749-6632.1994.tb30405.x; VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567; VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751; White PC, 2006, J CLIN INVEST, V116, P872, DOI 10.1172/JCI28296	62	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e96845	10.1371/journal.pone.0096845	http://dx.doi.org/10.1371/journal.pone.0096845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871614	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300005
J	Leijon, S; Magnusson, AK				Leijon, Sara; Magnusson, Anna K.			Physiological Characterization of Vestibular Efferent Brainstem Neurons Using a Transgenic Mouse Model	PLOS ONE			English	Article							CHOLINE-ACETYLTRANSFERASE GENE; MEDIAL OLIVOCOCHLEAR NEURONS; SEMICIRCULAR CANAL AFFERENTS; NERVE AFFERENTS; OPSANUS-TAU; ULTRASTRUCTURAL ANALYSIS; POTASSIUM CHANNELS; CRISTAE AMPULLARES; PYRAMIDAL NEURONS; COCHLEAR NUCLEUS	The functional role of efferent innervation of the vestibular end-organs in the inner ear remains elusive. This study provides the first physiological characterization of the cholinergic vestibular efferent (VE) neurons in the brainstem by utilizing a transgenic mouse model, expressing eGFP under a choline-acetyltransferase (ChAT)-locus spanning promoter in combination with targeted patch clamp recordings. The intrinsic electrical properties of the eGFP-positive VE neurons were compared to the properties of the lateral olivocochlear (LOC) brainstem neurons, which gives rise to efferent innervation of the cochlea. Both VE and the LOC neurons were marked by their negative resting membrane potential <-75 mV and their passive responses in the hyperpolarizing range. In contrast, the response properties of VE and LOC neurons differed significantly in the depolarizing range. When injected with positive currents, VE neurons fired action potentials faithfully to the onset of depolarization followed by sparse firing with long inter-spike intervals. This response gave rise to a low response gain. The LOC neurons, conversely, responded with a characteristic delayed tonic firing upon depolarizing stimuli, giving rise to higher response gain than the VE neurons. Depolarization triggered large TEA insensitive outward currents with fast inactivation kinetics, indicating A-type potassium currents, in both the inner ear-projecting neuronal types. Immunohistochemistry confirmed expression of Kv4.3 and 4.2 ion channel subunits in both the VE and LOC neurons. The difference in spiking responses to depolarization is related to a two-fold impact of these transient outward currents on somatic integration in the LOC neurons compared to in VE neurons. It is speculated that the physiological properties of the VE neurons might be compatible with a wide-spread control over motion and gravity sensation in the inner ear, providing likewise feed-back amplification of abrupt and strong phasic signals from the semi-circular canals and of tonic signals from the gravito-sensitive macular organs.	[Leijon, Sara; Magnusson, Anna K.] Karolinska Inst, Ctr Hearing & Commun Res, Stockholm, Sweden; [Leijon, Sara; Magnusson, Anna K.] Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Unit Audiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Magnusson, AK (corresponding author), Karolinska Inst, Ctr Hearing & Commun Res, Stockholm, Sweden.	anna.magnusson@ki.se			Swedish Research Council [80326601]; Horselskadades Riksforbund; Stiftelsen Tysta Skolan Institute; Karolinska Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Horselskadades Riksforbund; Stiftelsen Tysta Skolan Institute; Karolinska Institute(Karolinska Institutet)	This work was supported by grants from the Swedish Research Council grant no. 80326601, Horselskadades Riksforbund, Stiftelsen Tysta Skolan and Karolinska Institutets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TJ, 1999, EXP BRAIN RES, V124, P489, DOI 10.1007/s002210050645; ASCHOFF A, 1987, J COMP NEUROL, V264, P56, DOI 10.1002/cne.902640106; Birinyi A, 2001, BRAIN RES, V921, P44, DOI 10.1016/S0006-8993(01)03075-X; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; BOYLE R, 1990, J NEUROSCI, V10, P1570; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown MC, 2008, NEUROSCIENCE, V154, P147, DOI 10.1016/j.neuroscience.2007.12.045; BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; CAMPBELL JP, 1988, HEARING RES, V35, P271, DOI 10.1016/0378-5955(88)90124-4; CARPENTER MB, 1987, BRAIN RES, V408, P275, DOI 10.1016/0006-8993(87)90387-8; Castellano-Munoz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013777; Chen XX, 2004, J PHYSIOL-LONDON, V559, P187, DOI 10.1113/jphysiol.2004.068114; Chi FL, 2007, NEUROENDOCRINOLOGY, V85, P131, DOI 10.1159/000101959; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; Cullen KE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0002.2002; Darrow KN, 2006, NAT NEUROSCI, V9, P1474, DOI 10.1038/nn1807; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Felix RA, 2013, J NEUROPHYSIOL, V109, P2691, DOI 10.1152/jn.01041.2012; Fitzakerley JL, 2000, HEARING RES, V147, P31, DOI 10.1016/S0378-5955(00)00118-0; Fujino K, 1997, J NEUROPHYSIOL, V77, P2788, DOI 10.1152/jn.1997.77.5.2788; GACEK RR, 1974, ACTA OTO-LARYNGOL, V77, P92, DOI 10.3109/00016487409124603; GACEK RR, 1969, ACTA OTO-LARYNGOL, VS, P1; GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986, DOI 10.1152/jn.1980.43.4.986; HIGHSTEIN SM, 1986, J COMP NEUROL, V243, P309, DOI 10.1002/cne.902430303; HIGHSTEIN SM, 1985, J NEUROPHYSIOL, V54, P370, DOI 10.1152/jn.1985.54.2.370; HIGHSTEIN SM, 1992, ANN NY ACAD SCI, V656, P108, DOI 10.1111/j.1749-6632.1992.tb25203.x; Holt JC, 2006, J NEUROSCI, V26, P13180, DOI 10.1523/JNEUROSCI.3539-06.2006; Jacob RG, 2001, CURR OPIN NEUROL, V14, P41, DOI 10.1097/00019052-200102000-00007; Jamali M, 2009, J NEUROPHYSIOL, V101, P141, DOI 10.1152/jn.91066.2008; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Johnston J, 2008, EUR J NEUROSCI, V27, P1391, DOI 10.1111/j.1460-9568.2008.06116.x; KORTE GE, 1979, J COMP NEUROL, V184, P279, DOI 10.1002/cne.901840205; Lasker DM, 2008, JARO-J ASSOC RES OTO, V9, P334, DOI 10.1007/s10162-008-0120-4; Lendvai B, 2011, NEUROCHEM INT, V59, P150, DOI 10.1016/j.neuint.2011.05.015; Li C, 2005, NEUROSCI LETT, V385, P36, DOI 10.1016/j.neulet.2005.05.024; LI YP, 1993, J NEUROCHEM, V61, P748; LONNERBERG P, 1995, P NATL ACAD SCI USA, V92, P4046, DOI 10.1073/pnas.92.9.4046; Lysakowski A, 1997, J COMP NEUROL, V389, P419, DOI 10.1002/(SICI)1096-9861(19971222)389:3<419::AID-CNE5>3.0.CO;2-3; Lysakowski A, 2008, J COMP NEUROL, V511, P47, DOI 10.1002/cne.21827; Marcus DA, 2005, EXPERT OPIN PHARMACO, V6, P2691, DOI 10.1517/14656566.6.15.2691; Marlinski V, 2004, JARO-J ASSOC RES OTO, V5, P126, DOI 10.1007/s10162-003-4029-7; McCrea RA, 1999, J NEUROPHYSIOL, V82, P416, DOI 10.1152/jn.1999.82.1.416; MCCUE MP, 1994, J NEUROSCI, V14, P6071; Metts BA, 2006, EXP BRAIN RES, V172, P261, DOI 10.1007/s00221-005-0328-z; Minor LB, 1998, OTOLARYNG HEAD NECK, V118, pS5, DOI 10.1016/S0194-5998(98)70002-6; MISAWA H, 1992, J BIOL CHEM, V267, P20392; Murakami DM, 2002, P NATL ACAD SCI USA, V99, P17078, DOI 10.1073/pnas.252652299; Naciff JM, 1999, J NEUROCHEM, V72, P17, DOI 10.1046/j.1471-4159.1999.0720017.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Plotnik M, 2005, JARO-J ASSOC RES OTO, V6, P311, DOI 10.1007/s10162-005-0010-y; Purcell IM, 1997, J NEUROPHYSIOL, V78, P3234, DOI 10.1152/jn.1997.78.6.3234; Rabbitt RD, 2011, CURR OPIN OTOLARYNGO, V19, P376, DOI 10.1097/MOO.0b013e32834a5be1; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; Rusznak Z, 2008, J HISTOCHEM CYTOCHEM, V56, P443, DOI 10.1369/jhc.2008.950303; Sadeghi SG, 2007, J NEUROPHYSIOL, V97, P1503, DOI 10.1152/jn.00829.2006; Sadeghi SG, 2009, J NEUROPHYSIOL, V101, P988, DOI 10.1152/jn.91112.2008; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SHIMAZU H, 1966, J NEUROPHYSIOL, V29, P467, DOI 10.1152/jn.1966.29.3.467; Sterenborg JC, 2010, HEARING RES, V270, P119, DOI 10.1016/j.heares.2010.08.013; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Svirskis G, 2002, J NEUROSCI, V22, P11019; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Trifonov S, 2009, NEUROSCIENCE, V159, P344, DOI 10.1016/j.neuroscience.2008.12.054; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Yao WP, 1998, MICROSC RES TECHNIQ, V41, P270, DOI 10.1002/(SICI)1097-0029(19980501)41:3<270::AID-JEMT10>3.0.CO;2-L; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005	70	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98277	10.1371/journal.pone.0098277	http://dx.doi.org/10.1371/journal.pone.0098277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867596	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100045
J	Nombela, C; Nombela, M; Castell, P; Garcia, T; Lopez-Coronado, J; Herrero, MT				Nombela, Cristina; Nombela, Manuel; Castell, Pedro; Garcia, Teodoro; Lopez-Coronado, Juan; Trinidad Herrero, Maria			Alpha-Theta Effects Associated with Ageing during the Stroop Test	PLOS ONE			English	Article							COLOR-WORD TEST; ANTERIOR CINGULATE; WORKING-MEMORY; ORBITOFRONTAL CORTEX; ERROR NEGATIVITY; COUNTING STROOP; AGE-DIFFERENCES; INTERFERENCE; TASK; PERFORMANCE	The Stroop effect is considered as a standard attentional measure to study conflict resolution in humans. The response of the brain to conflict is supposed to change over time and it is impaired in certain pathological conditions. Neuropsychological Stroop test measures have been complemented with electroencephalography (EEG) techniques to evaluate the mechanisms in the brain that underlie conflict resolution from the age of 20 to 70. To study the changes in EEG activity during life, we recruited a large sample of healthy subjects of different ages that included 90 healthy individuals, divided by age into decade intervals, which performed the Stroop test while recording a 14 channel EEG. The results highlighted an interaction between age and stimulus that was focused on the prefrontal (Alpha and Theta band) and Occipital (Alpha band) areas. We concluded that behavioural Stroop interference is directly influenced by opposing Alpha and Theta activity and evolves across the decades of life.	[Nombela, Cristina; Castell, Pedro; Trinidad Herrero, Maria] Univ Murcia, Sch Med, Clin & Expt Neurosci NiCE CIBERNED, Murcia, Spain; [Nombela, Cristina] Univ Cambridge, Clin Neurosci Dept, Cambridge, England; [Nombela, Manuel] Nuestra Sra del Rosell Hosp, Dept Neurophysiol, Murcia, Spain; [Garcia, Teodoro; Lopez-Coronado, Juan] Tech Univ Cartagena, Dept Syst Engn & Automat, Murcia, Spain; [Trinidad Herrero, Maria] Univ Jaume 1, Sch Hlth Sci Med, Clin & Expt Neurosci NiCE CIBERNED, Castellon de La Plana, Spain	CIBERNED; University of Murcia; University of Cambridge; Universidad Politecnica de Cartagena; CIBERNED; Universitat Jaume I	Nombela, C (corresponding author), Univ Murcia, Sch Med, Clin & Expt Neurosci NiCE CIBERNED, Murcia, Spain.	cn331@cam.ac.uk	Otero, Cristina Nombela/AAA-1463-2019	HERRERO, MARIA TRINIDAD/0000-0003-4953-1446; Nombela Otero, Cristina/0000-0002-9806-2351	IRENE project, D.G. de Investigacion, Region of Murcia, Spain [BIO-MED 07/01/0006]; PHARMACOG-European Community [115009]; CIBERNED (Spanish Network of Research on Neurodegeneratives Diseases)	IRENE project, D.G. de Investigacion, Region of Murcia, Spain; PHARMACOG-European Community; CIBERNED (Spanish Network of Research on Neurodegeneratives Diseases)	This work was supported by BIO-MED 07/01/0006 (IRENE project, D.G. de Investigacion, Region of Murcia, Spain) to CN, PHARMACOG-European Community's Seventh Framework Program (FP7/2007-2013) for the Innovative Medicine Initiative under Grant Agreement No. 115009 and CIBERNED (Spanish Network of Research on Neurodegeneratives Diseases) to MTH and AAL actions from the Spanish Ministry of Industry (EXOLEGS project) to JLC and TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Barbas H, 2007, ANN NY ACAD SCI, V1121, P10, DOI 10.1196/annals.1401.015; BARRON SA, 1976, NEUROLOGY, V26, P1011, DOI 10.1212/WNL.26.11.1011; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Bugg JM, 2007, AGING NEUROPSYCHOL C, V14, P155, DOI 10.1080/138255891007065; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carlsson A, 1978, Adv Exp Med Biol, V113, P1; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Davidson DJ, 2003, AGING NEUROPSYCHOL C, V10, P85, DOI 10.1076/anec.10.2.85.14463; DULANEY CL, 1994, J EXP PSYCHOL LEARN, V20, P470, DOI 10.1037/0278-7393.20.2.470; Eppinger B, 2007, BIOL PSYCHOL, V75, P52, DOI 10.1016/j.biopsycho.2006.12.001; Gigaux J, 2013, SCHIZOPHR RES, V143, P297, DOI 10.1016/j.schres.2012.11.019; GLASER MO, 1982, J EXP PSYCHOL HUMAN, V8, P875, DOI 10.1037/0096-1523.8.6.875; Heflin LH, 2011, NEUROPSYCHOLOGY, V25, P655, DOI 10.1037/a0023863; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; JOSEPH JA, 1978, J GERONTOL, V33, P643, DOI 10.1093/geronj/33.5.643; Kawasaki M, 2010, EUR J NEUROSCI, V31, P1683, DOI 10.1111/j.1460-9568.2010.07217.x; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Maiea-Lerenc J, 2009, INT J PSYCHOPHYSIOL, V71, P248, DOI 10.1016/j.ijpsycho.2008.10.005; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Nombela Cristina, 2011, Front Neurol, V2, P82, DOI 10.3389/fneur.2011.00082; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Petrides M, 2007, ANN NY ACAD SCI, V1121, P33, DOI 10.1196/annals.1401.035; Pompei F, 2011, NEUROIMAGE, V57, P576, DOI 10.1016/j.neuroimage.2011.04.055; PRIBRAM KH, 1953, J NEUROPHYSIOL, V16, P324, DOI 10.1152/jn.1953.16.3.324; Price JL, 2007, ANN NEW YORK ACAD SC; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Restak R, 2012, BRAIN COMPLETE MIND; Rosenfeld JP, 2006, INT J PSYCHOPHYSIOL, V60, P240, DOI 10.1016/j.ijpsycho.2005.05.010; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schack B, 1999, J NEUROSCI METH, V93, P49, DOI 10.1016/S0165-0270(99)00117-X; Schack B, 1999, CLIN NEUROPHYSIOL, V110, P1410, DOI 10.1016/S1388-2457(99)00111-X; Schack B, 1999, INT J PSYCHOPHYSIOL, V31, P219, DOI 10.1016/S0167-8760(98)00052-X; Scholes KE, 2007, NEUROPSYCHOPHARMACOL, V32, P1600, DOI 10.1038/sj.npp.1301262; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; West R, 1997, NEUROPSYCHOLOGY, V11, P421, DOI 10.1037/0894-4105.11.3.421; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Wright BC, 2003, BRIT J PSYCHOL, V94, P475, DOI 10.1348/000712603322503042; YAKOVLEV P I, 1962, Res Publ Assoc Res Nerv Ment Dis, V39, P3	49	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e95657	10.1371/journal.pone.0095657	http://dx.doi.org/10.1371/journal.pone.0095657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867024	Green Published, gold, Green Submitted			2022-12-27	WOS:000336914100002
J	Quinones, RM; Holyoak, M; Johnson, ML; Moyle, PB				Quinones, Rebecca M.; Holyoak, Marcel; Johnson, Michael L.; Moyle, Peter B.			Potential Factors Affecting Survival Differ by Run-Timing and Location: Linear Mixed-Effects Models of Pacific Salmonids (Oncorhynchus spp.) in the Klamath River, California	PLOS ONE			English	Article							DENSITY-DEPENDENT MORTALITY; MAXIMUM REPRODUCTIVE RATE; CLIMATE VARIABILITY; MARINE SURVIVAL; POPULATIONS; RECRUITMENT; IMPACTS; STOCK; FISH; LIFE	Understanding factors influencing survival of Pacific salmonids (Oncorhynchus spp.) is essential to species conservation, because drivers of mortality can vary over multiple spatial and temporal scales. Although recent studies have evaluated the effects of climate, habitat quality, or resource management (e. g., hatchery operations) on salmonid recruitment and survival, a failure to look at multiple factors simultaneously leaves open questions about the relative importance of different factors. We analyzed the relationship between ten factors and survival (1980-2007) of four populations of salmonids with distinct life histories from two adjacent watersheds (Salmon and Scott rivers) in the Klamath River basin, California. The factors were ocean abundance, ocean harvest, hatchery releases, hatchery returns, Pacific Decadal Oscillation, North Pacific Gyre Oscillation, El Nino Southern Oscillation, snow depth, flow, and watershed disturbance. Permutation tests and linear mixed-effects models tested effects of factors on survival of each taxon. Potential factors affecting survival differed among taxa and between locations. Fall Chinook salmon O. tshawytscha survival trends appeared to be driven partially or entirely by hatchery practices. Trends in three taxa (Salmon River spring Chinook salmon, Scott River fall Chinook salmon; Salmon River summer steelhead trout O. mykiss) were also likely driven by factors subject to climatic forcing (ocean abundance, summer flow). Our findings underscore the importance of multiple factors in simultaneously driving population trends in widespread species such as anadromous salmonids. They also show that the suite of factors may differ among different taxa in the same location as well as among populations of the same taxa in different watersheds. In the Klamath basin, hatchery practices need to be reevaluated to protect wild salmonids.	[Quinones, Rebecca M.; Johnson, Michael L.; Moyle, Peter B.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Holyoak, Marcel] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Quinones, RM (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	rmquinones@ucdavis.edu	Holyoak, Marcel/C-3475-2009	Holyoak, Marcel/0000-0001-9727-3627	Klamath National Forest; CALPCC (California Association for Licenced Professional Clinical Counselors)	Klamath National Forest; CALPCC (California Association for Licenced Professional Clinical Counselors)	Partial funding was provided by the Klamath National Forest and the CALPCC (California Association for Licenced Professional Clinical Counselors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Alvarez LHR, 1998, MATH BIOSCI, V152, P63, DOI 10.1016/S0025-5564(98)10018-4; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 1999, REV SYNTHESIS EFFECT; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Azumaya Tomonori, 2000, North Pacific Anadromous Fish Commission Bulletin, V2, P165; Barrowman NJ, 2000, CAN J FISH AQUAT SCI, V57, P665, DOI 10.1139/cjfas-57-4-665; Bartholow JM, 2005, N AM J FISH MANAGE, V25, P152, DOI 10.1577/M04-007.1; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Beamish RJ, 1997, ICES J MAR SCI, V54, P1200, DOI 10.1006/jmsc.1997.0305; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bjorkstedt EP, 2000, CAN J FISH AQUAT SCI, V57, P459, DOI 10.1139/cjfas-57-2-459; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busby PJ, 1994, STATUS REV KLAMATH M; California Hatchery Scientific Review Group, 2012, CAL HATCH REV REV; Chenillat F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062281; Chilcote S, 2013, SPRING CHINOOK S FOR; CLARK CW, 1974, J CONSEIL, V36, P7; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COHEN D, 1968, J ECOL, V56, P219, DOI 10.2307/2258075; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Cooney RT, 1998, B MAR SCI, V62, P443; Costello CJ, 1998, AM J AGR ECON, V80, P765, DOI 10.2307/1244062; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; DiLorenzo E, 2013, N PACIFIC GYRE OSCIL; Drake D. J., 2000, California Agriculture, V54, P46, DOI 10.3733/ca.v054n06p46; Elder D, 2002, SALMON RIVER SUBBASI; Finney BP, 2000, SCIENCE, V290, P795, DOI 10.1126/science.290.5492.795; FISHER JP, 1988, CAN J FISH AQUAT SCI, V45, P1036, DOI 10.1139/f88-127; Foott JS, 2011, CONCEPTUAL MODEL DIS; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; Groot C., 1991, PACIFIC SALMON LIFE; Gustafson R, 2006, PACIFIC SALMON EXTIN, P24; Hard JJ, 2008, EVOL APPL, V1, P388, DOI 10.1111/j.1752-4571.2008.00020.x; Healey MC, 1995, AM FISH S S, V17, P176; Holt CA, 2010, ICES J MAR SCI, V67, P2018, DOI 10.1093/icesjms/fsq117; Hoopa Valley Tribal Fisheries Department Yurok Tribal Fisheries Department, 1999, 1998 KLAM RIV FALL C; Hubbart JA, 2007, FOREST SCI, V53, P169; Isaak DJ, 2007, ECOL APPL, V17, P352, DOI 10.1890/05-1949; Johnson RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028880; Kaeriyama M, 2004, 5 NPAFC; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Klamath River Technical Advisory Team, 2005, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2008, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2011, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2004, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2006, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2012, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2013, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2010, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2007, KLAM RIV FALL CHIN A; Kostow K, 2009, REV FISH BIOL FISHER, V19, P9, DOI 10.1007/s11160-008-9087-9; Lackey RT, 2003, REV FISH SCI, V11, P35, DOI 10.1080/16226510390856529; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; LICHATOWICH J, 1995, FISHERIES, V20, P10, DOI 10.1577/1548-8446(1995)020<0010:AATTDA>2.0.CO;2; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Mahnken C., 1998, NORTH PAC ANADROMOUS, V1, P38; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mantua NJ, 2013, PACIFIC DECADAL OSCI; MARSCHALL EA, 1995, CAN J FISH AQUAT SCI, V52, P136, DOI 10.1139/f95-013; Marshall M, 1996, 1995 KLAMATH RIVER F; McCann KS, 2003, CAN J FISH AQUAT SCI, V60, P971, DOI 10.1139/F03-078; MCGURK BJ, 1995, ENVIRON MANAGE, V19, P609, DOI 10.1007/BF02471972; McKelvey R., 2003, Risk and uncertainty in environmental and natural resource economics, P93; Menning K, 1996, SIERRA NEVADA ECOSYS, P33; Milner NJ, 2003, FISH RES, V62, P111, DOI 10.1016/S0165-7836(02)00157-1; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Moyle P, 2008, SALMON STEELHEAD TRO; Moyle P.B., 2002, INLAND FISHES CALIFO; Myers J. M., 1998, STATUS REV CHINOOK S; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 2004, SCIENCE, V303, P1980, DOI 10.1126/science.1095410; Myers RA, 1997, CAN J FISH AQUAT SCI, V54, P2449, DOI 10.1139/cjfas-54-10-2449; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P223, DOI 10.1139/f95-022; Myers RA, 1996, FISH B-NOAA, V94, P707; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; National Research Council, 2004, END THREAT FISH KLAM; NCRWQCB, 2005, TOT MAX DAIL LOAD TE; NCRWQCB, 2005, STAFF REP ACT PLAN S; NEAVE FERRIS, 1953, JOUR FISH RES BD CANADA, V9, P450; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Nichols K, 2007, MONITORING INCIDENCE; Nielsen JL, 2008, AM FISHERIES SOC S, V71, P1; Olson AD, 1996, FRESHWATER REARING S; PETERMAN RM, 1978, J FISH RES BOARD CAN, V35, P1434, DOI 10.1139/f78-226; PETERMAN RM, 1984, CAN J FISH AQUAT SCI, V41, P1825, DOI 10.1139/f84-223; Peterman RM, 2000, CAN J FISH AQUAT SCI, V57, P181, DOI 10.1139/cjfas-57-1-181; Petrosky CE, 2001, CAN J FISH AQUAT SCI, V58, P1196, DOI 10.1139/cjfas-58-6-1196; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Quinones RM, 2014, ENVIRON BIOL FISH, V97, P233, DOI 10.1007/s10641-013-0146-2; Quinones RM, 2011, RECOVERY PACIFIC SAL; Ray RA, 2012, J PARASITOL, V98, P520, DOI 10.1645/JP-GE-2737.1; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rosenfeld J, 2000, CAN J FISH AQUAT SCI, V57, P766, DOI 10.1139/cjfas-57-4-766; Ruggerone GT, 2003, FISH OCEANOGR, V12, P209, DOI 10.1046/j.1365-2419.2003.00239.x; Schtickzelle N, 2007, FISH FISH, V8, P297, DOI 10.1111/j.1467-2979.2007.00256.x; Sharma R, 2001, CAN J FISH AQUAT SCI, V58, P1453, DOI 10.1139/cjfas-58-7-1453; Stone R., 2008, COMP SUSCEPTIBILITY; Sullivan CM, 1989, JUVENILE LIFE HIST A; Suttle KB, 2004, ECOL APPL, V14, P969, DOI 10.1890/03-5190; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Walters C, 1998, CAN J FISH AQUAT SCI, V55, P2533, DOI 10.1139/cjfas-55-12-2533; WALTERS CJ, 1981, CAN J FISH AQUAT SCI, V38, P704, DOI 10.1139/f81-093; Waples RS, 2009, ECOL SOC, V14; Weitkamp L.A., 1995, STATUS REV COHO SALM; WOLTER K, 2010, MULTIVARIATE ENSO IN; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Young KA, 1999, CAN J FISH AQUAT SCI, V56, P1700, DOI 10.1139/cjfas-56-9-1700; Yurok Tribal Fisheries Department Hoopa Valley Tribal Fisheries Department, 2000, 1999 KLAM RIV FALL C; Zabel RW, 2006, CONSERV BIOL, V20, P190, DOI 10.1111/j.1523-1739.2005.00300.x	122	7	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98392	10.1371/journal.pone.0098392	http://dx.doi.org/10.1371/journal.pone.0098392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866173	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100056
J	Yan, J; Liu, XL; Xiao, G; Li, NL; Deng, YN; Han, LZ; Yin, LC; Ling, LJ; Liu, LX				Yan, Jian; Liu, Xiao-Long; Xiao, Gang; Li, Ning-Lei; Deng, Yi-Nan; Han, Lu-Zhe; Yin, Liang-Chun; Ling, Li-Juan; Liu, Li-Xin			Prevalence and Clinical Relevance of T-Helper Cells, Th17 and Th1, in Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							EXPANDING UNIVERSE; FAMILY CYTOKINES; TUMOR; CANCER; INTERLEUKIN-17; INFLAMMATION; LIVER; MICROENVIRONMENT; IMMUNITY; GROWTH	Background and Aims: An immune imbalance in the cytokine profile exerts a profound influence on the progression of hepatitis B virus (HBV) infections and hepatocellular carcinoma (HCC). The present study evaluated the immune status of T helper (Th) 17 and Th1 cells in patients with HBV-related and non-HBV-related HCC. Methods: We randomly enrolled 150 patients with HCC. Blood samples and tissue samples were obtained. The distributions and phenotypic features of Th17 and Th1 cells were determined by flow cytometry and/or immunohistochemistry. Results: Compared to corresponding non-tumor regions, the levels of Th17 and Th1 cells were significantly increased in tumors of patients with HCC (P<0.001). The intratumoral densities of IL-17-producing cells and IFN-gamma-producing cells were associated with overall survival (OS, P = 0.001) and disease-free survival (DFS, P = 0.001) of patients with HCC. The ratio of Th17 to Th1 in HBV-related HCC was higher than in non-HBV-related HCC. A multivariate Cox analysis revealed that the Th17 to Th1 ratio was an independent prognostic factor for OS (HR = 2.651, P = 0.007) and DFS (HR = 2.456, P = 0.002). Conclusions: HBV infections can lead to an imbalance in immune status in patients with HCC. An elevated Th17 to Th1 ratio may promote tumor progression. The Th17 to Th1 ratio could serve as a potential prognostic marker for scoring the severity of HCC.	[Yan, Jian; Liu, Xiao-Long; Xiao, Gang; Li, Ning-Lei; Han, Lu-Zhe; Yin, Liang-Chun; Ling, Li-Juan; Liu, Li-Xin] Southern Med Univ, Affiliated Hosp 3, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Deng, Yi-Nan] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Deng, Yi-Nan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510275, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University	Yan, J (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.	387718575@qq.com; liulixin@tom.com		liu, lixin/0000-0001-7063-4349; liu, lixin/0000-0003-3006-0111; Yin, Liangchun/0000-0002-2073-3311	National Natural Science Foundation of Guangdong Province [S2011010003094]; Medical Research Foundation of Guangdong Province [B2013261]	National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Research Foundation of Guangdong Province	This work was supported by: National Natural Science Foundation of Guangdong Province (S2011010003094, Li-Xin Liu). Medical Research Foundation of Guangdong Province (B2013261, Xiao-Long Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Jimenez-Sousa MA, 2010, EUR CYTOKINE NETW, V21, P84, DOI 10.1684/ecn.2010.0191; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DELPRETE GF, 1991, J CLIN INVEST, V88, P346, DOI 10.1172/JCI115300; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Gajewski TF, 2007, IMMUNITY, V27, P185, DOI 10.1016/j.immuni.2007.08.001; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Ge J, 2010, J CLIN IMMUNOL, V30, P60, DOI 10.1007/s10875-009-9328-2; Gulumian M, 1999, MOL CELL BIOCHEM, V196, P69, DOI 10.1023/A:1006918212866; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Jung MC, 2002, LANCET INFECT DIS, V2, P43, DOI 10.1016/S1473-3099(01)00172-4; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Negus RPM, 1997, AM J PATHOL, V150, P1723; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Schwartz M, 2007, NAT CLIN PRACT ONCOL, V4, P424, DOI 10.1038/ncponc0844; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Tartour E, 1999, CANCER RES, V59, P3698; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang XH, 2006, J HEPATOL, V45, P254, DOI 10.1016/j.jhep.2006.01.036; Yu MW, 2002, INT J EPIDEMIOL, V31, P1008, DOI 10.1093/ije/31.5.1008; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	40	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96080	10.1371/journal.pone.0096080	http://dx.doi.org/10.1371/journal.pone.0096080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867183	gold, Green Submitted, Green Published			2022-12-27	WOS:000336914100003
J	Granato, DC; Zanetti, MR; Kawahara, R; Yokoo, S; Domingues, RR; Aragao, AZ; Agostini, M; Carazzolle, MF; Vidal, RO; Flores, IL; Korvala, J; Cervigne, NK; Silva, ARS; Coletta, RD; Graner, E; Sherman, NE; Leme, AFP				Granato, Daniela C.; Zanetti, Mariana R.; Kawahara, Rebeca; Yokoo, Sami; Domingues, Romenia R.; Aragao, Annelize Z.; Agostini, Michelle; Carazzolle, Marcelo F.; Vidal, Ramon O.; Flores, Isadora L.; Korvala, Johanna; Cervigne, Nilva K.; Silva, Alan R. S.; Coletta, Ricardo D.; Graner, Edgard; Sherman, Nicholas E.; Paes Leme, Adriana F.			Integrated Proteomics Identified Up-Regulated Focal Adhesion-Mediated Proteins in Human Squamous Cell Carcinoma in an Orthotopic Murine Model	PLOS ONE			English	Article							CANCER; METABOLISM; EXPRESSION; BINDING; MARKER	Understanding the molecular mechanisms of oral carcinogenesis will yield important advances in diagnostics, prognostics, effective treatment, and outcome of oral cancer. Hence, in this study we have investigated the proteomic and peptidomic profiles by combining an orthotopic murine model of oral squamous cell carcinoma (OSCC), mass spectrometry-based proteomics and biological network analysis. Our results indicated the up-regulation of proteins involved in actin cytoskeleton organization and cell-cell junction assembly events and their expression was validated in human OSCC tissues. In addition, the functional relevance of talin-1 in OSCC adhesion, migration and invasion was demonstrated. Taken together, this study identified specific processes deregulated in oral cancer and provided novel refined OSCC-targeting molecules.	[Granato, Daniela C.; Zanetti, Mariana R.; Kawahara, Rebeca; Yokoo, Sami; Domingues, Romenia R.; Aragao, Annelize Z.; Carazzolle, Marcelo F.; Vidal, Ramon O.; Flores, Isadora L.; Paes Leme, Adriana F.] CNPEM, LNBio, Lab Espectrometria Massas, Lab Nacl Biociencias, Campinas, SP, Brazil; [Agostini, Michelle; Flores, Isadora L.; Cervigne, Nilva K.; Silva, Alan R. S.; Coletta, Ricardo D.; Graner, Edgard] Univ Estadual Campinas, UNICAMP, Fac Odontol Piracicaba, Piracicaba, Brazil; [Agostini, Michelle] Univ Fed Rio de Janeiro, Fac Odontol, Rio De Janeiro, Brazil; [Sherman, Nicholas E.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA USA; [Korvala, Johanna] Univ Oulu, Inst Dent, Oulu, Finland	Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro; University of Virginia; University of Oulu	Leme, AFP (corresponding author), CNPEM, LNBio, Lab Espectrometria Massas, Lab Nacl Biociencias, Campinas, SP, Brazil.	adriana.paesleme@lnbio.cnpem.br	Agostini, Michelle/I-1275-2012; Leme, Adriana F Paes/C-9679-2012; Graner, Edgard/K-4411-2012; Agostini, Michelle/AAD-6610-2022; Graner, Edgard/P-4651-2019; Carazzolle, Marcelo Falsarella/C-6503-2012; Flores, Isadora L/H-8329-2014; Aragão, Annelize Z B/I-6535-2012; Santos-Silva, Alan/C-9947-2016; Coletta, Ricardo D./B-4909-2015; UNICAMP, CCES -/J-7787-2015; Cervigne, Nilva K/L-1341-2016; Santos-Silva, Alan Roger/B-6121-2008; Kawahara, Rebeca/B-1532-2015	Leme, Adriana F Paes/0000-0001-7959-147X; Graner, Edgard/0000-0002-4737-7935; Agostini, Michelle/0000-0002-3648-337X; Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Flores, Isadora L/0000-0002-6628-2122; Santos-Silva, Alan/0000-0003-2040-6617; Coletta, Ricardo D./0000-0001-5285-3046; Cervigne, Nilva K/0000-0002-6129-9136; Santos-Silva, Alan Roger/0000-0003-2040-6617; Sherman, Nicholas/0000-0003-3206-3113; Yokoo, Sami/0000-0003-4658-9319; Rodrigues Zanetti, Mariana/0000-0001-8335-1575; Kawahara, Rebeca/0000-0002-0292-2637	FAPESP [2009/54067-3, 2010/19278-0, 2011/22421-2, 2009/53839-2, 2011/02267-9]; CNPq [470567/20090, 470549/2011-4, 301702/2011-0, 470268/2013-1, 505413/2013-2]; Science without Borders Program [MEC/MCTI/CAPES/CNPq/FAPs 109/2012]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science without Borders Program	This work was supported by FAPESP Grants: 2009/54067-3, 2010/19278-0, 2011/22421-2, 2009/53839-2 and 2011/02267-9; CNPq Grants: 470567/20090, 470549/2011-4, 301702/2011-0, 470268/2013-1, and 505413/2013-2; and Science without Borders Program Grant MEC/MCTI/CAPES/CNPq/FAPs 109/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Aragao AZB, 2012, J BIOL CHEM, V287, P43071, DOI 10.1074/jbc.M112.364513; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Findeisen P, 2012, PROTEOM CLIN APPL, V6, P60, DOI 10.1002/prca.201100058; Fujita Y, 2008, CANCER LETT, V263, P280, DOI 10.1016/j.canlet.2008.01.013; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heath CH, 2012, ANN SURG ONCOL, V19, P3879, DOI 10.1245/s10434-012-2435-y; Hwang YS, 2013, ARCH ORAL BIOL, V58, P218, DOI 10.1016/j.archoralbio.2012.04.023; Israel M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-70; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lai MT, 2011, J PATHOL, V224, P367, DOI 10.1002/path.2867; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Mognetti B, 2006, ORAL ONCOL, V42, P448, DOI 10.1016/j.oraloncology.2005.07.014; Myers JN, 2002, CLIN CANCER RES, V8, P293; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Panis C, 2013, CANCER LETT, V330, P57, DOI 10.1016/j.canlet.2012.11.020; Shen YF, 2011, J PROTEOME RES, V10, P3929, DOI 10.1021/pr200052c; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Team RDC, 2009, R LANG ENV STAT COMP; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wetting HL, 2011, AM J PATHOL, V178, P2389, DOI 10.1016/j.ajpath.2011.01.022; Wong DTW, 1996, CRIT REV ORAL BIOL M, V7, P319, DOI 10.1177/10454411960070040201; Yue JY, 2012, DNA REPAIR, V11, P192, DOI 10.1016/j.dnarep.2011.10.019; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	38	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98208	10.1371/journal.pone.0098208	http://dx.doi.org/10.1371/journal.pone.0098208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858105	Green Submitted, gold, Green Published			2022-12-27	WOS:000336839400056
J	Maawy, AA; Hiroshima, Y; Zhang, Y; Luiken, GA; Hoffman, RM; Bouvet, M				Maawy, Ali A.; Hiroshima, Yukihiko; Zhang, Yong; Luiken, George A.; Hoffman, Robert M.; Bouvet, Michael			Polyethylene Glycol (PEG) Linked to Near Infrared (NIR) Dyes Conjugated to Chimeric Anti-Carcinoembryonic Antigen (CEA) Antibody Enhances Imaging of Liver Metastases in a Nude-Mouse Model of Human Colon Cancer	PLOS ONE			English	Article							FLUORESCENCE-GUIDED SURGERY; PANCREATIC-CANCER; REAL-TIME; COMPLETE RESECTION; IDENTIFICATION	We report here that polyethylene glycol (PEG) linked to near infrared dyes conjugated to chimeric mouse-human anti-carcinoembryonic antigen (CEA) antibody greatly improves imaging of liver metastases in a nude mouse model of colon-cancer experimental metastases. PEGylated and non-PEGylated DyLight 650 and 750 dyes were conjugated to the chimeric anti-CEA antibody. The dyes were initially injected intravenously into nude mice without tumors. Tissue biodistribution was determined by tissue sonication and analyzing tissue dye concentration profiles over time. PEGylated dyes had significantly lower accumulation in the liver (p = 0.03 for the 650 dyes; p = 0.002 for the 750 dyes) compared to non-PEGylated dyes. In an experimental liver metastasis model of HT-29 colon cancer, PEGylated dyes conjugated to the anti-CEA antibody showed good labeling of metastatic tumors with high contrast between normal and malignant tissue which was not possible with the non-PEGylated dyes since there was so much non-specific accumulation in the liver. PEGylation of the DyLight 650 and 750 NIR dyes significantly altered tissue biodistribution, allowing brighter tissue labeling, decreased accumulation in normal organs, particularly the liver. This enabled high fidelity and high contrast imaging of liver metastases.	[Maawy, Ali A.; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko] Yokohama City Univ, Yokohama, Kanagawa 232, Japan; [Luiken, George A.] OncoFluor Inc, San Diego, CA USA; [Bouvet, Michael] VA San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; Anti Cancer Inc; Yokohama City University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu			National Cancer Institute [CA142669, CA132971]; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute CA142669 and CA132971 (to M. B. and AntiCancer, Inc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilefu S, 2010, ANGEW CHEM INT EDIT, V49, P9816, DOI 10.1002/anie.201005684; Bailon P, 2009, EXPERT OPIN DRUG DEL, V6, P1, DOI [10.1517/17425240802650568, 10.1517/17425240802650568 ]; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836; DELGADO C, 1992, CRIT REV THER DRUG, V9, P249; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Lee BT, 2010, PLAST RECONSTR SURG, V126, P1472, DOI 10.1097/PRS.0b013e3181f059c7; Lee H, 2006, J ORG CHEM, V71, P7862, DOI 10.1021/jo061284u; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; Matsui A, 2010, SURGERY, V148, P78, DOI 10.1016/j.surg.2009.12.003; Matsui A, 2010, SURGERY, V148, P87, DOI 10.1016/j.surg.2009.12.004; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/290634; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Ohnishi S, 2005, MOL IMAGING, V4, P172; Okuda T, 2012, J CLIN NEUROSCI, V19, P1719, DOI 10.1016/j.jocn.2011.12.034; Spinoglio G, 2013, SURG ENDOSC, V27, P2156, DOI 10.1007/s00464-012-2733-2; Tanaka E, 2009, J THORAC CARDIOV SUR, V138, P133, DOI 10.1016/j.jtcvs.2008.09.082; Uchugonova A, 2013, J CELL BIOCHEM, V114, P99, DOI 10.1002/jcb.24305; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Verbeek FPR, 2012, J HEPATO-BIL-PAN SCI, V19, P626, DOI 10.1007/s00534-012-0534-6; Verbeek FP, 2013, J UROL; Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	34	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97965	10.1371/journal.pone.0097965	http://dx.doi.org/10.1371/journal.pone.0097965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859320	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400032
J	Biswas, PK; Islam, MZ; Debnath, NC; Yamage, M				Biswas, Paritosh K.; Islam, Md. Zohorul; Debnath, Nitish C.; Yamage, Mat			Modeling and Roles of Meteorological Factors in Outbreaks of Highly Pathogenic Avian Influenza H5N1	PLOS ONE			English	Article							VIRUS; CHICKENS; PATTERNS	The highly pathogenic avian influenza A virus subtype H5N1 (HPAI H5N1) is a deadly zoonotic pathogen. Its persistence in poultry in several countries is a potential threat: a mutant or genetically reassorted progenitor might cause a human pandemic. Its world-wide eradication from poultry is important to protect public health. The global trend of outbreaks of influenza attributable to HPAI H5N1 shows a clear seasonality. Meteorological factors might be associated with such trend but have not been studied. For the first time, we analyze the role of meteorological factors in the occurrences of HPAI outbreaks in Bangladesh. We employed autoregressive integrated moving average (ARIMA) and multiplicative seasonal autoregressive integrated moving average (SARIMA) to assess the roles of different meteorological factors in outbreaks of HPAI. Outbreaks were modeled best when multiplicative seasonality was incorporated. Incorporation of any meteorological variable(s) as inputs did not improve the performance of any multivariable models, but relative humidity (RH) was a significant covariate in several ARIMA and SARIMA models with different autoregressive and moving average orders. The variable cloud cover was also a significant covariate in two SARIMA models, but air temperature along with RH might be a predictor when moving average (MA) order at lag 1 month is considered.	[Biswas, Paritosh K.; Islam, Md. Zohorul; Debnath, Nitish C.] Chittagong Vet & Anim Sci Univ, Dept Microbiol, Chittagong, Bangladesh; [Debnath, Nitish C.; Yamage, Mat] Food & Agr Org United Nation, Dhaka, Bangladesh	Food & Agriculture Organization of the United Nations (FAO)	Biswas, PK (corresponding author), Chittagong Vet & Anim Sci Univ, Dept Microbiol, Chittagong, Bangladesh.	biswaspk2000@yahoo.com	Islam, Zohorul/T-4023-2019	Islam, Zohorul/0000-0002-2015-5195	Food and Agriculture Organization of the United Nations [ORSO/BGD/101/USA (LOAFAOBGD-2012-002)]	Food and Agriculture Organization of the United Nations	Food and Agriculture Organization of the United Nations; Grant No: ORSO/BGD/101/USA (LOAFAOBGD-2012-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2010, EPIDEMIOL INFECT, V138, P843, DOI 10.1017/S0950268810000178; Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Ahmed SSU, 2012, VACCINE, V30, P7381, DOI 10.1016/j.vaccine.2012.09.081; [Anonymous], 2013, M EPT PARTN BANGL ST; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Chatfield C., 2000, TIME SERIES FORECAST; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; EMPRES/FAO-GLEWS, 2010, H5N1 HPAI GLOB OV MA, P5; Islam MR, 2012, TRANSBOUND EMERG DIS, V59, P460, DOI 10.1111/j.1865-1682.2011.01297.x; Kirkwood BR, 2003, ESSENTIAL MED STAT; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mahamat A, 2013, J INFECTION, V67, P141, DOI 10.1016/j.jinf.2013.03.018; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Urashima M, 2003, JPN J INFECT DIS, V56, P43; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; Webster RG, 2006, NEW ENGL J MED, V355, P543; WHO, 2013, CUM NUMB CONF HUM CA; World Health Organization, 2011, AVIAN INFLUENZA; World Organization for Animal Health, 2013, UPD AV INFL; World Organization for Animal Health, 2010, 63 COUNTR REP H5N1 A; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhang ZJ, 2012, VET J, V192, P417, DOI 10.1016/j.tvjl.2011.08.012	28	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98471	10.1371/journal.pone.0098471	http://dx.doi.org/10.1371/journal.pone.0098471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886857	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300070
J	Fischer, A; Kraff, O; Maderwald, S; Beiderwellen, K; Ladd, ME; Forsting, M; Lauenstein, TC; Umutlu, L				Fischer, Anja; Kraff, Oliver; Maderwald, Stefan; Beiderwellen, Karsten; Ladd, Mark E.; Forsting, Michael; Lauenstein, Thomas C.; Umutlu, Lale			Non-Enhanced T1-Weighted Liver Vessel Imaging at 7 Tesla	PLOS ONE			English	Article							NEPHROGENIC SYSTEMIC FIBROSIS; ENHANCED MR-ANGIOGRAPHY; FAST SPIN-ECHO; PREOPERATIVE EVALUATION; HEPATIC VASCULATURE; INITIAL-EXPERIENCE; CT ANGIOGRAPHY; PRECESSION; ANATOMY; DONORS	Objectives: Aim of the study was to assess the feasibility and to compare three non-enhanced T1-weighted (w) sequences for liver vessel imaging at 7 Tesla (T). Material and Methods: 12 healthy volunteers were examined on a 7 T whole-body MR-system. The following non-enhanced sequences were acquired: T1w 2D FLASH, T1w 3D FLASH and Time of flight (TOF)-MRA. Qualitative image analysis was performed by two radiologists including over all image quality as well as vessel delineation of the liver arteries, liver veins and portal vein and the presence of artifacts using a five-point scale (5 = excellent vessel delineation to 1 = non-diagnostic). Contrast ratios (CR), SNR und CNR of the above named vessels in correlation to adjacent liver tissue were calculated for quantitative assessment. For statistical analysis, a Wilcoxon Rank Test was applied. Results: All three sequences provided a homogenous hyperintense delineation of the assessed liver vessels. Qualitative image analysis demonstrated the superiority of TOF-MRA, providing best overall image quality (TOF 4.17, 2D FLASH 3.42, 3D FLASH 3.46; p < 0.01) as well as highest image quality values for all analyzed liver vessel segments. TOF-MRA was least impaired by B-1 inhomogeneity (4.13) and susceptibility artifacts (4.63) out of all three sequences (p < 0.01). Quantitative image analysis confirmed the superiority of TOF MRA showing significant higher CR values for all liver vessels (e. g. right hepatic artery TOF 0.47, 2D FLASH 0.09, 3D FLASH 0.11 with p = 0.02 and 0.01, respectively). Providing the lowest standard deviation in noise, TOF showed highest values for SNR and CNR. Conclusions: Non-enhanced T1w imaging in general and TOF MRA in particular, appear to be promising techniques for high quality non-enhanced liver vessel assessment at 7 T.	[Fischer, Anja; Beiderwellen, Karsten; Ladd, Mark E.; Forsting, Michael; Lauenstein, Thomas C.; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Fischer, Anja; Kraff, Oliver; Maderwald, Stefan; Beiderwellen, Karsten; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Fischer, A (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	anja.fischer@uk-essen.de	Kraff, Oliver/AAE-2238-2020; Maderwald, Stefan/B-4241-2011	Kraff, Oliver/0000-0002-6006-8934; Ladd, Mark/0000-0002-4128-9440				Aslam R, 2010, MAGN RESON IMAGING C, V18, P515, DOI 10.1016/j.mric.2010.08.005; Bernstein MA, 2006, J MAGN RESON IMAGING, V24, P735, DOI 10.1002/jmri.20698; Bitz AK, 2009, ISMRM, V4767; Carr JC, 2003, J VASC INTERV RADIOL, V14, P441, DOI 10.1097/01.RVI.0000064853.87207.42; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Duan Q, 2013, NMR BIOMED, V26, P1070, DOI 10.1002/nbm.2920; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; Grinstead JW, 2010, ISMRM, V18, P1429; Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki.5002338; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.0.CO;2-D; Johst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086274; Ladd Mark E, 2007, Top Magn Reson Imaging, V18, P139, DOI 10.1097/RMR.0b013e3180f612b3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lauenstein TC, 2007, J MAGN RESON IMAGING, V26, P1198, DOI 10.1002/jmri.21136; Lee MW, 2007, EUR RADIOL, V17, P1074, DOI 10.1007/s00330-006-0447-3; Lee MW, 2006, J MAGN RESON IMAGING, V24, P1081, DOI 10.1002/jmri.20726; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Metzger GJ, 2010, ISMRM, V403; Metzger GJ, 2013, MAGN RESON MED, V69, P114, DOI 10.1002/mrm.24237; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; Moser E, 2012, NMR BIOMED, V25, P695, DOI 10.1002/nbm.1794; Orzada S, 2009, ISMRM, V2999; Puippe GD, 2012, EUR J RADIOL, V81, pE823, DOI 10.1016/j.ejrad.2012.02.016; Ramalho Miguel, 2007, Magn Reson Imaging Clin N Am, V15, P321, DOI 10.1016/j.mric.2007.06.003; Saba L, 2008, CLIN RADIOL, V63, P312, DOI 10.1016/j.crad.2007.05.023; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Sahani D, 2004, RADIOGRAPHICS, V24, P1367, DOI 10.1148/rg.245035224; Shimada K, 2009, AM J ROENTGENOL, V193, P106, DOI 10.2214/AJR.08.1626; Shimada K, 2009, J MAGN RESON IMAGING, V29, P1140, DOI 10.1002/jmri.21753; Shimada K, 2009, EUR J RADIOL, V70, P111, DOI 10.1016/j.ejrad.2007.12.010; Shimada K, 2009, J MAGN RESON IMAGING, V29, P474, DOI 10.1002/jmri.21636; Streitparth F, 2007, ACTA RADIOL, V48, P20, DOI 10.1080/02841850601045146; Uchida K, 2010, LIVER TRANSPLANT, V16, P1062, DOI 10.1002/lt.22109; Umutlu L, 2012, INVEST RADIOL, V36, P714; Umutlu L, 2013, ACAD RADIOL, V20, P628, DOI 10.1016/j.acra.2012.12.012; Umutlu L, 2013, EUR J RADIOL, V82, P760, DOI 10.1016/j.ejrad.2011.07.004; Umutlu L, 2011, INVEST RADIOL, V46, P425, DOI 10.1097/RLI.0b013e31820e1467; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Wrede KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084562; Wu X, 2014, QUANT IMAGING MED SU, V4, P4; [No title captured]	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97465	10.1371/journal.pone.0097465	http://dx.doi.org/10.1371/journal.pone.0097465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887206	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300019
J	Rolland, B; Paille, F; Fleury, B; Cottencin, O; Benyamina, A; Aubin, HJ				Rolland, Benjamin; Paille, Francois; Fleury, Benoit; Cottencin, Olivier; Benyamina, Amine; Aubin, Henri-Jean			Off-Label Baclofen Prescribing Practices among French Alcohol Specialists: Results of a National Online Survey	PLOS ONE			English	Article							HIGH-DOSE BACLOFEN; DOUBLE-BLIND; DEPENDENT PATIENTS; USE DISORDERS; EFFICACY; SAFETY; TRIAL; DRUG; SUPPRESSION; ABSTINENCE	Objective: To evaluate, among alcohol specialists belonging to the Societe Francaise d'Alcoologie (SFA), i.e., the French Alcohol Society, the proportion of physicians who prescribed off-label baclofen for alcohol use disorders (AUDs). The secondary objective was to depict the features of individual prescribing and monitoring practices. Methods: On-line survey among 484 French alcohol specialists. Physicians were asked whether they prescribed baclofen for AUDs. If they did not, the reasons for this choice were investigated. If they did, the features of the physician's prescribing practice were explored, including the number of patients treated, the mean and maximum doses, the monitoring precautions and the pharmacovigilance reporting. Participants were also asked about their empirical findings on HDB's efficacy and safety. Results: In total, 302 physicians (response rate of 62.4%) participated in the survey. Data from 296 participants were analysed, representing 59.4% of all active prescribing physicians belonging to the SFA. HDB use was declared by 74.6% of participants (mean dose 109.5+/-43.6 mg/d; maximum dose 188+/-93.3 mg/d). However, 79.2% of prescribers had treated less than 30 patients, and 67.8% used HDB as a second-line medication. Although HDB was perceived as more efficacious than approved drugs by 54.3% of prescribers, it was also declared less safe by 62.8%. Nonetheless, 79.7% of prescribers had never filed any pharmacovigilance report. Non-prescribers (25.6%) were primarily deterred by the current lack of scientific data and official regulation. Conclusion: A majority of French alcohol specialists reported using HDB, although often on a limited number of their patients. HDB was considered efficacious but also potentially hazardous. Despite this, physicians reported minimal safety data to the health security system. While French health authorities are planning to draft a specific regulatory measure for framing off-label HDB prescribing practices, the sustained education of prescribers on spontaneous pharmacovigilance reporting should be enhanced.	[Rolland, Benjamin; Paille, Francois; Fleury, Benoit; Cottencin, Olivier; Benyamina, Amine; Aubin, Henri-Jean] Soc Francaise Alcool, Issy Les Moulineaux, France; [Rolland, Benjamin; Cottencin, Olivier] Univ Lille Nord France, CHU Lille, Serv Addictol, Lille, France; [Paille, Francois] Univ Nancy, CHU Nancy, Serv Addictol, Nancy, France; [Fleury, Benoit] CHU Bordeaux, Serv Hepatogastroenterol & Alcool, Bordeaux, France; [Benyamina, Amine; Aubin, Henri-Jean] Hop Paul Brousse, AP HP, INSERM, CERTA LAlbatros,U 669, Villejuif, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU de Nancy; Universite de Lorraine; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rolland, B (corresponding author), Soc Francaise Alcool, Issy Les Moulineaux, France.	benjamin.rolland@chru-lille.fr	ROLLAND, Benjamin/E-7374-2013; , Aubin/AAT-9739-2021; Aubin, Henri-Jean/AAP-8605-2021; ROLLAND, Benjamin/H-6625-2019; COTTENCIN, Olivier OC/I-4024-2015	ROLLAND, Benjamin/0000-0002-8666-3635; ROLLAND, Benjamin/0000-0002-8666-3635; COTTENCIN, Olivier OC/0000-0003-3663-1405; Aubin, Henri-Jean/0000-0002-6604-6672	SFA (Societe Francaise d'Alcoologie)	SFA (Societe Francaise d'Alcoologie)	The SFA (Societe Francaise d'Alcoologie) funded the survey and supported all costs related to the publication process. The scientific board of the SFA (Dr AUBIN, Dr PAILLE, Dr BENYAMINA, Dr FLEURY) designed the survey.	Addolorato G, 2002, ALCOHOL ALCOHOLISM, V37, P504, DOI 10.1093/alcalc/37.5.504; Addolorato G, 2007, LANCET, V370, P1915, DOI 10.1016/S0140-6736(07)61814-5; Agabio R, 2013, EUR ADDICT RES, V19, P325, DOI 10.1159/000347055; Ameisen O, 2005, ALCOHOL ALCOHOLISM, V40, P147, DOI 10.1093/alcalc/agh130; Ameisen O, 2008, DERNIER VERRE; Andreuccetti G, 2012, ADDICTION, V107, P848, DOI [10.1111/j.1360-0443.2011.03752.x, 10.1111/j.1360-0443.2011.03754.x]; Auffret M, 2014, ANN PHARMACOTHER, V48, P656, DOI 10.1177/1060028014525594; Bence C, 2014, J CLIN PHARMACOL, V54, P478, DOI 10.1002/jcph.233; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bucknam W, 2007, ALCOHOL ALCOHOLISM, V42, P158, DOI 10.1093/alcalc/agl091; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Dal Pan GJ, 2012, CLIN PHARMACOL THER, V91, P787, DOI 10.1038/clpt.2012.24; de Beaurepaire Renaud, 2012, Front Psychiatry, V3, P103, DOI 10.3389/fpsyt.2012.00103; Dom G, 2012, ACTA CLIN BELG, V67, P315, DOI 10.2143/ACB.67.5.2062682; Dupouy J, 2014, EUR NEUROPSYCHOPHARM, V24, P192, DOI 10.1016/j.euroneuro.2013.09.008; Emmerich J, 2012, NEW ENGL J MED, V367, P1279, DOI 10.1056/NEJMp1208347; Enserink M, 2011, SCIENCE, V332, P653, DOI 10.1126/science.332.6030.653; Franchitto N, 2014, ALCOHOL ALCOHOLISM, V49, P79, DOI 10.1093/alcalc/agt169; Gache Pascal, 2011, Rev Med Suisse, V7, P1458; Garbutt JC, 2010, ALCOHOL CLIN EXP RES, V34, P1849, DOI 10.1111/j.1530-0277.2010.01273.x; Geoffroy PA, 2014, PSYCHOSOMATICS; Gorsane MA, 2012, SUBST ABUS, V33, P336, DOI 10.1080/08897077.2012.663326; Luquiens A, 2011, ALCOHOL ALCOHOLISM, V46, P586, DOI 10.1093/alcalc/agr083; Pastor A, 2012, J CLIN PSYCHOPHARM, V32, P266, DOI 10.1097/JCP.0b013e31824929b2; Rigal L, 2012, ALCOHOL ALCOHOLISM, V47, P439, DOI 10.1093/alcalc/ags028; Rolland B, 2014, J CLIN PSYCHOPHARM, V34, P153, DOI 10.1097/JCP.0000000000000054; Rolland B, 2012, ALCOHOL ALCOHOLISM, V47, P577, DOI 10.1093/alcalc/ags076; Rolland B, 2010, THERAPIE, V65, P511, DOI 10.2515/therapie/2010073; SACHAIS BA, 1977, ARCH NEUROL-CHICAGO, V34, P422, DOI 10.1001/archneur.1977.00500190056008; Villier C, 2011, EFFETS INDESIRABLES	30	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98062	10.1371/journal.pone.0098062	http://dx.doi.org/10.1371/journal.pone.0098062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887094	gold, Green Published, Green Submitted			2022-12-27	WOS:000336956300036
J	Stilund, M; Reuschlein, AK; Christensen, T; Moller, HJ; Rasmussen, PV; Petersen, T				Stilund, Morten; Reuschlein, Ann-Kathrin; Christensen, Tove; Moller, Holger Jon; Rasmussen, Peter Vestergaard; Petersen, Thor			Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; IMMUNE; NEURODEGENERATION; INFLAMMATION; ASSOCIATION; ACTIVATION; DISEASES; LESIONS; SYSTEM; DAMAGE	Background: Soluble CD163 (sCD163) is a macrophage specific protein known to be up-regulated in serum from patients with multiple sclerosis (MS). Objective: To investigate sCD163 in serum and CSF (cerebrospinal fluid) from patients undergoing MS diagnostic work-up and analyse its potential as a diagnostic biomarker. Methods: After a full MS diagnostic work-up, including collection of paired samples of CSF and serum, 183 patients were evaluated for inclusion in this study. Patients were divided into groups based on their diagnosis. Patients with normal clinical and paraclinical findings were grouped as symptomatic controls. Serum and CSF levels of sCD163 were determined by enzyme-linked immunosorbent assay (ELISA). Results: sCD163 could be measured in all serum and CSF samples. A high sCD163 CSF/serum ratio in relation to molecular weight was found, strongly indicating local production in the CNS. Median levels of sCD163 were significantly decreased in serum and significantly elevated in CSF in patients with relapsing-remitting, and primary-progressive MS. There were, however, some overlaps of the measures between groups. In a receiver operating characteristic (ROC) analysis sCD163 CSF/serum ratio had an area under the curve of 0.72. Conclusion: The sCD163 CSF/serum ratio was significantly increased in patients with MS and may reflect macrophage activation in MS lesions. These results suggest that primary progressive MS also is driven by inflammation in which the innate immune system plays a pivotal role.	[Stilund, Morten; Rasmussen, Peter Vestergaard; Petersen, Thor] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Reuschlein, Ann-Kathrin; Moller, Holger Jon] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark; [Stilund, Morten; Christensen, Tove] Aarhus Univ, Dept Biomed, Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Stilund, M (corresponding author), Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark.	mortenleifms@gmail.com		Rasmussen, Peter Vestergaard/0000-0001-6417-7743; Christensen, Tove/0000-0003-3977-6677; Petersen, Thor/0000-0001-5633-2600; Moller, Holger Jon/0000-0001-7687-5995; Lindahl Christiansen, Ann-Kathrin/0000-0003-3917-9151	Danish Multiple Sclerosis Society [8990, 14567]	Danish Multiple Sclerosis Society	This study was funded by The Danish Multiple Sclerosis Society. Grant number(s): 8990 and 14567. Funder URL: http://scleroseforeningen.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Androdias G, 2010, ANN NEUROL, V68, P465, DOI 10.1002/ana.22054; Baeten D, 2004, ARTHRITIS RHEUM-US, V50, P1611, DOI 10.1002/art.20174; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Carpintero R, 2010, P NATL ACAD SCI USA, V107, P17692, DOI 10.1073/pnas.1009443107; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Ellwardt E., 2014, EXP NEUROL; Fabriek BO, 2007, J NEUROIMMUNOL, V187, P179, DOI 10.1016/j.jneuroim.2007.04.016; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Hametner S., 2013, ANN NEUROL; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Moller HJ, 2004, EUR J HAEMATOL, V72, P135, DOI 10.1046/j.0902-4441.2003.00193.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P29, DOI 10.1080/003655102762377466; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nockher WA, 1999, J NEUROIMMUNOL, V101, P161, DOI 10.1016/S0165-5728(99)00141-1; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; R N, 2003, STATA TECHNICAL J; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Teunissen C., 2013, MULT SCLER; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Timmermann M, 2004, IMMUNOL CELL BIOL, V82, P479, DOI 10.1111/j.0818-9641.2004.01277.x; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	44	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98588	10.1371/journal.pone.0098588	http://dx.doi.org/10.1371/journal.pone.0098588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886843	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300090
J	Chen, AY; Xia, SZ; Wilburn, P; Tully, T				Chen, Alex Y.; Xia, Shouzhen; Wilburn, Paul; Tully, Tim			Olfactory Deficits in an Alpha-Synuclein Fly Model of Parkinson's Disease	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; NEURODEGENERATIVE DISEASE; DISCRIMINATION THRESHOLDS; SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; CELL-PROLIFERATION; MUSHROOM BODIES; ANTENNAL LOBES; ODOR DETECTION; HONEY-BEE	Parkinson's disease (PD) is the most common motor neurodegenerative disorder. Olfactory dysfunction is a prevalent feature of PD. It often precedes motor symptoms by several years and is used in assisting PD diagnosis. However, the cellular and molecular bases of olfactory dysfunction in PD are not known. The fruit fly Drosophila melanogaster, expressing human alpha-synuclein protein or its mutant, A30P, captures several hallmarks of PD and has been successfully used to model PD in numerous studies. First, we report olfactory deficits in fly expressing A30P ( A30P), showing deficits in two out of three olfactory modalities, tested - olfactory acuity and odor discrimination. The remaining third modality is odor identification/naming. Second, oxidative stress is an important environmental risk factor of PD. We show that oxidative stress exacerbated the two affected olfactory modalities in younger A30P flies. Third, different olfactory receptor neurons are activated differentially by different odors in flies. In a separate experiment, we show that the odor discrimination deficit in A30P flies is general and not restricted to a specific class of chemical structure. Lastly, by restricting A30P expression to dopamine, serotonin or olfactory receptor neurons, we show that A30P expression in dopamine neurons is necessary for development of both acuity and discrimination deficits, while serotonin and olfactory receptor neurons appeared not involved. Our data demonstrate olfactory deficits in a synuclein fly PD model for exploring olfactory pathology and physiology, and for monitoring PD progression and treatment.	[Chen, Alex Y.; Xia, Shouzhen; Tully, Tim] Dart Neurosci LLC, San Diego, CA 92131 USA; [Chen, Alex Y.; Tully, Tim] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chen, Alex Y.] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; [Wilburn, Paul] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Michigan State University	Chen, AY (corresponding author), Dart Neurosci LLC, San Diego, CA 92131 USA.	Alexome.chen@gmail.com	Wilburn, Paul/ABG-7975-2020	Wilburn, Paul/0000-0002-3197-8410	Dart NeuroScience LLC	Dart NeuroScience LLC	This work is supported by Dart NeuroScience LLC (http://www.dartneuroscience.com). The funder provided support in the form of salaries for authors AYC, SX and TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Bardy C, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnnes.2010.00002; Barzilai A, 2003, TRENDS MOL MED, V9, P126, DOI 10.1016/S1471-4914(03)00020-0; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; BERKOWICZ DA, 1994, J NEUROPHYSIOL, V71, P2557, DOI 10.1152/jn.1994.71.6.2557; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bicker G, 1999, MICROSC RES TECHNIQ, V45, P174, DOI 10.1002/(SICI)1097-0029(19990501)45:3<174::AID-JEMT5>3.3.CO;2-L; Botella JA, 2009, NEUROMOL MED, V11, P268, DOI 10.1007/s12017-009-8098-6; Burns M, 2010, CHEM BIOL INTERACT; Cicchetti F, 2005, NEUROBIOL DIS, V20, P360, DOI 10.1016/j.nbd.2005.03.018; Daly KC, 2008, CHEM SENSES, V33, P95, DOI 10.1093/chemse/bjm068; Daly KC, 2007, BEHAV NEUROSCI, V121, P794, DOI 10.1037/0735-7044.121.4.794; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1992, ANN NEUROL, V32, P97, DOI 10.1002/ana.410320116; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fong Chin-Shih, 2005, Acta Neurol Taiwan, V14, P55; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Giasson BI, 2000, NAT NEUROSCI, V3, P1227, DOI 10.1038/81737; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hawkes C, 2003, MOVEMENT DISORD, V18, P364, DOI 10.1002/mds.10379; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Huisman E, 2008, MOVEMENT DISORD, V23, P1407, DOI 10.1002/mds.22009; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kirchhof BS, 1999, J COMP NEUROL, V411, P643; Kranick SM, 2008, NEUROSIGNALS, V16, P35, DOI 10.1159/000109757; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai BCL, 2002, PARKINSONISM RELAT D, V8, P297, DOI 10.1016/S1353-8020(01)00054-2; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lelan F, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/987084; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612; Markopoulou K, 1997, NEUROLOGY, V49, P1262, DOI 10.1212/WNL.49.5.1262; Marxreiter F, 2009, EUR J NEUROSCI, V29, P879, DOI 10.1111/j.1460-9568.2009.06641.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mizuno H., 2010, PARKINSONS DIS, V2011; Mobley AS, 2014, TRENDS NEUROSCI, V37, P77, DOI 10.1016/j.tins.2013.11.004; Montgomery EB, 1999, NEUROLOGY, V52, P757, DOI 10.1212/WNL.52.4.757; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Muller A, 2002, J CLIN NEUROSCI, V9, P521, DOI 10.1054/jocn.2001.1071; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Park SS, 2007, EUR J NEUROSCI, V26, P3104, DOI 10.1111/j.1460-9568.2007.05929.x; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Protocols CSH, 2012, FOOD MED DROS COLD S; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sobel N, 2001, P NATL ACAD SCI USA, V98, P4154, DOI 10.1073/pnas.071061598; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; STEVENS JC, 1987, PSYCHOL AGING, V2, P36, DOI 10.1037/0882-7974.2.1.36; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; Trombley P Q, 1993, Curr Opin Neurobiol, V3, P540, DOI 10.1016/0959-4388(93)90053-2; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Ueno K, 2013, J PHYSIOL-LONDON, V591, P287, DOI 10.1113/jphysiol.2012.242909; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wei CJ, 2006, BEHAV NEUROSCI, V120, P393, DOI 10.1037/0735-7044.120.2.393; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247, DOI 10.1111/j.1600-0404.1995.tb06998.x; Wilson RI, 2011, CURR OPIN NEUROBIOL, V21, P254, DOI 10.1016/j.conb.2011.03.002; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264	77	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97758	10.1371/journal.pone.0097758	http://dx.doi.org/10.1371/journal.pone.0097758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879013	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000338101500023
J	Irvine, KL; Gangloff, M; Walsh, CM; Spring, DR; Gay, NJ; Bryant, CE				Irvine, Katherine L.; Gangloff, Monique; Walsh, Catherine M.; Spring, David R.; Gay, Nicholas J.; Bryant, Clare E.			Identification of Key Residues That Confer Rhodobacter sphaeroides LPS Activity at Horse TLR4/MD-2	PLOS ONE			English	Article							RECEPTOR 4; TLR4-MD-2 COMPLEX; STRUCTURAL BASIS; LIPID IVA; LIPOPOLYSACCHARIDE; ENDOTOXIN; RECOGNITION; MD-2; ACTIVATION; AGONIST	The molecular determinants underpinning how hexaacylated lipid A and tetraacylated precursor lipid IVa activate Toll-like receptor 4 (TLR4) are well understood, but how activation is induced by other lipid A species is less clear. Species specificity studies have clarified how TLR4/MD-2 recognises different lipid A structures, for example tetraacylated lipid IVa requires direct electrostatic interactions for agonism. In this study, we examine how pentaacylated lipopolysaccharide from Rhodobacter sphaeroides (RSLPS) antagonises human TLR4/MD-2 and activates the horse receptor complex using a computational approach and cross-species mutagenesis. At a functional level, we show that RSLPS is a partial agonist at horse TLR4/MD-2 with greater efficacy than lipid IVa. These data suggest the importance of the additional acyl chain in RSLPS signalling. Based on docking analysis, we propose a model for positioning of the RSLPS lipid A moiety (RSLA) within the MD-2 cavity at the TLR4 dimer interface, which allows activity at the horse receptor complex. As for lipid IVa, RSLPS agonism requires species-specific contacts with MD-2 and TLR4, but the R2 chain of RSLA protrudes from the MD-2 pocket to contact the TLR4 dimer in the vicinity of proline 442. Our model explains why RSLPS is only partially dependent on horse TLR4 residue R385, unlike lipid IVa. Mutagenesis of proline 442 into a serine residue, as found in human TLR4, uncovers the importance of this site in RSLPS signalling; horse TLR4 R385G/P442S double mutation completely abolishes RSLPS activity without its counterpart, human TLR4 G384R/S441P, being able to restore it. Our data highlight the importance of subtle changes in ligand positioning, and suggest that TLR4 and MD-2 residues that may not participate directly in ligand binding can determine the signalling outcome of a given ligand. This indicates a cooperative binding mechanism within the receptor complex, which is becoming increasingly important in TLR signalling.	[Irvine, Katherine L.; Walsh, Catherine M.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Gangloff, Monique; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Spring, David R.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge; University of Cambridge	Bryant, CE (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	ceb27@cam.ac.uk	Spring, David R/K-2283-2016; Spring, David R/GRO-7225-2022; Spring, David/AAM-1944-2020	Spring, David R/0000-0001-7355-2824; Spring, David R/0000-0001-7355-2824; Spring, David/0000-0001-7355-2824; Irvine, Katherine/0000-0002-8630-3250; Gangloff, Monique/0000-0001-6131-0115	Horserace Betting Levy Board; Horserace Betting Levy Board Veterinary Research Training Scholarship; Wellcome Trust program; Medical Research Council [G1000133] Funding Source: researchfish; Wellcome Trust [100321/Z/12/Z] Funding Source: researchfish; MRC [G1000133] Funding Source: UKRI	Horserace Betting Levy Board; Horserace Betting Levy Board Veterinary Research Training Scholarship; Wellcome Trust program(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a project grant from the Horserace Betting Levy Board to CEB and a Horserace Betting Levy Board Veterinary Research Training Scholarship to KLI. This work was also supported by a Wellcome Trust program grant to NJG and CEB. CEB is a BBSRC Research Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lohmann KL, 2007, J ENDOTOXIN RES, V13, P235, DOI 10.1177/0968051907083193; Lohmann KL, 2003, J ENDOTOXIN RES, V9, P33, DOI [10.1177/09680519030090010301, 10.1179/096805103125001315]; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; QURESHI N, 1988, J BIOL CHEM, V263, P5502; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Walsh C, 2008, THESIS U CAMBRIDGE; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	24	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98776	10.1371/journal.pone.0098776	http://dx.doi.org/10.1371/journal.pone.0098776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879320	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500085
J	Perez-Porcuna, TSM; Ascaso, C; Malheiro, A; Abellana, R; Martins, M; Sardinha, JFJ; Quinco, P; Antunes, IA; Garrido, MD; Buhrer-Sekula, S; Martinez-Espinosa, FE				Perez-Porcuna, Toma S. M.; Ascaso, Carlos; Malheiro, Adriana; Abellana, Rosa; Martins, Marilaine; Jardim Sardinha, Jose Felipe; Quinco, Patricia; Antunes, Irineide Assumpcao; Garrido, Marlucia da Silva; Buehrer-Sekula, Samira; Martinez-Espinosa, Flor Ernestina			Mycobacterium tuberculosis Infection in Young Children: Analyzing the Performance of the Diagnostic Tests	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; SKIN-TEST; IRON; EXPRESSION; CHILDHOOD; PROTEINS; IMMUNODIAGNOSIS; CONTACT; DISEASE; UTILITY	Objective: This study evaluated the performance of the Tuberculin Skin Test (TST) and Quantiferon-TB Gold in-Tube (QFT) and the possible association of factors which may modify their results in young children (0-6 years) with recent contact with an index tuberculosis case. Materials and Methods: A cross-sectional study including 135 children was conducted in Manaus, Amazonas-Brazil. The TST and QFT were performed and the tests results were analyzed in relation to the personal characteristics of the children studied and their relationship with the index case. Results: The rates of positivity were 34.8% (TST) and 26.7% (QFT), with 14.1% of indeterminations by the QFT. Concordance between tests was fair (Kappa = 0.35 P<0.001). Both the TST and QFT were associated with the intensity of exposure (Linear OR = 1.286, P = 0.005; Linear OR = 1.161, P = 0.035 respectively) with only the TST being associated with the time of exposure (Linear OR = 1.149, P = 0.009). The presence of intestinal helminths in the TST+ group was associated with negative QFT results (OR = 0.064, P = 0.049). In the TST- group lower levels of ferritin were associated with QFT+ results (Linear OR = 0.956, P = 0.036). Conclusions: Concordance between the TST and QFT was lower than expected. The factors associated with the discordant results were intestinal helminths, ferritin levels and exposure time to the index tuberculosis case. In TST+ group, helminths were associated with negative QFT results suggesting impaired cell-mediated immunity. The TST-&QFT+ group had a shorter exposure time and lower ferritin levels, suggesting that QFT is faster and ferritin may be a potential biomarker of early stages of tuberculosis infection.	[Perez-Porcuna, Toma S. M.; Quinco, Patricia; Garrido, Marlucia da Silva; Buehrer-Sekula, Samira] Univ Estado Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Perez-Porcuna, Toma S. M.; Ascaso, Carlos; Abellana, Rosa] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona 7, Catalunya, Spain; [Perez-Porcuna, Toma S. M.] Hosp Univ Mutua Terrassa, Unitat Invest Fundacio Mutua Terrassa, CAP Valldoreix, Serv Pediat, Terrassa, Catalunya, Spain; [Ascaso, Carlos] Inst Invest Biomed August Pi i Sunyer, Barcelona, Catalunya, Spain; [Malheiro, Adriana] Fundacao Hematol & Hemoterapia Amazonas, Lab Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Malheiro, Adriana] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Jardim Sardinha, Jose Felipe] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Antunes, Irineide Assumpcao] Policlin Cardoso Fontes, Ctr Referencia TB, Manaus, Amazonas, Brazil; [Garrido, Marlucia da Silva] Fundacao Vigilancia Saude Estado Amazonas, Programa Controle TB, Dept Vigilancia Epidemiol, Manaus, Amazonas, Brazil; [Buehrer-Sekula, Samira] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Martinez-Espinosa, Flor Ernestina] Fundacao Oswaldo Cruz, Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidade Federal de Amazonas; Universidade Federal de Goias; Fundacao Oswaldo Cruz	Perez-Porcuna, TSM (corresponding author), Univ Estado Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.	tomas.perez.porcuna@gmail.com	Abellana, Rosa/D-7305-2014; Garrido, Marlucia/AAK-1001-2020; Buhrer-Sekula, Samira/H-5115-2012	Abellana, Rosa/0000-0003-4487-4431; Perez-Porcuna, Tomas Maria/0000-0002-9951-7768; Buhrer-Sekula, Samira/0000-0002-5984-7770; Ascaso Terren, Carlos/0000-0002-4895-7616	Brazilian National Counsel of Technological and Scientific Development (CNPq); Foundation of Research Support of the State of Amazonas (FAPEAM); University of Barcelona	Brazilian National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation of Research Support of the State of Amazonas (FAPEAM); University of Barcelona	This work was financially supported by the Brazilian National Counsel of Technological and Scientific Development (CNPq), the Foundation of Research Support of the State of Amazonas (FAPEAM), and the University of Barcelona. Cellestis Ltd. donated QuantiFERON test kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; [Anonymous], 2011, GLOB TUB CONTR 2011; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Friis H, 2009, BRIT J NUTR, V102, P310, DOI 10.1017/S0007114508162122; Grare M, 2010, DIAGN MICR INFEC DIS, V66, P366, DOI 10.1016/j.diagmicrobio.2009.11.002; Haile Y, 2002, MICROBIOL-SGM, V148, P3881, DOI 10.1099/00221287-148-12-3881; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lewinsohn DA, 2008, PEDIATR RES, V63, P115, DOI 10.1203/PDR.0b013e3181652085; LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Maher D, 2006, INT J TUBERC LUNG D, V10, P1091; Manabe YC, 1999, P NATL ACAD SCI USA, V96, P12844, DOI 10.1073/pnas.96.22.12844; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Powell DA, 2009, PEDIATR INFECT DIS J, V28, P676, DOI 10.1097/INF.0b013e3181ad5490; Raharimanga V, 2012, TROP MED INT HEALTH, V17, P871, DOI 10.1111/j.1365-3156.2012.03013.x; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Co TR, 2007, CLIN EXP IMMUNOL, V147, P45, DOI 10.1111/j.1365-2249.2006.03247.x; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Thom RE, 2012, VACCINE, V30, P3159, DOI 10.1016/j.vaccine.2012.03.008; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tristão-Sá Ricardo, 2002, Rev. Soc. Bras. Med. Trop., V35, P533, DOI 10.1590/S0037-86822002000500020; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; WHO, WHO CHILD GROWTH STA	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97992	10.1371/journal.pone.0097992	http://dx.doi.org/10.1371/journal.pone.0097992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879374	Green Published, Green Submitted, gold			2022-12-27	WOS:000338101500028
J	Rollin-Pinheiro, R; Liporagi-Lopes, LC; de Meirelles, JV; de Souza, LM; Barreto-Bergter, E				Rollin-Pinheiro, Rodrigo; Liporagi-Lopes, Livia Cristina; de Meirelles, Jardel Vieira; de Souza, Lauro M.; Barreto-Bergter, Eliana			Characterization of Scedosporium apiospermum Glucosylceramides and Their Involvement in Fungal Development and Macrophage Functions	PLOS ONE			English	Article							LIPOSOMAL AMPHOTERICIN-B; CRYPTOCOCCUS-NEOFORMANS; PSEUDALLESCHERIA-BOYDII; MONOCLONAL-ANTIBODY; BIOLOGICAL FUNCTIONS; FONSECAEA-PEDROSOI; ANTIFUNGAL AGENTS; VORICONAZOLE; CASPOFUNGIN; INFECTION	Scedosporium apiospermum is an emerging fungal pathogen that causes both localized and disseminated infections in immunocompromised patients. Glucosylceramides (CMH, GlcCer) are the main neutral glycosphingolipids expressed in fungal cells. In this study, glucosylceramides (GlcCer) were extracted and purified in several chromatographic steps. Using high-performance thin layer chromatography (HPTLC) and electrospray ionization mass spectrometry (ESI-MS), N-2'-hydroxyhexadecanoyl-1-beta-D-glucopyranosyl-9- methyl-4,8-sphingadienine was identified as the main GlcCer in S. apiospermum. A monoclonal antibody (Mab) against this molecule was used for indirect immunofluorescence experiments, which revealed that this CMH is present on the surface of the mycelial and conidial forms of S. apiospermum. Treatment of S. apiospermum conidia with the Mab significantly reduced fungal growth. In addition, the Mab also enhanced the phagocytosis and killing of S. apiospermum by murine cells. In vitro assays were performed to evaluate the CMHs for their cytotoxic activities against the mammalian cell lines L. 929 and RAW, and an inhibitory effect on cell proliferation was observed. Synergistic in vitro interactions were observed between the Mab against GlcCer and both amphotericin B (AmB) and itraconazole. Because Scedosporium species develop drug resistance, the number of available antifungal drugs is limited; our data indicate that combining immunotherapy with the available drugs might be a viable treatment option. These results suggest that in S. apiospermum, GlcCer are most likely cell wall components that are targeted by antifungal antibodies, which directly inhibit fungal development and enhance macrophage function; furthermore, these results suggest the combined use of monoclonal antibodies against GlcCer and antifungal drugs for antifungal immunotherapy.	[Rollin-Pinheiro, Rodrigo; de Meirelles, Jardel Vieira; Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Geral, Rio De Janeiro, RJ, Brazil; [Liporagi-Lopes, Livia Cristina] Univ Fed Rio de Janeiro, Fac Farm, Dept Anal Clin & Toxicol, Rio De Janeiro, RJ, Brazil; [de Souza, Lauro M.] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Parana	Barreto-Bergter, E (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Geral, Rio De Janeiro, RJ, Brazil.	eliana.bergter@micro.ufrj.br	Bergter, Eliana Barreto/E-2664-2013; Souza, Lauro/AAE-3273-2019	Souza, Lauro/0000-0001-9166-2146	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Programa de Nucleos de Excelencia (PRONEX); CAPES/FAPERJ; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Programa de Nucleos de Excelencia (PRONEX); CAPES/FAPERJ(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Conselho de Pesquisa da UFRJ, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ and Programa de Nucleos de Excelencia (PRONEX). LCLL and EBB are supported by CAPES/FAPERJ and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto-Bergter E, 2004, AN ACAD BRAS CIENC, V76, P67, DOI 10.1590/S0001-37652004000100007; Barreto-Bergter E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00239; Blyth CC, MED MYCOL S1, V48, pS37; CaesarTonThat TC, 1997, INFECT IMMUN, V65, P5354, DOI 10.1128/IAI.65.12.5354-5357.1997; Calixto R, 2010, RES MICROBIOL, V161, P720, DOI [10.1016/J.resmic.2010.07.005, 10.1016/j.resmic.2010.07.005]; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; Cimon B, 2000, EUR J CLIN MICROBIOL, V19, P53, DOI 10.1007/s100960050011; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Cuenca-Estrella M, 2008, ANTIMICROB AGENTS CH, V52, P1136, DOI 10.1128/AAC.01160-07; da Silva AFC, 2004, FEBS LETT, V561, P137, DOI 10.1016/S0014-5793(04)00156-5; Duarte RS, 1998, BBA-LIPID LIPID MET, V1390, P186, DOI 10.1016/S0005-2760(97)00179-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Guarro J, 2006, MED MYCOL, V44, P295, DOI 10.1080/13693780600752507; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Han Y, 2010, INT IMMUNOPHARMACOL, V10, P1526, DOI 10.1016/j.intimp.2010.08.027; Kanafani ZA, 2004, EUR J CLIN MICROBIOL, V23, P836, DOI 10.1007/s10096-004-1233-2; Kontoyiannis DP, 2003, CANCER, V98, P292, DOI 10.1002/cncr.11479; Lackner M, 2012, MED MYCOL, V50, P497, DOI 10.3109/13693786.2011.618939; Lackner M, 2011, MYCOSES, V54, P12, DOI 10.1111/j.1439-0507.2011.02110.x; Lackner M, ANTIMICROB AGENTS CH, V56, P2635; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Lamaris GA, 2006, CLIN INFECT DIS, V43, P1580, DOI 10.1086/509579; Lopes LC, PLOS NEGL TROP DIS, V4, pe853; Manavathu EK, 1999, J CLIN MICROBIOL, V37, P858, DOI 10.1128/JCM.37.3.858-861.1999; Nimrichter L, 2005, INFECT IMMUN, V73, P7860, DOI 10.1128/IAI.73.12.7860-7868.2005; Nimrichter L, 2004, MICROBES INFECT, V6, P657, DOI 10.1016/j.micinf.2004.03.004; Pinto MR, 2005, GLYCOBIOLOGY, V15, P895, DOI 10.1093/glycob/cwi084; Pinto MR, 2002, GLYCOBIOLOGY, V12, P251, DOI 10.1093/glycob/12.4.251; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, CLIN VACCINE IMMUNOL, V14, P1372, DOI 10.1128/CVI.00202-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Seifert T, 2002, J NEUROL, V249, P1109, DOI 10.1007/s00415-002-0723-3; Steinbach WJ, 2003, J CLIN MICROBIOL, V41, P3981, DOI 10.1128/JCM.41.8.3981-3985.2003; Tadros TS, 1998, HUM PATHOL, V29, P1266, DOI 10.1016/S0046-8177(98)90255-6; Toledo MS, 2001, GLYCOBIOLOGY, V11, P105, DOI 10.1093/glycob/11.2.105; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353; Wiederhold NP, 2009, MED MYCOL, V47, P422, DOI 10.1080/13693780802510224; Xu JG, 2003, PHARMACEUT RES, V20, P169, DOI 10.1023/A:1022254617664; Zouhair R, MED MYCOL, V51, P603	44	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98149	10.1371/journal.pone.0098149	http://dx.doi.org/10.1371/journal.pone.0098149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878570	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500033
J	Liukko, ALK; Kinnunen, TT; Rytkonen-Nissinen, MA; Kailaanmaki, AHT; Randell, JT; Maillere, B; Virtanen, TI				Liukko, Aino L. K.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Kailaanmaki, Anssi H. T.; Randell, Jukka T.; Maillere, Bernard; Virtanen, Tuomas I.			Human CD4(+) T Cell Responses to the Dog Major Allergen Can f 1 and Its Human Homologue Tear Lipocalin Resemble Each Other	PLOS ONE			English	Article							BLA G 4; IMMUNE-RESPONSES; IMMUNOGLOBULIN-E; PEPTIDE; DIFFERENTIATION; CLONING; RECOGNITION; PROTEINS; ANTIGEN; EPITOPE	Lipocalin allergens form a notable group of proteins, as they contain most of the significant respiratory allergens from mammals. The basis for the allergenic capacity of allergens in the lipocalin family, that is, the development of T-helper type 2 immunity against them, is still unresolved. As immunogenicity has been proposed to be a decisive feature of allergens, the purpose of this work was to examine human CD4(+) T cell responses to the major dog allergen Can f 1 and to compare them with those to its human homologue, tear lipocalin (TL). For this, specific T cell lines were induced in vitro from the peripheral blood mononuclear cells of Can f 1-allergic and healthy dog dust-exposed subjects with peptides containing the immunodominant T cell epitopes of Can f 1 and the corresponding TL peptides. We found that the frequency of Can f 1 and TL-specific T cells in both subject groups was low and close to each other, the difference being about two-fold. Importantly, we found that the proliferative responses of both Can f 1 and TL-specific T cell lines from allergic subjects were stronger than those from healthy subjects, but that the strength of the responses within the subject groups did not differ between these two antigens. Moreover, the phenotype of the Can f 1 and TL-specific T cell lines, determined by cytokine production and expression of cell surface markers, resembled each other. The HLA system appeared to have a minimal role in explaining the allergenicity of Can f 1, as the allergic and healthy subjects' HLA background did not differ, and HLA binding was very similar between Can f 1 and TL peptides. Along with existing data on lipocalin allergens, we conclude that strong antigenicity is not decisive for the allergenicity of Can f 1.	[Liukko, Aino L. K.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Kailaanmaki, Anssi H. T.; Virtanen, Tuomas I.] Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio, Finland; [Liukko, Aino L. K.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Kailaanmaki, Anssi H. T.; Virtanen, Tuomas I.] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Rytkonen-Nissinen, Marja A.] Univ Eastern Finland, Inst Dent, Sch Med, Kuopio, Finland; [Randell, Jukka T.] Kuopio Univ Hosp, Dept Pulm Dis, SF-70210 Kuopio, Finland; [Maillere, Bernard] Commissariat Energie Atom, Serv Ingn Mol Prot, Inst Biol & Technol, Gif Sur Yvette, France	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Liukko, ALK (corresponding author), Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio, Finland.	aino.liukko@uef.fi	Kinnunen, Tuure/D-4898-2011	Kinnunen, Tuure/0000-0003-1595-5371; Ronka, Aino/0000-0001-6007-3648; Kailaanmaki, Anssi/0000-0002-4737-980X; Rytkonen-Nissinen, Marja/0000-0002-2014-8315	Kuopio University Hospital [5021605]; Ida Montin Foundation; Foundation of the Finnish Anti-Tuberculosis Association; Finnish Cultural Foundation; Respiratory Foundation of Kuopio, Finland	Kuopio University Hospital; Ida Montin Foundation; Foundation of the Finnish Anti-Tuberculosis Association; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Respiratory Foundation of Kuopio, Finland	This study was financially supported by Kuopio University Hospital (project no. 5021605), the Ida Montin Foundation (http://www.idamontininsaatio.fi/pages/suomi/etusivu.php), the Foundation of the Finnish Anti-Tuberculosis Association (http://www.tb-foundation.org/), the Finnish Cultural Foundation (https://skr.fi/) and the Respiratory Foundation of Kuopio, Finland (http://www.hengityssaatio.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Arruda LK, 1995, J BIOL CHEM, V270, P31196, DOI 10.1074/jbc.270.52.31196; Barber JS, 2013, P NATL ACAD SCI USA, V110, P8164, DOI 10.1073/pnas.1302103110; Bateman EAL, 2006, J ALLERGY CLIN IMMUN, V118, P1350, DOI 10.1016/j.jaci.2006.07.040; Bellinghausen I, 2003, IMMUNOLOGY, V108, P167, DOI 10.1046/j.1365-2567.2003.01576.x; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; da Costa Santiago H, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0040552; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Emanuelsson C, 2007, MOL IMMUNOL, V44, P3256, DOI 10.1016/j.molimm.2007.01.019; Epton MJ, 2002, CLIN EXP ALLERGY, V32, P1341, DOI 10.1046/j.1365-2222.2002.01473.x; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Ganfornina M.D., 2006, LIPOCALINS, P17; Gebe JA, 2003, EUR J IMMUNOL, V33, P1409, DOI 10.1002/eji.200323871; Gelder CM, 1996, J VIROL, V70, P4787, DOI 10.1128/JVI.70.7.4787-4790.1996; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; Helm Ricki M, 2008, Clin Allergy Immunol, V21, P219; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hermann R, 2003, TISSUE ANTIGENS, V62, P162, DOI 10.1034/j.1399-0039.2003.00071.x; Hilger C, 2005, J ALLERGY CLIN IMMUN, V115, P617, DOI 10.1016/j.jaci.2004.11.052; Hilger C, 2012, CURR ALLERGY ASTHMA; Holt PG, 2005, NAT IMMUNOL, V6, P957, DOI 10.1038/ni1005-957; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Immonen A, 2007, CLIN EXP ALLERGY, V37, P939, DOI 10.1111/j.1365-2222.2007.02722.x; Immonen A, 2003, CLIN EXP ALLERGY, V33, P834, DOI 10.1046/j.1365-2222.2003.01669.x; Immonen A, 2005, J IMMUNOL, V175, P3614, DOI 10.4049/jimmunol.175.6.3614; Immonen AK, 2007, IMMUNOLOGY, V120, P38, DOI 10.1111/j.1365-2567.2006.02475.x; Janssen EM, 2000, J IMMUNOL, V164, P580, DOI 10.4049/jimmunol.164.2.580; Jeal H, 2004, CLIN EXP ALLERGY, V34, P1919, DOI 10.1111/j.1365-2222.2004.02126.x; Juntunen R, 2009, MOL IMMUNOL, V46, P3320, DOI 10.1016/j.molimm.2009.07.022; Kauppinen A, 2012, IMMUNOBIOLOGY, V217, P8, DOI 10.1016/j.imbio.2011.08.012; Kinnunen T, 2005, INT IMMUNOL, V17, P1573, DOI 10.1093/intimm/dxh332; Kinnunen T, 2003, EUR J IMMUNOL, V33, P1717, DOI 10.1002/eji.200322952; Kinnunen T, 2005, CLIN EXP ALLERGY, V35, P797, DOI 10.1111/j.1365-2222.2005.02247.x; Kinnunen T, 2010, EUR J IMMUNOL, V40, P2460, DOI 10.1002/eji.201040328; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Korb LC, 1999, J IMMUNOL, V162, P6401; Mantyjarvi R, 1996, J ALLERGY CLIN IMMUN, V97, P1297, DOI 10.1016/S0091-6749(96)70198-7; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Paddock CD, 2001, J IMMUNOL, V167, P2694, DOI 10.4049/jimmunol.167.5.2694; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; Parviainen S, 2013, SCAND J IMMUNOL, V77, P171, DOI 10.1111/sji.12023; Parviainen S, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.06.005; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Platts-Mills TAE, 2007, J ALLERGY CLIN IMMUN, V119, P297, DOI 10.1016/j.jaci.2006.12.647; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Rogers PR, 1999, J IMMUNOL, V163, P1205; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Saarelainen S, 2002, INT IMMUNOL, V14, P401, DOI 10.1093/intimm/14.4.401; Saarelainen S, 2004, CLIN EXP ALLERGY, V34, P1576, DOI 10.1111/j.1365-2222.2004.02071.x; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schountz T, 1996, J IMMUNOL, V157, P3893; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Smole U, 2010, ALLERGY; Tan YW, 2009, J BIOL CHEM, V284, P3148, DOI 10.1074/jbc.M807209200; Texier C, 2000, J IMMUNOL, V164, P3177, DOI 10.4049/jimmunol.164.6.3177; Texier C, 2001, EUR J IMMUNOL, V31, P1837, DOI 10.1002/1521-4141(200106)31:6&lt;1837::AID-IMMU1837&gt;3.0.CO;2-H; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Turner SJ, 2009, CURR OPIN IMMUNOL, V21, P286, DOI 10.1016/j.coi.2009.05.004; Van Overtvelt L, 2008, J IMMUNOL, V180, P4514, DOI 10.4049/jimmunol.180.7.4514; Virtanen T, 1999, INT ARCH ALLERGY IMM, V120, P247, DOI 10.1159/000024277; Virtanen T, 1999, IMMUNOL TODAY, V20, P398, DOI 10.1016/S0167-5699(99)01515-7; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; Virtanen T, 2014, ALLERGENS A IN PRESS; Virtanen T, 2007, J ALLERGY CLIN IMMUN, V120, P724, DOI 10.1016/j.jaci.2007.04.020; Virtanen Tuomas, 2008, Clin Allergy Immunol, V21, P201; Wambre E, 2011, CLIN EXP ALLERGY, V41, P192, DOI 10.1111/j.1365-2222.2010.03641.x; Wambre E, 2008, INT ARCH ALLERGY IMM, V146, P99, DOI 10.1159/000113513; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080; Zeiler T, 1999, J IMMUNOL, V162, P1415	83	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98461	10.1371/journal.pone.0098461	http://dx.doi.org/10.1371/journal.pone.0098461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875388	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800041
J	Kranjec, A; Lupyan, G; Chatterjee, A				Kranjec, Alexander; Lupyan, Gary; Chatterjee, Anjan			Categorical Biases in Perceiving Spatial Relations	PLOS ONE			English	Article							LANGUAGE; REPRESENTATIONS; COGNITION; SPACE; TIME; CATEGORIZATION	We investigate the effect of spatial categories on visual perception. In three experiments, participants made same/different judgments on pairs of simultaneously presented dot-cross configurations. For different trials, the position of the dot within each cross could differ with respect to either categorical spatial relations (the dots occupied different quadrants) or coordinate spatial relations (the dots occupied different positions within the same quadrant). The dot-cross configurations also varied in how readily the dot position could be lexicalized. In harder-to-name trials, crosses formed a "+" shape such that each quadrant was associated with two discrete lexicalized spatial categories (e.g., "above" and "left"). In easier-to-name trials, both crosses were rotated 45 degrees to form an "6" shape such that quadrants were unambiguously associated with a single lexicalized spatial category (e.g., "above" or "left"). In Experiment 1, participants were more accurate when discriminating categorical information between easier-to-name categories and more accurate at discriminating coordinate spatial information within harder-to-name categories. Subsequent experiments attempted to down-regulate or up-regulate the involvement of language in task performance. Results from Experiment 2 (verbal interference) and Experiment 3 (verbal training) suggest that the observed spatial relation type-by-nameability interaction is resistant to online language manipulations previously shown to affect color and object-based perceptual processing. The results across all three experiments suggest that robust biases in the visual perception of spatial relations correlate with patterns of lexicalization, but do not appear to be modulated by language online.	[Kranjec, Alexander] Duquesne Univ, Dept Psychol, Pittsburgh, PA 15219 USA; [Kranjec, Alexander] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Lupyan, Gary] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Chatterjee, Anjan] Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	Duquesne University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Pennsylvania Medicine	Kranjec, A (corresponding author), Duquesne Univ, Dept Psychol, Pittsburgh, PA 15219 USA.	kranjeca@duq.edu		Lupyan, Gary/0000-0001-8441-7433	National Institutes of Health [RO1 DC004817]; National Science Foundation [SBE0541957]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the National Institutes of Health [RO1 DC004817], and the National Science Foundation [subcontract under SBE0541957]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorapanth P, 2012, BRAIN LANG, V120, P226, DOI 10.1016/j.bandl.2011.09.007; Amorapanth PX, 2010, J COGNITIVE NEUROSCI, V22, P1739, DOI 10.1162/jocn.2009.21322; Bowerman M., 1996, LANGUAGE SPACE, P385; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Chatterjee A, 2001, TRENDS COGN SCI, V5, P55, DOI 10.1016/S1364-6613(00)01598-9; Chatterjee Anjan, 2008, Seminars in Speech and Language, V29, P226, DOI 10.1055/s-0028-1082886; Choi S, 1999, COGNITIVE DEV, V14, P241, DOI 10.1016/S0885-2014(99)00004-0; Dent K, 2009, Q J EXP PSYCHOL, V62, P2372, DOI 10.1080/17470210902853548; FRICK RW, 1995, MEM COGNITION, V23, P132, DOI 10.3758/BF03210562; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; Haun DBM, 2011, COGNITION, V119, P70, DOI 10.1016/j.cognition.2010.12.009; HAYWARD WG, 1995, COGNITION, V55, P39, DOI 10.1016/0010-0277(94)00643-Y; Hermer-Vazquez L, 1999, COGNITIVE PSYCHOL, V39, P3, DOI 10.1006/cogp.1998.0713; Holmes KJ, 2013, COGNITIVE PROCESSING, P1; Huttenlocher J, 2004, COGNITION, V93, P75, DOI 10.1016/j.cognition.2003.10.006; Kosslyn S, 1994, ARTIFICIAL INTELLIGE; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; Kosslyn SM, 1998, PSYCHOBIOLOGY, V26, P333; Kosslyn SM, 2006, NEUROPSYCHOLOGIA, V44, P1519, DOI 10.1016/j.neuropsychologia.2006.01.022; Kranjec A, 2013, CORTEX, V49, P1983, DOI 10.1016/j.cortex.2013.03.005; Kranjec A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00240; Kranjec A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011667; Lupyan G, 2008, COGNITION, V108, P566, DOI 10.1016/j.cognition.2008.03.009; Lupyan G, 2008, J EXP PSYCHOL GEN, V137, P348, DOI 10.1037/0096-3445.137.2.348; Lupyan G, 2007, PSYCHOL SCI, V18, P1077, DOI 10.1111/j.1467-9280.2007.02028.x; Lupyan G, 2010, PSYCHOL SCI, V21, P682, DOI 10.1177/0956797610366099; Lupyan G, 2009, PSYCHON B REV, V16, P711, DOI 10.3758/PBR.16.4.711; Majid A, 2004, TRENDS COGN SCI, V8, P108, DOI 10.1016/j.tics.2004.01.003; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Perry LK, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00122; Postma A, 2006, NEUROPSYCHOLOGIA, V44, P1515, DOI 10.1016/j.neuropsychologia.2006.01.016; QUINN PC, 1994, CHILD DEV, V65, P58, DOI 10.2307/1131365; Quinn PC, 1996, DEV PSYCHOL, V32, P942, DOI 10.1037/0012-1649.32.5.942; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Talmy Leonard, 2000, COGNITIVE SEMANTICS, VI; TVERSKY B, 1989, J EXP PSYCHOL GEN, V118, P387, DOI 10.1037/0096-3445.118.4.387; van der Ham IJM, 2007, NEUROPSYCHOLOGIA, V45, P2492, DOI 10.1016/j.neuropsychologia.2007.03.021; van der Ham IJM, 2011, J COGN PSYCHOL, V23, P922, DOI 10.1080/20445911.2011.586780; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98604	10.1371/journal.pone.0098604	http://dx.doi.org/10.1371/journal.pone.0098604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24870560	gold, Green Submitted, Green Published			2022-12-27	WOS:000336858300055
J	Misch, F; Messmer, AS; Nickel, CH; Gujan, M; Graber, A; Blume, K; Bingisser, R				Misch, Franziska; Messmer, Anna Sarah; Nickel, Christian Hans; Gujan, Madleina; Graber, Andreas; Blume, Katharina; Bingisser, Roland			Impact of Observation on Disposition of Elderly Patients Presenting to Emergency Departments with Non-Specific Complaints	PLOS ONE			English	Article							RISK-STRATIFICATION TOOL; ADVERSE HEALTH OUTCOMES; OLDER-ADULTS; SCREENING TOOL; PREDICTIVE-VALIDITY; SEVERITY INDEX; PRIMARY-CARE; TRIAGE; POPULATION; VALIDATION	Background: Emergency Departments (EDs) have to cope with an increasing number of elderly patients, often presenting with non-specific complaints (NSC), such as generalized weakness. Acute morbidity requiring early intervention is present in the majority of patients with NSC. Therefore, an early and optimal disposition plan is crucial. The objective of this study was to prospectively study the disposition process of patients presenting to the ED with NSC. Methods: For two years, all patients presenting with NSC presenting to an urban ED were screened and consecutively included. The initial disposition plan was compared to the effective transfer after observation. Optimal disposition was defined as a high accuracy regarding disposition of patients with acute morbidity to an internal medicine ward. Results: The final study population consisted of 669 patients with NSC. Admission to internal medicine increased from 297 (44%) planned admissions to 388 (58%) effective admissions after observation. Conversely, transfers to geriatric community hospitals and discharges decreased from the initially planned 372 (56%) patients to 281 (42%) effectively transferred and discharged patients. The accuracy regarding disposition of patients with acute morbidity increased from 53% to 68% after observation. Conclusion: Disposition planning in patients with NSC improves after observation, if defined by the accuracy regarding hospitalization of patients with acute morbidity. Further research should focus on risk stratification tools for timely disposition planning in order to reduce high admission rates for patients without acute morbidity and high readmission rates for discharged patients with non-specific complaints.	[Misch, Franziska; Messmer, Anna Sarah; Nickel, Christian Hans; Gujan, Madleina; Graber, Andreas; Blume, Katharina; Bingisser, Roland] Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland	University of Basel	Bingisser, R (corresponding author), Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland.	Roland.Bingisser@usb.ch		Messmer, Anna/0000-0002-3206-9112				Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Elmstahl S, 1999, AGING-CLIN EXP RES, V11, P56, DOI 10.1007/BF03399638; Exadaktylos Aristomenis K, 2008, J Trauma Manag Outcomes, V2, P11, DOI 10.1186/1752-2897-2-11; Fan J, 2006, AM J EMERG MED, V24, P540, DOI 10.1016/j.ajem.2006.01.015; George G, 2006, EMERG MED J, V23, P379, DOI 10.1136/emj.2005.029793; Graff L, 2009, AM COLL EMERGENCY PH, V176; Grossmann FF, 2012, ANN EMERG MED, V60, P317, DOI 10.1016/j.annemergmed.2011.12.013; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Hastings SN, 2007, J GEN INTERN MED, V22, P1527, DOI 10.1007/s11606-007-0343-9; Hustey FM, 2007, J AM GERIATR SOC, V55, P1269, DOI 10.1111/j.1532-5415.2007.01272.x; Jayaprakash N, 2009, WEST J EMERG MED, V10, P233; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Marx J., 2013, ROSENS EMERGENCY MED; MCCAIG LF, 2006, ADV DATA, V372, P1; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1111/j.1553-2712.2003.tb01996.x; Mudge AM, 2011, J HOSP MED, V6, P61, DOI 10.1002/jhm.811; Nemec M, 2010, ACAD EMERG MED, V17, P284, DOI 10.1111/j.1553-2712.2009.00658.x; Nickel CH, 2013, AM J EMERG MED; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nickel CH, 2009, SWISS MED WKLY, V139, P271, DOI smw-12620; Pines JM, 2010, ANN EMERG MED; Rudiger-Sturchler M, 2010, SWISS MED WKLY, V140, DOI [10.4414/smw.2010/13085, 10.4414/smw.2010.13085]; Ruger JP, 2007, AM J EMERG MED, V25, P794, DOI 10.1016/j.ajem.2007.01.014; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; Rutschmann OT, 2005, SWISS MED WKLY, V135, P145; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Schumacher JG, 2006, J EMERG MED, V30, P455, DOI 10.1016/j.jemermed.2005.07.008; Schumacher JG, 2005, AM J EMERG MED, V23, P556, DOI 10.1016/j.ajem.2004.12.011; van Bokhoven MA, 2008, J CLIN EPIDEMIOL, V61, P318, DOI 10.1016/j.jclinepi.2007.05.008	36	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98097	10.1371/journal.pone.0098097	http://dx.doi.org/10.1371/journal.pone.0098097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871340	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300024
J	Rhee, EJ; Lee, MK; Kim, JD; Jeon, WS; Bae, JC; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Rhee, Eun-Jung; Lee, Min Kyung; Kim, Jong Dae; Jeon, Won Seon; Bae, Ji Cheol; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young			Metabolic Health Is a More Important Determinant for Diabetes Development than Simple Obesity: A 4-Year Retrospective Longitudinal Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; RISK; ASSOCIATION; PREVALENCE; TOLERANCE; PROGNOSIS; MELLITUS	Background: Recent studies report the importance of metabolic health beyond obesity. The aim of this study is to compare the risk for diabetes development according to different status of metabolic health and obesity over a median follow-up of 48.7 months. Methods: 6,748 non-diabetic subjects (mean age 43 years) were divided into four groups according to the baseline metabolic health and obesity status: metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically unhealthy non-obese (MUHNO) and metabolically unhealthy obese (MUHO). Being metabolically healthy was defined by having less than 2 components among the 5 components, that is, high blood pressure, high fasting blood glucose, high triglyceride, low high-density lipoprotein cholesterol and being in the highest decile of homeostasis model assessment-insulin resistance (HOMA-IR) index. Obesity status was assessed by body mass index (BMI) higher than 25 kg/m 2. The development of diabetes was assessed annually from self-questionnaire, fasting glucose and HbA1c. Results: At baseline, 45.3% of the subjects were MHNO, 11.3% were MHO, 21.7% were MUHNO, and 21.7% were MUHO. During a median follow-up of 48.7 months, 277 subject (4.1%) developed diabetes. The hazard ratio for diabetes development was 1.338 in MHO group (95% CI 0.67-2.672), 4.321 in MUHNO group (95% CI 2.702-6.910) and 5.994 in MUHO group (95% CI 3.561-10.085) when MHNO group was considered as the reference group. These results were similar after adjustment for the changes of the risk factors during the follow-up period. Conclusion: The risk for future diabetes development was higher in metabolically unhealthy subgroups compared with those of metabolically healthy subjects regardless of obesity status.	[Rhee, Eun-Jung; Lee, Min Kyung; Kim, Jong Dae; Jeon, Won Seon; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea.	drlwy@hanmail.net	LEE, WON-YOUNG/C-7249-2018; Rhee, Eun-Jung/M-9294-2015; Park, Cheol-Young/C-6690-2018	LEE, WON-YOUNG/0000-0002-1082-7592; Rhee, Eun-Jung/0000-0002-6108-7758; Park, Cheol-Young/0000-0002-9415-9965				Alberti KG, 2009, CIRCULATION, V120, DOI DOI 10.1161/CIRCULATIONAHA.109.192644; Alqahtani N, 2013, INT J PREVENTIVE MED, V4, P1025; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Majka DS, 2009, AM J PREV MED, V36, P56, DOI 10.1016/j.amepre.2008.09.031; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; North KE, 2003, INT J OBESITY, V27, P491, DOI 10.1038/sj.ijo.0802261; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Samocha-Bonet D, 2012, TRENDS ENDOCRIN MET, V23, P116, DOI 10.1016/j.tem.2011.12.005; Schwartz Kendra L, 2005, BMC Fam Pract, V6, P28, DOI 10.1186/1471-2296-6-28; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steering Committee of the WHO Western Pacific Region IASO & IOTF, 2000, AS PAC PERSP RED OB; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yu JH, 2013, ENDOCRINOL METAB, V28, P33, DOI 10.3803/EnM.2013.28.1.33	27	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98369	10.1371/journal.pone.0098369	http://dx.doi.org/10.1371/journal.pone.0098369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870949	Green Published, Green Submitted, gold			2022-12-27	WOS:000336858300039
J	Auld, AF; Ekra, KA; Shiraishi, RW; Tuho, MZ; Kouakou, JS; Mohamed, F; Ettiegne-Traore, V; Sabatier, J; Essombo, J; Adjorlolo-Johnson, G; Marlink, R; Ellerbrock, TV				Auld, Andrew F.; Ekra, Kunomboa A.; Shiraishi, Ray W.; Tuho, Moise Z.; Kouakou, Joseph S.; Mohamed, Fayama; Ettiegne-Traore, Virginie; Sabatier, Jennifer; Essombo, Joseph; Adjorlolo-Johnson, Georgette; Marlink, Richard; Ellerbrock, Tedd V.			Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Cote d'Ivoire's National Antiretroviral Therapy Program	PLOS ONE			English	Article							PHYSICIAN-PATIENT RELATIONSHIPS; SUB-SAHARAN AFRICA; SCALE-UP; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; INFECTED ADULTS; COTRIMOXAZOLE PROPHYLAXIS; MULTIPLE IMPUTATION; FOOD INSECURITY; SEX-DIFFERENCES	Background: In C (o) over cap te d'Ivoire during 2004-2007, numbers of ART enrollees increased from,5,000 to 36,943. Trends in nationally representative ART program outcomes have not yet been reported. Methodology/Principal Findings: We conducted a retrospective chart review to assess trends in patient characteristics and attrition [death or loss to follow-up (LTFU)] over time, among a nationally representative sample of 3,682 adults (>= 15 years) initiating ART during 2004-2007 at 34 health facilities. Among ART enrollees during 2004-2007, median age was 36, the proportion female was 67%, the proportion HIV-2-infected or dually HIV-1&2 reactive was 5%, and median baseline CD4(+) T-cell (CD4) count was 135 cells/mu L. Comparing cohorts initiating ART in 2004 with cohorts initiating ART in 2007, median baseline weight declined from 55 kg to 52 kg (p = 0.008) and the proportion weighing <45 kg increased from 17% to 22% (p = 0.014). During 2004-2007, pharmacy-based estimates of the percentage of new ART enrollees >= 95% adherent to ART declined from 74% to 60% (p = 0.026), and twelve-month retention declined from 86% to 69%, due to increases in 12-month mortality from 2%-4% and LTFU from 12%-28%. In univariate analysis, year of ART initiation was associated with increasing rates of both LTFU and mortality. Controlling for baseline CD4, weight, adherence, and other risk factors, year of ART initiation was still strongly associated with LTFU but not mortality. In multivariate analysis, weight <45 kg and adherence <95% remained strong predictors of LTFU and mortality. Conclusions: During 2004-2007, increasing prevalence among ART enrollees of measured mortality risk factors, including weight <45 kg and ART adherence <95%, might explain increases in mortality over time. However, the association between later calendar year and increasing LTFU is not explained by risk factors evaluated in this analysis. Undocumented transfers, political instability, and patient dissatisfaction with crowded facilities might explain increasing LTFU.	[Auld, Andrew F.; Shiraishi, Ray W.; Sabatier, Jennifer; Ellerbrock, Tedd V.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Ekra, Kunomboa A.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Abidjan, Cote Ivoire; [Tuho, Moise Z.; Ettiegne-Traore, Virginie] Minist Hlth, Natl Program Med Care Persons Living HIV AIDS, Abidjan, Cote Ivoire; [Kouakou, Joseph S.; Mohamed, Fayama; Essombo, Joseph] Elizabeth Glaser Pediat AIDS Fdn, Abidjan, Cote Ivoire; [Mohamed, Fayama] Directorate Gen Budget & Finance, Dept Econ & Finance, Abidjan, Cote Ivoire; [Adjorlolo-Johnson, Georgette; Marlink, Richard] Elizabeth Glaser Pediat AIDS Fdn, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Auld, AF (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	aauld@cdc.gov		Auld, Andrew/0000-0001-5089-9163; Shiraishi, Ray/0000-0001-7640-0666	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the United States Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje-Toure CA, 2003, AIDS, V17, pS49, DOI 10.1097/00002030-200317003-00007; amfAR, 2018, ZIMB DAT PEPFAR MON; [Anonymous], 2008, WORLD POP PROSP 2008; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046680; Bechu N, 2006, IMPACT AIDS EC FAMIL; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Colson P, 2005, J MED VIROL, V75, P381, DOI 10.1002/jmv.20296; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dang BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042980; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Government Accountability Office, 2012, DES EV 2012 REV; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Harries K, 2010, T ROY SOC TROP MED H, V104, P154, DOI 10.1016/j.trstmh.2009.08.012; Isaka Y, 2001, ARCH VIROL, V146, P743, DOI 10.1007/s007050170143; Joint United Nations Programme on HIV/AIDS, 2012, REP GLOB AIDS EP; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP; Koole O, 2012, 19 INT AIDS C WASH D; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Messou E, 2011, JAIDS-J ACQ IMM DEF, V57, pS34, DOI 10.1097/QAI.0b013e3182208003; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Montaner JSG, 2010, ANN INTERN MED, V152, P131, DOI 10.7326/0003-4819-152-2-201001190-00019; Musheke M, 2013, AIDS PATIENT CARE ST; Musheke M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17366; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Ruelle J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-21; Schneider J, 2004, J GEN INTERN MED, V19, P1096, DOI 10.1111/j.1525-1497.2004.30418.x; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shimeles A, 2010, AFRICAN DEV BANK WOR; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; United Nations Development Programme, 2011, CONFL COT IV ITS EFF; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a; van der Ende ME, 2003, AIDS, V17, pS55, DOI 10.1097/00002030-200317003-00008; van der Loeff MFS, 2006, INT J EPIDEMIOL, V35, P1322, DOI 10.1093/ije/dyl037; van Tienen C, 2010, JAIDS-J ACQ IMM DEF, V53, P640, DOI 10.1097/QAI.0b013e3181bf1a25; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weiser SD, 2012, JAIDS-J ACQ IMM DEF, V61, P179, DOI 10.1097/QAI.0b013e318261f064; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, 2010, ANT THER HIV INF AD; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Witvrouw M, 1999, AIDS, V13, P1477, DOI 10.1097/00002030-199908200-00006; World Food Programme, 2011, WORLD FOOD PROGR FIG; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	78	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98183	10.1371/journal.pone.0098183	http://dx.doi.org/10.1371/journal.pone.0098183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866468	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100038
J	Kelly, JJ; Minalt, N; Culotti, A; Pryor, M; Packman, A				Kelly, John J.; Minalt, Nicole; Culotti, Alessandro; Pryor, Marsha; Packman, Aaron			Temporal Variations in the Abundance and Composition of Biofilm Communities Colonizing Drinking Water Distribution Pipes	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM; BACTERIAL COMMUNITIES; ACINETOBACTER; IDENTIFICATION; NITRIFICATION; DISINFECTION; GROWTH; RESISTANCE; SURFACES; SURVIVAL	Pipes that transport drinking water through municipal drinking water distribution systems (DWDS) are challenging habitats for microorganisms. Distribution networks are dark, oligotrophic and contain disinfectants; yet microbes frequently form biofilms attached to interior surfaces of DWDS pipes. Relatively little is known about the species composition and ecology of these biofilms due to challenges associated with sample acquisition from actual DWDS. We report the analysis of biofilms from five pipe samples collected from the same region of a DWDS in Florida, USA, over an 18 month period between February 2011 and August 2012. The bacterial abundance and composition of biofilm communities within the pipes were analyzed by heterotrophic plate counts and tag pyrosequencing of 16S rRNA genes, respectively. Bacterial numbers varied significantly based on sampling date and were positively correlated with water temperature and the concentration of nitrate. However, there was no significant relationship between the concentration of disinfectant in the drinking water (monochloramine) and the abundance of bacteria within the biofilms. Pyrosequencing analysis identified a total of 677 operational taxonomic units (OTUs) (3% distance) within the biofilms but indicated that community diversity was low and varied between sampling dates. Biofilms were dominated by a few taxa, specifically Methylomonas, Acinetobacter, Mycobacterium, and Xanthomonadaceae, and the dominant taxa within the biofilms varied dramatically between sampling times. The drinking water characteristics most strongly correlated with bacterial community composition were concentrations of nitrate, ammonium, total chlorine and monochloramine, as well as alkalinity and hardness. Biofilms from the sampling date with the highest nitrate concentration were the most abundant and diverse and were dominated by Acinetobacter.	[Kelly, John J.; Minalt, Nicole] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Culotti, Alessandro; Packman, Aaron] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA; [Pryor, Marsha] Pinellas Cty Util Lab, Largo, FL USA	Loyola University Chicago; Northwestern University	Kelly, JJ (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	jkelly7@luc.edu	Packman, Aaron/B-7085-2009	Kelly, John/0000-0002-0894-137X	Water Research Foundation [4259]	Water Research Foundation	This work was supported by Water Research Foundation grant 4259 to Aaron Packman and John Kelly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2005, BERGEYS MANUAL SYSTE; Beumer A, 2010, APPL ENVIRON MICROB, V76, P7367, DOI 10.1128/AEM.00730-10; BIFULCO JM, 1989, APPL ENVIRON MICROB, V55, P2214, DOI 10.1128/AEM.55.9.2214-2219.1989; Bois FY, 1997, WATER RES, V31, P3146, DOI 10.1016/S0043-1354(97)00178-4; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; CARSON LA, 1978, APPL ENVIRON MICROB, V36, P839, DOI 10.1128/AEM.36.6.839-846.1978; CHAO A, 1984, SCAND J STAT, V11, P265; Covert TC, 1999, APPL ENVIRON MICROB, V65, P2492; Critchley MM, 2001, WATER SCIENCE & TECHNOLOGY: WATER SUPPLY, VOL 1, NO 4, P247; CUNLIFFE DA, 1991, APPL ENVIRON MICROB, V57, P3399, DOI 10.1128/AEM.57.11.3399-3402.1991; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Falkinham JO, 2001, APPL ENVIRON MICROB, V67, P1225, DOI 10.1128/AEM.67.3.1225-1231.2001; Forster DH, 1998, EUR J CLIN MICROBIOL, V17, P73, DOI 10.1007/BF01682159; Gomez-Alvarez V, 2012, APPL ENVIRON MICROB, V78, P6095, DOI 10.1128/AEM.01018-12; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Hoefel D, 2005, APPL ENVIRON MICROB, V71, P6479, DOI 10.1128/AEM.71.11.6479-6488.2005; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Kalmbach S, 1997, APPL ENVIRON MICROB, V63, P4164, DOI 10.1128/AEM.63.11.4164-4170.1997; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; LECHEVALLIER MW, 1988, APPL ENVIRON MICROB, V54, P649, DOI 10.1128/AEM.54.3.649-654.1988; LECHEVALLIER MW, 1993, J AM WATER WORKS ASS, V85, P111; Ledder RG, 2006, J APPL MICROBIOL, V100, P1123, DOI 10.1111/j.1365-2672.2006.02847.x; Lipponen MTT, 2002, WATER RES, V36, P4319, DOI 10.1016/S0043-1354(02)00169-0; Liu Y, 2011, BIOFOULING, V27, P393, DOI 10.1080/08927014.2011.577525; Madigan MT, 2009, BROCK BIOL MICROORGA; Marin M, 1996, APPL MICROBIOL BIOT, V44, P660, DOI 10.1007/BF00172500; Marshall K. C., 1991, ANONYMOUS BIOFOULING, P29; MARSHALL KC, 1988, CAN J MICROBIOL, V34, P503, DOI 10.1139/m88-086; Martiny AC, 2003, APPL ENVIRON MICROB, V69, P6899, DOI 10.1128/AEM.69.11.6899-6907.2003; MCKEON DM, 1995, WATER RES, V29, P1902, DOI 10.1016/0043-1354(95)00013-B; McKew BA, 2011, ISME J, V5, P30, DOI 10.1038/ismej.2010.91; Norton CD, 2004, WATER RES, V38, P1457, DOI 10.1016/j.watres.2003.07.008; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pryor M, 2004, WATER SCI TECHNOL, V50, P83, DOI 10.2166/wst.2004.0025; Regan JM, 2002, APPL ENVIRON MICROB, V68, P73, DOI 10.1128/AEM.68.1.73-81.2002; Revetta RP, 2010, WATER RES, V44, P1353, DOI 10.1016/j.watres.2009.11.008; Rice E.W., 2012, STANDARD METHODS EXA; RIDGWAY HF, 1982, APPL ENVIRON MICROB, V44, P972, DOI 10.1128/AEM.44.4.972-987.1982; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmeisser C, 2003, APPL ENVIRON MICROB, V69, P7298, DOI 10.1128/AEM.69.12.7298-7309.2003; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHIREY JJ, 1991, APPL ENVIRON MICROB, V57, P2251, DOI 10.1128/AEM.57.8.2251-2254.1991; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001; WEINBERGER M, 1992, CLIN INFECT DIS, V14, P1229, DOI 10.1093/clinids/14.6.1229; WENTZEL MC, 1986, WATER SA, V12, P209; Wilczak A, 1996, J AM WATER WORKS ASS, V88, P74, DOI 10.1002/j.1551-8833.1996.tb06586.x; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zacheus OM, 2001, WATER RES, V35, P1757, DOI 10.1016/S0043-1354(00)00431-0; Zhang P, 2009, ENVIRON SCI TECHNOL, V43, P3169, DOI 10.1021/es802990e	60	51	51	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98542	10.1371/journal.pone.0098542	http://dx.doi.org/10.1371/journal.pone.0098542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858562	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400080
J	Riordan, AJ; Bennink, E; Dankbaar, JW; Viergever, MA; Velthuis, BK; Smit, EJ; de Jong, HWAM				Riordan, Alan J.; Bennink, Edwin; Dankbaar, Jan Willem; Viergever, Max A.; Velthuis, Birgitta K.; Smit, Ewoud J.; de Jong, Hugo W. A. M.			Comparison of Partial Volume Effects in Arterial and Venous Contrast Curves in CT Brain Perfusion Imaging	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ACUTE STROKE; QUANTITATIVE ASSESSMENT; COMPUTED-TOMOGRAPHY; ISCHEMIC-STROKE; DYNAMIC CT; PREDICTION; PENUMBRA; OUTPUT; SIZE	Purpose: In brain CT perfusion (CTP), the arterial contrast bolus is scaled to have the same area under the curve (AUC) as the venous outflow to correct for partial volume effects (PVE). This scaling is based on the assumption that large veins are unaffected by PVE. Measurement of the internal carotid artery (ICA), usually unaffected by PVE due to its large diameter, may avoid the need for partial volume correction. The aims of this work are to examine i) the assumptions behind PVE correction and ii) the potential of selecting the ICA obviating correction for PVE. Methods: The AUC of the ICA and sagittal sinus were measured in CTP datasets from 52 patients. The AUCs were determined by i) using commercial CTP software based on a Gaussian curve-fitting to the time attenuation curve, and ii) by simple integration of the time attenuation curve over a time interval. In addition, frames acquired up to 3 minutes after first bolus passage were used to examine the ratio of arterial and venous enhancement. The impact of selecting the ICA without PVE correction was illustrated by reporting cerebral blood volume (CBV) measurements. Results: In 49 of 52 patients, the AUC of the ICA was significantly larger than that of the sagittal sinus (p = 0.017). Measured after the first pass bolus, contrast enhancement remained 50% higher in the ICA just after the first pass bolus, and 30% higher 3 minutes later. CBV measurements were significantly lowered when the ICA was used without PVE correction. Conclusions: Contradicting the assumptions underlying PVE correction, contrast in the ICA was significantly higher than in the sagittal sinus, even 3 minutes after the first pass of the contrast bolus. PVE correction might lead to overestimation of CBV if the CBV is calculated using the AUC of the time attenuation curves.	[Riordan, Alan J.; Bennink, Edwin; Dankbaar, Jan Willem; Viergever, Max A.; Velthuis, Birgitta K.; Smit, Ewoud J.; de Jong, Hugo W. A. M.] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Riordan, AJ (corresponding author), Univ Med Ctr, Dept Radiol, Utrecht, Netherlands.	alan.riordan@gmail.com	Viergever, Max A/J-1215-2014; Smit, Ewoud J/A-5272-2011	Smit, Ewoud J/0000-0002-7090-2742; Bennink, Edwin/0000-0002-3689-8532	University medical center; Dutch heart foundation; University medical center Utrecht	University medical center; Dutch heart foundation(Netherlands Heart Foundation); University medical center Utrecht	The primary authors PhD program was directly funded by the University medical center with no outside funding. The CTP data was collected under the Dutch acute stroke trial details of which can be found at http://clinicaltrials.gov/ct2/show/NCT00880113. The funders of the Dutch acute stroke trial are University medical center Utrecht, and the Dutch heart foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPELIN P, 1978, ACTA RADIOL DIAGN, V19, P977, DOI 10.1177/028418517801900613; Aviv RI, 2009, RADIOLOGY, V250, P867, DOI 10.1148/radiol.2503080257; AXEL L, 1980, RADIOLOGY, V137, P679, DOI 10.1148/radiology.137.3.7003648; Axel L, 1981, Adv Neurol, V30, P67; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Cianfoni A, 2007, RADIOL MED, V112, P1225, DOI 10.1007/s11547-007-0219-4; Hoffmann KR, 2002, MED PHYS, V29, P1622, DOI 10.1118/1.1488603; Kalender WA, 2000, COMPUTED TOMOGRAPHY; Kamalian S, 2012, AM J NEURORADIOL, V33, P545, DOI 10.3174/ajnr.A2809; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Konstas AA, 2009, AM J NEURORADIOL, V30, P885, DOI 10.3174/ajnr.A1492; Krejza J, 2006, STROKE, V37, P1103, DOI 10.1161/01.STR.0000206440.48756.f7; Kudo K, 2009, RADIOLOGY, V251, P241, DOI 10.1148/radiol.2511080983; LAPIN GD, 1994, J COMPUT ASSIST TOMO, V18, P363, DOI 10.1097/00004728-199405000-00005; Lee T, 2007, MULTIDETECTOR COMPUT, P15; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Mayer TE, 2000, AM J NEURORADIOL, V21, P1441; Mchedlishvili G, 2003, CLIN HEMORHEOL MICRO, V29, P71; Prokop M., 2003, SPIRAL MULTISLICE CO; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; Riordan AJ, 2013, AM J NEURORADIOL, V34, P1353, DOI 10.3174/ajnr.A3397; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; van der Schaaf I, 2006, AM J NEURORADIOL, V27, P46; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2004, AM J NEURORADIOL, V25, P720; Wintermark M, 2002, ANN NEUROL, V51, P417, DOI 10.1002/ana.10136; Wintermark M, 2008, STROKE, V39, P1621, DOI 10.1161/STROKEAHA.107.512319; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97586	10.1371/journal.pone.0097586	http://dx.doi.org/10.1371/journal.pone.0097586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858308	Green Submitted, Green Published, gold			2022-12-27	WOS:000336839400020
J	Steinwand, BJ; Xu, SL; Polko, JK; Doctor, SM; Westafer, M; Kieber, JJ				Steinwand, Blaire J.; Xu, Shouling; Polko, Joanna K.; Doctor, Stephanie M.; Westafer, Mike; Kieber, Joseph J.			Alterations in Auxin Homeostasis Suppress Defects in Cell Wall Function	PLOS ONE			English	Article							RECEPTOR-LIKE KINASES; CELLULOSE SYNTHASE 5; ANISOTROPIC EXPANSION; ANCHORED PROTEIN; ROOT ELONGATION; SEED COAT; ARABIDOPSIS; GROWTH; BIOSYNTHESIS; EXPRESSION	The plant cell wall is a highly dynamic structure that changes in response to both environmental and developmental cues. It plays important roles throughout plant growth and development in determining the orientation and extent of cell expansion, providing structural support and acting as a barrier to pathogens. Despite the importance of the cell wall, the signaling pathways regulating its function are not well understood. Two partially redundant leucine-rich-repeat receptor-like kinases (LRR-RLKs), FEI1 and FEI2, regulate cell wall function in Arabidopsis thaliana roots; disruption of the FEIs results in short, swollen roots as a result of decreased cellulose synthesis. We screened for suppressors of this swollen root phenotype and identified two mutations in the putative mitochondrial pyruvate dehydrogenase E1 alpha homolog, IAA-Alanine Resistant 4 (IAR4). Mutations in IAR4 were shown previously to disrupt auxin homeostasis and lead to reduced auxin function. We show that mutations in IAR4 suppress a subset of the fei1 fei2 phenotypes. Consistent with the hypothesis that the suppression of fei1 fei2 by iar4 is the result of reduced auxin function, disruption of the WEI8 and TAR2 genes, which decreases auxin biosynthesis, also suppresses fei1 fei2. In addition, iar4 suppresses the root swelling and accumulation of ectopic lignin phenotypes of other cell wall mutants, including procuste and cobra. Further, iar4 mutants display decreased sensitivity to the cellulose biosynthesis inhibitor isoxaben. These results establish a role for IAR4 in the regulation of cell wall function and provide evidence of crosstalk between the cell wall and auxin during cell expansion in the root.	[Steinwand, Blaire J.; Xu, Shouling; Polko, Joanna K.; Doctor, Stephanie M.; Westafer, Mike; Kieber, Joseph J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Kieber, JJ (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	jkieber@unc.edu	Kieber, Joseph/GLN-6328-2022	Kieber, Joseph/0000-0002-5766-812X; xu, shouling/0000-0002-6741-9506	National Science Foundation [IOS 0624377, MCB-1021704]; Netherlands Organization for Scientific Research (NWO) [825.13.018]; Div Of Molecular and Cellular Bioscience [1021704] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by grants IOS 0624377, MCB-1021704 from the National Science Foundation to JJK and Rubicon grant 825.13.018 of the Netherlands Organization for Scientific Research (NWO) to JKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J BIOL CHEM, V270, P19093, DOI 10.1074/jbc.270.32.19093; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; ELIASSON L, 1989, PLANT PHYSIOL, V91, P310, DOI 10.1104/pp.91.1.310; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gish LA, 2011, PLANT J, V66, P117, DOI 10.1111/j.1365-313X.2011.04518.x; Gjetting KSK, 2012, J EXP BOT, V63, P3207, DOI 10.1093/jxb/ers040; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; GREEN PB, 1980, ANNU REV PLANT PHYS, V31, P51, DOI 10.1146/annurev.pp.31.060180.000411; Guo HQ, 2009, P NATL ACAD SCI USA, V106, P7648, DOI 10.1073/pnas.0812346106; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Harpaz-Saad S, 2012, PLANT SIGNAL BEHAV, V7, P285, DOI 10.4161/psb.18819; Harpaz-Saad S, 2011, PLANT J, V68, P941, DOI 10.1111/j.1365-313X.2011.04760.x; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; Hematy K, 2008, CURR OPIN PLANT BIOL, V11, P321, DOI 10.1016/j.pbi.2008.02.008; Im KH, 2000, PLANT PHYSIOL, V123, P463, DOI 10.1104/pp.123.2.463; Kaku T, 2002, PLANT CELL PHYSIOL, V43, P21, DOI 10.1093/pcp/pcf004; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; LANG JM, 1982, PROTOPLASMA, V110, P5, DOI 10.1007/BF01314675; LeClere S, 2004, PLANT PHYSIOL, V135, P989, DOI 10.1104/pp.104.040519; Lewis DR, 2013, PLANT CELL, V25, P3329, DOI 10.1105/tpc.113.114868; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENCES EP, 1987, J EXP BOT, V38, P960, DOI 10.1093/jxb/38.6.960; Monshausen GB, 2011, PLANT J, V65, P309, DOI 10.1111/j.1365-313X.2010.04423.x; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Quint M, 2009, PLANT PHYSIOL, V150, P748, DOI 10.1104/pp.109.136671; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Sauer M, 2011, PLANT CELL, V23, P2033, DOI 10.1105/tpc.111.087064; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Steinwand BJ, 2010, PLANT PHYSIOL, V153, P479, DOI 10.1104/pp.110.155887; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585, DOI 10.1146/annurev.pp.35.060184.003101; Tsang DL, 2011, PLANT PHYSIOL, V156, P596, DOI 10.1104/pp.111.175372; Alarcon MV, 2012, ACTA BIOL CRACOV BOT, V54, P16, DOI 10.2478/v10182-012-0001-3; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Willats WGT, 2001, PLANTA, V213, P37, DOI 10.1007/s004250000481; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354	51	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98193	10.1371/journal.pone.0098193	http://dx.doi.org/10.1371/journal.pone.0098193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859261	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400052
J	Yu, XM; Wang, MH; Dong, QZ; Jin, F				Yu, Xinmiao; Wang, Minghao; Dong, Qianze; Jin, Feng			Diversin Is Overexpressed in Breast Cancer and Accelerates Cell Proliferation and Invasion	PLOS ONE			English	Article							JNK; EXPRESSION; PATHWAYS; ER	Diversin was recently reported to play roles in Wnt and JNK pathways. However, the expression pattern and biological roles of diversin in human breast cancer have not been reported. In the present study, we found that diversin was overexpressed in breast cancer specimens by immunohistochemistry and western blot. Significant association was observed between diversin overexpression and TNM stage (p = 0.0036), nodal metastasis (p = 0.0033), negative estrogen receptor expression (p = 0.0012) and triple-negative status (p = 0.0017). Furthermore, colony formation assay and matrigel invasion assay showed that knockdown of diversin expression in MDA-MB-231 cell line with high endogenous expression decreased cell proliferation and cell invasion. Transfection of diversin plasmid in MCF-7 cell line increased cell proliferation and invasion. Further analysis showed that diversin depletion downregulated JNK phosphorylation while its overexpression upregulated JNK phosphorylation. In conclusion, our study demonstrated that diversin was overexpressed in human breast cancers. Diversin could contribute to breast cancer cell proliferation and invasion.	[Yu, Xinmiao] China Med Univ, Dept Surg Oncol & Breast Surg, Affiliated Hosp 1, Shenyang, Peoples R China; [Wang, Minghao; Jin, Feng] China Med Univ, Dept Neurosurg, Affiliated Hosp 1, Shenyang, Peoples R China; [Dong, Qianze] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Jin, F (corresponding author), China Med Univ, Dept Neurosurg, Affiliated Hosp 1, Shenyang, Peoples R China.	jinfengcmu@hotmail.com		Migliaccio, Antimo/0000-0002-4197-2055				Ahn S, 2012, TUMOR BIOL, V33, P1573, DOI 10.1007/s13277-012-0411-6; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Elfagieh M, 2012, TUMOR BIOL, V33, P2371, DOI 10.1007/s13277-012-0500-6; Fang YJ, 2012, TUMOR BIOL, V33, P1907, DOI 10.1007/s13277-012-0451-y; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Haribaskar R, 2009, BIOCHEM BIOPH RES CO, V387, P212, DOI 10.1016/j.bbrc.2009.07.012; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Itoh K, 2009, J CELL SCI, V122, P3791, DOI 10.1242/jcs.057067; Kabbage M, 2012, TUMOR BIOL, V33, P2279, DOI 10.1007/s13277-012-0490-4; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kurbel S, 2013, TUMOR BIOL, V34, P1, DOI 10.1007/s13277-012-0602-1; Mao XY, 2012, TUMOR BIOL, V33, P1565, DOI 10.1007/s13277-012-0410-7; Moeller H, 2006, P NATL ACAD SCI USA, V103, P15900, DOI 10.1073/pnas.0603808103; Prabhu JS, 2012, TUMOR BIOL, V33, P315, DOI 10.1007/s13277-012-0343-1; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tang ZP, 2013, TUMOR BIOL, V34, P2835, DOI 10.1007/s13277-013-0843-7; Yasunaga T, 2011, MECH DEVELOP, V128, P376, DOI 10.1016/j.mod.2011.07.004; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Yin YX, 2012, TUMOR BIOL, V33, P1581, DOI 10.1007/s13277-012-0412-5; Zhan X, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-180	22	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98591	10.1371/journal.pone.0098591	http://dx.doi.org/10.1371/journal.pone.0098591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858714	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400081
J	Bloom, DD; Fikacek, M; Short, AEZ				Bloom, Devin D.; Fikacek, Martin; Short, Andrew E. Z.			Clade Age and Diversification Rate Variation Explain Disparity in Species Richness among Water Scavenger Beetle (Hydrophilidae) Lineages	PLOS ONE			English	Article							ECOLOGICAL OPPORTUNITY; DEPENDENT DIVERSIFICATION; COLEOPTERA HYDROPHILIDAE; MOLECULAR PHYLOGENETICS; BIOME CONSERVATISM; EXTINCTION RATES; SPECIATION RATES; AQUATIC BEETLES; EVOLUTION; DIVERSITY	Explaining the disparity of species richness across the tree of life is one of the great challenges in evolutionary biology. Some lineages are exceptionally species rich, while others are relatively species poor. One explanation for heterogeneity among clade richness is that older clades are more species rich because they have had more time to accrue diversity than younger clades. Alternatively, disparity in species richness may be due to among-lineage diversification rate variation. Here we investigate diversification in water scavenger beetles (Hydrophilidae), which vary in species richness among major lineages by as much as 20 fold. Using a time-calibrated phylogeny and comparative methods, we test for a relationship between clade age and species richness and for shifts in diversification rate in hydrophilids. We detected a single diversification rate increase in Megasternini, a relatively young and species rich clade whose diversity might be explained by the stunning diversity of ecological niches occupied by this clade. We find that Amphiopini, an old clade, is significantly more species poor than expected, possibly due to its restricted geographic range. The remaining lineages show a correlation between species richness and clade age, suggesting that both clade age and variation in diversification rates explain the disparity in species richness in hydrophilids. We find little evidence that transitions between aquatic, semiaquatic, and terrestrial habitats are linked to shifts in diversification rates.	[Bloom, Devin D.; Short, Andrew E. Z.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Bloom, Devin D.; Short, Andrew E. Z.] Univ Kansas, Div Entomol, Biodivers Inst, Lawrence, KS 66045 USA; [Fikacek, Martin] Natl Museum, Dept Entomol, Prague, Czech Republic; [Fikacek, Martin] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	University of Kansas; University of Kansas; National Museum; Charles University Prague	Short, AEZ (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	aezshort@ku.edu		Fikacek, Martin/0000-0002-2078-6798	Czech Science Foundation [P506/12/P096]; Ministry of Culture of the Czech Republic [DKRVO 2014/13]; Ministry of Culture of the Czech Republic (National Museum) [00023272]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Culture of the Czech Republic; Ministry of Culture of the Czech Republic (National Museum)	MF received funding from the Czech Science Foundation grant P506/12/P096 and from the Ministry of Culture of the Czech Republic (DKRVO 2014/13, National Museum, 00023272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bernhard D, 2006, ZOOL SCR, V35, P597, DOI 10.1111/j.1463-6409.2006.00251.x; Betancur-R R, 2012, ECOL LETT, V15, P822, DOI 10.1111/j.1461-0248.2012.01802.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bloom DD, 2012, J EVOLUTION BIOL, V25, P701, DOI 10.1111/j.1420-9101.2012.02464.x; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2012, MOL BIOL EVOL, V25, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fikacek M, ZOOLOGICAL J LINNEAN; Fikacek M, 2010, ZOOTAXA, P1; Fikacek M, 2014, ZOOL J LINN SOC-LOND, V170, P710, DOI 10.1111/zoj.12114; Fikacek M, 2012, ACTA ENT MUS NAT PRA, V52, P89; Fikacek M, 2012, SYST ENTOMOL, V37, P420, DOI 10.1111/j.1365-3113.2012.00630.x; Fikacek M, 2011, ANN ZOOL, V61, P621, DOI 10.3161/000345411X622462; Fikacek M, 2010, ACTA ENT MUS NAT PRA, V50, P445; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jablonski D, 2006, AM NAT, V168, P556, DOI 10.1086/507994; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Kubisz Daniel, 2000, Polskie Pismo Entomologiczne, V69, P225; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maddison WP, 2011, MESQUITE MODULAR SYS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Martin CH, 2013, SCIENCE, V339, P208, DOI 10.1126/science.1227710; McKenna Duane D., 2009, P278; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; McPeek MA, 2007, PALAEONTOLOGY, V50, P111, DOI 10.1111/j.1475-4983.2006.00616.x; Minoshima Yusuke, 2012, Elytra, V2, P279; Moore BR, 2009, P NATL ACAD SCI USA, V106, P4307, DOI 10.1073/pnas.0807230106; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Parent CE, 2009, AM NAT, V174, P898, DOI 10.1086/646604; Prokin AA, 2009, PALEONTOL J+, V43, P660, DOI 10.1134/S0031030109060094; Pyron RA, 2013, TRENDS ECOL EVOL, V28, P729, DOI 10.1016/j.tree.2013.09.007; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2010, SYST BIOL, V59, P634, DOI 10.1093/sysbio/syq060; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Rabosky DL, 2013, ANN REV ECOLOGY EVOL, V44; Ribera I., 2008, Aquatic insects: challenges to populations, P289, DOI 10.1079/9781845933968.0289; Ribera I, 2001, MOL ECOL, V10, P721, DOI 10.1046/j.1365-294x.2001.01218.x; Ribera I, 2003, ECOGRAPHY, V26, P145, DOI 10.1034/j.1600-0587.2003.03271.x; Ribera I, 2008, CLADISTICS, V24, P563, DOI 10.1111/j.1096-0031.2007.00192.x; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; Ricklefs RE, 2006, AM NAT, V168, P805, DOI 10.1086/508711; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sequeira AS, 2008, MOL ECOL, V17, P1089, DOI 10.1111/j.1365-294X.2007.03642.x; Short A.E.Z., 2009, Koleopterologische Rundschau, V79, P189; Short AEZ, 2011, ACTA ENT MUS NAT PRA, V51, P83; Short AEZ, 2013, SYST ENTOMOL, V38, P723, DOI 10.1111/syen.12024; SMETANA A, 1978, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm110105fv; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Svensson EI, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P1; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Watts C. H. S., 1998, Records of the South Australian Museum (Adelaide), V30, P93; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	76	56	56	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98430	10.1371/journal.pone.0098430	http://dx.doi.org/10.1371/journal.pone.0098430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887453	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300066
J	Dunemann, F; Schrader, O; Budahn, H; Houben, A				Dunemann, Frank; Schrader, Otto; Budahn, Holger; Houben, Andreas			Characterization of Centromeric Histone H3 (CENH3) Variants in Cultivated and Wild Carrots (Daucus sp.)	PLOS ONE			English	Article							FUNCTIONAL CENTROMERES; CAROTA; DNA; GENES; SATELLITES; APIACEAE; REVEALS; INCLUDE; MARKERS; FISH	In eukaryotes, centromeres are the assembly sites for the kinetochore, a multi-protein complex to which spindle microtubules are attached at mitosis and meiosis, thereby ensuring segregation of chromosomes during cell division. They are specified by incorporation of CENH3, a centromere specific histone H3 variant which replaces canonical histone H3 in the nucleosomes of functional centromeres. To lay a first foundation of a putative alternative haploidization strategy based on centromere-mediated genome elimination in cultivated carrots, in the presented research we aimed at the identification and cloning of functional CENH3 genes in Daucus carota and three distantly related wild species of genus Daucus varying in basic chromosome numbers. Based on mining the carrot transcriptome followed by a subsequent PCR-based cloning, homologous coding sequences for CENH3s of the four Daucus species were identified. The ORFs of the CENH3 variants were very similar, and an amino acid sequence length of 146 aa was found in three out of the four species. Comparison of Daucus CENH3 amino acid sequences with those of other plant CENH3s as well as their phylogenetic arrangement among other dicot CENH3s suggest that the identified genes are authentic CENH3 homologs. To verify the location of the CENH3 protein in the kinetochore regions of the Daucus chromosomes, a polyclonal antibody based on a peptide corresponding to the N-terminus of DcCENH3 was developed and used for anti-CENH3 immunostaining of mitotic root cells. The chromosomal location of CENH3 proteins in the centromere regions of the chromosomes could be confirmed. For genetic localization of the CENH3 gene in the carrot genome, a previously constructed linkage map for carrot was used for mapping a CENH3-specific simple sequence repeat (SSR) marker, and the CENH3 locus was mapped on the carrot chromosome 9.	[Dunemann, Frank; Schrader, Otto; Budahn, Holger] JKI, Fed Res Ctr Cultivated Plants, Inst Breeding Res Hort Crops, Quedlinburg, Germany; [Houben, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Chromosome Struct & Funct Lab, Gatersleben, Germany	Julius Kuhn-Institut; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Dunemann, F (corresponding author), JKI, Fed Res Ctr Cultivated Plants, Inst Breeding Res Hort Crops, Quedlinburg, Germany.	frank.dunemann@jki.bund.de	Houben, Andreas/I-1517-2015	Houben, Andreas/0000-0003-3419-239X; Dunemann, Frank/0000-0002-3348-5177	Federal Ministry of Agriculture and Food(BMEL)	Federal Ministry of Agriculture and Food(BMEL)	This research was supported by the Federal Ministry of Agriculture and Food(BMEL)in frame of an implemented project at the Julius Kuhn-Institut, Quedlinburg, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandro MS, 2013, THEOR APPL GENET, V126, P415, DOI 10.1007/s00122-012-1989-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1981, ANALES JARD BOT MADR; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baranski R., 2008, TRANSGENIC PLANT J, V2, P18; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Cavagnaro PF, 2009, MOL GENET GENOMICS, V281, P273, DOI 10.1007/s00438-008-0411-9; Ferrie AMR, 2011, PLANT CELL TISS ORG, V104, P399, DOI 10.1007/s11240-010-9770-0; Grzebelus D, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P91, DOI 10.1007/978-3-642-20450-0_7; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEYWOOD VH, 1983, ISRAEL J BOT, V32, P51; Hirsch CD, 2009, MOL BIOL EVOL, V26, P2877, DOI 10.1093/molbev/msp208; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Houben A, 2011, CHROMOSOME RES, V19, P471, DOI 10.1007/s10577-011-9207-6; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iovene M, 2008, AM J BOT, V95, P793, DOI 10.3732/ajb.0700007; Iovene M, 2011, CHROMOSOME RES, V19, P493, DOI 10.1007/s10577-011-9202-y; Iwata A, 2013, PLANT J, V76, P47, DOI 10.1111/tpj.12269; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051315; Nagaki K, 2009, CHROMOSOMA, V118, P249, DOI 10.1007/s00412-008-0193-1; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Pimenov M.G., 2003, KARYOTAXONOMICAL ANA, P57; Ravi M, 2013, PLANT CENTROMERE BIOLOGY, P169; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Sanei M, 2011, P NATL ACAD SCI USA, V108, pE498, DOI 10.1073/pnas.1103190108; Schrader O, 2003, CARYOLOGIA, V56, P149, DOI 10.1080/00087114.2003.10589318; Spalik K, 2007, J BIOGEOGR, V34, P2039, DOI 10.1111/j.1365-2699.2007.01752.x; Tek AL, 2011, CHROMOSOME RES, V19, P969, DOI 10.1007/s10577-011-9247-y; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wally O, 2009, PLANTA, V231, P131, DOI 10.1007/s00425-009-1031-2; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	43	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98504	10.1371/journal.pone.0098504	http://dx.doi.org/10.1371/journal.pone.0098504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887084	gold, Green Published			2022-12-27	WOS:000336956300075
J	Dzunkova, M; Garcia-Garcera, M; Martinez-Priego, L; D'Auria, G; Calafell, F; Moya, A				Dzunkova, Maria; Garcia-Garcera, Marc; Martinez-Priego, Llucia; D'Auria, Giussepe; Calafell, Francesc; Moya, Andres			Direct Squencing from the Minimal Number of DNA Molecules Needed to Fill a 454 Picotiterplate	PLOS ONE			English	Article							WHOLE GENOME AMPLIFICATION; HIGH-THROUGHPUT; DISPLACEMENT AMPLIFICATION; SINGLE CELLS; LIBRARIES; POLYMERASE; BIAS	The large amount of DNA needed to prepare a library in next generation sequencing protocols hinders direct sequencing of small DNA samples. This limitation is usually overcome by the enrichment of such samples with whole genome amplification (WGA), mostly by multiple displacement amplification (MDA) based on phi 29 polymerase. However, this technique can be biased by the GC content of the sample and is prone to the development of chimeras as well as contamination during enrichment, which contributes to undesired noise during sequence data analysis, and also hampers the proper functional and/or taxonomic assignments. An alternative to MDA is direct DNA sequencing (DS), which represents the theoretical gold standard in genome sequencing. In this work, we explore the possibility of sequencing the genome of Escherichia coli fs 24 from the minimum number of DNA molecules required for pyrosequencing, according to the notion of one-bead-one-molecule. Using an optimized protocol for DS, we constructed a shotgun library containing the minimum number of DNA molecules needed to fill a selected region of a picotiterplate. We gathered most of the reference genome extension with uniform coverage. We compared the DS method with MDA applied to the same amount of starting DNA. As expected, MDA yielded a sparse and biased read distribution, with a very high amount of unassigned and unspecific DNA amplifications. The optimized DS protocol allows unbiased sequencing to be performed from samples with a very small amount of DNA.	[Dzunkova, Maria; Garcia-Garcera, Marc; Martinez-Priego, Llucia; D'Auria, Giussepe; Moya, Andres] Fdn Fomento Invest Sanitaria & Biomed Comunidad V, Area Genom & Salud, Valencia, Spain; [Dzunkova, Maria; Garcia-Garcera, Marc; Martinez-Priego, Llucia; D'Auria, Giussepe; Moya, Andres] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Dzunkova, Maria; D'Auria, Giussepe; Moya, Andres] CIBEResp, Madrid, Spain; [Garcia-Garcera, Marc; Calafell, Francesc] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Moya, A (corresponding author), Fdn Fomento Invest Sanitaria & Biomed Comunidad V, Area Genom & Salud, Valencia, Spain.	andres.moya@uv.es	D'Auria, Giuseppe/E-6583-2010; Calafell, Francesc/C-8595-2014; Dzunkova, Maria/AAE-3093-2022; Moya, Andrés/A-8190-2008	Calafell, Francesc/0000-0002-1083-9438; Dzunkova, Maria/0000-0002-1765-0697; Moya, Andrés/0000-0002-2867-1119; Martinez-Priego, Llucia/0000-0002-1073-269X; Garcia-Garcera, Marc/0000-0001-6408-7561; D'Auria, Giuseppe/0000-0003-0672-2541	Miguel Servet, Instituto de Salud Carlos III, Spain [CP09/00049]; Spanish Ministry for Science and Innovation (MCINN) [SAF2009-13032-C02-01, SAF 2012-31187, BFU2009-12895-CO2-01, SAF2010-16240]; Spanish Ministry for Science and Innovation(MCINN) in the frame of ERA-Net PathoGenoMics [FU2008-04501-E]; Conselleria D'Educacio Generalitat Valenciana, Spain [Prometeo/2009/092]; Spanish Ministry of Education FPU; Spanish Ministry of Science and Innovation [BES-2008-006029]	Miguel Servet, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Spanish Ministry for Science and Innovation (MCINN); Spanish Ministry for Science and Innovation(MCINN) in the frame of ERA-Net PathoGenoMics(Ministry of Science and Innovation, Spain (MICINN)); Conselleria D'Educacio Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Education FPU(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by grant CP09/00049 Miguel Servet, Instituto de Salud Carlos III, Spain to GD; by projects SAF2009-13032-C02-01 and SAF 2012-31187 (AM), BFU2009-12895-CO2-01 and SAF2010-16240 (FC) from the Spanish Ministry for Science and Innovation (MCINN), FU2008-04501-E from Spanish Ministry for Science and Innovation(MCINN) in the frame of ERA-Net PathoGenoMics and Prometeo/2009/092 from Conselleria D'Educacio Generalitat Valenciana, Spain, to AM. MD is recipient of a fellowship from Spanish Ministry of Education FPU2010. MGG was supported by a predoctoral fellowship from the Spanish Ministry of Science and Innovation (Grant number BES-2008-006029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017722; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ausubel M, 1989, CURRENT PROTOCOLS MO; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Bredel M, 2005, J MOL DIAGN, V7, P171, DOI 10.1016/S1525-1578(10)60543-0; Buehler B, 2010, METHODS, V50, pS15, DOI 10.1016/j.ymeth.2010.01.004; Danhorn T, 2012, ISME J, V6, P2056, DOI 10.1038/ismej.2012.35; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Gasparic MB, 2010, ANAL BIOANAL CHEM, V396, P2023, DOI 10.1007/s00216-009-3418-0; Hausser J, 2012, ENTROPY ENTROPY MUTU; Hroudova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036420; Huang JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019723; Hutchison CA, 2006, NAT BIOTECHNOL, V24, P657, DOI 10.1038/nbt0606-657; Iwamoto K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001306; Jiang Zhengwen, 2005, Nucleic Acids Res, V33, pe91, DOI 10.1093/nar/gni089; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Oksanen J., 2013, R PACKAGE VERSION 23, V2; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pages H, 2012, BIOSTRINGS STRING OB; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; R Core Development Team: R, 2011, LANG ENV STAT COMP; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; RocheDiagnostic, 2011, RAP LIB PREP METH MA; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Sarkar D, 2013, CHIPSEQ PACKAGE ANAL; Spits C, 2006, HUM MUTAT, V27, P496, DOI 10.1002/humu.20324; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Suzuki R., 2013, HIERARCHICAL CLUSTER; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Vicek C, 1980, GENE, V46, P215; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wolinsky H, 2007, EMBO REP, V8, P900, DOI 10.1038/sj.embor.7401070; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Xiao Y, 2012, CRAMER VON MISES 2 S; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	55	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97379	10.1371/journal.pone.0097379	http://dx.doi.org/10.1371/journal.pone.0097379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887077	Green Submitted, Green Published, gold			2022-12-27	WOS:000336956300015
J	Fujii, K; Ozeki, Y; Okayasu, H; Takano, Y; Shinozaki, T; Hori, H; Orui, M; Horie, M; Kunugi, H; Shimoda, K				Fujii, Kumiko; Ozeki, Yuji; Okayasu, Hiroaki; Takano, Yumiko; Shinozaki, Takahiro; Hori, Hiroaki; Orui, Masami; Horie, Minoru; Kunugi, Hiroshi; Shimoda, Kazutaka			QT Is Longer in Drug-Free Patients with Schizophrenia Compared with Age-Matched Healthy Subjects	PLOS ONE			English	Article							HEART-RATE; POTASSIUM CHANNEL; INTERVAL; GENE; KCNH2; VARIABILITY; NEUREGULIN-1; PROLONGATION; ISOFORM; BRAIN	The potassium voltage-gated channel KCNH2 is a well-known gene in which mutations induce familial QT interval prolongation. KCNH2 is suggested to be a risk gene for schizophrenia. Additionally, the disturbance of autonomic control, which affects the QT interval, is known in schizophrenia. Therefore, we speculate that schizophrenic patients have characteristic features in terms of the QT interval in addition to the effect of antipsychotic medication. The QT interval of patients with schizophrenia not receiving antipsychotics (n = 85) was compared with that of patients with schizophrenia receiving relatively large doses of antipsychotics (n = 85) and healthy volunteers (n = 85). The QT interval was corrected using four methods (Bazett, Fridericia, Framingham or Hodges method). In ANCOVA with age and heart rate as covariates, patients not receiving antipsychotic treatment had longer QT intervals than did the healthy volunteers, but antipsychotics prolonged the QT interval regardless of the correction method used (P<0.01). Schizophrenic patients with and without medication had a significantly higher mean heart rate than did the healthy volunteers, with no obvious sex-related differences in the QT interval. The QT interval prolongation may be manifestation of a certain biological feature of schizophrenia.	[Fujii, Kumiko; Ozeki, Yuji; Okayasu, Hiroaki; Takano, Yumiko; Shinozaki, Takahiro; Shimoda, Kazutaka] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan; [Ozeki, Yuji; Hori, Hiroaki; Kunugi, Hiroshi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Orui, Masami] Dokkyo Med Univ, Sch Med, Dept Hlth Care, Mibu, Tochigi, Japan; [Horie, Minoru] Shiga Univ, Sch Med Sci, Dept Cardiovasc & Resp Med, Hikone, Shiga, Japan	Dokkyo Medical University; National Center for Neurology & Psychiatry - Japan; Dokkyo Medical University; Shiga University	Ozeki, Y (corresponding author), Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan.	ozeki@dokkyomed.ac.jp	Kunugi, Hiroshi/ABC-5260-2021; Horie, Minoru/ABG-7128-2020	Kunugi, Hiroshi/0000-0002-7209-3790; Hori, Hiroaki/0000-0002-4548-7110	Japan Society for Promotion of Research (KAKENHI) [24591688]; SENSHIN Medical Research; Grants-in-Aid for Scientific Research [25861041] Funding Source: KAKEN	Japan Society for Promotion of Research (KAKENHI); SENSHIN Medical Research(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research C from Japan Society for Promotion of Research (KAKENHI) (24591688) and SENSHIN Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2001, J CLIN PSYCHOPHARM, V21, P8, DOI 10.1097/00004714-200102000-00003; Apud JA, 2012, AM J PSYCHIAT, V169, P725, DOI 10.1176/appi.ajp.2012.11081214; Atalar F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-27; Bar KJ, 2010, SCHIZOPHRENIA BULL, V36, P1050, DOI 10.1093/schbul/sbp024; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Charbit B, 2006, ANESTHESIOLOGY, V104, P255, DOI 10.1097/00000542-200602000-00009; Chong SA, 2003, HUM PSYCHOPHARM CLIN, V18, P647, DOI 10.1002/hup.540; Correll CU, 2011, J CHILD ADOL PSYCHOP, V21, P365, DOI 10.1089/cap.2011.0024; Fridericia L, 1920, ACTA MED SCAND, V57, P469, DOI DOI 10.1111/J.0954-6820.1920.TB18266.X; Garnett CE, 2012, AM HEART J, V163, P912, DOI 10.1016/j.ahj.2012.02.023; Girardin FR, 2013, AM J PSYCHIAT, V170, P1468, DOI 10.1176/appi.ajp.2013.12060860; Hashimoto R, 2013, WORLD J BIOL PSYCHIA, V14, P114, DOI 10.3109/15622975.2011.604350; Hingorani P, 2012, INT J NEUROPSYCHOPH, V15, P1535, DOI 10.1017/S1461145712000077; HODGES M, 1983, J AM COLL CARDIOL, V1, P694; Huertas-Vazquez A, 2013, HEART RHYTHM, V10, P994, DOI 10.1016/j.hrthm.2013.03.020; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jindal RD, 2009, SCHIZOPHR RES, V113, P176, DOI 10.1016/j.schres.2009.06.003; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; Lemmens K, 2006, J BIOL CHEM, V281, P19469, DOI 10.1074/jbc.M600399200; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Mujica-Parodi LR, 2005, NEUROPSYCHOBIOLOGY, V51, P10, DOI 10.1159/000082850; Nielsen J, 2011, CNS DRUGS, V25, P473, DOI 10.2165/11587800-000000000-00000; Ozeki Y, 2010, PROG NEURO-PSYCHOPH, V34, P401, DOI 10.1016/j.pnpbp.2010.01.008; Ramos-Rios R, 2010, SCHIZOPHR RES, V116, P35, DOI 10.1016/j.schres.2009.09.041; Reilly JG, 2000, LANCET, V355, P1048, DOI 10.1016/S0140-6736(00)02035-3; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Schwarz JR, 2004, J CELL MOL MED, V8, P22, DOI 10.1111/j.1582-4934.2004.tb00256.x; Shepard PD, 2007, SCHIZOPHRENIA BULL, V33, P1263, DOI 10.1093/schbul/sbm106; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Thomas D, 2006, CURR PHARM DESIGN, V12, P2271, DOI 10.2174/138161206777585102; Witchel HJ, 2007, EXPERT OPIN THER TAR, V11, P321, DOI 10.1517/14728222.11.3.321; Zhang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017584	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98555	10.1371/journal.pone.0098555	http://dx.doi.org/10.1371/journal.pone.0098555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887423	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300082
J	Shukla, AK; Pragya, P; Chaouhan, HS; Tiwari, AK; Patel, DK; Abdin, MZ; Chowdhuri, DK				Shukla, Arvind Kumar; Pragya, Prakash; Chaouhan, Hitesh Singh; Tiwari, Anand Krishna; Patel, Devendra Kumar; Abdin, Malik Zainul; Chowdhuri, Debapratim Kar			Heat Shock Protein-70 (Hsp-70) Suppresses Paraquat-Induced Neurodegeneration by Inhibiting JNK and Caspase-3 Activation in Drosophila Model of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN TOXICITY; OXIDATIVE STRESS; CHAPERONE SUPPRESSION; DOPAMINERGIC-NEURONS; HSP70; APOPTOSIS; PROTECTS; MELANOGASTER; NIGRA; NEUROPROTECTION	Parkinson's disease (PD) is one of the most common neurodegenerative disorders with limited clinical interventions. A number of epidemiological as well as case-control studies have revealed an association between pesticide exposure, especially of paraquat (PQ) and occurrence of PD. Hsp70, a molecular chaperone by function, has been shown as one of the modulators of neurological disorders. However, paucity of information regarding the protective role of Hsp70 on PQ-induced PD like symptoms led us to hypothesize that modulation of hsp70 expression in the dopaminergic neurons would improve the health of these cells. We took advantage of Drosophila, which is a well-established model for neurological research and also possesses genetic tools for easy manipulation of gene expression with limited ethical concern. Overexpression of hsp70 was found to reduce PQ-induced oxidative stress along with JNK and caspase-3 mediated dopaminergic neuronal cell death in exposed organism. Further, anti-apoptotic effect of hsp70 was shown to confer better homeostasis in the dopaminergic neurons of PQ-exposed organism as evidenced by their improved locomotor performance and survival. The study has merit in the context of human concern since we observed protection of dopaminergic neurons in PQ-exposed organism by over-expressing a human homologue of hsp70, HSPA1L, in these cells. The effect was parallel to that observed with Drosophila hsp70. These findings reflect the potential therapeutic applicability of hsp70 against PQ-induced PD like symptoms in an organism.	[Shukla, Arvind Kumar; Pragya, Prakash; Chaouhan, Hitesh Singh; Chowdhuri, Debapratim Kar] CSIR Indian Inst Toxicol Res, Embryotoxicol Sect, Lucknow, Uttar Pradesh, India; [Tiwari, Anand Krishna] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Gandhinagar, Gujrat, India; [Patel, Devendra Kumar] CSIR Indian Inst Toxicol Res, Analyt Sect, Lucknow, Uttar Pradesh, India; [Chaouhan, Hitesh Singh] Acad Sci & Innovat Res, New Delhi, India; [Shukla, Arvind Kumar; Pragya, Prakash; Abdin, Malik Zainul] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Jamia Hamdard University	Chowdhuri, DK (corresponding author), CSIR Indian Inst Toxicol Res, Embryotoxicol Sect, Lucknow, Uttar Pradesh, India.	dkchowdhuri@iitr.res.in	CHAOUHAN, HITESH/AGX-7625-2022; , AKS/I-3868-2019	Zainul Abdin, Malik/0000-0001-7346-0719; Shukla, Arvind/0000-0003-3334-0450	University Grants Commission [EU249IV/2008/JUNE/318721]; Council of Scientific and Industrial Research [31/029(0199)/2008-EMR-1, 19-06/2011(i)EU-IV, NWP-UNDO/2012-17]	University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by University Grants Commission (Grant number: EU249IV/2008/JUNE/318721 to AKS), Council of Scientific and Industrial Research (Grant number: 31/029(0199)/2008-EMR-1 to PP; 19-06/2011(i)EU-IV to HSC and NWP-UNDO/2012-17 to DKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Azad P, 2011, FREE RADICAL BIO MED, V51, P530, DOI 10.1016/j.freeradbiomed.2011.05.005; Berry C, 2010, CELL DEATH DIFFER, V17, P1115, DOI 10.1038/cdd.2009.217; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; BUS JS, 1976, ENVIRON HEALTH PERSP, V16, P139, DOI 10.2307/3428594; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; CORASANITI MT, 1993, J CHROMATOGR, V643, P419, DOI 10.1016/0021-9673(93)80578-V; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; DANIEL JW, 1966, BRIT J IND MED, V23, P133; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Donaire V, 2005, BRAIN RES BULL, V67, P509, DOI 10.1016/j.brainresbull.2005.08.002; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gupta SC, 2005, BBA-GEN SUBJECTS, V1725, P81, DOI 10.1016/j.bbagen.2005.04.033; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lee JS, 2005, J BIOL CHEM, V280, P6634, DOI 10.1074/jbc.M412393200; Li LB, 2007, J BIOL CHEM, V282, P37694, DOI 10.1074/jbc.M705211200; Lim SY, 2004, J BIOL CHEM, V279, P46263, DOI 10.1074/jbc.M406555200; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Merritt TJS, 2011, ANAL METHODS-UK, V3, P1428, DOI 10.1039/c0ay00759e; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mukhopadhyay I, 2003, ENVIRON HEALTH PERSP, V111, P1926, DOI 10.1289/ehp.6339; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan TH, 2005, FEBS LETT, V579, P6716, DOI 10.1016/j.febslet.2005.10.067; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Samuni Y, 2010, FREE RADICAL BIO MED, V48, P1559, DOI 10.1016/j.freeradbiomed.2010.03.001; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Singh MP, 2010, CHEMOSPHERE, V79, P577, DOI 10.1016/j.chemosphere.2010.01.054; Somayajulu-Nitu M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-88; Tanner CM, 2012, ENV HLTH PERSPECT, V119, P866; Wang Z, 2011, J NEUROCHEM, V119, P1294, DOI 10.1111/j.1471-4159.2011.07517.x; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Yang LC, 2011, METHODS MOL BIOL, V793, P401, DOI 10.1007/978-1-61779-328-8_27	57	50	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98886	10.1371/journal.pone.0098886	http://dx.doi.org/10.1371/journal.pone.0098886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887138	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300117
J	Huang, LD; Fan, YZ; Tian, Y; Yang, Y; Liu, Y; Wang, J; Zhao, WS; Zhou, WC; Cheng, XY; Cao, P; Lu, XY; Yu, Y				Huang, Li-Dong; Fan, Ying-Zhe; Tian, Yun; Yang, Yang; Liu, Yan; Wang, Jin; Zhao, Wen-Shan; Zhou, Wen-Chao; Cheng, Xiao-Yang; Cao, Peng; Lu, Xiang-Yang; Yu, Ye			Inherent Dynamics of Head Domain Correlates with ATP-Recognition of P2X4 Receptors: Insights Gained from Molecular Simulations	PLOS ONE			English	Article							BINDING-SITES; ACTIVE-SITE; ION-CHANNEL; ACTIVATION; PAIN; MECHANISMS; RELEASE; DOCKING; TARGETS	P2X receptors are ATP-gated ion channels involved in many physiological functions, and determination of ATP-recognition (AR) of P2X receptors will promote the development of new therapeutic agents for pain, inflammation, bladder dysfunction and osteoporosis. Recent crystal structures of the zebrafish P2X4 (zfP2X4) receptor reveal a large ATP-binding pocket (ABP) located at the subunit interface of zfP2X4 receptors, which is occupied by a conspicuous cluster of basic residues to recognize triphosphate moiety of ATP. Using the engineered affinity labeling and molecular modeling, at least three sites (S1, S2 and S3) within ABP have been identified that are able to recognize the adenine ring of ATP, implying the existence of at least three distinct AR modes in ABP. The open crystal structure of zfP2X4 confirms one of three AR modes (named AR1), in which the adenine ring of ATP is buried into site S1 while the triphosphate moiety interacts with clustered basic residues. Why architecture of ABP favors AR1 not the other two AR modes still remains unexplored. Here, we examine the potential role of inherent dynamics of head domain, a domain involved in ABP formation, in AR determinant of P2X4 receptors. In silico docking and binding free energy calculation revealed comparable characters of three distinct AR modes. Inherent dynamics of head domain, especially the downward motion favors the preference of ABP for AR1 rather than AR2 and AR3. Along with the downward motion of head domain, the closing movement of loop(139-146) and loop(169-183), and structural rearrangements of K70, K72, R298 and R143 enabled ABP to discriminate AR1 from other AR modes. Our observations suggest the essential role of head domain dynamics in determining AR of P2X4 receptors, allowing evaluation of new strategies aimed at developing specific blockers/allosteric modulators by preventing the dynamics of head domain associated with both AR and channel activation of P2X4 receptors.	[Huang, Li-Dong; Yang, Yang; Liu, Yan; Wang, Jin; Zhao, Wen-Shan; Zhou, Wen-Chao; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China; [Huang, Li-Dong; Yang, Yang; Liu, Yan; Wang, Jin; Zhao, Wen-Shan; Zhou, Wen-Chao; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200030, Peoples R China; [Tian, Yun; Lu, Xiang-Yang; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Fan, Ying-Zhe; Zhou, Wen-Chao] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai, Peoples R China; [Cao, Peng] Jiangsu Prov Inst Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine; Nanjing University of Chinese Medicine	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China.	yuye@shsmu.edu.cn		, Peng/0000-0002-2044-3074; Yu, Ye/0000-0002-4054-8543; Zhao, Wenshan/0000-0002-8018-5978	National Program on Key Basic Research Project of China [2014CB910300, 2014CB910302, 2010CB529800]; National Excellent Young Scientist Foundation of China [31222018]; National Natural Science Foundation of China [31170787]; Key National S&T Program "Major New Drug Development'' Grant [2012ZX09504001-003]; Natural Science Foundation of Shanghai [12ZR1415600]; Jiangsu Province [SBK201241903]; Shanghai Jiao Tong University-SMC Mutual Funds; Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Excellent Young Scientist Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program "Major New Drug Development'' Grant; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Jiangsu Province; Shanghai Jiao Tong University-SMC Mutual Funds; Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry	This study was supported by grants from the National Program on Key Basic Research Project of China (2014CB910300, 2014CB910302, and 2010CB529800), the National Excellent Young Scientist Foundation of China (No. 31222018), National Natural Science Foundation of China (No. 31170787), Key National S&T Program "Major New Drug Development'' Grant (No. 2012ZX09504001-003), Natural Science Foundation of Shanghai (12ZR1415600), and Jiangsu Province (SBK201241903), "Shanghai Jiao Tong University-SMC Mutual Funds'' for Excellent Young Scholar and "Opening project'' of Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bornstein JC, 2008, PURINERG SIGNAL, V4, P197, DOI 10.1007/s11302-007-9081-z; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gadakar PK, 2007, J CHEM INF MODEL, V47, P1446, DOI 10.1021/ci6005036; Galligan JJ, 2004, BRIT J PHARMACOL, V141, P1294, DOI 10.1038/sj.bjp.0705761; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hugel S, 2000, J NEUROSCI, V20, P2121; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; Li ZY, 2008, ASSAY DRUG DEV TECHN, V6, P277, DOI 10.1089/adt.2007.121; Lorinczi E, 2012, P NATL ACAD SCI US; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM	42	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97528	10.1371/journal.pone.0097528	http://dx.doi.org/10.1371/journal.pone.0097528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878662	gold, Green Published, Green Submitted			2022-12-27	WOS:000338101500016
J	Li, N; Zhou, P; Zheng, J; Deng, JQ; Wu, HC; Li, W; Li, F; Li, HB; Lu, JC; Zhou, YF; Zhang, C				Li, Na; Zhou, Ping; Zheng, Jian; Deng, Jieqiong; Wu, Hongchun; Li, Wei; Li, Fang; Li, Hongbin; Lu, Jiachun; Zhou, Yifeng; Zhang, Chun			A Polymorphism rs12325489C > T in the LincRNA-ENST00000515084 Exon Was Found to Modulate Breast Cancer Risk via GWAS-Based Association Analyses	PLOS ONE			English	Article							LONG NONCODING RNA; GENOME-WIDE ASSOCIATION; GENE; EXPRESSION; CARCINOMA; SUSCEPTIBILITY; DISEASE; LUNG; PLURIPOTENCY; ESTROGEN	Breast cancer, one of the most common malignancies diagnosed among women worldwide, is a complex polygenic disease in the etiology of which genetic factors play an important role. Thus far, a subset of breast cancer genetic susceptibility loci has been addressed among Asian woman through genome-wide association studies (GWASs). In this study, we identified numerous long, intergenic, noncoding RNAs (lincRNAs) enriched in these breast cancer risk-related loci and identified 16 single nucleotide polymorphisms (SNPs) located within the sequences of lincRNA exonic regions. We examined whether these 16 SNPs are associated with breast cancer risk in 2539 cancer patients and 2818 control subjects from eastern, southern, and northern Chinese populations. We found that the C allele of the rs12325489C>T polymorphism in the exonic regions of lincRNA-ENST00000515084 was associated with a significantly increased risk of breast cancer (adjusted odds ratio [OR] = 1.79; 95% confidence interval [CI] = 1.50-2.12), compared with the rs12325489TT genotype. Biochemical analysis demonstrated that the C to T base change at rs12325489C>T disrupts the binding site for miRNA-370, thereby influencing the transcriptional activity of lincRNA-ENST00000515084 in vitro and in vivo, and affecting cell proliferation and tumor growth. Our findings indicate that the rs12325489C>T polymorphism in the lincRNA-ENST00000515084 exon may be a genetic modifier in the development of breast cancer.	[Li, Na; Zheng, Jian; Deng, Jieqiong; Wu, Hongchun; Li, Wei; Li, Fang; Zhou, Yifeng] Soochow Univ, Coll Med, Dept Genet, Suzhou, Peoples R China; [Li, Na; Zhou, Ping; Zhang, Chun] Nantong Univ, Affiliated Hosp 3, Dept Gen Surg, Wuxi, Peoples R China; [Li, Hongbin] Harbin Med Univ, Affiliated Hosp 3, Dept Med Oncol, Harbin, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Soochow University - China; Nantong University; Harbin Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhou, YF (corresponding author), Soochow Univ, Coll Med, Dept Genet, Suzhou, Peoples R China.	zhouyifeng@suda.edu.cn; wx3hzc@hotmail.com	Li, Wei/H-8477-2018		National Scientific Foundation of China [81001278, 81171895, 81072366]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD2010005]; Jiangsu Provincial Natural Science Foundation [BK2011297, BK2011176]; Jiangsu Province Science and Technology Support Program [BE2012648]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20101561]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province Science and Technology Support Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by the National Scientific Foundation of China grants 81001278, 81171895 and 81072366; A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD2010005), Jiangsu Provincial Natural Science Foundation (No. BK2011297 and BK2011176); Jiangsu Province Science and Technology Support Program (No. BE2012648) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (No. 20101561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheng EC, 2013, DEV CELL, V25, P1, DOI 10.1016/j.devcel.2013.03.020; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Feig S A, 1997, J Natl Cancer Inst Monogr, P119; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Lee RS, 2013, NAT GENET, V45, P1268, DOI 10.1038/ng.2805; LI H, 2011, MOL CARCINOG; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Ng SY, 2013, WIRES RNA, V4, P121, DOI 10.1002/wrna.1146; Nupponen NN, 2001, CANCER METAST REV, V20, P155, DOI 10.1023/A:1015557308033; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Sato K, 2010, ONCOL REP, V24, P701, DOI 10.3892/or_00000910; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vance KW, 2014, EMBO J, V33, P296, DOI 10.1002/embj.201386225; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhu ZS, 2012, CANCER RES, V72, P6163, DOI 10.1158/0008-5472.CAN-12-0010	58	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98251	10.1371/journal.pone.0098251	http://dx.doi.org/10.1371/journal.pone.0098251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879036	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500042
J	Zhou, J; Liu, FW; Pan, CY				Zhou, Jun; Liu, Fenwu; Pan, Chengyi			Effects of Cationic Polyacrylamide Characteristics on Sewage Sludge Dewatering and Moisture Evaporation	PLOS ONE			English	Article							ACTIVATED-SLUDGE; PILOT-SCALE; WASTE; DEWATERABILITY; IMPROVEMENT	The effects of the molecular weight (MW) and charge density (CD) of cationic polyacrylamide (CPAM) on sludge dewatering and moisture evaporation were investigated in this study. Results indicated that in sludge conditioning, the optimum dosages were 10, 6, 6, 4, and 4 mg g(-1) CPAM with 5 million MW and 20% CD, 5 million MW and 40% CD, 3 million MW and 40% CD, 8 million MW and 40% CD, and 5 million MW and 60% CD, respectively. The optimum dosage of CPAM was negatively correlated with its CD or MW if the CD or MW of CPAM was above 20% or 5 million. In the centrifugal dewatering of sludge, the moisture content in the conditioned sludge gradually decreased with the extension of centrifugation time, and the economical centrifugal force was 400 x g. The moisture evaporation rates of the conditioned sludge were closely related to sludge dewaterability, which was in turn significantly correlated either positively with the solid content of sludge particles that were >2 mm in size or negatively with that of particles measuring 1 mm to 2 mm in diameter. During treatment, sludge moisture content was reduced from 80% to 20% by evaporation, and the moisture evaporation rates were 1.35, 1.49, 1.62, and 2.24 times faster in the sludge conditioned using 4 mg g(-1) CPAM with 5 million MW and 60% CD than in the sludge conditioned using 4 mg g(-1) CPAM with 8 million MW and 40% CD, 6 mg g(-1) CPAM with 5 million MW and 40% CD, 6 mg g(-1) CPAM with 3 million MW and 40% CD, and 10 mg g(-1) CPAM with 5 million MW and 20% CD, respectively. Hence, the CPAM with 5 million MW and 60% CD was ideal for sludge dewatering.	[Zhou, Jun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Fenwu; Pan, Chengyi] Shanxi Agr Univ, Coll Resource & Environm, Environm Engn Lab, Taigu, Peoples R China	Nanjing Tech University; Shanxi Agricultural University	Liu, FW (corresponding author), Shanxi Agr Univ, Coll Resource & Environm, Environm Engn Lab, Taigu, Peoples R China.	lfwlfw2008@163.com	zhou, jun/D-5706-2015		National Natural Science Foundation of China [21307058]; Doctoral Scientific Research Starting Foundation of Shanxi Agricultural University [2012YJ06]; Jiangsu Province Science Foundation [BK20130931]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJB610006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Research Starting Foundation of Shanxi Agricultural University; Jiangsu Province Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 21307058), the Doctoral Scientific Research Starting Foundation of Shanxi Agricultural University (No. 2012YJ06), the Jiangsu Province Science Foundation for Youths (No. BK20130931), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 13KJB610006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA AWWA WEF., 2005, STANDARD METHODS EXA; Bohm N, 1997, COLLOID POLYM SCI, V275, P73, DOI 10.1007/s003960050054; Buyukkamaci N, 2007, J HAZARD MATER, V144, P323, DOI 10.1016/j.jhazmat.2006.10.034; Chang GR, 2001, WATER RES, V35, P786, DOI 10.1016/S0043-1354(00)00326-2; Chen YX, 2005, J HAZARD MATER, V123, P196, DOI 10.1016/j.jhazmat.2005.03.047; Chu CP, 2001, WATER RES, V35, P1038, DOI 10.1016/S0043-1354(00)00338-9; Defrance L, 2000, BIORESOURCE TECHNOL, V73, P105, DOI 10.1016/S0960-8524(99)00163-7; Deng WY, 2009, J HAZARD MATER, V162, P186, DOI 10.1016/j.jhazmat.2008.05.022; Dewil R, 2005, J HAZARD MATER, V117, P161, DOI 10.1016/j.jhazmat.2004.09.025; Feng X, 2009, BIORESOURCE TECHNOL, V100, P1074, DOI 10.1016/j.biortech.2008.07.055; GREGORY J, 1988, COLLOID SURFACE, V31, P231, DOI 10.1016/0166-6622(88)80196-3; Hsiau PC, 1998, WATER RES, V32, P1103, DOI 10.1016/S0043-1354(97)00230-3; KATSIRIS N, 1987, WATER RES, V21, P1319, DOI 10.1016/0043-1354(87)90004-2; Kleimann J, 2005, LANGMUIR, V21, P3688, DOI 10.1021/la046911u; Laguna A, 1999, WATER SCI TECHNOL, V40, P1, DOI 10.1016/S0273-1223(99)00602-2; Li H, 2009, J HAZARD MATER, V161, P1421, DOI 10.1016/j.jhazmat.2008.04.113; Liu Fen-wu, 2011, Huanjing Kexue, V32, P2993; Liu FW, 2012, J ENVIRON SCI, V24, P1403, DOI 10.1016/S1001-0742(11)60958-3; Liu FW, 2012, J HAZARD MATER, V221, P170, DOI 10.1016/j.jhazmat.2012.04.028; Lo IMC, 2001, ENVIRON SCI TECHNOL, V35, P4691, DOI 10.1021/es010834x; Lu MC, 2003, ADV ENVIRON RES, V7, P667, DOI 10.1016/S1093-0191(02)00039-4; Lu YJ, 2009, WASTE MANAGE, V29, P1152, DOI 10.1016/j.wasman.2008.06.030; Luo HJ, 2013, BIORESOURCE TECHNOL, V139, P330, DOI 10.1016/j.biortech.2013.04.035; Ohm TI, 2010, J HAZARD MATER, V178, P483, DOI 10.1016/j.jhazmat.2010.01.107; Stefanakis AI, 2012, J HAZARD MATER, V213, P393, DOI 10.1016/j.jhazmat.2012.02.016; Thapa KB, 2009, COLLOID SURFACE A, V334, P66, DOI 10.1016/j.colsurfa.2008.10.007; Vaxelaire J, 2000, WATER RES, V34, P4318, DOI 10.1016/S0043-1354(00)00193-7; Wilen BM, 1999, WATER RES, V33, P391, DOI 10.1016/S0043-1354(98)00208-5; Wu ZH, 2012, J HAZARD MATER, V243, P357, DOI 10.1016/j.jhazmat.2012.10.054; Xu CB, 2008, WATER RES, V42, P1571, DOI 10.1016/j.watres.2007.11.007; Yang C, 2011, CHEMOSPHERE, V85, P418, DOI 10.1016/j.chemosphere.2011.07.068; Zhang WJ, 2012, ADV MATER RES-SWITZ, V518-523, P2991, DOI 10.4028/www.scientific.net/AMR.518-523.2991; Zhang ZQ, 2010, WATER RES, V44, P3087, DOI 10.1016/j.watres.2010.02.033	33	7	7	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98159	10.1371/journal.pone.0098159	http://dx.doi.org/10.1371/journal.pone.0098159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878582	gold, Green Submitted, Green Published			2022-12-27	WOS:000338101500034
J	Cundell, MJ; Price, C				Cundell, Michael John; Price, Clive			The Budding Yeast Amphiphysin Complex Is Required for Contractile Actin Ring (CAR) Assembly and Post-Contraction GEF-Independent Accumulation of Rho1-GTP	PLOS ONE			English	Article							MITOTIC-EXIT NETWORK; PROTEIN-PROTEIN INTERACTION; SACCHAROMYCES-CEREVISIAE; ACTOMYOSIN RING; SEPTUM FORMATION; MYOSIN-II; IN-VIVO; REGULATES CYTOKINESIS; CHITIN-SYNTHASE; CLEAVAGE FURROW	The late events of the budding yeast cell division cycle, cytokinesis and cell separation, require the assembly of a contractile actomyosin ring (CAR), primary and secondary septum formation followed by enzymatic degradation of the primary septum. Here we present evidence that demonstrates a role for the budding yeast amphiphysin complex, a heterodimer comprising Rvs167 and Rvs161, in CAR assembly and cell separation. The iqg1-1 allele is synthetically lethal with both rvs167 and rvs161 null mutations. We show that both Iqg1 and the amphiphysin complex are required for CAR assembly in early anaphase but cells are able to complete assembly in late anaphase when these activities are, respectively, either compromised or absent. Amphiphysin dependent CAR assembly is dependent upon the Rvs167 SH3 domain, but this function is insufficient to explain the observed synthetic lethality. Dosage suppression of the iqg1-1 allele demonstrates that endocytosis is required for the default cell separation pathway in the absence of CAR contraction but is unlikely to be required to maintain viability. The amphiphysin complex is required for normal, post-mitotic, localization of Chs3 and the Rho1 GEF, Rom2, which are responsible for secondary septum deposition and the accumulation of GTP bound Rho1 at the bud neck. It is concluded that a failure of polarity establishment in the absence of CAR contraction and amphiphysin function leads to loss of viability as a result of the consequent cell separation defect.	[Cundell, Michael John; Price, Clive] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Lancaster University	Price, C (corresponding author), Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	c.price1@lancaster.ac.uk			BBSRC [BBS/S/K/2005/12131]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M. J. C. was supported by a BBSRC funded Research studentship, BBS/S/K/2005/12131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AEM, 1991, METHOD ENZYMOL, V194, P565; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; Bi E, 2001, CELL STRUCT FUNCT, V26, P529, DOI 10.1247/csf.26.529; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boyne JR, 2000, J CELL SCI, V113, P4533; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Coll PM, 2007, EMBO J, V26, P1865, DOI 10.1038/sj.emboj.7601641; Colwill K, 1999, GENETICS, V152, P881; Corbett M, 2006, EUR J CELL BIOL, V85, P1201, DOI 10.1016/j.ejcb.2006.08.001; Devrekanli A, 2012, J CELL SCI, V125, P5453, DOI 10.1242/jcs.109157; Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8; Fang XD, 2010, J CELL BIOL, V191, P1333, DOI 10.1083/jcb.201005134; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Friesen H, 2005, GENETICS, V170, P555, DOI 10.1534/genetics.104.040063; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Jendretzki A, 2009, MOL GENET GENOMICS, V282, P437, DOI 10.1007/s00438-009-0476-0; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6; Krause SA, 2012, J CELL SCI, V125, P2721, DOI 10.1242/jcs.100685; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Nishihama R, 2009, J CELL BIOL, V185, P995, DOI 10.1083/jcb.200903125; Nkosi PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057846; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Onishi M, 2013, J CELL BIOL, V202, P311, DOI 10.1083/jcb.201302001; Palani S, 2012, J CELL SCI, V125, P3091, DOI 10.1242/jcs.106021; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Phillipsen P, 1991, METHODS ENZYMOL, V194, P169; Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124; Sanchez-Diaz A, 2008, NAT CELL BIOL, V10, P395, DOI 10.1038/ncb1701; Sanchez-Diaz A, 2012, EMBO J, V31, P3620, DOI 10.1038/emboj.2012.224; Schmidt M, 2002, J CELL SCI, V115, P293; Shannon KB, 1999, MOL BIOL CELL, V10, P283, DOI 10.1091/mbc.10.2.283; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sivadon P, 1997, FEBS LETT, V417, P21, DOI 10.1016/S0014-5793(97)01248-9; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Wloka C, 2013, J CELL BIOL, V200, P271, DOI 10.1083/jcb.201208030; Wright DJ, 2008, GENETICS, V178, P1903, DOI 10.1534/genetics.107.082685; Xiong Y, 2007, THESIS LANCASTER U; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhao HX, 2013, CELL REP, V4, P1213, DOI 10.1016/j.celrep.2013.08.024	64	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97663	10.1371/journal.pone.0097663	http://dx.doi.org/10.1371/journal.pone.0097663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874185	Green Submitted, Green Published, gold			2022-12-27	WOS:000336790800010
J	Tornevi, A; Bergstedt, O; Forsberg, B				Tornevi, Andreas; Bergstedt, Olof; Forsberg, Bertil			Precipitation Effects on Microbial Pollution in a River: Lag Structures and Seasonal Effect Modification	PLOS ONE			English	Article							DRINKING-WATER TURBIDITY; GASTROINTESTINAL ILLNESS; ESCHERICHIA-COLI; RAINFALL; ASSOCIATION; INDICATOR; OUTBREAKS; DISEASE; RISK	Background: The river Gota Alv is a source of freshwater for 0.7 million swedes. The river is subject to contamination from sewer systems discharge and runoff from agricultural lands. Climate models projects an increase in precipitation and heavy rainfall in this region. This study aimed to determine how daily rainfall causes variation in indicators of pathogen loads, to increase knowledge of variations in river water quality and discuss implications for risk management. Methods: Data covering 7 years of daily monitoring of river water turbidity and concentrations of E. coli, Clostridium and coliforms were obtained, and their short-term variations in relation with precipitation were analyzed with time series regression and non-linear distributed lag models. We studied how precipitation effects varied with season and compared different weather stations for predictive ability. Results: Generally, the lowest raw water quality occurs 2 days after rainfall, with poor raw water quality continuing for several more days. A rainfall event of >15 mm/24-h (local 95 percentile) was associated with a three-fold higher concentration of E. coli and 30% higher turbidity levels (lag 2). Rainfall was associated with exponential increases in concentrations of indicator bacteria while the effect on turbidity attenuated with very heavy rainfall. Clear associations were also observed between consecutive days of wet weather and decreased water quality. The precipitation effect on increased levels of indicator bacteria was significant in all seasons. Conclusions: Rainfall elevates microbial risks year-round in this river and freshwater source and acts as the main driver of varying water quality. Heavy rainfall appears to be a better predictor of fecal pollution than water turbidity. An increase of wet weather and extreme events with climate change will lower river water quality even more, indicating greater challenges for drinking water producers, and suggesting better control of sources of pollution.	[Tornevi, Andreas; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Bergstedt, Olof] Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden	Umea University; Chalmers University of Technology	Tornevi, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	andreas.tornevi@umu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [10-104]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	This research was founded by The Swedish Water & Wastewater Association and The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), grant number 10-104. The funding is external to our organization. The project is entitled: Climate change, freshwater quality, treatment and distribution-risk assessment by health studies. (URL in Swedish: http://www.svensktvatten.se/FoU/SVU/Pagaende-projekt/Dricksvatten/SVU-projekt-10-104/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrom J, 2007, J WATER HEALTH, V5, P81, DOI 10.2166/wh.2007.139; Blaustein RA, 2013, WATER RES, V47, P569, DOI 10.1016/j.watres.2012.10.027; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Egorov AI, 2003, INT J ENVIRON HEAL R, V13, P81, DOI 10.1080/0960312021000071567; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Gauthier F, 2001, WATER RES, V35, P2207, DOI 10.1016/S0043-1354(00)00506-6; Gilbert Marie-Line, 2006, Journal of Water and Health, V4, P225, DOI 10.2166/wh.2006.0019; Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002; Morris RD, 1996, AM J PUBLIC HEALTH, V86, P237, DOI 10.2105/AJPH.86.2.237; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Odonkor ST, 2013, MICROBIOL RES-ITALY, V4, DOI 10.4081/mr.2013.e2; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Signor R. S., 2005, Journal of Water and Health, V3, P453; Swedish Commission on Climate and Vulnerability, 2007, SWED GOV OFF REP, VSOU 2007:60; Team R, 2010, R LANG ENV STAT COMP; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Tornevi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069918; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	25	44	48	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98546	10.1371/journal.pone.0098546	http://dx.doi.org/10.1371/journal.pone.0098546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874010	Green Published, gold, Green Submitted			2022-12-27	WOS:000336790800048
J	van Gent, R; Di Sanza, C; van den Broek, NJF; Fleskens, V; Veenstra, A; Stout, GJ; Brenkman, AB				van Gent, Rogier; Di Sanza, Claudio; van den Broek, Niels J. F.; Fleskens, Veerle; Veenstra, Aukje; Stout, Gerdine J.; Brenkman, Arjan B.			SIRT1 Mediates FOXA2 Breakdown by Deacetylation in a Nutrient-Dependent Manner	PLOS ONE			English	Article							LIPID-METABOLISM; GENE-EXPRESSION; PROTEIN; TRANSCRIPTION; ACETYLATION; LIVER; DIFFERENTIATION; HOMEOSTASIS; ACTIVATION; HEPATOCYTE	The Forkhead transcription factor FOXA2 plays a fundamental role in controlling metabolic homeostasis in the liver during fasting. The precise molecular regulation of FOXA2 in response to nutrients is not fully understood. Here, we studied whether FOXA2 could be controlled at a post-translational level by acetylation. By means of LC-MS/MS analyses, we identified five acetylated residues in FOXA2. Sirtuin family member SIRT1 was found to interact with and deacetylate FOXA2, the latter process being dependent on the NAD+-binding catalytic site of SIRT1. Deacetylation by SIRT1 reduced protein stability of FOXA2 by targeting it towards proteasomal degradation, and inhibited transcription from the FOXA2-driven G6pase and CPT1a promoters. While mutation of the five identified acetylated residues weakly affected protein acetylation and stability, mutation of at least seven additional lysine residues was required to abolish acetylation and reduce protein levels of FOXA2. The importance of acetylation of FOXA2 became apparent upon changes in nutrient levels. The interaction of FOXA2 and SIRT1 was strongly reduced upon nutrient withdrawal in cell culture, while enhanced Foxa2 acetylation levels were observed in murine liver in vivo after starvation for 36 hours. Collectively, this study demonstrates that SIRT1 controls the acetylation level of FOXA2 in a nutrient-dependent manner and in times of nutrient shortage the interaction between SIRT1 and FOXA2 is reduced. As a result, FOXA2 is protected from degradation by enhanced acetylation, hence enabling the FOXA2 transcriptional program to be executed to maintain metabolic homeostasis.	[van Gent, Rogier; Di Sanza, Claudio; van den Broek, Niels J. F.; Veenstra, Aukje; Stout, Gerdine J.; Brenkman, Arjan B.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Sect Metab Dis, Utrecht, Netherlands; [van Gent, Rogier; Di Sanza, Claudio; van den Broek, Niels J. F.; Veenstra, Aukje; Stout, Gerdine J.; Brenkman, Arjan B.] Netherlands Metabol Ctr, Utrecht, Netherlands; [van Gent, Rogier] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Fleskens, Veerle] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Brenkman, AB (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Sect Metab Dis, Utrecht, Netherlands.	a.b.brenkman@umcutrecht.nl			UMC Utrecht, The Netherlands	UMC Utrecht, The Netherlands(Netherlands Government)	This study was funded by the UMC Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048019; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Grempler R, 2004, BIOCHEM J, V382, P471, DOI 10.1042/BJ20040160; Guarente L, 2011, CELL METAB, V14, P151, DOI 10.1016/j.cmet.2011.07.007; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; von Meyenn F, 2013, CELL METAB, V17, P436, DOI 10.1016/j.cmet.2013.01.014; Wang HY, 2005, TRENDS MOL MED, V11, P262, DOI 10.1016/j.molmed.2005.04.003; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	37	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98438	10.1371/journal.pone.0098438	http://dx.doi.org/10.1371/journal.pone.0098438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875183	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800039
J	Winkelmann, R; Sandrock, L; Kirberg, J; Jack, HM; Schuh, W				Winkelmann, Rebecca; Sandrock, Lena; Kirberg, Joerg; Jaeck, Hans-Martin; Schuh, Wolfgang			KLF2-A Negative Regulator of Pre-B Cell Clonal Expansion and B Cell Activation	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; TRANSCRIPTION-FACTOR; T-CELLS; GENE-EXPRESSION; UP-REGULATION; IN-VIVO; RECEPTOR; QUIESCENCE; DIFFERENTIATION; CHAIN	Maturation as well as antigen-dependent activation of B cells is accompanied by alternating phases of proliferation and quiescence. We and others have previously shown that Kruppel-like factor 2 (KLF2), a regulator of T cell quiescence and migration, is upregulated in small resting precursor (pre)-B cells after assembly of the immature pre-B cell receptor (pre-BCR) and is downregulated upon antigen-induced proliferation of mature B cells. These findings suggest that KLF2, besides its function in maintaining follicular B cell identity, peripheral B cell homeostasis and homing of antigen-specific plasma cells to the bone marrow, also controls clonal expansion phases in the B cell lineage. Here, we demonstrate that enforced expression of KLF2 in primary pre-B cells results in a severe block of pre-BCR-induced proliferation, upregulation of the cell cycle inhibitors p21 and p27 and downregulation of c-myc. Furthermore, retroviral KLF2 transduction of primary B cells impairs LPS-induced activation, favors apoptosis and results in reduced abundance of factors, such as AID, IRF4 and BLIMP1, that control the antigen-dependent phase of B cell activation and plasma cell differentiation. Hence, we conclude that KLF2 is not only a key player in terminating pre-B cell clonal expansion but also a potent suppressor of B cell activation.	[Winkelmann, Rebecca; Sandrock, Lena; Jaeck, Hans-Martin; Schuh, Wolfgang] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany; [Kirberg, Joerg] Paul Ehrlich Inst, Div Immunol, Langen, Germany	University of Erlangen Nuremberg; Paul Ehrlich Institute	Schuh, W (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany.	wschuh@molmed.uni-erlangen.de		Jack, Hans-Martin/0000-0002-6332-8463	IZKF [J21]; ELAN; DFG [FOR832]	IZKF; ELAN; DFG(German Research Foundation (DFG))	This project was funded in part by IZKF project J21 (to R. W.), intramural funding ELAN (to W. S.), and DFG research grant FOR832 (to H.-M.J.). IZKF: "Interdisziplinares Zentrum fur klinische Forschung, Universitat Erlangen" ELAN: "Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung" DFG: "Deutsche Forschungsgemeinschaft." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bradl H, 2001, J IMMUNOL, V167, P6403, DOI 10.4049/jimmunol.167.11.6403; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Fruman DA, 2002, P NATL ACAD SCI USA, V99, P359, DOI 10.1073/pnas.012605099; Glynne R, 2000, IMMUNOL REV, V176, P216; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Hart GT, 2012, J IMMUNOL, V188, P521, DOI 10.4049/jimmunol.1101530; Hart GT, 2011, P NATL ACAD SCI USA, V108, P716, DOI 10.1073/pnas.1013168108; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Hoek KL, 2010, IMMUNITY, V33, P254, DOI 10.1016/j.immuni.2010.07.016; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Metzner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008883; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Schober SL, 1999, J IMMUNOL, V163, P3662; Schuh W, 2003, J IMMUNOL, V171, P3343, DOI 10.4049/jimmunol.171.7.3343; Schuh W, 2008, MOL IMMUNOL, V45, P362, DOI 10.1016/j.molimm.2007.06.154; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Vettermann C, 2006, SEMIN IMMUNOL, V18, P44, DOI 10.1016/j.smim.2006.01.001; Vettermann C, 2010, TRENDS IMMUNOL, V31, P176, DOI 10.1016/j.it.2010.02.004; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	31	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97953	10.1371/journal.pone.0097953	http://dx.doi.org/10.1371/journal.pone.0097953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874925	Green Published, Green Submitted, gold			2022-12-27	WOS:000336790800017
J	Chew, KS; Schmidt, TM; Rupp, AC; Kofuji, P; Trimarchi, JM				Chew, Kylie S.; Schmidt, Tiffany M.; Rupp, Alan C.; Kofuji, Paulo; Trimarchi, Jeffrey M.			Loss of G(q11) Genes Does Not Abolish Melanopsin Phototransduction	PLOS ONE			English	Article							EXPRESSING GANGLION-CELLS; G-PROTEINS; RESPONSES; DIVERSITY; DEFECTS; RETINA; MOUSE	In mammals, a subset of retinal ganglion cells (RGCs) expresses the photopigment melanopsin, which renders them intrinsically photosensitive (ipRGCs). These ipRGCs mediate various non-image-forming visual functions such as circadian photoentrainment and the pupillary light reflex (PLR). Melanopsin phototransduction begins with activation of a heterotrimeric G protein of unknown identity. Several studies of melanopsin phototransduction have implicated a G-protein of the G(q/11) family, which consists of Gna11, Gna14, Gnaq and Gna15, in melanopsin-evoked depolarization. However, the exact identity of the G(q/11) gene involved in this process has remained elusive. Additionally, whether G(q/11) G-proteins are necessary for melanopsin phototransduction in vivo has not yet been examined. We show here that the majority of ipRGCs express both Gna11 and Gna14, but neither Gnaq nor Gna15. Animals lacking the melanopsin protein have well-characterized deficits in the PLR and circadian behaviors, and we therefore examined these non-imaging forming visual functions in a variety of single and double mutants for G(q/11) family members. All G(q/11) mutant animals exhibited PLR and circadian behaviors indistinguishable from WT. In addition, we show persistence of ipRGC light-evoked responses in Gna11(-/-); Gna14(-/-) retinas using multielectrode array recordings. These results demonstrate that G(q), G(11), G(14), or G(15) alone or in combination are not necessary for melanopsin-based phototransduction, and suggest that ipRGCs may be able to utilize a G(q/11)-independent phototransduction cascade in vivo.	[Chew, Kylie S.; Schmidt, Tiffany M.; Rupp, Alan C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Kofuji, Paulo] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Trimarchi, Jeffrey M.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University	Chew, KS (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	kchew1@jhu.edu	Schmidt, Tiffany M/A-9660-2012; Schmidt, Tiffany/L-7598-2014; Kofuji, Paulo/AAR-7835-2021	Schmidt, Tiffany M/0000-0002-4791-6775; Schmidt, Tiffany/0000-0002-4791-6775; Kofuji, Paulo/0000-0002-4840-9986; Trimarchi, Jeffrey/0000-0001-7923-1538; Chew, Kylie/0000-0003-4752-009X; Rupp, Alan/0000-0001-5363-4494	National Institutes of Health [1R01EY019053, GM076430]; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL EYE INSTITUTE [P30EY011374, R01EY019053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM076430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health Grant: 1R01EY019053, National Institutes of Health Grant: GM076430. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davignon I, 2000, MOL CELL BIOL, V20, P797, DOI 10.1128/MCB.20.3.797-804.2000; Davignon I, 1996, GENOMICS, V31, P359, DOI 10.1006/geno.1996.0059; Dennis EA, 2011, INTERCELLULAR SIGNAL; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Goetz JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3824; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Offermanns S, 1999, N-S ARCH PHARMACOL, V360, P5, DOI 10.1007/s002109900030; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; PARK DG, 1993, J BIOL CHEM, V268, P4573; Perez-Leighton CE, 2011, EUR J NEUROSCI, V33, P856, DOI 10.1111/j.1460-9568.2010.07583.x; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98356	10.1371/journal.pone.0098356	http://dx.doi.org/10.1371/journal.pone.0098356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870805	gold, Green Published, Green Submitted			2022-12-27	WOS:000336858300038
J	Grandone, E; Villani, M; Tiscia, GL; Dentali, F; Colaizzo, D; Cappucci, F; Fischetti, L; Ageno, W; Margaglione, M				Grandone, Elvira; Villani, Michela; Tiscia, Giovanni L.; Dentali, Francesco; Colaizzo, Donatella; Cappucci, Filomena; Fischetti, Lucia; Ageno, Walter; Margaglione, Maurizio			Clinical Utility of Antithrombotic Prophylaxis in ART Procedures: An Italian Experience	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; ASSISTED CONCEPTION; BIRTH-RATES; THROMBOPHILIA; METAANALYSIS; OUTCOMES; HEPARIN; WOMEN	Background: The usefulness of antithrombotic prophylaxis in management of Assisted Reproductive Technologies (ART) is questionable. Objectives: We prospectively examined the contribution of an antithrombotic prophylaxis in influencing clinical pregnancy and live-birth in an unselected cohort of women approaching ART. Patients/Methods: 1107 women with fertility problems and a valid indication for ART were recruited. Baseline and follow-up information of obstetric outcomes and antithrombotic treatment were collected. Results and Conclusions: Median follow-up time was 34.5 months (range: 2-143). During the follow-up period, 595 (53.8%) women underwent ART (total 1234 cycles); 202 (33.9%) women achieved a pregnancy for a total of 255 clinical pregnancies. The concomitant use of LMWH and aspirin was significantly associated with a higher rate of clinical pregnancies (p: 0.003, OR: 4.9, 95% CI: 1.7-14.2). The pregnancy rate was also significantly increased by the use of LMWH alone (p: 0.005, OR: 2.6, 95% CI: 1.3-5.0). Carriership of inherited or acquired thrombophilia did not affect clinical outcomes of the ART. The efficacy of antithrombotic treatment was confirmed when the outcome "live-birth" was considered. Present data suggest a potential benefit of antithrombotic prophylaxis during ART in improving the number of live-births.	[Grandone, Elvira; Villani, Michela; Tiscia, Giovanni L.; Colaizzo, Donatella; Cappucci, Filomena; Fischetti, Lucia] IRCCS Casa Sollievo Sofferenza, Atherosclerosis & Thrombosis Unit, Foggia, Italy; [Dentali, Francesco; Ageno, Walter] Insubria Univ, Dept Clin Med, Varese, Italy; [Margaglione, Maurizio] Univ Foggia, Foggia, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Insubria; University of Foggia	Grandone, E (corresponding author), IRCCS Casa Sollievo Sofferenza, Atherosclerosis & Thrombosis Unit, Foggia, Italy.	e.grandone@operapadrepio.it	Tiscia, Giovanni/AAC-8788-2019; COLAIZZO, DONATELLA/K-5654-2016; Grandone, Elvira/M-1127-2019; Villani, Michela/D-9169-2017	Tiscia, Giovanni/0000-0001-5896-2024; COLAIZZO, DONATELLA/0000-0001-6927-7428; Grandone, Elvira/0000-0002-8980-9783; Cappucci, Filomena/0000-0001-7745-7330; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221; ageno, walter/0000-0002-1922-8879; Fischetti, Lucia/0000-0002-0297-1105; Villani, Michela/0000-0002-7571-1267	Italian Ministry of Health (Ricerca Corrente)	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	The study was supported by grants from Italian Ministry of Health (Ricerca Corrente 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dentali F, 2012, J THROMB HAEMOST, V10, P2075, DOI 10.1111/j.1538-7836.2012.04886.x; Dentali F, 2011, J THROMB HAEMOST, V9, P2503, DOI 10.1111/j.1538-7836.2011.04535.x; Di Nisio M, 2011, BLOOD, V118, P2670, DOI 10.1182/blood-2011-03-340216; Gilbert WM, 1999, OBSTET GYNECOL, V93, P9, DOI 10.1016/S0029-7844(98)00382-2; Grandone E, 2014, THROMB RES, V133, P168, DOI 10.1016/j.thromres.2013.11.016; Grandone E, 2011, J THROMB HAEMOST, V9, P496, DOI 10.1111/j.1538-7836.2011.04183.x; Grandone E, 2001, FERTIL STERIL, V76, P201, DOI 10.1016/S0015-0282(01)01832-5; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Kimberly Liu, 2012, Int J Gynaecol Obstet, V117, P95; Luke B, 2012, NEW ENGL J MED, V366, P2483, DOI 10.1056/NEJMoa1110238; Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nelson SM, 2008, HUM REPROD UPDATE, V14, P623, DOI 10.1093/humupd/dmn031; Pandian Z, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003357.pub2; Ricci G, 2011, HUM REPROD, V26, P3068, DOI 10.1093/humrep/der261; Siristatidis CS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004832.pub3, 10.1002/14651858.CD004832]; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97604	10.1371/journal.pone.0097604	http://dx.doi.org/10.1371/journal.pone.0097604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870449	Green Submitted, gold, Green Published			2022-12-27	WOS:000336858300015
J	Periyakoil, VS; Neri, E; Fong, A; Kraemer, H				Periyakoil, Vyjeyanthi S.; Neri, Eric; Fong, Ann; Kraemer, Helena			Do Unto Others: Doctors' Personal End-of-Life Resuscitation Preferences and Their Attitudes toward Advance Directives	PLOS ONE			English	Article							CANCER-PATIENTS; PHYSICIANS ATTITUDES; CARE; SIZE	Objective: High-intensity interventions are provided to seriously-ill patients in the last months of life by medical sub-specialists. This study was undertaken to determine if doctors' age, ethnicity, medical sub-specialty and personal resuscitation and organ donation preferences influenced their attitudes toward Advance Directives (AD) and to compare a cohort of 2013 doctors to a 1989 (one year before the Patient Self Determination Act in 1990) cohort to determine any changes in attitudes towards AD in the past 23 years. Design: Doctors in two academic medical centers participated in an AD simulation and attitudes survey in 2013 and their responses were compared to a cohort of doctors in 1989. Outcomes: Resuscitation and organ donation preferences (2013 cohort) and attitudes toward AD (1989 and 2013 cohorts). Results: In 2013, 1081 (94.2%) doctors of the 1147 approached participated. Compared to 1989, 2013 cohort did not feel that widespread acceptance of AD would result in less aggressive treatment even of patients who do not have an AD (p<0.001, AUC = 0.77); had greater confidence in their treatment decisions if guided by an AD (p<.001, AUC = 0.58) and were less worried about legal consequences of limiting treatment when following an AD (p<.001, AUC = 0.57). The gender (p = 0.00172), ethnicity (chi(2) 14.68, DF = 3, p = .0021) and sub-specialty (chi(2) 28.92, p = .004, DF = 12) influenced their attitudes towards AD. 88.3% doctors chose do-not-resuscitate status and wanted to become organ donors. Those less supportive of AD were more likely to opt for "full code'' even if terminally ill and were less supportive of organ donation. Conclusions: Doctors' attitudes towards AD has not changed significantly in the past 23 years. Doctors' gender, ethnicity and sub-specialty influence their attitudes towards AD. Our study raises questions about why doctors continue to provide high-intensity care for terminally ill patients but personally forego such care for themselves at the end of life.	[Periyakoil, Vyjeyanthi S.; Neri, Eric; Kraemer, Helena] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Periyakoil, Vyjeyanthi S.] Vet Affairs VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Fong, Ann] Stanford Hosp & Clin, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Periyakoil, VS (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.	periyakoil@stanford.edu			National Institutes of Health Grants [1R25MD006857]; Stanford University School of Medicine and the Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R25CA115562] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R25MD006857] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University School of Medicine and the Department of Veterans Affairs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr. Periyakoil's work is supported by National Institutes of Health Grants 1R25MD006857, Stanford University School of Medicine and the Department of Veterans Affairs. Project site http://aging.stanford.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Blechman JA, 2013, J PALLIAT MED, V16, P1285, DOI 10.1089/jpm.2013.0257; Blondeau D, 1998, J MED ETHICS, V24, P328, DOI 10.1136/jme.24.5.328; Bond CJ, 2011, AGE AGEING, V40, P450, DOI 10.1093/ageing/afr025; Bradley CT, 2010, SURGERY, V148, P209, DOI 10.1016/j.surg.2010.05.020; Brotherton Sarah E, 2013, JAMA, V310, P2328, DOI 10.1001/jama.2013.278364; Cassell J, 2003, CRIT CARE MED, V31, P1551, DOI 10.1097/00003246-200305000-00039; Chow E, 2001, CLIN ONCOL-UK, V13, P209, DOI 10.1007/s001740170078; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Cutler D.M., 2013, NBER WORKING PAPER S; DAVIDSON KW, 1989, JAMA-J AM MED ASSOC, V262, P2415, DOI 10.1001/jama.262.17.2415; Gallo JJ, 2003, J AM GERIATR SOC, V51, P961, DOI 10.1046/j.1365-2389.2003.51309.x; Gallup GH, 1997, SPIRITUAL BELIEFS DY; Hsu LA, 2004, PSYCHOL METHODS, V9, P183, DOI 10.1037/1082-989X.9.2.183; HUGHES DL, 1992, CAN MED ASSOC J, V146, P1937; Kraemer H. C, 2008, WILEY ENCY CLIN TRIA, P1; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kung HC, 2008, NATL VITAL STAT REPO; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Periyakoil VS, 2010, J PALLIAT MED, V13, P495, DOI 10.1089/jpm.2009.0279; Periyakoil VS, 2009, J PALLIAT MED, V12, P1125, DOI 10.1089/jpm.2009.0123; Redmann AJ, 2012, ANN SURG, V255, P418, DOI 10.1097/SLA.0b013e31823b6782; Schuklenk U, 2011, BIOETHICS, V25, P1, DOI 10.1111/j.1467-8519.2011.01939.x; Schwarze ML, 2010, CRIT CARE MED, V38, P843, DOI 10.1097/CCM.0b013e3181cc466b; Smits HL, 2002, PALLIATIVE CARE OPPO; Straton JB, 2004, J AM GERIATR SOC, V52, P577, DOI 10.1111/j.1532-5415.2004.52165.x; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Toller CAS, 2006, J PALLIATIVE CARE, V22, P141, DOI 10.1177/082585970602200303; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wittink MN, 2008, ARCH INTERN MED, V168, P2125, DOI 10.1001/archinte.168.19.2125; Wu SY, 2000, PROJECTION CHRONIC I	33	59	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98246	10.1371/journal.pone.0098246	http://dx.doi.org/10.1371/journal.pone.0098246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24869673	Green Submitted, Green Published, gold			2022-12-27	WOS:000336858300028
J	Shen, ZZ; Wang, DS; Ruan, YZ; Xue, C; Zhang, J; Li, R; Shen, QR				Shen, Zongzhuan; Wang, Dongsheng; Ruan, Yunze; Xue, Chao; Zhang, Jian; Li, Rong; Shen, Qirong			Deep 16S rRNA Pyrosequencing Reveals a Bacterial Community Associated with Banana Fusarium Wilt Disease Suppression Induced by Bio-Organic Fertilizer Application	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BIOLOGICAL-CONTROL; SOIL PROPERTIES; STRAIN G10; MUSA SPP.; ROOT-ROT; DIVERSITY; MANAGEMENT; PATHOGENS; COMPOST	Our previous work demonstrated that application of a bio-organic fertilizer (BIO) to a banana mono-culture orchard with serious Fusarium wilt disease effectively decreased the number of soil Fusarium sp. and controlled the soil-borne disease. Because bacteria are an abundant and diverse group of soil organisms that responds to soil health, deep 16 S rRNA pyrosequencing was employed to characterize the composition of the bacterial community to investigate how it responded to BIO or the application of other common composts and to explore the potential correlation between bacterial community, BIO application and Fusarium wilt disease suppression. After basal quality control, 137,646 sequences and 9,388 operational taxonomic units (OTUs) were obtained from the 15 soil samples. Proteobacteria, Acidobacteria, Bacteroidetes, Gemmatimonadetes and Actinobacteria were the most frequent phyla and comprised up to 75.3% of the total sequences. Compared to the other soil samples, BIO-treated soil revealed higher abundances of Gemmatimonadetes and Acidobacteria, while Bacteroidetes were found in lower abundance. Meanwhile, on genus level, higher abundances compared to other treatments were observed for Gemmatimonas and Gp4. Correlation and redundancy analysis showed that the abundance of Gemmatimonas and Sphingomonas and the soil total nitrogen and ammonium nitrogen content were higher after BIO application, and they were all positively correlated with disease suppression. Cumulatively, the reduced Fusarium wilt disease incidence that was seen after BIO was applied for 1-year might be attributed to the general suppression based on a shift within the bacteria soil community, including specific enrichment of Gemmatimonas and Sphingomonas.	[Shen, Zongzhuan; Xue, Chao; Zhang, Jian; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Natl Engn Res Ctr Organ Based Fertilizers,Jiangsu, Nanjing, Jiangsu, Peoples R China; [Ruan, Yunze] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Wang, Dongsheng] Nanjing Inst Vegetable Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Hainan University	Shen, QR (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Natl Engn Res Ctr Organ Based Fertilizers,Jiangsu, Nanjing, Jiangsu, Peoples R China.	shenqirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020		National Natural Science Foundation of China [41101231, 31372142]; Natural Science Foundation of Hainan province [313045]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; Agricultural Ministry of China [201103004]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; China Postdoctoral Science Foundation [2011M501248, 2012T50479, KJ2011007];  [ZDZX2013023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Innovative Research Team Development Plan of the Ministry of Education of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 	This work was supported by the National Natural Science Foundation of China (41101231 and 31372142), Natural Science Foundation of Hainan province (313045), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), 111 project (B12009), the Agricultural Ministry of China (201103004), the Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), the China Postdoctoral Science Foundation (2011M501248 and 2012T50479), and the (KJ2011007) and The Central Financial Support to the Central and Western Nniversities to Specially Enhance the Comprehensive Strength (ZDZX2013023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Balkwill D.L., 2006, PROKARYOTES, P605, DOI DOI 10.1007/0-387-30747-8_23; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bonanomi G, 2007, J PLANT PATHOL, V89, P311; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Butler D, 2013, NATURE, V504, P195, DOI 10.1038/504195a; CHAO A, 1984, SCAND J STAT, V11, P265; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Chen LH, 2011, BIORESOURCE TECHNOL, V102, P3900, DOI 10.1016/j.biortech.2010.11.126; Chen YF, 2013, PLANT PATHOL, V62, P112, DOI 10.1111/j.1365-3059.2012.02620.x; Cotxarrera L, 2002, SOIL BIOL BIOCHEM, V34, P467, DOI 10.1016/S0038-0717(01)00205-X; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El-Hassan SA, 2006, J PHYTOPATHOL, V154, P148, DOI 10.1111/j.1439-0434.2006.01075.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Getha K, 2005, J IND MICROBIOL BIOT, V32, P24, DOI 10.1007/s10295-004-0199-5; Getha K, 2002, J IND MICROBIOL BIOT, V28, P303, DOI [10.1038/sj/jim/7000247, 10.1038/sj.jim.7000247]; Hamel C, 2005, PLANT SOIL, V268, P75, DOI 10.1007/s11104-004-0228-1; Hoper H, 1996, EUR J SOIL BIOL, V32, P41; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kavino M, 2010, APPL SOIL ECOL, V45, P71, DOI 10.1016/j.apsoil.2010.02.003; Kyselkova M, 2009, ISME J, V3, P1127, DOI 10.1038/ismej.2009.61; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leps J., 2005, AUSTRAL ECOL, V86, P6, DOI [10.1890/0012-9623(2005)86[6a:MAOEDU]2.0.CO;2, DOI 10.1111/J.1442-9993.2005.01433.X]; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Mallett KI, 1998, FOREST ECOL MANAG, V105, P37, DOI 10.1016/S0378-1127(97)00294-6; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Oyarzun PJ, 1998, APPL SOIL ECOL, V10, P151, DOI 10.1016/S0929-1393(98)00042-0; Perez-Piqueres A, 2006, SOIL BIOL BIOCHEM, V38, P460, DOI 10.1016/j.soilbio.2005.05.025; Poulsen PHB, 2013, SOIL BIOL BIOCHEM, V57, P784, DOI 10.1016/j.soilbio.2011.12.023; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2012, R LANG ENV STAT COMP; Raguchander T., 1997, Journal of Biological Control, V11, P101; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sanguin H, 2009, NEW PHYTOL, V184, P694, DOI 10.1111/j.1469-8137.2009.03010.x; Saravanan T, 2003, CROP PROT, V22, P1117, DOI 10.1016/S0261-2194(03)00146-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; SIVAMANI E, 1988, PLANT SOIL, V107, P3, DOI 10.1007/BF02371537; Sun HY, 2004, APPL ENVIRON MICROB, V70, P5868, DOI 10.1128/AEM.70.10.5868-5874.2004; Wachowska U, 2013, BIOCONTROL SCI TECHN, V23, P1110, DOI 10.1080/09583157.2013.812185; Wang BB, 2013, BIOL FERT SOILS, V49, P435, DOI 10.1007/s00374-012-0739-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes GR, 2011, GPLOTS VARIOUS R PRO; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Yin CT, 2013, APPL ENVIRON MICROB, V79, P7428, DOI 10.1128/AEM.01610-13; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010	52	80	89	4	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98420	10.1371/journal.pone.0098420	http://dx.doi.org/10.1371/journal.pone.0098420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871319	Green Published, gold, Green Submitted			2022-12-27	WOS:000336858300043
J	Echevarria-Vargas, IM; Valiyeva, F; Vivas-Mejia, PE				Echevarria-Vargas, Ileabett M.; Valiyeva, Fatma; Vivas-Mejia, Pablo E.			Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway	PLOS ONE			English	Article							CARCINOMA CELL-LINES; MIGRATION ABILITIES; PROMOTES APOPTOSIS; ANTITUMOR-ACTIVITY; INHIBITS INVASION; DOWN-REGULATION; BREAST-CANCER; AP-1 ACTIVITY; EXPRESSION; MICRORNA	Cisplatin has been the most accepted drug for the treatment of ovarian cancer for almost 40 years. Although the majority of patients with ovarian cancer respond to front-line platinum combination chemotherapy, many patients will develop cisplatin-resistance disease, which is extremely rapid and fatal. Although various mechanisms of cisplatin resistance have been postulated, the key molecules involved in such resistance have not been identified. MiRNAs are endogenously expressed small non-coding RNAs, which are evolutionarily conserved and function as post-transcriptional regulators of gene expression. Dysregulation of miRNAs have been associated with cancer initiation, progression and drug resistance. The oncogenic miRNA-21, one of the best-studied miRNAs, is upregulated in almost all human cancers. However, the regulation of miR-21 in cisplatin resistant ovarian cancer cells has not been assessed. In this study, we measured the miR-21 expression by real-time PCR and found upregulation of miR-21 in cisplatin resistant compared with cisplatin sensitive ovarian cancer cells. Chromatin immunoprecipitation studies demonstrated the association of the c-Jun transcription factor to the pri-mir-21 DNA promoter regions. Blocking the JNK-1, the major activator of c-Jun phosphorylation, reduced the expression of pre-mir-21 and increased the expression of its well-known target gene, PDCD4. Overexpression of miR-21 in cisplatin sensitive cells decreased PDCD4 levels and increased cell proliferation. Finally, targeting miR-21 reduced cell growth, proliferation and invasion of cisplatin resistant ovarian cancer cells. These results suggest that the JNK-1/c-Jun/miR-21 pathway contributes to the cisplatin resistance of ovarian cancer cells and demonstrated that miR-21 is a plausible target to overcome cisplatin resistance.	[Echevarria-Vargas, Ileabett M.; Valiyeva, Fatma; Vivas-Mejia, Pablo E.] Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA; [Echevarria-Vargas, Ileabett M.; Vivas-Mejia, Pablo E.] Univ Puerto Rico, Dept Biochem, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	Vivas-Mejia, PE (corresponding author), Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA.	pablo.vivas@upr.edu			NIH/NCI [1K22CA166226-01A1]; University of Puerto Rico Comprehensive Cancer Center; National Institute of Health; Minority Biomedical Research Support (MBRS) RISE Grant [R25-GM061838 (IEV)]; NATIONAL CANCER INSTITUTE [K22CA166226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008149] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Puerto Rico Comprehensive Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minority Biomedical Research Support (MBRS) RISE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported partially by the NIH/NCI (1K22CA166226-01A1) to PEVM, institutional seed funds from the University of Puerto Rico Comprehensive Cancer Center (PEVM), National Institute of Health, and Minority Biomedical Research Support (MBRS) RISE Grant Number R25-GM061838 (IEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Apte SM, 2004, GYNECOL ONCOL, V93, P78, DOI 10.1016/j.ygyno.2003.12.041; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; BEHRENS BC, 1987, CANCER RES, V47, P414; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Chen Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-86; Chen Y, 2012, J PEDIATR SURG, V47, P1797, DOI 10.1016/j.jpedsurg.2012.05.013; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Di Leva G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00153; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kikuchi Y, 2001, Hum Cell, V14, P115; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Lou YH, 2011, CLIN INVEST MED, V34, pE281, DOI 10.25011/cim.v34i5.15671; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skilling JS, 1996, GYNECOL ONCOL, V60, P72, DOI 10.1006/gyno.1996.0014; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Sood AK, 2001, AM J PATHOL, V158, P1279, DOI 10.1016/S0002-9440(10)64079-5; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vargas IME, 2013, METHODS MOL BIOL, V1049, P171, DOI 10.1007/978-1-62703-547-7_13; Vasey PA, 2003, BRIT J CANCER, V89, pS23, DOI 10.1038/sj.bjc.6601497; Vivas-Mejia P, 2010, CLIN CANCER RES, V16, P184, DOI 10.1158/1078-0432.CCR-09-1180; Vivas-Mejia PE, 2011, CLIN CANCER RES, V17, P3716, DOI 10.1158/1078-0432.CCR-11-0233; Vivas-Mejia PE, 2009, INT J CANCER, V125, P264, DOI 10.1002/ijc.24341; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xie Z, 2013, ONCOL LETT, V6, P795, DOI 10.3892/ol.2013.1432; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	51	87	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97094	10.1371/journal.pone.0097094	http://dx.doi.org/10.1371/journal.pone.0097094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865582	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100010
J	Eshraghi, A; Abu Osman, NA; Karimi, M; Gholizadeh, H; Soodmand, E; Abas, WAW				Eshraghi, Arezoo; Abu Osman, Noor Azuan; Karimi, Mohammad; Gholizadeh, Hossein; Soodmand, Ehsan; Abas, Wan Abu Bakar Wan			Gait Biomechanics of Individuals with Transtibial Amputation: Effect of Suspension System	PLOS ONE			English	Article							LOWER-LIMB AMPUTEES; PATELLAR TENDON BEARING; BELOW-KNEE AMPUTEES; PROSTHETIC COMPONENTS; INTERFACE PRESSURE; DEVIATION INDEX; WALKING; SOCKET; LINER; FOOT	Prosthetic suspension system is an important component of lower limb prostheses. Suspension efficiency can be best evaluated during one of the vital activities of daily living, i.e. walking. A new magnetic prosthetic suspension system has been developed, but its effects on gait biomechanics have not been studied. This study aimed to explore the effect of suspension type on kinetic and kinematic gait parameters during level walking with the new suspension system as well as two other commonly used systems (the Seal-In and pin/lock). Thirteen persons with transtibial amputation participated in this study. A Vicon motion system (six cameras, two force platforms) was utilized to obtain gait kinetic and kinematic variables, as well as pistoning within the prosthetic socket. The gait deviation index was also calculated based on the kinematic data. The findings indicated significant difference in the pistoning values among the three suspension systems. The Seal-In system resulted in the least pistoning compared with the other two systems. Several kinetic and kinematic variables were also affected by the suspension type. The ground reaction force data showed that lower load was applied to the limb joints with the magnetic suspension system compared with the pin/lock suspension. The gait deviation index showed significant deviation from the normal with all the systems, but the systems did not differ significantly. Main significant effects of the suspension type were seen in the GRF (vertical and fore-aft), knee and ankle angles. The new magnetic suspension system showed comparable effects in the remaining kinetic and kinematic gait parameters to the other studied systems. This study may have implications on the selection of suspension systems for transtibial prostheses.	[Eshraghi, Arezoo] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Abu Osman, Noor Azuan; Gholizadeh, Hossein; Abas, Wan Abu Bakar Wan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Karimi, Mohammad] Isfahan Univ Med Sci, Dept Orthot & Prosthet, Esfahan, Iran; [Soodmand, Ehsan] Tech Univ Chemnitz, Dept Human Locomot, D-09111 Chemnitz, Germany	Universiti Malaya; Universiti Malaya; Isfahan University Medical Science; Technische Universitat Chemnitz	Eshraghi, A (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	arezooeshraghi@yahoo.ca	ABU OSMAN, NOOR AZUAN/B-9265-2010; Gholizadeh, Hossein/G-4838-2010; Karimi, Mohammad Taghi/AFQ-0990-2022; Soodmand, Ehsan/H-5820-2017	ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Gholizadeh, Hossein/0000-0001-5847-7985; Karimi, Mohammad Taghi/0000-0001-6162-8131; Eshraghi, Arezoo/0000-0002-1525-8093; Soodmand, Ehsan/0000-0002-4409-7663	Malaysia UM/MOHE/HIR [D000014-16001]; FRGS [FP017-2011A]	Malaysia UM/MOHE/HIR; FRGS	This study was supported by Malaysia UM/MOHE/HIR (Project Number:D000014-16001) and FRGS grant (FP017-2011A). http://www.hir.um.edu.my/http://susci.um.edu.my/?modul=Grants&pilihan=External_Grants&subpilihan=Fundamental_Research_Grant_Scheme_(FRGS). Some of the prosthetic components were donated by Ossur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, CLIN BIOMECH, V27, P943, DOI 10.1016/j.clinbiomech.2012.06.004; BAKER PA, 1990, PROSTHET ORTHOT INT, V14, P80; BATENI H, 2002, J PROSTHET ORTHOT, V14, P2; Boutwell E, 2012, J REHABIL RES DEV, V49, P227, DOI 10.1682/JRRD.2010.06.0121; BREAKEY J, 1976, ORTHOTICS PROSTHET, V30, P17; CHEUNG C, 1983, PROSTHET ORTHOT INT, V7, P131; Cimolin V, 2011, RES DEV DISABIL, V32, P377, DOI 10.1016/j.ridd.2010.10.017; COLBORNE GR, 1992, AM J PHYS MED REHAB, V71, P272, DOI 10.1097/00002060-199210000-00004; Dingwell JB, 1996, PROSTHET ORTHOT INT, V20, P101; ENGSBERG JR, 1993, PROSTHET ORTHOT INT, V17, P83; Eshraghi A, 2013, CLIN BIOMECH, V28, P55, DOI 10.1016/j.clinbiomech.2012.10.002; Eshraghi A, 2012, AM J PHYS MED REHAB, V91, P1028, DOI 10.1097/PHM.0b013e318269d82a; Eshraghi A, 2012, PROSTHET ORTHOT INT, V36, P15, DOI 10.1177/0309364611431625; Farahmand F, 2006, SCI IRAN, V13, P261; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Gholizadeh H, 2012, CLIN BIOMECH, V27, P34, DOI 10.1016/j.clinbiomech.2011.07.004; Goujon H, 2006, PROSTHET ORTHOT INT, V30, P213, DOI 10.1080/03093640600805134; Hachisuka K, 1998, ARCH PHYS MED REHAB, V79, P783, DOI 10.1016/S0003-9993(98)90356-2; Isakov E, 2000, PROSTHET ORTHOT INT, V24, P216, DOI 10.1080/03093640008726550; Kark L, 2012, GAIT POSTURE, V35, P238, DOI 10.1016/j.gaitpost.2011.09.013; KRISTINSSON O, 1993, PROSTHET ORTHOT INT, V17, P49, DOI 10.3109/03093649309164354; LEMAIRE ED, 1994, ARCH PHYS MED REHAB, V75, P1094, DOI 10.1016/0003-9993(94)90084-1; Meier, 1991, J PROSTHET ORTHOT, V3, P150; Melzer I, 2001, J RHEUMATOL, V28, P169; Narita H, 1997, PROSTHET ORTHOT INT, V21, P175; Nolan L, 2000, PROSTHET ORTHOT INT, V24, P117, DOI 10.1080/03093640008726534; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Silverman AK, 2008, GAIT POSTURE, V28, P602, DOI 10.1016/j.gaitpost.2008.04.005; SKINNER HB, 1985, AM J PHYS MED REHAB, V64, P82; Smidt GL, 1990, GAIT REHABILITATION; Stergiou N, 2002, CLIN BIOMECH, V17, P615, DOI 10.1016/S0268-0033(02)00072-4; Supan T., 2010, J PROSTHET ORTHOT, V22, P43; TORBURN L, 1990, Journal of Rehabilitation Research and Development, V27, P369; van der Linden ML, 1999, J BIOMECH, V32, P877, DOI 10.1016/S0021-9290(99)00086-X; Vanicek N, 2009, GAIT POSTURE, V29, P415, DOI 10.1016/j.gaitpost.2008.10.062; WINTER DA, 1988, J BIOMECH, V21, P361, DOI 10.1016/0021-9290(88)90142-X; Winter DA., 1987, BIOMECHANICS MOTOR C; Yigiter K, 2002, PROSTHET ORTHOT INT, V26, P206, DOI 10.1080/03093640208726649; Zmitrewicz RJ, 2006, ARCH PHYS MED REHAB, V87, P1334, DOI 10.1016/j.apmr.2006.06.013	40	15	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96988	10.1371/journal.pone.0096988	http://dx.doi.org/10.1371/journal.pone.0096988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865351	Green Published, Green Submitted, gold			2022-12-27	WOS:000336914100008
J	Harada-Hada, K; Harada, K; Kato, F; Hisatsune, J; Tanida, I; Ogawa, M; Asano, S; Sugai, M; Hirata, M; Kanematsu, T				Harada-Hada, Kae; Harada, Kana; Kato, Fuminori; Hisatsune, Junzo; Tanida, Isei; Ogawa, Michinaga; Asano, Satoshi; Sugai, Motoyuki; Hirata, Masato; Kanematsu, Takashi			Phospholipase C-Related Catalytically Inactive Protein Participates in the Autophagic Elimination of Staphylococcus aureus Infecting Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							INS(1,4,5)P-3 BINDING-PROTEIN; GABA(A) RECEPTOR; BACTERIAL PATHOGENS; SURFACE EXPRESSION; CELL-SURFACE; P130; PRIP; INHIBITION; MODULATION; MATURATION	Autophagy is an intrinsic host defense system that recognizes and eliminates invading bacterial pathogens. We have identified microtubule-associated protein 1 light chain 3 (LC3), a hallmark of autophagy, as a binding partner of phospholipase C-related catalytically inactive protein (PRIP) that was originally identified as an inositol trisphosphate-binding protein. Here, we investigated the involvement of PRIP in the autophagic elimination of Staphylococcus aureus in infected mouse embryonic fibroblasts (MEFs). We observed significantly more LC3-positive autophagosome-like vacuoles enclosing an increased number of S. aureus cells in PRIP-deficient MEFs than control MEFs, 3 h and 4.5 h post infection, suggesting that S. aureus proliferates in LC3-positive autophagosome-like vacuoles in PRIP-deficient MEFs. We performed autophagic flux analysis using an mRFP-GFP-tagged LC3 plasmid and found that autophagosome maturation is significantly inhibited in PRIP-deficient MEFs. Furthermore, acidification of autophagosomes was significantly inhibited in PRIP-deficient MEFs compared to the wild-type MEFs, as determined by LysoTracker staining and time-lapse image analysis performed using mRFP-GFP-tagged LC3. Taken together, our data show that PRIP is required for the fusion of S. aureus-containing autophagosome-like vacuoles with lysosomes, indicating that PRIP is a novel modulator in the regulation of the innate immune system in non-professional phagocytic host cells.	[Harada-Hada, Kae; Harada, Kana; Asano, Satoshi; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan; [Kato, Fuminori; Hisatsune, Junzo; Sugai, Motoyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Bacteriol, Hiroshima, Japan; [Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Ogawa, Michinaga] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan	Hiroshima University; Hiroshima University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kyushu University	Kanematsu, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan.	tkanema2@hiroshima-u.ac.jp	Asano, Satoshi/AAQ-3817-2020; Harada, Kae/AAT-1162-2020; Kato, Fuminori/V-2948-2017	Harada, Kae/0000-0001-7620-9212; Kato, Fuminori/0000-0001-8177-1728; Asano, Satoshi/0000-0003-1537-4307; Tanida, Isei/0000-0001-8999-3990	Funding Program for Next Generation World-Leading Researchers [LS087]; JSPS KAKENHI [25861757, 25861756]; Grants-in-Aid for Scientific Research [25460533, 26670809, 25861757] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funding from the Funding Program for Next Generation World-Leading Researchers (LS087) to T. K., and by JSPS KAKENHI (Grant No. 25861757 to K. H-H., Grant No. 25861756 to S. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Krut O, 2003, INFECT IMMUN, V71, P2716, DOI 10.1128/IAI.71.5.2716-2723.2003; Lerena MC, 2010, CELL MICROBIOL, V12, P10, DOI 10.1111/j.1462-5822.2009.01403.x; Mauthe Mario, 2012, Int J Cell Biol, V2012, P179207, DOI 10.1155/2012/179207; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Orsi A, 2010, CURR OPIN CELL BIOL, V22, P150, DOI 10.1016/j.ceb.2009.11.013; Otsuki M, 1999, BIOCHEM BIOPH RES CO, V266, P97, DOI 10.1006/bbrc.1999.1784; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Umebayashi H, 2013, BIOCHEM BIOPH RES CO, V432, P268, DOI 10.1016/j.bbrc.2013.01.119; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317	45	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98285	10.1371/journal.pone.0098285	http://dx.doi.org/10.1371/journal.pone.0098285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865216	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100047
J	Plieninger, T; Hui, C; Gaertner, M; Huntsinger, L				Plieninger, Tobias; Hui, Cang; Gaertner, Mirijam; Huntsinger, Lynn			The Impact of Land Abandonment on Species Richness and Abundance in the Mediterranean Basin: A Meta-Analysis	PLOS ONE			English	Article							ALIEN PLANT INVASIONS; AGRICULTURAL LAND; BIODIVERSITY; DIVERSITY; CONSEQUENCES; LANDSCAPES; MANAGEMENT; SYSTEMS; ECOSYSTEMS; INDICATORS	Land abandonment is common in the Mediterranean Basin, a global biodiversity hotspot, but little is known about its impacts on biodiversity. To upscale existing case-study insights to the Pan-Mediterranean level, we conducted a meta-analysis of the effects of land abandonment on plant and animal species richness and abundance in agroforestry, arable land, pastures, and permanent crops of the Mediterranean Basin. In particular, we investigated (1) which taxonomic groups (arthropods, birds, lichen, vascular plants) are more affected by land abandonment; (2) at which spatial and temporal scales the effect of land abandonment on species richness and abundance is pronounced; (3) whether previous land use and current protected area status affect the magnitude of changes in the number and abundance of species; and (4) how prevailing landforms and climate modify the impacts of land abandonment. After identifying 1240 potential studies, 154 cases from 51 studies that offered comparisons of species richness and abundance and had results relevant to our four areas of investigation were selected for meta-analysis. Results are that land abandonment showed slightly increased (effect size = 0.2109, P<0.0001) plant and animal species richness and abundance overall, though results were heterogeneous, with differences in effect size between taxa, spatial-temporal scales, land uses, landforms, and climate. In conclusion, there is no "one-size-fits-all'' conservation approach that applies to the diverse contexts of land abandonment in the Mediterranean Basin. Instead, conservation policies should strive to increase awareness of this heterogeneity and the potential trade-offs after abandonment. The strong role of factors at the farm and landscape scales that was revealed by the analysis indicates that purposeful management at these scales can have a powerful impact on biodiversity.	[Plieninger, Tobias] Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark; [Hui, Cang; Gaertner, Mirijam] Univ Stellenbosch, Dept Math Sci, Ctr Invas Biol, Matieland, South Africa; [Hui, Cang] African Inst Math Sci, Cape Town, South Africa; [Huntsinger, Lynn] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of Copenhagen; Stellenbosch University; University of California System; University of California Berkeley	Plieninger, T (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Frederiksberg, Denmark.	tobias.plieninger@ign.ku.dk	Huntsinger, Lynn/G-5453-2011; Plieninger, Tobias/E-3861-2010; Hui, Cang/A-1781-2008	Huntsinger, Lynn/0000-0001-9444-4152; Plieninger, Tobias/0000-0003-1478-2587; Hui, Cang/0000-0002-3660-8160	German Ministry of Education and Research [FKZ 01UU0904A]; European Community [603447]; DST-NRF Centre of Excellence for Invasion Biology	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community(European Commission); DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India))	T.P. has received funding from the German Ministry of Education and Research (FKZ 01UU0904A) and the European Community's Seventh Framework Programme under Grant Agreement No. 603447 (Project HERCULES). M. G. acknowledges support from the DST-NRF Centre of Excellence for Invasion Biology. The funding sources are not involved in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the article for publication.	[Anonymous], 2007, OLD FIELDS; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Bignal Eric M., 2000, Environmental Reviews, V8, P149, DOI 10.1139/a00-009; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Blondel J, 2010, MEDITERRANEAN REGION; Bonet A, 2007, OLD FIELDS DYNAMICS, P247; BOSSARD M, 2000, CORINE LAND COVER TE; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Centre for Evidence-Based Conservation, 2010, GUID SYST REV ENV MA; Cocca G, 2012, LAND USE POLICY, V29, P878, DOI 10.1016/j.landusepol.2012.01.005; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Cuttelod A., 2008, 2008 REV IUCN RED LI; Davis M. A., 2009, INVASION BIOL; Felton A, 2010, BIOL CONSERV, V143, P545, DOI 10.1016/j.biocon.2009.11.030; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gondard H, 2001, BIODIVERS CONSERV, V10, P189, DOI 10.1023/A:1008997625523; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grashof-Bokdam CJ, 2005, LANDSCAPE ECOL, V20, P417, DOI 10.1007/s10980-004-5646-1; Grove A. T., 2001, NATURE MEDITERRANEAN, DOI 10.1002/ESP.247; Henrichs T., 2010, ECOSYSTEMS HUMAN WEL, P151; Humbert JY, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-9; Keenleyside C., 2010, FARMLAND ABANDONMENT; LAVOREL S, 1994, OIKOS, V70, P455, DOI 10.2307/3545786; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Magurran A.E, 2004, MEASURING BIOL DIVER; Mazzoleni S., 2004, RECENT DYNAMICS MEDI; Mottet A, 2006, AGR ECOSYST ENVIRON, V114, P296, DOI 10.1016/j.agee.2005.11.017; Munroe DK, 2013, CURR OPIN ENV SUST, V5, P471, DOI 10.1016/j.cosust.2013.06.010; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Neeman G, 1996, J VEG SCI, V7, P465, DOI 10.2307/3236294; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Oppermann R., 2012, HIGH NATURE VALUE FA; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Papanatasis VP., 2007, OLD FIELDS DYNAMICS, P225; Pauchard A, 2004, DIVERS DISTRIB, V10, P371, DOI 10.1111/j.1366-9516.2004.00116.x; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Peco B, 2006, AGR ECOSYST ENVIRON, V113, P284, DOI 10.1016/j.agee.2005.09.017; Peco B, 2012, AGR ECOSYST ENVIRON, V152, P27, DOI 10.1016/j.agee.2012.02.009; Pereira E., 2005, Ecology and Society, V10, P14; Perevolotsky A, 1998, BIOSCIENCE, V48, P1007, DOI 10.2307/1313457; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; PICKETT S T A, 1989, P110; Plexida SG, 2012, ISR J ECOL EVOL, V58, P1, DOI 10.1560/IJEE.58.1.1; Plieninger T, 2014, ECOLOGY SOC IN PRESS; Plieninger T, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-3; Plieninger T, 2013, ECOL SOC, V18, DOI 10.5751/ES-05877-180420; Plieninger T, 2011, REG ENVIRON CHANGE, V11, P603, DOI 10.1007/s10113-010-0192-7; Plieninger T, 2011, J NAT CONSERV, V19, P18, DOI 10.1016/j.jnc.2010.04.001; Pointereau P., 2008, ANAL FARMLAND ABANDO; Queiroz AI, 2013, THESIS STOCKHOLM U S; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Renwick A, 2013, LAND USE POLICY, V30, P446, DOI 10.1016/j.landusepol.2012.04.005; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Santos-Martin F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073249; Sax DF, 2005, OIKOS, V108, P457, DOI 10.1111/j.0030-1299.2005.13402.x; Schaich H, 2013, FOREST ECOL MANAG, V305, P146, DOI 10.1016/j.foreco.2013.05.013; Sikor T, 2013, CURR OPIN ENV SUST, V5, P522, DOI 10.1016/j.cosust.2013.06.006; Sirami C, 2008, BIOL CONSERV, V141, P450, DOI 10.1016/j.biocon.2007.10.015; Sluiter R, 2007, LANDSCAPE ECOL, V22, P559, DOI 10.1007/s10980-006-9049-3; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Tarrega R, 2009, FOREST ECOL MANAG, V257, P731, DOI 10.1016/j.foreco.2008.10.004; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Weissteiner CJ, 2011, GLOBAL PLANET CHANGE, V79, P20, DOI 10.1016/j.gloplacha.2011.07.009; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492	72	136	141	4	231	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98355	10.1371/journal.pone.0098355	http://dx.doi.org/10.1371/journal.pone.0098355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865979	gold, Green Published, Green Submitted			2022-12-27	WOS:000336914100053
J	Botto, L; Cunati, D; Coco, S; Sesana, S; Bulbarelli, A; Biasini, E; Colombo, L; Negro, A; Chiesa, R; Masserini, M; Palestini, P				Botto, Laura; Cunati, Diana; Coco, Silvia; Sesana, Silvia; Bulbarelli, Alessandra; Biasini, Emiliano; Colombo, Laura; Negro, Alessandro; Chiesa, Roberto; Masserini, Massimo; Palestini, Paola			Role of Lipid Rafts and GM1 in the Segregation and Processing of Prion Protein	PLOS ONE			English	Article							INFECTED NEUROBLASTOMA-CELLS; RESISTANT MEMBRANE DOMAINS; CEREBELLAR GRANULE CELLS; ENRICHED DOMAINS; CULTURED NEURONS; GANGLIOSIDE GM1; CHOLERA-TOXIN; SURFACE; PRP; PH	The prion protein (PrPC) is highly expressed within the nervous system. Similar to other GPI-anchored proteins, PrPC is found in lipid rafts, membrane domains enriched in cholesterol and sphingolipids. PrPC raft association, together with raft lipid composition, appears essential for the conversion of PrPC into the scrapie isoform PrPSc, and the development of prion disease. Controversial findings were reported on the nature of PrPC-containing rafts, as well as on the distribution of PrPC between rafts and non-raft membranes. We investigated PrPC/ganglioside relationships and their influence on PrPC localization in a neuronal cellular model, cerebellar granule cells. Our findings argue that in these cells at least two PrPC conformations coexist: in lipid rafts PrPC is present in the native folding (alpha-helical), stabilized by chemico-physical condition, while it is mainly present in other membrane compartments in a PrPSc-like conformation. We verified, by means of antibody reactivity and circular dichroism spectroscopy, that changes in lipid raft-ganglioside content alters PrPC conformation and interaction with lipid bilayers, without modifying PrPC distribution or cleavage. Our data provide new insights into the cellular mechanism of prion conversion and suggest that GM1-prion protein interaction at the cell surface could play a significant role in the mechanism predisposing to pathology.	[Botto, Laura; Cunati, Diana; Coco, Silvia; Sesana, Silvia; Bulbarelli, Alessandra; Masserini, Massimo; Palestini, Paola] Univ Milano Bicocca, Sch Med, Dept Hlth Sci, Monza, Italy; [Biasini, Emiliano; Chiesa, Roberto] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Colombo, Laura] IRCCS Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Negro, Alessandro] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Milano-Bicocca; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Padua	Botto, L (corresponding author), Univ Milano Bicocca, Sch Med, Dept Hlth Sci, Monza, Italy.	laura.botto@unimib.it	Coco, Silvia/AAD-6719-2022; colombo, laura/AAA-6716-2020; Chiesa, Roberto/G-1561-2017; Palestini, PAOLA/AAD-9376-2019; Biasini, Emiliano/A-3147-2011	colombo, laura/0000-0002-3243-0270; Chiesa, Roberto/0000-0002-3842-3733; Palestini, PAOLA/0000-0002-1045-8838; Biasini, Emiliano/0000-0002-3927-6341; COCO, SILVIA/0000-0002-3883-9472; NEGRO, ALESSANDRO/0000-0003-3142-7632	MIUR (Rome, Italy) [200833SZ2F]; FAR	MIUR (Rome, Italy)(Ministry of Education, Universities and Research (MIUR)); FAR	This investigation was supported by grants from MIUR (Rome, Italy) Prin 2008 (prot. 200833SZ2F) and FAR 60% 2010-2011 to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alonso DOV, 2002, PHILOS T R SOC A, V360, P1165, DOI 10.1098/rsta.2002.0986; Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Biljan I, 2012, BIOCHEMISTRY-US, V51, P7465, DOI 10.1021/bi3009856; Botto L, 2007, J NEUROSCI RES, V85, P443, DOI 10.1002/jnr.21111; Botto L, 2004, FEBS LETT, V557, P143, DOI 10.1016/S0014-5793(03)01463-7; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Campana V, 2006, J CELL SCI, V119, P433, DOI 10.1242/jcs.02768; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Cancellotti E, 2013, EMBO J, V32, P756, DOI 10.1038/emboj.2013.6; Castilla J, 2011, CHEM BIOL, V18, P1345, DOI 10.1016/j.chembiol.2011.11.002; Chigorno V, 2000, EUR J BIOCHEM, V267, P4187, DOI 10.1046/j.1432-1327.2000.01454.x; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cordes H, 2008, J IMMUNOL METHODS, V337, P106, DOI 10.1016/j.jim.2008.07.004; Daffara R, 2004, J APPL PHYSIOL, V97, P1575, DOI 10.1152/japplphysiol.00236.2004; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Eckert GP, 2003, BRAIN RES, V962, P144, DOI 10.1016/S0006-8993(02)03986-0; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Farina F, 2009, J NEUROCHEM, V110, P1038, DOI 10.1111/j.1471-4159.2009.06198.x; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GHIDONI R, 1981, J LIPID RES, V22, P1286; GHIDONI R, 1989, J NEUROCHEM, V53, P1567, DOI 10.1111/j.1471-4159.1989.tb08553.x; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; GONATAS NK, 1983, MOL CELL BIOL, V3, P91, DOI 10.1128/MCB.3.1.91; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; Hooper NM, 2005, BIOCHEM SOC T, V33, P335, DOI 10.1042/BST0330335; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Jeong JK, 2012, INT J MOL MED, V29, P387, DOI 10.3892/ijmm.2011.864; JOSEPH KC, 1979, J CELL BIOL, V81, P543, DOI 10.1083/jcb.81.3.543; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Korth C, 1999, METHOD ENZYMOL, V309, P106; Kubota T, 2012, J BIOL CHEM, V287, P14023, DOI 10.1074/jbc.M111.318352; Kupfer L, 2009, CURR MOL MED, V9, P826, DOI 10.2174/156652409789105543; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Moore MK, 2000, ANAL BIOCHEM, V279, P241, DOI 10.1006/abio.2000.4482; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Naslavsky N, 1999, J BIOL CHEM, V274, P20763, DOI 10.1074/jbc.274.30.20763; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Palestini P, 1998, BIOCHEMISTRY-US, V37, P3143, DOI 10.1021/bi971838a; Palestini P, 2000, J BIOL CHEM, V275, P9978, DOI 10.1074/jbc.275.14.9978; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Re F, 2008, FEBS LETT, V582, P215, DOI 10.1016/j.febslet.2007.12.003; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Sanghera N, 2011, CHEM BIOL, V18, P1422, DOI 10.1016/j.chembiol.2011.08.016; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1999, MOL BIOL CELL, V10, P3187, DOI 10.1091/mbc.10.10.3187; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Vila-Vicosa D, 2012, J PHYS CHEM B, V116, P8812, DOI 10.1021/jp3034837; Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	72	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98344	10.1371/journal.pone.0098344	http://dx.doi.org/10.1371/journal.pone.0098344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859148	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400068
J	Zhang, KW; Liu, HH; Tao, PL; Chen, H				Zhang, Kewei; Liu, Hanhan; Tao, Peilin; Chen, Huan			Comparative Proteomic Analyses Provide New Insights into Low Phosphorus Stress Responses in Maize Leaves	PLOS ONE			English	Article							GLYCINEBETAINE SYNTHESIS; TRANSCRIPTOMIC ANALYSIS; PHOSPHATE DEFICIENCY; ARABIDOPSIS ROOTS; HYDROGEN-PEROXIDE; METABOLIC-CHANGES; SUSPENSION CELLS; RICE LEAVES; PHOTOSYNTHESIS; PLANTS	Phosphorus deficiency limits plant growth and development. To better understand the mechanisms behind how maize responds to phosphate stress, we compared the proteome analysis results of two groups of maize leaves that were treated separately with 1,000 mu M (control, +P) and 5 mu M of KH2PO4 (intervention group, -P) for 25 days. In total, 1,342 protein spots were detected on 2-DE maps and 15.43% had changed (P < 0.05; >= 1.5-fold) significantly in quantity between the +P and -P groups. These proteins are involved in several major metabolic pathways, including photosynthesis, carbohydrate metabolism, energy metabolism, secondary metabolism, signal transduction, protein synthesis, cell rescue and cell defense and virulence. The results showed that the reduction in photosynthesis under low phosphorus treatment was due to the down-regulation of the proteins involved in CO2 enrichment, the Calvin cycle and the electron transport system. Electron transport and photosynthesis restrictions resulted in a large accumulation of peroxides. Maize has developed many different reactive oxygen species (ROS) scavenging mechanisms to cope with low phosphorus stress, including up-regulating its antioxidant content and antioxidase activity. After being subjected to phosphorus stress over a long period, maize may increase its internal phosphorus utilization efficiency by altering photorespiration, starch synthesis and lipid composition. These results provide important information about how maize responds to low phosphorus stress.	[Zhang, Kewei; Liu, Hanhan; Chen, Huan] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Enhancement, Jinan 250100, Peoples R China; [Tao, Peilin] Xuzhou Biol Engn Tech Coll, Coll Agr Vocat, Xuzhou, Peoples R China	Shandong University	Zhang, KW (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Enhancement, Jinan 250100, Peoples R China.	zhangkw@sdu.edu.cn	zhang, ke/AAH-8217-2019		National Natural Science Foundation of China [31172028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31172028) (http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2009, ELECTROPHORESIS, V30, P1594, DOI 10.1002/elps.200800549; Alexova R, 2013, PROTEOMICS, V13, P609, DOI 10.1002/pmic.201200266; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 1992, CROP PHOTOSYNTHESIS, P289; Bozzo GG, 2006, PLANT CELL ENVIRON, V29, P303, DOI 10.1111/j.1365-3040.2005.01422.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chen ZJ, 2011, PROTEOMICS, V11, P4648, DOI 10.1002/pmic.201100231; Cordell D, 2011, CHEMOSPHERE, V84, P77; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Fan GH, 2005, MODERN INSTRUMENTS, V3, P34; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; FOYER C, 1986, PLANTA, V167, P369, DOI 10.1007/BF00391341; Grundy FJ, 2004, CURR OPIN MICROBIOL, V7, P126, DOI 10.1016/j.mib.2004.02.013; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hammond JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024606; Hammond JP, 2004, ANN BOT-LONDON, V94, P323, DOI 10.1093/aob/mch156; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Hernandez G, 2007, PLANT PHYSIOL, V144, P752, DOI 10.1104/pp.107.096958; Igarashi D, 2003, PLANT J, V33, P975, DOI 10.1046/j.1365-313X.2003.01688.x; JACOB J, 1992, PLANT PHYSIOL, V98, P801, DOI 10.1104/pp.98.3.801; Katam R, 2010, J PROTEOME RES, V9, P2236, DOI 10.1021/pr901009n; Kern J, 2009, ADV PHOTOSYNTH RESP, V30, P203; Kim SG, 2011, J KOREAN SOC APPL BI, V54, P667, DOI 10.3839/jksabc.2011.102; Kim ST, 2001, ELECTROPHORESIS, V22, P2103, DOI 10.1002/1522-2683(200106)22:10&lt;2103::AID-ELPS2103&gt;3.0.CO;2-W; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Lee SK, 2008, PLANT CELL ENVIRON, V31, P1851, DOI 10.1111/j.1365-3040.2008.01890.x; Li KP, 2008, PLANT J, V55, P927, DOI 10.1111/j.1365-313X.2008.03561.x; Li KP, 2007, PROTEOMICS, V7, P1501, DOI 10.1002/pmic.200600960; Li KP, 2007, PLANT SCI, V172, P255, DOI 10.1016/j.plantsci.2006.09.004; Li KP, 2011, GENE, V485, P106, DOI 10.1016/j.gene.2011.06.016; Li LH, 2010, CHINESE SCI BULL, V55, P251, DOI 10.1007/s11434-010-0012-y; Lin WY, 2009, J EXP BOT, V60, P1427, DOI 10.1093/jxb/ern303; Lutts S., 2013, ECOPHYSIOLOGY RESPON, P315, DOI [DOI 10.1007/978-1-4614-4747-4_12, 10.1007/978-1-4614-4747-4_12]; Lv S, 2007, MOL BREEDING, V20, P233, DOI 10.1007/s11032-007-9086-x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Mouillon JM, 1999, PLANT J, V20, P197, DOI 10.1046/j.1365-313x.1999.00591.x; MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; PREISS J, 1984, TRENDS BIOCHEM SCI, V9, P24, DOI 10.1016/0968-0004(84)90043-4; Quan RD, 2004, PLANT SCI, V166, P141, DOI 10.1016/j.plantsci.2003.08.018; RAO IM, 1989, PLANT PHYSIOL, V90, P814, DOI 10.1104/pp.90.3.814; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Sawada S, 2003, PLANT CELL PHYSIOL, V44, P190, DOI 10.1093/pcp/pcg024; Shanghai Plant Physiology Association, 1999, HDB PLANT PHYS EXP, P126; Shimojima M, 2011, PROG LIPID RES, V50, P234, DOI 10.1016/j.plipres.2011.02.003; SINGH P, 1986, PHYSIOL PLANTARUM, V66, P169, DOI 10.1111/j.1399-3054.1986.tb01252.x; Suriyagoda LDB, 2010, FUNCT PLANT BIOL, V37, P713, DOI 10.1071/FP09284; Torabi S, 2009, PROTEOMICS, V9, P159, DOI 10.1002/pmic.200800350; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55, DOI DOI 10.1021/ja00874a010; Wang DF, 2008, PLANT PHYSIOL, V148, P557, DOI 10.1104/pp.108.120709; Wang LS, 2012, PLANT CELL PHYSIOL, V53, P1093, DOI 10.1093/pcp/pcs072; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wissuwa M, 2005, J EXP BOT, V56, P1943, DOI 10.1093/jxb/eri189; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yao YA, 2011, PLANTA, V233, P523, DOI 10.1007/s00425-010-1311-x; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P1159, DOI 10.1073/pnas.0308215100; Zhang HW, 2009, PLANT SOIL, V320, P91, DOI 10.1007/s11104-008-9873-0; Zhao CF, 2005, PROTEOMICS, V5, P961, DOI 10.1002/pmic.200401131	73	95	97	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98215	10.1371/journal.pone.0098215	http://dx.doi.org/10.1371/journal.pone.0098215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858307	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400057
J	Grant-Downton, RT; Terhem, RB; Kapralov, MV; Mehdi, S; Rodriguez-Enriquez, MJ; Gurr, SJ; van Kan, JAL; Dewey, FM				Grant-Downton, Robert T.; Terhem, Razak B.; Kapralov, Maxim V.; Mehdi, Saher; Josefina Rodriguez-Enriquez, M.; Gurr, Sarah J.; van Kan, Jan A. L.; Dewey, Frances M.			A Novel Botrytis Species Is Associated with a Newly Emergent Foliar Disease in Cultivated Hemerocallis	PLOS ONE			English	Article							GENETIC-VARIATION; PLANT; HOST; INFECTION; ELLIPTICA; FUNGI; ARMILLARIA; DIVERSITY; PATHOGEN; SEED	Foliar tissue samples of cultivated daylilies (Hemerocallis hybrids) showing the symptoms of a newly emergent foliar disease known as 'spring sickness' were investigated for associated fungi. The cause(s) of this disease remain obscure. We isolated repeatedly a fungal species which proved to be member of the genus Botrytis, based on immunological tests. DNA sequence analysis of these isolates, using several different phyogenetically informative genes, indicated that they represent a new Botrytis species, most closely related to B. elliptica (lily blight, fire blight) which is a major pathogen of cultivated Lilium. The distinction of the isolates was confirmed by morphological analysis of asexual sporulating cultures. Pathogenicity tests on Hemerocallis tissues in vitro demonstrated that this new species was able to induce lesions and rapid tissue necrosis. Based on this data, we infer that this new species, described here as B. deweyae, is likely to be an important contributor to the development of 'spring sickness' symptoms. Pathogenesis may be promoted by developmental and environmental factors that favour assault by this necrotrophic pathogen. The emergence of this disease is suggested to have been triggered by breeding-related changes in cultivated hybrids, particularly the erosion of genetic diversity. Our investigation confirms that emergent plant diseases are important and deserve close monitoring, especially in intensively inbred plants.	[Grant-Downton, Robert T.; Kapralov, Maxim V.; Mehdi, Saher; Gurr, Sarah J.; Dewey, Frances M.] Univ Oxford, Dept Plant Sci, Oxford, England; [Terhem, Razak B.; van Kan, Jan A. L.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Josefina Rodriguez-Enriquez, M.] Univ La Laguna, Inst Bioorgan Antonio Gonzalez IUBO, Tenerife, Spain	University of Oxford; Wageningen University & Research; Universidad de la Laguna	Grant-Downton, RT (corresponding author), Univ Oxford, St Peters Coll, Oxford, England.	robert.grant-downton@spc.ox.ac.uk		van Kan, Jan/0000-0003-3563-1550; Kapralov, Maxim/0000-0001-7966-0295	British Hosta and Hemerocallis Society; Stanley Smith (UK) Horticultural Trust; Universiti Putra Malaysia; Ministry of Higher Education of Malaysia; 'Movilidad del Profesorado' Initiative, MEC, Spain [PR2007-0487]; Beca de Movilidad del Gobierno de Canarias; BBSRC [BB/E00282X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00282X/1] Funding Source: researchfish; Cancer Research UK [16563, 10118, 11022] Funding Source: researchfish	British Hosta and Hemerocallis Society; Stanley Smith (UK) Horticultural Trust; Universiti Putra Malaysia; Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); 'Movilidad del Profesorado' Initiative, MEC, Spain(Spanish Government); Beca de Movilidad del Gobierno de Canarias; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by a small grant from the British Hosta and Hemerocallis Society to develop research on this disease and a small grant from the Stanley Smith (UK) Horticultural Trust for other work on Hemerocallis. R.B.T. was supported by research grants from the Universiti Putra Malaysia and the Ministry of Higher Education of Malaysia. J.R.-E. acknowledges financial support under the 'Movilidad del Profesorado' (PR2007-0487) Initiative, MEC, Spain and Beca de Movilidad del Gobierno de Canarias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Barnes SE, 2003, PHYTOPATHOLOGY, V93, P573, DOI 10.1094/PHYTO.2003.93.5.573; BERGERON S, 2001, DAYLILY J, V56, P434; BERGERON S, 2010, DAYLILY J, V65, P16; Blaedow KE, 2010, CAN J PLANT PATHOL, V32, P351, DOI 10.1080/07060661.2010.508629; Chang SeogWon, 2001, Plant Pathology Journal, V17, P305; Chiou AL, 2001, J PHYTOPATHOL, V149, P319, DOI 10.1046/j.1439-0434.2001.00627.x; Dewey FM, 2008, AM J ENOL VITICULT, V59, P47; Dewey FM, 2013, AM J ENOL VITICULT, V64, P291, DOI 10.5344/ajev.2012.12103; DIEZ A, 2000, EXPT APPL ACAROLOGY, V24, P85; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elad Y, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P223; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Furukawa Toshiko, 2005, Journal of General Plant Pathology, V71, P95, DOI 10.1007/s10327-004-0167-y; GRAY EG, 1975, PLANT PATHOL, V24, P105, DOI 10.1111/j.1365-3059.1975.tb01872.x; HARRISON JG, 1986, T BRIT MYCOL SOC, V86, P171, DOI 10.1016/S0007-1536(86)80135-8; HELLER RENE, 1953, ANN SCI NAT BOT 11E SER, V14, P1; Huang JB, 2001, MYCOL RES, V105, P833, DOI 10.1017/S0953756201004051; LAUNDON GF, 1978, NEW ZEAL J AGR RES, V21, P705, DOI 10.1080/00288233.1978.10427471; Li XP, 2012, MYCOLOGIA, V104, P650, DOI 10.3852/11-218; Lorbeer JW, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P273; Meyer UM, 2000, MYCOL RES, V104, P979, DOI 10.1017/S0953756200002501; Mueller DS, 2003, HORTSCIENCE, V38, P1137, DOI 10.21273/HORTSCI.38.6.1137; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ploch S, 2011, MOL ECOL, V20, P3692, DOI 10.1111/j.1365-294X.2011.05188.x; Rayner A, 2017, NATURAL INCLUSION; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Rodriguez-Enriquez MJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls055; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schnabel G, 2005, PLANT DIS, V89, P683, DOI 10.1094/PD-89-0683A; Schubert K, 2007, STUD MYCOL, P105, DOI 10.3114/sim.2007.58.05; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Shipunov A, 2008, AM J BOT, V95, P1096, DOI 10.3732/ajb.0800024; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sowley ENK, 2010, EUR J PLANT PATHOL, V126, P61, DOI 10.1007/s10658-009-9524-1; Staats M, 2007, EUR J PLANT PATHOL, V117, P219, DOI 10.1007/s10658-006-9085-5; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Staats M, 2007, FUNGAL GENET BIOL, V44, P52, DOI 10.1016/j.fgb.2006.07.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stukenbrock EH, 2012, P NATL ACAD SCI USA, V109, P10954, DOI 10.1073/pnas.1201403109; Tomkins JP, 2001, THEOR APPL GENET, V102, P489, DOI 10.1007/s001220051672; TOMPKINS CM, 1950, PHYTOPATHOLOGY, V40, P780; VANDERVLUGTBERGMANS CJB, 1993, MYCOL RES, V97, P1193, DOI 10.1016/S0953-7562(09)81284-7; Walker AS, 2011, PHYTOPATHOLOGY, V101, P1433, DOI 10.1094/PHYTO-04-11-0104; Williams-Woodward J. L., 2001, Plant Disease, V85, P1121, DOI 10.1094/PDIS.2001.85.10.1121C; WOOTEN J, 1972, P FLORIDA STATE HORT, V85, P438; Yang YL, 2012, TROP PLANT PATHOL, V37, P165, DOI 10.1590/S1982-56762012000300001; Zhang J, 2010, MYCOSCIENCE, V51, P421, DOI 10.1007/s10267-010-0057-4; Zhang J, 2010, MYCOLOGIA, V102, P1114, DOI 10.3852/09-217	51	27	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e89272	10.1371/journal.pone.0089272	http://dx.doi.org/10.1371/journal.pone.0089272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887415	Green Published, gold, Green Accepted			2022-12-27	WOS:000336956300002
J	Irvin, VL; Kaplan, RM				Irvin, Veronica L.; Kaplan, Robert M.			Screening Mammography & Breast Cancer Mortality: Meta-Analysis of Quasi-Experimental Studies	PLOS ONE			English	Article							PUBLIC-HEALTH POLICY; ALL-CAUSE MORTALITY; FOLLOW-UP; WOMEN; POPULATION; TRIAL; SWEDEN; PROGRAM; BENEFITS; NORWAY	Background: The magnitude of the benefit associated with screening has been debated. We present a meta-analysis of quasi-experimental studies on the effects of mammography screening. Methods: We searched MEDLINE/PubMed and Embase for articles published through January 31, 2013. Studies were included if they reported: 1) a population-wide breast cancer screening program using mammography with 5+ years of data post-implementation; 2) a comparison group with equal access to therapies; and 3) breast cancer mortality. Studies excluded were: RCTs, case-control, or simulation studies. We defined quasi-experimental as studies that compared either geographical, historical or birth cohorts with a screening program to an equivalent cohort without a screening program. Meta-analyses were conducted in Stata using the metan command, random effects. Meta-analyses were conducted separately for ages screened: under 50, 50 to 69 and over 70 and weighted by population and person-years. Results: Among 4,903 published papers that were retrieved, 19 studies matched eligibility criteria. Birth cohort studies reported a significant benefit for women screened <age 50, but not for women screened ages 50-69. Significant reductions in breast cancer mortality were observed in historical comparisons. For geographical comparisons, there was a significant 20% reduction in mortality for women <age 50 and a significant 21-22% reduction for women ages 50-69. Studies that tested the interaction of geographical and historical comparisons produced a pooled, significant 13-17% reduction in incident breast cancer mortality for women ages 50-69, but the effects in most individual studies were non-significant. All studies of women ages 70+ were non-significant. Conclusions: Mammography screening may have modest effects on cancer mortality between the ages of 50 and 69 and non-significant effects for women older than age 70. Results are consistent with meta-analyses of RCTs. Effects on total mortality could not be assessed because of the limited number of studies.	[Irvin, Veronica L.; Kaplan, Robert M.] NIH, Dept Rehabil Med, Clin Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Irvin, VL (corresponding author), NIH, Dept Rehabil Med, Clin Res Ctr, Bethesda, MD 20892 USA.	Veronica.irvin@nih.gov	KAPLAN, Robert/AAK-7342-2021	Irvin, Veronica/0000-0001-6337-9108	National Institutes of Health, Clinical Center, Department of Rehabilitation Medicine	National Institutes of Health, Clinical Center, Department of Rehabilitation Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Intramural Research Program of the National Institutes of Health, Clinical Center, Department of Rehabilitation Medicine. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the National Institutes of Health or the United States government. The National Institutes of Health did not have any role in the design, analyses, interpretation or writing of this manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Anderson WF, 2006, BREAST CANCER RES TR, V99, P333, DOI 10.1007/s10549-006-9214-z; Anttila A, 2002, J MED SCREEN, V9, P153, DOI 10.1136/jms.9.4.153; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Broeders M, 2012, J MED SCREEN, V19, P14, DOI 10.1258/jms.2012.012078; Broeders MJM, 2001, INT J CANCER, V92, P303, DOI 10.1002/1097-0215(200102)9999:9999&lt;::AID-IJC1186&gt;3.0.CO;2-B; Campbell D. T., 1963, EXPT QUASIEXPERIMENT, P171; Coldman A, 2011, PREV MED, V53, P115, DOI 10.1016/j.ypmed.2011.07.005; Cooper GS, 1998, AM J PUBLIC HEALTH, V88, P281, DOI 10.2105/AJPH.88.2.281; Duffy SW, 2012, BREAST CANCER MANAG, V1, P31, DOI 10.2217/BMT.12.8; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2002, J SURG ONCOL, V81, P159, DOI 10.1002/jso.10193; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Gabe R, 2005, ANN ONCOL, V16, P153, DOI 10.1093/annonc/mdi718; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Grembowski D, 2001, PRACTICE HLTH PROGRA, P89; Hakama M, 1997, BRIT MED J, V314, P864; Hakama M, 1999, J MED SCREEN, V6, P209, DOI 10.1136/jms.6.4.209; HAKAMA M, 1995, INT J CANCER, V63, P55, DOI 10.1002/ijc.2910630111; Harris R, 2011, PREV MED, V53, P108, DOI 10.1016/j.ypmed.2011.07.004; Hellquist BN, 2011, CANCER-AM CANCER SOC, V117, P714, DOI 10.1002/cncr.25650; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Jonsson H, 2000, ACTA ONCOL, V39, P617; Jonsson H, 2003, CANCER DETECT PREV, V27, P360, DOI 10.1016/S0361-090X(03)00131-4; Jonsson H, 2003, BREAST, V12, P183, DOI 10.1016/S0960-9776(03)00031-6; Jonsson H, 2001, J MED SCREEN, V8, P152, DOI 10.1136/jms.8.3.152; Jonsson H, 2007, J MED SCREEN, V14, P87, DOI 10.1258/096914107781261918; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Leung GM, 2002, AM J PUBLIC HEALTH, V92, P1841, DOI 10.2105/AJPH.92.11.1841; Lynge E, 2011, ACTA ONCOL, V50, P1062, DOI 10.3109/0284186X.2011.599339; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Miller Anthony B, 2014, BMJ, V348, pg366, DOI 10.1136/bmj.g366; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Njor S, 2012, J MED SCREEN, V19, P33, DOI 10.1258/jms.2012.012080; Olsen AH, 2005, ACTA ONCOL, V44, P120, DOI 10.1080/02841860510007576; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsen AH, 2013, INT J CANCER, V132, P208, DOI 10.1002/ijc.27609; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Paci E, 2002, BRIT MED J, V325, P418, DOI 10.1136/bmj.325.7361.418; Parvinen I, 2006, J MED SCREEN, V13, P34, DOI 10.1258/096914106776179845; PEER PGM, 1995, INT J CANCER, V60, P808, DOI 10.1002/ijc.2910600614; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Sarkeala T, 2008, BRIT J CANCER, V98, P641, DOI 10.1038/sj.bjc.6604203; Schopper D, 2009, EUR J CANCER, V45, P1916, DOI 10.1016/j.ejca.2009.03.022; Smith R, 2002, J SURG ONCOL, V81, P164, DOI 10.1002/jso.10196; Sun E., 2010, Forum for Health Economics & Policy, V13, P1, DOI 10.2202/1558-9544.1195; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; Tabar L, 2002, J MED SCREEN, V9, P159, DOI 10.1136/jms.9.4.159; Toriola AT, 2013, BREAST CANCER RES TR, V138, P665, DOI 10.1007/s10549-013-2500-7; VanDijck JAAM, 1997, INT J CANCER, V70, P164, DOI 10.1002/(SICI)1097-0215(19970117)70:2<164::AID-IJC5>3.3.CO;2-N; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132; Zakharova N, 2011, ECANCERMEDICALSCIENC, V5, DOI 10.3332/ecancer.2011.195	59	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98105	10.1371/journal.pone.0098105	http://dx.doi.org/10.1371/journal.pone.0098105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887150	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300038
J	Morris, KT; Nofchissey, RA; Pinchuk, IV; Beswick, EJ				Morris, Katherine T.; Nofchissey, Robert A.; Pinchuk, Irina V.; Beswick, Ellen J.			Chronic Macrophage Migration Inhibitory Factor Exposure Induces Mesenchymal Epithelial Transition and Promotes Gastric and Colon Cancers	PLOS ONE			English	Article							FACTOR MIF; CELLS; GROWTH; CD74; EXPRESSION; INVASION; MYOFIBROBLASTS; TRANSFORMATION; PROLIFERATION; FIBROBLASTS	Macrophage Migration Inhibitory Factor (MIF) is an inflammatory cytokine that is highly produced in gastrointestinal cancers. Since chronic inflammation is a risk factor for tumorigenesis in these cancers, in this study, the role of MIF in pro-tumorigenic events was examined. MIF and its receptor, CD74, were examined in gastric and colon tumors and found to be increased in most tumors with significantly higher expression in tumors from patients with lymph node metastasis. MIF was also found to be highly produced by cancer associated fibroblasts isolated from human tumors compared to fibroblasts from matched normal tissues from uninvolved areas. Fibroblast-produced MIF highly increased GI cancer cell proliferation, which was decreased upon neutralizing MIF or CD74. Chronic MIF treatment led to sustained proliferation and signaling events in non-transformed GI fibroblast cells, which was maintained upon removing MIF treatment for 8 weeks. Additionally, chronic treatment of normal GI cells expressing fibroblast markers for up to 16 weeks with MIF led to a drastic decrease of fibroblast markers with concurrent increase of epithelial markers. Transformation was examined by telomerase and focus forming assays. These results suggest the MIF promotes mesenchymal epithelial transition, cell transformation and tumorigenesis in GI cancers, and thus may be an important link between chronic inflammation and tumorigenesis.	[Pinchuk, Irina V.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Morris, Katherine T.] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [Nofchissey, Robert A.; Beswick, Ellen J.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico; University of New Mexico	Beswick, EJ (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	ebeswick@salud.unm.edu	Pinchuk, Irina V/A-7227-2008	Pinchuk, Irina V/0000-0003-1505-5779	American Cancer Society [RSG-10-159-01-LIB]; United States National Institutes of Health (NIH) [1UL1RR031977-01]; University of New Mexico Clinical and Translational Sciences Center; NIH NCATS [KL2TR000072]; University of Texas Medical Branch KL2 Program; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000072, KL2TR000089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI068712] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Clinical and Translational Sciences Center; NIH NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Texas Medical Branch KL2 Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by American Cancer Society RSG-10-159-01-LIB (http://www.cancer.org/research/researchprogramsfunding/fundingopportunities/indexofgrants/researchgrantsforindependentinvestigators/research-scholar-grants), United States National Institutes of Health (NIH) 1UL1RR031977-01, University of New Mexico Clinical and Translational Sciences Center (http://www.nih.gov/), NIH NCATS (KL2TR000072), and the University of Texas Medical Branch KL2 Program (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; Beswick EJ, 2008, INFECT IMMUN, V76, P3233, DOI 10.1128/IAI.01534-07; Beswick EJ, 2006, J IMMUNOL, V176, P6794, DOI 10.4049/jimmunol.176.11.6794; Beswick EJ, 2011, INFECT IMMUN, V79, P2737, DOI 10.1128/IAI.01146-10; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Burger-Kentischer A, 2006, ATHEROSCLEROSIS, V184, P28, DOI 10.1016/j.atherosclerosis.2005.03.028; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Camlica H, 2008, PATHOL ONCOL RES, V14, P79, DOI 10.1007/s12253-008-9002-7; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; GILLEN CD, 1994, GUT, V35, P1590, DOI 10.1136/gut.35.11.1590; He XX, 2006, GUT, V55, P797, DOI 10.1136/gut.2005.078113; Kim Hae-Rim, 2010, Korean Journal of Internal Medicine, V25, P317, DOI 10.3904/kjim.2010.25.3.317; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li GQ, 2009, WORLD J GASTROENTERO, V15, P5541, DOI 10.3748/wjg.15.5541; Liu YH, 2008, J IMMUNOL, V181, P6584, DOI 10.4049/jimmunol.181.9.6584; Lo MC, 2013, CANCER LETT, V335, P81, DOI 10.1016/j.canlet.2013.01.052; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Morand EF, 2005, FRONT BIOSCI-LANDMRK, V10, P12, DOI 10.2741/1501; Morris KT, 2014, BRIT J CANCER, V110, P1211, DOI 10.1038/bjc.2013.822; Nishihira J, 2009, CURR PHARM DESIGN, V15, P2104, DOI 10.2174/138161209788489113; Ogatai H, 2010, ONCOL REP, V24, P1479, DOI 10.3892/or_00001008; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P781, DOI 10.1007/s00262-004-0636-3; Owens BMJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00307; Palumbo S, 2014, STEM CELLS DEV, V23, P852, DOI 10.1089/scd.2013.0294; Pei XJ, 2014, INT J MED SCI, V11, P106, DOI 10.7150/ijms.7264; Pinchuk IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053798; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Shima Y, 2007, BIOCHEM BIOPH RES CO, V353, P60, DOI 10.1016/j.bbrc.2006.11.137; Sun B, 2005, CLIN CANCER RES, V11, P1050; Tas F, 2014, TUMOR BIOL, V35, P3327, DOI 10.1007/s13277-013-1438-z; Worthley DL, 2010, CANCER MICROENVIRON, V3, P117, DOI 10.1007/s12307-009-0033-8; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Yamaoka E, 2011, INT J ONCOL, V39, P5, DOI 10.3892/ijo.2011.1029; Zheng YX, 2012, WORLD J GASTROENTERO, V18, P2253, DOI 10.3748/wjg.v18.i18.2253	47	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98656	10.1371/journal.pone.0098656	http://dx.doi.org/10.1371/journal.pone.0098656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887129	gold, Green Submitted, Green Published			2022-12-27	WOS:000336956300097
J	Stallings-Smith, S; Goodman, P; Kabir, Z; Clancy, L; Zeka, A				Stallings-Smith, Sericea; Goodman, Pat; Kabir, Zubair; Clancy, Luke; Zeka, Ariana			Socioeconomic Differentials in the Immediate Mortality Effects of the National Irish Smoking Ban	PLOS ONE			English	Article							SECONDHAND SMOKE; SOCIAL-CLASS; HOSPITAL ADMISSIONS; FREE LEGISLATION; HOUSING TENURE; HEART-DISEASE; HEALTH SURVEY; CAR ACCESS; INEQUALITIES; POSITION	Background: Consistent evidence has demonstrated that smoking ban policies save lives, but impacts on health inequalities are uncertain as few studies have assessed post-ban effects by socioeconomic status (SES) and findings have been inconsistent. The aim of this study was to assess the effects of the national Irish smoking ban on ischemic heart disease (IHD), stroke, and chronic obstructive pulmonary disease (COPD) mortality by discrete and composite SES indicators to determine impacts on inequalities. Methods: Census data were used to assign frequencies of structural and material SES indicators to 34 local authorities across Ireland with a 2000-2010 study period. Discrete indicators were jointly analysed through principal component analysis to generate a composite index, with sensitivity analyses conducted by varying the included indicators. Poisson regression with interrupted time-series analysis was conducted to examine monthly age and gender-standardised mortality rates in the Irish population, ages >= 35 years, stratified by tertiles of SES indicators. All models were adjusted for time trend, season, influenza, and smoking prevalence. Results: Post-ban mortality reductions by structural SES indicators were concentrated in the most deprived tertile for all causes of death, while reductions by material SES indicators were more equitable across SES tertiles. The composite indices mirrored the results of the discrete indicators, demonstrating that post-ban mortality decreases were either greater or similar in the most deprived when compared to the least deprived for all causes of death. Conclusions: Overall findings indicated that the national Irish smoking ban reduced inequalities in smoking-related mortality. Due to the higher rates of smoking-related mortality in the most deprived group, even equitable reductions across SES tertiles resulted in decreases in inequalities. The choice of SES indicator was influential in the measurement of effects, underscoring that a differentiated analytical approach aided in understanding the complexities in which structural and material factors influence mortality.	[Stallings-Smith, Sericea; Zeka, Ariana] Brunel Univ, Inst Environm, London, England; [Goodman, Pat] Dublin Inst Technol, Environm Hlth Sci Inst, Dublin, Ireland; [Goodman, Pat; Clancy, Luke] TobaccoFree Res Inst Ireland, Dublin, Ireland; [Kabir, Zubair] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	Brunel University; Technological University Dublin; University College Cork	Stallings-Smith, S (corresponding author), Brunel Univ, Inst Environm, London, England.	sericealee@gmail.com; Ariana.Zeka@brunel.ac.uk	clancy, luke/ABA-1826-2020; Clancy, Luke/O-6597-2019	Clancy, Luke/0000-0003-2407-2263; Zeka, Ariana/0000-0002-9570-8831; Kabir, Zubair/0000-0003-1529-004X				ABRAMSON JH, 1982, SOC SCI MED, V16, P1739, DOI 10.1016/0277-9536(82)90267-2; Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; [Anonymous], 2006, CHILD POVERTY LARGE; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Balanda K. P., 2001, INEQUALITIES MORTALI; Barnett R, 2009, AUST NZ J PUBL HEAL, V33, P515, DOI 10.1111/j.1753-6405.2009.00446.x; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bartley M., 1999, DETERMINNNTS HLTH, P81; Bobak M, 2000, TOB CONTROL, V9, P310, DOI 10.1136/tc.9.3.310; Central Statistics Office Ireland, CENS 2006 NON NAT LI; Central Statistics Office Ireland, WOM MEN IR; Central Statistics Office Ireland, 2002, CENS INT TABL CENS 1; Cesaroni G, 2003, EUR RESPIR J, V22, P619, DOI 10.1183/09031936.03.00091202; Cesaroni Giulia, 2006, Epidemiol Prev, V30, P352; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Cesaroni G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-41; Cesaroni G, 2009, STROKE, V40, P2812, DOI 10.1161/STROKEAHA.108.542944; Chittleborough CR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-54; Currie LM, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2011-050248; Davies H, 1997, J ROY STAT SOC A STA, V160, P107, DOI 10.1111/1467-985X.00048; Dengler R, 1997, J EPIDEMIOL COMMUN H, V51, P46, DOI 10.1136/jech.51.1.46; Denton M, 2004, SOC SCI MED, V58, P2585, DOI 10.1016/j.socscimed.2003.09.008; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Eisner Mark D, 2006, BMC Pulm Med, V6, P12, DOI 10.1186/1471-2466-6-12; Eisner Mark D, 2009, Int J Chron Obstruct Pulmon Dis, V4, P169; Ekholm O, 2010, SCAND J PUBLIC HEALT, V38, P699, DOI 10.1177/1403494810382474; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; He Y, 2012, CHEST, V142, P909, DOI 10.1378/chest.11-2884; Ireland Health Information and Quality Authority, SLAN SURV LIF ATT NU; Irish Health Protection Surveillance Centre, PREV INFL SEAS SURV; Irish National Tobacco Control Office, IR NAT TOB CONTR OFF; Irish National Tobacco Control Office, CIG SMOK TRENDS; Jarvis MJ., 2006, SOCIAL DETERMINANTS, P224; Kabir Z, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-428; KAISER HF, 1992, PERCEPT MOTOR SKILL, V74, P595, DOI 10.2466/PMS.74.2.595-598; Kline P., 1994, EASY GUIDE FACTOR AN; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Layte R, 2009, EUR SOCIOL REV, V25, P399, DOI 10.1093/esr/jcn022; Leyland AH, 2004, J EPIDEMIOL COMMUN H, V58, P296, DOI 10.1136/jech.2003.007278; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Lunn P, 2011, HOUSEHOLD FAMILY STR; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; MACINTYRE S, 1994, J PUBLIC HEALTH MED, V16, P53, DOI 10.1093/oxfordjournals.pubmed.a042936; Macintyre S, 1998, J EPIDEMIOL COMMUN H, V52, P657, DOI 10.1136/jech.52.10.657; Macintyre S, 2003, J PUBLIC HEALTH MED, V25, P288, DOI 10.1093/pubmed/fdg089; Macintyre S, 2001, J EPIDEMIOL COMMUN H, V55, P330, DOI 10.1136/jech.55.5.330; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Mackay DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062597; Mantey K., 2000, EUROSURVEILLANCE, V5; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Michelozzi P, 1999, J EPIDEMIOL COMMUN H, V53, P687, DOI 10.1136/jech.53.11.687; Millett C, 2013, PEDIATRICS, V131, pE495, DOI 10.1542/peds.2012-2592; Oono IP, 2011, J PUBLIC HEALTH-UK, V33, P496, DOI 10.1093/pubmed/fdr025; Prescott E, 2003, EUR RESPIR J, V21, P821, DOI 10.1183/09031936.03.00047502; Reijneveld SA, 2000, J EPIDEMIOL COMMUN H, V54, P306, DOI 10.1136/jech.54.4.306; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; SAS, PROD GLIMMIX PROC; SAS, FACTOR PROC; Shaw M, 2006, SOCIAL DETERMINANTS, P196; Siahpush M, 2006, TOB CONTROL, V15, P71, DOI 10.1136/tc.2004.008763; Siahpush M, 2006, SOC SCI MED, V63, P2801, DOI 10.1016/j.socscimed.2006.07.015; Sims M, 2012, ENVIRON HEALTH PERSP, V120, P425, DOI 10.1289/ehp.1103680; SMITH GD, 1992, AM J PUBLIC HEALTH, V82, P1079, DOI 10.2105/AJPH.82.8.1079; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Sobotka T, 2008, DEMOGR RES, V19, P225, DOI 10.4054/DemRes.2008.19.9; Stallings-Smith S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062063; Tello JE, 2005, SOC SCI MED, V61, P2096, DOI 10.1016/j.socscimed.2005.04.018; U.S. Department of Health and Human Services, 2010, REP SURG GEN TOB SMO; van Lenthe FJ, 2006, J EPIDEMIOL COMMUN H, V60, P699, DOI 10.1136/jech.2005.043851; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; Whitlock G, 1998, TOB CONTROL, V7, P276, DOI 10.1136/tc.7.3.276; World Health Organization, 2003, SOCIAL DETERMINANTS; Zeka A, 2006, INT J EPIDEMIOL, V35, P1347, DOI 10.1093/ije/dyl132	76	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98617	10.1371/journal.pone.0098617	http://dx.doi.org/10.1371/journal.pone.0098617			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24887027	Green Published, gold, Green Submitted			2022-12-27	WOS:000336956300093
J	Zhu, HT; Zhuang, J; Feng, HL; Liang, RF; Wang, JY; Xie, LH; Zhu, P				Zhu, Hongtao; Zhuang, Jun; Feng, Hongli; Liang, Rongfeng; Wang, Jiangyong; Xie, Lianhui; Zhu, Ping			Cryo-EM Structure of Isomeric Molluscan Hemocyanin Triggered by Viral Infection	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; FUNCTIONAL UNIT; CATECHOLOXIDASE ACTIVITY; PHENOLOXIDASE ACTIVITY; SCORPION HEMOCYANIN; ATOMIC STRUCTURES; IMMUNE-RESPONSE; SYSTEM; TYROSINASE; MECHANISM	Hemocyanins (Hcs) of arthropods and mollusks function not only as oxygen transporters, but also as phenoloxidases (POs). In invertebrates, PO is an important component in the innate immune cascade, where it functions as the initiator of melanin synthesis, a pigment involved in encapsulating and killing of pathogenic microbes. Although structures of Hc from several species of invertebrates have been reported, the structural basis for how PO activity is triggered by structural changes of Hc in vivo remains poorly understood. Here, we report a 6.8 angstrom cryo-electron microscopy (cryo-EM) structure of the isomeric form of hemocyanin, which was isolated from Abalone Shriveling syndrome-associated Virus (AbSV) infected abalone (Halitotis diversicolor), and build a pseudoatomic model of isomeric H. diversicolor hemocyanin 1 (HdH1). Our results show that, compared with native form of HdH1, the architecture of isomeric HdH1 turns into a more relaxed form. The interactions between certain functional units (FUs) present in the native form of Hc either decreased or were totally abolished in the isomeric form of Hc. As a result of that, native state Hc switches to its isomeric form, enabling it to play its role in innate immune responses against invading pathogens.	[Zhu, Hongtao; Feng, Hongli; Zhu, Ping] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhuang, Jun; Liang, Rongfeng; Xie, Lianhui] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou, Peoples R China; [Zhuang, Jun; Xie, Lianhui] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Wang, Jiangyong] Chinese Fisheries Acad, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China; [Zhu, Hongtao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, LH (corresponding author), Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou, Peoples R China.	fjxlh@126.com; zhup@ibp.ac.cn			National Basic Research Program of China [2010CB912400]; National Natural Science Foundation of China [31230018, 31172428, 81261120418]; Program for Distinguished Young Scientists/Taiwan Strait-West Coast [K8812007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Distinguished Young Scientists/Taiwan Strait-West Coast	This work was supported by grants from the National Basic Research Program of China (2010CB912400), the National Natural Science Foundation of China (31230018, 31172428, 81261120418), and from the Program for Distinguished Young Scientists/Taiwan Strait-West Coast (K8812007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird S, 2007, BBA-PROTEINS PROTEOM, V1774, P1380, DOI 10.1016/j.bbapap.2007.08.019; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Coates CJ, 2011, DEV COMP IMMUNOL, V35, P155, DOI 10.1016/j.dci.2010.08.015; Cong Y, 2009, STRUCTURE, V17, P749, DOI 10.1016/j.str.2009.03.005; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Decker H, 2004, DEV COMP IMMUNOL, V28, P673, DOI 10.1016/j.dci.2003.11.007; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; HELLING F, 1994, CANCER RES, V54, P197; Jaenicke E, 2004, MICRON, V35, P89, DOI 10.1016/j.micron.2003.10.027; Jaenicke E, 2008, FEBS J, V275, P1518, DOI 10.1111/j.1742-4658.2008.06311.x; Jaenicke E, 2011, IUBMB LIFE, V63, P183, DOI 10.1002/iub.435; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; LAMM DL, 1993, UROL RES, V21, P33, DOI 10.1007/BF00295189; Lee SY, 2003, J BIOL CHEM, V278, P7927, DOI 10.1074/jbc.M209239200; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Nillius D, 2008, FEBS LETT, V582, P749, DOI 10.1016/j.febslet.2008.01.056; Perbandt M, 2003, BIOCHEMISTRY-US, V42, P6341, DOI 10.1021/bi020672x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rolff M, 2011, CHEM SOC REV, V40, P4077, DOI 10.1039/c0cs00202j; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Siddiqui NI, 2004, MICRON, V35, P91, DOI 10.1016/j.micron.2003.10.028; Siddiqui NI, 2006, BIOCHEM BIOPH RES CO, V348, P1138, DOI 10.1016/j.bbrc.2006.07.172; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terwilliger NB, 2007, INTEGR COMP BIOL, V47, P662, DOI 10.1093/icb/icm039; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Holde KE, 2000, BIOPHYS CHEM, V86, P165, DOI 10.1016/S0301-4622(00)00154-X; Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhuang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013850	44	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98766	10.1371/journal.pone.0098766	http://dx.doi.org/10.1371/journal.pone.0098766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336956300105
J	Bailey-Downs, LC; Thorpe, JE; Disch, BC; Bastian, A; Hauser, PJ; Farasyn, T; Berry, WL; Hurst, RE; Ihnat, MA				Bailey-Downs, Lora C.; Thorpe, Jessica E.; Disch, Bryan C.; Bastian, Anja; Hauser, Paul J.; Farasyn, Taleah; Berry, William L.; Hurst, Robert E.; Ihnat, Michael A.			Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression	PLOS ONE			English	Article							TUMOR-GROWTH; ORTHOTOPIC MODEL; SUB-POPULATIONS; IN-VIVO; METASTASIS; CARCINOMA; CELLS; DORMANCY; INHIBITION; EXPRESSION	Most cancer patients die with metastatic disease, thus, good models that recapitulate the natural process of metastasis including a dormancy period with micrometastatic cells would be beneficial in developing treatment strategies. Herein we report a model of natural metastasis that balances time to complete experiments with a reasonable dormancy period, which can be used to better study metastatic progression. The basis for the model is a 4T1 triple negative syngeneic breast cancer model without resection of the primary tumor. A cell titration from 500 to 15,000 GFP tagged 4T1 cells implanted into fat pad number four of immune proficient eight week female BALB/cJ mice optimized speed of the model while possessing metastatic processes including dormancy and beginning of reactivation. The frequency of primary tumors was less than 50% in animals implanted with 500-1500 cells. Although implantation with over 10,000 cells resulted in 100% primary tumor development, the tumors and macrometastases formed were highly aggressive, lacked dormancy, and offered no opportunity for treatment. Implantation of 7,500 cells resulted in > 90% tumor take by 10 days; in 30-60 micrometastases in the lung (with many animals also having 2-30 brain micrometastases) two weeks post-implantation, with the first small macrometastases present at five weeks; many animals displaying macrometastases at five weeks and animals becoming moribund by six weeks post-implantation. Using the optimum of 7,500 cells the efficacy of a chemotherapeutic agent for breast cancer, doxorubicin, given at its maximal tolerated dose (MTD; 1 mg/kg weekly) was tested for an effect on metastasis. Doxorubicin treatment significantly reduced primary tumor growth and lung micrometastases but the number of macrometastases at experiment end was not significantly affected. This model should prove useful for development of drugs to target metastasis and to study the biology of metastasis.	[Bailey-Downs, Lora C.; Thorpe, Jessica E.; Disch, Bryan C.; Hauser, Paul J.; Farasyn, Taleah; Hurst, Robert E.; Ihnat, Michael A.] DormaTarg Inc, Oklahoma City, OK 73117 USA; [Thorpe, Jessica E.; Bastian, Anja; Ihnat, Michael A.] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK USA; [Hauser, Paul J.; Hurst, Robert E.] Univ Oklahoma, Coll Med, Dept Urol, Oklahoma City, OK USA; [Berry, William L.] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73190 USA; [Hurst, Robert E.] Oklahoma Coll Med, Dept Biochem & Mol Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ihnat, MA (corresponding author), DormaTarg Inc, Oklahoma City, OK 73117 USA.	mihnat@dormatarg.com		Berry, William/0000-0002-1661-5443; Hurst, Robert/0000-0003-0370-1817	Oklahoma Center for the Advancement of Science and Technology - Oklahoma Applied Research Support (OCAST-OARS) [AR11-073]; phase II NCI SBIR [2R44 CA135867-02]; NATIONAL CANCER INSTITUTE [R44CA135867] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology - Oklahoma Applied Research Support (OCAST-OARS); phase II NCI SBIR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Oklahoma Center for the Advancement of Science and Technology - Oklahoma Applied Research Support (OCAST-OARS) grant AR11-073 and a phase II NCI SBIR 2R44 CA135867-02 grant to M.A.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sahaf O, 2010, ANN SURG, V252, P1037, DOI 10.1097/SLA.0b013e3181efc635; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bausero MA, 2004, TUMOR BIOL, V25, P243, DOI 10.1159/000081387; BURNET M, 1957, BRIT MED J, V1, P779, DOI 10.1136/bmj.1.5022.779; Chow KS, 2011, JOVE-J VIS EXP, DOI 10.3791/3159; CLAYTON F, 1993, CANCER-AM CANCER SOC, V71, P1780, DOI 10.1002/1097-0142(19930301)71:5<1780::AID-CNCR2820710512>3.0.CO;2-2; Connolly EM, 2002, BRIT J CANCER, V87, P231, DOI 10.1038/sj.bjc.6600462; DAMATO R, 1993, MICROVASC RES, V46, P135, DOI 10.1006/mvre.1993.1042; Das Roy L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2345; Erin N, 2004, ANTICANCER RES, V24, P1003; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Gingrich JR, 1996, CANCER RES, V56, P4096; Grippo PJ, 2000, AM J PATHOL, V157, P805, DOI 10.1016/S0002-9440(10)64594-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; HEPPNER GH, 1978, CANCER RES, V38, P3758; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Ihnat MA, 1999, ONCOL RES, V11, P303; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Li HT, 2007, J GENE MED, V9, P161, DOI 10.1002/jgm.1005; Lirdprapamongkol K, 2005, EUR J PHARM SCI, V25, P57, DOI 10.1016/j.ejps.2005.01.015; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; MAHONEY KH, 1985, J LEUKOCYTE BIOL, V38, P573, DOI 10.1002/jlb.38.5.573; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Melchior SW, 1997, CLIN CANCER RES, V3, P249; Mittempergher L, 2013, MOL ONCOL, V7, P987, DOI 10.1016/j.molonc.2013.07.006; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Nishikawa S, 2012, INT J ONCOL, V41, P979, DOI 10.3892/ijo.2012.1531; NKRUMAH FK, 1976, INT J CANCER, V17, P455, DOI 10.1002/ijc.2910170407; POLLACK VA, 1982, J NATL CANCER I, V69, P137; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Pulaski BA, 1998, CANCER RES, V58, P1486; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Sawant A, 2012, J IMMUNOL, V189, P4258, DOI 10.4049/jimmunol.1101855; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Toh B, 2012, IMMUNOL RES, V53, P229, DOI 10.1007/s12026-012-8288-4; VINEY JL, 1995, CANCER METAST REV, V14, P77, DOI 10.1007/BF00665792; WEBSTER MA, 1994, SEMIN CANCER BIOL, V5, P69; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wenzel J, 2010, CLIN EXP METASTAS, V27, P25, DOI 10.1007/s10585-009-9299-y; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YUHAS JM, 1975, CANCER RES, V35, P242	52	50	50	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98624	10.1371/journal.pone.0098624	http://dx.doi.org/10.1371/journal.pone.0098624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878664	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500075
J	Hayashi, Y; Kuroda, T; Kishimoto, H; Wang, CS; Iwama, A; Kimura, K				Hayashi, Yuki; Kuroda, Takao; Kishimoto, Hiroyuki; Wang, Changshan; Iwama, Atsushi; Kimura, Keiji			Downregulation of rRNA Transcription Triggers Cell Differentiation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS INHIBITORS; POLYMERASE-I TRANSCRIPTION; GRANULOCYTE DIFFERENTIATION; TUMOR-SUPPRESSOR; ACTIVATES P53; CYCLE ARREST; HL-60 CELLS; DNA-DAMAGE; STEM-CELLS; NUCLEOLUS	Responding to various stimuli is indispensable for the maintenance of homeostasis. The downregulation of ribosomal RNA (rRNA) transcription is one of the mechanisms involved in the response to stimuli by various cellular processes, such as cell cycle arrest and apoptosis. Cell differentiation is caused by intra-and extracellular stimuli and is associated with the downregulation of rRNA transcription as well as reduced cell growth. The downregulation of rRNA transcription during differentiation is considered to contribute to reduced cell growth. However, the downregulation of rRNA transcription can induce various cellular processes; therefore, it may positively regulate cell differentiation. To test this possibility, we specifically downregulated rRNA transcription using actinomycin D or a siRNA for Pol I-specific transcription factor IA (TIF-IA) in HL-60 and THP-1 cells, both of which have differentiation potential. The inhibition of rRNA transcription induced cell differentiation in both cell lines, which was demonstrated by the expression of the common differentiation marker CD11b. Furthermore, TIF-IA knockdown in an ex vivo culture of mouse hematopoietic stem cells increased the percentage of myeloid cells and reduced the percentage of immature cells. We also evaluated whether differentiation was induced via the inhibition of cell cycle progression because rRNA transcription is tightly coupled to cell growth. We found that cell cycle arrest without affecting rRNA transcription did not induce differentiation. To the best of our knowledge, our results demonstrate the first time that the downregulation of rRNA levels could be a trigger for the induction of differentiation in mammalian cells. Furthermore, this phenomenon was not simply a reflection of cell cycle arrest. Our results provide a novel insight into the relationship between rRNA transcription and cell differentiation.	[Hayashi, Yuki; Kishimoto, Hiroyuki; Kimura, Keiji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Science City, Ibaraki, Japan; [Kuroda, Takao; Kishimoto, Hiroyuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba Science City, Ibaraki, Japan; [Wang, Changshan; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan	University of Tsukuba; University of Tsukuba; Chiba University	Kimura, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Science City, Ibaraki, Japan.	kekimura@tara.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Comai L, 2000, CELL GROWTH DIFFER, V11, P63; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2013, NUCL GUARDIAN CELLUL; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jurate S GT, 2010, CENT EUR J BIOL, V5, P600; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Koizumi T, 2010, INT J HEMATOL, V91, P611, DOI 10.1007/s12185-010-0563-3; Kreiner G, 2013, CELL DEATH DIFFER, V20, P1455, DOI 10.1038/cdd.2013.66; Krichevsky AM, 1999, J BIOL CHEM, V274, P14295, DOI 10.1074/jbc.274.20.14295; Kumazawa T, 2011, J BIOL CHEM, V286, P20861, DOI 10.1074/jbc.M110.209916; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Okamoto A, 2010, BIOCHEM BIOPH RES CO, V394, P42, DOI 10.1016/j.bbrc.2010.02.065; PILZ RB, 1987, J CLIN INVEST, V79, P1006, DOI 10.1172/JCI112867; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; SCHWARTZ EL, 1988, J CELL PHYSIOL, V136, P526, DOI 10.1002/jcp.1041360319; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; WEIL SC, 1987, P NATL ACAD SCI USA, V84, P2057, DOI 10.1073/pnas.84.7.2057; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	42	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98586	10.1371/journal.pone.0098586	http://dx.doi.org/10.1371/journal.pone.0098586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879416	Green Submitted, Green Published, gold			2022-12-27	WOS:000338101500070
J	Zhang, N; Huang, H; Su, BN; Zhao, JL; Zhang, B				Zhang, Nan; Huang, Hong; Su, Boni; Zhao, Jinlong; Zhang, Bo			Information Dissemination Analysis of Different Media towards the Application for Disaster Pre-Warning	PLOS ONE			English	Article								Knowing the information dissemination mechanisms of different media and having an efficient information dissemination plan for disaster pre-warning plays a very important role in reducing losses and ensuring the safety of human beings. In this paper we established models of information dissemination for six typical information media, including short message service (SMS), microblogs, news portals, cell phones, television, and oral communication. Then, the information dissemination capability of each medium concerning individuals of different ages, genders, and residential areas was simulated, and the dissemination characteristics were studied. Finally, radar graphs were used to illustrate comprehensive assessments of the six media; these graphs show directly the information dissemination characteristics of all media. The models and the results are essential for improving the efficiency of information dissemination for the purpose of disaster pre-warning and for formulating emergency plans which help to reduce the possibility of injuries, deaths and other losses in a disaster.	[Zhang, Nan; Huang, Hong; Su, Boni; Zhao, Jinlong; Zhang, Bo] Tsinghua Univ, Inst Publ Safety Res, Dept Engn Phys, Beijing 100084, Peoples R China	Tsinghua University	Huang, H (corresponding author), Tsinghua Univ, Inst Publ Safety Res, Dept Engn Phys, Beijing 100084, Peoples R China.	hhong@mail.tsinghua.edu.cn		Zhang, Nan/0000-0003-2092-4334	National Natural Science Foundation of China [71173128, 91224008]; Ministry of Science and Technology of the People's Republic of China [2011BAK07B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China under Grant No. 71173128, 91224008, and the Ministry of Science and Technology of the People's Republic of China under Grant No. 2011BAK07B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068914; Basher R, 2006, PHILOS T R SOC A, V364, P2167, DOI 10.1098/rsta.2006.1819; Beijing Bureau of Statistics, 2009, CENS INF BEIJ; Chenglan B, 2005, RECENT DEV WORLD SEI, V1, P14; Eugster PT, 2004, COMPUTER, V37, P60, DOI 10.1109/MC.2004.1297243; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Katada T, 1999, J JPN SOC CIV ENG, P1; Lang SY, 2012, RES PORTAL WEBSITES; Lengel L., 1988, ACAD MANAGEMENT PERS, V2, P225, DOI DOI 10.5465/AME.1988.4277259; Li DH, 2008, ELECTRON COMMER R A, V7, P55, DOI 10.1016/j.elerap.2007.02.010; Li QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058270; Macilwain C, 2013, NATURE, V498, P273, DOI 10.1038/498273a; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Oikawa Y, 2000, J CIV ENG INF PROCES, V9, P129; Preis T, 2013, SCI REP, P1; Sattler DN, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1826; Shim JP, 2007, COMMUN ASSOC INF SYS, V20, P442; Uchida N., 2011, Proceedings of the 2011 International Conference on Complex, Intelligent and Software Intensive Systems (CISIS 2011), P24, DOI 10.1109/CISIS.2011.14; Wei JC, 2010, DISASTERS, V34, P1013, DOI 10.1111/j.1467-7717.2010.01180.x; Whittaker S, 2006, COMMUN ACM, V49, P68, DOI 10.1145/1107458.1107494; Zhang N, 2013, P 3 INT C MULT TECHN, P183, DOI [10.1007/978-3-642-41407-7_18, DOI 10.1007/978-3-642-41407-7_18]; Zhang N, 2013, NAT HAZARDS, V69, P1629, DOI 10.1007/s11069-013-0767-y	22	15	15	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98649	10.1371/journal.pone.0098649	http://dx.doi.org/10.1371/journal.pone.0098649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878739	gold, Green Published			2022-12-27	WOS:000338101500077
J	Zouikr, I; James, MH; Campbell, EJ; Clifton, VL; Beagley, KW; Dayas, CV; Hodgson, DM				Zouikr, Ihssane; James, Morgan H.; Campbell, Erin J.; Clifton, Vicki L.; Beagley, Kenneth W.; Dayas, Christopher V.; Hodgson, Deborah M.			Altered Formalin-Induced Pain and Fos Induction in the Periaqueductal Grey of Preadolescent Rats following Neonatal LPS Exposure	PLOS ONE			English	Article							STIMULATION-PRODUCED ANALGESIA; LATERAL HABENULAR NUCLEUS; C-FOS; DESCENDING MODULATION; INFANT RATS; SPINAL-CORD; ELECTRICAL-STIMULATION; NOCICEPTIVE RESPONSES; ENDOTOXIN CHALLENGE; GRAY-MATTER	Animal and human studies have demonstrated that early pain experiences can produce alterations in the nociceptive systems later in life including increased sensitivity to mechanical, thermal, and chemical stimuli. However, less is known about the impact of neonatal immune challenge on future responses to noxious stimuli and the reactivity of neural substrates involved in analgesia. Here we demonstrate that rats exposed to Lipopolysaccharide (LPS; 0.05 mg/kg IP, Salmonella enteritidis) during postnatal day (PND) 3 and 5 displayed enhanced formalin-induced flinching but not licking following formalin injection at PND 22. This LPS-induced hyperalgesia was accompanied by distinct recruitment of supraspinal regions involved in analgesia as indicated by significantly attenuated Fos-protein induction in the rostral dorsal periaqueductal grey (DPAG) as well as rostral and caudal axes of the ventrolateral PAG (VLPAG). Formalin injections were associated with increased Fos-protein labelling in lateral habenula (LHb) as compared to medial habenula (MHb), however the intensity of this labelling did not differ as a result of neonatal immune challenge. These data highlight the importance of neonatal immune priming in programming inflammatory pain sensitivity later in development and highlight the PAG as a possible mediator of this process.	[Zouikr, Ihssane; Hodgson, Deborah M.] Univ Newcastle, Sch Psychol, Lab Neuroimmunol, Newcastle, NSW 2300, Australia; [James, Morgan H.; Campbell, Erin J.; Dayas, Christopher V.] Univ Newcastle, Sch Biomed Sci & Pharm, Neurobiol Addict Lab, Newcastle, NSW 2300, Australia; [Clifton, Vicki L.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld 4001, Australia	University of Newcastle; University of Newcastle; Robinson Research Institute; University of Adelaide; Queensland University of Technology (QUT)	Zouikr, I (corresponding author), Univ Newcastle, Sch Psychol, Lab Neuroimmunol, Newcastle, NSW 2300, Australia.	Ihssane.zouikr@uon.edu.au	Dayas, Chris/ABE-9173-2020; Clifton, Vicki/A-1445-2012; James, Morgan/AEM-8428-2022; Clifton, Vicki/AAV-2749-2021; Zouikr, Ihssane/X-9165-2019; Beagley, Kenneth/J-1129-2012	Clifton, Vicki/0000-0002-4892-6748; James, Morgan/0000-0001-9298-8607; Clifton, Vicki/0000-0002-4892-6748; Beagley, Kenneth/0000-0003-3112-6557; Dayas, Christopher/0000-0002-9175-3854; Campbell, Erin/0000-0002-4722-6897	Australian Research Council [ARC DP 09787599]	Australian Research Council(Australian Research Council)	This study was supported by a grant from the Australian Research Council (ARC DP 09787599). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1977, BRAIN RES, V122, P229, DOI 10.1016/0006-8993(77)90291-8; ARAKI M, 1988, BRAIN RES, V441, P319, DOI 10.1016/0006-8993(88)91410-2; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Barr GA, 2013, EUR J PAIN, V17, P676, DOI 10.1002/j.1532-2149.2012.00245.x; BARR GA, 1992, BRAIN RES, V584, P83, DOI 10.1016/0006-8993(92)90881-9; Barr GA, 2011, J PAIN, V12, P263, DOI 10.1016/j.jpain.2010.09.005; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Baulmann J, 2000, NEUROSCIENCE, V95, P813; Beggs S, 2012, BRAIN, V135, P404, DOI 10.1093/brain/awr288; BEITZ AJ, 1985, J COMP NEUROL, V237, P445, DOI 10.1002/cne.902370403; Boisse L, 2005, PAIN, V119, P133, DOI 10.1016/j.pain.2005.09.022; Butkevich IP, 2001, BRAIN RES, V915, P88, DOI 10.1016/S0006-8993(01)02819-0; CANNON JT, 1982, BRAIN RES, V243, P315, DOI 10.1016/0006-8993(82)90255-4; CARSTENS E, 1995, J NEUROPHYSIOL, V73, P2179, DOI 10.1152/jn.1995.73.6.2179; CODERRE TJ, 1994, NEUROREPORT, V5, P1337, DOI 10.1097/00001756-199406000-00011; COHEN SR, 1986, NEUROSCI LETT, V70, P165; COHEN SR, 1985, BRAIN RES, V359, P131, DOI 10.1016/0006-8993(85)91420-9; D'Mello R, 2008, BRIT J ANAESTH, V101, P8, DOI 10.1093/bja/aen088; DAFNY N, 1990, Neurological Research, V12, P117; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; FARDIN V, 1984, BRAIN RES, V306, P105, DOI 10.1016/0006-8993(84)90360-3; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FITZGERALD M, 1984, NEUROSCIENCE, V13, P933, DOI 10.1016/0306-4522(84)90107-6; FITZGERALD M, 1986, DEV BRAIN RES, V24, P261, DOI 10.1016/0165-3806(86)90194-X; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Goffaux P, 2008, EUR J PAIN, V12, P945, DOI 10.1016/j.ejpain.2008.01.003; GUY ER, 1992, PAIN, V51, P81, DOI 10.1016/0304-3959(92)90012-Z; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hodgson DM, 2001, PEDIATR RES, V50, P750, DOI 10.1203/00006450-200112000-00020; ITO M, 1985, BRAIN RES, V337, P245, DOI 10.1016/0006-8993(85)90060-5; JACQUET YF, 1974, SCIENCE, V185, P1055, DOI 10.1126/science.185.4156.1055; James MH, 2011, NEUROSCIENCE, V199, P235, DOI 10.1016/j.neuroscience.2011.09.047; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; LI YQ, 1993, NEUROSCI LETT, V158, P55, DOI 10.1016/0304-3940(93)90611-N; Loyd DR, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/462879; MAHIEUX G, 1987, BRAIN RES, V406, P118, DOI 10.1016/0006-8993(87)90776-1; MAYER DJ, 1971, SCIENCE, V174, P1351, DOI 10.1126/science.174.4016.1351; MORGAN MM, 1991, BRAIN RES, V545, P17, DOI 10.1016/0006-8993(91)91264-2; MORGAN MM, 1989, BRAIN RES, V502, P61, DOI 10.1016/0006-8993(89)90461-7; NADEL L, 1990, ANN NY ACAD SCI, V608, P613, DOI 10.1111/j.1749-6632.1990.tb48912.x; NAGAO M, 1993, NEUROSCI LETT, V151, P37, DOI 10.1016/0304-3940(93)90039-N; NICHOLS DS, 1990, PAIN, V41, P347, DOI 10.1016/0304-3959(90)90011-2; Nilsson C, 2002, EUR J ENDOCRINOL, V146, P251, DOI 10.1530/eje.0.1460251; Okuda K, 2001, PAIN, V92, P107, DOI 10.1016/S0304-3959(00)00476-0; OLIVERAS JL, 1974, EXP BRAIN RES, V20, P32; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; REYNOLDS DV, 1969, SCIENCE, V164, P444, DOI 10.1126/science.164.3878.444; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Shelton L, 2012, J NEUROPHYSIOL, V107, P2633, DOI 10.1152/jn.00012.2012; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; VACCARINO AL, 1994, BRAIN RES, V666, P104, DOI 10.1016/0006-8993(94)90288-7; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Walker FR, 2006, PHYSIOL BEHAV, V87, P126, DOI 10.1016/j.physbeh.2005.09.008; Walker FR, 2008, J PSYCHIATR RES, V42, P1094, DOI 10.1016/j.jpsychires.2007.12.006; Walker FR, 2009, J NEUROIMMUNOL, V207, P57, DOI 10.1016/j.jneuroim.2008.11.012; Walker SM, 2009, PAIN, V147, P99, DOI 10.1016/j.pain.2009.08.017; Wang S, 1984, PHYSL SCI, V4, P37; WHEELERACETO H, 1991, PSYCHOPHARMACOLOGY, V104, P35, DOI 10.1007/BF02244551; Wiedenmayer CP, 2001, BEHAV BRAIN RES, V126, P147, DOI 10.1016/S0166-4328(01)00260-1; WILLIAMS S, 1990, NEUROSCI LETT, V109, P309, DOI 10.1016/0304-3940(90)90013-Y; YI DK, 1995, PAIN, V60, P257, DOI 10.1016/0304-3959(94)00119-Y; YU LC, 1990, INT J NEUROSCI, V54, P245, DOI 10.3109/00207459008986640; Zouikr I, 2014, PSYCHONEUROENDOCRINO, V41, P1, DOI 10.1016/j.psyneuen.2013.11.016; Zouikr I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053384	71	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98382	10.1371/journal.pone.0098382	http://dx.doi.org/10.1371/journal.pone.0098382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878577	Green Published, gold, Green Submitted			2022-12-27	WOS:000338101500054
J	Blain, C; Gagnon, P				Blain, Caitlin; Gagnon, Patrick			Canopy-Forming Seaweeds in Urchin-Dominated Systems in Eastern Canada: Structuring Forces or Simple Prey for Keystone Grazers?	PLOS ONE			English	Article							BRYOZOAN MEMBRANIPORA-MEMBRANACEA; FRAGILE SSP TOMENTOSOIDES; GREEN SEA-URCHINS; SULFURIC-ACID; PHASE-SHIFTS; MARINE-INVERTEBRATES; COMMUNITY STRUCTURE; ALGAL SUCCESSION; STABLE STATES; NOVA-SCOTIA	Models of benthic community dynamics for the extensively studied, shallow rocky ecosystems in eastern Canada emphasize kelp-urchin interactions. These models may bias the perception of factors and processes that structure communities, for they largely overlook the possible contribution of other seaweeds to ecosystem resilience. We examined the persistence of the annual, acidic (H2SO4), brown seaweed Desmarestia viridis in urchin barrens at two sites in Newfoundland (Canada) throughout an entire growth season (February to October). We also compared changes in epifaunal assemblages in D. viridis and other conspicuous canopy-forming seaweeds, the non-acidic conspecific Desmarestia aculeata and kelp Agarum clathratum. We show that D. viridis can form large canopies within the 2-to-8 m depth range that represent a transient community state termed "Desmarestia bed''. The annual resurgence of Desmarestia beds and continuous occurrence of D. aculeata and A. clathratum, create biological structure for major recruitment pulses in invertebrate and fish assemblages (e.g. from quasi-absent gastropods to >150 000 recruits kg(-1) D. viridis). Many of these pulses phase with temperature-driven mass release of acid to the environment and die-off in D. viridis. We demonstrate experimentally that the chemical makeup of D. viridis and A. clathratum helps retard urchin grazing compared to D. aculeata and the highly consumed kelp Alaria esculenta. In light of our findings and related studies, we propose fundamental changes to the study of community shifts in shallow, rocky ecosystems in eastern Canada. In particular, we advocate the need to regard certain canopy-forming seaweeds as structuring forces interfering with top-down processes, rather than simple prey for keystone grazers. We also propose a novel, empirical model of ecological interactions for D. viridis. Overall, our study underscores the importance of studying organisms together with cross-scale environmental variability to better understand the factors and processes that shape marine communities.	[Blain, Caitlin; Gagnon, Patrick] Mem Univ Newfoundland, Ctr Ocean Sci, Dept Ocean Sci, St John, NF, Canada	Memorial University Newfoundland	Gagnon, P (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, Dept Ocean Sci, St John, NF, Canada.	pgagnon@mun.ca		Gagnon, Patrick/0000-0001-5834-0217	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1993, FUNCT ECOL, V7, P305, DOI 10.2307/2390209; Adey WH, 2011, NORTHEAST NAT, V18, P1; Amsler C. D., 2008, P91; AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; Amsler CD, 2005, MAR ECOL PROG SER, V294, P141, DOI 10.3354/meps294141; Ankisetty S, 2004, J NAT PROD, V67, P1295, DOI 10.1021/np049965c; Aumack CF, 2011, J PHYCOL, V47, P36, DOI 10.1111/j.1529-8817.2010.00927.x; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; Blain C, 2013, J EXP MAR BIOL ECOL, V440, P176, DOI 10.1016/j.jembe.2012.12.013; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Caines S, 2012, MAR BIOL, V159, P1817, DOI 10.1007/s00227-012-1972-z; CHAPMAN A R O, 1971, Phycologia, V10, P63, DOI 10.2216/i0031-8884-10-1-63.1; CHAPMAN A R O, 1972, Syesis, V5, P1; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V192, P77, DOI 10.1007/BF00006228; Clark RP, 2004, MAR ECOL PROG SER, V267, P107, DOI 10.3354/meps267107; Connell SD, 2011, J EXP MAR BIOL ECOL, V400, P296, DOI 10.1016/j.jembe.2011.02.031; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P249, DOI 10.1016/0022-0981(87)90057-8; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P217, DOI 10.1016/0022-0981(87)90056-6; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; DUGGINS DO, 1990, J EXP MAR BIOL ECOL, V143, P27, DOI 10.1016/0022-0981(90)90109-P; Gagnon P, 2003, J EXP MAR BIOL ECOL, V290, P179, DOI 10.1016/S0022-0981(03)00077-7; Gagnon P, 2005, J PHYCOL, V41, P498, DOI 10.1111/j.1529-8817.2005.00078.x; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Gagnon P, 2006, J EXP MAR BIOL ECOL, V334, P10, DOI 10.1016/j.jembe.2006.01.012; Gagnon P, 2013, MAR BIOL, V160, P439, DOI 10.1007/s00227-012-2101-8; GILINSKY E, 1984, ECOLOGY, V65, P455, DOI 10.2307/1941408; Gorley C.K., 2006, GETTING STARTED PRIM; HAGEN NT, 1995, MAR ECOL PROG SER, V123, P95, DOI 10.3354/meps123095; HIMMELMAN J H, 1984, Naturaliste Canadien (Quebec), V111, P337; HIMMELMAN JH, 1990, CAN J FISH AQUAT SCI, V47, P1011, DOI 10.1139/f90-116; Huang YSM, 2006, J EXP MAR BIOL ECOL, V329, P55, DOI 10.1016/j.jembe.2005.08.013; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Iken K, 1999, J EXP MAR BIOL ECOL, V236, P133, DOI 10.1016/S0022-0981(98)00199-3; IRLANDI EA, 1991, OECOLOGIA, V87, P307, DOI 10.1007/BF00634584; KEATS DW, 1990, MAR ECOL PROG SER, V68, P181, DOI 10.3354/meps068181; Kelly JR, 2011, MAR ECOL PROG SER, V437, P69, DOI 10.3354/meps09284; Konar B, 2000, OECOLOGIA, V125, P208, DOI 10.1007/s004420000440; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; LUNING K, 1985, MAR BIOL, V87, P119, DOI 10.1007/BF00539419; Lyons DA, 2008, AQUAT BIOL, V2, P17, DOI 10.3354/ab00035; Lyons DA, 2007, MAR BIOL, V153, P179, DOI 10.1007/s00227-007-0795-9; McCullagh P, 1989, GEN LINEAR MODELS; Molis M, 2009, POLAR BIOL, V32, P71, DOI 10.1007/s00300-008-0504-2; Pelletreau KN, 2002, MAR BIOL, V141, P1, DOI 10.1007/s00227-002-0809-6; Petraitis PS, 2010, MAR ECOL PROG SER, V413, P189, DOI 10.3354/meps08691; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ruitton S, 2000, ESTUAR COAST SHELF S, V50, P217, DOI 10.1006/ecss.1999.0546; Sasaki H, 1999, J PHYCOL, V35, P732, DOI 10.1046/j.1529-8817.1999.3540732.x; Saunders M, 2007, MAR ECOL PROG SER, V344, P95, DOI 10.3354/meps06924; Scheibling RE, 1999, CAN J FISH AQUAT SCI, V56, P2300, DOI 10.1139/cjfas-56-12-2300; Scheibling RE, 2009, MAR ECOL PROG SER, V390, P1, DOI 10.3354/meps08207; Scheibling RE, 2006, MAR ECOL PROG SER, V325, P1, DOI 10.3354/meps325001; Schiel D.R., 2001, SCIENCE CONSERV, P5; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Steinberg PD, 2002, J PHYCOL, V38, P621, DOI 10.1046/j.1529-8817.2002.02042.x; TAYLOR RB, 1994, MAR ECOL PROG SER, V115, P271, DOI 10.3354/meps115271; Vadas R.L., 1968, ECOLOGY AGARUM KELP; VADAS RL, 1977, ECOL MONOGR, V47, P337, DOI 10.2307/1942173; Watson J, 2011, ECOL MONOGR, V81, P215, DOI 10.1890/10-0262.1; Wessels H, 2006, J EXP MAR BIOL ECOL, V329, P20, DOI 10.1016/j.jembe.2005.08.006; Wiencke C., 2012, SEAWEED BIOL ECOLOGI, P265, DOI [10.1007/978-3-642-28451-9_13, DOI 10.1007/978-3-642-28451-9_13]; Zamzow JP, 2011, ANTARCT SCI, V23, P107, DOI 10.1017/S095410201000091X	69	15	15	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98204	10.1371/journal.pone.0098204	http://dx.doi.org/10.1371/journal.pone.0098204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859311	Green Published, Green Accepted, gold			2022-12-27	WOS:000336839400054
J	Ferraris, J; Zarate, S; Jaita, G; Boutillon, F; Bernadet, M; Auffret, J; Seilicovich, A; Binart, N; Goffin, V; Pisera, D				Ferraris, Jimena; Zarate, Sandra; Jaita, Gabriela; Boutillon, Florence; Bernadet, Marie; Auffret, Julien; Seilicovich, Adriana; Binart, Nadine; Goffin, Vincent; Pisera, Daniel			Prolactin Induces Apoptosis of Lactotropes in Female Rodents	PLOS ONE			English	Article							ANTERIOR-PITUITARY GLAND; MESSENGER-RIBONUCLEIC-ACID; ESTROUS-CYCLE; PRL RECEPTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL TRANSDUCER; RAT HYPOTHALAMUS; GENE-EXPRESSION; CELL TURNOVER; SHORT-FORM	Anterior pituitary cell turnover occurring during female sexual cycle is a poorly understood process that involves complex regulation of cell proliferation and apoptosis by multiple hormones. In rats, the prolactin (PRL) surge that occurs at proestrus coincides with the highest apoptotic rate. Since anterior pituitary cells express the prolactin receptor (PRLR), we aimed to address the actual role of PRL in the regulation of pituitary cell turnover in cycling females. We showed that acute hyperprolactinemia induced in ovariectomized rats using PRL injection or dopamine antagonist treatment rapidly increased apoptosis and decreased proliferation specifically of PRL producing cells (lactotropes), suggesting a direct regulation of these cell responses by PRL. To demonstrate that apoptosis naturally occurring at proestrus was regulated by transient elevation of endogenous PRL levels, we used PRLR-deficient female mice (PRLRKO) in which PRL signaling is totally abolished. According to our hypothesis, no increase in lactotrope apoptotic rate was observed at proestrus, which likely contributes to pituitary tumorigenesis observed in these animals. To decipher the molecular mechanisms underlying PRL effects, we explored the isoform-specific pattern of PRLR expression in cycling wild type females. This analysis revealed dramatic changes of long versus short PRLR ratio during the estrous cycle, which is particularly relevant since these isoforms exhibit distinct signaling properties. This pattern was markedly altered in a model of chronic PRLR signaling blockade involving transgenic mice expressing a pure PRLR antagonist (TG(Delta 1-9-G129R-hPRL)), providing evidence that PRL regulates the expression of its own receptor in an isoform-specific manner. Taken together, these results demonstrate that i) the PRL surge occurring during proestrus is a major proapoptotic signal for lactotropes, and ii) partial or total deficiencies in PRLR signaling in the anterior pituitary may result in pituitary hyperplasia and eventual prolactinoma development, as observed in TG(Delta 1-9-G129R-hPRL) and PRLRKO mice, respectively.	[Ferraris, Jimena; Zarate, Sandra; Jaita, Gabriela; Seilicovich, Adriana; Pisera, Daniel] UBA CONICET, Inst Invest Biomed, Buenos Aires, DF, Argentina; [Boutillon, Florence; Bernadet, Marie; Goffin, Vincent] Univ Paris 05, Sorbonne Paris Cite, INSERM, U1151,INEM,Team PRL GH Pathophysiol,Fac Med, F-75993 Paris 14, France; [Auffret, Julien; Binart, Nadine] INSERM, U693, F-94276 Le Kremlin Bicetre, France; [Auffret, Julien; Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, UMR S693, F-94276 Le Kremlin Bicetre, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Pisera, D (corresponding author), UBA CONICET, Inst Invest Biomed, Buenos Aires, DF, Argentina.	dpisera@fmed.uba.ar	GOFFIN, Vincent/G-3322-2013; Binart, Nadine/F-2949-2013	GOFFIN, Vincent/0000-0002-8021-3086; Binart, Nadine/0000-0002-5606-3866; JAITA, GABRIELA/0000-0002-6513-0514; Ferraris, Jimena/0000-0001-7472-0439; Pisera, Daniel/0000-0001-8795-1551	Agencia Nacional de Promocion de Ciencia y Tecnica (ANPCYT) [PICT 092, PICT 0088]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); University of Buenos Aires, Argentine [UBACYT M057]; INSERM-CONICET, Argentina; INSERM-CONICET, France; Association for International Cancer Research (AICR) [05-0603]; Institut National de la Sante et de la Recherche Medicale; University Paris Descartes, France; ANPCyT (Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (Argentina); Bourse Doctorale Universitaire de Mobilite from the Universite Paris Descartes (France)	Agencia Nacional de Promocion de Ciencia y Tecnica (ANPCYT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires, Argentine(University of Buenos Aires); INSERM-CONICET, Argentina; INSERM-CONICET, France; Association for International Cancer Research (AICR); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes, France; ANPCyT (Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Bourse Doctorale Universitaire de Mobilite from the Universite Paris Descartes (France)	This work was supported by PICT 092 and PICT 0088 Agencia Nacional de Promocion de Ciencia y Tecnica (ANPCYT) http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt, Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (PIP 2010-2012) www.conicet.gov.ar and University of Buenos Aires (UBACYT M057) www.uba.ar, Argentine; INSERM-CONICET project conjoint de cooperation international 2009-2010 www.conicet.gov.ar, Argentina and France; Association for International Cancer Research (AICR grant #05-0603) http://www.aicr.org.uk/CurrentProjects.stm, the Institut National de la Sante et de la Recherche Medicale and University Paris Descartes, France. Ferraris Jimena obtained fellowships from the ANPCyT (Argentina), Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) (Argentina) and a Bourse Doctorale Universitaire de Mobilite from the Universite Paris Descartes (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral VC, 2013, GEN COMP ENDOCRINOLO; ARZT E, 1993, ENDOCRINOLOGY, V132, P459, DOI 10.1210/en.132.1.459; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berlanga JJ, 1997, MOL ENDOCRINOL, V11, P1449, DOI 10.1210/me.11.10.1449; Bernichtein S, 2010, J ENDOCRINOL, V206, P1, DOI 10.1677/JOE-10-0069; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Binart N, 2003, MOL ENDOCRINOL, V17, P1066, DOI 10.1210/me.2002-0181; Binart N, 2010, TRENDS ENDOCRIN MET, V21, P362, DOI 10.1016/j.tem.2010.01.008; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bouilly J, 2012, MOL CELL ENDOCRINOL, V356, P80, DOI 10.1016/j.mce.2011.05.004; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Candolfi M, 2006, FRONT HORM RES, V35, P9, DOI 10.1159/000094260; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Chesnokova V, 2013, P NATL ACAD SCI USA, V110, pE3331, DOI 10.1073/pnas.1310589110; Childs AJ, 2006, PHYSL REPROD; CHIU S, 1992, ENDOCRINOLOGY, V130, P1747, DOI 10.1210/en.130.3.1747; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P301, DOI 10.1016/j.tem.2006.08.002; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; Cruz-Soto ME, 2002, ENDOCRINOLOGY, V143, P4429, DOI 10.1210/en.2002-220173; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; Devost D, 1999, MOL CELL ENDOCRINOL, V158, P99, DOI 10.1016/S0303-7207(99)00178-1; Dworakowska D, 2009, BEST PRACT RES CL EN, V23, P525, DOI 10.1016/j.beem.2009.05.004; Fernandez I, 2010, J NEUROENDOCRINOL, V22, P771, DOI 10.1111/j.1365-2826.2010.02011.x; Ferraris J, 2013, NEUROENDOCRINOLOGY; Ferraris J, 2012, AM J PHYSIOL-ENDOC M, V302, pE356, DOI 10.1152/ajpendo.00333.2011; Ferraris J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021806; FLURKEY K, 1982, BIOL REPROD, V26, P835, DOI 10.1095/biolreprod26.5.835; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Goffin V, 2011, NAT REV UROL, V8, P597, DOI 10.1038/nrurol.2011.143; HASHI A, 1995, ENDOCRINOLOGY, V136, P4665, DOI 10.1210/en.136.10.4665; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Jabbour H N, 1997, Rev Reprod, V2, P14; Jahn GA, 1997, BIOL REPROD, V57, P894, DOI 10.1095/biolreprod57.4.894; Jaita G, 2005, ENDOCRINOLOGY, V146, P4737, DOI 10.1210/en.2005-0279; Jaita G, 2011, ENDOCRINE, V39, P21, DOI 10.1007/s12020-010-9407-4; Jin L, 1997, J CLIN ENDOCR METAB, V82, P963, DOI 10.1210/jc.82.3.963; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; KROWN KA, 1992, ENDOCRINOLOGY, V131, P595, DOI 10.1210/en.131.2.595; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma FY, 2005, ENDOCRINOLOGY, V146, P93, DOI 10.1210/en.2004-0800; Ma FY, 2005, ENDOCRINOLOGY, V146, P5112, DOI 10.1210/en.2005-0770; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; MICHAEL SD, 1976, P SOC EXP BIOL MED, V153, P254, DOI 10.3181/00379727-153-39522; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; NAGANO M, 1994, J BIOL CHEM, V269, P13337; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; Newey PJ, 2013, NEW ENGL J MED, V369, P2012, DOI 10.1056/NEJMoa1307557; Nolan LA, 1998, J NEUROENDOCRINOL, V10, P207, DOI 10.1046/j.1365-2826.1998.00191.x; OISHI Y, 1993, ANAT RECORD, V235, P111, DOI 10.1002/ar.1092350111; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Pisera D, 2004, AM J PHYSIOL-ENDOC M, V287, pE767, DOI 10.1152/ajpendo.00052.2004; Radl DB, 2008, NEUROENDOCRINOLOGY, V88, P43, DOI 10.1159/000116117; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sangeeta Devi Y, 2013, MOL CELL ENDOCRINOL; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Shao R, 2008, BIOL REPROD, V79, P748, DOI 10.1095/biolreprod.108.070003; SHIU RPC, 1983, ENDOCRINOLOGY, V113, P159, DOI 10.1210/endo-113-1-159; Silveyra P, 2007, AM J PHYSIOL-ENDOC M, V292, pE820, DOI 10.1152/ajpendo.00467.2006; Stankiewicz TR, 2012, J BIOL CHEM, V287, P16835, DOI 10.1074/jbc.M111.302166; TAKAHASHI S, 1984, CELL TISSUE RES, V235, P497, DOI 10.1007/BF00226945; Recouvreux MV, 2012, ENDOCRINOLOGY, V153, P3861, DOI 10.1210/en.2012-1007; Recouvreux MV, 2011, ENDOCRINOLOGY, V152, P2722, DOI 10.1210/en.2010-1464; Zaldivar V, 2011, NEUROENDOCRINOLOGY, V93, P106, DOI 10.1159/000323760; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2010, FRONT HORM RES, V38, P25, DOI 10.1159/000318491; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008; Zarate S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041299	71	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97383	10.1371/journal.pone.0097383	http://dx.doi.org/10.1371/journal.pone.0097383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859278	Green Published, Green Submitted, gold			2022-12-27	WOS:000336839400014
J	Guillot, M; Taylor, PM; Rialland, P; Klinck, MP; Martel-Pelletier, J; Pelletier, JP; Troncy, E				Guillot, Martin; Taylor, Polly M.; Rialland, Pascale; Klinck, Mary P.; Martel-Pelletier, Johanne; Pelletier, Jean-Pierre; Troncy, Eric			Evoked Temporal Summation in Cats to Highlight Central Sensitization Related to Osteoarthritis-Associated Chronic Pain: A Preliminary Study	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; 2ND PAIN; NMDA RECEPTOR; WIND-UP; SENSITIVITY; SENSATIONS; DIAGNOSIS; RESPONSES; NEURONS; RELIEF	In cats, osteoarthritis causes significant chronic pain. Chronicity of pain is associated with changes in the central nervous system related to central sensitization, which have to be quantified. Our objectives were 1) to develop a quantitative sensory testing device in cats for applying repetitive mechanical stimuli that would evoke temporal summation; 2) to determine the sensitivity of this test to osteoarthritis-associated pain, and 3) to examine the possible correlation between the quantitative sensory testing and assessment using other pain evaluation methods. We hypothesized that mechanical sub-threshold repetitive stimuli would evoke temporal summation, and that cats with osteoarthritis would show a faster response. A blinded longitudinal study was performed in 4 non-osteoarthritis cats and 10 cats with naturally occurring osteoarthritis. Quantification of chronic osteoarthritis pain-related disability was performed over a two week period using peak vertical force kinetic measurement, motor activity intensity assessment and von Frey anesthesiometer-induced paw withdrawal threshold testing. The cats afflicted with osteoarthritis demonstrated characteristic findings consistent with osteoarthritis-associated chronic pain. After a 14-day acclimation period, repetitive mechanical sub-threshold stimuli were applied using a purpose-developed device. Four stimulation profiles of predetermined intensity, duration and time interval were applied randomly four times during a four-day period. The stimulation profiles were different (P<0.001): the higher the intensity of the stimulus, the sooner it produced a consistent painful response. The cats afflicted with osteoarthritis responded more rapidly than cats osteoarthritis free (P = 0.019). There was a positive correlation between the von Frey anesthesiometer-induced paw withdrawal threshold and the response to stimulation profiles #2 (2N/0.4 Hz) and #4 (2N/0.4 Hz): Rho(s) = 0.64 (P = 0.01) and 0.63 (P = 0.02) respectively. This study is the first report of mechanical temporal summation in awake cats. Our results suggest that central sensitization develops in cats with naturally occurring osteoarthritis, providing an opportunity to improve translational research in osteoarthritis-associated chronic pain.	[Guillot, Martin; Rialland, Pascale; Klinck, Mary P.; Troncy, Eric] Univ Montreal, Fac Vet Med, Dept Biomed Sci, GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada; [Guillot, Martin; Rialland, Pascale; Klinck, Mary P.; Martel-Pelletier, Johanne; Pelletier, Jean-Pierre; Troncy, Eric] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Osteoarthrit Res Unit, Montreal, PQ H3C 3J7, Canada; [Taylor, Polly M.] Gravel Head Farm, Topcat Metrol, Nr Ely, Cambs, England	Universite de Montreal; Universite de Montreal	Troncy, E (corresponding author), Univ Montreal, Fac Vet Med, Dept Biomed Sci, GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada.	eric.troncy@umontreal.ca	Pelletier, Jean-Pierre/AAG-2896-2019; Martel-Pelletier, Johanne/AAG-2928-2019; Troncy, Eric/J-6650-2013; Taylor, Polly/M-3239-2015	Troncy, Eric/0000-0003-0209-5261; Taylor, Polly/0000-0003-1322-3468	Quebec Bio-Imaging Network of the Fonds de recherche du Quebec - Sante [5886]; ArthroLab, Inc. from the Natural Sciences and Engineering Research Council (NSERC) of Canada; New Opportunities Fund grant [9483]; Leader Opportunity Fund grant [24601]; Alexander Graham Bell NSERC Canada Graduate Scholarship; Canadian Institutes of Health Research - MENTOR Strategic Training Initiative in Health Research Program; NSERC of Canada [406726]; Fonds de recherche du Quebec - Nature et Technologies [144812]; ArthroLab, Inc.;  [327158-2008];  [441651-2013];  [RDCPJ 418399-11]	Quebec Bio-Imaging Network of the Fonds de recherche du Quebec - Sante; ArthroLab, Inc. from the Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Opportunities Fund grant; Leader Opportunity Fund grant; Alexander Graham Bell NSERC Canada Graduate Scholarship; Canadian Institutes of Health Research - MENTOR Strategic Training Initiative in Health Research Program(Canadian Institutes of Health Research (CIHR)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et Technologies; ArthroLab, Inc.; ; ; 	This study was supported in part by a Pilot Study grant from the Quebec Bio-Imaging Network (#5886) of the Fonds de recherche du Quebec - Sante (Pr. Eric Troncy), by a Discovery grant (#327158-2008, #441651-2013, supporting salaries) and a Collaborative Research and Development grant (#RDCPJ 418399-11, supporting operations and salaries) in partnership with ArthroLab, Inc. from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Pr. Eric Troncy), as well as an ongoing New Opportunities Fund grant (#9483) and a Leader Opportunity Fund grant (#24601), supporting pain/function equipment from the Canada Foundation for Innovation (Pr. Eric Troncy). The funding sources were not involved in the study design, collection, analysis and interpretation of data, writing of the manuscript, nor in the decision to submit the manuscript for publication. Dr. Martin Guillot was the recipient of an Alexander Graham Bell NSERC Canada Graduate Scholarship for doctorate research, and a Doctoral Scholarship from the Canadian Institutes of Health Research - MENTOR Strategic Training Initiative in Health Research Program. Dr. Pascale Rialland received a doctoral Industrial Innovation Scholarship from a partnership including NSERC of Canada (#406726), Fonds de recherche du Quebec - Nature et Technologies (#144812) and ArthroLab, Inc. Dr. Mary Klinck was the recipient of a Zoetis - Morris Animal Foundation (#D10-901) doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2011, BEST PRACT RES CL RH, V25, P209, DOI 10.1016/j.berh.2010.01.013; Arendt-Nielsen L, 2011, REGION ANESTH PAIN M, V36, P585, DOI 10.1097/AAP.0b013e31822b0db0; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Beale BS, 2005, VET CLIN N AM-SMALL, V35, P655, DOI 10.1016/j.cvsm.2005.01.001; Bennett D, 2012, J FELINE MED SURG, V14, P65, DOI 10.1177/1098612X11432828; Bennett D, 2009, J FELINE MED SURG, V11, P997, DOI 10.1016/j.jfms.2009.09.016; Boyce-Rustay JM, 2010, NEUROPHARMACOLOGY, V58, P537, DOI 10.1016/j.neuropharm.2009.08.008; Brown H, 2006, APPL MIXED MODELS ME, P107; Brown H, 2006, APPL MIXED MODELS ME, P215; Brydges NM, 2012, VET J, V193, P545, DOI 10.1016/j.tvjl.2012.01.019; D'Anjou MA, 2008, VET SURG, V37, P166, DOI 10.1111/j.1532-950X.2007.00363.x; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; Dixon MJ, 2010, LAB ANIM-UK, V44, P247, DOI 10.1258/la.2010.009080; Dolgin E, 2010, NAT MED, V16, P1237, DOI 10.1038/nm1110-1237; Frakes EP, 2011, CURR MED RES OPIN, V27, P2361, DOI 10.1185/03007995.2011.633502; Guillot M, 2013, VET J, V196, P360, DOI 10.1016/j.tvjl.2013.01.009; Guillot M, 2012, VET SURG, V41, P328, DOI 10.1111/j.1532-950X.2012.00976.x; Hardie EM, 2002, J AM VET MED ASSOC, V220, P628, DOI 10.2460/javma.2002.220.628; Hendiani JA, 2003, J PAIN, V4, P203, DOI 10.1016/S1526-5900(03)00557-1; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Imamura M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1424, DOI 10.1002/art.24120; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klinck MP, 2012, CAN VET J, V53, P1181; Lascelles BDX, 2010, J VET INTERN MED, V24, P487, DOI 10.1111/j.1939-1676.2010.0495.x; Lascelles BDX, 2007, J VET INTERN MED, V21, P410, DOI 10.1892/0891-6640(2007)21[410:EOCOMA]2.0.CO;2; Lascelles BDX, 2013, VET J, V197, P115, DOI 10.1016/j.tvjl.2013.02.025; Lascelles BDX, 2010, VET SURG, V39, P2, DOI 10.1111/j.1532-950X.2009.00597.x; Littell R. C, 2006, SAS MIXED MODELS, P159; Lomas LM, 2005, PSYCHOPHARMACOLOGY, V180, P84, DOI 10.1007/s00213-005-2153-2; Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759; MENDELL LM, 1965, NATURE, V206, P97, DOI 10.1038/206097a0; Moreau M, 2013, RES VET SCI, V95, P219, DOI 10.1016/j.rvsc.2013.01.020; Navratilova E, 2013, ANN NY ACAD SCI, V1282, P1, DOI 10.1111/nyas.12095; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; PRICE DD, 1994, PAIN, V59, P165, DOI 10.1016/0304-3959(94)90069-8; Slingerland LI, 2011, VET J, V187, P304, DOI 10.1016/j.tvjl.2009.12.014; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6; Stroup W. W, 2013, GEN LINEAR MIXED MOD, P413; Suokas AK, 2012, OSTEOARTHR CARTILAGE, V20, P1075, DOI 10.1016/j.joca.2012.06.009; Vierck CJ, 1997, J NEUROPHYSIOL, V78, P992, DOI 10.1152/jn.1997.78.2.992; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; YEOMANS DC, 1995, BRAIN RES, V670, P297, DOI 10.1016/0006-8993(94)01349-M; Zamprogno H, 2010, AM J VET RES, V71, P1417, DOI 10.2460/ajvr.71.12.1417; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e97347	10.1371/journal.pone.0097347	http://dx.doi.org/10.1371/journal.pone.0097347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24859251	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400013
J	Khan, WA; Galagan, SR; Prue, CS; Khyang, J; Ahmed, S; Ram, M; Alam, MS; Haq, MZ; Akter, J; Glass, G; Norris, DE; Shields, T; Sack, DA; Sullivan, DJ; Nyunt, MM				Khan, Wasif A.; Galagan, Sean R.; Prue, Chai Shwai; Khyang, Jacob; Ahmed, Sabeena; Ram, Malathi; Alam, Mohammad Shafiul; Haq, M. Zahirul; Akter, Jasmin; Glass, Gregory; Norris, Douglas E.; Shields, Timothy; Sack, David A.; Sullivan, David J., Jr.; Nyunt, Myaing M.			Asymptomatic Plasmodium falciparum Malaria in Pregnant Women in the Chittagong Hill Districts of Bangladesh	PLOS ONE			English	Article							INTERMITTENT SULFADOXINE-PYRIMETHAMINE; INFANT-MORTALITY; DIAGNOSTIC-TESTS; VIVAX MALARIA; BURDEN; ANEMIA; AREA; EPIDEMIOLOGY; PREVENTION; RISK	Background: Pregnancy is a known risk factor for malaria which is associated with increased maternal and infant mortality and morbidity in areas of moderate-high malaria transmission intensity where Plasmodium falciparum predominates. The nature and impact of malaria, however, is not well understood in pregnant women residing in areas of low, unstable malaria transmission where P. falciparum and P. vivax co-exist. Methods: A large longitudinal active surveillance study of malaria was conducted in the Chittagong Hill Districts of Bangladesh. Over 32 months in 2010-2013, the period prevalence of asymptomatic P. falciparum infections was assessed by rapid diagnostic test and blood smear and compared among men, non-pregnant women and pregnant women. A subset of samples was tested for infection by PCR. Hemoglobin was assessed. Independent risk factors for malaria infection were determined using a multivariate logistic regression model. Results: Total of 34 asymptomatic P. falciparum infections were detected by RDT/smear from 3,110 tests. The period prevalence of asymptomatic P. falciparum infection in pregnant women was 2.3%, compared to 0.5% in non-pregnant women and 0.9% in men. All RDT/smear positive samples that were tested by PCR were PCR-positive, and PCR detected additional 35 infections that were RDT/smear negative. In a multivariate logistic regression analysis, pregnant women had 5.4-fold higher odds of infection as compared to non-pregnant women. Malaria-positive pregnant women, though asymptomatic, had statistically lower hemoglobin than those without malaria or pregnancy. Asymptomatic malaria was found to be evenly distributed across space and time, in contrast to symptomatic infections which tend to cluster. Conclusion: Pregnancy is a risk factor for asymptomatic P. falciparum infection in the Chittagong Hill Districts of Bangladesh, and pregnancy and malaria interact to heighten the effect of each on hemoglobin. The even distribution of asymptomatic malaria, without temporal and spatial clustering, may have critical implications for malaria elimination strategies.	[Khan, Wasif A.; Prue, Chai Shwai; Khyang, Jacob; Ahmed, Sabeena; Alam, Mohammad Shafiul; Haq, M. Zahirul; Akter, Jasmin] Int Ctr Diarrhoeal Dis Res, Ctr Populat Urbanizat & Climate Change, Dhaka 1000, Bangladesh; [Galagan, Sean R.; Glass, Gregory; Norris, Douglas E.; Shields, Timothy; Sack, David A.; Sullivan, David J., Jr.; Nyunt, Myaing M.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Galagan, Sean R.; Sack, David A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Nyunt, Myaing M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Nyunt, MM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	mnyunt@medicine.umaryland.edu	Norris, Doug/GXV-3397-2022; Alam, Mohammad Shafiul/C-2285-2011	Alam, Mohammad Shafiul/0000-0001-8330-5499; Akter, Jasmin/0000-0003-3685-0106; Norris, Douglas/0000-0002-4631-2777	Johns Hopkins Malaria Research Institute of Johns Hopkins Bloomberg School of Public Health; Bloomberg Family Foundation [00679]	Johns Hopkins Malaria Research Institute of Johns Hopkins Bloomberg School of Public Health; Bloomberg Family Foundation	This research is funded by Johns Hopkins Malaria Research Institute of Johns Hopkins Bloomberg School of Public Health, and Bloomberg Family Foundation, grant number 00679. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S M, 2001, Asia Pac J Public Health, V13, P100, DOI 10.1177/101053950101300208; Ahmed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069713; Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Bouvier P, 1997, AM J TROP MED HYG, V56, P378, DOI 10.4269/ajtmh.1997.56.378; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Haque U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-185; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Khan WA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-124; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; McGregor I, 1984, ANN TROP MED PARASIT, V63, P245; Ndao CT, 2009, AM J EPIDEMIOL, V170, P847, DOI 10.1093/aje/kwp207; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; Reid HL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-170; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rogerson SJ, 2000, T ROY SOC TROP MED H, V94, P549, DOI 10.1016/S0035-9203(00)90083-X; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Sartelet H, 1996, LANCET, V347, P1121, DOI 10.1016/S0140-6736(96)90321-9; Schachterle SE, 2011, J CLIN MICROBIOL, V49, P3885, DOI 10.1128/JCM.01157-11; Shulman CE, 2003, T ROY SOC TROP MED H, V97, P30, DOI 10.1016/S0035-9203(03)90012-5; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Steketee RW, 1996, AM J TROP MED HYG, V55, P24, DOI 10.4269/ajtmh.1996.55.24; Steketee RW, 1996, AM J TROP MED HYG, V55, P17, DOI 10.4269/ajtmh.1996.55.17; Steketee RW, 1996, AM J TROP MED HYG, V55, P33, DOI 10.4269/ajtmh.1996.55.33; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, pS25, DOI 10.1080/00034989957718; *WHO EXP COMM MAL, 2000, WHO TECH REP SER, V892, pR1	39	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98442	10.1371/journal.pone.0098442	http://dx.doi.org/10.1371/journal.pone.0098442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858193	gold, Green Submitted, Green Published			2022-12-27	WOS:000336839400077
J	Nieminen, MT; Novak-Frazer, L; Rautemaa, V; Rajendran, R; Sorsa, T; Ramage, G; Bowyer, P; Rautemaa, R				Nieminen, Mikko T.; Novak-Frazer, Lily; Rautemaa, Vilma; Rajendran, Ranjith; Sorsa, Timo; Ramage, Gordon; Bowyer, Paul; Rautemaa, Riina			A Novel Antifungal Is Active against Candida albicans Biofilms and Inhibits Mutagenic Acetaldehyde Production In Vitro	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TRANSCRIPTIONAL RESPONSE; SURFACE-PROTEINS; ACETYL-COENZYME; ORAL CANDIDOSIS; GENOME DATABASE; ALCOHOL; GROWTH; SUSCEPTIBILITY; IDENTIFICATION	The ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We have previously shown that most Candida spp. can produce significant levels of mutagenic acetaldehyde (ACH). ACH is also an important mediator of candidal biofilm formation. We have also reported that D,L-2-hydroxyisocaproic acid (HICA) significantly inhibits planktonic growth of C. albicans. The aim of the present study was to investigate the effect of HICA on C. albicans biofilm formation and ACH production in vitro. Inhibition of biofilm formation by HICA, analogous control compounds or caspofungin was measured using XTT to measure biofilm metabolic activity and PicoGreen as a marker of biomass. Biofilms were visualised by scanning electron microscopy (SEM). ACH levels were measured by gas chromatography. Transcriptional changes in the genes involved in ACH metabolism were measured using RT-qPCR. The mean metabolic activity and biomass of all pre-grown (4, 24, 48 h) biofilms were significantly reduced after exposure to HICA (p<0.05) with the largest reductions seen at acidic pH. Caspofungin was mainly active against biofilms pre-grown for 4 h at neutral pH. Mutagenic levels (>40 mu M) of ACH were detected in 24 and 48 h biofilms at both pHs. Interestingly, no ACH production was detected from D-glucose in the presence of HICA at acidic pH (p<.05). Expression of genes responsible for ACH catabolism was up-regulated by HICA but down-regulated by caspofungin. SEM showed aberrant hyphae and collapsed hyphal structures during incubation with HICA at acidic pH. We conclude that HICA has potential as an antifungal agent with ability to inhibit C. albicans cell growth and biofilm formation. HICA also significantly reduces the mutagenic potential of C. albicans biofilms, which may be important when treating bacterial-fungal biofilm infections.	[Nieminen, Mikko T.; Rautemaa, Riina] Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland; [Nieminen, Mikko T.; Sorsa, Timo] Univ Helsinki, Dept Periodontol, Inst Dent, SF-00300 Helsinki, Finland; [Nieminen, Mikko T.; Rautemaa, Riina] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Sorsa, Timo; Rautemaa, Riina] Univ Helsinki, Cent Hosp Finland, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Nieminen, Mikko T.; Novak-Frazer, Lily; Rautemaa, Vilma; Bowyer, Paul; Rautemaa, Riina] Univ Manchester, Univ S Manchester Hosp, Wythenshawe Hosp, Inst Inflammat & Repair,Manchester Acad Hlth Sci, Manchester, Lancs, England; [Rajendran, Ranjith; Ramage, Gordon] Univ Glasgow, Sch Med, Coll Med Vet & Life Sci, Infect & Immun Res Grp,Glasgow Dent Sch & Hosp, Glasgow, Lanark, Scotland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Glasgow	Rautemaa, R (corresponding author), Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland.	riina.richardson@manchester.ac.uk	Frazer, LilyAnn Novak/O-1831-2017; Ramage, Gordon/AAX-1315-2020	Frazer, LilyAnn Novak/0000-0002-1434-3915; Rautemaa, Vilma/0000-0003-2493-2198; bowyer, paul/0000-0002-1083-9286; Rajendran, Ranjith/0000-0002-1069-7986; Nieminen, Mikko/0000-0001-6427-3196; Richardson, Riina/0000-0002-1071-6040	Yrjo Jahsson Foundation; Orion Research Foundation; Finnish Dental Society Apollonia; National Aspergillosis Centre, UK; EU; Helsinki University Central Hospital Research Foundation	Yrjo Jahsson Foundation; Orion Research Foundation; Finnish Dental Society Apollonia; National Aspergillosis Centre, UK; EU(European Commission); Helsinki University Central Hospital Research Foundation	MN received funding from Yrjo Jahsson Foundation (www.yjs.fi), Orion Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/) and Finnish Dental Society Apollonia (www.apollonia.fi). R. Rautemaa, VR and LNF were supported by the National Aspergillosis Centre, UK (www.uhsm.nhs.uk/nac/Pages/default.aspx). PB received funding from EU framework 7 (http://cordis.europa.eu/fp7/home_en.html). TS was supported by Helsinki University Central Hospital Research Foundation (http://www.hus.fi/tutkijalle/tutkimusrahoitus/Sivut/default.aspx). GR and R. Rajendran received no funding towards this piece of work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Baillie GS, 1999, METHOD ENZYMOL, V310, P644; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; BOEBEL KP, 1982, J NUTR, V112, P1929, DOI 10.1093/jn/112.10.1929; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carman AJ, 2008, EUKARYOT CELL, V7, P1733, DOI 10.1128/EC.00253-08; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crowley S, 2012, J APPL MICROBIOL, V113, P1417, DOI 10.1111/jam.12012; Crowley S, 2013, FOLIA MICROBIOL, V58, P291, DOI 10.1007/s12223-012-0209-3; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Dowd SE, 2011, J WOUND CARE, V20, P40, DOI 10.12968/jowc.2011.20.1.40; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guo JH, 2012, BIOENGINEERED, V3, P104, DOI 10.4161/bbug.19624; Hennicke F, 2013, EUKARYOT CELL, V12, P604, DOI 10.1128/EC.00336-12; HIETALA PK, 1979, NUTR METAB, V23, P227; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kohler Gerwald A, 2012, Infect Dis Obstet Gynecol, V2012, P636474, DOI 10.1155/2012/636474; Kucharikova S, 2011, J MED MICROBIOL, V60, P1261, DOI 10.1099/jmm.0.032037-0; LAND GA, 1975, INFECT IMMUN, V12, P119, DOI 10.1128/IAI.12.1.119-127.1975; Hernaez ML, 2010, J PROTEOMICS, V73, P1404, DOI 10.1016/j.jprot.2010.02.008; Maestre O, 2008, APPL ENVIRON MICROB, V74, P702, DOI 10.1128/AEM.01805-07; Marstorp H, 1999, SOIL BIOL BIOCHEM, V31, P1443, DOI 10.1016/S0038-0717(99)00065-6; Martinez-Gomariz M, 2009, PROTEOMICS, V9, P2230, DOI 10.1002/pmic.200700594; Marttila E, 2013, MOL ORAL MICROBIOL, V28, P281, DOI 10.1111/omi.12024; Marttila E, 2013, OR SURG OR MED OR PA, V116, P61, DOI 10.1016/j.oooo.2013.02.009; Mero AA, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-1; Monteoliva L, 2011, J PROTEOME RES, V10, P502, DOI 10.1021/pr100710g; Mousa HAL, 1999, BURNS, V25, P145, DOI 10.1016/S0305-4179(98)00148-X; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Nieminen MT, 2009, ORAL ONCOL, V45, pE245, DOI 10.1016/j.oraloncology.2009.08.002; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Odds FC, 1979, CANDIDA CANDIDOSIS; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaller M, 2011, J CLIN MICROBIOL, V49, P624, DOI 10.1128/JCM.02120-10; Pfaller MA, 2006, J CLIN MICROBIOL, V44, P760, DOI 10.1128/JCM.44.3.760-763.2006; Pierce JV, 2013, EUKARYOT CELL, V12, P37, DOI 10.1128/EC.00236-12; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Ramage G, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00220; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rautemaa R, 2007, ORAL ONCOL, V43, P607, DOI 10.1016/j.oraloncology.2006.07.005; Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Sakko M, 2014, MYCOSES, V57, P214, DOI 10.1111/myc.12145; Sakko M, 2012, INT J ANTIMICROB AG, V39, P539, DOI 10.1016/j.ijantimicag.2012.02.006; Salaspuro M, 2009, SCAND J GASTROENTERO, V44, P912, DOI 10.1080/00365520902912563; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Saravanan P, 2009, J HAZARD MATER, V162, P476, DOI 10.1016/j.jhazmat.2008.05.069; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Seneviratne CJ, 2008, PROTEOMICS, V8, P2936, DOI 10.1002/pmic.200701097; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; Stichternoth C, 2009, APPL ENVIRON MICROB, V75, P3663, DOI 10.1128/AEM.00098-09; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Strijbis K, 2009, FASEB J, V23, P2349, DOI 10.1096/fj.08-127985; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Thomas DP, 2006, PROTEOMICS, V6, P6033, DOI 10.1002/pmic.200600321; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Uittamo J, 2009, INT J CANCER, V124, P754, DOI 10.1002/ijc.23976; Uittamo J, 2011, INT J CANCER, V129, P2038, DOI 10.1002/ijc.25844; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vediyappan G, 2010, ANTIMICROB AGENTS CH, V54, P2096, DOI 10.1128/AAC.01638-09; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WAIN WH, 1975, SABOURAUDIA, V13, P74; Walker LA, 2013, ANTIMICROB AGENTS CH, V57, P146, DOI 10.1128/AAC.01486-12; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; Westermarck HW, 1997, Patent, Patent No. [EP 0871438 B1, 0871438]; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; WINSTEN S, 1956, J BACTERIOL, V71, P738, DOI 10.1128/JB.71.6.738-738.1956	86	21	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97864	10.1371/journal.pone.0097864	http://dx.doi.org/10.1371/journal.pone.0097864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867320	Green Published, gold, Green Accepted			2022-12-27	WOS:000336914100024
J	Zhang, DP; Chen, L; Li, DH; Lv, B; Chen, Y; Chen, JG; Yan, XJ; Liang, JS				Zhang, Dongping; Chen, Li; Li, Dahong; Lv, Bing; Chen, Yun; Chen, Jingui; Yan, Xuejiao; Liang, Jiansheng			OsRACK1 Is Involved in Abscisic Acid- and H2O2-Mediated Signaling to Regulate Seed Germination in Rice (Oryza sativa, L.)	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PROTEOMIC ANALYSIS; INNATE IMMUNITY; ABA CATABOLISM; RACK1; DORMANCY; PROTEIN; GENE; TRANSCRIPTION; NETWORKS	The receptor for activated C kinase 1 (RACK1) is one member of the most important WD repeat-containing family of proteins found in all eukaryotes and is involved in multiple signaling pathways. However, compared with the progress in the area of mammalian RACK1, our understanding of the functions and molecular mechanisms of RACK1 in the regulation of plant growth and development is still in its infancy. In the present study, we investigated the roles of rice RACK1A gene (OsRACK1A) in controlling seed germination and its molecular mechanisms by generating a series of transgenic rice lines, of which OsRACK1A was either over-expressed or under-expressed. Our results showed that OsRACK1A positively regulated seed germination and negatively regulated the responses of seed germination to both exogenous ABA and H2O2. Inhibition of ABA biosynthesis had no enhancing effect on germination, whereas inhibition of ABA catabolism significantly suppressed germination. ABA inhibition on seed germination was almost fully recovered by exogenous H2O2 treatment. Quantitative analyses showed that endogenous ABA levels were significantly higher and H2O2 levels significantly lower in OsRACK1A-down regulated transgenic lines as compared with those in wildtype or OsRACK1A-up regulated lines. Quantitative real-time PCR analyses showed that the transcript levels of OsRbohs and amylase genes, RAmy1A and RAmy3D, were significantly lower in OsRACK1A-down regulated transgenic lines. It is concluded that OsRACK1A positively regulates seed germination by controlling endogenous levels of ABA and H2O2 and their interaction.	[Zhang, Dongping; Chen, Li; Lv, Bing; Chen, Yun; Yan, Xuejiao; Liang, Jiansheng] Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Li, Dahong] Huanghuai Univ, Dept Biol Engn, Zhumadian City, Henan Province, Peoples R China; [Chen, Jingui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Yangzhou University; Huanghuai University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Liang, JS (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China.	jsliang@yzu.edu.cn	Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011; Zhang, Dongping/AAD-9164-2019	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Zhang, Dongping/0000-0001-8564-8348; Yu, Jianming/0000-0001-5326-3099	National Science Foundation of China [31271622]; Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China [2008AA10Z120]; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	This work was supported by the National Science Foundation of China (grant no: 31271622 to JSL) and the Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China (grant no: 2008AA10Z120 to JSL), and by the College Postgraduate Research and Innovation Project in Jiangsu Province (to DPZ) and University Innovation Training Program of Jiangsu Province (to SJY) for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 2011, CELL COMMUN SIGNAL, V9, P823; Bahin E, 2011, PLANT CELL ENVIRON, V34, P980, DOI 10.1111/j.1365-3040.2011.02298.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Barba-Espin G, 2010, PLANT CELL ENVIRON, V33, P981, DOI 10.1111/j.1365-3040.2010.02120.x; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Chaudhuri A., 2013, J PLANT BIOCH PHYSL, DOI [10.4172/jpbp.1000103, DOI 10.4172/JPBP.1000103]; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Diaz-Vivancos P, 2013, PLANT CELL REP, V32, P1491, DOI 10.1007/s00299-013-1473-7; El-Maarouf-Bouteau H, 2008, PLANT SIGNAL BEHAV, V3, P175, DOI 10.4161/psb.3.3.5539; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Guo J., 2007, INT J PLANT DEV BIOL, V1, P95; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Ishibashi Yushi, 2013, Ann Bot, V111, P95, DOI 10.1093/aob/mcs240; Ishibashi Y, 2008, PLANT SIGNAL BEHAV, V3, P183, DOI 10.4161/psb.3.3.5540; Ishida S, 1996, PLANT CELL PHYSIOL, V37, P439, DOI 10.1093/oxfordjournals.pcp.a028965; ISHIDA S, 1993, P NATL ACAD SCI USA, V90, P11152, DOI 10.1073/pnas.90.23.11152; Islas-Flores T, 2012, PLANT SIGNAL BEHAV, V7, P132, DOI 10.4161/psb.7.1.18485; Islas-Flores T, 2009, PHYSIOL PLANTARUM, V137, P264, DOI 10.1111/j.1399-3054.2009.01280.x; IWASAKI Y, 1995, PLANT CELL PHYSIOL, V36, P505, DOI 10.1093/oxfordjournals.pcp.a078786; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Kundu N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24012; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Li Da-hong, 2008, Zhongguo Shuidao Kexue, V22, P447; Li DC, 2011, ENZYM RES, V2011, DOI DOI 10.1016/J.CATT0D.2011.04.007; Liu Jian, 2012, PLoS One, V7, pe33817, DOI 10.1371/journal.pone.0033817; Liu YG, 2010, J EXP BOT, V61, P2979, DOI 10.1093/jxb/erq125; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; QUARRIE SA, 1988, PLANTA, V173, P330, DOI 10.1007/BF00401020; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Wamaitha MJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-35; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022	53	33	37	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97120	10.1371/journal.pone.0097120	http://dx.doi.org/10.1371/journal.pone.0097120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	25072699	Green Published, gold			2022-12-27	WOS:000336914100011
J	Liu, W; Deng, LS; Song, YC; Redell, M				Liu, Wei; Deng, Lisheng; Song, Yongcheng; Redell, Michele			DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy	PLOS ONE			English	Article							RNA EXPRESSION LEVELS; HISTONE H2AX; H3K79 METHYLTRANSFERASE; METHYLATION; LINEAGE; CELLS; LEUKEMIA; CHEMORESISTANCE; TRANSLOCATIONS; RECRUITMENT	DOT1L, the only known histone H3-lysine 79 (H3K79) methyltransferase, has been shown to be essential for the survival and proliferation of mixed-linkage leukemia (MLL) gene rearranged leukemia cells, which are often resistant to conventional chemotherapeutic agents. To study the functions of DOT1L in MLL-rearranged leukemia, SYC-522, a potent inhibitor of DOT1L developed in our laboratory, was used to treat MLL-rearranged leukemia cell lines and patient samples. SYC-522 significantly inhibited methylation at H3K79, but not H3K4 or H3K27, and decreased the expression of two important leukemia-relevant genes, HOXA9 and MEIS1, by more than 50%. It also significantly reduced the expression of CCND1 and BCL2L1, which are important regulators of cell cycle and anti-apoptotic signaling pathways. Exposure of MLL-rearranged leukemia cells to this compound caused cell cycle arrest and promoted differentiation of those cells, both morphologically and by increased CD14 expression. SYC-522 did not induce apoptosis, even at 10 mM for as long as 6 days. However, treatment with this DOT1L inhibitor decreased the colony formation ability of primary MLL-rearranged AML cells by up to 50%, and promoted monocytic differentiation. Notably, SYC-522 treatment significantly increased the sensitivity of MLL-rearranged leukemia cells to chemotherapeutics, such as mitoxantrone, etoposide and cytarabine. A similar sensitization was seen with primary MLL-rearranged AML cells. SYC-522 did not affect chemotherapy-induced apoptosis in leukemia cells without MLL-rearrangement. Suppression of DOT1L activity inhibited the mitoxantrone-induced increase in the DNA damage response marker, cH2AX, and increased the level of cPARP, an intracellular marker of apoptosis. These results demonstrated that SYC-522 selectively inhibited DOT1L, and thereby altered gene expression, promoted differentiation, and increased chemosensitivity by preventing DNA damage response. Therefore, inhibition of DOT1L, in combination with DNA damaging chemotherapy, represents a promising approach to improving outcomes for MLL-rearranged leukemia.	[Liu, Wei; Redell, Michele] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Deng, Lisheng; Song, Yongcheng] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Redell, M (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	mlredell@txch.org		Redell, Michele/0000-0002-2515-3703	Cancer Prevention & Research Institute of Texas [RP110050]; NIH/NHLBI [K08 HL085018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085018] Funding Source: NIH RePORTER	Cancer Prevention & Research Institute of Texas; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cancer Prevention & Research Institute of Texas RP110050 (Y.S. and M. R.), www.cprit.state.tx.us; NIH/NHLBI K08 HL085018 (M.R.), www.nhlbi.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Anglin JL, 2012, J MED CHEM, V55, P8066, DOI 10.1021/jm300917h; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Balgobind BV, 2011, LEUKEMIA, V25, P1239, DOI 10.1038/leu.2011.90; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chen L, 2013, MANAGE COMMUN Q, V27, P3, DOI 10.1177/0893318913475485; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Deng LS, 2013, MEDCHEMCOMM, V4, P822, DOI 10.1039/c3md00021d; Deshpande AJ, 2013, BLOOD, V121, P2533, DOI 10.1182/blood-2012-11-465120; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; Gannon OM, 2013, CLIN CANCER RES, V19, P428, DOI 10.1158/1078-0432.CCR-12-2505; Guenther MG, 2008, GENE DEV, V22, P3403, DOI 10.1101/gad.1741408; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915; Neff T, 2013, BLOOD, V121, P4847, DOI 10.1182/blood-2013-02-474833; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Redell MS, 2013, BLOOD, V121, P1083, DOI 10.1182/blood-2012-04-421925; Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schultz N, 2003, NUCLEIC ACIDS RES, V31, P4959, DOI 10.1093/nar/gkg703; Smulson ME, 1998, CANCER RES, V58, P3495; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Thiel AT, 2013, HAEMATOLOGICA, V98, P918, DOI 10.3324/haematol.2012.074195; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-97; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wiltshire T, 2007, MOL PHARMACOL, V71, P1051, DOI 10.1124/mol.106.029504; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	41	79	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98270	10.1371/journal.pone.0098270	http://dx.doi.org/10.1371/journal.pone.0098270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858818	gold, Green Published, Green Submitted			2022-12-27	WOS:000336839400062
J	Yan, YF; Wang, H; Li, DF; Yang, XW; Wang, ZY; Qi, ZZ; Zhang, QW; Cui, BZ; Guo, ZB; Yu, C; Wang, J; Wang, J; Liu, GM; Song, YJ; Li, YR; Cui, YJ; Yang, RF				Yan, Yanfeng; Wang, Hu; Li, Dongfang; Yang, Xianwei; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong; Guo, Zhaobiao; Yu, Chang; Wang, Jun; Wang, Jian; Liu, Guangming; Song, Yajun; Li, Yingrui; Cui, Yujun; Yang, Ruifu			Two-Step Source Tracing Strategy of Yersinia pestis and Its Historical Epidemiology in a Specific Region	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PLAGUE-TRANSMISSION; MAXIMUM-LIKELIHOOD; INSIGHTS; MICROEVOLUTION; EVOLUTION; DYNAMICS; CHINA; DNA; POLYMORPHISMS	Source tracing of pathogens is critical for the control and prevention of infectious diseases. Genome sequencing by high throughput technologies is currently feasible and popular, leading to the burst of deciphered bacterial genome sequences. Utilizing the flooding genomic data for source tracing of pathogens in outbreaks is promising, and challenging as well. Here, we employed Yersinia pestis genomes from a plague outbreak at Xinghai county of China in 2009 as an example, to develop a simple two-step strategy for rapid source tracing of the outbreak. The first step was to define the phylogenetic position of the outbreak strains in a whole species tree, and the next step was to provide a detailed relationship across the outbreak strains and their suspected relatives. Through this strategy, we observed that the Xinghai plague outbreak was caused by Y. pestis that circulated in the local plague focus, where the majority of historical plague epidemics in the Qinghai-Tibet Plateau may originate from. The analytical strategy developed here will be of great help in fighting against the outbreaks of emerging infectious diseases, by pinpointing the source of pathogens rapidly with genomic epidemiological data and microbial forensics information.	[Yan, Yanfeng; Yang, Xianwei; Guo, Zhaobiao; Song, Yajun; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Hu; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong] Qinghai Inst Endem Dis Prevent & Control, Xining, Peoples R China; [Yan, Yanfeng; Li, Dongfang; Yu, Chang; Wang, Jun; Wang, Jian; Li, Yingrui; Cui, Yujun; Yang, Ruifu] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Guangming] Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Beijing Genomics Institute (BGI); National University of Defense Technology - China	Cui, YJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	cuiyujun.new@gmail.com; ruifuyang@gmail.com	Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Song, Yajun/GQQ-0476-2022; Yu, Chang/AAE-8538-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269; Song, Yajun/0000-0002-6628-2747; Wang, Jun/0000-0002-2113-5874; Li, Dongfang/0000-0002-6587-2892; Yang, Xianwei/0000-0003-4388-9674; Wang, Jun/0000-0002-8540-8931	State Key Development Program for Basic Research of China [2009CB522601]; Industry Research Special Foundation of China Ministry of Health [201202021]; National Natural Science Foundation of China [31000015]; National Key Program for Infectious Diseases of China [2012ZX10004215, 2013ZX10004221-002]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Industry Research Special Foundation of China Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This work was supported by the State Key Development Program for Basic Research of China (2009CB522601), the Industry Research Special Foundation of China Ministry of Health (201202021), the National Natural Science Foundation of China (31000015), and the National Key Program for Infectious Diseases of China (2012ZX10004215 and 2013ZX10004221-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Budowle B, 2005, INT J LEGAL MED, V119, P317, DOI 10.1007/s00414-005-0535-y; Colman RE, 2009, EMERG INFECT DIS, V15, P1623, DOI 10.3201/eid1510.090188; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Ji S., 1988, PLAGUE; Kaiser J, 2005, SCIENCE, V308, P31; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li M, 2005, EMERG INFECT DIS, V11, P1494, DOI 10.3201/eid1109.041147; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066567; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Takahashi H, 2004, EMERG INFECT DIS, V10, P117, DOI 10.3201/eid1001.030238; Wang H, 2011, CLIN INFECT DIS, V52, P185, DOI 10.1093/cid/ciq107; Yang R, 2012, J BIOTERR BIODEF S, VS3, DOI [10.4172/2157-2526.S3-007, DOI 10.4172/2157-2526.S3-007]; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	41	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85374	10.1371/journal.pone.0085374	http://dx.doi.org/10.1371/journal.pone.0085374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24866893	Green Submitted, gold, Green Published			2022-12-27	WOS:000329866300074
J	Li, MM; Wu, MQ; Xu, J; Du, J; Yan, CH				Li, Min-ming; Wu, Mei-qin; Xu, Jian; Du, Juan; Yan, Chong-huai			Body Burden of Hg in Different Bio-Samples of Mothers in Shenyang City, China	PLOS ONE			English	Article							BLOOD MERCURY LEVELS; UMBILICAL-CORD BLOOD; MATERNAL FISH INTAKE; PRENATAL EXPOSURE; METHYLMERCURY EXPOSURE; INORGANIC MERCURY; BREAST-MILK; GROWTH-RETARDATION; LACTATING WOMEN; PREGNANT-WOMEN	Hg is an accumulative and neuro-toxic heavy metal which has a wide range of adverse effects in human health. However, few studies are available on body burden of Hg level in different bio-samples of pregnant women in Chinese population. Therefore, this study evaluated Hg levels in different maternal bio-samples in Shenyang city, China and investigated the correlation of Hg levels in different bio-samples. From October to December 2008, 200 pregnant women about to deliver their babies at ShengJing Hospital (Shenyang city, northeast of China) participated in this study. The geometric mean (GM) of Hg levels in cord blood, maternal venous blood, breast milk, and maternal urine were 2.18 mu g/L, 1.17 mu g/L, 1.14 mu g/L, and 0.73 mu g/L, respectively, and the GM of maternal hair Hg level was 404.45 mu g/kg. There was a strong correlation between cord blood and maternal blood total Hg level (r = 0.713, P<0.001). Frequency of fish consumption more than or equal to 3 times per week during pregnancy was suggested as a significant risk factor of prenatal Hg exposure (unadjusted OR 3.5, adjusted OR 2.94, P<0.05). This study provides evidence about Hg burden of mothers and the risk factors of prenatal Hg exposure in Shenyang city, China.	[Li, Min-ming; Wu, Mei-qin; Xu, Jian; Yan, Chong-huai] Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Shanghai 200030, Peoples R China; [Du, Juan] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China	Shanghai Jiao Tong University; China Medical University	Yan, CH (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Shanghai 200030, Peoples R China.	yanch@shkeylab-ceh.org	Wu, Meiqin/HHS-2963-2022		Science and Technology Commission of Shanghai Municipality [09DZ2200900]; Natural Science Foundation of China [30872806]; Shanghai Municipal Health Bureau, China [SNXD 2011056]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau, China	This work was supported by a grant from the Science and Technology Commission of Shanghai Municipality (09DZ2200900), Natural Science Foundation of China (Grant No. 30872806), and Shanghai Municipal Health Bureau, China (SNXD 2011056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrad DA, 2007, ENVIRON HEALTH PERSP, V115, P609, DOI 10.1289/ehp.9303; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Carrington CD, 2004, REGUL TOXICOL PHARM, V40, P272, DOI 10.1016/j.yrtph.2004.07.006; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Chinese Nutrition Society, 2010, DIET GUID CHIN INH, V2010, P44; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Dastoor AP, 2004, ATMOS ENVIRON, V38, P147, DOI 10.1016/j.atmosenv.2003.08.037; DOI R, 1984, B ENVIRON CONTAM TOX, V33, P69, DOI 10.1007/BF01625513; Dorea JG, 2004, BRIT J NUTR, V92, P21, DOI 10.1079/BJN20041163; Fok TF, 2007, ENVIRON INT, V33, P84, DOI 10.1016/j.envint.2006.08.002; Gao Y, 2007, ENVIRON RES, V105, P390, DOI 10.1016/j.envres.2007.05.015; Garcia-Esquinas E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-841; Goldman LR, 2001, PEDIATRICS, V108, P197, DOI 10.1542/peds.108.1.197; Grandjean P, 1998, ENVIRON RES, V77, P165, DOI 10.1006/enrs.1997.3804; Grandjean P, 2005, ENVIRON HEALTH PERSP, V113, P905, DOI 10.1289/ehp.7842; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Gundacker C, 2002, PEDIATRICS, V110, P873, DOI 10.1542/peds.110.5.873; Guo BQ, 2013, TOXICOLOGY, V304, P57, DOI 10.1016/j.tox.2012.11.019; Halldorsson TI, 2007, AM J EPIDEMIOL, V166, P687, DOI 10.1093/aje/kwm133; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jackson LW, 2011, HUM REPROD, V26, P2887, DOI 10.1093/humrep/der250; Jedrychowski W, 2006, ANN EPIDEMIOL, V16, P439, DOI 10.1016/j.annepidem.2005.06.059; Jo Eun Mi, 2010, J Prev Med Public Health, V43, P377, DOI 10.3961/jpmph.2010.43.5.377; Kim BM, 2011, SCI TOTAL ENVIRON, V410, P26, DOI 10.1016/j.scitotenv.2011.08.060; KIM DS, 2011, TOXICOL ENV HEALTH, V3, P254, DOI DOI 10.1007/s13530-011-0099-9; Kim NS, 2010, SCI TOTAL ENVIRON, V408, P4841, DOI 10.1016/j.scitotenv.2010.06.026; Kowalski R, 2009, ECOL CHEM ENG S, V16, P155; MASON HJ, 1994, OCCUP ENVIRON MED, V51, P287, DOI 10.1136/oem.51.4.287-a; Miao LJ, 2013, MODERN FOOD SCI TECH, V29, P687; Morrissette J, 2004, ENVIRON RES, V95, P363, DOI 10.1016/j.envres.2003.12.007; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Nesheim M, 2007, SEAFOOD CHOICES BALA, P67; Ng DKK, 2007, PEDIATR INT, V49, P80, DOI 10.1111/j.1442-200X.2007.02303.x; NRC (National Research Council), 2000, TOX EFF METH, P250; Office of Science and Technology Office of Water US EPA (United States Environmental Protection Agency), 2001, WAT QUAL CRIT PROC H, P18; Oken E, 2004, AM J EPIDEMIOL, V160, P774, DOI 10.1093/aje/kwh282; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; OLSTAD ML, 1987, J DENT RES, V66, P1179, DOI 10.1177/00220345870660061701; Oskarsson A, 1996, ARCH ENVIRON HEALTH, V51, P234, DOI 10.1080/00039896.1996.9936021; Pacyna EG, 2006, ATMOS ENVIRON, V40, P4048, DOI 10.1016/j.atmosenv.2006.03.041; Pesch A, 2002, J EXPO ANAL ENV EPID, V12, P252, DOI 10.1038/sj.jea.7500228; Ramirez GB, 2000, PEDIATRICS, V106, P774, DOI 10.1542/peds.106.4.774; Ramon R, 2008, SCI TOTAL ENVIRON, V392, P69, DOI 10.1016/j.scitotenv.2007.11.025; Ramon R, 2009, AM J CLIN NUTR, V90, P1047, DOI 10.3945/ajcn.2009.27944; Reus IS, 2003, J BIOCHEM MOL TOXIC, V17, P161, DOI 10.1002/jbt.10074; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; RICHARDSON RA, 1976, CLIN CHEM, V22, P1604; Rogers I, 2004, J EPIDEMIOL COMMUN H, V58, P486, DOI 10.1136/jech.2003.013565; Sakamoto M, 2004, ENVIRON SCI TECHNOL, V38, P3860, DOI 10.1021/es034983m; Sakamoto M, 2007, ENVIRON RES, V103, P106, DOI 10.1016/j.envres.2006.03.004; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Stern AH, 2003, ENVIRON HEALTH PERSP, V111, P1465, DOI 10.1289/ehp.6187; Steuerwald U, 2000, J PEDIATR-US, V136, P599, DOI 10.1067/mpd.2000.102774; Unuvar E, 2007, SCI TOTAL ENVIRON, V374, P60, DOI 10.1016/j.scitotenv.2006.11.043; US Department of Health and Human Services US Environmental Protection Agency, 2004, WHAT YOU NEED KNOW M; US EPA (United States Environmental Protection Agency), 1997, CHAR HUM HLTH WILDL, VVII; Vahter M, 2000, ENVIRON RES, V84, P186, DOI 10.1006/enrs.2000.4098; Weil M, 2005, JAMA-J AM MED ASSOC, V293, P1875, DOI 10.1001/jama.293.15.1875; Weiner R, 1996, S AFR MED J, V86, P943; Wilson SJ, 2006, ATMOS ENVIRON, V40, P4621, DOI 10.1016/j.atmosenv.2006.03.042; Wu MQ, 2013, J ENVIRON SCI-CHINA, V25, P386, DOI 10.1016/S1001-0742(12)60061-8; Wu Y, 2006, ENVIRON SCI TECHNOL, V40, P5312, DOI 10.1021/es060406x; Yoshida M, 2002, TOHOKU J EXP MED, V196, P79, DOI 10.1620/tjem.196.79; Zalups RK, 1997, J TOXICOL ENV HEALTH, V50, P173, DOI 10.1080/009841097160564; Zalups RK, 1999, CHEM-BIOL INTERACT, V123, P171, DOI 10.1016/S0009-2797(99)00135-0	72	26	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98121	10.1371/journal.pone.0098121	http://dx.doi.org/10.1371/journal.pone.0098121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858815	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400044
J	Zhao, QH; Zhou, B; Ding, D; Teramukai, S; Guo, QH; Fukushima, M; Hong, Z				Zhao, Qianhua; Zhou, Bin; Ding, Ding; Teramukai, Satoshi; Guo, Qihao; Fukushima, Masanori; Hong, Zhen			Cognitive Decline in Patients with Alzheimer's Disease and Its Related Factors in a Memory Clinic Setting, Shanghai, China	PLOS ONE			English	Article							COMMUNITY POPULATION; OLDER PERSONS; COLOR-WORD; PROGRESSION; DEMENTIA; EDUCATION; PREDICT; AGE; TESTS; MODEL	Objectives: Progressive cognitive decline is a characteristic hallmark of AD. It is important to identify prognostic markers to improve patient care and long-term planning. We aimed to identify the characteristics of disease progression in AD patients, focusing on cognitive decline and its related factors. Methods: Clinically diagnosed AD patients in a memory clinic were followed. The mini-mental state examination (MMSE) and a battery of other neuropsychological tests were performed to assess the rate of cognitive decline and to analyze the related factors. Results: A total of 165 AD patients were analyzed for cognitive changes. The MMSE scores declined at a rate of 1.52 points per year. Most neuropsychological test scores deteriorated significantly over time. Younger and early-onset AD patients deteriorated more rapidly than older and late-onset patients in global cognition and executive function. Men declined faster in memory but slower in attention than women. Higher education was associated with more rapid deterioration in visuo-spatial ability. Family history, hypertension and cerebral vascular disease were also associated with disease progression. Conclusion: Attention, executive and visuo-spatial functions deteriorate at faster rates than other cognitive functions in AD patients. Age and age at onset were the main factors that associated with deterioration.	[Zhao, Qianhua; Guo, Qihao; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Zhou, Bin; Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Zhao, Qianhua; Ding, Ding; Guo, Qihao; Hong, Zhen] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Teramukai, Satoshi] Kyoto Univ Hosp, Translat Res Ctr, Dept Clin Trial Design & Management, Kyoto 606, Japan	Fudan University; Institute for Biomedical Research & Innovation (IBRI); Fudan University; Kyoto University	Zhou, B (corresponding author), Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan.	zhoubin@tri-kobe.org; profzhong@sina.com	Zhou, Bin/AAW-5985-2020; Teramukai, Satoshi/I-2249-2019	Teramukai, Satoshi/0000-0003-2184-0597	Natural Science Foundation of China [81200835]; National 973 Project [2013CB530900, 2013CB530904, 2011ZX09307-00103]; Eisai Co. Ltd.	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China); Eisai Co. Ltd.(Eisai Co Ltd)	The study was supported by Natural Science Foundation of China (81200835), National 973 Project (2013CB530900, 2013CB530904, 2011ZX09307-00103) and Eisai Co. Ltd. Eisai was not involved in the design and conduct of the study or in the data analysis and interpretation of the results.	Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bernick C, 2012, ARCH NEUROL; Bracco L., 1997, ALZ DIS ASSOC DIS, V12, P347; Buccione I, 2007, EUR J NEUROL, V14, P440, DOI 10.1111/j.1468-1331.2007.01693.x; Cao X, 2010, INT J GERIATR PSYCHI; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; DEHOUWER J, 1994, PSYCHOL RES-PSYCH FO, V56, P293, DOI 10.1007/BF00419659; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; Guo Qihao LC, 2001, CHINESE J MENTAL HLT, V15, P13; Hall CB, 2007, NEUROLOGY, V69, P1657, DOI 10.1212/01.wnl.0000278163.82636.30; Helzner EP, 2007, ARCH NEUROL-CHICAGO, V64, P1749, DOI 10.1001/archneur.64.12.1749; Huan Yu QG, 2005, NEUROL DIS MENT HYGE, V5, P89; Junchao Lu QG, 2006, CHIN J CLIN PSYCHOL, V14, P118; Lin C GQ, 2011, CHINESE J BEHAV MED, V20, P11; Fernandez AL, 2009, CLIN NEUROPSYCHOL, V23, P501, DOI 10.1080/13854040802279675; Mangone CA, 2004, REV NEUROLOGIA, V38, P675, DOI 10.33588/rn.3807.2003542; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; Mungas D, 2001, ARCH NEUROL-CHICAGO, V58, P1243, DOI 10.1001/archneur.58.8.1243; Musicco M, 2010, DEMENT GERIATR COGN, V30, P219, DOI 10.1159/000319533; Musicco M, 2009, J NEUROL, V256, P1288, DOI 10.1007/s00415-009-5116-4; Pavlik VN, 2006, DEMENT GERIATR COGN, V22, P367, DOI 10.1159/000095640; Qihao Guo CL, 2000, CHIN J CLIN PSYCHOL, V8, P205; Qihao Guo ZH, 2005, CHIN J NEUROMED, V4, P701; Qihao Guo ZH, 2006, CHIN MENT HLTH J, V20, P81; Regan C, 2006, NEUROLOGY, V67, P1357, DOI 10.1212/01.wnl.0000240129.46080.53; Roselli F, 2009, CLIN NEUROL NEUROSUR, V111, P327, DOI 10.1016/j.clineuro.2008.10.006; Sanz C, 2009, NEUROLOGY, V73, P1359, DOI 10.1212/WNL.0b013e3181bd80e9; Schmidt C, 2011, ARCH NEUROL-CHICAGO, V68, P1124, DOI 10.1001/archneurol.2011.189; Small BJ, 1997, J GERONTOL A-BIOL, V52, pM299, DOI 10.1093/gerona/52A.5.M299; Suh GH, 2004, INT J GERIATR PSYCH, V19, P817, DOI 10.1002/gps.1168; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P126; Wilson RS, 2004, NEUROLOGY, V63, P1198, DOI 10.1212/01.WNL.0000140488.65299.53; Wilson RS, 2003, NEUROLOGY, V61, P812, DOI 10.1212/01.WNL.0000083989.44027.05; [赵倩华 ZHAO Qianhua], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P233; Zhou B, 2010, J ALZHEIMERS DIS, V22, P673, DOI 10.3233/JAD-2010-100318	43	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95755	10.1371/journal.pone.0095755	http://dx.doi.org/10.1371/journal.pone.0095755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24870360	Green Submitted, gold, Green Published			2022-12-27	WOS:000335227400118
